@@95229799480 Cervicovaginal/JJ foetal/NEWGENE fibronectin/NEWGENE in/IN the/DT prediction/NN of/IN preterm/JJ labour/NN in/IN a/DT low-risk/JJ population/NN ./.
@@98823379047 Varicella-zoster/NEWGENE virus/NEWGENE (/NEWGENE VZV/NEWGENE )/NEWGENE glycoprotein/NEWGENE gI/NEWGENE is/VBZ a/DT type/NEWGENE 1/NEWGENE transmembrane/NEWGENE glycoprotein/NEWGENE which/WDT is/VBZ one/PRP component/NN of/IN the/DT heterodimeric/NN gE/NEWGENE :/: gI/NEWGENE Fc/NEWGENE receptor/NEWGENE complex/NN ./.
@@81395429709 A/DT segment/NN of/IN mRNA/NN encoding/VBG the/DT leader/NN peptide/NN of/IN the/DT CPA1/NEWGENE gene/NEWGENE confers/VBZ repression/NN by/IN arginine/NN on/IN a/DT heterologous/JJ yeast/NN gene/NN transcript/NN ./.
@@83032338277 In/NN addition/NN ,/, lexical/JJ priming/NN was/VBD examined/VBN by/IN presenting/VBG an/DT identity/NN prime/RB earlier/JJR in/IN the/DT text/NN ./.
@@40346664700 Lower/JJR extremity/NN weight/NN bearing/JJ under/IN various/JJ standing/JJ conditions/NNS in/IN independently/RB ambulatory/JJ patients/NNS with/IN hemiparesis/NN ./.
@@19306602252 Insulin-like/NEWGENE growth/NEWGENE factor/NEWGENE 1/NEWGENE (/( IGF-1/NEWGENE )/SYM in/IN burn/NN patients/NNS ./.
@@36106634277 This/DT approach/NN enables/VBZ the/DT sources/NNS of/IN error/NN in/IN the/DT calculation/NN of/IN nutrient/JJ utilization/NN to/IN be/VB readily/RB identified/VBN ,/, and/CC their/PRP effect/NN on/IN precision/NN to/IN be/VB assessed/VBN in/IN different/JJ nutritional/JJ and/CC metabolic/JJ states/NNS ./.
@@16485301583 We/PRP identify/VBP the/DT "M/NN region"/NN of/IN the/DT muscle-specific/NEWGENE Xenopus/NEWGENE cardiac/NEWGENE actin/NEWGENE gene/NEWGENE promoter/NEWGENE from/IN -282/CD to/RB -348/CD as/IN necessary/JJ for/IN the/DT embryonic/JJ expression/NN of/IN a/DT cardiac/NEWGENE actin-beta-globin/NEWGENE reporter/NEWGENE gene/NEWGENE injected/VBN into/IN fertilized/JJ eggs/NNS ./.
@@86494253785 We/PRP found/VBP that/IN 120/CD bp/NN of/IN the/DT enhancer's/NNS transcriptional/JJ core/NN becomes/VBZ DNase/NEWGENE I/NEWGENE hypersensitive/JJ early/RB in/IN B-cell/NN development/NN ./.
@@114288973936 Biochemical/NNP experiments/NNS have/VBP shown/VBP that/DT CopG/NEWGENE co-operatively/JJ associates/VBP to/IN its/PRP target/NN DNA/NN at/IN low/JJ protein/NN :/: DNA/NN ratios/NNS ,/, completely/RB protecting/JJ four/CD helical/JJ turns/NNS on/IN the/DT same/JJ face/NN of/IN the/DT double/JJ helix/NN in/IN both/DT directions/NNS from/IN the/DT inverted/JJ repeat/NN that/WDT constitutes/VBZ the/DT CopG/NEWGENE primary/NN target/NN ./.
@@55701755604 3/CD ./CD
@@85316693973 Competition/NN needs/NN to/IN be/VB better/RBR studied/VBN ,/, since/IN in/IN Central/NNP America/NN and/CC Caribean/NN islands/VBZ this/DT kind/NN of/IN study/NN has/VBZ favored/VBN the/DT biological/JJ control/NN of/IN planorbid/JJ species/NN ./.
@@75467947420 Echocardiography/NNS revealed/VBD right/JJ ventricular/JJ diastolic/JJ collapse/NN (/( RVDC/NNP )/SYM without/IN physical/JJ signs/NNS of/IN cardiac/JJ tamponade/NN ./.
@@13393732909 Structure/NNS and/CC expression/NN of/IN a/DT gene/NN from/IN Arabidopsis/NN thaliana/NN encoding/VBG a/DT protein/NN related/VBN to/IN SNF1/NEWGENE protein/NEWGENE1 kinase/NEWGENE1 ./.
@@92686611279 Our/PRP results/NNS indicate/VBP that/IN the/DT retroplasmid/JJ reverse/NEWGENE transcriptase/NEWGENE is/VBZ uniquely/RB adapted/VBN to/IN initiate/NN cDNA/NN synthesis/NN by/IN recognizing/VBG a/DT 3'/CD CCA/NN sequence/NN ./.
@@93937719453 TNF-alpha/NEWGENE exposure/NN markedly/RB increased/VBD activity/NN of/IN several/DT RNA-binding/NN proteins/NN ,/, especially/RB a/DT novel/JJ Mr/NNP 50/NN ,/NN 000-55/NN ,/NN 000/NN RNA-binding/NN protein/NN ./.
@@110312525757 The/DT LMW/NEWGENE FGF-2/NEWGENE up-regulated/IN the/DT PKC/NEWGENE epsilon/NEWGENE levels/NNS by/IN 1/CD ./CD 6-fold/CD ;/: by/IN contrast/NN the/DT HMW/NEWGENE isoform/NEWGENE down-regulated/IN the/DT level/NN of/IN this/DT PKC/NEWGENE isotype/NEWGENE by/IN about/RB 3-fold/CD and/CC increased/VBD the/DT amount/NN of/IN PKC/NEWGENE delta/NEWGENE by/IN 1/CD ./CD 7-fold/CD ./.
@@118978881805 Urine/NNS samples/NNS collected/VBN after/IN the/DT administration/NN of/IN these/DT supplements/NNS can/MD test/NN positive/JJ ./.
@@68825786682 In/NN the/DT ultramarathon/NN runner/NN the/DT testosterone/NN levels/NNS sharply/RB rose/VBD at/IN the/DT beginning/NN of/IN the/DT training/NN session/NN (/( from/IN the/DT 7/NN ,/NN 20/NN ng/NN //NN ml/NN to/IN 11/CD ,/CD 50/CD ng/NN //NN ml/NN after/IN 20'/CD training/NN )/SYM ,/, and/CC subsequently/RB decrease/VB after/IN 3/CD hours/NNS (/( 9/CD ,/CD 20/CD ng/NN //NN ml/NN )/SYM and/CC at/IN the/DT end/NN of/IN the/DT 6/CD hours/NNS training/NN (/( 4/CD ,/CD 60/CD ng/NN //NN ml/NN )/SYM ./.
@@12813221925 A/DT significant/JJ direct/JJ relationship/NN was/VBD observed/VBN between/IN the/DT percent/NN area/NN density/NN of/IN smooth/JJ muscle/NN and/CC the/DT percent/NN change/NN in/IN peak/NN urinary/JJ flow/NN rate/NN ./.
@@46158282294 60th/CD birthday/NN of/IN colonel/NN prof/NN ./. e/NN ./NN cerny/NN m/CD ./CD d/CD ./.
@@296514990 In/NN a/DT previous/JJ study/NN (/( Brandl/NNP ,/, C/NNP ./NNP
@@106080531664 Thrombolysis/NN was/VBD followed/VBN by/IN a/DT similar/JJ increase/NN of/IN platelet/NN activity/NN with/IN maximal/JJ values/NNS reached/VBN at/IN the/DT 3rd/CD hour/NN in/IN both/DT groups/NNS (/( 196/CD +/NN //NN -/NN 43/CD IU/NNS //NNS ml/NNS in/IN Group/NNP 1/CD and/CC 192/CD +/NN //NN -/NN 39/CD in/IN Group/NNP 2/CD :/: p/NN </SYM 001versus/CD baseline/NN and/CC p/NN NS/NN between/IN the/DT groups/NNS )/SYM ./.
@@35534398015 The/DT latter/NN was/VBD determined/VBN as/IN follows/VBZ :/: Type/NN I-solid/NN tumor/NN tissue/NN without/IN significant/JJ peripheral/RB isolated/VBN tumor/NN cells/NNS ;/: Type/NN II-solid/NN tumor/NN tissue/NN associated/VBN with/IN peripheral/RB isolated/VBN tumor/NN cells/NNS ;/: Type/NN III-isolated/JJ tumor/NN cells/NNS only/RB ./.
@@1717925275 Comparison/NNS of/IN the/DT nucleotide/NN sequences/NNS between/IN the/DT human/JJ and/CC bovine/NN DNA/NN showed/VBN that/IN the/DT sequence/NN similarity/NN extended/VBN 2400/CD bp/NN downstream/RB from/IN the/DT coding/JJ region/NN ./.
@@50453515334 Periodic/JJ breathing/NN and/CC apnea/NN in/IN preterm/JJ infants/NNS ./.
@@47942185819 Antivitamin/NN K/NN agents/NNS ./.
@@14837712101 Simultaneously/RB a/DT greater/JJR NA/NN was/VBD found/VBN with/IN no/DT change/NN in/IN plasma/NN epinephrine/NN response/NN ./.
@@92251519177 The/DT behavior/NN of/IN different/JJ types/NNS of/IN polytetrafluoroethylene/NN (/( PTFE/NN )/SYM prostheses/NNS in/IN the/DT reparative/JJ scarring/NN process/NN of/IN abdominal/JJ wall/NN defects/NNS ./.
@@53591305491 IX/NNP ./NNP
@@18377874942 The/DT murine/NEWGENE Mov-34/NEWGENE gene/NEWGENE :/: full-length/JJ cDNA/NN and/CC genomic/JJ organization/NN ./.
@@76996324548 Among/IN the/DT mixed/JJ race/NN persons/NNS one/PRP Chukcha-Eskimo/NN had/VBP AS/NNP ,/, one/PRP Eskimo-Russian/JJ had/VBP psoriatic/JJ arthritis/NN (/( PsA/NN )/SYM ./.
@@93352987825 To/TO examine/VB the/DT basis/NN for/IN the/DT apparent/JJ differences/NNS in/IN postsegregational/JJ killing/NN between/IN the/DT two/JJ E/NNP ./NNP coli/JJ strains/NNS ,/, transformation/NN assays/NNS were/VBD carried/VBN out/RB to/IN determine/VB the/DT relative/JJ sensitivities/NNS of/IN the/DT strains/NNS to/IN the/DT ParE/NEWGENE toxin/NEWGENE protein/NEWGENE ./.
@@93681007690 The/DT mHIF-1/NEWGENE alpha/NEWGENE structural/NEWGENE gene/NEWGENE is/VBZ composed/VBN of/IN 15/CD exons/NNS ./.
@@1296591935 Variability/NNS within/IN Down's/NNP syndrome/NN (/( trisomy-21/NN )/SYM :/: empirically/RB observed/VBN sex/NN differences/NNS in/IN IQs/NNS ./.
@@81921407630 The/DT participants/NNS were/VBD homosexual/JJ men/NNS in/IN hepatitis/NN B/NN vaccine/NN trials/NNS in/IN Amsterdam/NN (/( n/NN =/SYM 74/CD )/SYM ,/, New/NNP York/NNP City/NNP (/( n/NN =/SYM 120/CD )/SYM ,/, and/CC San/NNP Francisco/NN (/( n/NN =/SYM 168/CD )/SYM ./.
@@20650222271 Very/RB small/JJ deletions/NNS within/IN the/DT conserved/VBN region/NN completely/RB abolished/VBD transforming/JJ activity/NN of/IN dbl/NEWGENE ,/, while/CC extensive/JJ deletion/NN outside/RB of/IN this/DT region/NN had/VBP no/DT effect/NN ./.
@@42622684890 Studies/NNS on/IN the/DT organic/JJ matrix/NN of/IN human/JJ ear/NN ossicles/NNS ./.
@@5097035372 These/DT differences/NNS are/VBP smaller/JJR than/IN those/DT described/VBN in/IN standard/JJ textbooks/NNS ./.
@@100905354526 The/DT algorithm/NN also/RB limited/VBD TG/NN to/IN 20/CD and/CC 64%/CD ,/, apoB/NEWGENE to/IN 6/CD and/CC 20%/CD ,/, and/CC Lp/NEWGENE (/NEWGENE a/NEWGENE )/NEWGENE to/IN 15/CD and/CC 56%/CD ,/, of/IN low-/DT and/CC high-risk/JJ groups/NNS ,/, respectively/RB ./.
@@21234669976 Like/IN other/DT members/NNS of/IN this/DT family/NN ,/, the/DT AP-4/NEWGENE HLH/NEWGENE1 motif/NEWGENE1 and/CC the/DT adjacent/JJ basic/JJ domain/NN are/VBP necessary/JJ and/CC sufficient/JJ to/IN confer/VB site-specific/NN DNA/NN binding/JJ ./.
@@26660348492 Following/VBG the/DT patients/NNS during/IN a/DT course/NN of/IN therapy/NN with/IN a/DT selective/JJ vasodilator/NN calcium/NN antagonist/NN ,/, the/DT beta-adrenergic/JJ reflex/NN vasodilation/NN became/VBD substantially/RB attenuated/VBN but/CC was/VBD preserved/VBN during/IN a/DT placebo/NN course/NN of/IN therapy/NN ./.
@@96220554152 Two/CD members/NNS of/IN the/DT Cbl/NEWGENE family/NEWGENE have/NN since/IN been/VBN defined/VBN in/IN mammals/NNS (/( c-Cbl/NEWGENE and/CC Cbl-b/NEWGENE )/SYM ,/, one/PRP in/IN C/NNP ./NNP elegans/NNS (/( Sli-1/NEWGENE )/SYM and/CC one/PRP in/IN Drosophila/NN (/( D-Cbl/NEWGENE )/SYM ./.
@@96655039633 Fourteen/CD healthy/JJ male/JJ volunteers/NNS completed/VBD the/DT study/NN ./.
@@80573566256 Comparisons/NNS of/IN the/DT four/CD operon/NN control/NN regions/NNS studied/VBN indicate/VB that/IN the/DT NarL/NEWGENE heptamers/NEWGENE are/VBP arranged/VBN with/IN diverse/JJ orientations/NNS and/CC spacing/VBG ./.
@@63008366603 Hybridization/NNS of/IN plasmid-transformed/JJ Escherichia/NN coli/JJ RR1/NN colonies/NNS with/IN 32P-labeled/JJ viral/JJ genome/NN RNAs/NNS demonstrated/VBD the/DT presence/NN of/IN DNA/NN clones/NNS representative/NN of/IN each/DT of/IN the/DT 10/CD reovirus/NN RNAs/NNS and/CC 10/CD of/IN the/DT 11/CD constituent/JJ segments/NNS of/IN the/DT rotavirus/NN genome/NN ./.
@@31828021511 Sci/NNS ./.
@@82809255069 The/DT secondary/NN ,/, but/CC not/RB the/DT primary/NN ,/, antibody/NN responses/NNS of/IN male/JJ C57Bl/NNP //NNP 6/NNP mice/NNS were/VBD higher/JJ among/IN mice/NNS housed/VBN alone/RB compared/VBN to/IN mice/NNS housed/VBN in/IN groups/NNS ;/: differences/NNS were/VBD observed/VBN for/IN both/DT IgM/NEWGENE and/CC IgG/NEWGENE anti-KLH/NEWGENE antibodies/NEWGENE ./.
@@104231563473 TaV/NNP particles/NNS have/VBP a/DT buoyant/JJ density/NN of/IN 1/CD ./CD 296/CD g/NN //NN cm3/NN in/IN CsCl/NN and/CC consist/VB of/IN two/JJ capsid/NN proteins/NNS of/IN 56/CD and/CC 6/CD kDa/NN ./.
@@94518579407 Demonstration/NNS of/IN tissue/NN lesions/NNS after/IN intramuscular/JJ injection/NN by/IN determination/NN of/IN creatine/NEWGENE kinase/NEWGENE in/IN blood/NN ./.
@@91712399540 These/DT six/CD amino/JJ acids/NNS are/VBP part/NN of/IN an/DT amphipathic/JJ helix/NN that/WDT is/VBZ highly/RB conserved/VBN among/IN nuclear/NEWGENE hormone/NEWGENE receptors/NEWGENE and/CC contains/VBZ the/DT core/NN domain/NN of/IN the/DT ligand-dependent/JJ transactivation/NN function/NN ,/, AF-2/NEWGENE ./.
@@90280898991 Therefore/RB ,/, it/PRP is/VBZ important/JJ to/IN control/NN hypertension/NN and/CC keep/VB appropriate/JJ renal/JJ blood/NN flow/NN during/IN living/JJ renal/JJ transplantation/NN surgery/NN ./.
@@92902072411 Neither/CC mutant/RB exhibited/VBN derepression/NN of/IN the/DT silent/NEWGENE mating/NEWGENE type/NEWGENE loci/NEWGENE ./.
@@85467073717 Transcriptional/JJ activation/NN of/IN the/DT chicken/NEWGENE lysozyme/NEWGENE gene/NEWGENE by/IN NF-kappa/NEWGENE Bp65/NEWGENE (/( RelA/NEWGENE )/SYM and/CC c-Rel/NEWGENE ,/, but/CC not/RB by/IN NF-kappa/NEWGENE Bp50/NEWGENE ./.
@@8479678446 Current/JJ diagnostic/JJ uses/NNS of/IN computerized/JJ tomography/NN in/IN clinical/JJ medicine/NN ./.
@@1013005232 59/CD cases/NNS of/IN surgically/RB resectable/JJ cancers/NNS (/( T1/NN ,/, T2/NN ,/, T3/NN ,/, N0/NN ,/, N1/NN )/SYM had/VBP a/DT minimum/JJ followup/NN of/IN two/JJ years/NNS (/( average/JJ 4/CD years/NNS +/NN //NN -/NN 3/CD months/NNS )/SYM ./.
@@44950344994 Re-examining/VBG methylbenzene/NN (/( toluene/NN )/SYM as/IN a/DT treatment/NN for/IN Ancylostomum/NNP caninum/NN ./.
@@34659574164 Mean/VB fluorosis/NN scores/NNS ,/, however/RB ,/, were/VBD similar/JJ ./.
@@66720946434 The/DT subgroup/NN innervating/VBG the/DT medial/JJ rectus/NN lies/NNS exclusively/RB along/IN the/DT medial/JJ face/NN of/IN the/DT oculomotor/JJ nucleus/NN ,/, with/IN no/DT aberrant/JJ neurons/NNS in/IN the/DT medial/JJ longitudinal/JJ fasciculus/NN ,/, as/IN have/NN been/VBN found/VB in/IN other/DT mammals/NNS ./.
@@256282577 Responsiveness/NNS to/IN beta-2/NN agonist/NN therapy/NN was/VBD retained/VBN with/IN both/DT agents/NNS (/( p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@97510612083 POU-domain/NEWGENE proteins/NEWGENE ,/, such/JJ as/IN the/DT pituitary-specific/NEWGENE factor/NEWGENE Pit-1/NEWGENE ,/, are/VBP members/NNS of/IN the/DT homeodomain/NEWGENE family/NEWGENE of/IN proteins/NNS which/WDT are/VBP important/JJ in/IN development/NN and/CC homeostasis/NN ,/, acting/JJ constitutively/RB or/CC in/IN response/NN to/IN signal-transduction/JJ pathways/NNS to/IN either/DT repress/VB or/CC activate/VB the/DT expression/NN of/IN specific/JJ genes/NNS ./.
@@20832534005 The/DT TCF-1/NEWGENE alpha/NEWGENE binding/NEWGENE site/NEWGENE was/VBD also/RB required/VBN for/IN TCR/NEWGENE alpha/NEWGENE enhancer/NEWGENE activity/NN in/IN transcriptionally/RB active/JJ extracts/NNS from/IN Jurkat/NN but/CC not/RB HeLa/IN cells/NNS ,/, confirming/VBG that/IN TCF-1/NEWGENE alpha/NEWGENE is/VBZ a/DT T-cell-specific/NEWGENE transcription/NEWGENE factor/NEWGENE ./.
@@78621684043 The/DT interleukin/NEWGENE 2/NEWGENE receptor/NEWGENE alpha-chain/NEWGENE (/( IL-2R/NEWGENE alpha/NEWGENE )/SYM gene/NN is/VBZ rapidly/RB and/CC potently/RB induced/VBN in/IN T/NN cells/NNS in/IN response/NN to/IN mitogenic/JJ stimuli/NNS ./.
@@1498992114 Prediction/NNS of/IN the/DT times/NNS of/IN sandfly/NN development/NN ./.
@@569019721 A/DT mixture/NN of/IN human/NEWGENE albumin/NEWGENE 5%/NN and/CC hydroxy-ethyl-starch/NN was/VBD used/VBN as/IN a/DT solution/NN for/IN dilution/NN ./.
@@16797492387 The/DT localization/NN of/IN this/DT proteoglycan/NEWGENE locus/NEWGENE in/IN the/DT human/JJ genome/NN and/CC the/DT availability/NN of/IN new/JJ RFLPs/NNS provide/VBP the/DT tools/NNS for/IN future/JJ studies/NNS of/IN human/JJ diseases/NNS where/CC the/DT HSPG2/NEWGENE proteoglycan/NEWGENE gene/NEWGENE is/VBZ suspected/VBN to/IN be/VB involved/VBN ./.
@@105710474169 Several/JJ 7SL/NEWGENE RNA-encoding/NEWGENE sequences/NEWGENE and/CC various/JJ intergenic/JJ spacers/NNS were/VBD amplified/VBN from/IN the/DT individual/JJ HindIII/NEWGENE fragments/NEWGENE of/IN about/RB 1/CD ./CD 3/CD and/CC 2/CD ./CD 8/CD kb/CD ./CD
@@97120378481 Tctex-1/NEWGENE binding/JJ required/VBN the/DT first/JJ 19/CD amino/JJ acids/NNS of/IN Fyn/NEWGENE and/CC integrity/NN of/IN two/JJ lysine/NN residues/NNS within/IN this/DT sequence/NN that/WDT were/VBD previously/RB shown/VBP to/IN be/VB important/JJ for/IN Fyn/NEWGENE interactions/NNS with/IN the/DT immunoreceptor/NEWGENE tyrosine-based/NEWGENE activation/NEWGENE motifs/NEWGENE (/( ITAMs/NEWGENE )/SYM of/IN lymphocyte/NEWGENE Ag/NEWGENE receptors/NEWGENE ./.
@@58590165777 Hydroxypropyl/NNP methacrylate/NN ,/, a/DT new/JJ water-miscible/JJ embedding/NN medium/NN for/IN electron/NN microscopy/NN ./.
@@10215485157 Significant/JJ correlations/NNS between/IN mental/JJ status/NN as/IN measured/VBN by/IN the/DT Mini-Mental/NNP State/NNP Examination/NN and/CC NA/NNP //NNP mI/NNP ,/, mI/NN //NN Cr/NN and/CC NA/NN were/VBD found/VBN ./.
@@118652181755 Treatment/NNP for/IN this/DT condition/NN often/RB involves/VBZ use/NN of/IN a/DT wax/NN softening/NN or/CC dispersing/JJ agent/NN (/( cerumenolytic/JJ )/SYM before/IN syringing/VBG ./.
@@78755957873 Like/IN humans/NNS ,/, the/DT PITSLRE/NEWGENE PK/NEWGENE genes/NEWGENE in/NEWGENE chickens/NEWGENE must/MD be/VB closely/RB linked/JJ ,/, based/VBN on/IN fluorescent/JJ in/IN situ/NN hybridization/NN (/( FISH/ORG )/SYM localization/NN of/IN these/DT genes/NNS to/IN a/DT single/JJ chicken/NN microchromosome/NN ./.
@@80373386468 PURPOSE/NNS :/: To/TO evaluate/VB the/DT kinetics/NN of/IN erythropoietin/NEWGENE (/( EPO/NEWGENE )/SYM production/NN and/CC address/VB the/DT pathogenesis/NN of/IN anemia/NN of/IN prematurity/NN ,/, we/PRP measured/VBD EPO/NEWGENE levels/NNS in/IN infants/NNS during/IN the/DT first/JJ year/NN of/IN life/NN ./.
@@85366947477 Protein/NEWGENE kinases/NEWGENE play/VBP pivotal/JJ roles/NNS in/IN the/DT control/NN of/IN many/JJ cellular/JJ processes/NNS ./.
@@97105997134 In/NN the/DT former/JJ cells/NNS ,/, ets-2/NEWGENE was/VBD a/DT CSF-1/NEWGENE immediate-early/NEWGENE1 response/NEWGENE1 gene/NEWGENE1 ,/, and/CC phosphorylated/VBN ets-2/NEWGENE was/VBD detected/VBN after/IN 2/CD to/IN 4/CD h/NN ,/, coincident/JJ with/IN expression/NN of/IN ets-2/NEWGENE protein/NEWGENE ./.
@@97353717382 In/NN particular/JJ ,/, unc-86/NEWGENE encodes/VBZ a/DT POU-type/NEWGENE homeodomain/NEWGENE protein/NEWGENE needed/VBN for/IN the/DT production/NN of/IN the/DT touch/NN cells/NNS ,/, while/CC mec-3/NEWGENE encodes/VBZ a/DT LIM-type/NEWGENE homeodomain/NEWGENE protein/NEWGENE needed/VBN for/IN the/DT differentiation/NN of/IN the/DT touch/NN cells/NNS ./.
@@18759224532 Mutation/NN analysis/NN implicated/VBN multiple/JJ segments/NNS of/IN the/DT 5'/CD untranslated/JJ region/NN as/IN contributing/JJ to/IN the/DT inhibitory/JJ effect/NN ./.
@@44458744972 Pathology/NNP of/IN neuritis/NN caudae/NNS equinae/NNS in/IN the/DT horse/NN ./.
@@36873134353 Two/CD new/JJ glucosidase/NEWGENE inhibitors/NN (/( BAY/NN m/NN 1099/CD and/CC BAY/NN o/NN 1248/CD )/SYM were/VBD studied/VBN in/IN volunteers/NNS and/CC type/NN II/NNP diabetics/NNS under/IN various/JJ conditions/NNS ./.
@@78363903740 The/DT characteristics/NNS of/IN the/DT VirD1/JJ //JJ VirD2-mediated/JJ cleavage/NN reaction/NN strongly/RB resemble/VB those/DT observed/VBN with/IN relaxosomes/NNS of/IN IncP/NN plasmids/NNS involved/VBN in/IN initiation/NN of/IN transfer/NN DNA/NN replication/NN during/IN bacterial/JJ conjugation/NN ./.
@@13212805494 To/TO define/VB the/DT number/NN and/CC nature/NN of/IN the/DT E6/NEWGENE and/CC E7/NEWGENE gene/NEWGENE products/NN expressed/VBN in/IN BPV-1-transformed/JJ cells/NNS ,/, we/PRP performed/VBD immunoprecipitation/NN experiments/NNS with/IN antisera/NNS raised/VBN to/IN bacterially/RB expressed/VBN BPV-1/NEWGENE E6/NEWGENE and/CC E7/NEWGENE fusion/NEWGENE proteins/NEWGENE ./.
@@93252737985 These/DT results/NNS suggest/VBP that/IN UBP41/NEWGENE may/MD play/VB an/DT important/JJ role/NN in/IN the/DT recycling/NN of/IN ubiquitin/NEWGENE by/IN hydrolysis/NN of/IN branched/NEWGENE poly-ubiquitin/NEWGENE chains/NEWGENE generated/VBN by/IN the/DT action/NN of/IN 26/NEWGENE S/NEWGENE proteasome/NEWGENE on/IN poly-ubiquitinated/JJ protein/NN substrates/NNS ,/, as/RB well/VB as/IN in/IN the/DT production/NN of/IN free/JJ ubiquitin/NEWGENE from/IN linear/NEWGENE poly-ubiquitin/NEWGENE chains/NEWGENE and/CC of/IN certain/JJ ribosomal/JJ proteins/NNS from/IN ubiquitin/NEWGENE fusion/NEWGENE proteins/NEWGENE ./.
@@74950592869 Results/NNS of/IN the/DT ECAT/NN Angina/NNP Pectoris/NN Study/NNP Group/NNP ./.
@@78239195453 Conversely/RB ,/, activation/NN of/IN Oct-3/NEWGENE //NEWGENE 4/NEWGENE promoter/NEWGENE by/IN RAR/NEWGENE :/: RXR/NEWGENE heterodimers/NEWGENE was/VBD completely/RB abolished/VBN by/IN EAR-3/NEWGENE //NEWGENE COUP-TFI/NEWGENE and/CC by/IN ARP-1/NEWGENE //NEWGENE COUP-TFII/NEWGENE ./.
@@61363745952 At/NN both/DT water/JJ temperatures/NNS ,/, VO2/NN increased/VBN linearly/RB with/IN increasing/JJ swimming/JJ velocity/NN ./.
@@80067727999 To/TO see/VB if/IN a/DT pulse/NN oximeter/NN can/MD monitor/VB the/DT fetus/NN during/IN labour/NN we/PRP recruited/VBD 100/CD Caucasian/JJ women/NNS in/IN normal/JJ uncomplicated/JJ labour/NN ./.
@@7499242625 In/NN adult/JJ tissues/NNS ,/, it/PRP was/VBD less/PRP restricted/VBN ,/, indicating/VBG that/IN RAFTK/NEWGENE expression/NN is/VBZ developmentally/RB up-regulated/DT ./.
@@94276273340 A/DT cytosolic/JJ variant/NN of/IN the/DT protein/NN underwent/VBD efficient/JJ transphosphorylation/NN ,/, yet/RB failed/VBN to/IN activate/VB appreciably/RB either/DT p70/NEWGENE (/NEWGENE S6k/NEWGENE )/NEWGENE or/CC MAP/NEWGENE kinase/NEWGENE following/IN treatment/NN with/IN FK1012/NN ./.
@@9267519224 Recent/JJ studies/NNS have/VBP shown/VBP the/DT rat/NN larynx/NN to/IN be/VB an/DT important/JJ organ/NN in/IN the/DT evaluation/NN of/IN irritancy/NN of/IN inhaled/JJ materials/NNS ./.
@@93598872278 Taken/VBN together/RB ,/, our/PRP data/NN suggest/VB that/IN Rat7p/NEWGENE //NEWGENE Nup159p/NEWGENE is/VBZ anchored/VBN within/IN the/DT NPC/NEWGENE through/RB its/PRP coiled-coil/NN region/NN and/CC adjacent/JJ sequences/NNS ./.
@@13161255919 The/DT experiment/NN results/NNS showed/VBD :/: (/( i/NN )/SYM not/RB only/RB 1O2/CD ,/, but/CC also/RB free/JJ radicals/NNS (/( O2-/NN ./. ./NN OH/NN and/CC YHPD-/NN ./NN )/SYM can/MD be/VB formed/VBN by/IN the/DT aid/NN of/IN YHPD/NNP ;/: and/CC (/( ii/NN )/SYM as/IN to/IN the/DT ability/NN of/IN producing/JJ 1O2/NN ,/, YHPD/NN less/PRP than/IN BHPD/NNP ,/, while/CC for/IN generating/JJ O2-/NN ./. and/CC ./NN OH/NN ,/, YHPD/NN greater/JJR than/IN BHPD/NNP ./.
@@67944802455 There/EX is/VBZ now/RB a/DT significative/JJ difference/NN between/IN age/NN group/NN 1-5/CD and/CC the/DT others/NNS (/( p/NN Less/RBR Than/IN 0/NN ,/NN 02/NN )/SYM ./.
@@47041375102 Role/NN of/IN histoclinical/JJ studies/NNS in/IN the/DT prophylaxis/NN of/IN spontaneous/JJ abortions/NNS ./.
@@91221762786 Our/PRP results/NNS indicate/VBP that/IN RA-mediated/JJ repression/NN of/IN the/DT hMGP/NEWGENE gene/NEWGENE is/VBZ due/NN to/IN binding/NN of/IN liganded/JJ RAR/NEWGENE //NEWGENE RXR/NEWGENE to/IN a/DT novel/JJ negative/JJ RA/NEWGENE response/NEWGENE element/NEWGENE ./.
@@115740883047 The/DT mean/JJ waiting/JJ time/NN to/IN receive/VB the/DT pancreas/NN transplant/NN was/VBD 244/CD days/NNS for/IN SPK/NN and/CC 167/CD days/NNS for/IN PAK/NN recipients/NNS (/( P/NN =/SYM 0/CD ./CD 001/CD )/SYM ./.
@@86217304413 An/DT AP-1/NEWGENE binding/NEWGENE sequence/NEWGENE is/VBZ essential/JJ for/IN regulation/NN of/IN the/DT human/NEWGENE alpha2/NEWGENE (/NEWGENE I/NEWGENE )/NEWGENE collagen/NEWGENE (/( COL1A2/NEWGENE )/SYM promoter/NN activity/NN by/IN transforming/NEWGENE growth/NEWGENE factor-beta/NEWGENE ./.
@@106225746411 The/DT prevalence/NN of/IN hepatitis/NN C/NN virus/NN (/( HCV/NN )/SYM infection/NN is/VBZ relatively/JJ low/NN in/IN childhood/NN ,/, with/IN anti-HCV/NN prevalence/NN rates/NNS of/IN 0/CD ./CD 1-0/CD ./CD 4%/CD in/IN the/DT Western/JJ world/NN ./.
@@2457922385 Hybridization/NNS of/IN a/DT probe/NN from/IN this/DT region/NN to/IN electrophoretic/JJ blots/NNS of/IN RNAs/NNS from/IN different/JJ human/JJ tissues/NNS showed/VBD a/DT predominant/JJ 2/CD ./CD 8-kilobase/CD (/( kb/NN )/SYM message/NN accompanied/VBN by/IN weaker/JJR bands/NNS 4/CD ./CD 1/CD and/CC 2/CD ./CD 1/CD kb/NN in/IN size/NN ./.
@@21744273256 Both/DT strains/NNS grew/VBD very/RB poorly/RB ,/, or/CC not/RB at/IN all/DT ,/, on/IN nonfermentable/JJ carbon/NN sources/NNS and/CC exhibited/VBN ,/, at/IN most/RB ,/, only/JJ 5%/NN of/IN wild-type/NEWGENE ubiquinol-cytochrome/NEWGENE c/NEWGENE oxidoreductase/NEWGENE activity/NN ./.
@@10962738783 Consciousness/NN is/VBZ connected/VBN with/IN attention/NN ,/, working/JJ memory/NN and/CC perception/NN ./.
@@114333793268 SIT/NEWGENE (/( SHP2-interacting/NEWGENE transmembrane/NEWGENE adaptor/NEWGENE protein/NEWGENE )/SYM is/VBZ a/DT recently/RB identified/VBN transmembrane/NN adaptor/NN protein/NN ,/, which/WDT is/VBZ expressed/VBN in/IN lymphocytes/NNS ./.
@@85414994433 Certain/JJ transcript/NN patterns/NNS in/IN Epifagus/NNP plastids/NNS are/VBP highly/RB complex/VBP and/CC similar/JJ to/IN those/DT of/IN tobacco/NN operons/NNS ./.
@@3280946127 The/DT putative/JJ immunity/NN protein/NN was/VBD detected/VBN among/IN the/DT [/NN 35S/NN ]/NN methionine-labelled/NN proteins/NNS produced/VBN by/IN minicells/NNS carrying/VBG cni/NEWGENE cloned/VBN under/IN lac/NEWGENE promoter/NEWGENE control/NN ,/, and/CC when/CC the/DT gene/NN was/VBD subcloned/JJ into/IN expression/NN vectors/NNS under/IN the/DT control/NN of/IN a/DT bacteriophage/NN T7/NN promoter/NN ./.
@@86436464151 This/DT region/NN includes/VBZ verA/NEWGENE ,/, a/DT structural/JJ gene/NN previously/RB shown/VBP to/IN be/VB required/VBN for/IN ST/NEWGENE biosynthesis/NN ,/, and/CC 24/CD additional/JJ closely/RB spaced/VBN transcripts/NNS ranging/VBG in/IN size/NN from/IN 0/CD ./CD 6/CD to/IN 7/CD ./CD 2/CD kb/NN that/WDT are/VBP coordinately/RB induced/VBN only/RB under/IN ST-producing/JJ conditions/NNS ./.
@@25004322877 In/NN transformed/VBN E/NNP ./NNP coli/JJ ,/, constitutive/NEWGENE CAT/NEWGENE expression/NN is/VBZ maintained/VBN when/CC as/RB little/JJ as/IN 0/CD ./CD 3/CD kilobase/NN of/IN DNA/NN from/IN the/DT 3'/CD end/NN of/IN the/DT 1/NN ./NN 6-kilobase/NN segment/NN is/VBZ inserted/VBN in/IN the/DT correct/JJ orientation/NN in/IN front/NN of/IN the/DT CAT/NEWGENE gene/NEWGENE ./.
@@30025016535 Comparison/NNS of/IN sequences/NNS of/IN ovine/JJ and/CC bovine/JJ ,/, rat/NN and/CC guinea-pig/NEWGENE alpha/NEWGENE s1-casein/NEWGENE mRNAs/NEWGENE has/VBZ revealed/VBN a/DT greater/JJR homology/NN in/IN the/DT 3'/CD and/CC especially/RB 5'/CD non/FW coding/JJ regions/NNS ./.
@@72982096170 The/DT determination/NN of/IN physical/JJ performance/NN capacity/NN was/VBD based/VBN on/IN W170/NNS ,/, W85%/NNP and/CC on/IN predicted/VBN VO2/NN max/JJ measured/VBN with/IN continuously/RB increasing/JJ work/NN load/NN on/IN a/DT bicycle/NN ergometer/NN ./.
@@75017007099 The/DT effects/NNS of/IN a/DT 1-/CD or/CC 24-hour/CD pretreatment/JJ regimen/NN with/IN monophosphoryl/NN lipid/NN A/NN (/( MLA/NN ,/, 35/CD micrograms/NN //NN kg/NN i/CD ./CD v/CD ./CD )/SYM on/IN myocardial/JJ stunning/JJ produced/VBN by/IN repetitive/JJ coronary/JJ occlusions/NNS were/VBD studied/VBN in/IN barbital-anesthetized/JJ dogs/NNS ./.
@@33751844064 The/DT spermicide/NN nonoxynol-9/NN is/VBZ a/DT member/NN of/IN a/DT homologous/JJ series/NN of/IN alkylphenol-ethoxylates/VBZ (/( polyethoxyethanols/NNS )/SYM of/IN general/JJ formula/NN C9H19-C6H6-O-/NN (/NN CH2CH2O/NN )/NN n-1/NN CH2CH2OH/NNP ./.
@@1111749625 According/VBG to/IN their/PRP functional/JJ properties/NNS the/DT latter/JJ neurons/NNS were/VBD subdivided/VBN into/IN :/: (/( a/DT )/SYM neurons/NNS responding/VBG to/IN stimuli/NNS near/IN the/DT eyes/NNS ;/: (/( b/NN )/SYM neurons/NNS triggered/VBN by/IN complex/NN visual/NN stimuli/NNS ;/: (/( c/NN )/SYM neurons/NNS inhibited/VBN by/IN visual/JJ stimuli/NNS ./.
@@82904215272 To/TO our/PRP knowledge/NN ,/, type/NN IV/NN renal/JJ tubular/JJ acidosis/NN has/VBZ not/RB been/VBN reported/VBN previously/RB in/IN association/NN with/IN Alport's/NNP syndrome/NN in/IN an/DT adult/JJ patient/NN ./.
@@97774773063 Observers/NNS with/IN brain/NN injury/NN and/CC control/NN participants/NNS performed/VBD a/DT vigilance/NN task/NN during/IN which/WDT they/PRP received/VBD periodic/JJ whiffs/NNS of/IN unscented/JJ air/NN or/CC air/NN scented/VBN with/IN peppermint/NN ./.
@@78726736837 To/TO explore/VB the/DT functional/JJ relationship/NN between/IN c-fos/NEWGENE and/CC Rb/NEWGENE ,/, a/DT eukaryotic/JJ expression/NN plasmid/NN was/VBD constructed/VBN containing/JJ the/DT c-fos/NEWGENE gene/NEWGENE under/IN control/NN of/IN the/DT SV40/NN promoter/NN complex/NN ./.
@@9704883552 The/DT neuroleptic-induced/JJ increase/NN in/IN central/NN DA/NN turnover/NN (/( an/DT indicator/NN for/IN the/DT degree/NN of/IN DA/NEWGENE receptor/NEWGENE blocking/JJ )/SYM was/VBD found/VBN to/IN be/VB positively/RB correlated/VBN with/IN the/DT therapeutic/JJ effect/NN of/IN neuroleptics/NNS and/CC the/DT development/NN of/IN hypokinetic-rigid/JJ symptoms/NNS ./.
@@111313212485 Effects/NNPS of/IN Trypanosoma/NN vivax/NN on/IN pregnancy/NN of/IN Yankasa/NNP sheep/NN and/CC the/DT results/NNS of/IN homidum/NN chloride/NN chemotherapy/NN ./.
@@10906317732 The/DT two/JJ main/JJ experimental/JJ variables/NNS were/VBD the/DT attended/VBN hemifield/NN (/( left/NN or/CC right/JJ )/SYM and/CC the/DT proportion/NN of/IN trials/NNS requiring/JJ a/DT shift/NN within/IN that/DT hemifield/NN (/( 20%/CD or/CC 80%/CD )/SYM ./.
@@86549461347 155/CD aa/NNS ,/, shares/VBP 78%/JJ identity/NN with/IN the/DT analogous/JJ region/NN of/IN Xenopus/NN laevis/NN FGF3/NEWGENE and/CC 72%/JJ identity/NN with/IN the/DT product/NN of/IN the/DT more/RB distantly/RB related/VBN human/JJ gene/NN ./.
@@17403307005 J/NNP ./NNP
@@106886639886 Removal/NNP of/IN all/DT core/NEWGENE histone/NEWGENE tail/NN domains/NNS by/IN limited/JJ trypsin/NEWGENE proteolysis/NN or/CC acetylation/NN of/IN the/DT core/NEWGENE histone/NEWGENE tails/NNS significantly/RB relieves/VBZ this/DT inhibition/NN and/CC allows/VBZ TFIIIA/NEWGENE to/IN exhibit/NN high-affinity/JJ binding/NN to/IN nucleosomal/JJ DNA/NN ./.
@@98636248472 Agonist-induced/NEWGENE receptor/NEWGENE internalization/NN ,/, determined/VBN as/IN the/DT percent/NN of/IN total/JJ [/NN 125I/NN ]/NN Tyr0-oCRF/NEWGENE bound/RB located/VBN in/IN the/DT acid-resistant/JJ fraction/NN of/IN transfected/VBN Cos/NNS 7/CD cells/NNS ,/, increased/VBN with/IN time/NN (/( 0-60/JJ min/NN at/IN 37/CD degrees/NNS C/NN )/SYM for/IN both/DT wild-type/NN and/CC variant/NN oCRF1/NEWGENE ./.
@@29133686574 Pharmacology/NNS studies/NNS with/IN potassium/NN chloride/NN and/CC acetylcholine/NN suggest/VB that/IN raveron/NN acts/NNS as/IN a/DT calcium/NN antagonist/NN by/IN blocking/JJ the/DT influx/NN of/IN extracellular/JJ calcium/NN ./.
@@79837164710 Surprisingly/RB ,/, Northern/NNP (/( RNA/NN )/SYM blot/NN analysis/NN and/CC reverse/JJ transcriptase-PCRs/NNS performed/VBN after/IN transfection/NN of/IN COS-7/NNP or/CC HeLa/IN cells/NNS with/IN these/DT viral/JJ RNAs/NNS revealed/VBN that/IN Y88S/NEWGENE and/CC Y88L/NEWGENE RNAs/NEWGENE replicated/VBN at/IN only/RB very/RB low/JJ levels/NNS ./.
@@15449285935 Comparison/NNS of/IN the/DT genomic/JJ DNA/NN sequence/NN with/IN that/DT of/IN the/DT four/CD different/JJ mRNAs/NNS indicates/VBZ that/IN these/DT transcripts/NNS are/VBP produced/VBN by/IN alternative/JJ splicing/JJ of/IN the/DT murine/NN pre-mRNA/NN according/VBG to/IN a/DT cassette/NN model/NN ./.
@@104480952959 The/DT STAT/NEWGENE protein/NEWGENE accumulation/NN resulting/JJ from/IN C/NEWGENE //NEWGENE EBP/NEWGENE expression/NN was/VBD tightly/RB coupled/VBN to/IN the/DT morphological/JJ conversion/NN of/IN fibroblasts/NNS to/IN adipocytes/NNS and/CC represents/VBZ an/DT expression/NN profile/NN identical/JJ to/IN that/DT reported/VBD for/IN mature/JJ adipocytes/NNS in/IN vivo/NN ./.
@@10805390617 To/TO illustrate/VB its/PRP performance/NN ,/, measurements/NNS of/IN photoluminescence/NN in/IN GaAs/NNS //NNS AlGaAs/NNS heterostructures/NNS are/VBP presented/VBN ./.
@@76858235279 RNA/NEWGENE polymerase/NEWGENE bound/JJ to/IN the/DT +10A/NEWGENE promoter/NEWGENE partially/RB protects/VBZ a/DT 20/CD base-pair/NN sequence/NN from/IN DNase/NEWGENE I/NEWGENE digestion/NN upstream/RB of/IN the/DT start/NN site/NN ./.
@@84300875647 Further/RB ,/, the/DT ability/NN of/IN recombinant/NEWGENE beta/NEWGENE and/NEWGENE //NEWGENE or/NEWGENE gamma/NEWGENE chains/NEWGENE to/IN function/NN in/IN defined/VBN biochemical/JJ assays/NNS of/IN beta/NEWGENE gamma/NEWGENE activity/NN was/VBD assessed/VBN for/IN membrane/NN extracts/NNS and/CC supernatant/JJ fractions/NNS from/IN infected/VBN Sf9/CD cells/NNS ./.
@@98823033696 TRAF2/NEWGENE is/NNS known/VBP to/IN associate/NN with/IN TRADD/NEWGENE ,/, and/CC expression/NN of/IN a/DT dominant-negative/JJ N-terminal/NN deletion/NN TRAF2/NEWGENE mutant/NEWGENE was/VBD found/VBN to/IN partially/RB inhibit/VB LMP1-induced/NN JNK/NEWGENE activation/NN in/IN 293/CD cells/NNS ./.
@@2165589873 A/DT portion/NN of/IN Region/NN II/NN also/RB resembles/VBZ part/NN of/IN the/DT human/NN c-jun/NEWGENE oncoprotein's/NN leucine/NN zipper/NN ,/, which/WDT in/IN turn/NN ,/, has/VBZ been/VBN demonstrated/VBN to/IN be/VB the/DT heterodimerization/NN site/NN between/IN the/DT jun/NEWGENE and/CC fos/NEWGENE oncoproteins/NEWGENE ./.
@@27753334604 Buflomedil/NN (/( i/CD ./CD v/CD ./CD )/SYM induced/VBN a/DT dose-dependent/NN increase/NN of/IN cardiac/JJ output/NN at/IN 0/CD ./CD 16-0/CD ./CD 64/CD mg/CD //CD kg/CD ,/, biphasic/JJ changes/NNS at/IN 1/CD ./CD 28/CD and/CC 2/CD ./CD 56/CD mg/CD //CD kg/CD and/CC a/DT marked/JJ decrease/NN and/CC subsequent/JJ slight/JJ increase/NN at/IN a/DT large/JJ dose/NN of/IN 5/CD ./CD 12/CD mg/CD //CD kg/CD ./.
@@63493646150 These/DT results/NNS indicate/VBP that/IN both/DT naturally/RB acquired/VBN and/CC passive/JJ (/( modified/JJ immune/NN serum/NN globulin/NN )/SYM antibodies/NNS to/IN type/NEWGENE III/NEWGENE group/NEWGENE B/NEWGENE Streptococcus/NEWGENE antigen/NEWGENE are/VBP partially/RB protective/JJ against/IN intra-amniotic/JJ infection/NN ./.
@@40797384763 The/DT rates/NNS of/IN total/JJ energy/NN use/NN (/( mean/JJ +/NN //NN -/NN SD/NN =/SYM 39/CD ./CD 3/CD +/NN //NN -/NN 1/CD ./CD 2/CD vs/NNP 35/CD ./CD 7/CD +/NN //NN -/NN 1/CD ./CD 3/CD kJ/NN X/NN min-1/NN ;/: P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM were/VBD significantly/RB higher/JJ at/IN -10/CD degrees/NNS C/NN than/IN at/IN 22/CD degrees/NNS C/NNP ./NNP
@@82469876615 In/NN addition/NN to/IN the/DT protein-tyrosine/NEWGENE kinase/NEWGENE domain/NEWGENE ,/, p56lck/NEWGENE possesses/VBZ Src/NEWGENE homology/NEWGENE 2/NEWGENE and/NEWGENE 3/NEWGENE (/( SH2/NEWGENE and/CC SH3/NEWGENE )/SYM domains/NNS as/RB well/VBP as/IN a/DT unique/JJ N-terminal/NN region/NN ./.
@@96680966926 Each/DT binding/JJ site/NN ,/, however/RB ,/, was/VBD different/JJ in/IN its/PRP preference/NN for/IN binding/JJ partners/NNS ./.
@@106304711692 An/DT ASIC-chip/NN for/IN stereoscopic/JJ depth/NN analysis/NN in/IN video-real-time/NN based/VBN on/IN visual/JJ cortical/JJ cell/NN behavior/NN ./.
@@10963577789 Picture/NNP the/DT smell/NN ./.
@@90069024696 We/PRP have/VBP isolated/VBN a/DT cDNA/NN encoding/VBG human/NEWGENE MEKK3/NEWGENE ./.
@@89551595257 Human/NEWGENE acid/NEWGENE ceramidase/NEWGENE (/NEWGENE (/NEWGENE AC/NEWGENE )/NEWGENE N-acylsphingosine/NEWGENE amidohydrolase/NEWGENE ,/, EC/NEWGENE 3/NEWGENE ./NEWGENE 5/NEWGENE ./.
@@11278583771 Mutagenesis/NNS of/IN SNT1/NEWGENE (/NEWGENE IRS/NEWGENE )/NEWGENE CX/NEWGENE identified/VBD three/CD classes/NNS of/IN effector/NN motifs/NNS within/IN SNT/NEWGENE critical/JJ for/IN both/DT sustained/JJ ERK/NEWGENE activation/NN and/CC neuronal/JJ differentiation/NN :/: 1/NN )/NN four/CD phosphotyrosine/NN motifs/NN that/WDT mediate/VBP recruitment/NN of/IN Grb2/NEWGENE ,/, 2/NN )/NN two/JJ phosphotyrosine/NN motifs/NN that/WDT mediate/VBP recruitment/NN of/IN Shp2/NEWGENE ,/, and/CC 3/NN )/NN a/DT C-terminal/NN motif/NN that/IN functions/NNS by/IN helping/JJ to/IN recruit/NN Sos/NEWGENE ./.
@@37120503662 Indium-111/NN leukocyte/NN imaging/JJ in/IN patients/NNS with/IN rheumatoid/JJ arthritis/NN ./.
@@77741378530 The/DT potential/JJ impact/NN of/IN using/VBG a/DT rapid/JJ diagnostic/JJ test/NN (/( Strep/NN A/DT OIA/NN )/SYM on/IN detection/NN and/CC treatment/NN of/IN group/NN A/DT beta-hemolytic/JJ streptococcal/JJ (/( GABHS/NN )/SYM pharyngitis/NN in/IN a/DT large-volume/JJ pediatric/JJ and/CC adolescent/JJ clinic/NN was/VBD examined/VBN ./.
@@32161318270 The/DT only/JJ isolate/NN of/IN Aeromonas/NNS hydrophila/NN produced/VBD cytotoxic/NN enterotoxin/NEWGENE and/CC was/VBD invasive/JJ ./.
@@28768993581 On/IN Days/NN 1/CD and/CC 14/CD ,/, most/RB young/JJ and/CC elderly/JJ subjects/NNS exhibited/VBD monoexponential/JJ decline/NN in/IN bevantolol/NN plasma/NN concentrations/NNS after/IN absorption/NN phase/NN ./.
@@67883887503 Although/IN the/DT mechanism/NN of/IN action/NN of/IN ICRF-159/NN and/CC 187/CD has/VBZ not/RB been/VBN clearly/RB defined/VBN ,/, it/PRP is/VBZ evident/JJ from/IN both/DT preclinical/JJ and/CC early/JJ clinical/JJ studies/NNS that/WDT these/DT compounds/NNS are/VBP of/IN interest/NN ./.
@@80659018519 Our/PRP results/NNS indicate/VBP that/IN the/DT KRAB/NEWGENE domain/NEWGENE present/NN in/IN the/DT non-finger/NN region/NN of/IN many/JJ ZFP/NEWGENE genes/NEWGENE quenches/VBZ transcription/NN possibly/RB due/NN to/IN specific/NN protein-protein/NN interactions/NNS between/IN the/DT KRAB-A/NEWGENE domain/NEWGENE and/CC components/NNS of/IN the/DT proximal/JJ transcriptional/JJ apparatus/NN ./.
@@65242021526 A/DT new/JJ variant/NN of/IN the/DT EMG-BFB/NN method/NN (/( multichannel/JJ )/SYM is/VBZ offered/VBN which/WDT has/VBZ made/VBP it/PRP possible/JJ to/IN use/NN the/DT method/NN not/RB only/RB for/IN training/NN weakened/VBD muscles/NNS and/CC reducing/JJ spasticity/NN in/IN their/PRP antagonists/NNS but/CC also/RB for/IN improving/JJ motor/JJ coordination/NN ./.
@@26317437059 We/PRP investigated/VBD the/DT incidence/NN of/IN congenital/JJ color/NN deficiency/NN among/IN Koreans/NNS by/IN the/DT use/NN of/IN H-R-R/NN pseudoisochromatic/JJ plates/NNS ./.
@@67044676461 We/PRP suggest/VBP that/DT sensitivity/NN to/IN photoperiod/NN in/IN pallid/JJ bats/NNS ,/, as/IN in/IN several/DT other/DT mammals/NNS ,/, is/VBZ mediated/JJ by/IN the/DT pineal/JJ gland/NN ./.
@@7575947970 The/DT debate/NN over/RB electives--1899/NN ./.
@@8218338185 This/DT report/NN presents/VBP an/DT analysis/NN of/IN the/DT vocal/JJ repertoire/NN of/IN howler/NN monkeys/NNS (/( Alouatta/NN palliata/NN )/SYM observed/VBN during/IN a/DT field/NN study/NN in/IN southwestern/JJ Panama/NN ./.
@@103334812521 Additionally/RB ,/, deletion/NN analysis/NN of/IN the/DT UCP2/NEWGENE promoter-PLAP/NEWGENE constructs/NEWGENE indicated/VBN that/IN the/DT minimal/JJ region/NN exhibiting/VBG the/DT promoter/NN activity/NN was/VBD located/VBN between/IN nt/NN -33/CD and/CC +100/CD ,/, and/CC that/IN a/DT strong/JJ enhancer/NN was/VBD present/VB within/IN 601/CD bp/NN of/IN the/DT 5'-promoter/NN region/NN ./.
@@29959999103 The/DT sequence/NN analysis/NN of/IN both/DT products/NNS of/IN individual/JJ phi/NN 80/NN site-specific/JJ recombination/NN events/NNS in/IN vivo/NN shows/VBZ that/DT recombination/NN with/IN a/DT secondary/JJ attachment/NN (/( att/NN )/SYM site/NN generates/VBZ several/DT different/JJ novel/JJ joints/NNS at/IN the/DT mismatched/JJ position/NN :/: one/PRP recombination/NN event/NN resulted/VBN in/IN a/DT single/JJ base-pair/NN deletion/NN and/CC two/JJ other/DT recombination/NN events/NNS resulted/VBN in/IN two/JJ different/JJ single/JJ base-pair/NN substitutions/NNS ./.
@@110597869681 Epidermal/NEWGENE growth/NEWGENE factor/NEWGENE receptor/NEWGENE transcriptionally/RB up-regulates/VBZ vascular/NEWGENE endothelial/NEWGENE growth/NEWGENE factor/NEWGENE expression/NN in/IN human/JJ glioblastoma/NN cells/NNS via/NN a/DT pathway/NN involving/VBG phosphatidylinositol/NEWGENE 3'-kinase/NEWGENE and/CC distinct/JJ from/IN that/DT induced/VBD by/IN hypoxia/NN ./.
@@79644588358 A/DT candidate/NN gene/NN for/IN Bcg/NEWGENE ,/, designated/VBN natural/NEWGENE resistance-associated/NEWGENE macrophage/NEWGENE protein/NEWGENE (/( Nramp/NEWGENE )/SYM ,/, has/VBZ been/VBN isolated/VBN and/CC shown/VBP to/IN encode/VB a/DT novel/JJ macrophage-specific/NN membrane/NN protein/NN ,/, which/WDT is/VBZ altered/VBN in/IN susceptible/JJ animals/NNS ./.
@@87946018779 The/DT triple/JJ combination/NN of/IN nizatidine/NN ,/, clarithromycin/NN ,/, and/CC bismuth/NN subcitrate/NN resulted/VBN in/IN an/DT ulcer/NN healing/NN rate/NN of/IN 98%/CD and/CC an/DT H/NNP ./NNP pylori/NNS eradication/NN rate/NN of/IN 90%/CD ./.
@@105573088367 Connector/NEWGENE enhancer/NEWGENE of/NEWGENE KSR/NEWGENE (/( CNK/NEWGENE )/SYM is/VBZ a/DT multidomain/JJ protein/NN required/VBN for/IN RAS/NEWGENE signaling/JJ ./.
@@84092845166 Continued/VBN absorption/NN of/IN amino/JJ acids/NNS by/IN the/DT NBB/NN carrier/NN (/( for/IN neutral/JJ amino/JJ acids/NNS )/SYM ,/, the/DT Y+/NNP system/NN (/( for/IN dibasic/JJ amino/JJ acids/NNS )/SYM ,/, and/CC the/DT PHE/NN carrier/NN were/VBD operative/JJ even/VB during/IN the/DT actively/RB purging/JJ stage/NN of/IN watery/JJ diarrhoea/NN due/NN to/IN cholera/NN ./.
@@36123168987 Weaned/JJ rats/NNS were/VBD fed/VBN a/DT normal/JJ diet/NN or/CC a/DT low-protein/NN ,/, low-energy/JJ diet/NN ,/, and/CC injected/VBD with/IN saline/NN or/CC thyroxine/NN (/( 5/CD micrograms/NN //NN 100/NN g/NN BW/NN )/SYM for/IN 22/CD days/NNS ./.
@@103610381451 They/PRP also/RB occur/VBP in/IN similar/JJ locations/NNS in/IN the/DT promoters/NNS of/IN several/DT other/DT ribosomal/NEWGENE protein/NEWGENE genes/NEWGENE ./.
@@111639681058 In/NN the/DT present/NN work/NN ,/, the/DT complete/JJ genome/NN sequences/NNS of/IN Pyrococcus/NNP horikoshii/NN and/CC Pyrococcus/NNP abyssi/NN ,/, two/JJ species/NN in/IN a/DT genus/NN of/IN hyperthermophilic/JJ archaeon/NN (/( archaebacterium/NN )/SYM ,/, were/VBD compared/VBN to/IN detect/VB large/JJ genome/NN polymorphisms/NNS linked/JJ with/IN restriction-modification/NEWGENE gene/NEWGENE homologs/NEWGENE ./.
@@12871971929 For/IN the/DT first/JJ group/NN ,/, the/DT maximal/JJ decrease/NN in/IN plasma/NN potassium/NN elicited/VBN by/IN salbutamol/NN was/VBD 0/CD ./CD 80/CD +/NN //NN -/NN 0/CD ./CD 19/CD ,/, 0/CD ./CD 48/CD +/NN //NN -/NN 0/CD ./CD 22/CD ,/, and/CC 0/CD ./CD 78/CD +/NN //NN -/NN 0/CD ./CD 46/CD mmol/NN //NN l/NN ,/, and/CC for/IN the/DT second/JJ group/NN ,/, maximal/JJ decrement/NN was/VBD 1/CD ./CD 31/CD +/NN //NN -/NN 0/CD ./CD 37/CD ,/, 0/CD ./CD 70/CD +/NN //NN -/NN 0/CD ./CD 24/CD ,/, and/CC 0/CD ./CD 84/CD +/NN //NN -/NN 0/CD ./CD 17/CD mmol/NN //NN l/NN for/IN the/DT iv/NN ,/, po/RB ,/, and/CC it/PRP routes/NNS ,/, respectively/RB ./.
@@91771699536 A/DT similar/JJ chimera/NN was/VBD assembled/VBN from/IN the/DT two/JJ halves/NNS of/IN the/DT molecule/NN expressed/VBN separately/RB in/IN different/JJ bacteria/NNS and/CC refolded/VBN together/RB ./.
@@82324122761 The/DT lemdr1/NEWGENE gene/NEWGENE was/VBD cloned/VBN in/IN the/DT expression/NN vector/NN pALTNEO/NN and/CC transfected/VBN into/IN wild-type/NNP L/NNP ./NNP enriettii/NN and/CC the/DT resulting/VBG transfected/VBN cells/NNS were/VBD resistant/JJ to/IN vinblastine/NN but/CC at/IN lower/JJR levels/NNS than/IN in/IN the/DT selected/VBN mutant/JJ cells/NNS ./.
@@95805639565 The/DT predicted/VBN amino/JJ acid/NN sequence/NN is/VBZ 78/NN ./NN 0%/NN identical/JJ to/IN the/DT cytoplasmic/NEWGENE dynein/NEWGENE heavy/NEWGENE chain/NEWGENE of/NEWGENE Neurospora/NEWGENE crassa/NEWGENE ,/, 70/NN ./NN 2%/NN identical/JJ to/IN that/IN of/IN Aspergillus/NNS nidulans/NNS and/CC 24/NN ./NN 8%/NN identical/JJ to/IN that/DT of/IN Saccharomyces/NN cerevisiae/NN ./.
@@19681569763 Dose/NNS standardisation/NN of/IN botulinum/NEWGENE toxin/NEWGENE ./.
@@111161312605 These/DT cells/NNS produced/VBD P2Y/NEWGENE (/NEWGENE 11/NEWGENE )/NEWGENE mRNA/NEWGENE during/IN culture/NN ./.
@@100228508588 In/NN contrast/NN ,/, an/DT amino-terminal/NN fragment/NN containing/JJ the/DT C/NEWGENE //NEWGENE H1/NEWGENE domain/NEWGENE was/VBD sufficient/JJ for/IN coactivation/NN of/IN Zta/NEWGENE transcription/NN and/CC viral/JJ reactivation/NN function/NN ./.
@@32125513905 The/DT pathogenesis/NN of/IN Dupuytren's/NNP contracture/NN ./.
@@115958404458 The/DT uptake/NN of/IN fluorine-18/JJ fluorodeoxyglucose/NN (/( F-18/NN FDG/NN )/SYM by/IN a/DT malignant/JJ tumor/NN depends/VBZ on/IN the/DT blood/NN glucose/NN level/NN ./.
@@104035755547 The/DT inhibition/NN of/IN StAR/NEWGENE gene/NEWGENE transcription/NN by/IN DAX-1/NEWGENE was/VBD dose-dependent/JJ reducing/JJ transcription/NN to/IN 6%/NN of/IN control/NN levels/NNS ./.
@@7572582255 Mibefradil/IN (/( Ro/NN 40-5967/CD )/SYM is/VBZ a/DT novel/JJ calcium/NN antagonist/NN from/IN a/DT new/JJ chemical/JJ class/NN and/CC is/VBZ the/DT first/JJ that/WDT selectively/RB blocks/NNS the/DT T-type/NN calcium/NN channel/NN ./.
@@21963118710 These/DT results/NNS suggest/VBP that/IN 5/NN KE/NN X/NN 3/NN //NN W/NN may/MD be/VB the/DT optimal/JJ regimen/NN to/IN augment/VB the/DT antitumor/JJ immunity/NN of/IN RNL/NN ./.
@@95818343569 Taken/VBN together/RB ,/, these/DT results/NNS suggest/VBP that/DT silymarin/NN may/MD exert/VB a/DT strong/JJ anticarcinogenic/JJ effect/NN against/IN PCA/NN and/CC that/IN this/DT effect/NN is/VBZ likely/RB to/IN involve/VB impairment/NN of/IN erbB1-SHC-mediated/JJ signaling/JJ pathway/NN ,/, induction/NN of/IN CDKIs/NEWGENE ,/, and/CC a/DT resultant/JJ G1/NN arrest/NN ./.
@@79668737956 Articles/NNPS addressing/VBG valvular/JJ heart/NN disease/NN or/CC heart/NN failure/NN secondary/JJ to/IN acute/JJ myocardial/JJ infarction/NN or/CC Chagas'/NNPS disease/NN were/VBD excluded/VBN ./.
@@95069625672 We/PRP further/RB show/VBP that/IN proteolytic/JJ targeting/NN by/IN calpain/NEWGENE II/NEWGENE and/CC the/DT proteasome/NN involves/VBZ different/JJ structural/JJ elements/NNS of/IN YY1/NEWGENE ./.
@@85177378483 These/DT findings/NNS suggest/VBP that/IN a/DT range/NN of/IN microenvironmental/JJ conditions/NNS exist/VBP within/IN purified/VBN water/JJ systems/NNS ,/, leading/VBG to/IN variable/JJ populations/NNS of/IN bacteria/NNS ./.
@@10655230608 Like/IN their/PRP yeast/NN counterpart/NN ,/, the/DT mouse/NN GCN2/NEWGENE isoforms/NN contain/VBP HisRS-related/NEWGENE sequences/NEWGENE juxtaposed/VBN to/IN the/DT kinase/NN catalytic/JJ domain/NN ./.
@@74901564740 Vitamin/NN D3/NN plus/IN nicotine/NN treatment/NN produced/VBD parallel/JJ increases/NNS in/IN cardiac/JJ mass/JJ and/CC elastic/JJ modulus/NN ,/, with/IN a/DT significant/JJ correlation/NN between/IN the/DT two/NN ./.
@@75271687404 Microvessels/NNS were/VBD counted/VBN in/IN a/DT x200/CD field/NN (/( 0/CD ./CD 754/CD mm2/NN )/SYM in/IN the/DT area/NN of/IN maximal/JJ angiogenesis/NN ./.
@@107023894481 In/NN endemic/JJ BL/NNP ,/, the/DT RB2/NEWGENE //NEWGENE p130/NEWGENE gene/NEWGENE is/VBZ mutated/JJ in/IN most/RB of/IN the/DT cases/NNS ,/, and/CC the/DT protein/NN is/VBZ restricted/VBN to/IN the/DT cytoplasm/NN ./.
@@84016143265 French/JJ bean/NN contains/VBZ a/DT small/JJ family/NN of/IN genes/NEWGENE encoding/NEWGENE PAL/NEWGENE and/CC two/NN of/IN these/DT genes/NNS ,/, PAL2/NEWGENE and/CC PAL3/NEWGENE ,/, have/VB been/VBN shown/VBP to/IN be/VB differentially/RB expressed/VBN at/IN the/DT mRNA/NN level/NN in/IN bean/NN tissues/NNS ./.
@@25778671795 The/DT avian/JJ cellular/JJ homolog/NN of/IN the/DT oncogene/NEWGENE jun/NEWGENE ./.
@@39238284570 The/DT availability/NN of/IN cryoprecipitate/NN and/CC DDAVP/NN offers/VBP an/DT alternative/JJ and/CC effective/JJ treatment/NN for/IN the/DT temporary/JJ reversal/NN of/IN uremic/JJ bleeding/NN in/IN patients/NNS who/WP require/VBP urgent/JJ invasive/JJ procedures/NNS ./.
@@88780198833 The/DT intranodal/JJ mesothelial/JJ cells/NNS occupied/VBD the/DT sinusoids/NNS of/IN the/DT lymph/NN nodes/NNS and/CC were/VBD initially/RB suspected/VBN of/IN being/VBP metastatic/JJ from/IN the/DT ovarian/JJ tumor/NN in/IN each/DT case/NN ./.
@@8204403209 A/DT total/NN of/IN 7/CD (/( 4/CD males/NNS and/CC 3/CD females/NNS )/SYM patients/NNS were/VBD included/VBN in/IN this/DT retrospective/JJ study/NN to/IN determine/VB the/DT sensitivity/NN of/IN radioimmunoscintigraphy/NN with/IN I-131/NN labeled/JJ anti/JJ CEA/NEWGENE //NEWGENE CA/NEWGENE 19-9/CD monoclonal/JJ antibodies/NNS ./.
@@22292821703 Patients/NNS with/IN detectable/JJ serum/JJ TNF/NEWGENE levels/NNS had/VBP significantly/RB lower/JJR serum/JJ T3/NN concentrations/NNS compared/VBN to/IN those/DT with/IN undetectable/JJ levels/NNS [/NN 1/NN ./NN 072/NN +/NN //NN -/NN 0/CD ./CD 588/CD vs/IN ./IN
@@118638118949 We/PRP find/VBP that/IN the/DT measured/VBN Nusselt/NNP number/NN decreased/VBN about/RB 20%/CD over/RB the/DT range/NN of/IN Pr/NN spanned/VBN in/IN the/DT experiment/NN ./.
@@28375759754 Sodium/NN dodecyl/NN sulphate-induced/JJ cleavage/NN by/IN eukaryotic/NEWGENE topoisomerase/NEWGENE I/NEWGENE is/NNS known/VBP to/IN yield/NN enzyme/NN covalently/RB attached/VBD to/IN the/DT 3'/CD cut/JJ end/NN of/IN the/DT DNA/NN ./.
@@85438103629 To/TO identify/VB some/DT of/IN the/DT genes/NNS expressed/VBN in/IN LPS-activated/JJ coelomocytes/NNS ,/, we/PRP sequenced/VBN randomly/RB chosen/VBP clones/NNS from/IN a/DT directionally/RB constructed/VBN cDNA/NN library/NN to/IN produce/NN a/DT set/NN of/IN expressed/VBN sequence/NN tags/NNS (/( ESTs/NNS )/SYM ./.
@@111520816179 Adding/VBG 10/CD mmol/NN SDS/NNP //NNP l/NNP led/VBD to/IN transient/JJ inhibition/NN of/IN acidification/NN ,/, metal/NN solubilization/NN and/CC sulfur/JJ oxidation/NN ./.
@@92784416648 Overexpression/NNS of/IN CARP/NEWGENE in/IN cardiomyocytes/NNS suppresses/VBZ cardiac/NEWGENE troponin/NEWGENE C/NEWGENE and/CC atrial/NEWGENE natriuretic/NEWGENE factor/NEWGENE transcription/NN ./.
@@110560075533 It/PRP contained/VBD seven/JJ extra/JJ amino/JJ acids/NNS of/IN FVVLNLQ/NEWGENE ;/: this/DT short/JJ stretch/NN of/IN extra/JJ sequence/NN was/VBD found/VBN between/IN Gln/NN (/NN 421/NN )/NN and/CC Phe/NN (/NN 422/NN )/NN within/IN the/DT SET/NEWGENE (/( Suvar3-9/NEWGENE ,/NEWGENE Enhancer-of-zeste/NEWGENE ,/NEWGENE Trithorax/NEWGENE )/SYM interacting/VBG domain/NN (/( SID/NEWGENE )/SYM of/IN rMTM/NEWGENE ./.
@@98206117060 Therapeutic/JJ use/NN of/IN continuous/JJ subcutaneous/JJ infusion/NN of/IN recombinant/NEWGENE human/NEWGENE erythropoietin/NEWGENE in/IN malnourished/JJ predialysis/JJ anemic/JJ patients/NNS with/IN diabetic/JJ nephropathy/NN ./.
@@68699867154 Circulating/VBG platelets/NNS may/MD be/VB activated/VBN by/IN exposed/JJ triple-helical/JJ collagen/NEWGENE in/IN atherosclerotic/JJ lesions/NNS in/IN Mg-deficient/NNP ruminants/NNS ./.
@@60848645901 Elevated/NNP maternal/NEWGENE alpha/NEWGENE fetoproteins/NEWGENE and/CC oligoamnios/NNS :/: fetal/JJ prognosis/NN ./.
@@92280921582 These/DT analyses/NNS demonstrate/VBP that/IN the/DT dUTPase/NEWGENE isoforms/NN are/VBP encoded/VBN by/IN the/DT same/JJ gene/NN with/IN isoform-specific/NN transcripts/NN arising/VBG through/RB the/DT use/NN of/IN alternative/JJ 5'/CD exons/NNS ./.
@@9032267892 Overexpression/NNS of/IN the/DT bZip/NN interaction/NN domain/NN of/IN CBP/NEWGENE specifically/RB abolishes/VBZ the/DT positive/JJ cross/NN talk/NN between/IN TR/NEWGENE and/CC p45/NEWGENE //NEWGENE NF-E2/NEWGENE ./.
@@19249202547 Of/IN these/DT 179/CD samples/NNS ,/, Mobiluncus/NN SP/NN was/VBD observed/VBN in/IN 35/CD (/( 19/CD ./CD 6%/CD )/SYM using/VBG Gram/JJ staining/NN and/CC in/IN 18/CD (/( 10/CD ./CD 1%/CD )/SYM this/DT microorganism/NN was/VBD isolated/VBN in/IN agar/NN RLK/NN and/CC anaerobic/JJ atmosphere/NN ./.
@@82620413278 The/DT phi/NEWGENE AP3/NEWGENE factor/NEWGENE is/VBZ a/DT nuclear/NN phosphoprotein/NN ;/: the/DT extent/NN of/IN its/PRP phosphorylation/NN is/VBZ regulated/VBN during/IN the/DT cell/NN cycle/NN ./.
@@78573447843 As/IN the/DT half-life/NN of/IN the/DT compound/NN did/VBD never/RB exceed/VB 8-9/CD h/NN ,/, the/DT data/NN do/NN not/RB support/VB any/DT change/NN of/IN pidotimod/NN administration/NN schedule/NN (/( every/DT 24-12/CD h/NN )/SYM ./SYM
@@23115445595 Studies/NNS also/RB have/VBP alluded/VBN to/IN a/DT relationship/NN between/IN the/DT MSMR/NN cyst/NN and/CC certain/JJ signs/NNS or/CC symptoms/NNS of/IN disease/NN ./.
@@83324922033 One/CD member/NN of/IN this/DT multigene/NN family/NN ,/, GATA-3/NEWGENE ,/, is/VBZ most/RB abundantly/RB expressed/VBN in/IN T/NN lymphocytes/NNS ,/, a/DT cellular/JJ target/NN for/IN human/JJ immunodeficiency/NN virus/NN type/NN 1/CD (/( HIV-1/NNP )/SYM infection/NN and/CC replication/NN ./.
@@10595315422 There/EX were/VBD minimal/JJ negative/JJ effects/NNS on/IN hematological/JJ parameters/NNS ,/, acid-base/NN status/NN ,/, and/CC blood/NN gases/NNS ./.
@@105103797439 A/DT crucial/JJ transcription/NN factor/NN in/IN this/DT process/NN is/VBZ STAT6/NEWGENE ,/, which/WDT binds/VBZ to/IN a/DT specific/JJ DNA/NN element/NN upon/IN cytokine/NN activation/NN ./.
@@7720709378 Using/VBG Ki-ras-transformed/JJ 3T3/CD cells/NNS as/IN a/DT model/NN system/NN ,/, we/PRP show/VBP that/IN both/DT RA/NN and/CC the/DT 'dissociating'/NN retinoids/NNS inhibit/VBP anchorage-independent/JJ cell/NN proliferation/NN ,/, suggesting/VBG that/IN retinoid-induced/JJ growth/NN inhibition/NN may/MD be/VB related/VBN to/IN AP1/NEWGENE transrepression/NN ./.
@@34480354154 Ovarian/JJ tumors/NNS in/IN pregnancy/NN ./.
@@87987624540 Altogether/RB ,/, our/PRP results/NNS indicate/VBP that/IN the/DT transcriptional/JJ activity/NN of/IN Cut/NEWGENE proteins/NEWGENE is/VBZ modulated/VBN by/IN PKC/NEWGENE ./.
@@36870784351 References/NNS for/IN occupational/JJ fitness/NN of/IN adolescents/NNS with/IN diseases/NNS of/IN the/DT respiratory/JJ tract/NN and/CC lungs/NNS ./.
@@33089095673 Lysosomal/NN enzymes/NN that/WDT degrade/VBP cartilage/NN are/VBP released/VBN ./.
@@98068261992 We/PRP have/VBP previously/RB mapped/VBN the/DT defect/NN in/IN RIIIS/NNP //NNP J/NNP to/IN distal/JJ mouse/NN Chr/NN 11/CD ,/, distinct/JJ from/IN the/DT Vwf/NEWGENE locus/NEWGENE on/IN Chr/NN 6/CD ./CD
@@30279053455 Plasma/NEWGENE renin/NEWGENE activity/NN rose/VBD and/CC the/DT plasma/NN aldosterone/NN level/NN fell/NN after/IN taking/VBG lisinopril/NN ./.
@@4885345226 In/NN addition/NN a/DT significant/JJ Treatment/NNP X/NN Strain/NNS interaction/NN was/VBD due/NN to/IN the/DT larger/JJR defecation/NN numbers/NNS displayed/VBN by/IN the/DT taurine-injected/JJ MR/NN rats/NNS relative/JJ to/IN the/DT saline-injected/JJ MR/NN rats/NNS ./.
@@107752671048 Retroviral/JJ transduction/NN of/IN T/NEWGENE //NEWGENE T/NEWGENE (/NEWGENE L/NEWGENE )/NEWGENE causes/VBZ a/DT rapidly/RB fatal/JJ myeloproliferative/JJ disease/NN in/IN a/DT murine/JJ bone/NN marrow/NN transplant/NN (/( BMT/NN )/SYM model/NN ,/, whereas/IN T/NEWGENE //NEWGENE T/NEWGENE (/NEWGENE F/NEWGENE )/NEWGENE causes/VBZ a/DT long-latency/NN ,/, pre-B-cell/NN lymphoblastic/JJ lymphoma/NN ./.
@@94596855443 Typical/JJ configurations/NNS of/IN psychosocial/JJ stress/NN factors/NN of/IN psychiatrically/RB conspicuous/JJ children/NNS and/CC adolescents/NNS ./.
@@790367099 The/DT mutant/NN allele/NN of/IN the/DT alpha/NEWGENE 1-tubulin/NEWGENE gene/NEWGENE was/VBD designated/VBN tua1-1/NEWGENE ./.
@@111776861018 Treatment/NNP includes/VBZ both/DT medical/JJ and/CC surgical/JJ options/NNS ,/, with/IN medical/JJ therapy/NN further/RB subclassified/VBN into/IN pharmacologic/JJ and/CC pneumatic/JJ dilation/NN ./.
@@78166306762 Similarly/RB approximately/RB 300/CD bp/NN of/IN sequence/NN downstream/RB of/IN the/DT translation/NN terminator/NN TGA/NN of/IN the/DT beta-tubulin/NEWGENE 2/NEWGENE (/( BTU2/NEWGENE )/SYM gene/NN could/MD substitute/VB for/IN the/DT 3'/CD region/NN of/IN the/DT H4-I/NEWGENE gene/NEWGENE ./.
@@85498597007 The/DT gene/NN was/VBD uniquely/RB mapped/VBN with/IN odds/NNS >/SYM 1/CD ,/CD 000/CD :/: 1/CD on/IN chromosome/NN 3p/NN in/IN Centre/NNP d'Etude/NNP du/NNP Polymorphisme/NNP Humain/NNP pedigrees/NNS ./.
@@112569446460 Furthermore/RB ,/, the/DT soluble/JJ forms/NNS of/IN ATF6/NEWGENE and/CC the/DT G13/NEWGENE gene/NEWGENE product/NEWGENE are/VBP unable/JJ to/IN bind/NN to/IN several/DT point/NN mutants/NNS of/IN the/DT cis-acting/JJ ER/NEWGENE stress/NEWGENE response/NEWGENE element/NEWGENE in/IN vitro/FW that/WDT hardly/RB respond/VB to/IN ER/NN stress/NN in/IN vivo/NN ./.
@@38820295711 A/DT retrospective/JJ study/NN of/IN banked/JJ sera/NNS from/IN 19/CD cats/NNS with/IN the/DT eosinophilic/JJ granuloma/NN complex/NN revealed/VBD that/DT 68%/NN of/IN affected/VBN cats/NNS had/VBP circulating/JJ antibodies/NNS to/IN components/NNS of/IN normal/JJ cat/NN epithelium/NN ./.
@@80905718067 Elimination/NN of/IN natural/JJ antibodies/NNS in/IN discordant/JJ xenografts/NNS ./.
@@106012801872 The/DT first/JJ one/PRP is/VBZ a/DT TPA-responsive/NEWGENE element/NEWGENE that/WDT controls/VBZ the/DT base-line/NN ST3/NEWGENE promoter/NEWGENE activity/NN but/CC is/VBZ not/RB required/VBN for/IN its/PRP activation/NN ./.
@@105518797224 Cyclic/NEWGENE AMP-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE binding/JJ to/IN A-kinase/NEWGENE anchoring/NN proteins/NN in/IN living/VBG cells/NNS by/IN fluorescence/NN resonance/NN energy/NN transfer/NN of/IN green/JJ fluorescent/JJ protein/NN fusion/NN proteins/NNS ./.
@@110492411173 RESULTS/NNS :/: In/NN the/DT pregnant/JJ group/NN ,/, serum/JJ PP14/NEWGENE concentrations/NNS were/VBD markedly/RB increased/VBN after/IN ET/NNP ,/, and/CC a/DT significant/JJ difference/NN between/IN the/DT pregnant/JJ group/NN and/CC the/DT nonpregnant/JJ group/NN was/VBD observed/VBN 8/CD days/NNS following/IN ET/NNP (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM ./.
@@8552095934 Paf1p/NEWGENE may/MD therefore/RB be/VB required/VBN for/IN both/DT positive/JJ and/CC negative/JJ regulation/NN of/IN subsets/NNS of/IN yeast/NN genes/NNS ./.
@@25261658246 The/DT sign/NN of/IN Leser-Trelat/NNP :/: does/VBP it/PRP exist/VBP ?/. The/DT sign/NN of/IN Leser-Trelat/NN is/VBZ usually/RB regarded/VBN as/IN a/DT reliable/JJ cutaneous/JJ marker/NN of/IN internal/JJ malignancy/NN ./.
@@92185205609 We/PRP have/VBP initiated/VBN studies/NNS to/IN identify/VB candidate/NN signal/NN transducers/NN that/WDT associate/VBP with/IN the/DT cytosolic/JJ domain/NN (/( cd/NN )/SYM of/IN the/DT IL-1R/NEWGENE ./.
@@110718523740 To/TO test/VB whether/IN or/CC not/RB SOCS-3/NEWGENE also/RB binds/VBZ to/IN the/DT IGFIR/NEWGENE ,/, we/PRP cloned/VBN human/NEWGENE SOCS-3/NEWGENE by/IN reverse/JJ transcription-polymerase/JJ chain/NN reaction/NN from/IN human/JJ skeletal/JJ muscle/NN mRNA/NN ./.
@@88358957815 The/DT CD4/NEWGENE count/NN at/IN which/WDT remission/NN occurs/VBZ may/MD reflect/VB severe/JJ immunodeficiency/NN such/JJ that/DT risk/NN for/IN AIDS-related/JJ infection/NN is/VBZ high/JJ ./.
@@109610466815 Platelet/NN counts/NNS and/CC function/NN as/RB well/VB as/IN fibrinogen/NEWGENE and/CC von/NEWGENE Willebrand/NEWGENE factor/NEWGENE (/( vWF/NEWGENE )/SYM levels/NNS were/VBD determined/VBN in/IN each/DT sample/NN ./.
@@109189433273 Developmental/NN toxicity/NN of/IN the/DT class/NN III/NN antiarrhythmic/JJ agent/NN almokalant/NN in/IN mice/NNS ./.
@@77899715705 The/DT absence/NN of/IN other/DT regions/NNS of/IN hybridization/NN suggests/VBZ that/IN there/RB are/VBP no/DT closely/RB related/VBN sequences/NNS (/( e/FW ./FW g/FW ./FW ,/, reverse/RB transcribed/VBN pseudogenes/NNS )/SYM scattered/JJ throughout/IN the/DT genome/NN and/CC that/IN if/IN there/RB are/VBP closely/RB related/VBN genes/NNS ,/, they/PRP must/MD be/VB clustered/VBN near/IN GSTT2/NEWGENE ./.
@@113691061209 Recent/JJ advances/NNS have/VBP shown/VBP that/IN volatile/JJ sulfur/NN is/VBZ a/DT result/NN of/IN ecological/JJ interactions/NNS and/CC transformation/NN processes/NNS through/RB planktonic/JJ food/NN webs/NNS ./.
@@109319509649 Cdk2/NEWGENE and/CC MAPK/NEWGENE precipitates/NNS from/IN untreated/JJ tumor/NN lysates/NNS phosphorylated/VBN recombinant/NEWGENE wild-type/NEWGENE p27/NEWGENE but/CC not/RB the/DT T187A/NN mutant/NN in/IN vitro/FW ./.
@@105010342705 Ribonuclease/NEWGENE protection/NN assays/NNS revealed/VBN that/IN hmg1/NEWGENE and/CC hmg2/NEWGENE are/VBP differentially/RB expressed/VBN in/IN a/DT developmentally-/JJ and/CC spatially-modulated/JJ manner/NN during/IN morphogenesis/NN of/IN specialized/JJ terpenoid-containing/JJ pigment/NN glands/NNS in/IN embryos/NNS ./.
@@113745593189 SERS/NN spectra/NNS were/VBD obtained/VBN by/IN vacuum/NN evaporation/NN and/CC casting/NN of/IN p-NTP/JJ onto/IN silver/JJ island/NN films/NNS ,/, and/CC also/RB from/IN colloidal/JJ silver/JJ solutions/NNS ./.
@@34407802974 From/IN these/DT results/NNS ,/, it/PRP is/VBZ concluded/VBN that/IN EDLF/NN has/VBZ clear/JJ vasoconstrictor/JJ properties/NNS which/WDT are/VBP not/RB due/NN to/IN adrenergic/NN or/CC calcium/NN entry/NN mechanisms/NNS and/CC that/IN there/RB are/VBP differences/NNS in/IN the/DT vasoconstrictor/JJ effects/NNS of/IN EDLFs/NNP with/IN respect/NN to/IN different/JJ vascular/JJ beds/NNS ./.
@@80653665508 Taken/VBN together/RB ,/, our/PRP data/NN suggest/VB that/IN Dbf8p/NEWGENE plays/VBP an/DT essential/JJ role/NN in/IN chromosome/NN segregation/NN ./.
@@29680553682 The/DT HOI/NN induced/VBD a/DT nearly/RB fourfold/JJ increase/NN in/IN ANF/NEWGENE in/IN the/DT elderly/NN ,/, whereas/IN that/DT for/IN the/DT young/NN was/VBD threefold/RB ./.
@@15872672790 The/DT sequence/NN data/NN now/RB permit/VB a/DT detailed/JJ interpretation/NN of/IN the/DT X-ray/JJ crystallographic/JJ structure/NN of/IN the/DT enzyme/NN and/CC the/DT cloning/NN and/CC expression/NN of/IN the/DT clostridial/JJ gene/NN will/MD facilitate/VB site-directed/JJ mutagenesis/NN ./.
@@39566474608 Dissolution/NNS of/IN the/DT Pt-30%Ir/NN microelectrode/NN tip/NN was/VBD observed/VBN by/IN scanning/JJ electron/NN microscopy/NN at/IN charge/NN densities/NNS as/RB low/JJ as/IN 200/NN microC/NN //NN cm2/NN X/NN ph/NN (/( 1/CD A/NN //NN cm2/NN )/SYM ,/, whereas/IN erosion/NN of/IN activated/VBN iridium/NN microelectrodes/NNS occurred/VBN only/RB at/IN the/DT highest/JJS charge/NN and/CC current/JJ densities/NNS (/( 3200/NN microC/NN //NN cm2/NN X/NN ph/NN ,/, 16/CD A/NN //NN cm2/NN )/SYM ./.
@@71074626910 The/DT steepness/NN of/IN the/DT standard/JJ O2/NN dissociation/NN curve/NN becomes/VBZ greater/JJR during/IN the/DT training/NN period/NN (/( increase/NN in/IN Hill's/NNP n/NN from/IN 2/CD ./CD 68/CD +/NN //NN -/NN 0/CD ./CD 10/CD to/IN 2/CD ./CD 96/CD +/NN //NN -/NN 0/CD ./CD 15/CD )/SYM ./.
@@14362614294 Subcutaneous/JJ administration/NN of/IN the/DT somatostatin/NEWGENE analogue/NN ,/, octreotide/NN ,/, 100/CD micrograms/NNS thrice/RB daily/JJ ,/, resulted/VBN in/IN a/DT sustained/JJ improvement/NN in/IN diarrhoea/NN and/CC disappearance/NN of/IN faecal/JJ incontinence/NN without/IN reducing/JJ calcitonin/NEWGENE levels/NNS ./.
@@75994497500 The/DT fracture/NN groups/NNS were/VBD significantly/RB older/JJR and/CC had/VBP more/JJ years/NNS since/IN menopause/NN than/IN the/DT control/NN groups/NNS ./.
@@102314547606 Total/JJ serum/JJ calcium/NN was/VBD 7/CD ./CD 8/CD +/NN //NN -/NN 0/CD ./CD 8/CD mg/NN //NN dl/NN ,/, whereas/IN ionized/JJ calcium/NN was/VBD 5/CD ./CD 7/CD +/NN //NN -/NN 0/CD ./CD 7/CD mg/NN //NN dl/NN ,/, phosphorus/NN 3/CD ./CD 2/CD +/NN //NN -/NN 1/CD ./CD 2/CD mg/NN //NN dl/NN ,/, and/CC alkaline/NEWGENE phosphatase/NEWGENE 149/NN +/NN //NN -/NN 48/CD ./CD 6/CD U/NNS //NNS liter/NNS ./.
@@96411677983 CONCLUSION/IN :/: TNF/NEWGENE alpha/NEWGENE ,/, TGF/NEWGENE beta/NEWGENE ,/, PDGF/NEWGENE and/CC IL-1beta/NEWGENE increased/VBN LDLr/NEWGENE gene/NEWGENE expression/NN by/IN increasing/JJ sterol-independent/JJ and/CC mitogenesis-independent/NN gene/NN transcription/NN ./.
@@45516504385 Cell/NNP viability/NN and/CC lysosomal/NN enzymes/NN ./.
@@57693072452 Automatic/NNP view/NN box/NN ./.
@@94789718657 Reporter/NNP constructs/NNS function/NN in/IN a/DT parallel/JJ manner/NN ,/, demonstrating/VBG the/DT key/NN role/NN of/IN the/DT AhR/NEWGENE in/RB constitutive/JJ as/RB well/VB as/IN TCDD-induced/JJ expression/NN of/IN Cyp1B1/NEWGENE in/IN mouse/NN embryo/NN fibroblasts/NNS ./.
@@10442493287 At/NN baseline/NN ,/, serum/JJ levels/NNS of/IN lycopene/NN and/CC FLOP/NN were/VBD abnormally/RB high/JJ and/CC serum/JJ FLOP/NNP was/VBD correlated/VBN significantly/RB with/IN plasma/NN cyclosporine/NN levels/NNS (/( r/JJ =/SYM 0/CD ./CD 646/CD ,/, p/NN =/SYM 0/CD ./CD 016/CD )/SYM ./.
@@73413467193 2/CD ./CD numerous/JJ narrow/JJ shunt/NN vessels/NNS departing/VBG continuously/RB from/IN the/DT primary/JJ arteries/NNS to/IN feed/VBD a/DT secondary/JJ arterial/JJ system/NN which/WDT parallels/VBP the/DT primary/JJ one/PRP ./.
@@111132015904 Pmt2/NEWGENE is/VBZ a/DT member/NN of/IN a/DT six-protein/NN family/NN in/IN yeast/NN that/WDT catalyzes/VBZ the/DT first/JJ step/NN in/IN O/NN mannosylation/NN of/IN target/NN proteins/NNS ./.
@@86611166823 Promoter/NNS activity/NN was/VBD high/JJ in/IN cell/NN lines/NNS that/WDT expressed/VBD high/JJ levels/NNS of/IN endogenous/JJ D3/NEWGENE mRNA/NEWGENE ,/, as/IN indicated/VBN by/IN Northern/NNP blot/NN analyses/NNS ,/, and/CC was/VBD significantly/RB reduced/VBN when/CC the/DT promoter/NN was/VBD truncated/JJ to/IN -122/CD bp/CD ./CD
@@14066887611 Sequencing/NN analysis/NN has/VBZ shown/VBP that/IN each/DT rap1t/NEWGENE allele/NEWGENE contains/VBZ a/DT nonsense/NN mutation/NN within/IN a/DT discrete/JJ region/NN between/IN amino/JJ acids/NNS 663/CD and/CC 684/CD ./.
@@93715669538 This/DT protein/NN is/VBZ present/NN in/IN both/DT HeLa/JJ nuclear/JJ extracts/NNS and/CC S100/NN extracts/NNS but/CC absent/VB from/IN SR/NEWGENE protein/NEWGENE preparations/NNS ,/, suggesting/VBG that/IN it/PRP is/VBZ not/RB a/DT classical/JJ SR/NEWGENE protein/NEWGENE ./.
@@112787132389 Finally/RB a/DT 10-nucleotide/NN region/NN flanking/JJ the/DT exon/NN 4/NN protein-binding/NN site/NN is/VBZ homologous/JJ to/IN instability/NN elements/NNS within/IN five/CD other/DT transcripts/NNS ,/, suggesting/VBG that/IN a/DT common/JJ coding/JJ region/NN determinant/NN may/MD exist/VB ./.
@@65273793205 Alternating/VBG proline/NN //NN alanine/NN sequence/NN of/IN beta/NEWGENE B1/NEWGENE subunit/NEWGENE originates/VBZ from/IN a/DT repetitive/JJ DNA/NN sequence/NN ./.
@@87312226037 The/DT distribution/NN and/CC organization/NN of/IN projections/NNS from/IN the/DT spinal/JJ cervical/JJ enlargement/NN to/IN subnucleus/NN reticularis/JJ dorsalis/JJ (/( SRD/NN )/SYM and/CC the/DT neighbouring/JJ Cuneate/JJ nucleus/NN (/( Cu/NN )/SYM area/NN was/VBD studied/VBN in/IN the/DT rat/NN by/IN using/VBG microinjections/NNS of/IN Phaseolus/NEWGENE vulgaris/NEWGENE leucoagglutinin/NEWGENE (/( PHA-L/NEWGENE )/SYM into/IN different/JJ laminae/NNS around/IN the/DT C7/NN level/NN ./.
@@75406076792 Retreatment/NNS of/IN these/DT 2/CD dogs/NNS resulted/VBN in/IN a/DT similar/JJ ,/, but/CC blunted/VBD ,/, response/NN to/IN human/NEWGENE immunoglobulin/NEWGENE ./.
@@88638245775 Cloning/VBG and/CC sequence/NN analyses/NNS revealed/VBD a/DT second/JJ cDNA/NN with/IN a/DT 95-nt/CD deletion/NN in/IN the/DT region/NN coding/JJ for/IN the/DT putative/JJ second/JJ intracellular/JJ loop/NN and/CC the/DT fourth/JJ transmembrane/JJ domain/NN of/IN the/DT 5-HT2C-R/NEWGENE ./.
@@27316717975 The/DT relative/JJ toxicity/NN of/IN nickel/NN oxide/NN (/( NiO/NNP )/SYM ,/, nickel/NN sulfate/NN hexahydrate/NN (/( NiSO4/NNP ./NNP 6H2O/NNP )/SYM ,/, and/CC nickel/NN subsulfide/NN (/( Ni3S2/NN )/SYM was/VBD studied/VBN in/IN F344/NNP //NNP N/NNP rats/NNS and/CC B6C3F1/NN mice/NNS after/IN inhalation/NN exposure/NN for/IN 6/CD hr/NN //NN day/NN ,/, 5/CD days/NN //NN week/NN ,/, for/IN 13/CD weeks/NNS ./.
@@3887769139 In/NN the/DT region/NN Walgau/NN with/IN mixed/JJ industrial-rural/JJ population/NN an/DT iodine/NN deficiency/NN I/NN was/VBD found/VBN in/IN 81%/JJ and/CC an/DT iodine/NN deficiency/NN II/NN in/IN 45%/NN ./.
@@13711815123 We/PRP propose/VBP that/IN plasmids/NNS of/IN the/DT pLS1/NN family/NN (/( pE194/NN ,/, pADB201/NN ,/, and/CC pLB4/NN )/SYM share/VB functional/JJ and/CC structural/JJ characteristics/NNS for/IN the/DT regulation/NN of/IN their/PRP copy/NN numbers/NNS ./.
@@27621986086 Reye's/NN syndrome/NN :/: reports/NNS of/IN 7/CD cases/NNS in/IN the/DT period/NN 1982-1987/CD ./.
@@91033829048 The/DT new/JJ FIGO/NN definition/NN of/IN cervical/JJ cancer/NN stage/NN IA/NN :/: a/DT critique/NN ./.
@@32769243167 In/NN one/PRP of/IN these/DT tumors/NNS the/DT observed/VBN rearrangement/NN was/VBD not/RB due/NN to/IN the/DT insertion/NN of/IN an/DT intact/JJ MoMuLV/NNP provirus/NN ./.
@@62514691789 Among/IN six/CD different/JJ library/NN isolates/NNS containing/JJ 6/NEWGENE ./NEWGENE 5-/NEWGENE to/NEWGENE 7-kb/NEWGENE IAP/NEWGENE units/NEWGENE ,/, some/DT restriction/NN sites/NNS were/VBD highly/RB conserved/VBN whereas/IN others/NNS varied/VBN in/IN both/DT occurrence/NN and/CC position/NN ./.
@@62235863835 Immunochemotherapy/NNS with/IN schizophyllan/NN (/( SPG/NN )/SYM combined/JJ with/IN chemotherapeutic/JJ agents/NNS was/VBD evaluated/VBN in/IN two/JJ syngeneic/JJ tumor-C3H/JJ //JJ He/JJ mouse/NN systems/NNS ./.
@@115332388747 Mutation/NN of/IN the/DT octamer/NN element/NN also/RB significantly/RB reduced/VBN the/DT ability/NN of/IN HDAC1/NEWGENE to/IN confer/VB repression/NN of/IN inducible/JJ HLA-DRA/NEWGENE promoter/NEWGENE activation/NN ./.
@@79772399293 Outflow/NNS obstruction/NN of/IN pancreatic/JJ juice/NN ,/, i/FW ./FW e/FW ./FW ,/, "relative/JJ stenosis/NN of/IN the/DT minor/JJ papilla/NN ,/NN "/NN was/VBD considered/VBN to/IN be/VB present/NN in/IN the/DT patients/NNS with/IN type/NN II/NN papilla/NN ,/, and/CC ,/, therefore/RB ,/, the/DT patients/NNS with/IN type/NN II/NN papilla/NN might/MD suffer/VB from/IN acute/JJ pancreatitis/NN resulting/JJ from/IN poor/JJ drainage/NN of/IN pancreatic/JJ juice/NN and/CC excessive/JJ pressure/NN in/IN the/DT dorsal/JJ duct/NN ./.
@@35101851393 Natl/JJ ./.
@@752950429 Pharmacological/JJ and/CC pharmacokinetic/JJ characteristics/NNS of/IN the/DT non-ionic/JJ monomeric/JJ X-ray/NN contrast/NN agent/NN iopromide/NN (/( Ultravist/NNP ,/, CAS/NN 73334-07-3/NN )/SYM were/VBD evaluated/VBN in/IN preclinical/JJ studies/NNS ./.
@@86082222888 The/DT membrane-distal/NN cytoplasmic/NN region/NN of/IN human/NEWGENE granulocyte/NEWGENE colony-stimulating/NEWGENE factor/NEWGENE receptor/NEWGENE is/VBZ required/VBN for/IN STAT3/NEWGENE but/CC not/RB STAT1/NEWGENE homodimer/NEWGENE formation/NN ./.
@@100909439186 The/DT mean/JJ value/NN of/IN the/DT CD79b/NEWGENE to/IN the/DT CD79b/NEWGENE internally/RB deleted/VBN ratio/NN was/VBD 0/CD ./CD 64/CD +/NN //NN -/NN 0/CD ./CD 20/CD SD/NN in/IN normal/JJ donors/NNS and/CC 0/CD ./CD 44/CD +/NN //NN -/NN 0/CD ./CD 27/CD SD/NN in/IN B-CLL/NN (/( P/NN =/CD ./CD 01/CD )/SYM ./.
@@28377632631 Amino/NN acid/NN sequence/NN of/IN one/PRP human/JJ liver/NN clone/NN (/( HL-14/NN )/SYM was/VBD identical/JJ to/IN the/DT rabbit/NEWGENE skeletal/NEWGENE muscle/NEWGENE phosphatase/NEWGENE 2A/NEWGENE cDNA/NEWGENE (/( with/IN 97%/CD nucleotide/NN identity/NN )/SYM ./.
@@105535518761 Factor/NEWGENE XI/NEWGENE deficiency/NN is/VBZ a/DT rare/JJ hereditary/JJ bleeding/NN disorder/NN affecting/VBG the/DT intrinsic/JJ pathway/NN ./.
@@82256578202 The/DT effect/NN of/IN ibopamine/NN and/CC furosemide/NN in/IN 130/CD patients/NNS with/IN NYHA/NN Class/NN I/NN and/CC II/NNP heart/NN failure/NN were/VBD studied/VBN in/IN a/DT parallel/NN ,/, double-blind/JJ ,/, randomized/JJ placebo-controlled/JJ multi-centre/JJ trial/NN ./.
@@85954143461 The/DT assembly/NN of/IN sequence/NN ready/JJ ,/, high-resolution/JJ physical/JJ maps/NNS and/CC construction/NN of/IN minimally/RB overlapping/JJ contigs/NNS for/IN the/DT human/JJ as/RB well/NN as/IN model/NN genomes/NNS requires/VBZ accurate/JJ determination/NN of/IN the/DT extent/NN of/IN overlap/NN between/IN adjacent/JJ clones/NNS as/RB well/VBP as/IN their/PRP relative/JJ orientation/NN ./.
@@3280021981 The/DT SSB-poly/NN (/NN dT/NN )/NN affinity/NN is/VBZ too/RB high/JJ to/IN measure/NN in/IN buffers/NNS containing/JJ even/VB 5/CD M/NN NaCl/NN ;/: however/RB ,/, in/IN 1/CD ./CD 8-2/CD ./CD 5/CD M/NNP NaBr/NNP ,/, we/PRP measure/VBP alpha/NN log/NN Kobsd/NNP //NNP alpha/NNP log/NN [/NN NaBr/NN ]/NN =/SYM -5/CD ./CD 7/CD +/NN //NN -/NN 0/CD ./CD 7/CD ,/, with/IN a/DT lower/JJR value/NN of/IN omega/NN T/NNP //NNP O/NNP =/SYM 130/CD +/NN //NN -/NN 70/CD ./CD
@@118461677119 Selenium/NN is/VBZ an/DT essential/JJ element/NN for/IN humans/NNS ,/, animals/NNS and/CC some/DT species/NN of/IN microorganisms/NNS ./.
@@108118044935 Consistent/JJ with/IN this/DT ,/, we/PRP show/VBP that/IN peptides/NNS representing/VBG docking/JJ sites/NNS within/IN the/DT target/NN substrates/NN Elk-1/NEWGENE and/CC p90/NEWGENE (/NEWGENE rsk/NEWGENE )/NEWGENE inhibit/VB ERK-dependent/NN activation/NN of/IN MKP-3/NEWGENE ./.
@@68728002230 Acute/NN type/NN A/NN hepatitis/NN in/IN three/CD patients/NNS with/IN chronic/JJ HBV/NN infection/NN ./.
@@24773731672 A/DT potential/JJ TATA/NN box/NN is/VBZ located/VBN 29/CD base/NN pairs/NNS upstream/RB of/IN the/DT first/JJ transcription/NN initiation/NN site/NN ./.
@@3392894087 Use/VB of/IN radioactive/JJ isotopes/NNS in/IN the/DT chemistry/NN of/IN proteins/NNS ./.
@@88876597703 Mutations/NNS at/IN two/JJ neighboring/JJ sites/NNS ,/, serine/NN 242/CD and/CC threonine/NN 255/CD ,/, exacerbated/VBD the/DT effect/NN ./.
@@842758382 Preface/NNP ./.
@@27323419449 Light/NNP microscopical/JJ and/CC routine/JJ immunohistochemical/JJ studies/NNS of/IN a/DT cervical/JJ neoplasm/NN in/IN a/DT 32/CD year/NN old/JJ woman/NN initially/RB suggested/VBD a/DT histiocytic/JJ lymphoma/NN ,/, but/CC histochemical/JJ staining/NN for/IN chloroacetate/NEWGENE esterase/NEWGENE established/VBD the/DT correct/JJ diagnosis/NN ./.
@@29273913587 All/DT of/IN the/DT newly/RB acquired/VBN proviruses/NNS identified/VBN in/IN mosaic/NN founder/NN SWR/NEWGENE //NEWGENE J-RF/NEWGENE //NEWGENE J/NEWGENE mice/NNS that/WDT could/MD be/VB transmitted/VBN through/RB the/DT germ/NN line/NN were/VBD also/RB present/VB in/IN somatic/JJ tissues/NNS ,/, demonstrating/VBG that/IN viral/JJ integration/NN occurred/VBN before/IN the/DT germ/NN line/NN was/VBD set/NN aside/NN from/IN the/DT somatic/JJ lineages/NNS ./.
@@99037229910 Autoionization/NNS rates/NNS and/CC energy/NN levels/NNS of/IN triplet/NN nf/NN ,/, v/NN =/NN 1/NN Rydberg/NNP states/NNS of/IN H2/NNP ./NNP
@@114419521316 At/NN 20/CD days/NNS (/( D/NN )/SYM and/CC at/IN 3/CD months/NNS post-TBI/JJ ,/, irradiated/JJ rats/NNS had/VBP a/DT significantly/RB lower/JJR percentage/NN of/IN avoidance/NN than/IN controls/NNS but/CC no/DT statistical/JJ difference/NN was/VBD found/VBN at/IN 5/CD months/NNS post-TBI/JJ ./. b/NNP //NNP Two-way/NNP avoidance/NN test/NN :/: this/DT test/NN was/VBD performed/VBN only/RB after/IN TBI/NN ./.
@@40403394715 Monitoring/NN changes/NNS in/IN the/DT heart/NN rate/NN of/IN the/DT premature/JJ fetus/NN during/IN tocolysis/NN with/IN the/DT beta-adrenomimetics/NNS partusisten/NN and/CC Pre-par/NN ./.
@@66436126378 Thin-layer/NNP chromatographic/JJ methods/NNS were/VBD up-dated/JJ for/IN pharmacokinetic/JJ studies/NNS of/IN imipramine/NN in/IN plasma/NN and/CC urine/NN ./.
@@10502216298 This/DT study/NN was/VBD designed/VBN to/IN compare/NN the/DT efficacy/NN of/IN efegatran/NN plus/IN streptokinase/NEWGENE versus/IN heparin/NN plus/IN accelerated/JJ tissue/NEWGENE plasminogen/NEWGENE activator/NEWGENE (/( TPA/NEWGENE )/SYM in/IN coronary/JJ reperfusion/NN in/IN acute/JJ MI/NNP ./NNP
@@95568619512 Based/VBN on/IN the/DT current/JJ literature/NN ,/, the/DT mechanisms/NNS involved/VBN in/IN the/DT toxicity/NN of/IN OA/NN indicate/VB three/CD major/JJ effects/NNS :/: (/( 1/CD )/SYM inhibition/NN of/IN mitochondrial/JJ respiration/NN correlated/VBN with/IN a/DT depletion/NN of/IN ATP/NN ;/: (/( 2/CD )/SYM inhibition/NN of/IN tRNA-synthetase/NEWGENE accompanied/VBN by/IN a/DT reduced/JJ protein/NN synthesis/NN ;/: and/CC (/( 3/CD )/SYM enhanced/VBN lipid/NN peroxidation/NN ./.
@@114355783451 And/CC ,/, most/RB importantly/RB ,/, reconstitution/NN of/IN a/DT consensus/NEWGENE CRE/NEWGENE ,/, within/IN the/DT 21-bp/JJ enhancers/NNS increases/NNS binding/NN of/IN CREB/NEWGENE //NEWGENE ATF/NEWGENE proteins/NEWGENE but/CC abrogates/VBZ basal/JJ repression/NN of/IN LTR-directed/JJ transcription/NN in/IN vitro/FW ./.
@@71754746997 The/DT cause/NN of/IN death/NN is/VBZ often/RB quite/RB apparent/JJ from/IN the/DT pathological/JJ and/CC toxicological/JJ findings/NNS ;/: however/RB ,/, the/DT manner/NN of/IN death/NN often/RB gives/VBZ the/DT examining/VBG official/JJ some/DT difficulty/NN ./.
@@64608896265 In/NN doses/NNS of/IN 0/CD ./CD 03-0/CD ./CD 3/CD mg/CD //CD kg/CD i/CD ./CD v/CD ./CD ,/, SG-75/NN did/VBD not/RB significantly/RB affect/VB pulse/NN pressure/NN ,/, heart/NN rate/NN ,/, aortic/JJ blood/NN flow/NN ,/, left/NN ventricular/JJ pressure/NN (/( LVP/NN )/SYM and/CC LVdP/NNP //NNP dt/NNP max/JJ ./.
@@106471771411 The/DT RNA/NN aptamer/NN contains/VBZ three/CD stems/NNS separated/VBN by/IN a/DT pair/NN of/IN two-base/JJ bulges/NNS ,/, and/CC adopts/VBZ an/DT unanticipated/JJ fold/NN in/IN which/WDT both/DT junctional/JJ sites/NNS are/VBP anchored/VBN through/JJ base/NN triple/JJ formation/NN ./.
@@29823326509 Phase/NNP II/NNP study/NN of/IN VP-16/NN (/( capsule/NN )/SYM in/IN solid/JJ tumors/NNS ./.
@@80839981866 These/DT results/NNS suggest/VBP that/IN leader-mRNA/NN fusion/NN in/IN coronavirus/NN transcription/NN does/VBP not/RB require/VB direct/JJ RNA-RNA/NNP interaction/NN between/IN complementary/JJ sequences/NNS ./.
@@108731581167 Activation/NNS of/IN nuclear/NEWGENE factor/NEWGENE (/NEWGENE NF/NEWGENE )/NEWGENE -kappaB/NEWGENE and/CC subsequent/JJ proinflammatory/JJ gene/NN expression/NN in/IN human/JJ airway/NN epithelial/JJ cells/NNS can/MD be/VB evoked/VBN by/IN oxidative/JJ stress/NN ./.
@@94227275507 A/DT cAMP-responsive/NEWGENE element-like/NEWGENE (/( CRE-like/NEWGENE ,/, TGACGTGA/NEWGENE )/SYM promoter/NN sequence/NN and/CC a/DT protein/NEWGENE kinase/NEWGENE A/NEWGENE signaling/JJ pathway/NN are/VBP involved/VBN in/IN this/DT induction/NN ,/, and/CC activation/NN of/IN both/DT CRE/NEWGENE binding/NEWGENE protein/NEWGENE (/( CREB/NEWGENE )/SYM and/CC activating/NEWGENE transcription/NEWGENE factor-2/NEWGENE (/( ATF-2/NEWGENE )/SYM is/VBZ required/VBN in/IN the/DT above/JJ process/NN ./.
@@63743696175 These/DT data/NN suggest/VB that/IN a/DT major/JJ part/NN of/IN the/DT reduction/NN in/IN food/NN intake/NN in/IN hyperphagic/JJ rats/NNS eating/JJ a/DT quinine-adulterated/JJ diet/NN is/VBZ due/NN to/IN postingestional/JJ events/NNS ./.
@@90102237842 Similarly/RB ,/, we/PRP examined/VBD whether/IN the/DT ELK1/NEWGENE ,/, SAP1a/NEWGENE ,/, FLI1/NEWGENE ,/, EWS-FLI1/NEWGENE ,/, ETS1/NEWGENE ,/, ETS2/NEWGENE ,/, PEA3/NEWGENE and/CC PU/NEWGENE ./NEWGENE 1/NEWGENE proteins/NEWGENE can/MD form/VB ternary/JJ complexes/NNS with/IN SRF/NEWGENE on/IN the/DT Egr1/NEWGENE SREI/NEWGENE1 and/NEWGENE1 II/NEWGENE1 ./.
@@93684199642 In/NN Arabidopsis/NN ,/, the/DT induction/NN of/IN a/DT dehydration-responsive/NEWGENE gene/NEWGENE ,/, rd22/NEWGENE ,/, is/VBZ mediated/JJ by/IN abscisic/JJ acid/NN (/( ABA/NN )/SYM and/CC requires/VBZ protein/NN biosynthesis/NN for/IN ABA-dependent/NEWGENE gene/NEWGENE expression/NN ./.
@@91505957158 Like/IN the/DT elicitors/NNS of/IN the/DT hypersensitive/JJ reaction/NN (/( HR/NN )/SYM produced/VBN by/IN E/NNP ./NNP chrysanthemi/NN (/( HarpinEch/NNP )/SYM and/CC E/NNP ./NNP amylovora/NN (/( HarpinEa/NNP )/SYM ,/, the/DT deduced/VBN 36-kDa/NN protein/NN does/VBP not/RB possess/VB a/DT typical/JJ signal/JJ sequence/NN ,/, but/CC it/PRP contains/VBZ a/DT putative/JJ membrane-spanning/JJ domain/NN ./.
@@89938312214 During/IN skeletal/JJ muscle/NN development/NN ,/, different/JJ types/NNS of/IN muscle/NN fibers/NNS are/VBP generated/VBN ,/, which/WDT express/VBP different/JJ combinations/NNS of/IN muscle-specific/NN gene/NN products/NN ./.
@@94887132763 This/DT resulted/VBN in/IN a/DT complete/JJ inhibition/NN of/IN Site-1/NN cleavage/NN that/WDT was/VBD restored/VBN by/IN concomitant/JJ overexpression/NN of/IN full-length/JJ SCAP/NEWGENE ./.
@@84470058407 Elimination/NN of/IN Haemophilus/NN influenzae/NNS type/NN b/NN meningitis/NN after/IN introduction/NN of/IN vaccination/NN ./.
@@97074985614 MK-801/NN administration/NN resulted/VBN in/IN a/DT biphasic/JJ response/NN in/IN seizure/NN latency/NN ./.
@@82620676209 The/DT functional/JJ homology/NN of/IN Cwg2/NEWGENE with/IN Cdc43/NEWGENE ,/, which/WDT has/VBZ been/VBN implicated/VBN in/IN the/DT control/NN of/IN cell/NN polarity/NN ,/, suggests/VBZ a/DT link/NN between/IN two/JJ morphogenetic/JJ events/NNS such/JJ as/IN establishment/NN of/IN cell/NN polarity/NN and/CC cell/NN wall/NN biosynthesis/NN ./.
@@88810364785 Using/VBG anchored/VBN PCR/NN ,/, a/DT VL/NEWGENE element/NEWGENE rearranged/JJ to/IN CL2/NEWGENE was/VBD isolated/VBN ./.
@@111524513242 The/DT Schistosoma/NEWGENE mansoni/NEWGENE homologue/NEWGENE (/( SmSmad2/NEWGENE )/SYM was/VBD overexpressed/VBN in/RB bacteria/NNS as/IN a/DT Sj26-GST/NEWGENE fusion/NEWGENE protein/NEWGENE and/CC used/VBN to/IN raise/NN specific/JJ antibodies/NNS ./.
@@86555555439 In/NN addition/NN ,/, 5'/NN deletions/NNS removing/JJ all/DT but/CC 34/CD bp/NN upstream/RB of/IN the/DT transcription/NN start/NN point/NN retained/VBN greater/JJR than/IN 90%/CD promoter/NN activity/NN ,/, suggesting/VBG that/IN the/DT -35/NN hexamer/NN was/VBD not/RB essential/JJ for/IN promoter/NN activity/NN ./.
@@29075333612 This/DT loss/NN was/VBD independent/NN of/IN drug/NN concentration/NN and/CC a/DT correction/NN factor/NN was/VBD employed/VBN to/IN calculate/VB the/DT true/JJ free/JJ diazepam/NN concentration/NN ./.
@@112891351171 Coexposure/NNS to/IN FP/NN also/RB resulted/VBD in/IN a/DT more/RB pronounced/VBN and/CC sustained/JJ activation/NN of/IN the/DT mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE kinase/NEWGENE //NEWGENE extracellular/NEWGENE signal-regulated/NEWGENE protein/NEWGENE kinase/NEWGENE cascade/NN after/IN PMA/NN treatment/NN ,/, although/IN disruption/NN of/IN this/DT pathway/NN by/IN the/DT mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE kinase/NEWGENE 1/NEWGENE inhibitor/NN U0126/NN did/VBD not/RB prevent/VB potentiation/NN of/IN apoptosis/NN ./.
@@95823082106 Indeed/RB ,/, it/PRP is/NNS shown/VBP that/IN it/PRP mediates/VBZ the/DT formation/NN of/IN disulfide-linked/NN homodimers/NN and/CC that/IN the/DT formation/NN of/IN homo-/JJ and/CC heterodimers/NNS are/VBP mutually/RB excluded/VBN ./.
@@16746623764 We/PRP enrolled/VBD 253/CD HIV-antibody/NEWGENE positive/JJ heroin/NN addicts/NNS without/IN HIV-related/JJ disease/NN (/( n/NN =/SYM 81/CD )/SYM or/CC with/IN persistent/JJ generalized/JJ lymphadenopathy/NN (/( n/NN =/SYM 172/CD )/SYM in/IN a/DT prospective/JJ study/NN to/IN evaluate/VB clinical/JJ progression/NN to/IN AIDS/NN related/NN complex/NN (/( ARC/NN )/SYM or/CC AIDS/NN and/CC to/IN identify/VB factors/NNS of/IN possible/JJ prognostic/JJ relevance/NN ./.
@@90583734599 Functional/JJ tests/NNS using/VBG a/DT reporter/NN gene/NN ,/, containing/NN Stat5-binding/NEWGENE elements/NEWGENE ,/, confirmed/VBN that/IN while/CC the/DT variant/NN form/NN was/VBD inactive/JJ by/IN itself/PRP ,/, it/PRP could/MD inhibit/VB the/DT function/NN of/IN the/DT full-length/JJ receptor/NN ./.
@@91650395769 The/DT monkey/NEWGENE LHR/NEWGENE cDNA/NEWGENE displayed/VBN 83-94%/CD overall/JJ sequence/NN homology/NN with/IN the/PDT other/DT mammalian/NEWGENE LHR/NEWGENE cDNAs/NEWGENE ./.
@@115669481440 In/NN hypertensive/JJ nephrosclerosis/NN ,/, therapy/NN containing/JJ an/DT ACEI/NN alone/RB or/CC in/IN combination/NN significantly/RB reduces/VBZ the/DT incidence/NN of/IN renal/JJ events/NNS ./.
@@14576952068 Removal/NNP of/IN beta/NEWGENE 2-microglobulin/NEWGENE by/IN hemodialysis/NN and/CC hemofiltration/NN :/: a/DT four/CD year/NN follow/VB up/RB ./RB
@@12955004147 Most/JJS of/IN the/DT patients/NNS presented/VBN with/IN Transient/NN Ischemic/NN Attacks/VBZ (/( 64%/JJ )/SYM or/CC Reversible/NNP Ischemic/NNP Neurologic/NNP Deficits/NNS (/( 19%/CD )/SYM ./.
@@27788738148 Another/DT segment/NN of/IN CRL3/NEWGENE (/( -296/CD to/IN -184/CD )/SYM ,/, also/RB displaying/VBG enhancer/NN function/NN ,/, contained/VBN tandem/NN repeated/JJ sequences/NNS (/( DR-A1/NEWGENE and/CC DR-A2/NEWGENE )/SYM ./.
@@112357771066 In/NNP Klinefelter's/NNP syndrome/NN (/( 47XXY/CD )/SYM ,/, serum/JJ testosterone/NN levels/NNS are/VBP at/IN the/DT lower/JJR end/NN of/IN the/DT normal/JJ range/NN and/CC dihydrotestosterone/NN levels/NNS are/VBP low/JJ ./.
@@28447977207 Whereas/IN the/DT muscle/NN isoform/NN consists/VBZ of/IN 997/CD amino/JJ acids/NNS and/CC terminates/VBZ with/IN the/DT sequence/NEWGENE Ala-Ile-Leu-Glu/NEWGENE ,/, the/DT second/JJ isoform/NN is/VBZ 1043/CD amino/JJ acids/NNS in/IN length/NN due/NN to/IN the/DT replacement/NN of/IN these/DT last/NN 4/CD amino/JJ acids/NNS with/IN a/DT 50-amino/JJ acid/NN sequence/NN that/WDT contains/VBZ a/DT potential/JJ transmembrane/JJ domain/NN followed/VBN by/IN a/DT consensus/NN sequence/NN for/IN an/DT N-linked/NN glycosylation/NN site/NN ./.
@@17144523416 Homology/NNS with/IN the/DT human/JJ protein/NN is/VBZ only/RB 34%/JJ in/IN the/DT tandem/NN repeat/NN domain/NN ,/, mainly/RB showing/VBG conservation/NN of/IN serines/NNS and/CC threonines/NNS ,/, presumed/VBN sites/NNS of/IN O-linked/JJ carbohydrate/NN attachment/NN ./.
@@4787145159 Efficacy/NNS of/IN a/DT three-/DT versus/IN a/DT five-week/JJ alcohol/NN treatment/NN program/NN ./.
@@10407184676 An/DT overexpression/NN of/IN the/DT betaAPP/NEWGENE gene/NEWGENE in/IN certain/JJ areas/NNS of/IN the/DT AD/NN brain/NN has/VBZ been/VBN suggested/VBN to/IN be/VB an/DT important/JJ factor/NN in/IN the/DT neuropathology/NN of/IN AD/NNP ./NNP
@@93248788820 Widening/NN of/IN the/DT abdominal/JJ aortic/JJ wall/NN on/IN an/DT ultrasound/JJ examination/NN was/VBD the/DT key/NN to/IN the/DT incidental/JJ diagnosis/NN of/IN a/DT clinically/RB unsuspected/JJ type/NN B/NN dissection/NN ./.
@@40887335638 Activity/NN of/IN acid/NEWGENE hydrolases/NEWGENE of/IN peripheral/JJ blood/NN leukocytes/NNS in/IN focal/JJ and/CC segmental/JJ pneumonia/NN in/IN children/NNS ./.
@@4236494872 These/DT techniques/NNS have/NN been/VBN used/VBN by/IN many/JJ people/NN for/IN many/JJ years/NNS and/CC no/DT claim/NN is/NNS being/VBP made/VBP for/IN any/DT innovation/NN in/IN this/DT regard/NN ./.
@@114132771029 In/NN conclusion/NN ,/, primary/JJ chemotherapy/NN based/VBN on/IN high/JJ dose/NN MTX/NN and/CC ara-C/NN is/VBZ highly/RB efficient/JJ in/IN PCNSL/NN ./.
@@16154931221 His/NN HC/NEWGENE II/NEWGENE activity/NN and/CC antigen/NN levels/NNS were/VBD 49%/CD and/CC 50%/CD ,/, respectively/RB ,/, and/CC his/PRP daughter/JJ also/RB showed/VBD similar/JJ low/JJ levels/NNS ./.
@@88538937618 In/NN this/DT study/NN ,/, we/PRP identified/VBD four/CD distinct/JJ E2F/NEWGENE complexes/NEWGENE present/VBP in/IN aged/VBN and/CC senescent/JJ normal/NN ,/, human/JJ diploid/JJ fibroblasts/NNS ./.
@@97334939712 Our/PRP results/NNS show/VBP that/IN ,/, from/IN a/DT thermodynamical/JJ standpoint/NN ,/, melatonin/NN may/MD directly/RB scavenge/VB hydroxyl/NN radicals/NNS both/DT in/NN vacuum/NN and/CC in/IN aqueous/JJ solution/NN ./.
@@15189268894 Selected/JJ topics/NNS in/IN pediatric/JJ ultrasonography--1992/NN ./.
@@107787571955 We/PRP report/VBP here/RB on/IN the/DT molecular/JJ nature/NN of/IN an/DT EMS-induced/NN mutant/NN ,/, mn1-89/NEWGENE ,/, a/DT leaky/JJ semidominant/JJ allele/NN of/IN the/DT Miniature1/NEWGENE (/( Mn1/NEWGENE )/SYM seed/JJ locus/NN that/IN encodes/VBZ a/DT seed-specific/NEWGENE cell/NEWGENE wall/NEWGENE invertase/NEWGENE ,/, INCW2/NEWGENE ./.
@@85567072989 These/DT data/NN indicate/VB that/IN although/IN 218leu/NN retains/VBZ normal/JJ transactivation/NN activity/NN on/IN a/DT p53/NEWGENE promoter/NEWGENE in/IN yeast/NN at/IN physiological/JJ temperatures/NNS ,/, it/PRP is/VBZ not/RB capable/JJ of/IN normal/JJ p53/NEWGENE function/NN in/IN the/DT presence/NN of/IN a/DT 248trp/NEWGENE allele/NEWGENE in/IN SNU-C5/NNP cells/NNS ./.
@@76076077508 Increase/VB in/IN urinary/JJ calcium/NN and/CC oxalate/NN after/IN fructose/NN infusion/NN ./.
@@95083775157 These/DT results/NNS would/MD suggest/VB that/IN a/DT high/JJ UV/NN sensitivity/NN is/VBZ associated/VBN with/IN high/JJ phaeomelanin/NN and/CC low/JJ eumelanin/NN levels/NNS ,/, and/CC point/NN to/IN the/DT eumelanin/NN //NN phaeomelanin/NN ratio/NN as/IN a/DT novel/JJ chemical/JJ parameter/NN that/WDT could/MD be/VB used/VBN for/IN predicting/JJ individuals/NNS at/IN high/JJ risk/NN for/IN skin/NN cancer/NN and/CC melanoma/NN ./.
@@116873528359 METHODS/IN :/: This/DT retrospective/JJ review/NN comprised/VBN 2711/CD eyes/NNS that/WDT had/VBP LASIK/NN between/IN September/NN 1996/CD and/CC September/NN 1999/CD ./.
@@85677177200 The/DT Saccharomyces/NN cerevisiae/NN spindle/NN pole/NN body/NN duplication/NN gene/NEWGENE MPS1/NEWGENE is/VBZ part/NN of/IN a/DT mitotic/JJ checkpoint/NN ./.
@@18620272457 These/DT features/NNS were/VBD considered/VBN consistent/JJ with/IN a/DT diagnosis/NN of/IN Rothmund-Thomson/NNP syndrome/NN ./.
@@93676764667 Transfection/NNS analyses/NNS indicated/VBN that/IN the/DT expression/NN of/IN Tbxas1/NEWGENE is/VBZ controlled/VBN by/IN a/DT short/JJ (/( 70-bp/JJ )/SYM positive/JJ regulatory/JJ sequence/NN and/CC several/DT upstream/RB repressive/JJ elements/NNS ./.
@@40814254765 Clinical/NNP aspects/NNS and/CC therapy/NN ./.
@@43089794917 Effect/NN of/IN variations/NNS in/IN time/NN interval/NN between/IN treatment/NN with/IN BCG/NN and/CC quartz/NN dust/NN on/IN translocation/NN of/IN quartz/NN dust/NN from/IN the/DT lungs/NNS to/IN their/PRP regional/JJ lymph/NN nodes/NNS ./.
@@41750074837 To/TO the/DT problem/NN of/IN the/DT stimulation/NN of/IN the/DT growth/NN of/IN transplantable/JJ tumors/NNS of/IN animals/NNS previously/RB treated/VBN with/IN antineoplastic/JJ antibiotics/NNS ./.
@@23320182429 Despite/IN the/DT absence/NN of/IN exercise-induced/JJ asthma/NN (/( EIA/NN )/SYM while/CC breathing/JJ WH/NN air/NN ,/, asthmatic/JJ patients/NNS still/RB had/VBP significantly/RB higher/JJ mean/JJ GH/NN increments/NNS than/IN normal/JJ subjects/NNS (/( 9/CD ./CD 2/CD vs/NNP 2/CD ./CD 3/CD ng/NN //NN ml/NN ,/, P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@117324171578 The/DT cut-off/JJ percentage/NN positivity/NN value/NN was/VBD established/VBN using/VBG 500/CD brucellosis-positive/JJ and/CC 500/CD brucellosis-negative/JJ serum/JJ samples/NNS ,/, confirmed/VBN with/IN reference/NN to/IN the/DT sample/NN data/NN using/VBG the/DT indirect/JJ ELISA/NN kit/NN ./.
@@94056851876 As/IN a/DT sequence-specific/NN DNA/NN binding/NN transcription/NN factor/NN ,/, p53/NEWGENE specifically/RB binds/VBZ to/IN a/DT 20-bp/NEWGENE consensus/NEWGENE motif/NEWGENE 5'-PuPuPuC/NEWGENE (/NEWGENE A/NEWGENE //NEWGENE T/NEWGENE )/NEWGENE (/NEWGENE T/NEWGENE //NEWGENE A/NEWGENE )/NEWGENE GPyPyPyPuPuPuC/NEWGENE (/NEWGENE A/NEWGENE //NEWGENE T/NEWGENE )/NEWGENE (/NEWGENE T/NEWGENE //NEWGENE A/NEWGENE )/NEWGENE GPyPyPy-3'/NEWGENE ./.
@@9931216815 Airflow/NN was/VBD measured/VBN with/IN a/DT custom-designed/JJ turbine/NN and/CC a/DT 45-ft/NN ./NN -long/NN cable/NN to/IN reach/NN the/DT volume-measuring/JJ module/NN ./.
@@63101591705 Viral/JJ RNA/NN ,/, molecularly/RB cloned/VBN proviral/JJ DNA/NN ,/, and/CC virus-specific/NN protein/NN of/IN avian/JJ retrovirus/NN MH2/NN were/VBD analyzed/VBN ./.
@@77232477676 To/TO study/VB the/DT mechanisms/NNS as/RB well/VBP as/IN magnitude/NN of/IN the/DT transmembrane/JJ transfer/NN of/IN bacterial/JJ products/NNS from/IN the/DT dialysate/NN ,/, we/PRP developed/VBD a/DT computerized/NN in/IN vitro/FW dialysis/NN model/NN which/WDT provides/VBZ continuous/JJ pressure/NN recording/JJ from/IN the/DT arterial/JJ ,/, venous/JJ ,/, dialysate/NN inflow/NN and/CC outflow/NN ports/NNS ./.
@@109321967424 Mutations/NNS in/IN the/DT RP2/NEWGENE locus/NEWGENE at/NEWGENE Xp11/NEWGENE ./NEWGENE 3/NEWGENE were/VBD found/VBN in/IN a/DT further/JJ 10-20%/NN of/IN XLRP/NNP patients/NNS ,/, as/IN predicted/VBN from/IN linkage/NN studies/NNS ./.
@@64677976272 There/EX was/VBD a/DT close/JJ correlation/NN between/IN plasma/NN clearance/NN of/IN NT/NN by/IN 10-hydroxylation/JJ and/CC the/DT D/NN metabolic/JJ ratio/NN (/( D/NNP //NNP 4-OH-D/NNP in/IN urine/NN )/SYM in/IN the/DT Ghanaians/NNPS (/( rs/NNS =/SYM -0/CD ./CD 95/CD ;/: P/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM and/CC Swedes/NNPS (/( rs/NNS =/SYM -0/CD ./CD 84/CD ;/: P/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ./.
@@10520800353 METHODS/IN :/: We/PRP studied/VBD 20/CD symptomatic/JJ patients/NNS with/IN HOCM/NNS (/( 12/CD men/NNS )/SYM ,/, mean/JJ age/NN 52/NN +/NN //NN -/NN 17/CD years/NNS ,/, before/IN and/CC after/IN septal/JJ reduction/NN using/VBG echocardiography/NN and/CC electrocardiogram/NN (/( ECG/NN )/SYM ./.
@@90552213679 The/DT intensity/NN of/IN the/DT SSTEs/NN is/VBZ an/DT order/NN of/IN magnitude/NN larger/JJR than/IN that/DT of/IN the/DT MSEs/NN and/CC determines/VBZ the/DT signal/JJ contrast/NN if/IN both/DT effects/NNS are/VBP selected/VBN simultaneously/RB ./.
@@10932329748 The/DT limit/NN between/IN the/DT cecum/NN and/CC the/DT ascending/JJ colon/NN was/VBD externally/RB marked/JJ by/IN the/DT sulcus/NN cecocolicus/NN dorsalis/JJ and/CC ventralis/NN ./.
@@114309768409 Special/JJ issues/NNS devoted/VBN to/IN the/DT biosynthesis/NN of/IN woody/JJ plant/NN biopolymers/NNS and/CC related/VBN substances/NNS ./.
@@100686373366 Interestingly/RB ,/, Csx/NEWGENE //NEWGENE Nkx2/NEWGENE ./.
@@95965369551 Consequently/RB ,/, it/PRP is/VBZ not/RB known/VBP how/RB knee/VBP loading/VBG changes/NNS following/IN ACL/NN transection/NN ,/, and/CC how/RB it/PRP contributes/VBZ to/IN cartilage/NN degeneration/NN ./.
@@87700215321 Increased/VBN PTHRP/NEWGENE production/NN by/IN a/DT tyrosine/NEWGENE kinase/NEWGENE oncogene/NEWGENE ,/, Tpr-Met/NEWGENE :/: role/NN of/IN the/DT Ras/NEWGENE signaling/JJ pathway/NN ./.
@@16783922534 The/DT 95%/CD confidence/NN values/NNS (/( 2SD/CD )/SYM for/IN the/DT change/NN in/IN Ros/NNS required/VBN to/IN exclude/VB natural/JJ variability/NN were/VBD 0/CD ./CD 39/CD ,/, 0/CD ./CD 50/CD and/CC 0/CD ./CD 53/CD cmH2O/NN l-1/NN s/NN ,/, respectively/RB ./.
@@88876781986 Expression/NNS of/IN the/DT proapoptotic/NEWGENE protein/NEWGENE Bax/NEWGENE under/IN the/DT control/NN of/IN a/DT GAL10/NEWGENE promoter/NEWGENE in/IN Saccharomyces/NN cerevisiae/NN resulted/VBN in/IN galactose-inducible/JJ cell/NN death/NN ./.
@@94070263583 TSA/NN treatment/NN ,/, however/RB ,/, did/VBD not/RB detectably/RB alter/VB enhancer/NN factor/NN binding/JJ or/CC the/DT positioning/NN of/IN nuc-1/NEWGENE on/IN the/DT majority/NN of/IN the/DT chromatin/NN templates/NNS indicating/VBG that/DT protein/NN acetylation/NN and/CC chromatin/NN remodeling/NN may/MD be/VB limiting/JJ steps/NNS that/WDT occur/VBP only/RB on/IN transcriptionally/RB competent/JJ templates/NNS ,/, or/CC that/DT remodeling/NN of/IN nuc-1/NEWGENE requires/VBZ additional/JJ factors/NNS ./.
@@63099696095 I/NNP ./NNP
@@102285618286 We/PRP analyzed/VBD the/DT modular/JJ organization/NN of/IN DNA/NEWGENE polymerase/NEWGENE beta/NEWGENE and/CC found/VB that/IN residues/NNS making/VBG contact/NN with/IN DNA/NN phosphates/NNS were/VBD localized/VBN to/IN five/CD modules/NNS ./.
@@11710201552 The/DT effects/NNS initiated/VBN from/IN the/DT nucleus/NN accumbens/NNS septi/NN were/VBD most/RB marked/JJ ./.
@@91547951638 Using/VBG various/JJ techniques/NNS ,/, we/PRP have/VBP undertaken/VBP a/DT systematic/JJ analysis/NN of/IN the/DT natural/JJ TATA-less/NNP human/NEWGENE DNA/NEWGENE polymerase/NEWGENE beta/NEWGENE (/( beta-pol/NEWGENE )/SYM gene/NN promoter/NN ./.
@@2195651959 The/DT incidence/NN of/IN hepatitis/NEWGENE B/NEWGENE antigen/NEWGENE following/IN transfusion/NN was/VBD about/RB 2/CD ./CD 8/CD per/IN cent/NN ./.
@@2102202701 Molecular/NNP neurochemistry/NN of/IN addictive/JJ drugs/NNS ./.
@@1541556186 Radiolabelled/JJ palmitate/NN was/VBD not/RB incorporated/VBN into/IN the/DT mutated/NN protein/NN ,/, showing/VBG that/DT lipid/NN modification/NN occurs/VBZ at/IN the/DT Cys-22/NN residue/NN ./.
@@96730379643 METHODS/IN :/: Fibrotic/JJ changes/NNS involving/VBG bone/NN marrow/NN were/VBD evaluated/VBN histologically/RB semiquantitatively/RB using/VBG reticulin/NN fiber/NN impregnation/NN (/( method/NN of/IN Gomori/NN )/SYM ./.
@@106825707812 LPO/NN and/CC SOD/NEWGENE levels/NNS were/VBD measured/VBN at/IN five/CD points/NNS before/IN and/CC during/IN the/DT operation/NN ./.
@@2800435752 Acute/JJ experiments/NNS on/IN nembutal-anesthetized/JJ cats/NNS (/( 50/CD mg/CD //CD kg/CD )/SYM were/VBD employed/VBN to/IN investigate/VB the/DT effect/NN of/IN 1/CD T/NN pulsating/JJ magnetic/JJ field/NN (/( PMF/NN )/SYM on/IN neuromuscular/JJ system/NN of/IN the/DT leg/NN ./.
@@23738104405 In/NN contrast/NN ,/, 2/NN ,/NN 397/NN (/( 74%/JJ )/SYM had/VBP one/PRP or/CC more/JJ risk/NN factors/NNS (/( not/RB low/JJ risk/NN )/SYM ;/: of/IN these/DT ,/, 5/CD ./CD 3%/CD died/VBN in/IN 6/CD weeks/NNS (/( p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ./.
@@91173457826 Activation/NNS of/IN alpha/NEWGENE 4/NEWGENE beta/NEWGENE 1/NEWGENE with/IN TS2/NEWGENE //NEWGENE 16/NEWGENE inhibited/VBN the/DT cytoplasmic/JJ protrusions/NNS and/CC cell/NN migration/NN but/CC did/VBD not/RB affect/VB the/DT pattern/NN of/IN phosphorylation/NN ./.
@@19061666993 Mitomycin-C/NN can/MD cause/VB severe/JJ necrosis/NN and/CC ulceration/NN when/CC extravasated/JJ inadvertently/RB into/IN skin/NN and/CC soft/JJ tissues/NNS following/IN IV/NN drug/NN administration/NN ./.
@@85504603438 The/DT transposon-inactivated/JJ gene/NN ,/, designated/VBN pilP/NEWGENE ,/, is/VBZ 525/CD bp/NN long/JJ ,/, potentially/RB encoding/VBG a/DT 19/NN ./NN 1-kDa/NN protein/NN precursor/NN that/WDT contains/VBZ a/DT typical/JJ membrane/NN lipoprotein/NN leader/NN sequence/NN ./.
@@61303485949 Isolation/NNS of/IN Aeromonas/NNS from/IN faeces/NNS ./.
@@29679156342 The/DT seco-steroid/NN hormone/NN 1/NN ,/NN 25-dihydroxyvitamin/NN D3/NN is/NNS known/VBP to/IN induce/VB the/DT expression/NN of/IN a/DT calcium/NN binding/NN protein/NN termed/JJ calbindin-D28K/NEWGENE in/IN a/DT variety/NN of/IN target/NN tissues/NNS ./.
@@90016678960 In/NN all/DT cases/VBZ the/DT antigenemia/NN was/VBD transient/JJ and/CC cleared/VBN by/IN 28th/CD day/NN post-vaccination/NN ./.
@@90291596625 The/DT interferon/NEWGENE (/( IFN/NEWGENE )/NN -induced/NN double-stranded/NEWGENE RNA/NEWGENE (/NEWGENE dsRNA/NEWGENE )/NEWGENE -activated/NEWGENE Ser/NEWGENE //NEWGENE Thr/NEWGENE protein/NEWGENE kinase/NEWGENE (/( PKR/NEWGENE )/SYM plays/VBP a/DT role/NN in/IN the/DT antiviral/JJ and/CC antiproliferative/JJ effects/NNS of/IN IFN/NEWGENE ./.
@@111184406492 Differential/JJ association/NN of/IN products/NNS of/IN alternative/JJ transcripts/NNS of/IN the/DT candidate/NN tumor/NEWGENE suppressor/NEWGENE ING1/NEWGENE with/IN the/DT mSin3/NEWGENE //NEWGENE HDAC1/NEWGENE transcriptional/NEWGENE corepressor/NEWGENE complex/NEWGENE ./.
@@8139577540 Identical/JJ components/NNS of/IN yeast/NN transcription/NEWGENE factor/NEWGENE IIIB/NEWGENE are/VBP required/VBN and/CC sufficient/JJ for/IN transcription/NN of/IN TATA/NN box-containing/JJ and/CC TATA-less/NN genes/NNS ./.
@@91124006947 DNA-binding/NN activity/NN was/VBD not/RB increased/VBN by/IN the/DT addition/NN of/IN forskolin/NN to/IN thecal/JJ or/CC luteal/JJ cells/NNS ./.
@@974998822 Badcock/NNP and/CC Westheimer/NNP (/( Spatial/JJ Vision/NN 1/NN (/( 1/CD )/SYM ,/, 3-11/CD ,/, 1985/NN )/NN showed/VBD that/IN a/DT thin/JJ vertical/JJ line/NN induces/VBZ nearby/JJ zones/NNS of/IN attraction/NN and/CC repulsion/NN ;/: this/DT study/NN extends/VBZ those/DT results/NNS by/IN more/RB closely/RB examining/VBG the/DT horizontal/JJ and/CC vertical/JJ extents/NNS of/IN the/DT repulsion/NN zone/NN and/CC by/IN using/VBG an/DT illusory/JJ contour/NN to/IN induce/VB repulsion/NN ./.
@@90240398988 Forty-one/JJ ASA/NN physical/JJ status/NN I/PRP or/CC II/NNP adult/JJ patients/NNS undergoing/VBG a/DT variety/NN of/IN 1-1/CD ./CD 5/CD h/NN surgical/JJ procedures/NNS were/VBD randomly/RB allocated/VBN to/IN receive/VB CCA/NN with/IN desflurane/NN or/CC isoflurane/NN with/IN ventilation/NN being/VBP either/DT spontaneous/JJ or/CC controlled/VBN ./.
@@107756239580 The/DT codon/NN usage/NN is/VBZ particularly/RB marked/JJ for/IN the/DT gag/NEWGENE ,/, pol/NEWGENE ,/, and/CC env/NEWGENE genes/NEWGENE ./.
@@18552552552 Premature/JJ initiation/NN of/IN mitosis/NN in/IN yeast/NN lacking/JJ RCC1/NEWGENE or/CC an/DT interacting/VBG GTPase/NEWGENE ./.
@@95125596563 Position-independent/JJ expression/NN of/IN a/DT human/NEWGENE nerve/NEWGENE growth/NEWGENE factor-luciferase/NEWGENE reporter/NEWGENE gene/NEWGENE cloned/VBN on/IN a/DT yeast/NN artificial/JJ chromosome/NN vector/NN ./.
@@1978857990 Judicious/JJ use/NN of/IN laboratory/NN testing/NN ,/, including/JJ monitoring/NN of/IN CD4/NEWGENE cell/NN counts/NNS ,/, is/VBZ recommended/VBN ./.
@@22666792904 Plasma/NN Al/NN was/VBD obtained/VBN during/IN each/DT baseline/NN and/CC drug/NN course/NN ./.
@@53891255519 The/DT exploratory/JJ behaviour/NN in/IN normal/JJ and/CC aggressive/JJ mice/NNS ./.
@@10102000767 31/CD ,/, 1997/CD ,/, 40/CD patients/NNS had/VBP died/VBN (/( 35/CD in/IN the/DT ERA-II/NN group/NN and/CC 5/CD in/IN the/DT ERA-III/NN group/NN )/SYM ,/, for/IN a/DT crude/JJ mortality/NN rate/NN of/IN 8/CD ./CD 0%/CD ./.
@@18235242427 The/DT relatively/JJ scanty/JJ number/NN of/IN examples/NNS ,/, which/WDT could/MD be/VB justified/VBN by/IN the/DT variety/NN and/CC complexity/NN of/IN combined/JJ exposure/NN ,/, allows/VBZ to/IN conclude/VB that/IN life-style/NN factors/NNS have/VBP considerable/JJ influence/NN on/IN interindividual/JJ differences/NNS in/IN susceptibility/NN to/IN xenobiotics/NNS toxicity/NN ./.
@@90411233199 However/RB ,/, the/DT action/NN of/IN each/DT cognate/NN ligand/NN and/CC the/DT accessory/JJ cellular/JJ factors/NNS that/WDT can/MD differentially/RB regulate/VB the/DT transcriptional/JJ responses/NNS of/IN a/DT heterodimer-DNA/NN complex/NN are/VBP not/RB well/VB understood/VBP ./.
@@196255918 REM/NN dream/NN content/NN was/VBD scored/VBN for/IN categories/NNS suggesting/VBG the/DT predominant/JJ influence/NN of/IN the/DT left/NN hemisphere/NN ,/, e/FW ./FW g/FW ./FW ,/, good/JJ ego/NN functioning/NN ,/, verbalization/NN ,/, or/CC the/DT right/JJ hemisphere/NN ,/, e/FW ./FW g/FW ./FW ,/, music/NN ,/, spatial/JJ salience/NN ,/, bizarreness/NN ./.
@@103205796419 We/PRP suggest/VBP that/IN FlgN/NEWGENE and/CC FliT/NEWGENE are/VBP substrate-specific/JJ flagellar/JJ chaperones/NNS that/WDT prevent/VBP oligomerization/NN of/IN the/DT HAPs/NEWGENE by/IN binding/JJ to/IN their/PRP helical/JJ domains/NNS before/IN export/NN ./.
@@86210174911 LY290181/NN appears/VBZ to/IN inhibit/VB uPA/NEWGENE promoter/NEWGENE activation/NN by/IN blocking/JJ phorbol/NN ester-stimulated/JJ binding/NN of/IN nuclear/JJ proteins/NNS to/IN the/DT uPA/NEWGENE PEA3/NEWGENE1 //NEWGENE1 12-0-tetradecanoylphorbol/NEWGENE1 13-acetate/NEWGENE1 responsive/NEWGENE1 element/NEWGENE1 (/( TRE/NEWGENE )/SYM ./.
@@72824447137 Forty-five/CD cases/NNS were/VBD surgically/RB by/IN direct/JJ approach/NN to/IN the/DT tumour/NN ,/, while/CC two/JJ cases/NNS were/VBD treated/VBN only/RB with/IN a/DT shunt/NN ./.
@@18046719256 In/NN line/NN with/IN the/DT small/JJ values/NNS for/IN QS/NNP //NNP QC/NNP ,/, our/PRP results/NNS further/RB indicate/VBP that/WDT even/VBP large/JJ ,/, well-perfused/JJ ,/, occluded/VBN air/NN spaces/NNS in/IN the/DT lung/NN will/MD hardly/RB affect/VB the/DT recovered/VBN ventilation/NN //NN perfusion/NN distribution/NN obtained/VBN from/IN inert/JJ gas/NN data/NN when/CC CDCSF6/NN exceeds/VBZ 0/CD ./CD 1/CD ml/CD ./CD min-1/CD ./CD mmHg-1/CD ./.
@@5191735427 All/DT 13/CD patients/NNS showed/VBD endoscopic/JJ evidence/NN of/IN oesophagitis/NN ,/, moderate/JJ in/IN 4/CD and/CC severe/JJ in/IN 9/CD ./CD
@@75435923864 A/DT transformation-competent/JJ mutant/NN ,/, like/VB the/DT wild-type/NEWGENE E5/NEWGENE protein/NEWGENE ,/, bound/VBD the/DT receptor/NN and/CC induced/VBN receptor/NN tyrosine/NN phosphorylation/NN and/CC down-regulation/NN ./.
@@98587457415 The/DT location/NN of/IN the/DT IBS/NNS within/IN the/DT catB/NEWGENE structural/NEWGENE gene/NEWGENE ,/, the/DT cooperativity/NN observed/VBN in/IN footprinting/VBG studies/NNS and/CC phasing/JJ studies/NNS suggest/VBP that/IN the/DT IBS/NNS participates/VBZ in/IN the/DT interaction/NN of/IN CatR/NEWGENE with/IN the/DT upstream/RB binding/JJ sites/NNS by/IN looping/NN out/RB the/IN intervening/JJ DNA/NN ./.
@@88251789223 The/DT initial/JJ inpatient/NN experience/NN for/IN individuals/NNS with/IN HIV-related/NN TB/NN may/MD be/VB pivotal/JJ to/IN the/DT acceptance/NN of/IN and/CC participation/NN in/IN ongoing/JJ TB/NN care/NN ./.
@@89001647605 T/NNP ./NNP ,/, Patel/NNP ,/, S/NNP ./NNP
@@79289543366 DNA/NN sequence/NN analysis/NN showed/VBN that/IN the/DT gene/NN was/VBD 525/CD bp/NN long/JJ and/CC encoded/VBN a/DT 175-amino-acid/JJ protein/NN with/IN a/DT molecular/JJ weight/NN of/IN 19/CD ,/CD 094/CD containing/JJ a/DT 21-residue/JJ typical/JJ lipoprotein/NN signal/JJ peptide/NN and/CC consensus/NN prolipoprotein/NN processing/VBG site/NN ./.
@@17319339489 Zn/NEWGENE (/NEWGENE II/NEWGENE )/NEWGENE coordination/NEWGENE domain/NEWGENE mutants/NEWGENE of/NEWGENE T4/NEWGENE gene/NEWGENE 32/NEWGENE protein/NEWGENE ./.
@@28466403668 All/DT of/IN the/DT indigo-producing/JJ bacteria/NNS had/VBP an/DT indoxyl/NEWGENE phosphatase/NEWGENE with/IN a/DT pI/NN of/IN 6/CD ./CD 4/CD ./.
@@84900028450 Xylose-/NNP and/CC arabinose-containing/JJ polymers/NNS were/VBD better/RBR digested/VBN than/IN was/VBD cellulose/NEWGENE for/IN both/DT breads/NNS ./.
@@91547977622 Saturable/NNP spermidine/NN transport/NN in/IN stk2/NEWGENE :/: :/: lacZ/NEWGENE mutants/NEWGENE had/VBP an/DT approximately/RB fivefold-lower/JJ affinity/NN and/CC twofold-lower/JJ Vmax/NN than/IN in/IN the/DT parental/JJ strain/NN ./.
@@112550356931 Unlike/IN other/DT progenitor/NN cells/NNS of/IN the/DT brain/NN ,/, SVZa/NNS progenitor/NN cells/NNS have/VBP the/DT capacity/NN to/IN divide/NN even/VB though/CC they/PRP express/VBP a/DT neuronal/NN phenotype/NN ./.
@@98379071624 The/DT decrease/NN of/IN TNF/NEWGENE receptors/NEWGENE by/IN IL-4/NEWGENE was/VBD accompanied/VBD by/IN down-regulation/NN of/IN TNF-induced/JJ activities/NNS ,/, including/JJ cytotoxicity/NN ,/, caspase-3/NEWGENE activation/NN ,/, NF-kappaB/NEWGENE and/CC AP-1/NEWGENE activation/NN ,/, and/CC c-Jun/NEWGENE N-terminal/NEWGENE kinase/NEWGENE induction/NN ./.
@@107584899268 Here/RB we/PRP report/VBP on/IN the/DT isolation/NN of/IN ICK2/NEWGENE ,/, and/CC show/VB that/IN it/PRP interacts/VBZ with/IN Cdc2aAt/NEWGENE ,/, but/CC not/RB with/IN a/DT second/JJ CDK/NEWGENE from/NEWGENE Arabidopsis/NEWGENE ,/, Cdc2bAt/NEWGENE ./.
@@105266703607 Rac/NEWGENE causes/NNS uncapping/VBG of/IN actin/NEWGENE filaments/NEWGENE (/( F-actin/NEWGENE )/SYM at/IN the/DT plus-ends/NNS ,/, through/JJ phosphatidylinositol/NN 4/CD ,/CD 5/CD bisphosphate/NN (/( PIP2/NN )/SYM ,/, and/CC eventually/RB induces/VBZ membrane/NN ruffling/JJ ./.
@@93094575845 Assays/NNS of/IN total/JJ cholesterol/NN as/RB well/VB as/IN the/DT HDL/NEWGENE ,/, HDL2/NEWGENE ,/, LDL/NEWGENE ,/, triglycerides/NNS ,/, endothelin-1/NEWGENE ,/, lipoprotein/NEWGENE (/NEWGENE a/NEWGENE )/NEWGENE ,/, estradiol/NN and/CC FSH/NEWGENE were/VBD also/RB obtained/VBN at/IN baseline/NN before/IN receiving/JJ ERT/NN and/CC after/IN 3/CD months/NNS of/IN ERT/NN ./.
@@76156344522 These/DT transcripts/NNS have/NN a/DT unique/RB 5'untranslated/VBN region/NN and/CC NH2-terminal/NN sequence/NN and/CC encode/VB a/DT predicted/VBN protein/NN of/IN 121/CD kD/CD ./CD
@@99228565886 Trinipatch/NN is/VBZ a/DT small/NN ,/, transparent/JJ ,/, matricial/JJ ,/, monolayer/JJ patch/NN with/IN an/DT absorption/NN promoter/NN ,/, marketed/VBN in/IN two/JJ dose-strengths/NNS (/( 5/CD mg/CD //CD 24/CD h/NN and/CC 10/CD mg/CD //CD 24/CD h/NN )/SYM by/IN Laboratoires/NNP Synthelabo/NNP ./.
@@90052735159 CONCLUSION/IN :/: Some/DT Gulf/NNP War/NNP veterans/NNS may/MD have/VB delayed/JJ ,/, chronic/JJ neurotoxic/JJ syndromes/NNS from/IN wartime/NN exposure/NN to/IN combinations/NNS of/IN chemicals/NNS that/WDT inhibit/VBP butyrylcholinesterase/NEWGENE and/CC neuropathy/NEWGENE target/NEWGENE esterase/NEWGENE ./.
@@78571637838 The/DT activity/NN of/IN 6-fluoroquinolones/CD and/CC their/PRP nonfluorinated/JJ derivatives/NNS is/VBZ compared/VBN in/IN general/NN ./.
@@23271597291 Lars/NNP has/VBZ AIDS--a/NN more/RB dignified/JJ life/NN with/IN care/NN at/IN home/NN ./.
@@86571573951 Transcriptional/NN regulators/NN utilizing/VBG the/DT POU/NEWGENE domain/NEWGENE DNA-binding/NN motif/NN have/NN been/VBN shown/VBP to/IN form/NN multi-protein/JJ complexes/NNS dependent/JJ on/IN the/DT POU/NEWGENE domain/NEWGENE itself/PRP and/CC its/PRP flexible/JJ recognition/NN of/IN various/JJ octamer/NN sequence/NN elements/NNS ./.
@@90508676209 These/DT elements/NNS comprise/VBP a/DT binding/JJ site/NN for/IN Krox/NEWGENE proteins/NEWGENE ,/, one/PRP for/IN nuclear/NEWGENE factor/NEWGENE 1/NEWGENE ,/, an/DT octamer/NN motif/NN that/WDT binds/VBZ POU-homeodomain/NEWGENE proteins/NEWGENE ,/, and/CC a/DT novel/JJ TN/NEWGENE control/NEWGENE element/NEWGENE ./.
@@67403736503 In/NN this/DT study/NN the/DT splenectomized/JJ captive/JJ born/JJ cynomolgus/RB appeared/VBN to/IN be/VB capable/JJ of/IN supplementing/VBG rhesus/NN as/IN an/DT antimalarial/JJ drug/NN testing/NN model/NN ./.
@@32324101922 It/PRP has/VBZ been/VBN calculated/VBN that/IN 600/NN ,/NN 000/NN new/JJ cases/NNS of/IN lung/NN cancer/NN occur/VB worldwide/RB every/DT year/NN ,/, most/RB of/IN them/PRP due/NN to/IN smoking/NN ./.
@@113697009455 In/NN this/DT manuscript/NN we/PRP demonstrate/VBP that/IN two/JJ tandem/NEWGENE Ets/NEWGENE sites/NEWGENE in/IN the/DT mouse/NEWGENE GL/NEWGENE alpha/NEWGENE promoter/NEWGENE bind/NN the/DT transcription/NEWGENE factors/NEWGENE Elf-1/NEWGENE and/CC PU/NEWGENE ./NEWGENE 1/NEWGENE ,/, and/CC that/IN the/DT 3'/NN site/NN is/VBZ essential/JJ for/IN expression/NN of/IN a/DT luciferase/NEWGENE reporter/NEWGENE gene/NEWGENE driven/VBP by/IN the/DT GL/NEWGENE alpha/NEWGENE promoter/NEWGENE ./.
@@92366561485 The/DT mean/JJ total/JJ white/JJ cell/NN count/NN increased/VBN from/IN a/DT baseline/NN of/IN 11/CD ./CD 3/CD x/NN 10/NN (/NN 9/NN )/NN //NN L/NN (/( SD/NN 2/NN ./NN 3/NN )/SYM to/IN 16/CD ./CD 2/CD x/NN 10/NN (/NN 9/NN )/NN //NN L/NN (/( SD/NN 4/NN ./NN 6/NN )/SYM on/IN day/NN 1/CD ,/, normalising/JJ thereafter/RB ./.
@@105687286533 The/DT level/NN of/IN serum/NEWGENE creatine/NEWGENE kinase/NEWGENE was/VBD significantly/RB high/JJ 2/CD days/NNS after/IN ESWIB/NN ,/, but/CC it/PRP recovered/VBD in/IN a/DT week/NN ./.
@@37346414400 The/DT results/NNS show/NN that/DT nerve/NN and/CC roots/NNS differ/VB considerably/RB both/DT in/NN the/DT force/NN they/PRP sustain/VBP before/IN failure/NN and/CC in/IN the/PDT other/DT biomechanics/NN they/PRP exhibit/VBP ./.
@@113761655954 FLP/NEWGENE and/CC Cre/NEWGENE recombinase/NEWGENE function/NN in/IN Xenopus/NN embryos/NNS ./.
@@98130935811 We/PRP detected/VBD no/DT effect/NN of/IN deleting/VBG YCL024W/NEWGENE ,/, either/DT alone/RB or/CC in/IN combination/NN with/IN deletion/NN of/IN GIN4/NEWGENE ./.
@@11006283778 Recombinant/NEWGENE AROM-p64/NEWGENE displayed/VBN high/JJ binding/NN to/IN single-stranded/JJ DNA/NN and/CC poly/NN (/NN A/NN )/NN homopolymers/NNS suggesting/VBG that/IN this/DT protein/NN could/MD play/NN a/DT role/NN in/IN mRNA/NN maturation/NN //NN metabolism/NN ./.
@@82804762009 In/NN our/PRP studies/NNS ,/, we/PRP utilized/VBD HIV-1/NN HXB2/NEWGENE and/CC HIV-1/NNP Z2Z6/NEWGENE core/NEWGENE enhancers/NEWGENE because/IN the/DT Z2Z6/NN strain/NN has/VBZ a/DT single/JJ point/NN mutation/NN flanking/JJ the/DT right/JJ ETS-binding/NEWGENE site/NEWGENE ./.
@@14986074225 Four/CD short/JJ nucleotide/NN sequences/NNS (/( boxes/NEWGENE I/NEWGENE to/NEWGENE IV/NEWGENE )/SYM contribute/VB to/IN the/DT light/NN responsiveness/NN of/IN the/DT parsley/NEWGENE chalcone/NEWGENE synthase/NEWGENE promoter/NEWGENE ./.
@@8627667669 ZEBRA/NEWGENE and/CC cellular/JJ AP-1/NEWGENE bZip/NEWGENE activators/NEWGENE ,/, such/JJ as/IN c-Fos/NEWGENE ,/, have/VB homologous/JJ DNA-binding/NN domains/NN ,/, and/CC their/PRP DNA-binding/NN specificities/NNS overlap/NN ./.
@@82756188256 Drug/NNP effect/NN ,/, measured/VBN as/IN postural/JJ sway/NN ,/, was/VBD also/RB similar/JJ in/IN the/DT patients/NNS with/IN cirrhosis/NN and/CC control/NN subjects/NNS ;/: therefore/RB the/DT ratio/NN of/IN effect/NN area/NN under/IN the/DT curve/NN to/IN concentration/NN area/NN under/IN the/DT curve/NN ,/, a/DT measure/NN of/IN sensitivity/NN ,/, did/VBD not/RB differ/VB significantly/RB between/IN the/DT patients/NNS with/IN cirrhosis/NN and/CC the/DT control/NN subjects/NNS ./.
@@89559288915 Damage/NN to/IN the/DT BBB/NN was/VBD judged/VBN by/IN extravasation/NN of/IN Evans/NNP Blue/NNP (/( EB/NN )/SYM dye/NN ,/, which/WDT was/VBD administered/VBN either/DT 2/CD ,/, 3/CD ,/, 24/CD or/CC 48/CD h/NN after/IN onset/NN of/IN MCAo/DT ./.
@@23358156094 At/NN the/DT carboxyl/NN terminus/NN ,/, deletion/NN as/RB far/RB as/IN residue/NN 388/CD did/VBD not/RB affect/VB in/IN vitro/NN TRF/NEWGENE ./NEWGENE C/NEWGENE assembly/NN ,/, although/IN trans-activating/JJ activity/NN was/VBD abolished/VBN ./.
@@118117437687 The/DT procedure/NN facilitated/VBN the/DT retention/NN of/IN a/DT mandibular/JJ molar/NN with/IN a/DT Class/NN III/NN FI/NN in/IN a/DT manner/NN acceptable/JJ to/IN both/PDT the/DT patient/NN and/CC the/DT clinician/NN ./.
@@68408036634 Histological/JJ signs/NNS of/IN the/DT flare-up/NN reaction/NN were/VBD already/RB present/VB at/IN 6/CD hr/NN after/IN i/CD ./CD v/CD ./. challenge/NN and/CC lasted/VBN for/IN at/IN least/RB 4/CD days/NNS ./.
@@81724168142 Moxidectin/NNP (/( at/IN 3/CD times/VBZ the/DT therapeutic/JJ dose/NN )/SYM did/VBD not/RB have/VB deleterious/JJ effects/NNS on/IN cow/NN reproductive/JJ performance/NN as/IN examined/VBN (/( eg/NN ,/, at/IN folliculogenesis/NN ,/, ovulation/NN ,/, and/CC the/DT early/JJ embryonic/JJ phase/NN of/IN development/NN )/SYM ./.
@@11384225529 To/TO this/DT end/NN ,/, an/DT expression/NN cassette/NN consisting/VBG of/IN the/DT gene/NN for/IN a/DT green/NEWGENE fluorescent/NEWGENE protein/NEWGENE (/( GFP/NEWGENE )/SYM flanked/VBN at/IN its/PRP 3'/CD end/NN by/IN EAV-specific/NN transcription-regulating/NN sequences/NN was/VBD constructed/VBN ./.
@@91999322831 Promoter/NNS recognition/NN algorithms/NNS identified/VBD divergent/JJ promoter/NN elements/NNS within/IN the/DT CpG/NN island/NN ,/, which/WDT lies/VBZ between/IN the/DT ATM/NEWGENE and/CC E14/NEWGENE //NEWGENE NPAT/NEWGENE genes/NEWGENE ,/, and/CC provide/VB evidence/NN for/IN a/DT putative/JJ second/JJ ATM/NEWGENE promoter/NEWGENE located/VBN within/IN intron/NN 3/CD ,/, immediately/RB upstream/RB of/IN the/DT first/JJ coding/JJ exon/NN ./.
@@75462567417 A/DT retrospective/JJ epidemiological/JJ study/NN is/VBZ reported/VBN concerning/VBG burn/NN injuries/NNS in/IN 775/CD children/NNS hospitalized/VBN at/IN the/DT unit/NN of/IN burn/NN care/NN of/IN Casablanca/NNP between/IN 1985/CD and/CC 1993/CD ./.
@@108510898691 Thus/RB ,/, SAG/NEWGENE appears/VBZ to/IN control/NN cell/NN cycle/NN progression/NN in/IN yeast/NN by/IN promoting/JJ ubiquitination/NN and/CC degradation/NN of/IN cell/NN cycle/NN regulatory/JJ proteins/NNS ./.
@@10478275316 The/DT main/JJ issues/NNS are/VBP the/DT need/NN to/IN explain/VB a/DT number/NN of/IN still/RB unknown/JJ mechanisms/NNS ,/, to/IN determine/VB which/WDT "natural/JJ diet"/NN carries/VBZ the/DT minimum/JJ coronary/JJ risk/NN and/CC whether/IN "new"/NN foods/NNS produced/VBN by/IN modern/JJ technology/NN are/VBP really/RB needed/VBN to/IN contrast/NN this/DT epidemic/NN ./.
@@98875449884 BACKGROUND/IN :/: Diazepam/IN ,/, one/PRP of/IN the/DT benzodiazepine/NN group/NN of/IN tranquilizers/NNS ,/, is/VBZ used/VBN as/IN an/DT adjunctive/JJ drug/NN for/IN sedation/NN and/CC for/IN relief/NN of/IN anxiety/NN in/IN the/DT treatment/NN of/IN epilepsy/NN ./.
@@74137811933 Hippocampal/JJ stimulation/NN overlapping/JJ conditioned/JJ stimulus/NN preexposure/RB produced/VBD attenuation/NN of/IN latent/JJ inhibition/NN ,/, as/IN did/VBD stimulation/NN presented/VBN during/IN conditioning/JJ after/IN preexposure/JJ ./.
@@86364287839 Taken/VBN together/RB ,/, our/PRP results/NNS indicate/VBP that/IN thrombin-stimulated/JJ vascular/JJ smooth/JJ muscle/NN proliferation/NN is/VBZ delayed/JJ and/CC requires/VBZ the/DT de/FW novo/FW expression/NN of/IN one/PRP or/CC more/RB autocrine/JJ mitogens/NNS ./.
@@90034622179 However/RB ,/, five/CD new/JJ mutation/NN sites/NNS (/( S61/NEWGENE ,/, SL1/NEWGENE ,/, S29/NEWGENE ,/, SL11/NEWGENE ,/, SL196/NEWGENE and/CC SL126/NEWGENE )/SYM are/VBP unique/JJ to/IN the/DT nrdB/NEWGENE intron/NN and/CC disrupt/VB self-splicing/JJ ./.
@@90117444543 The/DT murine/JJ chromosomal/JJ locations/NNS of/IN the/DT five/CD NMDA/NEWGENE receptor/NEWGENE channel/NEWGENE subunits/NEWGENE ,/, the/DT epsilon/NEWGENE 1/NEWGENE (/( Grin2a/NEWGENE )/SYM ,/, epsilon/NEWGENE 2/NEWGENE (/( Grin2b/NEWGENE )/SYM ,/, epsilon/NEWGENE 3/NEWGENE (/( Grin2c/NEWGENE )/SYM ,/, epsilon/NEWGENE 4/NEWGENE (/( Grin2d/NEWGENE )/SYM and/CC zeta/NEWGENE 1/NEWGENE (/( Grinl/NEWGENE )/SYM subunits/NNS ,/, were/VBD determined/VBN using/VBG an/DT interspecific/JJ backcross/NN mapping/NN panel/NN derived/VBN from/IN crosses/NNS of/IN [/NN (/NN C57BL/NN //NN 6JxM/NN ./. spretus/NN )/NN F1xC57BL/NN //NN 6J/NN ]/NN mice/NNS ./.
@@90290915721 Surprisingly/RB ,/, however/RB ,/, TCR-mediated/JJ tyrosine/NN phosphorylation/NN of/IN phospholipase/NEWGENE C/NEWGENE gamma/NEWGENE 1/NEWGENE remains/VBP intact/JJ in/IN the/DT Jurkat/NN cells/NNS expressing/JJ the/DT A2/NEWGENE //NEWGENE HCP/NEWGENE chimera/NN ./.
@@71741227927 Serum/NEWGENE creatine/NEWGENE kinase/NEWGENE (/( SCK/NEWGENE )/SYM was/VBD measured/VBN in/IN ten/CD subjects/NNS in/IN the/DT laboratory/NN before/IN and/CC after/IN the/DT performance/NN of/IN bicycle/NN ergometry/NN and/CC a/DT lifting/JJ task/NN ./.
@@95823266042 N/NNP ./NNP ,/, and/CC Fanning/NNP ,/, E/NNP ./NNP
@@18747524627 This/DT indicates/VBZ that/IN under/IN certain/JJ experimental/JJ conditions/NNS cdc2/NEWGENE //NEWGENE p58/NEWGENE and/CC cdc2/NEWGENE //NEWGENE p62/NEWGENE may/MD express/VB some/DT differences/NNS in/IN their/PRP catalytic/JJ activity/NN ./.
@@49924785294 Plasma/NEWGENE histaminase/NEWGENE in/IN patients/NNS of/IN bronchial/JJ asthma/NN and/CC the/DT effect/NN of/IN prednisolone/NN administration/NN on/IN it/CD ./CD
@@31106925776 40/CD ./CD 3/CD +/NN //NN -/NN 10/CD ./CD 1/CD mg/NN //NN l/NN (/( SD/NN )/SYM vs/NNP 31/CD ./CD 2/CD +/NN //NN -/NN 8/CD ./CD 0/CD ,/, P/NN less/PRP than/IN 0/NN ./NN 01/NN )/NN ./. beta/NN 2m/NN was/VBD not/RB significantly/RB higher/JJ in/IN patients/NNS with/IN bone/NN cysts/NNS (/( 37/CD ./CD 7/CD +/NN //NN -/NN 11/CD ./CD 4/CD mg/NNP //NNP l/NNP vs/NNP 37/CD ./CD 0/CD +/NN //NN -/NN 10/CD ./CD 0/CD )/SYM ,/, but/CC median/JJ duration/NN of/IN dialysis/NN was/VBD significantly/RB (/( P/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM longer/JJR in/IN patients/NNS with/IN bone/NN cysts/NNS (/( 90/CD vs/NNP 57/CD months/NNS )/SYM ./. beta/NEWGENE 2m/NEWGENE was/VBD lower/JJR in/IN patients/NNS maintained/VBN on/IN dialysis/NN for/IN less/PRP than/IN 1/CD year/NN and/CC whose/WP residual/JJ urine/NN volume/NN was/VBD greater/JJR than/IN 0/CD ./CD 1/CD litre/NN per/IN day/NN ./.
@@114276111301 The/DT susceptibility/NN of/IN Aspergillus/NNS fumigatus/NN to/IN mulundocandin/NN ,/, an/DT echinocandin-like/JJ compound/NN ,/, and/CC other/DT antifungal/JJ agents/NNS was/VBD assessed/VBN by/IN the/DT National/NNP Committee/NNP for/IN Clinical/NNP Laboratory/NNP Standards/NNPS (/( NCCLS/NNP )/SYM M38-P/NN method/NN ,/, a/DT 2/NN ,/NN 3-bis/NN (/NN 2-methoxy-4-nitro-5-sulfophenyl/NN )/NN -5-/NN [/NN (/NN phenyl-amino/NN )/NN carbonyl/NN ]/NN -2H-tetrazolium/NN hydroxide/NN (/( XTT/NNP )/NN -based/NN colorimetric/JJ assay/NN ,/, and/CC determination/NN of/IN morphologic/JJ alterations/NNS by/IN microscopy/NN ./.
@@2007045633 The/DT authors/NNS report/NN a/DT case/NN in/IN which/WDT stereotactic/JJ irrigation/NN of/IN a/DT brain/NN cyst/NN was/VBD temporally/RB associated/VBN with/IN respiratory/JJ distress/NN ./.
@@98836399877 Number/NN of/IN patients/NNS infected/VBN with/IN nontuberculous/JJ mycobacteria/NNS (/( NTM/IN )/SYM is/VBZ increasing/JJ world-wide/JJ in/IN recent/JJ years/NNS ./.
@@112974193270 An/DT F222W/NEWGENE :/NEWGENE W21F/NEWGENE rGST/NEWGENE A1-1/NEWGENE double/NEWGENE mutant/NEWGENE provides/VBZ a/DT direct/JJ fluorescence/NN probe/NN of/IN changes/NNS in/IN the/DT environment/NN of/IN the/DT C-terminal/NN residue/NN ./.
@@106846605274 Comparison/NNS of/IN the/DT plant/NEWGENE nuclear/NEWGENE tRNA/NEWGENE 3'/NEWGENE processing/NEWGENE enzyme/NEWGENE with/IN the/DT plant/NN mitochondrial/JJ one/PRP suggests/VBZ that/IN both/DT activities/NNS are/VBP different/JJ enzymes/NNS ./.
@@81063255329 DtxR/NEWGENE is/VBZ an/DT iron-dependent/NN sequence-specific/NN DNA-binding/NN protein/NN that/WDT binds/VBZ to/IN the/DT tox/NEWGENE operator/NEWGENE ,/, an/DT inverted-repeat/NN nucleotide/NN sequence/NN located/VBN upstream/RB from/IN the/DT diphtheria/NEWGENE toxin/NEWGENE gene/NEWGENE ./.
@@81664024637 Cerebral125/NEWGENE albumin/NEWGENE was/VBD increased/VBN to/IN similar/JJ proportions/NNS in/IN those/DT groups/NNS submitted/VBN to/IN hyperosmolality/NN ./.
@@13391257479 Laboratory/NNP studies/NNS using/VBG Ca45/NN labeled/JJ teeth/NNS and/CC biologically/RB stained/VBN teeth/NNS confirmed/VBN that/IN the/DT dentifrice/NN did/VBD not/RB decalcify/VB enamel/NN or/CC bleach/NN teeth/NNS ./.
@@34667304167 Autonomic/NNP dysfunctions/NNS were/VBD restricted/VBN to/IN tonic/JJ pupils/NNS ./.
@@85242927511 Results/NNS from/IN the/DT mechanism/NN study/NN have/NN revealed/VBN that/IN YY1/NEWGENE is/VBZ able/JJ to/IN inhibit/VB transactivation/NN mediated/JJ by/IN either/DT AP1/NEWGENE or/CC the/DT Sp1-related/NEWGENE protein/NEWGENE ,/, and/CC YY1/NEWGENE suppressive/JJ activity/NN is/VBZ DNA/NN binding/JJ dependent/NN ./.
@@86225968594 The/DT men/NNS self-selected/VBD a/DT prescribed/VBN diet/NN at/IN home/JJ emphasizing/VBG saturated/JJ fat/NN as/IN the/DT visible/JJ fat/NN for/IN 1/CD week/NN ./.
@@93059447638 By/IN analyzing/VBG the/DT RanGAP/NEWGENE activity/NN of/IN a/DT series/NN of/IN recombinantly/RB expressed/VBN rna1p/NEWGENE mutant/NEWGENE derivatives/NNS ,/, we/PRP show/VBP that/IN the/DT highly/RB acidic/NN sequence/NN in/IN the/DT C-terminal/NN domain/NN of/IN both/DT yeast/NN proteins/NNS is/VBZ indispensable/JJ for/IN activating/NN Ran-mediated/NN GTP/NN hydrolysis/NN ./.
@@17389365952 One/CD patients/NNS had/VBP plasma/NEWGENE C-peptide/NEWGENE greater/JJR than/IN 3/CD pM/NN and/CC was/VBD therefore/RB excluded/VBN from/IN analysis/NN ./.
@@83212035084 NF-kappa/NEWGENE B/NEWGENE p65/NEWGENE1 ,/NN p50/NEWGENE ,/, and/CC Rel/NEWGENE functionally/RB synergize/VB with/IN C/NEWGENE //NEWGENE EBP/NEWGENE alpha/NEWGENE ,/, C/NEWGENE //NEWGENE EBP/NEWGENE beta/NEWGENE ,/, and/CC C/NEWGENE //NEWGENE EBP/NEWGENE delta/NEWGENE ./.
@@4507605002 Cryoglobulinemia/NN in/IN Raynaud's/NNP syndrome/NN ./.
@@64334421399 Freezing/NN of/IN plasma/NN to/IN obtain/VB better/JJR yield/NN of/IN factor/NEWGENE VIII/NEWGENE :/: C/NN ./.
@@77590944530 A/DT polymorphic/JJ dinucleotide/NN (/( GT/NN //NN CA/NN )/NN n/NN repeat/NN contained/VBN in/IN the/DT NHE5/NN cosmid/NN was/VBD identified/VBN and/CC developed/VBN into/IN a/DT microsatellite/NN PCR/NN marker/NN ./.
@@8902641297 In/NN the/DT VA-SMV/NNP mode/NN ,/, the/DT connection/NN was/VBD made/VBP with/IN valved/JJ conduits/NNS from/IN the/DT LV/NN apex/NN (/( inflow/NN )/SYM to/IN the/DT ascending/JJ aorta/NN (/( outflow/NN )/SYM (/( n/NN =/SYM 11/CD )/SYM or/CC to/IN the/DT DAo/NNP (/( n/NN =/SYM 12/CD )/SYM ./.
@@89710095170 To/TO circumvent/VB this/DT problem/NN ,/, a/DT simple/JJ two-step/JJ strategy/NN was/VBD devised/VBN by/IN which/WDT essential/JJ cis-acting/JJ sites/NNS like/VBP the/PDT a/DT sequence/NN can/MD be/VB readily/RB deleted/VBN from/IN their/PRP natural/JJ loci/NNS in/IN large/JJ viral/JJ DNA/NN genomes/NNS ./.
@@10509768339 The/DT reduction/NN in/IN saturated/JJ fatty/JJ acids/NNS intake/NN led/VBN to/IN modest/JJ (/( but/CC in/IN group/NN 1/CD significant/JJ )/SYM 0/CD ./CD 15/CD mmol/NN //NN l/NN (/( 2/CD ./CD 5%/CD )/SYM reduction/NN in/IN total/JJ serum/JJ cholesterol/NN level/NN ./.
@@110168504227 We/PRP cloned/VBN a/DT DNA/NN fragment/NN encoding/VBG the/DT N-terminal/NN part/NN of/IN a/DT protein/NN with/IN significant/JJ similarity/NN to/IN members/NNS of/IN the/DT LysR/NEWGENE family/NEWGENE of/NEWGENE transcriptional/NEWGENE regulators/NEWGENE (/( LTTRs/NEWGENE )/SYM ./.
@@68055376576 Advances/NNS in/IN hemophilia/NN treatment/NN :/: a/DT hepatitis-safe/JJ factor/NEWGENE VIII/NEWGENE concentrate/NN ./.
@@11196581036 The/DT records/NNS from/IN 1948/CD through/RB 1967/CD of/IN 344/CD previously/RB untreated/JJ patients/NNS with/IN squamous/JJ cell/NN carcinoma/NN of/IN the/DT oral/JJ cavity/NN ,/, oropharynx/NN ,/, supraglottic/JJ larynx/NN and/CC hypopharynx/NN who/WP had/VBP clinically/RB positive/JJ cervical/JJ lymph/NN node/NN metastases/NNS staged/VBN N1/NN ,/, N2A/NN ,/, or/CC N2B/NN ,/, and/CC whose/WP initial/JJ neck/NN treatment/NN consisted/VB of/IN external/NN radiation/NN therapy/NN alone/RB were/VBD reviewed/VBN ./.
@@98084419782 A/DT comparative/JJ analysis/NN of/IN the/DT reported/VBN MOCT-associated/JJ malignant/JJ melanomas/NNS emphasizes/VBZ the/DT singularity/NN of/IN our/PRP case/NN in/IN the/DT amelanotic/JJ character/NN of/IN the/DT melanoma/NN ,/, its/PRP lymphotropism/NN and/CC the/DT coexistence/NN of/IN invasive/JJ squamous/JJ cell/NN carcinoma/NN ./.
@@85163086684 The/DT remaining/JJ RAD+/NEWGENE cells/NNS progressed/VBN to/IN form/NN microcolonies/NNS (/( </SYM 30/CD cells/NNS )/SYM containing/JJ aberrantly/RB shaped/JJ inviable/VBP cells/NNS ./.
@@32391063930 Increasing/VBG the/DT phosphorus/NN content/NN of/IN the/DT diet/NN improved/VBD the/DT reabsorption/NN of/IN calcium/NN and/CC magnesium/NN ./.
@@85448208451 Characterization/NNS of/IN an/DT EcR/NEWGENE //NEWGENE USP/NEWGENE heterodimer/NEWGENE target/NEWGENE site/NEWGENE that/WDT mediates/VBZ ecdysone/NN responsiveness/NN of/IN the/DT Drosophila/NEWGENE Lsp-2/NEWGENE gene/NEWGENE ./.
@@73970662449 Drug/NNP inhibition/NN of/IN whole/JJ blood/NN aspirin/NEWGENE esterase/NEWGENE ./.
@@34033134099 The/DT actuarial/JJ local/JJ control/NN rates/NNS at/IN 10/CD years/NNS for/IN the/DT three/CD treatment/NN groups/NNS were/VBD as/IN follows/VBZ :/: subtotal/JJ excision/NN alone/RB ,/, 18%/JJ ;/: subtotal/JJ excision/NN plus/IN postoperative/JJ radiation/NN therapy/NN ,/, 82%/JJ ;/: and/CC total/JJ excision/NN alone/RB ,/, 77%/JJ ./.
@@98803272338 It/PRP is/VBZ related/VBN to/IN a/DT variety/NN of/IN mammalian/JJ Golgi-associated/NN proteins/NN and/CC to/IN the/DT yeast/NN Uso1p/NEWGENE ,/, an/DT essential/JJ protein/NN involved/VBN in/IN docking/JJ of/IN endoplasmic/JJ reticulum-derived/JJ vesicles/NNS to/IN the/DT cis-Golgi/NN ./.
@@118850531777 We/PRP found/VBP three/CD out/RB of/IN four/CD original/JJ (/( Volkan's/NNP )/SYM groups/NNS of/IN linking/JJ objects/NNS ,/, but/CC also/RB an/DT additional/JJ one/PRP ,/, hitherto/RB undescribed/JJ ,/, comprising/VBG objects/NNS used/VBN for/IN designing/JJ a/DT memorial/NN shrine/NN to/IN the/DT deceased/VBN ./.
@@89741357476 To/TO examine/VB whether/IN thiamine/NN (/( vitamin/NN B1/NN )/SYM deficiency/NN is/VBZ associated/VBN with/IN recurrent/JJ aphthous/JJ stomatitis/NN ,/, we/PRP studied/VBD vitamin/NN B1/NN levels/NNS in/IN 70/CD patients/NNS with/IN recurrent/JJ aphthous/JJ stomatitis/NN and/CC in/IN 50/CD members/NNS of/IN a/DT control/NN group/NN ./.
@@17377897384 The/DT upstream/NN delta-alpha/NN breakpoint/NN is/VBZ flanked/VBN by/IN the/DT direct/JJ repeats/NNS of/IN the/DT acceptor/NN splice/NN site/NN ,/, whereas/IN the/DT down-stream/JJ alpha-delta/JJ breakpoint/NN is/VBZ located/VBN in/IN the/DT adjacent/JJ intron/NN ./.
@@78917089895 Like/IN Epo/NEWGENE ,/, HNF-4/NEWGENE is/VBZ expressed/VBN in/IN kidney/NN ,/, liver/NN ,/, and/CC Hep3B/NNP cells/NNS but/CC not/RB in/IN HeLa/DT cells/NNS ./.
@@79597606396 The/DT centromeric/JJ YAC/NN contig/NN ,/, which/WDT consists/VBZ of/IN 23/CD overlapping/JJ YACs/NNS and/CC orders/NNS 19/NN sequence-tagged/NN sites/NN (/( STSs/NN )/SYM ,/, covers/VBP a/DT minimum/NN of/IN 2/CD ./CD 2/CD Mb/NN and/CC spans/VBZ the/DT Ewing/NN sarcoma/NN breakpoint/NN ./. c-ets/NEWGENE 1/NEWGENE and/CC Fli-1/NEWGENE ,/, two/JJ members/NNS of/IN the/DT ets/NEWGENE family/NEWGENE ,/, have/VB been/VBN linked/JJ within/IN 400/CD kb/NN of/IN intervening/JJ DNA/NN within/IN this/DT contig/NN ,/, which/WDT also/RB comprises/VBZ a/DT polymorphic/JJ microsatellite/NN ,/, D11S912/NEWGENE (/NEWGENE CA/NEWGENE )/NEWGENE n/NEWGENE ,/, which/WDT we/PRP have/VBP localized/VBN within/IN the/DT Fli-1/NEWGENE gene/NEWGENE ./.
@@104716965186 Null/NNP alleles/NNS of/IN SAS4/NEWGENE and/CC SAS5/NEWGENE bypassed/VBN the/DT role/NN of/IN the/DT Abf1p/NEWGENE binding/NEWGENE site/NEWGENE of/IN the/DT HMR-E/NEWGENE silencer/NEWGENE but/CC not/RB the/DT role/NN of/IN the/DT ACS/NEWGENE or/CC Rap1p/NEWGENE binding/NEWGENE site/NEWGENE ./.
@@35633998013 For/IN signal/JJ durations/NNS less/PRP than/IN 10/CD ms/NN ,/, however/RB ,/, the/DT SoNo/NNP and/CC S/NN pi/NN No/DT threshold/NN functions/NNS converged/VBN and/CC the/DT masking-level/JJ difference/NN decreased/VBN ./.
@@90283084003 The/DT initial/JJ patients/NNS treated/VBN with/IN AZQ/NN and/CC mitroxantrone/NN experienced/VBD prolonged/JJ bone/NN marrow/NN suppression/NN and/CC ,/, therefore/RB ,/, subsequent/JJ cohorts/NNS were/VBD treated/VBN with/IN G-CSF/NEWGENE ,/, 5/CD micrograms/NN //NN kg/NN ,/, beginning/VBG the/DT day/NN after/IN completion/NN of/IN the/DT third/JJ cycle/NN of/IN chemotherapy/NN ./.
@@79887302720 The/DT basal/JJ promoter/NN strength/NN of/IN constructs/NNS that/WDT contained/VBD deletions/NNS in/IN the/PDT U5/NEWGENE region/NEWGENE of/IN the/DT LTR/NEWGENE was/VBD analyzed/VBN by/IN chloramphenicol/NEWGENE acetyltransferase/NEWGENE (/( CAT/NEWGENE )/SYM assays/NNS following/IN transfection/NN of/IN HeLa/DT cells/NNS or/CC Jurkat/NN T-cells/NNS in/IN the/DT presence/NN or/CC absence/NN of/IN viral/NN transactivator/NN tax/NEWGENE protein/NN ./.
@@91351492149 In/NN Schizosaccharomyces/NN pombe/NN ,/, the/DT activity/NN of/IN the/DT M-phase-inducing/JJ Cdc2/NEWGENE //NEWGENE Cdc13/NEWGENE cyclin-dependent/NEWGENE kinase/NEWGENE is/VBZ inhibited/VBN by/IN Wee1/NEWGENE and/CC Mik1/NEWGENE tyrosine/NEWGENE1 kinases/NEWGENE1 ,/, and/CC activated/VBN by/IN Cdc25/NEWGENE and/CC Pyp3/NEWGENE tyrosine/NEWGENE1 phosphatases/NEWGENE1 ./.
@@91719696579 Measurement/NNP of/IN the/DT time/NN constant/NN of/IN VO2/NN and/CC oxygen/NN pulse/NN during/IN constant/JJ work/NN rate/NN exercise/NN are/VBP useful/JJ for/IN the/DT objective/JJ evaluation/NN of/IN the/DT training/NN effect/NN of/IN patients/NNS with/IN COPD/NN ./.
@@35086984670 By/IN order/NN of/IN decreasing/JJ rate/NN ,/, finger/NN flexors/NN ,/, jaw/NN ,/, crossed/JJ adductors/NNS ,/, and/CC triceps/NN reflexes/NNS were/VBD less/PRP frequently/RB elicited/VBN in/IN both/DT groups/NNS ./.
@@62094996022 The/DT direct/JJ effects/NNS of/IN transmitter/NN release/NN were/VBD (/( a/DT )/SYM an/DT early/JJ fall/NN in/IN MAP/NN followed/VBN by/IN a/DT late/JJ pressor/JJ effect/NN ;/: and/CC (/( b/NN )/SYM an/DT early/JJ bradycardia/NN followed/VBN by/IN a/DT late/JJ tachycardia/NN ./.
@@13092559589 66/CD :/: 469-479/CD ,/, 1992/NN )/NN ./.
@@16018693096 A/DT 724-bp/JJ segment/NN of/IN the/DT 5'-flanking/JJ region/NN consisting/VBG of/IN the/DT proximal/JJ E-box/NNS flanked/VBN upstream/RB by/IN a/DT mammalian-specific/JJ 352-bp/JJ region/NN was/VBD sufficient/JJ for/IN maximal/JJ transcriptional/JJ activation/NN in/IN postconfluent/NN BC3H1/NN myoblasts/NNS ./.
@@73477285242 Arachnoid/NN cyst/NN ./.
@@45186245008 Glutathione/NEWGENE peroxidase/NEWGENE in/IN human/JJ red/JJ cells/NNS in/IN health/NN and/CC disease/NN ./.
@@21131742520 It/PRP encodes/VBZ a/DT protein/NN with/IN three/CD zinc/NN fingers/NNS similar/JJ to/IN those/DT of/IN the/DT transcription/NEWGENE factor/NEWGENE Sp1/NEWGENE ./.
@@92230422029 Liver/NN regional/NN blood/NN volume/NN (/( LRBV/NN )/SYM is/VBZ altered/VBN by/IN several/DT disease/NN states/NNS and/CC various/JJ drugs/NNS ./.
@@94878417823 The/DT ESEM/NN differs/VBZ from/IN conventional/JJ SEM/NN in/IN that/DT no/DT sample/NN preparation/NN is/VBZ needed/VBN ,/, eliminating/JJ artifactual/JJ changes/NNS ./.
@@79354727807 Enhancers/NNS containing/JJ disrupted/VBN Ets-1/NEWGENE binding/NEWGENE sites/NEWGENE were/VBD tested/VBN in/IN transient/JJ expression/NN assays/NNS in/IN the/DT murine/JJ T-cell/NN line/NN EL4/CD ./CD E1/CD ;/: alterations/NNS in/IN the/DT LVb/NEWGENE element/NEWGENE affected/VBD constitutive/JJ enhancer/NN activity/NN ,/, while/CC mutation/NN of/IN either/DT the/DT LVb/NEWGENE or/CC LVc/NEWGENE element/NEWGENE disrupted/VBD phorbol/NN ester-induced/NN enhancer/NN activity/NN ./.
@@111617933920 The/DT presence/NN of/IN truncated/JJ receptor/NN isoforms/NNS in/IN diverse/JJ species/NN suggests/VBZ that/IN these/DT proteins/NNS may/MD have/NN important/JJ functional/JJ roles/NNS in/IN regulating/JJ EGFR/NEWGENE activity/NN ./.
@@68806506677 The/DT results/NNS confirm/VBP and/CC extend/VB previous/JJ work/NN by/IN other/DT researchers/NNS ./.
@@27353645130 In/NN the/DT final/JJ model/NN ,/, grade/NN (/( p/NN =/SYM 0/CD ./CD 0002/CD )/SYM ,/, peritoneal/JJ cytologic/JJ results/NNS (/( p/NN =/SYM 0/CD ./CD 0002/CD )/SYM ,/, progesterone/NEWGENE receptor/NEWGENE status/NN (/( p/NN =/SYM 0/CD ./CD 004/CD )/SYM ,/, and/CC age/NN as/IN a/DT continuous/JJ variable/JJ (/( p/NN =/SYM 0/CD ./CD 008/CD )/SYM were/VBD most/RB closely/RB associated/VBN with/IN disease-free/NN survival/NN ./.
@@28321495289 The/DT lack/NN of/IN change/NN in/IN the/DT ratio/NN of/IN the/DT two/RB spliced/VBN products/NNS expressed/VBN from/IN either/DT the/DT normal/JJ or/CC the/DT 5'-rearranged/NEWGENE myb/NEWGENE further/RB indicates/VBZ that/IN the/DT insertion/NN of/IN the/DT unique/JJ 121/CD amino/JJ acids/NNS in/IN the/DT larger/JJR myb/NEWGENE transcripts/NEWGENE is/VBZ not/RB a/DT consequence/NN of/IN tumor-specific/JJ activation/NN of/IN the/DT mouse/NEWGENE myb/NEWGENE oncogene/NEWGENE ./.
@@14576953464 Removal/NNP of/IN beta/NEWGENE 2-microglobulin/NEWGENE by/IN hemodialysis/NN and/CC hemofiltration/NN :/: a/DT four/CD year/NN follow/VB up/RB ./RB
@@13288544931 A/DT single/NN MEF-2/NEWGENE site/NEWGENE is/VBZ a/DT major/JJ positive/JJ regulatory/JJ element/NN required/VBN for/IN transcription/NN of/IN the/DT muscle-specific/NN subunit/NN of/IN the/DT human/NEWGENE phosphoglycerate/NEWGENE mutase/NEWGENE gene/NEWGENE in/IN skeletal/JJ and/CC cardiac/JJ muscle/NN cells/NNS ./.
@@67211886496 The/DT statistical/JJ analysis/NN consist/VB of/IN the/DT F/NN test/NN followed/VBN by/IN Snedecor/NNP 's/POS contrast/NN test/NN ./.
@@113829481225 In/NN conclusion/NN ,/, USPIO-enhanced/JJ MRI/NN data/NN were/VBD capable/JJ to/IN characterize/VB tumor/NN microvessel/NN properties/NNS in/IN this/DT breast/NN cancer/NN model/NN :/: microvascular/JJ permeability/NN (/( determined/VBN using/VBG USPIO/NNP )/SYM correlated/VBN significantly/RB with/IN tumor/NN grade/NN ./.
@@92611551075 Furthermore/RB ,/, the/DT PH/NEWGENE and/CC PTB/NN domains/NN are/VBP highly/RB homologous/JJ (/( at/IN least/RB 40%/CD identical/JJ )/SYM to/IN those/DT found/VB in/IN insulin/NEWGENE receptor/NEWGENE substrates/NEWGENE 1/NEWGENE ,/NEWGENE 2/NEWGENE ,/NEWGENE and/NEWGENE 3/NEWGENE (/( IRS-1/NEWGENE ,/, IRS-2/NEWGENE ,/, and/CC IRS-3/NEWGENE )/SYM ./.
@@11236583644 The/DT authors/NNS describe/VBP the/DT technique/NN of/IN transverse/JJ axial/JJ tomography/NN of/IN the/DT spine/NN and/CC give/NN a/DT detailed/JJ description/NN of/IN the/DT axial/JJ anatomy/NN of/IN the/DT normal/JJ lumbar/JJ spine/NN from/IN L-4/NN to/IN the/DT sacrum/NN ./.
@@9130595559 Here/RB we/PRP report/VBP the/DT cloning/NN of/IN the/DT protein/NN that/WDT binds/VBZ to/IN enhancer/NEWGENE site/NEWGENE III/NEWGENE ./.
@@113589623672 Foxp1/NEWGENE and/CC Foxp2/NEWGENE are/VBP expressed/VBN at/IN high/JJ levels/NNS in/IN the/DT lung/NN as/RB early/RB as/IN E12/CD ./CD 5/CD of/IN mouse/NN development/NN with/IN Foxp2/NEWGENE expression/NN restricted/VBN to/IN the/DT airway/NN epithelium/NN ./.
@@74492537327 In/NN the/DT unclipped/JJ group/NN arterial/JJ pressure/NN decreased/VBN 50/CD mmHg/NN to/IN normal/JJ by/IN 24/CD h/NN and/CC was/VBD associated/VBN with/IN increased/VBN diuresis/NN and/CC a/DT small/JJ decrease/NN in/IN blood/NN volume/NN (/( 9/CD ./CD 8%/CD )/SYM ./.
@@92303849258 The/DT mean/JJ times/NNS to/IN detection/NN of/IN all/DT mycobacteria/NNS with/IN BACTEC/NN 9000/NN MB/NN and/CC BACTEC/NN 460/NN TB/NN were/VBD similar/JJ (/( 10/CD ./CD 3/CD and/CC 10/CD ./CD 0/CD days/NNS ,/, respectively/RB )/SYM ./.
@@17178332829 The/DT alpha/NEWGENE inhibin/NEWGENE promoter/NEWGENE containing/JJ a/DT mutated/JJ CRE/NEWGENE was/VBD not/RB regulated/VBN by/IN forskolin/NN in/IN granulosa/NN cells/NNS and/CC did/VBD not/RB bind/VB the/DT CREB/NEWGENE protein/NEWGENE ./.
@@21761524920 We/PRP show/VBP also/RB that/DT RA/NN represses/VBZ the/DT transcriptional/JJ activity/NN of/IN a/DT reporter/NN gene/NN containing/NN a/NN TPA/NEWGENE responding/VBG AP1/NEWGENE binding/NEWGENE site/NEWGENE driving/JJ the/DT HSV/NEWGENE tk/NEWGENE promoter/NEWGENE ./.
@@82236134652 We/PRP also/RB compared/VBD the/DT sequence/NN with/IN the/DT partly/RB homologous/JJ products/NNS of/IN the/DT S/NNP ./NNP cerevisiae/NN genes/NN TPS2/NEWGENE and/CC TSL1/NEWGENE which/WDT code/VBP for/IN the/DT larger/JJR subunits/NNS of/IN the/DT trehalose/NEWGENE synthase/NEWGENE complex/NEWGENE and/CC with/IN a/DT TSL1/NEWGENE homologue/NEWGENE ,/, TPS3/NEWGENE ,/, of/IN unknown/JJ function/NN ./.
@@32079758798 Seventy-two/NNS hours/NNS after/IN administration/NN of/IN vitamin/NN K1/NN ,/, plasma/NN concentrations/NNS of/IN the/DT vitamin/NN were/VBD not/RB different/JJ from/IN normal/NN ./.
@@101926383162 Methanesulfonyl/NNP fluoride/NN (/( MSF/NN )/SYM :/: a/DT double-blind/JJ ,/, placebo-controlled/JJ study/NN of/IN safety/NN and/CC efficacy/NN in/IN the/DT treatment/NN of/IN senile/JJ dementia/NN of/IN the/DT Alzheimer/NN type/NN ./.
@@16172424498 FDA/NN regulations/NNS for/IN growth/NEWGENE factors/NEWGENE and/CC related/VBN products/NNS ./.
@@109133046569 Six/CD distinct/JJ Ets/NEWGENE mRNAs/NEWGENE were/VBD identified/VBN :/: Ets2/NEWGENE ,/, Fli1/NEWGENE ,/, GABPalpha/NEWGENE ,/, SAP1/NEWGENE ,/, Elk1/NEWGENE ,/, and/CC PE1/NEWGENE ./.
@@93227389141 The/DT histidine-tagged/JJ gene/NN ,/, rpoCHIS/NEWGENE ,/, was/VBD used/VBN to/IN replace/VB the/DT wild-type/NN allele/NN in/IN the/DT chromosome/NN of/IN S/NNP ./NNP coelicolor/NN and/CC S/NNP ./NNP lividans/NNS ./.
@@104007949221 Identification/NNP of/IN a/DT spliced/VBN gene/NN from/IN Kaposi's/NN sarcoma-associated/JJ herpesvirus/NN encoding/VBG a/DT protein/NN with/IN similarities/NNS to/IN latent/NEWGENE membrane/NEWGENE proteins/NEWGENE 1/NEWGENE and/NEWGENE 2A/NEWGENE of/NEWGENE Epstein-Barr/NEWGENE virus/NEWGENE ./.
@@216275493 To/TO identify/VB these/DT sites/NNS ,/, the/DT deduced/VBN amino/JJ acid/NN sequence/NN of/IN the/DT 3T3-L1/NN adipocyte/NEWGENE insulin/NEWGENE receptor/NEWGENE of/IN the/DT mouse/NN was/VBD determined/VBN ./.
@@98521362634 Wild/NEWGENE type/NEWGENE HA-p190/NEWGENE induced/NN a/NN phenotype/NN of/IN rounded/JJ cells/NNS with/IN long/JJ ,/, beaded/JJ extensions/NNS similar/JJ to/IN that/DT seen/VBP when/CC Rho/NEWGENE function/NN is/VBZ disrupted/VBN by/IN ADP-ribosylation/NN ./.
@@92888485119 Following/VBG 2/CD ./CD 5/CD Gy/JJ ,/, HbO2/NEWGENE changes/NNS were/VBD minimal/JJ ./.
@@91620971753 In/NN summary/NN ,/, the/DT data/NN establish/VB that/IN the/DT previously/RB reported/VBN human/NEWGENE MAdCAM-1/NEWGENE cDNA/NEWGENE does/VBP indeed/RB encode/VB the/DT human/JJ homologue/NN of/IN mouse/NEWGENE MAdCAM-1/NEWGENE ,/, despite/IN gross/JJ dissimilarities/NNS in/IN the/DT MAdCAM-1/NEWGENE C-terminal/NN structures/NNS ./.
@@85504621317 Upstream/NNS of/IN the/DT dra/NEWGENE gene/NEWGENE an/DT open/JJ reading/JJ frame/NN of/IN 313/CD amino/JJ acids/NNS was/VBD identified/VBN ./.
@@10468033310 Chemical/NNP uptake/NN into/IN human/JJ stratum/NN corneum/NN in/IN vivo/NN from/IN volatile/JJ and/CC non-volatile/JJ solvents/NNS ./.
@@94120799368 Diet/NNP therapy/NN with/IN soy/NN proteins/NNS for/IN chronic/JJ stomach/NN ulcers/NNS ./.
@@14731962088 This/DT may/MD result/NN in/IN more/JJ reabsorption/NN and/CC hence/RB reduced/VBN renal/JJ clearance/NN ./.
@@4204609055 In/NN patients/NNS who/WP had/VBP received/VBN no/DT previous/JJ drug/NN treatment/NN ,/, log/NN baseline/NN plasma/NEWGENE renin/NEWGENE activity/NN and/CC change/NN in/IN mean/JJ blood/NN pressure/NN after/IN SQ/NN 20881/CD correlated/VBN significantly/RB (/( r/JJ =/SYM 0/CD ./CD 651/CD ,/, P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@82533874086 We/PRP conclude/VBP that/IN sequences/NNS outside/RB of/IN the/DT hLEF/NEWGENE HMG/NEWGENE box/NEWGENE mediate/VB cell-/DT and/CC context-specific/JJ activation/NN of/IN the/DT TCR/NEWGENE alpha/NEWGENE enhancer/NEWGENE and/CC may/MD facilitate/VB interactions/NNS between/IN hLEF/NEWGENE and/CC other/DT T-cell-specific/NN factors/NN recruited/VBN to/IN the/DT enhancer/NN ./.
@@26686916053 More/JJR mRNA/NN corresponding/JJ to/IN nagB/NEWGENE and/CC nagA/NEWGENE is/VBZ detected/VBN than/IN that/DT corresponding/JJ to/IN the/DT distal/JJ genes/NNS ,/, nagC/NEWGENE and/CC nagD/NEWGENE ./.
@@106523242717 However/RB ,/, its/PRP participation/NN in/IN collagen/NEWGENE binding/NN has/VBZ not/RB been/VBN shown/VBP ./.
@@35869254250 Development/NNP of/IN a/DT provisional/JJ information-retrieval/JJ descriptor/NN language/NN for/IN "Roentgenology/NN and/CC Medical/NNP Radiology"/NNP for/IN use/NN in/IN the/DT Medinform/NNP system/NN ./.
@@80209653685 The/DT sequenced/VBN genomic/JJ region/NN thus/RB accounts/VBZ for/IN essentially/RB all/DT of/IN the/DT longest/JJS known/VBP transcript/NN (/( 4/CD ./CD 5/CD kb/NN )/SYM ,/, although/IN the/DT precise/JJ ends/NNS of/IN this/DT transcript/NN have/NN not/RB been/VBN defined/VBN ./.
@@25186453169 Neonatal/JJ Chagas/NN disease/NN :/: laboratory/NN diagnosis/NN during/IN the/DT first/JJ year/NN of/IN life/NN ./.
@@84563788411 This/DT study/NN evaluates/VBZ the/DT feasibility/NN of/IN indirect/JJ mesenteric/JJ lymphangiography/NN as/IN a/DT colonoscopic/JJ technique/NN in/IN a/DT canine/JJ model/NN ./.
@@111583374110 The/DT gonadotrope-specific/JJ and/CC regulated/VBN expression/NN of/IN the/DT GnRH/NEWGENE receptor/NEWGENE (/( GnRH-R/NEWGENE )/SYM gene/NN is/VBZ dependent/JJ on/IN multiple/JJ transcription/NN factors/NNS that/WDT interact/VBP with/IN the/DT noncanonical/NEWGENE GnRH-R/NEWGENE activating/NEWGENE sequence/NEWGENE (/( GRAS/NEWGENE )/SYM ,/, the/DT activator/NEWGENE protein-1/NEWGENE (/( AP-1/NEWGENE )/SYM element/NN ,/, and/CC the/DT steroidogenic/NEWGENE factor-1/NEWGENE (/( SF-1/NEWGENE )/SYM binding/JJ site/NN ./.
@@89466682622 FK506/NNS is/VBZ 10-/CD to/IN 100-fold/CD more/RB potent/JJ than/IN cyclosporin/NN A/NN in/NN preventing/JJ organ/NN rejection/NN and/CC in/IN toxicity/NN ./.
@@8760889805 Comparison/NNS of/IN the/DT deduced/VBN amino/JJ acid/NN sequences/NNS with/IN protein/NN sequences/NNS of/IN T/NNP ./NNP pyriformis/NN H2As/NEWGENE showed/VBD only/RB two/JJ and/CC three/CD differences/NNS respectively/RB ,/, in/IN a/DT total/NN of/IN 137/CD amino/JJ acids/NNS for/IN H2A1/NEWGENE ,/, and/CC 132/CD amino/JJ acids/NNS for/IN H2A2/NEWGENE ,/, indicating/VBG the/DT two/JJ genes/NNS arose/VBD before/IN the/DT divergence/NN of/IN these/DT two/JJ species/NN ./.
@@112593471093 Anecdotal/JJ observations/NNS scattered/JJ throughout/IN the/DT literature/NN have/NN often/RB provided/VBD clues/NNS to/IN underlying/JJ variations/NNS in/IN humans'/NN ability/NN to/IN handle/NN dietary/JJ chemicals/NNS ./.
@@104389416951 Fewer/JJR recombination/NN events/NNS are/VBP detected/VBN in/IN four/CD different/JJ B/NNP and/CC T/NN cell/NN lines/NNS that/WDT do/VBP not/RB undergo/VB switch/NN recombination/NN of/IN their/PRP endogenous/JJ genes/NNS ./.
@@104987178425 These/DT observations/NNS establish/VBP that/IN RsmC/NEWGENE negatively/RB regulates/VBZ rsmB/NEWGENE transcription/NN but/CC positively/RB affects/VBP RsmA/NEWGENE production/NN ./.
@@33598604047 The/DT relations/NNS among/IN various/JJ negative/JJ emotional/JJ and/CC behavioral/JJ characteristics/NNS (/( e/FW ./FW g/FW ./FW ,/, aggression/NN ,/, anxiety/NN ,/, undercompliance/NN ,/, depressive/JJ mood/NN )/SYM and/CC adjustment/NN were/VBD examined/VBN through/JJ use/NN of/IN data/NN from/IN the/DT 31-year-old/NNP New/NNP York/NNP Longitudinal/NNP Study/NNP ./.
@@113357106862 This/DT was/VBD most/RB pronounced/VBN during/IN the/DT initial/JJ phase/NN of/IN Erk/NEWGENE activation/NN ./.
@@15626595719 Institution/NNP of/IN both/DT intravenous/JJ and/CC intracisternal/JJ administration/NN of/IN amphotericin/NN B/NN and/CC possibly/RB concomitant/JJ intravenous/JJ administration/NN of/IN dexamethasone/NN may/MD be/VB warranted/VBN in/IN situations/NNS in/IN which/WDT the/DT association/NN of/IN C/NNP ./NNP immitis/JJ with/IN CNS/NN vasculitis/NN or/CC encephalitis/NN appears/VBZ likely/RB before/IN serologic/JJ or/CC cultural/JJ confirmation/NN of/IN C/NNP ./NNP immitis/JJ infection/NN involving/VBG the/DT CNS/NN is/VBZ available/JJ ./.
@@18939272513 Increasing/VBG mean/JJ arterial/JJ pressure/NN by/IN phenylephrine/NN infusion/NN to/IN levels/NNS much/RB greater/RBR than/IN produced/VBN by/IN NMA/DT and/CC NNA/NN caused/VBN only/RB small/JJ reductions/NNS in/IN cardiac/JJ output/NN ./.
@@88962721398 The/DT nucleotide/NN sequence/NN of/IN 22/CD ,/CD 846/CD bp/NN of/IN the/DT left/NN arm/NN of/IN chromosome/NN IV/NN is/VBZ described/VBN ./.
@@23298402977 The/DT application/NN of/IN these/DT microelectrodes/NNS to/IN the/DT measurement/NN of/IN rapid/JJ ,/, transient/JJ changes/NNS in/IN retinal/JJ [/NN K+/NN ]/NN o/NN is/VBZ presented/VBN ./.
@@13910017011 From/IN all/DT clinically/RB important/JJ yeasts/NNS species/NN ,/, a/DT total/NN of/IN 96%/CD were/VBD identified/VBN by/IN ATB/NN method/NN according/VBG to/IN conventional/JJ methods/NNS ./.
@@111567897159 To/TO account/VB for/IN this/DT observation/NN ,/, other/DT possible/JJ causes/NNS include/VBP increased/VBN CSF/NN pulsation/NN in/IN children/NNS creating/VBG motion/NN artifact/NN ,/, changes/VBZ in/IN arterial/JJ oxygen/NN concentration/NN intrinsic/JJ to/IN propofol/NN or/CC related/VBN to/IN the/DT supplemental/JJ oxygen/NN normally/RB administered/VBD ,/, or/CC changes/NNS in/IN CSF/NN protein/NN levels/NNS related/VBN to/IN propofol/NN binding/JJ to/IN proteins/NNS for/IN uptake/NN into/IN CSF/NN ./.
@@2390146634 A/DT gas-liquid/JJ chromatographic/JJ method/NN for/IN the/DT determination/NN of/IN p-chlorophenoxyisobutyric/JJ (/( CPIB/NN )/SYM acid/NN in/IN blood/NN plasma/NN is/VBZ described/VBN ./.
@@1002933718 The/DT fatigue/NN exercise/NN showed/VBD relatively/JJ high/JJ blood/NN lactate/NN concentration/NN [/NN 12/NN ./NN 5/NN (/( SD/NN 2/NN ./NN 6/NN )/SYM mmol/NN x/NN l/NN (/NN -1/NN )/NN ]/NN and/CC an/DT increase/NN of/IN serum/NEWGENE creatine/NEWGENE kinase/NEWGENE (/( CK/NEWGENE )/SYM activity/NN delayed/JJ by/IN 2/CD days/NNS [/NN 540/NN (/( SD/NN 407/NN )/SYM U/NN x/NN l/NN (/NN -1/NN )/NN ]/NN ./.
@@10823630628 However/RB ,/, the/DT presence/NN of/IN effacement/NN seems/VBZ to/IN be/VB a/DT more/RB reliable/JJ and/CC practical/JJ parameter/NN that/WDT will/MD be/VB preferred/VBN in/IN that/DT prediction/NN ./.
@@111522835644 We/PRP have/VBP investigated/VBN the/DT role/NN of/IN NGF/NEWGENE in/IN regulating/JJ gene/NN transcription/NN in/IN PC12/CELL and/CC INS-1/CELL cells/NNS ,/, in/IN order/NN to/IN define/VB if/IN there/RB are/VBP NGF-regulated/NN genes/NN per/IN se/CD ./CD
@@87769017093 Chloroplast/NEWGENE mutator/NEWGENE (/( chm/NEWGENE )/SYM of/IN Arabidopsis/NN is/VBZ a/DT recessive/JJ nuclear/JJ mutation/NN that/IN causes/NNS green/JJ and/CC white/JJ variegation/NN in/IN leaves/NNS and/CC is/VBZ inherited/JJ in/IN a/DT non-Mendelian/JJ fashion/NN ./.
@@6445396253 In/NN three/CD of/IN the/DT seven/NN ,/, inhalation/NN of/IN 2/CD ml/NN normal/JJ saline/RB produced/VBN FEV1/NN falls/NNS of/IN 25%/JJ to/IN 30%/CD ,/, but/CC these/DT falls/NNS were/VBD not/RB as/RB great/JJ as/IN each/DT subject's/NNS reactions/NNS to/IN the/DT test/NN solutions/NNS ./.
@@92611849599 As/IN demonstrated/VBN by/IN gel/NN mobility/NN shift/NN analysis/NN and/CC supershift/NN experiments/NNS ,/, FIRE1/NEWGENE ,/, located/VBN between/IN -516/NN and/CC -498/NN ,/, is/VBZ responsible/JJ for/IN binding/JJ NF-Y/NEWGENE ./.
@@36935434357 The/DT less-polar/JJ mycolic/JJ acid-containing/NNP Rhodococcus/NNP species/NN showed/VBD chromatographic/JJ patterns/NNS that/WDT partially/RB overlapped/VBN (/( in/IN elution/NN times/NNS )/SYM the/DT patterns/NNS of/IN Nocardia/DT asteroides/NN ,/, N/NNP ./NNP otitidiscaviarum/NN ,/, and/CC N/NNP ./NNP brasiliensis/NN ,/, but/CC the/DT larger/JJR number/NN of/IN peaks/NNS in/IN the/DT last/NN species/NN made/VBP separation/NN between/IN the/DT genera/NNS possible/JJ ./.
@@107418503271 Electrophile/NEWGENE Response/NEWGENE Elements/NEWGENE (/( EpREs/NEWGENE )/SYM ,/, located/VBN in/IN 5'-flanking/JJ sequences/NNS of/IN both/PDT the/DT GCSh/NEWGENE and/CC GCSl/NEWGENE subunit/NEWGENE genes/NEWGENE ,/, are/VBP hypothesized/VBN to/IN at/IN least/RB partially/RB mediate/VB gene/NN induction/NN following/IN xenobiotic/NN exposure/NN ./.
@@106751544254 Extreme/JJ potency/NN of/IN botulinum/NEWGENE toxin/NEWGENE ./.
@@73943641244 It/PRP appears/VBZ that/IN the/DT pulmonary/JJ gas/NN exchange/NN parenchyma/NN of/IN these/DT smallest/JJS mammals/NNS is/VBZ well/VB suited/VBN to/IN supply/NN the/DT organism/NN with/IN the/DT comparatively/RB high/JJ levels/NNS of/IN O2/NN required/VBN by/IN the/DT high/JJ metabolic/JJ rates/NNS ,/, exhibiting/VBG a/DT structural/JJ adaptation/NN of/IN the/DT lung/NN to/IN higher/JJ VO2/NN ./.
@@64532906258 The/DT development/NN and/CC histostructural/JJ organization/NN of/IN intrahepatic/JJ biliary/JJ ducts/NNS were/VBD studied/VBN on/IN a/DT human/JJ embryofetal/JJ material/NN 6/CD to/IN 32/CD weeks/NNS old/JJ ./.
@@13286816257 Labile/JJ LTR-binding/NEWGENE proteins/NEWGENE appear/VBP to/IN be/VB essential/JJ for/IN c-myc/NEWGENE hyperexpression/NN ,/, since/IN both/DT LTR-enhanced/JJ transcription/NN and/CC the/DT activities/NNS of/IN LTR-binding/NEWGENE proteins/NEWGENE are/VBP specifically/RB decreased/VBN after/IN inhibition/NN of/IN protein/NN synthesis/NN (/( A/NNP ./NNP
@@20174141814 Age/NNP at/IN POI/NN and/CC asymptote/NN were/VBD achieved/VBN later/JJR for/IN Line/NNP RBC2/CELL than/IN for/IN Line/NNP F/NN ./NN
@@42263604863 Disorders/NNS of/IN platelet/NN function/NN in/IN chronic/JJ myeloid/JJ leukemias/NNS ./.
@@75081407390 Hepatitis/NEWGENE B/NEWGENE surface/NEWGENE antigen/NEWGENE was/VBD detected/VBN in/IN 2/CD patients/NNS ,/, with/IN negative/JJ hepatitis/NEWGENE C/NEWGENE virus/NEWGENE antibody/NEWGENE ./.
@@50286285327 Clinical/NNP and/CC angiographic/JJ examinations/NNS in/IN occlusion/NN disease/NN of/IN the/DT great/JJ intestinal/JJ arteries/NNS ./.
@@10870391684 Prevention/NNP ,/, differential/JJ diagnosis/NN and/CC therapy/NN of/IN travel/NN diarrhea/NN ./.
@@96492656004 CONCLUSIONS/IN :/: Two/CD consecutive/JJ sets/NNS of/IN transrectal/JJ ultrasound/RB guided/VBN sextant/NN biopsies/NNS of/IN the/DT prostate/NN performed/VBN in/IN a/DT single/JJ office/NN visit/NN represent/VB a/DT cost-effective/JJ biopsy/NN strategy/NN for/IN men/NNS presenting/VBG with/IN an/DT abnormal/JJ digital/JJ rectal/JJ examination/NN and/IN //IN or/IN elevated/VBN serum/NEWGENE PSA/NEWGENE ./.
@@11140472986 We/PRP compare/VBP the/DT results/NNS of/IN this/DT algorithm/NN with/IN the/DT results/NNS obtained/VBN with/IN two/JJ other/DT algorithms/NNS ,/, the/DT optimal/JJ algorithm/NN for/IN monochannel/NN nonoverlapping/JJ noise/NN and/CC the/DT optimal/JJ algorithm/NN for/IN multichannel/JJ additive/JJ noise/NN ,/, and/CC we/PRP show/VBP that/IN in/IN both/DT cases/NNS improvement/NN can/MD be/VB obtained/VBN ./.
@@96961649676 A/DT safe/JJ and/CC simple/JJ system/NN for/IN the/DT detection/NN of/IN sudden/JJ infant/NN death/NN syndrome/NN (/( SIDS/NN )/SYM is/VBZ proposed/VBN ./.
@@10764760787 Transactivation/NNS of/IN naturally/RB occurring/VBG HIV-1/NNP long/JJ terminal/JJ repeats/NNS by/IN the/DT JNK/NEWGENE signaling/JJ pathway/NN ./.
@@30662085089 Histological/JJ examination/NN revealed/VBD a/DT small/JJ simple/JJ renal/NN cyst/NN associated/VBN with/IN renal/JJ cell/NN carcinoma/NN ./.
@@29942533145 Those/DT dosages/NNS that/WDT inhibited/VBD mean/JJ NTE/NEWGENE activity/NN in/IN spinal/JJ cord/NN greater/JJR than/IN or/CC equal/NN to/IN 72%/NN and/CC brain/NN greater/JJR than/IN or/CC equal/NN to/IN 66%/NN of/IN control/NN values/NNS within/IN 44/CD hr/NN postexposure/RB produced/VBD marked/JJ spinal/JJ cord/NN pathology/NN 14/CD days/NNS postexposure/RB in/IN greater/JJR than/IN or/CC equal/NN to/IN 90%/CD of/IN similarly/RB dosed/VBN animals/NNS ./.
@@98100879787 RESULTS/NNS :/: An/DT herpetic/JJ seroconversion/NN is/VBZ observed/VBN with/IN presence/NN of/IN type/NN I/NN herpes/NN simplex/JJ virus/NN (/( HSV/NN I/NN )/SYM nucleic/JJ acids/NNS in/IN the/DT recipient's/NNS aqueous/JJ humor/NN ./.
@@6694380748 Plasma/NN NE/NN was/VBD also/RB low/JJ in/IN the/DT anephric/JJ group/NN (/( 289/CD mg/NN //NN liter/NN +/NN //NN -/NN 126/CD (/( 1/CD SD/NN )/SYM vs/NNP 612/NN +/NN //NN -/NN 189/CD ,/, P/NN =/SYM 0/CD ./CD 033/CD ,/, resting/NN )/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@15889135183 A/DT gene/NN homologous/JJ to/IN the/DT Escherichia/NEWGENE coli/NEWGENE dnaA/NEWGENE gene/NEWGENE was/VBD isolated/VBN from/IN Pseudomonas/NNS putida/NN and/CC its/PRP transcription/NN was/VBD investigated/VBN in/IN E/NNP ./NNP coli/JJ as/RB well/VB as/IN in/IN P/NNP ./NNP putida/NN ./.
@@107562256816 CONCLUSION/IN :/: More/RBR than/IN 50%/CD of/IN patients/NNS with/IN perennial/JJ rhinitis/NN and/CC CRS/NN do/NN not/RB improve/VB after/IN surgery/NN ,/, a/DT response/NN that/WDT may/MD be/VB predicted/VBN by/IN more/JJ cells/NNS expressing/NN IL-5/NEWGENE mRNA/NEWGENE in/IN the/DT ethmoid/JJ sinuses/NNS ./.
@@59691855849 Concussion/NNS of/IN the/DT spinal/JJ cord/NN ./.
@@16987619978 Relatively/RB large/JJ DNA/NN rearrangements/NNS spanning/VBG the/DT region/NN with/IN tandem/NN direct/JJ repeats/NNS encoding/VBG the/DT carboxy-terminal/NEWGENE histone/NEWGENE H1-like/NEWGENE structure/NEWGENE of/IN AlgP/NEWGENE were/VBD detected/VBN in/IN several/DT strains/NNS upon/IN conversion/NN from/IN the/DT mucoid/NN to/IN the/DT nonmucoid/NN phenotype/NN ./.
@@85667516241 This/DT approach/NN places/NNS gHoxb-1/NEWGENE into/IN the/DT normal/JJ embryonic/JJ spatiotemporal/JJ context/NN in/IN which/WDT lab/NN acts/NNS ./.
@@94231232384 IVOX/NN was/VBD named/VBN as/IN an/DT acronym/NN for/IN intravascular/JJ oxygenator/NN ./.
@@97703782928 EGFR/NEWGENE levels/NNS were/VBD found/VBN to/IN be/VB elevated/VBN 5-/CD ,/, 3/CD ./CD
@@9882334214 However/RB ,/, serial/JJ passages/NNS of/IN fetal/JJ lamb/NN kidney/NN (/( FLK/NN )/SYM cells/NNS ,/, which/WDT are/VBP sensitive/JJ to/IN infection/NN with/IN BLV/NN ,/, after/IN transient/JJ transfection/NN revealed/VBD that/DT mutation/NN of/IN a/DT second/JJ tyrosine/NN residue/NN in/IN the/DT N-terminal/NN motif/NN completely/RB prevented/VBD the/DT propagation/NN of/IN the/DT virus/NN ./.
@@6037831528 Serum/NN levels/NNS of/IN IgG/NEWGENE and/CC IgM/NEWGENE were/VBD also/RB raised/VBN ,/, but/CC contrary/NN to/IN the/DT findings/NNS of/IN other/DT observers/NNS IgA/NEWGENE levels/NNS were/VBD normal/JJ ./.
@@9703205546 The/DT performance/NN of/IN three/CD commonly/RB used/VBN chemical/JJ cartridge/NN respirators/NNS for/IN SO2/NN was/VBD measured/VBN under/IN working/JJ conditions/NNS in/IN a/DT copper/JJ smelter/NN ./.
@@89851229529 The/DT promoter/NN region/NN (/( P1/NN )/SYM corresponding/JJ to/IN the/DT main/JJ group/NN of/IN transcription/NN initiation/NN sites/NNS is/VBZ devoid/JJ of/IN TATA/NN and/CC CAAT/NN boxes/NNS but/CC has/VBZ putative/JJ binding/JJ sites/NNS for/IN the/DT transcription/NEWGENE factor/NEWGENE SP1/NEWGENE and/CC is/VBZ embedded/VBN in/IN a/DT large/NN G/NN +/SYM C-rich/NN domain/NN of/IN a/DT CpG/NN island/NN ,/, features/NNS shared/VBN by/IN the/DT promoters/NNS of/IN constitutively/RB expressed/VBN housekeeping/NN genes/NNS ./.
@@113088511138 We/PRP find/VBP that/IN our/PRP response/NN function/NN is/VBZ well/VB approximated/VBN by/IN the/DT GSER/NN only/RB within/IN a/DT particular/JJ frequency/NN range/NN determined/VBN by/IN the/DT material/NN parameters/NNS of/IN both/PDT the/DT bead/NN and/CC the/DT network/NN ./.
@@93178309284 THE/DT SCALING/NN OF/IN SONG/NNP FREQUENCY/NNP IN/IN CICADAS/NNP ./.
@@27111453385 HIV/NN infectiousness/NN and/CC the/DT AIDS/NN epidemic/JJ ./.
@@78761946832 Endocytosis/NNS and/CC lysosomal/JJ targeting/NN of/IN epidermal/NEWGENE growth/NEWGENE factor/NEWGENE receptors/NEWGENE are/VBP mediated/JJ by/IN distinct/JJ sequences/NNS independent/NN of/IN the/DT tyrosine/NEWGENE kinase/NEWGENE domain/NEWGENE ./.
@@10429184463 Expansins/NEWGENE are/VBP a/DT family/NN of/IN proteins/NNS that/WDT catalyse/VBP long-term/JJ extension/NN of/IN isolated/VBN plant/NN cell/NN walls/NNS due/NN to/RB an/DT as/IN yet/RB unknown/JJ biochemical/JJ mechanism/NN ./.
@@115173993913 The/DT patterns/NNS of/IN early/JJ mRNA/NN and/CC protein/NN expression/NN in/IN these/DT seven/JJ mutants/NNS were/VBD examined/VBN ,/, and/CC it/PRP was/VBD found/VBN that/DT mutation/NN of/IN the/DT T'/NEWGENE (/NEWGENE 135/NEWGENE )/NEWGENE acceptor/NEWGENE site/NEWGENE resulted/VBN in/IN the/DT utilization/NN of/IN cryptic/JJ splice/NN sites/NNS and/CC the/DT generation/NN of/IN new/JJ T'/NEWGENE species/NEWGENE ./.
@@44682644979 Problems/NNS common/JJ to/IN pediatrics/NN and/CC anesthesiology/NN ./.
@@912143053 Shc/NEWGENE stimulates/VBZ Ras/NEWGENE //NEWGENE mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE (/( MAPK/NEWGENE )/SYM through/RB forming/NN a/NN complex/NN with/IN Grb2/NEWGENE at/IN the/DT phosphorylated/VBN tyrosine/NN (/( Y/NN )/SYM residue/NN 317/CD ./.
@@75906577490 Cholangiography/NNS was/VBD performed/VBN in/IN all/DT cases/NNS and/CC classified/VBN by/IN a/DT scoring/JJ system/NN specifically/RB developed/VBD for/IN pediatric/JJ patients/NNS ./.
@@63360454466 Frog/NN type/NN I/NN (/( Ft/NN I/NN )/SYM and/CC frog/NN type/NN II/NN (/( Ft/NN II/NN )/SYM slowly/RB adapting/JJ (/( SA/NNP )/SYM units/NNS produced/VBD spikes/NNS only/RB at/IN the/DT indentation/NN phase/NN ,/, and/CC the/DT threshold/NN response/NN phase/NN (/( TRP/NN )/SYM ,/, i/FW ./FW e/FW ./FW ./. the/DT phase/NN of/IN the/DT first/JJ spike/NN was/VBD for/IN ca/NN ./NN
@@105854402612 We/PRP describe/VBP here/RB a/DT Drosophila/NEWGENE melanogaster/NEWGENE FAK/NEWGENE homologue/NEWGENE ,/, DFak56/NEWGENE ,/, which/WDT maps/NNS to/IN band/NN 56D/NN on/IN the/DT right/JJ arm/NN of/IN the/DT second/JJ chromosome/NN ./.
@@106176135847 Chem/NNP ./.
@@101030022201 A/DT single/NN N-glycosylation/NN site/NN present/NN in/IN chicken/NEWGENE gp42/NEWGENE is/VBZ conserved/VBN among/IN all/DT five/CD of/IN these/DT proteins/NNS :/: carbohydrate/NN analysis/NN of/IN gp42/NEWGENE revealed/VBN the/DT presence/NN of/IN a/DT complex/NN type/NN glycan/NN chain/NN at/IN this/DT site/NN ./.
@@18141827387 Different/JJ doses/NNS of/IN 15-methyl-PGF2/NN alpha/NN (/( 0/CD ./CD 125-10/CD mg/NN )/SYM were/VBD used/VBN to/IN induce/VB luteolysis/NN and/CC oestrus/NN in/IN 7/CD heifers/NNS with/IN 28/CD treatments/NNS on/IN day/NN 8-12/CD of/IN the/DT oestrous/JJ cycle/NN ./.
@@74757937365 BSE/NN and/CC farmworkers/NNS ./.
@@31447058394 The/DT distribution/NN of/IN the/DT sites/NNS of/IN recombinational/JJ resolution/NN is/VBZ inversely/RB correlated/VBN with/IN that/DT of/IN the/DT gradient/NN of/IN sequence/NN divergence/NN ,/, with/IN only/RB approximately/JJ 7%/NN of/IN the/DT X/NN recombinants/NNS resolved/VBN within/IN the/DT 3'/CD third/RB of/IN the/DT X/NN blocks/NNS where/CC two/RB diverged/VBN Alu/NEWGENE family/NEWGENE repeats/NEWGENE reside/VBP ./.
@@92309457613 A/DT pre-boutonniere/JJ deformity/NN was/VBD simulated/JJ by/IN dividing/JJ the/DT central/NN slip/NN ./.
@@106886463042 First/RB ,/, human/JJ erythroid/JJ K562/NNP cells/NNS stably/RB integrated/JJ with/IN various/JJ HS-40/NEWGENE mutants/NEWGENE cis/JJ linked/JJ to/IN a/DT human/NEWGENE alpha-globin/NEWGENE promoter-growth/NEWGENE hormone/NEWGENE hybrid/NEWGENE gene/NEWGENE were/VBD analyzed/VBN by/IN genomic/JJ footprinting/VBG and/CC expression/NN analysis/NN ./.
@@73068397170 Electron/NNP microscopic/JJ picture/NN of/IN the/DT cerebral/JJ cortex/NN in/IN rats/NNS cooled/VBN to/IN 22/CD degrees/NNS C/NNP ./NNP
@@88911318841 Enterococcus/DT faecium/NN strains/NNS with/IN vanA-mediated/JJ glycopeptide/NN resistance/NN were/VBD isolated/VBN by/IN enrichment/NN culture/NN from/IN the/DT intestines/NNS and/CC feces/NNS of/IN several/DT animal/NN species/NN ,/, mainly/RB horses/NNS and/CC dogs/NNS (/( 8%/JJ positive/JJ )/SYM ,/, chickens/NNS (/( 7%/JJ positive/JJ )/SYM ,/, and/CC pigs/NNS (/( 6%/JJ positive/JJ )/SYM ./.
@@62549739404 Poly/NN (/NN dT/NN )/NN and/CC denatured/JJ calf/NN thymus/NN DNA/NN were/VBD more/RB effective/JJ than/IN were/VBD other/DT polynucleotides/NNS tested/VBN in/IN promoting/JJ accumulation/NN of/IN 19/CD HDP*/NEWGENE ;/: (/( dT/NN )/NN 8/NN was/VBD as/RB effective/JJ as/IN were/VBD longer/JJR molecules/NNS of/IN (/( dT/NN )/NN n/NN ,/, but/CC (/( dT/NN )/NN 4/NN and/CC (/( dT/NN )/NN 6/NN were/VBD much/JJ less/PRP effective/JJ ,/, indicating/VBG that/IN the/DT binding/JJ site/NN involved/VBN in/IN 19/CD HDP*/NEWGENE accumulation/NN covered/VBN between/IN 6/CD and/CC 8/CD residues/NNS of/IN (/( dT/NN )/NN n/NN ./.
@@59090345819 Studies/NNS on/IN powdered/JJ preparations/NNS ./.
@@41646695829 Ultraviolet/NN light-induced/NN kinin/NEWGENE formation/NN in/IN human/JJ skin/NN ./.
@@61528445975 Effect/NN of/IN bromazepam/NN on/IN growth/NEWGENE hormone/NEWGENE and/CC prolactin/NEWGENE secretion/NN in/IN normal/JJ subjects/NNS ./.
@@16557137040 In/NN this/DT study/NN ,/, we/PRP have/VBP cloned/VBN a/DT region/NN that/WDT complements/VBZ the/DT exoenzyme/NN S-deficient/NNP phenotype/NN of/IN strain/NN 388/CD exs1/NEWGENE :/: :/: Tn1/NEWGENE ,/, a/DT chromosomal/NEWGENE Tn1/NEWGENE insertional/NEWGENE mutation/NEWGENE ./.
@@10584138408 Cytoprotection/NNS with/IN amifostine/NN in/IN radiotherapy/NN or/CC radio-chemotherapy/NN of/IN head/NN and/CC neck/NN tumors/NNS ./.
@@98728329513 The/DT BAL/NN concentrations/NNS of/IN the/DT nine/JJ cytokines/NNS evaluated/VBN for/IN the/DT more/RB and/CC less/PRP affected/VBN lungs/NNS were/VBD compared/VBN :/: interleukin-6/NEWGENE (/( IL-6/NEWGENE )/SYM ,/, IL-8/NEWGENE ,/, IL-12/NEWGENE ,/, tumor/NEWGENE necrosis/NEWGENE factor-alpha/NEWGENE (/( TNF-alpha/NEWGENE )/SYM ,/, and/CC interferon/NEWGENE gamma/NEWGENE (/( IFN-gamma/NEWGENE )/SYM showed/VBD significant/JJ differences/NNS (/( p/NN ranged/VBN between/IN 0/CD ./CD
@@19180733836 Comparison/NNS of/IN the/DT cDNA-predicted/JJ avian/NEWGENE TnIcardiac/NEWGENE amino/NEWGENE acid/NEWGENE sequences/NEWGENE with/IN known/VBP TnI/NEWGENE sequences/NEWGENE indicated/VBN 1/NN )/NN that/IN the/DT presence/NN of/IN an/DT N-terminal/NN extension/NN sequence/NN carrying/JJ a/DT dual/JJ protein/NEWGENE kinase/NEWGENE A/NEWGENE phosphorylation/NN target/NN site/NN and/CC an/DT adjacent/JJ proline-rich/JJ segment/NN is/VBZ an/DT ancient/JJ cardiac-specific/JJ feature/NN of/IN TnI/NEWGENE which/WDT has/VBZ been/VBN conserved/VBN since/IN the/DT bird/JJ //JJ mammal/JJ divergence/NN ,/, 2/NN )/NN that/IN features/NNS of/IN the/DT near-N-terminal/NN troponin/NEWGENE C/NEWGENE (/( TnC/NEWGENE )/NN -binding/NN site/NN sequence/NN suggest/VB isoform-specific/JJ adaptation/NN of/IN TnI/NEWGENE and/CC TnC/NEWGENE ,/, and/CC 3/NN )/NN that/IN the/DT avian/JJ TnIcardiac/NEWGENE internal/JJ actin/NEWGENE //NEWGENE TnC-binding/NEWGENE ,/NEWGENE actomyosin-inhibitory/NEWGENE ,/NEWGENE domain/NEWGENE shows/VBZ significant/JJ sequence/NN divergence/NN from/IN mammalian/NEWGENE TnIcardiac/NEWGENE sequences/NEWGENE ,/, including/JJ the/DT absence/NN of/IN a/DT protein/NEWGENE kinase/NEWGENE C/NEWGENE target/NN site/NN which/WDT is/VBZ a/DT cardiac-specific/JJ feature/NN of/IN TnI/NEWGENE in/NN mammals/NNS ./.
@@81381806978 Certain/JJ spt10/NEWGENE spontaneous/JJ alleles/NNS are/VBP good/JJ suppressors/NNS but/CC have/VB a/DT normal/JJ growth/NN rate/NN ,/, suggesting/VBG that/IN the/DT SPT10/NEWGENE protein/NEWGENE may/MD have/VB two/JJ distinct/JJ functions/NNS ./.
@@109728941539 Genomic/NN libraries/NNS were/VBD stored/VBN as/IN frozen/JJ cultures/NNS in/IN a/DT 96-well/CD format/NN ,/, each/DT well/JJ containing/JJ approximately/RB 300-600/JJ colonies/NNS (/( 12/CD plates/NNS for/IN small/JJ library/NN ,/, four/CD for/IN medium-size/JJ library/NN and/CC four/CD for/IN large/JJ library/NN )/SYM ./.
@@85435958529 In/NN summary/NN ,/, the/DT efficacies/NNS of/IN adjuvant/JJ carboplatin/NN and/CC of/IN abdominal/JJ radiotherapy/NN seem/VB to/IN be/VB identical/JJ ./.
@@108252937828 Immobilized/JJ dimers/NNS of/IN N-cadherin-Fc/NEWGENE chimera/NEWGENE mimic/NN cadherin-mediated/JJ cell/NN contact/NN formation/NN :/: contribution/NN of/IN both/DT outside-in/JJ and/CC inside-out/RB signals/VBZ ./.
@@13149537153 In/NN contrast/NN ,/, gel/NN mobility/NN shift/NN experiments/NNS have/VBP failed/VBN to/IN reveal/VB that/IN HAP2/NEWGENE or/CC HAP3/NEWGENE binds/VBZ to/IN domain/NN 1/CD or/CC that/IN hap3/NEWGENE mutations/NN affect/VBP the/DT complexes/NNS bound/JJ to/IN it/CD ./CD
@@95159241719 The/DT PDH/NEWGENE complex-encoding/NEWGENE genes/NEWGENE were/VBD identified/VBN by/IN hybridization/NN experiments/NNS and/CC sequence/NN analysis/NN in/IN two/JJ separate/JJ gene/NN regions/NNS in/IN the/DT genome/NN of/IN Z/NNP ./NNP mobilis/NN ./.
@@95832019530 None/NN of/IN the/DT patients/NNS was/VBD obese/JJ ./.
@@40190668484 Sensory/RB evoked/VBN field/NN potentials/NNS were/VBD recorded/VBN from/IN the/DT mesencephalic/JJ reticular/JJ formation/NN (/( MRF/NN )/SYM ,/, central/JJ gray/JJ (/( CG/NN )/SYM and/CC somatosensory/JJ cortex/NN (/( SCX/NNP )/SYM ,/, following/IN incremental/JJ doses/NNS of/IN halothane/NN in/IN freely-moving/JJ rats/NNS ./.
@@109838575656 Mucosal/JJ application/NN of/IN NCX-4016/NN ,/, however/RB ,/, did/VBD not/RB cause/VB PD/NN reduction/NN and/CC luminal/JJ H+/NN loss/NN ,/, but/CC produced/VBD a/DT marked/JJ hyperemia/NN ,/, resulting/JJ in/IN no/DT damage/NN in/IN the/DT stomach/NN of/IN both/DT normal/JJ and/CC STZ-diabetic/JJ rats/NNS ./.
@@77982172558 A/DT role/NN for/IN glycogen/NEWGENE synthase/NEWGENE kinase-3/NEWGENE in/IN the/DT control/NN of/IN gene/NN expression/NN ./.
@@98684128597 CONCLUSION/IN :/: Our/PRP study/NN shows/VBZ that/IN (/( 1/CD )/SYM total/JJ body/NN BMD/NN and/CC femoral/JJ neck/NN BMD/NN were/VBD significantly/RB higher/JJ in/IN the/DT study/NN group/NN that/WDT performed/VBD weight-bearing/NN exercises/NNS than/IN in/IN control/JJ subjects/NNS ,/, (/( 2/CD )/SYM swimming/JJ exercise/NN had/VBP no/DT effect/NN on/IN BMD/NN ,/, and/CC (/( 3/CD )/SYM although/IN swimming/NN is/VBZ not/RB a/DT bone-building/JJ exercise/NN ,/, it/PRP can/MD significantly/RB improve/VB shoulder/NN ,/, back/NN ,/, and/CC grip/NN muscle/NN strength/NN ./.
@@11127955970 Adjuvant/NN therapy/NN for/IN colon/NN cancer/NN Surgery/NNP alone/RB may/MD fail/VB to/IN cure/NN a/DT considerable/JJ number/NN of/IN locally/RB advanced/JJ colon/NN cancers/NNS ./.
@@89524836213 Several/JJ particular/JJ features/NNS of/IN this/DT polypeptide/NN fragment/NN from/IN the/DT hamster/NEWGENE lysyl-tRNA/NEWGENE synthetase/NEWGENE suggest/VB that/IN it/PRP is/VBZ implicated/VBN in/IN the/DT assembly/NN of/IN that/DT enzyme/NN within/IN the/DT multisynthetase/NN complex/NN ./.
@@107927187628 Identification/NNP of/IN an/DT AfsA/NEWGENE homologue/NEWGENE (/( BarX/NEWGENE )/SYM from/IN Streptomyces/NN virginiae/NNS as/IN a/DT pleiotropic/JJ regulator/NN controlling/JJ autoregulator/NN biosynthesis/NN ,/, virginiamycin/NN biosynthesis/NN and/CC virginiamycin/NN M1/NN resistance/NN ./.
@@87566091475 The/DT deduced/VBN amino/JJ acid/NN sequence/NN was/VBD highly/RB conserved/VBN across/IN the/DT wide/JJ range/NN of/IN eukaryotes/NNS (/( vertebrates/NNS ,/, invertebrates/NNS ,/, fungi/NNS ,/, plants/NNS and/CC protozoa/NNS )/SYM in/IN which/WDT this/DT gene/NN has/VBZ now/RB been/VBN identified/VBN ./.
@@111494723032 We/PRP observed/VBD NP/NEWGENE //NEWGENE NMP4/NEWGENE //NEWGENE CIZ/NEWGENE expression/NN in/IN osteocytes/NNS ,/, osteoblasts/NNS ,/, and/CC chondrocytes/NNS in/IN rat/NN bone/NN ./.
@@1829460992 Southwestern/NNP blot/NN analysis/NN demonstrated/VBN that/IN this/DT phosphoprotein/NN can/MD bind/NN the/DT kappa/NEWGENE B/NEWGENE element/NEWGENE directly/RB and/CC specifically/RB ./.
@@82688333570 The/DT therapeutic/JJ action/NN of/IN cyclosporin/NN A/NN (/( Sandimmun/NN )/SYM :/: its/PRP application/NN in/IN rheumatoid/JJ arthritis/NN ./.
@@39404264601 Results/NNS of/IN this/DT study/NN indicate/VB that/DT GLC/NN of/IN short/JJ chain/NN fatty/JJ acids/NNS produced/VBN on/IN agar/NN medium/NN by/IN anaerobes/NNS ,/, combined/JJ with/IN simple/JJ tests/NNS such/JJ as/IN Gram's/NNP stain/NN and/CC colonial/JJ morphology/NN ,/, may/MD allow/VB fir/NN direct/JJ presumptive/JJ genus/NN identification/NN from/IN an/DT initial/JJ pure/JJ agar/NN culture/NN ./.
@@96427646082 Moreover/RB ,/, the/DT mass/RB estimated/VBN with/IN the/DT QCM/NN response/NN through/RB the/DT Sauerbrey/NNP equation/NN and/CC the/DT mass/JJ which/WDT can/MD be/VB measured/VBN thanks/NNS to/IN other/DT analytical/JJ techniques/NNS ,/, in/IN our/PRP case/NN an/DT enzymatic/JJ assay/NN ,/, are/VBP different/JJ :/: the/DT deposited/VBN mass/NN is/VBZ generally/RB overestimated/VBN by/IN the/DT QCM/NNP ./.
@@107289863502 The/DT Wnt/NEWGENE signaling/JJ pathway/NN functions/NNS reiteratively/RB during/IN animal/NN development/NN to/IN control/NN cell/NN fate/NN decisions/NNS ./.
@@46767345089 The/DT relationship/NN of/IN human/JJ umbilical/JJ arterial/JJ and/CC venous/JJ plasma/NN levels/NNS of/IN corticosteroids/NNS to/IN gestational/JJ age/NN ./.
@@105361258091 Oseltamivir/NN (/( GS4104/NN )/SYM ,/, which/WDT can/MD be/VB administered/VBN orally/RB ,/, is/VBZ the/DT prodrug/NN of/IN GS4071/NN ,/, a/DT potent/JJ and/CC selective/JJ inhibitor/NN of/IN influenzavirus/NEWGENE neuraminidases/NEWGENE ./.
@@9515858330 BACKGROUND/IN :/: Defensins/NEWGENE ,/, also/RB known/VBP as/IN human/NEWGENE neutrophil/NEWGENE peptides/NEWGENE ,/, are/VBP antimicrobial/JJ peptides/NNS present/VBP in/IN the/DT azurophil/NN granules/NNS of/IN neutrophils/NNS ./.
@@93882462888 We/PRP also/RB show/VBP by/IN immunogold/NN electron/NN microscopy/NN immunocytochemistry/NN that/DT amphiphysin/NEWGENE I/NEWGENE is/VBZ localized/VBN in/IN the/DT nerve/NN terminal/JJ cytomatrix/NN and/CC is/VBZ partially/RB associated/VBN with/IN endocytic/JJ intermediates/NNS ./.
@@85303427173 The/DT human/NEWGENE gp39/NEWGENE promoter/NEWGENE ./.
@@11488681372 The/DT metabolic/JJ clearance/NN rate/NN of/IN progesterone/NN was/VBD 295/CD +/NN //NN -/NN 49/CD (/( S/NNS ./NNS E/NNS ./NNS )/SYM 1/CD //CD day/CD ./.
@@89709844476 The/DT SCMV/NEWGENE SNE/NEWGENE sites/NEWGENE contain/VBP potential/JJ overlapping/JJ core/NN recognition/NN binding/JJ motifs/NNS for/IN SRF/NEWGENE ,/, Rel/NEWGENE //NEWGENE NFkappaB/NEWGENE ,/, ETS/NEWGENE ,/, and/CC YY1/NEWGENE class/NEWGENE transcription/NEWGENE factors/NEWGENE but/CC fail/NN to/IN respond/NN to/IN either/DT serum/NN or/CC tumor/NEWGENE necrosis/NEWGENE factor/NEWGENE alpha/NEWGENE ./.
@@43850606516 Disulfiram/NN and/CC the/DT drug-induced/JJ effects/NNS on/IN motility/NN ./.
@@94140749370 Resistance/NNP training/NN shifts/VBZ the/DT power/NN curve/NN in/IN a/DT positive/JJ direction/NN when/CC the/DT measurements/NNS are/VBP determined/VBN with/IN absolute/JJ loads/NNS ,/, but/CC the/DT increased/VBN power/NN may/MD not/RB be/VB transferred/VBN to/IN an/DT absolute/JJ performance/NN task/NN like/NN the/DT SSP/NN ./.
@@11859569378 The/DT authors/NNS concluded/VBN that/IN ultrasonic/JJ Doppler-cardiography/NN can/MD be/VB used/VBN for/IN measuring/JJ the/DT relative/JJ changes/NNS in/IN the/DT stroke/NN volume/NN ./.
@@15493466920 The/DT c-Ets-1/NEWGENE oncoprotein/NEWGENE is/VBZ a/DT transcription/NN activator/NN that/WDT specifically/RB binds/VBZ to/IN DNA/NN ./.
@@6339096128 Internally/RB oriented/VBN patients'/NN scores/NNS on/IN Rotter's/NNP Internal-External/JJ Locus/NN of/IN Control/NNP Scale/NNP remained/VBD the/DT same/JJ over/JJ treatment/NN but/CC those/DT of/IN externally/RB oriented/VBN patients/NNS shifted/VBN toward/IN greater/RBR internal/JJ control/NN ./.
@@89103734562 Percent/NN identities/NNS of/IN the/DT mouse/NEWGENE PP2/NEWGENE to/IN mouse/NEWGENE Y1/NEWGENE ,/, mouse/NEWGENE Y4/NEWGENE //NEWGENE PP1/NEWGENE and/CC human/NEWGENE Y2/NEWGENE receptors/NEWGENE are/VBP 53/CD ,/, 42/CD ,/, and/CC 31/CD ,/, respectively/RB ./.
@@106675972119 ZK7/NEWGENE and/CC HZF16/NEWGENE genes/NEWGENE appear/VBP to/IN be/VB the/DT splice/NN variants/NNS transcribed/VBN from/IN the/DT same/JJ gene/NN ./.
@@41645954829 Evidence/NN for/IN two/JJ distinctive/JJ clinical/JJ ,/, epidemiological/JJ ,/, and/CC immunological/JJ types/NNS of/IN infection/NN ./.
@@91591609030 Positional/JJ cloning/NN has/VBZ already/RB produced/VBN the/DT sequences/NNS of/IN more/RB than/IN 70/NN human/NN genes/NN associated/VBN with/IN specific/JJ diseases/NNS ./.
@@75594788053 15/CD ,/, 2500-2508/JJ ;/: O'Neill/NNP ,/, T/NNP ./NNP
@@50310745331 Serum/NN lipid/NN changes/NNS during/IN pregnancy/NN due/NN to/IN oral/JJ calcium/NN administration/NN ./.
@@112666153602 The/DT protein/NN is/VBZ composed/VBN of/IN two/JJ major/JJ domains/NNS separated/VBN by/IN a/DT hydrophobic/JJ linker/NN region/NN of/IN 20/CD amino/JJ acid/NN residues/NNS ./.
@@81317469313 MEK/NEWGENE itself/PRP is/VBZ activated/VBN via/NN serine/NN phosphorylation/NN by/IN upstream/NEWGENE activator/NEWGENE kinases/NEWGENE ,/, including/JJ c-raf/NEWGENE ,/, mos/NEWGENE and/CC MEK/NEWGENE kinase/NEWGENE ./.
@@110719246405 A/DT protein/NN lacking/JJ the/DT SH2/NEWGENE and/CC RING/NN finger/NN domains/NNS has/VBZ no/DT activity/NN ,/, but/CC a/DT chimeric/JJ protein/NN with/IN the/DT SH2/NEWGENE and/CC RING/NN finger/NN domains/NNS of/IN SLI-1/NEWGENE replaced/VBN by/IN the/DT equivalent/JJ domains/NNS of/IN c-Cbl/NEWGENE has/VBZ activity/NN ./.
@@100950614656 Sequence/NN analysis/NN revealed/VBN that/IN the/DT MEMA/NEWGENE protein/NEWGENE is/VBZ identical/JJ with/IN a/DT 160/NEWGENE kDa/NEWGENE nuclear/NEWGENE 'domain/NEWGENE rich/NEWGENE in/NEWGENE serines'/NEWGENE (/NEWGENE DRS/NEWGENE )/NEWGENE protein/NEWGENE occurring/VBG free/JJ in/IN the/DT nucleoplasm/NN and/CC in/IN U2-ribonucleoprotein/NEWGENE structures/NEWGENE ./.
@@80559393646 The/DT central/JJ globular/JJ domain/NN is/VBZ highly/RB similar/JJ to/IN those/DT regions/NNS from/IN other/DT H1/NEWGENE molecules/NEWGENE ,/, and/CC the/DT carboxyl-terminal/NN domain/NN contains/VBZ a/DT repeating/JJ hexapeptide/NN motif/NN ,/, variants/NNS of/IN which/WDT are/VBP conserved/VBN among/IN H1/NEWGENE molecules/NEWGENE ./.
@@60987195925 Neither/CC side/JJ effect/NN nor/CC abnormal/JJ laboratory/NN findings/NNS due/NN to/IN this/DT drug/NN were/VBD observed/VBN ./.
@@30027863725 One/CD group/NN (/( n/NN =/SYM 9/CD )/SYM was/VBD premedicated/VBN with/IN midazolam/NN ,/, 0/CD ./CD 1/CD mg/NN kg-1/NN ,/, and/CC atropine/NN 0/CD ./CD 2-0/CD ./CD 4/CD mg/NN i/CD ./CD m/CD ./.
@@20613337435 No/DT evidence/NN for/IN the/DT presence/NN of/IN introns/NNS within/IN the/DT acvA/NEWGENE gene/NEWGENE has/VBZ been/VBN found/VB ./.
@@23727122217 The/DT effects/NNS of/IN tap/NN (/( TW/NNP )/SYM or/CC carbonated/JJ (/( CW/JJ )/SYM water/NN on/IN arterial/JJ pH/NN ,/, partial/JJ pressure/NN of/IN carbon/NN dioxide/NN (/( PCO2/NN )/SYM and/CC plasma/NN lactate/NN were/VBD determined/VBN in/IN heat-stressed/JJ broilers/NNS ./.
@@84385848899 Weak/JJ promoter/NN activity/NN was/VBD observed/VBN for/IN the/DT promoter/NN of/IN the/DT C1/NEWGENE and/NEWGENE C2/NEWGENE ORFs/NEWGENE (/( C1-C2/NEWGENE gene/NEWGENE )/SYM and/CC for/IN the/DT promoter/NN of/IN the/DT V1/NEWGENE ORF/NEWGENE ./.
@@16999442991 These/DT results/NNS strongly/RB suggested/VBN that/IN similar/JJ ,/, if/IN not/RB identical/JJ ,/, the/DT CArG/NEWGENE box/NEWGENE binding/NEWGENE proteins/NEWGENE interact/VBP with/IN the/DT functionally/RB different/JJ promoter/NN element/NN in/IN the/DT VLC1/NEWGENE ,/, cardiac/NEWGENE alpha-actin/NEWGENE ,/, and/CC c-fos/NEWGENE genes/NEWGENE ./.
@@8771781257 The/DT ORFII/NEWGENE gene/NEWGENE product/NEWGENE is/VBZ targeted/VBN to/IN the/DT chloroplast/NN ,/, which/WDT is/VBZ consistent/JJ with/IN previous/JJ data/NN indicating/VBG the/DT presence/NN of/IN PMSR/NEWGENE activity/NN in/IN the/DT chloroplast/NN ./.
@@107176122864 BACKGROUND/IN :/: The/DT aim/NN of/IN this/DT study/NN was/VBD to/IN determine/VB the/DT response/NN rates/NNS and/CC toxicity/NN of/IN two/JJ regimens/NNS containing/NN granulocyte-macrophage-colony/NEWGENE stimulating/NEWGENE factor/NEWGENE (/( GM-CSF/NEWGENE )/SYM in/IN combination/NN with/IN interleukin-2/NEWGENE (/( IL-2/NEWGENE )/SYM in/IN the/DT treatment/NN of/IN patients/NNS with/IN metastatic/JJ renal/JJ cell/NN carcinoma/NN ./.
@@107482042290 (/( 1998/CD )/SYM J/NNP ./NNP
@@40014134661 For/IN this/DT purpose/NN ,/, a/DT simple/JJ respiration-control/JJ device/NN has/VBZ been/VBN developed/VBN that/WDT enables/VBZ the/DT patient/NN to/IN monitor/NN breath-holding/NN during/IN successive/JJ scans/NNS ./.
@@113556151206 Additional/JJ education/NN and/CC research/NN is/VBZ needed/VBN to/IN provide/VB further/JJ direction/NN for/IN intervention/NN and/CC incorporation/NN into/IN practice/NN ./.
@@112676794006 The/DT 438/NEWGENE bp/NEWGENE EcoRI/NEWGENE fragment/NEWGENE ,/, which/WDT was/VBD detected/VBN by/IN Southern/NNP hybridization/NN ,/, reveals/VBZ an/DT open/JJ reading/JJ frame/NN which/WDT encodes/VBZ a/DT protein/NN of/IN 103/CD amino/JJ acids/NNS ./.
@@113791061216 In/NN the/DT meantime/NN ,/, one/PRP has/VBZ succeeded/VBN to/IN establish/VB the/DT deammonification/NN processes/NNS in/IN a/DT continuous/JJ flow/NN moving-bed/JJ pilot/JJ plant/NN ./.
@@62861916077 Restoration/NNP of/IN impaired/VBN immune/JJ functions/NNS in/IN aging/NN animals/NNS ./.
@@110111394021 While/IN this/DT Saccharomyces/NN cerevisiae/NN SIN4/NEWGENE gene/NEWGENE product/NEWGENE is/VBZ a/DT component/NN of/IN a/DT mediator/NN complex/NN associated/VBN with/IN RNA/NEWGENE polymerase/NEWGENE II/NEWGENE ,/, various/JJ studies/NNS suggest/VBP the/DT involvement/NN of/IN Sin4/NEWGENE in/IN the/DT alteration/NN of/IN higher-order/JJ chromatin/NN structure/NN ./.
@@79722379818 A/DT high-resolution/JJ restriction/NN map/NN of/IN over/RB 200/CD kb/NN of/IN contiguous/JJ DNA/NN containing/NN N-myc/NEWGENE has/VBZ been/VBN generated/VBN by/IN subcloning/NN YACs/NNS into/IN cosmids/NNS ./.
@@8442384128 While/IN the/DT latter/RB corresponded/VBN to/IN a/DT protein/NN of/IN 824/CD amino/JJ acids/NNS ,/, an/DT upstream/RB open/JJ reading/JJ frame/NN (/( uORF/NN )/SYM within/IN the/DT 5'/CD leader/NN could/MD potentially/RB encode/VB a/DT 54/CD amino/JJ acid/NN peptide/NN ./.
@@10445161290 In/NN summary/NN ,/, the/DT no-adverse-effect-level/NN for/IN this/DT study/NN was/VBD determined/VBN to/IN be/VB 1000/CD ppm/NN ,/, based/VBN on/IN decreased/VBN weight/NN gain/NN in/IN female/JJ rats/NNS ,/, and/CC on/IN slight/JJ organ/NN weight/NN changes/NNS in/IN both/DT sexes/NNS at/IN 3000/CD ppm/NN ./.
@@86508188608 A/DT secondary/JJ spread/NN of/IN an/DT imported/VBN methicillin-resistant/JJ Staphylococcus/NN aureus/NN strain/NN (/( MRSA/NN )/SYM to/IN two/JJ other/DT patients/NNS occurred/VBN within/IN a/DT Danish/JJ surgical/JJ ward/NN in/IN spite/NN of/IN isolation/NN of/IN a/DT multitraumatized/VBN index-patient/JJ immediately/RB after/IN arrival/NN from/IN a/DT hospital/NN in/IN the/DT Mediterranean/JJ area/NN ./.
@@94853084391 The/DT FMN/NN moiety/NN but/CC not/RB the/DT [/NN 3Fe-4S/NN ]/NN cluster/NN of/IN the/DT subunit/NN appears/VBZ to/IN participate/VB in/IN this/DT reaction/NN ./.
@@93518239632 It/PRP thus/RB appears/VBZ that/IN MAPK/NEWGENE functions/NNS in/IN meiotic/JJ maturation/NN by/IN preventing/JJ unfertilized/JJ eggs/NNS from/IN proceeding/NN into/IN parthenogenetic/JJ development/NN ./.
@@108601315027 Tolterodine/NNP users/NNS were/VBD 7/CD ./CD 5/CD times/NNS more/RB likely/RB to/IN have/NN received/VBD another/DT spasmolytic/JJ drug/NN (/( RR/NN 7/NN ./NN 5/NN ,/, 95%/CD CI/NN 4/NN ./NN 8/NN to/IN 11/CD ./CD 9/CD )/SYM ./.
@@42460545843 Effect/NN of/IN immune/JJ lymphocytes/NNS and/CC of/IN rabbit-anti-lymphocyte/NEWGENE globulin/NEWGENE (/( RAMLG/NEWGENE )/SYM on/IN infected/VBN macrophages/NNS exposed/VBN to/IN increased/VBN incubation/NN temperature/NN in/IN vitro/FW ./.
@@108572158082 The/DT Menopause-Rating-Scale/NNP (/( MRS/NN I/NN )/SYM was/VBD used/VBN in/IN clinical/JJ practice/NN since/IN 1992/CD ./.
@@92787588719 CONCLUSION/IN :/: Patients/NNS wit/NN clinically/RB palpable/JJ neck/NN disease/NN (/( N1-3/NN )/SYM ,/, histological/JJ evidence/NN of/IN metastatic/JJ nodal/JJ disease/NN ,/, extracapsular/JJ spread/NN ,/, and/CC three/CD or/CC more/RB positive/JJ lymph/NN nodes/NNS are/VBP at/IN greater/JJR risk/NN of/IN developing/JJ failure/NN at/IN distant/JJ sites/NNS ./.
@@29198323630 Cardiac/NNP disease/NN was/VBD not/RB detected/VBN with/IN M-mode/NN ,/, 2-dimensional/JJ real-time/NN or/CC pulsed-wave/JJ Doppler/NN echocardiography/NN ./.
@@111271619904 Bupropion/NN to/IN aid/NN smoking/NN cessation/NN ./.
@@40051906003 One/CD extract/NN with/IN the/DT lowest/JJS PCA/NN content/NN was/VBD non-carcinogenic/JJ ./.
@@91010854785 The/DT derivatives/NNS of/IN the/DT latter/JJ two/JJ cell/NN lines/NNS showed/VBD increased/VBN expression/NN of/IN the/DT p27Kip1/NEWGENE protein/NEWGENE and/CC inhibition/NN of/IN cell/NN growth/NN ./.
@@81966168807 Interestingly/RB ,/, the/DT interaction/NN of/IN ZAP-70/NEWGENE with/IN the/DT motif/NN was/VBD dependent/JJ on/IN the/DT presence/NN of/IN both/DT ZAP-70/NEWGENE SH2/NEWGENE1 domains/NEWGENE1 and/CC both/DT of/IN the/DT tyrosine/NN residues/NNS in/IN the/DT motif/NN ,/, suggesting/VBG that/IN ZAP-70/NEWGENE interacts/VBZ with/IN two/JJ phosphotyrosine/NN residues/NNS and/CC that/IN the/DT binding/NN of/IN the/DT two/JJ SH2/NEWGENE domains/NEWGENE is/VBZ cooperative/JJ ./.
@@81889788162 The/DT baroreflex/NN latency/NN (/( from/IN the/DT ECG/NN R-wave/NNS to/IN the/DT integrated/JJ MSNA/NNS burst/NN peak/NN )/SYM was/VBD constant/JJ at/IN approximately/RB 1/CD ./CD 20/CD s/NN during/IN sleep/NN ,/, suggesting/VBG that/DT pulse-synchronicity/NN was/VBD maintained/VBN ./.
@@119020689263 One/CD CKD/NN patient's/VBZ journey/NN ./.
@@10764970576 The/DT mode/NN of/IN resistance/NN to/IN quinupristin/NN //NN dalfopristin/NN was/VBD not/RB evident/JJ (/( sat/VBP A-negative/NNP by/IN PCR/NN )/SYM ;/: and/CC these/DT cases/NNS illustrate/VBP the/DT existence/NN of/IN streptogramin-resistant/JJ isolates/NNS before/IN the/DT introduction/NN of/IN this/DT antimicrobial/JJ class/NN into/IN human/JJ clinical/JJ practice/NN ./.
@@89805362700 The/DT conservation/NN of/IN both/PDT the/DT G-box/NN and/CC H-box/NNP in/IN different/JJ CHS/NEWGENE promoters/NEWGENE emphasizes/VBZ their/PRP importance/NN as/IN regulatory/JJ motifs/NNS ./.
@@114159581283 In/NN the/DT past/JJ decade/NN ,/, there/RB have/VB been/VBN enormous/JJ advances/NNS in/IN the/DT use/NN of/IN Bayesian/JJ methodology/NN for/IN analysis/NN of/IN epidemiologic/JJ data/NN ,/, and/CC there/RB are/VBP now/RB many/JJ practical/JJ advantages/NNS to/IN the/DT Bayesian/JJ approach/NN ./.
@@96420428442 Binding/NN affinities/NNS of/IN different/JJ nucleotide/NN mono-/JJ ,/, di-/JJ and/CC triphosphates/NNS and/CC non-hydrolyzable/JJ analogs/NNS indicate/VBP that/IN the/DT beta-phosphate/NN moiety/NN is/VBZ required/VBN for/IN substrate/NN binding/JJ ./.
@@80839639342 The/DT LTR-binding/JJ activities/NNS of/IN VBP/NEWGENE ,/, a1/NEWGENE //NEWGENE EBP/NEWGENE ,/, and/CC B-cell/NN nuclear/JJ extract/NN protein/NN were/VBD compared/VBN and/CC mapped/VBN by/IN gel/NN shift/NN ,/, DNase/NEWGENE I/NEWGENE footprinting/VBG ,/, and/CC methylation/NN interference/NN assays/NNS ./.
@@88146518794 The/DT importance/NN of/IN temporal/NN factors/NN on/IN the/DT presence/NN and/CC severity/NN of/IN ethanol/NN withdrawal/NN signs/NNS in/IN the/DT rat/NN was/VBD quantified/VBN using/VBG rating/JJ scale/NN ,/, tremor/NN ,/, and/CC acoustic/JJ startle/VB paradigms/NNS ./.
@@10602838432 In/NN this/DT study/NN 26/CD patients/NNS (/( 20/CD females/NNS and/CC 6/CD males/NNS )/SYM were/VBD evaluated/VBN ./.
@@80536978043 BACKGROUND/IN AND/CC DESIGN/IN :/: Fifty-nine/JJ melanocytic/JJ nevi/NNS with/IN eccentric/JJ foci/NNS of/IN hyperpigmentation/NN (/( "small/NN dark/JJ dots"/NN )/SYM that/WDT measured/VBD primarily/RB 1/CD to/IN 2/CD mm/NN in/IN diameter/NN were/VBD prospectively/RB examined/VBN to/IN determine/VB the/DT histologic/JJ correlates/VBP of/IN the/DT dark/JJ dots/NNS ./.
@@97603415368 Phosphocreatine/NNP hydrolysis/NN during/IN submaximal/JJ exercise/NN :/: the/DT effect/NN of/IN FIO2/NN ./.
@@28781003582 Present/JJ results/NNS reveal/VBP a/DT frequency-dependent/JJ inhibition/NN of/IN ganglionic/JJ transmission/NN by/IN diltiazem/NN ,/, and/CC suggest/VB that/DT diltiazem/NN may/MD depress/VB excessive/JJ sympathetic/JJ activity/NN without/IN affecting/VBG normal/JJ ganglionic/JJ transmission/NN ./.
@@29478661961 Thus/RB ,/, quantitative/JJ analysis/NN of/IN thallium-201/NN uptake/NN and/CC washout/NN provided/VBD objective/JJ evidence/NN for/IN improved/VBN myocardial/JJ perfusion/NN after/IN coronary/JJ angioplasty/NN ./.
@@82895936581 However/RB ,/, artificially/RB ventilated/VBN rats/NNS ,/, pretreated/VBN with/IN MK-801/NN ,/, were/VBD more/RB sensitive/JJ (/( lethal/JJ cocaine/NN dose/NN ,/, 76/NN ./NN 6/NN +/NN //NN -/NN 8/CD ./CD 0/CD mg/CD //CD kg/CD ,/, n/NN =/SYM 5/CD )/SYM than/IN vehicle/NN pretreated/VBN rats/NNS (/( 129/CD ./CD 4/CD +/NN //NN -/NN 15/CD ./CD 8/CD mg/CD //CD kg/CD ,/, n/NN =/SYM 6/CD )/SYM ,/, indicating/VBG that/IN MK-801/NN may/MD increase/VB both/PDT the/DT respiratory/JJ and/CC the/DT cardiac/JJ toxicity/NN of/IN cocaine/NN in/IN urethane/NN anesthetized/JJ rats/NNS ./.
@@21070733736 However/RB ,/, overexpression/NN of/IN both/PDT the/DT STE4/NEWGENE and/CC STE18/NEWGENE proteins/NEWGENE did/VBD not/RB generate/VB a/DT stronger/JJR pheromone/NN response/NN than/IN overexpression/NN of/IN STE4/NEWGENE in/IN the/DT presence/NN of/IN wild-type/NN levels/NNS of/IN STE18/NEWGENE ./.
@@109034958156 In/NN a/DT gel/NN retardation/NN assay/NN using/VBG HepG2/NN nuclear/JJ extracts/NNS ,/, the/DT 5'/CD flanking/JJ sequence/NN from/IN -74/CD to/IN -46/CD showed/VBD a/DT shifted/VBN band/NN ./.
@@103926692972 In/NN an/DT attempt/NN to/IN reduce/VB the/DT incidence/NN of/IN NSAID-induced/JJ gastrointestinal/JJ lesions/NNS ,/, the/DT following/NN approaches/NNS have/VBP been/VBN proposed/VBN :/: (/( i/NN )/SYM use/NN of/IN the/DT prostaglandin/NN analogue/NN misoprostol/NN ,/, which/WDT is/VBZ an/DT antiulcer/JJ drug/NN which/WDT has/VBZ been/VBN proven/VBP to/RB be/VB as/IN effective/JJ in/IN the/DT prevention/NN of/IN NSAID-induced/JJ gastric/JJ and/CC duodenal/JJ ulcers/NNS as/IN in/IN the/DT reduction/NN of/IN serious/JJ upper/JJ gastrointestinal/JJ complications/NNS ;/: (/( ii/NN )/SYM histamine/NEWGENE H2/NEWGENE receptor/NEWGENE antagonists/NNS (/( H2/NN antagonists/NNS )/SYM ,/, e/NN ./NN g/NN ./. ranitidine/NN ,/, cimetidine/NN and/CC famotidine/NN ,/, which/WDT are/VBP useful/JJ in/IN the/DT prevention/NN of/IN NSAID-induced/JJ duodenal/JJ ulcers/NNS during/IN long/JJ term/NN treatment/NN ,/, but/CC not/RB in/IN the/DT prevention/NN of/IN NSAID-induced/JJ gastric/JJ ulcers/NNS ;/: (/( iii/NN )/SYM proton/NN pump/NN inhibitors/NNS ,/, e/NN ./NN g/NN omeprazole/NN ,/, and/CC pantoprazole/NN ,/, whose/WP efficacy/NN in/IN preventing/JJ NSAID-associated/JJ ulcers/NNS has/VBZ been/VBN recently/RB demonstrated/VBN ;/: and/CC (/( iv/NN )/SYM barrier/NN agents/NNS ,/, e/NN ./NN g/NN ./. sucralfate/NN ,/, which/WDT cannot/MD be/VB recommended/VBN as/IN prophylactic/JJ agents/NNS to/IN prevent/VB NSAID-induced/JJ gastropathy/NN ./.
@@97926274743 SRC-1/NEWGENE can/MD relieve/VB the/DT NF-kappaB-mediated/JJ repression/NN of/IN GR/NEWGENE activity/NN ./.
@@106907259591 Two/CD other/DT patients/NNS underwent/VBD PRFR/NN ./.
@@84193186891 Biol/NNP ./.
@@34010604096 Thin/JJ melanomas/NNS can/MD metastasize/VB and/CC be/VB lethal/JJ ./.
@@109038438383 The/DT chromosomal/JJ localization/NN on/IN distal/JJ chromosome/NN 7/CD places/NNS it/PRP in/IN a/DT cluster/NN of/IN imprinted/JJ genes/NNS ,/, flanked/VBN by/IN the/DT previously/RB described/VBN Tapa1/NEWGENE and/CC Kcnq1/NEWGENE genes/NEWGENE ./.
@@94479624482 Consistent/JJ with/IN this/DT interpretation/NN ,/, a/DT mutant/JJ form/NN of/IN XRN1/NEWGENE ,/, which/WDT encodes/VBZ a/DT 5'-3'/JJ exonuclease/NN ,/, was/VBD identified/VBN as/IN an/DT extragenic/JJ suppressor/NN that/WDT increases/VBZ the/DT half-life/NN of/IN rhis4/NEWGENE mRNA/NEWGENE ,/, leading/JJ to/IN a/DT 10-fold/JJ increase/NN in/IN steady-state/JJ mRNA/NN levels/NNS compared/VBN to/IN the/DT wild-type/NEWGENE HIS4/NEWGENE mRNA/NEWGENE level/NN ./.
@@18857522501 Chlamydia/NN trachomatis/JJ and/CC Chlamydia/NN psittaci/NNS were/VBD not/RB affected/VBN by/IN methanol/NN fixation/NN ./.
@@114519953426 Topological/JJ and/CC Mutational/NNP Analysis/NNP of/IN Saccharomyces/NEWGENE cerevisiae/NEWGENE Ste14p/NEWGENE ,/, Founding/NNP Member/NN of/IN the/DT Isoprenylcysteine/NEWGENE Carboxyl/NEWGENE Methyltransferase/NEWGENE Family/NEWGENE ./.
@@80211756038 The/DT pexB/NEWGENE upstream/NEWGENE region/NEWGENE contained/VBN 245/CD nucleotides/NNS within/IN which/WDT sequences/NNS approximating/VBG the/DT consensus/NN for/IN cyclic/NEWGENE AMP/NEWGENE receptor/NEWGENE protein/NEWGENE and/CC integration/NEWGENE host/NEWGENE factor/NEWGENE binding/NEWGENE sites/NEWGENE were/VBD discernible/JJ ./.
@@79665837212 Transient/JJ transfections/NNS of/IN a/DT construct/NN expressing/JJ the/DT RNA/NN transcript/NN defined/VBN by/IN clone/NN B1/CD ./CD 1/CD into/IN D17/NNP cells/NNS led/VBN to/IN the/DT expression/NN of/IN an/DT Env/NEWGENE //NEWGENE Mlvi-4/NEWGENE fusion/NEWGENE protein/NEWGENE with/IN an/DT apparent/JJ molecular/JJ mass/NN of/IN 33/CD kDa/NN ./.
@@114083381272 This/DT study/NN suggests/VBZ that/DT PSP/NN is/VBZ more/RB common/JJ than/IN previously/RB considered/VBN ,/, is/VBZ commonly/RB misdiagnosed/VBN and/CC that/IN the/DT majority/NN of/IN cases/NNS are/VBP not/RB initially/RB referred/VBN to/IN neurologists/NNS ./.
@@90832916173 While/IN TGF-beta1/NEWGENE does/VBP not/RB alter/VB the/DT mitogen-induced/JJ expression/NN and/CC abundance/NN of/IN G1/NN phase/NN cyclin/NEWGENE D1/NEWGENE and/CC cdks/NEWGENE 4/NEWGENE and/NEWGENE 2/NEWGENE in/IN MCs/NNS ,/, it/PRP inhibits/VBZ cyclin/NEWGENE E-cdk/NEWGENE 2/NEWGENE activity/NN ,/, thus/RB preventing/JJ mitogen-elicited/JJ phosphorylation/NN and/CC inactivation/NN of/IN pRb/NEWGENE in/IN G1/NNP phase/NN and/CC transition/NN to/IN S/NNP phase/NN ./.
@@113927729963 The/DT application/NN of/IN the/DT biotechnology/NN at/IN the/DT plants/NNS for/IN treatment/NN of/IN the/DT surface/NN storm/NN waters/NNS from/IN the/DT industrial/JJ zone/NN Telychka/NNP of/IN the/DT city/NN of/IN Kyiv/NN has/VBZ allowed/VBN the/DT content/NN of/IN petroleum/NN in/IN water/NN dropped/VBN to/IN the/DT Dnieper/NNP to/IN be/VB constantly/RB reduced/VBN 50-100/JJ times/NNS ./.
@@24847146123 Structural/NNP organization/NN and/CC expression/NN of/IN the/DT mouse/NEWGENE estrogen/NEWGENE receptor/NEWGENE ./.
@@29896377623 These/DT data/NN suggest/VB that/IN dopaminergic/JJ regulation/NN of/IN adrenal/JJ zona/NN glomerulosa/NN corticosteroid/NN and/CC renal/NEWGENE renin/NEWGENE secretion/NN is/VBZ absent/VB in/IN patients/NNS with/IN high/JJ spinal/JJ cord/NN transections/NNS ,/, suggesting/VBG that/IN intact/JJ neural/JJ pathways/NNS from/IN the/DT central/JJ nervous/JJ system/NN are/VBP necessary/JJ for/IN metoclopramide/NN stimulation/NN of/IN aldosterone/NN and/CC renin/NEWGENE secretion/NN in/IN men/NNS ./.
@@77526447717 Thus/RB ,/, VF/NN resistant/JJ to/IN defibrillation/NN is/VBZ not/RB necessarily/RB associated/VBN with/IN both/DT toxic/JJ plasma/NN drug/NN level/NN and/CC remarkably/RB decreased/VBN conduction/NN ./.
@@118381021706 Wegener's/NNP granulomatosis/NN
@@24377925050 Comparison/NNS of/IN elastase-1/NEWGENE with/IN amylase/NEWGENE ,/, lipase/NEWGENE ,/, and/CC trypsin-like/JJ immunoreactivity/NN in/IN the/DT diagnosis/NN of/IN acute/JJ pancreatitis/NN ./.
@@111796892930 The/DT Sox/NEWGENE gene/NEWGENE family/NEWGENE (/( Sry/NEWGENE like/JJ HMG/NEWGENE box/NEWGENE gene/NEWGENE )/SYM is/VBZ characterised/VBN by/IN a/DT conserved/VBN DNA/NN sequence/NN encoding/VBG a/DT domain/NN of/IN approximately/RB 80/CD amino/JJ acids/NNS which/WDT is/VBZ responsible/JJ for/IN sequence/NN specific/JJ DNA/NN binding/JJ ./.
@@92655349600 The/DT dose/NN was/VBD 50/CD Gy/NNP //NNP 20/NNP fractions/NN //NN 5/NN weeks/NNS ./.
@@110294678778 Vasoactive/NEWGENE intestinal/NEWGENE peptide/NEWGENE and/CC pituitary/NEWGENE adenylate/NEWGENE cyclase-activating/NEWGENE polypeptide/NEWGENE inhibit/VB nuclear/NEWGENE factor-kappa/NEWGENE B-dependent/NEWGENE gene/NEWGENE activation/NN at/IN multiple/JJ levels/NNS in/IN the/DT human/JJ monocytic/JJ cell/NN line/NN THP-1/CELL ./.
@@22068581604 Homozygous/JJ protein/NEWGENE C/NEWGENE (/( PC/NEWGENE )/SYM deficiency/NN is/VBZ reported/VBN in/IN two/JJ siblings/NNS (/( girl/NN and/CC boy/NN )/SYM who/WP received/VBD their/PRP proper/JJ diagnoses/NNS at/IN the/DT ages/NNS of/IN 7/CD 4/CD //CD 12/CD and/CC 1/CD 3/CD //CD 12/CD years/NNS respectively/RB ./.
@@88100408089 A/DT subsequent/JJ screen/NN for/IN the/DT loss/NN of/IN the/DT positively/RB selectable/JJ target/NN locus/NN marker/NN detects/VBZ the/DT desired/JJ replacement/NN at/IN modest/JJ frequency/NN (/( >/SYM 2%/JJ )/SYM ./.
@@11353774359 Here/RB we/PRP report/VBP the/DT isolation/NN and/CC characterization/NN of/IN the/DT forkhead/NEWGENE homologue/NEWGENE in/NEWGENE rhabdomyosarcoma/NEWGENE (/( FKHR/NEWGENE )/SYM ,/, a/DT recently/RB described/VBN member/NN of/IN the/DT hepatocyte/NEWGENE nuclear/NEWGENE factor/NEWGENE 3/NEWGENE //NEWGENE forkhead/NEWGENE homeotic/NEWGENE gene/NEWGENE family/NN ,/, as/IN a/DT nuclear/NEWGENE hormone/NEWGENE receptor/NEWGENE (/( NR/NEWGENE )/SYM intermediary/JJ protein/NN ./.
@@22878602944 Ultrastructural/JJ and/CC morphometric/JJ study/NN of/IN the/DT myeloid/JJ parenchyma/NN cells/NNS of/IN mice/NNS prior/NN and/CC after/IN X-ray/NN exposure/NN ./.
@@80293347945 Cloning/NN of/IN higher/NEWGENE plant/NEWGENE omega-3/NEWGENE fatty/NEWGENE acid/NEWGENE desaturases/NEWGENE ./.
@@94887253405 To/TO determine/VB the/DT true/JJ molecular/JJ identity/NN of/IN SFD/NEWGENE ,/, both/PDT the/DT 50-/CD and/CC 57-kDa/NN polypeptides/NN were/VBD directly/RB sequenced/VBN ./.
@@70150186793 Synchronous/JJ extracts/NNS showed/VBD no/DT significant/JJ migration/NN inhibition/NN in/IN allogeneic/JJ assays/NNS ./.
@@94773167284 In/NN order/NN to/IN decipher/VB the/DT pathway/NN that/WDT leads/VBP to/IN Hox/NEWGENE gene/NEWGENE induction/NN ,/, we/PRP have/VBP investigated/VBN whether/IN a/DT Hox/NEWGENE gene/NEWGENE regulator/NN ,/, the/DT leucine/NN zipper/NN transcription/NN factor/NN MafB/NEWGENE //NEWGENE Kr/NEWGENE ,/, is/VBZ itself/PRP transcriptionally/RB regulated/VBD by/IN the/DT environmental/JJ signals/NNS ./.
@@87260248705 Eight/CD cats/NNS infected/VBN with/IN H/NNP ./NNP pylori/NNS were/VBD used/VBN in/IN the/DT study/NN ./.
@@65168476307 However/RB ,/, subcutaneously/RB administered/VBN pneumococci/NNS gave/VBD a/DT lower/JJR mortality/NN than/IN pneumococci/NNS given/VBP intravenously/RB or/CC intraperitoneally/RB ./.
@@95579122630 Their/PRP mean/JJ IOP/NN was/VBD 15/CD ./CD 3/CD (/( SD/NN 3/NN ./NN 7/NN )/SYM mmHg/NN prior/NN to/IN induction/NN of/IN anesthesia/NN ,/, 13/CD ./CD 5/CD (/( SD/NN 3/NN ./NN 5/NN )/SYM mmHg/NN after/IN loss/NN of/IN eyelash/NN reflex/NN following/IN injection/NN of/IN methohexitone/NN ,/, 16/CD ./CD 1/CD (/( SD/NN 2/NN ./NN 4/NN )/SYM mmHg/NN after/IN cessation/NN of/IN muscle/NN fasciculations/NNS induced/VBN by/IN suxamethonium/NN ,/, 19/CD ./CD 2/CD (/( SD/NN 5/NN ./NN 6/NN )/SYM mmHg/NN after/IN cessation/NN of/IN convulsion/NN and/CC 15/CD ./CD 5/CD (/( SD/NN 4/NN ./NN 4/NN )/SYM mmHg/NN following/IN resumption/NN of/IN regular/JJ spontaneous/JJ respiration/NN ./.
@@8164684485 The/DT ligand/NN for/IN RXR/NEWGENE ,/, 9-cis/CD retinoic/JJ acid/NN ,/, has/VBZ the/DT opposite/NN effect/NN of/IN destabilizing/JJ the/DT heterodimeric-DNA/NN complex/NN ./.
@@92593136905 The/DT majority/NN of/IN PI/NEWGENE kinase/NEWGENE activity/NN appeared/VBN to/IN be/VB cbl-associated/JJ after/IN PRL/NEWGENE stimulation/NN ./.
@@1004797051 Current/JJ world/NN literature/NN ./.
@@84064978523 Defects/NNPS of/IN fibrillin/NEWGENE (/( FBN1/NEWGENE )/SYM ,/, a/DT glycoprotein/NN component/NN of/IN the/DT extracellular/JJ microfibril/NN ,/, cause/NN Marfan/NN syndrome/NN ./.
@@107481757288 The/DT substrates/NNS for/IN glycan/NN synthesis/NN in/IN the/DT lumen/NN of/IN the/DT Golgi/JJ are/VBP nucleotide/NN sugars/NNS that/WDT must/MD be/VB transported/VBN from/IN the/DT cytosol/NN by/IN specific/NN membrane-bound/NN transporters/NN ./.
@@110838686939 DNA/NN binding/NN and/CC glutathione/NEWGENE S-transferase/NEWGENE pull-down/JJ assays/NNS demonstrate/VBP that/DT binding/NN requires/VBZ Elk-1/NEWGENE (/NEWGENE 1-212/NEWGENE )/NEWGENE but/CC not/RB the/DT C-terminal/NN transactivation/NN domain/NN ./.
@@91264871632 (/( 1994/CD ,/, Hum/NN ./.
@@106275189543 The/DT synergistic/JJ effect/NN due/NN to/IN the/DT 5'-3'/JJ cooperation/NN was/VBD at/IN least/RB fourfold/RB greater/JJR than/IN the/DT sum/NN of/IN the/DT contributions/NNS of/IN the/DT individual/JJ UTRs/NNS ./.
@@6212776406 At/NNP Cabras/NNP (/( Oristano/NNP )/SYM ,/, a/DT town/NN characterized/VBN by/IN a/DT high/JJ incidence/NN of/IN thalassaemia/NN and/CC G6PD/NEWGENE deficiency/NN less/PRP than/IN half/PDT the/DT people/NN between/IN 18/CD and/CC 35/CD have/VB a/DT fair/JJ knowledge/NN of/IN genetic/JJ diseases/NNS and/CC of/IN their/PRP prevention/NN ./.
@@74957266139 These/DT motifs/NNS include/VBP a/DT Chi/NEWGENE motif/NEWGENE and/CC a/DT Chi-like/NEWGENE element/NEWGENE previously/RB found/VB in/IN the/DT recombination/NN hotspot/NN region/NN of/IN the/DT Bcl-2/NEWGENE proto-oncogene/NEWGENE and/CC close/JJ to/IN chromosomal/JJ breakpoints/NNS in/IN T-ALL/NN lines/NNS ./.
@@97719859761 16/CD subjects/NNS were/VBD repatch/NN tested/VBN to/IN ethylmercury/NN chloride/NN (/( EtHgCl/NNP )/SYM and/CC to/IN solutions/NNS containing/JJ EtHgCl/NNP mixed/JJ with/IN L-cysteine/NN and/CC glutathione/NN ,/, respectively/RB ./.
@@37215945301 Adhesion/NNS ,/, phagocytosis/NN ,/, chemotactic/JJ and/CC random/JJ migration/NN ,/, nitroblue/NN tetrazolium/NN dye/NN reduction/NN of/IN peritoneal/JJ exudate/NN neutrophils/NNS and/CC macrophages/NNS ,/, fibrinogen/NEWGENE level/NN ,/, gelation/NN of/IN soluble/NN fibrin/NEWGENE and/CC serial/JJ dilution/NN protamine/NN sulfate/NN test/NN were/VBD investigated/VBN in/IN 115/CD New/NNP Zealand/NNP white/JJ rabbits/NNS with/IN experimentally/RB induced/VBN Shwartzman/NN phenomenon/NN in/IN the/DT colon/NN ,/, and/CC in/IN control/NN animals/NNS ./.
@@72626257103 Corticosteroid/NN therapy/NN is/NNS known/VBP to/IN be/VB hazardous/JJ in/IN patients/NNS with/IN occult/JJ infection/NN but/CC the/DT mechanism/NN by/IN which/WDT the/DT host/NN parasite/NN relationship/NN is/VBZ altered/VBN by/IN steroids/NNS is/VBZ not/RB known/NN ./NN We/NN have/VB used/VBN an/DT intestinal/JJ protozoal/JJ parasite/NN ,/, Giardia/NN muris/NN ,/, to/IN examine/VB the/DT effects/NNS of/IN corticosteroids/NNS on/IN the/DT number/NN of/IN parasites/NNS in/IN the/DT intestine/NN in/IN the/DT course/NN of/IN a/DT primary/JJ infection/NN ./.
@@102020069423 Each/DT recombinant/JJ product/NN was/VBD a/DT fusion/NN protein/NN with/IN a/DT B/NEWGENE domain/NEWGENE of/IN Staphylococcal/NEWGENE protein/NEWGENE A/NEWGENE (/( SPA/NEWGENE )/SYM ./.
@@17110412224 The/DT C5/NEWGENE alpha-chain/NEWGENE was/VBD encoded/VBN by/IN 49/CD kilobases/NNS containing/JJ 26/CD exons/NNS ;/: the/DT beta-chain/NN was/VBD encoded/VBN by/IN 29/CD kilobases/NNS containing/JJ 16/CD exons/NNS ./.
@@92432673480 METHODS/IN :/: Four/CD hundred/JJ fifty/CD patients/NNS with/IN the/DT diagnosis/NN of/IN squamous/JJ cell/NN carcinoma/NN of/IN the/DT oral/JJ cavity/NN received/VBD their/PRP primary/JJ treatment/NN at/IN Roswell/NNP Park/NNP Cancer/NNP Center/NNP (/( RPCI/NN )/SYM from/IN 1971/CD to/IN 1991/CD ./.
@@26318873302 Eighty/CD patients/NNS presenting/VBG to/IN HGGM/NNP with/IN non-Hodgkin's/JJ lymphomas/NNS between/IN 1962/CD and/CC 1986/CD ,/, were/VBD reviewed/VBN ./.
@@89188855274 In/NN contrast/NN ,/, dig1/NEWGENE dig2/NEWGENE1 cells/NNS constitutively/RB invade/VBP agar/NN medium/NN ,/, whereas/IN a/DT dig1/NEWGENE dig2/NEWGENE1 ste12/NEWGENE triple/JJ mutant/JJ does/VBP not/RB ,/, indicating/VBG that/IN Dig1/NEWGENE and/CC Dig2/NEWGENE share/VB a/DT role/NN in/IN negatively/RB regulating/JJ the/DT invasive/JJ growth/NN pathway/NN ./.
@@98497229837 During/IN presentation/NN of/IN happy/JJ facial/JJ expressions/NNS ,/, we/PRP detected/VBD a/DT signal/JJ increase/NN predominantly/RB in/IN the/DT left/JJ anterior/JJ cingulate/JJ gyrus/NN ,/, bilateral/JJ posterior/JJ cingulate/JJ gyri/NNS ,/, medial/JJ frontal/JJ cortex/NN and/CC right/JJ supramarginal/JJ gyrus/NN ,/, brain/NN regions/NNS previously/RB implicated/VBN in/IN visuospatial/JJ and/CC emotion/NN processing/VBG tasks/NNS ./.
@@16525152254 In/NN contrast/NN to/IN behavioral/JJ deviation/NN (/( the/DT avoidance/NN conditioning/JJ lost/VBP )/SYM ,/, the/DT haloperidol/NN intrastriatal/JJ microinjections/NNS did/VBD not/RB affect/VB the/DT DA/NN synaptic/JJ level/NN in/IN rostral/JJ neostriatum/NN ./.
@@74767017544 Considerably/RB high/JJ levels/NNS of/IN IgE/NEWGENE antibodies/NEWGENE was/VBD also/RB established/VBN while/CC other/DT pollens/NNS did/VBD not/RB show/VB such/JJ correspondence/NN ./.
@@9400613882 Coexpression/NNS of/IN mouse/NN PKR/NEWGENE (/NEWGENE 1-515/NEWGENE )/NEWGENE WT/NEWGENE as/IN a/DT Gal4/NEWGENE DNA-binding/NN domain/NN fusion/NN with/IN either/DT the/DT catalytic-deficient/JJ human/JJ PKR/NEWGENE (/NEWGENE 1-551/NEWGENE )/NEWGENE K296R/NN mutant/NN ,/, the/DT RNA-binding-deficient/NNP human/JJ PKR/NEWGENE (/NEWGENE 1-551/NEWGENE )/NEWGENE K64E/NEWGENE //NEWGENE K296R/NEWGENE double/JJ mutant/NN ,/, or/CC wild-type/NN mouse/NN PKR/NEWGENE (/NEWGENE 1-515/NEWGENE )/NEWGENE WT/NEWGENE as/IN full-length/JJ PKR-Gal4/NEWGENE activation/NN domain/NN fusions/NNS resulted/VBN in/IN activation/NN of/IN the/DT HIS3/NEWGENE and/CC lacZ/NEWGENE reporters/NNS ./.
@@101877983178 Overexpression/NNS of/IN either/DT DAP-1/NEWGENE or/CC sentrin/NEWGENE causes/NNS apoptosis/NN of/IN TNF-sensitive/NNP L929/CD fibroblast/NN cell/NN line/NN ,/, as/RB well/VB as/IN TNF-resistant/NNP osteosarcoma/NN cell/NN line/NN ,/, U2OS/NNP ./.
@@95729904830 An/DT association/NN between/IN hSIE/NEWGENE and/CC Stat-3/NEWGENE after/IN MHC-I/NEWGENE ligation/NN was/VBD directly/RB demonstrated/VBN by/IN precipitating/JJ Stat-3/NEWGENE from/IN nuclear/JJ extracts/NNS with/IN biotinylated/JJ hSIE/NEWGENE probe/NN and/CC avidin-coupled/JJ agarose/NN ./.
@@9136239189 The/DT mechanism/NN by/IN which/WDT large/JJ molecules/NNS ,/, such/JJ as/IN the/DT diphosphonate/NN 99mTc-labeled/NN EHDP/NN or/CC 99mTc-labeled/NN pyrophosphate/NN ,/, pass/NN through/JJ capillaries/NNS in/IN bone/NN is/VBZ by/IN passive/JJ diffusion/NN ./.
@@25384506635 We/PRP have/VBP isolated/VBN cDNA/NN clones/NNS from/IN rat/NN brain/NN and/CC human/JJ liver/NN encoding/VBG a/DT putative/JJ isoform/NN of/IN the/DT Na/NEWGENE ,/NEWGENE K-ATPase/NEWGENE beta/NEWGENE subunit/NEWGENE ./.
@@57632875710 I/NNP ./NNP
@@110126801716 Src/NEWGENE activation/NN induced/VBN by/IN FGF1/NEWGENE was/VBD blocked/VBN by/IN the/DT SH2/NEWGENE domain/NEWGENE of/IN Src/NEWGENE and/CC PP2/NEWGENE ,/, a/DT specific/JJ inhibitor/NN of/IN Src/NEWGENE ./.
@@87345388720 In/NN a/DT third/JJ experiment/NN ,/, crossover/JJ AM/NN between/IN dissimilar/JJ textures/NNS was/VBD investigated/VBN ,/, and/CC it/PRP was/VBD found/VBN that/IN the/DT more/RB salient/JJ textures/NNS carried/VBD the/DT AM/NNP ./NNP
@@24898953146 Muscle/NN action/NN potential/JJ and/CC masticatory/JJ rhythm/NN of/IN anterior/JJ temporal/NN and/CC masseter/NN muscles/NNS in/IN children/NNS and/CC adults/NNS ./.
@@47126265108 Chemical/NNP constituents/NNS of/IN the/DT gentianaceae/NNS V/NN :/: tetraoxygenated/JJ xanthones/NNS of/IN Swertia/NNP chirata/NNP Buch/NNP ./NNP -Ham/NNP ./.
@@93034373684 However/RB ,/, although/IN deletion/NN of/IN Fp1/NEWGENE in/IN the/DT hCRBP1/NEWGENE gene/NEWGENE yielded/VBN increased/VBN CAT/NEWGENE activity/NN ,/, pointing/VBG toward/IN a/DT negative/JJ regulatory/JJ function/NN exerted/VBN by/IN this/DT element/NN ,/, its/PRP insertion/NN upstream/RB of/IN the/DT p12/NEWGENE basal/NEWGENE promoter/NEWGENE results/NNS in/IN an/DT impressive/JJ positive/JJ stimulation/NN of/IN CAT/NEWGENE gene/NEWGENE expression/NN ./.
@@84668647614 Mutational/JJ analyses/NNS have/VBP demonstrated/VBN the/DT importance/NN of/IN sequences/NNS within/IN the/DT 327/CD bp/NN segment/NN that/WDT contain/VBP a/DT putative/JJ cyclic/NEWGENE AMP/NEWGENE responsive/NEWGENE element/NEWGENE binding/NEWGENE protein/NEWGENE (/( CREB/NEWGENE )/SYM binding/JJ site/NN for/IN TGF-beta/NEWGENE 1/NEWGENE and/CC PMA/NN responsiveness/NN and/CC putative/JJ PU-1/NEWGENE and/CC Sp1/NEWGENE binding/NEWGENE sites/NEWGENE for/IN basal/JJ promoter/NN activity/NN ./.
@@82709858245 Response/NNP durations/NNS were/VBD short/JJ ./.
@@112037024225 Thus/RB ,/, Xlim-1/NEWGENE not/RB only/RB contains/VBZ a/DT unique/JJ tyrosine-rich/JJ activation/NN domain/NN but/CC also/RB contains/VBZ a/DT negative/JJ regulatory/JJ domain/NN in/IN CT239-403/NEWGENE ,/, suggesting/VBG a/DT complex/JJ regulatory/JJ mechanism/NN underlying/JJ the/DT transcriptional/JJ activity/NN of/IN Xlim-1/NEWGENE in/IN the/DT organizer/NN ./.
@@17357215726 The/DT predicted/VBN amino/JJ acid/NN sequence/NN exhibited/VBN 70%/NN identity/NN to/IN that/DT of/IN Bacillus/NEWGENE stearothermophilus/NEWGENE TyrTS/NEWGENE and/CC 55%/JJ identity/NN to/IN that/DT of/IN E/NEWGENE ./NEWGENE coli/NEWGENE TyrTS/NEWGENE ,/, while/CC identity/NN to/IN a/DT second/JJ cryptic/JJ B/NEWGENE ./NEWGENE subtilis/NEWGENE TyrTS/NEWGENE gene/NEWGENE ,/, designated/VBN tyrZ/NEWGENE ,/, was/VBD only/RB 27%/JJ ./.
@@27481883440 Behaviorally/RB ,/, a/DT pain-tolerant/JJ group/NN (/( PT/NN =/SYM 29/CD Ss/NNS )/SYM tolerated/VBN the/DT entire/JJ 3-min/JJ test/NN (/( means/NN =/SYM 180/CD +/NN //NN -/NN 0/CD sec/NN )/SYM ,/, while/CC a/DT pain-sensitive/JJ group/NN (/( PS/NN =/SYM 13/CD Ss/NNS )/SYM averaged/VBN only/RB 50/CD ./CD 31/CD +/NN //NN -/NN 20/CD ./CD 81/CD sec/NN of/IN the/DT cold-pressor/JJ test/NN (/( t/NN =/SYM 16/CD ./CD 75/CD ,/, P/NN less/PRP than/IN 0/CD ./CD 0001/CD )/SYM ,/, replicating/JJ our/PRP earlier/JJR studies/NNS ./.
@@86286814051 Sequence/NN conservation/NN is/VBZ greatest/JJS for/IN residues/NNS located/VBN near/IN the/DT active/JJ centers/NNS of/IN the/DT exo/NEWGENE and/CC pol/NEWGENE domains/NEWGENE of/IN the/DT E/NEWGENE ./NEWGENE coli/NEWGENE DNA/NEWGENE polymerase/NEWGENE I/NEWGENE structure/NN ./.
@@84311008385 This/DT study/NN compared/VBD the/DT gross/JJ and/CC fine/JJ motor/JJ performance/NN of/IN 14/CD traumatically/RB brain-injured/JJ children/NNS (/( five/CD to/IN 15/CD years/NNS old/JJ ,/, with/IN loss/NN of/IN consciousness/NN for/IN at/IN least/RB 24/CD hours/NNS )/SYM to/IN 14/CD normal/JJ children/NNS group/NN matched/JJ for/IN age/NN and/CC sex/NN ./.
@@84418692594 The/DT plateau/NN MO2/NN value/NN was/VBD that/WDT predicted/VBD by/IN allometric/JJ relation/NN ./.
@@72975767161 One/CD was/VBD allowed/VBN fresh/JJ drinking/JJ water/NN ad/NN libitum/NN whilst/JJ the/PDT other/DT received/VBN Aludrox/NN in/IN their/PRP drinking/JJ water/NN ./.
@@9428799488 Although/IN the/DT gene/NN is/VBZ substantially/RB smaller/JJR than/IN the/DT human/JJ genes/NNS for/IN other/DT mitochondrial/JJ enzymes/NNS ,/, its/PRP intron/NN //NN exon/NN organization/NN is/VBZ very/RB similar/JJ ,/, especially/RB to/IN that/DT of/IN P450scc/NEWGENE ./.
@@97511668898 This/DT and/CC previous/JJ results/NNS suggest/VBP that/IN the/DT CRE/NEWGENE and/CC Sp1/NEWGENE site/NEWGENE may/MD synergistically/RB activate/VB TH/NEWGENE transcription/NN in/IN a/DT promoter/NN context-dependent/JJ manner/NN ./.
@@33522544040 The/DT same/JJ rhythmic/JJ structure/NN enables/VBZ a/DT prediction/NN to/IN be/VB made/VBP concerning/VBG when/CC vowels/NNS of/IN stressed/VBN syllables/NNS will/MD be/VB auditorily/RB perceived/JJ ./.
@@81279501728 In/NN order/NN to/IN evaluate/VB the/DT function/NN of/IN the/DT hypothalamic-pituitary-thyroid/JJ (/( HPT/NN )/NN -axis/NN in/IN unipolar/JJ depression/NN ,/, the/DT authors/NNS measured/VBD basal/NN 0800h/NN plasma/NN levels/NNS of/IN free/JJ thyroxine/NN (/( FT4/NN )/SYM ,/, free/JJ triiodothyronine/NN (/( FT3/NN )/SYM ,/, and/CC thyroid/NEWGENE stimulating/NEWGENE hormone/NEWGENE (/( TSH/NEWGENE )/SYM by/IN means/NN of/IN the/DT new/JJ ,/, ultrasensitive/JJ assays/NNS (/( TSH-IRMA/NNP )/SYM in/IN 69/CD healthy/JJ controls/NNS ,/, 62/CD minor/JJ ,/, 101/CD simple/JJ major/NN ,/, and/CC 57/CD melancholic/JJ depressed/VBN subjects/NNS ./.
@@81147104149 We/PRP have/VBP previously/RB shown/VBP that/IN LBP-1/NEWGENE represses/VBZ HIV-1/NNP transcription/NN by/IN inhibiting/JJ the/DT binding/NN of/IN TFIID/NEWGENE to/IN the/DT TATA/NN box/NN ./.
@@11045180887 Leptinaemia/NN does/VBP not/RB correlate/VB with/IN the/DT actual/JJ or/CC mean/JJ blood/NN pressure/NN reading/JJ nor/CC with/IN stage/NN of/IN hypertension/NN according/VBG to/IN the/DT WHO/WP classification/NN ./.
@@107675538537 Hex/NEWGENE is/VBZ expressed/VBN in/IN the/DT developing/JJ liver/NN coincident/JJ with/IN the/DT forkhead/NEWGENE //NEWGENE winged/NEWGENE helix/NEWGENE transcription/NEWGENE factor/NEWGENE ,/, Hepatocyte/NEWGENE Nuclear/NEWGENE Factor/NEWGENE 3beta/NEWGENE (/( HNF3beta/NEWGENE )/SYM ./.
@@15699458836 The/DT SEN1/NEWGENE gene/NEWGENE corresponds/VBZ to/IN a/DT 6/JJ ,/JJ 336-bp/JJ open/JJ reading/JJ frame/NN coding/JJ for/IN a/DT 2/JJ ,/JJ 112-amino-acid/JJ protein/NN (/( molecular/JJ mass/NN ,/, 239/CD kDa/NN )/SYM ./.
@@97018214065 In/NN contrast/NN ,/, transcription/NN initiating/JJ from/IN opuE/NEWGENE P-1/NEWGENE (/( sigma/NEWGENE A/NEWGENE )/SYM rose/VBD in/IN proportion/NN to/IN the/DT external/NN osmolarity/NN and/CC was/VBD maintained/VBN at/IN high/JJ levels/NNS ./.
@@1901946880 A/DT synthetic/JJ oligonucleotide/NN containing/JJ the/DT SRE/NEWGENE sequence/NEWGENE from/IN the/DT mouse/NEWGENE c-fos/NEWGENE gene/NEWGENE promoter/NEWGENE (/( -299/CD to/IN -322/CD )/SYM was/VBD radioactively/RB labeled/JJ ,/, used/VBN as/IN a/DT probe/NN for/IN the/DT mobility/NN shift/NN assay/NN and/CC Southwestern/NNP (/( DNA-protein/NN )/SYM blotting/NN ,/, and/CC also/RB used/VBN for/IN sequence-specific/JJ affinity/NN chromatography/NN ./.
@@88868455379 As/IN extensively/RB examined/VBN with/IN the/DT myogenin/NEWGENE promoter/NEWGENE ,/, presence/NN of/IN one/PRP or/CC multiple/JJ copies/NNS of/IN Me/NEWGENE in/IN the/DT vectors/NNS elevated/VBD the/DT expression/NN activity/NN in/IN myotubes/NNS by/IN 4/CD ./CD 5-/CD to/IN 19-fold/CD over/RB those/DT without/IN Me/NEWGENE ,/, but/CC not/RB significantly/RB in/IN myoblasts/NNS ./.
@@17107664708 The/DT proteins/NNS differ/VBP in/IN the/DT presence/NN or/CC absence/NN of/IN a/DT 21-amino-acid/JJ sequence/NN located/VBN 24/CD amino/JJ acids/NNS C/NN terminal/NN of/IN the/DT translational/JJ initiation/NN codon/NN ./.
@@82070225263 Subunit/NNS composition/NN and/CC domain/NN structure/NN of/IN the/PDT Spo0A/NEWGENE sporulation/NEWGENE transcription/NEWGENE factor/NEWGENE of/NEWGENE Bacillus/NEWGENE subtilis/NEWGENE ./.
@@114354284060 Cytosolic/NEWGENE acetyl-CoA/NEWGENE synthetase/NEWGENE (/( AceCS1/NEWGENE )/SYM activates/VBZ acetate/NN to/IN supply/NN the/DT cells/NNS with/IN acetyl-CoA/NN for/IN lipid/NN synthesis/NN ./.
@@10936920756 Previous/JJ experience/NN and/CC contextual/JJ cues/NNS are/VBP essential/JJ elements/NNS in/IN the/DT generation/NN of/IN a/DT subjective/JJ prediction/NN ./.
@@18992092519 Increases/NNS in/IN the/DT perfusate/NN PCO2/NN but/CC not/RB in/IN the/DT perfusate/NN H+/NN were/VBD highly/RB correlated/VBN with/IN decreases/NNS in/IN both/DT myocardial/JJ contractility/NN and/CC oxygen/NN consumption/NN (/( r2/NN =/SYM ./CD 88/CD )/SYM ./.
@@92857156291 Although/IN previous/JJ data/NN have/NN suggested/VBN that/IN Rev/NEWGENE uses/VBZ the/DT same/JJ export/NN pathway/NN as/IN uracil-rich/NEWGENE small/NEWGENE nuclear/NEWGENE RNAs/NEWGENE and/CC 5S/NEWGENE ribosomal/NEWGENE RNA/NEWGENE ,/, the/DT CTE/NEWGENE seems/VBZ to/IN interact/VB with/IN evolutionarily/RB conserved/VBN factors/NNS that/WDT are/VBP essential/JJ for/IN cellular/JJ mRNA/NN export/NN ./.
@@84325263689 These/DT exons/NNS were/VBD identified/VBN by/IN cloning/NN and/CC sequencing/VBG cDNAs/NNS obtained/VBN by/IN polymerase/NEWGENE chain/NN reaction/NN amplification/NN of/IN a/DT fibroblast/NN cDNA/NN library/NN ./.
@@75305492479 Analysis/NNP of/IN the/DT sequences/NNS with/IN the/DT BLAST/NN and/CC GRAIL/NNP programs/NNS provided/VBD additional/JJ independent/JJ evidence/NN that/IN 15/CD of/IN these/DT 17/CD clones/NNS contain/VBP coding/JJ sequences/NNS and/CC that/IN nine/JJ other/DT clones/NNS are/VBP likely/RB to/IN contain/VB sequences/NNS coding/JJ for/IN portions/NNS of/IN new/JJ genes/NNS ./.
@@59944219195 Consanguinity/NNS and/CC migration/NN in/IN the/DT marriages/NNS of/IN the/DT region/NN of/IN Nunoa/NN ,/, Santiago/NN ,/, 1850-1960/CD ./.
@@98473973760 Approximately/RB 50%/CD of/IN the/DT residues/NNS are/VBP conserved/VBN among/IN all/DT three/CD sequences/NNS ,/, yet/RB all/DT three/CD viruses/NNS have/VBP retained/VBN response/NN elements/NN for/IN glucocorticoids/NNS ,/, two/JJ positionally/RB conserved/VBN CCAAT/NNP boxes/NNS ,/, and/CC positionally/RB conserved/VBN TATA/NN boxes/NNS ./.
@@23200087944 TMBr-1/NEWGENE is/VBZ identical/JJ to/IN striated/NEWGENE muscle/NEWGENE alpha-tropomyosin/NEWGENE from/IN amino/JJ acids/NNS 1/CD through/RB 258/CD but/CC contains/VBZ a/DT novel/JJ COOH-terminal/NN region/NN from/IN amino/JJ acids/NNS 259/CD through/RB 281/CD ./.
@@34864058938 Most/JJS of/IN the/DT prepeptide/NN portion/NN of/IN the/DT precursor/NN polypeptide/NN is/VBZ encoded/VBN by/IN the/DT next/JJ three/CD exons/NNS ,/, and/CC the/DT mature/JJ form/NN of/IN IL-1/NEWGENE alpha/NEWGENE is/VBZ encoded/VBN by/IN the/DT remaining/JJ three/CD exons/NNS ./.
@@89143886181 The/DT assessment/NN using/VBG 7/CD H/NN 9/CD liquid/JJ medium/NN by/IN the/DT former/JJ author/NN demonstrated/VBD the/DT potent/JJ activities/NNS of/IN both/DT CS-940*/NN and/CC sparfloxacin/NN (/( SPFX/NNP )/SYM ,/, followed/VBN by/IN AM-1155*/NN ,/, ciprofloxacin/NN (/( CPFX/NN )/SYM ,/, levofloxacin/NN (/( LVFX/NNP )/SYM ,/, OPC-17116*/NN ,/, NM-394*/NN in/IN sequence/NN ./.
@@94987698693 Its/PRP expression/NN pattern/NN is/VBZ representative/NN of/IN many/JJ B/NN cell-specific/NN proteins/NN ,/, which/WDT are/VBP essential/JJ for/IN B/NNP cell/NN development/NN and/CC activation/NN but/CC are/VBP down-regulated/IN after/IN B/NNP cells/NNS become/VBP terminally/RB differentiated/VBN plasma/NN cells/NNS ./.
@@89770139954 The/DT implications/NNS for/IN estimates/NNS of/IN cortical/JJ magnification/NN and/CC possible/JJ differences/NNS in/IN the/DT specializations/NNS of/IN foveal/JJ and/CC peripheral/NN vision/NN are/VBP discussed/VBN ./.
@@20621161089 Pargyline/NNP ,/, a/DT monoamine/NEWGENE oxidase/NEWGENE inhibitor/NN ,/, reduces/VBZ peak/NN 3/CD transiently/RB (/( max/JJ ./.
@@108057294581 The/DT stoichiometry/NN of/IN the/DT complexes/NNS formed/VBN with/IN the/DT dodeca-satellite/NEWGENE C/NEWGENE strand/NEWGENE suggests/VBZ that/IN ,/, in/IN DDP1/NEWGENE ,/, the/DT 15/CD consecutive/JJ KH/NEWGENE domains/NEWGENE are/VBP organized/VBN such/JJ that/IN they/PRP define/VBP two/JJ nucleic/JJ acid/NN binding/JJ surfaces/NNS ./.
@@105523576262 CONCLUSIONS/IN :/: In/NN addition/NN to/IN the/DT superiority/NN of/IN octafluoropropane-filled/JJ microspheres/NNS to/IN air-filled/JJ microspheres/NNS for/IN LV/JJ opacification/NN ,/, the/DT efficacy/NN of/IN OCTA/NN is/VBZ relatively/JJ unaffected/JJ by/IN impaired/JJ LV/NN function/NN and/CC is/VBZ less/PRP susceptible/JJ to/IN the/DT effects/NNS of/IN poor/JJ echogenicity/NN than/IN AIR/NNP ./.
@@93056314654 Overexpression/NNS of/IN BAG-1/NEWGENE also/RB protected/VBN certain/JJ cell/NN lines/NNS from/IN heat/NN shock-induced/JJ cell/NN death/NN ./.
@@103301596872 Thus/RB ,/, VDR/NEWGENE acts/NNS selectively/RB on/IN the/DT two/JJ components/NNS required/VBN for/IN activation/NN of/IN this/DT promoter/NN //NN enhancer/NN :/: it/PRP competes/VBZ with/IN NFAT1/NEWGENE for/IN binding/JJ to/IN the/DT composite/JJ site/NN ,/, positioning/VBG itself/PRP adjacent/JJ to/IN Jun-Fos/NEWGENE on/IN the/DT DNA/NN ./.
@@104696565449 The/DT nucleosomal/JJ response/NN associated/VBN with/IN immediate-early/NEWGENE gene/NEWGENE induction/NN is/VBZ mediated/JJ via/NN alternative/JJ MAP/NEWGENE kinase/NEWGENE cascades/NEWGENE :/: MSK1/NEWGENE as/IN a/DT potential/JJ histone/NEWGENE H3/NEWGENE //NEWGENE HMG-14/NEWGENE kinase/NEWGENE ./.
@@112218365411 More/RBR importantly/RB ,/, this/DT fusion/NN converted/VBD a/DT less/PRP effective/JJ vaccine/NN into/IN one/PRP with/IN significant/JJ potency/NN against/IN established/VBN E7-expressing/JJ metastatic/JJ tumors/NNS ./.
@@85904657924 Its/PRP organization/NN and/CC regulation/NN indicate/VB that/IN the/DT S/NEWGENE ./NEWGENE pombe/NEWGENE URA1/NEWGENE gene/NEWGENE product/NEWGENE appears/VBZ very/RB similar/JJ to/IN the/DT S/NEWGENE ./NEWGENE cerevisiae/NEWGENE URA2/NEWGENE gene/NEWGENE product/NEWGENE ./.
@@100228674808 Elimination/NN of/IN ETH1/NEWGENE in/IN apn1/NEWGENE strains/NNS also/RB increased/VBN spontaneous/JJ mutation/NN rates/NNS 9-/CD or/CC 31-fold/RB compared/VBN to/IN the/DT wild/JJ type/NN as/IN determined/VBN by/IN reversion/NN to/IN adenine/NN or/CC lysine/NN prototrophy/NN ,/, respectively/RB ./.
@@92714173766 The/DT MCAD/NEWGENE nuclear/NEWGENE receptor/NEWGENE response/NEWGENE element/NEWGENE 1/NEWGENE (/( NRRE-1/NEWGENE )/SYM interacts/VBZ in/IN vitro/FW with/IN ERR/NEWGENE alpha/NEWGENE expressed/VBN in/IN COS-7/NNP cells/NNS ./.
@@39408185860 Fulminant/NNP hepatitis/NN A/NN in/NN chronic/JJ HBV/NN carrier/NN ./.
@@11331604144 Srb10/NEWGENE is/VBZ a/DT physiological/JJ regulator/NN of/IN Gcn4/NEWGENE stability/NN because/IN both/DT phosphorylation/NN and/CC turnover/NN of/IN Gcn4/NEWGENE are/VBP diminished/VBN in/IN srb10/NEWGENE mutants/NEWGENE ./.
@@86433828115 An/DT apparent/JJ N-terminal/NN transit/NN peptide/NN in/IN the/DT coding/JJ region/NN and/CC a/DT 3'/NN poly/NN (/NN A/NN )/NN tail/NN exist/VB in/IN the/DT cDNA/NN clone/NN indicated/VBN that/IN this/DT chloroplast/NN protein/NN as/IN nuclear/RB encoded/VBN ./.
@@13704463788 These/DT sites/NNS are/VBP also/RB potential/JJ keratan/NN sulfate/NN attachment/NN sites/NNS ./.
@@12590271893 The/DT concept/NN of/IN "structural/JJ identifiability"/NN is/VBZ employed/VBN in/IN this/DT analysis/NN to/IN determine/VB which/WDT model/VBP parameters/NNS can/MD be/VB and/CC which/WDT cannot/MD be/VB determined/VBN "uniquely"/NN from/IN given/VBP input-output/JJ data/NN ;/: a/DT step-by-step/JJ procedure/NN based/VBN on/IN an/DT extension/NN of/IN this/DT concept/NN is/VBZ presented/VBN for/IN adapting/JJ the/DT overall/JJ approach/NN to/IN the/DT experimental/JJ design/NN problem/NN ./.
@@28291834061 DNA/NN sequence/NN analysis/NN revealed/VBN that/IN these/DT clones/NNS encode/VBP two/JJ distinct/JJ forms/NNS of/IN translocase/NEWGENE ./.
@@10684534502 Protamine/NEWGENE and/CC heparin/NN doses/NNS ,/, their/PRP sum/NN (/( Sigma-dose/NNP )/SYM and/CC differential/JJ (/( Delta-dose/NNP )/SYM doses/NNS ,/, and/CC activated/VBN clotting/JJ times/NNS were/VBD tabulated/VBN ./.
@@78776199121 In/NN addition/NN ,/, we/PRP found/VBP that/IN cell-specific/JJ suppression/NN of/IN RA-stimulated/JJ zif268/NEWGENE gene/NEWGENE expression/NN can/MD be/VB attributed/VBN to/IN a/DT 29/CD base/NN pair/NN nucleotide/NN sequence/NN ,/, located/VBD downstream/RB of/IN the/DT RA-responsive/NEWGENE region/NEWGENE in/IN the/DT zif268/NEWGENE gene/NEWGENE ./.
@@7806492107 This/DT structure/NN of/IN cucumisin/NEWGENE suggests/VBZ that/IN it/PRP is/VBZ probably/RB synthesized/VBN as/IN an/DT inactive/JJ precursor/NN ./.
@@57223415669 Identification/NNP and/CC estimation/NN of/IN monosaccharides/NNS and/CC disaccharides/NNS in/IN urine/NN by/IN gas-liquid/JJ chromatography/NN ./.
@@100213505087 In/NN the/DT current/JJ model/NN ,/, Wingless/NEWGENE //NEWGENE Wnt/NEWGENE signal/NN stabilizes/VBZ Armadillo/NEWGENE //NEWGENE beta-catenin/NEWGENE ,/, which/WDT then/RB accumulates/VBZ in/IN nuclei/NNS and/CC binds/VBZ TCF/NEWGENE //NEWGENE LEF/NEWGENE family/NEWGENE proteins/NEWGENE ,/, forming/JJ bipartite/JJ transcription/NN factors/NNS which/WDT activate/VBP transcription/NN of/IN Wingless/NEWGENE //NEWGENE Wnt/NEWGENE responsive/NEWGENE genes/NEWGENE ./.
@@112589064730 In/NN DNA/NN strand/NN exchange/NN reactions/NNS using/VBG oligonucleotides/NNS ,/, we/PRP found/VBP that/IN Rec2/NEWGENE exhibited/VBN a/DT pairing/NN bias/NN that/WDT is/VBZ opposite/NN that/IN of/IN RecA/NEWGENE ./.
@@109438916582 The/DT ability/NN of/IN U6-U57/NEWGENE mutants/NEWGENE to/IN influence/NN the/DT fidelity/NN of/IN both/DT branch/NN site/NN and/CC 3'/CD splice/NN site/NN recognition/NN suggests/VBZ that/IN this/DT nucleotide/NN may/MD participate/VB in/IN the/DT formation/NN of/IN the/DT active/JJ site/NN (/NN s/NN )/NN of/IN the/DT spliceosome/NN ./.
@@69776056160 Endorphins/NEWGENE and/CC legal/JJ issues/NNS ./.
@@113186085189 Human/NNP brain/NN cDNA/NN library/NN screening/JJ and/CC 5'/CD rapid/JJ amplification/NN of/IN cDNA/NN ends/NNS yielded/VBD full-length/NEWGENE DENTT/NEWGENE cDNA/NEWGENE containing/JJ an/DT 1899-bp/CD open/JJ reading/JJ frame/NN encoding/VBG a/DT predicted/VBN 633-amino-acid/JJ protein/NN with/IN four/CD potential/JJ nuclear/JJ localization/NN signals/NNS (/( NLSs/NNS )/SYM and/CC two/JJ coiled-coil/NN regions/NN ./.
@@119076911816 The/DT orientations/NNS of/IN the/DT contact/NN surfaces/NNS and/CC their/PRP locations/NNS relative/JJ to/IN the/DT object's/NNS center/NN of/IN mass/NN were/VBD varied/VBN ./.
@@97744446726 The/DT carboxyl-terminal/NN portion/NN of/IN UKLF/NEWGENE contains/VBZ three/CD zinc/NN fingers/NNS of/IN the/DT Cys2-His2/NN type/NN and/CC binds/VBZ in/IN vitro/FW to/IN the/DT CACCC/NEWGENE motif/NEWGENE of/IN the/DT beta-globin/NEWGENE promoter/NEWGENE and/CC to/IN the/DT Sp1/NEWGENE recognition/NEWGENE sequence/NEWGENE ./.
@@9931769928 Since/IN myoglobin/NEWGENE is/VBZ co-extracted/VBN with/IN the/DT hemoglobin/NEWGENE ,/, the/DT 2/CD heme/NN pigments/NNS are/VBP separated/VBN in/IN one/PRP portion/NN of/IN the/DT extract/NN by/IN precipitating/JJ the/DT hemoglobin/NEWGENE in/IN an/DT 85%/JJ (/( NH4/IN )/NN 2SO4/NN solution/NN ./.
@@112416724065 Cloning/VBG and/CC characterization/NN of/IN the/DT murine/NEWGENE beta/NEWGENE (/NEWGENE 3/NEWGENE )/NEWGENE integrin/NEWGENE gene/NEWGENE promoter/NN :/: identification/NN of/IN an/DT interleukin-4/NEWGENE responsive/NEWGENE element/NEWGENE and/CC regulation/NN by/IN STAT-6/NEWGENE ./.
@@92889161852 Polarised/JJ expression/NN of/IN human/JJ intestinal/JJ N-benzoyl-L-tyrosyl-p-aminobenzoic/NEWGENE acid/NEWGENE hydrolase/NEWGENE (/( human/NEWGENE meprin/NEWGENE )/SYM alpha/NN and/CC beta/NN subunits/NN in/IN Madin-Darby/NNP canine/JJ kidney/NN cells/NNS ./.
@@15021579981 ME1a1/NEWGENE ,/, a/DT 16-base-pair/JJ nuclear/JJ factor/NN binding/JJ site/NN residing/VBG between/IN the/DT c-MYC/NEWGENE P1/NEWGENE and/NEWGENE P2/NEWGENE transcription/NEWGENE initiation/NEWGENE sites/NEWGENE ,/, is/VBZ required/VBN for/IN P2/NEWGENE activity/NN ./.
@@15725494850 Protein/NEWGENE tyrosine/NEWGENE kinases/NEWGENE (/( PTKs/NEWGENE )/SYM are/VBP implicated/VBN in/IN the/DT control/NN of/IN cell/NN growth/NN by/IN virtue/NN of/IN their/PRP frequent/VB appearance/NN as/IN products/NNS of/IN retroviral/NN oncogenes/NN ,/, as/IN intracellular/JJ signal/NN transducers/NN ,/, and/CC as/IN growth/NEWGENE factor/NEWGENE receptors/NEWGENE or/CC components/NNS thereof/RB ./.
@@110768609316 Experiments/NNS with/IN epitope-tagged/NN proteins/NN show/VBP that/IN UEV1A/NEWGENE is/VBZ a/DT nuclear/JJ protein/NN ,/, whereas/IN both/DT Kua/NEWGENE and/CC Kua-UEV/NEWGENE localize/VB to/IN cytoplasmic/JJ structures/NNS ,/, indicating/VBG that/IN the/DT Kua/NEWGENE domain/NEWGENE determines/VBZ the/DT cytoplasmic/JJ localization/NN of/IN Kua-UEV/NEWGENE ./.
@@33823101661 Abnormal/JJ technetium/NN Tc/NN 99m/NN medronate/NN scans/NNS in/IN patients/NNS with/IN previously/RB undiagnosed/JJ polyarthralgias/NNS suggested/VBD inflammatory/JJ arthropathy/NN and/CC influenced/VBN management/NN decisions/NNS with/IN favorable/JJ therapeutic/JJ outcomes/NNS ./.
@@80485821272 However/RB ,/, regional/NN MVO2/NN increased/VBN to/IN about/RB the/DT same/JJ extent/NN in/IN the/DT CFX/NNP (/( from/IN 6/CD ./CD 0/CD +/NN //NN -/NN 0/CD ./CD 7/CD to/IN 12/CD ./CD 4/CD +/NN //NN -/NN 0/CD ./CD 9/CD ml/NN O2/CD ./CD min-1/CD times/NNS 100/CD g-1/NN )/SYM and/CC the/DT LAD/NN region/NN (/( from/IN 7/CD ./CD 0/CD +/NN //NN -/NN 0/CD ./CD 6/CD to/IN 14/CD ./CD 5/CD +/NN //NN -/NN 1/CD ./CD 3/CD ml/NN O2/CD ./CD min-1/CD times/NNS 100/CD g-1/NN )/SYM ./.
@@40883964557 Among/IN the/DT patients/NNS grades/NNS 1-2-3/NN ,/, 81%/JJ had/VBP a/DT good/JJ out/RB come/VB without/IN any/DT neurological/JJ abnormality/NN ,/, among/IN the/DT patients/NNS graded/JJ 4-5/CD ,/, only/RB 27%/JJ had/VBP a/DT fair/JJ out/RB come/VB ./.
@@51100495375 1st/CD data/NN on/IN the/DT immunosuppressive/JJ therapy/NN of/IN scleroderma/NN ./.
@@68211471108 Sulphur/NN amino/JJ acids/NNS (/( g/NN //NN 16/NN g/NN N/NN )/SYM were/VBD higher/JJ in/IN the/DT isolates/NNS than/IN in/IN the/DT flours/NNS ./.
@@13027652002 These/DT components/NNS both/DT had/VBP a/DT median/JJ R2/NN of/IN 0/CD ./CD 84/CD ,/, compared/VBN to/IN median/JJ R2s/NNS ranging/VBG from/IN 0/CD ./CD 37/CD to/IN 0/CD ./CD 83/CD for/IN five/CD commonly/RB used/VBN ad/NN hoc/FW EEG/NN components/NN ./.
@@98194118475 By/IN DNase/NEWGENE I/NEWGENE footprint/NN analysis/NN of/IN the/DT PNR/NEWGENE element/NEWGENE ,/, a/DT palindrome/NN of/IN two/JJ high-affinity/JJ Ets-binding/NEWGENE sites/NEWGENE (/( CTTCCCTGGAAG/NEWGENE )/SYM was/VBD identified/VBN ./.
@@97084503057 Toxicity/NNS during/IN the/DT therapeutic/JJ period/NN was/VBD not/RB significant/JJ in/IN the/DT study/NN group/NN compared/VBN with/IN the/DT historical/JJ control/NN ,/, treated/VBN with/IN the/DT same/JJ regimen/NN without/IN G-CSF/NEWGENE ./.
@@17327362489 Transcripts/NNS from/IN a/DT second/JJ POU-domain/NEWGENE gene/NEWGENE ,/, Oct-25/NEWGENE ,/, were/VBD present/VB at/IN low/JJ levels/NNS in/IN oocytes/NNS and/CC early/JJ embryos/NNS and/CC were/VBD dramatically/RB upregulated/VBN during/IN early/JJ gastrulation/NN ./.
@@25287306818 Moreover/RB ,/, exons/NNS 2a/NN and/CC 2b/NN share/VB the/DT same/JJ 5'/NN sequence/NN but/CC differ/VB from/IN each/DT other/DT by/IN the/DT use/NN of/IN two/JJ distinct/JJ donor/NN splice/NN sites/NNS 171/CD bp/NN apart/RB in/IN the/DT gene/NN ./.
@@88746319217 Discrimination/NNP between/IN HIV-1/NNP and/CC HIV-2/NN showed/VBD evidence/NN for/IN the/DT presence/NN of/IN HIV-1/NNP only/RB ./.
@@94350562151 The/DT functional/JJ mature/JJ domain/NN of/IN pediocin/NEWGENE AcH/NEWGENE (/NEWGENE Lys+1/NEWGENE to/NEWGENE Cys+44/NEWGENE )/NEWGENE is/VBZ targeted/VBN into/IN the/DT E/NNP ./NNP coli/JJ sec/NN machinery/NN and/CC secreted/VBN to/IN the/DT periplasm/NN in/IN active/JJ form/NN when/CC fused/VBN in/IN frame/NN to/IN the/DT COOH/NNP terminus/NN of/IN the/DT secretory/NEWGENE protein/NEWGENE maltose-binding/NEWGENE protein/NEWGENE (/( MBP/NEWGENE )/SYM ./.
@@78831672037 In/NN yeast/NN ,/, the/DT products/NNS of/IN the/DT UPF1/NEWGENE and/CC UPF3/NEWGENE genes/NEWGENE are/VBP required/VBN for/IN this/DT decay/NN pathway/NN ,/, and/CC in/IN this/DT report/NN we/PRP focus/VBP on/IN the/DT identification/NN and/CC characterization/NN of/IN additional/JJ factors/NNS required/VBN for/IN rapid/JJ decay/NN of/IN nonsense-containing/NN mRNAs/NN ./.
@@99401329936 Unified/NNP theory/NN of/IN segregated-stack/JJ organic/JJ charge-transfer/JJ solids/NNS :/: Magnetic/JJ properties/NNS ./.
@@76525752046 Furthermore/RB ,/, microinjection/NN of/IN dominant/JJ negative/JJ forms/NNS of/IN Rac/NEWGENE and/CC Cdc42/NEWGENE or/CC of/IN the/DT Rho/NEWGENE inhibitor/NN C3/NEWGENE transferase/NEWGENE blocked/VBD serum-induced/NN DNA/NN synthesis/NN ./.
@@87548525507 In/NN gel/NN retardation/NN assays/NNS ,/, an/DT RCS/NN cell-specific/NN protein/NN and/CC another/DT closely/RB related/VBN protein/NN expressed/VBN only/RB in/IN RCS/NN cells/NNS and/CC primary/JJ chondrocytes/NNS bound/JJ to/IN a/DT 10-bp/JJ sequence/NN within/IN the/DT 18-mer/NN ./.
@@113125841157 Copyright/NNP 2001/CD Academic/NNP Press/NNP ./.
@@112923355366 It/PRP is/VBZ surprising/VBG that/IN dnaE173/NN ,/, a/DT potent/JJ mutator/NN mutation/NN specific/JJ for/IN sequence/NN substitution/NN as/RB well/VB as/IN single-base/JJ frameshift/NN ,/, did/VBD not/RB enhance/VB the/DT frequency/NN of/IN the/DT hot-spot/JJ frameshift/JJ mutation/NN ./.
@@18464913953 However/RB ,/, the/DT relative/JJ positions/NNS of/IN the/DT VV/NN genes/NN (/( genus/NN Orthopoxvirus/NN )/SYM are/VBP different/JJ than/IN those/DT of/IN the/DT corresponding/JJ ORFs/NNS in/IN SFV/NN (/( genus/NN Leporipoxvirus/NNP )/SYM ,/, indicating/VBG complex/NN rearrangements/NNS of/IN DNA/NN in/IN the/DT genome/NN of/IN one/PRP or/CC both/DT of/IN these/DT viruses/NNS subsequent/JJ to/IN their/PRP divergence/NN from/IN a/DT common/JJ ancestor/NN ./.
@@114845781369 CONCLUSION/IN :/: There/EX are/VBP no/DT differences/NNS in/IN the/DT measurement/NN data/NN derived/VBN from/IN this/DT method/NN and/CC actual/JJ measurement/NN data/NN from/IN an/DT object/NN created/VBN by/IN the/DT computer-aided/JJ dental/JJ design/NN program/NN ./.
@@89276126425 Ki-ras/NEWGENE and/CC p53/NEWGENE mutations/NEWGENE in/IN pancreatic/JJ ductal/JJ adenocarcinoma/NN ./.
@@38616874527 Eleven/CD healthy/JJ ,/, normotensive/JJ males/NNS undergoing/VBG routine/JJ restorative/JJ dental/JJ care/NN were/VBD evaluated/VBN during/IN treatment/NN for/IN possible/JJ hemodynamic/JJ alterations/NNS in/IN response/NN to/IN potential/JJ sympathetic/JJ nervous/JJ system/NN stimulation/NN ./.
@@113697008782 CSR/NNP is/VBZ directed/VBN to/IN specific/JJ heavy/JJ chain/NN isotypes/NNS by/IN cytokines/NNS and/CC B/NN cell/NN activators/NN that/WDT induce/VBP transcription/NN from/IN the/DT unrearranged/NN ,/, or/CC germline/NN (/( GL/NN )/SYM ,/, C/NN (/NN H/NN )/NN region/NN genes/NNS ./.
@@96284199600 As/IN predicted/VBN by/IN the/DT Wing/NNP and/CC Kristofferson/NNP model/NN ,/, the/DT durations/NNS of/IN successive/JJ ISIs/NNS tended/VBN to/IN be/VB negatively/RB correlated/VBN ./.
@@9802206344 Based/VBN on/IN sequence/NN homology/NN ,/, the/DT genes/NNS were/VBD identified/VBN as/IN TEF/NEWGENE ,/, encoding/VBG translation/NEWGENE elongation/NEWGENE factor-1/NEWGENE alpha/NEWGENE and/CC RPS7/NEWGENE ,/, encoding/VBG ribosomal/NEWGENE protein/NEWGENE S7/NN ./NN
@@31479126606 Symptomatic/JJ hyperventilators/NNS had/VBP a/DT larger/JJR number/NN of/IN sighs/NNS and/CC abnormally/RB wide/JJ fluctuations/NNS in/IN baseline/NN for/IN inspiratory/JJ time/NN ,/, expiratory/JJ time/NN ,/, and/CC PETCO2/NN ./.
@@96657201520 As/IN the/DT high-affinity/JJ Mg2+/NN binding/JJ sites/NNS are/VBP filled/VBN ,/, the/DT primer/NN terminus/NN migrates/VBZ from/IN the/DT exonuclease/NEWGENE site/NEWGENE to/IN a/DT highly/RB based/VBN stacked/JJ polymerase/NEWGENE active/NEWGENE site/NEWGENE ./.
@@10503812334 A/DT population/NN pharmacokinetic/JJ study/NN of/IN cyclosporin/NN in/IN organ/NN transplant/NN patients/NNS ,/, including/JJ elderly/JJ allograft/NN recipients/NNS up/JJ to/IN 75/CD years/NNS of/IN age/NN ,/, did/VBD not/RB identify/VB age/NN as/IN a/DT covariable/JJ influencing/VBG cyclosporin/NN pharmacokinetics/NN ./.
@@74459717322 The/DT same/JJ response/NN occurs/VBZ whether/IN acrylamide/NN is/NNS given/VBP immediately/RB after/IN nerve/NN ligation/NN or/CC 1/CD week/NN later/JJR ./.
@@82005287513 This/DT strategy/NN was/VBD used/VBN to/IN place/NN both/PDT the/DT Tn903/NEWGENE neo/NEWGENE gene/NEWGENE and/CC the/DT Rhodosporidium/NEWGENE toruloides/NEWGENE phenylalanine/NEWGENE ammonia/NEWGENE lyase/NEWGENE (/( PAL/NEWGENE )/NN -encoding/NN gene/NN under/IN the/DT transcriptional/JJ control/NN of/IN pPGK/NEWGENE :/: :/: REP2/NEWGENE ./.
@@47668882591 Early/NN heparin/NN therapy/NN in/IN 60/CD children/NNS with/IN acute/JJ meningococcemia/NN ./.
@@75080827387 The/DT highest/JJS decrease/NN in/IN mutagenic/NN activity/NN was/VBD observed/VBN when/CC enzymatic/JJ bleaching/NN was/VBD used/VBN together/RB with/IN chlorine/NN ./.
@@117235111562 Regarding/VBG gestational/JJ risk/NN ,/, 3/NN ,/NN 243/NN drugs/NNS used/VBN (/( 34%/JJ )/SYM belonged/VBN to/IN category/NN A/DT risk/NN ,/, 1/NN ,/NN 923/NN (/( 22/NN ./NN 6%/NN )/SYM to/IN category/NN B/NNP ,/, 3/CD ,/CD 798/CD (/( 39/NN ./NN 7%/NN )/SYM to/IN category/NN C/NN ,/, 289/CD (/( 3/NN ./NN 0%/NN )/SYM to/IN category/NN D/NN ,/, and/CC 55/CD (/( 0/NN ./NN 6%/NN )/SYM to/IN category/NN X/NNP ./NNP
@@80019669805 These/DT same/JJ regions/NNS showed/VBD remarkable/JJ homology/NN to/IN two/JJ invertebrate/NN proteins/NN ,/, CNC/NEWGENE and/CC skin-1/NEWGENE ,/, postulated/VBN to/IN regulate/VB embryonic/JJ development/NN in/IN Drosophila/NN melanogaster/NN and/CC Caenorhabditis/NNP elegans/NNS ,/, respectively/RB ./.
@@66683166418 Using/VBG a/DT MOS-Hypersil/NNP reversed-phase/JJ column/NN with/IN a/DT phosphate/NN buffer--acetonitrile/JJ mobile/JJ phase/NN ,/, baseline/NN separation/NN of/IN antipyrine/NN ,/, its/PRP metabolites/NNS 3-hydroxymethylantipyrine/JJ ,/, norantipyrine/NN and/CC 4-hydroxyantipyrine/JJ ,/, and/CC the/DT internal/JJ standard/NN ,/, phenacetin/NN ,/, was/VBD achieved/VBN within/IN 6/CD min/NN ./.
@@79885591789 The/DT other/DT element/NN bound/JJ RBP-J/NEWGENE kappa/NEWGENE with/IN low/JJ affinity/NN ./.
@@115282531403 Copyright/NNP 2001/CD S/NNP ./NNP
@@36355974310 In/NN addition/NN ,/, on/IN the/DT Cohler's/NNP maternal/JJ scale/NN ,/, Korean/JJ mothers/NNS were/VBD found/VBN to/IN view/NN their/PRP infants/NNS as/IN more/RB passive/JJ and/CC dependent/JJ than/IN American/JJ mothers/NNS did/VBD (/( P/NN less/PRP than/IN 0/CD ./CD 00/CD )/SYM ./.
@@92350739192 A/DT 2/CD years/NNS and/CC 9/CD months/NNS old/JJ female/JJ patient/NN ,/, with/IN the/DT diagnosis/NN of/IN Weaver/NNP syndrome/NN is/VBZ reported/VBN ./.
@@106536972067 Actins/NEWGENE show/VB two/JJ different/JJ forms/NNS of/IN N-terminal/NN processing/VBG dependent/JJ on/IN their/PRP N-terminal/NN sequence/NN ./.
@@36518404188 Ex/NN vivo/NN MAO/NEWGENE inhibition/NN data/NN indicated/VBN DPGPEA/NNP to/IN be/VB an/DT inhibitor/NN of/IN MAO-B/NEWGENE ,/, although/IN the/DT effect/NN was/VBD much/RB weaker/JJR than/IN seen/VBP with/IN tranylcypromine/NN or/CC pargyline/NN ./.
@@110317736617 For/IN this/DT purpose/NN ,/, the/DT writhing/JJ test/NN ,/, capsaicin/NN and/CC formalin/NN induced-pain/NN in/IN mice/NNS were/VBD used/VBN ./.
@@66303196369 Brain/NN pH/NN following/IN 3/CD h/NN of/IN cerebral/JJ focal/JJ ischemia/NN changed/VBN from/IN a/DT normal/JJ value/NN of/IN 7/CD ./CD 0/CD to/IN 6/CD ./CD 5/CD and/CC 6/CD ./CD 2/CD in/IN animals/NNS studied/VBN under/IN barbiturate/NN and/CC halothane/NN anesthesia/NN ,/, respectively/RB ./.
@@3178097328 The/DT CHARGE/NN association/NN is/VBZ a/DT collection/NN of/IN multisystem/JJ congenital/JJ anomalies/NNS including/JJ choanal/JJ atresia/NN ./.
@@109897772516 No/DT specific/NN subgroup/NN of/IN clients/NNS benefited/VBN more/RB from/IN URD/NN ,/, although/IN a/DT prospective/JJ study/NN employing/VBG random/JJ assignment/NN might/MD be/VB more/RB successful/JJ in/IN identifying/JJ such/JJ a/DT group/NN ./.
@@15122595183 Because/IN of/IN this/DT latter/JJ phenomenon/NN ,/, we/PRP were/VBD able/JJ to/IN identify/VB a/DT particular/JJ cysteine/NN motif/NN that/WDT was/VBD repeated/JJ multiple/JJ times/NNS in/IN Dfurin2/NEWGENE but/CC present/VB only/RB twice/RB in/IN mammalian/NEWGENE furin/NEWGENE ./.
@@23394476438 We/PRP have/VBP synthesized/VBN [/NN 7/NN ,/NN 7-2H2/NN ]/NN -19-OHA/NN with/IN high/JJ deuterium/NN content/NN and/CC ,/, together/RB with/IN [/NN 7/NN ,/NN 7-2H2/NN ]/NN A/NN and/CC [/NN 9/NN ,/NN 11-2H2/NN ]/NN estrone/NN (/( E1/NN )/SYM ,/, have/VB developed/VBN a/DT quantitative/JJ assay/NN of/IN serum/JJ level/NN 19-OHA/CD ,/, A/DT ,/, and/CC E1/NN using/VBG the/DT gas/NN chromatography/NN //NN mass/NN spectrometry-mass/NN fragmentography/NN method/NN to/IN monitor/NN individual/JJ subjects/NNS throughout/IN pregnancy/NN ./.
@@85676831466 The/DT human/NEWGENE purH/NEWGENE cDNA/NEWGENE is/VBZ 1776/CD base/NN pairs/NNS in/IN length/NN encoding/VBG for/IN a/DT 591-amino/CD acid/NN polypeptic/JJ (/( Mr/NNP =/SYM 64/CD ,/CD 425/CD )/SYM ./.
@@32354873750 Incorporation/NNS of/IN 0/CD ./CD 1/CD or/CC 0/CD ./CD 2/CD M/NN sodium/NN dihydrogen/NN phosphate/NN in/IN the/DT sugar/NN solutions/NNS resulted/VBN in/IN a/DT decrease/NN in/IN the/DT shelf-life/NN of/IN diltiazem/NN ./.
@@89155089598 Moloney/NN murine/JJ leukemia/NN virus/NN (/( MMLV/NNP )/NN -derived/NN pUCMoTiN-based/JJ retroviral/JJ vectors/NNS were/VBD engineered/VBN to/IN allow/VB constitutive/JJ and/CC Tat/NEWGENE (/( trans-activator/NEWGENE of/NEWGENE transcription/NEWGENE )/NN -inducible/NN expression/NN of/IN five/CD hammerhead/NEWGENE ribozymes/NEWGENE targeted/VBN against/IN highly/RB conserved/VBN sequences/NNS within/IN the/DT group/NEWGENE antigen/NEWGENE (/( Gag/NEWGENE )/SYM ,/, protease/NEWGENE (/( Pro/NEWGENE )/SYM ,/, reverse/NEWGENE transcriptase/NEWGENE (/( RT/NEWGENE )/SYM ,/, tat/NEWGENE ,/, and/CC envelope/NEWGENE (/( Env/NEWGENE )/SYM coding/JJ regions/NNS of/IN human/JJ immunodeficiency/NN virus/NN type-1/NN (/( HIV-1/NN )/SYM RNA/NN ./.
@@49473475261 Spleen/NNS weight/NN in/IN rats/NNS during/IN tumour/NN growth/NN and/CC in/IN homograft/NN rejection/NN ./.
@@85119945065 We/PRP have/VBP found/VBN out/RB that/IN one-year-old/JJ carps/NNS are/VBP extremely/RB sensitive/JJ to/IN ichthiomycin/NN in/IN concentrations/NNS between/IN 25-125/JJ micrograms/NN //NN dm3/NN ./.
@@79371324827 Remarkably/RB ,/, U21/NEWGENE contains/VBZ a/DT long/JJ stretch/NN (/( 13/CD nt/CD ./CD )/SYM of/IN complementarity/NN to/IN a/DT highly/RB conserved/VBN sequence/NN in/IN 28S/NEWGENE rRNA/NEWGENE ./.
@@86431111457 The/DT humanized/NEWGENE LL2/NEWGENE (/( hLL2/NEWGENE )/SYM ,/, lacking/VBG light/NEWGENE chain/NEWGENE variable/NEWGENE region/NEWGENE glycosylation/NN ,/, exhibited/VBN immunoreactivities/NNS that/WDT were/VBD comparable/JJ to/IN that/DT of/IN chimeric/NEWGENE LL2/NEWGENE (/( cLL2/NEWGENE )/SYM ,/, which/WDT was/VBD shown/VBP previously/RB to/IN have/NN antigen-binding/NN properties/NNS similar/JJ to/IN its/PRP murine/JJ counterpart/NN ,/, suggesting/VBG that/IN the/DT VK-appended/JJ oligosaccharides/NNS found/VBP in/IN mLL2/NEWGENE are/VBP not/RB necessary/JJ for/IN antigen/NN binding/JJ ./.
@@109559134506 Once/RB HIT/NN II/NN is/VBZ suspected/VBN ,/, heparin/NN (/( and/CC low-molecular-weight/JJ heparins/NNS )/SYM should/MD be/VB stopped/VBN immediately/RB ./.
@@69539579496 Whereas/IN creatine/NEWGENE kinase/NEWGENE activity/NN declined/VBN exponentially/RB from/IN a/DT single/JJ peak/NN ,/, myoglobin/NEWGENE appeared/VBD in/IN multiple/JJ episodes/NNS inadequately/RB represented/VBN by/IN a/DT single/JJ peak/NN value/NN and/CC having/VBG no/DT clear/JJ clinical/JJ correlation/NN ./.
@@87548345040 Twelve/CD genomic/JJ fragments/NNS containing/JJ novel/JJ response/NN elements/NN are/VBP described/VBN ,/, and/CC the/DT transcription/NN unit/NN associated/VBN with/IN one/PRP of/IN them/PRP ,/, NN-84AG/NEWGENE ,/, was/VBD characterized/VBN in/IN detail/NN ./.
@@100497427532 Analysis/NNP of/IN the/DT consensus/NN binding/JJ sequence/NN and/CC the/DT DNA-binding/NN domain/NN of/IN ZF5/NEWGENE ./.
@@79776485481 Sequencing/NN of/IN the/DT TP53/NEWGENE transcripts/NEWGENE from/IN exons/NNS 2/CD to/IN 10/CD ,/, however/RB ,/, did/VBD not/RB reveal/VB mutations/NNS of/IN the/DT remaining/JJ allele/NN in/IN any/DT of/IN these/DT tumors/NNS ./.
@@45786869475 Pneumothorax/NN following/IN lung/NN abscess/NN in/IN the/DT renal/JJ transplant/NN patient/NN ./.
@@113362111184 The/DT iterative/JJ method/NN proposed/VBN by/IN Bengtsson/NNP [/NN Appl/NN ./.
@@10878675700 CONCLUSION/IN :/: The/DT alpha2-adrenergic/NN antagonist/NN idazoxan/NN increases/NNS glucose-induced/JJ sympathetic/JJ activity/NN but/CC not/RB energy/NN expenditure/NN in/IN obese/JJ subjects/NNS ./.
@@21452685128 These/DT losses/NNS account/NN for/IN the/DT resistance/NN of/IN EDS-IV/NN collagen/NEWGENE to/IN cyanogen/NN bromide/NN and/CC mammalian/NEWGENE collagenase/NEWGENE digestion/NN ./.
@@41010034795 Relations/NNS between/IN cellular/JJ electrical/JJ activity/NN and/CC cardiac/JJ mechanical/JJ activity/NN in/IN man/NN ,/, the/DT dog/NN and/CC the/DT rabbit/NN ./.
@@98609799533 Expression/NNS of/IN p130/NEWGENE (/NEWGENE Cas/NEWGENE )/NEWGENE (/( Cas/NEWGENE )/SYM ,/, a/DT major/JJ binding/JJ protein/NN for/IN the/DT Crk/NEWGENE SH2-domain/NEWGENE1 ,/, also/RB induced/VBN JNK/NEWGENE activation/NN ,/, which/WDT was/VBD blocked/VBN by/IN the/DT SH2-mutant/NEWGENE of/IN Crk/NEWGENE ./.
@@19343782556 Skeletal/NEWGENE muscle/NEWGENE metaboreceptor/NEWGENE responses/NNS are/VBP impaired/VBN in/IN heart/NN failure/NN ./.
@@96135746169 The/DT purified/VBN recombinant/JJ protein/NN was/VBD assayed/VBN for/IN its/PRP enzyme/NN activity/NN by/IN monitoring/VBG transfer/NN of/IN [/NN 3H/NN ]/NN methyl/NN groups/NNS from/IN the/DT substrate/NN DNA/NN to/IN the/PDT MGMT/NEWGENE protein/NEWGENE ;/: the/DT activity/NN was/VBD found/VBN to/IN be/VB stable/JJ at/IN 90/CD degrees/NNS C/NN for/IN at/IN least/RB 30/CD min/NN ./.
@@92873627287 This/DT interaction/NN involved/VBD the/DT SH3/NEWGENE region/NEWGENE of/IN p50/NEWGENE (/NEWGENE csk/NEWGENE )/NEWGENE and/CC a/DT proline-rich/JJ region/NN (/( PPPLPERTPESFVLADM/NEWGENE )/SYM outside/RB the/DT catalytic/JJ region/NN of/IN PTP-PEST/NEWGENE ./.
@@86646679550 SETTING--Delhi/NN ,/, urban/JJ India/NNP ,/, 1985-6/CD ./.
@@81436679507 The/DT mean/JJ (/( +/NN //NN -/NN sd/NN )/SYM intra-vesicular/JJ pressure/NN (/( IVP/NN )/SYM and/CC maximal/JJ urethral/JJ closure/NN pressures/NNS (/( MUCP/NN )/SYM were/VBD 10/CD ./CD 3/CD (/( +/NN //NN -/NN 1/CD ./CD 7/CD )/SYM and/CC 129/CD ./CD 8/CD (/( +/NN //NN -/NN 19/CD ./CD 6/CD )/SYM cmH2O/NN ,/, respectively/RB ,/, and/CC the/DT ratio/NN between/IN MUCP/NN and/CC IVP/NN was/VBD 13/CD ./CD 2/CD (/( +/NN //NN -/NN 2/CD ./CD 5/CD )/SYM ./.
@@11565747996 Data/NNP from/IN in/IN vitro/FW splicing/JJ assays/NNS ,/, UV/NN crosslinking/JJ and/CC RNA-binding/NN competition/NN experiments/NNS indicates/VBZ a/DT strong/JJ correlation/NN between/IN the/DT binding/JJ affinities/NNS of/IN PSI/NEWGENE for/IN the/DT SELEX/NN sequences/NN and/CC their/PRP ability/NN to/IN modulate/VB splicing/JJ of/IN P/NEWGENE element/NEWGENE IVS3/NEWGENE in/IN vitro/FW ./.
@@70782636859 Use/VB of/IN subcutaneous/JJ deferoxamine/NN in/IN a/DT child/NN with/IN hemochromatosis/NN associated/VBN with/IN congenital/JJ dyserythropoietic/JJ anemia/NN ,/, type/NN I/NNP ./NNP
@@39747907016 The/DT primary/NN CT/NN findings/NNS were/VBD misinterpreted/VBN as/IN a/DT brain/NN infarct/NN or/CC possibly/RB a/DT tumour/NN ./.
@@86283024987 If/IN hnRNP/NEWGENE K/NEWGENE is/VBZ a/DT transcription/NN factor/NN ,/, then/JJ interactions/NNS with/IN the/DT RNA/NEWGENE polymerase/NEWGENE II/NEWGENE transcription/NN apparatus/NN are/VBP predicted/VBN ./.
@@110381183731 Methyl/NN formate/NN was/VBD used/VBN as/IN the/DT solvent/NN of/IN biodegradable/JJ oligoesters/NNS for/IN the/DT fabrication/NN of/IN microspheres/NNS with/IN encapsulated/JJ bovine/NEWGENE serum/NEWGENE albumin/NEWGENE (/( BSA/NEWGENE )/SYM ./.
@@9135066196 We/PRP report/VBP here/RB that/IN constitutively/RB active/JJ Mek1/NEWGENE could/MD activate/VB p96h2bk/NEWGENE in/IN the/DT absence/NN of/IN oncogenic/NEWGENE Ras/NEWGENE ./.
@@1106316984 Botulinum/NEWGENE toxin/NEWGENE A/NEWGENE in/NN the/DT treatment/NN of/IN hemiplegic/JJ spastic/JJ foot/JJ drop--clinical/JJ and/CC functional/JJ outcomes/NNS ./.
@@86493897790 Mutational/JJ analysis/NN of/IN the/DT P2-proximal/NEWGENE CTCF/NEWGENE binding/NEWGENE site/NEWGENE and/CC transient-cotransfection/JJ experiments/NNS demonstrate/VBP that/IN CTCF/NEWGENE is/VBZ a/DT transcriptional/JJ repressor/NN of/IN the/DT human/NEWGENE c-myc/NEWGENE gene/NEWGENE ./.
@@82137477091 To/TO determine/VB whether/IN the/DT excess/NN prevalence/NN of/IN human/JJ immunodeficiency/NN virus/NN type/NN 1/CD (/( HIV-1/NNP )/SYM infection/NN in/IN US/NN black/NN and/CC Hispanic/NN homosexual/JJ men/NNS relative/JJ to/IN white/JJ men/NNS can/MD be/VB explained/VBN by/IN differences/NNS in/IN sociodemographic/JJ factors/NNS ,/, history/NN of/IN sexually/RB transmitted/VBN diseases/NNS ,/, or/CC sexual/JJ and/CC drug-use/JJ behaviors/NNS ,/, the/DT authors/NNS conducted/VBD a/DT cross-sectional/JJ analysis/NN of/IN baseline/NN HIV-1/NN seroprevalence/NN and/CC HIV-1/NNP risk/NN factors/NNS among/IN 4/CD ,/CD 475/CD non-Hispanic/JJ white/NN ,/, 234/CD Hispanic/NN white/JJ ,/, and/CC 194/CD black/JJ homosexual/JJ men/NNS from/IN four/CD centers/NNS in/IN the/DT United/NNP States/NNPS (/( Baltimore/NNP //NNP Washington/NNP ,/, DC/JJ ,/, Pittsburgh/NN ,/, Chicago/NN ,/, and/CC Los/NNP Angeles/NNP )/SYM ./.
@@24039261265 Antibodies/NNS raised/VBN against/IN a/DT bacterially/RB produced/VBN beta/NEWGENE gal-trk/NEWGENE receptor/NEWGENE kinase/NEWGENE fusion/NEWGENE protein/NEWGENE recognized/VBD a/DT 44/NN kd/NN phosphoprotein/NN phosphorylated/VBN on/IN serine/NN ,/, threonine/NN and/CC tyrosine/NN in/IN extracts/NNS of/IN trk-2h/NEWGENE transformed/VBN NIH3T3/NNP cells/NNS ./.
@@1027644179 Potscoital/JJ test/NN ./.
@@84590128429 Fibular/JJ dimelia/NN with/IN deficiency/NN of/IN the/DT tibia/NN ./.
@@88684731667 Thus/RB ,/, although/IN p28/NEWGENE may/MD play/VB only/RB a/DT limited/VBN role/NN during/IN the/DT early/JJ embryonic/JJ cleavages/NNS ,/, it/PRP may/MD function/VB later/JJR in/IN development/NN to/IN establish/VB a/DT somatic/JJ type/NN of/IN cell/NN cycle/NN ./.
@@21208334393 In/NN Denmark/NN only/RB 1-3/CD cases/NNS of/IN transfusion-associated/JJ hepatitis/NN NANB/NN (/( TAH-NANB/NN )/SYM are/VBP registered/VBN annually/RB or/CC about/RB 1/CD case/NN per/IN 100/CD ,/CD 000/CD units/NNS transfused/VBN ./.
@@10364425593 These/DT indications/NNS of/IN deregulated/JJ signalling/JJ in/IN the/DT absence/NN of/IN tyrosine/NN 118/CD were/VBD substantiated/VBN by/IN sustained/JJ activation/NN of/IN STAT3/NEWGENE ./.
@@110807963240 Interestingly/RB ,/, this/DT mutant/JJ cell/NN line/NN lacks/VBZ expression/NN of/IN the/DT IKK/NEWGENE regulatory/NEWGENE protein/NEWGENE ,/, IKKgamma/NEWGENE ./.
@@75305022028 Membrane-bound/NNP Steel/NEWGENE factor/NEWGENE induces/VBZ more/RB persistent/JJ tyrosine/NEWGENE kinase/NEWGENE activation/NN and/CC longer/JJR life/NN span/NN of/IN c-kit/NEWGENE gene-encoded/JJ protein/NN than/IN its/PRP soluble/JJ form/NN ./.
@@28637475022 Replacement/NEWGENE variant/NEWGENE histone/NEWGENE genes/NEWGENE contain/VBP intervening/JJ sequences/NNS ./.
@@9712644610 Transcriptional/JJ regulation/NN of/IN the/DT GluR2/NEWGENE gene/NEWGENE :/: neural-specific/JJ expression/NN ,/, multiple/JJ promoters/NNS ,/, and/CC regulatory/JJ elements/NNS ./.
@@72982597164 Determination/NNS of/IN lead/NN in/IN blood/NN ./.
@@106734263619 The/DT central/JJ (/( R/NN )/SYM domain/NN is/VBZ responsible/JJ for/IN receptor-binding/NN activity/NN whereas/IN the/DT N-terminal/NN (/( T/NN )/SYM domain/NN mediates/VBZ translocation/NN ,/, the/DT process/NN by/IN which/WDT the/DT C-terminal/NN cytotoxic/JJ domain/NN is/VBZ transported/VBN from/IN the/DT receptor/NN to/IN the/DT site/NN of/IN its/PRP cytotoxicity/NN ./.
@@110142138935 To/TO determine/VB whether/IN interaction/NN of/IN arsenite/NN with/IN the/DT hormone-binding/JJ domain/NN results/NNS in/IN receptor/NN activation/NN ,/, COS-1/NNP cells/NNS were/VBD transiently/RB cotransfected/VBN with/IN the/DT chimeric/NEWGENE receptors/NEWGENE GAL-ER/NEWGENE ,/, which/WDT contains/VBZ the/DT hormone-binding/JJ domain/NN of/IN ERalpha/NEWGENE and/CC the/DT DNA-binding/NN domain/NN of/IN the/DT transcription/NN factor/NN GAL4/NEWGENE ,/, and/CC a/DT GAL4-responsive/NNP CAT/NEWGENE reporter/NEWGENE gene/NEWGENE ./.
@@113116879259 The/DT JHRLSS/NN has/VBZ been/VBN used/VBN in/IN prior/NN studies/NNS to/IN assess/VB RLS/NNS severity/NN ,/, but/CC has/VBZ not/RB previously/RB been/VBN validated/VBN in/IN relation/NN to/IN direct/JJ measures/NNS of/IN the/DT morbidity/NN associated/VBN with/IN RLS/NNS ./.
@@82043487733 VP-16/NN ,/, ifosfamide/NN and/CC cisplatin/NN (/( VIP/NN )/SYM for/IN extensive/JJ small/JJ cell/NN lung/NN cancer/NN ./.
@@109211975877 Measurements/NNS were/VBD compared/VBN with/IN two/JJ computerised/JJ treatment/NN planning/NN systems--Theraplan/JJ VO5B/NN and/CC ADAC/NN Pinnacle3/NN V4/NN ./NN 0b/NN ./.
@@108415375803 The/DT experimentally/RB mapped/VBN regions/NNS of/IN RPB5/NEWGENE involved/VBN in/IN these/DT interactions/NNS correspond/VBP to/IN distinct/JJ and/CC surface-exposed/JJ alpha-helical/JJ structures/NNS ./.
@@10945010766 The/DT role/NN of/IN daunorubicin/NN in/IN induction/NN therapy/NN for/IN adult/JJ acute/JJ myeloid/JJ leukemia/NN ./.
@@26454315559 These/DT data/NN suggest/VB that/DT hypocitraturia/NN in/IN type/NN I/NN renal/JJ tubular/JJ acidosis/NN may/MD be/VB due/NN to/IN a/DT defect/NN in/IN proximal/JJ tubule/NN function/NN ./.
@@80628243026 Each/DT expressed/VBN domain/NN ,/, as/RB well/VB as/IN FKBP-33/NEWGENE itself/PRP ,/, possesses/VBZ peptidyl-prolyl/NEWGENE cis-trans/NEWGENE isomerase/NEWGENE activity/NN ,/, though/CC with/IN much/RB lower/JJR specific/JJ activities/NNS than/IN FKBP-12/NEWGENE ./.
@@56712675635 5-/NN (/NN Dimethylaminopropyl/NN )/NN -19/NN ,/NN 11-dihydro-5H-benzo/NN [/NN 2/NN ,/NN 3/NN ]/NN pyrido/NN [/NN 6/NN ,/NN 7-b/NN ]/NN azepine/NN ./.
@@23078509738 The/DT induction/NN of/IN RNKP-1/NEWGENE expression/NN in/IN the/DT Con/JJ A-cultured/JJ spleen/NN cells/NNS is/VBZ accompanied/VBN by/IN increases/NNS in/IN both/DT NK/NN and/CC lymphokine-activated/JJ killer/NN lymphocyte/NN activities/NNS ./.
@@33199121119 Cephradine/NN 250/NN mg/NN at/IN night/NN for/IN 12/CD months/NNS was/VBD given/VBP as/IN a/DT prophylactic/JJ measure/NN to/IN 33/CD female/JJ patients/NNS of/IN mean/JJ age/NN 41/CD ./CD 6/CD years/NNS ,/, who/WP had/VBP a/DT history/NN in/IN the/DT preceding/JJ 12/CD months/NNS of/IN between/IN three/CD and/CC 24/CD (/( median/JJ =/SYM 7/CD )/SYM episodes/NNS of/IN frequency/NN and/DT //DT or/DT dysuria/NN ./.
@@84555982745 Sterile/NNP mutants/NNS of/IN Saccharomyces/NN cerevisiae/NN were/VBD isolated/VBN from/IN alpha/NN */SYM cells/NNS having/VBG the/DT a/NEWGENE //NEWGENE alpha/NEWGENE aar1-6/NEWGENE genotype/NN (/( exhibiting/VBG alpha/NN mating/JJ ability/NN and/CC weak/JJ a/DT mating/JJ ability/NN as/IN a/DT result/NN of/IN a/DT defect/NN in/IN a1-alpha/NEWGENE 2/NEWGENE repression/NN )/SYM ./.
@@11113823954 Four/CD cases/NNS of/IN synovial/JJ chondromatosis/NN are/VBP presented/VBN ./.
@@105861158929 We/PRP report/VBP here/RB that/IN out/RB of/IN the/DT major/JJ pro-inflammatory/JJ cytokines/NNS examined/VBN ,/, IL-1alpha/NEWGENE ,/, IL-1beta/NEWGENE ,/, TNF-alpha/NEWGENE and/CC IL-6/NEWGENE ,/, only/JJ IL-6/NEWGENE was/VBD generated/VBN and/CC secreted/VBN in/IN PKCeta/NNP -expressing/CD cells/NNS without/IN any/DT additional/JJ inducer/NN in/IN serum-supplemented/JJ cultures/NNS (/( 10%/CD FCS/NN )/SYM ./.
@@9150901549 Twenty-nine/CD days/NNS after/IN injection/NN of/IN 5/CD ./CD 8/CD mCi/NN of/IN Tc-99m/NN ,/, which/WDT gives/VBZ 28/CD rads/NNS to/IN the/DT testis/NN ,/, the/DT number/NN of/IN sperm/NN hads/NNS decreased/VBN to/IN 70%/CD of/IN control/NN ./.
@@69626348368 Fluorometric/NN methods/NNS can/MD also/RB provide/VB information/NN about/JJ porphyrin/NN binding/NN sites/NN that/WDT is/VBZ useful/JJ in/IN understanding/NN porphyrin/NN transport/NN and/CC clearance/NN ./.
@@21957152816 Homozygous/JJ individuals/NNS usually/RB develop/VBP purpura/NN fulminans/NNS as/IN newborns/NNS ;/: heterozygous/JJ protein/NN C-deficient/NN individuals/NNS are/VBP at/IN increased/VBN risk/NN for/IN venous/JJ thrombosis/NN and/CC pulmonary/JJ embolism/NN ./.
@@10358075675 DAF16/NEWGENE is/NNS known/VBP to/IN be/VB a/DT component/NN of/IN a/DT signaling/JJ pathway/NN that/WDT has/VBZ been/VBN partially/RB dissected/VBN genetically/RB and/CC includes/VBZ homologues/NNS of/IN the/DT insulin/NEWGENE //NEWGENE IGF-1/NEWGENE receptor/NEWGENE ,/, PtdIns/NEWGENE 3-kinase/NEWGENE and/CC PKB/NEWGENE ./.
@@68805636672 The/DT prevalence/NN of/IN CPAF/NNP was/VBD similar/JJ in/IN type/NN 1/CD and/CC type/NN 2/CD diabetes/NN ,/, was/VBD greater/JJR in/IN women/NNS than/IN in/IN men/NNS ,/, and/CC was/VBD significantly/RB greater/JJR after/IN repeated/JJ administrations/NNS than/IN after/IN one/PRP single/JJ administration/NN of/IN chlorpropamide/NN ./.
@@74725821490 The/DT identification/NN of/IN viable/JJ myocardium/NN with/IN both/DT 99mTc-tetrofosmin/NN and/CC 201Tl/NN can/MD be/VB greatly/RB enhanced/VBN to/IN a/DT similar/JJ degree/NN if/IN the/DT severity/NN of/IN reduction/NN in/IN activity/NN within/IN nonreversible/JJ defects/NNS is/VBZ considered/VBN ./.
@@85980518552 Molecular/NNP analysis/NN of/IN a/DT novel/JJ schizosaccharomyces/NNS pombe/NN gene/NN containing/JJ two/JJ RNP/NEWGENE consensus-sequence/NEWGENE RNA-binding/NEWGENE domains/NEWGENE ./.
@@108158072685 Interestingly/RB ,/, a/DT decreased/VBN transcription/NN from/IN the/DT endogenous/JJ c-Myb/NEWGENE promoter/NEWGENE was/VBD observed/VBN in/IN several/DT HTLV-I/NN transformed/VBD T-cell/NN lines/NNS ./.
@@20775602684 The/DT role/NN of/IN pharmacological/JJ profiling/VBG in/IN safety/NN assessment/NN ./.
@@109729908097 The/DT tumor-suppressor/NEWGENE protein/NEWGENE p53/NEWGENE is/VBZ involved/VBN in/IN maintaining/VBG genomic/JJ stability/NN ./.
@@110377598067 Catch-up/NN growth/NN and/CC craniofacial/JJ dimensions/NNS following/IN administration/NN of/IN the/DT antineoplastic/JJ agent/NN vincristine/NN to/IN young/JJ rats/NNS ./.
@@104545504258 Previous/JJ experimental/JJ evidence/NN had/VBP indicated/VBN that/IN Reg1/NEWGENE might/MD target/VB Glc7/NEWGENE to/IN nuclear/JJ substrates/NNS such/JJ as/IN the/DT Snf1/NEWGENE kinase/NEWGENE complex/NEWGENE ./.
@@103706751383 The/DT main/JJ causes/NNS of/IN liver/NN disease/NN in/IN the/DT patients/NNS with/IN HCC/NN were/VBD hepatitis/NN C/NN virus/NN (/( HCV/NN )/SYM (/( 77%/JJ )/SYM ,/, alcohol/NN abuse/NN (/( 73%/JJ )/SYM ,/, and/CC the/DT combination/NN of/IN HCV/NN and/CC alcohol/NN abuse/NN (/( 50%/CD )/SYM ./.
@@70762226848 Recommendations/NNS to/IN deal/NN with/IN these/DT and/CC related/VBN issues/NNS are/VBP presented/VBN ./.
@@76509583850 The/DT changes/NNS after/IN treatment/NN were/VBD observed/VBN chiefly/RB by/IN electromyography/NN while/CC sensory/JJ and/CC motor/JJ improvement/NN were/VBD also/RB recorded/VBN as/IN auxiliary/NN indicators/NN ./.
@@108987954823 Specific/NN class/NEWGENE I/NEWGENE and/NEWGENE II/NEWGENE histone/NEWGENE deacetylases/NEWGENE (/( HDACs/NEWGENE )/SYM interact/VB in/IN vivo/NN with/IN BCoR/NEWGENE ,/, suggesting/VBG that/IN BCoR/NEWGENE may/MD functionally/RB link/VB these/DT two/JJ classes/NNS of/IN HDACs/NEWGENE ./.
@@55256525578 Preliminary/JJ report/NN ./.
@@75926766616 Using/VBG varying/JJ conditions/NNS ,/, three/CD distinct/JJ complexes/NNS were/VBD shown/VBP to/IN interact/VB specifically/RB with/IN the/DT NIP/NEWGENE region/NEWGENE ,/, although/IN only/RB one/PRP correlates/VBP with/IN repressor/NN activity/NN ./.
@@14199454816 Localization/NNS of/IN the/DT brachial/JJ plexus/NN with/IN the/DT nerve/NN stimulator/NN is/VBZ equally/RB effective/JJ at/IN the/DT interscalene/JJ ,/, supraclavicular/JJ ,/, and/CC axillary/JJ sites/NNS ./.
@@108252949662 Although/IN the/DT OC/NEWGENE promoter/NEWGENE is/VBZ activated/VBN in/IN a/DT C/NN terminus/NN dependent/JJ manner/NN ,/, the/DT MDR/NEWGENE ,/, LTR/NN and/CC BSP/NEWGENE promoters/NEWGENE are/VBP repressed/VBN by/IN three/CD distinct/JJ mechanisms/NNS ,/, either/DT independent/NN of/IN or/CC involving/VBG the/DT AML/NEWGENE C/NEWGENE terminus/NEWGENE ,/, or/CC requiring/JJ only/RB the/DT conserved/VBN C-terminal/NEWGENE pentapeptide/NEWGENE VWRPY/NEWGENE ./.
@@106551642656 We/PRP critically/RB assess/VBP current/JJ systematic/JJ uncertainties/NNS and/CC determine/VB the/DT primordial/JJ Li/NN abundance/NN within/IN new/JJ ,/, much/JJ tighter/JJR limits/NNS :/: &parl0/NN ;/: Li&solm0/NN ;/: H&parr0/NN ;/: p/NN =/NN 1/NN ./NN 23+0/NN ./NN 68-0/NN ./NN 32x10-10/NN ./.
@@3120334486 In/NN 64%/VBD a/DT small/NN cardiac/NN vein/NN does/VBP not/RB exist/VB ,/, but/CC its/PRP origin/NN ,/, the/DT right/JJ marginal/JJ vein/NN ,/, joins/VBP the/DT system/NN of/IN anterior/JJ cardiac/JJ veins/NNS ./.
@@22336807343 These/DT results/NNS indicate/VBP that/IN the/DT cis-regulatory/NN elements/NN required/VBN for/IN developmental/JJ control/NN of/IN the/DT HaG3-A/NEWGENE helianthinin/NEWGENE gene/NEWGENE are/VBP located/VBN in/IN a/DT 2/CD ./CD 4/CD kb/NN upstream/JJ region/NN of/IN this/DT gene/NN ./.
@@108018091897 Transcriptional/JJ regulation/NN of/IN the/DT yeast/NEWGENE PHO8/NEWGENE promoter/NEWGENE in/IN comparison/NN to/IN the/DT coregulated/VBN PHO5/NEWGENE promoter/NEWGENE ./.
@@24039263323 The/DT trk-2h/NEWGENE oncogene/NEWGENE ,/, isolated/VBN from/IN the/DT human/JJ breast/NN carcinoma/NN cell/NN line/NN MDA-MB/CELL 231/CD by/IN genomic/JJ DNA-transfection/NNP into/IN NIH3T3/NNP cells/NNS ,/, consists/VBZ of/IN the/DT trk/NEWGENE proto-oncogene/NEWGENE receptor/NEWGENE kinase/NEWGENE domain/NEWGENE fused/VBN to/IN a/DT N-terminal/NN 41/NN amino/JJ acid/NN activating/NN sequence/NN (/( Kozma/NNP ,/, S/NN ./NN C/NN ./NN ,/, Redmond/NNP ,/, S/NNP ./NNP M/NNP ./NNP S/NNP ./NNP ,/, Xiao-Chang/NNP ,/, F/NN ./NN ,/, Saurer/NNP ,/, S/NNP ./NNP M/NNP ./NNP ,/, Groner/NNP ,/, B/NNP ./NNP and/CC Hynes/NN ,/, N/NNP ./NNP E/NNP ./.
@@93249883841 Substrates/NNS include/VBP the/DT p21/NEWGENE (/NEWGENE ras/NEWGENE )/NEWGENE proteins/NEWGENE ,/, nuclear/NEWGENE lamins/NEWGENE ,/, and/CC a/DT series/NN of/IN retinal/JJ proteins/NNS ./.
@@19044379958 Transcription/NNS of/IN the/DT metH/NEWGENE gene/NEWGENE in/NEWGENE Salmonella/NEWGENE typhimurium/NEWGENE and/NEWGENE Escherichia/NEWGENE coli/NEWGENE is/VBZ positively/RB regulated/VBN by/IN the/DT metR/NEWGENE gene/NEWGENE product/NEWGENE ,/, a/DT DNA/NN binding/JJ protein/NN ./.
@@67986092137 Morphine-dependent/NNP and/CC control/NN rats/NNS in/IN an/DT oral/JJ free-choice/JJ protocol/NN were/VBD treated/VBN with/IN gamma-vinyl/NN GABA/NN (/( GVG/NN )/SYM ,/, 60/CD ,/, 120/CD and/CC 240/CD mg/CD //CD kg/CD IP/JJ ,/, for/IN 3/CD days/NNS over/RB three/CD successive/JJ periods/NNS ./.
@@107068873671 Approximately/RB 20%/CD of/IN ALCLs/NNS that/WDT express/VBP ALK/NEWGENE do/NN not/RB contain/VB the/DT t/NN (/NN 2/NN ;/: 5/NN )/NN ,/, suggesting/VBG that/IN other/DT genetic/JJ abnormalities/NNS can/MD result/VB in/IN aberrant/JJ ALK/NEWGENE expression/NN ./.
@@110383667329 Furthermore/RB ,/, loss/NN of/IN methylation/NN also/RB greatly/RB reduced/VBN the/DT association/NN of/IN another/DT yeast/NEWGENE B-type/NEWGENE subunit/NEWGENE ,/, Rts1p/NEWGENE ./.
@@97139967018 Cytogenetic/JJ and/CC molecular/JJ characterization/NN of/IN random/JJ chromosomal/JJ rearrangements/NNS activating/JJ the/DT drug/NN resistance/NN gene/NN ,/, MDR1/NEWGENE //NEWGENE P-glycoprotein/NEWGENE ,/, in/IN drug-selected/JJ cell/NN lines/NNS and/CC patients/NNS with/IN drug/NN refractory/JJ ALL/NN ./.
@@91573379110 The/DT husband/NN in/IN one/PRP of/IN the/DT married/JJ couples/NNS was/VBD treated/VBN for/IN hepatitis/NN of/IN unidentified/JJ etiology/NN in/IN an/DT Infectology/NNP Department/NNP four/CD years/NNS ago/RB ./.
@@79195402412 These/DT genetic/JJ alterations/NNS do/VBP not/RB affect/VB synthesis/NN of/IN the/DT major/JJ c-myc/NEWGENE protein/NEWGENE ,/, p64/NEWGENE ,/, which/WDT is/VBZ initiated/VBN from/IN the/DT first/JJ AUG/NNS codon/NN in/IN exon/NN 2/CD ./CD
@@20780802686 Its/PRP application/NN in/IN Madagascar/NN :/: advantages/NNS and/CC disadvantages/NNS ./.
@@115723885226 This/DT paper/NN describes/VBZ the/DT results/NNS of/IN an/DT initial/JJ study/NN on/IN the/DT application/NN of/IN linear/JJ solvation/NN energy/NN relationships/NNS (/( LSERs/NNP )/SYM to/IN the/DT prediction/NN of/IN internal/JJ standard/JJ compounds/NNS in/IN reversed-phase/JJ liquid/JJ chromatographic/JJ (/( RPLC/NN )/SYM method/NN development/NN ./.
@@90226328987 What's/IN new/JJ in/IN gynecologic/JJ and/CC obstetrical/JJ surgery/NN ./.
@@8665777190 Treatment/NNP with/IN heparin/NN ,/, plasminogen/NEWGENE activators/NN and/CC fibrinogenolytic/JJ agents/NNS was/VBD disappointing/VBG although/IN renal/JJ function/NN has/VBZ stabilized/VBN in/IN one/PRP patient/NN on/IN long/JJ term/NN oral/JJ anticoagulant/JJ therapy/NN ./.
@@107995762862 M/NNP ./NNP
@@110721554765 There/EX was/VBD a/DT weak/JJ significant/JJ correlation/NN between/IN TGF/NEWGENE beta/NEWGENE 1/NEWGENE levels/NNS and/CC normal/JJ cell/NN radiosensitivity/NN (/( lymphocyte/NN SF2/NN )/SYM ./.
@@100698159532 We/PRP now/RB provide/VBP evidence/NN for/IN physical/JJ and/CC functional/JJ interaction/NN between/IN Doa4/NEWGENE and/CC the/DT proteasome/NN ./.
@@103204806314 We/PRP describe/VBP a/DT genetic/JJ system/NN for/IN further/RB characterizing/VBG the/DT role/NN of/IN the/DT extreme/JJ C-terminus/NN of/IN the/DT beta/NN subunit/NN of/IN E/NEWGENE ./NEWGENE coli/NEWGENE RNA/NEWGENE polymerase/NEWGENE ./.
@@13509326055 The/DT single/JJ site/NN of/IN glycosylation/NN is/VBZ located/VBN near/IN the/DT C-terminus/NN in/IN the/DT N-glycosylation/NEWGENE sequon/NEWGENE -Asn-Cys-Ser-/NEWGENE in/IN which/WDT Cys/NNS forms/NNS part/NN of/IN a/DT disulphide/NN bridge/NN ./.
@@17630658706 P/NNP ./NNP
@@111622781005 Mental/NNP rotation/NN of/IN paired/JJ figures/NNS engendered/VBD activation/NN in/IN the/DT left/JJ superior/JJ parietal/JJ lobule/NN and/CC the/DT right/JJ frontal/JJ medial/JJ gyrus/NN ./.
@@75391196754 When/WRB combined/JJ with/IN independent/NN activating/NN mutations/NN in/IN the/DT c-abl/NEWGENE kinase/NEWGENE domain/NEWGENE or/CC NH2-terminus/NNS ,/, the/DT G128R/NEWGENE mutation/NN blocked/VBD transformation/NN by/IN the/DT double/JJ mutant/NN ,/, suggesting/VBG that/IN the/DT G128R/NEWGENE mutant/NEWGENE was/VBD unable/JJ to/IN transform/VB cells/NNS for/IN trivial/JJ reasons/NNS ./.
@@17440421110 The/DT csbA/NEWGENE fusion/NEWGENE was/VBD maximally/RB expressed/VBN during/IN early/JJ stationary/JJ phase/NN in/IN cells/NNS grown/VBP in/IN Luria/NN broth/NN containing/JJ 5%/JJ glucose/NN and/CC 0/CD ./CD 2%/CD glutamine/NN ./.
@@112853291120 9/CD ./CD 7/CD (/( 95%/CD CI/NN :/: 9/CD ./CD 6-9/CD ./CD 7/CD )/SYM micromol/NN //NN L/NN among/IN women/NNS (/( P/NN =/SYM 0/CD ./CD 003/CD )/SYM ./.
@@89223914898 A/DT single/JJ protease-resistant/JJ structure/NN formed/VBN by/IN the/DT entirety/NN of/IN both/DT PDZ/NEWGENE repeats/NEWGENE 1/NEWGENE and/NEWGENE 2/NEWGENE (/( PDZ1-2/NEWGENE )/SYM contains/VBZ the/DT protein/NEWGENE 4/NEWGENE ./NEWGENE 1-binding/NEWGENE site/NEWGENE ./.
@@66060435265 All/PDT other/DT changes/NNS at/IN the/PDT 3-/DT ,/, 5-/CD ,/, and/CC 6-positions/NN ,/, as/RB well/VB as/IN the/DT replacement/NN of/IN the/DT phenyl/NN group/NN at/IN position/NN 2/CD ,/, caused/VBD a/DT marked/JJ decrease/NN of/IN activity/NN ./.
@@82827498642 Thomas'/NNP Hospital/NNP solution/NN (/( with/IN 95%/CD O2/NN :/: 5%/JJ CO2/NN )/SYM can/MD meet/VB the/DT metabolic/JJ demand/NN of/IN the/DT ischaemic/JJ myocardium/NN and/CC thus/RB increase/VB the/DT safe/JJ duration/NN of/IN cardiac/JJ arrest/NN ./.
@@93115689248 The/DT cleavage/NN dipeptides/NNS of/IN C1YVV/NEWGENE NIa/NEWGENE protease/NEWGENE are/VBP Q/NEWGENE (/NEWGENE E/NEWGENE )/NEWGENE //NEWGENE S/NEWGENE (/NEWGENE A/NEWGENE ,/NEWGENE G/NEWGENE )/NEWGENE ./.
@@91928425830 Using/VBG mouse-human/JJ somatic/JJ hybrids/NNS and/CC FISH/ORG analysis/NN ,/, the/DT PE-2/NEWGENE gene/NEWGENE is/VBZ localized/VBN to/IN human/JJ chromosome/NN 19q13/CD ./CD 2/CD ,/, a/DT region/NN involved/VBN in/IN translocations/NNS and/CC deletions/NNS in/IN leukemias/NNS and/CC several/DT solid/JJ tumors/NNS ,/, suggesting/VBG that/IN this/DT novel/JJ ETS/NEWGENE factor/NEWGENE may/MD play/VB a/DT role/NN in/IN carcinogenesis/NN ./.
@@85050758466 Maximum/NNP number/NN of/IN strains/NNS (/( 39/CD ./CD 1%/CD )/SYM were/VBD resistant/JJ in/IN S/NNP ./NNP bareilly/JJ serotype/NN ,/, followed/VBN by/IN S/NNP ./NNP typhimurium/NN (/( 21/CD ./CD 7%/CD )/SYM and/CC least/RB in/IN S/NNP ./NNP typhi/NN (/( 17/CD ./CD 4%/CD )/SYM ./.
@@69466936716 Use/VB of/IN prostaglandin/NN F2/NN alpha/NN (/( PGF2/NN alpha/NN )/SYM in/IN cattle/NNS breeding/JJ ./.
@@79354912625 Interestingly/RB ,/, these/DT response/NN elements/NN display/NN dramatically/RB reduced/VBD affinity/NN for/IN retinoic/NEWGENE acid/NEWGENE receptor-retinoid-X/NEWGENE receptor/NEWGENE heterodimers/NEWGENE ./.
@@97105914941 Mutations/NNS within/IN the/DT C/NN terminus/NN of/IN c-fos/NEWGENE at/IN serine/NN residues/NNS that/WDT are/VBP phosphorylation/NN targets/NNS for/IN growth/NEWGENE factors/NEWGENE and/CC MAP/NEWGENE kinase/NEWGENE completely/RB abrogate/VB transactivation/NN and/CC block/NN potentiation/NN by/IN MAP/NEWGENE kinase/NEWGENE ./.
@@29066733048 Efficacy/NNS and/CC field/NN evaluation/NN of/IN Bacillus/NN thuringiensis/FW (/( H-14/NN )/SYM and/CC B/NNP ./NNP sphaericus/NN against/IN floodwater/NN mosquitoes/NNS in/IN California/NN ./.
@@118857373483 The/DT range/NN of/IN 200/NN 000-300/NN 000/NN spermatozoa/NN //NN microl/NN appeared/VBN to/IN be/VB a/DT reasonable/JJ compromise/NN for/IN both/DT criteria/NNS ./.
@@77484936754 The/DT characterized/VBN Aplysia/NEWGENE Afurin2/NEWGENE is/VBZ a/DT candidate/NN PC/NEWGENE that/WDT may/MD play/VB an/DT important/JJ role/NN in/IN the/DT processing/NN of/IN egg-laying/NEWGENE hormone/NEWGENE (/( ELH/NEWGENE )/NN -related/NN precursors/NNS in/IN the/DT secretory/JJ cells/NNS of/IN the/DT atrial/JJ gland/NN ./.
@@96513671265 A/DT role/NN for/IN RalGDS/NEWGENE and/CC a/DT novel/JJ Ras/NEWGENE effector/NN in/IN the/DT Ras-mediated/JJ inhibition/NN of/IN skeletal/JJ myogenesis/NN ./.
@@75796833079 Analyses/NNS of/IN hGMR/NEWGENE beta/NEWGENE subunit/NEWGENE mutants/NEWGENE revealed/VBD two/JJ cytoplasmic/JJ regions/NNS involved/VBN in/IN activation/NN of/IN the/DT c-myc/NEWGENE promoter/NEWGENE ,/, one/PRP is/VBZ essential/JJ and/CC the/PDT other/DT is/VBZ dispensable/JJ but/CC enhances/VBZ the/DT activity/NN ./.
@@93145544455 Previously/RB ,/, we/PRP reported/VBD that/DT scanthrough/NN translation/NN ,/, where/CC the/DT initiating/JJ AUG/NNS of/IN a/DT primary/JJ open/JJ reading/JJ frame/NN is/VBZ bypassed/VBN ,/, is/VBZ most/RB likely/RB to/IN account/NN for/IN the/DT presentation/NN of/IN cryptic/JJ epitopes/NNS from/IN alternative/JJ reading/JJ frames/NNS within/IN the/DT influenza/NEWGENE A/NEWGENE PR/NEWGENE //NEWGENE 8/NEWGENE //NEWGENE 34/NEWGENE nucleoprotein/NEWGENE gene/NEWGENE ./.
@@25020963151 Lowering/NN of/IN the/DT renal/JJ blood/NN flow/NN alters/VBZ the/DT glomerular/JJ and/CC tubular/JJ excretion/NN processes/NNS ./.
@@98241587409 We/PRP find/VBP that/IN BCL-6/NEWGENE POZ/NEWGENE1 domain/NEWGENE1 mutations/NNS that/WDT disrupt/VBP the/DT interaction/NN with/IN N-CoR/NEWGENE and/CC SMRT/NEWGENE no/RB longer/JJR repress/VB transcription/NN ./.
@@113728829228 Maternal/JJ p/NN ,/NN p'DDE/NN and/CC beta-HCH/NN levels/NNS were/VBD also/RB associated/VBN with/IN newborn/JJ levels/NNS ,/, but/CC levels/NNS of/IN PCBs/NNS were/VBD not/RB ./.
@@112882088817 Children/NNS who/WP developed/VBD lower/JJR respiratory/JJ tract/NN infections/NNS or/CC PCP/NN had/VBP increased/VBN rates/NNS of/IN decline/NN of/IN CD4/NEWGENE cell/NN counts/NNS during/IN the/DT first/JJ 6/CD months/NNS of/IN life/NN ./.
@@384088776 Selective/JJ stimulation/NN of/IN central/NN alpha-autoreceptors/NEWGENE following/IN treatment/NN with/IN alpha-methyldopa/NN and/CC FLA/NN 136/NN ./.
@@90240978989 OBJECTIVE/IN :/: Our/PRP goal/NN was/VBD to/IN determine/VB whether/IN chlamydia-infected/JJ women/NNS have/VBP a/DT higher/JJ rate/NN of/IN febrile/JJ complications/NNS after/IN postpartum/JJ tubal/JJ ligation/NN ./.
@@96327859845 The/DT pre-mRNA/JJ splicing/JJ factor/NN U2AF/NEWGENE (/( U2/NEWGENE small/NEWGENE nuclear/NEWGENE ribonucleoprotein/NEWGENE particle/NEWGENE [/NEWGENE snRNP/NEWGENE ]/NEWGENE auxiliary/NEWGENE factor/NEWGENE )/SYM plays/VBP a/DT critical/JJ role/NN in/IN 3'/CD splice/NN site/NN selection/NN ./.
@@31434859815 The/DT Euglena/NEWGENE ribosomal/NEWGENE protein/NEWGENE gene/NEWGENE cluster/NEWGENE resembles/VBZ the/DT S-10/NEWGENE ribosomal/NEWGENE protein/NEWGENE operon/NEWGENE of/NEWGENE Escherichia/NEWGENE coli/NEWGENE in/IN gene/NN organization/NN and/CC follows/VBZ the/DT exact/JJ linear/JJ order/NN of/IN the/DT analogous/JJ genes/NNS in/IN the/DT tobacco/NN and/CC liverwort/NN chloroplast/NN genomes/NNS ./.
@@109053523303 The/DT linear/JJ plasmid/NN pCLU1/NN from/IN the/DT yeast/NN Kluyveromyces/NN lactis/NN normally/RB replicates/VBZ in/IN the/DT cytoplasm/NN ,/, with/IN the/DT aid/NN of/IN the/DT helper/NN linear/JJ plasmid/NN pGKL2/NN ,/, using/VBG terminal/NEWGENE protein/NEWGENE (/( TP/NEWGENE )/SYM as/IN a/DT primer/NN ./.
@@117915711654 A/DT high-efficiency/JJ cross-flow/JJ micronebulizer/NN interface/NN for/IN capillary/JJ electrophoresis/NN and/CC inductively/RB coupled/VBN plasma/NN mass/JJ spectrometry/NN ./.
@@94679558699 This/DT hypothesis/NN is/VBZ consistent/JJ with/IN the/DT occurrence/NN of/IN PEA3/NEWGENE binding/NEWGENE sites/NEWGENE in/IN the/DT PEA3/NEWGENE promoter/NEWGENE and/CC with/IN the/DT ability/NN of/IN PEA3/NEWGENE to/IN transactivate/VB this/DT promoter/NN ./.
@@63406436131 DMCM/NNP also/RB permits/VBP extension/NN of/IN the/DT possibilities/NNS of/IN obtaining/JJ and/CC transplanting/JJ donor/NN organs/NNS ./.
@@106494494262 The/DT sequences/NNS showed/VBD extensive/JJ homologies/NNS with/IN squalene/NEWGENE synthase/NEWGENE genes/NEWGENE and/CC enzymes/NNS from/IN a/DT number/NN of/IN other/DT organisms/NNS and/CC extreme/JJ amino/JJ acid/NN conservation/NN within/IN the/DT binding/JJ and/CC catalytic/JJ domains/NNS ./.
@@110945909909 When/WRB 10/CD fields/NNS were/VBD analysed/VBN ,/, a/DT strong/JJ relationship/NN was/VBD found/VBN between/IN the/DT presence/NN of/IN bacteria/NNS on/IN Gram/JJ staining/NN and/CC the/DT final/JJ diagnosis/NN of/IN VAP/NN (/( for/IN PSB/NN and/CC PTC/NN respectively/RB :/: sensitivity/NN 74/CD and/CC 81%/CD ,/, specificity/NN 94/NN and/CC 100%/CD ,/, positive/JJ predictive/JJ value/NN 91/CD and/CC 100%/NN ,/, negative/JJ predictive/JJ value/NN 82/CD and/CC 88%/JJ )/SYM ./.
@@113711606884 They/PRP correspond/VBP to/IN nucleotides/NNS equivalent/JJ to/IN base-pair/NN C1-G72/NN and/CC discriminator/NN base/NN A73/NN in/IN the/DT amino/JJ acid-acceptor/NN branch/NN of/IN the/DT molecule/NN ./.
@@114006441804 As/IN a/DT reflection/NN of/IN uncertainties/NNS in/IN the/DT estimates/NNS for/IN individual/JJ sources/NNS ,/, the/DT 90th/CD percentiles/NNS of/IN PCDD/NN //NN F/NN releases/NNS for/IN 1999/CD ranged/VBN up/JJ to/IN 4/CD ./CD 1/CD g/NN I-TEQ/NNP //NNP y/NNP ./.
@@84395978404 The/DT evaluation/NN was/VBD performed/VBN using/VBG a/DT retrospective/JJ study/NN design/NN with/IN newborn/JJ blood/NN samples/NNS from/IN three/CD screening/JJ centres/NNS ./.
@@106695947649 Two/CD distinct/JJ Salmonella/NEWGENE fimbrins/NEWGENE ,/, AgfA/NEWGENE and/CC SefA/NEWGENE ,/, comprising/VBG thin/JJ aggregative/JJ fimbriae/NNS SEF17/NEWGENE and/CC SEF14/NEWGENE ,/, respectively/RB ,/, were/VBD each/DT genetically/RB engineered/VBN to/IN carry/NN PT3/NEWGENE ,/, an/DT alpha-helical/JJ 16-amino/JJ acid/NN Leishmania/NN T-cell/NN epitope/NN derived/VBN from/IN the/DT metalloprotease/NEWGENE gp63/NEWGENE1 ./.
@@10857215890 The/DT MRS/NN II/NN meets/VBP a/DT high/JJ methodological/JJ standard/NN as/IN an/DT instrument/NN standardized/JJ in/IN the/DT population/NN ./.
@@40515214729 Duration/NN of/IN remission/NN in/IN advanced/JJ gastric/JJ cancer/NN patients/NNS responding/VBG to/IN sequential/JJ dose/NN of/IN MTX/NN and/CC 5-FU/JJ ./.
@@94685149346 Northern/NNP analysis/NN indicated/VBD differential/JJ expression/NN by/IN tissue/NN with/IN highest/JJS expression/NN in/IN the/DT heart/NN ./.
@@105402929275 These/DT data/NN show/NN that/IN the/DT spv/NEWGENE virulence/NEWGENE genes/NEWGENE belong/VBP simultaneously/RB to/IN several/DT regulons/NNS in/IN the/DT cell/NN ,/, raising/VBG the/DT possibility/NN that/DT spv/NEWGENE expression/NN can/MD be/VB fine-tuned/JJ in/IN response/NN to/IN multiple/JJ environmental/JJ inputs/NNS ./.
@@86493725423 Clb2/NEWGENE //NEWGENE Cdc28/NEWGENE kinase/NEWGENE is/VBZ not/RB required/VBN for/IN the/DT repression/NN of/IN MCB-binding/NEWGENE factor/NEWGENE transcriptional/JJ activity/NN in/IN G2/NNP and/CC M/NN phase/NN ./.
@@79570855319 Cbf3/NEWGENE contains/VBZ three/CD proteins/NNS ,/, Cbf3a/NEWGENE ,/, Cbf3b/NEWGENE and/CC Cbf3c/NEWGENE ./.
@@16583569067 The/DT results/NNS of/IN induced/VBN coexpression/NN were/VBD also/RB supported/VBN by/IN rapid/JJ generation/NN of/IN FeLV/NN recombinants/NNS when/CC FeLV-C/NN was/VBD used/VBN to/IN infect/VB the/DT feline/JJ 3201B/CELL cell/NN line/NN that/IN constitutively/RB expresses/VBP high/JJ levels/NNS of/IN endogenous/JJ FeLV-specific/NN mRNAs/NN ./.
@@25929613245 COGLAB/NN includes/VBZ measures/NNS of/IN preattentional/JJ ,/, attentional/JJ ,/, conceptual/JJ ,/, and/CC psychomotor/JJ performance/NN ./.
@@10479382317 We/PRP discuss/VBP these/DT results/NNS in/IN terms/NNS of/IN the/DT influence/NN that/DT time/NN and/CC nutritional/JJ constraints/NNS have/VBP on/IN odonate/NN development/NN patterns/NNS and/CC fitness/NN ./.
@@27937536269 Within/IN each/DT lobe/NN ,/, the/DT PA/JJ dispersion/NN was/VBD up/JJ to/IN 10/CD cmH2O/NN at/IN CFV/DT of/IN 90/CD l/NN //NN min/NN ;/: when/CC flow/NN decreased/VBN ,/, PA/JJ at/IN all/DT sites/NNS decreased/VBN ,/, as/IN did/VBD the/DT intralobar/JJ dispersion/NN ./.
@@105642317786 N/NNP ./NNP van/NNP Hoek/NNP ,/, and/CC M/NNP ./NNP
@@2856622193 Use/VB of/IN serum/JJ thyroglobulin/NEWGENE determination/NN in/IN the/DT follow-up/NN of/IN differentiated/VBN carcinomas/NNS of/IN the/DT thyroid/NN ./.
@@70646626827 Large/JJ and/CC small/JJ medullary/JJ lesions/NNS inhibited/VBD the/DT occurrence/NN of/IN target/NN fibres/NNS in/IN the/DT tenotomized/JJ muscles/NNS ,/, the/DT smallest/JJS one/PRP being/VBP neurolysis/NN of/IN the/DT dorsal/JJ roots/NNS ./.
@@16757632275 No/DT such/JJ benefits/NNS were/VBD seen/VBP for/IN children/NNS with/IN CD4+/NEWGENE counts/NNS below/RB 0/CD ./CD 2/CD x/NN 10/NN (/NN 9/NN )/NN per/IN liter/NN at/IN entry/NN ./.
@@98441062645 Pyk2/NEWGENE phosphorylation/NN increased/VBN upon/IN adherence/NN of/IN FLG/NN 29/CD ./CD 1/CD cells/NNS to/IN fibronectin/NEWGENE and/CC to/IN ST2/NNP stromal/JJ cells/NNS ./.
@@63143126104 Supplementing/VBG a/DT soybean/NN protein/NN and/CC sucrose-based/JJ diet/NN with/IN levels/NNS of/IN 2/CD ./CD 2/CD ,/, 11/CD ,/, and/CC 55/CD ppm/NN of/IN the/DT antibiotic/NN ,/, from/IN the/DT two/JJ sources/NNS each/DT with/IN two/JJ different/JJ purities/NNS ,/, improved/VBN weight/NN gain/NN of/IN chicks/NNS an/DT average/NN of/IN 23%/JJ and/CC improved/VBN feed/JJ efficiency/NN an/DT average/NN of/IN 13%/JJ at/IN the/DT higher/JJ levels/NNS (/( all/DT P/NN less/PRP than/IN ./CD 01/CD )/SYM ./.
@@7828584357 Mutagenesis/NNS of/IN IM1/NEWGENE enhances/VBZ the/DT ability/NN of/IN c-Fos/NEWGENE to/IN activate/VB an/DT AP1/NEWGENE bearing/NEWGENE promoter/NEWGENE ./.
@@10625721448 Hypothermia/NNS After/IN Cardiac/NNP Arrest/NN (/( HACA/NNP )/SYM Study/NNP Group/NNP ./.
@@76538122570 Intrathecal/JJ acetyl/NEWGENE cholinesterase/NEWGENE inhibitors/NN produce/VBP analgesia/NN that/WDT is/VBZ synergistic/JJ with/IN morphine/NN and/CC clonidine/NN in/IN rats/NNS ./.
@@95905405361 The/DT bZP2/NEWGENE cDNA/NEWGENE (/NEWGENE 115-1914/NEWGENE nt/NEWGENE ,/NEWGENE 1/NEWGENE ./NEWGENE 8/NEWGENE kb/NEWGENE )/NEWGENE ,/, excluding/JJ sequences/NNS coding/JJ for/IN N-terminal/NN signal/NN sequence/NN and/CC C-terminal/NN transmembranelike/NN domain/NN ,/, was/VBD PCR/NN amplified/VBN and/CC Sac1-Sal1/NEWGENE restricted/NEWGENE fragment/NEWGENE cloned/VBN in/IN frame/NN downstream/RB of/IN the/DT T5/NN promoter/NN under/IN the/DT lac/NEWGENE operator/NEWGENE control/NN in/IN a/DT pQE-30/JJ vector/NN ./.
@@23301102981 Combining/VBG multiple/JJ laboratory/NN studies/NNS may/MD be/VB of/IN value/NN in/IN predetermining/VBG the/DT eventual/JJ outcome/NN in/IN near-drowning/NN ./.
@@87271928710 STUDY/NN DESIGN/DT ./.
@@75009505429 A/DT tobacco/NN homologue/NN (/( trolC/NEWGENE )/SYM of/IN the/DT rolC/NEWGENE gene/NEWGENE of/NEWGENE the/NEWGENE Agrobacterium/NEWGENE rhizogenes/NEWGENE Ri-plasmid/NEWGENE was/VBD cloned/VBN and/CC sequenced/VBN from/IN Nicotiana/NNP tabacum/NN L/NNP ./NNP cv/CD ./CD
@@92082149161 Sternocleidomastoid/JJ ,/, neck/NN or/CC facial/JJ muscles/NNS wasting/NN were/VBD also/RB found/VB in/IN three/CD cases/NNS ./.
@@113694101211 The/DT first/JJ hypothesis/NN was/VBD supported/VBN in/IN the/DT sense/NN that/IN stimulus/NN differences/NNS might/MD affect/VB behaviour/NN even/VB without/IN their/PRP successful/JJ attentive/JJ processing/NN in/IN normal/JJ participants/NNS ./.
@@93891379340 The/DT prescription/NN for/IN apoplexy/NN includes/VBZ C1-7/NN ,/, T1-9/NN and/CC L2-4/NN ./.
@@75593475936 The/DT expression/NN of/IN the/DT putative/JJ operon/NN bglPH/NEWGENE of/IN Bacillus/NN subtilis/JJ was/VBD studied/VBN by/IN using/VBG bglP'-lacZ/NEWGENE transcriptional/NEWGENE fusions/NEWGENE ./.
@@3345706585 The/DT correlation/NN between/IN PaCO2/NN and/CC PtcO2/NN in/IN RDS/NNS was/VBD insufficient/JJ to/IN make/NN clinical/JJ judgement/NN ./.
@@76530944507 A/DT series/NN of/IN amino/JJ terminal/JJ deletion/NN mutants/NNS (/( d10/NN ,/, d20/NN ,/, d27/NN ,/, d31/NN ,/, d40/NN ,/, d44/NN ,/, and/CC d73/NN )/SYM were/VBD compared/VBN for/IN processing/VBG ,/, cell/NN surface/NN expression/NN ,/, and/CC maintenance/NN of/IN their/PRP biological/JJ attributes/NNS by/IN recombinant/JJ expression/NN of/IN mutant/JJ genes/NNS using/VBG a/DT plasmid/NN vector/NN (/( pcDL-SR/NN alpha-296/NN )/SYM in/IN CV-1/NNP and/CC HeLa/DT cells/NNS ./.
@@107998797042 Cloning/VBG and/CC characterization/NN of/IN human/NEWGENE Lnk/NEWGENE ,/, an/DT adaptor/NN protein/NN with/IN pleckstrin/NEWGENE homology/NN and/CC Src/NEWGENE homology/NEWGENE 2/NEWGENE domains/NEWGENE that/WDT can/MD inhibit/VB T/NN cell/NN activation/NN ./.
@@73938567238 As/IN a/DT result/NN ,/, beta-apo-8'-carotenoic/JJ acid/NN ethyl/NN ester/NN (/( apo-EE/JJ )/SYM was/VBD used/VBN as/IN a/DT reference/NN standard/JJ in/IN Experiments/NNS 4/CD to/IN 6/CD ./CD
@@105567511538 Nevertheless/RB ,/, in/IN view/NN of/IN the/DT potential/JJ transmission/NN rates/NNS of/IN HGV/NN and/CC the/DT lack/NN of/IN effective/JJ immunization/NN ,/, HGV/NN should/MD be/VB regarded/VBN as/IN a/DT potential/JJ occupational/JJ hazard/NN for/IN medical/JJ and/CC dental/JJ staff/NN ./.
@@79252827946 Disruption/NNS of/IN any/DT one/PRP of/IN the/DT four/CD genes/NNS encoding/VBG the/DT newly/RB identified/VBN SRP/NEWGENE proteins/NEWGENE results/NNS in/IN slow/JJ cell/NN growth/NN and/CC inefficient/JJ protein/NN translocation/NN across/IN the/DT ER/NN membrane/NN ./.
@@117780441623 We/PRP derive/VBP joint/JJ probability/NN density/NN distributions/NNS for/IN three/CD key/NN uncertain/JJ properties/NNS of/IN the/DT climate/NN system/NN ,/, using/VBG an/DT optimal/JJ fingerprinting/NN approach/NN to/IN compare/NN simulations/NNS of/IN an/DT intermediate/JJ complexity/NN climate/NN model/NN with/IN three/CD distinct/JJ diagnostics/NNS of/IN recent/JJ climate/NN observations/NNS ./.
@@106657981024 An/DT increase/NN in/IN the/DT level/NN of/IN serum/JJ enzymes/NNS ,/, such/JJ as/IN aspartate/NEWGENE transaminase/NEWGENE ,/, alkaline/NEWGENE phosphatase/NEWGENE ,/, creatine/NEWGENE phosphokinase/NEWGENE ,/, lactate/NEWGENE dehydrogenase/NEWGENE after/IN D/NN ./NN russelli/NN venom/NN injection/NN in/IN albino/NN rats/NNS is/VBZ indicative/NN of/IN cell/NN or/CC tissue/NN damage/NN ./.
@@32648868839 Among/IN a/DT population/NN of/IN 18/CD ,/CD 175/CD children/NNS below/RB 7/CD years/NNS of/IN age/NN in/IN medium/NN sized/JJ towns/NNS and/CC rural/JJ areas/NNS in/IN south-western/JJ Germany/NN 552/NN (/( 3/CD ./CD 03%/CD )/SYM cases/NNS of/IN croup/NN were/VBD registered/VBN during/IN a/DT 12/CD months/NNS period/NN in/IN 1984-85/CD by/IN their/PRP physicians/NNS ./.
@@81924517001 The/DT 7-day/CD treatment/NN resulted/VBN in/IN a/DT decrease/NN in/IN mitochondrial/JJ uptake/NN of/IN Rh123/NN and/CC an/DT increase/NN in/IN NAO/NN uptake/NN ./.
@@15777407588 Primer/NNS extension/NN and/CC mung/NEWGENE bean/NEWGENE and/NEWGENE S1/NEWGENE nuclease/NEWGENE mapping/NN indicated/VBD multiple/JJ transcription/NN initiation/NN sites/NNS and/CC were/VBD consistent/JJ with/IN Northern/NNP analyses/NNS ./.
@@30623709130 GCN4/NEWGENE encodes/VBZ a/DT transcriptional/JJ activator/NN of/IN amino/JJ acid/NN biosynthetic/JJ genes/NNS in/IN Saccharomyces/NN cerevisiae/NN ./.
@@93873339336 The/DT progress/NN of/IN morphological/JJ research/NN on/IN the/DT parabrachial/JJ nucleus/NN ./.
@@81444976726 The/DT cysteine-rich/JJ region/NN of/IN raf-1/NEWGENE kinase/NEWGENE contains/VBZ zinc/NN ,/, translocates/VBZ to/IN liposomes/NNS ,/, and/CC is/VBZ adjacent/JJ to/IN a/DT segment/NN that/WDT binds/VBZ GTP-ras/NEWGENE ./.
@@97270463694 The/DT CBF1/NEWGENE site/NEWGENE within/IN HS2/NEWGENE resides/VBZ near/IN sites/NNS for/IN hematopoietic/NN regulators/NN such/JJ as/IN GATA-1/NEWGENE ,/, NF-E2/NEWGENE ,/, and/CC TAL1/NEWGENE ./.
@@113509826703 Here/RB we/PRP provide/VBP the/DT first/JJ evidence/NN for/IN the/DT involvement/NN of/IN GCN1-GCN2/NEWGENE interaction/NN in/IN activation/NN of/IN GCN2/NEWGENE per/IN se/CD ./CD
@@31254222150 The/DT results/NNS of/IN these/DT experiments/NNS indicate/VBP that/IN at/IN least/RB two/JJ upstream/JJ activator/NN sequences/NNS (/( UAS/NN )/SYM mediate/VB maximum/JJ induction/NN by/IN galactose/NN ./.
@@85765469466 In/NN a/DT second/JJ series/NN of/IN experiments/NNS ,/, the/DT efficacy/NN of/IN PDC/NN //NN HDC/NN Ac/NN was/VBD evaluated/VBN in/IN both/DT single/JJ and/CC multiple/JJ dose/NN regiments/NNS ./.
@@85845305551 Significant/JJ correlations/NNS existed/VBN between/IN FEV1/NN and/CC the/DT corresponding/JJ values/NNS of/IN Raw/JJ ,/, MEF50/NNS and/CC MEF25/NN ,/, although/IN there/RB were/VBD considerable/JJ individual/JJ differences/NNS between/IN test/NN results/NNS ./.
@@66698646420 The/DT liver/NN in/IN the/DT severely/RB ill/JJ ./.
@@93598446592 20%/CD of/IN total/JJ HSL/NEWGENE transcripts/NEWGENE in/IN human/JJ subcutaneous/JJ adipocytes/NNS ./.
@@98226853289 Western/JJ analyses/NNS with/IN antisera/NNS raised/VBN against/IN Lu-ECAM-1/NEWGENE peptides/NEWGENE show/VBP that/IN the/DT N-terminal/NN region/NN of/IN the/DT predicted/VBN open/JJ reading/JJ frame/NN is/VBZ present/VB only/RB in/IN the/DT larger/JJR size/NN proteins/NNS (/( i/CD ./CD e/CD ./.
@@77558847726 Intrastriatal/JJ grafts/NNS of/IN nigral/JJ and/CC adrenal/JJ tissues/NNS have/VBP been/VBN found/VB to/IN be/VB effective/JJ in/IN alleviating/JJ many/NN of/IN the/DT simple/JJ motor/JJ and/CC sensorimotor/JJ deficits/NNS associated/VBN with/IN lesions/NNS of/IN the/DT nigrostriatal/JJ dopamine/NN system/NN ./.
@@109099735449 In/NN contrast/NN ,/, the/DT action/NN of/IN GLP-1/NEWGENE at/IN the/DT CRE/NEWGENE was/VBD not/RB blocked/VBN by/IN cotransfection/NN with/IN M1-CREB/NEWGENE ,/, an/DT isoform/NN that/WDT lacks/VBZ a/DT consensus/NN serine/NN residue/NN serving/VBG as/IN substrate/NN for/IN PKA-mediated/JJ phosphorylation/NN ./.
@@11016737852 Post-operative/JJ functional/JJ outcome/NN is/VBZ related/VBN to/IN pre-operative/NN functional/JJ status/NN ./.
@@9642276296 The/DT cleavage/NN of/IN Fak/NEWGENE by/IN caspases/NEWGENE may/MD thus/RB play/VB an/DT important/JJ role/NN in/IN the/DT execution/NN of/IN the/DT suicide/NN program/NN by/IN disabling/JJ the/DT anti-apoptotic/JJ function/NN of/IN Fak/NEWGENE ./.
@@4299494045 As/IN authorized/VBN by/IN the/DT World/NNP Health/NNP Organization/NNP 29th/CD Expert/NNP Committee/NNP on/IN Biological/JJ Standardization/NN ,/, the/DT preparation/NN of/IN human/NEWGENE prolactin/NEWGENE in/IN ampoules/NNS coded/VBN 75/CD //CD 504/CD has/VBZ been/VBN established/VBN as/IN the/DT International/NNP Reference/NNP Preparation/NN (/( IRP/NN )/SYM of/IN human/NEWGENE prolactin/NEWGENE for/IN immunoassay/NN ./.
@@6825641955 Many/JJ of/IN these/DT landfill/NN operations/NNS were/VBD undertaken/VBP in/IN the/DT early/NN 1950s/NN and/CC 1960s/CD ,/, when/CC knowledge/NN regarding/IN the/DT safe/JJ and/CC prolonged/JJ containment/NN of/IN the/DT waste/RB buried/VBN was/VBD nonexistent/JJ or/CC minimal/JJ at/IN best/JJS ./.
@@17109791802 The/DT SH2/NEWGENE and/CC SH3/NEWGENE domains/NEWGENE of/IN pp60src/NEWGENE direct/JJ stable/JJ association/NN with/IN tyrosine/NN phosphorylated/VBN proteins/NN p130/NEWGENE and/CC p110/NEWGENE ./.
@@118746371768 The/DT use/NN of/IN highly/RB active/JJ antiretroviral/JJ therapy/NN (/( HAART/IN )/SYM has/VBZ resulted/VBN in/IN significant/JJ improvements/NNS in/IN the/DT treatment/NN of/IN HIV/NN infection/NN ,/, including/JJ a/DT decrease/NN in/IN the/DT incidence/NN and/CC severity/NN of/IN several/DT acquired/VBN immune/JJ deficiency/NN syndrome/NN (/( AIDS/NN )/NN -related/NN malignancies/NNS ./.
@@75233637693 A/DT particularly/RB striking/JJ HpaII/NEWGENE tiny/JJ fragment/NN island/NN ,/, extending/VBG over/RB nearly/RB 2/CD ,/CD 000/CD base/JJ pairs/NNS ,/, surrounds/VBZ the/DT USF2/NEWGENE translation/NEWGENE initiation/NEWGENE site/NEWGENE ./.
@@105085225553 Our/PRP results/NNS implicate/VBP TGF-beta/NEWGENE RII/NEWGENE as/IN a/DT direct/JJ target/NN of/IN EWS-FLI1/NEWGENE ./.
@@27764713475 It/PRP was/VBD possible/JJ to/IN classify/VB the/DT animals/NNS into/IN high/JJ and/CC low/JJ responders/NNS according/VBG to/IN the/DT pattern/NN of/IN humoral/JJ immune/JJ response/NN ./.
@@112643721072 Requirements/NNS for/IN the/DT nuclear-cytoplasmic/JJ translocation/NN of/IN infected-cell/NEWGENE protein/NEWGENE 0/NEWGENE of/IN herpes/NN simplex/JJ virus/NN 1/CD ./CD
@@95709449612 Localization/NNS of/IN 67/CD exons/NNS on/IN a/DT YAC/NN contig/NN spanning/VBG 1/CD ./CD 5/CD Mb/NN around/IN the/DT multidrug/NEWGENE resistance/NEWGENE gene/NEWGENE region/NEWGENE of/IN human/JJ chromosome/NN 7q21/CD ./CD 1/CD ./.
@@10448440297 The/DT role/NN of/IN 'scientific/JJ psychiatry'/NN in/IN understanding/NN patients/NNS with/IN chronic/JJ schizophrenia/NN or/CC severe/JJ personality/NN disorder/NN ./.
@@96435484945 The/DT genes/NNS encoding/VBG (/NEWGENE 2Fe-2S/NEWGENE )/NEWGENE plant-like/NEWGENE ferredoxins/NEWGENE were/VBD studied/VBN in/IN the/DT widely/RB used/VBN cyanobacterium/NN Synechocystis/NN PCC6803/NN ./.
@@7899634303 PURPOSE/NNS :/: The/DT aim/NN of/IN this/DT study/NN was/VBD to/IN evaluate/VB the/DT bony/JJ anchorage/NN of/IN a/DT new/JJ implant/NN (/( orderly/RB wired/VBN surface/NN effect/NN with/IN alloy/NN Ti/NN Al/NN Va/NN and/CC ordered/JJ pores/NNS of/IN 488/CD mu/NN )/SYM ./.
@@16609257395 Transfer/NEWGENE RNA/NEWGENE genes/NEWGENE from/NEWGENE Dictyostelium/NEWGENE discoideum/NEWGENE are/VBP frequently/RB associated/VBN with/IN repetitive/JJ elements/NNS and/CC contain/VB consensus/NN boxes/NNS in/IN their/PRP 5'/CD and/CC 3'-flanking/CD regions/NNS ./.
@@66895136447 Ultrastructural/JJ studies/NNS of/IN retinopathy/NN of/IN premature/JJ infants/NNS ./.
@@25925433243 The/DT present/NN studies/NNS compare/VBP the/DT biochemical/JJ characteristics/NNS ,/, Kanagawa/NNP hemolysin/NN reactions/NNS ,/, and/CC plasmid/NN profiles/NNS of/IN 13/CD patient/NN and/CC 221/CD environmental/JJ isolates/NNS of/IN the/DT organism/NN ./.
@@71843751510 A/DT preliminary/JJ study/NN of/IN vincristine/NN ,/, methotrexate/NN ,/, and/CC prednisolone/NN (/( VM*P/NN )/SYM combination/NN chemotherapy/NN for/IN advanced/JJ adult/JJ non-Hodgkin's/JJ lymphoma/NN ./.
@@4016764683 Accurate/JJ pathologic/JJ staging/NN identifies/VBZ patients/NNS who/WP are/VBP potentially/RB curable/JJ with/IN radiotherapy/NN ./.
@@13778182576 In/NN addition/NN ,/, C/NEWGENE //NEWGENE EBP/NEWGENE beta/NEWGENE and/CC C/NEWGENE //NEWGENE EBP/NEWGENE gamma/NEWGENE readily/RB heterodimerize/VB with/IN each/DT other/DT as/JJ well/NN as/IN with/IN C/NEWGENE //NEWGENE EBP/NEWGENE alpha/NEWGENE ./.
@@80236621687 Intraoperative/JJ measurement/NN of/IN activated/VBN partial/JJ thromboplastin/NEWGENE time/NN and/CC prothrombin/NEWGENE time/NN with/IN a/DT new/JJ compact/JJ monitor/NN ./.
@@99173893334 The/DT pattern/NN of/IN RNase/NEWGENE E/NEWGENE digestion/NN of/IN finP305/NEWGENE RNA/NEWGENE differed/VBN from/IN FinP/NEWGENE ,/, and/CC GST-FinO/NEWGENE did/VBD not/RB protect/VB finP305/NEWGENE RNA/NEWGENE from/IN cleavage/NN in/IN vitro/FW ./.
@@19709262588 During/IN exercise/NN K+/NN is/VBZ released/VBN from/IN contracting/JJ muscle/NN and/CC plasma/NN K+/NN concentration/NN rises/NNS ./.
@@92359985114 Second/JJ ,/, the/DT membrane/NN expression/NN of/IN alpha/NN and/CC beta/NN subunits/NN was/VBD mimicked/VBN by/IN cholesterol/NN and/CC 17-ketocholesterol/JJ ,/, both/DT of/IN which/WDT inhibit/VBP HMG-CoA/NEWGENE reductase/NEWGENE ./.
@@95315596557 In/NN vitro/FW affinity/NN analyses/NNS demonstrated/VBN that/IN recombinant/JJ 130-kD/NN protein/NN directly/RB interacts/VBZ with/IN ZO-1/NEWGENE and/CC the/DT cytoplasmic/JJ domain/NN of/IN occludin/NEWGENE ,/, but/CC not/RB with/IN ZO-2/NEWGENE ./.
@@10488875142 Clinical/NNP differentiation/NN of/IN patients/NNS with/IN mild/JJ diplegic/JJ cerebral/JJ palsy/NN (/( CP/NN )/SYM and/CC idiopathic/JJ toe/NN walking/NN (/( ITW/NN )/SYM can/MD be/VB difficult/JJ ./.
@@87027285206 Next/JJ ,/, we/PRP stably/RB overexpressed/VBN wild-type/NEWGENE Shc/NEWGENE or/CC Y317F/NEWGENE mutant/NEWGENE Shc/NEWGENE into/IN HIRc/NNP cells/NNS ./.
@@7735833206 CONCLUSIONS/IN :/: A/DT comparison/NN of/IN the/DT LysU/NEWGENE crystal/NN structure/NN with/IN the/DT structures/NNS of/IN seryl-/NEWGENE and/NEWGENE aspartyl-tRNA/NEWGENE synthetases/NEWGENE enables/VBZ a/DT conserved/VBN core/NN to/IN be/VB identified/VBN ./.
@@29635173670 Quantitative/JJ analysis/NN of/IN the/DT coronary/JJ stenosis/NN was/VBD assessed/VBN before/IN and/CC after/IN PTCA/NN ,/, and/CC the/DT dilatation/NN resulted/VBN in/IN an/DT increase/NN in/IN minimal/JJ luminal/JJ cross-sectional/JJ area/NN from/IN 1/CD ./CD 1/CD +/NN //NN -/NN 0/CD ./CD 8/CD to/IN 2/CD ./CD 7/CD +/NN //NN -/NN 1/CD ./CD 2/CD mm2/NN ./.
@@92169019174 Thirty-two/NNS rats/NNS were/VBD divided/VBN into/IN four/CD groups/NNS ./.
@@112388845872 Mice/NNS homozygous/JJ for/IN the/DT dlg/NEWGENE mutation/NN exhibit/NN growth/NN retardation/NN in/IN utero/NN ,/, have/VB hypoplasia/NN of/IN the/DT premaxilla/NN and/CC mandible/NN ,/, have/VB a/DT cleft/JJ secondary/JJ palate/NN ,/, and/CC die/NN perinatally/RB ./.
@@75763076430 Here/RB we/PRP focused/VBD on/IN the/DT role/NN of/IN the/DT 5'/CD proximal/JJ regulatory/JJ cassette/NN (/( -190/CD ;/: +53/CD bp/NN )/SYM of/IN the/DT rat/NEWGENE enkephalin/NEWGENE (/( rENK/NEWGENE )/SYM gene/NN in/IN the/DT developmental/JJ regulation/NN of/IN the/DT enkephalin/NEWGENE phenotype/NN ./.
@@84193765774 The/DT nucleotide/NN sequence/NN of/IN the/DT gene/NN predicts/VBZ a/DT polypeptide/NN of/IN 215/CD amino/JJ acids/NNS (/( 25/CD ./CD 2/CD kDa/NN )/SYM with/IN two/JJ putative/JJ membrane-spanning/NN domains/NN ./.
@@99992569997 Quantum-statistical/JJ theory/NN of/IN high-field/JJ transport/NN phenomena/NNS ./.
@@83099758293 Depletion/NNS of/IN dopamine/NN in/IN the/DT nucleus/NN accumbens/NNS led/VBN to/IN a/DT dramatic/JJ shift/NN in/IN behavior/NN in/IN which/WDT there/RB was/VBD a/DT significant/JJ decrease/NN in/IN lever/NN pressing/JJ but/CC a/DT significant/JJ increase/NN in/IN consumption/NN of/IN lab/NN chow/NN ./.
@@16626099964 The/DT two/JJ genes/NNS code/NN for/IN polypeptides/NEWGENE of/NEWGENE 420/NEWGENE amino/NEWGENE acids/NEWGENE (/NEWGENE M/NEWGENE ./NEWGENE HgiCI/NEWGENE )/NEWGENE and/CC 345/NEWGENE amino/NEWGENE acids/NEWGENE (/NEWGENE R/NEWGENE ./NEWGENE HgiCI/NEWGENE )/NEWGENE ./.
@@11585125931 Glucose-6-phosphate/NEWGENE dehydrogenase/NEWGENE (/( G-6-PD/NEWGENE )/SYM deficiency/NN in/IN the/DT newborn/NN ./.
@@50259183004 Angiography/NNS of/IN aneurysmal/JJ bone/NN cyst/NN ./.
@@92338093788 The/DT two/JJ mouse/NN lines/NNS carrying/JJ the/DT unfragmented/JJ Hnf3g-lacZ/NEWGENE YAC/NEWGENE showed/VBD tissue-specific/JJ ,/, copy/NN number-dependent/JJ and/CC position-independent/JJ expression/NN ,/, proving/VBG that/IN 170/CD kb/NN of/IN the/DT Hnf3g/NEWGENE locus/NN contain/VB all/DT elements/NNS important/JJ in/IN the/DT regulation/NN of/IN Hnf3g/NEWGENE ./.
@@81576635128 These/DT results/NNS are/VBP the/DT first/NN to/IN demonstrate/VB the/DT structural/JJ organization/NN of/IN a/DT vertebrate/NN gene/NN encoding/VBG an/DT integral/JJ membrane/NN protein/NN of/IN the/DT nuclear/JJ envelope/NN that/WDT may/MD be/VB a/DT member/NN of/IN a/DT family/NN of/IN polypeptides/NNS conserved/VBN in/IN evolution/NN ./.
@@102339469923 Previous/JJ work/NN has/VBZ shown/VBP that/DT spleen/NN necrosis/NN virus/NN (/( SNV/NN )/SYM long/JJ terminal/JJ repeats/NNS (/( LTRs/NNS )/SYM are/VBP associated/VBN with/IN Rex/NN //NN Rex-responsive/NN element-independent/NN expression/NN of/IN bovine/JJ leukemia/NN virus/NN RNA/NN and/CC supports/VBP the/DT hypothesis/NN that/DT SNV/NN RNA/NN contains/VBZ a/DT cis-acting/JJ element/NN that/WDT interacts/VBZ with/IN cellular/NEWGENE Rex-like/NEWGENE proteins/NEWGENE ./.
@@7192722895 After/IN successful/JJ subtotal/JJ parathyroidectomy/NN ,/, evident/JJ by/IN the/DT decrease/NN of/IN serum/JJ iPTH/NEWGENE levels/NNS ,/, both/PDT the/DT CL/NN of/IN group/NN 2/CD PMNs/NNS and/CC the/DT ability/NN of/IN group/NN 2/CD sera/NNS to/IN induce/VB augmented/VBN CL/NN in/IN normal/JJ PMNs/NNS decreased/VBN (/( p/NN </SYM 0/CD ./CD 025/CD )/SYM ./.
@@72785787135 Current/JJ status/NN of/IN chemotherapy/NN for/IN Hodgkin's/NNP disease/NN ./.
@@87501738737 AIMS/NNP //NNP METHODS/NNP :/: Reticuloendothelial/JJ system/NN function/NN ,/, as/IN assessed/VBN by/IN clearance/NN of/IN radiolabelled/JJ bacteria/NNS ,/, was/VBD evaluated/VBN in/IN acute/JJ liver/NN injury/NN induced/VBN by/IN D-galactosamine/DT in/NN rats/NNS ,/, and/CC compared/VBD with/IN that/DT after/IN 70%/NN liver/NN resection/NN model/NN ./.
@@4396183539 Lethal/NN Tachmalcor/NN (/( 4-/NN (/NN 3'-diethylamino-2'-hydroxypropyl/NN )/NN -ajmaline/NN )/NN poisoning/NN in/IN childhood/NN ./.
@@1098592818 IgG/NEWGENE levels/NNS of/IN 1/CD //CD 100/CD were/VBD present/VB in/IN only/RB four/CD out/RB of/IN ten/CD samples/NNS obtained/VBN 150/CD days/NNS after/IN the/DT clinical/JJ onset/NN ./.
@@76793906226 RNase/NEWGENE protection/NN and/CC primer/NN extension/NN assays/NNS confirmed/VBN that/IN the/DT 5'/NN non-coding/JJ exon/NN is/VBZ included/VBN in/IN the/DT DDT1/NN aFGF/NEWGENE mRNA/NEWGENE and/CC that/IN a/DT major/JJ transcription/NN start/NN site/NN is/VBZ approximately/RB 136/CD bp/NN upstream/RB of/IN the/DT 5'/CD non-coding/JJ splice/NN junction/NN of/IN this/DT exon/NN ./.
@@94720386072 Cytoskeletal/JJ polarization/NN of/IN T/NN cells/NNS is/VBZ regulated/VBN by/IN an/DT immunoreceptor/JJ tyrosine-based/JJ activation/NN motif-dependent/NN mechanism/NN ./.
@@5786485722 Functional/JJ effects/NNS following/IN subacute/JJ administration/NN ./.
@@16987729324 (/( 1988/CD )/SYM J/NNP ./NNP
@@28302148407 The/DT effect/NN of/IN acetazolamide/NN (/( ACZ/NN )/SYM on/IN HCO3-/NN and/CC Cl-/NN activities/NNS in/IN inner/JJ ear/NN fluid/NN was/VBD investigated/VBN by/IN ion-selective/JJ microelectrode/NN methods/NNS ./.
@@89954106089 Eukaryotic/NEWGENE initiation/NEWGENE factor/NEWGENE 3/NEWGENE (/( eIF3/NEWGENE )/SYM is/VBZ a/DT large/JJ multisubunit/JJ complex/NN that/WDT stabilizes/VBZ the/DT ternary/JJ complex/NN ,/, eIF2/NEWGENE x/NN GTP/NEWGENE x/NN tRNA/NEWGENE (/NEWGENE Met/NEWGENE )/NEWGENE i/NEWGENE and/CC promotes/VBZ mRNA/NN binding/JJ to/IN the/DT 40/NEWGENE S/NEWGENE ribosomal/NEWGENE subunit/NEWGENE ./. eIF3/NEWGENE also/RB functions/VBZ as/IN a/DT ribosome/NN subunit/NN anti-association/JJ factor/NN ./.
@@29582041309 To/TO investigate/VB the/DT effects/NNS of/IN isotretinoin/NN on/IN HDL/NEWGENE ,/, we/PRP measured/VBD HDL-C/NEWGENE ,/, HDL/NEWGENE phospholipids/NNS (/( HDL-PL/NEWGENE )/SYM ,/, apoprotein/NEWGENE A1/NEWGENE (/( apo/NEWGENE A-1/NEWGENE )/SYM ,/, and/CC HDL-C/NEWGENE subfractions/NNS (/( HDL2-C/NEWGENE and/CC HDL3-C/NEWGENE )/SYM in/IN 24/CD healthy/JJ ,/, male/JJ patients/NNS receiving/JJ a/DT 16-week/JJ course/NN of/IN isotretinoin/NN (/( 1/CD ./CD 0/CD mg/NN //NN kg/NN //NN day/NN )/SYM for/IN treatment/NN of/IN severe/JJ acne/NN vulgaris/JJ ./.
@@75651042019 The/DT expression/NN of/IN the/DT pilin/NEWGENE gene/NEWGENE ,/, tcpA/NEWGENE ,/, is/VBZ dependent/JJ upon/IN ToxR/NEWGENE and/CC upon/IN ToxT/NEWGENE ./.
@@25421943184 These/DT results/NNS indicate/VBP that/IN patients/NNS who/WP undergo/VBP postoperative/JJ irradiation/NN for/IN low/JJ grade/NN spinal/JJ astrocytomas/NNS and/CC localized/VBN spinal/JJ ependymomas/NNS achieve/VBP excellent/JJ survival/NN ./.
@@6026222592 A/DT one-week/JJ ulcer/NN therapy/NN with/IN atropine/NN and/CC Vikalin/NN (/( Roter/NN )/SYM led/VBN to/IN a/DT significant/JJ (/( p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM reduction/NN of/IN the/DT nocturnal/JJ proteolytic/JJ activity/NN ./.
@@88582117644 This/DT GAP/NEWGENE activity/NN was/VBD observed/VBN in/IN 3T3-L1/CD adipocyte/NN lysates/NNS ,/, and/CC was/VBD able/JJ to/IN accelerate/VB the/DT hydrolysis/NN of/IN the/DT [/NN alpha-32P/NN ]/NN GTP/NN bound/JJ to/IN GST-Rab4/NEWGENE into/IN [/NN alpha-32P/NN ]/NN GDP/NN ./.
@@92259982678 NF-kappa/NEWGENE B/NEWGENE //NEWGENE Rel/NEWGENE transcription/NEWGENE factors/NEWGENE participate/VBP in/IN the/DT activation/NN of/IN numerous/JJ genes/NNS involved/VBN in/IN immune/JJ regulation/NN //NN inflammation/NN including/JJ cytokines/NNS ,/, cell/NN surface/NN receptors/NNS ,/, adhesion/NN molecules/NNS ,/, and/CC acute/JJ phase/NN proteins/NNS ./.
@@105559649552 S/NNP ./NNP ,/, Kim/NN ,/, S/NNP ./NNP
@@87404163883 The/DT predicted/VBN protein/NN ,/, Seb1p/NEWGENE ,/, consists/VBZ of/IN 82/CD amino/JJ acids/NNS and/CC contains/VBZ one/PRP potential/JJ membrane-spanning/NN region/NN at/IN the/DT C-terminus/NN but/CC no/DT N-terminal/NN signal/NN sequence/NN ./.
@@22336262878 Droperidol-induced/JJ extrapyramidal/JJ symptoms/NNS in/IN an/DT adolescent/NN following/IN strabismus/NN surgery/NN ./.
@@7651734493 Northern/NNP blot/NN analysis/NN revealed/VBD the/DT expression/NN of/IN LIMK-1/NEWGENE mRNA/NEWGENE predominantly/RB in/IN the/DT brain/NN and/CC the/DT expression/NN of/IN LIMK-2/NEWGENE mRNA/NEWGENE in/IN various/JJ tissues/NNS in/IN the/DT rat/NN ./.
@@86470861597 Cyclin-dependent/NEWGENE kinase-2/NEWGENE (/( Cdk2/NEWGENE )/SYM forms/VBZ an/DT inactive/JJ complex/NN with/IN cyclin/NEWGENE D1/NEWGENE since/IN Cdk2/NEWGENE associated/VBN with/IN cyclin/NEWGENE D1/NEWGENE is/VBZ not/RB phosphorylated/VBN by/IN Cdk7-cyclin-H/NEWGENE ./.
@@110732185767 The/DT sixth/JJ nucleotide/NN was/VBD bulged/JJ out/RB to/IN allow/VB stacking/JJ of/IN this/DT U/NN ./NN G/NN pair/NN on/IN the/DT adjacent/JJ helical/JJ region/NN ./.
@@20221881566 I/PRP propose/VBP that/IN their/PRP gene/NN products/NNS bind/VBP to/IN the/DT chromatin/NN to/IN establish/VB or/CC maintain/VB a/DT proper/JJ higher/JJ order/NN structure/NN as/IN a/DT prerequisite/NN for/IN a/DT regulated/NN gene/NN expression/NN ./.
@@65992826355 The/DT invasive/JJ pattern/NN of/IN squamous/JJ cell/NN carcinoma/NN in/IN the/DT mandibular/JJ gingiva/NN ./.
@@11123054960 Paraneoplastic/JJ rheumatic/JJ syndromes/NNS ./.
@@100229789524 The/DT distribution/NN of/IN the/DT various/JJ repeats/NNS suggests/VBZ its/PRP organization/NN is/VBZ similar/JJ to/IN the/DT beta-heterochromatic/NN regions/NN near/IN the/DT base/NN of/IN the/DT major/JJ chromosome/NN arms/NNS ./.
@@8304342499 In/NN the/DT present/NN report/NN ,/, 66/CD hemochromatosis/NN families/NNS yielding/JJ 151/CD hemochromatosis/NN chromosomes/NNS and/CC 182/CD normal/JJ chromosomes/NNS were/VBD RFLP-typed/JJ with/IN a/DT battery/NN of/IN probes/NNS ,/, including/JJ two/JJ newly/RB derived/VBN polymorphic/JJ markers/NNS from/IN the/DT 6/CD ./CD 7/CD and/CC HLA-F/NEWGENE loci/NEWGENE located/VBN 150/CD and/CC 250/CD kb/NN telomeric/JJ to/IN HLA-A/NEWGENE ,/, respectively/RB ./.
@@26743279941 The/DT p34/NEWGENE ./NEWGENE 8/NEWGENE gene/NEWGENE has/VBZ a/DT strong/JJ codon/NN usage/NN bias/NN which/WDT is/VBZ strikingly/RB different/JJ from/IN that/DT of/IN the/DT polyhedrin/NEWGENE gene/NEWGENE ./.
@@113694537720 There/EX was/VBD an/DT increase/NN in/IN protein/NN binding/JJ onto/IN this/DT element/NN only/RB after/IN peptide/NN treatment/NN ./.
@@32580693956 The/DT purposes/NNS of/IN this/DT study/NN were/VBD 1/NN )/NN to/IN examine/VB the/DT effect/NN of/IN high/JJ intensity/NN ,/, low/JJ frequency/NN transcutaneous/JJ electrical/JJ nerve/NN stimulation/NN at/IN auricular/JJ acupuncture/NN points/NNS on/IN experimental/JJ pain/NN threshold/NN measured/VBN at/IN the/DT wrist/NN and/CC 2/NN )/NN to/IN determine/VB the/DT changes/NNS in/IN effect/NN over/JJ time/NN ./.
@@75651134287 The/DT chloramphenicol-resistance/NEWGENE transposon/NEWGENE Tn4451/NEWGENE1 undergoes/VBZ precise/JJ conjugative/JJ deletion/NN from/IN its/PRP parent/NN plasmid/NN plP401/NN in/IN Clostridium/NN perfringens/NNS and/CC precise/JJ spontaneous/JJ excision/NN from/IN multicopy/JJ plasmids/NNS in/IN Escherichia/NN coli/JJ ./.
@@13980719865 These/DT temperature-/JJ and/CC cold-sensitive/JJ strains/NNS were/VBD used/VBN to/IN prepare/VB extracts/NNS deficient/JJ in/IN BRF1/NEWGENE activity/NN and/CC were/VBD tested/VBN for/IN transcriptional/JJ activity/NN by/IN RNA/NEWGENE polymerases/NEWGENE I/NEWGENE ,/NEWGENE II/NEWGENE ,/NEWGENE and/NEWGENE III/NEWGENE in/IN vitro/FW ./.
@@91191128182 These/DT data/NN are/VBP consistent/JJ with/IN a/DT model/NN in/IN which/WDT GATA-5/NEWGENE performs/VBZ a/DT unique/JJ temporally/RB and/CC spatially/RB restricted/VBN function/NN in/IN the/DT embryonic/JJ heart/NN and/CC lung/NN ./.
@@86518538611 Mesial/JJ temporal/JJ sclerosis/NN ./.
@@110700565075 The/DT Cili-2/NEWGENE sequences/NEWGENE possess/VBP similarity/NN to/IN the/DT RNaseH/NEWGENE domain/NEWGENE of/IN Lian-Aa1/NEWGENE ,/, a/DT mosquito/NN non-LTR/JJ retrotransposon/NN ./.
@@77370247684 Whole/JJ bowel/NN irrigation/NN is/VBZ a/DT recently/RB described/VBN technique/NN to/IN enhance/VB the/DT passage/NN of/IN drugs/NNS already/RB beyond/RB the/DT pylorus/NN ./.
@@22612542901 Experiments/NNS showed/VBN that/IN temporary/JJ arrest/NN of/IN pulmonary/JJ circulation/NN under/IN conditions/NNS of/IN extracorporeal/JJ circulation/NN is/VBZ attended/VBN by/IN the/DT development/NN of/IN ischemia/NN of/IN the/DT respiratory/JJ pulmonary/JJ tissue/NN ./.
@@27609225439 Heterogeneous/NEWGENE nuclear/NEWGENE ribonucleoprotein/NEWGENE (/NEWGENE hnRNP/NEWGENE )/NEWGENE core/NEWGENE protein/NEWGENE A1/NEWGENE is/VBZ a/DT major/JJ component/NN of/IN mammalian/NEWGENE hnRNP/NEWGENE 40/NEWGENE S/NEWGENE particles/NEWGENE ./.
@@67143546481 Monkeys/NNS were/VBD evaluated/VBN before/IN and/CC after/IN unilateral/JJ and/CC serial/JJ bilateral/JJ removal/NN of/IN superior/JJ temporal/JJ cortex/NN ./.
@@96302458544 Yeast/NEWGENE U1/NEWGENE snRNP/NEWGENE is/VBZ considerably/RB more/JJ complex/NN than/IN its/PRP metazoan/JJ counterpart/NN ,/, which/WDT suggests/VBZ possible/JJ differences/NNS between/IN yeast/NN and/CC metazoa/NNS in/IN early/JJ splicing/JJ events/NNS ./.
@@98774171769 Plasma/NN CCK/NEWGENE levels/NNS were/VBD determined/VBN at/IN regular/JJ intervals/NNS ./.
@@113810945354 In/NN addition/NN ,/, stonin/NEWGENE 2/NEWGENE binds/VBZ to/IN the/DT C2B/NEWGENE domains/NEWGENE of/IN synaptotagmins/NEWGENE I/NEWGENE and/NEWGENE II/NNS ./NNS
@@10376446249 12/CD healthy/JJ women/NNS (/( age/NN 18-38/JJ years/NNS )/SYM were/VBD examined/VBN using/VBG the/DT 2-hour's/NNS method/NN of/IN passive/JJ leg/NN rising/JJ (/( PLR/NNS )/SYM in/IN follicular/JJ (/( FP/NN )/SYM and/CC luteal/JJ (/( LP/NN )/SYM phases/NNS of/IN normal/JJ ovulatory/JJ cycle/NN ./.
@@9512550230 E1A/NEWGENE represses/VBZ apolipoprotein/NEWGENE AI/NEWGENE enhancer/NEWGENE activity/NN in/IN liver/NN cells/NNS through/RB a/DT pRb-/JJ and/CC CBP-independent/NNP pathway/NN ./.
@@104412439669 RESULTS/NNS :/: Circulating/VBG leptin/NEWGENE concentrations/NNS in/IN AN/DT were/VBD 3/CD ./CD 5+/CD //CD -0/CD ./CD 5/CD versus/IN 7/CD ./CD 6+/CD //CD -1/CD ./CD 2/CD ng/NN //NN ml/NN in/IN control/NN subjects/NNS ./.
@@77489523087 In/NN addition/NN ,/, two/JJ internal/JJ promoters/NNS ,/, PmiaA/NEWGENE and/CC P1hfq/NEWGENE were/VBD identified/VBN and/CC mapped/VBN to/IN 201/CD and/CC 837/CD nucleotides/NNS upstream/RB from/IN the/DT respective/JJ translation/NN start/NN sites/NNS ./.
@@15183962140 George/NNP T/NNP ./NNP
@@44882324991 Effects/NNPS of/IN alcoholism/NN on/IN the/DT family/NN ./.
@@17913632404 These/DT results/NNS were/VBD superior/JJ to/IN those/DT in/NN 24/CD patients/NNS with/IN conventional/JJ end-to-end/JJ sutures/NNS on/IN clinical/JJ testing/NN ./.
@@107491661720 These/DT results/NNS indicate/VBP that/IN virulence-associated/NN genes/NN and/CC their/PRP overall/JJ chromosomal/JJ arrangement/NN are/VBP relatively/JJ well/NN conserved/VBN between/IN B/NNP ./NNP henselae/NNS and/CC other/DT gram-negative/JJ bacteria/NNS such/JJ as/IN A/NNP ./NNP tumefaciens/NN ./.
@@46383655065 Effect/NN of/IN triftazin/NN and/CC aminazin/NN on/IN hippocampal/JJ bioelectric/JJ activity/NN ./.
@@13895732021 TBPf/NN is/VBZ defined/VBN as/IN a/DT quotient/NN of/IN the/DT difference/NN of/IN the/DT first/JJ and/CC the/DT second/JJ measurement/NN :/: TBPf/NNP =/SYM (/( P1/NN -/: P2/NN )/NN //NN (/NN A1/NN -/: A2/NN )/NN ./.
@@117415549931 Comparison/NNS of/IN remnant-like/NN lipoprotein/NN particles/NNS in/IN postmenopausal/JJ women/NNS with/IN and/CC without/IN coronary/JJ artery/NN disease/NN and/CC in/IN men/NNS with/IN coronary/JJ artery/NN disease/NN ./.
@@14786728809 One/CD phage/NN clone/NN contains/VBZ a/DT junction/NN between/IN alpha/NN satellite/JJ DNA/NN and/CC a/DT novel/JJ low-copy/JJ repeated/JJ sequence/NN ./.
@@97054973907 The/DT yeast/NEWGENE MMS2/NEWGENE gene/NEWGENE was/VBD cloned/VBN by/IN its/PRP ability/NN to/IN complement/NN the/DT methyl/NN methanesulfonate/NN sensitivity/NN of/IN the/DT mms2-1/NEWGENE mutant/NEWGENE and/CC was/VBD later/JJR shown/VBP to/IN be/VB involved/VBN in/IN DNA/NN post-replication/JJ repair/NN ./.
@@39257124572 Biopsies/NNS of/IN the/DT jejunal/JJ mucosa/NN have/NN shown/VBP abnormal/JJ enzyme/NN activity/NN or/CC deficiencies/NNS in/IN transport/NN mechanisms/NNS ./.
@@21264177694 In/NN the/DT controls/NNS ,/, it/PRP was/VBD found/VBN that/IN all/DT right-handed/JJ and/CC 10/CD out/RB of/IN 14/CD left-handed/JJ control/NN subjects/NNS showed/VBD a/DT right/JJ VHF/NN (/( i/FW ./FW e/FW ./FW ,/, left/NN hemisphere/NN )/SYM advantage/NN ./.
@@9267439382 Genes/NNS belonging/NN to/IN the/DT ras/NEWGENE superfamily/NEWGENE encode/VB low-molecular-weight/NEWGENE GTP/NEWGENE //NEWGENE GDP-binding/NEWGENE proteins/NEWGENE that/WDT are/VBP highly/RB conserved/VBN in/IN wide/JJ variety/NN of/IN organisms/NNS ./.
@@82401708225 Four/CD forms/NNS of/IN salmonellosis/NN were/VBD recognised/VBN in/IN feedlots/NNS and/CC during/IN transport/NN by/IN sea/NN :/: septicaemic/JJ ,/, and/CC acute/JJ ,/, subacute/JJ and/CC chronic/JJ enteric/NN ./.
@@93684194712 A/DT cDNA/NN encoding/VBG a/DT MYC-related/NEWGENE DNA/NEWGENE binding/NEWGENE protein/NEWGENE was/VBD isolated/VBN by/IN DNA-ligand/NN binding/JJ screening/NN ,/, using/VBG the/DT 67-bp/JJ region/NN as/IN a/DT probe/NN ,/, and/CC designated/VBD rd22BP1/NEWGENE ./.
@@81634983569 Two/CD phosphopeptides/NNS ,/, identified/VBN as/IN RS-/NEWGENE [/NEWGENE 32P/NEWGENE ]/NEWGENE SGASGLLTSEHHSR/NEWGENE and/CC S-/NEWGENE [/NEWGENE 32P/NEWGENE ]/NEWGENE SGASGLLTSEHHSR/NEWGENE ,/, were/VBD obtained/VBN after/IN stoichiometric/JJ phosphorylation/NN and/CC trypsinization/NN of/IN the/DT peptide/NN ./.
@@114435094504 DESIGN/IN :/: Prospective/JJ cohort/NN study/NN with/IN a/DT 20/CD y/NN follow-up/JJ period/NN ,/, the/DT First/NNP National/NNP Health/NNP and/CC Examination/NNP Survey/NNP (/( NHANES/NN 1/NN )/SYM Epidemiologic/NNP Follow-up/JJ Study/NNP (/( NHEFS/NNP )/SYM ./.
@@94631749414 We/PRP present/VBP the/DT preliminary/JJ results/NNS obtained/VBN on/IN 36/CD patients/NNS which/WDT were/VBD followed/VBN for/IN a/DT mean/JJ period/NN of/IN 12/CD months/NNS ./.
@@90233781202 Moreover/RB ,/, expression/NN of/IN CBF1/NEWGENE in/IN yeast/NN was/VBD found/VBN to/IN activate/VB transcription/NN of/IN reporter/NN genes/NNS containing/JJ the/DT C-repeat/NEWGENE //NEWGENE DRE/NEWGENE as/IN an/DT upstream/JJ activator/NN sequence/NN but/CC not/RB mutant/JJ versions/NNS of/IN the/DT DNA/NN element/NN ./.
@@22036722822 The/DT computer-programmed/JJ cytocentrifuge/NN is/VBZ currently/RB most/RB popular/JJ ./.
@@75927309079 Levels/NNS of/IN TSG-14/NEWGENE protein/NEWGENE (/( also/RB termed/JJ PTX-3/NEWGENE )/SYM become/VB elevated/VBN in/IN the/DT serum/NN of/IN mice/NNS and/CC humans/NNS after/IN injection/NN with/IN bacterial/JJ lipopolysaccharide/NN ,/, but/CC in/IN contrast/NN to/IN conventional/JJ acute/JJ phase/NN proteins/NNS ,/, the/DT bulk/NN of/IN TSG-14/NEWGENE synthesis/NN in/IN the/DT intact/JJ organism/NN occurs/VBZ outside/RB the/DT liver/NN ./.
@@86847428666 OBJECTIVE/IN :/: To/TO compare/VB pregnancy/NN complications/NNS in/IN women/NNS having/VBG genetic/JJ amniocentesis/NN at/IN 11-14/JJ weeks/NNS versus/IN those/DT undergoing/VBG amniocentesis/NN at/IN 16-19/CD weeks'/NN gestation/NN ./.
@@88914748844 These/DT findings/NNS suggest/VBP that/IN the/DT F-wave/NNS may/MD be/VB elicited/VBN in/IN motoneuron/NN of/IN different/JJ depolarization/NN threshold/NN but/CC primarily/RB in/IN larger/JJR and/CC faster/JJR nerve/NN fibers/NNS ,/, with/IN a/DT lower/JJR threshold/NN of/IN depolarization/NN ./.
@@10446833293 Microcirculatory/JJ oxygenation/NN and/CC shunting/NN in/IN sepsis/NN and/CC shock/NN ./.
@@87564336731 Thus/RB ,/, the/DT characterization/NN of/IN the/DT promoter/NN region/NN should/MD help/VB to/IN define/VB regulatory/JJ elements/NNS that/WDT control/VBP neuron-specific/JJ and/CC developmental/JJ expression/NN of/IN the/DT MAP1B/NEWGENE gene/NEWGENE ./.
@@101006056897 The/DT induced/VBN respiratory/JJ burst/NN was/VBD investigated/VBN by/IN the/DT intracellular/JJ oxidative/JJ transformation/NN of/IN dihydrorhodamine/NN 123/NN to/IN the/DT fluorescent/JJ dye/NN rhodamine/NN 123/NN via/NN flow/NN cytometry/NN ./.
@@77840794855 Transfection/NNS of/IN non-deleted/JJ expression/NN vector/NN into/IN NIH3T3/NNP cells/NNS results/NNS in/IN acquisition/NN of/IN focus-forming/JJ activity/NN while/CC a/DT deleted/VBN form/NN of/IN expression/NN vector/NN fails/VBZ to/IN show/NN this/DT activity/NN even/VB in/IN the/DT presence/NN of/IN basic/NEWGENE FGF/NEWGENE ./.
@@92059656211 The/DT results/NNS suggest/VBP that/IN the/DT bulbospinal/JJ micturition/NN reflex/NN evoked/VBN by/IN bladder/NN filling/NN and/CC L-dopa/NN involves/VBZ a/DT descending/JJ pathway/NN where/CC transmission/NN is/VBZ partly/RB mediated/JJ by/IN spinal/NEWGENE alpha/NEWGENE 1-adrenoceptors/NEWGENE ./.
@@88336538348 Although/IN isl-1/NEWGENE binds/VBZ to/IN both/PDT the/DT insulin/NEWGENE and/CC amylin/NEWGENE gene/NEWGENE promoter/NEWGENE elements/NEWGENE in/IN vitro/FW ,/, these/DT sequences/NNS display/NN marked/JJ differences/NNS in/IN their/PRP relative/JJ transcriptional/JJ properties/NNS when/CC ligated/VBN adjacent/JJ to/IN a/DT heterologous/JJ promoter/NN and/CC transfected/VBN into/IN InR1/NN -G9/CD islet/NN cells/NNS ./.
@@115707355033 RESULTS/NNS :/: The/DT subjects/NNS in/IN the/DT augmented/VBN feedback/NN group/NN significantly/RB reduced/VBD their/PRP peak/NN vertical/JJ ground/JJ reaction/NN force/NN in/IN both/DT post-test/JJ conditions/NNS (/( 2-minute/NN post-test/JJ reduction/NN ,/, 0/NN ./NN 85+/NN //NN -0/NN ./NN 62/NN ;/: 1-week/JJ post-test/JJ reduction/NN ,/, 0/NN ./NN 74+/NN //NN -0/NN ./NN 58/NN )/SYM as/IN compared/VBN to/IN the/DT sensory/JJ ,/, control/NN I/NN ,/, and/CC control/NN II/NN feedback/NN groups/NNS ./.
@@49196135239 Study/NNP of/IN antinuclear/NEWGENE autoantibodies/NEWGENE by/IN immunofluorescence/NN technic/NN in/IN collagen/NEWGENE diseases/NNS ./.
@@8435755533 PNT/NN ,/, ADD/NNS and/CC BSS/IN in/IN the/DT initial/JJ stage/NN of/IN kindling/NN ,/, kindling/NN rate/NN for/IN the/DT stage-3/NN and/CC -5/CD seizures/NNS ,/, seizure/NN parameters/NNS at/IN the/DT first/JJ stage-3/NN and/CC -5/CD were/VBD recorded/VBN and/CC compared/VBN to/IN the/DT values/NNS of/IN saline-treated/JJ ,/, control/NN group/NN ./.
@@63699546167 Effects/NNPS of/IN negative/JJ pleural/JJ pressure/NN on/IN left/NN ventricular/JJ hemodynamics/NN ./.
@@14471892462 These/DT data/NN indicate/VB that/IN RNK-Met-1/NEWGENE is/VBZ a/DT serine/NEWGENE protease/NEWGENE with/IN unique/JJ activity/NN that/WDT is/VBZ expressed/VBN in/IN the/DT granules/NNS of/IN large/JJ granular/JJ lymphocytes/NNS ./.
@@117753011619 No/DT effect/NN of/IN the/DT intervention/NN on/IN depression/NN scores/NNS was/VBD found/VBN ./.
@@13286814046 Ruddell/NNP ,/, M/NNP ./NNP
@@10709705528 Rigid/JJ point/NN feature/NN registration/NN using/VBG mutual/JJ information/NN ./.
@@112792079242 Together/RB ,/, these/DT results/NNS identify/VBP HPK1/NEWGENE as/IN a/DT new/JJ component/NN of/IN TCR/NEWGENE signaling/JJ ./.
@@118950242768 Nine/CD cases/NNS of/IN GBS/NN and/CC five/CD of/IN TM/NN reported/VBN to/IN the/DT active/JJ AFP/NN surveillance/NN were/VBD not/RB found/VB in/IN the/DT hospital/NN searches/NNS ./.
@@104775453096 The/DT B-oligomer/NNS of/IN pertussis/NEWGENE toxin/NEWGENE deactivates/VBZ CC/NEWGENE chemokine/NEWGENE receptor/NEWGENE 5/NEWGENE and/CC blocks/NNS entry/NN of/IN M-tropic/NNP HIV-1/NNP strains/NNS ./.
@@118937671798 The/DT mass-specific/JJ resting/JJ minute/JJ ventilation/NN (/( E/NN )/SYM and/CC the/DT ventilatory/JJ equivalent/JJ (/( E/NN //NN (/NN O/NN (/NN 2/NN )/NN )/NN )/NN were/VBD approximately/RB the/DT same/JJ at/IN the/DT two/JJ ages/NNS ,/, with/IN a/DT breathing/JJ pattern/NN significantly/RB deeper/JJR and/CC slower/JJR at/IN day/NN 1/CD ./CD
@@106840971283 Forty/CD 4-month/JJ old/JJ SD/NN female/JJ rats/NNS were/VBD randomly/RB divided/VBN into/IN four/CD groups/NNS ,/, namely/RB sham/VBP operation/NN ,/, bilateral/JJ ovariectomy/NN ,/, ovariectomy/NN plus/IN supplementary/JJ ethinyl/NN estradiol/NN (/( 0/CD ./CD 2/CD microgram/NN //NN 100/NN g/NN B/NNP ./NNP
@@91190314373 The/DT different/JJ holoenzyme/NEWGENE RNA/NEWGENE polymerases/NEWGENE generated/VBN upon/IN reconstituting/JJ these/DT mutants/NNS independently/RB with/IN core/NEWGENE RNA/NEWGENE polymerase/NEWGENE (/( alpha2beta/NEWGENE beta'/NEWGENE )/SYM have/VB shown/VBP reduced/VBN transcriptional/JJ activity/NN in/IN comparison/NN to/IN the/DT enzyme/NN containing/NN wild-type/NEWGENE sigma/NEWGENE factor/NEWGENE ./.
@@39286784579 Thyrotropin-releasing/JJ hormone-induced/JJ contraction/NN of/IN urethral/JJ and/CC vaginal/JJ muscle/NN ./.
@@92547092354 Contacts/NNPS between/IN Bacillus/NN subtilis/JJ catabolite/NN regulatory/JJ protein/NN CcpA/NEWGENE and/CC amyO/NEWGENE target/NN site/NN ./.
@@90858426274 Thus/RB ,/, the/DT tri-snRNP-specific/NEWGENE 27K/NEWGENE protein/NEWGENE could/MD potentially/RB be/VB involved/VBN in/IN SR/NEWGENE protein-mediated/NN protein/NN //NN protein/NN interactions/NNS and/CC ,/, additionally/RB ,/, its/PRP phosphorylation/NN state/NN could/MD modulate/VB pre-mRNA/VB splicing/JJ ./.
@@94070367165 Tcn1p/NEWGENE //NEWGENE Crz1p/NEWGENE ,/, a/DT calcineurin-dependent/NN transcription/NN factor/NN that/WDT differentially/RB regulates/VBZ gene/NN expression/NN in/IN Saccharomyces/NN cerevisiae/NN ./.
@@78406431433 A/DT comparison/NN of/IN the/DT Flavobacterium/NN glycosylasparaginase/NEWGENE with/IN a/DT mammalian/JJ glycosylasparaginase/NEWGENE revealed/VBN 30%/CD structural/JJ identity/NN and/CC 60%/CD overall/JJ similarity/NN between/IN the/DT prokaryotic/JJ and/CC eukaryotic/JJ forms/NNS of/IN the/DT enzyme/NN ./.
@@94535376963 This/DT region/NN ,/, however/RB ,/, contains/VBZ a/DT CCAATC/NN box/NN in/IN the/DT reverse/JJ complement/NN and/CC several/DT GC/NN boxes/NNS that/WDT are/VBP recognition/NN sites/NNS for/IN SP1/NEWGENE ./.
@@93715643955 Furthermore/RB ,/, the/DT amount/NN of/IN tRNA/NEWGENE (/NEWGENE 3Lys/NEWGENE )/NEWGENE that/WDT was/VBD placed/VBN onto/IN viral/JJ RNA/NN in/IN mutated/JJ viruses/NNS was/VBD significantly/RB less/PRP than/IN that/DT placed/VBD in/IN the/DT wild-type/NN virus/NN ./.
@@6790572550 All/DT 62/CD isolates/NNS were/VBD resistant/JJ to/IN lincomycin/NN ,/, colistin/NN ,/, nystatin/NN ,/, amphotericin/NN B/NN ,/, trimethoprim/NN lactate/NN ,/, polymyxin/NN B/NN ,/, and/CC anisomycin/NN ./.
@@94114599366 However/RB ,/, in/IN a/DT new/JJ experiment/NN in/IN which/WDT the/DT deletion/NN task/NN was/VBD presented/VBN as/IN a/DT puppet/NN game/JJ ,/, and/CC with/IN pretraining/JJ and/CC selection/NN on/IN vowel/NN deletion/NN ,/, a/DT significantly/RB higher/JJ level/NN of/IN success/NN was/VBD achieved/VBN by/IN the/DT children/NNS working/JJ with/IN the/DT CVCC/NNP material/NN ./.
@@68566696652 These/DT results/NNS indicate/VBP that/IN significant/JJ pulmonary/JJ metabolism/NN of/IN 5-HT/RB followed/VBN by/IN efflux/NN of/IN 5-HIAA/JJ into/IN venous/JJ output/NN occurs/VBZ during/IN single-pass/NN circulation/NN ./.
@@20732228073 Thirty/CD seven/JJ patients/NNS (/( amitriptyline/NN n/NN =/SYM 16/CD ,/, moclobemide/NN n/NN =/SYM 21/CD )/SYM completed/VBN the/DT six/CD week/NN protocol/NN ,/, which/WDT was/VBD conducted/VBN under/IN double/JJ blind/JJ conditions/NNS ./.
@@88561328806 Evidence/NN for/IN the/DT promoting/JJ role/NN of/IN the/DT intra-uterine/NEWGENE kinin/NEWGENE release/NN in/IN the/DT development/NN of/IN late/JJ hypertonic/JJ saline-induced/JJ abortion/NN ./.
@@113133987697 Cross-linking/NN FcalphaR/NEWGENE on/IN wt-ITAM/NEWGENE or/CC IIA-ITAM/NEWGENE cells/NNS triggered/VBD equivalent/JJ PI/NN 3-kinase-dependent/JJ activation/NN of/IN PKBalpha/NEWGENE ./.
@@106518053120 Characterization/NNS of/IN a/DT human/NEWGENE alternatively/NEWGENE spliced/NEWGENE truncated/NEWGENE reduced/NEWGENE folate/NEWGENE carrier/NEWGENE increasing/JJ folate/NN accumulation/NN in/IN parental/JJ leukemia/NN cells/NNS ./.
@@34293719749 We/PRP conclude/VBP that/DT cephalothin/NN clearance/NN of/IN S/NNP ./NNP aureus/NN from/IN a/DT site/NN accessible/JJ to/IN phagocytes/NNS was/VBD delayed/JJ when/CC compared/VBN to/IN a/DT phagocyte-inaccessible/NN site/NN ./.
@@11313342673 Recently/RB ,/, we/PRP discovered/VBD that/IN alanine/NN substitutions/NNS of/IN the/DT active/JJ center/NN cleft/JJ residues/NNS significantly/RB impair/VBP the/DT depurinating/NN and/CC ribosome/NN inhibitory/JJ activity/NN of/IN PAP/NEWGENE ./.
@@114746421361 The/DT decrements/NNS in/IN cerebrovascular/JJ resistance/NN induced/VBN by/IN hexamethonium/NN ,/, in/IN mm/NN Hg/NN ml/NN (/NN -1/NN )/NN ./NN min/NN (/NN -1/NN )/NN ,/, were/VBD :/: under/IN control/NN ./.
@@78962914475 The/DT resulting/JJ integrated/JJ physical/NN ,/, genetic/JJ ,/, and/CC cytogenetic/JJ map/NN constitutes/VBZ a/DT resource/NN for/IN the/DT characterization/NN of/IN genes/NNS that/WDT may/MD be/VB involved/VBN in/IN the/DT WAGR/NN syndrome/NN ./.
@@85217808491 Umweltchem/NNP ./.
@@27401963428 In/NN Experiment/NN 2/CD ,/, we/PRP again/RB used/VBD classification/NN ,/, but/CC the/DT fixed/JJ standard/JJ 75/CD was/VBD not/RB at/IN the/DT center/NN of/IN the/DT range/NN of/IN target/NN numbers/NNS (/( 20/CD ,/, 21/CD ,/, ./: ./: ./:
@@55020545576 Leukemia/NNP in/IN twins/NNS :/: world-wide/JJ review/NN of/IN clinical/JJ cases/NNS ./.
@@22470697464 The/DT TUP1/NEWGENE gene/NEWGENE was/VBD isolated/VBN in/IN a/DT screen/NN for/IN genes/NNS that/WDT regulate/VBP mating/JJ type/NN (/( V/NNP ./NNP L/NNP ./.
@@75882402700 The/DT Caenorhabditis/NEWGENE elegans/NEWGENE death/NEWGENE susceptibility/NEWGENE gene/NEWGENE ,/, ced-3/NEWGENE ,/, has/VBZ a/DT number/NN of/IN homologs/NNS in/IN vertebrate/JJ species/NN ,/, including/JJ interleukin-1/NEWGENE beta/NEWGENE (/NEWGENE IL-1/NEWGENE beta/NEWGENE )/NEWGENE -converting/NEWGENE enzyme/NEWGENE (/( ICE/NEWGENE )/SYM ,/, Ich-1long/NEWGENE ,/, and/CC CPP32/NEWGENE ./.
@@37852126352 RPS14/NEWGENE introns/NNS 3/CD and/CC 4/CD both/DT contain/VB Alu/NEWGENE sequences/NEWGENE ./.
@@98047798891 Transcription/NNS factors/NNS of/IN the/DT Stat/NEWGENE family/NEWGENE are/VBP controlled/VBN by/IN protein/NEWGENE kinases/NEWGENE ./.
@@91110489019 A/DT novel/NN ,/, testis-specific/NEWGENE mRNA/NEWGENE transcript/NEWGENE encoding/VBG an/DT NH2-terminal/NEWGENE truncated/NEWGENE nitric-oxide/NEWGENE synthase/NEWGENE ./. mRNA/NN diversity/NN represents/VBZ a/DT major/JJ theme/NN of/IN neuronal/NEWGENE nitric-oxide/NEWGENE synthase/NEWGENE (/( nNOS/NEWGENE )/SYM gene/NN expression/NN in/IN somatic/JJ cells/NNS //NNS tissues/NNS ./.
@@115358328344 The/DT isoform/NN ,/, designated/VBN HDAC9a/NEWGENE ,/, is/VBZ 132/CD aa/NNS shorter/JJR at/IN the/DT C/NN terminus/NN than/IN HDAC9/NEWGENE ./.
@@74555216859 The/DT ESEG's/NN are/VBP a/DT direct/JJ result/NN of/IN the/DT NEXT/NNP study/NN ./.
@@28828933591 Body/NNP temperature/NN and/CC overall/JJ conductance/NN in/IN the/DT cold/JJ appear/VB to/IN be/VB more/RB variable/JJ in/IN P/NNP ./NNP s/CD ./CD campbelli/NN than/IN in/IN nominative/JJ sp/NN ./NN
@@20172712627 After/IN 6/CD months/NNS ,/, definite/JJ improvement/NN in/IN strength/NN occurred/VBN in/IN 4/CD of/IN 7/CD carnitine-treated/NN patients/NNS and/CC in/IN none/NN of/IN 7/CD controls/NNS ./.
@@1003700434 Fifty-seven/CD patients/NNS aged/VBN </SYM 55/CD years/NNS with/IN acute/JJ lymphoblastic/JJ leukemia/NN (/( ALL/NN )/SYM in/IN second/JJ or/CC third/JJ bone/NN marrow/NN (/( BM/NN )/SYM relapse/NN or/CC refractory/JJ to/IN first-line/NN therapy/NN were/VBD enrolled/VBN in/IN an/DT Italian/JJ cooperative/JJ study/NN ./.
@@109515797777 After/IN gamma-irradiation/NN ,/, the/DT majority/NN of/IN F9/NN cells/NNS undergo/VBP apoptosis/NN implying/VBG that/IN wt-p53/NEWGENE likely/RB triggers/VBP pro-apoptotic/NN gene/NN expression/NN in/IN DNA/NN damaged/VBD cells/NNS ./.
@@87173914630 While/IN fusion/NN to/IN the/DT N-terminus/NN required/VBD a/DT linker/NN to/IN become/VB surface/NN accessible/JJ ,/, both/DT fusion/NN to/IN the/DT N-terminus/NN and/CC to/IN the/DT C-terminus/NN was/VBD compatible/JJ with/IN particle/NN assembly/NN and/CC preserved/VBD the/DT native/JJ antigenicity/NN and/CC immunogenicity/NN of/IN HBcAg/NEWGENE ./.
@@10573781393 Studies/NNS have/VBP substantiated/VBN the/DT involvement/NN of/IN numerous/JJ loci/NNS on/IN certain/JJ chromosomes/NNS ;/: in/IN excess/NN of/IN 10/CD chromosomes/NNS are/VBP thought/VBP to/IN be/VB involved/VBN ./.
@@10343189202 Grade/NNP 3/CD mucositis/NN was/VBD reported/VBN in/IN 1/CD patient/NN ./.
@@112270394180 Multiparous/JJ women/NNS presented/VBD higher/JJ BMI/NN (/( P/NN =/SYM 0/CD ./CD 01/CD )/SYM and/CC PBF/NN (/( P/NN =/SYM 0/CD ./CD 03/CD )/SYM compared/VBN with/IN primi-/JJ and/CC nulliparous/JJ groups/NNS ./.
@@86397424168 Isolation/NNS by/IN PCR/NN of/IN a/DT cDNA/NN clone/NN from/IN pea/NN petals/NNS with/IN similarity/NN to/IN petunia/NN and/CC wheat/NEWGENE zinc/NEWGENE finger/NEWGENE proteins/NEWGENE ./.
@@118864731782 Gastritis/NNS score/NN was/VBD significantly/RB lower/JJR in/IN nodminus/NN sign/NN //NN CagAminus/NN signchildren/NN than/IN in/IN nod+/NN //NN CagAminus/NN sign/NN (/( p/NN =/CD ./CD 004/CD )/SYM ,/, nodminus/NN sign/NN //NN CagA+/NN (/( p/NN =/CD ./CD 002/CD )/SYM and/CC nod+/NN //NN CagA+/NN (/( p/NN </SYM ./CD 001/CD )/SYM ,/, both/DT in/NN the/DT antrum/NN and/CC corpus/NN ./.
@@11737900496 We/PRP found/VBP no/DT correlation/NN between/IN plasma/NN COP/NN and/CC body/NN weight/NN at/IN the/DT same/JJ age/NN (/( r2/NN =/SYM 0/CD ./CD 05/CD ,/, P/NN =/SYM 0/CD ./CD 155/CD )/SYM ./.
@@82646315448 The/DT 227-to-239/NN region/NN blocked/VBN ADR1/NEWGENE activity/NN independently/RB of/IN the/DT TAD/NEWGENE present/NN on/IN ADR1/NEWGENE ,/, ADR1/NEWGENE DNA/NN binding/JJ ,/, and/CC specific/NN ADH2/NEWGENE promoter/NEWGENE sequences/NEWGENE ./.
@@61854936129 A/DT polypeptide/NN chain/NN of/IN 34/CD residues/NNS of/IN the/DT deduced/VBN yeast/NN amino/JJ acid/NN sequence/NN closely/RB resembles/VBZ a/DT peptide/NN sequence/NN at/IN the/DT ADP/NN binding/NN site/NN of/IN bovine/NEWGENE muscle/NEWGENE pyruvate/NEWGENE kinase/NEWGENE ./.
@@63604264925 The/DT enzymic/JJ hydrolysis/NN of/IN urea/NN produces/VBZ ammonia/NN which/WDT causes/VBZ a/DT vivid/JJ yellow/NN to/IN purple/JJ colour/NN change/NN in/IN the/DT pH/NN indicator/NN ./.
@@86661028945 ZIOS/NNP was/VBD significantly/RB more/RB sensitive/JJ than/IN all/DT subsequent/JJ methods/NNS ,/, and/CC Ptc/NN ,/NN O2/NN was/VBD significantly/RB more/RB sensitive/JJ than/IN FEV1/NN ./.
@@33810394069 In/NN contrast/NN ,/, the/DT MAN/NNP showed/VBD a/DT unimodal/JJ ,/, skewed/VBN distribution/NN ,/, with/IN a/DT range/NN from/IN approximately/RB 1/CD to/IN 14/CD micron/NN and/CC a/DT maximum/NN at/IN 3-4/CD micron/NN ./.
@@104529517495 Nuclear/NEWGENE hormone/NEWGENE receptors/NEWGENE (/( NRs/NEWGENE )/SYM are/VBP ligand-inducible/NN transcription/NN factors/NN that/WDT mediate/VBP critical/JJ functions/NNS in/IN many/JJ species/NN ./.
@@116870831535 OBJECTIVES/NNS :/: The/DT objective/NN of/IN this/DT review/NN was/VBD to/IN assess/VB the/DT effects/NNS of/IN prophylactic/JJ prostaglandin/NN use/NN in/IN the/DT third/JJ stage/NN of/IN labour/NN ./.
@@98624965013 Ethylene/NN is/VBZ involved/VBN in/IN endosperm/NN rupture/NN and/CC high-level/JJ betaGLU/NEWGENE I/NEWGENE expression/NN ;/: but/CC ,/, it/PRP does/VBP not/RB affect/VB the/DT spatial/JJ and/CC temporal/JJ pattern/NN of/IN betaGLU/NEWGENE I/NEWGENE expression/NN ./.
@@68683456664 The/DT presence/NN of/IN visna-maedi/JJ in/IN Italy/NN is/VBZ reported/VBN for/IN the/DT first/JJ time/NN ./.
@@60485055879 Derivatives/NNS of/IN fluorene/NN ./.
@@76361799071 The/DT normal/JJ cell/NN cycle/NN is/VBZ regulated/VBN by/IN several/DT molecules/NNS ,/, such/JJ as/IN the/DT tumor-suppressor/NEWGENE protein/NEWGENE pRb/NEWGENE ,/, the/DT G1/NEWGENE cyclins/NEWGENE ,/, the/DT cyclin-dependent/NEWGENE kinases/NEWGENE ,/, and/CC their/PRP inhibitors/NNS ./.
@@82918868271 Fast/NNP continuous/JJ expansion/NN ./.
@@83080087962 In/NN this/DT paper/NN ,/, we/PRP demonstrate/VBP that/DT binding/NN of/IN the/DT GA-binding/NEWGENE protein/NEWGENE (/( GABP/NEWGENE )/SYM to/IN ets/NEWGENE sequence/NEWGENE motifs/NEWGENE within/IN each/DT repeated/JJ unit/NN is/VBZ required/VBN for/IN transcriptional/JJ activation/NN of/IN the/DT COXIV/NEWGENE promoter/NEWGENE ./.
@@94420179863 (/( 1997/CD )/SYM Science/NNP 275/CD ,/, 1927-1930/NN )/NN ./.
@@67313027390 No/DT patient/NN with/IN bradyarrhythmia/NN -related/NN SCD/NN had/VBP manifest/VB atrioventricular/JJ block/NN or/CC bundle/NN branch/NN block/NN ./.
@@92423751163 Overall/RB ,/, these/DT findings/NNS demonstrate/VBP that/IN mutations/NNS E768D/NN and/CC V804L/NN are/VBP gain-of-function/VBG mutations/NNS that/WDT confer/VBP to/IN the/DT long/NEWGENE RET/NEWGENE isoform/NEWGENE the/DT capacity/NN to/IN exert/VB a/DT biological/JJ effect/NN ,/, although/IN these/DT mutations/NNS are/VBP more/RB weakly/RB activating/JJ than/IN the/DT MEN2A/NEWGENE and/CC MEN2B/NEWGENE mutations/NN ./.
@@88248057366 Several/JJ of/IN the/DT exon/NN boundaries/NNS correspond/VBP to/IN the/DT boundaries/NNS of/IN functional/JJ domains/NNS in/IN the/DT p55/NEWGENE protein/NEWGENE ./.
@@86823174664 HS/JJ inducibility/NN required/VBD the/DT HSE/NEWGENE which/WDT was/VBD bound/JJ by/IN HS/NEWGENE transcription/NEWGENE factor-1/NEWGENE (/NEWGENE HSF-1/NEWGENE )/NEWGENE present/NN in/IN extracts/NNS prepared/VBN from/IN cells/NNS exposed/VBN to/IN HS/NNP ./NNP
@@22256872861 Comprehensive/NNP care/NN of/IN the/DT patient/NN exposed/VBN to/IN a/DT human/NN teratogen/NN may/MD also/RB include/VB discussion/NN of/IN prenatal/JJ diagnostic/JJ procedures/NNS and/CC other/DT pregnancy/NN management/NN options/NNS ./.
@@75089548825 The/DT avidin-biotin/NEWGENE complex/NEWGENE peroxidase/NEWGENE (/( ABC-P/NEWGENE )/SYM method/NN was/VBD used/VBN to/IN detect/VB Mycobacterium/NN bovis/NNS ,/, and/CC the/DT results/NNS were/VBD compared/VBN with/IN those/DT obtained/VBN by/IN the/DT Ziehl-Neelsen/NNP (/( ZN/NN )/SYM technique/NN ./.
@@89503528902 Therefore/RB ,/, both/PDT the/DT Chilean/JJ and/CC the/DT Japanese/JJ samples/NNS collected/VBN in/IN high-risk/JJ areas/NNS showed/VBD higher/JJ mutagenic/NN rates/NNS than/IN the/DT Japanese/JJ ones/NNS in/IN a/DT low-risk/JJ area/NN ,/, with/IN a/DT statistical/JJ significance/NN (/( p/NN </SYM 0/CD ./CD 001/CD )/SYM ,/, chi-square/NN test/NN )/NN ./.
@@54451875546 Counter-current/JJ heat/NN exchange/NN in/IN the/DT respiratory/JJ passages/NNS :/: effect/NN on/IN water/NN and/CC heat/NN balance/NN ./.
@@86361498288 Both/DT mutant/JJ receptors/NNS were/VBD expressed/VBN on/IN the/DT cell/NN surface/NN and/CC bound/JJ insulin/NEWGENE normally/RB ,/, but/CC showed/VBD markedly/RB impaired/VBN autophosphorylation/NN in/IN response/NN to/IN insulin/NEWGENE ./.
@@74500313336 Marked/JJ sedative/JJ activity/NN was/VBD observed/VBN with/IN 9-methoxy-5-phenylpyrrolo/NN [/NN 2/NN ,/NN 1-d/NN ]/NN [/NN 1/NN ,/NN 5/NN ]/NN benzothiazepin-6/NN ,/NN 6-dioxide/NN (/( NF19/NN )/SYM and/CC 9-chloro-5-p-nitrophenylpyrrolo/NN [/NN 2/NN ,/NN 1-d/NN ]/NN [/NN 1/NN ,/NN 5/NN ]/NN benzothiazepin-6/NN ,/NN 6-dioxide/NN (/( NF20/NNP )/SYM ./.
@@23241044455 A/DT second/NN ,/, novel/JJ C/NEWGENE subunit/NEWGENE (/( CeCAT/NEWGENE alpha'/NEWGENE ,/, 374/CD residues/NNS )/SYM has/VBZ a/DT unique/JJ 56-residue/JJ carboxyl-terminal/NN region/NN that/WDT is/VBZ generated/VBN by/IN the/DT alternative/JJ splicing/JJ of/IN the/DT C/NEWGENE pre-mRNA/NEWGENE ./.
@@92611781026 The/DT mouse/NN extracellular/NEWGENE signal-regulated/NEWGENE kinase/NEWGENE 2/NEWGENE gene/NEWGENE ./.
@@13534781155 Interaction/NNS of/IN H-2Eb/NEWGENE with/IN an/DT IAP/NEWGENE retrotransposon/NEWGENE in/IN the/DT A20/NN //NN 2J/NN B/NN cell/NN lymphoma/NN ./.
@@100514005468 The/DT Lp/NEWGENE mouse/NEWGENE mutant/NEWGENE provides/VBZ a/DT model/NN for/IN the/DT severe/JJ human/JJ neural/JJ tube/NN defect/NN (/( NTD/NN )/SYM ,/, cranio-rachischisis/NN ./.
@@111583268689 These/DT effects/NNS were/VBD not/RB seen/VBP with/IN SHIP2/NEWGENE possessing/VBG a/DT mutation/NN in/IN the/DT SH2/NEWGENE domain/NEWGENE (/( R47G/NEWGENE )/SYM ./.
@@85520863174 We/PRP have/VBP identified/VBN and/CC characterized/VBD a/DT vitamin/NEWGENE D/NEWGENE response/NEWGENE element/NEWGENE (/( VDRE/NEWGENE )/SYM in/IN the/DT promoter/NN of/IN c-fos/NEWGENE ./.
@@22650552903 Plasma/NN concentrations/NNS of/IN atracurium/NN and/CC laudanosine/NN were/VBD 0/CD ./CD 73-3/CD ./CD 11/CD micrograms/NNS ml-1/NN and/CC 0/CD ./CD 48-8/CD ./CD 65/CD micrograms/NNS ml-1/NN ,/, respectively/RB ;/: CSF/NN concentration/NN of/IN laudanosine/NN was/VBD 70-440/JJ ng/NN ml-1/NN ./.
@@90422698997 These/DT findings/NNS suggest/VBP that/IN intraarterial/JJ neoadjuvant/JJ chemotherapy/NN should/MD be/VB effective/JJ on/IN advanced/JJ cervical/JJ cancer/NN ./.
@@84081943937 Distinguishing/JJ roles/NNS of/IN the/DT membrane-cytoskeleton/NN and/CC cadherin/NEWGENE mediated/JJ cell-cell/JJ adhesion/NN in/IN generating/JJ different/JJ Na+/NEWGENE ,/NEWGENE K/NEWGENE (/NEWGENE +/NEWGENE )/NEWGENE -ATPase/NEWGENE distributions/NNS in/IN polarized/JJ epithelia/NNS ./.
@@78916856905 These/DT results/NNS suggest/VBP that/IN gluconeogenic/JJ genes/NNS are/VBP derepressed/VBN upon/IN binding/NN of/IN Cat8p/NEWGENE ,/, whose/WP synthesis/NN depends/VBZ on/IN the/DT release/NN of/IN Cat4p/NEWGENE (/( Mig1p/NEWGENE )/SYM from/IN the/DT CAT8/NEWGENE promoter/NEWGENE ./.
@@85230318494 We/PRP failed/VBD to/IN find/NN these/DT data/NN to/IN be/VB useful/JJ in/IN predicting/JJ the/DT time/NN of/IN onset/NN of/IN initial/JJ seizures/NNS after/IN acute/JJ ischemic/JJ stroke/NN and/CC recurrence/NN ./.
@@97927146492 The/DT interaction/NN of/IN AF-1/NEWGENE with/IN proteins/NNS that/WDT regulate/VBP distinct/JJ steps/NNS of/IN transcription/NN may/MD provide/VB a/DT mechanism/NN for/IN synergistic/JJ activation/NN of/IN gene/NN expression/NN by/IN AF-1/NEWGENE ./.
@@114186624973 The/DT N-terminal/NN portion/NN of/IN Notch/NEWGENE (/NEWGENE IC/NEWGENE )/NEWGENE inhibited/VBD p50/NEWGENE DNA/NN binding/JJ and/CC interacted/VBN specifically/RB with/IN p50/NEWGENE subunit/NEWGENE ,/, not/RB p65/NEWGENE of/IN NF-kappaB/NEWGENE ./.
@@29073083609 2/CD cases/NNS of/IN type/NN II/NN tyrosinosis/NN (/( Richner-Hanhart/NNP syndrome/NN )/SYM ./.
@@22374317605 Expression/NNS of/IN the/DT human/JJ T/NEWGENE cell/NEWGENE receptor/NEWGENE (/NEWGENE TCR/NEWGENE )/NEWGENE alpha/NEWGENE gene/NEWGENE is/VBZ regulated/VBN by/IN a/DT T/NN cell-specific/NN transcriptional/NN enhancer/NN that/WDT is/VBZ located/VBN 4/CD ./CD 5/CD kilobases/NNS (/( kb/NN )/SYM 3'/CD to/IN the/DT C/NEWGENE alpha/NEWGENE gene/NEWGENE segment/NEWGENE ./.
@@13746881985 Each/DT group/NN received/VBN 15/CD ml/NN //NN kg/NN of/IN either/DT 6%/JJ pentafraction/NN ,/, 6%/JJ pentastarch/NN ,/, or/CC plasma/NN followed/VBD two/JJ hours/NNS later/JJR by/IN 1/CD ./CD 5/CD micrograms/CD //CD kg/CD //CD 0/CD ./CD 5/CD hr/NN E/NNP ./NNP
@@9499048536 Infectious/JJ mutant/JJ virus/NN progeny/NN was/VBD obtained/VBN only/RB on/IN complementing/JJ gK-expressing/JJ cells/NNS ,/, suggesting/VBG that/IN gK/NEWGENE has/VBZ an/DT important/JJ function/NN in/IN the/DT replication/NN cycle/NN ./.
@@77063073253 The/DT amino/JJ acid/NN sequence/NN of/IN the/DT protein/NN in/IN the/DT region/NN of/IN the/DT specificity/NN pocket/NN is/VBZ similar/JJ to/IN that/DT of/IN S/NEWGENE ./NEWGENE griseus/NEWGENE proteases/NEWGENE A/NEWGENE ,/NEWGENE B/NEWGENE ,/NEWGENE and/NEWGENE C/NNP ./NNP
@@7600111309 The/DT prevalence/NN and/CC incidence/NN of/IN human/JJ immunodeficiency/NN virus/NN types/NNS 1/CD and/CC 2/CD (/( HIV-1/NN ,/, HIV-2/NN )/SYM ,/, human/JJ T-lymphotropic/NNP virus/NN types/NNS I/PRP and/CC II/NN (/( HTLV-I/NN //NN II/NN )/SYM ,/, and/CC syphilitic/JJ infections/NNS and/CC the/DT association/NN between/IN these/DT infections/NNS were/VBD determined/VBN in/IN a/DT cohort/NN of/IN police/NNS officers/NNS in/IN Guinea-Bissau/DT ./.
@@7556717442 As/IN expected/VBN ,/, the/DT heparin/NN did/VBD produce/NN increased/VBD recalcification/NN times/NNS and/CC the/DT development/NN of/IN occasional/JJ subcutaneous/JJ hematomas/NNS ./.
@@80754217325 The/DT partial/JJ ORF/NN was/VBD found/VBN to/IN be/VB identical/JJ to/IN the/DT C/NN terminus/NN of/IN HrpJ2/NEWGENE ./.
@@93714313652 Expression/NNS of/IN thiamin/NEWGENE biosynthetic/NEWGENE genes/NEWGENE (/( thiCOGE/NEWGENE )/SYM and/CC production/NN of/IN symbiotic/NEWGENE terminal/NEWGENE oxidase/NEWGENE cbb3/NEWGENE in/IN Rhizobium/NN etli/NN ./.
@@109873017992 In/NN this/DT regard/NN ,/, we/PRP have/VBP recently/RB observed/VBN that/IN a/DT constitutively/RB active/JJ G/NEWGENE protein-coupled/NEWGENE receptor/NEWGENE (/( GPCR/NEWGENE )/SYM encoded/VBN by/IN the/DT Kaposi's/NNP sarcoma-associated/JJ herpes/NN virus/NN (/( KSHV/NN )/NN //NN human/NN herpes/NN virus/NN 8/CD is/VBZ oncogenic/JJ and/CC stimulates/VBZ angiogenesis/NN by/IN increasing/JJ the/DT secretion/NN of/IN vascular/NEWGENE endothelial/NEWGENE growth/NEWGENE factor/NEWGENE (/( VEGF/NEWGENE )/SYM ,/, which/WDT is/VBZ a/DT key/JJ angiogenic/JJ stimulator/NN and/CC a/DT critical/JJ mitogen/NN for/IN the/DT development/NN of/IN Kaposi's/NNP sarcoma/NN ./.
@@44606924977 Selected/JJ topics/NNS in/IN laboratory/NN animal/NN medicine/NN ./.
@@38270714505 II/NNS ./NNS
@@80839983878 These/DT results/NNS suggest/VBP that/IN leader-mRNA/NN fusion/NN in/IN coronavirus/NN transcription/NN does/VBP not/RB require/VB direct/JJ RNA-RNA/NNP interaction/NN between/IN complementary/JJ sequences/NNS ./.
@@109405532870 These/DT regions/NNS may/MD be/VB differentially/RB involved/VBN in/IN tissue-specificity/NN ,/, and/IN //IN or/IN circadian/JJ regulation/NN ,/, of/IN the/DT human/NEWGENE hPer1/NEWGENE gene/NEWGENE transcription/NN ./.
@@2409297649 Polyclonal/JJ antiserum/NN generated/VBN to/IN the/DT fusion/NN protein/NN was/VBD capable/JJ of/IN detecting/JJ 42-/DT and/CC 46-kilodalton/JJ polypeptides/NNS from/IN virus/NN particles/NNS ;/: both/DT polypeptides/NNS were/VBD also/RB shown/VBP to/IN contain/VB HBsAg/NEWGENE determinants/NEWGENE ./.
@@116002527193 The/DT LA/NN 50s/NN derived/VBN from/IN this/DT combined/JJ data/NN when/CC compared/VBN with/IN our/PRP earlier/JJR series/NN from/IN 1965/CD to/IN 1970/CD also/RB did/VBD not/RB show/VB a/DT significant/JJ change/NN in/IN mortality/NN ./.
@@114474901325 The/DT amount/NN of/IN drained/VBN effusion/NN was/VBD measured/VBN ,/, and/CC fluid/NN was/VBD sent/VBP for/IN diagnostic/JJ assessment/NN ./.
@@104955739584 Since/IN sildenafil/NN came/VBD on/IN the/DT market/NN ,/, it/PRP seems/VBZ that/IN the/DT place/NN of/IN MUSE/NN is/VBZ reduced/VBN because/IN comparative/JJ studies/NNS give/VBP better/JJR results/NNS for/IN sildenafil/NN than/IN MUSE/NNP (/( 70%/CD vs/NNP 40%/CD )/SYM and/CC of/IN course/NN with/IN a/DT better/JJR acceptance/NN ./.
@@71555796974 Asymptomatic/JJ bacteriospermia/NN and/CC fertility/NN ./.
@@80067738000 There/EX was/VBD no/DT difference/NN in/IN plasma/NN concentrations/NNS of/IN PGI2/NN (/( figure/NN 4/CD )/SYM and/CC TxA2/NN in/IN patients/NNS with/IN normal/JJ blood/NN pressure/NN ,/, mild/JJ preeclampsia/NN and/CC hypotension/NN ,/, whereas/IN in/IN severe/JJ preeclampsia/NN ,/, the/DT plasma/NN concentration/NN of/IN PGI2/NN was/VBD significantly/RB lower/JJR (/( p/NN </SYM 0/CD ./CD 001/CD )/SYM and/CC of/IN TxA2/NN significantly/RB higher/JJ (/( p/NN </SYM 0/CD ./CD 001/CD )/SYM ./.
@@49256175241 Labial/JJ bar/NN ./.
@@28752243570 Reperfusion/NNS with/IN normal/JJ blood/NN in/IN the/DT beating/NN ,/, working/JJ hearts/NNS caused/VBD extensive/JJ structural/JJ damage/NN ,/, reduced/VBN reflow/NN ,/, and/CC failed/VBD to/IN restore/VB contractility/NN in/IN any/DT instance/NN (/( -27%/CD systolic/JJ shortening/NN ,/, p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@29060277852 By/IN sequence/NN comparison/NN ,/, 42/CD blocks/NNS of/IN homology/NN are/VBP defined/VBN in/IN the/DT 5'-terminal/NN region/NN ,/, of/IN which/WDT 36/CD appear/VB in/IN the/DT CpG/NN island/NN and/CC contain/VB numerous/JJ conserved/VBN CpG/NN dinucleotides/NN ./.
@@75426164314 GCD10/NEWGENE was/VBD first/RB identified/VBN genetically/RB as/IN a/DT translational/JJ repressor/NN of/IN GCN4/NEWGENE ./.
@@95991028728 Analysis/NNP of/IN a/DT Mac1p/NEWGENE mutant/NEWGENE ,/, refractile/JJ for/IN copper-dependent/JJ repression/NN of/IN the/PDT Cu/NEWGENE (/NEWGENE I/NEWGENE )/NEWGENE transport/NEWGENE genes/NEWGENE ,/, showed/VBD an/DT aberrant/JJ pattern/NN of/IN CUP1/NEWGENE expression/NN and/CC copper/JJ sensitivity/NN ./.
@@2325208984 French/JJ ,/, M/NNP ./NNP
@@92113546338 Stromelysin-1/NEWGENE ,/, matrix/NEWGENE metalloproteinase-3/NEWGENE (/( MMP-3/NEWGENE )/SYM ,/, is/VBZ an/DT important/JJ endopeptidase/NEWGENE selectively/RB expressed/VBD by/IN somatic/JJ cells/NNS in/IN organ/NN tissues/NNS ./.
@@71133658524 Ficat/NNP and/CC Bizou's/NNP condylar/JJ depth/NN index/NN and/CC the/DT condylar-joint/JJ surface/NN angle/NN of/IN Brattstrom/NN are/VBP recommended/VBN as/IN especially/RB suitable/JJ methods/NNS of/IN measurement/NN ./.
@@27815673477 A/DT soap/NN and/CC water/NN (/( 1/CD :/: 1/CD ,/, v/NN //NN v/NN )/SYM solution/NN effectively/RB decontaminated/VBN powdered/JJ stratum/NN corneum/NN ./.
@@82939924530 Each/DT repeat/NN consists/VBZ of/IN 12/CD nt/NN ,/, coding/JJ for/IN the/DT reiterated/VBN sequence/NN ,/, K/NEWGENE //NEWGENE NPAG/NEWGENE ./.
@@95142726738 Purification/NN of/IN MvaT/NEWGENE enriched/VBN for/IN two/JJ polypeptides/NNS of/IN approximate/JJ molecular/JJ mass/JJ 15/CD kDa/NN and/CC 16/CD kDa/NN ,/, designated/VBN P15/NEWGENE and/CC P16/NEWGENE ./.
@@101962664038 The/DT Asian/JJ mouse/NN Mus/NNS castaneus/NN is/VBZ resistant/JJ to/IN infection/NN by/IN the/DT polytropic/JJ mink/NN cell/NN focus-inducing/JJ (/( MCF/NN )/SYM subgroup/NN of/IN murine/JJ leukemia/NN viruses/NNS (/( MuLVs/NNS )/SYM ./.
@@106207771934 AB004534/NEWGENE ./.
@@17143585175 The/DT 10/CD kDa/NN polypeptide/NN was/VBD phosphorylated/VBN in/IN vitro/FW by/IN incubating/JJ wheat/NN etioplast/NN membranes/NNS with/IN [/NN gamma/NN 32P/NN ]/NN ATP/NN ./.
@@99232452420 The/DT RMRI/NN was/VBD tested/VBN for/IN interrater/JJ reliability/NN using/VBG three/CD simulated/JJ and/CC 10/CD actual/JJ patients/NNS ./.
@@67959716565 The/DT rat/NN incisor/NN is/VBZ an/DT excellent/JJ model/NN system/NN in/IN which/WDT to/IN study/NN amelgenesis/NN ./.
@@25719246210 Haploid/JJ cells/NNS of/IN mating/NN type/NN A/NN of/IN the/DT basidiomycetous/JJ yeast/NN Rhodosporidium/NNP toruloides/NNS secrete/VBP a/DT mating/JJ pheromone/NN ,/, rhodotorucine/NEWGENE A/NEWGENE ,/, which/WDT is/VBZ an/DT undecapeptide/JJ containing/JJ S-farnesyl/NNP cysteine/NN at/IN its/PRP carboxy/JJ terminus/NN ./.
@@90426832593 The/DT FBF/NN questionnaire/NN did/VBD not/RB highlight/VB a/DT characteristic/JJ basic/JJ symptoms/NNS profile/NN of/IN schizoaffective/JJ disorder/NN ,/, when/CC compared/VBD with/IN bipolar/JJ affective/JJ disorder/NN and/CC schizophrenia/NN ./.
@@1003584133 Magnetic/JJ trapping/NN of/IN spin-polarized/JJ atomic/JJ hydrogen/NN ./.
@@110902725621 The/DT transcription/NN and/CC alternative/JJ splicing/JJ of/IN human/NEWGENE ORL1/NEWGENE and/CC GAIP/NEWGENE are/VBP cell-type/JJ specific/JJ ./.
@@115338631408 In/NN the/DT single/JJ case/NN the/DT restoration/NN of/IN a/DT structured/JJ daily/JJ routine/NN represents/VBZ the/DT presupposition/NN for/IN a/DT cognitive/JJ therapy/NN ./.
@@96332749606 Exercise/NN training/NN has/VBZ become/VBN increasingly/RB important/JJ in/IN the/DT treatment/NN of/IN heart/NN failure/NN patients/NNS ./.
@@10443990289 BACKGROUND/IN :/: Chronic/NN alcohol/NN consumption/NN has/VBZ been/VBN demonstrated/VBN to/IN be/VB deleterious/JJ to/IN bone/NN health/NN ./.
@@91214541625 The/DT similar/JJ phenotypes/NNS of/IN bur6/NEWGENE and/CC bur3/NEWGENE (/( mot1/NEWGENE )/SYM mutations/NNS suggest/VBP that/IN Bur6p/NEWGENE and/CC Mot1p/NEWGENE have/VB related/VBN ,/, but/CC not/RB identical/JJ ,/, functions/VBZ in/IN modulating/JJ the/DT activity/NN of/IN the/DT general/JJ transcription/NN machinery/NN in/IN vivo/NN ./.
@@86452148324 Escherichia/NN coli/JJ BL21/NN (/( DE3/NN )/NN plysS/NN ,/, harbouring/VBG a/DT recombinant/JJ plasmid/NN containing/JJ the/DT catalase-peroxidase/NEWGENE gene/NEWGENE ,/, produced/VBD a/DT large/JJ amount/NN of/IN proteins/NNS that/WDT co-migrated/JJ on/IN SDS/NNS //NNS PAGE/NNS with/IN the/DT native/JJ enzyme/NN ./.
@@83894538400 Uracil/NEWGENE DNA/NEWGENE glycosylase/NEWGENE catalyzes/VBZ the/DT initial/JJ step/NN in/IN the/DT repair/NN pathway/NN that/WDT removes/VBZ potentially/RB mutagenic/VBP uracil/NN from/IN duplex/JJ DNA/NN ./.
@@89550718747 Disruption/NNS of/IN re-replication/NN control/NN by/IN overexpression/NN of/IN human/NEWGENE ORC1/NEWGENE in/IN fission/NN yeast/NN ./.
@@112782901635 Whereas/IN Smad2/NEWGENE was/VBD rapidly/RB phosphorylated/VBN by/IN TGF-beta/NEWGENE and/CC involved/VBN in/IN the/DT initial/JJ activation/NN of/IN Agc/NEWGENE expression/NN in/IN confluent/JJ cells/NNS ,/, Smad2/NEWGENE activation/NN was/VBD not/RB required/VBN for/IN maintaining/VBG the/DT high/JJ level/NN of/IN Agc/NEWGENE expression/NN ./.
@@89366408893 DATA/NNP SOURCES/NNS :/: Epidemiologic/NNP studies/NNS ,/, research/NN studies/NNS ,/, review/NN articles/NNS ,/, and/CC government/NN reports/NNS pertaining/VBG to/IN epidemiology/NN of/IN lung/NN cancer/NN ./.
@@88721627547 Both/DT alleles/NNS are/VBP functionally/RB expressed/VBN and/CC are/VBP distributed/VBN within/IN CD4+/NEWGENE //NEWGENE CD8+/NEWGENE T/NN cell/NN subsets/NNS ./.
@@18513862449 The/DT Italian/NNP Lung/NNP Cancer/NNP Task/NNP Force/NNP (/( FONICAP/NN )/SYM ./.
@@6225566029 These/DT show/NN that/IN the/DT collagen/NEWGENE in/IN this/DT tissue/NN is/VBZ modified/JJ compared/VBN with/IN that/DT in/NN tendon/NN ./.
@@96502994317 Taken/VBN together/RB ,/, these/DT data/NN indicate/VB that/IN the/DT VirD2/NEWGENE omega/NEWGENE domain/NEWGENE is/VBZ important/JJ for/IN efficient/JJ T-DNA/NN integration/NN ./.
@@95159211254 The/DT spontaneous/JJ mutation/NN blocking/JJ pca/NEWGENE gene/NEWGENE expression/NN was/VBD located/VBN in/IN the/DT promoter/NN for/IN the/DT pca/NEWGENE operon/NEWGENE ./.
@@83763978469 The/DT binding/JJ specificity/NN of/IN this/DT protein/NN was/VBD compared/VBN to/IN that/DT of/IN human/NEWGENE E2F/NEWGENE using/VBG a/DT number/NN of/IN mutant/NEWGENE E2F/NEWGENE sites/NEWGENE as/IN competitors/NNS ./.
@@25087266567 These/DT case/NN reports/NNS provide/VBP further/JJ evidence/NN that/IN LiCO3/NN can/MD be/VB a/DT useful/JJ medication/NN in/IN the/DT treatment/NN of/IN aggressive/JJ behavior/NN and/CC affective/JJ instability/NN after/IN brain/NN injury/NN ,/, but/CC that/IN it/PRP has/VBZ significant/JJ potential/NN for/IN neurotoxicity/NN in/IN this/DT population/NN ,/, particularly/RB when/CC used/VBN in/IN conjunction/NN with/IN neuroleptic/JJ agents/NNS ./.
@@75890695815 We/PRP also/RB isolated/VBD two/JJ alternatively/RB spliced/VBN forms/NNS of/IN human/NEWGENE CD6/NEWGENE cDNA/NEWGENE lacking/JJ sequences/NNS encoding/VBG membrane-proximal/NN regions/NN of/IN the/DT cytoplasmic/JJ domain/NN which/WDT maintain/VBP the/DT same/JJ reading/JJ frame/NN as/IN CD6-PB1/NEWGENE ./.
@@11597936551 Eight/CD CAD/NN patients/NNS who/WP were/VBD matched/JJ to/IN the/DT treated/VBN patients/NNS for/IN age/NN (/( +/NN //NN -3/NN years/NNS )/SYM ,/, baseline/NN low/NEWGENE density/NEWGENE lipoprotein/NEWGENE (/( +/JJ //JJ -5/JJ mg/NN //NN dL/NN )/SYM ,/, and/CC triglycerides/NNS (/( +/JJ //JJ -50/JJ mg/NN //NN dL/NN )/SYM but/CC who/WP had/VBP never/RB been/VBN treated/VBN with/IN lipid-lowering/JJ drugs/NNS were/VBD selected/VBN as/IN controls/NNS ./.
@@101198274099 Judge/NNP OKs/NN docs'/NN bid/NN for/IN Chicago/NN hospital/NN ./.
@@87984203025 The/DT characterization/NN of/IN the/DT promoter/NN region/NN indicated/VBN that/IN three/CD distinct/JJ regulatory/JJ elements/NNS corresponding/JJ to/IN an/DT AP-1/NEWGENE binding/NEWGENE site/NEWGENE (/( or/CC TRE/NEWGENE )/SYM ,/, a/DT PRDII/NEWGENE //NEWGENE kappaB/NEWGENE domain/NEWGENE ,/, and/CC a/DT CAAT/NN box/NN are/VBP involved/VBN in/IN the/DT activation/NN by/IN pp60/NEWGENE (/NEWGENE v-/NEWGENE )/NEWGENE src/NEWGENE ./.
@@13333176456 The/DT -64/JJ //JJ -37/JJ region/NN interacted/VBN with/IN purified/VBN Sp1/NEWGENE and/CC an/DT unidentified/JJ protein/NN (/NN s/NN )/NN ,/, proximal/NEWGENE regulatory/NEWGENE factor/NEWGENE (/NEWGENE s/NEWGENE )/NEWGENE I/NEWGENE (/( PRF-I/NEWGENE )/SYM ./.
@@77003617082 Although/IN most/RB SH2-pTyr/NEWGENE interactions/NNS occur/VBP between/IN two/JJ different/JJ types/NNS of/IN molecules/NNS ,/, some/DT appear/VB to/IN involve/VB only/RB a/DT single/JJ molecular/JJ type/NN ./.
@@23078506952 From/IN an/DT RNK-16/NN lambda-gt11/NN library/NN ,/, we/PRP have/VBP isolated/VBN and/CC sequenced/VBN a/DT novel/JJ cDNA/NN rat/NEWGENE NK/NEWGENE cell/NEWGENE protease/NEWGENE 1/NEWGENE (/( RNKP-1/NEWGENE )/SYM that/WDT has/VBZ characteristics/NNS unique/JJ to/IN serine/NEWGENE proteases/NEWGENE ./.
@@78658888760 Similarly/RB ,/, in/IN mammalian/JJ cells/NNS PBP74/NEWGENE is/VBZ synthesized/VBN as/IN a/DT pre-protein/NN that/WDT requires/VBZ membrane/NN potential-dependent/JJ import/NN into/IN mitochondria/NNS for/IN its/PRP maturation/NN ./.
@@38249086876 The/DT M/NEWGENE reading/NEWGENE frame/NEWGENE differed/VBN from/IN the/DT reported/VBN sequence/NN by/IN a/DT single/JJ nucleotide/NN corresponding/JJ to/IN a/DT conservative/JJ lysine/NN to/IN arginine/NN amino/JJ acid/NN substitution/NN near/IN the/DT carboxy-terminus/NN conserved/VBN among/IN the/DT M/NEWGENE proteins/NEWGENE of/IN paramyxoviruses/NNS ./.
@@85856392542 Occupational/NNP exposure/NN to/IN hepatitis/NN B/NN virus/NN and/CC human/JJ immunodeficiency/NN virus/NN :/: a/DT comparative/JJ risk/NN analysis/NN ./.
@@26514873328 Although/IN it/PRP is/VBZ well/VB known/VBP that/DT calcium/NN channel/NN blockers/NNS can/MD influence/VB contraction/NN of/IN vascular/JJ smooth/JJ muscle/NN ,/, there/RB is/VBZ less/PRP knowledge/NN on/IN its/PRP effect/NN on/IN excitation/NN contraction/NN coupling/NN in/IN the/DT endocrine/JJ glands/NNS and/CC more/RB specifically/RB on/IN insulin/NEWGENE and/CC glucagon/NN release/NN ./.
@@110580084700 There/EX were/VBD no/DT instances/NNS of/IN major/JJ flap/NN necrosis/NN although/IN two/JJ flaps/NN showed/VBD tip/NN ischaemia/NN ./.
@@57633473769 Clinical/NNP applications/NNS of/IN inhibition/NN of/IN beta-adrenergic/NEWGENE receptors/NEWGENE with/IN propranolol/NN ./.
@@87831808772 Improved/VBN methods/NNS have/VBP been/VBN developed/VBN for/IN maintaining/VBG and/CC breeding/JJ the/DT neotropical/JJ short-tailed/JJ fruit/NN bat/NN ,/, Carollia/NNP perspicillata/NN ,/, in/IN an/DT easily-reproduced/NN ,/, laboratory/NN setting/NN ./.
@@29992673342 The/DT intensity/NN of/IN myocardial/JJ uptake/NN of/IN Tc-99m-PYP/NN in/IN patients/NNS with/IN echocardiographic/JJ left/NN ventricular/JJ hypertrophy/NN and/IN //IN or/IN highly/RB refractile/JJ myocardial/JJ echoes/NNS ,/, so-called/JJ granular/JJ sparkling/JJ appearance/NN (/( GS/NNP )/SYM was/VBD slightly/RB greater/JJR than/IN that/IN in/NN patients/NNS with/IN neither/DT myocardial/JJ hypertrophy/NN nor/CC GS/NNP ./NNP
@@119170611831 The/DT only/JJ predictor/NN of/IN response/NN to/IN tacrolimus/NN was/VBD a/DT previous/JJ response/NN to/IN cyclosporin/NN and/CC prednisone/NN ,/, either/DT as/IN a/DT complete/JJ or/CC partial/JJ remission/NN (/( remission/NN rate/NN 75%/NNP vs/NNP 15/CD ./CD 3/CD ;/: P/CD =/CD 0/CD ./CD 036/CD )/SYM ./.
@@83948628359 Three/CD group/NN 1/CD patients/NNS developed/VBD CMV/NN disease/NN ;/: 1/NN group/NN 2/NN patient/NN developed/VBD CMV/NN hepatitis/NN ./.
@@98693569857 CAL/NN gain/NN amounted/VBN to/IN 4/CD ./CD 2+/CD //CD -1/CD ./CD 3/CD mm/NN ,/, 60%/NN of/IN the/DT defects/NNS showing/VBG CAL/NN gain/NN >/SYM or/CC =/CD 4/CD mm/NN ./NN
@@66537555314 After/IN clofelin/NN administration/NN the/DT autoregulation/NN borders/NN shifted/VBN to/IN the/DT right/JJ i/JJ ./JJ e/NN ./NN towards/IN higher/JJ AP/NN levels/NNS ./.
@@35909114252 Persistent/JJ acantholytic/JJ dermatosis/NN with/IN increased/VBN light/NN sensitivity/NN ./.
@@10490662532 In/NN fact/NN ,/, SPT/NEWGENE activity/NN in/IN the/DT fly/NN expressing/NN epitope-tagged/NN Lace/NEWGENE was/VBD absorbed/VBN by/IN epitope-specific/JJ antibody/NN ./.
@@8900282187 The/DT length/NN scales/NNS of/IN the/DT turbulence/NN were/VBD also/RB estimated/VBN :/: at/IN a/DT Reynolds/NN number/NN near/IN 4/CD ,/CD 000/CD the/DT macroscale/NN is/VBZ about/RB 1/CD ./CD 25/CD mm/NN ,/, the/DT Taylor/NN microscale/NN is/VBZ about/RB 0/CD ./CD 85/CD mm/NN ,/, and/CC the/DT Kolmogoroff/NN scale/NN is/VBZ near/IN 0/CD ./CD 075/CD mm/NN ./NN
@@94202513225 C/NNP ./NNP
@@119103101821 DESIGN/IN :/: Prospective/JJ ,/, randomized/JJ ,/, double-blind/JJ ,/, controlled/VBN trial/NN ./.
@@100377746403 In/NN this/DT study/NN ,/, we/PRP investigated/VBD the/DT signal/JJ transduction/NN pathways/NNS that/WDT are/VBP involved/VBN in/IN OM-induced/NN LDLR/NEWGENE transcription/NN ./.
@@30184911310 The/DT hexanucleotide/NEWGENE 5'-TGTCCT-3'/NEWGENE ,/, thought/VBP to/IN be/VB important/JJ for/IN GRE/NEWGENE activity/NN ,/, not/RB only/RB was/VBD found/VBN in/IN this/DT sequence/NN and/CC in/IN the/DT 5'-flanking/JJ region/NN ,/, but/CC also/RB was/VBD present/VB twice/RB in/IN the/DT 3'/CD end/NN of/IN the/DT gene/NN that/WDT did/VBD not/RB show/VB specific/JJ receptor/NN binding/JJ ./.
@@77488487711 The/DT term/NN endovascular/JJ papillary/JJ haemangioma/NN is/VBZ suggested/VBN ./.
@@8389074598 Mutations/NNS at/IN the/DT extreme/JJ C-terminus/NN of/IN EIAV/NEWGENE Tat/NEWGENE impaired/VBN both/DT RNA/NN binding/NN and/CC activation/NN domain/NN functions/NNS ,/, suggesting/VBG effects/NNS on/IN secondary/JJ or/CC tertiary/JJ structure/NN ./.
@@13601807745 Repeated/VBN efforts/NNS to/IN isolate/NN recombinant/JJ baculoviruses/NNS containing/NN a/NN wild-type/NEWGENE kinase/NEWGENE failed/VBN ,/, whereas/IN recombinants/NNS expressing/JJ a/DT nonfunctional/JJ kinase/NEWGENE with/IN a/DT catalytic/JJ domain/NEWGENE II/NEWGENE mutation/NN were/VBD readily/RB isolated/VBN ./.
@@79648148997 Elementary/NN visual/NN hallucinations/NNS in/IN migraine/NN and/CC epilepsy/NN ./.
@@100727748882 RT-PCR/NN was/VBD performed/VBN using/VBG previously/RB reported/VBN degenerate/JJ oligonucleotide/NN primers/NNS to/IN the/DT ligand/NN binding/JJ domain/NN (/( LBD/NNS )/SYM of/IN known/VBP beta/NEWGENE integrin/NEWGENE subunits/NEWGENE and/CC Bge/NEWGENE cDNA/NEWGENE ./.
@@33789945589 Chronic/NN administration/NN of/IN sodium/NN cyanate/NN decreases/NNS O2/NN extraction/NN ratio/NN in/IN dogs/NNS ./.
@@105185616725 Efficient/JJ phosphorylation/NN of/IN BRDG1/NEWGENE by/IN Tec/NEWGENE required/VBD the/DT PH/NEWGENE and/CC SH2/NEWGENE domains/NEWGENE as/RB well/VBP as/IN the/DT kinase/NN domain/NN of/IN the/DT latter/NN ./.
@@113143731158 Evidence-based/JJ care/NN :/: a/DT new/JJ formula/NN for/IN an/DT old/JJ problem/NN ?/.
@@105997277565 With/IN this/DT GH/NEWGENE and/CC estrogen/NN treatment/NN regimen/NN ,/, most/JJ girls/NNS with/IN TS/NN can/MD grow/VB and/CC develop/VB much/JJ more/RB in/IN conformity/NN with/IN their/PRP healthy/JJ peers/NNS ./.
@@70215054315 After/IN acclimation/NN ,/, resting/JJ supine/NN and/CC sitting/NN DPB/NN decreased/VBN (/( P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM by/IN 6/CD and/CC 9/CD mmHg/NN ,/, respectively/RB ./.
@@8719697358 METHODS/IN :/: DSF/NN was/VBD instilled/VBN in/IN one/PRP eye/NN chosen/VBP at/IN random/NN and/CC CF/NN in/IN the/DT fellow/JJ eye/NN of/IN 13/CD normal/JJ subjects/NNS and/CC in/IN 13/CD patients/NNS with/IN KCS/NNP ./.
@@105505748646 With/IN regard/NN to/IN nonhematologic/JJ toxicities/NNS ,/, diarrhea/NN ,/, infection/NN and/CC elevated/VBN serum/NEWGENE alkaline/NEWGENE phosphatase/NEWGENE of/IN grade/NN 3/CD or/CC over/RB were/VBD observed/VBN in/IN 2%/NN of/IN cycles/NNS ,/, but/CC were/VBD tolerable/JJ and/CC reversible/JJ ./.
@@18710332477 Tests/NNS showed/VBN that/IN an/DT overall/JJ impression/NN of/IN the/DT force/NN applied/VBN could/MD be/VB obtained/VBN from/IN a/DT laboratory/NN simulation/NN ,/, but/CC that/DT clearing/NN cement/NN and/CC testing/NN cement/NN were/VBD not/RB modelled/VBN by/IN this/DT method/NN ./.
@@83242808303 These/DT lesions/NNS were/VBD asymptomatic/JJ ,/, but/CC both/DT were/VBD characterized/VBN clinically/RB by/IN central/JJ ulceration/NN ./.
@@89788178478 In/NN addition/NN ,/, double/JJ mutants/NNS with/IN either/DT dim1-delta/NEWGENE or/CC dim2-1/NEWGENE and/CC the/DT endocytosis/NN mutants/NEWGENE end4-1/NEWGENE or/CC act1-1/NEWGENE displayed/VBN synthetic/JJ growth/JJ defects/NNS ,/, indicating/VBG that/IN the/DT DIM/NEWGENE gene/NEWGENE products/NEWGENE function/NN in/IN a/DT common/JJ or/CC parallel/JJ endocytic/JJ pathway/NN ./.
@@40323499745 35/CD patients/NNS with/IN acute/JJ arterial/JJ occlusions/NNS [/NN 27/NN ]/NN and/CC graft/NN thromboses/NNS [/NN 8/NN ]/NN ,/, responsible/JJ for/IN severe/JJ and/CC recent/JJ ischemia/NN ,/, were/VBD treated/VBN by/IN fibrinolytic/JJ therapy/NN (/( Urokinase/NEWGENE :/: 1/CD 000/CD units/NN //NN kg/NN //NN hour/NN ,/, and/CC Lys/NN Plasminogen/NEWGENE )/SYM ./.
@@95355793458 Moreover/RB ,/, it/PRP is/VBZ the/DT assumptions/NNS behind/RB steady-state/JJ O2/NN uptake/NN that/WDT do/VBP not/RB permit/VB proper/JJ interpretation/NN of/IN energy/NN expenditure/NN during/IN EPOC/NN ;/: 1/CD l/NN O2/NN not/RB =/SYM 20/CD ./CD 9/CD kJ/CD ./CD
@@24065701346 An/DT examination/NN of/IN the/DT properties/NNS of/IN sequences/NNS surrounding/JJ ARS1/NEWGENE left/NN open/NN the/DT possibility/NN that/IN ABFI/NEWGENE enhances/VBZ the/DT initiation/NN of/IN DNA/NN replication/NN at/IN ARS1/NEWGENE by/IN transcriptional/JJ activation/NN ./.
@@104670043521 The/DT intron/NN is/VBZ capable/JJ of/IN splicing/JJ despite/IN the/DT fact/NN that/IN both/PDT the/DT EBS1/NEWGENE //NEWGENE IBS1/NEWGENE and/CC the/DT EBS2/NEWGENE //NEWGENE IBS2/NEWGENE sequence/NEWGENE motifs/NEWGENE ,/, thought/VBP to/IN be/VB necessary/JJ for/IN correct/JJ splicing/JJ ,/, extend/VB over/RB 5/CD instead/RB of/IN 6/CD bp/CD ./CD
@@76168027527 From/IN day/NN 10/CD ,/, a/DT significant/JJ increase/NN in/IN platelet/NN count/NN was/VBD observed/VBN in/IN eight/CD of/IN the/DT ten/CD patients/NNS treated/VBN with/IN heparin/NN (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM ,/, with/IN return/NN to/IN the/DT initial/JJ value/NN after/IN heparin/NN cessation/NN in/IN six/CD of/IN the/DT responders/NNS ./.
@@76670979683 The/DT association/NN of/IN p255/NEWGENE with/IN splicing/JJ complexes/NNS is/VBZ suggested/VBN by/IN the/DT finding/VBG that/DT mAb/NEWGENE CC3/NEWGENE can/MD inhibit/VB in/IN vitro/FW splicing/JJ and/CC immunoprecipitate/NN pre-messenger/NN RNA/NN and/CC splicing/JJ products/NNS ./.
@@13272801958 In/NN rats/NNS anaesthetized/JJ with/IN +-chloralose/VBD the/DT changes/NNS in/IN extracellular/JJ pH/NN and/CC K+/NN in/IN spinal/JJ cord/NN dorsal/JJ horn/NN were/VBD studied/VBN using/VBG pH/NN and/CC K+/JJ ion-selective/JJ electrodes/NNS ./.
@@98069199199 Rather/RB ,/, usp/NEWGENE is/VBZ required/VBN in/IN late/JJ third/JJ instar/NN larvae/NNS for/IN appropriate/JJ developmental/JJ and/CC transcriptional/JJ responses/NNS to/IN the/DT ecdysone/NN pulse/NN that/WDT triggers/VBP puparium/NN formation/NN ./.
@@1227186354 The/DT majority/NN of/IN MRF/NN units/NNS were/VBD behaviorally/RB incongruent/JJ ;/: in/IN the/DT most/RB frequently/RB observed/VBN case/NN ,/, their/PRP activity/NN failed/VBN to/IN change/NN reliably/RB when/CC behavior/NN habituated/VBN ./.
@@76047837503 There/EX were/VBD no/DT significant/JJ changes/NNS in/IN either/DT the/DT fatty/JJ acid/NN composition/NN of/IN biliary/JJ lecithin/NN or/CC in/IN the/DT bile/NN acid/NN composition/NN of/IN bile/NN ./.
@@95817751509 In/NN the/DT present/NN study/NN ,/, we/PRP sought/VBP to/IN investigate/VB whether/IN constitutive/NEWGENE NF-kappaB/NEWGENE activity/NN in/IN chronically/RB HIV-1-infected/JJ promonocytic/JJ U937/CD (/( U9-IIIB/NN )/SYM and/CC myeloblastic/NN PLB-985/NN (/( PLB-IIIB/NN )/SYM cells/NNS affects/VBP apoptotic/JJ signaling/NN ./.
@@62908998700 Survey/NNP on/IN antibody/NN against/IN egg/NN drop/NN syndrome-1976/NN virus/NN among/IN chicken/NN flocks/NNS in/IN Japan/NN ./.
@@106791901639 We/PRP present/VBP evidence/NN that/IN the/DT upstream/RB open/JJ reading/JJ frame/NN (/( uORF/NN )/SYM represses/VBZ the/DT translation/NN of/IN the/DT downstream/RB major/JJ open/JJ reading/JJ frame/NN (/( mORF/NN )/SYM ./.
@@104632423534 In/NN EEG/NN only/RB single/JJ slow/JJ waves/NNS above/JJ left/NN temporal/NN region/NN were/VBD revealed/VBN ./.
@@118258011694 No/DT increased/VBN tumor-related/JJ mortality/NN was/VBD observed/VBN after/IN a/DT mean/JJ follow-up/NN of/IN 44/CD months/NNS ./.
@@26483967663 In/NNP Rat-1a/NNP cells/NNS the/DT expression/NN of/IN human/NEWGENE c-jun/NEWGENE mRNA/NEWGENE was/VBD associated/VBN with/IN the/DT ability/NN to/IN clone/NN in/IN soft/JJ agarose/NN and/CC form/NN tumors/NNS in/IN nude/JJ mice/NNS ./.
@@74900839207 Carbonic/NEWGENE anhydrase/NEWGENE V/NEWGENE (/( CA/NEWGENE V/NEWGENE )/SYM is/VBZ expressed/VBN in/IN mitochondrial/JJ matrix/NN in/IN liver/NN and/CC several/DT other/DT tissues/NNS ./.
@@80956981830 Metabolism/NNS of/IN calcium/NN and/CC vitamin/NN D3/NN in/IN patients/NNS with/IN acute/JJ tubulointerstitial/JJ nephritis/NN :/: a/DT study/NN of/IN 41/CD patients/NNS with/IN nephropathia/NN epidemica/NN ./.
@@114060251269 OBJECTIVES/NNS :/: The/DT objective/NN of/IN this/DT review/NN was/VBD to/IN compare/NN the/DT effectiveness/NN ,/, safety/NN and/CC acceptability/NN of/IN the/DT diaphragm/NN with/IN and/CC without/IN spermicide/NN ./.
@@88074083961 METHODS/IN AND/CC RESULTS/NNS :/: A/DT 64-year-old/CD woman/NN with/IN confirmed/VBN AV/NN nodal/NN reentrant/JJ tachycardia/NN underwent/VBD a/DT successful/JJ "slow/NN pathway"/NN AV/JJ modification/NN with/IN a/DT single/JJ radiofrequency/NN application/NN ./.
@@87469818732 In/NN 3/CD treatments/NNS the/DT diet/NN was/VBD supplemented/VBN with/IN 0/CD ,/, 100/CD and/CC 150/CD mg/NN probiotic/NN //NN kg/NN food/NN ./.
@@74998485442 We/PRP show/VBP that/DT stimulation/NN of/IN resting/JJ splenic/JJ B/NNP cells/NNS with/IN CD40L-expressing/VBG Sf9/NNP cells/NNS induces/VBZ germ-line/NN gamma/NEWGENE 1/NEWGENE and/CC epsilon/NEWGENE transcripts/NEWGENE independently/RB of/IN cytokines/NNS ./.
@@96213727874 Routine/JJ blood/NN examination/NN showed/VBD leukocytosis/NN ,/, thrombocytopenia/NN ,/, positive/JJ CRP/NEWGENE ,/, and/CC elevated/VBD myocardial/JJ enzymes/NNS ./.
@@74344317303 We/PRP propose/VBP that/DT refeeding/NN may/MD be/VB an/DT important/JJ mechanism/NN for/IN activation/NN of/IN certain/JJ viral/JJ infections/NNS previously/RB suppressed/VBN by/IN famine/NN ./.
@@78920768370 Survival/NNP after/IN development/NN of/IN symptomatic/JJ infection/NN (/( P-2/NN )/SYM did/VBD not/RB differ/VB by/IN transmission/NN mode/NN ./.
@@1002749817 Most/JJS other/DT end/NN points/NNS were/VBD highly/RB significant/JJ ,/, and/CC death/NN ,/, which/WDT was/VBD monitored/VBN across/IN the/DT U/NNP ./NNP S/NNP ./. program/NN ,/, was/VBD different/JJ with/IN p/NN </SYM 0/CD ./CD 0001/CD ./.
@@79427227917 Constipation/NNS is/VBZ not/RB a/DT risk/NN factor/NN for/IN hemorrhoids/NN :/: a/DT case-control/NN study/NN of/IN potential/JJ etiological/JJ agents/NNS ./.
@@82082474484 Mutational/JJ analysis/NN of/IN chromosomal/JJ segment/NN 64AB/NN ,/, a/DT region/NN containing/JJ the/DT glutamic/NEWGENE acid/NEWGENE decarboxylase/NEWGENE gene/NEWGENE ./.
@@13581902796 Substitution/NNS of/IN the/DT DR1/NEWGENE beta/NEWGENE chain/NEWGENE with/IN H-2E/NEWGENE beta/NEWGENE k/NEWGENE led/VBN to/IN a/DT dramatic/JJ loss/NN of/IN recognition/NN ;/: alpha/NN chain/NN substitution/NN had/VBP a/DT less/PRP marked/JJ effect/NN ./.
@@86184333355 In/NN contrast/NN to/IN the/DT selective/JJ expression/NN of/IN the/DT receptor/NN ,/, FL/NEWGENE expression/NN was/VBD detected/VBN in/IN 90-100%/CD of/IN the/DT various/JJ cell/NN types/NNS of/IN leukemia/NN cell/NN lines/NNS from/IN all/DT hematopoietic/JJ cell/NN lineages/NNS ./.
@@77903779232 Antibodies/NNS to/IN the/DT human/NEWGENE PTS1R/NEWGENE recognize/VB this/DT protein/NN in/IN human/JJ ,/, monkey/NN ,/, rat/NN ,/, and/CC hamster/NN cells/NNS ./.
@@9685346627 The/DT combination/NN of/IN Pitx2/NEWGENE and/CC another/DT homeodomain/NEWGENE protein/NEWGENE ,/, Pit-1/NEWGENE ,/, yielded/VBD a/DT synergistic/JJ 55-fold/JJ activation/NN of/IN the/DT prolactin/NEWGENE promoter/NEWGENE in/IN transfection/NN assays/NNS ./.
@@110350084516 Consistent/JJ with/IN the/DT specificity/NN observed/VBN for/IN the/DT interaction/NN of/IN DmCKIIalpha/NEWGENE with/IN these/DT bHLH/NEWGENE proteins/NEWGENE ,/, sequence/NN alignment/NN suggests/VBZ that/IN only/RB m5/NEWGENE ,/, m7/NEWGENE ,/, and/CC m8/NEWGENE contain/VB a/DT consensus/NN site/NN for/IN phosphorylation/NN by/IN CKII/NEWGENE within/IN a/DT subdomain/NN unique/JJ to/IN these/DT three/CD proteins/NNS ./.
@@86549465456 The/DT transcription/NN start/NN point/NN of/IN the/DT proximal/JJ promoter/NN aligns/VBZ to/IN that/DT of/IN mouse/NEWGENE promoter/NEWGENE P3/NEWGENE and/CC lies/NNS within/IN a/DT conserved/VBN region/NN of/IN sequence/NN ./.
@@11154491990 METHODS/IN :/: One/CD hundred/JJ fourteen/CD consecutive/JJ patients/NNS (/( mean/JJ age/NN 61/CD years/NNS )/SYM with/IN focal/JJ pancreatic/JJ masses/NNS ,/, detected/VBN on/IN CT/NN ,/, underwent/VBD EUS-FNA/NNP by/IN using/VBG a/DT linear-array/JJ echoendoscope/NN and/CC 22-gauge/JJ needles/NNS ./.
@@83476774007 The/DT phosphorylation/NN efficiency/NN is/VBZ improved/VBN by/IN increasing/JJ the/DT number/NN of/IN N-terminal/NN arginine/NN residues/NNS and/CC by/IN moving/JJ the/DT arginyl/NN cluster/NN one/PRP residue/NN further/RB away/RB from/IN the/DT serine/NN ,/, the/DT nonapeptide/NEWGENE (/NEWGENE Arg/NEWGENE )/NEWGENE 4-Ala-Ala-Ser-Val-Ala/NEWGENE being/NN the/DT best/JJS substrate/NN among/IN all/PDT the/DT short/JJ peptides/NNS tested/VBN (/( Km/NN =/SYM 15/CD microM/NN )/SYM ./.
@@118836821774 Here/RB is/VBZ presented/VBN the/DT monitoring/NN of/IN the/DT accidental/JJ spill/NN on/IN vertical/JJ distribution/NN of/IN heavy/JJ metals/NNS in/IN the/DT estuarine/NN sediments/NNS ./.
@@82893427513 A/DT mutant/NN in/IN the/DT AAV/JJ terminal/JJ resolution/NN site/NN (/( trs/NNS )/SYM was/VBD defective/JJ for/IN DNA/NN replication/NN in/IN the/DT in/NN vitro/FW assay/NN ./.
@@90914035168 Analysis/NNP of/IN homologous/JJ DNA/NN sequences/NNS within/IN the/DT first/JJ intron/NN of/IN the/DT mouse/NEWGENE and/NEWGENE human/NEWGENE mts1/NEWGENE genes/NEWGENE :/: kB-like/NEWGENE site/NEWGENE and/CC microsatellite/NN DNA/NN ./.
@@93411588848 The/DT medium/NN chains/NNS of/IN these/DT complexes/NNS ,/, mu1/NEWGENE and/CC mu2/NEWGENE ,/, have/VB been/VBN implicated/VBN in/IN two/JJ types/NNS of/IN interaction/NN :/: assembly/NN with/IN the/DT beta1/NEWGENE and/NEWGENE beta2/NEWGENE chains/NEWGENE of/IN the/DT corresponding/JJ complexes/NNS and/CC recognition/NN of/IN tyrosine-based/JJ sorting/JJ signals/NNS ./.
@@14003968874 The/DT promoter/NN was/VBD stimulated/VBN 8-20-fold/JJ by/IN phorbol/NN esters/NNS accounting/NN for/IN the/DT previously/RB observed/VBN transcriptional/JJ activation/NN of/IN protein/NEWGENE kinase/NEWGENE C/NEWGENE beta/NEWGENE ./.
@@37615234427 The/DT rats/NNS were/VBD used/VBN for/IN the/DT study/NN of/IN the/DT effects/NNS of/IN sepsis/NN on/IN the/DT utilization/NN of/IN exogenous/JJ fat/JJ emulsion/NN ./.
@@98065469631 Its/PRP interaction/NN with/IN RFX5/NEWGENE and/CC RFXAP/NEWGENE is/VBZ essential/JJ for/IN binding/NN of/IN the/PDT RFX/NEWGENE complex/NEWGENE to/IN MHC-II/NEWGENE promoters/NEWGENE ./.
@@76238144143 In/NNP CV-1/NNP cells/NNS ,/, cotransfection/NN of/IN the/DT retinoid/NEWGENE and/NEWGENE estrogen/NEWGENE receptors/NEWGENE led/VBN to/IN mutual/JJ inhibition/NN of/IN the/DT other's/NNS activity/NN ,/, while/CC an/DT RA-dependent/NN inhibition/NN of/IN ER/NEWGENE activity/NN was/VBD observed/VBN in/IN breast/NN cancer/NN cells/NNS ./.
@@21186122718 Thirty/CD minutes/NNS of/IN supine/JJ restraint/NN decreased/VBD DOPAC/NN concentrations/NNS in/IN the/DT median/JJ eminence/NN of/IN female/JJ rats/NNS that/WDT were/VBD not/RB exposed/VBN to/IN ether/NN ,/, and/CC brief/JJ exposure/NN to/IN ether/NN enhanced/VBD this/DT effect/NN ./.
@@102214672779 Constrictive/NNP pericarditis/NN and/CC pleuropulmonary/JJ disease/NN linked/JJ to/IN ergot/NN dopamine/NN agonist/NN therapy/NN (/( cabergoline/NN )/SYM for/IN Parkinson's/NNP disease/NN ./.
@@19990352613 The/DT first/JJ follow-up/NN was/VBD at/IN a/DT nearly/RB constant/JJ interval/NN of/IN 5/CD ./CD 1/CD years/NNS in/IN Caerphilly/RB and/CC 3/CD ./CD 2/CD years/NNS in/IN Speedwell/NNP ;/: 251/CD major/JJ IHD/NN events/NNS had/VBP occurred/VBN ./.
@@87943487445 A/DT transgenic/JJ complementation/NN assay/NN was/VBD used/VBN to/IN test/NN whether/IN NIa/NEWGENE supplied/VBD in/IN trans/JJ could/MD rescue/VB amplification-defective/JJ viral/JJ genomes/NNS encoding/VBG altered/VBN NIa/NEWGENE proteins/NEWGENE ./.
@@100002532 Chirality-glass/NNP and/CC spin-glass/NN correlations/NNS in/IN the/DT two-dimensional/JJ random-bond/VBD XY/DT model/NN ./.
@@84556231787 Initial/JJ results/NNS indicate/VBP that/IN this/DT 23S/NEWGENE pre-rRNA/NEWGENE is/VBZ the/DT same/JJ as/IN the/DT species/NN detected/VBN on/IN depletion/NN of/IN the/DT small/NEWGENE nucleolar/NEWGENE RNA-associated/NEWGENE proteins/NEWGENE NOP1/NEWGENE1 and/CC GAR1/NEWGENE and/CC in/IN an/DT snr10/NEWGENE mutant/NEWGENE strain/NN ./.
@@89735272870 Complementary/NNP DNAs/NNS encompassing/VBG the/DT coat/NEWGENE protein/NEWGENE coding/JJ and/CC adjacent/JJ regions/NNS of/IN Agropyron/NNP mosaic/NN virus/NN (/( AgMV/NNP )/SYM and/CC Hordeum/NN mosaic/NN virus/NN (/( HoMV/NNP )/SYM were/VBD cloned/VBN and/CC sequenced/VBN ./.
@@8838314135 To/TO understand/VB further/RB the/DT expression/NN and/CC regulation/NN of/IN the/DT V1aR/NEWGENE ,/, we/PRP now/RB describe/VBP the/DT genomic/JJ characteristics/NNS ,/, tissue/NN expression/NN ,/, chromosomal/JJ localization/NN ,/, and/CC regional/JJ mapping/NN of/IN the/DT human/NEWGENE V1aR/NEWGENE gene/NEWGENE ,/, AVPR1A/NEWGENE ./.
@@80839999664 Vaccinia/NN virus-expressed/JJ ,/, purified/VBN full-length/NEWGENE HPV-16/NEWGENE and/NEWGENE BPV-1/NEWGENE E2/NEWGENE proteins/NEWGENE bound/VBD a/DT consensus/NN E2/NEWGENE site/NEWGENE with/IN high/JJ specific/JJ affinities/NNS (/( Kd/NN =/SYM approximately/RB 10/NN (/NN -9/NN )/SYM M/NN )/NN and/CC stimulated/VBN in/IN vitro/FW transcription/NN up/JJ to/IN six-/DT to/IN eightfold/RB ./.
@@9159183959 Genes/NNS for/IN ocs/NEWGENE element/NEWGENE binding/NEWGENE factors/NEWGENE (/( OBFs/NEWGENE )/SYM ,/, belonging/NN to/IN a/DT specific/JJ class/NN of/IN basic-region/NEWGENE leucine/NEWGENE zipper/NEWGENE (/NEWGENE bZIP/NEWGENE )/NEWGENE transcription/NEWGENE factors/NEWGENE ,/, have/VB been/VBN isolated/VBN in/IN a/DT number/NN of/IN plants/NNS ./.
@@103799421335 Interestingly/RB ,/, highly/RB charged/VBN residues/NNS were/VBD abundantly/RB possessed/VBN in/IN the/DT carboxy-terminal/JJ part/NN of/IN the/DT MDV2/NEWGENE UL10/NEWGENE protein/NEWGENE ./.
@@14096432539 By/IN using/VBG lambda/NN gt11/NN expression/NN cloning/NN with/IN oligonucleotides/NNS corresponding/JJ to/IN the/DT human/JJ immunodeficiency/NN virus/NN 1/NN TATA/NN element/NN ,/, we/PRP report/VBP the/DT identification/NN of/IN a/DT cellular/JJ protein/NN with/IN a/DT calculated/VBN molecular/JJ mass/NN of/IN 123/CD kDa/NN that/IN we/PRP designate/VBP TATA/NEWGENE element/NEWGENE modulatory/NEWGENE factor/NEWGENE (/( TMF/NEWGENE )/SYM ./.
@@76284516885 We/PRP show/VBP here/RB that/DT RA/NN and/CC E1A/NEWGENE induce/VB phosphorylation/NN of/IN the/DT E1A-associated/NEWGENE 300/NEWGENE kDa/NEWGENE protein/NEWGENE (/( p300/NEWGENE )/SYM during/IN the/DT differentiation/NN of/IN F9/NN cells/NNS ./.
@@22572512896 Pathophysiology/NNS of/IN bone/NN loss/NN in/IN castrated/JJ animals/NNS ./.
@@28987523604 A/DT strong/JJ correlation/NN exists/VBZ between/IN the/DT numbers/NNS of/IN CFU-GM/NN transfused/VBN and/CC the/DT rate/NN of/IN granulocytes/NNS and/CC platelets/NNS recovery/NN ./.
@@3003146875 Because/IN of/IN serious/JJ infections/NNS (/( fever/NN larger/JJR than/IN or/CC equal/NN to/IN 101/CD degrees/NNS F/NN ./NN granulocytes/NNS less/PRP than/IN 1/CD ,/CD 000/CD //CD mm/CD ,/, 3/CD and/CC hospitalization/NN )/SYM and/CC 1/CD drug/NN death/NN in/IN the/DT first/JJ 4/CD patients/NNS ,/, oral/JJ calcium/NN leucovorin/NN ,/, 20/CD to/IN 30/CD mg/NN //NN m2/NN orally/RB ,/, was/VBD given/VBP 2/CD days/NNS after/IN methotrexate/NN in/IN subsequent/JJ treatment/NN cycles/NNS ./.
@@115131801391 Of/IN the/DT six/CD cases/NNS of/IN malignant/JJ polyposis/NN ,/, none/NN were/VBD identified/VBN using/VBG CT/NN ,/, and/CC only/JJ two/NN were/VBD diagnosed/VBN by/IN small/JJ bowel/NN follow-through/JJ ./.
@@100376814655 Successful/JJ interaction/NN of/IN ARF/NEWGENE and/CC PKC-alpha/NEWGENE with/IN PLD1/NEWGENE was/VBD not/RB achieved/VBN ,/, but/CC a/DT C-terminal/NN fragment/NN of/IN human/NEWGENE PLD1/NEWGENE (/( denoted/VBN "D4"/CD )/SYM interacted/VBN with/IN the/DT active/JJ mutant/NN of/IN RhoA/NEWGENE ,/, RhoAVal-14/NEWGENE ./.
@@37803716656 Repetitive/JJ sequences/NNS are/VBP present/VB in/IN at/IN least/RB three/CD introns/NNS of/IN the/DT cytochrome/NEWGENE P-450PBc2/NEWGENE gene/NEWGENE ,/, but/CC not/RB in/IN exons/NNS or/CC the/DT 5'-flanking/JJ region/NN ./.
@@108622896035 (/( GUT/NNP )/NN Sera/NN of/IN 30/CD montoux/NN negative/JJ healthy/JJ adults/NNS (/( age/NN //NN sex/NN matched/JJ )/SYM were/VBD taken/VBP as/IN control/NN by/IN detecting/JJ IgG/NEWGENE anti/NEWGENE bodies/NEWGENE to/IN A60/NEWGENE antigen/NEWGENE ./.
@@105415507338 Using/VBG immunolocalization/NN ,/, we/PRP observe/VBP that/IN ACE3/NEWGENE ,/, a/DT 440-bp/JJ chorion/NN element/NN that/WDT contains/VBZ information/NN sufficient/JJ to/IN drive/NN amplification/NN ,/, directs/VBZ DmORC/NN localization/NN in/IN follicle/NN cells/NNS ./.
@@94884919176 E2F/NEWGENE activity/NN is/VBZ regulated/VBN in/IN part/NN by/IN the/DT retinoblastoma/NEWGENE family/NEWGENE of/NEWGENE tumor/NEWGENE suppressor/NEWGENE proteins/NEWGENE ./.
@@36155508908 The/DT rate-decreasing/JJ effects/NNS of/IN morphine/NN and/CC U50488/NN were/VBD reversed/VBN completely/RB by/IN a/DT 0/CD ./CD 01/CD and/CC 1/CD ./CD 0/CD mg/CD //CD kg/CD dose/NN of/IN naloxone/NN ,/, respectively/RB ./.
@@41399435538 Demonstration/NNS of/IN fine/JJ structure/NN of/IN the/DT guinea/NN pig/NN organ/NN of/IN Corti/NN after/IN electron/NN microscopic/JJ silver/NN staining/NN ./.
@@27890629109 A/DT cDNA/NN encoding/VBG the/DT NF-4FB/NEWGENE enhancer/NEWGENE binding/NEWGENE protein/NEWGENE has/VBZ been/VBN cloned/VBN by/IN screening/JJ a/DT lambda/NN gt11/NN cDNA/NN library/NN with/IN a/DT rabiolabelled/VBN oligonucleotide/NN corresponding/JJ to/IN the/DT NF-4FB/NEWGENE recognition/NEWGENE sequence/NEWGENE ./.
@@96788372184 The/DT aim/NN of/IN the/DT study/NN was/VBD to/IN correlate/NN the/DT responsiveness/NN to/IN bronchoprovocation/NN with/IN methacholine/NN in/IN subjects/VBZ a/DT with/IN allergic/JJ rhinitis/NN during/IN and/CC out/RB of/IN the/DT pollen/NN season/NN with/IN total/JJ serum/JJ IgE/NEWGENE and/CC blood/NN eosinophils/NNS ./.
@@108018602892 The/DT Siglecs/NEWGENE are/VBP a/DT subfamily/NN of/IN I-type/NEWGENE lectins/NEWGENE (/( immunoglobulin/NEWGENE superfamily/NEWGENE proteins/NEWGENE that/WDT bind/VBP sugars/NNS )/SYM that/WDT specifically/RB recognize/VB sialic/JJ acids/NNS ./.
@@95524699508 The/DT interaction/NN between/IN piroxicam/NN and/CC poloxamer/NN was/VBD studied/VBN by/IN x-ray/NN diffractometry/NN (/( XRD/NNP )/SYM ,/, infrared/JJ (/( IR/JJ )/SYM spectroscopy/NN and/CC differential/JJ thermal/JJ analysis/NN (/( DTA/NN )/SYM with/IN a/DT solid/JJ dispersion/NN ,/, coprecipitate/VB ,/, or/CC physical/JJ mixture/NN ./.
@@48903368759 Immunelectrophoretic/JJ pattern/NN of/IN Wassermann/VB reagin/NN and/CC comparison/NN of/IN the/DT appearance/NN time/NN between/IN RPCF/NEWGENE and/CC FTA/NEWGENE antibodies/NEWGENE ./.
@@92518439213 Reactive/JJ lymphoid/JJ hyperplasia/NN was/VBD found/VBN in/IN 15/CD cases/NNS ,/, 2/CD cases/NNS had/VBP angiofollicular/JJ lymphoid/JJ hyperplasia/NN or/CC Castleman's/NNP disease/NN ,/, atypical/JJ lymphoid/JJ hyperplasia/NN suggestive/JJ of/IN malignant/JJ lymphoma/NN was/VBD observed/VBN in/IN 3/CD cases/NNS ,/, and/CC malignant/JJ lymphoma/NN was/VBD diagnosed/VBN in/IN the/DT remaining/JJ 4/CD cases/NNS ./.
@@95382586696 In/NN this/DT report/NN ,/, we/PRP investigate/VBP the/DT mechanism/NN underlying/JJ Ras/NEWGENE activation/NN upon/IN stimulation/NN of/IN these/DT two/JJ types/NNS of/IN receptors/NNS in/IN hematopoietic/JJ cells/NNS ./.
@@61383135959 The/DT distribution/NN phase/NN is/VBZ followed/VBN by/IN an/DT elimination/NN phase/NN with/IN a/DT much/RB longer/JJR half-life/NN (/( mean/JJ value/NN 375/CD min/NN )/SYM and/CC a/DT volume/NN of/IN distribution/NN of/IN approximately/RB 200-400/VBD l/DT ./DT
@@88434199408 OKA/NN and/CC calyculin/NN A/NN do/NN not/RB decrease/VB OCFRE/NEWGENE DNA-protein/NN interactions/NNS ,/, suggesting/VBG that/IN important/JJ protein-protein/JJ interactions/NNS are/VBP phosphatase/NN regulated/VBN ./.
@@105637897350 In/NN addition/NN ,/, media/NN containing/JJ F/NEWGENE beta/NEWGENE alpha/NEWGENE //NEWGENE CG/NEWGENE beta/NEWGENE displayed/VBD high-affinity/JJ binding/NN to/IN both/DT CG/NEWGENE and/CC FSH/NEWGENE receptors/NEWGENE ./.
@@90730746733 Antisense/NNP transcription/NN of/IN a/DT murine/NEWGENE FGFR-3/NEWGENE psuedogene/NEWGENE during/IN fetal/JJ developement/NN ./.
@@3863561744 Within/IN the/DT Strep/NN ./. mutans/NNS group/NN there/RB was/VBD a/DT highly-significant/JJ difference/NN between/IN Strep/NN ./. mutans/NN //NN Strep/NN ./. cricetus/NN (/( p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM with/IN respect/NN to/IN mean/JJ clump/NN size/NN ./.
@@10722969548 Here/RB we/PRP review/VBP progress/VBP to/IN date/NN in/IN this/DT area/NN ./.
@@26494453322 Both/DT BG/NN and/CC IRI/NEWGENE concentrations/NNS during/IN the/DT OGTT/NN were/VBD the/DT lowest/JJS in/IN body/NN builders/NNS ,/, medium/NN in/IN controls/NNS ,/, and/CC the/DT highest/JJS in/IN obese/JJ men/NNS ./.
@@39671444615 Hypersplenism/NN ./.
@@104589051512 We/PRP report/VBP the/DT construction/NN of/IN an/DT approximately/RB 1/CD ./CD 7-Mb/CD sequence-ready/NN YAC/NN //NN BAC/NN clone/NN contig/NN of/IN 8p22-p23/NN ./.
@@96283759596 In/NN the/DT ePTFE/JJ specimens/NNS ,/, tissue/NN coverage/NN had/VBP increased/VBN ./.
@@6180786000 A/DT decrease/NN of/IN the/DT lysozyme/NEWGENE activity/NN coincided/VBN with/IN the/DT clinical/JJ improvement/NN of/IN the/DT bacterial/JJ meningitis/NN ./.
@@100851207657 In/NN this/DT study/NN ,/, we/PRP elucidate/VBP signaling/JJ pathways/NNS induced/VBN by/IN photodynamic/JJ therapy/NN (/( PDT/NN )/SYM with/IN hypericin/NN ./.
@@84633203753 In/NN situ/NN copper-phenanthroline/JJ footprinting/VBG of/IN individual/JJ gel/NN shift/NN assembly/NN intermediates/NNS shows/VBZ that/IN on/IN the/DT 302-nucleotide/NNP G4oric/NNP ,/, the/DT first/JJ two/JJ SSB/NEWGENE tetramers/NEWGENE assemble/VBP at/IN random/JJ ,/, but/CC the/DT addition/NN of/IN more/JJ SSB/NEWGENE tetramers/NEWGENE results/NNS in/IN formation/NN of/IN a/DT unique/JJ structure/NN ./.
@@39221168890 The/DT distribution/NN of/IN patients/NNS was/VBD as/IN follows/VBZ :/: group/NN 1--complex/NN gamma-therapy/NN (/( 55/CD cases/NNS )/SYM ,/, group/NN 2--complex/NN gamma-therapy/NN plus/IN iliac/JJ lymphadenectomy/NN (/( 50/CD cases/NNS )/SYM and/CC group/NN 3--complex/NN radiation/NN treatment/NN with/IN megavolt/NN bremsstrahlung/NN beam/NN from/IN the/DT luc/NN type/NN installation/NN and/CC iliac/JJ lymphadenectomy/NN (/( 50/CD cases/NNS )/SYM ./.
@@91487703318 Cellular/NEWGENE Csk/NEWGENE was/VBD associated/VBN with/IN several/DT phosphoproteins/NNS ,/, some/DT of/IN which/WDT were/VBD interacting/VBG with/IN the/DT Csk/NEWGENE SH2/NEWGENE1 domain/NEWGENE1 ./.
@@100965738516 Previous/JJ studies/NNS characterized/VBD a/DT cytokine-inducible/NN ,/, functional/JJ nuclear/NEWGENE factor/NEWGENE (/NEWGENE NF/NEWGENE )/NEWGENE -kappaB/NEWGENE consensus/NEWGENE element/NEWGENE in/IN the/DT immediate/JJ 5'/CD regulatory/JJ region/NN of/IN the/DT MGSA/NEWGENE //NEWGENE GRO-alpha/NEWGENE gene/NEWGENE at/IN -78/CD bp/CD ./CD
@@90322546526 Enhancer/NNS activity/NN requires/VBZ both/PDT the/DT AP-1/NEWGENE site/NEWGENE and/CC these/DT adjacent/JJ sequences/NNS ./.
@@33437309522 A/DT significant/JJ association/NN between/IN a/DT family/NN history/NN and/CC a/DT higher/JJ urinary/NN pH/NN was/VBD observed/VBN among/IN the/DT female/JJ calcium/NN stone/NN patients/NNS ./.
@@50316591666 Successful/JJ treatment/NN of/IN candidiasis/NN with/IN transfer/NN factor/NN ./.
@@68584496657 Disturbances/NNS of/IN placental/JJ maturation/NN ,/, 2/NN ./NN
@@13780529000 Between/IN acoR/NEWGENE and/CC acoXABC/NEWGENE ,/, two/JJ different/JJ types/NNS of/IN sequences/NNS with/IN dual/JJ rotational/JJ symmetry/NN [/NN CAC-/NN (/NN N11/NN to/IN N18/NN )/NN -GTG/NN and/CC TGT-/NN (/NN N10/NN to/IN N14/NN )/NN -ACA/NN ]/NN were/VBD found/VBN ;/: these/DT sequences/NNS are/VBP similar/JJ to/IN NtrC/NEWGENE and/CC NifA/NEWGENE upstream/NEWGENE activator/NEWGENE sequences/NEWGENE ,/, respectively/RB ./.
@@11151826989 Workload/NNS ,/, UAPs/NNP ,/, and/CC you/PRP ./.
@@113272921178 This/DT unique/JJ location/NN of/IN cavernous/JJ malformation/NN is/VBZ associated/VBN with/IN a/DT risk/NN of/IN permanent/JJ loss/NN of/IN the/DT vision/NN ./.
@@103967939001 Results/NNS for/IN men/NNS who/WP drank/VBD up/JJ to/IN two/JJ drinks/NNS per/IN day/NN suggest/VB that/IN if/IN the/DT dependence/NN criteria/NNS were/VBD invalid/JJ ,/, reductions/NNS in/IN the/DT prevalence/NN of/IN specific/NN indicators/NN of/IN alcohol/NN dependence/NN would/MD range/VB from/IN 0/CD ./CD 3%/CD to/IN 5/CD ./CD 2%/CD ./.
@@92721382240 The/DT complete/JJ response/NN (/( CR/NN )/SYM rate/NN was/VBD 34%/JJ in/IN the/DT CODE/NNP with/IN rhG-CSF/NEWGENE group/NN and/CC 23%/JJ in/IN the/DT CODE/NNP alone/JJ group/NN ;/: the/DT median/JJ survival/NN was/VBD 59/CD and/CC 32/CD weeks/NNS ,/, respectively/RB ,/, in/IN these/DT groups/NNS (/( P/NN =/SYM 0/CD ./CD 004/CD )/SYM ./.
@@87096376038 The/DT data/NN further/RB indicate/VB that/IN the/DT IL-7R/NEWGENE alpha/NEWGENE chains/NEWGENE are/VBP directly/RB involved/VBN in/IN the/DT activation/NN of/IN JAKs/NEWGENE and/CC STATs/NEWGENE and/CC have/VB a/DT major/JJ role/NN in/IN proliferative/JJ signaling/NN in/IN precursor/NN B/NNP cells/NNS ./.
@@87225683990 Chromatin/NNS repression/NN of/IN these/DT replacement/NN genes/NNS would/MD be/VB avoided/VBN ,/, consistent/JJ with/IN the/DT high/NN ,/, constitutive/JJ expression/NN of/IN replacement/NN H3/NEWGENE histone/NEWGENE genes/NEWGENE in/IN plants/NNS ./.
@@63106082784 The/DT mutants/NNS were/VBD obtained/VBN by/IN substitution/NN into/IN a/DT molecular/JJ clone/NN of/IN M-MuLV/NN DNA/NN by/IN DNA/NN from/IN two/JJ acutely/RB transforming/JJ viruses/NNS ,/, Ableson/NNP MuLV/NN (/( Ab-MuLV/NNP )/SYM and/CC Moloney/NN murine/JJ sarcoma/NN virus/NN (/( M-MSV/NNP )/SYM ./.
@@77637277816 Plasmids/NNS pAMS12/NN ,/, pAMS13/NN and/CC pAMS14/NN were/VBD transformed/VBN into/IN a/DT laboratory/NN strain/NN of/IN Saccharomyces/NN cerevisiae/NN ,/, whereas/IN pAMS15/NN was/VBD stably/RB introduced/VBN into/IN two/JJ commercial/JJ wine/NN yeast/NN strains/NNS ./.
@@31042484040 Within/IN Stage/NNP IA/NN ,/, 141/CD patients/NNS had/VBP well/VB differentiated/VBN tumor/NN (/( G1/NN )/SYM ,/, 20/CD had/VBP moderately/RB well/VB differentiated/VBN tumor/NN (/( G2/NN )/SYM ,/, and/CC 12/CD patients/NNS had/VBP poorly/RB differentiated/VBN (/( G3/NN )/SYM ./.
@@99313919927 Complete/JJ recovery/NN of/IN liver/NN function/NN after/IN this/DT surgery/NN tended/VBN to/IN be/VB slow/JJ ./.
@@18695658847 USF/NEWGENE synthesized/VBN in/IN an/DT in/NN vitro/FW transcription/NN and/CC translation/NN system/NN also/RB binds/VBZ to/IN the/DT ADH/NEWGENE promoter/NEWGENE as/RB well/VB as/IN to/IN the/DT MLP/NN ./.
@@88514348826 In/NN lean/JJ mice/NNS ,/, the/DT fat/NN //NN water/NN intensity/NN ratio/NN was/VBD about/RB 1/CD :/: 4/CD ,/, about/JJ half/NN that/IN in/IN normal/JJ mice/NNS ./.
@@91645439112 MATERIAL/NNP AND/CC METHODS/IN :/: The/DT authors/NNS analyzed/VBN 41/CD persons/NNS formerly/RB submitted/VBN to/IN surgery/NN (/( after/IN 8/CD years/NNS and/CC 4/CD months/NNS ,/, as/IN a/DT mean/JJ )/SYM ,/, 31/CD to/IN highly/RB selective/JJ vagotomy/NN ,/, and/CC 10/CD to/IN truncal/JJ or/CC selective/JJ vagotomy/NN plus/IN gastroduodenal/JJ drainage/NN ./.
@@4547803248 Ultimate/NNP strengthes/NNS seem/VBP to/IN be/VB reached/VBN for/IN cast/JJ cobalt/NN alloys/NNS ,/, whereas/IN titanium/NN alloys/NNS ,/, such/JJ as/IN Ta/NN 6/NN V/NN ,/, present/VB very/RB high/JJ fatigue/NN limit/NN under/IN corrosion/NN ./.
@@98235619808 Low-grade/NNP gastric/JJ MALT/NN lymphoma/NN and/CC helicobacter/NN heilmannii/NN (/( Gastrospirillum/NN hominis/JJ ./.
@@79267486093 NOT4/NEWGENE interacts/VBZ with/IN NOT1/NEWGENE and/CC NOT3/NEWGENE in/IN the/DT two-hybrid/JJ assay/NN ,/, and/CC overexpression/NN of/IN NOT3/NEWGENE or/CC NOT4/NEWGENE suppresses/VBZ not1/NEWGENE and/CC not2/NEWGENE mutations/NN ./.
@@28839639901 Six/CD patients/NNS with/IN human/JJ T-cell/NN lymphotropic/JJ virus/NN type/NN I/NN (/( HTLV-I/NN )/NN -associated/NN myelopathy/NN (/( HAM/IN )/SYM were/VBD studied/VBN by/IN electrophysiologic/JJ methods/NNS ./.
@@10891632715 The/DT naltrexone/NN //NN lofexidine/NN combination/NN was/VBD associated/VBN with/IN a/DT more/RB rapid/JJ resolution/NN of/IN the/DT opiate/JJ withdrawal/NN syndrome/NN than/IN a/DT 7-day/CD lofexidine-only/JJ treatment/NN schedule/NN ,/, without/IN substantial/JJ increases/NNS in/IN withdrawal/NN symptoms/NNS or/CC hypotensive/JJ side-effects/NNS ./.
@@21250167574 PBSX/ORG is/VBZ induced/VBN by/IN agents/NNS which/WDT elicit/VBP the/DT SOS/NN response/NN ./.
@@97221614369 Regulation/NN of/IN embryonic/JJ growth/NN and/CC lysosomal/JJ targeting/NN by/IN the/DT imprinted/JJ Igf2/NEWGENE //NEWGENE Mpr/NEWGENE gene/NEWGENE ./.
@@72353559831 Five/CD control/NN subjects/NNS with/IN COPD/NN ,/, who/WP performed/VBD the/DT same/JJ sequence/NN of/IN tests/NNS without/IN breathing/JJ 30%/CD O2/NN ,/, showed/VBD no/DT change/NN in/IN flow/NN rates/NNS or/CC density/NN dependence/NN ./.
@@107560202850 The/DT protein/NN was/VBD associated/VBN with/IN purified/VBN vaccinia/NN virus/NN particles/NNS and/CC with/IN membranes/NNS of/IN immature/JJ and/CC mature/JJ virions/NNS that/WDT were/VBD visualized/VBN by/IN electron/NN microscopy/NN of/IN infected/VBN cells/NNS ./.
@@78923535234 Both/DT factors/NNS demonstrated/VBD significant/JJ correlations/NNS with/IN rCBF/NN in/IN the/DT medial/JJ prefrontal/JJ cortex/NN and/CC frontal/JJ polar/JJ cortex/NN while/CC for/IN each/DT factor/NN there/RB were/VBD also/RB unique/JJ patterns/NNS of/IN correlations/NNS with/IN posterior/JJ brain/NN regions/NNS ./.
@@84441844419 Sudomoina/NNP ,/, A/NNP ./NNP
@@100971206966 An/DT exon/NN that/WDT prevents/VBZ transport/NN of/IN a/DT mature/JJ mRNA/NN ./.
@@73859207221 The/DT results/NNS revealed/VBN increased/VBN blood/NN lead/NN level/NN associated/VBN with/IN decreased/VBN blood/NEWGENE haemoglobin/NEWGENE and/CC increased/VBN urinary/JJ excretion/NN of/IN delta/JJ amino/JJ levulinic/JJ acid/NN ./.
@@95531435160 An/DT in/NN vivo/NN ZAP-70/NEWGENE substrate/NN ,/, SLP-76/NEWGENE ,/, implicated/VBN in/IN Erk/NEWGENE activation/NN ,/, also/RB became/VBD rapidly/RB tyrosine-phosphorylated/JJ in/IN Jurkat/NN cells/NNS ,/, but/CC not/RB in/IN P116/NNP cells/NNS ,/, upon/IN treatment/NN with/IN H2O2/NN ./.
@@109651352356 Promoter/NNS activity/NN was/VBD dose-dependently/RB inhibited/VBN by/IN cotransfection/NN with/IN either/DT ras/NEWGENE or/CC mos/NEWGENE oncogenes/NEWGENE ,/, but/CC oncogene/NN inhibition/NN was/VBD reversed/VBN and/CC the/DT overall/JJ activity/NN increased/VBN when/CC cells/NNS were/VBD treated/VBN with/IN the/DT MAP/NEWGENE kinase/NEWGENE kinase/NEWGENE (/( MKK/NEWGENE )/SYM inhibitor/NN PD98059/NN ./.
@@17386532320 Bone/NN and/CC bones/NNS ./.
@@80417939733 In/NN earlier/JJR studies/NNS we/PRP identified/VBD several/DT regulatory/JJ elements/NNS that/WDT control/VBP transcriptional/JJ activation/NN and/CC aerobic/JJ repression/NN of/IN one/PRP of/IN these/DT genes/NNS ,/, COX5b/NEWGENE ./.
@@85296628648 Furthermore/RB ,/, we/PRP have/VBP identified/VBN a/DT soluble/JJ form/NN of/IN ERp57/NEWGENE //NEWGENE GRP58/NEWGENE by/IN Western/JJ blotting/NN and/CC biosynthetic/JJ labeling/NN ./.
@@36882025749 The/DT models/NNS accurately/RB localized/VBN the/DT common/JJ boundaries/NNS between/IN the/DT PBB/NN and/CC CN/NN ./NN
@@64732526279 This/DT experiment/NN was/VBD conducted/VBN to/IN determine/VB if/IN the/DT sex/NN or/CC actual/JJ egg/NN production/NN was/VBD the/DT important/JJ factor/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@37819484466 Respiratory/NNP adaptation/NN to/IN chronic/JJ hypoxia/NN in/IN newborn/JJ rats/NNS ./.
@@109381027096 Collectively/RB ,/, these/DT and/CC previously/RB published/VBN data/NN suggest/VB a/DT model/NN where/CC NS1/NEWGENE recruits/NNS eIF4GI/NEWGENE specifically/RB to/IN the/DT 5'/CD untranslated/JJ region/NN (/( 5'/CD UTR/NNS )/SYM of/IN the/DT viral/JJ mRNA/NN ,/, allowing/VBG for/IN the/DT preferential/JJ translation/NN of/IN the/DT influenza/NN virus/NN messengers/NNS ./.
@@36782694341 Today/NN there/RB is/VBZ no/DT doubt/NN that/WDT elevated/VBD plasma/NN cholesterol/NN levels/NNS should/MD be/VB lowered/VBN first/JJ by/IN dietary/JJ modification/NN even/VB in/IN early/JJ childhood/NN ,/, beginning/NN at/IN the/DT age/NN of/IN two/JJ years/NNS ./.
@@98805431991 HEED/NEWGENE was/VBD found/VBN to/IN bind/NN to/IN MA/NEWGENE protein/NEWGENE in/IN vitro/FW ,/, as/RB efficiently/RB as/IN in/IN vivo/NN in/IN yeast/NN cells/NNS ./.
@@109397852567 Patients/NNS were/VBD randomly/RB assigned/VBN to/IN treatment/NN with/IN the/DT ACE/NEWGENE inhibitor/NN perindopril/NN (/( and/CC the/DT diuretic/JJ indapamide/NN for/IN those/DT with/IN no/DT definite/JJ indication/NN for/IN or/CC contraindication/NN to/IN treatment/NN with/IN a/DT diuretic/JJ )/SYM or/CC matching/JJ placebo/NN (/NN s/NN )/NN ./.
@@57972875730 I/NNP ./NNP
@@79139262448 Northern/NNP analysis/NN of/IN RNA/NN samples/NNS isolated/VBN from/IN ammonium-grown/JJ cultures/NNS of/IN the/DT ntcA/NEWGENE mutant/NEWGENE showed/VBD reduced/VBN amounts/NNS of/IN glnA/NEWGENE message/NEWGENE and/CC the/DT absence/NN of/IN a/DT 1/CD ./CD 7-kb/CD transcript/NN ./.
@@88361727427 RVR/NEWGENE 'loss/NN of/IN function'/NN studies/NNS by/IN constitutive/JJ over-expression/NN of/IN a/DT dominant/JJ negative/JJ RVR/NEWGENE delta/NEWGENE E/NEWGENE resulted/VBN in/IN increased/VBN levels/NNS of/IN p21Cip1/NEWGENE //NEWGENE Waf1/NEWGENE and/CC myogenin/NEWGENE mRNAs/NEWGENE after/IN serum/JJ withdrawal/NN ./.
@@984092838 Consistent/JJ with/IN this/DT ,/, purified/VBN Dlk/NEWGENE phosphorylated/VBN core/NN histones/NEWGENE H3/NEWGENE ,/, H2A/NEWGENE and/CC H4/NEWGENE as/IN exogenous/JJ substrates/NNS and/CC endogenous/JJ histone/NEWGENE H3/NEWGENE in/IN kinase/NN assays/NNS with/IN nuclear/JJ extracts/NNS ./.
@@53885675518 The/DT effects/NNS of/IN taloximine/NN and/CC aminophylline/NN on/IN isolated/VBN human/JJ smooth/JJ muscle/NN ./.
@@21377042562 In/NN a/DT highly/RB select/VB group/NN of/IN stable/JJ hypertensive/JJ patients/NNS ,/, we/PRP have/VBP assessed/VBN the/DT strength/NN of/IN association/NN between/IN various/JJ blood/NN pressure/NN measurements/NNS (/( 24/CD h/NN average/JJ automated/JJ ambulatory/JJ blood/NN pressure/NN ,/, 4/CD h/NN automated/JJ ambulatory/JJ morning/NN average/JJ blood/NN pressure/NN ,/, multiple/JJ office/NN visit/NN average/JJ blood/NN pressure/NN ,/, and/CC a/DT single/JJ office/NN visit/NN average/JJ blood/NN pressure/NN )/SYM and/CC various/JJ echocardiographic/JJ indices/NNS of/IN hypertensive/JJ cardiac/NN target/NN organ/NN damage/NN (/( left/NN atrial/JJ diameter/NN ,/, left/NN ventricular/JJ end/NN diastolic/JJ diameter/NN ,/, posterior/JJ wall/NN thickness/NN ,/, combined/JJ wall/NN thickness/NN ,/, relative/JJ wall/NN thickness/NN ,/, left/NN ventricular/JJ mass/JJ and/CC mass/JJ index/NN ,/, and/CC combined/JJ wall/NN thickness/NN //NN left/NN ventricular/JJ diastolic/JJ diameter/NN ratio/NN )/SYM ./.
@@7607233120 The/DT structural/JJ gene/NN encoding/VBG the/DT novel/JJ lantibiotic/JJ epilancin/NEWGENE K7/NEWGENE from/IN Staphylococcus/NN epidermidis/NN K7/NN was/VBD cloned/VBN and/CC its/PRP nucleotide/NN sequence/NN was/VBD determined/VBN ./.
@@104096568640 Overexpression/NNS of/IN H411/NEWGENE cDNA/NEWGENE in/IN the/DT RAW/NNP 264/CD ./CD 7/CD macrophage/NN cell/NN line/NN promoted/VBD an/DT increased/VBN growth/NN rate/NN ,/, suggesting/VBG that/DT expression/NN of/IN H411/NEWGENE is/VBZ part/NN of/IN the/DT proliferative/JJ cell/NN response/NN to/IN LPS/NN ./.
@@74153407269 Number/NN and/CC size/NN of/IN the/DT myelin/NN structures/NNS in/IN the/DT pneumocytes/NN typ/NN II/NN increased/VBD simultaneously/RB ./.
@@103667221833 cDNA/NN and/CC structural/JJ organization/NN of/IN the/DT gene/NEWGENE Pole1/NEWGENE for/IN the/DT mouse/NEWGENE DNA/NEWGENE polymerase/NEWGENE epsilon/NEWGENE catalytic/NEWGENE subunit/NEWGENE ./.
@@26869858031 A/DT transcription/NN factor/NN exclusion/NN assay/NN was/VBD used/VBN to/IN show/NN that/IN the/DT PCF1/NEWGENE mutation/NEWGENE affects/VBP two/JJ distinct/JJ stages/NNS in/IN transcription/NN :/: one/PRP prior/NN to/IN and/CC one/PRP after/IN stable/JJ complex/NN formation/NN ;/: and/CC that/IN these/DT effects/NNS are/VBP mediated/JJ by/IN a/DT component/NN of/IN the/DT stable/JJ complex/NN ./.
@@102234988559 Efficacy/NNS was/VBD determined/VBN by/IN responses/NNS to/IN question/NN 3/CD (/( ability/NN to/IN achieve/VB an/DT erection/NN )/SYM and/CC question/NN 4/CD (/( ability/NN to/IN maintain/VB an/DT erection/NN )/SYM of/IN the/DT 15-item/NNP International/NNP Index/NNP of/IN Erectile/NNP Function/NN (/( IIEF/NN )/SYM ./.
@@19671301292 The/DT 1489-base/CD pair/NN EFIA/NEWGENE cDNA/NN encodes/VBZ a/DT 322-amino/JJ acid/NN protein/NN which/WDT is/VBZ nearly/RB identical/JJ to/IN two/JJ previously/RB described/VBN human/JJ DNA/NN binding/JJ proteins/NNS ./.
@@95449913974 PRL/NEWGENE receptor/NEWGENE also/RB activates/VBZ SHP-2/NEWGENE ,/, a/DT cytosolic/NEWGENE tyrosine/NEWGENE phosphatase/NEWGENE ./.
@@73230637184 Thirty-one/JJ age-matched/NN ,/, conscious/JJ ,/, virgin/JJ ,/, male/JJ Sprague-Dawley/NN rats/NNS and/CC spontaneously/RB hypertensive/JJ rats/NNS (/( SHRs/NNS )/SYM were/VBD individually/RB injected/VBN with/IN a/DT single/JJ subcutaneous/JJ dose/NN of/IN 85/CD mg/NN //NN kg/NN dl-isoproterenol/JJ to/IN determine/VB the/DT degree/NN and/CC time/NN course/NN of/IN drug-induced/JJ cardiac/JJ failure/NN and/CC functional/JJ recovery/NN ./.
@@111399748849 Termination/NN of/IN induced/VBN VT/NN on/IN the/DT first/JJ attempt/NN was/VBD comparable/JJ with/IN BV/NN pacing/NN (/( 87/CD ./CD 4%/CD )/SYM versus/IN RV/NN pacing/NN (/( 89/CD ./CD 6%/CD )/SYM ./.
@@97907671 We/PRP mapped/VBD two/JJ overlapping/JJ expressed/VBN sequence/NN tag/NN clones/NNS within/IN a/DT genomic/JJ contig/NN on/IN human/JJ chromosome/NN 5/CD ,/, band/NN q31/NN ./.
@@791754027 60/CD patients/NNS were/VBD entered/VBN into/IN a/DT randomised/JJ study/NN comparing/VBG vindesine/NN (/( 3/CD mg/CD //CD m2/CD //CD week/CD )/SYM plus/IN interferon-alpha/NEWGENE 2b/NEWGENE (/( 6/CD U/NN //NN m2/NN 3/CD times/NNS per/IN week/NN )/SYM to/IN vindesine/NN alone/RB or/CC to/IN interferon/NEWGENE alone/RB for/IN the/DT treatment/NN of/IN metastatic/JJ malignant/JJ melanoma/NN ./.
@@96513834953 However/RB ,/, mutations/NNS in/IN the/DT HNF-4/NEWGENE binding/NEWGENE site/NEWGENE on/IN element/NEWGENE CIIB/NEWGENE and/CC inhibition/NN of/IN HNF-4/NEWGENE synthesis/NN in/IN HepG2/NNP cells/NNS by/IN antisense/NN HNF-4/NEWGENE constructs/NEWGENE decreased/VBD the/DT apoCII/NEWGENE promoter/NEWGENE activity/NN to/IN 25-40%/NN of/IN the/DT control/NN ,/, indicating/VBG that/IN HNF-4/NEWGENE is/VBZ a/DT positive/JJ regulator/NN of/IN the/DT apoCII/NEWGENE gene/NEWGENE ./.
@@114086047679 Our/PRP results/NNS indicate/VBP that/IN D/NEWGENE (/NEWGENE 4/NEWGENE )/NEWGENE and/CC D/NEWGENE (/NEWGENE 2L/NEWGENE )/NEWGENE receptors/NEWGENE activate/VBP the/DT ERK/NEWGENE kinase/NEWGENE cascade/NN by/IN first/JJ mobilizing/JJ signaling/NN by/IN the/DT PDGF/NEWGENE receptor/NEWGENE ,/, followed/VBN by/IN the/DT subsequent/JJ activation/NN of/IN ERK1/NEWGENE //NEWGENE 2/NEWGENE by/IN pathways/NNS associated/JJ with/IN this/DT receptor/NEWGENE tyrosine/NEWGENE kinase/NEWGENE ./.
@@34034124100 The/DT effects/NNS of/IN anabolic/JJ implants/NNS on/IN rate/NN ,/, composition/NN and/CC energetic/JJ efficiency/NN of/IN growth/NN were/VBD determined/VBN in/IN steers/VBZ fed/VBN diets/NNS varying/JJ in/IN forage/NN and/CC grain/NN content/NN ./.
@@10349443205 The/DT results/NNS of/IN the/DT lab/NN and/CC field/NN tests/NNS yielded/VBD high/JJ levels/NNS of/IN infestation/NN in/IN larvae/NNS with/IN values/NNS ranging/VBG from/IN 90/CD to/IN 100%/CD and/CC from/IN 85/CD to/IN 95%/CD ,/, respectively/RB ./.
@@97380103472 The/DT FAS/NEWGENE promoter/NEWGENE was/VBD up-regulated/IN by/IN insulin/NEWGENE through/RB the/DT proximal/JJ insulin/NEWGENE response/NEWGENE sequence/NEWGENE containing/JJ an/DT E-box/NN motif/NN at/IN the/DT -65-base/CD pair/NN position/NN ./.
@@90675778631 In/NN cell/NN lines/NNS transformed/VBN by/IN BCR/NEWGENE //NEWGENE ABL/NEWGENE ,/, CRKL/NEWGENE was/VBD tyrosine/NN phosphorylated/VBN ,/, while/CC CRK/NEWGENE was/VBD not/RB ./.
@@106626144046 The/DT two-hybrid/JJ assay/NN was/VBD then/RB performed/VBN using/VBG full-length/JJ genes/NNS of/IN CI/NEWGENE ,/, HC-Pro/NEWGENE ,/, P1/NEWGENE ,/, P3/NEWGENE ,/, and/CC CP/NEWGENE ,/, but/CC no/DT heterologous/JJ interactions/NNS were/VBD detected/VBN ./.
@@313734666 The/DT nucleolin/NEWGENE gene/NEWGENE extends/VBZ over/RB 9000/CD base-pairs/NNS and/CC is/VBZ split/JJ into/IN 14/CD exons/NNS that/WDT encode/VBP the/DT 706/CD amino/JJ acid/NN residues/NNS of/IN the/DT protein/NN ./.
@@54638379257 The/DT absolute/JJ configuration/NN at/IN C-2/NN in/IN monocrotalic/JJ acid/NN ./.
@@13571902450 With/IN the/DT exception/NN of/IN mutants/NNS that/WDT remove/VBP the/DT membrane/NN anchor/NN domain/NN ,/, all/DT of/IN the/DT mutant/JJ glycoproteins/NNS retained/VBD the/DT ability/NN to/IN cause/NN fusion/NN of/IN CD4-bearing/JJ cells/NNS ./.
@@95030178674 We/PRP also/RB present/VBP evidence/NN that/IN human/NEWGENE HYAL1/NEWGENE is/VBZ identical/JJ to/IN an/DT uncharacterized/JJ gene/NN positionally/RB cloned/VBN by/IN others/NNS from/IN chromosome/NN 3p21/NN ./NN 3/NN that/WDT is/VBZ homozygously/RB deleted/VBN in/IN several/DT small-cell/JJ lung/NN carcinoma/NN cell/NN lines/NNS ./.
@@86681584110 Furthermore/RB ,/, strains/NNS with/IN mutant/NEWGENE RPM1/NEWGENE genes/NEWGENE also/RB accumulate/VBP precursor/NEWGENE Rpm1r/NEWGENE ,/, suggesting/VBG that/IN mutations/NNS in/IN either/DT gene/NN can/MD lead/NN to/IN similar/JJ biogenesis/NN defects/NNS ./.
@@114166501288 Isolated/JJ Systolic/NNP Hypertension/NN :/: An/DT Update/NNP ./.
@@89184644671 STK/VBG //VBG RON-expressing/VBG Ba/NNP //NNP F3/NNP pro-B/NNP cells/NNS (/( BaF/NN //NN STK/NN )/SYM exhibited/VBN MSP-dependent/NNP growth/NN ,/, whereas/IN STK/NEWGENE //NEWGENE RON-expressing/VBG mouse/NN erythroleukaemia/NN cells/NNS (/( MEL/NNP //NNP STK/NEWGENE )/SYM displayed/VBN MSP-induced/JJ apoptosis/NN ./.
@@30976439999 Also/RB ,/, the/DT BALB/NEWGENE //NEWGENE c/NEWGENE gene/NEWGENE contains/VBZ a/DT single/JJ substitution/NN in/IN a/DT conserved/VBN octamer/NN sequence/NN approximately/RB equal/VB to/IN 100/CD nucleotides/NNS upstream/RB of/IN the/DT coding/JJ region/NN ,/, which/WDT could/MD affect/VB its/PRP expression/NN ./.
@@98847476758 Immunological/JJ testing/NN was/VBD performed/VBN on/IN all/DT brewery/JJ workers/NNS and/CC some/DT control/NN volunteers/NNS using/VBG skin/NN prick/NN testing/NN with/IN hops/NNS ,/, barley/NN ,/, and/CC yeast/NN antigens/NNS as/RB well/VBP as/IN other/DT nonoccupational/JJ allergens/NNS ,/, and/CC by/IN determining/JJ total/JJ serum/NEWGENE IgE/NEWGENE levels/NNS ./.
@@76165633784 Purified/VBN CarP/NEWGENE binds/VBZ in/IN vitro/FW to/IN the/DT carAB/NEWGENE control/NEWGENE region/NEWGENE and/CC protects/VBZ against/IN DNase/NEWGENE I/NEWGENE two/JJ approximately/RB 25/CD bp/NN long/JJ stretches/NNS ,/, one/PRP of/IN which/WDT is/VBZ located/VBN just/RB downstream/RB of/IN the/PDT GATC/NEWGENE sequence/NEWGENE ./.
@@98077559633 An/DT intact/JJ neurovascular/JJ supply/NN is/VBZ essential/JJ for/IN the/DT viability/NN of/IN a/DT muscle/NN flap/NN ./.
@@41891587201 Prevention/NNP of/IN maternal/JJ Rh/NN sensitization/NN :/: anti-Rh/NEWGENE immune/NEWGENE globulin/NEWGENE ./.
@@10704196275 The/DT pCMBS-reactive/JJ sulfhydryl/NN groups/NNS were/VBD located/VBN exclusively/RB in/IN the/DT exofacial/JJ half/NN of/IN the/DT plasma/NN membrane/NN and/CC ,/, when/CC presented/VBD in/IN a/DT helical/JJ model/NN ,/, lie/VB along/IN one/PRP side/NN of/IN the/DT helices/NNS ./.
@@30651409350 These/DT mutations/NNS alter/VBP two/JJ regions/NNS of/IN GAL4/NEWGENE protein/NEWGENE :/: the/DT DNA/NN binding/JJ domain/NN ,/, and/CC the/DT transcription/NN activation/NN domain/NN ./.
@@99867965897 However/RB ,/, deletions/NNS of/IN the/DT C/NN terminal/NN 11/NN or/CC 14/CD amino/JJ acids/NNS had/VBP more/RB substantial/JJ effects/NNS ./.
@@23474077559 In/NN the/DT local/JJ geomagnetic/JJ field/NN ,/, the/DT animals/NNS preferred/VBD the/DT SE-sector/NN ./.
@@96386508100 It/PRP contains/VBZ a/DT 5'-noncoding/JJ region/NN (/( NCR/NNP )/SYM of/IN 73/CD nucleotides/NNS ,/, five/CD open/JJ reading/JJ frames/NNS (/( ORFs/NNS 1/CD to/IN 5/CD )/SYM which/WDT encode/VBP proteins/NNS with/IN M/NN (/NN r/NN )/NN 160/NEWGENE kDa/NEWGENE RNA-dependent/NEWGENE RNA/NEWGENE polymerase/NEWGENE (/NEWGENE ORF1/NEWGENE )/NEWGENE ,/, 26/NEWGENE kDa/NEWGENE movement/NEWGENE protein/NEWGENE 1/NEWGENE (/NEWGENE ORF2/NEWGENE )/NEWGENE ,/, 13/NEWGENE kDa/NEWGENE movement/NEWGENE protein/NEWGENE 2/NEWGENE (/NEWGENE ORF3/NEWGENE )/NEWGENE ,/, 10/NEWGENE kDa/NEWGENE movement/NEWGENE protein/NEWGENE 3/NEWGENE (/NEWGENE ORF4/NEWGENE )/NEWGENE ,/, 24/NEWGENE kDa/NEWGENE coat/NEWGENE protein/NEWGENE (/NEWGENE OFR5/NEWGENE )/NEWGENE ,/, and/CC a/DT 3'/CD NCR/NNP of/IN 76/CD nucleotides/NNS ./.
@@115351401410 Audiological/JJ findings/NNS in/IN pregnancy/NN ./.
@@29205915219 Hemodynamic/NN assessment/NN was/VBD obtained/VBN before/IN and/CC following/IN administration/NN of/IN digoxin/NN 10/CD micrograms/NN //NN kg/NN IV/NN or/CC dopamine/NN ,/, 5/CD to/IN 12/CD micrograms/NN //NN kg/NN //NN min/NN IV/DT ./DT
@@68588056660 Both/DT groups/NNS were/VBD subjected/VBN to/IN tests/NNS of/IN delayed/JJ hypersensitivity/NN with/IN Candidin/VB ,/, Trycophytin/NNP and/CC Tuberculin/NN ./.
@@79572439715 Notably/RB ,/, these/DT residues/NNS are/VBP located/VBN in/IN different/JJ domains/NNS ./.
@@92576511653 The/DT human/NN U4/NEWGENE //NEWGENE U6/NEWGENE snRNP/NEWGENE contains/VBZ 60/CD and/CC 90kD/NN proteins/NN that/WDT are/VBP structurally/RB homologous/JJ to/IN the/DT yeast/NN splicing/JJ factors/NNS Prp4p/NEWGENE and/CC Prp3p/NEWGENE ./.
@@96696412751 The/DT diagnostic/JJ accuracy/NN of/IN serum/JJ PE-1/NEWGENE was/VBD 0/CD ./CD 80/CD ,/, and/CC that/IN of/IN amylase/NEWGENE 0/CD ./CD 97/CD ./.
@@3297181450 Six/CD healthy/JJ male/JJ subjects/NNS received/VBD single/JJ oral/JJ doses/NNS of/IN regular/JJ release/NN (/( RR/NN )/SYM quinidine/NN sulfate/NN ,/, sustained/JJ release/NN (/( SR/NN )/SYM quinidine/NN bisulfate/NN and/CC the/DT same/JJ dose/NN of/IN the/DT SR/NN product/NN with/IN food/NN (/( SR-F/NN )/SYM ./.
@@24549762404 We/PRP discuss/VBP the/DT results/NNS in/IN relation/NN to/IN previous/JJ systems/NNS for/IN parcellating/VBG the/DT posterior/JJ ectosylvian/JJ gyrus/NN of/IN the/DT cat/NN and/CC consider/VB the/DT possibility/NN that/IN divisions/NNS of/IN the/DT feline/NN posterior/NN ectosylvian/JJ gyrus/NN correspond/VB directly/RB to/IN areas/NNS making/VBG up/VB the/DT superior/JJ temporal/JJ gyrus/NN in/IN primates/NNS ./.
@@9771555555 The/DT results/NNS indicate/VBP that/DT anthraquinone/NN sennoside/NN B/NN and/CC rhein/NN are/VBP weakly/RB genotoxic/JJ ./.
@@1036714229 Studies/NNS of/IN biochemical/JJ and/CC morphological/JJ changes/NNS (/( between/IN normal/JJ and/CC treated/VBN animals/NNS )/SYM show/VB that/DT chrysotile/NN induces/VBZ an/DT increase/NN in/IN the/DT lung/NN free/JJ cell/NN population/NN and/CC pulmonary/JJ surfactant/JJ levels/NNS ./.
@@10226838166 The/DT motility/NN of/IN sperm/NN ,/, except/VB for/IN those/DT adjacent/JJ to/IN both/DT electrodes/NNS ,/, did/VBD not/RB change/VB after/IN stimulation/NN for/IN 60s/CD ,/, despite/IN a/DT high/JJ electrical/JJ energy/NN ./.
@@91152473079 11-Aminoundecanoyl-SK-NH2/NN and/CC 11-aminoundecanoyl-SH-NH2/NN establish/VB that/IN a/DT simple/JJ alkyl/NN backbone/NN can/MD maintain/VB an/DT appropriate/JJ distance/NN between/IN three/CD elements/NNS critical/JJ for/IN recognition/NN by/IN the/DT fungal/JJ enzyme's/NN peptide-binding/NN site/NN :/: a/DT simple/JJ omega-terminal/JJ amino/JJ group/NN ,/, a/DT beta-hydroxyl/NN ,/, and/CC an/DT epsilon-amino/NN group/NN or/CC an/DT imidazole/NN ./.
@@113027044842 Homo-oligomerisation/NNP and/CC nuclear/JJ localisation/NN of/IN mouse/NEWGENE histone/NEWGENE deacetylase/NEWGENE 1/NEWGENE ./CD
@@75927233535 Phorbol/IN esters/NNS stimulated/VBD phosphorylation/NN of/IN CSK/NEWGENE 35H/NEWGENE proteins/NEWGENE ,/, thus/RB emphasizing/VBG that/IN sequences/NNS isolated/VBN according/VBG to/IN PKC/NEWGENE binding/JJ activity/NN in/IN vitro/FW are/VBP also/RB PKC/NEWGENE substrates/NN in/IN vivo/NN ./.
@@43257364933 Serodiagnosis/NNS of/IN ectromelia/NN in/IN laboratory/NN mice/NNS ./.
@@97161835512 TBP/NEWGENE can/MD be/VB phosphorylated/VBN in/IN vitro/FW by/IN extracts/NNS of/IN U937/CD cells/NNS or/CC by/IN bacterially/RB expressed/JJ activated/VBN ERK2/NEWGENE ;/: the/DT phosphorylation/NN sites/NNS were/VBD mapped/VBN to/IN ERK/NEWGENE kinase/NEWGENE consensus/NEWGENE sites/NEWGENE in/IN the/DT TBP/NEWGENE amino-terminal/NEWGENE domain/NEWGENE ./.
@@81249568092 Sodium-taurocholate-induced/JJ acute/JJ necrotizing/JJ pancreatitis/NN does/VBP not/RB affect/VB jejunal/JJ oxygenation/NN in/IN pigs/NNS ./.
@@97476519729 Laser/NNP ablation/NN has/VBZ been/VBN employed/VBN as/IN a/DT therapeutic/JJ measure/NN for/IN chronic/JJ pulmonary/JJ emphysema/NN ./.
@@17819239495 This/DT differential/JJ sensitivity/NN to/IN DB/NN ,/, as/IN measured/VBN by/IN a/DT lower/JJR concentration/NN of/IN DB/NN which/WDT caused/VBD loss/NN of/IN righting/JJ in/IN LS/NNP ,/, was/VBD accompanied/VBN by/IN an/DT equal/NN rate/NN of/IN water-soluble/JJ barbiturate/NN brain/NN distribution/NN and/CC elimination/NN in/IN the/DT two/JJ lines/NNS ./.
@@87942541158 In/NN the/DT SPK/NN and/CC PTA/NN category/NN ,/, anti-T-cell/JJ therapy/NN significantly/RB lowered/VBD the/DT risk/NN of/IN graft/NN loss/NN ./.
@@6233616033 Smoking/NNP was/VBD regarded/VBN as/IN the/DT major/JJ contribution/NN to/IN pulmonary/JJ dysfunction/NN ./.
@@111396051726 Deletion/NNS analysis/NN showed/VBN that/IN the/DT -321/NN //NN +41/NN sequence/NN was/VBD sufficient/JJ for/IN both/PDT the/DT constitutive/JJ promoter/NN activity/NN and/CC auto-activation/NN and/CC electrophoretic/JJ mobility/NN shift/NN assays/NNS identified/VBD the/DT interaction/NN of/IN C/NEWGENE //NEWGENE EBPs/NEWGENE and/CC Sp1/NEWGENE to/IN this/DT region/NN ./.
@@78483581100 A/DT reduction/NN of/IN the/DT aspartate/NEWGENE aminotransferase/NEWGENE activity/NN was/VBD observed/VBN from/IN 800/CD mg/CD //CD kg/CD b/CD ./CD w/CD ./CD //CD d/CD onwards/RB ./.
@@113278583106 Through/IN two/CD novel/JJ mechanisms/NNS ,/, Arf/NEWGENE inhibits/VBZ the/DT oncoprotein/NEWGENE Hdm2/NEWGENE ,/, a/DT negative/JJ regulator/NN of/IN p53/NEWGENE ./.
@@22201028789 Incidence/NNS correlated/VBN with/IN the/DT grade/NN of/IN oral/JJ hygiene/NN und/NN periodontal/JJ disease/NN ./.
@@87943638398 On/IN the/DT basis/NN of/IN its/PRP bZIP/NEWGENE structural/JJ homology/NN ,/, meq/NEWGENE is/VBZ perhaps/RB the/DT only/JJ member/NN of/IN the/DT jun-fos/NEWGENE gene/NEWGENE family/NEWGENE completely/RB viral/JJ in/IN origin/NN ./.
@@76059903272 Although/IN further/JJ studies/NNS are/VBP required/VBN to/IN determine/VB the/DT precise/JJ role/NN of/IN PEBP2/NEWGENE in/IN the/DT GM-CSF/NEWGENE promoter/NEWGENE activity/NN ,/, the/DT present/NN findings/NNS suggested/VBD the/DT importance/NN of/IN the/DT relative/JJ ratio/NN of/IN different/JJ PEBP2/NEWGENE isoforms/NEWGENE in/IN regulating/JJ the/DT levels/NNS of/IN the/DT promoter/NN activity/NN ./.
@@104136763381 FAK/NEWGENE localizes/VBZ to/IN sites/NNS of/IN transmembrane/NEWGENE integrin/NEWGENE receptor/NEWGENE clustering/NN and/CC facilitates/VBZ intracellular/JJ signaling/JJ events/NNS ./.
@@99900604037 In/NN concert/NN with/IN the/DT coactivator/NN CREB/NEWGENE binding/NEWGENE protein/NEWGENE //NEWGENE p300/NEWGENE ,/, which/WDT interacts/VBZ with/IN GABPalpha/NEWGENE ,/, the/DT binding/NN of/IN GABPalpha/NEWGENE and/NEWGENE -beta/NEWGENE to/IN the/DT dyad/NN symmetry/NN element/NN controls/VBZ the/DT induction/NN of/IN IL-16/NEWGENE promoter/NEWGENE in/IN T/NN cells/NNS ./.
@@86178003594 DNase/NEWGENE I/NEWGENE footprinting/VBG and/CC electrophoretic/JJ mobility/NN shift/NN assays/NNS indicate/VBP that/DT PBP/NEWGENE binds/VBZ to/IN the/DT half-site/NN of/IN each/DT palindrome/NN with/IN the/DT core/NEWGENE recognition/NEWGENE sequence/NEWGENE TGGGAG/NEWGENE ./.
@@31862703880 You/PRP make/VBP the/DT diagnosis/NN ./.
@@108783983526 In/NN hemodialyzed/JJ patients/NNS (/( Epo/NEWGENE and/CC Non-Epo/NNP group/NN )/SYM leptin/NEWGENE levels/NNS were/VBD significantly/RB higher/JJ when/CC compared/VBN to/IN CAPD/NN patients/NNS (/( Epo/NEWGENE and/CC Non-Epo/NNP group/NN ,/, respectively/RB )/SYM ./.
@@56729035637 Osteogenesis/NNS imperfecta/NN ./.
@@36089892880 This/DT region/NN of/IN 60/CD amino/JJ acids/NNS may/MD be/VB involved/VBN in/IN coiled-coil/NN interactions/NNS similar/JJ to/IN those/DT that/WDT facilitate/VBP the/DT filament/NN formation/NN in/IN the/DT rod/NN region/NN ./.
@@68082877659 Detection/NNS of/IN hemophilia/NN A/NN carriers/NN ./.
@@97053246151 DNase/NEWGENE I/NEWGENE footprinting/VBG and/CC electrophoretic/JJ mobility/NN shift/NN analyses/NNS revealed/VBD two/JJ hepatocyte/NEWGENE nuclear/NEWGENE factor-1/NEWGENE (/( HNF1/NEWGENE )/SYM ,/, three/CD CCAAT/NEWGENE //NEWGENE enhancer-binding/NEWGENE protein/NEWGENE (/( C/NEWGENE //NEWGENE EBP/NEWGENE )/SYM ,/, and/CC one/PRP consensus/NN palindromic/JJ thyroid/NEWGENE hormone/NEWGENE response/NEWGENE elements/NEWGENE within/IN the/DT first/JJ 215/CD base/NN pairs/NNS (/( bp/NN )/SYM of/IN the/DT promoter/NN sequence/NN of/IN rat/NEWGENE Std/NEWGENE ./.
@@15511769830 GR63178A/NN is/VBZ a/DT water-soluble/JJ analogue/NN of/IN mitoquidone/NN ,/, a/DT pentacyclic/JJ pyrroloquinone/NN ./.
@@97106144183 Identification/NNP of/IN a/DT proline-rich/JJ sequence/NN in/IN the/DT CD2/NEWGENE cytoplasmic/NEWGENE domain/NEWGENE critical/JJ for/IN regulation/NN of/IN integrin-mediated/JJ adhesion/NN and/CC activation/NN of/IN phosphoinositide/NEWGENE 3-kinase/NEWGENE ./.
@@15972722187 16/CD women/NNS were/VBD treated/VBN with/IN methadone/NN to/IN prevent/VB withdrawal/NN symptoms/NNS ./.
@@97890258093 Galphaq/NEWGENE ,/, Galpha12/NEWGENE ,/, and/CC Galpha13/NEWGENE ,/, but/CC not/RB Galphai/NEWGENE ,/, activate/VB SRF/NEWGENE through/RB RhoA/NEWGENE ./.
@@27133109296 Fundus/NNS changes/NNS in/IN (/( type/NN II/NN )/SYM mesangiocapillary/JJ glomerulonephritis/NN simulating/VBG drusen/NNS :/: a/DT histopathological/JJ report/NN ./.
@@93233663574 The/DT malate/NEWGENE synthase/NEWGENE gene/NEWGENE ,/, MLS1/NEWGENE ,/, of/IN the/DT yeast/NN Saccharomyces/NN cerevisiae/NN is/VBZ transcriptionally/RB regulated/VBN by/IN the/DT carbon/NN source/NN in/IN the/DT growth/NN medium/NN ./.
@@102055883924 OBJECTIVE/IN :/: To/TO follow-up/JJ prospectively/RB patients/NNS with/IN arthritis/NN after/IN infection/NN with/IN beta-haemolytic/JJ streptococci/NNS of/IN Lancefield/NNP group/NN A/DT (/( beta/NN HSA/NN )/SYM ,/, with/IN emphasis/NN on/IN clinical/JJ characteristics/NNS and/CC serological/JJ features/NNS ./.
@@20766207056 Gemfibrozil/NN in/IN hyperlipidaemic/JJ patients/NNS with/IN peripheral/JJ arterial/JJ disease/NN :/: some/DT undiscovered/JJ actions/NNS ./.
@@108400015382 Mucin/NEWGENE gene/NEWGENE expression/NN has/VBZ been/VBN shown/VBP to/IN be/VB altered/VBN in/IN many/JJ intestinal/JJ diseases/NNS and/CC especially/RB cancers/NNS of/IN the/DT gastrointestinal/JJ tract/NN ./.
@@13992069679 The/DT results/NNS support/NN earlier/JJR reports/VBZ that/IN collagenase/NEWGENE inhibitors/NN are/VBP useful/JJ in/IN controlling/VBG blister/NN formation/NN in/IN recessive/JJ dystrophic/JJ epidermolysis/NN bullosa/NN ./.
@@38188664500 Framingham/NN Type/NN A/NN behavior/NN was/VBD positively/RB associated/VBN with/IN diastolic/JJ blood/NN pressure/NN (/( r/JJ =/SYM 0/CD ./CD 17/CD ,/, p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM among/IN the/DT women/NNS ./.
@@83161005085 The/DT neglect/NN of/IN Richards's/NN theory/NN demonstrates/VBZ the/DT range/NN of/IN factors/NNS ,/, other/DT than/IN the/DT strictly/RB scientific/JJ ,/, which/WDT can/MD be/VB important/JJ in/IN determining/VBG the/DT influence/NN or/CC otherwise/RB of/IN a/DT psychological/JJ theory/NN ./.
@@89974904719 C/NEWGENE //NEWGENE EBP/NEWGENE beta/NEWGENE V/NEWGENE >/SYM A/DT selectively/RB binds/VBZ only/RB the/DT subset/NN of/IN C/NEWGENE //NEWGENE EBP/NEWGENE sites/NEWGENE that/WDT are/VBP also/RB DBP/NEWGENE sites/NEWGENE ,/, both/DT as/IN oligonucleotides/NNS and/CC within/IN the/DT natural/JJ contexts/NNS of/IN the/DT albumin/NEWGENE and/CC cholesterol/NEWGENE hydroxylase/NEWGENE promoters/NEWGENE ./.
@@18897539675 The/DT nucleotide/NN (/( nt/NN )/SYM sequences/NNS of/IN the/DT exons/NNS ,/, exon/NN //NN intron/NN boundaries/NNS and/CC 5'-/JJ and/CC 3'-untranslated/JJ regions/NNS were/VBD determined/VBN ./.
@@105340485248 The/DT first/JJ algorithm/NN ,/, FOREPROJ/NN ,/, is/VBZ a/DT fast-forward/JJ projection/NN algorithm/NN that/WDT allows/VBZ calculation/NN of/IN the/DT 3-D/JJ attenuation/NN correction/NN factors/NNS (/( ACF's/NNP )/SYM directly/RB from/IN a/DT two-dimensional/JJ (/( 2-D/JJ )/SYM transmission/NN scan/NN ,/, without/IN first/JJ reconstructing/VBG the/DT attenuation/NN map/NN and/CC then/RB performing/JJ a/DT 3-D/JJ forward/JJ projection/NN ./.
@@90043045057 The/DT aim/NN of/IN this/DT study/NN was/VBD to/IN assess/VB the/DT reproducibility/NN of/IN a/DT number/NN of/IN simplified/JJ clearance/NN methods/NNS using/VBG chromium-51/NN ethylenediamine/NN tetraacetic/JJ acid/NN (/( 51Cr-EDTA/JJ )/SYM and/CC to/IN compare/NN these/DT with/IN the/DT multiple/JJ blood/NN sample/NN technique/NN ./.
@@114356053684 Site-directed/JJ mutagenesis/NN of/IN CAR/NEWGENE revealed/VBD that/IN CAR/NEWGENE residues/NEWGENE Leu73/NEWGENE and/NEWGENE Lys121/NEWGENE and/NEWGENE //NEWGENE or/NEWGENE Lys123/NEWGENE are/VBP critical/JJ contact/JJ residues/NNS ,/, with/IN Tyr80/NN and/CC Tyr83/NN being/VBP peripherally/RB involved/VBN in/IN the/DT binding/JJ interaction/NN with/IN the/DT Ad5/NN ,/, Ad9/NN ,/, Ad12/NN ,/, and/CC Ad41L/NN fiber/NN knobs/NNS ./.
@@66980478297 The/DT Prolactin/NEWGENE levels/NNS were/VBD within/IN the/DT physiological/JJ norms/NNS ;/: the/DT responses/NNS to/IN TRH/NEWGENE were/VBD normal/JJ ,/, and/CC elevated/VBD only/RB in/IN a/DT few/JJ cases/NNS ./.
@@94215082037 To/TO investigate/VB the/DT activity/NN of/IN TCF11/NEWGENE through/RB this/DT selected/VBN site/NN ,/, both/DT alone/RB and/CC in/IN the/DT presence/NN of/IN MafG/NEWGENE ,/, we/PRP have/VBP used/VBN a/DT transient/JJ transfection/NN assay/NN ./.
@@93972612727 Interleukin-1/NEWGENE levels/NNS remained/VBD low/JJ throughout/IN the/DT course/NN ./.
@@104136765063 This/DT dominant-negative/JJ effect/NN of/IN FRNK/NEWGENE was/VBD reversed/VBN by/IN a/DT point/NN mutation/NN (/( Leu-1034/NN to/IN Ser/NN )/SYM which/WDT prevented/VBD FRNK/NEWGENE localization/NN to/IN focal/JJ contact/NN sites/NNS ./.
@@17870858999 In/NN ten/CD other/DT experiments/NNS (/( 5/CD experimental/JJ and/CC 5/CD control/NN rats/NNS )/SYM 99mTc-sulfur/NN colloid/NN was/VBD injected/VBN intravenously/RB ./.
@@107237237828 Additionally/RB ,/, the/DT mouse/NN promoter/NN contains/VBZ 22/CD copies/NNS of/IN a/DT CT/NEWGENE dinucleotide/NEWGENE repeat/NEWGENE sequence/NEWGENE located/VBN approximately/RB 155/CD bp/NN 5'/CD to/IN exon/NN 1/CD ./CD
@@104136764986 Expression/NNS of/IN various/JJ FAK/NEWGENE mutants/NEWGENE in/IN the/DT FAK-/NNP cells/NNS showed/VBN that/IN FAK/NEWGENE kinase/NEWGENE activity/NN ,/, the/DT Tyr-397/NEWGENE //NEWGENE SH2/NEWGENE domain/NEWGENE binding/NEWGENE site/NEWGENE ,/, and/CC the/DT first/JJ proline-rich/JJ SH3/NEWGENE binding/NEWGENE region/NEWGENE in/IN the/DT FAK/NEWGENE C-terminal/NEWGENE domain/NEWGENE were/VBD individually/RB needed/VBN to/IN promote/VB full/JJ FAK-mediated/NNP FAK-/NNP cell/NN migration/NN to/IN FN/NEWGENE whereas/IN direct/JJ paxillin/NEWGENE binding/JJ to/IN FAK/NEWGENE was/VBD not/RB required/VBN ./.
@@76445032314 In/NN contrast/NN ,/, over-expression/NN of/IN RAR/NEWGENE beta/NEWGENE only/RB poorly/RB restored/VBN differentiation/NN ,/, although/IN it/PRP could/MD replace/VB RAR/NEWGENE gamma/NEWGENE for/IN the/DT activation/NN of/IN target/NN genes/NNS ./.
@@8030704943 CONCLUSION/IN :/: Human/NNP preterm/JJ birth/NN is/VBZ associated/VBN with/IN significantly/RB lower/JJR progesterone/NN //NN 17/NN beta-estradiol/NN ratios/NNS than/IN those/DT of/IN women/NNS with/IN preterm/JJ labor/NN delivered/VBN at/IN term/NN ./.
@@18909893087 Thus/RB ,/, two/JJ very/RB different/JJ regulatory/JJ elements/NNS are/VBP used/VBN to/IN mediate/VB estrogen/NN induction/NN of/IN related/VBN genes/NNS in/IN chickens/NNS and/CC amphibians/NNS ./.
@@8139031565 Specifically/RB ,/, by/IN oligonucleotide-directed/JJ site-specific/JJ mutagenesis/NN ,/, we/PRP demonstrate/VBP that/IN of/IN 10/CD cysteine/NN residues/NNS in/IN the/DT ORF4/NNS polypeptide/NN ,/, only/RB C-421/NN and/CC C-426/NN are/VBP essential/JJ for/IN transactivator/NN function/NN and/CC suggest/VB that/IN these/DT cysteine/NN residues/NNS may/MD participate/VB in/IN critical/JJ protein-protein/JJ interactions/NNS rather/RB than/IN protein-nucleic/JJ acid/NN interactions/NNS to/IN mediate/VB ORF4/NNS inducibility/NN ./.
@@2149566993 The/DT ratio/NN of/IN P-31/NN NMR-S/NN derived/VBD inorganic/JJ phosphates/NNS [/NN Pi/NN ]/NN to/IN phosphocreatine/NN [/NN PCr/NN ]/NN was/VBD significantly/RB greater/JJR at/IN rest/NN in/IN LVH/NN baboons/NNS [/NN 0/NN ./NN 53/NN +/NN //NN -/NN 0/CD ./CD 06/CD versus/IN controls/NNS =/SYM 0/CD ./CD 41/CD +/NN //NN -/NN 0/CD ./CD 17/CD ;/: P/NN less/PRP than/IN 0/NN ./NN 05/NN ]/NN ./.
@@77917687779 The/DT effect/NN of/IN these/DT cell/NN cycle/NN regulators/NN is/VBZ not/RB specific/JJ to/IN the/DT rap1s/NEWGENE or/CC hmr/NEWGENE delta/NEWGENE A/NEWGENE mutation/NEWGENE ,/, since/IN swi6/NEWGENE ,/, swi4/NEWGENE ,/, and/CC clb5/NEWGENE mutations/NEWGENE also/RB suppress/VBP mutations/NNS in/IN SIR1/NEWGENE ,/, another/DT gene/NN implicated/VBN in/IN the/DT establishment/NN of/IN silencing/VBG ./.
@@97841923050 Some/DT of/IN the/DT peptide/NEWGENE :/NEWGENE MBP/NEWGENE fusions/NEWGENE were/VBD also/RB analyzed/VBN using/VBG surface/NN plasmon/NN resonance/NN ./.
@@20496172659 3/CD ./CD
@@115858569951 METHODS/IN :/: We/PRP studied/VBD the/DT clinical/JJ benefit/NN of/IN depth-dependent/NN RR/NN ,/, nonuniform/JJ AC/NN using/VBG a/DT scanning/JJ line/NN source/NN ,/, and/CC scatter/NN correction/NN (/( photon/NN energy/NN recovery/NN [/NN PER/NN ]/NN )/SYM compared/VBN with/IN filtered/JJ backprojection/NN alone/RB ./.
@@22965096544 All/DT 89/CD participating/VBG household/NN members/NNS were/VBD anti-HIV/NN seronegative/JJ ,/, and/CC 78/CD who/WP were/VBD tested/VBN were/VBD serum/NEWGENE p24/NEWGENE antigen/NEWGENE negative/JJ ./.
@@77999312308 In/NN contrast/NN ,/, a/DT Maf-related/NEWGENE protein/NEWGENE ,/, Nrl/NEWGENE ,/, completely/RB mimicked/VBN c-Maf/NEWGENE actions/NNS ./.
@@104775976831 TRAF2/NEWGENE is/VBZ a/DT potent/JJ activator/NN of/IN a/DT 95-kDa/NEWGENE serine/NEWGENE //NEWGENE threonine/NEWGENE kinase/NEWGENE termed/JJ germinal/NEWGENE center/NEWGENE kinase/NEWGENE related/NEWGENE (/( GCKR/NEWGENE ,/, also/RB referred/VBN to/RB as/IN KHS1/NEWGENE )/SYM ,/, which/WDT signals/VBZ activation/NN of/IN the/DT SAPK/NEWGENE pathway/NN ./.
@@117235001560 Clinical/NNP and/CC epidemiological/JJ characteristics/NNS of/IN oral/JJ squamous/JJ cell/NN carcinoma/NN in/IN women/NNS BACKGROUND/WDT :/: Squamous/JJ cell/NN carcinoma/NN (/( SCC/NN )/SYM of/IN the/DT oral/JJ cavity/NN occurs/VBZ mainly/RB in/IN the/DT male/JJ population/NN ./.
@@21645858349 The/DT TraD/NEWGENE protein/NEWGENE (/NEWGENE 83/NEWGENE ,/NEWGENE 899/NEWGENE Da/NEWGENE )/NEWGENE contains/VBZ three/CD hydrophobic/JJ regions/NNS ,/, of/IN which/WDT two/JJ are/VBP located/VBN near/IN the/DT amino-terminal/NN region/NN ./.
@@72963037159 Responses/NNS to/IN brainstem/NN of/IN nuclei/NNS medialis/NN dorsalis/JJ ,/, lateralis/JJ posterior/NN were/VBD of/IN considerably/RB longer/JJR latency/NN ./.
@@95069903718 Human/NN ZFM1/NEWGENE protein/NEWGENE is/VBZ a/DT transcriptional/JJ repressor/NN that/WDT interacts/VBZ with/IN the/DT transcription/NEWGENE activation/NEWGENE domain/NEWGENE of/NEWGENE stage-specific/NEWGENE activator/NEWGENE protein/NEWGENE ./.
@@7433357301 Reaction/NN times/NNS to/IN tachistoscopically/RB presented/VBN stimuli/NNS in/IN diabetics/NNS ./.
@@5407079266 Following/VBG the/DT satisfactory/JJ results/NNS and/CC taking/VBG into/IN account/NN that/IN the/DT complications/NNS had/VBP reduced/VBN to/IN a/DT very/RB low/JJ rate/NN (/( in/IN 2/CD cases/NNS lead/VBP tip/NN displacement/NN and/CC pouch/NN haematoma/NN occurred/VBN respectively/RB )/SYM ,/, the/DT Authors/NNS consider/VBP the/DT adopted/VBN method/NN an/DT useful/JJ approach/NN for/IN PMK/NN implantation/NN particularly/RB when/CC the/DT use/NN of/IN the/DT vena/NN cephalica/NN is/VBZ deemed/VBN impossible/JJ ./.
@@95823508745 In/NN patients/NNS with/IN type/NN IA/NN maple/NN syrup/NN urine/NN disease/NN ,/, the/DT E1alpha/NEWGENE subunit/NEWGENE is/VBZ affected/VBN ,/, resulting/VBG in/IN the/DT loss/NN of/IN E1/NEWGENE and/CC branched-chain/NEWGENE ketoacid/NEWGENE dehydrogenase/NEWGENE catalytic/JJ activities/NNS ./.
@@26498113326 Postcoital/JJ contraception/NN :/: a/DT family/NN planning/NN study/NN ./.
@@82645919273 These/DT data/NN indicate/VB that/IN the/DT largest/JJS subunit/NN of/IN RNA/NEWGENE polymerase/NEWGENE II/NEWGENE and/CC TFIIB/NEWGENE are/VBP important/JJ determinants/NNS of/IN transcription/NN start/NN site/NN selection/NN in/IN S/NNP ./NNP cerevisiae/NN and/CC suggest/VB that/IN this/DT function/NN might/MD be/VB conferred/VBN by/IN interaction/NN between/IN these/DT two/JJ proteins/NNS ./.
@@10487953320 Two/CD patients/NNS with/IN recurrent/JJ tumors/NNS had/VBP high/JJ S-phase/NN fractions/NNS both/DT on/IN the/DT first/RB resected/VBN specimens/NNS and/CC at/IN the/DT time/NN of/IN the/DT second/JJ operation/NN ./.
@@82223848309 SIN-1/NN had/VBP no/DT influence/NN on/IN either/DT the/DT ischemic/JJ parameters/NNS in/IN the/DT surface/NN electrocardiogram/NN (/( ECG/NN )/SYM or/CC the/DT intracoronary/JJ ECG/NN ./.
@@96536412318 Human/NNP isoforms/NNS ,/, designated/VBN 1/CD to/IN 4/CD ,/, differ/VB from/IN each/DT other/DT by/IN the/DT start/NN codon/NN used/VBN ./.
@@35207294075 No/DT relevant/JJ changes/NNS in/IN heart/NN rate/NN ,/, body/NN weight/NN ,/, and/CC plasma/NN levels/NNS of/IN renin/NEWGENE activity/NN and/CC aldosterone/NN concentration/NN were/VBD observed/VBN ./.
@@8387994948 The/DT orf61/NEWGENE gene/NEWGENE product/NEWGENE ,/, when/CC expressed/VBD from/IN an/DT exogenous/JJ promoter/NN ,/, inhibited/VBN int-mediated/JJ integration/NN at/IN the/DT chromosomal/NEWGENE attB/NEWGENE site/NEWGENE ./.
@@51281495385 Surgical/NNP treatment/NN of/IN pathologic/JJ scars/NNS of/IN myocardial/JJ infarct/NN ./.
@@85858833743 Hybrid/NNP female/JJ mice/NNS (/( C57BL/NNP x/NN CBA/NN )/SYM were/VBD paired/JJ with/IN breeder/NN males/NNS (/( CD-1/NN )/SYM and/CC LNG/NN pellets/NNS were/VBD implanted/VBN on/IN day/NN 0/CD ,/, the/DT day/NN on/IN which/WDT copulation/NN plugs/NNS were/VBD found/VBN ,/, or/CC on/IN day/NN 2/CD or/CC day/NN 3/CD in/IN the/DT postcoital/JJ period/NN ./.
@@16628844628 Temafloxacin/NN 400/NN mg/NN b/CD ./CD i/CD ./CD d/CD ./. administered/VBN orally/RB for/IN 28/CD days/NNS represents/VBZ a/DT safe/JJ and/CC effective/JJ treatment/NN for/IN chronic/JJ bacterial/JJ prostatitis/NN ./.
@@18981642518 The/DT currently/RB proposed/VBN extended/VBN arch/NN repair/NN should/MD be/VB reserved/VBN for/IN the/DT small/JJ group/NN of/IN infants/NNS with/IN transverse/JJ aortic/JJ arch/NN to/IN ascending/JJ aorta/NN diameter/NN ratios/NNS (/( arch/NN indices/NNS )/SYM of/IN less/PRP than/IN 0/CD ./CD 25/CD ./.
@@36736401504 Low/NNP MAO/NEWGENE subjects/NNS showed/VBD a/DT pattern/NN of/IN higher/JJ scores/NNS in/IN KSP/NNS Impulsiveness/NNS ,/, EPQ/NNP Neuroticism/NN ,/, and/CC KSP/NN Somatic/NNP Anxiety/NNP and/CC Irritability/NNP and/CC lower/JJR scores/NNS in/IN KSP/NNS Socialization/NN ,/, in/IN line/NN with/IN personality/NN profiles/NNS found/VBP in/IN alcoholics/NNS ,/, psychopaths/NNS ,/, and/CC suicide/NN attempters/NNS who/WP also/RB tend/VB to/IN have/NN low/JJ platelet/NN MAO/NEWGENE activity/NN ./.
@@10851745657 It/PRP brings/VBZ about/JJ fatigue/NN ,/, negative/JJ moods/NNS ,/, and/CC impaired/VBN health/NN ,/, sleep/NN ,/, safety/NN ,/, and/CC working/JJ capacity/NN ./.
@@108804862765 Next/JJ ,/, we/PRP show/VBP that/IN two/JJ EMS-induced/NN mutations/NN ,/, previously/RB shown/VBP to/IN interact/VB genetically/RB with/IN zipper/NEWGENE (/NEWGENE Ebr/NEWGENE )/NEWGENE ,/, disrupt/VB the/PDT RhoA/NEWGENE locus/NEWGENE ./.
@@112928447094 HSF/NEWGENE binds/VBZ DNA/NN as/IN a/DT trimer/NN ,/, and/CC additional/JJ trimers/NNS can/MD bind/VB DNA/NN co-operatively/JJ ./.
@@112091009882 Apart/RB from/IN antimicrobial/JJ properties/NNS ,/, recent/JJ data/NN indicate/VB that/DT PMN/NN also/RB exert/VB anti-inflammatory/JJ effects/NNS by/IN stimulation/NN and/CC release/NN of/IN cytokine/NN antagonists/NNS such/JJ as/IN interleukin-1/NEWGENE receptor/NEWGENE antagonist/NEWGENE (/( IL-1ra/NEWGENE )/SYM ./.
@@11116084438 Mouse/NEWGENE Impact/NEWGENE is/VBZ a/DT paternally/RB expressed/VBN gene/NN encoding/VBG an/DT evolutionarily/RB conserved/VBN protein/NN of/IN unknown/JJ function/NN ./.
@@89948252410 BACKGROUND/IN :/: Mitosis/NNS is/VBZ regulated/VBN by/IN MPF/NEWGENE (/( maturation/NEWGENE promoting/NEWGENE factor/NEWGENE )/SYM ,/, the/DT active/JJ form/NN of/IN Cdc2/NEWGENE //NEWGENE 28-cyclin/NEWGENE B/NEWGENE complexes/NEWGENE ./.
@@88928595298 We/PRP report/VBP an/DT example/NN of/IN an/DT MDV-transformed/JJ T-lymphoblastoid/JJ cell/NN line/NN (/( T9/CD )/SYM expressing/JJ high/JJ levels/NNS of/IN a/DT truncated/NEWGENE C-MYB/NEWGENE protein/NEWGENE as/IN a/DT result/NN of/IN RAV/NN integration/NN within/IN one/PRP c-myb/NEWGENE allele/NEWGENE ./.
@@51325583722 The/DT interaction/NN of/IN caffeine/NN ,/, theophylline/NN and/CC theobromine/NN with/IN monoamine/NEWGENE oxidase/NEWGENE inhibitors/NN ./.
@@75490057422 However/RB ,/, parallax/NN measurements/NNS showed/VBN that/IN at/IN 150K/NN ,/, collapse/NN of/IN Epon/VB sections/NNS does/VBP not/RB take/VB place/NN ./.
@@114040191177 To/TO gain/VB an/DT understanding/NN of/IN the/DT mGSTM2/NEWGENE regulation/NN ,/, we/PRP have/VBP also/RB cloned/VBN and/CC analyzed/VBN its/PRP promoter/NN region/NN ./.
@@88164839987 Mutations/NNS in/IN three/CD loci/NNS (/( SIC1/NEWGENE ,/, SWI5/NEWGENE ,/, and/CC RIC3/NEWGENE )/SYM were/VBD identified/VBN ./.
@@79641625713 Therefore/RB ,/, mechanisms/NNS that/WDT control/VBP activation/NN of/IN the/DT MAP/NEWGENE kinase/NEWGENE cascade/NEWGENE temporally/RB and/CC spatially/RB may/MD be/VB important/JJ for/IN specification/NN of/IN cellular/JJ responses/NNS ./.
@@32374463929 None/NN had/VBP a/DT past/JJ history/NN of/IN opportunistic/JJ infections/NNS ;/: neither/DT did/VBD any/DT have/NN lymphopenia/NN ./.
@@86266674918 EMSA/NN competition/NN experiments/NNS showed/VBN that/IN mutations/NNS within/IN the/DT direct/JJ repeats/NNS failed/VBN to/IN compete/VB for/IN binding/NN of/IN the/DT nuclear/JJ proteins/NNS to/IN labeled/JJ wild/JJ type/NN oligonucleotide/NN ./.
@@79804402478 In/NNP H4IIE/NNP rat/NN hepatoma/NN cells/NNS ,/, glucocorticoids/NNS ,/, retinoic/JJ acid/NN and/CC cyclic/JJ AMP/NN (/( cAMP/NN )/SYM increase/NN PEPCK/NEWGENE gene/NEWGENE transcription/NN whereas/IN insulin/NEWGENE and/CC phorbol/NN esters/NNS have/VBP the/DT opposite/NN effect/NN ./.
@@97304131118 Until/IN such/JJ investigations/NNS are/VBP performed/VBN ,/, we/PRP conclude/VBP that/IN the/DT role/NN for/IN adjuvant/JJ treatment/NN is/VBZ questionable/JJ and/CC that/DT TME/NN surgery/NN is/VBZ preferred/VBN as/IN the/DT treatment/NN option/NN for/IN Stage/NNP T1-T3/NN rectal/JJ cancers/NNS ./.
@@107373669758 It/PRP was/VBD established/VBN that/IN intrathecal/JJ or/CC intraperitoneal/JJ PTFL/NN ,/, elevated/VBD the/DT nociceptive/JJ threshold/NN for/IN mechanical/JJ stimuli/NNS in/IN the/DT formalin/NN test/NN in/IN rats/NNS ./.
@@83823033825 The/DT E1/NEWGENE nuclear/NEWGENE transport/NEWGENE motif/NEWGENE is/VBZ highly/RB conserved/VBN in/IN the/DT animal/NN and/CC human/JJ papillomaviruses/NNS and/CC is/VBZ encoded/VBN in/IN a/DT similar/JJ region/NN in/IN the/DT related/VBN E1/NEWGENE genes/NEWGENE ./.
@@111609298176 Rapid/NNP evolution/NN of/IN the/DT DNA-binding/NN site/NN in/IN LAGLIDADG/NEWGENE homing/NEWGENE endonucleases/NEWGENE ./.
@@24558219074 The/DT gene/NN is/VBZ contained/VBN within/IN a/DT 1/NEWGENE ./NEWGENE 8-kilobase/NEWGENE AccI-EcoRI/NEWGENE restriction/NEWGENE fragment/NEWGENE mapping/NN at/IN map/NN coordinates/NNS 0/CD ./CD 136/CD to/IN 0/CD ./CD 148/CD in/IN the/DT UL/NEWGENE region/NEWGENE of/IN the/DT EHV-1/NN genome/NN and/CC is/VBZ transcribed/VBN from/IN right/JJ to/IN left/NN ./.
@@78968468251 Alternatively/RB processed/VBN isoforms/NNS of/IN cellular/NEWGENE nucleic/NEWGENE acid-binding/NEWGENE protein/NEWGENE interact/VB with/IN a/DT suppressor/NN region/NN of/IN the/DT human/NEWGENE beta-myosin/NEWGENE heavy/NEWGENE chain/NEWGENE gene/NEWGENE ./.
@@75121595574 Improvement/NNP of/IN the/DT polypyrimidine/NN tract/NN also/RB increased/VBD the/DT splicing/JJ efficiency/NN ,/, but/CC to/IN a/DT degree/NN slightly/RB less/PRP than/IN that/DT obtained/VBD with/IN the/DT branchpoint/NN mutation/NN ./.
@@88398322502 Thus/RB ,/, the/DT predicted/VBN CD30v/NEWGENE protein/NEWGENE retains/VBZ most/RB of/IN the/DT cytoplasmic/JJ region/NN ,/, but/CC lacks/VBZ the/DT extracellular/JJ and/CC transmembrane/JJ domains/NNS ./.
@@98868438861 To/TO evaluate/VB whether/IN the/DT human/JJ gene/NN is/VBZ also/RB a/DT target/NN of/IN thyroid/JJ hormone/NN we/PRP have/VBP searched/VBN for/IN T3-responsive/NEWGENE elements/NEWGENE in/IN NRGN/NEWGENE cloned/VBN genomic/JJ fragments/NNS spanning/VBG the/DT whole/JJ gene/NN ./.
@@25477063197 Validity/NNS of/IN immunohistology/NN and/CC in/IN situ/NN hybridization/NN in/IN the/DT differential/JJ diagnosis/NN of/IN cytomegalovirus/NN pneumonia/NN and/CC idiopathic/JJ interstitial/JJ pneumonia/NN after/IN allogenic/JJ bone/NN marrow/NN transplantation/NN ./.
@@7575416175 This/DT work/NN ,/, therefore/RB ,/, also/RB emphasizes/VBZ the/DT importance/NN of/IN careful/JJ choice/NN of/IN oligonucleotide/NN and/CC cDNA/NN probes/NNS to/IN study/NN PKC/NEWGENE zeta/NEWGENE mRNA/NEWGENE ./.
@@92376953560 A/DT prospective/JJ observational/JJ study/NN was/VBD conducted/VBN to/IN identify/VB early/NN indicators/NN of/IN acute/JJ dengue/NN virus/NN infection/NN ./.
@@76473035411 The/DT homeobox/NEWGENE gene/NEWGENE ATK1/NEWGENE of/IN Arabidopsis/NN thaliana/NN is/VBZ expressed/VBN in/IN the/DT shoot/NN apex/NN of/IN the/DT seedling/NN and/CC in/IN flowers/NNS and/CC inflorescence/NN stems/NNS of/IN mature/JJ plants/NNS ./.
@@44879204989 From/IN the/DT Icelandic/NNP Red/NNP Cross/NN activities/NNS ./.
@@982787860 Since/IN glutathione/NEWGENE peroxidase/NEWGENE (/( GPX/NEWGENE )/SYM and/CC superoxide/NEWGENE dismutase/NEWGENE (/( SOD/NEWGENE )/SYM play/VB a/DT significant/JJ role/NN in/IN erythrocyte/NN antioxidative/JJ defence/NN ,/, it/PRP is/VBZ very/RB important/JJ to/IN determine/VB their/PRP activity/NN in/IN occupationally/RB exposed/VBN workers/NNS ./.
@@27922701669 Oligosynaptic/JJ EPSP/NN components/NN were/VBD consistently/RB modulated/VBN only/RB in/IN the/DT superficial/JJ peroneal/JJ responses/NNS in/IN flexor/NN motoneurons/NNS ,/, which/WDT exhibited/VBD enhanced/VBN amplitude/NN during/IN the/DT flexion/NN phase/NN ./.
@@113570632916 Like/IN the/DT consensus/NEWGENE mammalian/NEWGENE LHbeta/NEWGENE gene/NEWGENE ,/, the/DT 5'-flanking/JJ region/NN of/IN the/DT gpLH/NEWGENE //NEWGENE CGbeta/NEWGENE gene/NEWGENE contains/VBZ a/DT single/JJ TATA/NN sequence/NN 37/CD bp/NN upstream/RB of/IN the/DT translation/NN start/NN codon/NN ./.
@@40159884679 Marrow/NN cell/NN necrosis/NN in/IN anorexia/NN nervosa/JJ and/CC involuntary/JJ starvation/NN ./.
@@67384106501 Blood/NNP pressure/NN in/IN children/NNS ./.
@@87683773207 Because/IN the/DT hcf109/NEWGENE locus/NEWGENE was/VBD mapped/VBN at/IN a/DT distance/NN </SYM 0/CD ./CD 1/CD centimorgans/NNS from/IN the/DT phytochrome/NEWGENE C/NEWGENE gene/NEWGENE ,/, its/PRP molecular/JJ characterization/NN by/IN positional/JJ cloning/NN is/VBZ possible/JJ ./.
@@94835969377 Despite/IN this/DT there/RB was/VBD no/DT difference/NN in/IN the/DT intubating/JJ conditions/NNS at/IN one/PRP minute/JJ with/IN 25/CD excellent/NN //NN 5/NN good/JJ in/IN the/DT suxamethonium/NN group/NN and/CC 27/CD excellent/NN //NN 3/NN good/JJ in/IN the/DT rocuronium/NN group/NN ./.
@@8030243698 However/RB ,/, by/IN an/DT NS35-specific/NEWGENE RNA/NEWGENE capture/NN assay/NN ,/, the/DT multimers/NNS were/VBD shown/VBP to/IN possess/VB the/DT RNA-binding/NN activity/NN previously/RB demonstrated/VBD for/IN NS35/NEWGENE ./.
@@111603079659 This/DT molecule/NN ,/, wH22xeGFP/NEWGENE ,/, consists/VBZ of/IN the/DT entire/NEWGENE humanized/NEWGENE anti-FcgammaRI/NEWGENE mAb/NEWGENE H22/NEWGENE1 with/IN eGFP/NEWGENE genetically/RB fused/VBD to/IN the/DT C-terminal/NN end/NN of/IN each/DT CH3/NEWGENE domain/NEWGENE ./. wH22xeGFP/NEWGENE binds/VBZ within/IN the/DT ligand-binding/NN region/NN by/IN its/PRP Fc/NEWGENE end/NN ,/, as/RB well/VB as/IN outside/RB the/DT ligand-binding/NN region/NN by/IN its/PRP Fab/NEWGENE ends/NNS ,/, thereby/RB cross-linking/VBG FcgammaRI/NEWGENE ./.
@@97075773388 In/NN contrast/NN ,/, the/DT distribution/NN of/IN endocytic/JJ markers/NNS is/VBZ not/RB affected/VBN ./.
@@10545281658 For/IN example/NN ,/, introduction/NN of/IN immunogenic/JJ and/CC purification/NN tag/NN sequences/NNS into/IN the/DT C-terminal/NN coding/JJ region/NN significantly/RB decreased/VBD bop/NEWGENE gene/NEWGENE mRNA/NEWGENE and/CC protein/NN accumulation/NN ./.
@@106523629130 Together/RB ,/, these/DT data/NN suggest/VB that/IN the/DT carboxyl/NN terminus/NN of/IN CFTR/NEWGENE contains/VBZ a/DT tyrosine-based/JJ internalization/NN signal/JJ that/WDT interacts/VBZ with/IN the/DT endocytic/JJ adaptor/NN complex/NN AP-2/NEWGENE to/IN facilitate/VB efficient/JJ entry/NN of/IN CFTR/NEWGENE into/IN clathrin-coated/JJ vesicles/NNS ./.
@@18249447196 After/IN treatment/NN with/IN tunicamycin/NN ,/, the/DT transfectants/NNS secreted/VBN unglycosylated/JJ 18-kDa/NN polypeptides/NN which/WDT could/MD also/RB bind/VB IgE/NEWGENE ./.
@@11048832571 Fisher's/NNP exact/JJ test/NN or/CC Pearson's/NNP chi2/NN test/NN were/VBD used/VBN for/IN statistical/JJ analysis/NN ./.
@@81399286148 RNP1/NEWGENE ,/, a/DT new/JJ ribonucleoprotein/NN gene/NN of/IN the/DT yeast/NN Saccharomyces/NN cerevisiae/NN ./.
@@86128523667 RESULTS/NNS :/: Basal/JJ plasma/NEWGENE IGF-I/NEWGENE levels/NNS as/RB well/VBP as/IN body/NN mass/JJ index/NN (/( BMI/NN )/SYM were/VBD lower/JJR in/IN amenorrheic/JJ patients/NNS than/IN in/IN healthy/JJ controls/NNS ./.
@@59595887595 Studies/NNS on/IN Coxsackie/NNP B/NN Type/NN 5/NN virus/NN infections/NNS ./.
@@20309101950 Polymerase/NN chain/NN reaction/NN analysis/NN of/IN ETS1/NEWGENE cDNA/NEWGENE identified/VBD several/DT amplified/VBN products/NNS ,/, indicating/VBG alternative/JJ splicing/JJ ./.
@@88165048007 Platelet-derived/JJ growth/NN factor-dependent/NN activation/NN of/IN phosphatidylinositol/NEWGENE 3-kinase/NEWGENE is/VBZ regulated/VBN by/IN receptor/NN binding/NN of/IN SH2-domain-containing/NEWGENE proteins/NEWGENE which/WDT influence/VBP Ras/NEWGENE activity/NN ./.
@@115699004837 APC-resistance/NNP was/VBD determined/VBN with/IN a/DT functional/JJ method/NN with/IN high/JJ sensitivity/NN and/CC specificity/NN for/IN the/DT factor/NEWGENE V/NEWGENE Leiden/NN mutation/NN ./.
@@84385846782 The/DT activity/NN of/IN the/DT coat/NEWGENE protein/NEWGENE promoter/NEWGENE of/IN chloris/NN striate/JJ mosaic/NN virus/NN is/VBZ enhanced/VBN by/IN its/PRP own/VB and/CC C1-C2/NEWGENE gene/NEWGENE products/NEWGENE ./.
@@95473498006 The/DT ether/NN phospholipid/NN 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine/JJ (/( ET-18-OCH3/NN ;/: edelfosine/NN )/SYM is/VBZ a/DT potent/JJ inducer/NN of/IN apoptosis/NN in/IN human/JJ tumor/NN cells/NNS ./.
@@86730268642 The/DT factor/NN structure/NN of/IN "schizotypal'/NN traits/NNS :/: a/DT large/JJ replication/NN study/NN ./.
@@4792227307 Resistance/NNP to/IN the/DT simulated/JJ physiologic/JJ environment/NN was/VBD tested/VBN by/IN measured/JJ retention/NN of/IN mechanical/JJ properties/NNS after/IN immersion/NN times/NNS in/IN pseudo-extracellular/JJ fluid/NN (/( PECF/NN )/SYM at/IN 37/CD degrees/NNS C/NN for/RB as/RB long/RB as/IN three/CD years/NNS ./.
@@39312934587 In/NN the/DT absence/NN of/IN other/DT stabilizers/NNS ,/, increased/VBN sucrose/NN can/MD provide/VB increased/VBN thermoresistance/NN to/IN the/DT virus/NN in/IN 2/CD ./CD 5%/CD albumin/NEWGENE ./.
@@16439432145 We/PRP found/VBP that/DT lung/NN cancer/NN tissues/NNS of/IN positive/JJ 67Ga/CD scan/NN expressed/VBD TFR/NEWGENE ,/, but/CC those/DT of/IN a/DT negative/JJ scan/NN did/VBD not/RB ./.
@@93716262925 The/DT results/NNS of/IN replicase/NEWGENE assays/NNS performed/VBN with/IN mutant/NEWGENE VP2/NEWGENE containing/JJ a/DT deletion/NN in/IN its/PRP RNA-binding/NN domain/NN suggests/VBZ that/IN the/DT essential/JJ role/NN for/IN VP2/NEWGENE in/IN replication/NN is/VBZ linked/JJ to/IN the/DT protein's/NNS ability/NN to/IN bind/NN the/DT mRNA/NN template/NN for/IN minus-strand/NN synthesis/NN ./.
@@28022803500 No/DT significant/JJ differences/NNS were/VBD found/VBN between/IN the/DT TS/NN and/CC the/DT PTS/NN ./.
@@98637209852 Recurrent/JJ arterial/JJ thrombotic/JJ disease/NN on/IN young/JJ onset/NN and/CC protein/NEWGENE S/NEWGENE deficiency/NN ./.
@@75210099771 Three/CD mutants/NNS (/( pms1/NEWGENE ,/, pms2/NEWGENE and/CC pms3/NEWGENE )/SYM isolated/VBN earlier/JJR from/IN MW104-1B/NN were/VBD shown/VBP to/IN correct/JJ in/IN vitro/FW constructed/VBN plasmids/NNS with/IN defined/VBN DNA/NN mismatches/NNS (/( G/NNP //NNP T/NNP ,/, A/NN //NN C/NN ,/, G/NNP //NNP G/NNP ,/, etc/FW ./FW )/SYM poorly/RB (/( Kramer/NNP et/FW al/NNS ./NNS ,/, 1989a/CD )/SYM ./.
@@7597488832 Hemolytic/JJ jaundice/NN due/NN to/IN G6PD/NEWGENE deficiency/NN causing/JJ kernicterus/NN in/IN a/DT female/JJ newborn/NN ./.
@@111321488289 The/DT presence/NN of/IN locus-specific/JJ residues/NNS throughout/IN the/DT entire/JJ promoter/NN region/NN strongly/RB suggests/VBZ that/IN the/DT various/JJ HLA/NEWGENE class/NEWGENE I/NEWGENE loci/NEWGENE are/VBP differentially/RB regulated/VBN ./.
@@94733174084 Copyright/NNP 1998/CD Academic/NNP Press/NNP ./.
@@38714454528 Computer/NNP assisted/JJ mapping/NN in/IN quantitative/JJ analysis/NN of/IN cerebral/JJ positron/NN emission/NN tomograms/NNS ./.
@@10619254442 Animal/NN studies/NNS showed/VBD that/DT beam/NN equalization/NN significantly/RB improved/VBD fluoroscopic/JJ and/CC angiographic/JJ image/NN quality/NN ./.
@@12335611867 Maternal/JJ lactation/NN ./.
@@112764267312 In/NN mouse/NN ,/, Mmip1/NEWGENE (/( Mad/NEWGENE member/NEWGENE interacting/NEWGENE protein/NEWGENE 1/NEWGENE )/SYM and/CC Smc3/NEWGENE share/VB 99%/CD sequence/NN identity/NN and/CC are/VBP products/NNS of/IN the/DT same/JJ gene/NN ./.
@@45369645016 Intracellular/JJ pH/NN ,/, H/NN ion/NN flux/NN and/CC H/NN ion/NN permeability/NN coefficient/NN in/IN bullfrog/NN toe/NN muscle/NN ./.
@@31712216136 The/DT variability/NN is/VBZ most/RB likely/RB a/DT result/NN of/IN alternative/JJ splicing/JJ of/IN exons/NNS from/IN the/DT primary/NN elastin/NEWGENE transcripts/NEWGENE ./.
@@79295607344 Identification/NNP of/IN the/DT plakoglobin-binding/JJ domain/NN in/IN desmoglein/NEWGENE and/CC its/PRP role/NN in/IN plaque/NN assembly/NN and/CC intermediate/JJ filament/NN anchorage/NN ./.
@@115171906740 Analysis/NNP of/IN the/DT promoter/NN sequence/NN revealed/VBD the/DT presence/NN of/IN a/DT major/JJ transcriptional/JJ start/NN site/NN ,/, a/DT canonical/JJ TATA/NN box/NN and/CC putative/JJ cis/NN regulatory/NN elements/NN for/IN pituitary/JJ specific/JJ expression/NN as/RB well/VB as/IN an/DT E-responsive/NEWGENE element/NEWGENE ./.
@@30373347678 We/PRP previously/RB showed/VBD that/IN the/DT upstream/NEWGENE promoter/NEWGENE element/NEWGENE of/IN the/DT yeast/NEWGENE RP39A/NEWGENE gene/NEWGENE consists/VBZ of/IN these/DT identical/JJ sequence/NN motifs/NNS ./.
@@76800358020 The/DT roles/NNS of/IN phorbol/NN esters/NNS and/CC cyclic/JJ AMP/NN in/IN mediating/JJ the/DT GnRH/NEWGENE response/NN were/VBD also/RB investigated/VBN ./.
@@92000299154 Clinical/NNP and/CC haematological/JJ signs/NNS are/VBP not/RB specific/JJ in/IN this/DT setting/NN ,/, and/CC the/DT diagnosis/NN relies/VBZ on/IN histological/JJ features/NNS ,/, mainly/RB bone/VBP marrow/NN examination/NN ./.
@@80334908033 In/NN conclusion/NN ,/, the/DT disposition/NN of/IN venlafaxine/NN and/CC O-desmethylvenlafaxine/CHEM is/VBZ markedly/RB altered/VBN in/IN renal/JJ disease/NN ;/: therefore/RB dosage/NN adjustment/NN is/VBZ warranted/VBN for/IN patients/NNS with/IN creatinine/NN clearance/NN values/NNS below/RB 30/CD ml/NN //NN min/NN ./.
@@115224311842 The/DT prevalence/NN of/IN tobacco/NN dependence/NN diagnosed/VBN according/VBG to/IN the/DT ICD-10/NN criteria/NNS was/VBD higher/JJ in/IN alcohol-dependent/NN individuals/NNS (/( 58/CD ./CD 1%/CD )/SYM than/IN in/IN nondrinkers/NNS or/CC social/JJ drinkers/NNS (/( 12/CD ./CD 8%/CD )/SYM ./.
@@76238258209 The/DT carboxyl-terminal/NN transactivation/NN domain/NN of/IN heat/NEWGENE shock/NEWGENE factor/NEWGENE 1/NEWGENE is/VBZ negatively/RB regulated/VBN and/CC stress/NN responsive/JJ ./.
@@103707783911 Three/CD new/JJ aromatase/NEWGENE inhibitors/NN have/VBP recently/RB completed/VBN phase/NN III/NNP evaluation/NN as/IN treatment/NN of/IN metastatic/JJ breast/NN cancer/NN in/IN post-menopausal/JJ women/NNS whose/WP disease/NN has/VBZ progressed/VBN despite/IN tamoxifen/NN therapy/NN :/: anastrozole/NN (/( ARIMIDEX/NNP ,/, Zeneca/NNP )/SYM ,/, letrozole/NN (/( FEMARA/NNP ,/, Novartis/NNP )/SYM and/CC vorozole/NN (/( RIVIZOR/NN ,/, Janssen/NNP )/SYM ./.
@@93058708132 The/DT recognition/NN specificity/NN of/IN the/DT p55/NEWGENE PDZ/NEWGENE1 domain/NEWGENE1 appears/VBZ to/IN be/VB unique/JJ ,/, since/IN the/DT three/CD PDZ/NEWGENE domains/NEWGENE of/IN hDlg/NEWGENE (/( human/JJ lymphocyte/NN homologue/NN of/IN the/DT Drosophila/NEWGENE discs/NEWGENE large/NEWGENE tumor/NEWGENE suppressor/NEWGENE )/SYM do/VB not/RB bind/VB the/DT cytoplasmic/JJ domain/NN of/IN glycophorin/NEWGENE C/NEWGENE ./.
@@114359831313 Tolerance/NN in/IN renal/JJ transplantation/NN after/IN allogeneic/JJ bone/NN marrow/NN transplantation-6-year/JJ follow-up/NN ./.
@@89721824727 The/DT Fas/NEWGENE receptor/NEWGENE mediates/VBZ a/DT signalling/JJ cascade/NN resulting/JJ in/IN programmed/JJ cell/NN death/NN (/( apoptosis/NN )/SYM within/IN hours/NNS of/IN receptor/NN cross-linking/VBG ./.
@@88689547198 Moreover/RB ,/, it/PRP also/RB discusses/VBZ the/DT effects/NNS of/IN antihypertensive/JJ drugs/NNS currently/RB regarded/VBN as/IN first-choice/JJ agents/NNS ,/, i/CD ./CD e/CD ./. calcium/NN antagonists/NNS and/CC the/DT angiotensin/NEWGENE converting/NEWGENE enzyme/NEWGENE inhibitors/NN ,/, on/IN intrarenal/JJ hemodynamics/NN ./.
@@114327484814 Regulation/NN of/IN laminin/NEWGENE beta2/NEWGENE chain/NEWGENE gene/NEWGENE expression/NN in/IN human/JJ cancer/NN cell/NN lines/NNS ./.
@@79565789166 Lesion/NNS diameters/NNS of/IN greater/JJR than/IN 20/CD mm/NN and/CC the/DT large/NN sessile-type/NN configurations/NNS were/VBD factors/NNS that/WDT were/VBD associated/VBN with/IN incomplete/JJ removal/NN ./.
@@4732497220 Effect/NN of/IN intraventricular/JJ administration/NN of/IN streptolysin/NEWGENE O/NEWGENE on/IN the/DT electroencephalogram/NN of/IN rabbits/NNS ./.
@@110461466632 Thus/RB ,/, diamide/NN treatment/NN of/IN nuclear/JJ extracts/NNS strongly/RB reduces/VBZ the/DT binding/NN of/IN NFI/NEWGENE proteins/NEWGENE ,/, and/CC the/DT addition/NN of/IN higher/JJ concentrations/NNS of/IN dithiothreitol/NN to/IN nuclear/JJ extracts/NNS from/IN TG-treated/JJ cells/NNS restores/VBZ NFI-DNA/NEWGENE binding/JJ to/IN levels/NNS in/IN extracts/NNS from/IN untreated/JJ cells/NNS ./.
@@21326364162 Subjects/NNS were/VBD 16/CD male/JJ chronic/JJ schizophrenics/NNS consisting/VBG of/IN 8/NN DST/NN suppressors/NN and/CC 8/CD nonsuppressors/NNS ./.
@@28397163297 In/NN these/DT cells/NNS ,/, E2/NEWGENE proteins/NEWGENE had/VBP little/JJ or/CC no/DT stimulatory/JJ effect/NN on/IN the/DT transcriptional/JJ activity/NN of/IN the/DT HPV-11/NEWGENE enhancer-SV40/NEWGENE promoter/NEWGENE ./.
@@7864652264 Constructs/NNS designed/VBN and/CC expressed/VBN were/VBD E2L1/NEWGENE (/NEWGENE 1-98/NEWGENE )/NEWGENE ,/, E2L1/NEWGENE ./NEWGENE H1/NEWGENE (/NEWGENE 1-128/NEWGENE )/NEWGENE ,/, E2L2/NEWGENE (/NEWGENE 120-233/NEWGENE )/NEWGENE ,/, E2H1/NEWGENE ./NEWGENE L2/NEWGENE (/NEWGENE 98-233/NEWGENE )/NEWGENE ,/, and/CC E2L1/NEWGENE ./NEWGENE H1/NEWGENE ./NEWGENE L2/NEWGENE (/NEWGENE 1-233/NEWGENE )/NEWGENE ,/, where/CC numbers/NNS in/IN parentheses/NNS give/VBP the/DT amino/JJ acid/NN sequence/NN for/IN the/DT portions/NNS of/IN the/DT E2/NEWGENE component/NN incorporated/VBN into/IN a/DT construct/NN ./.
@@97864049764 633+/JJ //JJ -258/JJ aggregates/NN //NN ml/NN at/IN 0/CD rpm/NN ;/: P/NN </SYM 0/NN ./NN 001/NN )/NN ./.
@@78327796749 Deglycosylation/NNS with/IN endoglycosidase/NEWGENE H/NEWGENE showed/VBN that/IN the/DT mutant/JJ receptors/NNS had/VBP mainly/RB high-mannose/JJ oligosaccharide/NN chains/NNS ./.
@@46329675060 Pulmonary/NNP arterial/JJ pressure/NN and/CC structure/NN in/IN the/DT patas/NN monkey/NN after/IN prolonged/JJ administration/NN of/IN aminorex/NN fumarate/NN ./.
@@4298934912 This/DT multiple-electrode/JJ array/NN for/IN round/JJ window/NN cochlear/JJ implantation/NN is/VBZ a/DT robust/JJ ,/, reliable/JJ system/NN for/IN inserting/VBG 20/CD mm/NN along/IN the/DT scala/NN tympani/NN with/IN a/DT minimum/NN of/IN trauma/NN and/CC can/MD provide/VB for/IN bipolar/JJ stimulation/NN ./.
@@10932679749 Although/IN there/RB is/VBZ little/JJ evidence/NN that/DT diet/NN composition/NN plays/VBP a/DT clinically/RB important/JJ role/NN in/IN the/DT absorption/NN or/CC expenditure/NN of/IN energy/NN ,/, it/PRP does/VBP appear/VB to/IN play/NN a/DT role/NN in/IN food/NN intake/NN ./.
@@890613917 This/DT observation/NN calls/VBZ for/IN careful/JJ monitoring/NN of/IN calcium/NN and/CC alkaline/NEWGENE phosphatase/NEWGENE values/NNS and/CC possible/JJ adjustments/NNS of/IN vitamin/NN D/NN intake/NN when/CC fortifiers/NNS are/VBP used/VBN for/IN extended/VBN periods/NNS ./.
@@38917663909 Interference/NNP with/IN rheumatoid/NEWGENE factor/NEWGENE was/VBD only/RB observed/VBN in/IN the/DT ELISA/NN enzygnost/NN if/IN sera/NNS were/VBD not/RB pretreated/VBN with/IN latex/NN adsorbents/NNS ./.
@@84966018281 A/DT comparison/NN of/IN the/DT promoters/NNS for/IN muMIP-1/NEWGENE beta/NEWGENE and/CC muMIP-1/NEWGENE alpha/NEWGENE reveals/VBZ a/DT conserved/VBN CK-1/NEWGENE element/NEWGENE ,/, but/CC transient/JJ expression/NN studies/NNS in/IN RAW/NNP 264/CD ./CD 7/CD macrophages/NNS with/IN proximal/JJ fragments/NNS of/IN either/DT the/DT muMIP-1/NEWGENE beta/NEWGENE or/CC the/DT muMIP-1/NEWGENE alpha/NEWGENE 5'/NEWGENE promoter/NEWGENE fused/VBN to/IN a/DT human/NEWGENE growth/NEWGENE hormone/NEWGENE reporter/NEWGENE gene/NEWGENE link/NN LPS-inducibility/NN in/IN both/DT to/IN promoter/NN segments/NNS near/IN to/IN ,/, but/CC not/RB identical/JJ with/IN ,/, the/DT consensus/NEWGENE CK-1/NEWGENE sequence/NEWGENE ./.
@@114864761133 Cardiac/NN markers/NN troponin/NEWGENE T/NEWGENE ,/, CK-MB/NEWGENE mass/NN and/CC myoglobin/NEWGENE were/VBD helpful/JJ in/IN the/DT differential/JJ diagnosis/NN of/IN chest/NN pain/NN ,/, even/VB when/CC the/DT ECG/NN was/VBD unremarkable/JJ or/CC nonspecific/JJ ./.
@@16575947720 We/PRP have/VBP determined/VBN that/IN the/DT mutants/NNS define/VBP two/JJ complementation/NN groups/NNS ,/, designated/VBN cgs1+/NEWGENE and/CC cgs2+/NEWGENE (/( continues/VBZ to/IN grow/VB in/IN stationary/JJ )/SYM ./.
@@76786958658 The/DT ectopic/JJ expression/NN of/IN Oct-3/NEWGENE //NEWGENE 4/NEWGENE in/IN hybrid/JJ cells/NNS under/IN a/DT constitutive/JJ promoter/NN is/VBZ sufficient/JJ for/IN transcriptional/JJ activation/NN of/IN an/DT octamer-dependent/NN promoter/NN ./.
@@89384208573 The/DT accumulation/NN of/IN both/DT LHA4/NEWGENE and/CC LHA2/NEWGENE mRNAs/NEWGENE is/VBZ induced/VBN by/IN the/DT addition/NN of/IN exogenous/JJ sugars/NNS and/CC this/DT induction/NN appears/VBZ to/IN be/VB dependent/JJ on/IN sugar/NN uptake/NN and/CC metabolism/NN ,/, because/IN mannitol/NN and/CC 3-O-methylglucose/JJ do/NN not/RB stimulate/VB mRNA/NN accumulation/NN ./.
@@71906276157 A/DT further/JJ study/NN on/IN plasminogen/NEWGENE activator/NEWGENE release/NN by/IN vasoactive/JJ agents/NNS in/IN the/DT isolated/VBN perfused/VBN dog/NN leg/NN ./.
@@79699547959 Distal/RB lower/JJR motor/JJ neuron/NN syndrome/NN with/IN high-titer/NN serum/NEWGENE IgM/NEWGENE anti-GM1/NEWGENE antibodies/NEWGENE :/: improvement/NN following/IN immunotherapy/NN with/IN monthly/JJ plasma/NN exchange/NN and/CC intravenous/JJ cyclophosphamide/NN ./.
@@104339709806 Spfkh1/NEWGENE is/VBZ transcribed/VBN in/IN one/PRP open/JJ reading/JJ frame/NN that/WDT contains/VBZ the/DT DNA/NN binding/JJ domain/NN ,/, nuclear/JJ localization/NN signal/NN and/CC transactivation/NN domain/NN ./.
@@21482913403 Using/VBG appropriate/JJ synthetic/NEWGENE HSE/NEWGENE oligonucleotides/NEWGENE ,/, three/CD types/NNS of/IN clones/NNS with/IN potential/NN HSE/NEWGENE binding/NEWGENE domains/NEWGENE were/VBD isolated/VBN from/IN a/DT tomato/NN lambda/NN gt11/NN expression/NN library/NN by/IN DNA-ligand/NN screening/JJ ./.
@@108607522378 The/DT presence/NN of/IN such/JJ a/DT putative/JJ RNA-/NN binding/JJ domain/NN suggests/VBZ a/DT mechanism/NN for/IN the/DT observed/VBN autoregulation/NN of/IN bacteriophage/NN T4/NEWGENE DNA/NEWGENE polymerase/NEWGENE synthesis/NN by/IN binding/JJ to/IN its/PRP own/VB mRNA/NN ./.
@@93805073984 Glutathione/NEWGENE S-transferase/NEWGENE (/( GST/NEWGENE )/NN -E2F/NEWGENE and/CC GST-DP/NEWGENE fusion/NEWGENE proteins/NEWGENE were/VBD found/VBN to/IN cooperate/VB in/IN binding/JJ to/IN the/DT three/CD E2F/NEWGENE sites/NEWGENE in/IN the/DT DNA/NEWGENE polymerase/NEWGENE alpha/NEWGENE gene/NEWGENE promoter/NEWGENE in/IN vitro/FW ./.
@@21195302721 Influence/NNS of/IN metoprolol/NN treatment/NN on/IN sympatho-adrenal/JJ activation/NN of/IN fibrinolysis/NN ./.
@@83832142925 Secondary/JJ cleavage/NN of/IN RT/NEWGENE at/IN Trp-595-Tyr-596/NEWGENE of/NEWGENE Pol/NEWGENE yields/VBZ a/DT truncated/JJ form/NN lacking/JJ the/DT C-terminal/NEWGENE RNase/NEWGENE H/NEWGENE domain/NEWGENE ./.
@@8990168265 Although/IN p48/NEWGENE gene/NEWGENE induction/NN is/VBZ dependent/JJ on/IN STAT1/NEWGENE and/CC JAK1/NEWGENE ,/, activated/VBN STAT1/NEWGENE does/VBP not/RB bind/VB to/IN GATE/NEWGENE ./.
@@14316028399 The/DT second/JJ method/NN ,/, the/DT "macro"/NN assay/NN ,/, has/VBZ a/DT sensitivity/NN range/NN of/IN 0/CD ./CD 03-5/CD ./CD 0/CD micrograms/NNS phosphorus/NN with/IN 100-500/JJ microliters/NNS HClO4/NN ./.
@@108610867856 In/NN contrast/NN ,/, c-Src-derived/NEWGENE construct/NEWGENE (/( a-Src/NEWGENE )/SYM ,/, that/WDT was/VBD excluded/VBN from/IN detergent-resistant/JJ membranes/NNS ,/, could/MD not/RB restore/VB the/DT series/NN of/IN phagocytosis/NN signaling/JJ ./.
@@95604305544 Ime1/NEWGENE plays/VBP a/DT pivotal/JJ role/NN in/IN the/DT initiation/NN of/IN meiosis/NN in/IN a/JJ //JJ alpha/JJ diploid/JJ cells/NNS of/IN Saccharomyces/NN cerevisiae/NN ./.
@@119027812285 Concentrations/NNS of/IN N/NN (/NN O3-/NN )/NN -N/NN and/CC N/NN (/NN H3-/NN )/NN -N/NN at/IN Deoprayag/NN varied/VBD from/IN 0/CD ./CD 30/CD to/IN 0/CD ./CD 50/CD and/CC 0/CD ./CD 02/CD to/IN 0/CD ./CD 12/CD mg/NN //NN L/NN ,/, respectively/RB ,/, depending/VBG on/IN season/NN ./.
@@109381027661 To/TO characterize/VB this/DT effect/NN ,/, we/PRP looked/VBD for/IN targets/NNS of/IN NS1/NEWGENE influenza/NEWGENE virus/NEWGENE protein/NEWGENE among/IN cellular/JJ translation/NN factors/NNS ./.
@@1985102596 Innervation/NNS of/IN the/DT ventral/JJ diaphragm/NN of/IN the/DT locust/NN (/( Locusta/NN migratoria/NN )/SYM ./.
@@64123856985 In/NN the/DT 37/CD patients/NNS without/IN lung/NN disease/NN respiratory/JJ muscle/NN weakness/NN was/VBD accompanied/VBN by/IN significant/JJ decreases/NNS in/IN vital/JJ capacity/NN ,/, total/JJ lung/NN capacity/NN ,/, and/CC maximum/JJ voluntary/JJ ventilation/NN ;/: by/IN significant/JJ increases/NNS in/IN residual/JJ volume/NN and/CC arterial/JJ carbon/NN dioxide/NN tension/NN (/( PaCO2/NN )/SYM ;/: and/CC greater/JJR likelihood/NN of/IN dependence/NN on/IN ventilators/NNS ,/, atelectasis/NN ,/, and/CC pneumonia/NN ./.
@@568375643 Of/IN 600/CD mediastinoscopies/NNS carried/VBN out/RB from/IN 1966/CD to/IN 1973/CD ,/, 479/CD were/VBD performed/VBN to/IN assess/VB the/DT operability/NN of/IN a/DT pulmonary/JJ carcinoma/NN ./.
@@10077533485 These/DT data/NN provide/VB the/DT molecular/JJ tools/NNS for/IN the/DT final/JJ identification/NN of/IN the/DT MKS/NEWGENE and/CC the/DT MUL/NEWGENE genes/NEWGENE ./.
@@106247879636 Compared/VBN to/IN those/DT with/IN normal/JJ renal/JJ functions/NNS ,/, these/DT patients/NNS were/VBD older/JJR (/( P/NN </SYM or/CC =/SYM 0/CD ./CD 01/CD )/SYM ,/, had/VBP significantly/RB elevated/VBN blood/NN pressures/NNS (/( P/NN </SYM 0/CD ./CD 01/CD or/CC P/NN =/SYM 0/CD ./CD 0001/CD )/SYM ,/, and/CC in/IN the/DT case/NN of/IN Type/NN 1/NN DM/NN ,/, with/IN a/DT higher/JJ body/NN mass/JJ index/NN (/( P/NN =/SYM 0/CD ./CD 0001/CD )/SYM and/CC waist-hip/JJ ratio/NN (/( P/NN </SYM 0/CD ./CD 01/CD )/SYM ./.
@@112027051040 Implications/NNS in/IN biomonitoring/JJ of/IN the/DT observed/VBN accumulation/NN patterns/NNS ,/, especially/RB in/IN the/DT different/JJ tissues/NNS of/IN Posidonia/JJ oceanica/NN ,/, are/VBP discussed/VBN ./.
@@13300779794 T-cell/NEWGENE receptor/NEWGENE beta/NEWGENE (/( TCR/NEWGENE beta/NEWGENE )/SYM gene/NN rearrangements/NNS occur/VBP in/IN a/DT third/RB of/IN early/JJ B-cell/NN acute/JJ lymphoblastic/JJ leukemias/NNS (/( ALLs/NNS )/SYM ./.
@@77766852524 This/DT study/NN assesses/VBZ the/DT feasibility/NN and/CC toxicity/NN of/IN adoptive/JJ immunotherapy/NN with/IN tumor/NN infiltrating/JJ lymphocytes/NNS and/CC recombinant/NEWGENE interleukin-2/NEWGENE in/IN 29/CD patients/NNS who/WP underwent/VBD resection/NN for/IN stage/NN III/NNP non-small-cell/JJ lung/NN cancer/NN ./.
@@105645935004 The/DT MXR/NEWGENE gene/NEWGENE encodes/VBZ a/DT half-transporter/NN and/CC the/DT absence/NN of/IN cytogenetic/JJ evidence/NN of/IN coamplification/NN of/IN other/DT regions/NNS suggests/VBZ that/IN a/DT partner/NN may/MD not/RB be/VB overexpressed/VBN ,/, and/CC instead/RB the/DT MXR/NEWGENE half-transporter/NEWGENE homodimerizes/VBZ to/IN mediate/VB drug/NN transport/NN ./.
@@84321375536 We/PRP compared/VBD the/DT parameters/NNS pleural/NEWGENE adenosine/NEWGENE deaminase/NEWGENE (/( PADA/NEWGENE ,/, determined/VBN in/IN 405/CD patients/NNS )/SYM ,/, the/DT PADA/NEWGENE //NEWGENE serum/NEWGENE ADA/NEWGENE ratio/NN (/( P/NEWGENE //NEWGENE SADA/NEWGENE ;/: 276/CD cases/NNS )/SYM ,/, pleural/NEWGENE lysozyme/NEWGENE (/( PLYS/NEWGENE ,/, 276/CD cases/NNS )/SYM ,/, the/DT PLYS/NEWGENE //NEWGENE serum/NEWGENE LYS/NEWGENE ratio/NN (/( P/NEWGENE //NEWGENE SLYS/NEWGENE ;/: 276/CD cases/NNS )/SYM ,/, and/CC pleural/NEWGENE interferon/NEWGENE gamma/NEWGENE (/( IFN/NEWGENE ,/, 145/CD cases/NNS )/SYM regarding/IN their/PRP ability/NN to/IN differentiate/VB tuberculous/JJ pleural/JJ effusions/NNS from/IN others/NNS ./.
@@8289784936 176/CD :/: 787-792/CD ,/, 1992/CD ;/: M/NNP ./NNP
@@25212171869 An/DT immunologically/RB related/VBN protein/NN was/VBD detected/VBN in/IN ribosome/NN and/CC membrane/NN fractions/NNS of/IN mitochondria/NNS from/IN Saccharomyces/NN cerevisiae/NN ./.
@@84219101948 As/IN the/DT components/NNS of/IN these/DT complexes/NNS ,/, at/IN least/RB five/CD TRBPs/NEWGENE (/( p30/NEWGENE ,/, p37/NEWGENE ,/, p46/NEWGENE ,/, p50/NEWGENE ,/, and/CC p56/NEWGENE )/SYM showing/VBG specific/JJ binding/NN to/IN the/DT TAR/NEWGENE RNA/NEWGENE were/VBD detected/VBN in/IN the/DT uv/NN cross-linking/VBG assay/NN ./.
@@117433609246 Acute/JJ stress/NN in/IN 7/CD rats/NNS also/RB increased/VBN the/DT mean/JJ amount/NN of/IN IL-6/NEWGENE released/VBN in/IN the/DT urine/NN by/IN 31/CD ./CD 5%/CD from/IN 775/CD ./CD 9/CD +/NN //NN -/NN 69/CD ./CD 2/CD to/IN 1/CD ,/CD 021/CD ./CD 1/CD +/NN //NN -/NN 93/CD ./CD 3/CD pg/CD ./CD //CD ml/CD ./.
@@81643028136 All/DT of/IN the/DT basal/NN TPN/NN solutions/NNS were/VBD isonitrogenous/JJ and/CC identical/JJ in/IN nutrient/JJ composition/NN ,/, except/VB for/IN the/DT difference/NN in/IN energy/NN level/NN ,/, which/WDT was/VBD adjusted/VBN with/IN glucose/NN ./.
@@114094259337 We/PRP used/VBD stored/VBN plasma/NN samples/NNS from/IN 409/CD patients/NNS in/IN the/DT National/NNP Institute/NNP of/IN Neurological/NNP Diseases/NNPS and/CC Stroke/NN (/( NINDS/NNP )/SYM tissue/NEWGENE plasminogen/NEWGENE activator/NEWGENE (/( t-PA/NEWGENE )/SYM Stroke/NN Trial/NN to/IN examine/VB the/DT relationship/NN between/IN an/DT apolipoprotein/NEWGENE (/NEWGENE Apo/NEWGENE )/NEWGENE E2/NEWGENE or/CC an/DT Apo/NEWGENE E4/NEWGENE phenotype/NN and/CC a/DT favorable/JJ outcome/NN 3/NN months/NNS after/IN stroke/NN ,/, the/DT risk/NN of/IN intracerebral/JJ hemorrhage/NN ,/, and/CC the/DT response/NN to/IN intravenous/JJ t-PA/NEWGENE therapy/NN ./.
@@23034703362 The/DT introns/NNS are/VBP 1/CD ./CD 6-1/CD ./CD 9/CD kbp/NN long/JJ ./.
@@57403895689 Relations/NNS between/IN adrenergic/JJ mechanisms/NNS and/CC analgesic/JJ effects/NNS ./.
@@112832561815 Here/RB we/PRP demonstrate/VBP that/IN native/NEWGENE MRCK/NEWGENE exists/VBZ in/IN high-molecular-weight/JJ complexes/NNS ./.
@@112384475146 In/NN vitro/FW binding/JJ studies/NNS demonstrate/VBP that/IN eIF-5A/NEWGENE is/VBZ required/VBN for/IN efficient/JJ interaction/NN of/IN Rev-NES/NEWGENE with/IN CRM1/NEWGENE //NEWGENE exportin1/NEWGENE and/CC that/IN eIF-5A/NEWGENE interacts/VBZ with/IN the/DT nucleoporins/NNP CAN/NEWGENE //NEWGENE nup214/NEWGENE ,/, nup153/NEWGENE ,/, nup98/NEWGENE ,/, and/CC nup62/NEWGENE ./.
@@19487832573 The/DT antihypertensive/JJ effect/NN of/IN Estulic/NN has/VBZ been/VBN examined/VBN over/RB a/DT 12-month/JJ period/NN in/IN 101/CD hypertensive/JJ patients/NNS ./.
@@24957453056 The/DT thrombolytic/JJ effects/NNS of/IN native/JJ tissue-type/NEWGENE plasminogen/NEWGENE activator/NEWGENE (/( AK-124/NEWGENE )/SYM on/IN experimental/JJ canine/JJ coronary/JJ thrombosis/NN ./.
@@85147571351 Both/DT immunophilins/NEWGENE may/MD have/NN important/JJ roles/NNS in/IN receptor/NN assembly/NN and/CC may/MD represent/VB a/DT new/JJ category/NN of/IN ligand-/NN and/CC calcium-dependent/NN modulators/NN of/IN protein/NN function/NN ./.
@@104906093359 Substitutions/NNS of/IN region/NN I/NN with/IN synthetic/JJ sequences/NNS showed/VBN that/IN no/DT specific/JJ sequence/NN but/CC rather/RB repeats/VBZ of/IN three/CD or/CC more/RB consecutive/JJ adenines/NNS or/CC thymines/NNS ,/, without/IN interruption/NN by/IN guanine/NN or/CC cytosine/NN ,/, are/VBP required/VBN for/IN the/DT ARS/NEWGENE activity/NN ./.
@@30247038475 The/DT coding/JJ region/NN of/IN 2385/CD nucleotides/NNS corresponds/VBZ to/IN a/DT polypeptide/NN chain/NN of/IN 795/CD amino/JJ acids/NNS ,/, giving/JJ a/DT molecular/JJ weight/NN of/IN 91/CD ,/CD 555/CD for/IN the/DT hsp108/NEWGENE protein/NEWGENE ./.
@@62818916076 Both/DT neural/JJ and/CC hormonal/JJ pathways/NNS and/CC both/DT opiate/JJ and/CC nonopiate/JJ substances/NNS play/VBP roles/NNS in/IN the/DT complex/NN modulation/NN of/IN pain/NN transmission/NN ./.
@@102314857844 Sequence/NN analysis/NN suggests/VBZ that/DT TtrA/NEWGENE contains/VBZ a/DT molybdopterin/NN guanine/NN dinucleotide/NN cofactor/NN and/CC a/DT [/NN 4Fe-4S/NN ]/NN cluster/NN ,/, that/IN TtrB/NEWGENE binds/VBZ four/CD [/NN 4Fe-4S/NN ]/NN clusters/NNS ,/, and/CC that/IN TtrC/NEWGENE is/VBZ an/DT integral/JJ membrane/NN protein/NN containing/JJ a/DT quinol/NN oxidation/NN site/NN ./.
@@104877444260 A/DT tyrosine-based/JJ sorting/JJ signal/NN in/IN the/DT beta2/NEWGENE integrin/NEWGENE cytoplasmic/NEWGENE domain/NEWGENE mediates/VBZ its/PRP recycling/JJ to/IN the/DT plasma/NN membrane/NN and/CC is/VBZ required/VBN for/IN ligand-supported/JJ migration/NN ./.
@@18953849786 The/DT IE0/NEWGENE gene/NEWGENE product/NN also/RB transactivated/VBN the/DT IE1/NEWGENE promoter/NEWGENE but/CC did/VBD not/RB affect/VB expression/NN from/IN its/PRP own/VB promoter/NN ./.
@@45469745026 Variations/NNS of/IN the/DT timing/NN of/IN deflections/NNS in/IN the/DT His/NN bundle/NN recordings/NNS ./.
@@115628701439 The/DT probability/NN of/IN treatment/NN with/IN lamotrigine/NN being/VBP maintained/VBN for/IN six/CD months/NNS was/VBD 86%/JJ ,/, for/IN twelve/CD months/NNS 61%/JJ and/CC for/IN three/CD years/NNS 31%/JJ ./.
@@4974945283 The/DT ventilation/NN did/VBD not/RB increase/VB when/CC PACO2/NN was/VBD increased/VBN ./.
@@85348556960 The/DT Arabidopsis/NEWGENE FAD7/NEWGENE gene/NEWGENE encodes/VBZ a/DT chloroplast/NEWGENE omega-3/NEWGENE fatty/NEWGENE acid/NEWGENE desaturase/NEWGENE that/WDT catalyzes/VBZ the/DT desaturation/NN of/IN lipid-linked/JJ dienoic/JJ fatty/JJ acids/NNS (/( 18/CD :/: 2/CD and/CC 16/CD :/: 2/CD )/SYM ./.
@@91548198620 Transient/JJ overexpression/NN of/IN c-Jun/NEWGENE induced/VBN tenascin-C/NEWGENE expression/NN in/IN primary/JJ REF/NN and/CC in/IN FR3T3/NNP ,/, an/DT established/VBN fibroblast/NN cell/NN line/NN ./.
@@99170641085 Dual/JJ roles/NNS of/IN p82/NEWGENE ,/, the/DT clam/NN CPEB/NEWGENE homolog/NEWGENE ,/, in/IN cytoplasmic/JJ polyadenylation/NN and/CC translational/JJ masking/NN ./.
@@18699685626 Arterial/JJ radioactivity/NN content/NN after/IN the/DT intravenous/JJ administration/NN of/IN HMPAO/NN in/IN seven/JJ human/JJ subjects/NNS was/VBD analyzed/VBN ./.
@@12415889465 The/DT alterations/NNS of/IN 5-HT/JJ and/CC 5-HIAA/JJ levels/NNS in/IN several/DT regions/NNS of/IN the/DT brain/NN under/IN the/DT conditions/NNS examined/VBN may/MD indicate/VB that/IN IDPN's/NN neurotoxicity/NN primarily/RB affects/VBP 5-HT-containing/JJ neurones/NNS ./.
@@104643024471 The/DT recruitment/NN of/IN constitutively/RB phosphorylated/VBN p185/NEWGENE (/NEWGENE neu/NEWGENE )/NEWGENE and/CC the/DT activated/VBN mitogenic/JJ pathway/NN proteins/NN to/IN this/DT membrane-microfilament/JJ interaction/NN site/NN provides/VBZ a/DT physical/JJ model/NN for/IN integrating/JJ the/DT assembly/NN of/IN the/DT mitogenic/JJ pathway/NN with/IN the/DT transmission/NN of/IN growth/NEWGENE factor/NEWGENE signal/JJ to/IN the/DT cytoskeleton/NN ./.
@@75517877432 The/DT outcome/NN of/IN the/DT optimization/NN of/IN the/DT seven-field/JJ plan/NN prompted/VBD an/DT investigation/NN into/IN the/DT best/JJS results/NNS that/WDT could/MD be/VB achieved/VBN by/IN an/DT "ideal"/JJ conformal/JJ radiotherapy/NN technique/NN ./.
@@79491644434 The/DT site-directed/NN mutation/NN of/IN the/DT kappa/NEWGENE B/NEWGENE motif/NEWGENE in/IN IL-6/NEWGENE //NEWGENE CAT/NEWGENE plasmid/NN resulted/VBN in/IN the/DT complete/JJ abrogation/NN of/IN IL-6/NEWGENE promoter/NEWGENE activity/NN in/IN these/DT cells/NNS ./.
@@117739217298 METHODS/IN :/: P-selectin/NEWGENE expression/NN of/IN nonstimulated/JJ and/CC ADP-stimulated/JJ platelets/NNS was/VBD flow/NN cytometrically/RB measured/VBD before/IN the/DT clopidogrel/NN loading/NN dose/NN and/CC on/IN 3/CD consecutive/JJ days/NNS in/IN 52/NNP patients/NNS with/IN coronary/JJ artery/NN disease/NN :/: 21/CD patients/NNS in/IN group/NN 1/CD received/VBN 300/CD mg/NN of/IN clopidogrel/NN after/IN stent/NN implantation/NN and/CC 11/CD patients/NNS in/IN group/NN 2/CD received/VBN the/DT higher/JJ 450-mg/JJ clopidogrel/NN loading/NN dose/NN followed/VBN by/IN a/DT daily/JJ dose/NN of/IN 75/CD mg/NN of/IN clopidogrel/NN for/IN both/DT groups/NNS ./.
@@75927713137 The/DT mouse/NEWGENE beta/NEWGENE 2-syntrophin/NEWGENE gene/NEWGENE (/( >/SYM 33/CD kilobases/NNS )/SYM contains/VBZ seven/JJ exons/NNS ,/, all/DT of/IN which/WDT have/VBP homologues/NNS at/IN the/DT corresponding/JJ position/NN in/IN the/DT alpha/NEWGENE 1-syntrophin/NEWGENE gene/NEWGENE ./.
@@94020296986 Interestingly/RB ,/, the/DT avirulent/JJ strain/NN H37Ra/CELL showed/VBD weak/JJ hybridization/NN with/IN these/DT two/JJ probes/NNS ,/, suggesting/VBG that/IN these/DT genes/NNS might/MD have/NN been/VBN deleted/VBN in/IN the/DT avirulent/JJ strain/NN or/CC are/VBP present/VB in/IN limited/VBN copy/NN numbers/NNS as/IN opposed/VBN to/IN those/DT in/NN the/DT virulent/JJ strain/NN H37Rv/CELL ./.
@@114393433780 In/NN contrast/NN to/IN MPc3/NEWGENE ,/, data/NN indicate/VB that/IN the/DT Pc/NEWGENE protein/NEWGENE M33/NEWGENE1 does/VBP not/RB interact/VB with/IN AF9/NEWGENE ./.
@@85094198911 Expression/NNS of/IN this/DT protein/NN in/IN E/NNP ./NNP coli/RB demonstrated/VBD that/DT tyrosine/NN was/VBD incorporated/VBN during/IN suppression/NN and/CC that/DT yeast/NEWGENE cytoplasmic/NEWGENE TyrRS/NEWGENE activity/NN was/VBD produced/VBN ./.
@@19931813451 Nucleotide/NN sequence/NN analysis/NN of/IN the/DT Pseudomonas/NEWGENE putida/NEWGENE PpG7/NEWGENE salicylate/NEWGENE hydroxylase/NEWGENE gene/NEWGENE (/( nahG/NEWGENE )/SYM and/CC its/PRP 3'-flanking/JJ region/NN ./.
@@104987062383 Taken/VBN together/RB ,/, our/PRP data/NN suggest/VB that/IN PecS/NEWGENE attenuates/VBZ pelD/NEWGENE and/CC pelE/NEWGENE expression/NN rather/RB than/RB acting/JJ as/IN a/DT true/JJ repressor/NN like/JJ KdgR/NEWGENE ./.
@@109729804124 In/NN several/DT cell/NN lines/NNS ,/, mTOR/NEWGENE or/CC its/PRP downstream/RB targets/VBZ can/MD be/VB regulated/VBN by/IN phosphatidylinositol/NEWGENE (/NEWGENE PI/NEWGENE )/NEWGENE 3-kinase/NEWGENE ;/: protein/NEWGENE kinases/NEWGENE A/NEWGENE ,/NEWGENE B/NEWGENE ,/NEWGENE and/NEWGENE C/NEWGENE ;/: heterotrimeric/NEWGENE G-proteins/NEWGENE ;/: a/DT PD98059-sensitive/NN kinase/NEWGENE or/CC calcium/NN ;/: as/RB well/VB as/IN by/IN amino/JJ acids/NNS ./.
@@90890935083 Sequences/NNS downstream/RB of/IN the/DT two/JJ human/NEWGENE CA/NEWGENE genes/NEWGENE ,/, possibly/RB containing/JJ homologous/JJ enhancer/NN elements/NNS ,/, have/VB not/RB yet/RB been/VBN reported/VBN ./.
@@89786901258 This/DT establishes/VBZ Rad3/NEWGENE //NEWGENE Mec1/NEWGENE as/IN the/DT only/RB conserved/VBN protein/NN which/WDT is/VBZ required/VBN for/IN all/PDT the/DT DNA/NN structure/NN checkpoints/NNS in/IN both/DT yeast/NN model/NN systems/NNS ./.
@@112262281436 However/RB ,/, plasmids/NNS carrying/VBG the/DT yeast/NEWGENE TyrRS/NEWGENE gene/NEWGENE could/MD not/RB be/VB stably/RB maintained/VBN in/IN E/NNP ./NNP coli/JJ ./.
@@105280355316 16/CD percent/NN ,/, P/NN </NN 0/NN ./NN 001/NN )/NN ,/, and/CC sustained/JJ normalization/NN of/IN serum/NEWGENE alanine/NEWGENE aminotransferase/NEWGENE levels/NNS (/( 41/CD percent/NN vs/IN ./IN
@@19562859692 The/DT sequence/NN was/VBD determined/VBN of/IN 6493/CD nucleotides/NNS encompassing/VBG the/DT bet/NEWGENE genes/NEWGENE of/NEWGENE Escherichia/NEWGENE coli/NEWGENE which/WDT encode/VBP the/DT osmoregulatory/JJ choline-glycine/NEWGENE betaine/NEWGENE pathway/NEWGENE ./.
@@92741131589 135/CD students/NNS had/VBP a/DT count/NN of/IN less/PRP than/IN 50/NN eggs/NN //NN 10/NN ml/NN ./NN urine/NN and/CC 56/CD had/VBP more/RB than/IN 50/CD eggs/NN //NN 10/NN ml/NN ./NN
@@113400853664 Based/VBN on/IN the/DT hypothesis/NN that/IN evolutionarily/RB conserved/VBN regions/NNS are/VBP functionally/RB important/JJ and/CC likely/RB to/IN interact/VB with/IN coactivators/NNS ,/, we/PRP compared/VBD the/DT amino/JJ acid/NN sequence/NN of/IN C/NEWGENE //NEWGENE EBPalpha/NEWGENE from/IN different/JJ species/NN (/( frog/NN to/IN human/JJ )/SYM and/CC identified/VBN four/CD highly/RB conserved/VBN regions/NNS (/( CR1-CR4/NEWGENE )/SYM within/IN the/DT transactivation/NN domain/NN ./.
@@97183728859 Evidence/NN for/IN a/DT novel/JJ MAPKKK-independent/NN pathway/NN controlling/JJ the/DT stress/NN activated/VBN Sty1/NEWGENE //NEWGENE Spc1/NEWGENE MAP/NEWGENE kinase/NEWGENE in/IN fission/NN yeast/NN ./.
@@104136623192 A/DT recombinant/JJ derivative/NN harboring/VBG the/DT pMJ101/NN replication/NN region/NN proved/VBN to/IN be/VB compatible/JJ with/IN pJM1/NN ,/, a/DT plasmid/NN containing/JJ the/DT iron/NN acquisition/NN system/NN required/VBN for/IN the/DT virulence/NN of/IN V/NNP ./NNP anguillarum/NN 775/NN ,/, another/DT important/JJ pathogen/NN that/IN causes/NNS vibriosis/NN ./.
@@91864309133 Five/CD of/IN these/DT have/JJ ocular/JJ or/CC oculocutaneous/JJ albinism/NN ./.
@@99997429998 NH3/NN and/CC NO/DT interaction/NN with/IN Si/NN (/NN 100/NN )/NN -/NN (/NN 2/NN x/NN 1/NN )/NN surfaces/NNS ./.
@@46619615085 Normal/JJ values/NNS for/IN the/DT peripheral/JJ blood/NN and/CC bone/NN marrow/NN of/IN the/DT grey/JJ (/( Armenian/NN )/SYM hamster/NN ./.
@@19180106116 Lipoprotein/NEWGENE lipase/NEWGENE (/( LPL/NEWGENE )/SYM ,/, a/DT key/NN enzyme/NN in/IN normal/JJ lipoprotein/NN metabolism/NN ,/, has/VBZ a/DT complex/NN pattern/NN of/IN regulation/NN and/CC tissue-specific/JJ expression/NN ./.
@@75696401165 Protein/NN electrophoresis/NN showed/VBD decreased/VBN albumin/NEWGENE levels/NNS in/IN both/DT groups/NNS ,/, with/IN lower/JJR values/NNS in/IN G2/NNP ./NNP
@@91686238130 A/DT xylE/NEWGENE transcriptional/NEWGENE fusion/NEWGENE to/IN the/DT putative/JJ mxbD/NEWGENE promoter/NEWGENE showed/VBD low-level/JJ expression/NN in/IN wild-type/NN cells/NNS grown/VBP on/IN one-carbon/JJ (/( C1/NN )/SYM compounds/NNS and/CC no/DT detectable/JJ expression/NN in/IN cells/NNS grown/VBP on/IN succinate/NN ./.
@@110063314163 The/DT variable/JJ phenotype/NN of/IN the/DT allotetraploids/NNS could/MD not/RB be/VB explained/VBN by/IN cytological/JJ abnormalities/NNS ./.
@@1398074455 The/DT RNase/NEWGENE MRP/NEWGENE RNA/NEWGENE gene/NEWGENE was/VBD deleted/VBN by/IN insertional/JJ replacement/NN and/CC found/VB to/IN be/VB essential/JJ for/IN cellular/JJ viability/NN ,/, indicating/VBG a/DT critical/JJ nuclear/JJ role/NN for/IN RNase/NEWGENE MRP/NEWGENE ./.
@@57190315667 Studies/NNS on/IN the/DT method/NN of/IN size/NN reduction/NN of/IN medicinal/JJ compounds/NNS ./.
@@103905387480 A/DT human/NEWGENE Raf-responsive/NEWGENE zinc-finger/NEWGENE protein/NEWGENE that/WDT binds/VBZ to/IN divergent/JJ sequences/NNS ./.
@@104414498165 Copyright/NNP 1999/CD Academic/NNP Press/NNP ./.
@@95142605943 One/CD of/IN these/DT small/NEWGENE inteins/NEWGENE might/MD be/VB inactive/JJ or/CC a/DT "pseudo/NEWGENE intein/NEWGENE ./NEWGENE "/NEWGENE The/DT results/NNS suggest/VBP a/DT modular/JJ architecture/NN for/IN inteins/NEWGENE ,/, clarify/VB their/PRP origin/NN and/CC relationship/NN to/IN other/DT protein/NN families/NNS ,/, and/CC extend/VB recent/JJ experimental/JJ findings/NNS on/IN the/DT functional/JJ roles/NNS of/IN intein/NEWGENE N/NEWGENE ,/NEWGENE C/NEWGENE ,/NEWGENE and/NEWGENE EN/NEWGENE motifs/NEWGENE ./.
@@88989163117 220/CD ,/, 263-273/NN )/NN ./.
@@81947536119 As/IN in/IN S/NNP ./NNP cerevisiae/NN ,/, the/DT sequence/NN of/IN rhp51+/NEWGENE showed/VBD two/JJ MluI/NEWGENE cell-cycle/NEWGENE boxes/NEWGENE and/CC a/DT putative/JJ DNA/NN damage-responsive/JJ element/NN in/IN its/PRP upstream/JJ region/NN ./.
@@103952831458 There/EX was/VBD no/DT competition/NN between/IN activin/NEWGENE A/NEWGENE and/CC OP-1/NEWGENE for/IN availability/NN of/IN Smad4/NEWGENE ,/, indicating/VBG that/IN the/DT concentration/NN of/IN this/DT common/JJ signal/NN transducer/NN is/VBZ not/RB limiting/JJ for/IN generating/JJ the/DT observed/VBN biological/JJ responses/NNS ./.
@@71400606950 Intra-articular/JJ dislocation/NN of/IN the/DT patella/NN ./.
@@83050589614 Pneumothorax/NN during/IN laparoscopic/JJ dissection/NN of/IN the/DT diaphragmatic/JJ hiatus/NN ./.
@@96564145277 Dosage/NNS in/IN both/DT cases/NNS was/VBD 0/CD ./CD 2/CD g/NN //NN m2/NN ./.
@@97269797268 Molecular/NNP cloning/NN and/CC functional/JJ characterization/NN of/IN murine/NEWGENE sphingosine/NEWGENE kinase/NEWGENE ./.
@@98910497794 Processing/NNP of/IN the/DT polycistronic/JJ precursor/NN requires/VBZ nucleases/NEWGENE also/RB involved/VBN in/IN rRNA/NEWGENE processing/VBG ,/, i/FW ./FW e/FW ./FW ,/, Rnt1p/NEWGENE and/CC Rat1p/NEWGENE ./.
@@110290451421 Hyperactivation/NNS of/IN Cdc2/NEWGENE in/IN fission/NN yeast/NN causes/NNS cells/NNS to/IN undergo/VB a/DT lethal/JJ premature/JJ mitosis/NN called/VBN mitotic/JJ catastrophe/NN ./.
@@79354151577 Tissue-specific/NN expression/NN of/IN the/DT diazepam-binding/NEWGENE inhibitor/NEWGENE in/IN Drosophila/NN melanogaster/NN :/: cloning/NN ,/, structure/NN ,/, and/CC localization/NN of/IN the/DT gene/NN ./.
@@15519108095 Competition/NN analysis/NN by/IN gel/NN mobility/NN shift/NN electrophoresis/NN indicates/VBZ that/IN this/DT DNA-protein/NN interaction/NN is/VBZ novel/JJ and/CC not/RB related/VBN to/IN many/JJ transcription/NN factors/NNS previously/RB reported/VBN ./.
@@103472208790 Nevertheless/RB ,/, we/PRP demonstrate/VBP that/IN the/DT entire/JJ three-component/JJ yeast/NN capping/JJ apparatus/NN ,/, consisting/VBG of/IN RNA/NEWGENE 5'-triphosphatase/NEWGENE (/( Cet1p/NEWGENE )/SYM ,/, RNA/NEWGENE guanylyltransferase/NEWGENE (/( Ceg1p/NEWGENE )/SYM ,/, and/CC Abd1p/NEWGENE could/MD be/VB replaced/VBN in/IN vivo/NN by/IN the/DT two-component/JJ mammalian/JJ apparatus/NN consisting/VBG of/IN a/DT bifunctional/JJ triphosphatase-guanylyltransferase/NEWGENE Mce1p/NEWGENE and/CC the/DT methyltransferase/NEWGENE Hcm1/NEWGENE (/NEWGENE 121-476/NEWGENE )/NEWGENE p/NEWGENE ./.
@@20261475369 We/PRP purified/VBN a/DT Ca2+/NEWGENE //NEWGENE calmodulin/NEWGENE (/NEWGENE CaM/NEWGENE )/NEWGENE -dependent/NEWGENE protein/NEWGENE kinase/NEWGENE (/NEWGENE CaM/NEWGENE kinase/NEWGENE )/NEWGENE from/NEWGENE the/NEWGENE yeast/NEWGENE Saccharomyces/NEWGENE cerevisiae/NEWGENE with/IN properties/NNS similar/JJ to/IN mammalian/NEWGENE type/NEWGENE II/NEWGENE CaM/NEWGENE kinases/NEWGENE ./.
@@82515067063 The/DT 247-kDa/NN complex/NN appears/VBZ to/IN contain/VB two/JJ distinct/JJ protein-DNA/JJ complexes/NNS of/IN approximately/RB 232/CD and/CC 256/CD kDa/NN and/CC represents/VBZ two/JJ proteins/NNS covalently/RB cross-linked/VBN to/IN a/DT single/JJ DRE/NEWGENE oligonucleotide/NN ,/, while/CC the/DT 97/CD ,/, 105/CD ,/, and/CC 115-kDa/JJ complexes/NNS represent/VBP single/JJ protein-DRE/NEWGENE cross-links/NNS ./.
@@90323041248 Identification/NNP of/IN a/DT promoter-specific/JJ transactivation/NN domain/NN in/IN the/DT herpes/NEWGENE simplex/NEWGENE virus/NEWGENE regulatory/NEWGENE protein/NEWGENE ICP4/NEWGENE ./.
@@97030211094 In/JJ insects/NNS ,/, arylalkylamine/NEWGENE N-acetyltransferases/NEWGENE (/( AANATs/NEWGENE )/SYM have/VB been/VBN implicated/VBN in/IN several/DT physiological/JJ processes/NNS ,/, including/JJ sclerotization/NN ,/, inactivation/NN of/IN certain/JJ neurotransmitters/NNS ,/, and/CC ,/, similar/JJ to/IN the/DT function/NN in/IN vertebrates/NNS ,/, catalysis/NN of/IN the/DT rate-limiting/JJ step/NN in/IN melatonin/NN biosynthesis/NN ./.
@@117106856506 Eliminating/VBG any/DT subset/NN of/IN ASCUS/NN reduces/VBZ the/DT ASCUS/NNP //NNP SIL/NNP ratio/NN but/CC also/RB significantly/RB diminishes/VBZ the/DT sensitivity/NN of/IN the/DT Papanicolaou/NN test/NN ./.
@@5178906 The/DT enteric/JJ route/NN is/VBZ the/DT principal/JJ mode/NN of/IN transmission/NN for/IN hepatitis/NN A/NN ,/, but/CC maximal/JJ levels/NNS of/IN hepatitis/NN A/NN virus/NN excretion/NN occur/VB before/IN the/DT onset/NN of/IN jaundice/NN ./.
@@103232253728 Km/NN values/NNS for/IN ammonium/NN ,/, 2-oxoglutarate/JJ ,/, NADH/NN ,/, glutamate/NN and/CC NAD+/NN were/VBD 6/CD ./CD 5/CD ,/, 3/CD ./CD 5/CD ,/, 0/CD ./CD 06/CD ,/, 37/CD ./CD 1/CD and/CC 0/CD ./CD 046/CD mM/NN ,/, respectively/RB ./.
@@13212777730 ROS/NEWGENE x/NN SRC/NEWGENE (/( R/NEWGENE )/SYM contains/VBZ a/DT 16-amino-acid/JJ deletion/NN that/WDT includes/VBZ the/DT 3'/CD half/NN of/IN the/DT transmembrane/JJ domain/NN of/IN ros/NEWGENE ./.
@@15794724935 Unlike/IN the/DT typical/JJ enhancer/NN element/NN ,/, this/DT region/NN functions/NNS in/IN an/DT orientation-dependent/JJ manner/NN ./.
@@87787005092 We/PRP present/VBP this/DT case/NN because/IN of/IN the/DT rarity/NN of/IN left/NN ventricular/JJ involvement/NN associated/VBN with/IN ARVD/NN ./.
@@92686521791 We/PRP describe/VBP a/DT novel/JJ zinc/NEWGENE finger/NEWGENE protein/NEWGENE ,/, dsRBP-ZFa/NEWGENE ,/, isolated/VBN by/IN screening/JJ an/DT expression/NN library/NN with/IN dsRNA/NN ./.
@@25974843247 With/IN respect/NN to/IN effective/JJ diffusivity/NN of/IN platelets/NNS (/( De/NNP )/SYM and/CC the/DT surface/NN reactivity/NN constant/JJ (/( K/NN )/SYM ,/, less/PRP significant/JJ differences/NNS were/VBD found/VBN among/IN artificial/JJ materials/NNS ./.
@@64821798962 Catch-up/NN growth/NN was/VBD observed/VBN only/RB for/IN a/DT 12-month/JJ period/NN in/IN 4/CD children/NNS with/IN a/DT bone/NN age/NN of/IN 7/CD to/IN 8/CD years/NNS ./.
@@86266127267 Am/NNP ./NNP
@@29600123667 The/DT frequency/NN of/IN PPNG/NN strains/NNS increased/VBN from/IN 1/CD ./CD 7%/CD in/IN 1981/CD to/IN 6/CD ./CD 7%/CD in/IN 1985/CD ./.
@@75923378623 These/DT results/NNS suggested/VBN that/IN NfxB/NEWGENE negatively/RB autoregulates/VBZ the/DT expression/NN of/IN nfxB/NEWGENE itself/PRP ./.
@@91055301144 An/DT egg/NN protein/NN ,/, lysozyme/NEWGENE ,/, is/VBZ a/DT still/RB unlabeled/JJ additive/JJ currently/RB used/VBN in/IN cheese/NN preparation/NN ./.
@@40707256553 Component/NN P100/NN was/VBD associated/VBN with/IN a/DT frontal/JJ negativity/NN of/IN similar/JJ latency/NN favoring/JJ the/DT hypothesis/NN of/IN a/DT dipolar/JJ occipital/JJ generator/NN ./.
@@97421298124 W/NN ./NN
@@62094039986 No/DT direct/JJ repeats/NNS flank/NN the/DT pseudogene/NN in/IN the/DT U2/NEWGENE //NEWGENE 4/NEWGENE locus/NEWGENE ./.
@@99746429965 Crossover/NNS in/IN the/DT specific/JJ heat/NN of/IN dilute/JJ magnets/NNS induced/VBN by/IN critical/JJ spin-wave/JJ dynamics/NNS ./.
@@23575377083 The/DT effects/NNS on/IN reflex/NN latencies/NNS but/CC not/RB on/IN paCO2/NN or/CC pHa/NN were/VBD blocked/VBN by/IN naloxone/NN (/( 2/CD mg/CD //CD kg/CD )/SYM ,/, and/CC were/VBD not/RB present/VB in/IN morphine-tolerant/JJ animals/NNS ./.
@@40589854997 Pharmacologic/NNP doses/NNS of/IN vitamin/NN B6/NN administered/VBN to/IN lactating/JJ women/NNS have/VBP been/VBN reported/VBN to/IN suppress/VB plasma/NEWGENE prolactin/NEWGENE ./.
@@72825527138 In/NNP Group/NNP V/NN ,/, the/DT salvaged/VBN tissue/NN was/VBD primarily/RB subepicardial/JJ with/IN virtually/RB no/DT lateral/JJ zone/NN of/IN salvaged/VBN tissue/NN (/( ratio/NN of/IN salvaged/VBN subepicardium/NN to/IN salvaged/VBN subendocardium/NN 14/CD ./CD 8/CD +/NN //NN -/NN 1/CD ./CD 9/CD to/IN 1/CD )/SYM ./SYM
@@34885324180 In/NN a/DT previous/JJ interim/NN report/NN we/PRP noted/VBD more/RB prompt/JJ resolution/NN of/IN dermatomal/JJ signs/NNS and/CC symptoms/NNS with/IN acyclovir/NN treatment/NN ./.
@@90723613419 In/NN cellular/JJ supernatant/JJ fraction/NN ,/, SHRSP/NNS showed/VBD a/DT decrease/NN of/IN magnesium/NN in/IN many/JJ tissues/NNS and/CC an/DT elevation/NN of/IN the/DT calcium/NN to/IN magnesium/NN ratio/NN when/CC compared/VBN to/IN age-matched/JJ WKY/NN and/CC SHRSR/NN ./.
@@93378611416 Cloning/NN of/IN a/DT human/NEWGENE phosphoinositide/NEWGENE 3-kinase/NEWGENE with/IN a/DT C2/NEWGENE domain/NEWGENE that/WDT displays/VBP reduced/VBN sensitivity/NN to/IN the/DT inhibitor/NN wortmannin/NN ./.
@@8425228380 Selective/JJ bronchial/JJ intubation/NN in/IN the/DT management/NN of/IN unilateral/JJ pulmonary/JJ interstitial/JJ emphysema/NN ./.
@@27145253402 Kidney/NNS weight/NN and/CC kidney-to-body/JJ weight/NN ratio/NN were/VBD significantly/RB elevated/VBN at/IN the/DT highest/JJS dose/NN level/NN after/IN 10/CD weeks/NNS and/CC at/IN the/DT two/JJ higher/JJ dose/NN levels/NNS after/IN 15/CD weeks/NNS of/IN exposure/NN ./.
@@95287661673 However/RB ,/, inhibition/NN of/IN both/PDT the/DT ERK/NEWGENE //NEWGENE RSK/NEWGENE and/CC the/DT p38/NEWGENE //NEWGENE MAPKAP/NEWGENE kinase/NEWGENE 2/NEWGENE pathways/NNS completely/RB abolished/VBN NGF-induced/NN CREB/NEWGENE Ser-133/NN phosphorylation/NN ./.
@@74757337363 Malaria/NN ,/, anaemia/NN ,/, and/CC HIV-1/NNP transmission/NN in/IN central/JJ Africa/NN ./.
@@11727348099 Association/NNP with/IN HL-A/NEWGENE W-27/NEWGENE ./.
@@108828507837 Endonuclease/NEWGENE III/NEWGENE (/( Nth/NEWGENE )/SYM of/IN Escherichia/NN coli/NN is/VBZ a/DT DNA/NEWGENE glycosylase/NEWGENE essential/JJ for/IN the/DT removal/NN of/IN oxidised/JJ pyrimidine/NN base/NN residues/NNS from/IN DNA/NN ./.
@@97336474398 This/DT sequence/NN ,/, Thr-Gly-X-X-Gly-Asp-Gly-Lys-Ile-Phe/NEWGENE ,/, forms/NNS part/NN of/IN the/DT B-loop/NEWGENE and/CC is/VBZ conserved/VBN in/IN a/DT wide/JJ variety/NN of/IN organisms/NNS that/WDT include/VBP bacteria/NNS ,/, algae/NNS and/CC archeabacteria/NNS ./.
@@108252004970 Hierarchy/NNS of/IN protein/NEWGENE tyrosine/NEWGENE kinases/NEWGENE in/IN interleukin-2/NEWGENE (/( IL-2/NEWGENE )/SYM signaling/JJ :/: activation/NN of/IN syk/NEWGENE depends/VBZ on/IN Jak3/NEWGENE ;/: however/RB ,/, neither/DT Syk/NEWGENE nor/CC Lck/NEWGENE is/VBZ required/VBN for/IN IL-2-mediated/JJ STAT/NEWGENE activation/NN ./.
@@2176822801 Multifunctional/NEWGENE protein/NEWGENE kinase/NEWGENE (/( MFPK/NEWGENE )/SYM phosphorylates/VBZ ATP-citrate/NEWGENE lyase/NEWGENE on/IN peptide/NEWGENE B/NEWGENE on/IN two/JJ sites/NNS ,/, BT/NN and/CC BS/NN ,/, on/IN threonine/NN and/CC serine/NN ,/, respectively/RB ,/, inhibitor/NEWGENE 2/NEWGENE on/IN a/DT threonyl/NN residue/NN ,/, and/CC glycogen/NEWGENE synthase/NEWGENE at/IN sites/NNS 2/CD and/CC 3/CD ./CD
@@113315969678 Prrp/NEWGENE can/MD also/RB associate/VB with/IN the/DT EVH1/NEWGENE domain/NEWGENE of/IN Mena/NEWGENE ,/, another/DT microfilament-associated/NN protein/NN ./.
@@93580459485 The/DT full/JJ length/NN cDNA/NN sequence/NN of/IN a/DT Type/NEWGENE I/NEWGENE transforming/NEWGENE growth/NEWGENE factor-beta/NEWGENE (/NEWGENE TGF-beta/NEWGENE )/NEWGENE receptor/NEWGENE has/VBZ been/VBN isolated/VBN from/IN the/DT filarial/JJ parasitic/JJ nematode/JJ Brugia/NN pahangi/NN ./.
@@7968409944 The/DT sample/NN includes/VBZ all/PDT the/DT HIV-infected-patients/NNS continuously/RB referred/VBN to/IN the/DT Outpatient/NNP Service/NNP of/IN the/DT Infectious/JJ Diseases/NNPS dept/NN ./. of/IN Bologna's/NNP "Ospedale/NNP Maggiore"/NNP General/NNP Hospital/NNP during/IN some/DT five/CD days/NNS (/( 19-23rd/NN ,/, July/NN 1993/CD )/SYM ./.
@@39648552457 Angiography/NNS was/VBD performed/VBN following/IN the/DT rCBF/NN study/NN and/CC the/DT degree/NN of/IN vasospasm/NN was/VBD measured/VBN on/IN the/DT angiograms/NNS ./.
@@16180273891 Furthermore/RB ,/, no/DT transcripts/NNS of/IN the/DT same/JJ size/NN and/CC having/VBG the/DT same/JJ developmental/JJ profile/NN as/IN those/DT generated/VBN by/IN the/DT wild-type/NEWGENE E10/NEWGENE fragment/NEWGENE were/VBD identified/VBN by/IN probes/NNS covering/VBG the/DT remainder/NN of/IN the/DT cloned/VBN region/NN ./.
@@84619818437 We/PRP discuss/VBP the/DT need/NN to/IN use/NN animals/NNS older/JJR than/IN 3/CD months/NNS for/IN the/DT study/NN of/IN 'adult'/NN regeneration/NN phenomena/NNS since/IN 3-month-old/NN rats/NNS may/MD be/VB somewhat/RB immature/JJ ./.
@@88087568937 Sequence/NN analysis/NN of/IN reverse/RB transcribed/VBN ,/, amplified/VBN cDNA/NN generated/VBN from/IN total/JJ RNA/NN isolated/VBN from/IN transfected/VBN cells/NNS demonstrated/VBD the/DT presence/NN of/IN abnormally/RB spliced/VBN products/NNS containing/JJ 13/CD and/CC 78/CD additional/JJ bases/NNS as/RB well/VBP as/IN the/DT accumulation/NN of/IN unspliced/JJ mRNA/NN ./.
@@83567928871 Furthermore/RB ,/, a/DT p21X/NEWGENE protein/NEWGENE lacking/JJ the/DT N-terminus/NN of/IN Rex1/NEWGENE was/VBD expressed/VBN at/IN high/JJ levels/NNS ;/: our/PRP data/NN indicate/VB that/IN p21X/NEWGENE is/VBZ translated/VBN from/IN the/DT 1/CD ./CD 6-kb/CD mRNA/NN which/WDT is/VBZ derived/VBN primarily/RB from/IN deleted/VBN proviruses/NNS ./.
@@32938443979 Diet/NNP and/CC atopic/JJ eczema/NN ./.
@@25926401590 High/NNP values/NNS of/IN both/DT retinol/NN and/CC beta-carotene/NN were/VBD found/VBN in/IN full/JJ fat/JJ cheeses/NNS and/CC whipping/JJ cream/NN :/: from/IN 179/CD ./CD 0/CD (/( cheese/NN ,/, Edam-type/NNP )/SYM to/IN 318/CD ./CD 7/CD micrograms/NN //NN 100/NN g/NN (/( whipping/JJ cream/NN )/SYM and/CC from/IN 86/CD ./CD 7/CD (/( cheese/NN ,/, Edam-type/NNP )/SYM to/IN 186/CD ./CD 5/CD micrograms/NN //NN 100/NN g/NN (/( whipping/JJ cream/NN )/SYM for/IN all-trans/NNS retinol/NN and/CC total/JJ beta-carotene/NN ,/, respectively/RB ./.
@@101327306458 Troubled/NNP CareNetwork/NN gets/VBZ pact/NN from/IN largest/JJS teacher/NN union/NN in/IN Wis/NNP ./.
@@110043694123 OBJECTIVE/IN :/: To/TO evaluate/VB the/DT relationship/NN between/IN blood/NN flow/NN in/IN the/DT tumor/NN assessed/VBN by/IN color/NN Doppler/NN ultrasound/JJ ,/, microvessel/NN density/NN ,/, and/CC vascular/NEWGENE endothelial/NEWGENE growth/NEWGENE factor/NEWGENE levels/NNS in/IN endometrial/JJ carcinoma/NN ./.
@@104308837768 Among/IN mucus-secreting/CD cells/NNS ,/, the/DT gastric/JJ gland/NN mucous/JJ cells/NNS ,/, Brunner's/NNP glands/NNS ,/, accessory/JJ glands/NNS of/IN pancreaticobiliary/JJ tract/NN ,/, and/CC pancreatic/JJ ducts/NNS exhibiting/VBG gastric/JJ metaplasia/NN are/VBP unique/JJ in/IN that/DT they/PRP express/NN class/NEWGENE III/NEWGENE mucin/NEWGENE identified/VBN by/IN paradoxical/JJ Con/NEWGENE A/NEWGENE staining/NN composed/VBN of/IN periodate/NN oxidation/NN ,/, sodium/NN borohydride/NN reduction/NN ,/, Con/NEWGENE A/NEWGENE ,/, and/CC horseradish/NEWGENE peroxidase/NEWGENE reaction/NN ./.
@@28539223543 Elevated/NNP IOP/NN developed/VBN in/IN 35/CD patients/NNS (/( 44/CD eyes/NNS )/SYM during/IN the/DT study/NN ./.
@@101963167157 To/TO determine/VB the/DT function/NN of/IN VZV/NEWGENE gK/NEWGENE in/IN virus/NN growth/NN ,/, a/DT series/NN of/IN gK/NEWGENE deletion/NEWGENE mutants/NEWGENE were/VBD constructed/VBN with/IN VZV/NN cosmid/NN DNA/NN derived/VBN from/IN the/DT Oka/NN strain/NN ./.
@@97380877589 The/DT effect/NN of/IN independent/NN predictors/NN on/IN survival/NN was/VBD examined/VBN in/IN a/DT Cox/NN regression/NN model/NN with/IN adjustment/NN for/IN existing/JJ illnesses/NNS ./.
@@1990122603 Ectopic/NNP ACTH/NEWGENE syndrome/NN and/CC medullary/JJ thyroid/JJ carcinoma/NN ./.
@@75178691914 We/PRP observed/VBD that/DT dephosphorylation/NN severely/RB inhibits/VBZ the/DT DNA-binding/NN ability/NN of/IN C/NEWGENE //NEWGENE EBP-delta/NEWGENE and/CC its/PRP transactivating/JJ potential/JJ increases/NNS in/IN the/DT presence/NN of/IN cellular/JJ phosphatase/NEWGENE inhibitors/NN ,/, such/JJ as/IN okadaic/JJ acid/NN and/CC sodium/NN orthovanadate/NN ./.
@@97367157970 Furthermore/RB ,/, phosphatidylinositol/NN (/NN 3/NN ,/NN 4/NN ,/NN 5/NN )/NN trisphosphate/NN specifically/RB stimulates/VBZ the/DT activity/NN of/IN ILK/NEWGENE in/IN vitro/FW ,/, and/CC in/IN addition/NN ,/, membrane/NN targetted/VBN constitutively/RB active/JJ Pi/NEWGENE (/NEWGENE 3/NEWGENE )/NEWGENE K/NEWGENE activates/VBZ ILK/NEWGENE in/IN vivo/NN ./.
@@36975874364 49/CD ,/, XXXXY/NN chromosome/NN anomaly/NN :/: an/DT unusual/JJ variant/NN of/IN Klinefelter's/NNP syndrome/NN ./.
@@79914372139 Propafenone/NN is/VBZ well/VB tolerated/VBN in/IN the/DT majority/NN of/IN young/JJ patients/NNS ./.
@@9315632906 Furthermore/RB ,/, our/PRP novel/JJ observation/NN that/DT expression/NN of/IN a/DT highly/RB activated/VBN FGFR3/NEWGENE kinase/NEWGENE domain/NEWGENE is/VBZ able/JJ to/IN morphologically/RB transform/VB fibroblasts/NNS suggests/VBZ that/DT dysregulation/NN of/IN FGFR3/NEWGENE has/VBZ the/DT potential/NN to/IN play/NN a/DT role/NN in/IN human/JJ neoplasia/NN ./.
@@117969771662 Postdocs/JJ face/NN hardship/NN across/IN mainland/JJ Europe/NN ./.
@@79590112495 C/NEWGENE //NEWGENE EBP/NEWGENE alpha/NEWGENE also/RB activates/VBZ the/DT promoter/NN of/IN the/DT rat/NEWGENE class-I/NEWGENE ADH/NEWGENE gene/NEWGENE in/IN a/DT sequence-specific/JJ manner/NN [/NN Potter/NN et/FW al/NNS ./NNS ,/, Arch/NNP ./.
@@65885016347 An/DT experimental/JJ long-term/JJ study/NN ./.
@@75574249723 XYL1/NEWGENE was/VBD isolated/VBN as/IN a/DT highly/RB expressed/VBN fusion/NN clone/NN from/IN a/DT 'lacZ/NEWGENE translational/JJ fusion/NN library/NN ./.
@@109034408364 Only/JJ transcripts/NNS specific/JJ for/IN TSGF-2/NEWGENE are/VBP detected/VBN in/IN ovary/NN and/CC testes/NNS tissues/NNS of/RB adults/NNS as/RB well/VBP as/IN in/IN puparia/NNS ,/, while/CC neither/DT gene/NN is/VBZ expressed/VBN during/IN the/DT larval/JJ developmental/JJ stages/NNS ./.
@@1130610113 Using/VBG RACE/NN techniques/NNS we/PRP have/VBP cloned/VBN and/CC sequenced/VBN one/PRP of/IN the/DT hamster/NN liver/NN 3-hydroxy-hexobarbital/NEWGENE dehydrogenases/NEWGENE which/WDT catalyze/VBP not/RB only/RB cyclic/JJ alcohols/NNS but/CC also/RB 17beta-hydroxy-steroids/VBZ and/CC 3alpha-hydroxysteroids/NNS ./.
@@112336435201 Currently/RB ,/, the/DT clinical/JJ use/NN of/IN 5-aminolaevulinic/JJ acid/NN (/( ALA/NN )/SYM induced/VBN protoporphyrin/NEWGENE IX/NEWGENE (/( PPIX/NEWGENE )/SYM for/IN photodynamic/JJ therapy/NN (/( PDT/NN )/SYM is/VBZ limited/VBN by/IN the/DT maximum/RB tolerated/VBN oral/JJ ALA/NN dose/NN (/( 60/CD mg/CD //CD kg/CD )/SYM ./.
@@79030998298 The/DT presence/NN of/IN an/DT unusual/JJ transcript/NN possessing/VBG IVS2C/NEWGENE beta/NEWGENE 1/NEWGENE at/IN the/DT 5'/NN terminus/NN suggests/VBZ that/DT cleavage/NN of/IN its/PRP splice/NN acceptor/NN is/VBZ inefficient/JJ or/CC negatively/RB regulated/VBN ./.
@@96910376803 We/PRP found/VBP sequences/NNS related/VBN to/IN this/DT insertion/NN in/IN wild-type/NN strains/NNS of/IN N/NNP ./NNP crassa/NN and/CC other/DT Neurospora/NN species/NN ./.
@@91518285957 The/DT altered/VBN amino/JJ acid/NN residues/NNS of/IN the/DT seven/JJ mutant/NEWGENE 9ORF1/NEWGENE polypeptides/NEWGENE clustered/VBN within/IN three/CD separate/JJ regions/NNS referred/VBN to/RB as/IN region/NN I/NN (/( residues/NNS 34/CD to/IN 41/CD )/SYM ,/, region/NN II/NN (/( residues/NNS 89/CD to/IN 91/CD )/SYM ,/, and/CC C-terminal/NN region/NN III/NN (/( residues/NNS 122/CD to/IN 125/CD )/SYM ./.
@@114959208548 A/DT one/PRP base/NN pair/NN mismatch/NN within/IN the/DT corresponding/JJ region/NN of/IN the/DT CYP3A4/NEWGENE gene/NEWGENE was/VBD sufficient/JJ for/IN a/DT differential/JJ enhancer/NN activity/NN ./.
@@103471448790 The/DT recombinant/RB purified/VBN protein/NN expressed/VBN in/IN the/DT baculovirus/NN system/NN had/VBP an/DT approximate/JJ molecular/JJ size/NN 20/CD kDa/NN with/IN amino-terminal/NEWGENE sequence/NEWGENE of/NEWGENE AVQGP/NEWGENE ./.
@@97362394461 During/IN the/DT 2h/CD resuscitation/NN period/NN ,/, extracellular/JJ aspartate/NN and/CC glutamate/NN concentrations/NNS in/IN the/DT cerebral/JJ striatum/NN were/VBD higher/JJ during/IN hypoxaemic/JJ resuscitation/NN (/( p/NN =/SYM 0/CD ./CD 044/CD and/CC p/NN =/SYM 0/CD ./CD 055/CD ,/, respectively/RB )/SYM than/IN during/IN resuscitation/NN with/IN 21%/JJ O2/NN or/CC 100%/NN O2/NN ,/, suggesting/VBG an/DT unfavourable/NN accumulation/NN of/IN potent/JJ excitotoxins/NNS during/IN hypoxaemic/JJ resuscitation/NN ./.
@@86423131350 When/WRB overexpressed/VBN in/IN an/DT appropriate/JJ cell/NN line/NN ,/, TAN-1C/NEWGENE prevented/VBD kappa/NN B-dependent/NN transactivation/NN in/IN transient/JJ reporter/NN gene/NN assays/NNS in/IN a/DT fashion/NN similar/JJ to/IN the/DT structurally/RB related/VBN protein/NN ,/, Bcl-3/NEWGENE ./.
@@106815204732 Ras-GRF1/NEWGENE transiently/RB expressed/VBN with/IN v-Src/NEWGENE was/VBD tyrosine-phosphorylated/JJ and/CC showed/VBD significant/JJ GEF/NEWGENE activity/NN toward/IN Rac/NEWGENE ,/, but/CC not/RB Rho/NEWGENE and/CC Cdc42/NEWGENE ,/, which/WDT was/VBD comparable/JJ with/IN that/DT induced/VBD by/IN Gbetagamma/NEWGENE ./.
@@87473438735 Protein/NN films/NNS are/VBP distinctly/RB different/JJ in/IN mechanical/JJ profiles/NNS from/IN those/DT films/NNS made/VBP of/IN other/DT materials/NNS ./.
@@96019403276 The/DT 5'/CD flanking/JJ region/NN of/IN the/DT CD1/NEWGENE gene/NEWGENE contained/VBD the/DT binding/JJ motifs/NNS for/IN two/JJ cytokine-inducible/JJ transcription/NN factors/NNS ,/, NF-IL2-A/NEWGENE and/CC NF-IL6/NEWGENE ./.
@@22487322885 This/DT ,/, together/RB with/IN the/DT data/NN obtained/VBN with/IN haloperidol/NN ,/, suggests/VBZ that/IN a/DT minimal/JJ increase/NN in/IN the/DT firing/JJ rate/NN of/IN LC/NN cells/NNS (/( +140%/NN )/SYM is/VBZ required/VBN before/IN it/PRP could/MD influence/VB the/DT turnover/NN of/IN NA/NN ,/, as/IN measured/VBN by/IN DOPAC/NN changes/NNS ./.
@@63300826777 A/NNP ./NNP
@@82192279292 Replacement/NN of/IN the/DT CRE/NEWGENE with/IN a/DT second/JJ copy/NN of/IN the/DT AP-1/NEWGENE site/NEWGENE results/NNS in/IN a/DT level/NN of/IN transcriptional/JJ activity/NN comparable/JJ with/IN that/DT of/IN the/DT wild-type/NN sequence/NN ,/, but/CC replacement/NN of/IN the/DT AP-1/NEWGENE site/NEWGENE with/IN a/DT CRE/NEWGENE abolishes/VBZ activity/NN ./.
@@89882578718 Silencing/NN can/MD be/VB restored/VBN by/IN creation/NN of/IN a/DT telomere/NN at/IN 13/CD kb/NN from/IN the/DT reporter/NN construct/NN ,/, or/CC by/IN insertion/NN of/IN 340/CD bp/NN of/IN yeast/NN telomeric/NN repeat/NN sequence/NN at/IN this/DT site/NN without/IN chromosomal/JJ truncation/NN ./.
@@115003778606 In/JJ mammals/NNS ,/, the/DT transcriptional/JJ repressors/NNS in/IN the/DT Wnt/NEWGENE pathway/NEWGENE are/VBP not/RB well/VB defined/VBN ./.
@@84064192004 They/PRP were/VBD found/VBN to/IN be/VB seropositive/JJ for/IN antibodies/NNS to/IN hepatitis/NN C/NN virus/NN by/IN second-generation/JJ testing/NN (/( RIBA/NN 2/NN ,/, Ortho/NNP Diagnostic/NNP Systems/NNPS Inc/JJ ,/, Westwood/NNP ,/, MA/NN )/SYM ./.
@@15055167069 Replacing/VBG the/DT aspartic/JJ acid/NN with/IN a/DT lysine/NN but/CC not/RB with/IN an/DT alanine/NN or/CC valine/NN residue/NN allowed/VBD formation/NN of/IN disulfide-linked/NN dimers/NN ./.
@@111980531496 Acute/JJ effects/NNS of/IN LI/NN 160/NN (/( extract/NN of/IN Hypericum/NN perforatum/NN ,/, St/NNP John's/NNP wort/NN )/SYM and/CC two/NN of/IN its/PRP constituents/NNS on/IN neuroendocrine/JJ responses/NNS in/IN the/DT rat/NN ./.
@@105674302791 Additional/JJ studies/NNS revealed/VBN that/IN bovine/NEWGENE brain/NEWGENE Galpha/NEWGENE (/NEWGENE q/NEWGENE //NEWGENE 11/NEWGENE )/NEWGENE could/MD also/RB bind/VB to/IN an/DT N-terminal/NN construct/NN of/IN GRK2/NEWGENE ,/, while/CC no/DT binding/NN of/IN Galpha/NEWGENE (/NEWGENE q/NEWGENE //NEWGENE 11/NEWGENE )/NEWGENE ,/, Galpha/NEWGENE (/NEWGENE s/NEWGENE )/NEWGENE ,/, Galpha/NEWGENE (/NEWGENE i/NEWGENE )/NEWGENE ,/, or/CC Galpha/NEWGENE (/NEWGENE 12/NEWGENE //NEWGENE 13/NEWGENE )/NEWGENE to/IN comparable/JJ constructs/NNS of/IN GRK5/NEWGENE or/CC GRK6/NEWGENE was/VBD observed/VBN ./.
@@22096057032 Within/IN this/DT sequence/NN the/DT MSAS/NEWGENE gene/NEWGENE was/VBD identified/VBN as/IN a/DT 5322-bp-long/JJ open/JJ reading/JJ frame/NN coding/JJ for/IN a/DT protein/NN of/IN 1774/CD amino/JJ acids/NNS and/CC 190/CD ,/CD 731/CD Da/NNP molecular/JJ mass/NN ./.
@@17652695482 These/DT introns/NNS belong/VBP to/IN the/DT class/NN of/IN nuclear/JJ pre-mRNA/NN introns/NNS and/CC contain/VB typical/JJ 5'-/NN and/CC 3'-consensus/JJ sequences/NNS ,/, as/RB well/VB as/IN unique/JJ features/NNS ./.
@@35756562619 Due/JJ to/IN its/PRP relatively/JJ soluble/JJ chemical/JJ form/NN ,/, 90Sr/NN was/VBD rapidly/RB translocated/VBN from/IN lung/NN to/IN bone/NN where/CC a/DT substantial/JJ portion/NN was/VBD retained/VBN for/IN a/DT long/JJ period/NN of/IN time/NN ./.
@@94327529385 Patients/NNS and/CC their/PRP relatives/NNS must/MD be/VB informed/VBN about/RB the/DT available/JJ effective/JJ treatment/NN possibilities/NNS and/CC about/RB the/DT right/JJ moment/NN for/IN their/PRP application/NN in/IN an/DT individual/JJ patient/NN ./.
@@96527421889 Initially/RB ,/, we/PRP observed/VBD that/IN unmutated/NN p53/NEWGENE is/VBZ strongly/RB expressed/VBN in/IN premalignant/JJ mammary/JJ glands/NNS and/CC in/IN mammary/JJ tumors/NNS derived/VBN from/IN the/DT MMTV-c-myc/NNP strain/NN ./.
@@1811243958 Regional/NNP cerebral/JJ blood/NN flow/NN (/( rCBF/NN )/SYM measurements/NNS and/CC psychiatric/JJ ratings/NNS were/VBD performed/VBN on/IN seven/JJ schizophrenic/JJ patients/NNS (/( mean/JJ age/NN =/SYM 41/CD ./CD 4/CD years/NNS )/SYM who/WP had/VBP been/VBN examined/VBN 18/CD years/NNS previously/RB in/IN a/DT study/NN that/WDT used/VBD similar/JJ psychiatric/JJ ratings/NNS and/CC a/DT comparable/JJ rCBF/NN technique/NN ./.
@@86681249804 The/DT Dox-A2/NEWGENE ORF/NEWGENE driven/VBP by/IN the/DT TDH3/NEWGENE promoter/NEWGENE complemented/VBD the/DT phenotype/NN of/IN a/DT strain/NN deleted/VBN for/IN sun2/NEWGENE ./.
@@18098542416 Examples/NNS are/VBP using/VBG more/RB subjects/VBZ or/CC an/DT improved/VBN research/NN design/NN ,/, developing/JJ consensus/NN statements/NNS or/CC using/VBG meta-analysis/NN ./.
@@81945498171 Eight/CD highly/RB trained/VBN male/JJ kayakers/NNS were/VBD studied/VBN to/IN determine/VB the/DT relationship/NN between/IN critical/JJ power/NN (/( CP/NN )/SYM and/CC the/DT onset/NN of/IN blood/NN lactate/NN accumulation/NN (/( OBLA/NNP )/SYM ./.
@@81591742737 The/DT presence/NN of/IN the/DT foreign/JJ gene/NN was/VBD confirmed/VBN by/IN Southern/NNP analysis/NN ./.
@@108733866977 We/PRP have/VBP isolated/VBN and/CC functionally/RB characterized/VBN the/DT mouse/NN gene/NN for/IN the/DT C2/NEWGENE subunit/NEWGENE of/IN the/DT 20S/NEWGENE proteasome/NEWGENE ./.
@@72688287120 A/DT fluoroimmunoassay/NN for/IN the/DT determination/NN of/IN serum/NN of/IN plasma/NN levels/NNS of/IN propranolol/NN was/VBD developed/VBN using/VBG antibodies/NNS to/IN propranolol/NN coupled/VBN to/IN magnetizable/JJ solid-phase/JJ particles/NNS and/CC fluorescein-labeled/JJ propranolol/NN as/IN tracer/NN ./.
@@109625646844 A/DT beta2/NEWGENE RARE/NEWGENE reporter/NEWGENE construct/NEWGENE in/IN which/WDT the/DT methylation-susceptible/JJ cytosines/NNS in/IN the/DT sense/NN strand/NN were/VBD replaced/VBN by/IN thymine/NN displayed/VBD marked/JJ loss/NN of/IN activity/NN in/IN a/DT replicated/VBN chromatin-dependent/JJ manner/NN ./.
@@43773284949 I/NNP ./NNP
@@72985233341 Effect/NN of/IN indomethacin/NN and/CC prostaglandin/NN F2/NN alpha/NN on/IN parturition/NN in/IN swine/NN ./.
@@37096277313 The/DT subjects/NNS received/VBD a/DT single/NN 500/NN mg/NN dose/NN of/IN acetaminophen/NN i/CD ./CD v/CD ./. and/CC concentrations/NNS in/IN plasma/NN were/VBD measured/VBN for/IN 360/CD minutes/NNS and/CC in/IN urine/NN for/IN 24/CD h/NN in/IN order/NN to/IN estimate/NN the/DT production/NN of/IN metabolites/NNS ./.
@@1007873478 The/DT H-reflex/NN recovery/NN curve/NN was/VBD obtained/VBN after/IN stimulation/NN of/IN the/DT median/JJ nerve/NN at/IN the/DT elbow/NN and/CC recording/JJ from/IN the/DT flexor/NN carpi/NNS radialis/NN ./.
@@117918531657 The/DT experimental/JJ results/NNS showed/VBN that/IN the/DT coagulation-electrooxidation/JJ process/NN could/MD efficiently/RB remove/VB the/DT color/NN and/CC the/DT COD/NN from/IN the/DT simulated/JJ dye/NN wastewater/NN ./.
@@28330129291 The/DT predicted/VBN L/NEWGENE mRNA/NEWGENE was/VBD 6398/CD nucleotides/NNS long/JJ and/CC contained/VBD a/DT single/JJ open/JJ reading/JJ frame/NN corresponding/JJ to/IN an/DT L/NEWGENE protein/NEWGENE encompassing/NEWGENE 2109/NEWGENE amino/NEWGENE acids/NEWGENE with/IN a/DT MW/NN of/IN 241/CD ,/CD 546/CD ./.
@@103504845587 The/DT kinetics/NN of/IN kinase/NEWGENE activity/NN within/IN these/DT complexes/NNS compared/VBN to/IN CheA/NEWGENE alone/RB indicate/VB approximately/RB a/DT 50%/CD decrease/NN in/IN the/DT KM/NN for/IN ATP/NN and/CC a/DT 100-fold/JJ increase/NN in/IN the/DT Vmax/NN ./.
@@23031589987 Thyrotropin-induced/JJ expression/NN of/IN a/DT gene/NN for/IN a/DT ribosomal/JJ protein/NN related/VBN to/IN the/DT trk/NEWGENE oncogene/NEWGENE ./.
@@16911848923 Gap/NEWGENE b3/NEWGENE consists/VBZ of/IN two/JJ polypeptide/NN chains/NNS (/( Mr/NNP =/SYM 110/CD ,/CD 000/CD and/CC 30/CD ,/CD 000/CD )/SYM ,/, which/WDT seem/VBP to/IN be/VB proteolytic/JJ cleavage/NN products/NNS connected/VBN by/IN disulfide/NN bonds/NNS from/IN a/DT precursor/NN protein/NN ./.
@@16288064112 The/DT observed/VBN sequence/NN variation/NN disrupts/VBZ the/DT first/JJ ORF/NN in/IN many/JJ Y's/NEWGENE while/CC most/RB of/IN the/DT second/JJ ORF/NN including/JJ the/DT putative/JJ helicase/NEWGENE region/NEWGENE is/VBZ unaffected/JJ ./.
@@16950982109 Serum/NN IgG/NEWGENE was/VBD initially/RB elevated/VBN in/IN 6/CD patients/NNS ./.
@@113156331754 The/DT cleavage/NN site/NN between/IN VPg/NEWGENE and/CC RNA/NEWGENE dependent/NEWGENE RNA/NEWGENE polymerase/NEWGENE was/VBD predicted/VBN to/IN be/VB E445-T446/NNP based/VBD on/IN the/DT amino/JJ acid/NN sequence/NN analysis/NN of/IN the/DT polyprotein/NN from/IN different/JJ sobemoviruses/NNS ./.
@@67430616510 Twenty-one/CD percent/NN of/IN these/DT patients/NNS had/VBP neurologic/JJ disease/NN that/WDT appeared/VBD to/IN be/VB responsible/JJ for/IN the/DT tinnitus/NN ./.
@@81062451261 The/DT indoor/JJ radon/NN concentration/NN in/IN the/DT summer/NN (/( 1990/CD )/SYM period/NN ranged/VBN between/IN 8/CD and/CC 81/NN Bq/NN m-3/NN ,/, while/CC in/IN the/DT winter/NN (/( 1989-1990/CD )/SYM it/PRP ranged/VBD between/IN 20/CD and/CC 143/NN Bq/NN m-3/NN for/IN the/DT first/JJ year/NN of/IN measurements/NNS or/CC between/IN 8/CD and/CC 92/NN Bq/NN m-3/NN in/IN the/DT summer/NN (/( 1991/CD )/SYM period/NN and/CC between/IN 12/CD and/CC 119/NN Bq/NN m-3/NN in/IN the/DT winter/NN (/( 1990-1991/CD )/SYM for/IN the/DT second/JJ year/NN of/IN measurements/NNS ./.
@@17648992369 The/DT model/NN is/VBZ able/JJ to/IN anticipate/VB why/RB the/DT effect/NN of/IN water/NN fluoridation/NN on/IN caries/NN prevalence/NN is/VBZ most/RB pronounced/VBN when/CC caries/NN is/VBZ diagnosed/VBN at/IN cavity/NN level/NN ./.
@@50874965363 Coronary/NNP arteries--old/JJ and/CC new/JJ ./.
@@10838399154 False/NNP positive/JJ PET/NN FDG/NN corresponded/VBN to/IN lung/NN infection/NN ,/, degenerative/JJ bone/NN disease/NN ,/, and/CC reconstruction/NN artifact/NN ./.
@@64355656238 These/DT changes/NNS were/VBD the/DT result/NN of/IN a/DT decrease/NN in/IN afterload/NN :/: mean/JJ aortic/JJ pressure/NN fell/NN from/IN 85/CD +/NN //NN -/NN 11/CD ./CD 8/CD to/IN 68/CD +/NN //NN -/NN 19/CD ./CD 6/CD mmHg/NN (/( p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM and/CC systemic/JJ arterial/JJ resistance/NN fell/NN from/IN 2/CD 886/CD +/NN //NN -/NN 745/CD to/IN 2/CD 010/CD +/NN //NN -/NN 610/CD dynes/NN //NN cm-5/NN //NN sec/NN //NN m-2/NN (/( p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ./.
@@111583102120 Furthermore/RB ,/, we/PRP showed/VBD that/IN ERSF/NEWGENE including/JJ NF-Y/NEWGENE and/CC ATF6alpha/NEWGENE and/NEWGENE //NEWGENE or/NEWGENE beta/NEWGENE and/CC capable/JJ of/IN binding/JJ to/IN ERSE/NEWGENE is/VBZ indeed/RB formed/VBN when/CC the/DT cellular/JJ UPR/NEWGENE is/VBZ activated/VBN ./.
@@96040529569 Demographic/NN and/CC clinical/JJ data/NN were/VBD compared/VBN with/IN a/DT control/NN group/NN of/IN 339/CD healthy/JJ age-matched/JJ women/NNS and/CC with/IN a/DT sample/NN of/IN 224/CD women/NNS with/IN wrist/NN fracture/NN ./.
@@13980744619 The/DT gene/NN sequence/NN also/RB identified/VBD a/DT 340-nucleotide/NN RNA/NN in/IN total/JJ yeast/NN RNA/NN and/CC in/IN purified/VBN RNase/NEWGENE MRP/NEWGENE enzyme/NEWGENE preparations/NNS ./.
@@60350015877 Further/JJ observations/NNS on/IN resorption/NN in/IN guinea/NN pigs/NNS following/IN injections/NNS of/IN trypan/JJ blue/NN ./.
@@32634654306 The/DT murine/NEWGENE MHC/NEWGENE class/NEWGENE I/NEWGENE genes/NEWGENE ,/, H-2Dq/NEWGENE and/CC H-2Lq/NEWGENE ,/, are/VBP strikingly/RB homologous/JJ to/IN each/DT other/DT ,/, H-2Ld/NEWGENE ,/, and/CC two/JJ genes/NNS reported/VBN to/IN encode/VB tumor-specific/NEWGENE antigens/NEWGENE ./.
@@78192257918 The/DT introduction/NN of/IN an/DT acidic/NN residue/NN at/IN the/DT second/JJ site/NN was/VBD essential/JJ for/IN suppression/NN of/IN the/DT Asn-285/NN mutation/NN because/IN Lys-220/NNP and/CC Gln-220/NNP second-site/NN mutants/NNS of/IN the/DT Asn-285/NN mutant/NN showed/VBD very/RB low/JJ tetracycline/NN resistance/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@66925176452 The/DT effects/NNS of/IN antithrombotic/JJ drugs/NNS in/IN patients/NNS with/IN left/NN ventricular/JJ thrombi/NNS :/: assessment/NN with/IN indium-111/NN platelet/NN imaging/JJ and/CC two-dimensional/JJ echocardiography/NN ./.
@@100825854082 To/TO identify/VB additional/JJ non-Sir/NEWGENE factors/NEWGENE that/WDT affect/VBP rDNA/NN silencing/VBG ,/, we/PRP performed/VBD a/DT genetic/JJ screen/NN designed/VBN to/IN isolate/NN mutations/NN which/WDT alter/VBP the/DT expression/NN of/IN reporter/NN genes/NNS integrated/JJ within/IN the/DT rDNA/NN ./.
@@19231672544 Blood/NNP flow/NN velocity/NN waveforms/NNS were/VBD recorded/VBN by/IN pulsed/JJ Doppler/NN examination/NN of/IN the/DT fetal/JJ internal/JJ carotid/JJ and/CC middle/JJ cerebral/JJ arteries/NNS using/VBG the/DT established/VBN transabdominal/JJ route/NN as/RB well/VB as/IN a/DT new/JJ transvaginal/JJ approach/NN ./.
@@80628337195 The/DT first/JJ 85/CD nt/NN upstream/RB of/IN the/DT transcription/NN initiation/NN site/NN of/IN the/DT mouse/NEWGENE desmin/NEWGENE gene/NEWGENE ,/, which/WDT contain/VBP an/DT E/NN box/NN (/( E1/NEWGENE )/SYM ,/, the/DT binding/JJ site/NN of/IN the/DT helix-loop-helix/JJ myogenic/JJ regulators/NNS ,/, are/VBP sufficient/JJ to/IN confer/VB low/JJ level/NN muscle-specific/JJ expression/NN ./.
@@85094303421 The/DT first/RB involved/VBN complementation/NN of/IN a/DT nonphotosynthetic/JJ mutant/NN of/IN Chlamydomonas/NN ,/, CC-2341/NN (/( ac-u-g-2/NN ./NN 3/NN )/SYM ,/, which/WDT has/VBZ a/DT frameshift/JJ mutation/NN in/IN the/DT psaB/NEWGENE gene/NEWGENE ,/, and/CC selection/NN of/IN photosynthetic/JJ transformants/NNS on/IN minimal/JJ medium/NN ./.
@@8861955601 Moreover/RB ,/, the/DT second/JJ RCC1-like/NEWGENE motif/NEWGENE located/VBN at/IN the/DT amino-terminus/NN of/IN p619/NEWGENE stimulates/VBZ guanine/NN nucleotide/NN exchange/NN on/IN ARF1/NEWGENE and/CC on/IN members/NNS of/IN the/DT related/VBN Rab/NEWGENE proteins/NEWGENE ,/, but/CC not/RB on/IN other/DT small/NEWGENE GTP/NEWGENE binding/NEWGENE proteins/NEWGENE such/JJ as/IN Ran/NEWGENE or/CC R-Ras2/NEWGENE //NEWGENE TC21/NEWGENE ./.
@@29872205782 Subcloning/NN of/IN DNA/NN fragments/NNS from/IN the/DT 8/CD ./CD 5-kilobase/CD (/( kb/NN )/SYM insert/NN of/IN pAVO4/NN defined/VBN a/DT 4-kb/JJ DNA/NN fragment/NN which/WDT contained/VBD the/DT functional/NEWGENE FBP+/NEWGENE gene/NEWGENE and/CC its/PRP regulatory/JJ region/NN ./.
@@1005497655 Spectroscopy/NNS of/IN negative/JJ ions/NNS utilizing/VBG multiphoton/NN detachment/NN in/IN a/DT Raman/JJ coupling/NN regime/NN ./.
@@11335116797 Bandshift/NN experiments/NNS demonstrate/VBP that/IN BmHR3A/NEWGENE binds/VBZ specifically/RB to/IN RORE/NEWGENE (/( Retinoic/NEWGENE acid-related/NEWGENE Orphan/NEWGENE receptor/NEWGENE Response/NEWGENE Element/NEWGENE )/NN -like/NN sequences/NNS in/IN the/DT promoters/NNS of/IN both/DT genes/NNS ,/, thus/RB suggesting/VBG a/DT direct/JJ role/NN for/IN BmHR3A/NEWGENE in/IN regulating/JJ the/DT expression/NN of/IN BmGATAbeta/NEWGENE and/CC ESP/NEWGENE genes/NEWGENE during/IN vitellogenesis/NN ./.
@@35821844244 Drugs/NNS that/WDT are/VBP transformed/VBN via/NN phase/NN II/NNP reactions/NNS usually/RB do/VBP not/RB require/VB dosage/NN adjustment/NN ./.
@@13048091944 100/CD years/NNS of/IN dentistry/NN at/IN the/DT Friedrich/NNP Schiller/NNP University/NNP in/IN Jena/NNP ./.
@@338738269 Gamma/NEWGENE glutamyl/NEWGENE transpeptidase/NEWGENE (/( GGTP/NEWGENE )/SYM activity/NN in/IN the/DT seminal/JJ fluid/NN ./.
@@117080328153 In/NN addition/NN to/IN that/DT ,/, she/PRP received/VBD hepatic/JJ intra-arterial/JJ infusion/NN of/IN levoforinate/NN (/( l-LV/NN )/SYM 250/CD mg/NN and/CC 5-fluorouracil/NN (/( 5-FU/NN )/SYM 500/CD mg/NN for/IN combined/JJ multiple/JJ hepatic/JJ metastases/NNS starting/VBG on/IN postoperative/JJ day/NN 14/CD ,/, and/CC these/DT medications/NNS were/VBD administered/VBN over/RB 48/CD hours/NNS once/CC weekly/JJ by/IN infuser/NN pump/NN ./.
@@8816301801 The/DT morphological/JJ effects/NNS of/IN two/JJ snake/NN venoms/NNS ,/, N/NNP ./NNP naja/NN and/CC A/NNP ./NNP piscivorus/NN ,/, and/CC of/IN the/DT Direct/NEWGENE Lytic/NEWGENE Factor/NEWGENE and/CC Phospholipase-A/NEWGENE ,/, compounds/NNS purified/VBN from/IN N/NNP ./NNP naja/NN crude/JJ venom/NN ,/, were/VBD investigated/VBN on/IN lung/NN and/CC cremaster/NN vessels/NNS of/IN rats/NNS ./.
@@10694210506 The/DT regional/JJ blockade/NN of/IN H1R/NEWGENE was/VBD observed/VBN mainly/RB in/IN the/DT frontal/JJ ,/, temporal/JJ and/CC anterior/JJ cingulate/JJ cortices/NNS ,/, and/CC the/DT intravenous/JJ administration/NN of/RB d-chlorpheniramine/NN as/IN a/DT therapeutic/JJ dose/NN (/( 2/CD mg/NN )/SYM blocked/VBN over/RB 60%/CD of/IN H1R/NEWGENE in/IN the/DT frontal/JJ cortices/NNS ./.
@@92256824586 The/DT frequency/NN of/IN positive/JJ anti-GM1/NEWGENE antibody/NEWGENE titers/NNS in/IN the/DT Guillain-Barre/NNP syndrome/NN patients/NNS with/IN PEN/NN 19/NN isolates/NNS was/VBD higher/JJ than/IN that/DT in/NN the/DT Guillain-Barre/NNP syndrome/NN and/CC Fisher's/NNP syndrome/NN patients/NNS without/IN PEN/NN 19/NN isolates/NNS ./.
@@79444613624 TG-day/NN and/CC TG-night/NN were/VBD 19/CD ./CD 4/CD +/NN //NN -/NN 6/CD ./CD 1%/CD ,/, 26/CD ./CD 6/CD +/NN //NN -/NN 5/CD ./CD 3%/CD ,/, (/( 750/CD mm3/NN </SYM T/NNP ./NNP
@@76595294109 We/PRP used/VBD deletion/NN analysis/NN and/CC transfection/NN assays/NNS with/IN reporter/NN gene/NN constructs/NNS to/IN examine/VB the/DT transcription/NN control/NN elements/NNS in/IN the/DT 5'/CD flanking/JJ region/NN of/IN the/DT human/NEWGENE EpoR/NEWGENE gene/NEWGENE ./.
@@76961834011 However/RB ,/, there/RB were/VBD some/DT properties/NNS of/IN Rak/NEWGENE that/WDT are/VBP distinct/JJ from/IN Src-like/NEWGENE kinases/NEWGENE :/: (/( a/DT )/SYM expression/NN of/IN Rak/NEWGENE was/VBD predominantly/RB in/IN epithelial-derived/JJ cell/NN lines/NNS and/CC tissues/NNS ,/, especially/RB normal/JJ liver/NN and/CC kidney/NN ,/, and/CC cell/NN lines/NNS of/IN breast/NN and/CC colon/NN origin/NN ;/: (/( b/NN )/SYM Rak/NEWGENE does/VBP not/RB harbor/VB the/DT NH2-terminal/NN glycine/NN essential/JJ for/IN myristylation/NN and/CC membrane/NN localization/NN ;/: and/CC (/( c/NN )/SYM Rak/NEWGENE possesses/VBZ a/DT putative/JJ bipartite/JJ nuclear/JJ localization/NN signal/JJ in/IN the/DT SH2/NEWGENE domain/NEWGENE ,/, and/CC subcellular/JJ fractionation/NN studies/NNS revealed/VBN that/IN p54rak/NEWGENE resides/VBZ predominantly/RB in/IN the/DT nucleus/NN ./.
@@67867569051 The/DT role/NN of/IN DNA/NN rearrangement/NN and/CC alternative/JJ RNA/NN processing/VBG in/IN the/DT expression/NN of/IN immunoglobulin/NEWGENE delta/NEWGENE genes/NEWGENE ./.
@@109405628567 Genomic/NN and/CC functional/JJ characterization/NN of/IN the/DT oas/NEWGENE gene/NEWGENE family/NEWGENE encoding/VBG O-acetylserine/NEWGENE (/NEWGENE thiol/NEWGENE )/NEWGENE lyases/NEWGENE ,/, enzymes/NNS catalyzing/VBG the/DT final/JJ step/NN in/IN cysteine/NN biosynthesis/NN in/IN Arabidopsis/NN thaliana/NN ./.
@@10940413762 The/DT results/NNS indicate/VBP that/IN the/DT open-section/JJ effect/NN decreases/VBZ the/DT torsional/JJ stiffness/NN and/CC stress/NN concentration/NN effects/NNS decrease/NN the/DT torsional/JJ strength/NN of/IN a/DT long/JJ bone/NN with/IN a/DT longitudinal/JJ defect/NN ./.
@@28708517126 Output/NN of/IN 99mTcO-4/NN by/IN the/DT parotid/JJ gland/NN closely/RB mimicked/VBN fluctuations/NNS in/IN parotid/JJ saliva/NN flow/NN rate/NN ./.
@@56420515619 Evaluating/VBG dietary/JJ department/NN management/NN ./.
@@95057339471 A/DT review/NN of/IN studies/NNS published/VBN between/IN 1983/CD and/CC 1995/CD shows/VBZ that/IN there/RB are/VBP some/DT common/JJ factors/NNS as/IN regards/VBZ the/DT psychological/JJ distress/NN and/CC social/JJ and/CC functional/JJ limitations/NNS this/DT group/NN of/IN patients/NNS has/VBZ to/IN deal/NN with/RB ./.
@@40395254713 Plasma/NN and/CC bladder/NN platinum/NN concentration/NN were/VBD measured/VBN following/IN intravesical/JJ DDP/NN ,/, and/CC also/RB histopathological/JJ examination/NN ,/, urinalysis/NN ,/, complete/JJ blood/NN count/NN and/CC blood/NN chemistry/NN were/VBD performed/VBN in/IN order/NN to/IN know/NN the/DT toxicity/NN of/IN intravesical/JJ DDP/NN ./.
@@21633476446 The/DT cDNA/NN sequence/NN has/VBZ an/DT 813-bp/JJ open/JJ reading/JJ frame/NN (/( ORF/NN )/SYM whose/WP predicted/VBN amino/JJ acid/NN sequence/NN is/VBZ 97/NN ./NN 6%/NN identical/JJ to/IN the/DT 272/CD carboxy-terminal/JJ amino/JJ acids/NNS of/IN the/DT human/NEWGENE ets-1/NEWGENE protein/NEWGENE ./.
@@35377218495 Tetrad/NN analysis/NN and/CC mitotic/JJ recombination/NN experiments/NNS localized/VBN the/DT PEP4/NEWGENE gene/NEWGENE proximal/JJ to/IN GAL4/NEWGENE on/IN chromosome/NN XVI/NNS ./.
@@24278122557 These/DT results/NNS support/NN the/DT view/NN that/DT clonidine/NN and/CC 6-OHDA/CD ,/, but/CC not/RB alpha-MD/VB ,/, have/VB central/NN pressor/NN actions/NNS in/IN the/DT rat/NN that/WDT oppose/VBP their/PRP antihypertensive/JJ action/NN ./.
@@63734092608 Lauciello/NN describes/VBZ a/DT technique/NN for/IN the/DT placement/NN of/IN functionally/RB generated/VBN amalgam/NN stops/NNS as/IN restorations/NNS within/IN mandibular/JJ acrylic/JJ teeth/NNS ./.
@@16825092764 Here/RB we/PRP present/VBP evidence/VBP that/IN major/NEWGENE IE/NEWGENE proteins/NEWGENE IE86/NEWGENE1 ,/, IE72/NEWGENE ,/, and/CC IE55/NEWGENE are/VBP capable/JJ of/IN trans-activating/VBD the/DT HIV/NN LTR/NN in/IN a/DT T-cell/NN line/NN ,/, HUT-78/NNP ./.
@@105709963383 A/DT phylogenetic/JJ analysis/NN with/IN the/DT TK/NEWGENE domains/NEWGENE from/IN these/DT sequences/NNS and/CC a/DT fourth/NN ,/, from/IN a/DT novel/JJ scavenger/NEWGENE RTK/NEWGENE (/( all/DT domains/NNS comprise/VBP the/DT signature/NN for/IN the/DT TK/NEWGENE class/NEWGENE II/NEWGENE receptors/NEWGENE )/SYM ,/, showed/VBD that/IN they/PRP are/VBP distantly/RB related/VBN to/IN the/DT insulin/NEWGENE and/CC insulin-like/NEWGENE receptors/NEWGENE ./.
@@81147028066 Members/NNS of/IN the/DT myocyte-specific/NEWGENE enhancer-binding/NEWGENE factor/NEWGENE 2/NEWGENE (/( MEF2/NEWGENE )/SYM family/NN of/IN transcription/NN factors/NNS bind/VBP a/DT conserved/VBN A/NN //NN T-rich/NN sequence/NN in/IN the/DT control/NN regions/NNS of/IN numerous/JJ muscle-specific/NN genes/NN ./.
@@83863185422 We/PRP show/VBP that/DT IL-6/NEWGENE activates/VBZ JRE-IL6/NEWGENE through/RB an/DT H7-sensitive/NNP pathway/NN that/WDT does/VBP not/RB involve/VB protein/NEWGENE kinase/NEWGENE C/NEWGENE ,/, cyclic/NEWGENE AMP-dependent/NEWGENE kinase/NEWGENE ,/, Ca/NEWGENE (/NEWGENE 2+/NEWGENE )/NEWGENE -/NEWGENE or/NEWGENE calmodulin-dependent/NEWGENE kinases/NEWGENE ,/, Ras/NEWGENE ,/, Raf-1/NEWGENE ,/, or/CC NF-IL6/NEWGENE (/( C/NEWGENE //NEWGENE EBP/NEWGENE beta/NEWGENE )/SYM ./.
@@106171268385 Histological/JJ analysis/NN showed/VBN that/IN the/DT neuronal/JJ loss/NN in/IN the/DT DHED-treated/JJ group/NN was/VBD notably/RB reduced/VBN in/IN the/DT hippocampal/JJ area/NN (/( CA1/RB )/SYM of/IN ischemic/JJ rats/NNS and/CC in/IN the/DT dentate/NN gyrus/NN and/CC hippocampal/JJ area/NN (/( CA1/RB and/CC CA3/NN )/SYM of/IN EC-lesioned/JJ rats/NNS compared/VBN with/IN the/DT nontreated/JJ group/NN ./.
@@97055645674 Expression/NNS of/IN the/DT human/NEWGENE papillomavirus/NEWGENE type/NEWGENE 11/NEWGENE E5A/NEWGENE protein/NEWGENE from/IN the/DT E1E4/NEWGENE ,/NEWGENE E5/NEWGENE transcript/NEWGENE ./.
@@15041782117 The/DT next/JJ twenty/CD years/NNS of/IN prevention/NN in/IN Indian/JJ country/NN :/: visionary/JJ ,/, complex/NN ,/, and/CC practical/JJ ./.
@@91291471759 The/DT Jem/NEWGENE peptide/NN sequence/NN shows/VBZ a/DT 'leucine-zipper'/NN dimerisation/NN motif/NN with/IN limited/VBN homology/NN to/IN Fos/NEWGENE //NEWGENE Jun/NEWGENE and/CC ATF/NEWGENE //NEWGENE CREB/NEWGENE proteins/NEWGENE and/CC several/DT putative/JJ phosphorylation/NN sites/NNS ./.
@@27890625622 We/PRP have/VBP utilized/VBN the/DT human/NEWGENE 4F2/NEWGENE heavy/NEWGENE chain/NEWGENE (/( 4F2HC/NEWGENE )/SYM gene/NN as/IN a/DT model/NN system/NN in/IN studies/NNS designed/VBN to/IN elucidate/VB the/DT molecular/JJ events/NNS involved/VBN in/IN regulating/JJ inducible/NN gene/NN expression/NN during/IN normal/JJ human/JJ T-cell/NN activation/NN ./.
@@12968152032 We/PRP cloned/VBN the/DT third/RB human/JJ gene/NN for/IN the/DT LD78/NEWGENE ,/, termed/JJ LD78/NEWGENE gamma/NEWGENE and/CC the/DT sequence/NN analysis/NN showed/VBN that/IN it/PRP is/VBZ a/DT 5'-truncated/JJ pseudogene/NN ./.
@@15384038834 Moreover/RB ,/, the/DT reconstitution/NN of/IN eUSF/NEWGENE and/CC TFIID-depleted/NN transcription/NN complexes/NNS with/IN purified/VBN protein/NN fractions/NNS demonstrate/VBP that/IN not/RB only/JJ TFIID/NEWGENE but/CC also/RB eUSF/NEWGENE essentially/RB participates/VBZ in/IN complex/NN formation/NN even/VB on/IN H5/NEWGENE promoter/NEWGENE mutations/NN lacking/JJ the/DT TATA-box/NN ./.
@@71124716915 Histamine/NNS reactivity/NN had/VBP returned/VBN to/IN normal/JJ in/IN half/PDT the/DT workers/NNS who/WP had/VBP left/NN their/PRP original/JJ factories/NNS ,/, but/CC in/IN only/RB one/PRP worker/NN who/WP had/VBP moved/VBN within/IN her/PRP original/JJ factory/NN ./.
@@98588838498 BIAcore/NNP analysis/NN gave/VBD a/DT Kaff/NNP of/IN 4/CD ./CD 4/CD x/NN 10/NN (/NN 10/NN )/NN M-1/NNP for/IN the/DT binding/NN of/IN N-A3/NEWGENE to/IN T84/NEWGENE ./NEWGENE 1/NEWGENE and/CC 2/CD ./CD 2/CD x/NN 10/NN (/NN 10/NN )/NN M-1/NNP for/IN the/DT binding/NN of/IN N-A3/NEWGENE to/IN T84/NEWGENE ./NEWGENE 66/NEWGENE ./.
@@114355602692 Together/RB these/DT data/NN imply/VB that/IN the/DT HFV/NEWGENE R/NEWGENE region/NEWGENE acts/NNS in/IN the/DT nucleus/NN to/IN modify/VB the/DT cytoplasmic/JJ fate/NN of/IN target/NEWGENE HFV/NEWGENE mRNA/NEWGENE ./.
@@88619635557 Transcription/NNS factor/NN recognition/NN surface/NN on/IN the/DT RNA/NEWGENE polymerase/NEWGENE alpha/NEWGENE subunit/NEWGENE is/VBZ involved/VBN in/IN contact/NN with/IN the/DT DNA/NN enhancer/NN element/NN ./.
@@117260681330 Rind/NN et/FW al/NNS ./NNS 's/NNS study's/VBZ main/JJ conclusions/NNS were/VBD not/RB supported/VBN by/IN the/DT original/JJ data/NN ./.
@@74943145106 Thus/RB ,/, transcriptional/JJ regulation/NN ,/, splicing/JJ ,/, kinase/NN interaction/NN sites/NNS ,/, and/CC tyrosine/NN phosphorylation/NN of/IN the/DT LMP2A/NEWGENE homologs/NEWGENE have/VBP been/VBN conserved/VBN despite/IN significant/JJ sequences/NNS heterogeneity/NN in/IN the/DT preterminal/NN repeat/NN regions/NN of/IN these/DT human/JJ and/CC nonhuman/JJ primate/NN EBVs/NNS ./.
@@115648713263 These/DT results/NNS indicate/VBP the/DT presence/NN of/IN TATA-unified/JJ transcription/NN systems/NNS in/IN contemporary/JJ eukaryotes/NNS and/CC provide/VB insight/NN into/IN the/DT residual/JJ need/NN for/IN TBP/NEWGENE by/IN all/DT three/CD Pols/NEWGENE in/IN other/DT eukaryotes/NNS despite/IN a/DT lack/NN of/IN TATA/NN elements/NN in/IN their/PRP promoters/NNS ./.
@@94098219822 The/DT Saccharomyces/NEWGENE cerevisiae/NEWGENE RAD30/NEWGENE gene/NEWGENE ,/, a/DT homologue/NEWGENE of/NEWGENE Escherichia/NEWGENE coli/NEWGENE dinB/NEWGENE and/CC umuC/NEWGENE ,/, is/VBZ DNA/NN damage/NN inducible/JJ and/CC functions/NNS in/IN a/DT novel/JJ error-free/JJ postreplication/JJ repair/NN mechanism/NN ./.
@@113913032540 Right/RB LHR/VBZ (/( R-LHR/NN )/SYM provided/VBN the/DT best/JJS interobserver/JJ and/CC intraobserver/JJ reproducibility/NN ./.
@@1006312262 Two-Channel/NNP Kondo/NNP Lattice/NNP :/: An/DT Incoherent/NNP Metal/NNP ./.
@@71726904781 A/DT limiting/JJ factor/NN were/VBD disturbances/NNS in/IN the/DT system/NN of/IN energy/NN transport/NN (/( creatine/NN phosphate/NN ,/, creatine/NEWGENE phosphokinase/NEWGENE )/SYM and/CC of/IN the/DT calcium/NN pump/NN (/( Ca++-ATPase/NEWGENE of/IN the/DT sarcoplasmic/JJ reticulum/NN ,/, SPR/NN )/SYM ,/, which/WDT evidently/RB led/VBN to/IN a/DT decrease/NN of/IN the/DT inotropic/JJ properties/NNS of/IN the/DT myocardium/NN at/IN 70%/CD restriction/NN of/IN coronary/JJ blood/NN flow/NN ./.
@@10347839204 The/DT IC50/NN values/NNS for/IN rat/NN and/CC dog/NN urinary/JJ bladder/NN were/VBD 3/CD ./CD 9/CD x/NN 10/NN (/NN -6/NN )/NN M/NN and/CC 3/CD ./CD 8/CD x/NN 10/NN (/NN -6/NN )/NN M/NN ,/, respectively/RB ./.
@@86208892155 It/PRP is/NNS shown/VBP that/IN the/DT (/( G+C/NN )/NN -rich/NN element/NN of/IN the/DT aldolase/NEWGENE C/NEWGENE promoter/NEWGENE directs/VBZ transcription/NN in/RB neuronal/JJ as/RB well/VB as/IN in/IN nonneuronal/JJ cells/NNS ./.
@@113713434682 During/IN most/RB of/IN the/DT cell/NN cycle/NN ,/, separase/NEWGENE is/NNS kept/VBP inactive/JJ by/IN binding/JJ to/IN an/DT inhibitory/JJ protein/NN called/VBN securin/NEWGENE ./.
@@79331072717 A/DT comparison/NN of/IN the/DT nucleotide/NN sequence/NN of/IN the/DT p54/NEWGENE gene/NEWGENE carried/VBN by/IN two/JJ virulent/JJ ASFV/ORG strains/NNS (/( E70/NN and/CC E75/NN )/SYM with/IN that/DT obtained/VBD from/IN virus/NN Ba71V/NNP showed/VBD 100%/CD similarity/NN ./.
@@104385937046 The/DT human/NEWGENE immunodeficiency/NEWGENE virus/NEWGENE type-1/NEWGENE (/NEWGENE HIV-1/NEWGENE )/NEWGENE Tat/NEWGENE protein/NEWGENE regulates/VBZ transcription/NN by/IN stimulating/NN RNA/NEWGENE polymerase/NEWGENE processivity/NN ./.
@@58795955786 Statistics/NNP of/IN the/DT past/JJ 5/CD years/NNS ./.
@@109346406347 TB/NN bone/NN area/NN (/( p/NN </SYM 0/CD ./CD 001/CD )/SYM ,/, height/NN (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM ,/, years/NNS in/IN present/NN colony/NN (/( p/NN =/SYM 0/CD ./CD 03/CD )/SYM ,/, and/CC menses/NN (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM predicted/VBN TB/NN BMC/NN ./.
@@104788447580 Cotransfection/NNS of/IN the/DT coactivator/NN CREB-binding/NEWGENE protein/NEWGENE relieved/VBD the/DT transcriptional/JJ repression/NN of/IN PPARalphawt/NEWGENE by/IN PPARalphatr/NEWGENE ,/, suggesting/VBG that/IN the/DT dominant/JJ negative/JJ effect/NN of/IN PPARalphatr/NEWGENE might/MD occur/VB through/JJ competition/NN for/IN essential/JJ coactivators/NNS ./.
@@6643201946 Looming/VBG detectors/NNS in/IN the/DT human/NN visual/NN pathway/NN ./.
@@112807999599 In/NN contrast/NN ,/, exogenous/NEWGENE PTHrP1-34/NEWGENE and/NEWGENE 1-86/NEWGENE peptides/NEWGENE did/VBD not/RB significantly/RB affect/VB IL-8/NEWGENE production/NN ;/: moreover/RB ,/, PTHrP-neutralizing/NEWGENE antibodies/NEWGENE did/VBD not/RB inhibit/VB the/DT production/NN of/IN IL-8/NEWGENE by/IN transfected/VBN PTHrP/NEWGENE ./.
@@61559675978 All/DT radiologists/NNS using/VBG the/DT machine/NN found/VB that/IN the/DT reporting/JJ terminal/NN was/VBD simple/JJ to/IN operate/VB ,/, but/CC found/VB that/IN reporting/JJ abnormalities/NNS caused/VBD an/DT increased/VBN effort/NN and/CC took/VBD a/DT longer/JJR time/NN ./.
@@10362897223 Results/NNS :/: Transpulmonary/NNP passage/NN of/IN contrast/NN occurred/VBN in/IN sufficient/JJ amounts/NNS to/IN enhance/VB the/DT intensity/NN of/IN the/DT Doppler/NN signal/JJ significantly/RB ,/, but/CC the/DT duration/NN of/IN this/DT effect/NN was/VBD short/JJ ./.
@@10619169564 Rams/NN were/VBD weighed/VBN and/CC testis/NN size/NN was/VBD estimated/VBN by/IN orchimetry/NN at/IN each/DT time/NN period/NN ./.
@@103665038393 Although/IN the/DT terminase/NEWGENE apparently/RB interacts/VBZ with/IN this/DT gp20/NEWGENE portal/NEWGENE peptide/NEWGENE ,/, polyclonal/JJ antibody/NN against/IN the/DT portal/JJ peptide/NN appears/VBZ unable/JJ to/IN access/NN it/PRP in/IN the/DT native/JJ structure/NN ,/, suggesting/VBG intimate/JJ association/NN of/IN gp20/NEWGENE and/CC gp17/NEWGENE possibly/RB internalizes/VBZ terminase/NEWGENE regions/NEWGENE within/IN the/DT portal/NN in/IN the/DT packasome/NN complex/NN ./.
@@114958331376 Simulating/VBG the/DT impact/NN during/IN human/JJ jumping/NN by/IN means/NN of/IN a/DT 4-degrees-of-freedom/JJ model/NN ./.
@@30466553764 We/PRP report/VBP a/DT prevalence/NN study/NN of/IN the/DT best/JJS visual/JJ acuity/NN in/IN the/DT affected/VBN eye/NN of/IN 100/CD selected/VBN patients/NNS with/IN herpetic/JJ keratitis/NN seen/VBP during/IN a/DT two-year/JJ period/NN ./.
@@92751648353 The/DT m7GpppN/NN cap/NN structure/NN of/IN eukaryotic/NN mRNA/NN is/VBZ formed/VBN cotranscriptionally/RB by/IN the/DT sequential/JJ action/NN of/IN three/CD enzymes/NNS :/: RNA/NEWGENE triphosphatase/NEWGENE ,/, RNA/NEWGENE guanylyltransferase/NEWGENE ,/, and/CC RNA/NEWGENE (/NEWGENE guanine-7/NEWGENE )/NEWGENE -methyltransferase/NEWGENE ./.
@@105313406161 R/NNP ./NNP ,/, Fleischmann/NNP ,/, R/NNP ./NNP ,/, Venter/NNP ,/, J/NNP ./NNP
@@74761645905 In/NN addition/NN ,/, two-dimensional/JJ nuclear/JJ magnetic/JJ resonance/NN studies/NNS with/IN F17A/NN ,/, K13Q/NN ,/, F15Y/NN and/CC F27Y/NN revealed/VBD that/IN the/DT mutants/NNS have/NN the/DT same/JJ overall/JJ structure/NN as/IN the/DT wild-type/NEWGENE CspB/NEWGENE protein/NEWGENE ./.
@@86343575612 The/DT extraction/NN recovery/NN of/IN Amphotericin/NN B/NN from/IN the/DT cerebrospinal/JJ fluid/NN is/VBZ higher/JJ than/IN 90%/CD over/RB the/DT entire/JJ linear/JJ range/NN ./.
@@110549706019 The/DT plexiform/JJ neurofibroma/NN and/CC multiple/RB localized/VBN neurofibromas/NNS are/VBP characteristic/NN of/IN NF1/NEWGENE ./.
@@96527363920 In/NN addition/NN ,/, we/PRP find/VBP that/IN E2F-1/NEWGENE can/MD cause/VB apoptosis/NN in/IN p53-/NEWGENE //NEWGENE -/NEWGENE tumour/NN cells/NNS and/CC further/RB p300/NEWGENE ,/, which/WDT also/RB functions/VBZ as/IN a/DT co-activator/NN for/IN the/DT E2F/NEWGENE //NEWGENE DP/NEWGENE heterodimer/NEWGENE ,/, enhances/VBZ the/DT apoptotic/JJ activity/NN of/IN E2F-1/NEWGENE ./.
@@12026161851 Following/VBG retransfusion/NN ,/, the/DT affected/VBN epithelial/JJ lining/NN appeared/VBN greatly/RB distended/VBN over/RB the/DT oedematous/JJ lamina/NN propria/NN ,/, with/IN almost/RB complete/JJ loss/NN of/IN structural/JJ detail/NN ./.
@@85520821652 Here/RB we/PRP report/VBP that/IN the/DT proline-rich/JJ region/NN of/IN CAP/NEWGENE is/VBZ recognized/VBN by/IN the/DT SH3/NEWGENE domains/NEWGENE of/IN several/DT proteins/NNS ,/, including/JJ the/DT yeast/NEWGENE actin-associated/NEWGENE protein/NEWGENE Abp1p/NEWGENE ./.
@@8263933873 Molecular/NNP cloning/NN of/IN a/DT P-type/NEWGENE ATPase/NEWGENE gene/NEWGENE from/IN the/DT cyanobacterium/NN Synechocystis/DT sp/NN ./NN
@@91240547577 The/DT prognosis/NN of/IN seven/JJ patients/NNS who/WP received/VBD ABSCT/NN was/VBD significantly/RB better/JJR than/IN that/DT of/IN 13/CD patients/NNS who/WP received/VBD conventional/JJ therapy/NN alone/RB ./.
@@105160117824 In/NN the/DT work/NN reported/VBN here/RB ,/, we/PRP used/VBD peptide/NN mapping/NN ,/, mass/JJ spectrometry/NN ,/, and/CC site-directed/JJ mutagenesis/NN to/IN identify/VB two/JJ sets/NNS of/IN pAP/NEWGENE phosphorylation/NN sites/NN ./.
@@7626806465 The/DT RAT3/NEWGENE gene/NEWGENE encodes/VBZ an/DT 1157-amino/JJ acid/NN protein/NN without/IN similarity/NN to/IN other/DT known/VBP proteins/NNS ./.
@@99188425864 The/DT high/JJ conservation/NN of/IN the/DT 3'/NN terminus/NN suggests/VBZ that/IN this/DT region/NN directs/VBZ the/DT assembly/NN of/IN proteins/NNS required/VBN for/IN the/DT initiation/NN of/IN RNA/NN replication/NN ./.
@@66150534052 Sixteen/CD patients/NNS were/VBD studied/VBN within/IN 24/CD hours/NNS of/IN resuscitation/NN and/CC all/DT showed/VBD depressed/VBN right/JJ ventricular/JJ ejection/NN (/( RVEF/NN )/SYM and/IN //IN or/IN an/DT increased/VBN end-diastolic/JJ volume/NN (/( RVEDVI/NN )/SYM ./.
@@103959082905 This/DT is/VBZ predicted/VBN to/IN encode/VB a/DT 315-residue/JJ protein/NN containing/JJ seven/JJ hydrophobic/JJ helical/JJ regions/NNS and/CC a/DT 17/CD amino/JJ acid/NN motif/NN characteristic/NN of/IN the/DT R7G/NEWGENE family/NEWGENE of/IN G-protein/NEWGENE coupled/NEWGENE membrane-bound/NEWGENE receptors/NEWGENE ./.
@@70652069504 In/NN 10/CD control/NN sheep/NN mean/JJ plasma/NN TXB2/NN concentration/NN increased/VBN from/IN 0/CD ./CD 39/CD ng/NN //NN ml/NN prebypass/NN to/IN about/RB 1/CD ./CD 1/CD ng/NN //NN ml/NN at/IN 8/CD and/CC 16/CD min/NN of/IN bypass/NN ./.
@@9765466822 J/NNP ./NNP
@@93111641727 The/DT distributed/VBN current/JJ density/NN J/NN is/VBZ calculated/VBN within/IN the/DT volume/NN defined/VBN by/IN the/DT motor/JJ unit/NN ./.
@@87493933562 The/DT PI3K_68D/NEWGENE cDNA/NEWGENE encodes/VBZ a/DT protein/NN of/IN 210/CD kDa/NN ,/, which/WDT lacks/VBZ sequences/NNS implicated/VBN in/IN linking/NN p110/NN PI/NEWGENE 3-kinases/NEWGENE to/IN p85/NEWGENE adaptor/NEWGENE proteins/NEWGENE ,/, but/CC contains/VBZ an/DT amino-terminal/JJ proline-rich/JJ sequence/NN ,/, which/WDT could/MD bind/VB to/IN SH3/NEWGENE domains/NEWGENE ,/, and/CC a/DT carboxy-terminal/NN C2/NN domain/NN ./.
@@62968335898 Two/CD mutations/NNS that/WDT affect/VBP larval/NEWGENE cuticle/NEWGENE protein/NEWGENE gene/NEWGENE expression/NN in/IN the/DT 2/NN //NN 3/NN variant/NN Drosophila/NN melanogaster/NN strain/NN were/VBD investigated/VBN ./.
@@5877915781 Nursing/NNP of/IN patients/NNS with/IN gynecological/JJ diseases/NNS ./.
@@11032677867 Prominent/JJ findings/NNS were/VBD chronic/JJ pancreatitis/NN with/IN acinar/JJ and/CC ductal/JJ plugs/NNS ,/, granulomatous/JJ and/CC necrotizing/JJ peripancreatic/JJ steatitis/NN ,/, degenerative/JJ myopathy/NN ,/, testicular/JJ atrophy/NN ,/, candidiasis/NN and/CC bacterial/JJ necrotizing/JJ glossitis/NN ./.
@@100712122566 Nipponbare/NNP as/NNP well/VB as/IN O/NNP ./NNP australiensis/NN ./.
@@98910922393 We/PRP show/VBP that/IN the/DT Sm-binding/NEWGENE site/NEWGENE and/CC stem-loop/NNP III/NNP structures/NNS are/VBP necessary/JJ for/IN correct/JJ 3'-end/CD formation/NN ./.
@@90621306833 Relief/NNP from/IN autoinhibition/NN and/CC a/DT subsequent/JJ 10-60-fold/JJ increase/NN in/IN V/NN (/NN max/NN )/NN have/NN been/VBN observed/VBN upon/IN N-SH2/NEWGENE domain/NEWGENE engagement/NN by/IN a/DT specific/NN phosphotyrosyl/NN ligand/NN or/CC upon/IN deletion/NN of/IN the/DT SH2/NEWGENE domains/NEWGENE to/IN yield/NN the/DT catalytic/JJ PTPase/NEWGENE domain/NEWGENE ./.
@@107729778577 Viral/JJ cell-to-cell/JJ movement/NN of/IN PVX/NEWGENE CP/NEWGENE mutant/NEWGENE was/VBD complemented/VBN in/IN Nicotiana/NNP tabacum/NN cv/CD ./CD
@@38785853925 The/DT percentage/NN RFR/NN reduction/NN at/IN the/DT end/NN of/IN CPB/NNP showed/VBD significant/JJ correlation/NN with/IN 1/NN )/NN CPB/NNP duration/NN (/( r/JJ =/SYM 0/CD ./CD 49/CD )/SYM ,/, 2/NN )/NN oxygen/NN flow/NN rate/NN index/NN (/( OFRI/NNP )/SYM ,/, i/CD ./CD e/CD ./. flow/NN //NN min/NN in/IN the/DT bubble/NN oxygenator/NN //NN m2/NN bsa/NN (/( r/JJ =/SYM 0/CD ./CD 38/CD )/SYM ,/, and/CC 3/NN )/NN blood/NN flow/NN rate/NN index/NN (/( BFRI/NNP )/SYM ,/, i/CD ./CD e/CD ./. average/JJ volume/NN of/IN blood/NN pumped/VBN through/RB the/DT heart-lung/NNP machine/NN //NN min/NN CPB/NN time/NN //NN m2/NN bsa/NN (/( r/JJ =/SYM 0/CD ./CD 51/CD )/SYM ./.
@@61422795960 Risk/NN of/IN HTLV/NN infection/NN in/IN patients/NNS on/IN haemodialysis/NN ./.
@@82267765826 Unfolding/NN can/MD be/VB described/VBN by/IN a/DT two-state/NN process/NN since/IN a/DT ratio/NN of/IN delta/JJ Hcalorimetric/NNP to/IN delta/JJ Hvan't/NNP Hoff/NNP equals/VBP 0/CD ./CD 96/CD ./.
@@115480277135 A/DT proposal/NN of/IN 50/CD performance/NN indicators/NNS divided/VBN into/IN five/CD different/JJ groups/NNS is/VBZ presented/VBN here/RB ,/, namely/RB structural/NN indicators/NN ,/, operational/JJ indicators/NNS ,/, water/NN and/CC service/NN quality/JJ indicators/NNS ,/, personnel/NN indicators/NNS and/CC economic/JJ indicators/NNS ./.
@@18488713298 This/DT study/NN tested/VBD the/DT hypothesis/NN that/DT sodium/NN channel/NN blocking/JJ drugs/NNS selectively/RB prolong/VBP the/DT late/JJ potential/NN ,/, or/CC terminal/JJ low/JJ amplitude/NN signal/JJ ,/, portion/NN of/IN the/DT signal-averaged/JJ QRS/NN complex/NN and/CC that/DT prolongation/NN of/IN the/DT late/JJ potential/NN would/MD correlate/VB with/IN slowing/NN of/IN ventricular/JJ tachycardia/NN ./.
@@30613839605 The/DT in/NN vitro/FW activity/NN of/IN mecillinam/NN and/CC amoxicillin/JJ //JJ clavulanic/JJ acid/NN against/IN Escherichia/NN coli/JJ strains/NNS producing/JJ beta-lactamases/NEWGENE of/IN the/DT TEM-1/NEWGENE ,/, Oxa-1/NEWGENE and/CC chromosomal/JJ type/NN were/VBD studied/VBN using/VBG the/DT broth/NN and/CC agar/NN dilution/NN technique/NN ./.
@@105560285582 The/DT cop/NEWGENE region/NEWGENE also/RB harbors/VBP a/DT region/NN of/IN plasmid/NN incompatibility/NN ,/, inc/NEWGENE ,/, encompassing/VBG a/DT stem-loop/NN structure/NN ,/, the/DT repA/NEWGENE promoter/NEWGENE ,/, Prep/NEWGENE ,/, as/RB well/VB as/IN two/JJ distinct/JJ RepA/NEWGENE binding/NEWGENE sites/NEWGENE ,/, BD-1/NEWGENE and/CC BD-2/NEWGENE ./.
@@105056946928 IL-12/NEWGENE production/NN was/VBD correlated/VBN with/IN C3a/NNP concentration/NN measured/VBN at/IN the/DT outlet/NN of/IN hemodialyzer/NN after/IN 15/CD min/NN of/IN dialysis/NN (/( r/JJ =/SYM 0/CD ./CD 69/CD ,/, P/NN </SYM 0/CD ./CD 01/CD )/SYM ./.
@@10964833793 Only/JJ two/NN of/IN 27/CD participants/NNS (/( 7/CD ./CD 4%/CD )/SYM with/IN definite/JJ POAG/WDT had/VBP been/VBN previously/RB diagnosed/VBN and/CC treated/VBN ,/, and/CC 66/CD ./CD 7%/CD of/IN the/DT previously/RB undiagnosed/JJ had/VBP IOP/NN less/PRP than/IN 22/CD mmHg/NN ./.
@@86611016922 DNA/NN sequence/NN analysis/NN reveals/VBZ that/IN the/DT gene/NN encodes/VBZ a/DT protein/NN highly/RB homologous/JJ to/IN rat/NEWGENE CRP1/NEWGENE ./.
@@96929656537 When/WRB cysteine/NN is/VBZ scanned/VBN through/RB the/DT helices/NNS ,/, characteristic/JJ repeating/JJ patterns/NNS of/IN solvent/JJ exposure/NN and/CC burial/NN are/VBP observed/VBN ./.
@@82646172077 Recombinant/JJ expression/NN of/IN a/DT chimeric/JJ EGFR/NEWGENE //NEWGENE ErbB-3/NEWGENE receptor/NEWGENE in/IN NIH/NN 3T3/CD fibroblasts/NNS allowed/VBN us/PRP to/IN investigate/VB cytoplasmic/JJ events/NNS associated/VBN with/IN ErbB-3/NEWGENE signal/JJ transduction/NN upon/IN ligand/NN activation/NN ./.
@@62728449557 Replicating/JJ simian/JJ virus/NN 40/CD (/( SV40/NN )/SYM chromosomes/NNS were/VBD found/VBN to/IN be/VB similar/JJ to/IN other/DT eukaryotic/JJ chromosomes/NNS in/IN that/DT the/DT rate/NN and/CC extent/NN of/IN micrococcal/NEWGENE nuclease/NEWGENE (/( MNase/NEWGENE )/SYM digestion/NN were/VBD greater/JJR with/IN replicating/JJ than/IN with/IN nonreplicating/JJ mature/JJ SV40/NN chromatin/NN ./.
@@79512352340 One/CD gene/NN appears/VBZ ubiquitously/RB expressed/VBN while/CC the/PDT other/DT is/VBZ prominently/RB expressed/VBN in/IN muscle/NN ./.
@@30751544722 Recurrence/NNS of/IN oxalate/NN deposition/NN in/IN a/DT renal/JJ transplant/NN during/IN ciclosporin/NN A/NN therapy/NN ./.
@@76397039647 As/IN retinoic/JJ acid/NN and/CC thyroid/JJ hormone/NN are/VBP frequently/RB involved/VBN in/IN developmental/JJ regulatory/JJ processes/NNS ,/, it/PRP is/VBZ possible/JJ that/IN this/DT element/NN may/MD be/VB important/JJ in/IN the/DT process/NN of/IN islet/NN cell/NN differentiation/NN ./.
@@10895417721 We/PRP have/VBP shown/VBP that/IN the/DT epidural/JJ (/( EPI/NN )/SYM delivery/NN of/IN morphine/NN encapsulated/JJ in/IN multivesicular/JJ liposomes/NNS (/( DepoFoam/NNP drug/NN delivery/NN system/NN )/SYM produces/VBZ a/DT sustained/JJ clearance/NN of/IN morphine/NN and/CC a/DT prolonged/JJ analgesia/NN ./.
@@103837642398 The/DT results/NNS of/IN these/DT studies/NNS support/NN a/DT model/NN in/IN which/WDT VirB4/NEWGENE dimers/NEWGENE or/CC homomultimers/NNS contribute/VB structural/JJ information/NN for/IN the/DT assembly/NN of/IN a/DT transenvelope/NN channel/NN competent/JJ for/IN bidirectional/JJ DNA/NN transfer/NN ,/, whereas/IN an/DT ATP-dependent/JJ activity/NN is/VBZ required/VBN for/IN configuring/VBG this/DT channel/NN as/IN a/DT dedicated/JJ export/NN machine/NN ./.
@@107787404168 The/DT C-terminal/NEWGENE Cdk2/NEWGENE truncations/NNS ,/, however/RB ,/, were/VBD non-functional/NN in/IN these/DT strains/NNS and/CC thus/RB dependent/JJ for/IN activity/NN on/IN the/DT pho85/NEWGENE coding/NEWGENE region/NEWGENE which/WDT remained/VBD in/IN the/DT mutant/NEWGENE pho85/NEWGENE :/: :/: HIS3/NEWGENE chromosomal/NEWGENE locus/NEWGENE ./.
@@60972855922 It/PRP is/VBZ concluded/VBN that/DT haloperidol/NN selectively/RB reduced/VBD the/DT animal's/NNS capacity/NN to/IN 'programme/NN non-stimulus/NN directed/VBD motor/JJ behaviour'/NN ./.
@@87767928764 Sleep/NN was/VBD determined/VBN again/RB for/IN an/DT additional/JJ 3/CD days/NNS and/CC 6/CD hours/NNS ./.
@@84433391092 Histochemical/JJ localization/NN of/IN GUS/NEWGENE revealed/VBD promoter/NN function/NN in/IN leaf/NN epidermis/NN ,/, mesophyll/JJ and/CC vascular/JJ bundles/NNS ,/, in/IN the/DT cortex/NN and/CC vascular/JJ cylinder/NN of/IN the/DT root/NN ./.
@@112665583413 We/PRP show/VBP here/RB that/IN the/DT in/NN vitro/FW transcription/NN extract/NN contains/VBZ a/DT binding/JJ activity/NN that/WDT is/VBZ specific/JJ for/IN the/DT initiator/NN element/NN and/CC thus/RB may/MD participate/VB in/IN recruiting/JJ RNA/NEWGENE polymerase/NEWGENE II/NEWGENE to/IN the/DT SL/NEWGENE RNA/NEWGENE gene/NEWGENE promoter/NEWGENE ./.
@@82997252157 The/DT inserted/VBN region/NN ,/, which/WDT represents/VBZ an/DT intron/NN in/IN brain/NN and/CC muscle/NN ,/, is/VBZ expressed/VBN in/IN the/DT tumor/NN cell/NN lines/VBZ either/DT as/IN a/DT "readthrough"/NN form/NN or/CC with/IN 78/CD residues/NNS deleted/VBN from/IN its/PRP 5'/CD end/NN ./.
@@84456555580 Localization/NNS of/IN the/DT insertion/NN locus/NN in/IN the/DT yeast/NN genome/NN and/CC complementation/NN studies/NNS with/IN the/DT temperature-sensitive/JJ mutant/JJ indicate/VB that/IN the/DT two/JJ mutations/NNS are/VBP allelic/JJ ./.
@@91778575743 The/DT conditions/NNS for/IN obtaining/JJ titanium/NN dioxide/NN from/IN the/DT substrates/NNS titanium/NN tetrachloride/NN and/CC oxygen/NN and/CC applying/VBG this/DT to/IN a/DT surgical/JJ stainless/JJ steel/NN of/IN the/DT type/NN 316L/NN by/IN the/DT plasma/NN assisted/JJ chemical/JJ vapour/NN deposition/NN method/NN have/NN been/VBN determined/VBN ./.
@@86494033400 The/DT growth/NN defect/NN of/IN a/DT reg1/NEWGENE reg2/NEWGENE1 double/NEWGENE1 mutant/NEWGENE1 is/VBZ alleviated/VBN by/IN a/DT loss-of-function/NN mutation/NN in/IN the/DT SNF1-encoded/NEWGENE protein/NEWGENE kinase/NEWGENE ./.
@@78872261700 When/WRB combined/JJ with/IN serum/JJ ferritin/NEWGENE and/CC hemoglobin/NEWGENE determinations/NNS ,/, the/DT serum/JJ transferrin/NEWGENE receptor/NEWGENE assay/NN is/VBZ a/DT valuable/NN addition/NN in/IN epidemiologic/JJ surveys/NNS because/IN it/PRP provides/VBZ a/DT quantitative/JJ measure/NN of/IN functional/JJ iron/NN deficiency/NN and/CC it/PRP distinguishes/VBZ true/JJ IDA/NN from/IN the/DT anemia/NN of/IN chronic/JJ disease/NN ./.
@@104978005282 The/DT MMPI-A/NN (/( Butcher/NNP et/FW al/NNS ./NNS ,/, 1992/CD )/SYM ,/, like/VB the/DT older/JJR MMPI/NN (/( Hathaway/NNP &/CC McKinley/NNP ,/, 1983/CD )/SYM ,/, distinguishes/VBZ between/IN anorexia/NN and/CC bulimia/NN ./.
@@95785701197 In/NN this/DT study/NN ,/, to/IN characterize/VB the/DT gene/NN for/IN protein/NEWGENE Z/NEWGENE ,/, its/PRP organization/NN and/CC structure/NN were/VBD determined/VBN by/IN a/DT combination/NN of/IN PCR/NN amplification/NN of/IN leukocyte/NN DNA/NN and/CC isolation/NN of/IN phage/NN clones/NNS from/IN a/DT human/JJ genomic/JJ library/NN ./.
@@28069161471 A/DT genomic/JJ DNA/NN clone/NN encoding/VBG oryzacystatin/NEWGENE (/( Oc/NEWGENE )/SYM ,/, a/DT cysteine/NEWGENE proteinase/NEWGENE inhibitor/NEWGENE (/( cystatin/NEWGENE )/SYM of/IN rice/NN ,/, was/VBD isolated/VBN from/IN a/DT lambda/NN EMBL3/NN phage/NN library/NN constructed/VBN with/IN Sau3AI/NEWGENE partial/JJ digests/NNS of/IN rice/NN chromosomal/JJ DNA/NN ,/, by/IN screening/JJ with/IN an/DT oc/NEWGENE cDNA/NEWGENE as/IN a/DT probe/NN ./.
@@91712397475 Surprisingly/RB ,/, the/DT RXR-specific/NN ligand/NN 9-cis-retinoic/NN acid/NN induced/VBD binding/NN of/IN SRC-1/NEWGENE to/IN the/PDT RXR/NEWGENE component/NEWGENE of/IN the/DT TRE-bound/NNP heterodimer/NN ./.
@@103404479551 The/DT average/JJ coefficients/NNS of/IN correlation/NN were/VBD 0/CD ./CD 9998/CD and/CC 0/CD ./CD 9993/CD for/IN the/DT QMF/NN and/CC the/DT QIT/NNP system/NN ,/, respectively/RB ./.
@@64942976376 The/DT results/NNS imply/VBP that/DT kindling/NN does/VBP not/RB produce/VB its/PRP facilitating/JJ effect/NN on/IN acquisition/NN of/IN HPC/NN SS/NN by/IN removing/JJ a/DT disruptive/JJ effect/NN of/IN the/DT stimulation/NN ./.
@@77538373796 When/WRB RNA/NN encoding/VBG the/DT tail/NN domain/NN of/IN desmoglein/NEWGENE was/VBD coinjected/VBN with/IN plakoglobin/NEWGENE RNA/NEWGENE ,/, both/PDT the/DT dorsalizing/JJ effect/NN and/CC nuclear/JJ accumulation/NN of/IN plakoglobin/NEWGENE were/VBD suppressed/VBN ./.
@@78137864304 Two/CD related/VBN cDNAs/NNS were/VBD isolated/VBN that/WDT encode/VBP proteins/NNS that/WDT recognize/VBP the/DT XMyoDa/NEWGENE TATA/NEWGENE motif/NEWGENE ./.
@@112274848263 Fluorimetric/NN determination/NN of/RB methylmercury/NN as/IN an/DT ion-association/JJ complex/NN with/IN rhodamine/NN B/NN in/IN the/DT presence/NN of/IN iodide/NN ./.
@@9328343726 Expression/NNS from/IN this/DT element/NN is/VBZ regulated/VBN by/IN a/DT heteromeric/JJ protein/NN complex/NN containing/JJ ubiquitous/JJ (/( i/CD ./CD e/CD ./. the/DT E2A-/NEWGENE and/CC HEB-encoded/NEWGENE proteins/NEWGENE )/SYM and/CC islet-enriched/JJ members/NNS of/IN the/DT bHLH/NEWGENE family/NEWGENE ./.
@@91237874780 The/DT electromyographically/RB recorded/VBN responses/NNS consisted/VBP of/IN an/DT early/NN R1/NN response/NN in/IN the/DT orbicularis/NN oculi/NNS muscle/NN ipsilateral/JJ to/IN the/DT side/NN of/IN stimulation/NN ,/, a/DT bilateral/JJ late/JJ response/NN (/( ipsilateral/JJ R2/NN and/CC contralateral/JJ Rc/NN )/SYM and/CC a/DT third/RB ,/, R3/NN response/NN ,/, in/IN the/DT ipsilateral/JJ orbicularis/NN oculi/NNS muscle/NN ./.
@@88778181161 The/DT amplification/NN was/VBD achieved/VBN using/VBG two/JJ primers/NNS which/WDT correspond/VBP to/IN TRH/NEWGENE progenitor/NEWGENE sequence/NEWGENE (/( Lys/NEWGENE //NEWGENE Arg-Arg-Gln-His-Pro-Gly-Lys/NEWGENE //NEWGENE Arg-Arg/NEWGENE )/SYM ./.
@@67203716493 Pilot/NN study/NN of/IN blood/NN coagulation/NN in/IN gout/NN patients/NNS ./.
@@94261833677 The/DT well-known/JJ Rel/NEWGENE //NEWGENE NF-kappaB/NEWGENE family/NEWGENE of/IN vertebrate/NN transcription/NN factors/NN comprises/VBZ a/DT number/NN of/IN structurally/RB related/VBN ,/, interacting/VBG proteins/NNS that/WDT bind/VBP DNA/NN as/IN dimers/NNS and/CC whose/WP activity/NN is/VBZ regulated/VBN by/IN subcellular/JJ location/NN ./.
@@69936605937 Contractile/NNP responses/NNS to/IN norepinephrine/NN ,/, serotonin/NN and/CC potassium/NN (/( K+/NN )/SYM and/CC relaxant/JJ responses/NNS to/IN isoproterenol/NN and/CC papaverine/NN were/VBD studied/VBN in/IN vitro/FW with/IN spirally/RB cut/JJ thoracic/JJ aortic/JJ strips/NNS from/IN aortic/RB coarcted/VBN hypertensive/JJ rats/NNS (/( AHR/NN )/NN 2/NN ,/, 6/NN ,/, 14/NN and/CC 28/NN days/NNS postoperatively/RB and/CC compared/VBN to/IN time-matched/JJ ,/, sham-operated/JJ normotensive/JJ controls/NNS ./.
@@8825554579 Tristetraprolin/NEWGENE (/( TTP/NEWGENE )/SYM is/VBZ the/DT prototype/NN of/IN a/DT group/NN of/IN potential/JJ transcription/NN factors/NNS that/WDT contain/VBP two/JJ or/CC more/RB unusual/JJ CCCH/NN zinc/NN fingers/NNS ./.
@@75630762840 These/DT intron/NN chimeras/NNS show/VBP that/IN peripheral/JJ sequences/NNS and/CC the/DT elements/NNS that/WDT define/VBP the/DT splice/NN sites/NNS are/VBP adequate/JJ for/IN self-splicing/JJ activity/NN but/CC that/IN the/DT central/JJ portions/NNS containing/JJ the/DT catalytic/JJ cores/NNS of/IN ai4/NEWGENE and/CC bi4/NEWGENE are/VBP deficient/JJ ;/: these/DT cores/NNS are/VBP the/DT likely/JJ targets/NNS of/IN the/DT splicing/JJ proteins/NNS ./.
@@13344284896 Km/NN and/CC Vmax/NN for/IN two/JJ substrates/NNS ,/, src-related/NEWGENE peptide/NEWGENE and/CC poly/NN (/NN Glu/NN ,/, Tyr/NN )/NN (/( 4/CD :/: 1/CD )/SYM ,/, were/VBD 2/CD ./CD 4/CD mM/NN and/CC 2/CD ./CD 5/CD mumol/NN min-1/NN mg-1/NN and/CC 0/CD ./CD 26/CD mM/NN and/CC 1/CD ./CD 2/CD mumol/NN min-1/NN mg-1/NN ,/, respectively/RB ./.
@@96930359911 Human/NEWGENE ULK1/NEWGENE ,/, a/DT novel/JJ serine/NEWGENE //NEWGENE threonine/NEWGENE kinase/NEWGENE related/VBN to/IN UNC-51/NEWGENE kinase/NEWGENE of/IN Caenorhabditis/NNP elegans/NNS :/: cDNA/NN cloning/NN ,/, expression/NN ,/, and/CC chromosomal/JJ assignment/NN ./.
@@10683259559 Sulfhydryl/NN titration/NN with/IN iodoacetamide/NN ,/, monitored/VBN by/IN quantitating/JJ the/DT residual/JJ thiols/NNS after/IN reaction/NN with/IN a/DT maleimide/NN derivative/NN of/IN biotin/NN ,/, revealed/VBD a/DT striking/JJ difference/NN in/IN the/DT apparent/JJ pK/NN (/NN a/NN )/NN values/NNS of/IN the/DT cysteines/NNS at/IN the/DT two/JJ splice/NN junctions/NNS ./.
@@75114965709 High/NNP plasma/NN concentrations/NNS of/IN soluble/NN E-selectin/NEWGENE were/VBD closely/RB associated/VBN with/IN multiple-organ/JJ dysfunction/NN and/CC death/NN ./.
@@98910468143 In/NN such/JJ a/DT manner/NN ,/, activated/VBN PKR/NEWGENE inhibits/VBZ cell/NN growth/NN and/CC induces/VBZ apoptosis/NN ,/, whereas/IN disruption/NN of/IN normal/JJ PKR/NEWGENE signaling/JJ results/NNS in/IN unregulated/JJ cell/NN growth/NN ./.
@@1035457210 When/WRB a/DT tumour/NN is/VBZ present/NN nipple/NN discharge/NN is/NNS of/IN little/JJ importance/NN for/IN the/DT diagnosis/NN and/CC treatment/NN ./.
@@255573209 When/WRB the/DT CO2/NN content/NN reached/VBN 9/CD Vol%/VBZ the/DT animals/NNS became/VBD apathic/JJ and/CC lost/VBP body/NN weight/NN ./.
@@89956523141 The/DT results/NNS demonstrate/VBP that/IN (/( i/NN )/SYM no/DT intact/JJ capsids/NNS were/VBD assembled/VBN when/CC the/DT full-length/JJ or/CC a/DT truncated/JJ (/( missing/JJ the/DT C-terminal/NN 65/NN amino/JJ acids/NNS )/SYM UL80/NEWGENE ./NEWGENE 5/NEWGENE protein/NEWGENE was/VBD tested/VBN ;/: (/( ii/NN )/SYM when/CC the/DT C-terminal/NN 65/NN amino/JJ acids/NNS of/IN the/DT UL80/NEWGENE ./NEWGENE 5/NEWGENE protein/NEWGENE were/VBD replaced/VBN with/IN the/DT C-terminal/NN 25/NN amino/JJ acids/NNS of/IN the/DT UL26/NEWGENE ./NEWGENE 5/NEWGENE protein/NEWGENE ,/, intact/JJ capsids/NNS were/VBD made/VBP and/CC direct/JJ interaction/NN of/IN the/DT UL80/NEWGENE ./NEWGENE 5/NEWGENE protein/NEWGENE with/IN VP5/NEWGENE was/VBD detected/VBN ;/: (/( iii/NN )/SYM assembly/NN of/IN intact/JJ capsids/NNS was/VBD demonstrated/VBN when/CC the/DT sequence/NN of/IN the/DT last/NN 12/CD amino/JJ acids/NNS of/IN the/DT UL80/NEWGENE ./NEWGENE 5/NEWGENE protein/NEWGENE was/VBD changed/VBN from/IN RRIFVA/NEWGENE ALNKLE/NEWGENE to/IN RRIFVAAMMKLE/NEWGENE ;/: (/( iv/NN )/SYM self-interaction/NN of/IN the/DT scaffold/NN proteins/NNS is/VBZ mediated/JJ by/IN sequences/NN N/NN terminal/NN to/IN the/DT maturation/NN cleavage/NN site/NN ;/: and/CC (/( v/NN )/SYM the/DT UL26/NEWGENE ./NEWGENE 5/NEWGENE and/CC UL80/NEWGENE ./NEWGENE 5/NEWGENE proteins/NEWGENE will/MD not/RB coassemble/VB into/IN scaffold/NN structures/NNS ./.
@@112072699554 Anti-nucleolin/NEWGENE mAb/NEWGENE was/VBD used/VBN to/IN confirm/VB the/DT antigenic/JJ properties/NNS of/IN this/DT p95/NEWGENE component/NEWGENE ./.
@@88743998832 Sixty/CD days/NNS after/IN the/DT intervention/NN ,/, twitch/NN and/CC tetanic/JJ tensions/NNS remained/VBD dependent/JJ upon/IN the/DT extracellular/JJ Ca2+/NN concentration/NN (/( [/NN Ca/NN ]/NN o/NN )/SYM both/DT in/NN groups/NNS A/DT and/CC B/NNP ./NNP
@@58371695773 Methoxyflurane/NNP and/CC renal/JJ function/NN ./.
@@39988134660 In/NN the/DT present/JJ experiments/NNS ,/, we/PRP investigate/VBP the/DT role/NN played/VBN by/IN the/DT temporal/JJ pattern/NN of/IN neural/JJ activity/NN during/IN the/DT ontogeny/NN of/IN frequency/NN tuning/JJ in/IN the/DT mouse/NN central/JJ auditory/JJ system/NN ./.
@@107931435750 Because/IN the/DT mutant/JJ defective/NN in/IN DNA/NN binding/JJ also/RB fails/VBZ to/IN stimulate/VB Abf1/NEWGENE ARS1/NEWGENE1 DNA-binding/NN activity/NN ,/, our/PRP results/NNS suggest/VBP that/IN Cdc6/NEWGENE DNA-binding/NN activity/NN may/MD play/VB a/DT pivotal/JJ role/NN in/IN the/DT initiation/NN of/IN DNA/NN replication/NN ./.
@@77062734521 Transcriptional/JJ regulation/NN of/IN the/DT vacuolar/NEWGENE H/NEWGENE (/NEWGENE +/NEWGENE )/NEWGENE -ATPase/NEWGENE B2/NEWGENE subunit/NEWGENE gene/NEWGENE in/IN differentiating/JJ THP-1/NNP cells/NNS ./.
@@118455471728 Potential/JJ treatments/NNS include/VBP dobutamine/NN ,/, KATP/NN channel/NN activators/NN ,/, and/CC 21-aminosteroids/NN ./.
@@68303517913 According/VBG to/IN Sugiura's/NNP classification/NN ,/, they/PRP consisted/VBP of/IN Type/NN Ia/NN in/IN 63%/JJ ,/, Type/NN Ib/NN in/IN 11%/JJ ,/, Type/NN II/NN in/IN 11%/JJ ,/, and/CC Type/NN III/NN in/IN 16%/NN ./.
@@110022362321 METHODS/IN :/: In/NN the/DT current/JJ study/NN the/DT authors/NNS reported/VBN on/IN PPB/NN cases/NNS from/IN a/DT national/JJ retrospective/JJ search/NN performed/VBN in/IN 18/CD Italian/NNP Associations/NNP for/IN Pediatric/NNP Hematology/NNS and/CC Oncology/NNP centers/NNS ./.
@@11781531628 D/NN ./NN
@@98116951019 These/DT results/NNS indicate/VBP that/IN HIV-1/NN Gag/NEWGENE sequences/NEWGENE can/MD influence/VB the/DT viral/JJ PR-mediated/JJ processing/NN of/IN the/DT MuLV/NN TM/NEWGENE Env/NEWGENE protein/NEWGENE p15/NEWGENE1 (/NEWGENE1 E/NEWGENE1 )/NEWGENE1 ./.
@@91825277649 Consistent/JJ with/IN its/PRP role/NN in/IN p53/NEWGENE ubiquitination/NN ,/, mE6-AP/NEWGENE was/VBD found/VBN both/DT in/NN the/DT nucleus/NN and/CC cytosol/NN ,/, while/CC Nedd-4/NEWGENE was/VBD found/VBN only/RB in/IN the/DT cytosol/NN ./.
@@73729286515 Tests/NNS of/IN the/DT method/NN indicate/VB (/( 1/CD )/SYM the/DT Mossbauer/NN source/NN can/MD be/VB placed/VBN on/IN the/DT basilar/JJ membrane/NN without/IN altering/VBG the/DT signal-transmission/JJ properties/NNS of/IN the/DT cochlea/NN ,/, and/CC (/( 2/CD )/SYM the/DT source/NN adheres/VBZ to/IN the/DT basilar/JJ membrane/NN ./.
@@82898345279 When/WRB expressed/VBN alone/RB in/IN test/NN cells/NNS ,/, Atr-I/NEWGENE is/VBZ unable/JJ to/IN bind/NN TGF-beta/NEWGENE ,/, activin/NEWGENE ,/, or/CC bone/NEWGENE morphogenetic/NEWGENE protein/NEWGENE 2/NEWGENE ./.
@@83006052555 One/CD of/IN these/DT elements/NNS ,/, the/DT homeodomain-binding/NEWGENE element/NEWGENE ,/, was/VBD identified/VBN to/IN mediate/VB negative/JJ regulation/NN ./.
@@81395428389 The/DT mutations/NNS did/VBD not/RB affect/VB the/DT repression/NN of/IN CPA1/NEWGENE by/IN arginine/NN ./.
@@81125268088 Increasing/VBG the/DT extracellular/JJ calcium/NN concentration/NN enhanced/VBD detrusor/NN contractility/NN in/IN a/DT dose-dependent/NN manner/NN in/IN both/DT control/NN and/CC obstructed/JJ bladders/NNS ./.
@@77412552568 These/DT six/CD districts/NNS have/VBP an/DT area/NN of/IN 34/NN ,/NN 000/NN km2/NN and/CC hold/VB a/DT population/NN of/IN 30/CD million/NN ./.
@@93331687227 Anti-hepatitis/NEWGENE A/NEWGENE virus/NN (/( HAV/NN )/SYM titer/NN after/IN vaccination/NN was/VBD measured/VBN in/IN 83/CD HIV-positive/NN and/CC 39/CD HIV-negative/NN men/NNS ./.
@@28740783555 An/DT endometrial/JJ luteal/JJ phase/NN deficiency/NN was/VBD detected/VBN in/IN 15/CD (/( 30%/CD )/SYM of/IN aborting/JJ patients/NNS ./.
@@81738148145 These/DT viruses/NNS depend/VBP on/IN the/DT host/NN cell/NN machinery/NN for/IN their/PRP existence/NN ,/, and/CC interference/NN with/IN these/DT processes/NNS typically/RB interferes/VBZ with/IN other/DT important/JJ host/NN physiology/NN ./.
@@88983364825 RNase/NEWGENE protection/NN analysis/NN of/IN two/JJ rRNA/NEWGENE fragments/NEWGENE whose/WP genes/NNS are/VBP adjacent/RB provided/VBN evidence/NN for/IN a/DT polycistronic/JJ transcript/NN containing/NN sequences/NN from/IN both/DT ,/, as/RB well/NN as/IN separate/JJ small/JJ RNAs/NNS ./.
@@116878691538 A/DT 38-year-old/JJ woman/NN with/IN ulcerative/JJ colitis/NN subsequently/RB developed/VBD sarcoidosis/NN ./.
@@14868367164 Patients/NNS receiving/JJ VPA/NN showed/VBD differences/NNS in/IN attention/NN ,/, visuomotor/JJ performance/NN ,/, verbal/JJ span/NN and/CC sensory/JJ discrimination/NN tasks/NNS at/IN T1/NN ,/, in/IN visuomotor/JJ performance/NN at/IN T2/NN and/CC in/IN spatial/JJ span/NN at/IN T3/NN ,/, whereas/IN no/DT differences/NNS were/VBD detected/VBN at/IN T4/NNP ./NNP
@@29264993634 Recently/RB ,/, an/DT electrical-mechanical/JJ analog/NN model/NN of/IN heat/NN flow/NN within/IN the/DT brain/NN has/VBZ been/VBN developed/VBN from/IN which/WDT an/DT expression/NN for/IN CBF/NN has/VBZ been/VBN derived/VBN :/: CBF/NN =/SYM Cb/NN //NN (/NN tau/NN rho/NN c/NN )/NN where/CC tau/NN is/VBZ the/DT thermal/JJ decay/NN constant/JJ ,/, rho/NN is/VBZ the/DT density/NN of/IN blood/NN ,/, and/CC c/NN is/VBZ its/PRP specific/JJ heat/NN ./.
@@74364597549 It/PRP is/VBZ suggested/VBN that/IN a/DT raised/VBN hydroxykynurenine/JJ //JJ hydroxyanthranilic/JJ acid/NN ratio/NN does/VBP not/RB necessarily/RB indicate/VB vitamin/NN B6/NN deficiency/NN but/CC may/MD represent/VB a/DT nonspecific/JJ response/NN of/IN tryptophan/NN metabolism/NN to/IN stress/NN ./.
@@96709129637 "Complex/NN partial"/NN seizures/NNS ./.
@@11072388905 Acute/JJ feasibility/NN and/CC safety/NN of/IN a/DT smoking/NN reduction/NN strategy/NN for/IN smokers/NNS with/IN schizophrenia/NN ./.
@@115997971527 RESULTS/NNS :/: A/DT novel/JJ gene/NN was/VBD cloned/VBN ./.
@@76241196846 To/TO compare/VB the/DT PAX3/NEWGENE and/CC putative/JJ PAX3-FKHR/NEWGENE transactivation/NEWGENE domains/NEWGENE ,/, we/PRP fused/VBD C-terminal/NN test/NN fragments/NNS to/IN the/DT heterologous/JJ GAL4/NEWGENE DNA-binding/NEWGENE domain/NEWGENE and/CC tested/VBN activation/NN of/IN a/DT reporter/NN gene/NN co-transfected/JJ into/IN four/CD cell/NN types/NNS ./.
@@81871775757 A/DT single/JJ amino/JJ acid/NN change/NN in/IN the/DT CPY/NEWGENE vacuolar/NEWGENE sorting/NEWGENE signal/NEWGENE prevents/VBZ this/DT interaction/NN ./.
@@78523613256 Removal/NNP of/IN PDMP/NN from/IN the/DT cell/NN medium/NN resulted/VBN in/IN reversal/NN of/IN the/DT cell/NN cycle/NN changes/NNS ,/, with/IN cells/NNS re-entering/VBG the/DT S/NNP phase/NN ./.
@@104911872359 The/DT phosphotransferase/NEWGENE system/NN (/( PTS/NN )/SYM of/IN Streptomyces/NN coelicolor/NN identification/NN and/CC biochemical/JJ analysis/NN of/IN a/DT histidine/NEWGENE phosphocarrier/NEWGENE protein/NEWGENE HPr/NEWGENE1 encoded/VBN by/IN the/DT gene/NN ptsH/NEWGENE ./.
@@78621413403 One/CD member/NN of/IN this/DT family/NN ,/, RFX1/NEWGENE ,/, is/VBZ a/DT transcription/NN factor/NN for/IN a/DT variety/NN of/IN viral/JJ and/CC cellular/JJ genes/NNS ./.
@@81080998083 Evaluation/NN of/IN desmopressin/NN for/IN dental/JJ extractions/NNS in/IN patients/NNS with/IN hemostatic/JJ disorders/NNS ./.
@@47887015164 Combination/NN of/IN 3/CD multiple/JJ primary/JJ malignant/JJ and/CC benign/JJ tumors/NNS of/IN the/DT breasts/NNS and/CC uterus/NN ./.
@@93261634213 RESULTS/NNS :/: The/DT standardised/JJ mortality/NN ratio/NN (/( SMR/NN )/SYM for/IN all/DT malignant/JJ neoplasms/NNS was/VBD 94/CD (/( 95%/CD CI/NN 74/NN to/IN 118/CD )/SYM ./.
@@85383826899 Erythrocyte/NN AA/NN in/IN FO+EPO-supplemented/JJ infants/NNS remained/VBD low/JJ and/CC below/RB breast-/JJ and/CC placebo/NN formula-fed/JJ levels/NNS ./.
@@23498278319 A/DT semiautomatic/JJ digital/JJ system/NN (/( Videoplan/NN 2/NN )/SYM was/VBD used/VBN ./.
@@23837713035 On/IN histologic/JJ examination/NN the/DT cuboidal/JJ epithelium/NN of/IN the/DT mucous/JJ membrane/NN was/VBD found/VBN to/IN be/VB changed/VBN into/IN columnar/JJ epithelium/NN ,/, with/IN uneven/JJ distribution/NN of/IN enlarged/JJ nuclei/NNS in/IN the/DT vacuolized/JJ cytoplasm/NN ./.
@@27235033412 Swim-over/NNP :/: an/DT alternative/JJ method/NN for/IN harvesting/JJ motile/JJ spermatozoa/NNS ./.
@@98226472850 The/DT rat/NEWGENE aldolase/NEWGENE C/NEWGENE gene/NEWGENE encodes/VBZ a/DT glycolytic/JJ enzyme/NN strongly/RB expressed/VBD in/IN adult/JJ brain/NN ./.
@@109754651790 The/DT human/NN cDNA/NN clone/NN NFBD1/NN (/( previously/RB designated/VBN KIAA0170/NN )/SYM encodes/VBZ a/DT novel/JJ protein/NN (/( 2089/CD amino/JJ acids/NNS in/IN length/NN ;/: calculated/VBN molecular/JJ mass/JJ 226/CD ,/CD 440/CD D/NN )/SYM with/IN possible/JJ BRCT/NEWGENE domains/NEWGENE at/IN its/PRP carboxy/JJ terminus/NN (/( amino/JJ acid/NN residues/NNS 1894-2089/CD )/SYM ./.
@@81998788173 The/DT effects/NNS of/IN systemic/JJ glucose/NN concentration/NN on/IN brain/NN metabolism/NN following/IN repeated/JJ brain/NN ischemia/NN ./.
@@98117305031 Mechanism/NNS of/IN interferon/NEWGENE action/NN :/: identification/NN of/IN essential/JJ positions/NNS within/IN the/DT novel/JJ 15-base-pair/NEWGENE KCS/NEWGENE element/NEWGENE required/VBN for/IN transcriptional/JJ activation/NN of/IN the/DT RNA-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE pkr/NEWGENE gene/NEWGENE ./.
@@84887003210 The/DT strategies/NNS by/IN which/WDT hepatitis/NN B/NN and/CC hepatitis/NN D/NN can/MD be/VB diminished/VBN and/CC eventually/RB eliminated/VBN are/VBP :/: immunization/NN ,/, measures/VBZ to/IN prevent/VB exposure/NN to/IN infective/JJ blood/NN or/CC blood/NN derivatives/NNS and/CC education/NN (/( in/IN particular/JJ awareness/NN that/DT hepatitis/NN B/NN is/VBZ a/DT sexually/RB transmitted/VBN disease/NN )/SYM ./.
@@83247928304 A/DT single/JJ five/CD minute/JJ period/NN of/IN rapid/JJ atrial/JJ pacing/NN fails/VBZ to/IN limit/NN infarct/NN size/NN in/IN the/DT in/NN situ/NN rabbit/NN heart/NN ./.
@@10610716256 Finally/RB ,/, three/CD new/JJ missense/JJ mutations/NNS ,/, E138V/NEWGENE ,/, R254G/NEWGENE ,/, and/CC P362R/NEWGENE ,/, were/VBD identified/VBN in/IN the/DT human/NEWGENE AC/NEWGENE gene/NEWGENE from/IN FD/NN patients/NNS ./.
@@117719791611 Although/IN the/DT spatial/JJ and/CC temporal/JJ variability/NN of/IN LDF/NN signals/NNS evoked/VBN by/IN cerebrocortical/JJ microflow/NN is/VBZ in/IN the/DT same/JJ range/NN as/IN with/IN other/DT methods/NNS and/CC in/IN other/DT organs/NNS ,/, LDF/NN cerebrocortical/JJ mapping/NN is/VBZ restricted/VBN by/IN the/DT large/JJ temporal/JJ and/CC spatial/JJ heterogeneity/NN of/IN the/DT cerebrocortical/JJ vasculature/NN ./.
@@34171044115 Taken/VBN together/RB ,/, the/DT results/NNS suggest/VBP that/DT chlorphentermine/NN may/MD be/VB capable/JJ of/IN producing/JJ dual/JJ stimulus/NN effects/NNS in/IN animals/NNS ./.
@@75740642061 However/RB ,/, 2/CD minimum/JJ alveolar/JJ concentration/NN anesthesia/NN did/VBD significantly/RB decrease/VBP the/DT calculated/VBN VE/NN at/IN a/DT PCO2/NN of/IN 60/CD mmHg/NN (/( from/IN 7/CD ./CD 4/CD +/NN //NN -/NN 1/CD ./CD 2/CD to/IN 4/CD ./CD 0/CD +/NN //NN -/NN 0/CD ./CD 6/CD l/CD ./CD min-1/CD )/SYM ,/, indicating/VBG a/DT rightward/JJ shift/NN in/IN the/DT response/NN relationship/NN ./.
@@111423801377 Nuclease/NEWGENE probing/JJ and/CC structure-directed/JJ mutagenesis/NN revealed/VBN that/IN the/DT 105-nt/NEWGENE TE/NEWGENE (/( TE105/NEWGENE )/SYM forms/VBZ a/DT cruciform/JJ secondary/JJ structure/NN containing/JJ four/CD helices/NNS connected/VBN by/IN single-stranded/JJ regions/NNS ./.
@@8960827258 These/DT results/NNS suggested/VBN that/IN the/DT GG/NN motifs/NNS contributed/VBN to/IN the/DT cell-specific/JJ transcription/NN of/IN the/DT human/NEWGENE insulin/NEWGENE gene/NEWGENE in/IN association/NN with/IN the/DT binding/NN of/IN the/DT sequence-specific/NN nuclear/NN factor/NN ./.
@@76369845088 To/TO investigate/VB the/DT potential/JJ role/NN of/IN SP1/NEWGENE ,/, we/PRP examined/VBD nuclear/JJ extracts/NNS from/IN HCMV-infected/JJ cells/NNS ./.
@@104469983575 In/NN contrast/NN ,/, the/DT differentiation/NN of/IN neoplastically/RB transformed/VBN cells/NNS does/VBP not/RB repress/VB mitogenic/JJ responsiveness/NN or/CC junB/NEWGENE or/CC c-fos/NEWGENE inducibility/NN ./.
@@15448547258 Of/IN the/DT drugs/NNS orally/RB administered/VBN ,/, WR-168643/NN was/VBD the/DT best/JJS protector/NN with/IN a/DT DMF/NN of/IN 1/CD ./CD 51/CD ./.
@@9755191434 Here/RB ,/, we/PRP report/VBP that/IN swa5-1/NEWGENE is/VBZ a/DT new/JJ temperature-sensitive/JJ allele/NN of/IN the/DT clathrin/NEWGENE heavy/NEWGENE chain/NEWGENE gene/NEWGENE (/( chc1-5/NEWGENE )/SYM ,/, which/WDT carries/VBZ a/DT frameshift/JJ mutation/NN near/IN the/DT 3'/CD end/NN of/IN the/DT CHC1/NEWGENE open/JJ reading/JJ frame/NN ./.
@@35789489065 Artificial/JJ ventilation/NN was/VBD conducted/VBN using/VBG a/DT tidal/JJ volume/NN of/IN 10/CD ml/NN X/NN kg-1/NN and/CC a/DT rate/NN of/IN 10/CD to/IN 12/CD c/NN X/NN min-1/NN ./.
@@90997459864 Active/JJ complexes/NNS eluted/VBN at/IN a/DT higher/JJ molecular/JJ weight/NN than/IN inactive/JJ complexes/NNS ,/, were/VBD relatively/JJ deficient/JJ in/IN both/DT p21/NEWGENE and/CC p27/NEWGENE ,/, and/CC contained/VBD Cdk2/NEWGENE with/IN increased/VBN threonine/NN 160/NN phosphorylation/NN ,/, consistent/JJ with/IN a/DT mechanism/NN of/IN activation/NN of/IN cyclin/NEWGENE E-Cdk2/NEWGENE involving/VBG both/DT reduced/VBN CDK/NEWGENE inhibitor/NN association/NN and/CC CDK-activating/JJ kinase-mediated/JJ phosphorylation/NN of/IN Cdk2/NEWGENE ./.
@@38904864550 Pancreaticoduodenal/JJ lymph/NN node/NN enlargement/NN ,/, regardless/RB of/IN cause/NN ,/, has/VBZ been/VBN a/DT source/NN of/IN imaging/JJ confusion/NN because/IN of/IN its/PRP propensity/NN to/IN mimic/NN pancreatic/JJ malignancy/NN yet/RB not/RB cause/VB biliary/JJ obstruction/NN ./.
@@95823313780 The/DT 5'-flanking/JJ region/NN ,/, from/IN nucleotide/NN -837/JJ to/IN -336/NN ,/, contains/VBZ TATA/NN and/CC inverted/JJ CAAT/NN boxes/NNS as/RB well/VBP as/IN GATA-1/NEWGENE //NEWGENE SP1/NEWGENE erythroid-specific/JJ cis-acting/JJ regulatory/JJ elements/NNS ./.
@@79366359093 Mutation/NN of/IN KRKR/NEWGENE to/IN NGER/NEWGENE retains/VBZ MO15/NEWGENE in/IN the/DT cytoplasmic/JJ compartment/NN ,/, whilst/JJ the/DT wild-type/NN protein/NN is/VBZ detected/VBN exclusively/RB in/IN the/DT nucleus/NN ./.
@@62235865017 However/RB ,/, when/CC combined/JJ with/IN mitomycin/NN C/NN given/VBP with/IN 1/CD to/IN 5-days/NNS interval/NN ,/, the/DT concurrent/JJ administration/NN of/IN SPG/NN prolonged/JJ significantly/RB the/DT life-span/NN of/IN the/DT tumor-bearing/JJ mice/NNS ./.
@@118529071738 The/DT equilibrium/NN phosphorus/NN content/NN (/( EPC0/NNP )/SYM of/IN surface/NN soil/NN was/VBD generally/RB higher/JJ than/IN the/DT SRP/NN content/NN of/IN drainage/NN water/NN ,/, at/IN one/PRP farm/NN by/IN 1/CD order/NN of/IN magnitude/NN ./.
@@6413958887 When/WRB blood/NN samples/NNS of/IN patients/NNS with/IN hyperbilirubinemia/NN were/VBD analyzed/VBN ,/, direct/JJ measurement/NN of/IN ZPP/NN by/IN this/DT fluorimeter/NN yielded/VBN significantly/RB higher/JJ levels/NNS than/IN did/VBD an/DT alternate/JJ extraction/NN method/NN ./.
@@104469988517 Transformation/NNS blocks/NNS differentiation-induced/JJ inhibition/NN of/IN serum/NEWGENE response/NEWGENE factor/NEWGENE interactions/NNS with/IN serum/NEWGENE response/NEWGENE elements/NEWGENE ./.
@@69666786744 The/DT monoexponential/JJ rate/NN of/IN clearance/NN of/IN tracer--obtained/JJ from/IN the/DT portion/NN of/IN the/DT residue-detection/JJ curve/NN reflecting/JJ metabolism/NN of/IN fatty/JJ acid/NN incorporated/VBN into/IN neutral/JJ lipids--correlated/JJ directly/RB with/IN induced/VBN changes/NNS in/IN tension-time/NN index/NN after/IN injections/NNS into/IN the/DT left/JJ atrium/NN (/( r/JJ =/SYM 0/CD ./CD 96/CD ,/, n/NN =/SYM 12/CD )/SYM ,/, right/JJ atrium/NN (/( r/JJ =/SYM 0/CD ./CD 86/CD ,/, n/NN =/SYM 14/CD )/SYM ,/, and/CC ear/NN vein/NN (/( r/JJ =/SYM 0/CD ./CD 93/CD ,/, n/NN =/SYM 14/CD )/SYM ./.
@@8022212837 Using/VBG a/DT previously/RB published/VBN two-frequency/JJ (/( AC/NN excitation/NN )/SYM three-electrode/JJ method/NN ,/, the/DT admittance/NN locus/NN plot/NN (/( ALP/NN )/SYM in/IN the/DT low-frequency/JJ region/NN (/( </SYM 1000/CD Hz/NN )/SYM has/VBZ been/VBN shown/VBP to/IN be/VB very/RB well/VB approximated/VBN by/IN a/DT straight/JJ line/NN and/CC can/MD be/VB described/VBN with/IN frequency-independent/JJ parameters/NNS ;/: phase/NN angle/NN alpha/NN pi/NN //NN 2/NN ,/, conductance/NN at/IN extrapolated/VBN zero/NN frequency/NN G0/NN =/SYM 1/CD //CD R0/CD ,/, and/CC ion/NN relaxation/NN time/NN tau/NN ./.
@@13138944681 A/DT rather/RB similar/JJ pattern/NN of/IN results/NNS was/VBD obtained/VBN with/IN respect/NN to/IN LMP2B/NEWGENE mRNA/NEWGENE expression/NN ,/, such/JJ transcripts/NNS being/VBP detectable/JJ only/RB in/IN a/DT subset/NN of/IN tumors/NNS ,/, and/CC then/RB at/IN apparently/RB low/JJ levels/NNS ./.
@@45800445037 Temporal/JJ relationships/NNS and/CC the/DT development/NN phase/NN affected/VBN ./.
@@76238075462 To/TO dissect/VB these/DT mechanisms/NNS ,/, wild-type/NN and/CC mutant/NEWGENE Raf-1/NEWGENE proteins/NEWGENE were/VBD studied/VBN in/IN an/DT in/NN vitro/FW system/NN with/IN purified/VBN plasma/NN membranes/NNS from/IN v-Ras-/JJ and/CC v-Src-transformed/JJ cells/NNS (/( transformed/VBN membranes/NNS )/SYM ./.
@@96472406230 The/DT influence/NN of/IN p53/NEWGENE on/IN cytokine-triggered/JJ Janus/NEWGENE kinase-STAT/NEWGENE signaling/NN was/VBD investigated/VBN in/IN human/JJ hepatoma/NN Hep3B/CELL cell/NN lines/NNS engineered/VBN to/IN constitutively/RB express/VBP the/DT temperature-sensitive/JJ Val135/NEWGENE mutant/NEWGENE of/NEWGENE p53/NEWGENE ./.
@@10628490449 Anatomy/NNS of/IN the/DT uterine/JJ artery/NN ./.
@@10867496681 Neurofibromatosis/NNS of/IN the/DT breast/NN in/IN a/DT patient/NN with/IN Morbus/NNP von/NNP Recklinghausen/NN ./.
@@115838805269 Endovascular/JJ aneurysm/NN repair/NN with/IN the/DT AneuRx/NN stent-graft/NN is/VBZ safe/JJ ,/, but/CC is/VBZ it/PRP effective/JJ ?/.
@@1086583848 Vascular/NEWGENE endothelial/NEWGENE growth/NEWGENE factor/NEWGENE (/( VEGF/NEWGENE )/SYM ,/, a/DT potent/JJ agonist/NN secreted/VBN by/IN virtually/RB all/DT cells/NNS ,/, controls/NNS migration/NN and/CC division/NN of/IN vascular/JJ endothelial/JJ cells/NNS ./.
@@87516356834 This/DT caused/VBN severe/JJ cortical/JJ damage/NN and/CC neuronal/JJ loss/NN in/IN hippocampus/NN subfields/NNS CA1/RB ,/, CA3/NN ,/, and/CC hilus/NN ./.
@@20346698571 Only/RB the/DT 3/CD ./CD 0-kb/CD transcript/NN was/VBD detected/VBN in/IN adult/JJ tissues/NNS ,/, where/CC its/PRP expression/NN was/VBD restricted/VBN almost/RB exclusively/RB to/IN the/DT central/JJ nervous/JJ system/NN ./.
@@13213374229 A/DT third/RB prominent/JJ component/NN of/IN apparent/JJ molecular/JJ mass/JJ 16/CD kDa/NN displayed/VBD several/DT properties/NNS ,/, including/JJ ability/NN to/IN bind/NN 45Ca2+/CD ,/, that/WDT are/VBP characteristic/NN of/IN the/DT regulatory/JJ (/( B/NNP )/SYM subunit/NN of/IN mammalian/NEWGENE calcineurin/NEWGENE and/CC was/VBD recognized/VBN by/IN an/DT antiserum/NN raised/VBN against/IN bovine/NEWGENE calcineurin/NEWGENE ./.
@@11038042876 Escalation/NN to/IN 180/CD mg/NN //NN m2/NN was/VBD to/IN be/VB carried/VBN out/RB if/IN white/JJ blood/NN cell/NN nadir/NN count/NN was/VBD >/SYM 2/CD ./CD 0/CD x/NN 10/NN (/NN 9/NN )/NN //NN l/NN and/CC platelet/NN nadir/NN count/NN was/VBD >/SYM 75/CD x/NN 10/NN (/NN 9/NN )/NN //NN l/NN ./.
@@31860917695 Change/NNP in/IN plasma/NEWGENE cystyl/NEWGENE aminopeptidase/NEWGENE (/( oxytocinase/NEWGENE )/SYM between/IN 30-34/JJ weeks'/NN gestation/NN as/IN a/DT predictor/NN of/IN pregnancy-induced/JJ hypertension/NN ./.
@@9852769842 Preflight/NNP ,/, inflight/JJ ,/, and/CC postflight/NN exercise/NN response/NN tests/NNS were/VBD conducted/VBN on/IN the/DT astronauts/NNS of/IN the/DT second/JJ Skylab/NNP mission/NN (/( Skylab/NNP 3/CD )/SYM as/IN part/NN of/IN an/DT evaluation/NN of/IN physiological/JJ adaptation/NN to/IN long-term/JJ weightlessness/NN ./.
@@9550919320 When/WRB data/NN were/VBD expressed/VBN in/IN a/DT cumulative/JJ manner/NN ,/, the/DT response/NN to/IN intravenous/JJ adenosine/NN 3/NN mg/NN ,/, 6/CD mg/NN ,/, 9/CD mg/NN and/CC 12/CD mg/NN in/IN the/DT 24/CD episodes/NNS of/IN PSVT/DT were/VBD 5/CD episodes/NNS (/( 21%/JJ )/SYM ,/, 16/CD episodes/NNS (/( 67%/JJ )/SYM ,/, 20/CD episodes/NNS (/( 83%/JJ )/SYM and/CC 20/CD episodes/NNS (/( 83%/JJ )/SYM respectively/RB ./.
@@48101314231 Letter/NNP :/: Aryl/NEWGENE hydrocarbon/NEWGENE hydroxylase/NEWGENE and/CC smoking/NN ./.
@@56840812857 Measurements/NNS of/IN activity/NN with/IN the/DT radioprotective/JJ chamber/NN VA-K-254/NN of/IN the/DT osimeter/NNP VA-J18/NNP ./.
@@77830642698 Serial/JJ followup/NN strength/NN data/NN for/IN 2/CD patients/NNS were/VBD compared/VBN to/IN change/NN in/IN creatinine/NEWGENE kinase/NEWGENE (/( CK/NEWGENE )/SYM levels/NNS ./.
@@112743576538 On/IN the/PDT other/DT hand/NN ,/, forced/JJ overexpression/NN of/IN the/DT wild/JJ type/NN ,/, but/CC not/RB the/DT kinase-inactivated/JJ mutant/NN of/IN nm23H1/NEWGENE ,/, converted/VBD the/DT GDP-bound/NNP forms/NNS of/IN Rac1/NEWGENE ,/, Cdc42/NEWGENE ,/, and/CC RhoA/NEWGENE to/IN their/PRP GTP-bound/NNP forms/NNS in/IN vitro/FW by/IN its/PRP nucleoside/NEWGENE diphosphate/NEWGENE kinase/NEWGENE activity/NN ,/, but/CC nm23H1/NEWGENE alone/RB apparently/RB did/VBD not/RB produce/VB the/DT GTP-bound/NNP form/NN of/IN these/DT GTPases/NEWGENE in/IN vivo/NN ./.
@@85618978229 Mobility/NN and/CC supershift/NN assays/NNS demonstrated/VBN that/IN upstream/NEWGENE stimulatory/NEWGENE factor/NEWGENE (/( USF/NEWGENE )/SYM and/CC Sp1/NEWGENE bind/VB to/IN the/DT former/JJ elements/NNS and/CC competition/NN experiments/NNS confirmed/VBN that/IN CREB/NEWGENE //NEWGENE ATF/NEWGENE and/CC AP-1/NEWGENE bind/VB to/IN the/DT CRE/NEWGENE //NEWGENE TRE/NEWGENE element/NEWGENE ./.
@@106840693747 The/DT results/NNS showed/VBN that/IN MIP/NN ,/, MMIF/NN ,/, FIC/NN ,/, Wimax/NN ,/, P0/NN ./NN 1/NN and/CC minute/JJ ventilation/NN (/( Vr/NN )/SYM were/VBD significantly/RB increased/VBN after/IN administration/NN of/IN methylphenidatum/NN and/CC aminophylline/NN ./.
@@31101197655 During/IN BH/NN the/DT ventilator/NN was/VBD disconnected/VBN and/CC a/DT bias/NN flow/NN of/IN 50%/CD O2/NN at/IN 4-5/CD l/NN //NN min/NN was/VBD delivered/VBN through/RB the/DT side/JJ ports/NNS of/IN a/DT small/JJ catheter/NN whose/WP tip/NN was/VBD positioned/VBN 1/CD cm/NN cephalad/RB of/IN the/DT carina/NN ./.
@@17486301695 Growth/NEWGENE factor/NEWGENE stimulation/NN of/IN cells/NNS causes/VBZ the/DT phosphorylation/NN of/IN the/DT c-Myc/NEWGENE transcriptional/NEWGENE activation/NEWGENE domain/NEWGENE at/IN Ser62/NN within/IN a/DT proline-rich/JJ region/NN that/WDT is/VBZ highly/RB conserved/VBN among/IN members/NNS of/IN the/DT Myc/NEWGENE family/NEWGENE (/( Alvarez/NNP ,/, E/NNP ./NNP ,/, Northwood/NNP ,/, I/NNS ./NNS C/NNS ./NNS ,/, Gonzalez/NNP ,/, F/NN ./NN
@@114106648030 In/NN this/DT report/NN this/DT technique/NN was/VBD applied/VBN to/IN human/JJ breast/NN carcinoma/NN MDA-MB231/NNP cells/NNS overexpressing/JJ human/NEWGENE MPG/NEWGENE in/IN order/NN to/IN assess/VB whether/IN up-regulation/NN of/IN the/DT initial/JJ step/NN in/IN BER/NN alters/VBZ the/DT activity/NN of/IN selected/VBN other/DT BER/NN (/( hOGG1/NEWGENE and/CC APE/NEWGENE //NEWGENE ref-1/NEWGENE )/SYM or/CC direct/JJ reversal/NN (/( MGMT/NEWGENE )/SYM repair/NN activities/NNS ./.
@@110427036691 When/WRB BFDS/NNP was/VBD taken/VBP as/IN the/DT reference/NN ,/, W/NN //NN A/NN Z/NN scores/NNS showed/VBD consistent/JJ positive/JJ increments/NNS ,/, from/IN birth/NN in/IN girls/NNS and/CC 1/CD mo/NN in/IN boys/NNS ./.
@@63142769989 Plasmids/NNS for/IN the/DT cloning/NN and/CC expression/NN of/IN full-length/JJ double-stranded/JJ cDNAs/NNS under/IN control/NN of/IN the/DT SV40/NEWGENE early/NEWGENE or/NEWGENE late/NEWGENE gene/NEWGENE promoter/NEWGENE ./.
@@10992983828 Regarding/VBG "the/NN relation/NN between/IN sexual/JJ orientation/NN and/CC penile/JJ size/NN ,/NN "/NN by/IN A/NNP ./NNP
@@13397731964 A/DT total/NN of/IN 281/CD patients/NNS were/VBD divided/VBN into/IN groups/NNS according/VBG to/IN their/PRP clinical/JJ diagnosis/NN and/CC were/VBD examined/VBN using/VBG capnography/NN ,/, spirometry/NN and/CC blood-gas/NN analysis/NN ./.
@@8621719859 A/DT substantial/JJ fraction/NN of/IN Cbl/NEWGENE was/VBD constitutively/RB associated/VBN with/IN Grb2/NEWGENE and/CC this/DT interaction/NN was/VBD mediated/JJ by/IN Grb2/NEWGENE SH3/NEWGENE domains/NEWGENE ./.
@@93432229601 The/DT AGM/NEWGENE and/NEWGENE NIH/NEWGENE //NEWGENE Swiss/NEWGENE mouse/NEWGENE CCR5/NEWGENE proteins/NEWGENE are/VBP 97/CD ./CD 7/CD to/IN 98/NN ./NN 3%/NN and/CC 79/NN ./NN 8%/NN identical/JJ to/IN the/DT human/JJ protein/NN ,/, respectively/RB ./.
@@103972571205 Mutagenesis/NNS of/IN the/DT CDE/NEWGENE //NEWGENE CHR/NEWGENE elements/NEWGENE and/CC Sp1/NEWGENE sites/NEWGENE in/IN this/DT region/NN ,/, alone/RB or/CC in/IN combination/NN ,/, reduced/VBN transcriptional/JJ activity/NN by/IN 40-60%/JJ in/IN asynchronously/RB growing/JJ cells/NNS and/CC abolished/VBN cell/NN cycle/NN periodicity/NN in/IN G2-M-synchronized/JJ cells/NNS ./.
@@80723522697 All/DT our/PRP patients/NNS had/VBP polyps/NNS ,/, 23/CD (/( 54%/JJ )/SYM had/VBP asthma/NN ,/, 12/CD (/( 27%/JJ )/SYM had/VBP aspirin/NN sensitivity/NN ,/, 20/CD (/( 65%/JJ )/SYM had/VBP eosinophilia/NN ,/, and/CC 9/CD (/( 69%/CD )/SYM had/VBP increased/VBN total/JJ IgE/NEWGENE levels/NNS ./.
@@8728040399 Differential/JJ activation/NN of/IN the/DT extracellular/NEWGENE signal-regulated/NEWGENE kinase/NEWGENE ,/, Jun/NEWGENE kinase/NEWGENE and/CC Janus/NEWGENE kinase-Stat/NEWGENE pathways/NNS by/IN oncostatin/NN M/NN and/CC basic/NEWGENE fibroblast/NEWGENE growth/NEWGENE factor/NEWGENE in/IN AIDS-derived/NN Kaposi's/NNP sarcoma/NN cells/NNS ./.
@@104005936964 By/IN contrast/NN ,/, PvirE/NEWGENE or/CC Plac/NEWGENE promoter/NEWGENE constructs/NEWGENE yielded/VBD functional/JJ VirE2/NEWGENE only/RB if/IN virE1/NEWGENE was/VBD coexpressed/VBN with/IN virE2/NEWGENE ./.
@@95715634741 PURPOSE/NNS :/: To/TO introduce/VB an/DT image/NN analysis/NN of/IN the/DT cornea/NN in/IN photorefractive/JJ keratectomy/NN (/( PRK/NN )/SYM for/IN preoperative/JJ and/CC early/JJ postoperative/JJ determination/NN of/IN changes/NNS in/IN the/DT condition/NN of/IN the/DT cornea/NN ./.
@@110241825000 Normal/JJ alpha1/NEWGENE (/NEWGENE I/NEWGENE )/NEWGENE collagen/NEWGENE mRNA/NEWGENE showed/VBD no/DT significant/JJ reduction/NN when/CC AR/NNS or/CC IR/NN was/VBD expressed/VBN from/IN the/DT pHbetaAPr-1-neo/JJ vector/NN and/CC a/DT small/JJ (/( 10-20%/JJ )/SYM but/CC significant/JJ reduction/NN when/CC either/DT ribozyme/NEWGENE was/VBD expressed/VBN from/IN the/DT pCI/CD ./CD neo/CD vector/NN ./.
@@20045213543 Patients/NNS with/IN apparently/RB minor/JJ CT/NN abnormalities/NNS may/MD have/VB significant/JJ epidural/JJ disease/NN ./.
@@40697564748 Diagnosis/NNP :/: progressive/JJ multifocal/JJ leukoencephalopathy/NN ./.
@@29381855346 Transformed/JJ cell/NN lines/NNS expressing/JJ solely/RB E1a/NEWGENE or/CC E1a/NEWGENE and/CC E1b/NEWGENE gene/NEWGENE products/NEWGENE derived/VBN from/IN these/DT viruses/NNS display/NN enhanced/VBD anchorage-independent/JJ growth/NN at/IN 37/CD degrees/NNS C/NN versus/IN 32/CD degrees/NNS C/NN and/CC display/VB a/DT cytoskeletal/JJ architecture/NN resembling/VBG untransformed/JJ fibroblastic/JJ CREF/NNP cells/NNS ./.
@@30648111026 The/DT amino/JJ acid/NN sequence/NN of/IN the/DT S/NNP ./NNP aureus/NN peptide/NN carrying/JJ the/DT phosphoryl/NN group/NN was/VBD found/VBN to/IN be/VB Gln-Val-Val-Ser-Thr-Phe-Met-Gly-Asn-Gly-Leu-Ala-Ile-Pro-His-Gly-Thr-Asp-/NEWGENE Asp/NEWGENE ./.
@@95064392335 PKC-gamma/NEWGENE ,/, which/WDT is/VBZ not/RB present/VB in/IN keratinocytes/NNS ,/, also/RB induces/VBZ involucrin/NEWGENE gene/NEWGENE expression/NN in/IN a/DT TPA-independent/NNP manner/NN ,/, when/CC introduced/VBD into/IN SVHK/NNP cells/NNS ./.
@@84465796136 The/DT exogenous/JJ fos/NEWGENE gene/NEWGENE was/VBD rapidly/RB induced/VBN to/IN maximal/JJ levels/NNS within/IN 1-2/CD hr/NN of/IN estrogen/NN addition/NN ./.
@@107068873037 In/NN addition/NN ,/, expected/VBN decreases/NNS in/IN ATIC/NEWGENE enzymatic/JJ function/NN in/IN ATIC-ALK-containing/JJ lymphomas/NNS may/MD render/VB these/DT tumors/NNS more/RB sensitive/JJ to/IN antifolate/NN drugs/NNS such/JJ as/IN methotrexate/NN ./.
@@14234542043 Examination/NN of/IN ANCA/NN is/VBZ not/RB only/RB a/DT significant/JJ contribution/NN towards/IN a/DT more/RB accurate/JJ diagnosis/NN of/IN renal/JJ vasculitis/NN ,/, but/CC also/RB an/DT indicator/NN of/IN the/DT activity/NN of/IN the/DT disease/NN and/CC thus/RB of/IN the/DT effectiveness/NN of/IN immunosuppressive/JJ treatment/NN ./.
@@114732547077 NaeI/NEWGENE ,/, a/DT novel/JJ DNA/NEWGENE endonuclease/NEWGENE ,/, shows/VBZ topoisomerase/NEWGENE and/CC recombinase/NEWGENE activities/NNS when/CC a/DT Lys/NN residue/NN is/VBZ substituted/JJ for/IN Leu/NN 43/CD ./CD
@@78761915856 Expression/NNS of/IN class/NEWGENE IV/NEWGENE ADH/NEWGENE mRNA/NEWGENE was/VBD detected/VBN in/IN human/JJ stomach/NN but/CC not/RB liver/NN ./.
@@74280377791 Within/IN the/DT 3'/CD terminal/NN 50/NN nucleotides/NN ,/, the/DT mouse/NEWGENE mt/NEWGENE 12S/NEWGENE rRNA/NEWGENE contains/VBZ a/DT potential/JJ 10/CD bp/NN hairpin/NN structure/NN and/CC a/DT sequence/NN of/IN 15/CD consecutive/JJ nucleotides/NNS common/JJ to/IN the/DT RNA/NN of/IN the/DT small/JJ ribosomal/JJ subunit/NN in/IN all/DT systems/NNS ,/, but/CC does/VBP not/RB contain/VB the/DT mRNA/NN binding/JJ site/NN (/( ACCUCC/NEWGENE )/SYM found/VB in/IN E/NNP ./NNP coli/NN and/CC corn/NN chloroplast/NN rRNAs/NNS ./.
@@10449072298 The/DT second/JJ goal/NN was/VBD to/IN ascertain/VB the/DT somatotopic/JJ arrangement/NN of/IN the/DT GPi/NN in/IN PD/NNP ./NNP
@@109199713727 In/NN addition/NN to/IN its/PRP effect/NN in/IN augmenting/JJ the/DT neutrophil/JJ response/NN to/IN eccentric/JJ exercise/NN ,/, vitamin/NN E/NN causes/VBZ a/DT greater/JJR increase/NN in/IN circulating/JJ creatine/NEWGENE kinase/NEWGENE activity/NN ,/, perhaps/RB indicating/VBG increased/VBN skeletal/JJ muscle/NN repair/NN ./.
@@78738767223 The/DT NR2/NN hybrid/NN is/VBZ a/DT powerful/JJ tool/NN for/IN the/DT mapping/NN of/IN new/JJ probes/NNS of/IN this/DT region/NN ,/, as/RB well/VB as/IN for/IN obtaining/JJ new/JJ informative/JJ probes/NNS specific/JJ for/IN the/DT deletion/NN by/IN subtractive/JJ cloning/NN of/IN the/DT region/NN ./.
@@82882404263 The/DT sequence/NN similarity/NN has/VBZ suggested/VBN that/IN SCG10/NEWGENE and/CC stathmin/NEWGENE have/NN been/VBN derived/VBN from/IN structurally/RB and/CC evolutionarily/RB related/VBN genes/NNS ./.
@@1581577784 PSI-G/NEWGENE and/CC PSI-K/NEWGENE probably/RB have/VB evolved/VBN from/IN a/DT gene/NN duplication/NN of/IN an/DT ancestral/JJ gene/NN ./.
@@91503349100 Each/DT sample/NN was/VBD analysed/VBN as/RB soon/RB as/IN possible/JJ ,/, and/CC repeated/JJ 15/CD ,/, 30/CD ,/, 60/CD and/CC 120/CD min/NN after/IN sampling/NN ./.
@@95198285965 Chimaeric/NEWGENE VP16-E2/NEWGENE molecules/NEWGENE suggest/VBP that/IN the/DT epithelial/JJ specific/JJ transcriptional/JJ activation/NN of/IN the/DT BPV-4/NN LCR/NN promoter/NN is/VBZ mediated/JJ by/IN the/DT E2/NEWGENE transactivation/NEWGENE domain/NEWGENE ./.
@@91266221179 The/DT pigment/NN intensity/NN of/IN both/DT melanized/VBN colonies/NNS and/CC appressoria/NN of/IN CAL/NN transformants/NNS was/VBD weaker/JJR than/IN that/DT of/IN the/DT wild/JJ type/NN ./.
@@90458428205 Mutations/NNS in/IN the/DT alpha/NEWGENE and/NEWGENE sigma-70/NEWGENE subunits/NEWGENE of/NEWGENE RNA/NEWGENE polymerase/NEWGENE affect/NN expression/NN of/IN the/DT mer/NEWGENE operon/NEWGENE ./.
@@49769882871 Heterogeneity/NNS of/IN human/NEWGENE serum/NEWGENE albumin/NEWGENE ./.
@@15877632177 Total/JJ body/NN irradiation/NN was/VBD delivered/VBN according/VBG to/IN a/DT hyperfractionated/JJ scheme/NN of/IN 12/CD fractions/NNS given/VBP three/CD per/IN day/NN 5/CD hr/NN apart/RB for/IN 4/CD days/NNS ./.
@@76918372489 This/DT 300/CD bp/NN 5'-upstream/CD sequence/NN of/IN K3/NEWGENE keratin/NEWGENE gene/NEWGENE ,/, which/WDT can/MD function/VB in/RB vitro/FW as/IN a/DT keratinocyte-specific/NN promoter/NN ,/, contains/VBZ two/JJ clusters/NNS of/IN partially/RB overlapping/JJ motifs/NNS ,/, one/PRP with/IN an/DT NFkB/NEWGENE consensus/NN sequence/NN and/CC another/DT with/IN a/DT GC/NN box/NN ./.
@@59017785812 The/DT effect/NN of/IN feeding/JJ patterns/NNS on/IN fat/JJ deposition/NN in/IN mice/NNS ./.
@@14298368130 A/DT mutant/JJ form/NN of/IN Vps1p/NEWGENE lacking/VBG the/DT entire/JJ GTP-binding/NN domain/NN interfered/VBN with/IN vacuolar/JJ protein/NN sorting/JJ in/IN wild-type/NN cells/NNS ./.
@@80149198010 Both/DT proprioceptive/JJ and/CC electroreceptive/JJ units/NNS showed/VBD a/DT progression/NN of/IN receptive/JJ fields/NNS from/IN anterior/JJ to/IN posterior/JJ body/NN in/IN the/DT rostral/JJ to/IN caudal/JJ direction/NN along/IN the/DT length/NN of/IN DGR/NN ./.
@@11368911740 Molecular/NNP identification/NN of/IN smg-4/NEWGENE ,/, required/VBN for/IN mRNA/NN surveillance/NN in/IN C/NNP ./NNP elegans/NNS ./.
@@105800711592 Of/IN these/DT patients/NNS ,/, 46/CD ,/CD 164/CD were/VBD placed/VBN on/IN a/DT waiting/JJ list/NN for/IN transplantation/NN ,/, 23/NN ,/NN 275/NN of/IN whom/WP received/VBD a/DT first/JJ cadaveric/JJ transplant/NN between/IN 1991/CD and/CC 1997/CD ./.
@@76312671030 Radiotherapy/NNS and/CC early/JJ orchiectomy/NN in/IN stage/NN D1/NN prostatic/JJ carcinoma/NN ./.
@@100943143354 Interestingly/RB ,/, the/DT RNA/NN sequences/NNS selected/VBN by/IN the/DT mutated/JJ zinc/NEWGENE knuckle/NEWGENE 9G8/NEWGENE variant/NEWGENE are/VBP efficiently/RB recognized/VBN by/IN SRp20/NEWGENE ,/, in/IN agreement/NN with/IN the/DT fact/NN that/IN the/DT RBD/NNS of/IN 9G8/NEWGENE and/CC SRp20/NEWGENE are/VBP similar/JJ ./.
@@86258067968 Krox-20/NEWGENE ,/, a/DT zinc/NN finger/NN gene/NN ,/, has/VBZ a/DT highly/RB conserved/VBN pattern/NN of/IN expression/NN in/IN r3/NEWGENE and/CC r5/NEWGENE and/CC is/VBZ functionally/RB required/VBN for/IN their/PRP maintenance/NN in/IN mouse/NN embryos/NNS ./.
@@81147452566 These/DT results/NNS illustrate/VBP an/DT important/JJ role/NN for/IN La/NEWGENE in/IN RNA/NN production/NN by/IN demonstrating/VBG its/PRP ability/NN to/IN clear/NN the/DT termination/NN sites/NNS of/IN class/NEWGENE III/NEWGENE templates/NEWGENE ,/, thereby/RB promoting/JJ efficient/JJ use/NN of/IN transcription/NN complexes/NNS by/IN pol/NEWGENE III/NEWGENE ./.
@@2689439213 The/DT cytosolic/JJ glutathione/NEWGENE S-transferases/NEWGENE (/( GSTs/NEWGENE ,/, EC/NN 2/CD ./CD 5/CD ./CD 1/CD ./CD 18/CD )/SYM are/VBP a/DT superfamily/NN of/IN dimeric/NN isoenzymes/NN which/WDT catalyze/VBP the/DT conjugation/NN of/IN electrophilic/JJ substrates/NNS with/IN glutathione/NN ./.
@@10701534514 The/DT patient/NN had/VBP developed/VBN left-sided/JJ low-frequency/JJ tremor/NN and/CC hemidystonia/NN after/IN a/DT severe/JJ head/JJ trauma/NN sustained/JJ at/IN 15/CD years/NNS of/IN age/NN ./.
@@87338818989 Full/JJ thyroid/JJ function/NN testing/NN was/VBD performed/VBN on/IN 600/CD randomly/RB selected/VBN samples/NNS with/IN normal/JJ TSH/NEWGENE values/NNS and/CC also/RB on/IN subjects/NNS with/IN abnormal/JJ TSH/NEWGENE levels/NNS ./.
@@88399118817 17/CD ./CD 5%/CD of/IN cycles/NN )/NN ./.
@@95287844184 The/DT mei4+/NEWGENE gene/NEWGENE of/IN the/DT fission/NN yeast/NN Schizosaccharomyces/NN pombe/NN was/VBD cloned/VBN by/IN functional/JJ complementation/NN ./.
@@7680629864 Molecular/NNP cloning/NN and/CC characterization/NN of/IN two/JJ genes/NEWGENE encoding/NEWGENE gp138/NEWGENE ,/, a/DT cell/NN surface/NN glycoprotein/NN involved/VBN in/IN the/DT sexual/JJ cell/NN fusion/NN of/IN Dictyostelium/DT discoideum/JJ ./.
@@79568697942 Routinely/RB collected/VBN ,/, processed/VBN and/CC stored/VBN breast/NN cancer/NN tissue/NN blocks/NNS recovered/VBN from/IN the/DT archives/NN of/IN the/DT Pathology/NNP laboratory/NN in/IN Dar/JJ es/NNS Salaam/FW after/IN storage/NN of/IN up/JJ to/IN 3/CD years/NNS were/VBD analysed/VBN by/IN a/DT flow/NN cytometry/NN for/IN DNA/NN ploidy/NN and/CC S-phase/NN fraction/NN ./.
@@69752066764 The/DT daily/JJ administration/NN of/IN betamethasone/NN for/IN three/CD weeks/NNS markedly/RB reduced/VBN the/DT absorption/NN of/IN calcium/NN and/CC phosphate/NN as/RB well/VB as/IN the/DT growth/NN rate/NN ./.
@@63166236107 Overall/JJ prevalences/NNS of/IN antibody/NN were/VBD 70/CD per/IN cent/NN in/IN cattle/NNS ,/, 67/CD per/IN cent/NN in/IN sheep/NN and/CC 76/CD per/IN cent/NN in/RB goats/NNS as/IN assessed/VBN by/IN an/DT immunodiffusion/NN test/NN ./.
@@18101542420 So/RB far/RB 15/CD children/NNS have/VBP been/VBN studied/VBN ./.
@@95519726524 Fluorescence/NN in/IN situ/NN hybridization/NN of/IN metaphase/NN spreads/VBP of/IN chromosome/NN 8/CD ,/, containing/JJ hybrid/JJ cell/NN line/NN 706-B6/NN clone/NN 17/NN (/( CL-17/NN )/SYM with/IN cosmid/NN c101F1/NN ,/, placed/VBD the/DT 9804/NEWGENE gene/NEWGENE close/JJ to/IN the/DT telomere/NN at/IN 8q24/CD ./CD 3/CD ./.
@@36277204435 Typical/JJ and/CC atypical/JJ clinical/JJ features/NNS of/IN this/DT lacrimal/JJ sac/NN cyst/NN are/VBP emphasized/VBN ./.
@@75283259111 Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN the/DT activated/VBN GH/NEWGENE receptor/NEWGENE can/MD stimulate/VB Stat1/NEWGENE ,/, a/DT cytoplasmic/JJ transcription/NN factor/NN that/WDT becomes/VBZ tyrosine/NN phosphorylated/VBN and/CC translocates/VBZ to/IN the/DT nucleus/NN ,/, where/CC it/PRP can/MD interact/VB with/IN specific/JJ DNA/NN sequences/NNS to/IN modulate/VB gene/NN expression/NN ./.
@@29858205782 Different/JJ sequence/NN elements/NNS of/IN both/PDT the/DT retroviral/NN vectors/NN and/CC the/DT c-myc/NEWGENE gene/NEWGENE recombined/VBN during/IN genesis/NN of/IN highly/RB oncogenic/JJ retroviruses/NNS CMII/ORG ,/, MC29/NN ,/, or/CC MH2/NN ./.
@@91691273418 The/DT close/JJ proximity/NN of/IN the/DT two/JJ neuropeptide/NEWGENE Y/NEWGENE receptor/NEWGENE genes/NEWGENE suggests/VBZ that/IN they/PRP have/VBP evolved/VBN from/IN a/DT gene/NN duplication/NN event/NN with/IN the/DT small/JJ intron/NN interrupting/VBG the/DT coding/JJ sequence/NN of/IN the/DT y1/NEWGENE gene/NEWGENE being/VBP converted/VBN into/IN a/DT functional/JJ sequence/NN within/IN the/DT y5/NEWGENE gene/NEWGENE ,/, while/CC the/DT reverse/JJ complementary/JJ sequence/NN was/VBD utilized/VBN as/IN an/DT alternatively/RB spliced/VBN 5'/CD exon/NN for/IN the/DT y1/NEWGENE gene/NEWGENE ./.
@@61634332935 Effect/NN of/IN 2-/NN (/NN p-chlorophenyl/NN )/NN cyclopropylamine/NN on/IN 5-hydroxyindole/CD concentration/NN and/CC monoamine/NEWGENE oxidase/NEWGENE activity/NN in/IN rat/NN brain/NN ./.
@@99717769477 Mutations/NNS affecting/VBG only/JJ CD4/NEWGENE regulation/NN mapped/VBN to/IN residues/NNS previously/RB shown/VBP to/IN mediate/VB the/DT binding/NN of/IN Nef/NEWGENE to/IN this/DT receptor/NN ,/, such/JJ as/IN W57/NNP and/CC L58/NNP ,/, as/RB well/VB as/IN to/IN an/DT AP-recruiting/NEWGENE dileucine/NEWGENE motif/NEWGENE and/CC to/IN an/DT acidic/NN dipeptide/NN in/IN the/DT C-terminal/NN region/NN of/IN the/DT protein/NN ./.
@@21185194551 Furthermore/RB ,/, we/PRP notice/VBP two/JJ potential/JJ consensus/NN motifs/NNS which/WDT are/VBP also/RB found/VB in/IN corresponding/JJ positions/NNS in/IN the/DT genes/NNS for/IN the/DT nerve/NEWGENE growth/NEWGENE factor/NEWGENE receptor/NEWGENE and/CC the/DT 68-kDa/NEWGENE neurofilament/NEWGENE protein/NEWGENE ./.
@@7374227214 Pathogens/NNS (/( Staphylococcus/NN aureus/NN or/CC Gram-negative/JJ bacilli/NNS )/SYM were/VBD isolated/VBN from/IN only/RB one/PRP member/NN of/IN staff/NN in/IN small/JJ numbers/NNS and/CC irregularly/RB and/CC rarely/RB in/IN large/JJ numbers/NNS from/IN patients/NNS ./.
@@94180403043 Mg-chelatase/NEWGENE of/IN tobacco/NN :/: identification/NN of/IN a/DT Chl/NEWGENE D/NEWGENE cDNA/NEWGENE sequence/NEWGENE encoding/VBG a/DT third/JJ subunit/NN ,/, analysis/NN of/IN the/DT interaction/NN of/IN the/DT three/CD subunits/NNS with/IN the/DT yeast/NN two-hybrid/JJ system/NN ,/, and/CC reconstitution/NN of/IN the/DT enzyme/NN activity/NN by/IN co-expression/NN of/IN recombinant/NEWGENE CHL/NEWGENE D/NEWGENE ,/, CHL/NEWGENE H/NEWGENE and/CC CHL/NEWGENE I/NEWGENE ./.
@@27568783455 The/DT nature/NN of/IN the/DT process/NN formed/VBN by/IN the/DT successive/JJ occurrences/NNS of/IN this/DT arrhythmia/NN was/VBD studied/VBN in/IN 8/CD patients/NNS with/IN a/DT history/NN of/IN symptomatic/JJ paroxysmal/JJ AF/NNP ./NNP
@@15295306137 Interferon-alpha-induced/NN gene/NN expression/NN :/: evidence/NN for/IN a/DT selective/JJ effect/NN of/IN ouabain/NN on/IN activation/NN of/IN the/DT ISGF3/NEWGENE transcription/NEWGENE complex/NEWGENE ./.
@@15458069528 Molecular/NNP and/CC genetic/JJ analysis/NN of/IN the/DT yeast/NEWGENE early/NEWGENE meiotic/NEWGENE recombination/NEWGENE genes/NEWGENE REC102/NEWGENE and/CC REC107/NEWGENE //NEWGENE MER2/NEWGENE ./.
@@32822323746 Antibodies/NNS made/VBP against/IN fusion/NN protein/NN produced/VBN by/IN the/DT DP1A/NEWGENE clone/NN reacted/VBN specifically/RB with/IN DP-I/NEWGENE and/NEWGENE -II/NEWGENE on/IN immunoblots/NNS ./.
@@89890258943 When/WRB voltage-operated/JJ Ca2+/NN channels/NNS (/( VOC/NN )/SYM were/VBD blocked/VBN by/IN nifedipine/NN ,/, midazolam/NN ,/, in/IN concentrations/NNS more/RB than/IN 1/CD microM/NN ,/, attenuated/VBN both/DT phasic/JJ and/CC tonic/JJ responses/NNS ./.
@@83317289141 Binding/NN of/IN U2/NEWGENE small/NEWGENE nuclear/NEWGENE ribonucleoprotein/NEWGENE was/VBD partially/RB inhibited/VBN ./.
@@9617119586 Hematology/NNS problem/NN of/IN the/DT month/NN :/: band/NN or/CC seg/VB ?/.
@@8654390261 Heme/NEWGENE oxygenase/NEWGENE 1/NEWGENE is/VBZ an/DT essential/JJ enzyme/NN in/IN heme/NN catabolism/NN that/WDT cleaves/VBZ heme/NN to/IN form/NN biliverdin/NN ,/, iron/NN ,/, and/CC carbon/NN monoxide/NN ./.
@@2780157407 The/DT characteristic/JJ feature/NN of/IN liver/NN and/CC spleen/NN MP/NN function/NN in/IN patients/NNS with/IN VHA/NN associated/VBN with/IN HBsAg/NEWGENE carriership/NN consisted/VB in/IN the/DT lack/NN of/IN the/DT compensatory/JJ reaction/NN on/IN the/DT part/NN of/IN spleen/NN MP/NN ,/, which/WDT was/VBD likely/RB to/IN be/VB connected/VBN with/IN overstrain/NN of/IN long/JJ standing/NN and/CC depletion/NN of/IN the/DT MP/NN system/NN due/NN to/IN permanent/JJ antigenic/JJ stimulation/NN of/IN HBsAg/NEWGENE ./.
@@109038374960 Since/IN the/DT RINX/NEWGENE gene/NEWGENE is/VBZ likely/RB an/DT ortholog/NN of/IN the/DT goldfish/NEWGENE Vsx1/NEWGENE gene/NEWGENE ,/, it/PRP has/VBZ been/VBN named/VBN VSX1/NEWGENE by/IN the/DT Human/NNP Gene/NNP Nomenclature/NNP Committee/NNP ./.
@@63085366091 The/DT hepatitis/NEWGENE A/NEWGENE virus/NEWGENE antibody/NEWGENE (/( anti-HAV/NEWGENE )/SYM in/IN chronic/JJ diffuse/JJ liver/NN diseases/NNS ./.
@@11024300217 Nature/NNP 398/CD ,/, 828-830/NN )/NN that/IN the/DT amino/JJ acid/NN sequences/NNS of/IN peptide/NN fragments/NNS obtained/VBN from/IN a/DT polypeptide/NN found/VB in/IN a/DT complex/NN of/IN proteins/NNS that/WDT alters/VBZ chromatin/NN structure/NN (/( ARC/NEWGENE )/SYM are/VBP identical/JJ to/IN portions/NNS of/IN the/DT deduced/VBN open/JJ reading/JJ frame/NN of/IN TIG-1/NEWGENE mRNA/NEWGENE ./.
@@30145933250 Diazepam/IN (/( 3/CD mg/CD //CD kg/CD )/SYM generalized/JJ to/IN Ro/NN 11-6896/CD whereas/IN the/DT structurally/RB related/VBN Ro/NN 5-4864/JJ (/( 3/CD mg/CD //CD kg/CD and/CC 30/CD mg/CD //CD kg/CD )/SYM did/VBD not/RB ./.
@@113740511213 Additional/JJ factors/NNS such/JJ as/IN advanced/JJ age/NN ,/, concomitant/JJ use/NN of/IN corticosteroids/NNS or/CC anticoagulants/NNS ,/, prior/NN ulcer/NN complications/NNS and/CC co-morbid/JJ diseases/NNS may/MD further/RB increase/VB the/DT risk/NN of/IN bleeding/NN ./.
@@12953734585 The/DT magnitude/NN of/IN the/DT early/JJ response/NN was/VBD 241/CD +/NN //NN -/NN 51%/JJ in/IN A/DT (/( %/NN baseline/NN RL/NN ;/: mean/JJ +/NN //NN -/NN SE/NN )/SYM ,/, and/CC significantly/RB less/PRP in/IN B/NN (/NN 119/NN +/NN //NN -/NN 7%/NN )/NN and/CC C/NN (/NN 131/NN +/NN //NN -/NN 16%/NN )/NN (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM ./.
@@14082192023 In/NN the/DT eight/CD patients/NNS with/IN persistent/JJ generalized/JJ lymph-adenopathy/JJ (/( PGL/NN )/SYM and/CC nontender/JJ ,/, nonenlarging/JJ nodes/NNS ,/, pathologic/JJ analysis/NN revealed/VBD lymphoid/JJ hyperplasia/NN ./.
@@25432263186 We/PRP conclude/VBP that/IN (/( a/DT )/SYM the/DT likelihood/NN of/IN detecting/JJ carcinoma/NN or/CC atypical/JJ hyperplasia/NN exclusively/RB in/IN the/DT adipose/JJ tissue/NN component/NN of/IN grossly/RB benign/JJ breast/NN biopsies/NNS is/VBZ extremely/RB low/JJ ,/, and/CC (/( b/NN )/SYM a/DT possible/JJ cost-effective/JJ method/NN of/IN sampling/JJ grossly/RB benign/JJ breast/NN biopsies/NNS consists/VBZ of/IN initially/RB submitting/VBG a/DT maximum/NN of/IN 10/CD blocks/NNS of/IN fibrous/JJ parenchyma/NN for/IN each/DT case/NN ,/, then/RB examining/VBG the/DT remaining/JJ tissue/NN histologically/RB only/RB if/IN carcinoma/NN or/CC atypical/JJ hyperplasia/NN is/VBZ found/VBN among/IN these/DT blocks/NNS ./.
@@10400712811 Simian/JJ parainfluenza/NN virus/NN 5/CD (/( SV5/NN )/SYM is/VBZ a/DT prototype/NN of/IN the/DT Paramyxoviridae/NNP family/NN of/IN nonsegmented/JJ negative-sense/JJ RNA/NN viruses/NNS ./.
@@112712973645 Nephrotoxicity/NNS after/IN orthotopic/JJ liver/NN transplantation/NN in/IN cyclosporin/NN A/NN and/CC FK/NN 506-treated/JJ patients/NNS ./.
@@118582561744 Despite/IN considerable/JJ research/NN ,/, an/DT explanation/NN of/IN this/DT effect/NN has/VBZ been/VBN elusive/JJ ./.
@@20547545591 The/DT standard/JJ principles/NNS of/IN surgical/JJ management/NN must/MD be/VB adhered/VBN to/IN when/CC using/VBG Sandostatin/NN to/IN treat/NN patients/NNS with/IN these/DT disorders/NNS ./.
@@47597224993 Polycythemia-1973/NN ./.
@@110141973280 From/IN two/CD inhibitor/NN scaffolds/NNS ,/, we/PRP have/VBP identified/VBN potent/JJ and/CC selective/JJ inhibitors/NNS for/IN sensitized/VBN kinases/NEWGENE from/IN five/CD distinct/JJ subfamilies/NNS ./.
@@112098141885 The/DT purpose/NN of/IN this/DT investigation/NN was/VBD to/IN study/NN the/DT morphological/JJ characteristics/NNS of/IN the/DT fibrous/JJ tissue/NN capsule/NN resulting/JJ from/IN the/DT implantation/NN of/IN aluminum/NN calcium/NN phosphate/NN (/( ALCAP/NN )/SYM and/CC hydroxyapetite/NN (/( HA/NN )/SYM bioceramics/NNS ./.
@@18517567462 Biol/NNP ./.
@@107609505991 A/DT distinct/JJ staining/NN pattern/NN for/IN the/DT N-utrophin/NEWGENE was/VBD not/RB detectable/JJ ,/, although/IN it/PRP was/VBD expected/VBN to/IN localise/VB at/IN the/DT actin/NEWGENE stress/NN fibers/NNS ./.
@@17797696147 The/DT sequence/NN of/IN the/DT repressor/NN locus/NN ,/, c/NN ,/, of/IN the/DT Streptomyces/JJ temperate/JJ phage/NN ,/, phi/NN C31/NN ,/, was/VBD shown/VBP previously/RB to/IN contain/VB an/DT open/JJ reading/JJ frame/NN encoding/VBG a/DT 74/NN kDa/NN protein/NN ./.
@@66481566380 Introductory/JJ remarks/NNS ./.
@@93829247020 Accumulated/JJ evidence/NN indicates/VBZ that/IN ,/, upon/IN stimulation/NN with/IN interferon-gamma/NEWGENE (/( IFN-gamma/NEWGENE )/SYM ,/, three/CD beta-type/NN subunits/NN ,/, designated/VBN LMP2/NEWGENE ,/, LMP7/NEWGENE ,/, and/CC PSMB10/NEWGENE ,/, are/VBP incorporated/VBN into/IN the/DT 20S/NEWGENE proteasome/NEWGENE by/IN displacing/JJ the/DT housekeeping/NN beta-type/NN subunits/NN designated/VBD PSMB6/NEWGENE ,/, PSMB5/NEWGENE ,/, and/CC PSMB7/NEWGENE ,/, respectively/RB ./.
@@90651709015 The/DT addition/NN of/IN zidovudine/NN did/VBD not/RB influence/VB this/DT transfer/NN ./.
@@96584052911 The/DT Dax-1/NEWGENE gene/NEWGENE encodes/VBZ a/DT protein/NN that/WDT is/VBZ structurally/RB related/VBN to/IN members/NNS of/IN the/DT orphan/NEWGENE nuclear/NEWGENE receptor/NEWGENE superfamily/NEWGENE ./.
@@107042854976 Human/NEWGENE AP-2rep/NEWGENE repressed/VBN both/DT reporter/NN expression/NN from/IN a/DT transiently/RB transfected/VBN AP-2alpha/NEWGENE promoter/NEWGENE and/CC the/DT endogenous/JJ AP-2alpha/NEWGENE gene/NEWGENE and/CC inversely/RB was/VBD negatively/RB regulated/VBN by/IN AP-2alpha/NEWGENE ./.
@@113524238274 The/DT radial/JJ forearm/NN flap/NN is/VBZ used/VBN most/RB commonly/RB ,/, however/RB the/DT lateral/JJ arm/NN flap/NN may/MD be/VB the/DT flap/NN of/IN choice/JJ in/IN certain/JJ situations/NNS ./.
@@82620544261 Similarly/RB ,/, the/DT N-terminal/NN cytoplasmic/JJ domain/NN of/IN the/DT latent/NEWGENE membrane/NEWGENE protein/NEWGENE 2A/NEWGENE (/( LMP2A/NEWGENE )/SYM of/IN the/DT Epstein-Barr/NNP virus/NN (/( EBV/NN )/SYM contains/VBZ a/DT single/JJ copy/NN of/IN the/DT Tyr-X-X-Leu/NEWGENE //NEWGENE Ile-containing/NEWGENE motif/NEWGENE which/WDT could/MD play/VB a/DT critical/JJ role/NN in/IN B/NNP cell/NN transformation/NN ./.
@@110350373288 The/DT N-terminal/NN small/NN segment/NN of/IN yeast/NEWGENE TAF145/NEWGENE (/( yTAF145/NEWGENE )/SYM binds/VBZ to/IN TBP/NEWGENE and/CC thereby/RB inhibits/VBZ TBP/NEWGENE function/NN ./.
@@110597863590 VEGF/NEWGENE promoter/NEWGENE activity/NN in/IN transient/JJ transfections/NNS was/VBD decreased/VBN by/IN either/DT pharmacological/JJ or/CC genetic/JJ inhibition/NN of/IN EGFR/NEWGENE ,/, Ras/NEWGENE ,/, or/CC phosphatidylinositol/NEWGENE 3'-kinase/NEWGENE [/NEWGENE1 PI/NEWGENE1 (/NEWGENE1 3/NEWGENE1 )/NEWGENE1 kinase/NEWGENE1 ]/NEWGENE1 ./.
@@108728314898 A/DT murine/RB expressed/VBN sequence/NN tag/NN (/( EST/NN )/SYM showing/VBG homology/NN with/IN erythropoietin/NEWGENE receptor/NEWGENE (/( EPOR/NEWGENE )/SYM was/VBD identified/VBN in/IN the/DT EST/NN database/NN ./.
@@98281378390 The/DT Schizosaccharomyces/NEWGENE pombe/NEWGENE rad1+/NEWGENE cell/NEWGENE cycle/NEWGENE checkpoint/NEWGENE control/NEWGENE gene/NEWGENE is/VBZ required/VBN for/IN S-phase/NN and/CC G2/NN //NN M/NN arrest/NN in/IN response/NN to/IN both/DT DNA/NN damage/NN and/CC incomplete/JJ DNA/NN replication/NN ./.
@@27460993437 The/DT mobility/NN of/IN the/DT upper/JJ and/CC lower/JJR premolars/NNS under/IN load/NN was/VBD investigated/VBN in/IN relation/NN to/IN the/DT interproximal/JJ contact/NN and/CC occlusal/JJ facets/NNS ./.
@@80357968485 32Pi/CD labeling/VBG or/CC isoelectric/JJ focusing/NN analysis/NN of/IN eIF-2/NEWGENE alpha/NEWGENE from/IN conditional/JJ casein/NEWGENE kinase/NEWGENE II/NEWGENE mutants/NEWGENE indicated/VBD that/DT phosphorylation/NN of/IN eIF-2/NEWGENE alpha/NEWGENE is/VBZ abolished/VBN or/CC dephosphorylated/VBN forms/NNS of/IN eIF-2/NEWGENE alpha/NEWGENE are/VBP detected/VBN when/CC these/DT strains/NNS are/VBP grown/VBP at/IN the/DT restrictive/JJ growth/NN conditions/NNS ./.
@@90381669008 Exons/NNP A1a/NN and/CC A1b/NN are/VBP separated/VBN from/IN each/DT other/DT by/IN a/DT 124-nucleotide/JJ intron/NN ./.
@@17340205425 Immunostaining/NN of/IN cells/NNS transfected/VBN with/IN these/DT constructs/NNS revealed/VBN that/IN both/PDT the/DT myristoylated/JJ and/CC nonmyristoylated/JJ mutants/NNS were/VBD localized/VBN in/IN nuclei/NNS ,/, whereas/IN wild-type/NEWGENE PKC/NEWGENE alpha/NEWGENE was/VBD primarily/RB cytoplasmic/JJ and/CC perinuclear/JJ ./.
@@23269469245 Plasma/NEWGENE lecithin/NEWGENE //NEWGENE cholesterol/NEWGENE acyltransferase/NEWGENE (/( LCAT/NEWGENE )/SYM activity/NN in/IN multiple-organ/JJ donors/NNS :/: a/DT predictor/NN of/IN allograft/NN viability/NN in/IN clinical/JJ liver/NN transplantation/NN ./.
@@93901831948 Western/JJ blot/NN analysis/NN of/IN various/JJ bovine/JJ tissues/NNS with/IN human/NN NMT/NEWGENE peptide/NEWGENE antibody/NEWGENE indicated/VBD a/DT common/JJ prominent/JJ immunoreactive/JJ band/NN with/IN an/DT apparent/JJ molecular/JJ mass/NN of/IN 48/CD ./CD 5-50/CD kDa/NN in/IN all/DT tissues/NNS ./.
@@20216306109 These/DT differences/NNS involve/VBP specific/JJ hydrogen-bonding/NN interactions/NNS between/IN the/DT protein/NN and/CC DNA/NN ,/, including/JJ guanine/NN N7/NN sites/NN in/IN the/DT major/JJ groove/NN of/IN DNA/NN ,/, and/CC alterations/NNS in/IN DNA/NN phosphodiester/NN conformation/NN induced/VBN by/IN protein/NN binding/JJ ./.
@@13213324629 Transient/JJ transfection/NN assays/NNS showed/VBD that/DT site/NN A/NN is/VBZ necessary/JJ and/CC sufficient/JJ for/IN RXR/NEWGENE alpha-mediated/JJ transactivation/NN of/IN the/DT apoAI/NEWGENE gene/NEWGENE basal/NEWGENE promoter/NEWGENE in/IN human/JJ hepatoma/NN HepG2/NNP cells/NNS in/IN the/DT presence/NN of/IN RA/NN and/CC that/IN this/DT transactivation/NN is/VBZ abolished/VBN by/IN increasing/JJ amounts/NNS of/IN cotransfected/VBN ARP-1/NEWGENE ./.
@@94907276246 This/DT structure/NN interconnects/VBZ specific/JJ triplets/NNS of/IN the/DT basal/JJ bodies/NNS with/IN the/DT microtubular/JJ bundles/NNS that/WDT emerge/VBP from/IN the/DT basal/JJ apparatus/NN ./.
@@88927552618 When/WRB this/DT DNA/NN fragment/NN was/VBD placed/VBN upstream/RB of/IN the/DT chloramphenicol/NEWGENE acetyltransferase/NEWGENE (/( CAT/NEWGENE )/SYM reporter/NN gene/NN and/CC transfected/VBN into/IN a/DT carp/NN CF/NN cell/NN line/NN ,/, it/PRP could/MD drive/VB the/DT synthesis/NN of/IN CAT/NEWGENE enzyme/NEWGENE 16/NN times/NNS more/RB efficiently/RB than/IN the/DT promoterless/JJ pCAT-Basic/NEWGENE ./.
@@1909960109 A/DT single/NN i/NN ./NN p/NN ./. injection/NN of/IN d/JJ ,/JJ l-baclofen/JJ 10/CD mg/CD //CD kg/CD both/DT reduced/VBN noradrenaline/NN (/( NA/NN )/SYM biosynthesis/NN in/IN vivo/NN (/( 31%/JJ )/SYM and/CC the/DT endogenous/JJ concentration/NN of/IN normetanephrine/NN (/( NMN/NN )/SYM (/( 32%/JJ )/SYM and/CC increased/VBN NA/NN levels/NNS (/( 28%/JJ )/SYM ./.
@@99597379209 The/DT case/NN for/IN neutrinos/NNS from/IN SN/NN 1987A/NN ./.
@@98784375648 The/DT active/JJ site/NN includes/VBZ the/DT acidic/NN triad/NN Asp53/NN (/( the/DT site/NN of/IN phosphorylation/NN )/SYM ,/, Asp10/NNP and/CC Glu9/CD ./.
@@94318288844 Furthermore/RB the/DT median/JJ increase/NN in/IN cyclosporine/NN DR/NN //NN C/NN (/NN SS/NN trough/NN )/NN was/VBD 18/CD l/NN h-1/NN (/( -3/CD ./CD 1/CD to/IN 42/CD ./CD 1/CD l/NN h-1/NN ,/, interquartile/JJ range/NN )/SYM ./.
@@106254946046 These/DT results/NNS show/NN that/IN the/DT CAAT-region/NN is/VBZ involved/VBN in/IN upregulating/JJ the/DT MDR1/NEWGENE promoter/NEWGENE in/IN HL60/NNP //NNP VCR/NNP cells/NNS ./.
@@96363582709 The/DT virus-associated/NN VAI/NN RNA/NN of/IN adenovirus/NN is/VBZ a/DT small/JJ highly/RB structured/JJ RNA/NN that/WDT is/VBZ required/VBN for/IN the/DT efficient/JJ translation/NN of/IN cellular/JJ and/CC viral/JJ mRNAs/NNS at/IN late/JJ times/NNS after/IN infection/NN ./.
@@36457334319 Hyperthyroidism/NNS ./.
@@109185723701 While/IN interactions/NNS of/IN WT/NEWGENE and/CC variant/NN TGF-alpha/NEWGENE with/IN the/DT ErbBs/NEWGENE all/DT result/NN in/IN ErbB2/NEWGENE activation/NN ,/, they/PRP produce/VBP different/JJ biological/JJ consequences/NNS ,/, suggesting/VBG that/IN the/DT various/JJ TGF-alpha/NEWGENE precursors/NEWGENE differentially/RB modulate/VBP ErbB/NEWGENE signaling/JJ ./.
@@279678988 By/IN contrast/NN ,/, secretory/NEWGENE HI/NEWGENE antibodies/NEWGENE were/VBD not/RB demonstrated/VBN at/IN the/DT onset/NN of/IN illness/NN in/IN any/DT of/IN the/DT patients/NNS ,/, but/CC their/PRP formation/NN started/VBD early/JJ and/CC the/DT antibodies/NNS reached/VBD maximal/JJ levels/NNS about/RB 10/CD days/NNS after/IN onset/NN of/IN illness/NN ./.
@@80133489487 Mammalian/NEWGENE ABPs/NEWGENE and/CC SHBGs/NEWGENE bind/VB sex/NN steroids/NNS with/IN high/JJ affinity/NN ,/, but/CC some/DT binding/JJ properties/NNS differ/VBP among/IN species/NN ./.
@@1727488699 PRDII-BF1-derived/NEWGENE cDNAs/NEWGENE did/VBD not/RB result/VB in/IN stimulation/NN of/IN either/DT basal/JJ or/CC tat-induced/RB activated/VBN gene/NN expression/NN ./.
@@83550635728 The/DT rCBF/NN ratio/NN was/VBD mainly/RB reduced/VBN in/IN frontal/JJ lobes/NNS (/( 65%/JJ )/SYM ./.
@@92120634438 We/PRP isolated/VBD several/DT overlapping/JJ A-phage/NNP and/CC cosmid/NN clones/NNS that/WDT cover/VBP more/RB than/IN 100/CD kb/NN of/IN human/JJ DNA/NN and/CC contained/VBD the/DT entire/JJ VDR/NEWGENE gene/NEWGENE ./.
@@13942002904 The/DT treatment/NN group/NN also/RB showed/VBD in/IN vivo/NN T-cell/NN activation/NN with/IN an/DT initial/JJ lymphopenia/NN followed/VBN by/IN a/DT rebound/JJ lymphocytosis/NN and/CC upregulation/NN of/IN the/DT subset/NN markers/NN CD25/NEWGENE (/( interleukin/NEWGENE 2/NEWGENE receptor/NEWGENE )/SYM and/CC CD45RO/NEWGENE (/( T-memory/JJ cells/NNS )/SYM ./.
@@91568831408 Selected/JJ parameters/NNS :/: heart/NN rate/NN (/( HR/NN )/SYM ,/, arterial/JJ blood/NN pressure/NN (/( ABP/NN )/SYM and/CC arterial/JJ O2/NN saturation/NN (/( SaO2/NN )/SYM monitored/VBN by/IN pulsoximetry/NN were/VBD measured/VBN during/IN the/DT procedure/NN ./.
@@9710599968 Persistent/JJ activation/NN of/IN mitogen-activated/NEWGENE protein/NEWGENE kinases/NEWGENE p42/NEWGENE and/CC p44/NEWGENE and/CC ets-2/NEWGENE phosphorylation/NN in/IN response/NN to/IN colony-stimulating/NEWGENE factor/NEWGENE 1/NEWGENE //NEWGENE c-fms/NEWGENE signaling/JJ ./.
@@109986791656 The/DT psychologic/JJ factors/NN associated/NN wth/NN serious/JJ illness/NN ,/, terminal/JJ prognoses/NNS ,/, and/CC dying/NN complicate/VB the/DT scenario/NN even/VB more/RB as/IN compared/VBN with/IN that/DT of/IN nonmalignant/JJ pain/NN ./.
@@18320192431 It/PRP is/VBZ transparent/JJ ,/, cheap/JJ to/IN be/VB made/VBP ,/, and/CC easy/RB to/IN empty/JJ and/CC was/VBD tested/VBN in/IN 118/CD animals/NNS for/IN two/JJ and/CC four/CD weeks/NNS ./.
@@22768911531 Coenzyme/NEWGENE Q10/NEWGENE :/: blood/NN levels/NNS and/CC metabolic/JJ demand/NN ./.
@@28838711120 A/DT drug/NN with/IN ISA/NNS "down/NN regulates"/NN beta/NEWGENE receptors/NEWGENE ;/: thus/RB ,/, when/CC the/DT drug/NN is/NNS withdrawn/VBP there/RB is/VBZ no/DT post-beta-blocking/JJ drug/NN hypersensitivity/NN in/IN contrast/NN to/IN agents/NNS without/IN ISA/NNS ./.
@@90365291166 The/DT workup/NN included/VBD skin/NN tests/NNS (/( up/JJ to/IN 1/CD microgram/NN //NN ml/NN ,/, Pharmacia/NNP )/SYM ,/, measurement/NN of/IN specific/NN serum/NN IgE/NEWGENE with/IN RAST-CAP/NN (/( Pharmacia/NNP )/SYM ,/, and/CC CAST/IN with/IN three/CD concentrations/NNS of/IN bee/NN (/( Apis/DT mellifera/NN )/SYM and/CC wasp/NN (/( Vespula/NNP spec/CD ./CD )/SYM venom/NN (/( Aquagen/NNP ALK/JJ )/SYM ./.
@@13244044425 A/DT position-independent/JJ activation/NN domain/NN which/WDT contained/VBD conserved/VBN regions/NN II/NN and/CC III/NNP was/VBD identified/VBN at/IN the/DT carboxyl/NN terminus/NN of/IN the/DT HNF-3/NEWGENE beta/NEWGENE protein/NEWGENE (/( amino/JJ acids/NNS 361/CD to/IN 458/CD )/SYM ./.
@@110079616257 Mutations/NNS in/IN genes/NNS encoding/VBG PR65/NEWGENE //NEWGENE A/NEWGENE subunits/NEWGENE have/VBP been/VBN identified/VBN in/IN several/DT different/JJ human/JJ cancers/NNS and/CC the/DT PP2A/NEWGENE inhibitor/NN ,/, termed/JJ fostriecin/NN ,/, is/NNS being/VBP tested/VBN as/IN an/DT anticancer/JJ drug/NN ./.
@@92941617947 In/NN contrast/NN to/IN the/DT wild-type/NN protein/NN ,/, expression/NN of/IN p45/NEWGENE NF-E2/NEWGENE lacking/VBG this/DT activation/NN domain/NN in/IN an/DT NF-E2/NEWGENE null/JJ cell/NN line/NN fails/VBZ to/IN support/NN enhancer-dependent/JJ transcription/NN in/IN transient/JJ assays/NNS ./.
@@69724436757 Similar/JJ clinical/JJ evaluation/NN of/IN an/DT obligate/JJ carrier/NN revealed/VBD no/DT ocular/JJ abnormalities/NNS ./.
@@18121025714 The/DT present/NN study/NN reports/NNS visual/RB evoked/VBN potential/JJ responses/NNS to/IN pattern/NN reversal/NN (/( VEP-P/NNP )/SYM in/IN ten/CD third/JJ trimester/NN pregnant/JJ women/NNS and/CC changes/NNS in/IN latency/NN of/IN NPN/NN complex/NN when/CC compared/VBN with/IN these/DT responses/NNS in/IN the/DT non/FW pregnant/JJ state/NN ./.
@@109729901323 Abrogation/NNS of/IN p53/NEWGENE function/NN by/IN E6/NEWGENE resulted/VBN in/IN an/DT increase/NN in/IN the/DT spontaneous/JJ mutation/NN frequencies/NNS at/IN the/DT heterozygous/JJ thymidine/NEWGENE kinase/NEWGENE (/( TK/NEWGENE )/SYM locus/NN but/CC not/RB at/IN the/DT hemizygous/JJ hypoxanthine/NEWGENE phosphoribosyl/NEWGENE transferase/NEWGENE (/( HPRT/NEWGENE )/SYM locus/NN ./.
@@40246854771 55/CD +/NN //NN -/NN 11%/NN )/NN ,/, all/PDT other/DT parameters/NNS showed/VBD a/DT significant/JJ increase/NN :/: RS/NN index/NN 5/CD ./CD 4/CD +/NN //NN -/NN 1/CD ./CD 4/CD mVolt/NN to/IN 6/CD ./CD 0/CD +/NN //NN -/NN 1/CD ./CD 7/CD mVolt/NN (/( p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ;/: EDD/NN 6/NN ./NN 3/NN +/NN //NN -/NN 0/CD ./CD 7/CD to/IN 6/CD ./CD 8/CD +/NN //NN -/NN 0/CD ./CD 9/CD cm/NN (/( p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ;/: HV/JJ 1017/CD +/NN //NN -/NN 151/CD ml/NN to/IN 1099/CD +/NN //NN -/NN 261/CD ml/NN (/( p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ;/: EDV/NN 371/NN +/NN //NN -/NN 131/CD ml/NN to/IN 441/CD +/NN //NN -/NN 175/CD ml/NN (/( p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ;/: RBV/NN 117/NN +/NN //NN -/NN 57/CD ml/NN to/IN 151/CD +/NN //NN -/NN 77/CD ml/NN (/( p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ./.
@@67116426475 Significant/JJ immunoglobulinuria/NN developed/VBD prior/NN to/IN the/DT development/NN of/IN azotemia/NN ,/, significantly/RB decreased/VBN creatinine/NN clearance/NN ,/, significant/JJ proteinuria/NN (/( greater/JJR than/IN or/CC equal/NN to/IN 3+/CD dipstick/NN or/CC greater/JJR than/IN or/CC equal/NN to/IN 5/CD gm/NN per/IN 24-hour/JJ urine/NN collection/NN )/SYM ,/, or/CC oliguria/NN ./.
@@88730635428 ECM/NN disruption/NN in/IN Lytechinus/NNP embryos/NNS caused/VBD a/DT relative/JJ drop/NN in/IN USF/NEWGENE RNA/NEWGENE accumulation/NN levels/NNS to/IN approximately/RB 60%/CD of/IN control/JJ embryos/NNS ,/, while/CC LpS1/NEWGENE RNA/NEWGENE accumulation/NN levels/NNS dropped/VBN to/IN less/PRP than/IN 5%/CD ./CD
@@6197822027 Deep/NNP tans/NNS were/VBD induced/VBN over/RB the/DT backs/NNS of/IN volunteers/NNS with/IN repeated/JJ exposure/NN to/IN longwave/NN ultraviolet/JJ radiation/NN (/( UV-A/NN )/SYM ./.
@@68017786572 Significance/NN of/IN the/DT pulmonary/JJ gas/NN exchange/NN reaction/NN to/IN physical/JJ loading/NN in/IN evaluating/VBG the/DT effectiveness/NN of/IN mitral/JJ commissurotomy/NN ./.
@@118106851678 It/PRP is/NNS shown/VBP that/IN the/DT displacement/NN distribution/NN measured/VBN by/IN q-space/JJ MRI/NN in/IN both/PDT the/DT large/JJ displacement/NN (/( i/FW ./FW e/FW ./FW ,/, large/NN r/NN )/SYM and/CC the/DT long-wavelength/JJ (/( i/FW ./FW e/FW ./FW ,/, small/NN q/NN )/SYM limits/NNS is/VBZ the/DT same/JJ 3D/JJ Gaussian/JJ displacement/NN distribution/NN assumed/VBN in/IN DT-MRI/NNP ./.
@@820723242 Electrophoretic/JJ mobility/NN shift/NN analysis/NN indicates/VBZ that/IN NF-IL-6/NEWGENE ,/, as/RB well/VB as/IN other/DT related/VBN members/NNS of/IN this/DT family/NN ,/, bind/NN specifically/RB to/IN the/DT NF-IL-6/NEWGENE site/NN in/IN the/DT IL-8/NEWGENE promoter/NEWGENE ./.
@@79842619927 The/DT ICBF/NN in/IN the/DT ischaemic/JJ cortex/NN revealed/VBD a/DT graded/JJ reduction/NN from/IN the/DT ischaemic/JJ centre/NN to/IN the/DT surrounding/JJ tissues/NNS ./.
@@36599949819 These/DT changes/NNS at/IN the/DT site/NN of/IN injection/NN consist/VB of/IN a/DT focal/JJ abnormality/NN characterized/VBN by/IN a/DT slight/JJ increase/NN in/IN signal/JJ intensity/NN on/IN T1/NN weighted/JJ images/NNS and/CC markedly/RB increased/VBN signal/JJ intensity/NN on/IN T2/NN weighted/JJ images/NNS ./.
@@68359146626 Copper/NN treatments/NNS were/VBD assigned/VBN to/IN simulate/VB the/DT different/JJ levels/NNS of/IN copper/JJ intake/NN that/WDT might/MD result/VB from/IN differences/NNS in/IN daily/JJ feed/JJ intake/NN similar/JJ to/IN the/DT practice/NN followed/VBN with/IN commercial/JJ industry/NN ./.
@@56894275650 3-/NN (/NN N-Alkyl-N-2-chloroethylaminomethyl/NN )/NN -5-/NN or/CC 7-halogenobenzo/NN [/NN b/NN ]/NN thiophen/NN hydrochlorides/NNS ./.
@@94758989437 Transcervical/JJ amnioinfusion/NN ./.
@@117616012163 A/DT computer/NN program/NN ,/, ACCESS-IAQ/NN ,/, is/VBZ developed/VBN to/IN simulate/VB the/DT airflow/NN pattern/NN ,/, the/DT time/NN history/NN of/IN the/DT contaminant/NN concentrations/NNS in/IN the/DT occupied/VBN zone/NN ,/, and/CC the/DT inhalation/NN exposures/NNS ./.
@@108713799832 As/IN with/IN VP16/NEWGENE ,/, the/DT transactivation/NN function/NN of/IN Luman/NEWGENE is/VBZ also/RB regulated/VBN by/IN HCF/NEWGENE ./.
@@23258956135 Slowly/RB adapting/JJ type/NEWGENE I/NEWGENE mechanoreceptor/NEWGENE discharge/NN as/IN a/DT function/NN of/IN dynamic/JJ force/NN versus/IN dynamic/JJ displacement/NN of/IN glabrous/JJ skin/NN of/IN raccoon/NN and/CC squirrel/NN monkey/NN hand/NN ./.
@@32700859965 Hypomagnesemia/NN was/VBD due/NN to/IN magnesium/NN wasting/NN by/IN the/DT kidney/NN ./.
@@109083177625 Interestingly/RB ,/, although/IN E/NEWGENE domains/NEWGENE of/IN these/DT two/JJ receptors/NNS are/VBP much/JJ less/PRP conserved/VBN ,/, replacement/NN of/IN this/DT domain/NN in/IN rtER/NEWGENE by/IN its/PRP human/JJ counterpart/NN resulted/VBN in/IN higher/JJ estradiol/NN sensitivity/NN but/CC no/DT increase/NN in/IN the/DT magnitude/NN of/IN transactivation/NN ./.
@@61370285956 Propranolol/NN also/RB effectively/RB controlled/VBN her/PRP familial/JJ tremor/NN ./.
@@78717213932 From/IN sequence/NN alignments/NNS with/IN phylogenetically/RB related/VBN viruses/NNS ,/, including/JJ tymoviruses/NNS ,/, we/PRP predicted/VBD that/IN p223/NEWGENE contained/VBN a/DT papain-like/NEWGENE proteinase/NEWGENE domain/NEWGENE with/IN a/DT putative/JJ catalytic/JJ cysteine994/NN and/CC histidine1075/NN ./.
@@23335457024 The/DT distribution/NN of/IN their/PRP fibrinogen/NEWGENE levels/NNS was/VBD Gaussian/JJ ,/, but/CC more/RB wide-based/JJ than/IN the/DT distribution/NN of/IN our/PRP normal/JJ controls/NNS ./.
@@78947615791 The/DT aim/NN of/IN this/DT retrospective/JJ study/NN was/VBD to/IN demonstrate/VB that/IN in/IN certain/JJ cases/NNS of/IN expulsive/JJ choroidal/JJ hemorrhage/NN (/( ECH/NN )/SYM anatomical/JJ success/NN and/CC useful/JJ vision/NN can/MD be/VB obtained/VBN with/IN repeated/JJ vitreoretinal/JJ surgery/NN ./.
@@15415772231 17/CD volunteer/NN deaf/JJ Ss/NNS were/VBD compared/VBN with/IN 18/CD volunteer/NN hearing/NN Ss/NN on/IN the/DT Stanford/NNP Hypnotic/NNP Clinical/NNP Scale/NNP (/( SHCS/NNP )/SYM of/IN Morgan/JJ and/CC J/NNP ./NNP
@@6199489579 1/CD The/DT effects/NNS in/IN normal/JJ subjects/NNS of/IN a/DT single/JJ oral/JJ dose/NN of/IN Motival/JJ (/( one/PRP tablet/NN ,/, containing/JJ fluphenazine/NN 0/CD ./CD 5/CD mg/NN and/CC nortriptyline/NN 10/NN mg/NN )/SYM on/IN the/DT contingent/JJ negative/JJ variation/NN (/( CNV/NN )/SYM ,/, reaction/NN time/NN ,/, heart/NN rate/NN ,/, blood/NN pressure/NN and/CC self-rating/NN scales/NNS for/IN alertness/NN ,/, anxiety/NN ,/, tension/NN ,/, detachment/NN and/CC depression/NN were/VBD compared/VBN with/IN those/DT of/IN diazepam/NN (/( 5/CD mg/NN and/CC 7/CD ./CD 5/CD mg/NN )/SYM and/CC placebo/NN or/CC propranolol/NN (/( 60/CD mg/NN )/SYM ./.
@@21570675149 Summers/NNP ,/, Virology/NNP 89/CD :/: 517-527/JJ ,/, 1978/NN )/NN ./.
@@67951196562 Lens/NEWGENE aldose/NEWGENE reductase/NEWGENE in/IN diabetic/JJ and/CC galactosemic/JJ cataracts/NNS ./.
@@15519109711 This/DT DNA/NN motif/NN represents/VBZ a/DT novel/JJ protein-binding/NN sequence/NN ./.
@@16448143565 The/DT virus/NN encodes/VBZ a/DT 40-kDa/NN protein/NN ,/, tax/NEWGENE ,/, that/WDT is/VBZ important/JJ for/IN the/DT immortalization/NN of/IN T/NN cells/NNS ./.
@@82267949681 [/NEWGENE Ala85/NEWGENE ]/NEWGENE Dk/NEWGENE (/NEWGENE 69-85/NEWGENE )/NEWGENE retains/VBZ full/JJ biological/JJ activity/NN ./.
@@7594007494 Platelet/NN serotonin/NN (/( 5-HT/NN )/SYM and/CC 5-HT/NEWGENE releasing/NEWGENE factor/NEWGENE in/IN plasma/NN of/IN migrainous/JJ patients/NNS ./.
@@95019828075 CONCLUSIONS/IN :/: XCoe2/NEWGENE may/MD play/VB a/DT pivotal/JJ role/NN in/IN the/DT transcriptional/JJ cascade/NN that/WDT specifies/VBZ primary/JJ neurons/NNS in/IN Xenopus/NN embryos/NNS :/: by/IN maintaining/VBG Delta-Notch/NNP signalling/JJ ,/, XCoe2/NEWGENE stabilises/VBZ the/DT higher/JJ neural/JJ potential/NN of/IN selected/VBN progenitor/NN cells/NNS that/WDT express/VBP X-ngnr-1/NEWGENE ,/, ensuring/VBG the/DT transition/NN between/IN neural/JJ competence/NN and/CC irreversible/JJ commitment/NN to/IN a/DT neural/JJ fate/NN ;/: and/CC it/PRP promotes/VBZ neuronal/JJ differentiation/NN by/IN activating/JJ XNeuroD/NEWGENE expression/NN ,/, directly/RB or/CC indirectly/RB ./.
@@72403431976 Strontium-90/NN was/VBD inject/VB i/CD ./CD v/CD ./. into/IN pregnant/JJ rats/NNS on/IN day/NN 18/CD post/JJ conception/NN (/( p/CD ./CD c/CD ./CD )/SYM ./.
@@55332145584 Iodine/NNP metabolism/NN in/IN chronic/JJ thyroiditis/NN ./.
@@100901256167 However/RB ,/, with/IN the/DT alpha1/NN antagonist/NN prazosin/NN (/( 5/CD x/NN 10/NN (/NN -8/NN )/NN -5/NN x/NN 10/NN (/NN -7/NN )/NN M/NN )/NN ,/, no/DT relaxation/NN occurred/VBN ./.
@@11580941919 RESULTS/NNS :/: At/NN latest/JJS examination/NN ,/, mean/JJ UPDRS/NN II/NN and/CC III/NNP scores/NNS had/VBP improved/VBN by/IN 30%/CD (/( on/IN stimulation/NN ,/, off/JJ therapy/NN )/SYM with/IN mean/JJ 50%/CD reduction/NN in/IN daily/JJ off/JJ time/NN ./.
@@96178074680 A/DT phylogenetic/JJ analysis/NN of/IN the/DT reverse/NEWGENE transcriptase/NEWGENE domain/NEWGENE confirms/VBZ our/PRP differential/JJ genetic/JJ assessment/NN that/DT Cyclops/NEWGENE from/IN pea/NN is/VBZ a/DT novel/JJ element/NN with/IN no/DT specific/JJ relationship/NN to/IN the/DT previously/RB described/VBN Gypsy-like/NEWGENE elements/NEWGENE from/IN plants/NNS ./.
@@9545353283 Instead/RB ,/, it/PRP contained/VBD two/JJ tandem/NN kappaB/NEWGENE elements/NEWGENE and/CC a/DT variant/NN activating/NEWGENE transcription/NEWGENE factor/NEWGENE //NEWGENE cAMP/NEWGENE response/NEWGENE element/NEWGENE site/NN ,/, which/WDT closely/RB resembled/VBN sites/NNS in/IN the/DT E-selectin/NEWGENE gene/NEWGENE that/WDT are/VBP required/VBN for/IN TNF-alpha-/NN or/CC LPS-inducible/NN expression/NN ./.
@@11112438560 Copyright/NNP 2000/CD Academic/NNP Press/NNP ./.
@@95242731523 This/DT paper/NN describes/VBZ the/DT genomic/JJ organization/NN of/IN mouse/NN gC1qBP/NEWGENE and/CC the/DT characterization/NN of/IN its/PRP 5'/CD flanking/JJ region/NN ./.
@@81966181145 PRL-1/NEWGENE is/VBZ able/JJ to/IN dephosphorylate/VB phosphotyrosine/NN substrates/NN ,/, and/CC mutation/NN of/IN the/DT active-site/NN cysteine/NN residue/NN abolishes/VBZ this/DT activity/NN ./.
@@98171316467 A/DT Chinese/JJ (/( HK/NN )/SYM SF-36/NN survey/NN form/NN was/VBD developed/VBN by/IN an/DT iterative/JJ translation/NN process/NN ./.
@@19034042530 Infarct/NNS regional/JJ ejection/NN fraction/NN improved/VBN by/IN 10/CD ./CD 1/CD +/NN //NN -/NN 2/CD ./CD 1%/CD between/IN early/JJ and/CC late/JJ studies/NNS when/CC the/DT infarct-related/JJ artery/NN was/VBD patent/JJ and/CC by/IN 4/CD ./CD 8/CD +/NN //NN -/NN 1/CD ./CD 4%/CD if/IN it/PRP was/VBD occluded/VBN (/( p/NN =/SYM 0/CD ./CD 048/CD )/SYM ;/: changes/NNS in/IN global/JJ and/CC noninfarct/JJ regional/JJ ejection/NN fraction/NN were/VBD similar/JJ irrespective/JJ of/IN perfusion/NN status/NN ./.
@@97739815410 The/DT activated/VBN glucocorticoid/NEWGENE receptor/NEWGENE forms/VBZ a/DT complex/NN with/IN Stat5/NEWGENE and/CC enhances/VBZ Stat5-mediated/NN transcriptional/JJ induction/NN ./.
@@113827011224 This/DT partial/JJ transection/NN could/MD permit/VB vasopressin/NEWGENE to/IN be/VB secreted/VBN in/IN response/NN to/IN a/DT larger/JJR rise/NN in/IN plasma/NN sodium/NN concentration/NN ./.
@@96882648203 This/DT repressor/NN is/VBZ however/RB unlikely/JJ to/IN mediate/VB spi/NEWGENE 2/NEWGENE ./NEWGENE 3/NEWGENE 3'/NEWGENE UTR/NEWGENE silencer/NEWGENE action/NN since/IN it/PRP was/VBD not/RB detected/VBN in/IN rat/NN hepatocytes/NNS ./.
@@14670882082 Abstracts/NNP ./.
@@113879401250 The/DT severity/NN of/IN pathologic/JJ changes/NNS increased/VBN with/IN the/DT magnitude/NN of/IN percussion/NN ./.
@@97437209722 ANIMALS/NNP :/: Fifty/CD dogs/NNS with/IN naturally/RB developing/JJ DM/NNP ./NNP
@@80498858041 Acute/JJ pancreatitis/NN :/: a/DT multisystem/JJ disease/NN ./.
@@93120287987 Interestingly/RB ,/, the/DT RXRalphaF318A/NEWGENE constitutive/JJ activity/NN generated/VBN within/IN heterodimers/NNS in/IN the/DT presence/NN of/IN BMS614/NN requires/VBZ the/DT integrity/NN of/IN both/DT RXR/NEWGENE and/CC RAR/NEWGENE AF-2/NEWGENE1 domains/NEWGENE1 ./.
@@17706512371 Fundamental/JJ and/CC clinical/JJ evaluation/NN of/IN equilibrium/NN dialysis--radioimmunoassay/JJ system/NN for/IN measurement/NN of/IN serum/JJ free/JJ thyroxine/NN ./.
@@102160522507 The/DT aims/NNS of/IN this/DT study/NN were/VBD to/IN determine/VB and/CC rank/VB the/DT frequency/NN of/IN self/NN reported/VBD visual/JJ disability/NN in/IN daily/JJ tasks/NNS performed/VBN by/IN glaucoma/NN patients/NNS ;/: to/IN examine/VB the/DT interrelation/NN between/IN disabilities/NNS using/VBG factor/NN analysis/NN ;/: to/IN study/NN the/DT relation/NN between/IN perceived/JJ visual/JJ difficulty/NN and/CC a/DT measure/NN of/IN the/DT severity/NN of/IN visual/JJ field/NN loss/NN ;/: to/IN develop/VB a/DT glaucoma/NN specific/NN subgroup/NN of/IN questions/NNS ;/: and/CC examine/VB the/DT validity/NN and/CC reliability/NN of/IN this/DT subgroup/NN of/IN questions/NNS ./.
@@84132097709 The/DT amino-terminal/JJ third/RB of/IN the/DT protein/NN contains/VBZ a/DT high-mobility-group/NEWGENE motif/NEWGENE characteristic/NN of/IN DNA-binding/NN proteins/NN ./.
@@9030688151 In/NN rlf2/NEWGENE mutants/NEWGENE ,/, telomeric/NN chromatin/NN is/VBZ perturbed/VBN :/: Telomeric/NN silencing/VBG is/VBZ reduced/VBN and/CC Rap1p/NEWGENE localization/NN is/VBZ altered/VBN ./.
@@102181094027 Solution/NNP structure/NN and/CC mechanism/NN of/IN the/DT MutT/NEWGENE pyrophosphohydrolase/NEWGENE ./.
@@95565617773 Among/IN the/DT H/NEWGENE //NEWGENE ACA/NEWGENE snoRNAs/NEWGENE associated/VBN with/IN Gar1p/NEWGENE ,/, one/PRP can/MD distinguish/VB a/DT large/JJ group/NN of/IN snoRNAs/NEWGENE that/WDT are/VBP not/RB essential/JJ in/IN yeast/NN and/CC serve/VB as/IN guides/NNS for/IN pseudouridine/NN synthesis/NN onto/IN the/DT pre-rRNA/NEWGENE molecule/NEWGENE ./.
@@116003659131 Against/IN gram-positive/JJ organisms/NNS ,/, E-4767/NN and/CC E-5065/NN were/VBD ,/, in/IN general/JJ ,/, eight-/DT and/CC fourfold/RB more/RB active/JJ than/IN tosufloxacin/NN ,/, which/WDT is/VBZ the/DT most/RB potent/JJ of/IN the/DT reference/NN compounds/NNS ./.
@@39284426391 A/DT significant/JJ degree/NN of/IN homology/NN was/VBD also/RB found/VB among/IN these/DT genes/NNS and/CC the/DT Mtase/NEWGENE gene/NEWGENE of/IN related/VBN phage/NN SPR/NN ,/, which/WDT codes/NNS for/IN an/DT enzyme/NN with/IN different/JJ modification/NN specificity/NN ./.
@@19155802986 These/DT results/NNS suggest/VBP that/IN NZ-107/NN may/MD be/VB a/DT useful/JJ drug/NN for/IN the/DT treatment/NN of/IN bronchial/JJ asthma/NN by/IN reducing/JJ late-phase/NN airway/NN responses/NNS and/CC airway/NN hyperreactivity/NN ./.
@@96275986409 RESULTS/NNS :/: Of/IN the/DT patients/NNS with/IN IS/VBZ ,/, 67%/JJ had/VBP significantly/RB greater/JJR values/NNS of/IN directional/JJ preponderance/NN on/IN the/DT OVAR/NN test/NN (/( a/DT measure/NN of/IN otolith/NN system/NN imbalance/NN )/SYM compared/VBN with/IN control/NN subjects/NNS ./.
@@113906504033 Additional/JJ deletion/NN mutations/NNS revealed/VBD a/DT new/JJ ,/, 67-amino-acid/JJ functional/JJ domain/NN within/IN the/DT proline-rich/JJ region/NN of/IN SLP-76/NEWGENE ,/, which/WDT we/PRP have/VBP termed/VBD the/DT P-1/NEWGENE domain/NEWGENE ./.
@@21293382919 The/DT deduced/VBN amino/JJ acid/NN sequence/NN has/VBZ the/DT greatest/JJS homology/NN (/( 61%/JJ )/SYM to/IN the/DT green/NEWGENE alga/NEWGENE Scenedemus/NEWGENE obliquus/NEWGENE plastocyanin/NEWGENE ./.
@@86053248123 The/DT viral/JJ LTR/NN was/VBD used/VBN as/IN the/DT promoter/NN ./.
@@29236873632 We/PRP also/RB examined/VBD the/DT relationship/NN between/IN the/DT side/NN of/IN sinusitis/NN and/CC the/DT cleft/JJ side/NN in/IN patients/NNS with/IN unilateral/JJ cleft/JJ palate/NN ./.
@@85225306995 When/WRB nifA/NEWGENE mRNA/NEWGENE 5'/CD start/NN points/NNS were/VBD mapped/VBN by/IN primer/NN extension/NN ,/, both/PDT a/DT minor/JJ upstream/JJ transcript/NN (/NN s/NN )/NN starting/JJ 45/CD bp/NN distal/JJ to/IN the/DT anaerobox/NN and/CC a/DT major/JJ downstream/JJ transcript/NN starting/JJ 10/CD bp/NN distal/JJ to/IN the/DT sigma/NEWGENE 54/NEWGENE box/NN were/VBD observed/VBN ./.
@@78221612456 The/DT sequence/NN of/IN monkey/NEWGENE opsin/NEWGENE closely/RB resembles/VBZ the/DT human/JJ sequence/NN at/IN the/DT nucleotide/NN and/CC the/DT amino/JJ acid/JJ levels/NNS ,/, with/IN the/DT latter/JJ having/VBG only/RB 7/CD differences/NNS out/RB of/IN 348/CD residues/NNS ./.
@@87632078754 It/PRP is/VBZ the/DT oxidation/NN peak/NN of/IN this/DT product/NN ,/, arising/VBG in/IN acidic/NN media/NN at/IN 0/CD ./CD 42/CD V/NN ,/, which/WDT was/VBD analysed/VBN using/VBG DPV/IN ,/, again/RB following/IN the/DT accumulation/NN of/IN clenbuterol/NN at/IN the/DT Nafion-modified/JJ CPE/NN ./.
@@9227799928 Its/PRP potential/JJ as/IN a/DT diagnostic/JJ tool/NN for/IN epidemiological/JJ surveillance/NN was/VBD assessed/VBN in/IN comparison/NN with/IN three/CD other/DT diagnostic/JJ tests/NNS :/: stool/NN examination/NN ,/, ELISA/NN with/IN soluble/NEWGENE egg/NEWGENE antigen/NEWGENE (/( SEA/NEWGENE )/SYM and/CC the/DT circumoval/JJ precipitin/NN test/NN (/( COPT/NNP )/SYM ./.
@@105422498467 Albumin/NEWGENE expression/NN is/VBZ maintained/VBN in/IN the/DT liver/NN by/IN a/DT combination/NN of/IN liver-enriched/JJ transcription/NN factors/NNS such/JJ as/IN CAAT/NEWGENE enhancer-binding/NEWGENE protein/NEWGENE (/NEWGENE C/NEWGENE //NEWGENE EBP/NEWGENE )/NEWGENE alpha/NEWGENE and/CC C/NEWGENE //NEWGENE EBPbeta/NEWGENE ./.
@@83068349938 T2/NN cancers/NNS should/MD not/RB be/VB excluded/VBN from/IN the/DT benefit/NN of/IN preoperative/JJ irradiation/NN ./.
@@30730914232 Amounts/NNS of/IN glucose/NN infused/VBN during/IN the/DT last/NN 20/CD min/NN of/IN each/DT 2/CD hour/NN insulin/NEWGENE infusion/NN were/VBD (/( at/IN 1/CD and/CC 10/CD m/NN //NN kg/NN //NN min/NN respectively/RB )/SYM :/: before/IN treatment/NN (/( K+/NN =/SYM 2/CD ./CD 7/CD mmol/NN //NN l/NN )/SYM :/: 2/CD ./CD 4/CD and/CC 8/CD ./CD 4/CD mg/NN //NN kg/NN //NN min/NN ;/: after/IN spironolactone/NN (/( K+/NN =/SYM 3/CD ./CD 9/CD mmol/NN //NN l/NN )/SYM :/: 3/CD ./CD 3/CD and/CC 15/CD ./CD 4/CD mg/NN //NN kg/NN //NN min/NN ;/: after/IN indomethacine/NN (/( K+/NN =/SYM 3/CD ./CD 7/CD mmol/NN //NN l/NN )/SYM :/: 5/CD and/CC 19/CD mg/NN //NN kg/NN //NN min/NN after/IN stopping/JJ drugs/NNS (/( K+/NN =/SYM 2/CD ./CD 9/CD mmol/NN //NN l/NN )/SYM :/: 2/CD ./CD 5/CD and/CC 5/CD ./CD 3/CD mg/NN //NN kg/NN //NN min/NN ./.
@@98927366450 A/DT gapped/JJ search/NN with/IN the/DT C-terminal/NN region/NN of/IN CDED/NEWGENE //NEWGENE LIOR/NEWGENE revealed/VBN a/DT 36-41%/JJ similarity/NN to/IN several/DT proteins/NNS related/VBN to/IN signal/JJ transduction/NN and/CC cell/NN replication/NN ,/, such/JJ as/IN ORC1/NEWGENE and/CC KSR/NEWGENE ./.
@@90714076496 Circulating/VBG oxytocin/NEWGENE in/IN male/JJ guinea/NN pigs/NNS affected/VBN by/IN the/DT female/JJ cohabitation/NN and/CC reproductive/JJ condition/NN ./.
@@112329472652 Prophylactic/JJ lymph/NN node/NN dissection/NN or/CC radiation/NN therapy/NN to/IN the/DT nodal/NN chain/NN may/MD decrease/VB local/JJ recurrence/NN but/CC does/VBP not/RB consistently/RB affect/VB overall/JJ survival/NN ./.
@@84999169851 The/DT COL7A1/NEWGENE gene/NEWGENE ,/, which/WDT encodes/VBZ type/NEWGENE VII/NEWGENE collagen/NEWGENE ,/, has/VBZ been/VBN implicated/VBN as/IN a/DT candidate/NN gene/NN for/IN dominantly/RB and/CC recessively/RB inherited/JJ forms/NNS of/IN dystrophic/JJ epidermolysis/NN bullosa/NN ./.
@@94202206479 Cell/NNP factor-mediated/JJ regulatory/JJ interactions/NNS are/VBP involved/VBN in/IN regulating/JJ the/DT restricted/VBN expression/NN of/IN the/DT HCMV/NEWGENE major/NEWGENE immediate-early/NEWGENE (/NEWGENE IE/NEWGENE )/NEWGENE gene/NEWGENE (/( J/NNP ./NNP
@@112374912414 AIMS/IN :/: To/TO establish/VB a/DT baseline/NN and/CC intraindividual/JJ fluctuations/NNS of/IN the/DT tumour/NN markers/NNS CEA/NEWGENE ,/, CA/NEWGENE 50/NEWGENE and/CC CA/NEWGENE 242/NEWGENE in/IN patients/NNS cured/VBN from/IN colorectal/JJ cancer/NN ,/, and/CC to/IN test/NN the/DT hypothesis/NN that/IN serum/JJ concentrations/NNS and/CC intraindividual/JJ fluctuations/NNS do/VBP not/RB differ/VB from/IN the/DT concentrations/NNS in/IN cancer-free/JJ individuals/NNS ./.
@@17345704253 Effects/NNPS of/IN thromboxane/NEWGENE synthetase/NEWGENE inhibition/NN on/IN postburn/JJ mesenteric/JJ vascular/JJ resistance/NN and/CC the/DT rate/NN of/IN bacterial/JJ translocation/NN in/IN a/DT chronic/JJ porcine/JJ model/NN ./.
@@41232174806 Formation/NNP of/IN hyphae/NNS and/CC chlamydospores/NNS by/IN Cryptococcus/NN laurentii/NN ./.
@@75185783492 The/DT transforming/NN protein/NN of/IN Rous/NN sarcoma/NN virus/NN ,/, pp60v-src/NEWGENE ,/, and/CC its/PRP normal/JJ cellular/JJ homolog/NN ,/, pp60c-src/NEWGENE ,/, differ/VB not/RB only/RB in/IN oncogenic/JJ potential/JJ but/CC also/RB in/IN their/PRP subcellular/JJ localization/NN and/CC cytoskeletal/JJ binding/JJ ability/NN ./. pp60v-src/NEWGENE has/VBZ been/VBN shown/VBP to/IN stably/JJ associate/NN with/IN a/DT detergent-insoluble/JJ cytoskeletal/JJ matrix/NN ,/, whereas/IN pp60c-src/NEWGENE does/VBP not/RB ./.
@@19963121739 DNA/NN from/IN PCR/NN was/VBD labeled/JJ and/CC used/VBN to/IN isolate/NN several/DT lambda/NN gt11/NN cDNA/NN clones/NNS ,/, including/JJ one/PRP full-length/JJ one/PRP (/( Dd/NEWGENE kinase-2/NEWGENE )/SYM ./.
@@105422776587 The/DT importin/NEWGENE alpha/NEWGENE ./NEWGENE beta/NEWGENE heterodimer/NEWGENE mediates/VBZ nuclear/JJ import/NN of/IN proteins/NNS containing/JJ classical/JJ nuclear/JJ localization/NN signals/NNS ./.
@@72969972804 Nineteen/CD patients/NNS with/IN non-visualized/JJ gallbladder/NN with/IN OCG/NN subsequently/RB had/VBP Tc-99m-PyG/NN cholescintigraphy/NN performed/VBN ./.
@@118673881758 The/DT EC/NN (/NN 50/NN )/NN for/IN suppression/NN of/IN long-term/JJ memory/NN (/( the/DT concentration/NN decreasing/JJ memory/NN by/IN 50%/CD )/SYM of/IN fear/NN conditioning/JJ to/IN context/NN was/VBD 2/CD ./CD 00%/CD plus/NN //NN minus/NN 0/CD ./CD 01%/CD (/( mean/JJ plus/NN //NN minus/NN SEM/NN )/SYM ,/, and/CC for/IN fear/NN conditioning/JJ to/IN tone/NN was/VBD 3/CD ./CD 45%/CD plus/NN //NN minus/NN 0/CD ./CD 26%/CD ,/, (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@10527106362 OBJECTIVE/IN :/: Although/IN the/DT preponderance/NN of/IN findings/NNS offer/VBP support/NN for/IN transient/JJ (/( where/CC is/VBZ it/PRP ?/. )/SYM as/IN opposed/VBN to/IN sustained/JJ (/( what/WP is/VBZ it/PRP ?/. )/SYM deficit/NN ,/, a/DT need/NN remains/VBP for/IN specific/JJ depiction/NN of/IN the/DT deficit/NN ./.
@@16967158614 E/NNP ./NNP
@@78345823884 Dietary/JJ supplement/NN with/IN fish/NN oil/NN and/CC related/VBN n-3/NN EFAs/NNS has/VBZ been/VBN used/VBN to/IN study/NN their/PRP antihypertensive/JJ property/NN in/IN animals/NNS and/CC humans/NNS with/IN borderline/JJ and/CC essential/JJ hypertension/NN ./.
@@75114444912 HCV/NN infection/NN acquired/VBN during/IN or/CC after/IN BMT/NN caused/VBN only/RB mild/JJ acute/NN hepatitis/NN C/NN ,/, which/WDT progressed/VBD to/IN chronic/JJ hepatitis/NN C/NN in/IN one/PRP patient/NN surviving/JJ 10/CD years/NNS after/IN BMT/NN ./.
@@79141926299 Gel-shift/NNP assays/NNS with/IN nuclear/JJ extracts/NNS and/CC oligonucleotide/NN sequences/NNS spanning/VBG the/DT 0/CD ./CD 125-kb/CD promoter/NN region/NN detected/VBD an/DT ETS-immunoreactive/NNP complex/NN ,/, present/VB most/RB abundantly/RB in/IN cells/NNS overexpressing/JJ HER2/NEWGENE ,/, whose/WP high-affinity/JJ binding/JJ depended/VBN on/IN the/DT GAGGAA/NEWGENE response/NEWGENE element/NEWGENE ./.
@@30388913588 Northern/NNP analyses/NNS of/IN RNAs/NNS from/IN mouse/NN tissues/NNS and/CC cell/NN lines/NNS indicated/VBN that/IN p11/NEWGENE mRNA/NEWGENE levels/NNS vary/VBP widely/RB ./.
@@110281318175 Further/JJ research/NN is/VBZ required/VBN to/IN better/JJR measure/NN treatment/NN effects/NNS ,/, modification/NN of/IN MS/NN natural/JJ history/NN ,/, and/CC net/JJ societal/JJ costs/NNS of/IN IFN/NEWGENE beta-1b/NEWGENE in/IN RRMS/NNP ./.
@@17767152385 If/IN delay/NN has/VBZ occurred/VBN between/IN centrifugation/NN and/CC the/DT measurement/NN ,/, causing/JJ substantial/JJ loss/NN of/IN CO2/NN ,/, equilibration/NN of/IN the/DT sample/NN with/IN a/DT gas/NN mixture/NN corresponding/JJ to/IN PCO2/NN =/SYM 5/CD ./CD 3/CD kPa/NN prior/NN to/IN the/DT measurement/NN is/VBZ recommended/VBN ./.
@@89150518873 Magnetic/JJ resonance/NN imaging/JJ in/IN coccidioidal/JJ arthritis/NN ./.
@@68055046146 For/IN steers/VBZ the/DT urinary/NN N/NN values/NNS were/VBD 403/CD and/CC 295/CD mg/CD //CD kg/CD W0/CD ./CD 75/CD at/IN 200/CD and/CC 350/CD kg/NN live/VB weight/NN respectively/RB and/CC total/JJ N/JJ excretion/NN including/JJ faecal/JJ N/NN was/VBD 408/CD and/CC 320/CD mg/CD //CD kg/CD W0/CD ./CD 75/CD ./.
@@7743697635 Data/NNP from/IN the/DT V-HeFT/NN II/NN show/NN that/IN at/IN 2-year/JJ follow-up/NN ,/, a/DT progressive/JJ rise/NN of/IN plasma/NN norepinephrine/NN was/VBD observed/VBN in/IN both/DT treatment/NN arms/NNS ,/, suggesting/VBG that/DT disease/NN progresses/VBZ despite/IN treatment/NN with/IN either/DT an/DT angiotensin-converting/NEWGENE enzyme/NEWGENE inhibitor/NN ,/, enalapril/NN ,/, or/CC vasodilator/JJ therapy/NN with/IN hydralazine/NN //NN isosorbide/NN dinitrate/NN ./.
@@91714689119 Diver/JJ respiratory/JJ responses/NNS to/IN a/DT tunable/JJ closed-circuit/JJ breathing/JJ apparatus/NN ./.
@@108486051115 Phosphorylation/NNS of/IN tyrosine/NN residues/NNS in/IN the/DT kinase/NEWGENE domain/NEWGENE and/CC juxtamembrane/NN region/NN regulates/VBZ the/DT biological/JJ and/CC catalytic/JJ activities/NNS of/IN Eph/NEWGENE receptors/NEWGENE ./.
@@32788293965 The/DT indications/NNS for/IN its/PRP use/NN include/VB every/DT primary/JJ and/CC secondary/JJ rhinoplasty/NN candidate/NN unless/IN tip/NN grafts/NNS are/VBP going/VBG to/IN be/VB under/IN tension/NN or/CC if/IN the/DT deformity/NN is/VBZ minor/JJ ./.
@@6968588514 The/DT effect/NN of/IN pure/JJ natural/NN porcine/NEWGENE secretin/NEWGENE on/IN endocrine/JJ and/CC exocrine/JJ pancreatic/JJ secretion/NN was/VBD studied/VBN in/IN the/DT totally/RB isolated/VBN perfused/VBN porcine/JJ pancreas/NN ./.
@@15048535035 Exogenous/JJ LHRH/NEWGENE is/VBZ also/RB known/VBP to/IN facilitate/VB mating/JJ behavior/NN in/IN several/DT species/NN ./.
@@90539739010 CONCLUSION/IN :/: Chronic/NN administration/NN of/IN misoprostol/NN may/MD have/VB caused/VBN a/DT negative/JJ natriuretic/JJ effect/NN in/IN cirrhotic/JJ patients/NNS with/IN ascites/NN ./.
@@14266357312 The/DT in/NN vivo/NN profile/NN of/IN ZFH-2/NEWGENE in/IN the/DT larval/JJ CNS/NN shows/VBZ intriguing/JJ overlap/NN with/IN DDC/NEWGENE in/IN specific/NN serotonin/NN and/CC dopamine/NN neurons/NNS ./.
@@80052303919 Using/VBG this/DT reporter/NN gene/NN system/NN ,/, we/PRP previously/RB showed/VBD that/IN EPO-induced/JJ activation/NN of/IN the/DT c-fos/NEWGENE promoter/NEWGENE can/MD be/VB detected/VBN rapidly/RB and/CC sensitively/RB as/IN an/DT elevation/NN of/IN cellular/NEWGENE luciferase/NEWGENE activity/NN ./.
@@12372061875 Demonstration/NNS of/IN the/DT agent/NN was/VBD performed/VBN from/IN the/DT 6th/CD to/IN the/DT 11th/CD day/NN p/CD ./CD i/CD ./. by/IN direct/JJ microscopic/JJ methods/NNS (/( Stamp/NNS and/CC auramine/NN staining/NN ,/, fluorescent/JJ antibody/NN technique/NN )/SYM ;/: the/DT Coxiella/NN content/NN was/VBD determined/VBN by/IN titration/NN in/IN embryonated/JJ hen's/NN eggs/NNS ./.
@@97993621189 These/DT characteristic/JJ structural/JJ features/NNS were/VBD used/VBN to/IN create/VB the/DT abbreviation/NN AZF1/NEWGENE (/( Asparagine-rich/NEWGENE Zinc/NEWGENE Finger/NEWGENE protein/NEWGENE )/SYM ./.
@@99641719961 NMR/NN of/IN diffusing/JJ atoms/NNS in/IN a/DT periodic/JJ porous/JJ medium/NN in/IN the/DT presence/NN of/IN a/DT nonuniform/JJ magnetic/JJ field/NN ./.
@@110281311172 Cost-effectiveness/NNS of/IN interferon/NEWGENE beta-1b/NEWGENE in/IN slowing/NN multiple/JJ sclerosis/NN disability/NN progression/NN ./.
@@84716298637 Pseudosubstrate/NN (/NN 19-36/NN )/NN ,/, derived/VBN from/IN the/DT C-terminus/NN of/IN Ca-dependent/NEWGENE PKC/NEWGENE isotypes/NEWGENE ,/, inhibited/VBN beta-PKC/NEWGENE but/CC not/RB nPKC/NEWGENE activity/NN using/VBG either/DT Histone/NEWGENE IIIS/NEWGENE or/CC peptide/NN (/NN 19-31/NN )/NN as/IN substrate/NN ./.
@@77716717740 Sensing/VBG with/IN chemically/RB and/CC biologically/RB modified/JJ carbon/NN electrodes/NNS ./.
@@80864534142 Structure/NNS ,/, promoter/NN analysis/NN and/CC chromosomal/JJ assignment/NN of/IN the/DT human/NEWGENE APEX/NEWGENE gene/NEWGENE ./.
@@106407346015 Upon/IN tyrosine/NN phosphorylation/NN at/IN the/DT ITIMs/NNP ,/, these/DT molecules/NNS recruit/NN SH2/NEWGENE domain-containing/NN phosphatases/NEWGENE such/JJ as/IN SH2-containing/NN tyrosine/NEWGENE phosphatase-1/NEWGENE and/CC negatively/RB regulate/VB cell/NN activity/NN ./.
@@87092517743 Homologous/JJ recombination/NN between/IN the/DT Autographa/NNP californica/NN nuclear/JJ polyhedrosis/NN virus/NN (/( AcNPV/NNP )/SYM genome/NN and/CC a/DT 0/CD ./CD 6-kbp-long/CD DNA/NN fragment/NN derived/VBN from/IN the/DT putative/JJ DNA/NEWGENE helicase/NEWGENE gene/NEWGENE of/NEWGENE Bombyx/NEWGENE mori/NEWGENE nuclear/NEWGENE polyhedrosis/NEWGENE virus/NEWGENE generates/VBZ eh2-AcNPV/JJ ,/, an/DT expanded-host-range/NNP AcNPV/NN mutant/NN (/( S/NNP ./NNP
@@104056359896 The/DT transcriptional/JJ activities/NNS of/IN the/DT full-length/JJ promoter/NN (/( -295/CD to/IN +85/CD )/SYM and/CC of/IN three/CD deletion/NN constructs/NNS (/( -197/NN ,/, -154/CD and/CC -74/CD to/IN +85/CD )/SYM were/VBD significantly/RB down-regulated/IN in/IN resistant/JJ cells/NNS ./.
@@95235516445 Both/DT variants/NNS display/NN the/DT seven-transmembrane/JJ topology/NN that/WDT is/VBZ typical/JJ for/IN G/NEWGENE protein-coupled/NEWGENE receptors/NEWGENE ./.
@@91648561843 This/DT region/NN does/VBP not/RB contain/VB an/DT identifiable/JJ TATA/NN element/NN ,/, indicating/VBG that/DT transcription/NN of/IN the/DT glutaminase/NEWGENE gene/NEWGENE is/NNS driven/VBP by/IN a/DT TATA-less/NNP promoter/NN ./.
@@108334868437 Age/NNP >/SYM //NN =/NN 50/CD years/NNS (/( odds/NNS ratio/NN [/NN OR/NN ]/NN ,/, 14/CD ./CD 1/CD )/SYM ,/, BMI/NN >/SYM //NN =/NN 28/CD kg/NN //NN m/NN (/NN 2/NN )/NN (/( OR/NN ,/, 5/CD ./CD 7/CD )/SYM ,/, triglycerides/NNS >/SYM //NN =/NN 1/CD ./CD 7/CD mmol/NN //NN L/NN (/( OR/NN ,/, 5/CD )/SYM ,/, and/CC alanine/NEWGENE aminotransferase/NEWGENE (/( ALT/NEWGENE )/SYM >/SYM //NN =/NN 2N/CD (/( OR/NN ,/, 4/CD ./CD 6/CD )/SYM were/VBD independently/RB associated/VBN with/IN septal/JJ fibrosis/NN ./.
@@2346262998 XXI/NNS ./.
@@63282722809 They/PRP generated/VBD ca/NN ./NN
@@13808255179 Northern/NNP blot/NN analyses/NNS demonstrate/VBP that/IN 3/NN ./NN 9-/NN and/CC 5-kilobase/NN mRNAs/NN corresponding/JJ to/IN the/DT cDNA/NN were/VBD present/NN in/IN all/DT tissues/NNS examined/VBN ,/, suggesting/VBG that/IN the/DT protein/NN it/PRP encodes/VBZ performs/VBZ a/DT housekeeping/NN function/NN ./.
@@20525447285 Furthermore/RB ,/, the/DT DNA/NEWGENE polymerase/NEWGENE II/NEWGENE complex/NEWGENE was/VBD difficult/JJ to/IN obtain/VB from/IN dpb2-1/NEWGENE mutant/JJ cells/NNS ,/, suggesting/VBG that/IN a/DT stable/JJ DNA/NEWGENE polymerase/NEWGENE II/NEWGENE complex/NEWGENE requires/VBZ DPB2/NEWGENE and/CC is/VBZ essential/JJ for/IN chromosomal/JJ replication/NN ./.
@@10982076815 Linking/VBG continuous/JJ community-based/JJ morbidity/NN recording/NN of/IN influenza-like/JJ illness/NN (/( ILI/NNP )/SYM with/IN virological/JJ sampling/NN has/VBZ consistently/RB proved/VBN its/PRP value/NN as/IN one/PRP of/IN the/DT earliest/JJS indicators/NNS of/IN circulating/JJ influenza/NN activity/NN ./.
@@94547351603 Levels/NNS of/IN the/DT MEK/NEWGENE inhibitor/NN PD98059/NN that/DT block/JJ EGF-induced/JJ mitogenesis/NN and/CC MAP/NEWGENE kinase/NEWGENE phosphorylation/NN also/RB abrogate/VB EGF-induced/JJ focal/JJ adhesion/NN disassembly/NN and/CC cell/NN motility/NN ./.
@@79599533016 IFI16/NEWGENE consists/VBZ of/IN ten/CD exons/NNS and/CC nine/JJ intervening/JJ introns/NNS spanning/VBG at/IN least/RB 28/CD kilobases/NNS (/( kb/NN )/SYM of/IN DNA/NN ./.
@@80823609621 Smoking/NNP history/NN and/CC awake/JJ oxygen/NN saturation/NN (/( SaO2/NN )/SYM was/VBD recorded/VBN in/IN all/DT of/IN them/PRP ./.
@@103596637090 In/NN a/DT heterologous/JJ transcriptional/JJ system/NN in/IN which/WDT the/DT upstream/JJ regions/NNS of/IN oIFNtau/NEWGENE were/VBD inserted/VBN in/IN front/NN of/IN simian/NEWGENE virus/NEWGENE 40/NEWGENE (/NEWGENE SV40/NEWGENE )/NEWGENE promoter/NEWGENE ,/, the/DT regions/NNS between/IN bases/NNS -654/NN and/CC -555/NN were/VBD determined/VBN as/IN being/VBP the/DT enhancer/NN region/NN required/VBN for/IN oIFNtau-SV40-CAT/NEWGENE transactivation/NN ./.
@@85999469363 The/DT evidence/NN presented/VBN here/RB suggests/VBZ that/IN the/DT p40/NEWGENE complex/NEWGENE is/VBZ a/DT ribonucleoprotein/NN complex/NN containing/JJ L1Hs/NEWGENE RNA/NEWGENE (/NEWGENE s/NEWGENE )/NEWGENE and/CC that/IN protein-protein/JJ interactions/NNS in/IN which/WDT alpha-helix/VBP structures/NNS participate/VBP ,/, for/IN example/NN coiled-coils/NNS ,/, may/MD occur/VB in/IN the/DT complex/NN ./.
@@10834781640 However/RB ,/, the/DT elderly/JJ group/NN showed/VBD significantly/RB longer/RBR mean/JJ residence/NN times/NNS (/( MRTs/NNS )/SYM and/CC lower/JJR plasma/NN clearance/NN of/IN lidocaine/NN during/IN the/DT period/NN compared/VBN with/IN the/DT adult/JJ group/NN (/( P/NN </SYM ./CD 05/CD )/SYM ./.
@@77820879820 Two/CD major/JJ and/CC one/PRP minor/JJ transcription/NN initiation/NN sites/NNS were/VBD assigned/VBN to/IN positions/NNS +1/NN and/CC +24/NN and/CC position/NN +14/CD ,/, respectively/RB ,/, by/IN a/DT combination/NN of/IN ribonuclease/NEWGENE protection/NN ,/, primer/NN extension/NN ,/, and/CC 5'/CD RACE/NN analyses/NNS ./.
@@85384833612 Taking/VBG into/IN consideration/NN weight/NN and/CC seasonal/JJ changes/NNS in/IN bone/NN mass/JJ ,/, total/JJ (/( TBBMC/NNP )/SYM and/CC regional/JJ body/NN bone/NN mineral/JJ content/NN were/VBD measured/VBN in/IN 38/CD women/NNS treated/VBN with/IN GnRH/NEWGENE agonists/NNS for/IN 6/CD months/NNS for/IN endometriosis/NN or/CC leiomyomata/NNS ./.
@@118756957365 Time/NNP to/IN progression/NN was/VBD 6/CD months/NNS (/( 5-7/CD months/NNS )/SYM with/IN a/DT median/JJ survival/NN from/IN registration/NN of/IN 9/CD ./CD 6/CD months/NNS (/( 95%/CD CI/NN 8-12/CD months/NNS )/SYM ./.
@@102281551147 SCFFWD1/NEWGENE may/MD be/VB critical/JJ for/IN tumor/NN development/NN and/CC suppression/NN through/JJ regulation/NN of/IN beta-catenin/NEWGENE protein/NEWGENE stability/NN ./.
@@16491733959 In/NN addition/NN to/IN the/DT previously/RB identified/VBN and/CC characterized/VBN attenuator/NEWGENE 1/NEWGENE situated/VBN 93/CD nucleotides/NNS downstream/RB from/IN the/DT major/JJ late/JJ transcription/NN start/NN site/NN ,/, a/DT second/JJ attenuator/NN ,/, attenuator/NEWGENE 2/NEWGENE ,/, situated/VBN 55/CD nucleotides/NNS downstream/RB from/IN it/PRP ,/, has/VBZ been/VBN identified/VBN ./.
@@21160716641 A/DT long/JJ follow-up/JJ study/NN revealed/VBN that/IN convalescent/JJ stage/NN children/NNS still/RB have/VBP the/DT potency/NN to/IN have/NN an/DT immediate/JJ type/NN hypersensitivity/NN reaction/NN on/IN exposure/NN to/IN mite/NN antigen/NN ,/, with/IN a/DT high/JJ titer/NN of/IN mite/NEWGENE specific/NEWGENE IgE/NEWGENE in/IN their/PRP sera/NNS ,/, but/CC they/PRP are/VBP free/JJ from/IN asthmatic/JJ attacks/NNS because/IN of/IN the/DT reduction/NN in/IN the/DT amount/NN of/IN mite/NN antigen/NN in/IN the/DT body/NN ,/, as/IN shown/VBP by/IN the/DT reduction/NN in/IN the/DT amount/NN of/IN mite/NEWGENE specific/NEWGENE IgG/NEWGENE ./.
@@17857492394 These/DT changes/NNS weren't/NN so/RB significant/JJ in/IN the/DT group/NN of/IN obese/JJ children/NNS who/WP didn't/VBD lose/VB weight/NN ./.
@@60933637990 USA/NN 80/CD ,/, 3618-3622/NN )/NN The/DT two/JJ proteins/NNS show/VBP 36%/JJ identities/NNS in/IN their/PRP amino/JJ acid/NN sequence/NN ,/, in/IN an/DT alignment/NN requiring/JJ six/CD gaps/NNS ./.
@@75952213870 After/IN cells/NNS were/VBD stably/RB transfected/VBN with/IN CIITA/NEWGENE ,/, endogenous/JJ MHC/NEWGENE class/NEWGENE II/NEWGENE genes/NEWGENE were/VBD constitutively/RB expressed/VBN ,/, and/CC MHC/NEWGENE class/NEWGENE II/NEWGENE promoters/NEWGENE ,/, delivered/VBN by/IN transfection/NN ,/, were/VBD actively/RB transcribed/VBN in/IN CIITA-expressing/VBG cells/NNS ./.
@@18867746681 POU-specific/NNP and/CC POU-homeo/NEWGENE domains/NEWGENE of/IN Oct3/NEWGENE were/VBD produced/VBN in/IN Echerichia/NNP coli/JJ for/IN characterization/NN of/IN DNA/NN binding/JJ to/IN the/DT octamer/NN sequence/NN ./.
@@67546626518 Bullous/JJ angiolymphoid/JJ hyperplasia/NN with/IN eosinophilia/NN ./.
@@10996934830 No/DT title/NN available/JJ ./.
@@107274336874 Regulation/NN of/IN urokinase/NEWGENE plasminogen/NEWGENE activator/NEWGENE gene/NEWGENE transcription/NN in/IN the/DT RAW264/NN murine/JJ macrophage/NN cell/NN line/NN by/IN macrophage/NEWGENE colony-stimulating/NEWGENE factor/NEWGENE (/( CSF-1/NEWGENE )/SYM is/VBZ dependent/JJ upon/IN the/DT level/NN of/IN cell-surface/NN receptor/NN ./.
@@112784611446 Polyclonal/JJ antibodies/NNS against/IN the/DT N-terminal/NN part/NN (/( amino/JJ acids/NNS 12-363/JJ )/SYM and/CC the/DT C-terminal/NN part/NN (/( amino/JJ acids/NNS 330-730/JJ )/SYM of/IN rainbow/NEWGENE trout/NEWGENE HIF-1alpha/NEWGENE protein/NEWGENE recognized/VBD rainbow/NEWGENE trout/NEWGENE and/NEWGENE chinook/NEWGENE salmon/NEWGENE HIF-1alpha/NEWGENE protein/NEWGENE in/IN Western/JJ blot/NN analysis/NN ./.
@@92490391914 It/PRP is/VBZ thus/RB one/PRP of/IN the/DT key/NN enzymes/NNS involved/VBN in/IN the/DT triiodothyronine-mediated/JJ control/NN of/IN growth/NN ,/, differentiation/NN and/CC basal/JJ metabolism/NN in/IN vertebrates/NNS ./.
@@10839470645 Similarly/RB ,/, comparison/NN of/IN percentage/NN reductions/NNS of/IN heart/NN rate/NN at/IN supine/JJ ,/, sitting/NN and/CC exercise/NN by/IN repeated/JJ measure/NN analysis/NN showed/VBD the/DT Malays/NNS to/IN have/NN significantly/RB higher/JJ change/NN compared/VBN to/IN the/DT Chinese/JJ (/( p/NN =/SYM 0/CD ./CD 040/CD )/SYM ./.
@@8917696857 To/TO analyze/VB the/DT mechanism/NN of/IN fos/NEWGENE //NEWGENE jun/NEWGENE activation/NN by/IN TCDD/NN we/PRP have/VBP used/VBN electrophoretic/JJ mobility/NN shift/NN and/CC transient/JJ expression/NN assays/NNS of/IN reporter/NN gene/NN constructs/NN containing/NN response/NN elements/NN for/IN 12-O-tetradecanoyl-phorbol-13-acetate/JJ (/( TRE/NEWGENE )/SYM ,/, serum/JJ (/( SRE/NEWGENE )/SYM ,/, cAMP/NN (/( CRE/NEWGENE )/SYM ,/, and/CC aromatic/JJ hydrocarbons/NNS (/( AhRE/NN )/SYM from/IN the/DT fos/NEWGENE and/CC jun/NEWGENE genes/NEWGENE fused/VBN to/IN the/DT firefly/NEWGENE luciferase/NEWGENE gene/NEWGENE under/IN the/DT control/NN of/IN the/DT SV40/NEWGENE minimal/NEWGENE promoter/NEWGENE ./.
@@10411160270 The/DT mysteries/NNS of/IN geographic/JJ variability/NN in/IN nonmelanoma/NN skin/NN cancer/NN incidence/NN ./.
@@86172374852 The/DT two/JJ different/JJ phosphoforms/NNS of/IN STAT5/NEWGENE have/NN identical/JJ in/IN vitro/NN DNA/NN binding/JJ specificity/NN and/CC reactivity/NN with/IN tyrosine/NN phosphopeptides/NN ,/, but/CC differ/VB in/IN their/PRP cellular/JJ localization/NN ./.
@@4138546395 Changes/NNS in/IN tissue/NN PCO2/NN were/VBD less/PRP dramatic/JJ and/CC did/VBD not/RB vary/VB significantly/RB from/IN those/DT recorded/VBN in/IN venous/JJ blood/NN ./.
@@97348089714 To/TO improve/VB test/NN efficiency/NN ,/, we/PRP modified/JJ our/PRP previously/RB introduced/VBN contrast/NN //NN color/NN card/NN test/NN by/IN including/JJ a/DT patterned/JJ test/NN stimulus/NN and/CC reducing/JJ the/DT number/NN of/IN stimuli/NNS in/IN both/DT experimental/JJ phases/NNS ./.
@@77474622868 Sequence/NN comparisons/NNS of/IN prokaryotic/NEWGENE RCR/NEWGENE initiators/NEWGENE has/VBZ revealed/VBN a/DT set/NN of/IN three/CD common/JJ motifs/NNS ,/, two/NN of/IN which/WDT ,/, a/DT putative/JJ metal/NN coordination/NN site/NN and/CC a/DT downstream/JJ active-site/NN tyrosine/NN motif/NN ,/, could/MD be/VB tentatively/RB identified/VBN in/IN parvoviral/NEWGENE replicator/NEWGENE proteins/NEWGENE ./.
@@94007386499 An/DT even/RB greater/RBR inflammatory/JJ response/NN was/VBD observed/VBN after/IN intratracheal/JJ instillation/NN of/IN ufCB/NN ,/, but/CC not/RB after/IN CB/NN instillation/NN ./.
@@111339275165 Validity/NNS of/IN NIR/NN spectroscopy/NN for/IN quantitatively/RB measuring/JJ muscle/NN oxidative/JJ metabolic/JJ rate/NN in/IN exercise/NN ./.
@@110831542689 Ten/CD males/NNS performed/VBD both/DT test/NN conditions/NNS and/CC oxygen/NN uptake/NN VO2/NN ,/, heart/NN rate/NN ,/, minute/JJ ventilation/NN VE/NN ,/, perceived/JJ exertion/NN and/CC spinal/JJ shrinkage/NN were/VBD recorded/VBN ./.
@@13330538682 A/DT major/JJ mechanism/NN whereby/RB steroid/NEWGENE hydroxylase/NEWGENE gene/NEWGENE transcription/NN is/VBZ regulated/VBN in/IN the/DT adrenal/JJ cortex/NN requires/VBZ the/DT pituitary/JJ peptide/NN hormone/NN ,/, ACTH/NEWGENE ,/, which/WDT acts/VBZ via/NN cAMP/NN ./.
@@11777632229 AF/NEWGENE showed/VBD a/DT mixed/JJ nuclear/JJ //JJ cytoplasmic/JJ pattern/NN of/IN expression/NN in/IN the/DT epithelial/JJ ,/, endothelial/JJ ,/, and/CC stromal/JJ component/NN of/IN the/DT normal/JJ breast/NN and/CC benign/JJ lesions/NNS ,/, whereas/IN an/DT impressive/JJ loss/NN of/IN AF/NEWGENE expression/NN was/VBD noted/VBN in/IN in/IN situ/NN and/CC invasive/JJ breast/NN cancer/NN and/CC tumoral/JJ stroma/NN ./.
@@71847952878 Based/VBN on/IN 213/CD determinations/NNS ,/, the/DT control/JJ mean/JJ serum/NEWGENE CPK/NEWGENE activity/NN was/VBD 262/CD +/NN //NN -/NN 113/CD I/NNP ./NNP U/NNP ./NNP //NNP liter/NNP ./.
@@85482913912 In/NN vivo/NN ,/, selective/JJ activation/NN of/IN SAPKs/NEWGENE stimulates/VBZ formation/NN of/IN the/DT ternary/JJ complex/NN containing/NN Elk-1/NEWGENE ,/, serum/NEWGENE response/NEWGENE factor/NEWGENE and/CC the/DT serum/NEWGENE response/NEWGENE element/NEWGENE ,/, and/CC enhances/VBZ Elk-1-dependent/NN transcription/NN ./.
@@10516738347 At/NN all/DT time-points/NNS ,/, most/JJ patients/NNS (/( >/SYM //CD =/CD 87%/CD )/SYM were/VBD receiving/JJ irbesartan/NN //NN HCTZ/NN alone/RB ./.
@@7916729477 A/DT leucine/NN zipper/NN domain/NN of/IN the/DT suppressor/NEWGENE of/NEWGENE Hairy-wing/NEWGENE protein/NEWGENE mediates/VBZ its/PRP repressive/JJ effect/NN on/IN enhancer/NN function/NN ./.
@@25865138024 Analysis/NNP of/IN the/DT inferred/VBN 1/NEWGENE ,/NEWGENE 859-residue/NEWGENE ama-1/NEWGENE product/NEWGENE showed/VBD considerable/JJ identity/NN with/IN the/DT largest/JJS subunit/NN of/IN RNAP/NEWGENE II/NEWGENE from/IN other/DT organisms/NNS ,/, including/JJ the/DT presence/NN of/IN a/DT zinc/NN finger/NN motif/NN near/IN the/DT amino/JJ terminus/NN ,/, and/CC a/DT carboxyl-terminal/NN domain/NN of/IN 42/CD tandemly/RB reiterated/VBN heptamers/NNS with/IN the/DT consensus/NN Tyr/NN Ser/NN Pro/NNP Thr/NN Ser/NN Pro/NNP Ser/NN ./.
@@107292204720 The/DT two/JJ contiguous/JJ IGF2/NEWGENE (/( human/NEWGENE insulin-like/NEWGENE growth/NEWGENE factor/NEWGENE II/NEWGENE )/SYM and/CC H19/NEWGENE genes/NEWGENE are/VBP reciprocally/RB imprinted/JJ in/IN both/DT human/NN and/CC mouse/NN ./.
@@106849415004 The/DT requirement/NN of/IN 3'/CD complementarity/NN for/IN a/DT ligation/NN reaction/NN is/VBZ reaffirmed/VBN by/IN results/NNS from/IN 1/CD nt/NN insertions/NNS on/IN either/DT the/DT 3'-/NN or/CC 5'-side/NN of/IN the/DT nick/NN ./.
@@9419421858 In/NN serum-stimulated/JJ cells/NNS ,/, the/DT binding/NN of/IN NF-Y/NEWGENE //NEWGENE CBF/NEWGENE to/IN TKC1/NEWGENE increased/VBN gradually/RB ,/, reaching/VBG a/DT plateau/NN at/IN the/DT S/NNP phase/NN ./.
@@62249746027 Data/NNP are/VBP presented/VBN hinting/VBG that/IN the/DT 15/CD beta-hydroxy-/JJ ,/, metabolite/NN of/IN CPA/NN may/MD actually/RB be/VB the/DT biologically/RB active/JJ agent/NN ./.
@@7121174745 A/DT sharp/JJ outbreak/NN of/IN influenza/NN A/DT occurred/VBN on/IN the/DT base/NN during/IN February/NN that/WDT was/VBD due/NN to/IN an/DT A/NNP //NNP Texas/NNP //NNP 1/NNP //NNP 77-like/NNP virus/NN ,/, a/DT variant/NN of/IN the/DT A/NN //NN Victoria/NN //NN 3/NN //NN 75/NN prototpye/NN ./.
@@96661034792 One/CD missense/JJ allele/NN (/( P236S/NEWGENE )/SYM with/IN complete/JJ loss/NN of/IN function/NN at/IN 30/CD degreesC/NN and/CC four/CD missense/JJ alleles/NNS (/( L173F/NEWGENE ,/, E225K/NEWGENE ,/, S269L/NEWGENE and/CC E274K/NEWGENE )/SYM that/WDT conferred/VBD a/DT temperature/NN sensitive/JJ phenotype/NN were/VBD identified/VBN ./.
@@103853841916 Similar/JJ results/NNS were/VBD obtained/VBN with/IN xylitol/NN ,/, an/DT activator/NN of/IN the/DT pentose/NN phosphate/NN pathway/NN ./.
@@6868366665 Pentane/NNP and/CC ethane/NN ,/, which/WDT arise/VBP during/IN lipid/NN peroxidation/NN in/IN vivo/NN ,/, were/VBD measured/VBN by/IN gas/NN chromatography/NN in/IN breath/NN samples/NNS of/IN rats/NNS fed/VBN for/IN 8/CD weeks/NNS a/DT vitamin/NN E-deficient/NNP diet/NN to/IN which/WDT had/VBP been/VBN added/VBN 0/CD ,/, 11/CD ,/, or/CC 40/CD IU/NN vitamin/NN E/NN acetate/NN per/IN kg/CD ./CD
@@63284854794 Here/RB we/PRP have/VBP determined/VBN the/DT nucleotide/NN sequence/NN of/IN 3/CD ./CD 5/CD kb/NN from/IN the/DT 3'/CD end/NN of/IN delta/NEWGENE gag/NEWGENE to/IN the/DT 3'/CD end/NN of/IN molecularly/RB cloned/VBN proviral/NN MH2/NN DNA/NN ,/, in/IN order/NN to/IN elucidate/VB the/DT genetic/JJ structure/NN of/IN the/DT virus/NN and/CC to/IN compare/NN it/PRP with/IN other/DT mht/NEWGENE -/: and/CC myc-containing/JJ oncogenic/JJ viruses/NNS as/RB well/VBP as/IN with/IN the/DT chicken/NEWGENE proto-myc/NEWGENE gene/NEWGENE ./.
@@87078467458 Concurrent/JJ with/IN ligand-dependent/JJ uptake/NN ,/, we/PRP now/RB show/VBP that/IN the/DT receptor/NN undergoes/VBZ ligand-induced/JJ ubiquitination/NN ,/, suggesting/VBG that/DT receptor/NN ubiquitination/NN may/MD function/VB in/IN the/DT ligand-dependent/JJ endocytosis/NN of/IN the/DT a-factor/NEWGENE receptor/NEWGENE as/RB well/VB as/IN in/IN its/PRP constitutive/JJ endocytosis/NN ./.
@@94990613033 Cleavage/NNS and/CC DNA/NN joining/VBG reactions/NNS ,/, carried/VBD out/RB by/IN human/NEWGENE immunodeficiency/NEWGENE virus/NEWGENE type/NEWGENE 1/NEWGENE (/NEWGENE HIV-1/NEWGENE )/NEWGENE integrase/NEWGENE ,/, are/VBP necessary/JJ to/IN effect/NN the/DT covalent/JJ insertion/NN of/IN HIV-1/NN DNA/NN into/IN the/DT host/NN genome/NN ./.
@@104288629071 Immunoprecipitation/NNS experiments/NNS using/VBG DokR-specific/NEWGENE antibodies/NEWGENE revealed/VBD an/DT interaction/NN between/IN endogenous/NEWGENE DokR/NEWGENE and/CC a/DT 150-kDa/NN protein/NN that/WDT is/VBZ tyrosine-phosphorylated/JJ in/IN EGF-stimulated/JJ BaF/NNP //NNP 3/NNP cells/NNS ./.
@@10542260804 The/DT requirement/NN for/IN proteolytic/JJ activity/NN of/IN both/DT FVIIa/NEWGENE and/CC FXa/NEWGENE suggests/VBZ that/IN protease-activated/NN receptors/NN may/MD be/VB involved/VBN ./.
@@117931721660 The/DT weight-bearing/NN surface/NN of/IN the/DT PE/NN head/NN became/VBD smoother/JJR with/IN time/NN after/IN THA/NN ,/, and/CC the/DT friction/NN coefficient/NN did/VBD not/RB differ/VB significantly/RB from/IN that/DT of/IN an/DT unused/JJ PE/NN head/JJ ./.
@@26369203767 Collaborative/NNP study/NN of/IN Japanese/JJ Pharmacopoeia/NN Heparin/NN Sodium/NN Reference/NNP Standard/NNP ./.
@@86318204068 The/DT cDNA/NN corresponding/JJ to/IN the/DT FPS1/NEWGENE gene/NEWGENE was/VBD isolated/VBN by/IN functional/JJ complementation/NN of/IN a/DT mutant/JJ yeast/NN strain/NN defective/JJ in/IN FPS/NEWGENE activity/NN (/( Delourme/NNP ,/, D/NN ./NN ,/, Lacroute/JJ ,/, F/NN ./NN ,/, and/CC Karst/NNP ,/, F/NN ./NN
@@8853303348 Pharmacokinetic/JJ parameters/NNS were/VBD similar/JJ to/IN values/NNS given/VBP in/IN the/DT literature/NN for/IN intravenous/JJ (/( IV/NN )/SYM or/CC intraarterial/JJ (/( IA/NN )/SYM bolus/NN MMC/NN injections/NNS (/( Tmax/NN =/SYM 7/CD ./CD 0/CD min/NN following/IN the/DT beginning/NN of/IN MMC/NN infusion/NN ,/, Vss/NNS =/SYM 0/CD ./CD 57/CD 1/CD //CD kg/CD ,/, C1/NN =/SYM 8/CD ./CD 9/CD ml/CD //CD min/CD ./CD kg/CD ,/, T1/NN //NN 2/NN alpha/NN =/SYM 8/CD ./CD 3/CD min/NN ,/, T1/NN //NN 2/NN beta/NN =/SYM 58/CD ./CD 6/CD min/NN )/SYM ./.
@@104545618733 In/NN the/DT present/NN study/NN ,/, we/PRP demonstrate/VBP that/DT expression/NN of/IN TD-IkappaBalpha/NEWGENE blocked/VBD phorbol/NN myristate/NN acetate-phytohemagglutinin/NEWGENE or/CC tumor/NEWGENE necrosis/NEWGENE factor/NEWGENE alpha-induced/NN IkappaBalpha/NEWGENE gene/NEWGENE transcription/NN and/CC abolished/VBN NF-kappaB/NEWGENE DNA/NN binding/JJ activity/NN ,/, due/NN to/IN the/DT continued/VBN cytoplasmic/JJ sequestration/NN of/IN RelA/NEWGENE (/NEWGENE p65/NEWGENE )/NEWGENE by/IN TD-IkappaBalpha/NEWGENE ./.
@@29095281655 A/DT second/JJ promoter/NN activity/NN was/VBD identified/VBN in/IN the/DT region/NN between/IN the/DT two/JJ major/JJ transcriptional/JJ start/NN sites/NNS ./.
@@107130831247 Unique/JJ to/IN this/DT system/NN ,/, the/DT activity/NN of/IN TraR/NEWGENE is/VBZ negatively/RB modulated/VBN by/IN an/DT antiactivator/NN called/VBN TraM/NEWGENE ./.
@@28927624893 Direct/JJ and/CC inverted/JJ repeat/NN elements/NNS of/IN 10/CD ,/, 11/CD ,/, 16/CD ,/, 19/CD ,/, and/CC 22/CD nucleotides/NNS (/( nt/NN )/SYM flank/NN the/DT promoter/NN site/NN ./.
@@67603947750 Single/NNP tooth/NN replacement/NN with/IN the/DT aid/NN of/IN the/DT ITI/NN (/( International/NNP Team/NNP fur/NN Implantologie/NNP )/SYM type/NN F/NN hollow-cylinder/JJ implant/NN ./.
@@13485082136 Interestingly/RB ,/, the/DT positions/NNS of/IN these/DT introns/NNS have/NN been/VBN conserved/VBN in/IN comparison/NN with/IN the/DT genes/NNS of/IN two/JJ other/DT transglutaminase-like/JJ activities/NNS described/VBN in/IN the/DT literature/NN ,/, but/CC the/DT TGM1/NEWGENE gene/NEWGENE is/VBZ by/IN far/RB the/DT smallest/RBS characterized/VBN to/IN date/NN because/IN its/PRP introns/NNS are/VBP relatively/RB smaller/JJR ./.
@@43236414930 Studies/NNS on/IN swine/NN enteroviruses/NNS ./.
@@86214534286 In/NN addition/NN ,/, anti-phosphotyrosine/NEWGENE antibodies/NEWGENE immunoprecipitated/VBN 80K-H/NEWGENE from/IN cell/NN lysates/NNS of/IN FGF-stimulated/JJ but/CC not/RB from/IN control/NN fibroblasts/NNS ./.
@@79993639095 Splice/NNP variations/NNS in/IN genes/NNS coding/JJ for/IN the/DT transmembrane/NEWGENE FGF/NEWGENE receptor/NEWGENE (/( FGFR/NEWGENE )/SYM result/NN in/IN isoforms/NNS that/WDT vary/VBP in/IN the/DT ectodomain/NN ,/, intracellular/JJ juxtamembrane/JJ domain/NN ,/, and/CC the/DT intracellular/NEWGENE kinase/NEWGENE domain/NEWGENE ./.
@@39819521376 The/DT efficacy/NN of/IN quantitative/JJ and/CC qualitative/JJ chloride/NN titrators/NN in/IN the/DT estimation/NN of/IN human/JJ salt/JJ intake/NN ./.
@@62593896061 During/IN the/DT period/NN from/IN May/NN to/IN August/NN ,/, 1978/CD ,/, an/DT epidemic/NN of/IN hand/NN ,/, foot/NN and/CC mouth/NN disease/NN (/( HFMD/NNP )/SYM occurred/VBN in/IN Gifu/NNP prefecture/NN ./.
@@118001191664 The/DT design/NN principle/NN based/VBN on/IN a/DT uniform/JJ vibration/NN mode/NN is/VBZ presented/VBN ./.
@@18784894982 The/DT enzymatic/JJ response/NN of/IN neutrophils/NNS and/CC monocytes/NNS was/VBD similar/JJ although/IN the/DT magnitude/NN of/IN the/DT NADPH/NEWGENE oxidase/NEWGENE activity/NN was/VBD significantly/RB higher/JJ in/IN neutrophils/NNS than/IN in/IN monocytes/NNS ./.
@@18839923989 These/DT results/NNS suggest/VBP that/IN beta-1/NEWGENE may/MD act/VB as/IN a/DT tissue-specific/NN ,/, trans-acting/JJ regulator/NN of/IN the/DT expression/NN of/IN the/DT beta-zein/NEWGENE gene/NEWGENE in/IN developing/JJ maize/NN endosperm/NN ./.
@@115648936729 Thus/RB ,/, through/RB a/DT change/NN in/IN conformation/NN upon/IN repair/NN of/IN the/DT 6RG/CD lesion/NN ,/, MGMT/NEWGENE switches/NNS from/IN a/DT DNA/NN repair/NN factor/NN to/IN a/DT transcription/NN regulator/NN (/( R-MGMT/NEWGENE )/SYM ,/, enabling/VBG the/DT cell/NN to/RB sense/NN as/RB well/VB as/IN respond/NN to/IN mutagens/NNS ./.
@@82784232615 Mothers/NNS with/IN severe/JJ anatomical/JJ abnormalities/NNS ,/, who/WP are/VBP HIV/NN positive/JJ ,/, have/VB active/JJ TB/NN or/CC whose/WP children/NNS have/VBP inherited/JJ mono-/NN or/CC disaccharide/NN intolerances/NNS should/MD not/RB breastfeed/VB ./.
@@47333915127 Metal/NNP coordination/NN compounds/NNS of/IN thiabendazole/NN ./.
@@8372628339 The/DT responsiveness/NN of/IN visual/JJ cortex/NN (/( VC/NN )/SYM and/CC superior/JJ colliculus/NN (/( SC/NN )/SYM was/VBD simultaneously/RB compared/VBN following/IN conditioning/JJ "ON"/NN or/CC "OFF"/NN stimulation/NN ,/, in/IN the/DT rabbit/NN ./.
@@31990433897 Existence/NN and/CC uniqueness/NN of/IN solutions/NNS of/IN the/DT appropriate/JJ boundary/NN value/NN problems/NNS are/VBP established/VBN ,/, in/IN the/DT case/NN of/IN small/JJ permeability/NN coefficients/NNS and/CC transport/NN rates/NNS ,/, or/CC large/JJ diffusion/NN coefficients/NNS and/CC small/JJ resistance/NN to/IN flow/NN constants/NNS ./.
@@13920125650 The/DT neurohypophysial/JJ vasopressin/NEWGENE and/CC oxytocin/NEWGENE content/NN was/VBD bioassayed/VBN by/IN pressor/JJ effect/NN following/IN Dekanski/NNP or/CC milk-ejection/NN activity/NN in/IN vitro/FW following/IN van/NNP Dongen/NNP and/CC Hays/NNP ,/, respectively/RB ./.
@@23621613021 MK-927/CD :/: a/DT topically/RB active/JJ ocular/JJ hypotensive/JJ carbonic/NEWGENE anhydrase/NEWGENE inhibitor/NN ./.
@@115860961476 Because/IN of/IN differences/NNS in/IN patient/JJ characteristics/NNS ,/, control/NN measurements/NNS were/VBD obtained/VBN from/IN normal/JJ muscle/NN in/IN all/DT patients/NNS ./.
@@104972623040 We/PRP have/VBP cloned/VBN the/DT single-copy/JJ gene/NN for/IN the/DT trans/NEWGENE -spliceosomal/NEWGENE U5/NEWGENE snRNA/NEWGENE from/IN the/DT trypanosomatid/NN species/NN Leptomonas/NNP seymouri/NN ,/, using/VBG U5/NEWGENE RNA/NEWGENE affinity/NN selection/NN and/CC cDNA/NN cloning/NN ./.
@@81260962351 In/NN these/DT experiments/NNS we/PRP begin/VBP to/IN study/NN the/DT potential/JJ functions/NNS of/IN the/DT alpha/NEWGENE 7/NEWGENE cytoplasmic/NEWGENE domain/NEWGENE by/IN analyzing/VBG homologies/NNS between/IN the/DT rat/NN and/CC human/JJ sequences/NNS ,/, by/IN immunologic/JJ studies/NNS using/VBG an/DT anti-cytoplasmic/JJ domain/NN antiserum/NN ,/, and/CC by/IN identifying/JJ two/JJ alternate/JJ forms/NNS ./.
@@22532747257 The/DT Mauriceville/NNP and/CC Varkud/NNP mitochondrial/JJ plasmids/NNS are/VBP closely/RB related/VBN ,/, closed-circular/JJ DNAs/NNS (/( 3/CD ./CD 6/CD and/CC 3/CD ./CD 7/CD kb/NN ,/, respectively/RB )/SYM that/WDT have/VBP characteristics/NNS of/IN mtDNA/NN introns/NNS and/CC retroid/NN elements/NN ./.
@@118497965752 RESULTS/NNS :/: The/DT target/NN dose/NN was/VBD comparable/JJ in/IN the/DT 3D-CRT/JJ and/CC IMRT/NN plans/VBZ ,/, although/IN improvements/NNS were/VBD seen/VBP when/CC seven/JJ and/CC nine/JJ IMRT/NNP fields/NNS were/VBD used/VBN ./.
@@93621058287 [/NN Pulmonary/NN vascular/JJ resistance/NN (/( PVR/NN )/SYM during/IN 10%/CD O2-PVR/NN during/IN 21%/JJ O2/NN //NN PVR/NN during/IN 21%/NN O2/NN ]/NN x/NN 100/CD was/VBD termed/JJ as/IN hypoxic/JJ pulmonary/JJ vasoconstriction/NN (/( HPV/NN )/SYM ./.
@@81886038694 This/DT analysis/NN revealed/VBD an/DT intact/JJ gene/NN (/( arg4/NEWGENE )/SYM showing/VBG a/DT high/JJ degree/NN of/IN homology/NN with/IN the/DT Saccharomyces/NEWGENE cerevisiae/NEWGENE CPA2/NEWGENE gene/NEWGENE encoding/VBG the/DT large/JJ subunit/NN of/IN carbamoyl-phosphate/NEWGENE synthetase/NEWGENE (/( CPS-A/NEWGENE )/SYM ./.
@@54374055543 Diminished/JJ forearm/NN arteriolar/JJ dilator/NN capacity/NN produced/VBN by/IN mineralocorticoid-induced/JJ salt/JJ retention/NN in/IN man/NN ./.
@@90069147335 The/DT effects/NNS of/IN dominant/JJ interfering/JJ forms/NNS of/IN the/DT JNK/NEWGENE //NEWGENE p38/NEWGENE signaling/JJ pathway/NN demonstrate/VB that/DT activation/NN of/IN these/DT kinases/NNS is/VBZ critical/JJ for/IN cytokine-induced/NN E-selectin/NEWGENE gene/NEWGENE expression/NN ./.
@@29306233638 During/IN flexion/NN whiplash/NN ,/, the/DT torque/NN at/IN the/DT occipital/JJ condyle/NN reverses/VBP its/PRP direction/NN at/IN about/RB 25/CD ms/NN after/IN impact/NN ./.
@@104908162338 Mutations/NNS of/IN the/PDT RET/NEWGENE gene/NEWGENE ,/, encoding/VBG a/DT receptor/NEWGENE tyrosine/NEWGENE kinase/NEWGENE ,/, have/VB been/VBN associated/VBN with/IN the/DT inherited/JJ cancer/NN syndromes/NNS MEN/NN 2A/NN and/CC MEN/NN 2B/CD ./CD
@@114136411280 Analyses/NNS revealed/VBD that/IN scale/NN matters/NNS above/RB and/CC beyond/RB the/DT effect/NN of/IN quadrat/NN area/NN ./.
@@80559416954 The/DT topology/NN and/CC chain/NN folding/NN of/IN the/DT beta/NN subunits/NN in/IN the/DT artifactual/JJ beta/NN 60/NN capsid/NN are/VBP similar/JJ to/IN the/DT native/NEWGENE alpha/NEWGENE 3/NEWGENE beta/NEWGENE 60/NEWGENE enzyme/NEWGENE ./.
@@88043899667 Northern/NNP blot/NN analysis/NN ,/, using/VBG the/DT Ltp4-specific/NNP probe/NN ,/, indicated/VBN that/IN Xanthomonas/NNP campestris/NN pv/CD ./CD translucens/NNS induced/VBD an/DT increase/NN over/RB basal/JJ levels/NNS of/IN Ltp4/NEWGENE mRNA/NEWGENE ,/, while/CC Pseudomonas/NNS syringae/JJ pv/CD ./CD japonica/NN caused/VBD a/DT decrease/NN ./.
@@107027945319 Together/RB ,/, these/DT data/NN identify/VB ERK2/NEWGENE as/IN a/DT specific/JJ and/CC direct/JJ target/NN of/IN HePTP/NEWGENE and/CC are/VBP consistent/JJ with/IN a/DT model/NN in/IN which/WDT HePTP/NEWGENE negatively/RB regulates/VBZ ERK2/NEWGENE activity/NN as/IN part/NN of/IN a/DT feedback/NN mechanism/NN ./.
@@86277198898 UV/NN cross-linking/VBG experiments/NNS demonstrated/VBD that/DT HSV/NN infection/NN caused/VBN enhanced/VBN binding/NN of/IN protein/NN factors/NNS ,/, including/JJ the/DT 64-kDa/NEWGENE component/NEWGENE of/NEWGENE cleavage/NEWGENE stimulation/NEWGENE factor/NEWGENE (/( CstF/NEWGENE )/SYM ,/, to/IN poly/NN (/NN A/NN )/NN site/NN RNAs/NNS from/IN virus/NN genes/NNS of/IN all/DT temporal/JJ classes/NNS and/CC that/IN this/DT enhanced/VBN binding/JJ required/VBN expression/NN of/IN IE63/NEWGENE ./.
@@108857506556 However/RB ,/, little/NN was/VBD understood/VBP about/RB the/DT normal/JJ function/NN of/IN CREB-2/NEWGENE in/IN mammalian/JJ development/NN or/CC organ/NN physiology/NN ./.
@@25159533159 Follow-up/JJ study/NN showed/VBD 85%/NN of/IN these/DT patients/NNS with/IN effectiveness/NN ./.
@@107043381530 In/NN order/NN to/IN gain/NN deeper/JJR insight/NN into/IN the/DT role/NN of/IN the/DT amino-terminal/JJ domain/NN of/IN the/DT p24/NEWGENE (/NEWGENE CA/NEWGENE )/NEWGENE protein/NN during/IN viral/JJ replication/NN ,/, eight/CD highly/RB conserved/VBN proline/NN residues/NNS known/VBP to/IN promote/VB turns/NNS and/CC to/IN terminate/VB alpha-helices/NNS within/IN the/DT p24/NEWGENE tertiary/JJ structure/NN were/VBD replaced/VBN by/IN a/DT leucine/NN residue/NN (/( P-position-L/NNP )/SYM ./.
@@114330148587 However/RB ,/, when/CC directed/VBD to/IN the/DT nucleosome/NN by/IN fusion/NN to/IN core/NEWGENE histone/NEWGENE H2A/NEWGENE or/CC H2B/NEWGENE ,/, the/DT non-histone/JJ tail/NN forms/VBZ an/DT MCB/NN that/WDT appears/VBZ identical/JJ to/IN that/DT of/IN the/DT endogenous/JJ protein/NN ./.
@@11245986521 A/DT novel/JJ growth-related/NN nuclear/NN protein/NN binds/VBZ and/CC inhibits/VBZ rat/NN aldolase/NEWGENE B/NEWGENE gene/NEWGENE promoter/NN ./.
@@24737187950 The/DT investigation/NN was/VBD apt/JJ at/IN studying/VBG the/DT relationship/NN between/IN urinary/JJ metabolites/NNS of/IN serotonin/NN and/CC catecholamine/NN (/( 5-HIAA/NN and/CC VMA/NN )/SYM ,/, T-cells/NNS (/( OKT3+/NEWGENE )/SYM ,/, T-helper/NN (/( OKT4+/NEWGENE )/SYM ,/, T-suppressor/NN (/( OKT8+/NEWGENE )/SYM and/CC B-cells/NNS (/( EAC-rosette/JJ forming/JJ cells/NNS )/SYM in/IN normal/JJ (/( 10/CD subjects/NNS ,/, 1/CD female/JJ ,/, 9/CD male/JJ ,/, age/NN 21/CD +/NN //NN -/NN 5/CD years/NNS )/SYM and/CC stress/NN administered/VBD subjects/NNS (/( 20/CD subjects/NNS ,/, 3/CD female/JJ ,/, 17/CD male/JJ ,/, age/NN 20/CD +/NN //NN -/NN 4/CD years/NNS )/SYM ./.
@@85888528563 During/IN the/DT following/JJ pregnancy/NN ultrasonographic/JJ studies/NNS of/IN the/DT male/JJ fetus/NN in/IN the/DT 16th/CD week/NN of/IN gestation/NN revealed/VBD severe/JJ micrognathia/NN ,/, short/JJ and/CC wide/JJ thumbs/NNS ,/, and/CC big/JJ toes/NNS ,/, and/CC bowed/JJ tibiae/NNS ./.
@@8073565003 Bacteriostatic/JJ and/CC bacteriacidal/JJ activity/NN of/IN hydroxy-9/NN ellipticine/NN in/IN vitro/FW ./.
@@82912338375 A/DT cDNA/NN clone/NN was/VBD isolated/VBN from/IN a/DT chicken/NN embryo/NN cDNA/NN library/NN employing/VBG a/DT PCR-generated/JJ radiolabeled/JJ probe/NN specific/JJ for/IN the/DT U3/NEWGENE region/NEWGENE of/IN the/DT Rous/NN sarcoma/NN virus/NN LTR/NN ./.
@@117087619795 Finally/RB ,/, there/RB are/VBP a/DT growing/JJ number/NN of/IN arguments/NNS favouring/VBG the/DT use/NN of/IN ACE/NEWGENE inhibitors/NN very/RB early/RB in/IN patients/NNS with/IN diabetes/NN mellitus/MD ./.
@@84589068426 5/CD micrograms/NN //NN l/NN was/VBD detected/VBN in/IN urine/NN from/IN some/DT non-occupationally/RB exposed/VBN persons/NNS ./.
@@77893967765 Lipiodol/NN was/VBD covalently/RB conjugated/JJ with/IN EDTB/NN ./.
@@93716986865 Transfection/NNS of/IN HepG2/CELL and/CC SK-N-MC/CELL cells/NNS with/IN constructs/NNS deleted/VBN of/IN additional/JJ 5'-flanking/JJ fragments/NNS permitted/VBD the/DT definition/NN of/IN a/DT minimal/JJ 200/CD bp/NN promoter/NN fragment/NN containing/JJ the/DT pseudo-TATA/JJ box/NN and/CC two/JJ putative/JJ SP1-binding/NEWGENE sites/NEWGENE ./.
@@96536486743 Comparison/NNS of/IN cDNA/NN and/CC genomic/JJ sequences/NNS shows/VBZ that/IN the/DT ZNF189/NEWGENE gene/NEWGENE spans/NNS approximately/RB 11/CD kb/NN and/CC is/VBZ organized/VBN into/IN at/IN least/RB four/CD exons/NNS ,/, the/DT large/JJ 3'-end/CD exon/NN coding/JJ for/IN the/DT complete/JJ zinc/NN finger/NN domain/NN and/CC the/DT 3'/CD untranslated/JJ region/NN ./.
@@17307476624 86/CD :/: 3199-3203/NN )/NN or/CC G1/NN to/IN S/NNP phase/NN (/( Reilly/NN ,/, C/NNP ./NNP
@@84375216446 Mutations/NNS truncating/JJ as/RB many/JJ as/IN 143/CD C-terminal/NN residues/NNS from/IN the/DT transcriptional/JJ activator/NN encoded/VBN by/IN the/DT areA/NEWGENE gene/NEWGENE ,/, mediating/JJ nitrogen/NN metabolite/NN repression/NN in/IN Aspergillus/NNS nidulans/NNS ,/, do/VB not/RB significantly/RB reduce/VB the/DT ability/NN of/IN the/DT areA/NEWGENE product/NEWGENE to/IN activate/VB expression/NN of/IN most/JJ genes/NNS under/IN areA/NEWGENE control/NN ./.
@@102252791368 However/RB ,/, we/PRP identified/VBD a/DT gene/NN between/IN the/DT MDV2/NEWGENE UL54/NEWGENE and/CC UL55/NEWGENE genes/NEWGENE with/IN homology/NN to/IN the/DT first/JJ ORF/NN (/( ORF-1/NEWGENE )/SYM of/IN equine/JJ herpesvirus/NN type/NN 1/CD and/CC corresponding/JJ gene/NN identified/VBN in/IN pseudorabies/NN virus/NN ./.
@@92593205082 Using/VBG lectin-affinity/JJ chromatography/NN ,/, discordance/NN between/IN the/DT pattern/NN of/IN O-glycosylation/NNS of/IN SSBP/NEWGENE and/CC DSBP/NEWGENE was/VBD demonstrated/VBN ./.
@@113998349544 The/DT first/JJ case/NN of/IN HCV/NN seroconversion/NN in/IN Portugal/NN after/IN the/DT introduction/NN of/IN HCV/NN NAT/NN screening/NN ./.
@@99175552400 Analysis/NNP of/IN hematopoietic/NEWGENE growth/NEWGENE factor/NEWGENE prescriptions/NNS in/IN 19/CD french/JJ cancer/NN centers/NNS ./.
@@94239686817 The/DT mechanism/NN underlying/JJ such/JJ analgesia/NN has/VBZ been/VBN suggested/VBN to/IN involve/VB the/DT interaction/NN between/IN the/DT two/JJ separate/JJ but/CC interconnected/VBN motivational/JJ systems/NNS "defense"/NN and/CC "pain/NN ./NN "/NN To/TO determine/VB the/DT developmental/JJ course/NN of/IN defense/NN and/CC nociception/NN ,/, these/DT processes/NNS were/VBD analyzed/VBN during/IN early/JJ ontogeny/NN in/IN rats/NNS ./.
@@76009864996 By/IN in/IN vitro/FW immunoprecipitations/NNS and/CC gel/NN shift/NN assays/NNS ,/, we/PRP identified/VBD two/JJ classes/NNS of/IN high/NN affinity/NN Engrailed-binding/NEWGENE sites/NEWGENE upstream/RB of/IN each/DT of/IN the/DT two/JJ polyhomeotic/JJ transcription/NN units/NNS ./.
@@30093662282 From/IN our/PRP ultrastructural/JJ and/CC biochemical/JJ studies/NNS ,/, it/PRP is/VBZ evident/JJ that/DT Type/NN II/NN pneumocytes/NNS are/VBP an/DT early/JJ target/NN of/IN radiation/NN and/CC the/DT release/NN of/IN surfactant/JJ into/IN the/DT alveolus/NN shortly/RB after/IN exposure/NN persists/VBZ for/IN days/NNS and/CC weeks/NNS ./.
@@115478191426 METHODS/IN :/: Experiments/NNS testing/VBG the/DT new/JJ catheter/NN and/CC comparing/VBG it/PRP to/IN the/DT existing/JJ catheter/NN included/VBN :/: (/( 1/CD )/SYM measurement/NN of/IN the/DT laser/NN output/NN beam/NN sizes/NNS and/CC divergences/NNS ;/: (/( 2/CD )/SYM evaluation/NN of/IN particulate/JJ matter/NN generation/NN during/IN ablation/NN of/IN atherosclerotic/JJ tissue/NN ;/: (/( 3/CD )/SYM measurement/NN of/IN ablation/NN hole/NN sizes/NNS and/CC tissue/NN penetration/NN rates/NNS ;/: (/( 4/CD )/SYM histopathologic/JJ examination/NN of/IN laser-induced/JJ in/IN vivo/NN vessel/NN wall/NN injury/NN ./.
@@74238037277 Treatment/NNP of/IN suppurative/JJ peritonitis/NN ./.
@@84357558395 In/NN Experiment/NN 2/CD scopolamine/NN hydrobromide/NN ,/, 0/CD ./CD 5/CD and/CC 1/CD ./CD 0/CD mg/CD //CD kg/CD i/CD ./CD p/CD ./CD ,/, was/VBD administered/VBN 1/CD h/NN before/IN each/DT electrical/JJ stimulation/NN until/IN each/DT rat/NN showed/VBD the/DT stage-3/NN seizure/NN ./.
@@94304619648 In/NN the/DT clinical/JJ study/NN ,/, the/DT defect/NN size/NN shown/VBP by/IN BMIPP/NN imaging/VBG was/VBD greater/JJR in/IN anterior/JJ than/IN in/IN inferior/JJ infarcts/NNS (/( p/NN </SYM 0/CD ./CD 001/CD )/SYM and/CC correlated/VBN well/VB with/IN the/DT risk/NN area/NN revealed/VBN by/IN contrast/NN ventriculography/NN (/( r/JJ =/SYM 0/CD ./CD 80/CD ,/, p/NN </SYM 0/CD ./CD 0001/CD )/SYM CONCLUSION/IN :/: The/DT above/RB preliminary/JJ data/NN ,/, admittedly/RB from/IN a/DT small/JJ group/NN of/IN patients/NNS ,/, suggest/VB that/IN tomographic/JJ BMIPP/NN imaging/VBG provides/VBZ an/DT accurate/JJ quantification/NN of/IN defect/NN size/NN by/IN means/NN of/IN a/DT simple/JJ threshold/NN technique/NN and/CC ,/, in/IN the/DT subacute/JJ phase/NN ,/, permits/VBP determination/NN of/IN the/DT amount/NN of/IN myocardium/NN at/IN risk/NN after/IN acute/JJ myocardial/JJ infarction/NN ./.
@@82596509671 Nucleotide/NN sequence/NN analysis/NN of/IN the/DT HA/NEWGENE gene/NEWGENE in/IN these/DT two/JJ mutants/NNS confirmed/VBD the/DT HA-/NEWGENE phenotype/NN ./.
@@78026553556 Characterization/NNS of/IN FIII/NEWGENE //NEWGENE YY1/NEWGENE ,/, a/DT Xenopus/NN laevis/NNS conserved/VBN zinc-finger/NN protein/NN binding/JJ to/IN the/DT first/JJ exon/NN of/IN L1/NEWGENE and/CC L14/NEWGENE ribosomal/NEWGENE protein/NEWGENE genes/NEWGENE ./.
@@94030592362 This/DT binary/JJ repeat/NN contains/VBZ repetitive/JJ DNA/NN elements/NNS that/WDT include/VBP LINES/NNS ,/, SINES/NNS ,/, medium/NN reiteration/NN frequency/NN repeats/NNS ,/, and/CC a/DT transposon-like/NN element/NN ./.
@@112782862600 Corticosteroid-mediated/JJ transcriptional/JJ inhibition/NN was/VBD greater/JJR for/IN MR/NEWGENE //NEWGENE GR/NEWGENE in/IN combination/NN than/IN for/IN MR/NEWGENE or/CC GR/NEWGENE alone/RB ./.
@@35972694254 The/DT other/DT model/NN was/VBD a/DT continuous/JJ exponential/NN plus/IN constant/NN of/IN the/DT form/NN La-/NN =/SYM a/DT +/SYM b/NN [/NN exp/NN (/NN cVO2/NN )/NN ]/NN ./.
@@81891746742 DESIGN--A/NN randomised/JJ study/NN was/VBD conducted/VBN in/IN all/DT women/NNS aged/VBD 50-70/JJ years/NNS who/WP were/VBD eligible/JJ for/IN breast/NN cancer/NN screening/JJ and/CC living/VBG in/IN the/DT city/NN of/IN Utrecht/NNP ./.
@@79588985681 Interestingly/RB ,/, dTFIIA-L/NEWGENE //NEWGENE S/NEWGENE is/VBZ also/RB able/JJ to/IN significantly/RB enhance/VB transcriptional/JJ activation/NN by/IN upstream/JJ transcription/NN factors/NNS including/JJ Sp1/NEWGENE ,/, VP16/NEWGENE ,/, and/CC NTF-1/NEWGENE ./.
@@96763493119 A/DT "Level/NNP A"/NNP in/IN vitro/NN //NN in/NN vivo/NN correlation/NN was/VBD established/VBN for/IN a/DT sustained/JJ release/NN theophylline/NN (/( CAS/IN 58-55-9/CD )/SYM preparation/NN (/( Bronchoretard/IN )/SYM under/IN investigation/NN ./.
@@97706869760 The/DT most/RB frequent/VB risk/NN factor/NN for/IN ischaemic/JJ was/VBD hypertension/NN ./.
@@102326007013 Prostate-specific/NEWGENE antigen/NEWGENE (/( PSA/NEWGENE )/SYM promoter-driven/JJ androgen-inducible/JJ expression/NN of/IN sodium/NEWGENE iodide/NEWGENE symporter/NEWGENE in/IN prostate/NN cancer/NN cell/NN lines/NNS ./.
@@110759442232 In/NN addition/NN ,/, npm3/NEWGENE ,/, which/WDT is/VBZ usually/RB coactivated/VBN with/IN fgf8/NEWGENE by/IN MMTV/NN insertion/NNS ,/NNS was/NNS not/RB up-regulated/IN by/IN androgens/NNS in/IN SC-3/NN cells/NNS ./.
@@22811189158 Prostaglandin/NN synthesis/NN inhibitors/NN have/VBP been/VBN shown/VBP to/IN delay/NN healing/NN of/IN bone/NN and/CC this/DT has/VBZ led/VBN to/IN limitations/NNS on/IN their/PRP use/NN clinically/RB in/IN some/DT situations/NNS ./.
@@114590481333 Here/RB we/PRP show/VBP that/DT independent/NN of/IN uncertainties/NNS in/IN the/DT models/NNS ,/, terrestrial/JJ planets/NNS with/IN dense/JJ atmosphere/NN like/JJ Venus/NN can/MD evolve/VB into/IN one/PRP of/IN only/RB four/CD possible/JJ rotation/NN states/NNS ./.
@@100228674368 Elimination/NN of/IN ETH1/NEWGENE in/IN apn1/NEWGENE strains/NNS also/RB increased/VBN spontaneous/JJ mutation/NN rates/NNS 9-/CD or/CC 31-fold/RB compared/VBN to/IN the/DT wild/JJ type/NN as/IN determined/VBN by/IN reversion/NN to/IN adenine/NN or/CC lysine/NN prototrophy/NN ,/, respectively/RB ./.
@@76513984084 In/JJ flies/NNS ,/, the/DT dShc/NEWGENE protein/NEWGENE physically/RB associates/VBP with/IN the/DT activated/VBN Drosophila/NEWGENE epidermal/NEWGENE growth/NEWGENE factor/NEWGENE receptor/NEWGENE homolog/NEWGENE (/( DER/NEWGENE )/SYM and/CC is/VBZ inducibly/RB phosphorylated/VBN on/IN tyrosine/NN by/IN DER/NEWGENE ./.
@@88232608805 FEV1/NN did/VBD not/RB fall/VB significantly/RB in/IN patients/NNS without/IN acute/JJ or/CC chronic/JJ GVHD/NN and/CC recovered/VBN earlier/JJR than/IN in/IN patients/NNS without/IN posttransplant/JJ pulmonary/JJ infection/NN ./.
@@11031366863 Helicobacter/NN pylori/NNS and/CC stomach/NN diseases/NNS :/: from/IN clinical/JJ point/NN of/IN view/NN
@@106886614952 Its/PRP cognate/NN binding/NN protein/NN ,/, REST/NEWGENE //NEWGENE NRSF/NEWGENE ,/, is/VBZ an/DT essential/JJ transcription/NN factor/NN ;/: its/PRP null/JJ mutations/NNS result/NN in/IN embryonic/JJ lethality/NN ,/, and/CC its/PRP dominant/JJ negative/JJ mutants/NNS produce/VBP aberrant/JJ expression/NN of/IN neuron-specific/NN genes/NN ./.
@@88375035258 These/DT two/JJ repeat/NN motifs/NNS are/VBP organized/VBN in/IN an/DT extremely/RB well-ordered/JJ pattern/NN in/IN each/DT domain/NN ,/, which/WDT suggests/VBZ that/IN SbHRGP3/NEWGENE belongs/VBZ to/IN a/DT new/JJ group/NN of/IN proteins/NNS having/VBG the/DT repeat/NN motifs/NNS of/IN two/JJ distinct/JJ groups/NNS of/IN dicot/NEWGENE extensins/NEWGENE ./.
@@108353555898 Here/RB ,/, we/PRP show/VBP that/IN the/DT zinc/NEWGENE finger/NEWGENE protein/NEWGENE Gis1/NEWGENE acts/NNS as/IN a/DT dosage-dependent/NN suppressor/NN of/IN the/DT rim15Delta/NEWGENE defect/NN in/IN nutrient/JJ limitation-induced/JJ transcriptional/JJ derepression/NN of/IN SSA3/NEWGENE ./.
@@78524002762 Rho/NEWGENE GDP/NEWGENE //NEWGENE GTP/NEWGENE exchange/NEWGENE inhibitor/NEWGENE ,/, Rho/NEWGENE GDI/NEWGENE ,/, comigrated/VBN with/IN Rac2/NEWGENE and/CC RhoA/NEWGENE ,/, but/CC not/RB Rac1/NEWGENE ./.
@@20358052646 Angina/NNS haemorrhagica/NN bullosa/NN causing/JJ respiratory/JJ obstruction/NN postoperatively/RB ./.
@@19065091241 In/NN this/DT study/NN ,/, we/PRP have/VBP cloned/VBN the/DT 5'-flanking/JJ region/NN of/IN the/DT human/NEWGENE nidogen/NEWGENE gene/NEWGENE ./.
@@68076596580 Phagocytosis/NNS of/IN tubercle/NN bacilli/NNS by/IN macrophages/NNS ./.
@@13164592197 Acad/NN ./.
@@75595638493 A/DT mutant/JJ (/( residues/NNS 1-332/CD )/SYM showed/VBD complete/JJ Ca2+/NNP //NNP CaM-dependent/NNP activity/NN ./.
@@12943455527 A/DT statistically/RB significant/JJ improvement/NN due/NN to/IN the/DT administration/NN of/IN Bromergon/NNP was/VBD observed/VBN in/IN symptoms/NNS associated/VBN with/IN overreactiveness/NN to/IN normal/JJ prolactin/NEWGENE levels/NNS ,/, i/CD ./CD e/CD ./. abdominal/JJ tension/NN ,/, edema/NN ,/, weight/NN gain/NN and/CC breast/NN tenderness/NN ./.
@@76334449809 Structural/NNP organization/NN and/CC developmental/JJ expression/NN pattern/NN of/IN the/DT mouse/NEWGENE WD-repeat/NEWGENE gene/NEWGENE DMR-N9/NEWGENE immediately/RB upstream/RB of/IN the/DT myotonic/NEWGENE dystrophy/NEWGENE locus/NEWGENE ./.
@@74057019042 Visual/JJ averaged/VBN evoked/VBN responses/NNS and/CC platelet/NEWGENE monoamine/NEWGENE oxidase/NEWGENE in/IN patients/NNS suffering/VBG from/IN alcoholism/NN ./.
@@82343088218 Notice/NN of/IN retraction/NN ./.
@@99652341829 Anisotropic/NNP heat/NN transport/NN in/IN the/DT octylcyanobiphenyl/NN (/( 8CB/NN )/SYM liquid/JJ crystal/NN ./.
@@98824892359 In/NN this/DT study/NN ,/, evidence/NN is/VBZ presented/VBN that/IN temporally/RB and/CC spatially/RB specific/NN mef2/NEWGENE expression/NN is/VBZ controlled/VBN by/IN a/DT complex/NN array/NN of/IN cis-acting/JJ regulatory/JJ modules/NNS that/WDT are/VBP responsive/JJ to/IN different/JJ genetic/JJ signals/NNS ./.
@@118888671785 BACKGROUND/IN :/: We/PRP hypothesized/VBN that/IN the/DT postoperative/JJ serum/JJ level/NN of/IN TA90-IC/NEWGENE ,/, an/DT immune/JJ complex/NN of/IN a/DT 90-kDa/CD tumor-associated/JJ antigen/NN and/CC its/PRP antibody/NN ,/, might/MD have/VB a/DT significant/JJ correlation/NN with/IN recurrence/NN and/CC survival/NN in/IN patients/NNS with/IN thick/JJ primary/JJ melanomas/NNS ./.
@@53944613129 Tolerance/NN test/NN of/IN HB/NN 419/NN in/IN animal/NN experiments/NNS ./.
@@112119367370 The/DT present/NN data/NN also/RB demonstrate/VB that/IN ectopic/JJ expression/NN of/IN blr1/NEWGENE increased/VBN JNK/NEWGENE //NEWGENE SAPK/NEWGENE activity/NN ,/, but/CC JNK/NEWGENE //NEWGENE SAPK/NEWGENE1 activation/NN was/VBD not/RB needed/VBN for/IN accelerated/JJ RA-induced/JJ differentiation/NN and/CC growth/NN arrest/NN ./.
@@111577634502 Structure/NNS of/IN the/DT EMAPII/NEWGENE domain/NEWGENE of/IN human/NEWGENE aminoacyl-tRNA/NEWGENE synthetase/NEWGENE complex/NEWGENE reveals/VBZ evolutionary/JJ dimer/NN mimicry/NN ./.
@@95519383113 To/TO identify/VB nuclear/JJ regulatory/JJ factors/NNS ,/, we/PRP have/VBP located/VBN and/CC functionally/RB characterized/VBN the/PDT CCR5/NEWGENE gene/NEWGENE promoter/NEWGENE ./.
@@81531308126 Effects/NNPS of/IN estradiol/NN on/IN worm/NN burden/NN and/CC peripheral/JJ leukocytes/NNS in/IN Parastrongylus/NNP malaysiensis-infected/JJ rats/NNS ./.
@@9468509354 The/DT protein/NN expressed/VBN by/IN F2771/NEWGENE cDNA/NEWGENE in/IN transfected/VBN COS/NN cells/NNS is/VBZ localized/VBN in/IN the/DT cytoplasm/NN ./.
@@98277246012 No/DT mutations/NNS were/VBD found/VBN in/IN follicular/JJ adenomas/NNS ./.
@@91698531396 Pax-3/NEWGENE is/VBZ a/DT paired-type/NEWGENE homeobox/NEWGENE gene/NEWGENE that/WDT is/VBZ specifically/RB expressed/VBN in/IN the/DT dorsal/JJ and/CC posterior/JJ neural/JJ tube/NN ./.
@@97178879701 The/DT present/NN study/NN sought/VBP to/IN develop/VB an/DT equation/NN to/IN estimate/NN VO2peak/NN in/IN peripheral/JJ arterial/JJ occlusive/JJ disease/NN (/( PAOD/IN )/SYM patients/NNS with/IN intermittent/JJ claudication/NN and/CC to/IN determine/VB independent/NN predictors/NN of/IN VO2peak/NN in/IN this/DT population/NN ./.
@@87215266628 The/DT predominant/JJ sensitizing/JJ allergens/NNS in/IN Swedish/JJ asthmatic/JJ children/NNS are/VBP furred/JJ pet/NN animals/NNS ./.
@@20532891465 There/EX were/VBD 45/CD to/IN 56/CD nt/NN differences/NNS between/IN the/DT virulent/JJ and/CC avirulent/JJ groups/NNS while/CC there/RB were/VBD 6/CD to/IN 14/CD nt/NN differences/NNS among/IN four/CD avirulent/JJ strains/NNS ./.
@@14216097887 These/DT data/NN demonstrate/VB that/IN DMVA/NN does/VBP not/RB cause/VB more/RB myocardial/JJ trauma/NN than/IN CPB/NNP when/CC used/VBN to/IN provide/VB resuscitative/JJ circulatory/JJ support/NN ./.
@@92388506619 This/DT night-day/JJ oscillation/NN is/NNS driven/VBP by/IN the/DT endogenous/JJ clock/NN (/( located/VBN in/IN the/DT suprachiasmatic/JJ nucleus/NN ,/, SCN/NN )/SYM ./.
@@98970329901 Magnetically/RB induced/VBN optical/JJ self-pulsing/NN in/IN a/DT nonlinear/JJ resonator/NN ./.
@@111066682676 Furthermore/RB ,/, transfection/NN of/IN cells/NNS with/IN the/DT spacer-RING/NN domain/NN alone/RB suppressed/VBD the/DT antiapoptotic/JJ function/NN of/IN the/DT N-terminal/NN BIR/NN domain/NN of/IN c-IAP1/NEWGENE and/CC induced/VBN apoptosis/NN ./.
@@81798279222 Factors/NNS associated/VBN with/IN intrafamilial/JJ transmission/NN of/IN hepatitis/NN B/NN virus/NN infection/NN in/IN Korea/NN ./.
@@104691743774 N-terminal/NN sequence/NN analysis/NN and/CC NMR/NN measurements/NNS revealed/VBN that/IN this/DT fragment/NN originates/VBZ from/IN the/DT C-terminal/NN 80/NN residues/NNS of/IN MBF1/NEWGENE and/CC form/VB a/DT well/JJ structured/JJ C-terminal/NN domain/NN of/IN MBF1/NEWGENE ,/, MBF1CTD/NEWGENE ./.
@@78968528425 Involvement/NNS of/IN early/NEWGENE growth/NEWGENE response/NEWGENE factor/NEWGENE Egr-1/NEWGENE in/IN apolipoprotein/NEWGENE AI/NEWGENE gene/NEWGENE transcription/NN ./.
@@15971706216 Eight/CD rabbits/NNS were/VBD exposed/VBN to/IN 0/CD ./CD 7/CD +/NN //NN -/NN 0/CD ./CD 4/CD mg/CD //CD m3/CD Co2+/RB as/IN CoCl2/NN and/CC 1/NN ./NN 2/NN +/NN //NN -/NN 0/CD ./CD 7/CD mg/CD //CD m3/CD Cr3+/NNP as/IN Cr/NN (/NN NO3/NN )/NN 3/NN (/( group/NN Co/NN +/SYM Cr/NN )/SYM ,/, eight/CD to/IN 0/CD ./CD 6/CD +/NN //NN -/NN 0/CD ./CD 5/CD mg/CD //CD m3/CD Co2+/IN (/( group/NN Co/NN )/SYM ,/, and/CC eight/CD to/IN filtered/JJ air/NN (/( control/NN group/NN )/SYM ,/, for/IN 4/CD months/NNS ,/, 5/CD days/NN //NN week/NN ,/, and/CC 6/CD hr/NN //NN day/NN ./.
@@38050909890 From/IN life-table/NN analyses/NNS of/IN these/DT patients/NNS ,/, we/PRP estimated/VBD that/IN the/DT incidence/NN of/IN secondary/JJ chondrosarcoma/NN in/IN patients/NNS who/WP have/VBP Ollier/NN disease/NN is/VBZ about/RB 25/CD per/IN cent/NN at/IN the/DT age/NN of/IN forty/CD years/NNS ,/, and/CC that/IN malignant/JJ degeneration/NN is/VBZ almost/RB a/DT certainty/NN in/IN patients/NNS who/WP have/VBP Maffucci/NNS syndrome/NN ./.
@@26091123274 Reagent/NNS strips/NNS are/VBP frequently/RB used/VBN in/IN the/DT practice/NN of/IN laboratory/NN medicine/NN as/RB well/VB as/IN outside/RB the/DT professional/JJ laboratories/NNS ./.
@@91080388266 Having/VBG an/DT LRR/NEWGENE domain/NEWGENE and/CC an/DT SH3-binding/NEWGENE domain/NEWGENE ,/, Acan125/NEWGENE and/CC the/DT C/NNP ./NNP elegans/NNS homologue/NN define/VB a/DT novel/JJ family/NN of/IN bifunctional/JJ binding/JJ proteins/NNS ./.
@@80719828057 The/DT newly/RB recognised/VBN skeletogenital/JJ syndrome/NN ./.
@@10710985535 Valuing/VBG families/NNS :/: social/JJ work/NN practice/NN with/IN families/NNS from/IN a/DT strengths/NNS perspective/NN ./.
@@110739545935 The/DT Psc2/NEWGENE cDNA/NEWGENE contained/VBD an/DT open/JJ reading/JJ frame/NN homologous/JJ to/IN CP2/NEWGENE family/NEWGENE proteins/NEWGENE ./.
@@84834793655 These/DT data/NN show/NN that/DT PTH/NEWGENE and/CC cAMP/NN can/MD repress/VB collagen/NEWGENE promoter/NEWGENE activity/NN in/IN calvariae/NN from/IN transgenic/JJ mice/NNS ,/, suggesting/VBG that/IN the/DT alpha/NEWGENE 1/NEWGENE (/NEWGENE I/NEWGENE )/NEWGENE collagen/NEWGENE promoter/NEWGENE may/MD contain/VB cis/NN elements/NN down-stream/NN of/IN -2/CD ./CD 3/CD kilobases/NNS that/WDT mediate/VBP PTH/NEWGENE and/CC cAMP/NN repression/NN of/IN collagen/NEWGENE gene/NEWGENE expression/NN in/IN bone/NN ./.
@@9852799844 Mean/VB corpuscular/NEWGENE hemoglobin/NEWGENE concentrations/NNS remained/VBD normal/JJ for/IN 48/CD h/NN and/CC then/RB decreased/VBN in/IN both/DT groups/NNS ,/, the/DT CO2/NN group/NN showing/VBG the/DT larger/JJR decrease/NN ./.
@@109637358018 The/DT aim/NN of/IN our/PRP study/NN was/VBD to/IN evaluate/VB the/DT level/NN of/IN oxidative/JJ stress/NN in/IN healthy/JJ controls/NNS (/( CTL/NN )/SYM compared/VBN with/IN CRF/NN and/CC HD/NN patients/NNS before/IN (/( pre-HD/JJ )/SYM and/CC after/IN (/( post-HD/JJ )/SYM the/DT dialysis/NN session/NN ,/, carried/VBD out/RB on/IN a/DT high/JJ biocompatible/JJ polyacrylonitrile/NN membrane/NN AN69/NN ./.
@@67262579735 Effects/NNPS of/IN methiothepin/NN and/CC lysergic/JJ acid/NN diethylamide/JJ on/IN serotonin/NN release/NN in/IN vitro/FW and/CC serotonin/NN synthesis/NN in/IN vivo/NN :/: possible/JJ relation/NN to/IN serotonin/NEWGENE autoreceptor/NEWGENE function/NN ./.
@@40400834714 Rabbit/IN eyes/NNS were/VBD removed/VBN and/CC held/VBP in/IN temperature-regulated/JJ chambers/NNS and/CC irrigated/VBN with/IN saline/NN ./.
@@77205722676 In/NN contrast/NN to/IN the/DT myoD/NEWGENE promoter/NEWGENE ,/, the/DT myoD/NEWGENE enhancer/NEWGENE shows/VBZ striking/JJ conservation/NN between/IN humans/NNS and/CC mice/NNS both/DT in/NN its/PRP sequence/NN and/CC its/PRP distal/JJ position/NN ./.
@@21881684214 Serum/NEWGENE beta/NEWGENE 2-microglobulin/NEWGENE levels/NNS (/( beta-2-M/NEWGENE )/SYM were/VBD studied/VBN in/IN 150/CD drug/NN addicts/NNS ,/, 50/CD of/IN them/PRP asymptomatic/JJ carriers/NNS of/IN anti/NEWGENE HIV-1/NEWGENE antibodies/NEWGENE ,/, 50/CD symptomatic/JJ carriers/NNS with/IN persistent/JJ generalized/JJ lymphadenopathy/NN (/( P/NNP ./NNP G/NNP ./NNP L/NNP ./NNP )/SYM and/CC 50/CD serum/JJ negative/JJ patients/NNS who/WP had/VBP been/VBN living/VBG in/IN a/DT closed/JJ community/NN for/IN at/IN least/RB 2/CD years/NNS ./.
@@26044201979 During/IN challenge/NN ,/, rebiopsy/NN was/VBD done/VBP when/CC reticulin/NEWGENE antibodies/NEWGENE turned/VBD positive/JJ (/( mean/JJ 0/CD ./CD 6/CD years/NNS ,/, range/NN 0/CD ./CD 2-2/CD ./CD 0/CD )/SYM or/CC at/IN the/DT end/NN of/IN the/DT two/JJ year/NN study/NN ./.
@@25490369583 The/DT Bacillus/NEWGENE subtilis/NEWGENE phage/NEWGENE phi/NEWGENE 105/NEWGENE repressor/NEWGENE ,/, a/DT lambda/NEWGENE repressor-like/NN transcriptional/NN regulatory/NN protein/NEWGENE ,/, was/VBD overproduced/VBN in/IN Escherichia/NN coli/JJ and/CC purified/VBN to/IN near/IN homogeneity/NN in/IN order/NN to/IN examine/VB its/PRP in/IN vitro/FW DNA-binding/NN properties/NNS ./.
@@5122151845 The/DT present/NN study/NN examined/VBD the/DT dependence/NN of/IN difference/NN tone/NN level/NN [/NN L/NN (/NN f2-f1/NN )/NN ]/NN on/IN the/DT following/NN parameters/NNS of/IN the/DT two-tone/JJ input/NN :/: f1/NN ,/, f2/NN //NN f1/NN (/( f2/NN greater/JJR than/IN f1/NN )/SYM ,/, L1/NN ,/, L2/NN ,/, and/CC L1/NN =/SYM L2/NNP ./NNP
@@84588493203 We/PRP now/RB show/VBP that/DT regulation/NN of/IN flaN/NEWGENE transcription/NN in/IN vivo/NN depends/VBZ on/IN a/DT sigma/NEWGENE 54/NEWGENE promoter/NEWGENE and/CC two/JJ ftr/NEWGENE elements/NEWGENE located/VBN downstream/RB of/IN the/DT transcription/NN start/NN site/NN at/IN +86/CD (/( ftr2/NEWGENE )/SYM and/CC +120/CD (/( ftr3/NEWGENE )/SYM ./.
@@110940752590 Subsequently/RB ,/, we/PRP show/VBP that/IN the/DT reexpression/NN of/IN the/DT r-PTPeta/NEWGENE gene/NEWGENE in/IN highly/RB malignant/JJ rat/NN thyroid/JJ cells/NNS transformed/VBN by/IN retroviruses/NNS carrying/VBG the/DT v-mos/NEWGENE and/CC v-ras-Ki/NEWGENE oncogenes/NEWGENE suppresses/VBZ their/PRP malignant/JJ phenotype/NN ./.
@@7102176897 Synovial/JJ cysts/NNS of/IN the/DT hip/JJ joint/JJ ./.
@@953154969 In/NN vitro/FW binding/JJ studies/NNS using/VBG GST/NEWGENE fusion/NN proteins/NN and/CC yeast/NN extracts/NNS defined/VBD distinct/JJ binding/JJ sites/NNS on/IN yAP180A/NEWGENE for/IN Pan1p/NEWGENE and/CC clathrin/NEWGENE ./. yAP180/NEWGENE proteins/NEWGENE and/CC Pan1p/NEWGENE ,/, like/JJ actin/NEWGENE ,/, localize/VB to/IN peripheral/JJ patches/NNS along/IN the/DT plasma/NN membrane/NN ./.
@@105765457302 The/DT availability/NN of/IN potent/JJ regulatory/JJ DNA/NN cassettes/NNS harboring/VBG the/DT murine/NEWGENE D1A/NEWGENE gene/NEWGENE promoter/NEWGENE could/MD aid/VB testing/VBG the/DT neuronal-specific/JJ expression/NN of/IN transgenes/NNS in/IN vivo/NN ./.
@@74134417256 Autoradiographic/NNP localisation/NN of/IN its/PRP cellular/JJ distribution/NN in/IN the/DT kidney/NN ./.
@@10582831406 Syndromes/NNS of/IN abnormal/JJ fat/JJ redistribution/NN and/CC metabolic/JJ complications/NNS in/IN HIV-infected/JJ patients/NNS ./.
@@82557587166 We/PRP have/VBP identified/VBN in/IN the/DT 5'/CD untranslated/JJ region/NN of/IN the/DT Drosophila/NEWGENE copia/NEWGENE retrotransposon/NEWGENE ,/, 3'/NN to/IN the/DT left/NN LTR/NN ,/, a/DT sequence/NN for/IN transcriptional/JJ regulation/NN by/IN homeoproteins/NNS ./.
@@44186874961 Effects/NNPS of/IN estrogen/NN and/CC glucocorticoids/NNS on/IN the/DT adrenal/JJ development/NN of/IN the/DT fetus/NN ./.
@@81751889392 A/DT concentration/NN of/IN 12/CD ./CD 5/CD ppm/NN SO2/NN induced/VBN a/DT decrease/NN from/IN baseline/NN values/NNS of/IN approximately/RB 80%/CD in/IN mean/JJ MCA/NN and/CC of/IN roughly/RB 70%/CD in/IN mean/JJ CBF/NN ./.
@@97763605179 CM/NN reduced/VBD the/DT nuclear/JJ binding/JJ activity/NN of/IN transcription/NEWGENE factor/NEWGENE AP-1/NEWGENE ./.
@@22470728854 The/DT SUP44/NEWGENE suppressor/NEWGENE mutation/NEWGENE occurs/VBZ near/IN a/DT region/NN of/IN the/DT protein/NN that/WDT corresponds/VBZ to/IN the/DT known/VBP positions/NNS of/IN alterations/NNS in/IN E/NEWGENE ./NEWGENE coli/NEWGENE S5/NEWGENE ram/NEWGENE mutations/NEWGENE ./.
@@31192275876 The/DT DNA/NN sequence/NN encodes/VBZ a/DT protein/NN of/IN 1520/CD amino/JJ acids/NNS with/IN sequence/NN homology/NN to/IN the/DT human/NEWGENE c-abl/NEWGENE proto-oncogene/NEWGENE product/NEWGENE ,/, beginning/NN at/IN the/DT amino/JJ terminus/NN and/CC extending/VBG 656/CD amino/JJ acids/NNS through/RB the/DT region/NN essential/JJ for/IN tyrosine/NEWGENE kinase/NEWGENE activity/NN ./.
@@79267396448 The/DT expression/NN pattern/NN of/IN GL2/NEWGENE ,/, as/IN demonstrated/VBN by/IN in/IN situ/NN hybridization/NN ,/, indicated/VBN that/IN the/DT gene/NN is/VBZ expressed/VBN in/IN trichome/NN progenitor/NN cells/NNS and/CC at/IN stages/NNS associated/VBN with/IN trichome/NN development/NN ./.
@@87985129953 The/DT amount/NN of/IN these/DT factors/NNS was/VBD reduced/VBN in/IN GEO/NN cells/NNS in/IN which/WDT the/DT u-PAR/NEWGENE gene/NEWGENE is/VBZ only/RB weakly/RB transcriptionally/RB activated/VBN ./.
@@96984578780 Homozygous/JJ mutant/JJ mice/NNS ,/, designated/VBN Cux/NEWGENE //NEWGENE CDPDeltaCR1/NEWGENE ,/, display/NN a/DT phenotype/NN characterized/VBN by/IN curly/JJ vibrissae/NNS and/CC wavy/JJ hair/NN ./.
@@81060875215 In/NN the/DT 3'/CD flanking/JJ region/NN of/IN the/DT 27/NEWGENE kDa/NEWGENE zein/NEWGENE gene/NEWGENE ,/, several/DT AATAAA-like/NN sequences/NN and/CC a/DT sequence/NN resembling/VBG the/DT mammalian/JJ GT-rich/NNP sequence/NN are/VBP present/VB around/IN the/DT polyadenylation/NN sites/NN ./.
@@13785261993 Furthermore/RB it/PRP was/VBD suggested/VBN that/IN FK506/NNS plasma/NN levels/NNS were/VBD concerned/VBN with/IN the/DT appearance/NN of/IN side/JJ effect/NN ./.
@@11083358918 CONCLUSION/IN :/: SPT/NN is/VBZ more/RB useful/JJ than/IN WST/NNP in/IN differentiating/JJ patients/NNS predisposed/VBN to/IN aspiration/NN ./.
@@17224792300 The/DT qualitative/JJ concentrations/NNS of/IN HCG/NEWGENE had/VBP a/DT sensitivity/NN of/IN 37/CD ./CD 5%/CD and/CC a/DT specificity/NN of/IN 100%/CD ./.
@@25216748280 Mapping/NN of/IN RNA-/NNP temperature-sensitive/NEWGENE mutants/NEWGENE of/NEWGENE Sindbis/NEWGENE virus/NEWGENE :/NEWGENE complementation/NEWGENE group/NEWGENE F/NEWGENE mutants/NEWGENE have/VBP lesions/NNS in/IN nsP4/NEWGENE ./.
@@95484814520 In/NN addition/NN to/IN a/DT previously/RB characterized/VBN promoter/NN (/( P1/NEWGENE )/SYM ,/, we/PRP now/RB show/VBP the/DT existence/NN of/IN a/DT second/JJ promoter/NN for/IN the/DT human/NEWGENE IL-5Ralpha/NEWGENE gene/NEWGENE ./.
@@17669993906 Allergenic/NNP activity/NN of/IN allergen/NN extract/NN Ambrosia/NN elatior/NN (/( AE/NN )/SYM was/VBD tested/VBN in/IN fifteen/CD volunteers/NNS extremely/RB sensitive/JJ to/IN the/DT allergen/NN ./.
@@24736931268 This/DT approach/NN was/VBD examined/VBN utilizing/VBG the/DT fetal/JJ protein/NN ,/, HGB/NEWGENE F/NEWGENE ./.
@@4511925996 Data/NNP were/VBD processed/VBN with/IN a/DT semi-automatic/JJ computer/NN program/NN which/WDT develops/VBZ an/DT averaged-volume/NN curve/NN from/IN an/DT assigned/VBN LV/NN region-of-interest/NN ./.
@@93731409343 The/DT mouse/NEWGENE M-lysozyme/NEWGENE downstream/NEWGENE enhancer/NEWGENE has/VBZ been/VBN previously/RB characterized/VBN on/IN several/DT levels/NNS of/IN gene/NN regulation/NN ./.
@@87220115345 This/DT complex/NN interacts/VBZ at/IN the/DT GTPase/NEWGENE domain/NEWGENE in/IN the/DT large/NEWGENE subunit/NEWGENE rRNA/NEWGENE ,/, overlapping/JJ the/DT binding/JJ site/NN of/IN the/DT protein/NEWGENE L11-like/NEWGENE eukaryotic/NEWGENE counterpart/NEWGENE (/( Saccharomyces/NEWGENE cerevisiae/NEWGENE protein/NEWGENE L15/NEWGENE and/CC mammalian/NEWGENE protein/NEWGENE L12/NEWGENE )/SYM ./.
@@64345872613 Each/DT patient/NN had/VBP measurable/JJ LH/NEWGENE and/CC FSH/NEWGENE levels/NNS ,/, with/IN pulsed/JJ nocturnal/JJ secretion/NN ,/, and/CC pubertal/JJ LH/NEWGENE and/CC FSH/NEWGENE responses/NNS to/IN LRH/NEWGENE ./.
@@87041246423 Using/VBG one/PRP of/IN the/DT six/CD fragments/NNS (/( CPK3-8/NEWGENE )/SYM ,/, we/PRP isolated/VBD a/DT 2022/NEWGENE bp/NEWGENE cDNA/NEWGENE (/NEWGENE VrCDPK-1/NEWGENE )/NEWGENE from/IN a/DT Vigna/NNP radiata/NN lambda/NN gt11/NN library/NN ./.
@@85325366122 TIEG/NEWGENE expression/NN in/IN hFOB/NNP cells/NNS was/VBD highly/RB induced/VBN by/IN TGF-beta/NEWGENE and/CC bone/NEWGENE morphogenetic/NEWGENE protein-2/NEWGENE (/( BMP-2/NEWGENE )/SYM ,/, with/IN a/DT moderate/JJ induction/NN by/IN epidermal/NEWGENE growth/NEWGENE factor/NEWGENE (/( EGF/NEWGENE )/SYM ,/, but/CC no/DT induction/NN by/IN other/DT growth/NN factors/NNS //NNS cytokines/NNS was/VBD observed/VBN ./.
@@28434958127 Introduction/NN of/IN v-fms/NEWGENE into/IN a/DT CSF-1/NEWGENE dependent/JJ murine/JJ macrophage/NN cell/NN line/NN induced/VBD factor/NN independence/NN and/CC tumorigenicity/NN by/IN a/DT nonautocrine/JJ mechanism/NN ./.
@@64048423247 Eighteen/CD patients/NNS were/VBD untreated/JJ ,/, and/CC 8/CD had/VBP been/VBN given/VBP previous/JJ treatment/NN with/IN depot/NN testosterone/NN 100/NN mg/NN intramuscularly/RB every/DT 2-3/CD weeks/NNS for/IN an/DT average/JJ duration/NN of/IN 4/CD ./CD 7/CD years/NNS ./.
@@16305697835 We/PRP tried/VBD amphotericin/NN B/NN (/( AmB/NN )/SYM ,/, and/CC remission/NN of/IN the/DT tumor/NN was/VBD obtained/VBN ./.
@@4167584833 Isolation/NNS of/IN T/NNP ./NNP gambiense/NN strains/NNS in/IN Zaire/NN and/CC their/PRP adaptation/NN to/IN laboratory/NN animals/NNS ./.
@@17653756357 The/DT mRNA/NN identified/VBN in/IN both/DT human/NN and/CC rat/NN cells/NNS with/IN the/DT human/NEWGENE clathrin/NEWGENE clone/NN revealed/VBD transcripts/NNS of/IN approximately/RB 6/CD ./CD 5/CD kb/NN ,/, which/WDT is/VBZ consistent/JJ with/IN the/DT predicted/VBN 180/CD kDa/NN molecular/JJ weight/NN of/IN the/DT clathrin/NEWGENE heavy/NEWGENE chain/NEWGENE ./.
@@68910516689 Survival/NNP of/IN 111/CD Indium-labelled/JJ autologous/JJ platelets/NNS was/VBD studied/VBN in/IN 2/CD patients/NNS after/IN correction/NN of/IN platelet/NN count/NN and/CC was/VBD still/RB found/VB shortened/VBN ./.
@@113093738922 Analysis/NNP of/IN mCTR/NEWGENE mRNAs/NEWGENE has/VBZ revealed/VBN that/IN the/DT three/CD alternative/JJ promoters/NNS give/VBP rise/NN to/IN at/IN least/RB seven/JJ mCTR/NEWGENE isoforms/NEWGENE in/IN the/DT 5'/CD region/NN of/IN the/DT gene/NN and/CC generate/VB 5'-untranslated/JJ regions/NNS of/IN very/RB different/JJ lengths/NNS ./.
@@7627635892 The/DT overall/JJ incidence/NN of/IN SIDS/NN was/VBD 1/CD ./CD 43/CD per/IN 1/NN ,/NN 000/NN live/VB births/NNS ./.
@@91060572551 A/DT method/NN for/IN the/DT simultaneous/JJ determination/NN of/IN de/NN (/NN N-methyl/NN )/NN -N-ethyl-8/NN ,/NN 9/NN -anhydroerythromycin/CD A/DT 6/JJ ,/JJ 9-hemiacetal/JJ (/( EM523/NN ,/, I/PRP )/SYM and/CC its/PRP three/CD metabolites/NNS in/IN human/JJ plasma/NN and/CC urine/NN has/VBZ been/VBN developed/VBN using/VBG high-performance/JJ liquid/JJ chromatography/NN (/( HPLC/NN )/SYM with/IN chemiluminescence/NN (/( CL/NN )/SYM detection/NN ./.
@@762915023 Expression/NNS of/IN the/DT CYP11A1/NEWGENE gene/NEWGENE is/VBZ increased/VBN by/IN hormones/NNS ,/, such/JJ as/IN adrenocorticotropin/NEWGENE and/CC luteinizing/NEWGENE hormone/NEWGENE ,/, as/RB well/VB as/IN by/IN a/DT number/NN of/IN growth/NEWGENE factors/NEWGENE ,/, suggesting/VBG that/IN its/PRP promoter/NN may/MD contain/VB regulatory/JJ elements/NNS that/WDT respond/VBP to/IN multiple/JJ signal/JJ transduction/NN pathways/NNS ./.
@@81966073579 Deletion/NNS analysis/NN of/IN the/DT ICL1/NEWGENE promoter/NEWGENE led/VBN to/IN the/DT identification/NN of/IN an/DT upstream/NN activating/NN sequence/NN element/NN ,/, UASICL1/NEWGENE (/( 5'/NEWGENE CATTCATCCG/NEWGENE 3'/NEWGENE )/SYM ,/, necessary/JJ and/CC sufficient/JJ for/IN conferring/JJ carbon/NN source-dependent/JJ regulation/NN on/IN a/DT heterologous/JJ reporter/NN gene/NN ./.
@@97602439447 Cotransfections/NNS with/IN ATF-2/NEWGENE and/CC HNF-4/NEWGENE expression/NN plasmids/NNS resulted/VBN in/IN additive/JJ transactivation/NN of/IN the/DT apoCIII/NEWGENE promoter/NEWGENE ./.
@@100132275689 Precision/NNP measurement/NN of/IN the/DT pion/NN mass/JJ difference/NN m/NN pi/NN --m/CD pi/NN 0/CD ./CD
@@24878983144 Once/RB NGF/NEWGENE administration/NN is/NNS proven/VBP effective/JJ it/PRP will/MD be/VB possible/JJ to/IN develop/VB alternative/JJ ways/NNS of/IN NGF/NEWGENE administration/NN ./.
@@23499423008 Environmental/NNP factors/NNS were/VBD more/RB important/JJ in/IN the/DT older/JJR cohorts/NNS (/( perhaps/RB because/IN of/IN less/PRP reliable/JJ recall/NN )/SYM ./.
@@102290842312 Two-dimensional/JJ gel/NN electrophoresis/NN of/IN anti-p59fyn/NEWGENE immunoprecipitates/NNS obtained/VBN from/IN non-transformed/JJ resting/JJ human/JJ T/NN lymphocytes/NNS resulted/VBN in/IN the/DT identification/NN of/IN an/DT oligomeric/JJ protein/NN complex/NN which/WDT is/VBZ constitutively/RB formed/VBN between/IN Fyn/NEWGENE and/CC several/DT additional/JJ phosphoproteins/NNS (/( pp43/NEWGENE ,/, pp72/NEWGENE ,/, pp85/NEWGENE ,/, the/DT protein/NEWGENE tyrosine/NEWGENE kinase/NEWGENE Pyk2/NEWGENE1 ,/, as/RB well/VB as/IN the/DT two/JJ recently/RB cloned/VBN adaptor/NN proteins/NN ,/, SKAP55/NEWGENE and/CC SLAP-130/NEWGENE )/SYM ./.
@@79459372945 Sequence/NN analysis/NN of/IN the/DT zebrafish/NEWGENE egr1/NEWGENE coding/NEWGENE region/NEWGENE revealed/VBD a/DT high/JJ level/NN of/IN homology/NN to/IN the/DT mouse/NN ,/, rat/NN ,/, and/CC human/NEWGENE Egr1/NEWGENE genes/NEWGENE with/IN the/DT notable/JJ exception/NN of/IN a/DT polymorphic/JJ ,/, triplet/NN nucleotide/NN repeat/NN sequence/NN in/IN the/DT region/NN coding/JJ for/IN the/DT amino/JJ terminus/NN of/IN the/DT Egr1/NEWGENE protein/NEWGENE ./.
@@97617119753 Pseudocontact/NNP shifts/NNS arise/VBP from/IN the/DT isotropic/JJ reorientational/JJ average/NN of/IN the/DT dipolar/JJ coupling/NN between/IN unpaired/JJ electron/NN and/CC nuclei/NNS ,/, in/IN the/DT presence/NN of/IN magnetic/JJ susceptibility/NN anisotropy/NN ./.
@@98567329847 However/RB ,/, no/DT studies/NNS have/NN been/VBN conducted/VBN to/IN further/RB investigate/VB this/DT potentially/RB hazardous/JJ effect/NN of/IN lidocaine/NN ./.
@@14295968002 On/IN the/DT basis/NN of/IN these/DT unique/JJ properties/NNS ,/, the/DT newly/RB characterized/VBN hemagglutinin/NEWGENE has/VBZ been/VBN termed/JJ Limulus/NEWGENE 18K/NEWGENE agglutination-aggregation/NEWGENE factor/NEWGENE (/( 18K-LAF/NEWGENE )/SYM ./.
@@62038435997 Products/NNS of/IN immune/JJ cells/NNS such/JJ as/IN transfer/NEWGENE factor/NEWGENE and/CC lymphokines/NNS form/NN the/DT third/RB and/CC possibly/RB most/RB important/JJ group/NN of/IN immune-stimulating/JJ agents/NNS ./.
@@16742429956 Its/PRP clearance/NN has/VBZ been/VBN found/VB to/IN be/VB decreased/VBN (/( typically/RB by/IN around/IN 25%/JJ ,/, but/CC often/RB by/IN far/RB more/RB )/SYM by/IN erythromycin/NN ,/, troleandomycin/NN (/( triacetyloleandomycin/NN )/SYM ,/, roxithromycin/NN ,/, enoxacin/NN ,/, ciprofloxacin/NN ,/, pefloxacin/NN ,/, norfloxacin/NN ,/, ofloxacin/NN ,/, fluoroquinolone/NN T-3262/NN ,/, pipemidic/JJ acid/NN ,/, cimetidine/NN ,/, etintidine/NN ,/, propranolol/NN ,/, verapamil/NN ,/, diltiazem/NN ,/, nifedipine/NN ,/, furosemide/NN (/( frusemide/NN )/SYM ,/, at/IN least/RB some/DT anovulent/JJ agents/NNS ,/, viloxazine/NN ,/, allopurinol/NN ,/, ticlopidine/NN ,/, idrocilamide/NN ,/, thiabendazole/NN ,/, disulfiram/NN ,/, influenza-/JJ and/CC BCG-vaccination/NNS ,/, interferon/NEWGENE ,/, and/CC caffeine/NN (/( half-life/NN increase/NN )/SYM ./.
@@26665689154 Of/IN 110/CD previously/RB untreated/JJ patients/NNS who/WP had/VBP entered/VBN the/DT study/NN of/IN protocol/NN TCL821/NN ,/, 96/CD were/VBD evaluable/JJ ./.
@@112156221050 Grippers/NNP with/IN integrated/JJ piezoresistive/JJ force/NN sensors/NNS and/CC with/IN attached/VBN strain/NN gauges/NNS have/VBP been/VBN reported/VBN ./.
@@107319266785 Advanced/NNP adenoma/NN was/VBD defined/VBN as/IN an/DT adenoma/NN larger/JJR than/IN 10/CD mm/NN or/CC an/DT adenoma/NN of/IN any/DT size/NN with/IN villous/NN component/NN ,/, high-grade/JJ dysplasia/NN or/CC invasive/JJ carcinoma/NN ./.
@@110959817280 Here/RB ,/, we/PRP identified/VBD three/CD cis-elements/NNS required/VBN for/IN replication/NN within/IN the/DT 200/CD bp/NN promoter/NN ,/, using/VBG autonomously/RB replicating/JJ plasmids/NNS carrying/JJ various/JJ mutations/NNS and/CC deletions/NNS ./.
@@85696843491 Oligonucleotides/NNS ,/, designed/VBN on/IN the/DT basis/NN of/IN conserved/VBN flanking/JJ amino/JJ acid/NN sequence/NN segments/NNS within/IN the/DT catalytic/JJ domain/NN of/IN eukaryotic/NEWGENE protein/NEWGENE kinase/NEWGENE C/NEWGENE (/NEWGENE1 PKC/NEWGENE1 )/NEWGENE1 proteins/NEWGENE1 ,/, were/VBD used/VBN as/IN primers/NNS for/IN polymerase/NN chain/NN reactions/NNS to/IN amplify/VB a/DT 427-bp/JJ chromosomal/JJ DNA/NN fragment/NN from/IN the/DT filamentous/JJ fungus/NN Trichoderma/NNP reesei/NN ./.
@@87620218744 Potentially/RB load-insensitive/JJ measures/NNS of/IN ventricular/JJ performance/NN were/VBD therefore/RB evaluated/VBN in/IN 10/CD open-/DT and/CC closed-chested/JJ ,/, anesthetized/JJ rabbits/NNS ./.
@@82553418238 Two/CD patients/NNS were/VBD treated/VBN successfully/RB with/IN a/DT combination/NN of/IN metronidazole/NN (/( a/DT tissue/NN amoebicide/NN )/SYM and/CC diloxanide/NN (/( a/DT lumenal/JJ amoebicide/NN )/SYM ./.
@@21134552714 The/DT interindividual/JJ variability/NN of/IN the/DT parameters/NNS is/NNS taken/VBP into/IN consideration/NN by/IN interactively/RB determining/JJ the/DT threshold/NN levels/NNS ./.
@@86682092964 Merlie/NNP ,/, Cold/NNP Spring/NNP Harbor/NNP Symp/NN ./.
@@614785969 Late/JJ complications/NNS of/IN catheterisation/NN for/IN intravenous/JJ nutrition/NN [/NN letter/NN ]/NN ./.
@@111064283830 Toward/IN this/DT end/NN ,/, we/PRP prepared/VBD synthetic/JJ proteins/NNS with/IN either/DT the/DT catalytic/JJ domain/NN of/IN FAP-1/NEWGENE (/NEWGENE C-terminal/NEWGENE 399/NEWGENE amino/NEWGENE acids/NEWGENE )/NEWGENE or/CC its/PRP inactive/JJ form/NN (/( Cys2408--/NNP >/NNP Ser/NNP )/SYM fused/VBN to/IN glutathione-S-transferase/NEWGENE (/( GST/NEWGENE )/SYM ./.
@@90069107266 To/TO investigate/VB the/DT mechanisms/NNS involved/VBN in/IN the/DT transcriptional/JJ control/NN of/IN retinoid/NEWGENE X/NEWGENE receptor/NEWGENE (/( RXR/NEWGENE )/SYM gene/NN expression/NN ,/, the/DT 5'-flanking/JJ region/NN of/IN the/DT human/NEWGENE RXRgamma2/NEWGENE isoform/NEWGENE was/VBD characterized/VBN ./.
@@84156434861 The/DT E1/NEWGENE gene/NEWGENE is/VBZ located/VBN within/IN the/DT first/JJ intron/NN of/IN the/DT gene/NN for/IN RCC1/NEWGENE ,/, a/DT protein/NN that/WDT regulates/VBZ onset/NN of/IN mitosis/NN ./.
@@18670692633 Young/NN CD-1/NN mice/NNS ,/, 4/CD days/NNS old/JJ ,/, exposed/VBN to/IN 0/CD ./CD 1%/CD nicotine/NN sulfate/NN on/IN gestational/JJ days/NNS 6-20/CD were/VBD compared/VBN with/IN untreated/JJ pups/NNS of/IN the/DT same/JJ age/NN to/IN determine/VB its/PRP effect/NN on/IN the/DT development/NN of/IN mandibular/JJ first/JJ molars/NNS ./.
@@92093724711 Here/RB we/PRP demonstrate/VBP that/IN AML1a/NEWGENE ,/, which/WDT solely/RB has/VBZ no/DT effects/NNS as/IN a/DT transcriptional/NN regulator/NN ,/, dominantly/RB suppresses/VBZ transcriptional/JJ activation/NN by/IN AML1b/NEWGENE ,/, and/CC that/IN AML1a/NEWGENE exhibits/VBP the/DT higher/JJ affinity/NN for/IN DNA-binding/NN than/IN AML1b/NEWGENE ./.
@@96828979658 During/IN the/DT past/JJ 4/CD years/NNS ,/, a/DT purposeful/JJ search/NN was/VBD made/VBP for/IN electrocardiograms/NNS with/IN documented/VBN reversible/JJ QRS/NN changes/NNS associated/VBN with/IN all/DT acute/JJ injury/NN pattern/NN ./.
@@66293704328 Four/CD patients/NNS (/( group/NN 1/CD )/SYM had/VBP type/NN I/NN basement/NN membrane/NN nephropathy/NN ,/, characterized/VBN by/IN marked/JJ thickening/NN and/CC lamellation/NN of/IN the/DT basement/NN membrane/NN in/IN a/DT pattern/NN resembling/VBG that/IN of/IN Alport's/NNP syndrome/NN ./.
@@104971999363 A/DT genetic/JJ screen/NN in/IN yeast/NN has/VBZ allowed/VBN us/PRP to/IN identify/VB a/DT novel/JJ transcriptional/JJ factor/NN binding/JJ to/IN the/DT GlRE/NEWGENE ,/, i/CD ./CD e/CD ./. the/DT chicken/NEWGENE ovalbumin/NEWGENE upstream/NEWGENE promoter-transcription/NEWGENE factor/NEWGENE II/NEWGENE (/( COUP-TFII/NEWGENE )/SYM ./.
@@115609924308 SAPK/NEWGENE //NEWGENE JNK/NEWGENE activation/NN was/VBD completely/RB abolished/VBN in/IN the/DT absence/NN of/IN MKK7/NEWGENE ,/, even/VB though/CC expression/NN of/IN MKK4/NEWGENE was/VBD strongly/RB upregulated/VBN in/IN mkk7/NEWGENE (/NEWGENE -/NEWGENE //NEWGENE -/NEWGENE )/NEWGENE mast/NN cell/NN lines/NNS ,/, and/CC phosphorylation/NN of/IN MKK4/NEWGENE occurred/VBN normally/RB in/IN response/NN to/IN multiple/JJ stress/NN stimuli/NNS ./.
@@105328058951 In/NN a/DT PC12/NN cell/NN mutant/NN that/WDT is/VBZ deficient/JJ in/IN protein/NEWGENE kinase/NEWGENE A/NEWGENE activity/NN (/( AB/CD ./CD 11/CD )/SYM ,/, all/DT three/CD differentiating/JJ agents/NNS were/VBD unable/JJ to/IN down-regulate/DT nrg-1/NEWGENE mRNA/NEWGENE ./.
@@17354479682 Thus/RB ,/, the/DT active-site/NN mutation/NN prevents/VBZ the/DT wild-type/NN processing/NN of/IN the/DT N-glycosylated/JJ 73-kDa/JJ precursor/NN of/IN PrB/NEWGENE to/IN the/DT 41/NEWGENE ./NEWGENE 5/NEWGENE kDa/NEWGENE pro-PrB/NEWGENE in/IN the/DT endoplasmic/JJ reticulum/NN ./.
@@90590391888 99mTc-HMPAO/NN was/VBD distributed/VBN in/IN the/DT territories/NNS of/IN the/DT ACA/NN and/CC MCA/NN in/IN the/DT two/JJ patients/NNS who/WP were/VBD treated/VBN with/IN intraarterial/JJ infusion/NN of/IN papaverine/NN from/IN the/DT C4/NN segment/NN ,/, but/CC was/VBD distributed/VBN only/RB to/IN the/DT territory/NN of/IN the/DT ACA/NN in/IN four/CD patients/NNS who/WP were/VBD treated/VBN with/IN intraarterial/JJ infusion/NN of/IN papaverine/NN from/IN the/DT C1/NN segment/NN at/IN 1/CD ml/NN //NN min/NN ./.
@@39721854620 The/DT diabetic/JJ state/NN was/VBD characterized/VBN by/IN mild/JJ insulin/NEWGENE deficiency/NN ,/, plasma/NN levels/NNS being/VBP 73%/NN of/IN controls/NNS ,/, and/CC mild/JJ hyperglycemia/NN ,/, with/IN nonfasting/JJ plasma/NN glucose/NN levels/NNS of/IN 1/CD ./CD 5/CD times/NNS normal/JJ ./.
@@111677782111 Acquired/VBN antithrombin/NEWGENE deficiency/NN in/IN sepsis/NN ./.
@@17479722331 Thrombolytic/JJ therapy/NN in/IN spontaneous/JJ coronary/JJ artery/NN dissection/NN ./.
@@112385865861 Structural/NNP studies/NNS have/VBP shown/VBP that/DT class/NEWGENE I/NEWGENE major/NEWGENE histocompatibility/NEWGENE complex/NEWGENE (/( MHC/NEWGENE )/NN -restricted/NN peptide-specific/NEWGENE T/NEWGENE cell/NEWGENE receptor/NEWGENE (/NEWGENE TCR/NEWGENE )/NEWGENE -alpha/NEWGENE //NEWGENE betas/NEWGENE make/VBP multiple/JJ contacts/NNS with/IN the/DT alpha1/NN and/CC alpha2/NN helices/NNS of/IN the/DT MHC/NEWGENE ,/, but/CC it/PRP is/VBZ unclear/JJ which/WDT or/CC how/RB many/NN of/IN these/DT interactions/NNS contribute/VBP to/IN functional/JJ binding/NN ./.
@@57518195701 The/DT bearing/NN of/IN season/NN and/CC sequence/NN of/IN calving/JJ on/IN frequency/NN of/IN male/JJ ,/, female/JJ and/CC total/JJ calvings/NNS in/IN Hariana/NNP cows/NNS ./.
@@71411307882 Histological/JJ evaluation/NN revealed/VBD a/DT more/RB than/IN twofold/JJ increase/NN in/IN the/DT number/NN of/IN interepithelial/JJ mononuclear/JJ cells/NNS (/( p/NN less/PRP than/IN 0/CD ./CD 005/CD )/SYM ,/, while/CC the/DT number/NN of/IN epithelial/JJ cells/NN //NN 100/NN microns/NNS of/IN villous/JJ mucosa/NN and/CC the/DT mean/JJ height/NN of/IN the/DT epithelial/JJ cells/NNS were/VBD comparable/JJ in/IN both/DT groups/NNS ./.
@@109088225549 8%/JJ (/( 95%/CD CI/NN ,/, 21/NN ./NN 3-44/NN ./NN 3%/NN )/SYM ./.
@@104299469481 The/DT responsive/NN region/NN of/IN the/DT alpha/NEWGENE 2/NEWGENE (/NEWGENE V/NEWGENE )/NEWGENE collagen/NEWGENE gene/NEWGENE was/VBD localized/VBN to/IN a/DT fragment/NN including/JJ 100/CD bp/NN of/IN basal/JJ promoter/NN and/CC 150/CD bp/NN of/IN exon/NN 1/CD sequences/NNS ,/, which/WDT contained/VBD two/JJ CRE-like/NEWGENE elements/NEWGENE ./.
@@21645887450 Various/JJ mutant/NEWGENE HN/NEWGENE genes/NEWGENE were/VBD constructed/VBN to/IN examine/VB the/DT role/NN of/IN residues/NNS flanking/JJ the/DT signal-anchor/JJ domain/NN ,/, including/JJ the/DT cytoplasmic/JJ tail/NN ,/, on/IN assembly/NN and/CC intracellular/JJ transport/NN of/IN the/DT HN/NEWGENE glycoprotein/NEWGENE ./.
@@76391067564 A/DT model/NN with/IN age/NN and/CC weight/NN described/VBD the/DT best/JJS fit/NN for/IN TBBMD/NNP ,/, whereas/IN age/NN ,/, weight/NN ,/, and/CC height/NN described/VBD the/DT best/JJS fit/NN for/IN total/JJ body/NN TBBMC/NN ./.
@@20255159161 In/NN view/NN of/IN the/DT short/JJ t1/NN //NN 2/NN ,/, we/PRP used/VBD three/CD doses/NN //NN day/NN ./.
@@11502758516 These/DT findings/NNS suggest/VBP a/DT novel/JJ ankyrin-independent/JJ role/NN for/IN LAD-1/NEWGENE related/VBN to/IN FGFR/NEWGENE signaling/JJ ./.
@@94202191417 To/TO facilitate/VB the/DT investigation/NN of/IN parameters/NNS that/WDT govern/VBP selective/JJ export/NN in/IN adenovirus-infected/JJ cells/NNS ,/, we/PRP constructed/VBD a/DT marked/JJ human/NN beta-actin/NEWGENE minigene/NEWGENE under/IN the/DT control/NN of/IN the/DT glucocorticoid-inducible/NEWGENE enhancer-promoter/NEWGENE of/IN mouse/NN mammary/JJ tumor/NN virus/NN and/CC introduced/VBN it/PRP into/IN the/DT left/JJ end/NN of/IN the/DT adenovirus/NN type/NN 5/CD (/( Ad5/IN )/SYM genome/NN ./.
@@61829796004 In/NN the/DT latter/JJ category/NN particular/JJ emphasis/NN is/NNS being/VBP placed/VBN on/IN new/JJ anthracycline/NN analogues/NNS of/IN doxorubicin/NN and/CC analogues/NNS of/IN cisplatinum/NN diammine/NN dichloride/NN ./.
@@97269873193 A/DT human/NEWGENE SPT3-TAFII31-GCN5-L/NEWGENE acetylase/NEWGENE complex/NEWGENE distinct/JJ from/IN transcription/NEWGENE factor/NEWGENE IID/NEWGENE ./.
@@9622229588 It/PRP is/VBZ possible/JJ that/IN cyclic/JJ variations/NNS in/IN heme/NN turnover/NN are/VBP related/VBN to/IN changes/NNS in/IN erythrocyte/NN characteristics/NNS during/IN the/DT progesterone/NN phase/NN ./.
@@86494279319 We/PRP report/VBP here/RB the/DT identification/NN of/IN a/DT cDNA/NN that/IN encodes/VBZ a/DT new/JJ member/NN of/IN the/DT GTPase-activating/NEWGENE protein/NEWGENE (/( GAP/NEWGENE )/SYM family/NN of/IN GTPase/NEWGENE regulators/NN ./.
@@106291767842 In/NN addition/NN ,/, CaMig1/NEWGENE formed/VBN specific/JJ complexes/NNS with/IN the/DT URS1/NEWGENE region/NEWGENE of/IN the/DT S/NEWGENE ./NEWGENE cerevisiae/NEWGENE FBP1/NEWGENE gene/NEWGENE ./.
@@6407348884 New/NNP beta-blocking/JJ drugs/NNS have/VBP been/VBN introduced/VBN which/WDT may/MD prove/VB beneficial/JJ in/IN certain/JJ clinical/JJ situations/NNS since/IN they/PRP exert/VBP more/RB selective/JJ blockade/NN of/IN the/DT cardiac/NEWGENE receptors/NEWGENE (/( beta1/NEWGENE )/SYM as/IN opposed/VBN to/IN smooth/NEWGENE muscle/NEWGENE receptors/NEWGENE (/( beta2/NEWGENE )/SYM ./.
@@89359917669 The/DT nucleotide/NN sequence/NN alignment/NN between/IN mouse/NN and/CC human/NEWGENE CA/NEWGENE IV/NEWGENE shows/VBZ 69%/CD identity/NN in/IN the/DT coding/JJ region/NN and/CC all/DT of/IN the/DT exon-intron/JJ boundaries/NNS are/VBP conserved/VBN ,/, as/IN are/VBP the/DT sizes/NNS of/IN the/DT introns/NNS ./.
@@27969887820 The/DT transcription/NN factor/NN Sp1/NEWGENE bound/JJ to/IN eight/CD sites/NNS ,/, as/IN demonstrated/VBN by/IN footprinting/VBG assays/NNS and/CC gel/NN shift/NN analysis/NN with/IN purified/VBN Sp1/NEWGENE ./.
@@35914646845 Thus/RB ,/, a/DT negative/JJ test/NN is/VBZ compatible/JJ with/IN low/JJ disease/NN activity/NN and/DT //DT or/DT efficacy/NN of/IN calcium/NN antagonist/NN treatment/NN ./.
@@104935757861 Structural/NNP changes/NNS in/IN the/DT C-terminus/NN of/IN Ca2+-bound/NN rat/NEWGENE S100B/NEWGENE (/( beta/NEWGENE beta/NEWGENE )/SYM upon/IN binding/JJ to/IN a/DT peptide/NN derived/VBN from/IN the/DT C-terminal/NN regulatory/JJ domain/NN of/IN p53/NEWGENE ./.
@@33708154055 Rapid/NNP detection/NN of/IN radioisotopically/RB contaminated/VBN test/NN serum/JJ before/IN radioassay/NN of/IN vitamin/NN B12/NN ./.
@@113114641148 These/DT disorders/NNS include/VBP low-back/JJ pain/NN ,/, saddle/NN anesthesia/NN ,/, bilateral/JJ sciatica/NN ,/, then/RB motor/JJ weakness/NN of/IN the/DT lower/JJR extremities/NNS or/CC chronic/JJ paraplegia/NN and/CC ,/, bladder/NN dysfunction/NN ./.
@@62395456039 Weight/NN loss/NN reduces/VBZ arterial/JJ pressure/NN by/IN a/DT decrease/NN in/IN intravascular/JJ volume/NN and/CC cardiac/JJ output/NN associated/VBN with/IN a/DT fall/NN in/IN sympathetic/JJ activity/NN ./.
@@91498255311 A/DT promising/JJ new/JJ cement/NN ,/, 4-META/NN //NN MMA-TBB/NN opaque/JJ resin/NN ,/, has/VBZ shown/VBP remarkable/JJ adhesive/JJ properties/NNS as/IN a/DT bone/NN cement/NN in/IN vivo/NN ./.
@@10892300718 The/DT first/JJ symptoms/NNS of/IN enzootic/JJ calcinosis/NN were/VBD noted/VBN in/IN March/NN 1998/CD ,/, when/CC some/DT of/IN the/DT cows/NNS developed/VBD locomotor/JJ abnormalities/NNS ./.
@@29977779307 Temperature-shift/NNP experiments/NNS using/VBG synchronously/RB grown/VBP cells/NNS of/IN a/DT delta/NEWGENE top1/NEWGENE top2/NEWGENE1 temperature-sensitive/NEWGENE1 (/NEWGENE1 ts/NEWGENE1 )/NEWGENE1 double/NEWGENE1 mutant/NEWGENE1 and/CC its/PRP isogenic/JJ top2/NEWGENE ts/NNS strain/NN show/NN that/IN ,/, whereas/IN mitotic/JJ blocks/NNS can/MD prevent/VB killing/NN of/IN the/DT top2/NEWGENE ts/NEWGENE mutant/NEWGENE at/IN a/DT nonpermissive/JJ temperature/NN ,/, the/DT same/JJ treatments/NNS are/VBP ineffective/JJ in/IN preventing/JJ cell/NN death/NN of/IN the/DT delta/NEWGENE top1/NEWGENE top2/NEWGENE1 ts/NEWGENE1 double/NEWGENE1 mutant/NEWGENE1 ./.
@@95150312564 These/DT results/NNS indicate/VBP that/IN TGF-betaf/NEWGENE potentiates/VBZ the/DT c-fos/NEWGENE SRE/NEWGENE1 activated/VBN by/IN PKC/NEWGENE through/RB the/DT SRF/NEWGENE binding/NEWGENE site/NEWGENE ./.
@@86929246775 By/IN using/VBG a/DT DNA/NN sequence/NN selected/VBN for/IN its/PRP ability/NN to/IN bind/NN recombinant/NEWGENE BCL-6/NEWGENE in/IN vitro/FW ,/, we/PRP show/VBP here/RB that/IN BCL-6/NEWGENE is/VBZ present/VB in/IN DNA-binding/NN complexes/NNS in/IN nuclear/JJ extracts/NNS from/IN various/JJ B-cell/NN lines/NNS ./.
@@13804542969 Here/RB we/PRP demonstrate/VBP that/IN the/DT protein/NN product/NN of/IN the/DT ref-1/NEWGENE gene/NEWGENE stimulates/VBZ the/DT DNA/NN binding/JJ activity/NN of/IN Fos-Jun/NEWGENE heterodimers/NEWGENE ,/, Jun-Jun/NEWGENE homodimers/NEWGENE and/CC Hela/NN cell/NN AP-1/NEWGENE proteins/NEWGENE as/RB well/VBP as/IN that/DT of/IN several/DT other/DT transcription/NN factors/NNS including/JJ NF-kappa/NEWGENE B/NEWGENE ,/, Myb/NEWGENE and/CC members/NNS of/IN the/DT ATF/NEWGENE //NEWGENE CREB/NEWGENE family/NEWGENE ./.
@@29884576881 The/DT data/NN obtained/VBD up/JJ to/IN now/RB only/RB suggest/VB the/DT future/JJ potentiality/NN of/IN Bestatin/NN treatment/NN for/IN these/DT types/NNS of/IN malignancy/NN ./.
@@21485082758 The/DT results/NNS supported/VBD the/DT therapeutic/JJ principle/NN of/IN TCM/NN :/: Treating/VBG patients/NNS according/VBG to/IN their/PRP pathophysiological/JJ patterns/NNS ./.
@@93469388294 Ki-ras4BVal-12/NEWGENE transfectant/NN cells/NNS expressed/VBN 2-fold/RB elevated/VBN protein/NN levels/NNS of/IN the/DT lysosomal/NEWGENE cysteine/NEWGENE protease/NEWGENE cathepsin/NEWGENE B/NEWGENE but/CC did/VBD not/RB up-regulate/DT cathepsin/NEWGENE B/NEWGENE mRNA/NEWGENE expression/NN ./.
@@107217176616 Fgd3/NEWGENE and/CC FGD1/NEWGENE share/VB a/DT high/JJ degree/NN of/IN sequence/NN identity/NN that/IN spans/NNS >/SYM 560/CD contiguous/JJ amino/JJ acid/NN residues/NNS ./.
@@100915946976 Conformational/JJ studies/NNS combining/JJ secondary/JJ structure/NN predictions/NNS ,/, CD/NN and/CC NMR/NN spectroscopy/NN together/RB with/IN ELISA/NN assays/NNS ,/, showed/VBD that/IN the/DT greater/JJR is/VBZ the/DT propensity/NN of/IN the/DT epitope/NN for/IN helix/NN formation/NN the/DT higher/JJ is/VBZ the/DT recognition/NN by/IN anti-K159/NEWGENE ./.
@@11030476861 Spores/NNS from/IN Rhizopus/NNP stolonifer/NN were/VBD suspended/VBN in/IN distilled/JJ water/NN (/( 1/CD x/NN 10/NN (/NN 6/NN )/SYM spores/NN //NN mL/NN )/NN and/CC used/VBN as/IN starter/NN ./.
@@88715671407 Gene/NEWGENE 1/NEWGENE has/VBZ been/VBN completely/RB sequenced/VBN ./.
@@94784229441 BACKGROUND/IN AND/CC OBJECTIVES/NNS :/: The/DT sexually/RB transmitted/VBN diseases/NNS (/( STD/NN )/SYM control/NN program/NN for/IN female/JJ sex/NN workers/NNS (/( FSW/NN )/SYM in/IN Lima/NN ,/, Peru/NN ,/, provided/VBN periodic/JJ serological/JJ tests/NNS for/IN syphilis/NN and/CC cervical/JJ smears/NNS for/IN gonococci/NNS ,/, but/CC not/RB medication/NN for/IN STD/NN or/CC condoms/NNS ./.
@@35429454414 Ciprofloxacin/NN :/: an/DT overview/NN of/IN adverse/JJ experiences/NNS ./.
@@59499715836 Persistence/NNS of/IN toxaphene/NN in/IN treated/VBN lakes/NNS ./.
@@10367240231 Nevertheless/RB cryopreservation/NN of/IN spermatozoa/NNS in/IN a/DT medium/JJ containing/JJ neither/DT SP/NN nor/CC biological/JJ substances/NNS could/MD offer/VB an/DT acceptable/JJ cryoprotection/NN of/IN spermatozoa/NNS to/IN be/VB used/VBN in/IN assisted/JJ fertilization/NN procedures/NNS ,/, especially/RB for/IN intracytoplasmic/JJ sperm/NN injection/NN ./.
@@68071496579 Comparison/NNS of/IN three/CD different/JJ preparations/NNS of/IN disodium/JJ cromoglycate/NN in/IN the/DT prevention/NN of/IN exercise-induced/JJ bronchospasm/NN :/: a/DT double-blind/JJ study/NN ./.
@@81057273058 Fenoldopam/NNP ,/, a/DT dopamine/NEWGENE receptor/NEWGENE agonist/NN ,/, has/VBZ been/VBN shown/VBP ,/, in/IN animal/JJ experiments/NNS ,/, to/IN improve/VB renal/JJ perfusion/NN ./.
@@77042733490 Escherichia/NN coli/JJ JRG582/NN is/VBZ an/DT ampD/NEWGENE ampE/NEWGENE1 deletion/NN derivative/NN of/IN strain/NN HfrH/NN and/CC accordingly/RB it/PRP is/VBZ derepressed/VBN for/IN expression/NN of/IN the/DT cloned/VBN inducible/NN beta-lactamase/NEWGENE gene/NEWGENE of/IN Citrobacter/NN freundii/NN ,/, carried/VBN on/IN plasmid/NN pNU305/NN ./.
@@5653145626 Guinea/NN pigs/NNS weighing/VBG 300/CD approximately/RB 350/CD g/NN were/VBD used/VBN ./.
@@80510194665 Alginate/NEWGENE biosynthesis/NN is/VBZ controlled/VBN by/IN a/DT complex/JJ regulatory/JJ mechanism/NN ./.
@@68844502298 In/NN visible/JJ tumours/NNS the/DT best/JJS results/NNS were/VBD obtained/VBN with/IN FB/NN (/( 85%/JJ )/SYM while/CC TBN/NN was/VBD positive/JJ in/IN 65%/NN ./.
@@103795476171 Molecules/NNS of/IN NH3/NN are/VBP capable/JJ of/IN emitting/JJ stimulated/VBN radiation/NN (/( MASER/NN )/SYM ./.
@@73095627177 A/DT simplified/JJ thin-layer/NN chromatographic/JJ determination/NN of/IN hippuric/JJ acid/NN and/CC methylhippuric/JJ acids/NNS ./.
@@83073388486 Mutations/NNS in/IN the/DT nuclear/NEWGENE gene/NEWGENE CBP1/NEWGENE of/NEWGENE Saccharomyces/NEWGENE cerevisiae/NEWGENE result/NN in/IN degradation/NN of/IN mitochondrially/NEWGENE encoded/NEWGENE cytochrome/NEWGENE b/NEWGENE (/( cob/NEWGENE )/SYM RNA/NN ;/: thus/RB ,/, the/DT cells/NNS are/VBP unable/JJ to/IN respire/VB ./.
@@1003251927 Radiative/JJ corrections/NNS to/IN beta/NN decay/NN and/CC the/DT possibility/NN of/IN a/DT fourth/NN generation/NN ./.
@@92221159997 Results/NNS support/NN the/DT hypothesis/NN that/IN endogenous/NEWGENE corticotropin-releasing/NEWGENE factor/NEWGENE ,/, perhaps/RB acting/JJ at/IN a/DT peripheral/JJ binding/JJ site/NN ,/, suppresses/VBZ the/DT active/JJ behavioral/JJ response/NN characteristic/NN of/IN pups/NNS during/IN the/DT early/JJ phase/NN of/IN isolation/NN in/IN novel/JJ surroundings/NNS ./.
@@83366981109 TFEC/NEWGENE ,/, a/DT basic/NEWGENE helix-loop-helix/NEWGENE protein/NEWGENE ,/, forms/NNS heterodimers/NNS with/IN TFE3/NEWGENE and/CC inhibits/VBZ TFE3-dependent/NN transcription/NN activation/NN ./.
@@86669132787 Ly-49/NEWGENE is/VBZ a/DT family/NEWGENE type/NEWGENE II/NEWGENE transmembrane/NEWGENE proteins/NEWGENE encoded/VBN by/IN a/DT gene/NN cluster/NN on/IN murine/JJ chromosome/NN 6/CD ./CD
@@96874989743 Our/PRP results/NNS suggest/VBP that/IN the/DT crucial/JJ role/NN of/IN the/DT mutations/NN activating/NN v-erbA/NEWGENE as/IN an/DT oncogene/NN is/VBZ to/IN 'freeze'/NN c-ErbA/NEWGENE //NEWGENE TRalpha/NEWGENE in/IN its/PRP non-liganded/JJ ,/, repressive/JJ conformation/NN and/CC to/IN facilitate/VB its/PRP overexpression/NN ./.
@@10499121535 All/DT were/VBD experienced/VBN hearing/JJ aid/NN users/NNS who/WP wore/VBD linear/JJ Class/NN D/NN instruments/NNS with/IN input/NN compression/NN limiting/JJ at/IN the/DT time/NN of/IN their/PRP enrollment/NN in/IN this/DT study/NN ./.
@@6513456285 Adenyl/NEWGENE cyclase/NEWGENE activity/NN of/IN gastric/JJ mucosa/NN in/IN patients/NNS with/IN duodenal/JJ ulcer/NN before/IN and/CC after/IN treatment/NN ./.
@@11137551978 In/NN whole/JJ sardine/NN ,/, domoic/JJ acid/NN was/VBD detected/VBN in/IN levels/NNS exceeding/VBG sometimes/RB the/DT regulatory/JJ limit/NN ./.
@@31106785324 Comparison/NNS of/IN beta/NEWGENE 2-microglobulin/NEWGENE removal/NN using/VBG the/DT same/JJ polysulphone/NN membrane/NN for/IN haemodialysis/NN and/CC haemofiltration/NN shows/VBZ that/DT beta/NEWGENE 2-microglobulin/NEWGENE is/VBZ more/RB effectively/RB removed/VBN by/IN convection/NN than/IN by/IN diffusion/NN when/CC both/DT treatment/NN modes/NNS are/VBP matched/JJ for/IN blood/NN flow/NN and/CC urea/NN clearance/NN ./.
@@113139614733 The/DT mice/NNS are/VBP phenotypically/RB normal/JJ and/CC do/VB not/RB develop/VB spontaneous/JJ tumors/NNS at/IN an/DT early/JJ age/NN ,/, in/IN contrast/NN to/IN knock-out/JJ (/( p53/NEWGENE (/NEWGENE -/NEWGENE //NEWGENE -/NEWGENE )/NEWGENE )/NN strains/NNS with/IN a/DT defective/NN p53/NEWGENE gene/NEWGENE ./.
@@117370561584 At/NN this/DT timepoint/NN ,/, many/JJ leucocytes/NNS in/IN the/DT ME/PRP and/CC ET/NNP mucosa/NN had/VBP incorporated/VBN BrdU/NN (/( between/IN 15/CD and/CC 25%/CD within/IN the/DT subsets/NNS )/SYM ./.
@@110230749344 The/DT cost/NN per/IN test/NN is/VBZ less/PRP than/IN those/DT for/JJ CC/NN ,/, kEIA/NN and/CC PACE2/NN ./.
@@2169398096 Effect/NN of/IN succimer/NN on/IN the/DT intensity/NN of/IN tricarboxylic/NEWGENE acid/NEWGENE dehydrogenase/NEWGENE reactions/NNS in/IN the/DT brain/NN of/IN rats/NNS poisoned/VBN with/IN mercuric/JJ chloride/NN ./.
@@113140307279 Our/PRP results/NNS suggest/VBP that/IN the/DT C-terminal/NN region/NN of/IN Crk/NEWGENE contains/VBZ negative/JJ regulatory/JJ elements/NNS important/JJ for/IN both/DT Abl/NEWGENE and/CC FAK/NEWGENE dependent/JJ signal/JJ pathways/NNS ,/, and/CC offers/VBP a/DT paradigm/NN for/IN an/DT autoinhibitory/JJ region/NN in/IN the/DT SH3/NEWGENE linker/NEWGENE //NEWGENE C-terminal/NEWGENE SH3/NEWGENE domain/NEWGENE ./.
@@3696834360 Adriamycin/NN :/: comparison/NN of/IN a/DT 5-week/JJ schedule/NN with/IN a/DT 3-week/JJ schedule/NN in/IN the/DT treatment/NN of/IN breast/NN cancer/NN ./.
@@108057474295 In/NN contrast/NN ,/, mutations/NNS affecting/VBG the/PDT other/DT two/JJ Nim1p-related/NEWGENE kinases/NEWGENE in/IN S/NNP ./NNP cerevisiae/NN ,/, Hsl1p/NEWGENE and/CC Kcc4p/NEWGENE ,/, produce/VB no/DT detectable/JJ effect/NN on/IN septin/NEWGENE organization/NN ./.
@@76513988444 A/DT Drosophila/NEWGENE shc/NEWGENE gene/NEWGENE product/NEWGENE is/VBZ implicated/VBN in/IN signaling/JJ by/IN the/DT DER/NEWGENE receptor/NEWGENE tyrosine/NEWGENE kinase/NEWGENE ./.
@@10212426153 Group/NNP psychometric/JJ functions/NNS for/IN listeners/NNS with/IN hearing/JJ loss/NN do/NN not/RB show/VB a/DT decrease/NN in/IN performance/NN at/IN the/DT largest/JJS values/NNS of/IN delta/NN f/NN included/VBN in/IN this/DT study/NN ./.
@@110716517141 Thus/RB ,/, blocks/NNS in/IN the/DT RARalpha-specific/NNP pathway/NN of/IN retinoid-induced/JJ differentiation/NN may/MD be/VB bypassed/VBN during/IN retinoid/JJ induction/NN of/IN FR-beta/NEWGENE expression/NN ./.
@@20234211103 Once/RB the/DT proliferation/NN of/IN fibroblasts/NNS and/CC collagen/NEWGENE synthesis/NN had/VBP led/VBN to/IN an/DT increase/NN of/IN mechanical/JJ strength/NN ,/, no/DT negative/JJ effect/NN on/IN wound/JJ healing/NN could/MD be/VB detected/VBN applying/VBG the/DT same/JJ chemotherapeutic/JJ agents/NNS ./.
@@24664143124 In/NN 10/CD pentobarbitalized/VBN dogs/NNS ,/, plasma/NN viscosity/NN (/( Ep/NNS )/SYM was/VBD raised/VBN fourfold/RB while/CC apparent/JJ blood/NN viscosity/NN (/( Ea/NN )/SYM increased/VBN about/RB twofold/RB by/IN two/JJ steps/NNS of/IN exchange/NN transfusion/NN of/IN 200/CD ml/NN of/IN plasma/NN with/IN plasma/NN containing/JJ high/JJ molecular/JJ weight/NN dextran/NN (/( mol/NN wt/NN 500/CD ,/CD 000/CD ,/, 20%/CD wt/NN //NN vol/NN )/SYM ./.
@@101873179850 Hospital/NNP hit/JJ for/IN hiring/JJ AHERF/NN physicians/NNS ./.
@@25670303221 After/IN overtraining/NN on/IN the/DT original/JJ discrimination/NN ,/, the/DT controls/NNS showed/VBD the/DT normal/JJ difficulty/NN in/IN learning/JJ the/DT first/JJ reversal/NN ./.
@@111608605736 Interestingly/RB ,/, the/DT activity/NN of/IN IkappaB/NEWGENE kinase/NEWGENE (/( IKK-beta/NEWGENE )/SYM ,/, which/WDT plays/VBP an/DT essential/JJ role/NN in/IN NF-kappaB/NEWGENE activation/NN through/RB IkappaB/NEWGENE phosphorylation/NN ,/, was/VBD largely/RB enhanced/VBN in/IN paclitaxel-treated/JJ cells/NNS ,/, detected/VBN as/IN IkappaBalpha/NEWGENE phosphorylation/NN ./.
@@98320992339 We/PRP evaluated/VBD regional/JJ right/JJ ventricular/JJ wall/NN motion/NN during/IN systole/NN in/IN patients/NNS with/IN surgically/RB repaired/VBN tetralogy/NN of/IN Fallot/NNS (/( TOF/NN )/SYM using/VBG color/NN kinesis/NN imaging/JJ ./.
@@97105829391 The/DT effect/NN of/IN Rho/NEWGENE on/IN AP-1/NEWGENE is/VBZ independent/NN of/IN the/DT mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE pathway/NEWGENE ,/, as/IN a/DT dominant-negative/NEWGENE MEK/NEWGENE and/CC a/DT MEK/NEWGENE inhibitor/NN (/( PD98059/NN )/SYM did/VBD not/RB affect/VB Rho-induced/NEWGENE AP-1/NEWGENE activity/NN ./.
@@3365471429 The/DT mortality/NN rate/NN and/CC histopathological/JJ features/NNS of/IN Nocardia/DT asteroides/NN and/CC Nocardia/DT brasiliensis/NN infections/NNS in/IN congenitally/RB athymic/JJ (/( nude/JJ )/SYM mice/NNS of/IN ICR/NNS and/CC C3H/NN //NN eB/NN origins/NNS were/VBD quite/RB different/JJ from/IN what/WP we/PRP found/VBP for/IN Swiss/JJ white/NN mice/NNS and/CC other/DT inbred/JJ mouse/NN strains/NNS (/( namely/RB ,/, C57/NNP //NNP BL/NNP //NNP 6J/NNP ,/, New/NNP Zealand/NNP Black/NNP ,/, BALB/NN //NN c/NN ,/, CBA/NNP //NNP LAC/NNP ,/, and/CC C3H/NN //NN eB/NN )/SYM ./.
@@11086872926 Influence/NNS of/IN oil/NN emulsions/NNS and/CC diphenyl/NN on/IN post-harvest/JJ physiconutritional/JJ changes/NNS in/IN Kagzi/NNP limes/NNS (/( Citrus/NNP aurantifolia/NN )/SYM was/VBD studied/VBN ./.
@@111455713903 IFN-stimulated/NEWGENE gene/NEWGENE factor-3/NEWGENE and/CC STAT1/NEWGENE homodimers/NEWGENE formed/VBN and/CC bound/VBD an/DT IFN-stimulated/NEWGENE response/NEWGENE element/NEWGENE (/( ISRE/NEWGENE )/SYM and/CC gamma-activated/NEWGENE sequence/NEWGENE (/( GAS/NEWGENE )/SYM element/NN ,/, respectively/RB ./.
@@71198908094 Re/NN :/: A/DT modified/JJ method/NN for/IN the/DT in/NN vivo/NN labeling/NN of/IN red/JJ blood/NN cells/NNS with/IN Tc-99m/NN ./.
@@92234791997 ORF/NEWGENE M1/NEWGENE has/VBZ striking/JJ homology/NN to/IN poxvirus/NN serpins/NEWGENE ,/, while/CC ORF/NEWGENE M11/NEWGENE encodes/VBZ a/DT potential/JJ homolog/NN of/IN Bcl-2-like/NEWGENE molecules/NEWGENE encoded/VBN by/IN other/DT gammaherpesviruses/NNS (/( gene/NEWGENE 16/NEWGENE of/IN HVS/NNS and/CC KSHV/NN and/CC the/DT BHRF1/NEWGENE gene/NEWGENE of/IN EBV/NN )/SYM ./.
@@8072547880 A/DT short/JJ sequence/NN surrounding/JJ the/DT major/JJ JNK/NEWGENE phosphorylation/NN site/NN of/IN c-Jun/NEWGENE is/VBZ conserved/VBN in/IN c-Fos/NEWGENE and/CC is/VBZ part/NN of/IN its/PRP activation/NN domain/NN ,/, suggesting/VBG that/IN c-Fos/NEWGENE may/MD be/VB similarly/RB regulated/VBN ./.
@@95105821250 Two/CD hundred/JJ sixty-four/NN patients/NNS scheduled/VBN for/IN DCBM/NN were/VBD randomized/JJ to/IN receive/VB intravenously/RB geG/VB 0/CD ./CD 25/CD mg/NN (/( geG-25/JJ )/SYM ,/, or/CC geG/NN 0/CD ./CD 5/CD mg/NN (/( geG-50/JJ )/SYM ,/, or/CC HBB/NN 20/NN mg/NN as/IN hypotonic/JJ agent/NN ./.
@@73773787066 Estrogen/NN replacement/NN ,/, either/DT as/IN 17/CD beta-estradiol/NN or/CC beta-estradiol-3-benzoate/JJ via/NN subcutaneous/JJ Silastic/NN capsules/NNS ,/, was/VBD associated/VBN with/IN elevated/VBN rates/NNS of/IN heat/NN production/NN and/CC dry/JJ heat/NN loss/NN relative/JJ to/IN untreated/JJ ovariectomized/JJ controls/NNS ./.
@@50277995326 Sodium/NN restriction/NN in/IN cardiac/JJ failure/NN ./.
@@113198802677 Rapamycin/NN (/( FRAP/NEWGENE //NEWGENE mTOR/NEWGENE inhibitor/NN )/SYM blocked/VBN 4E-BP1/NEWGENE phosphorylation/NN causing/JJ a/DT predominance/NN of/IN the/DT alpha/NN (/( hypophosphorylated/JJ )/SYM band/NN ./.
@@99290887324 CONTEXT/NNP :/: ThinPrep/NN ,/, AutoPap/NN ,/, and/CC Papnet/NN are/VBP 3/CD new/JJ technologies/NNS that/WDT increase/VBP the/DT sensitivity/NN and/CC cost/NN of/IN cervical/JJ cancer/NN screening/JJ ./.
@@78119646733 A/DT unique/JJ leucine-proline/NEWGENE repeat/NEWGENE element/NEWGENE found/VB N-terminal/NN to/IN the/DT DNA-binding/NN domain/NN of/IN EmBP-1/NEWGENE does/VBP not/RB appear/VB to/IN play/NN a/DT role/NN in/IN DNA-binding/NN or/CC dimerization/NN ./.
@@84491334103 Endosonography/NNS accurately/RB assessed/VBN tumor/NN extension/NN in/IN two/JJ T2/NN tumors/NNS ,/, 14/CD T3/NN tumors/NNS ,/, and/CC seven/JJ T4/NN tumors/NNS ./.
@@96773308072 The/DT PDE4A-subfamily-specific/NEWGENE linker/NEWGENE region/NEWGENE LR1/NEWGENE1 ,/, which/WDT joins/VBP UCR1/NEWGENE and/CC UCR2/NEWGENE ,/, is/VBZ encoded/VBN by/IN two/JJ exons/NNS ,/, whereas/IN LR2/NEWGENE ,/, which/WDT joins/VBP UCR2/NEWGENE to/IN the/DT catalytic/JJ unit/NN ,/, is/VBZ encoded/VBN by/IN a/DT single/JJ exon/NN ./.
@@47041865105 Range/NN behavior/NN of/IN Hereford/NNP ,/, Hereford/NNP x/NN Holstein/NN and/CC Holstein/NN non-lactating/JJ heifers/NNS ./.
@@118315126757 Forty-eight/NNS pigs/NNS were/VBD removed/VBN from/IN sows/NNS at/IN 1/CD d/NN of/IN age/NN and/CC randomly/RB assigned/VBN to/IN one/PRP of/IN three/CD treatments/NNS :/: 1/NN )/NN control/NN with/JJ lactose/NN as/IN the/DT carbohydrate/NN source/NN ,/, 2/NN )/NN lactose/NN replaced/VBN (/( gram/NN for/IN gram/NN )/SYM with/IN CSS/NNP (/( dextrose/NN equivalent/JJ [/NN DE/NN ]/NN -20/NN )/SYM ,/, and/CC 3/NN )/NN lactose/NN replaced/VBN with/IN DE-42/NN ./.
@@58066155744 Oxidative/JJ degradation/NN of/IN adrenaline/NN solutions/NNS :/: study/NN of/IN the/DT intermediate/JJ stages/NNS and/CC their/PRP analytic/JJ value/NN for/IN the/DT control/NN of/IN this/DT solute/NN ./.
@@112595032781 Forskolin/DT treatment/NN (/( 10/CD microM/NN )/SYM of/IN the/DT transfected/VBN cells/NNS for/IN 3--6/JJ h/NN maximally/RB induced/VBD luciferase/NEWGENE threefold/RB ./.
@@81767421262 We/PRP have/VBP used/VBN these/DT modified/JJ assay/NN conditions/NNS to/IN extend/VB studies/NNS on/IN the/DT transposition/NN pathway/NN ./.
@@91002021000 Thirty/CD Class/NN I/NN and/CC Class/NN II/NN recessions/NNS in/IN 30/CD patients/NNS were/VBD treated/VBN with/IN a/DT modified/JJ subepithelial/JJ connective/JJ tissue/NN graft/NN procedure/NN ./.
@@88434117908 Two/CD classes/NNS of/IN inactive/JJ receptors/NNS were/VBD identified/VBN :/: one/PRP in/IN which/WDT both/DT transcriptional/JJ activation/NN and/CC dimerization/NN were/VBD compromised/VBN and/CC a/DT second/NN in/IN which/WDT only/RB transcriptional/JJ activation/NN was/VBD abolished/VBN ./.
@@87066626618 The/DT results/NNS also/RB imply/VBP that/IN the/DT absence/NN of/IN perforin/NEWGENE expression/NN in/IN non-cytotoxic/JJ cells/NNS may/MD be/VB due/NN to/IN the/DT suppression/NN of/IN the/DT induction/NN of/IN the/DT killer-cell-specific/JJ trans-acting/JJ factor/NN NF-P2/NEWGENE ./.
@@79445427919 Vibrio/NN cholerae/NNS O139/CD in/IN Calcutta/NNP ./.
@@25486833201 A/DT brief/JJ account/NN of/IN the/DT 1988/CD seminar/NN in/IN Shanghai/NNP on/IN viral/JJ hepatitis/NNP A/NNP ./NNP
@@84193336302 To/TO characterize/VB the/DT expression/NN of/IN this/DT DNA/NEWGENE repair/NEWGENE enzyme/NEWGENE ,/, we/PRP have/VBP isolated/VBN the/DT corresponding/JJ genomic/JJ clone/NN ./.
@@277395101 Serum/NEWGENE gamma/NEWGENE glutamyltransferase/NEWGENE in/IN the/DT diagnosis/NN of/IN liver/NN disease/NN in/IN cattle/NNS ./.
@@90577039011 Snail/NN mortality/NN did/VBD not/RB differ/VB among/IN the/DT various/JJ treatment/NN conditions/NNS ./.
@@57339535684 The/DT effect/NN of/IN a/DT constant/JJ magnetic/JJ field/NN on/IN the/DT phagocytic/JJ activity/NN of/IN Paramecia/NNP ./.
@@93680588859 However/RB ,/, one/PRP CAK-phosphorylated/JJ phosphopeptide/NN comigrates/VBZ with/IN a/DT Cdc2-phosphorylated/JJ phosphopeptide/NN previously/RB shown/VBP to/IN be/VB mitosis-specific/JJ ,/, suggesting/VBG that/IN ,/, in/IN vitro/FW ,/, CAK/NEWGENE is/VBZ able/JJ to/IN phosphorylate/VB at/IN least/RB one/PRP site/NN that/WDT is/VBZ also/RB phosphorylated/VBN in/IN vivo/NN ./.
@@117731681052 The/DT 5-year/JJ overall/JJ survival/NN (/( OS/NNS )/SYM and/CC progression-free/JJ survival/NN (/( PFS/NN )/SYM rates/NNS were/VBD 58/CD ./CD 9%/CD and/CC 55/CD ./CD 4%/CD for/IN arm/NN A/NN and/CC 44/CD ./CD 5%/CD and/CC 41/CD ./CD 3%/CD for/IN arm/NN B/NN (/( P/NN =/CD ./CD 007/CD and/CC P/NN =/CD ./CD 02/CD )/SYM ,/, respectively/RB ./.
@@100875498841 The/DT JTc/NN delta/NN among/IN the/DT three/CD groups/NNS did/VBD not/RB differ/VB as/IN well/NN :/: JTc/NN delta/NN of/IN the/DT VT/NN group/NN was/VBD 70/CD ms/NN +/NN //NN -/NN 30/CD ms/NN ,/, the/DT JTc/NN delta/NN of/IN the/DT PVC/NN group/NN was/VBD 60/CD msec/NN +/NN //NN -/NN 25/CD msec/NN ,/, and/CC the/DT JTc/NN delta/NN of/IN the/DT control/NN group/NN was/VBD 70/CD ms/NN +/NN //NN -/NN 30/CD ms/CD ./CD
@@34435734249 Overall/RB least-squares/VBZ means/NN for/IN uncooked/JJ and/CC cooked/VBN longissimus/JJ muscle/NN and/CC subcutaneous/JJ fat/NN were/VBD 63/CD ./CD 32/CD ,/, 80/CD ./CD 27/CD and/CC 98/CD ./CD 90/CD mg/NN of/IN cholesterol/NN //NN 100/NN g/NN of/IN tissue/NN ,/, respectively/RB ./.
@@8806817797 Sequence/NN analysis/NN of/IN the/DT isolated/VBN genomic/JJ clone/NN revealed/VBN that/IN the/DT DNA/NN binding/JJ domain/NN of/IN this/DT orphan/NEWGENE receptor/NEWGENE is/VBZ most/RB homologous/JJ to/IN the/DT human/NEWGENE TR2/NEWGENE receptor/NEWGENE ./.
@@7636962352 Interestingly/RB ,/, this/DT amino-terminal/JJ determinant/NN appears/VBZ not/RB to/IN reside/VB in/IN the/DT HSV-alpha/NNP TIF/NEWGENE ,/, which/WDT displays/VBP no/DT independent/JJ amino-terminal/JJ activity/NN ./.
@@36513304320 UVA-induced/JJ melanocytic/JJ lesions/NNS ./.
@@111372961778 PFK-A/NEWGENE mRNA/NN was/VBD more/RB abundantly/RB expressed/VBN in/IN all/DT tissues/NNS than/IN were/VBD the/DT PFK-B/NEWGENE and/CC PFK-C/NEWGENE genes/NEWGENE ./.
@@103665599809 The/DT hybrid/JJ viruses/NNS were/VBD found/VBN to/IN accumulate/VB to/IN high/JJ levels/NNS in/IN infected/VBN plants/NNS ,/, to/IN form/NN stable/JJ virions/NNS ,/, and/CC to/IN be/VB mechanically/RB transmissible/JJ ./.
@@10521796358 The/DT ORs/NNS of/IN GC/NN ,/, adjusted/VBN for/IN age/NN and/CC sex/NN ,/, varied/VBN from/IN 17/CD ./CD 1/CD ,/, for/IN those/DT with/JJ baseline/NN diagnoses/NNS of/IN superficial/JJ intestinal/JJ metaplasia/NN (/( IM/RB )/SYM ,/, to/IN 29/CD ./CD 3/CD ,/, for/IN those/DT with/IN deep/JJ IM/RB or/CC mild/JJ dysplasia/NN (/( DYS/NNP )/SYM or/CC IM/RB with/IN glandular/JJ atrophy/NN and/CC neck/NN hyperplasia/NN ,/, to/IN 104/CD ./CD 2/CD ,/, for/IN those/DT with/IN moderate/JJ or/CC severe/JJ DYS/NN ,/, as/IN compared/VBN with/IN subjects/NNS with/IN superficial/JJ gastritis/NN (/( SG/NN )/SYM or/CC chronic/JJ atrophic/JJ gastritis/NN (/( CAG/NN )/SYM at/IN baseline/NN ./.
@@16297682223 Lesions/NNS were/VBD made/VBP by/IN pressure/NN injection/NN of/IN kainic/JJ acid/NN into/IN the/DT SOC/NN through/RB a/DT stereotaxically/RB positioned/VBN glass/NN micropipette/NN ./.
@@82944293202 Analysis/NNP of/IN the/DT intact/JJ hGH/NEWGENE gene/NEWGENE or/CC hGH/NEWGENE 5'-flanking/NEWGENE DNA/NEWGENE (/NEWGENE 5'-FR/NEWGENE )/NEWGENE coupled/VBN to/IN the/DT hGh/NEWGENE cDNA/NEWGENE or/CC chloramphenicol/NEWGENE acetyltransferase/NEWGENE or/CC luciferase/NEWGENE genes/NEWGENE ,/, indicated/VBD that/DT cAMP/NN primarily/RB stimulated/VBD hGH/NEWGENE promoter/NEWGENE activity/NN ./.
@@58573016195 Chemical/NNP histologic/JJ and/CC immunologic/JJ responses/NNS in/IN rats/NNS to/IN CC1-4/NN by/IN different/JJ routes/NNS of/IN administration/NN ./.
@@974953340 Clone/NN 39/NN was/VBD a/DT homolog/NN of/IN CONSTANS/NEWGENE ,/, which/WDT is/VBZ a/DT gene/NN involved/VBN in/IN controlling/VBG the/DT flowering/JJ time/NN in/IN Arabidopsis/NN ./.
@@99736079578 Here/RB we/PRP describe/VBP the/DT identification/NN and/CC characterization/NN of/IN several/DT Sp100/NEWGENE splice/NEWGENE variant/NEWGENE proteins/NEWGENE and/CC support/VB their/PRP existence/NN by/IN elucidation/NN of/IN the/DT 3'-end/CD of/IN the/DT Sp100/NEWGENE gene/NEWGENE ./.
@@103580803955 Although/IN linker/NN regions/NNS in/IN transcription/NN factors/NNS are/VBP known/VBP to/IN modulate/VB DNA/NN binding/JJ specificity/NN ,/, our/PRP studies/NNS suggest/VBP that/IN the/DT human/NEWGENE HSF1/NEWGENE linker/NN plays/VBP no/DT role/NN in/IN determining/NN HSF1/NEWGENE binding/JJ preferences/NNS in/IN vivo/NN but/CC is/VBZ a/DT critical/JJ determinant/NN in/IN regulating/JJ the/DT HSF1/NEWGENE monomer-trimer/NEWGENE equilibrium/NN ./.
@@110272747873 They/PRP also/RB negatively/RB modulate/VB the/DT PI/NEWGENE 3-kinase/NEWGENE catalytic/JJ activity/NN but/CC to/IN different/JJ extents/NNS ,/, dependent/JJ on/IN the/DT unique/JJ N-terminal/NN structure/NN of/IN each/DT isoform/NN ./.
@@63190726111 We/PRP conclude/VBP that/IN the/DT 'morning/JJ dip'/NN observed/VBN in/IN asthmatic/JJ patients/NNS cannot/MD simply/RB be/VB explained/VBN by/IN changes/NNS in/IN cell/NN receptor/NN number/NN or/CC affinity/NN ,/, as/IN our/PRP results/NNS suggest/VBP that/IN both/DT groups/NNS have/NN intact/JJ beta-adrenoceptor/NEWGENE function/NN ./.
@@28098311186 In/NN contrast/NN ,/, the/DT PPSF/NN +/SYM DBP/NN side/NN showed/VBD large/JJ amounts/NNS of/IN bone/NN formation/NN ,/, and/CC bone/NN almost/RB covered/VBD the/DT implant/NN ./.
@@50603885339 Clinicopathologic/NNP studies/NNS in/IN feminizing/JJ tumors/NNS of/IN the/DT ovary/NN ./.
@@68355161623 A/DT case/NN of/IN a/DT dense/JJ epidermoid/NN cyst/NN of/IN the/DT suprasellar/JJ cistern/NN is/VBZ presented/VBN ./.
@@98636245386 The/DT divergence/NN in/IN primary/JJ structure/NN between/IN the/DT sheep/NN CRF1/NEWGENE and/CC the/PDT other/DT mammalian/NEWGENE CRF1s/NEWGENE is/VBZ primarily/RB localized/VBN to/IN the/DT extracellular/JJ amino/JJ terminal/JJ domain/NN of/IN the/DT receptor/NN (/( 18/CD of/IN 22/CD divergent/JJ residues/NNS ,/, ovine/JJ vs/NNP human/NEWGENE CRF1/NEWGENE )/SYM ./.
@@91694753944 Localization/NNS of/IN the/DT cytokine/NEWGENE response/NEWGENE element/NEWGENE by/IN 5'-deletion/CD analysis/NN and/CC site-directed/JJ mutagenesis/NN revealed/VBD a/DT cis-acting/JJ binding/JJ site/NN for/IN activated/VBN STAT/NEWGENE complexes/NEWGENE ./.
@@78456729725 Comparison/NNS of/IN human/NEWGENE and/NEWGENE murine/NEWGENE blk/NEWGENE sequences/NEWGENE indicated/VBN that/IN they/PRP share/VBP 86%/JJ amino/JJ acid/NN identity/NN ,/, the/DT most/RB conserved/VBN region/NN being/VBP the/DT catalytic/JJ domain/NN (/( 93%/CD identity/NN )/SYM ./.
@@25733361668 An/DT experiment/NN on/IN the/DT return-of-fear/JJ (/( ROF/NN )/SYM was/VBD carried/VBN out/RB on/IN 40/CD snake-/JJ or/CC spider-phobic/JJ subjects/NNS in/IN order/NN to/IN determine/VB whether/IN an/DT arousing/JJ event/NN that/WDT occurs/VBZ shortly/RB before/IN retest/VB influences/VBZ the/DT magnitude/NN of/IN the/DT ROF/NN ./.
@@87563323807 Members/NNS of/IN the/DT Ras/NEWGENE subfamily/NEWGENE of/IN small/NEWGENE GTP-binding/NEWGENE proteins/NEWGENE have/VBP been/VBN shown/VBP to/IN be/VB promiscuous/JJ towards/IN a/DT variety/NN of/IN putative/JJ effector/NN molecules/NNS such/JJ as/IN the/DT protein/NEWGENE kinase/NEWGENE c-Raf/NEWGENE and/CC the/DT Ral-specific/NEWGENE guanine/NEWGENE nucleotide/NEWGENE exchange/NEWGENE factor/NEWGENE (/( Ral-GEF/NEWGENE )/SYM ./.
@@88053381995 Targeted/JJ disruption/NN of/IN the/DT OGG1/NEWGENE gene/NEWGENE in/IN yeast/NN revealed/VBD a/DT second/JJ OG/NEWGENE glycosylase/NEWGENE //NEWGENE lyase/NEWGENE protein/NEWGENE ,/, tentatively/RB named/VBN Ogg2/NEWGENE ,/, which/WDT differs/VBZ from/IN Ogg1/NEWGENE in/IN that/DT it/PRP preferentially/RB acts/VBZ on/IN OG/JJ :/: G/NN ./.
@@98176011879 Characterization/NNS of/IN the/DT regulatory/JJ regions/NNS of/IN the/DT human/NEWGENE aromatase/NEWGENE (/( P450arom/NEWGENE )/SYM gene/NN involved/VBN in/IN placenta-specific/JJ expression/NN ./.
@@89948325497 Ectopic/NN expression/NN of/IN Apo-3/NEWGENE in/IN HEK293/CD or/CC HeLa/IN cells/NNS induced/VBD marked/JJ apoptosis/NN ./.
@@31428752267 Here/RB we/PRP report/VBP the/DT complete/JJ 6-kilobase/NN cDNA/NN sequence/NN coding/JJ for/IN a/DT chain/NN of/IN 1775/CD amino/JJ acids/NNS ,/, as/RB well/VB as/IN the/DT genomic/JJ structure/NN ./.
@@111145216883 Regulation/NN of/IN RhoA/NEWGENE is/VBZ required/VBN to/IN maintain/VB adhesion/NN in/IN stationary/JJ cells/NNS ,/, but/CC is/VBZ also/RB critical/JJ for/IN cell/NN spreading/JJ and/CC migration/NN [/NN 3/NN ]/NN ./.
@@11411145999 Prolonged/VBN heavy/JJ work/NN effected/VBD an/DT increase/NN of/IN 10/CD ./CD 3/CD plus/IN or/CC minus/IN 0/CD ./CD 9/CD mmHg/NN in/IN in/IN vivo/NN P50/NN (/( 7/CD ./CD 30/CD PH-v/NNP ,/, 41/CD degrees/NNS C-v/NNP ,/, and/CC 45/CD Pv-CO2/NN )/SYM ;/: due/NN entirely/RB to/IN the/DT additive/JJ effects/NNS of/IN increased/VBN venous/JJ temperature/NN and/CC [/NN H+/NN ]/NN ./.
@@76936722383 DNase/NEWGENE I/NEWGENE footprinting/VBG of/IN the/DT proximal/JJ promoter/NN revealed/VBN four/CD regions/NNS of/IN protection/NN ./.
@@96384859399 Atmospheric/NNP benzene/NN ,/, urinary/JJ muconic/JJ acid/NN (/( tt-MA/NN )/SYM and/CC leukocyte/NEWGENE alkaline/NEWGENE phosphatase/NEWGENE activity/NN (/( LAPA/NNP )/SYM were/VBD evaluated/VBN among/IN 66/CD car/NN mechanics/NN ,/, 34/CD road/NN tanker/NN drivers/NNS ,/, and/CC 28/CD nonexposed/JJ workers/NNS ./.
@@107478906002 These/DT results/NNS indicate/VBP that/DT residue/NN 266/CD serves/VBP as/IN a/DT "protein/NN sensor"/NN of/IN altered/VBN minor/JJ groove/NN interactions/NNS and/CC identifies/VBZ which/WDT base/VBP pair/NN interactions/NNS are/VBP altered/VBN by/IN these/DT lesions/NNS ./.
@@40413464717 Supraventricular/JJ arrhythmias--digoxin/NN and/CC quinidine/NN revisited/VBN ./.
@@103188066732 In/NN the/DT present/NN study/NN ,/, we/PRP have/VBP investigated/VBN the/DT functional/JJ role/NN of/IN the/PDT other/DT MAP/NEWGENE kinases/NEWGENE in/IN PDGF-mediated/JJ cellular/JJ responses/NNS ./.
@@15259662148 Differentiating/VBG among/IN renal/JJ stones/NNS ./.
@@53561075489 Biological/JJ action/NN and/CC kinetics/NN of/IN the/DT elimination/NN of/IN tritium/NN oxide/NN in/IN dogs/NNS ./.
@@73127074974 Chordoma/NNS of/IN the/DT spinal/JJ cord/NN in/IN a/DT F344/NN rat/NN ./.
@@9519096095 Does/VBZ afferent/JJ loop/NN syndrome/NN exist/VB ?/. It/PRP is/VBZ the/DT author's/NNS opinion/NN that/DT diagnosis/NN of/IN the/DT "adducent/NN loop/NN syndrome"/NN is/VBZ unlikely/JJ to/IN be/VB correct/JJ in/IN patients/NNS subjected/VBN to/IN Billroth-II/NN gastrectomy/NN ./.
@@32640733960 The/DT active/JJ derivatives/NNS of/IN the/DT present/NN series/NN were/VBD also/RB tested/VBN for/IN their/PRP analgesic/JJ activity/NN against/IN aconitine-induced/JJ writhing/NN in/IN albino/NN mice/NNS and/CC ulcerogenic/JJ activity/NN in/IN albino/NN rats/NNS ./.
@@75657763172 Disruption/NNS of/IN the/DT HOG1/NEWGENE and/CC PBS2/NEWGENE genes/NEWGENE leads/VBP to/IN a/DT dramatic/JJ decrease/NN of/IN the/DT HSP12/NEWGENE inducibility/NN in/IN osmostressed/VBN cells/NNS ,/, whereas/IN overproduction/NN of/IN Hog1/NEWGENE produces/VBZ a/DT fivefold/JJ increase/NN in/IN wild-type/NN induced/VBD levels/NNS upon/IN a/DT shift/NN to/IN a/DT high/JJ salt/JJ concentration/NN ./.
@@92857896353 Human/NEWGENE Duo/NEWGENE contains/VBZ a/DT guanine/NEWGENE nucleotide/NEWGENE exchange/NEWGENE factor/NEWGENE (/( GEF/NEWGENE )/SYM domain/NN that/WDT is/VBZ likely/RB to/IN be/VB rac1-specific/JJ ,/, a/DT pleckstrin/NEWGENE homology/NEWGENE (/( PH/NEWGENE )/SYM domain/NN and/CC spectrin-like/NEWGENE repeat/NEWGENE units/NEWGENE ./.
@@37611222148 The/DT relations/NNS between/IN type/NN A/NN behavior/NN ,/, clinically/RB relevant/JJ behavior/NN ,/, academic/JJ achievement/NN ,/, and/CC IQ/NN in/IN children/NNS ./.
@@31099543417 The/DT results/NNS suggest/VBP that/IN the/DT greater/RBR estrogenic/JJ influence/NN associated/VBN with/IN the/DT ethinyl/NN estradiol-containing/NN OC/NN resulted/VBN in/IN inhibition/NN of/IN coronary/JJ artery/NN atherosclerosis/NN despite/IN a/DT pronounced/VBN progestin-induced/JJ lowering/NN of/IN plasma/NN HDL/NN cholesterol/NN concentration/NN and/CC ,/, further/RB ,/, that/IN hormonal/JJ balance/NN may/MD have/VB a/DT marked/JJ influence/NN on/IN the/DT relationship/NN between/IN plasma/NN lipids/NNS and/CC atherogenesis/NN ./.
@@96875142854 In/NN this/DT study/NN ,/, we/PRP describe/VBP a/DT mammalian/JJ cell-free/JJ transcription/NN system/NN reconstituted/VBN with/IN only/RB recombinant/JJ proteins/NNS and/CC epitope-tagged/NN multiprotein/NN complexes/NNS ./.
@@96093429576 We/PRP specially/RB devised/VBD 3/CD types/NNS of/IN turbo/JJ pumps/NNS ,/, a/DT centrifugal/JJ pump/NN (/( CFP/NNP )/SYM ,/, a/DT mixed/JJ flow/NN pump/NN (/( MFP/NN )/SYM ,/, and/CC an/DT axial/JJ flow/NN pump/NN (/( AFP/NN )/SYM ,/, and/CC analyzed/VBD their/PRP in/IN vitro/FW performance/NN ./.
@@78517583813 Physical/NNP analysis/NN maps/NNS SAL6/NEWGENE to/IN chromosome/NN XVI/NNS between/IN TPK2/NEWGENE and/CC spt14/NEWGENE ./.
@@1093055746 Calcium/NN and/CC phosphorus/NN metabolism/NN in/IN chronic/JJ uremia/NN ./.
@@10466825859 Role/NN of/IN the/DT 3'/CD untranslated/JJ region/NN of/IN baculovirus/NEWGENE p10/NEWGENE mRNA/NEWGENE in/IN high-level/JJ expression/NN of/IN foreign/JJ genes/NNS ./.
@@106447534936 The/DT three/CD isoforms/NNS purified/VBN with/IN anti-FLAG/NEWGENE antibody/NEWGENE affinity/NN column/NN transferred/VBD sulfate/NN to/IN heparan/NN sulfate/NN and/CC heparin/NN but/CC not/RB to/IN other/DT glycosaminoglycans/NNS ./.
@@105215449977 Cloning/VBG and/CC expression/NN of/IN a/DT specific/NN human/NEWGENE alpha/NEWGENE 1/NEWGENE ,/NEWGENE 2-mannosidase/NEWGENE that/WDT trims/VBZ Man9GlcNAc2/NN to/IN Man8GlcNAc2/NN isomer/NN B/NN during/IN N-glycan/NNS biosynthesis/NN ./.
@@21316522208 Higher/JJR fasting/JJ serum/JJ gastrin/NEWGENE concentration/NN (/( 102/CD ./CD 0/CD +/NN //NN -/NN 21/CD ./CD 1/CD vs/NNP 63/CD ./CD 3/CD +/NN //NN -/NN 8/CD ./CD 3/CD ng/CD ./CD l-1/CD )/SYM ,/, and/CC greater/RBR postprandial/JJ gastrin/NEWGENE release/NN (/( AUC0-120/NNP :/: 16690/CD +/NN //NN -/NN 2648/CD vs/NNP 10654/CD +/NN //NN -/NN 1283/CD ng/CD ./CD l-1/CD min/NN )/SYM were/VBD observed/VBN after/IN VTP-HM/NNP than/IN after/IN VTP-Cas/NNP ./.
@@84465796356 Second/JJ ,/, the/DT transcription/NEWGENE factor/NEWGENE Gal-ER/NEWGENE was/VBD rendered/VBN more/RB potent/JJ and/CC less/PRP susceptible/JJ to/IN cell/NN type-specific/JJ variation/NN by/IN fusing/JJ the/DT strong/JJ activating/JJ domain/NN of/IN the/DT herpesvirus/NEWGENE protein/NEWGENE VP16/NEWGENE onto/IN its/PRP C/NN terminus/NN ./.
@@74267457289 A/DT progressive/JJ growth/NN of/IN blood/NN erythrocyte/NN membrane/NN injury/NN has/VBZ been/VBN demonstrated/VBN after/IN rats/NNS were/VBD exposed/VBN to/IN gamma-irradiaton/JJ at/IN a/DT dose/NN of/IN 100/CD to/IN 500/CD Gy/NNP ./NNP
@@86319082932 VDR/NEWGENE //NEWGENE RXR/NEWGENE bound/JJ well/NN to/IN the/DT VDREs/NEWGENE and/CC to/IN DR4/NEWGENE and/CC DR5/NEWGENE using/VBG the/DT electrophoretic/JJ mobility/NN shift/NN assay/NN ./.
@@10634007451 We/PRP describe/VBP a/DT case/NN of/IN acetaminophen/NN overdose/NN that/WDT was/VBD treated/VBN with/IN both/DT hemodialysis/NN (/( HD/NN )/SYM and/CC NAC/NN due/NN to/IN severe/JJ intoxication/NN and/CC slow/JJ drug/NN clearance/NN ./.
@@106728999733 Acad/NN ./.
@@93879999337 The/DT amplitudes/NNS of/IN DPOAE/NN also/RB recovered/VBD to/IN a/DT greater/JJR extent/NN and/CC outer/JJ hair/NN cell/NN losses/NNS were/VBD less/PRP severe/JJ in/IN the/DT R-PIA-treated/JJ ears/NNS ./.
@@24278699488 Furthermore/RB ,/, beta/NEWGENE 2-adrenoceptor/NEWGENE sensitivity/NN appears/VBZ to/IN be/VB unaltered/JJ in/IN BHT/NN ./.
@@70344791219 Fifty-eight/NNS RMI's/NN occurred/VBN in/IN the/DT placebo/NN group/NN as/IN compared/VBN to/IN only/RB twenty/CD in/IN the/DT AC/NN group/NN (/( p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ./.
@@119094044819 Nodal/NN domains/NN are/VBP regions/NNS where/CC a/DT function/NN has/VBZ definite/JJ sign/NN ./.
@@11016014102 HYPOTHESIS/NNP :/: The/DT aim/NN of/IN this/DT study/NN was/VBD to/IN investigate/VB the/DT oxidative/JJ susceptibility/NN of/IN apolipoprotein/NEWGENE B-containing/NEWGENE lipoproteins/NEWGENE and/CC antioxidant/JJ status/NN in/IN patients/NNS with/IN acute/JJ coronary/JJ syndromes/NNS and/CC chronic/JJ stable/JJ angina/NN pectoris/JJ ./.
@@9778197972 Cost-effectiveness/NNS analysis/NN provides/VBZ a/DT rational/JJ means/NN of/IN allocating/JJ limited/VBN health/NN care/NN resources/NNS by/IN allowing/VBG the/DT comparison/NN of/IN the/DT costs/NNS of/IN lipid-lowering/JJ therapy/NN ,/, in/IN particular/JJ ,/, therapy/NN with/IN beta-hydroxy-beta-methylglutaryl-CoA/NEWGENE (/NEWGENE coenzyme/NEWGENE A/NEWGENE )/NEWGENE reductase/NEWGENE inhibitors/NN (/( statins/NNS )/SYM ,/, with/IN the/DT costs/NNS of/IN atherosclerosis/NN that/WDT could/MD be/VB prevented/VBN by/IN lowering/JJ cholesterol/NN ./.
@@96608234519 Further/RB ,/, Ser/NNP //NNP Thr/NNP phosphorylation/NN of/IN downstream/NN molecules/NN Akt/NEWGENE and/CC p70/NEWGENE S6/NEWGENE kinase/NEWGENE was/VBD inhibited/VBN ./.
@@82645795136 The/DT cloning/NN of/IN PTR2/NEWGENE represents/VBZ the/DT first/JJ example/NN of/IN the/DT molecular/JJ genetic/JJ characterization/NN of/IN a/DT eucaryotic/JJ peptide/NN transport/NN gene/NN ./.
@@105755455093 These/DT include/VB the/DT CACCC/NNP and/CC CAAT/NN motifs/NN ./.
@@90616971558 Sixty-nine/NNS (/( 44%/JJ )/SYM patients/NNS were/VBD administered/VBN 250/CD MBq/NN (/( 7/CD mCi/NN )/SYM 99Tcm-tetrofosmin/NN at/IN rest/NN followed/VBN 4/CD h/NN later/JJR by/IN 750/CD MBq/NN (/( 21/CD mCi/NN )/SYM during/IN stress/NN (/( the/DT 1/CD day/NN protocol/NN )/SYM ,/, whereas/IN 88/CD (/( 56%/JJ )/SYM patients/NNS had/VBP rest/NN and/CC stress/NN imaging/JJ studies/NNS on/IN two/JJ separate/JJ days/NNS ,/, receiving/JJ a/DT 500/CD MBq/NN (/( 14/CD mCi/NN )/SYM dose/NN of/IN 99Tcm-tetrofosmin/NN on/IN each/DT occasion/NN (/( the/DT 2/CD day/NN protocol/NN )/SYM ./.
@@11401849280 Liver/NN microsomes/NNS of/IN the/DT shag/JJ showed/VBD smaller/JJR than/IN 8%/NN of/IN the/DT epoxide/NEWGENE hydrase/NEWGENE activity/NN and/CC smaller/JJR than/IN 14%/NN of/IN the/DT hydroxylating/JJ capacity/NN of/IN liver/NN microsomes/NNS from/IN the/DT rat/NN ./.
@@86435137364 Deletion/NNS analysis/NN of/IN rOC/NEWGENE promoter-chloramphenicol/NEWGENE acetyltransferase/NEWGENE constructs/NEWGENE demonstrates/VBZ that/IN an/DT AML-1-binding/NEWGENE sequence/NEWGENE within/IN the/DT proximal/JJ promoter/NN (/( -138/CD to/IN -130/CD nt/NN )/SYM contributes/VBZ to/IN 75%/NN of/IN the/DT level/NN of/IN osteocalcin/NEWGENE gene/NEWGENE expression/NN ./.
@@112823956326 Recently/RB ,/, it/PRP was/VBD shown/VBP that/IN purified/VBN RAG1/NEWGENE //NEWGENE 2/NEWGENE proteins/NEWGENE can/MD cleave/VB DNA/NN hairpins/NNS in/IN vitro/FW ,/, but/CC the/DT same/JJ activity/NN was/VBD also/RB described/VBN for/IN a/DT protein/NN complex/NN of/IN the/DT DNA/NEWGENE repair/NEWGENE proteins/NEWGENE Nbs1/NEWGENE //NEWGENE Mre11/NEWGENE //NEWGENE Rad50/NEWGENE ./.
@@76936999461 Finally/RB ,/, the/DT stability/NN of/IN the/DT nucleotide/NN binding/JJ function/NN of/IN the/DT two/JJ proteins/NNS is/VBZ similar/JJ as/IN assessed/VBN by/IN sensitivity/NN to/IN urea/NN ./.
@@2164604618 Our/PRP studies/NNS extend/VBP these/DT findings/NNS and/CC show/NN that/IN the/DT E2/NEWGENE transactivation/NEWGENE gene/NEWGENE is/VBZ expressed/VBN from/IN multiple/JJ promoters/NNS ./.
@@110533706730 Expression/NNS of/IN a/DT hybrid/JJ protein/NN containing/JJ the/DT cytoplasmic/JJ C-terminal/NN half/NN of/IN UhpB/NEWGENE fused/VBN to/IN glutathione/NEWGENE S-transferase/NEWGENE (/( GST/NEWGENE )/SYM also/RB interfered/VBN with/IN Uhp/NEWGENE signaling/JJ ./.
@@49756765284 Morphological/JJ and/CC functional/JJ alterations/NNS noted/VBN after/IN baboon/NN renal/JJ allotransplantation/NN ./.
@@84173312569 The/DT sequence/NN of/IN the/DT HIR1/NEWGENE gene/NEWGENE predicts/VBZ an/DT 88-kDa/NN protein/NN with/IN three/CD repeats/NNS of/IN a/DT motif/NN found/VB in/IN the/DT G/NEWGENE beta/NEWGENE subunit/NEWGENE of/IN retinal/NEWGENE transducin/NEWGENE and/CC in/IN a/DT yeast/NN transcriptional/JJ repressor/NN ,/, Tup1/NEWGENE ./.
@@22528916528 65-kilodalton/JJ protein/NN phosphorylated/VBN by/IN interleukin/NEWGENE 2/NEWGENE stimulation/NN bears/VBP two/JJ putative/JJ actin-binding/NEWGENE sites/NEWGENE and/CC two/JJ calcium-binding/NN sites/NN ./.
@@17094866323 The/DT murine/NEWGENE mutation/NEWGENE dominant/NEWGENE white/NEWGENE spotting/NEWGENE (/( W/NEWGENE )/SYM is/VBZ in/IN the/DT proto-oncogene/NN ,/, c-kit/NEWGENE ./.
@@75754163948 Protein/NEWGENE kinase/NEWGENE C/NEWGENE (/( PKC/NEWGENE )/SYM ,/, a/DT widely-distributed/JJ enzyme/NN implicated/VBN in/IN the/DT regulation/NN of/IN many/JJ physiological/JJ processes/NNS ,/, consists/VBZ of/IN a/DT family/NN of/IN at/IN least/RB twelve/CD isoenzymes/NNS which/WDT differ/VBP in/IN tissue/NN distribution/NN ,/, subcellular/JJ localization/NN ,/, regulatory/JJ properties/NNS ,/, etc/NN ./.
@@18998461080 Therefore/RB ,/, the/DT rbcL-rbcS/NEWGENE locus/NEWGENE seems/VBZ to/IN be/VB barely/RB expressed/VBN under/IN a/DT standard/JJ condition/NN for/IN photoautotrophic/JJ growth/NN ./.
@@105439494802 In/NN particular/JJ ,/, the/DT S1'/NEWGENE specificity/NEWGENE site/NEWGENE is/VBZ a/DT deep/JJ and/CC highly/RB hydrophobic/JJ cavity/NN ./.
@@18081862413 Pigs/NNPS were/VBD switched/VBN from/IN the/DT growing/NN to/IN the/DT finishing/JJ diet/NN at/IN 57/CD and/CC 61/CD kg/NN in/IN Exp/NN ./.
@@78143887333 In/NN broken/VBP L-cell/NNS membranes/NNS expressing/JJ wild/NEWGENE type/NEWGENE or/NEWGENE mutant/NEWGENE M6P/NEWGENE //NEWGENE IGF/NEWGENE II/NEWGENE receptors/NEWGENE ,/, 30/CD nM/NN IGF/NEWGENE II/NEWGENE also/RB failed/VBD to/IN affect/NN the/DT pertussis/NEWGENE toxin/NEWGENE substrate/NN activity/NN ./.
@@84972733360 NF-HB/NEWGENE (/( BSAP/NEWGENE )/SYM is/VBZ a/DT repressor/NN of/IN the/DT murine/NEWGENE immunoglobulin/NEWGENE heavy-chain/NEWGENE 3'/NEWGENE alpha/NEWGENE enhancer/NEWGENE at/IN early/JJ stages/NNS of/IN B-cell/NN differentiation/NN ./.
@@112383751521 We/PRP found/VBP that/IN RhoA/NEWGENE can/MD initiate/NN a/DT linear/JJ kinase/NN cascade/NN leading/JJ to/IN the/DT activation/NN of/IN ERK6/NEWGENE (/( p38/NEWGENE gamma/NEWGENE )/SYM ,/, a/DT recently/RB identified/VBN member/NN of/IN the/DT p38/NEWGENE family/NEWGENE of/IN MAPKs/NEWGENE ./.
@@114222002747 Granulocyte/NEWGENE colony-stimulating/NEWGENE factor/NEWGENE (/( G-CSF/NEWGENE )/SYM administration/NN in/IN vivo/NN has/VBZ been/VBN shown/VBP to/IN improve/VB the/DT defence/NN mechanisms/NNS against/IN infection/NN by/IN different/JJ microbes/NNS ./.
@@81801297722 Exposure/NN to/IN higher/JJ TPA/NEWGENE concentrations/NNS decreased/VBD the/DT content/NN of/IN these/DT transcripts/NNS ./.
@@25029603152 100/CD and/CC 14/CD p/NN ./NN
@@25864853579 GN101/NN ,/, YC819-9/NN ,/, and/CC SB3/NN ./.
@@75927214483 Another/DT common/JJ mutation/NN involved/VBD amino/JJ acids/NNS that/WDT are/VBP thought/VBP to/IN make/NN specific/JJ contacts/NNS with/IN DNA/NN ./.
@@104523061213 Patients/NNS were/VBD assessed/VBN for/IN cardiac/JJ MIBG/NN uptake/NN ,/, circulating/JJ norepinephrine/NN concentration/NN ,/, LVEF/NN ,/, peak/NN Vo2/NN ,/, x-ray/NN cardiothoracic/JJ ratio/NN ,/, M-mode/NN echographic/JJ end-diastolic/JJ diameter/NN and/CC right-sided/JJ heart/NN catheterization/NN parameters/NNS ./.
@@98842326322 Comparison/NNS of/IN the/DT sequences/NNS of/IN attP/NEWGENE ,/, attB/NEWGENE and/CC bacteria-prophage/NN junctions/NNS attL/NEWGENE and/CC attR/NEWGENE showed/VBD a/DT 26/CD bp/NN common/JJ core/NN sequence/NN ,/, where/CC recombination/NN takes/VBP place/NN ,/, near/IN the/DT 5'/CD end/NN of/IN the/DT integrase/NEWGENE gene/NEWGENE ./.
@@105889467886 This/DT revealed/VBN a/DT minimum/NN of/IN six/CD novel/JJ OSBP-related/NEWGENE proteins/NEWGENE ,/, designated/VBN ORP-1/NEWGENE to/IN ORP-6/NEWGENE ./.
@@115954781485 Hp/IN positive/JJ relatives/NNS of/IN gastric/JJ cancer/NN had/VBP a/DT markedly/RB higher/JJ prevalence/NN of/IN atrophy/NN than/IN those/DT with/IN Hp/DT negativity/NN without/IN cancer/NN relatives/NNS (/( 29/CD vs/IN ./IN
@@94250384731 A/NNP ./NNP ,/, Swift/NNP ,/, A/NNP ./NNP
@@87103713996 We/PRP have/VBP been/VBN studying/VBG the/DT interaction/NN of/IN the/DT oncogenic/JJ human/JJ polyomavirus/NN BK/NN (/( BKV/NN )/SYM with/IN the/DT tumor-suppressor/NEWGENE protein/NEWGENE p53/NEWGENE to/IN understand/VB the/DT biology/NN of/IN this/DT virus/NN as/RB well/NN as/IN to/IN understand/VB the/DT basic/JJ mechanisms/NNS of/IN p53/NEWGENE transactivation/NN ./.
@@108619092465 The/DT pJR/NN vectors/NN differ/VBP among/IN them/PRP in/IN :/: (/( a/DT )/SYM the/DT selectable/JJ marker/NN (/( Saccharomyces/NN cerevisiae/NN LEU/NEWGENE 2/NEWGENE gene/NEWGENE ,/, which/WDT complements/VBZ S/NEWGENE ./NEWGENE pombe/NEWGENE leu1-/NEWGENE gene/NEWGENE and/CC S/NNP ./NNP pombe/NN ura4+/NEWGENE and/CC his3+/NEWGENE genes/NEWGENE )/SYM ;/: (/( b/NN )/SYM the/DT thiamine-repressible/JJ nmt1/NEWGENE promoter/NEWGENE (/( 3X/NN ,/, 41X/NN and/CC 81X/CD with/IN extremely/RB high/JJ ,/, moderate/JJ or/CC low/JJ transcription/NN efficiency/NN ,/, respectively/RB )/SYM ;/: and/CC (/( c/NN )/SYM the/DT multiple/JJ cloning/NN site/NN (/( two/JJ multiple/JJ cloning/NN sites/NNS ,/, with/IN 12/CD restriction/NN sites/NNS each/DT )/SYM ./.
@@17143221741 This/DT report/NN substantiates/VBZ that/IN at/IN least/JJ two/NN of/IN the/DT 18/NN kDa/NN hsps/NEWGENE in/IN maize/NN are/VBP products/NNS of/IN different/JJ but/CC related/VBN genes/NNS ./.
@@86184339943 The/DT novel/JJ hematopoietic/NEWGENE growth/NEWGENE factor/NEWGENE FLT3/NEWGENE ligand/NEWGENE (/( FL/NEWGENE )/SYM is/VBZ the/DT cognate/NN ligand/NN for/IN the/DT FLT3/NEWGENE ,/, tyrosine/NEWGENE kinase/NEWGENE receptor/NEWGENE (/( R/NEWGENE )/SYM ,/, also/RB referred/VBN to/RB as/IN FLK-2/NEWGENE and/CC STK-1/NEWGENE ./.
@@66879532341 The/DT mucosal/JJ defence/NN capacity/NN against/IN proteolytic/JJ leukocyte/NN enzymes/NN ./.
@@107087699408 The/DT Mif1/NEWGENE 5'/NEWGENE flanking/NEWGENE region/NEWGENE contains/VBZ a/DT functional/JJ ER/NEWGENE stress-responsive/NEWGENE element/NEWGENE which/WDT is/VBZ sufficient/JJ for/IN induction/NN by/IN tunicamycin/NN ./.
@@30501473587 After/IN infection/NN of/IN 293/CD cells/NNS (/( which/WDT provide/VBP complementary/JJ E1a-E1b/NEWGENE functions/NNS )/SYM ,/, both/DT viruses/NNS directed/VBD equal/NN amounts/NNS of/IN P/NEWGENE //NEWGENE C-specific/NEWGENE mRNA/NEWGENE transcription/NN ./.
@@84594656840 This/DT prospective/JJ study/NN compared/VBD the/DT measured/VBN energy/NN expenditures/NNS of/IN 30/CD patients/NNS using/VBG indirect/JJ calorimetry/NN with/IN their/PRP predicted/VBN basal/JJ energy/NN expenditure/NN according/VBG to/IN the/DT Harris-Benedict/NNP equation/NN ,/, or/CC their/PRP calculated/VBN energy/NN expenditure/NN derived/VBN from/IN basal/JJ energy/NN expenditure/NN times/NNS ,/, an/DT activity/NN factor/NN ,/, and/CC a/DT stress/NN factor/NN ./.
@@104390404970 To/TO determine/VB what/WP role/NN eIF4E/NEWGENE might/MD play/VB in/IN c-myc/NEWGENE expression/NN ,/, the/DT c-myc/NEWGENE 5'/NEWGENE untranslated/NEWGENE region/NEWGENE (/NEWGENE UTR/NEWGENE )/NEWGENE was/VBD fused/VBN in-frame/NN to/IN CAT/NEWGENE reporters/NEWGENE ,/, and/CC several/DT more/JJ derivative/NN constructs/NNS were/VBD made/VBP ./.
@@33667204052 Such/JJ a/DT change/NN may/MD involve/VB increased/VBN mammary/JJ utilization/NN of/IN pre-formed/JJ long-chain/JJ fatty/JJ acid/NN and/CC increased/VBN metabolism/NN of/IN glucose/NN via/NN glycolysis/NN ./.
@@87127998695 Unaided/JJ attempts/NNS to/IN quit/NN smoking/NN are/VBP generally/RB unsuccessful/JJ ./.
@@53408015480 Mycotoxins/NEWGENE in/IN feeds/NNS and/CC foods/NNS ./.
@@13964442012 The/DT experiments/NNS show/NN that/IN it/PRP is/VBZ the/DT micromilieu/NN of/IN the/DT alveoli/NNS and/CC the/DT condition/NN of/IN the/DT AM/NN (/( certain/JJ physiological/JJ activation/NN states/NNS ,/, such/JJ as/IN phagocytic/JJ activity/NN )/SYM that/WDT essentially/RB determine/VB the/DT degree/NN of/IN recovery/NN ./.
@@40889366942 Comparative/JJ studies/NNS of/IN the/DT antithrombin/NEWGENE III/NEWGENE level/NN and/CC plasminogen/NEWGENE activator/NEWGENE activity/NN in/IN patients/NNS with/IN thrombophlebitis/NN ./.
@@80358334639 Thus/RB ,/, YMIP/NEWGENE is/VBZ a/DT functional/JJ homolog/NN of/IN RMIP/NEWGENE and/CC represents/VBZ a/DT new/JJ component/NN of/IN the/DT yeast/NN mitochondrial/JJ import/NN machinery/NN ./.
@@83043018278 METHODS/IN :/: Forty-nine/JJ cases/NNS with/IN intrahepatic/JJ multiple/JJ nodules/NNS of/IN HCC/NN ,/, by/IN gross/JJ examination/NN ,/, among/IN 184/CD consecutive/RB resected/VBN HCCs/NNS were/VBD examined/VBN clinicopathologically/RB ./.
@@52763805450 Influence/NNS of/IN cigarette/NN smoking/NN on/IN some/DT blood/NN coagulation/NN tests/NNS ./.
@@24881482853 During/IN the/DT program's/NNS use/NN at/IN the/DT RSNA/NN meeting/NN ,/, the/DT program/NN selected/VBD the/DT correct/JJ diagnosis/NN in/IN the/DT top/JJ five/CD 22%/NN of/IN the/DT time/NN ./.
@@9259315105 Mutation/NN of/IN Enh4/NEWGENE ,/, an/DT essential/JJ GT-IIC-like/NEWGENE enhanson/NEWGENE in/IN the/DT context/NN of/IN the/DT intact/JJ enhancer/NN ,/, abolishes/VBZ silencer/NN activity/NN ,/, and/CC multimerized/JJ GT-IIC/NEWGENE enhansons/NEWGENE mimic/VBP the/DT intact/JJ CSEn/NEWGENE enhancer/NEWGENE //NEWGENE silencer/NEWGENE activities/NNS in/IN BeWo/NNP and/CC GC/NN cells/NNS ,/, respectively/RB ./.
@@80111662696 The/DT complete/JJ gene/NN organization/NN was/VBD obtained/VBN by/IN combining/JJ the/DT results/NNS of/IN the/DT sequence/NN of/IN these/DT clones/NNS and/CC those/DT of/IN the/DT characterization/NN of/IN polymerase/NEWGENE chain/NN reaction-amplified/JJ genomic/JJ segments/NNS ./.
@@9843378688 The/DT dopamine/NEWGENE D4/NEWGENE receptor/NEWGENE as/RB well/VB as/IN many/NN other/DT catecholaminergic/NEWGENE receptors/NEWGENE contain/VBP several/DT putative/JJ SH3/NEWGENE binding/NEWGENE domains/NEWGENE ./.
@@82995684784 These/DT data/NN indicate/VB that/DT activation/NN of/IN these/DT enzymes/NNS is/VBZ not/RB sufficient/JJ for/IN the/DT acute/JJ stimulation/NN of/IN glucose/NN transport/NN ./.
@@115129251633 EXAFS/NNS measurements/NNS around/IN the/DT Ge-K/NN edge/NN have/NN been/VBN carried/VBN out/RB for/IN liquid/JJ Ge-Si/NNP alloys/NNS for/IN the/DT first/JJ time/NN to/IN investigate/VB the/DT local/JJ structure/NN around/IN a/DT Ge/NN atom/NN ./.
@@11137367976 We/PRP used/VBD the/DT Toshiba/NNP IIDR/NN system/NN ,/, which/WDT is/VBZ composed/VBN of/IN an/DT X-ray/NN TV/NN system/NN and/CC a/DT digital/JJ image/NN managing/JJ circuit/NN ./.
@@118261411697 Dissociable/NNP effects/NNS of/IN lidocaine/NN inactivation/NN of/IN the/DT rostral/JJ and/CC caudal/JJ basolateral/JJ amygdala/NN on/IN the/DT maintenance/NN and/CC reinstatement/NN of/IN cocaine-seeking/JJ behavior/NN in/IN rats/NNS ./.
@@29362843643 Spontaneous/JJ degradation/NN of/IN atracurium/NN in/IN plasma/NN is/VBZ the/DT major/JJ route/NN of/IN elimination/NN in/IN man/NN and/CC contributes/VBZ to/IN a/DT short/JJ elimination/NN half-life/NN (/( approximatively/RB 20/CD min/NN )/SYM ./.
@@97739756198 Wild-type/NEWGENE AT1A/NEWGENE receptors/NEWGENE ,/, expressed/VBN in/IN Chinese/JJ hamster/NN ovary/NN cells/NNS ,/, rapidly/RB internalized/VBN after/IN Ang/NEWGENE II/NEWGENE stimulation/NN [/NN t1/NN //NN 2/NN 2/CD ./CD 3/CD min/NN ;/: maximal/JJ level/NN of/IN internalization/NN (/( Ymax/NNP )/SYM 78/NN ./NN 2%/NN ]/NN ,/, as/IN did/VBD mutant/JJ receptors/NNS carrying/JJ single/JJ acidic/NN substitutions/NNS (/( T332E/NN ,/, t1/NN //NN 2/NN 2/NN ./NN 7/NN min/NN ,/, Ymax/NNP 76/CD ./CD 3%/CD ;/: S335D/NN ,/, t1/NN //NN 2/NN 2/NN ./NN 4/NN min/NN ,/, Ymax/NNP 76/CD ./CD 7%/CD ;/: T336E/NN ,/, t1/NN //NN 2/NN 2/NN ./NN 5/NN min/NN ,/, Ymax/NNP 78/CD ./CD 2%/CD ;/: S338D/NN ,/, t1/NN //NN 2/NN 2/NN ./NN 6/NN min/NN ,/, Ymax/NNP 78/CD ./CD 4%/CD )/SYM ./.
@@88173238214 Almost/RB complete/JJ sequence/NN identity/NN was/VBD found/VBN between/IN the/DT 3'/CD end/NN of/IN the/DT DXS6673E/NEWGENE gene/NEWGENE and/CC two/RB expressed/VBN sequence/NN tags/NNS (/( ESTs/NNS )/SYM and/CC between/IN the/DT 5'/CD end/NN of/IN the/DT DXS6673E/NEWGENE gene/NEWGENE and/CC a/DT third/JJ EST/NN ./.
@@51613995405 1/CD ./CD
@@107866711598 The/DT rate-limiting/JJ step/NN for/IN telomerase/NEWGENE activity/NN seems/VBZ to/IN be/VB the/DT expression/NN of/IN the/DT catalytic/JJ subunit/NN of/IN the/DT enzyme/NN ,/, encoded/VBN by/IN the/DT human/NEWGENE telomerase/NEWGENE reverse/NEWGENE transcriptase/NEWGENE (/( hTERT/NEWGENE )/SYM gene/NN ./.
@@10691972411 Characterization/NNS of/IN the/DT 5'-flanking/JJ region/NN of/IN the/DT human/NEWGENE multidrug/NEWGENE resistance/NEWGENE protein/NEWGENE 2/NEWGENE (/( MRP2/NEWGENE )/SYM gene/NN and/CC its/PRP regulation/NN in/IN comparison/NN withthe/NN multidrug/NEWGENE resistance/NEWGENE protein/NEWGENE 3/NEWGENE (/( MRP3/NEWGENE )/SYM gene/NN ./.
@@105593037643 Epstein-Barr/NEWGENE virus/NEWGENE (/NEWGENE EBV/NEWGENE )/NEWGENE latent/NEWGENE membrane/NEWGENE protein/NEWGENE 1/NEWGENE (/( LMP1/NEWGENE )/SYM is/VBZ essential/JJ for/IN EBV-mediated/JJ transformation/NN of/IN primary/NN B/NN lymphocytes/NNS ./.
@@80637759804 Regulation/NN of/IN parathyroid/NEWGENE hormone-related/NEWGENE protein/NEWGENE (/( PTHrP/NEWGENE )/SYM gene/NN expression/NN ./.
@@94261433262 Taken/VBN together/RB ,/, our/PRP data/NN suggest/VB that/IN the/DT antagonistic/JJ effects/NNS of/IN CRP/NEWGENE and/CC KdgR/NEWGENE on/IN the/DT expression/NN of/IN the/DT pectinolysis/NEWGENE genes/NEWGENE occur/VBP by/IN different/JJ mechanisms/NNS ,/, including/JJ direct/JJ competition/NN between/IN the/DT two/JJ regulators/NNS or/CC between/IN the/DT repressor/NN and/CC RNA/NEWGENE polymerase/NEWGENE for/IN the/DT occupation/NN of/IN a/DT common/JJ DNA/NN region/NN on/IN the/DT target/NN genes/NNS ./.
@@95373757516 In/NN a/DT gntR/NEWGENE deletion/NEWGENE mutant/NEWGENE ,/, the/DT expression/NN of/IN a/DT chromosomal/NEWGENE gntT/NEWGENE :/NEWGENE :/NEWGENE lacZ/NEWGENE fusion/NEWGENE is/VBZ both/DT high/JJ and/CC constitutive/JJ ,/, confirming/VBG that/IN GntR/NEWGENE is/VBZ the/DT negative/JJ regulator/NN of/IN gntT/NEWGENE ./.
@@76361879429 Consistent/JJ with/IN the/DT protein/NN expression/NN data/NN ,/, V/NEWGENE beta/NEWGENE 8/NEWGENE ./NEWGENE 3/NEWGENE gene/NEWGENE transcripts/NEWGENE were/VBD found/VBN only/RB in/IN the/DT transgenic/JJ lines/NNS with/IN the/DT wild-type/NN promoter/NN ./.
@@106024199752 These/DT synergistic/JJ effects/NNS were/VBD strongly/RB Jem-1/NEWGENE dose-dependent/NN ./.
@@10220364160 Their/PRP afterglows/NNS are/VBP brighter/JJR than/IN supernovae/NNS and/CC therefore/RB are/VBP called/VBN hypernovae/NNS ./.
@@107878042428 AMDA/NN white/NN paper/NN identifies/VBZ ways/NNS to/IN improve/VB pharmaceutical/JJ care/NN in/IN SNFs/NNP ./.
@@60655075886 Compensatory/JJ renal/JJ hypertrophy/NN in/IN parabiotic/JJ rats/NNS ./.
@@59387205829 Story/NNP of/IN a/DT hospital/NN that/WDT filmed/VBD its/PRP employee/NN orientation/NN program/NN ./.
@@104775999688 An/DT activation-responsive/JJ element/NN in/IN single/NEWGENE C/NEWGENE motif-1/NEWGENE //NEWGENE lymphotactin/NEWGENE promoter/NEWGENE is/VBZ a/DT site/NN of/IN constitutive/JJ and/CC inducible/NN DNA-protein/NN interactions/NNS involving/VBG nuclear/JJ factor/NN of/IN activated/VBN T/NN cell/NN ./.
@@86172384068 TNF/NNP Treatment/NNP of/IN cell/NN activated/VBN the/DT p38/NEWGENE MAP/NEWGENE kinase/NEWGENE pathway/NN ,/, as/IN revealed/VBN by/IN increased/JJ phosphorylation/NN of/IN p38/NEWGENE MAP/NEWGENE kinase/NEWGENE itself/PRP ,/, activation/NN of/IN the/DT substrate/NN protein/NN MAPKAP/NEWGENE kinase-2/NEWGENE ,/, and/CC culminating/VBG in/IN the/DT phosphorylation/NN of/IN the/DT heat/NEWGENE shock/NEWGENE protein/NEWGENE 27/NEWGENE (/( hsp27/NEWGENE )/SYM ./.
@@4658295081 Nernst--Planck/NNP analog/NN equations/NNS and/CC stationary/JJ state/NN membrane/NN electric/JJ potentials/NNS ./.
@@2442837541 Two/CD of/IN the/DT three/CD groups/NNS were/VBD administered/VBN dauricine/NN ,/, as/IN a/DT new/JJ calcium/NN channel/NN blocker/NN ,/, and/CC verapamil/NN ,/, as/IN a/DT generally/RB recognized/VBN calcium/NN channel/NN blocker/NN ,/, respectively/RB ,/, from/IN 15/CD minutes/NNS pre-bypass/NN to/IN the/DT end/NN of/IN the/DT bypass/NN procedure/NN (/( a/DT period/NN of/IN 95/CD minutes/NNS )/SYM ./.
@@5830046921 Contrary/JJ to/IN 1/NN ,/NN 8-dihydroxy-9-anthrone/NN ,/, 1/NN ,/NN 8/NN ,/NN 9-triacetoxyanthracene/NN and/CC 1/NN ,/NN 8-diacetoxy-9-anthrone/NN are/VBP effective/JJ against/IN psoriatic/JJ lesions/NNS without/IN accompanying/JJ inflammations/NNS of/IN the/DT skin/NN ./.
@@21474228986 We/PRP have/VBP isolated/VBN and/CC sequenced/VBN the/DT gene/NN encoding/VBG the/DT human/NEWGENE U1-70K/NEWGENE snRNP/NEWGENE protein/NEWGENE ./.
@@93137559280 Underlying/VBG the/DT clustering/NN of/IN these/DT risk/NN variables/NNS were/VBD three/CD factors/NNS ./.
@@14871445955 We/PRP found/VBP that/IN the/DT gene/NN segment/NN containing/JJ the/DT mu/NEWGENE m/NEWGENE poly/NEWGENE (/NEWGENE A/NEWGENE )/NEWGENE signals/NEWGENE ,/, along/IN with/IN 536/CD bp/NN of/IN downstream/RB flanking/JJ sequence/NN ,/, acted/VBN as/IN a/DT transcription/NN terminator/NN in/IN both/DT myeloma/NN cells/NNS and/CC L/JJ cell/NN fibroblasts/NNS ./.
@@100825731889 These/DT results/NNS continue/VBP to/IN support/NN the/DT hypothesis/NN that/IN HS2/NEWGENE ,/, HS3/NEWGENE ,/, and/CC HS4/NEWGENE act/VB as/IN a/DT single/NN ,/, integral/JJ unit/NN to/IN regulate/VB human/NEWGENE globin/NEWGENE gene/NEWGENE transcription/NN as/IN a/DT holocomplex/NN ,/, but/CC they/PRP can/MD also/RB be/VB interpreted/VBN to/IN say/NN that/DT formation/NN of/IN a/DT DNase/NEWGENE I/NEWGENE hypersensitive/JJ holocomplex/NN alone/RB is/VBZ not/RB sufficient/JJ for/IN mediating/JJ high-level/JJ globin/NEWGENE gene/NEWGENE transcription/NN ./.
@@102320788885 Ischemia/NNS and/CC reperfusion/NN markedly/RB increased/VBD the/DT release/NN of/IN 6-keto-PGF1/NEWGENE alpha/NEWGENE and/CC TXB2/NEWGENE ./.
@@28746353560 Prenatal/JJ exposure/NN to/IN the/DT fungicide/NN dinocap/NN causes/NNS behavioral/JJ torticollis/NN ,/, ballooning/VBG and/CC cleft/JJ palate/NN in/IN mice/NNS ,/, but/CC not/RB rats/NNS or/CC hamsters/NNS ./.
@@54513248528 Calibration/NNS and/CC a/DT correction/NN of/IN blood/NN O2/NN content/NN measured/VBN by/IN Po2/NN and/CC CO/NN saturation/NN ./.
@@82025466991 In/NN addition/NN ,/, we/PRP observe/VBP that/IN the/DT hUBF-promoter/NEWGENE interaction/NN is/VBZ highly/RB sensitive/JJ to/IN the/DT antagonistic/JJ effects/NNS of/IN cisplatin-DNA/JJ adducts/NNS ./.
@@115135795929 Using/VBG the/DT two-hybrid/JJ system/NN ,/, we/PRP show/VBP that/IN nonprenylated/JJ Rac1/NEWGENE interacts/VBZ very/RB weakly/RB with/IN Rho-GDI/NEWGENE ,/, pointing/VBG to/IN the/DT predominant/JJ role/NN of/IN protein-isoprene/JJ interaction/NN in/IN complex/NN formation/NN ./.
@@111433841456 Tele-Talk/NN has/VBZ the/DT extra/JJ capability/NN of/IN operating/JJ in/IN live/VB conference/NN situations/NNS using/VBG microphone/NN input/NN ./.
@@16447513866 This/DT open/JJ reading/JJ frame/NN was/VBD confirmed/VBN the/DT correct/JJ one/PRP by/IN direct/JJ amino-terminal/NN sequence/NN analysis/NN of/IN the/DT overproduced/VBN msgB/NEWGENE gene/NEWGENE product/NEWGENE ./.
@@81432368116 Neither/CC ethanol/NN regimen/NN impaired/VBN spontaneous/JJ alternation/NN ,/, but/CC the/DT 4/CD g/NN ethanol/NN ./NN kg-1/NN x/NN day-1/NN regimen/NN increased/VBD the/DT percent/NN completed/VBD trials/NNS ./.
@@83006119554 Site-directed/JJ mutagenesis/NN of/IN the/DT traI/NEWGENE structural/NEWGENE gene/NEWGENE and/CC application/NN of/IN purified/VBN mutant/NN TraI/NEWGENE proteins/NEWGENE for/IN in/IN vitro/FW assays/NNS served/VBN to/IN evaluate/VB the/DT functional/JJ importance/NN of/IN conserved/VBN amino/JJ acid/NN residues/NNS ./.
@@81119741941 This/DT indicates/VBZ that/IN the/DT mechanism/NN by/IN which/WDT CX/JJ blocks/NNS rapid/JJ degradation/NN of/IN tubulin/NEWGENE mRNA/NEWGENE in/IN vivo/NN is/VBZ not/RB simply/RB by/IN preventing/JJ its/PRP translation/NN and/CC suggests/VBZ the/DT involvement/NN of/IN an/DT altered/VBN trans-factor/NN ./.
@@115971851487 By/IN using/VBG space-discrete/JJ //JJ continuous/JJ metapopulation/NN dynamic/JJ models/NNS and/CC computer/NN simulations/NNS ,/, we/PRP show/VBP that/IN there/RB can/MD be/VB two/JJ principally/RB different/JJ regimes/NNS of/IN metapopulation/NN dynamics/NNS ./.
@@10484818318 Activated/JJ areas/NNS have/VBP been/VBN identified/VBN by/IN means/NN of/IN cross-correlation/NN analysis/NN ./.
@@21645858371 The/DT protein/NN product/NN of/IN orfD/NEWGENE ,/, which/WDT is/VBZ probably/RB a/DT new/JJ tra/NEWGENE gene/NEWGENE (/( named/VBN traX/NEWGENE )/SYM ,/, contains/VBZ 65%/JJ hydrophobic/JJ amino/JJ acids/NNS ,/, especially/RB rich/JJ in/IN alanine/NN and/CC leucine/NN ./.
@@108912867880 Members/NNS of/IN the/DT titin/NEWGENE //NEWGENE myosin/NEWGENE light/NEWGENE chain/NEWGENE kinase/NEWGENE family/NEWGENE play/NN an/DT essential/JJ role/NN in/IN the/DT organization/NN of/IN the/DT actin/NN //NN myosin/NN cytoskeleton/NN ,/, especially/RB in/IN sarcomere/NN assembly/NN and/CC function/NN ./.
@@9705352230 Purified/VBN Hsk1/NEWGENE phosphorylates/VBZ the/DT Cdc19/NEWGENE (/( Mcm2/NEWGENE )/SYM subunit/NN of/IN the/DT six-member/NEWGENE minichromosome/NEWGENE maintenance/NEWGENE protein/NEWGENE complex/NEWGENE purified/VBN from/IN fission/NN yeast/NN ./.
@@79481295825 In/NN these/DT vectors/NNS the/DT chimeric/JJ long/JJ terminal/JJ repeat/NN (/( chLTR/NN )/SYM drives/VBZ the/DT expression/NN of/IN the/DT chloramphenicol/NEWGENE acetyl/NEWGENE transferase/NEWGENE (/( CAT/NEWGENE )/SYM reporter/NN gene/NN that/WDT is/VBZ followed/VBN by/IN an/DT internal/JJ SV40/NN virus/NN early/JJ region/NN promoter/NN linked/JJ to/IN the/DT neomycin/NEWGENE phosphotransferase/NEWGENE II/NEWGENE (/( NEO/NEWGENE )/SYM gene/NN ./.
@@86377174023 A/DT second/JJ peptide/NN (/( amino/JJ acids/NNS 58-77/JJ )/SYM also/RB antagonized/VBN p21-activity/JJ ,/, but/CC this/DT peptide/NN did/VBD not/RB affect/VB the/DT ability/NN of/IN p21/NEWGENE to/IN interact/VB with/IN cyclin/NEWGENE E/NEWGENE //NEWGENE Cdk2/NEWGENE ./.
@@49701315277 Some/DT reflexions/NNS apropos/RB of/IN a/DT personal/JJ statistical/JJ study/NN of/IN 513/CD arterial/JJ embolisms/NNS ./.
@@756577539 Mutational/JJ analysis/NN of/IN mRNA/NEWGENE capping/NEWGENE enzyme/NEWGENE identifies/VBZ amino/JJ acids/NNS involved/VBN in/IN GTP/NN binding/JJ ,/, enzyme-guanylate/JJ formation/NN ,/, and/CC GMP/NN transfer/NN to/IN RNA/NN ./.
@@7490766882 Preferential/JJ heterodimeric/JJ parallel/JJ coiled-coil/NN formation/NN by/IN synthetic/NEWGENE Max/NEWGENE and/CC c-Myc/NEWGENE leucine/NEWGENE zippers/NEWGENE :/: a/DT description/NN of/IN putative/JJ electrostatic/JJ interactions/NNS responsible/JJ for/IN the/DT specificity/NN of/IN heterodimerization/NN ./.
@@108508491985 For/IN oral/JJ administration/NN ,/, AUC0-infinity/NNS was/VBD 58/CD ./CD 47/CD +/NN //NN -/NN 16/CD ./CD 37/CD microg/NN x/NN h/NN //NN ml/NN ,/, t1/NN //NN 2beta/NN was/VBD 18/CD ./CD 39/CD +/NN //NN -/NN 0/CD ./CD 06/CD hours/NNS ,/, maximum/JJ concentration/NN (/( Cmax/NN )/SYM was/VBD 2/CD ./CD 12/CD +/NN //NN -/NN 00/CD ./CD 51/CD microg/NN //NN ml/NN ,/, time/NN to/IN Cmax/NN was/VBD 2/CD ./CD 20/CD +/NN //NN -/NN 2/CD ./CD 17/CD hours/NNS ,/, mean/JJ absorption/NN time/NN was/VBD 2/CD ./CD 09/CD +/NN //NN -/NN 0/CD ./CD 51/CD hours/NNS ,/, and/CC bioavailability/NN was/VBD 42/CD +/NN //NN -/NN 0/CD ./CD 42%/CD ./.
@@21798156838 Unlike/IN p59v-rel/NEWGENE ,/, which/WDT is/VBZ a/DT nuclear/JJ protein/NN in/IN CEF/NNP ,/, indirect/JJ immunofluorescence/NN showed/VBN that/IN p68c-rel/NEWGENE in/IN JD214c-rel/NNP infected/VBD CEF/NN is/VBZ located/VBN exclusively/RB in/IN the/DT cytoplasm/NN of/IN these/DT cells/NNS ,/, even/VB though/CC the/DT sequence/NN of/IN p68c-rel/NEWGENE showed/VBN that/IN it/PRP contains/VBZ a/DT nuclear/JJ localizing/JJ sequence/NN identical/JJ to/IN the/DT one/PRP previously/RB identified/VBN in/IN p59v-rel/NEWGENE ./.
@@76090373895 In/NN addition/NN ,/, depletion/NN of/IN Oct-1/NEWGENE from/IN the/DT nuclear/JJ extract/NN by/IN using/VBG Oct-1-specific/NNP antiserum/NN or/CC a/DT sequence-specific/NN DNA/NN affinity/NN resin/NN decreased/VBN in/IN vitro/FW transcription/NN from/IN the/DT wild-type/NN MMTV/NN promoter/NN to/IN a/DT level/JJ identical/JJ to/IN that/DT obtained/VBD from/IN a/DT promoter/NN in/IN which/WDT all/DT three/CD octamer-related/NN sequences/NN were/VBD mutated/JJ ./.
@@81952176618 Bacterially/RB expressed/VBN protein/NN ,/, as/RB well/VB as/IN the/DT in/NN vitro/NN reticulocyte/NN lysate/NN translation/NN product/NN ,/, comigrated/VBN with/IN the/DT purified/VBN 37-kDa/NN protein/NN on/IN sodium/NN dodecyl/NN sulfate-polyacrylamide/NN gels/NNS ./.
@@88359691066 Although/IN diagnostic/JJ laparoscopy/NN is/VBZ still/RB considered/VBN the/DT standard/JJ reference/NN in/IN the/DT diagnosis/NN of/IN ectopic/JJ pregnancy/NN (/( EP/NN )/SYM ,/, use/NN of/IN high-resolution/JJ endovaginal/JJ sonography/NN ,/, in/IN conjunction/NN with/IN qualitative/JJ serum/JJ assays/NNS of/IN the/DT beta/NN subunit/NN of/IN human/NEWGENE chorionic/NEWGENE gonadotropin/NEWGENE (/( beta-hCG/NEWGENE )/SYM ,/, allows/VBZ detection/NN of/IN earlier/JJR and/CC smaller/JJR EPs/NNS ./.
@@15477873754 Proprotein/NN processing/VBG occurs/VBZ intracellularly/RB ./.
@@17653869779 In/NN this/DT report/NN ,/, almost/RB 6/CD kb/NN of/IN DNA/NN sequence/NN is/VBZ presented/VBN ,/, including/JJ 1251/CD bp/NN 5'/CD to/IN the/DT gene/NN ,/, over/RB 4/CD kb/NN of/IN exon/NN and/CC exon-intron/JJ junctions/NNS ,/, and/CC 583/CD bp/NN 3'/CD to/IN the/DT gene/NN ./.
@@88081206519 Patients/NNS with/IN low/JJ probability/NN of/IN having/VBG aluminum/NN overload/NN (/( serum/JJ iron/NN levels/NNS </SYM 40/CD micrograms/NN //NN L/NN and/CC DAI/NNS </SYM 150/CD micrograms/NN //NN L/NN )/SYM had/VBP significantly/RB higher/JJ values/NNS of/IN serum/JJ iron/NN ,/, iron/NN transferrin/NEWGENE saturation/NN ,/, and/CC serum/NEWGENE ferritin/NEWGENE levels/NNS compared/VBN with/IN those/DT patients/NNS with/IN a/DT high/JJ probability/NN of/IN having/VBG aluminum/NN overload/NN (/( serum/JJ aluminum/NN levels/NNS >/SYM 40/CD micrograms/NN //NN L/NN and/CC DAI/NNS >/SYM 150/CD micrograms/NN //NN L/NN )/SYM ./.
@@10706513524 It/PRP has/VBZ a/DT grave/JJ prognosis/NN with/IN >/SYM 70%/CD mortality/NN in/IN 3/CD months/NNS ,/, despite/IN mechanical/JJ ventilation/NN ./.
@@36761744338 In/NN calves/NNS receiving/JJ milk-substitute/NN diets/NNS containing/NN 80-260/NN g/NN DM/NN //NN kg/NN ,/, milk/NN intakes/NNS were/VBD reduced/VBN by/IN up/JJ to/IN 30%/CD on/IN the/DT 1st/CD day/NN that/IN calves/NNS were/VBD fed/VBN once/CC daily/JJ instead/RB of/IN twice/RB daily/JJ ./.
@@92361183375 Our/PRP results/NNS suggest/VBP that/IN Lrp/NEWGENE binds/VBZ a/DT central/JJ palindromic/JJ site/NN ,/, interacting/VBG predominantly/RB with/IN the/DT major/JJ groove/NN of/IN its/PRP DNA/NN target/NN ,/, and/CC that/IN additional/JJ dimers/NNS bind/VBP to/IN flanking/JJ sites/NNS to/IN form/NN a/DT nucleoprotein/NN activation/NN complex/NN ./.
@@10463057992 In/NN vitro/FW expression/NN levels/NNS of/IN the/DT different/JJ plasmids/NNS differed/VBN by/RB as/RB much/JJ as/IN tenfold/RB ./.
@@96395588956 It/PRP could/MD also/RB inhibit/VB C1q-dependent/NNP haemolysis/NN of/IN both/DT IgG-/NN and/CC IgM-sensitized/JJ erythrocytes/NNS ./.
@@18610343446 After/IN resection/NN of/IN the/DT proximal/JJ fragment/NN ,/, all/DT scaphoid/JJ contact/NN area/NN and/CC pressure/NN was/VBD born/JJ by/IN the/DT distal/JJ scaphoid/NN fragment/NN ./.
@@112466799068 OBJECTIVE/IN :/: To/TO investigate/VB the/DT association/NN between/IN complete/JJ congenital/JJ heart/NN block/NN (/( CCHB/NN )/SYM in/IN the/DT fetus/NN and/CC adult/JJ disease/NN ./.
@@102020062631 Polypyrimidine/NN and/CC ssDNA/NN binding/JJ by/IN the/DT isolated/JJ VH/NEWGENE domain/NEWGENE of/IN immunization-induced/NN anti-Z-DNA/NEWGENE Ab/NEWGENE resembles/VBZ the/DT activity/NN of/IN natural/JJ autoantibodies/NNS and/CC suggests/VBZ that/IN VH-dependent/NNP binding/JJ to/IN a/DT ligand/NN mimicked/VBN by/IN polypyrimidines/NNS may/MD play/VB a/DT role/NN in/IN B/NNP cell/NN selection/NN before/IN immunization/NN with/IN Z-DNA/NN ./.
@@93434332920 Likewise/RB ,/, rad6-delta/NEWGENE reduces/VBZ silencing/VBG of/IN the/DT telomere-located/NEWGENE RNAP/NEWGENE II-transcribed/NEWGENE genes/NEWGENE URA3/NEWGENE and/CC ADE2/NEWGENE ./.
@@96422148160 In/NN this/DT report/NN we/PRP studied/VBD the/DT role/NN of/IN protein-tyrosine/NEWGENE phosphatase/NEWGENE SHP-2/NEWGENE1 in/IN ErbB-mediated/JJ activation/NN of/IN mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE (/( MAPK/NEWGENE )/SYM by/IN overexpressing/JJ SHP-2/NEWGENE mutants/NEWGENE in/IN COS-7/NNP cells/NNS ./.
@@80054127573 I/PRP hypothesize/VBP that/IN white/NEWGENE gene/NEWGENE expression/NN from/IN P/NN [/NN en/NN ]/NN is/VBZ repressed/VBN by/IN the/DT formation/NN of/IN a/DT protein/NN complex/NN which/WDT is/VBZ initiated/VBN at/IN the/DT engrailed/NEWGENE PS/NEWGENE sites/NEWGENE and/CC also/RB requires/VBZ interactions/NNS with/IN flanking/JJ genomic/JJ DNA/NN ./.
@@89139748870 Ninety-four/NNS percent/NN of/IN the/DT EPs/NNS were/VBD tubal/JJ ,/, and/CC 90%/CD of/IN the/DT tubes/NNS exhibited/VBD some/DT pathologic/JJ changes/NNS ,/, including/JJ chronic/JJ salpingitis/NN (/( 49/CD ./CD 5%/CD )/SYM and/CC follicular/JJ salpingitis/NN (/( 10%/CD )/SYM ,/, among/IN others/NNS ./.
@@98949629899 A/DT comparison/NN of/IN the/DT clinical/JJ profile/NN of/IN cavernous/JJ malformations/NNS with/IN and/CC without/IN associated/VBN venous/JJ malformations/NNS ./.
@@113190988311 These/DT genes/NNS encode/VBP a/DT tryptophanyl/NEWGENE tRNA/NEWGENE ,/, the/DT protein/NEWGENE translocase/NEWGENE component/NN SecE/NEWGENE ,/, the/DT antiterminator/NEWGENE protein/NEWGENE NusG/NEWGENE ,/, and/CC the/DT ribosomal/NEWGENE proteins/NEWGENE L11/NEWGENE and/NEWGENE L1/NEWGENE in/IN addition/NN to/IN PkwR/NEWGENE ,/, a/DT putative/JJ regulatory/JJ protein/NN of/IN the/DT LacI-GalR/NEWGENE family/NEWGENE ./.
@@15491186890 The/DT Caenorhabditis/NEWGENE elegans/NEWGENE vitellogenin/NEWGENE genes/NEWGENE are/VBP subject/NN to/IN sex-/DT ,/, stage-/JJ ,/, and/CC tissue-specific/JJ regulation/NN :/: they/PRP are/VBP expressed/VBN solely/RB in/IN the/DT adult/JJ hermaphrodite/JJ intestine/NN ./.
@@36843785871 For/IN colostral/CD milk/NN there/RB was/VBD a/DT significant/JJ correlation/NN of/IN vitamin/NN K1/NN to/IN cholesterol/NN (/( r/JJ =/SYM 0/CD ./CD 62/CD )/SYM but/CC not/RB to/IN total/JJ lipid/NN or/CC phospholipid/NN suggesting/VBG a/DT role/NN for/IN cholesterol/NN in/IN the/DT secretion/NN of/IN vitamin/NN K1/NN into/IN colostral/JJ milk/NN ./.
@@114076501271 Hypercalcemia/NNS associated/VBN with/IN elevated/VBN serum/NEWGENE PTH/NEWGENE concentration/NN indicating/VBG primary/JJ hyperparathyroidism/NN was/VBD found/VBN in/IN 7/CD BC/NN patients/NNS (/( 7%/JJ )/SYM and/CC in/IN none/NN of/IN healthy/JJ women/NNS or/CC patients/NNS with/IN thyroid/JJ cancer/NN ./.
@@115737711455 Effect/NN of/IN heat/NN treatments/NNS on/IN the/DT meltability/NN of/IN cheeses/NNS ./.
@@10419006277 Epidemiologic/NN evidence/NN indicates/VBZ that/DT estrogen/NN replacement/NN therapy/NN after/IN menopause/NN increases/NNS breast/NN cancer/NN risk/NN ./.
@@14142197510 In/NN 8/CD healthy/JJ volunteers/NNS there/RB were/VBD no/DT significant/JJ differences/NNS in/IN AUC/NN ,/, peak/NN plasma/NN concentrations/NNS or/CC time/NN to/IN peak/NN concentration/NN when/CC OXC/NN was/VBD administered/VBN either/DT with/IN or/CC without/IN ERY/NNP ./.
@@20025113051 Salient/NNP applications/NNS of/IN PB-PK/NN modeling/NN to/IN toxicological/JJ problems/NNS are/VBP illustrated/VBN with/IN examples/NNS ./.
@@68334226621 Determination/NNS of/IN 20/NN alpha-hydroxy-9/NN beta/NN ,/NN 10/NN alpha-pregna-4/NN ,/NN 6-dien-3-one/NN in/IN plasma/NN by/IN selected/JJ ion/NN monitoring/VBG ./.
@@84169523772 Metabolic/NNP labeling/VBG studies/NNS in/IN S/NNP ./NNP cerevisiae/NN and/CC co-expression/NN of/IN nmt72p/NEWGENE with/IN several/DT protein/NN substrates/NNS of/IN Nmt1p/NEWGENE in/IN Escherichia/NN coli/JJ indicate/VB that/IN the/DT Leu99--/NN >/NN Pro/NN substitution/NN causes/VBZ a/DT reduction/NN in/IN the/DT acylation/NN of/IN some/DT but/CC not/RB all/DT protein/NN substrates/NNS ./.
@@89772352224 G-CSF/NEWGENE activates/VBZ multiple/JJ signaling/NN molecules/NN ,/, including/JJ the/DT JAK1/NEWGENE and/CC JAK2/NEWGENE kinases/NEWGENE and/CC the/DT STAT/NEWGENE transcription/NN factors/NN ./.
@@77805257750 Schooling/NN is/VBZ found/VBN to/IN be/VB related/VBN to/IN good/JJ health/NN even/VB after/IN controlling/VBG for/IN differences/NNS in/IN observable/JJ health/NN inputs/NNS ./.
@@16467532251 The/DT reason/NN that/IN nitrous/JJ oxide/NN does/VBP not/RB produce/VB hydroxyl/NN radicals/NNS readily/RB might/MD be/VB that/IN the/DT one-electron/JJ reduction/NN proceeds/NNS through/RB an/DT N2O-/NNP intermediate/JJ which/WDT is/VBZ energetically/RB very/JJ unfavourable/NN :/: EO/NNS (/( N2O/NNP //NNP N2O-/NNP )/SYM =/SYM -1/CD ./CD 1/CD V/NNP ./NNP
@@66838076439 Parkinsonian/JJ patients/NNS had/VBP a/DT significantly/RB lower/JJR prevalence/NN of/IN alcohol/NN use/NN ./.
@@22464472548 There/EX was/VBD evidence/NN of/IN attenuated/VBN regression/NN slopes/NNS relating/VBG recalled/VBN to/IN observed/VBN portion/NN sizes/NNS for/IN 4/CD of/IN the/DT 10/CD food/NN groups/NNS ;/: adjusted/VBN r2/NN values/NNS for/IN the/DT recalled/VBN portion/NN sizes/NNS ranged/VBN from/IN 0/CD ./CD 02/CD to/IN 0/CD ./CD 94/CD ./.
@@98279938157 Retroviral/NEWGENE nucleocapsid/NEWGENE proteins/NEWGENE (/( NCPs/NEWGENE )/SYM are/VBP CCHC-type/NEWGENE zinc/NEWGENE finger/NEWGENE proteins/NEWGENE that/WDT mediate/VBP virion/NN RNA/NN binding/JJ activities/NNS associated/VBN with/IN retrovirus/NN assembly/NN and/CC genomic/JJ RNA/NN encapsidation/NN ./.
@@112791089825 Binding/NN of/IN serum/NEWGENE response/NEWGENE factor/NEWGENE to/IN CArG/NEWGENE box/NEWGENE sequences/NEWGENE is/VBZ necessary/JJ but/CC not/RB sufficient/JJ to/IN restrict/VB gene/NN expression/NN to/IN arterial/JJ smooth/JJ muscle/NN cells/NNS ./.
@@10885708705 Acquired/VBN bile/NN duct/NN blockage/NN :/: entry/NN of/IN hepatobiliary/JJ agent/NN into/IN an/DT intrahepatic/JJ abscess/NN ./.
@@21136999361 The/DT patients/NNS were/VBD divided/VBN into/IN 3/CD subgroups/NNS :/: 1/NN )/NN 13/CD N+/NNP patients/NNS with/IN multiple/JJ hot/JJ spots/NNS (/( greater/JJR than/IN 2/CD )/SYM (/( N+/NNP IM/RB )/SYM ;/: 2/NN )/NN 24/CD N+/NNP patients/NNS with/IN single/JJ hot/JJ spots/NNS (/( less/PRP than/IN or/CC equal/NN to/IN 2/CD )/SYM (/( N+/NN IS/VBZ )/SYM ;/: 3/NN )/NN 12/CD N-/DT patients/NNS with/IN single/JJ hot/JJ spots/NNS (/( less/PRP than/IN or/CC equal/NN to/IN 2/CD )/SYM (/( N-/DT IS/VBZ )/SYM ./.
@@88089397561 Carbon/NNP catabolite/NN repression/NN of/IN the/DT gnt/NEWGENE operon/NEWGENE of/NEWGENE Bacillus/NEWGENE subtilis/NEWGENE is/VBZ mediated/JJ by/IN the/DT catabolite/NN control/NN protein/NN CcpA/NEWGENE and/CC by/IN HPr/NEWGENE ,/, a/DT phosphocarrier/NN protein/NN of/IN the/DT phosphotransferase/NEWGENE system/NEWGENE ./.
@@86344238338 The/DT frequency/NN of/IN integrations/NNS that/WDT led/VBD to/IN transcription/NN of/IN the/DT lacZ/NEWGENE gene/NEWGENE was/VBD estimated/VBN to/IN be/VB 0/CD ./CD 5%/CD of/IN all/DT integrations/NNS ,/, of/IN which/WDT 14%/VBP were/VBD downregulated/VBN on/IN differentiation/NN of/IN 32D/CD cells/NNS towards/IN neutrophils/NNS ./.
@@98842759984 Interferon-alpha/NEWGENE treatment/NN of/IN posttransplant/JJ lymphoproliferative/JJ disorder/NN in/IN recipients/NNS of/IN solid/JJ organ/NN transplants/NNS ./.
@@95453237036 ATP-dependent/JJ assembly/NN of/IN a/DT ternary/JJ complex/NN consisting/VBG of/IN a/DT DNA/NN mismatch/NN and/CC the/DT yeast/NEWGENE MSH2-MSH6/NEWGENE and/CC MLH1-PMS1/NEWGENE protein/NEWGENE complexes/NEWGENE ./.
@@33461572610 Since/IN 1967/CD at/IN the/DT times/NNS of/IN their/PRP biennial/JJ ABCC/NN //NN RERF/NN radiological/JJ examinations/NNS ,/, all/DT Adult/NN Health/NNP Study/NNP (/( AHS/IN )/SYM subjects/NNS have/VBP been/VBN interviewed/VBN to/IN determine/VB the/DT exposures/NNS to/IN medical/JJ x-rays/NNS they/PRP experienced/VBD in/IN institutions/NNS other/DT than/IN RERF/NN in/IN order/NN to/IN estimate/NN the/DT numbers/NNS of/IN examinations/NNS and/CC corresponding/JJ doses/NNS which/WDT they/PRP received/VBD ./.
@@30010542361 We/PRP have/VBP determined/VBN that/IN these/DT nicks/NNS occur/VBP in/IN both/PDT the/DT wild-type/NN and/CC the/DT mutant/JJ sites/NNS ./.
@@80447945474 The/DT tumor/NN suppressor/NN and/CC transcriptional/NN factor/NN p53/NEWGENE is/VBZ a/DT phosphorylated/VBN protein/NN ./.
@@74936276163 Treatment/NNP of/IN PCC4/NNP ./NNP aza1R/NNP cells/NNS with/IN an/DT RAR-selective/NN agonist/NN also/RB repressed/VBN the/DT expression/NN of/IN EC-1/NEWGENE mRNA/NEWGENE while/CC treatment/NN with/IN an/DT RXR-selective/NNP agonist/NN reduced/VBD EC-1/NEWGENE expression/NN slightly/RB ./.
@@85520958647 By/IN comparing/VBG the/DT abundances/NNS of/IN many/JJ yeast/NN transcripts/NNS in/IN isogenic/JJ wild-type/NN and/CC paf1/NEWGENE mutant/NEWGENE strains/NNS ,/, we/PRP have/VBP identified/VBN genes/NNS whose/WP expression/NN is/VBZ affected/VBN by/IN PAF1/NEWGENE ./.
@@118156441681 The/DT physical/JJ characteristics/NNS of/IN these/DT calls/VBZ vary/VB among/IN species/NN of/IN bat/NN ,/, and/CC variations/NNS also/RB exist/VBP in/IN the/DT timing/JJ and/CC patterns/NNS of/IN respiratory/JJ muscle/NN recruitment/NN during/IN echolocation/NN ./.
@@105313603622 Most/JJS important/JJ ,/, infection/NN of/IN the/DT cells/NNS with/IN an/DT adenoviral/NN construct/NN expressing/JJ this/DT mutant/RB inhibited/VBN the/DT induction/NN of/IN VEGF/NEWGENE mRNA/NEWGENE under/IN conditions/NNS that/WDT mimic/VBP hypoxia/NN ./.
@@95241228250 A/DT constitutive/JJ allele/NN of/IN GPA2/NEWGENE could/MD stimulate/VB growth/VB of/IN a/DT strain/NN lacking/JJ both/DT RAS/NEWGENE genes/NEWGENE ./.
@@3043103759 The/DT end-stage/JJ or/CC involutional/JJ phase/NN of/IN proliferative/JJ diabetic/JJ retinopathy/NN may/MD result/VB in/IN stabilization/NN of/IN vision/NN for/IN long/JJ periods/NNS of/IN time/NN ./.
@@93330269324 We/PRP have/VBP previously/RB reported/VBN that/DT expression/NN of/IN a/DT tumour/NN derived/VBD brk/NEWGENE cDNA/NEWGENE in/IN mouse/NN embryonic/JJ fibroblasts/NNS and/CC human/JJ mammary/JJ epithelial/JJ cells/NNS supports/VBP anchorage/NN independent/JJ growth/NN ,/, and/CC in/IN the/DT latter/NN potentiates/VBZ the/DT mitogenic/JJ response/NN to/IN epidermal/NEWGENE growth/NEWGENE factor/NEWGENE ./.
@@3303644017 A/DT total/NN of/IN 26/CD BCG/NN strains/NNS ,/, out/RB of/IN them/PRP 10/CD Czechoslovak/JJ strains/NNS (/( 2/CD lyophilized/JJ cultures/NNS of/IN BCG/NN of/IN different/JJ batch/NN ,/, 6/CD strains/NNS isolated/VBN from/IN abscesses/NNS of/IN children/NNS after/IN BCG-vaccination/NNS and/CC 2/CD strains/NNS from/IN fatal/JJ cases/NNS after/IN BCG-vaccination/NNS )/SYM and/CC 16/CD strains/NNS obtained/VBN from/IN foreign/JJ laboratories/NNS ,/, were/VBD used/VBN ./.
@@63280024339 The/DT myeloproliferative/JJ sarcoma/NN virus/NN (/( MPSV/NNP )/SYM was/VBD derived/VBN by/IN passage/NN of/IN Moloney/NN sarcoma/NN virus/NN (/( Mo-MuSV/NNP )/SYM in/IN adult/JJ mice/NNS ./.
@@93666289327 Re/NN :/: "Assessing/JJ the/DT direction/NN of/IN causality/NN in/IN cross-sectional/JJ studies"/NN ./.
@@80061017998 Standard/NNP curve/NN correlation/NN coefficients/NNS of/IN 0/CD ./CD 995/CD or/CC greater/RBR were/VBD obtained/VBN during/IN validation/NN experiments/NNS and/CC analysis/NN of/IN study/NN samples/NNS ./.
@@68760069537 Echosismography/NN enables/VBZ to/IN improve/VB the/DT diagnosis/NN when/CC compared/VBN with/IN classical/JJ sonography/NN in/IN about/RB 20%/CD of/IN cases/NNS ./.
@@8816498844 The/DT serine/NEWGENE //NEWGENE threonine/NEWGENE kinase/NEWGENE Raf-1/NEWGENE functions/NNS downstream/RB of/IN Rats/NEWGENE in/IN a/DT signal/JJ transduction/NN cascade/NN which/WDT transmits/VBZ mitogenic/JJ stimuli/NNS from/IN the/DT plasma/NN membrane/NN to/IN the/DT nucleus/NN ./.
@@9353247956 Furthermore/RB ,/, the/DT over-replication/NN phenotype/NN produced/VBN by/IN this/DT mutant/NEWGENE p65cdc18/NEWGENE is/VBZ resistant/JJ to/IN increased/VBN mitotic/JJ cyclin/NEWGENE //NEWGENE CDK/NEWGENE activity/NN ,/, a/DT known/VBP inhibitor/NN of/IN over-replication/NN ./.
@@76065487506 Benefits/NNS of/IN obtaining/JJ board/NN certification/NN in/IN pharmacotherapy/NN ./.
@@71490477008 For/IN various/JJ dog/NN vessels/NNS in/IN vivo/NN ,/, Q/NNP //NNP Dk/NNP ranged/VBD from/IN 0/CD ./CD 15/CD to/IN 47/CD X/NN 10/NN (/NN 5/NN )/NN Torr/NN //NN cm2/NN ./.
@@18611886542 Plate/NNP luting/NN ,/, a/DT technique/NN that/WDT uses/VBZ polymethylmethacrylate/NN (/( PMMA/NN )/SYM interposed/VBN between/IN the/DT plate/NN and/CC the/DT bone/NN ,/, as/RB well/VB as/IN between/IN the/DT screw/NN heads/NNS and/CC the/DT plate/NN ,/, to/IN improve/VB the/DT stability/NN of/IN internal/JJ fixation/NN was/VBD tested/VBN in/IN vitro/FW using/VBG 20/CD paired/JJ equine/JJ third/RB metacarpal/JJ bones/NNS with/IN mid-diaphyseal/JJ osteotomies/NNS plated/VBN with/IN six-hole/JJ broad/JJ ASIF/NN compression/NN plates/NNS ./.
@@94580309412 Our/PRP study/NN was/VBD designed/VBN to/IN investigate/VB the/DT effect/NN of/IN MMF/NN on/IN in/IN vivo/NN bone/NN mineral/JJ metabolism/NN ./.
@@753726797 These/DT data/NN suggest/VB that/IN these/DT sequences/NNS located/VBN immediately/RB 3'/CD to/IN the/DT breakpoint/NN of/IN the/DT HPFH-3/NEWGENE deletion/NEWGENE ,/, exhibit/VB both/PDT the/DT structure/NN and/CC the/DT function/NN of/IN an/DT enhancer/NN ,/, and/CC can/MD modify/VB the/DT developmental/JJ specificity/NN of/IN the/DT fetal/NEWGENE gamma-globin/NEWGENE genes/NEWGENE ,/, resulting/VBG in/IN their/PRP continued/VBN expression/NN during/IN adult/JJ life/NN ./.
@@93899824242 CONCLUSIONS/IN :/: While/IN INR/NN correction/NN may/MD be/VB achieved/VBN by/IN all/PDT the/DT above/JJ methods/NNS ,/, that/IN relating/VBG log/NN reference/NN INR/NN to/IN log/NN local/JJ prothrombin/NEWGENE time/NN by/IN linear/JJ regression/NN analysis/NN is/VBZ the/DT simplest/JJS to/IN perform/VB ./.
@@5742225690 Sensory/JJ kindling/NN :/: implications/NNS for/IN development/NN of/IN sensory/JJ prostheses/NNS ./.
@@2405183070 A/DT rapid/JJ fluorimetric/JJ procedure/NN for/IN the/DT determination/NN of/IN the/DT fungicide/NN 5-fluorocytosine/NNP in/IN serum/NN is/VBZ described/VBN ./.
@@93680269783 In/NN this/DT study/NN ,/, we/PRP examine/VBP the/DT effects/NNS of/IN Msx2/NEWGENE expression/NN on/IN OC/NEWGENE promoter/NEWGENE activation/NN (/( luciferase/NEWGENE reporter/NEWGENE )/SYM by/IN FGF2/NEWGENE //NEWGENE FSK/NEWGENE and/CC calcitriol/NN in/IN MC3T3-E1/NNP osteoblasts/NNS ./.
@@100791734130 Human/NEWGENE neuronal/NEWGENE Elav-like/NEWGENE proteins/NEWGENE contain/VBP three/CD RNP-type/NEWGENE RNA/NEWGENE recognition/NEWGENE motifs/NEWGENE (/( RRMs/NEWGENE )/SYM ./.
@@96069249571 Liquid/NNP chromatographic/JJ method/NN for/IN analysis/NN of/IN all-rac-alpha-tocopheryl/JJ acetate/NN and/CC retinyl/JJ palmitate/NN in/IN milk-based/JJ infant/NN formula/NN using/VBG matrix/NN solid-phase/NN dispersion/NN ./.
@@85373882617 Interestingly/RB ,/, internal/JJ and/CC 5'/CD deletions/NNS revealed/VBN tha/VBG the/DT distal/JJ promoter/NN was/VBD not/RB required/VBN for/IN full/JJ transcriptional/JJ activity/NN and/CC that/IN the/DT first/JJ 631/CD base/NN pairs/NNS of/IN WNT-5A/NEWGENE harbored/VBD the/DT strongest/JJS promoter/NN activity/NN ./.
@@75927114169 Truncated/JJ forms/NNS of/IN a/DT novel/JJ yeast/NN protein/NN suppress/VB the/DT lethality/NN of/IN a/DT G/NEWGENE protein/NEWGENE alpha/NEWGENE subunit/NEWGENE deficiency/NN by/IN interacting/VBG with/IN the/DT beta/NN subunit/NN ./.
@@115204361397 Thus/RB ,/, BALB/NN //NN c/NN mice/NNS appear/VBP to/IN be/VB the/DT most/RB appropriate/JJ strain/NN of/IN mice/NNS to/IN perform/VB studies/NNS on/IN the/DT possible/JJ connection/NN between/IN infection/NN with/IN T/NNP ./NNP canis/NN and/CC allergic/JJ asthma/NN ./.
@@114161325370 These/DT studies/NNS demonstrate/VBP that/IN site-specific/JJ recognition/NN of/IN the/DT bxd/NEWGENE PRE/NEWGENE by/IN d/NN (/NN GA/NN )/NN (/NN n/NN )/NN repeat/NN binding/JJ activities/NNS mediates/VBZ PcG-dependent/NN silencing/VBG ./.
@@85130255007 We/PRP studied/VBD the/DT effect/NN of/IN skinfold/NN thickness/NN on/IN the/DT correlation/NN between/IN serum/JJ total/JJ bilirubin/NN level/NN and/CC transcutaneous/JJ bilirubin/NN (/( TcB/NN )/SYM readings/NNS ./.
@@103665036149 Binding/NN affinities/NNS of/IN these/DT recombinant/JJ phages/NNS as/IN determined/VBN by/IN the/DT retention/NN of/IN these/DT phages/NNS by/IN a/DT His-tag/NNP immobilized/JJ gp17/NEWGENE column/NN ,/, and/CC by/IN co-immunoprecipitation/NN with/IN purified/VBN terminase/NEWGENE supported/VBD the/DT specific/JJ nature/NN of/IN the/DT portal/NEWGENE protein/NEWGENE and/CC terminase/NEWGENE interaction/NEWGENE sites/NEWGENE ./.
@@6764166529 During/IN the/DT following/NN 9/CD 1/CD //CD 2/CD years/NNS three/CD sequential/JJ liver/NN biopsies/NNS were/VBD performed/VBN ./.
@@9755409744 Toward/IN absolute/JJ methods/NNS in/IN clinical/JJ chemistry/NN :/: application/NN of/IN mass/JJ fragmentography/NN to/IN high-accuracy/JJ analyses/NNS ./.
@@11098420931 Psychiatric/NNP disorders/NNS in/IN children/NNS and/CC adolescents/NNS carry/VB considerable/JJ morbidity/NN ,/, impede/VB development/NN ,/, and/CC carry/VB a/DT significant/JJ mortality/NN by/IN suicide/NN ./.
@@62295425630 Functional/JJ characterization/NN of/IN a/DT fraction/NN identified/VBN by/IN its/PRP activity/NN in/IN a/DT second/JJ template/NN rescue/NN assay/NN ./.
@@111184382328 Here/RB ,/, we/PRP describe/VBP the/DT isolation/NN of/IN MdPin1/NEWGENE ,/, a/DT Pin1/NEWGENE homologue/NN from/IN the/DT plant/NN species/NN apple/NN (/( Malus/NNP domestica/NN )/SYM and/CC show/VB that/IN it/PRP has/VBZ the/DT same/JJ phosphorylation-specific/JJ substrate/NN specificity/NN and/CC can/MD be/VB inhibited/VBN by/IN juglone/NN in/IN vitro/FW ,/, as/IN is/VBZ the/DT case/NN for/IN Pin1/NEWGENE ./.
@@64134926705 Commun/NNP ./.
@@221432848 Teratological/JJ study/NN of/IN etoperidone/NN in/IN the/DT rat/NN and/CC rabbit/NN ./.
@@91400796087 (/( 3/CD )/SYM This/DT effect/NN occurs/VBZ without/IN removing/JJ TRs/NEWGENE from/IN the/DT TRE/NEWGENE ./.
@@109586889574 A/DT Y/NEWGENE ./NEWGENE lipolytica/NEWGENE Kar2p/NEWGENE mutant/NEWGENE was/VBD isolated/VBN that/WDT restored/VBD interaction/NN with/IN an/DT Sls1p/NEWGENE mutant/NEWGENE ,/, suggesting/VBG that/IN the/DT interaction/NN with/IN Sls1p/NEWGENE could/MD be/VB nucleotide/NN and/DT //DT or/DT conformation/NN dependent/JJ ./.
@@111523447793 Nine/CD animals/NNS served/VBN as/IN control/JJ animals/NNS ,/, whereas/IN 20/CD animals/NNS received/VBD a/DT focal/JJ arachnoid/JJ scar/NN at/IN C1-C2/NN ,/, which/WDT was/VBD produced/VBN by/IN placement/NN of/IN a/DT kaolin-soaked/JJ fibrin/NEWGENE sponge/NN on/IN the/DT posterior/JJ surface/NN of/IN the/DT spinal/JJ cord/NN ./.
@@25822401676 High/NNP ATP/NNP //NNP GTP/NNP ratios/NNS promoted/VBD initiation/NN of/IN RNA/NN primer/NN synthesis/NN at/IN 3'-dCTTT/NEWGENE sites/NEWGENE ,/, whereas/IN low/JJ ATP/NNP //NNP GTP/NNP ratios/NNS promoted/VBD initiation/NN at/IN 3'-dCCC/NEWGENE sites/NEWGENE ./.
@@9111004881 Two/CD predominant/JJ effects/NNS were/VBD noted/VBN :/: (/( i/NN )/SYM the/DT Xaa/NNP residue/NN in/IN the/DT dual/NEWGENE phosphorylation/NEWGENE motif/NEWGENE Thr-Xaa-Tyr/NEWGENE as/NNP well/VB as/IN the/DT length/NN of/IN L12/NN influence/NN p38/NEWGENE substrate/NN specificity/NN ,/, and/CC (/( ii/NN )/SYM the/DT length/NN of/IN L12/NN plays/VBP a/DT major/JJ role/NN in/IN controlling/JJ autophosphorylation/NN ./.
@@29976226570 This/DT L-myc/NEWGENE sequence/NEWGENE is/VBZ amplified/VBN 10-20-fold/JJ in/IN four/CD SCLC/NN cell/NN line/NN DNAs/NNS and/CC in/IN one/PRP SCLC/NN tumour/NN specimen/NN taken/VBP directly/RB from/IN a/DT patient/NN ./.
@@118987979606 We/PRP have/VBP previously/RB reported/VBN reduced/VBN levels/NNS of/IN choline/NEWGENE acetyltransferase/NEWGENE activity/NN in/IN the/DT cerebral/JJ cortex/NN of/IN patients/NNS who/WP died/VBD after/IN a/DT head/JJ injury/NN ,/, demonstrating/VBG that/WDT there/RB is/VBZ a/DT loss/NN of/IN cortical/JJ cholinergic/JJ innervation/NN ./.
@@7671617601 Significant/JJ increases/NNS in/IN mean/JJ serum/JJ E2/NN concentration/NN (/( 100/CD to/IN 150/CD pg/NN //NN ml/NN )/SYM were/VBD noted/VBN at/IN 6/CD and/CC 8/CD hours/NNS after/IN administration/NN on/IN day/NN 1/CD and/CC at/IN 8/CD hours/NNS on/IN day/NN 4/CD ./CD
@@10521345356 Paleoceanographic/NNP data/NN from/IN the/DT Laurentian/NNP Fan/NNP ,/, used/VBN as/IN a/DT proxy/NN for/IN sea/NN surface/NN temperature/NN ,/, reveal/VB that/DT surface/NN slope/NN waters/NNS north/NN of/IN the/DT Gulf/NNP Stream/NNP experienced/VBD warming/NN during/IN the/DT Little/NNP Ice/NNP Age/NNP of/IN the/DT 16th/CD to/IN 19th/NN centuries/NNS and/CC support/VB the/DT notion/NN of/IN an/DT NAO-driven/NNP coupled/VBD system/NN ./.
@@98800298229 Six/CD putative/JJ MDV/NN genome/NN products/NN ,/, including/JJ one/PRP Rep/NEWGENE and/CC five/CD non-Rep/JJ proteins/NNS ,/, show/VB high/JJ (/( 70/CD ./CD 4-90/CD ./CD 9%/CD )/SYM amino/JJ acid/NN identity/NN to/IN the/DT corresponding/JJ six/CD FBNYV/NEWGENE proteins/NEWGENE ,/, whereas/IN two/JJ other/DT Rep/NEWGENE proteins/NEWGENE encoded/VBN by/IN MDV-C2/NEWGENE and/CC C3/NEWGENE are/VBP 82/NN ./NN 3%/NN and/CC 73/NN ./NN 0%/NN identical/JJ to/IN those/DT encoded/VBN by/IN SCSV-C2/NEWGENE and/CC C6/NEWGENE ,/, respectively/RB ./.
@@15112312131 We/PRP investigated/VBD the/DT smoking/NN habits/NNS of/IN relapsers/NNS 1/CD year/NN after/IN quitting/JJ in/IN a/DT smoking/NN cessation/NN trial/NN using/VBG nicotine/NN or/CC placebo/NN patches/NNS ./.
@@103425362982 While/IN determination/NN of/IN the/DT protein/NN content/NN of/IN the/DT formulae/NNS gave/VBD no/DT valid/JJ information/NN ,/, RAST/NNP //NNP EAST/NNP inhibition/NN was/VBD highest/JJS for/IN cow's/NNS milk/NN ,/, followed/VBN by/IN the/DT partially/RB hydrolysed/VBN whey/NN formula/NN ,/, partially/RB hydrolysed/VBN whey/NN //NN casein/NN formula/NN ,/, soy/NEWGENE //NEWGENE pork/NEWGENE collagen/NEWGENE formula/NN ,/, and/CC the/DT amino/JJ acid/NN formula/NN ./.
@@93647505870 Transcriptional/JJ regulation/NN of/IN SUP35/NEWGENE and/CC SUP45/NEWGENE in/NEWGENE Saccharomyces/NEWGENE cerevisiae/NEWGENE ./.
@@23196107682 The/DT clinical/JJ relevance/NN of/IN these/DT findings/NNS is/VBZ strengthened/VBN by/IN the/DT observation/NN that/IN similar/JJ results/NNS were/VBD obtained/VBN when/CC P/NN ./NN HCl/NN was/VBD given/VBP by/IN the/DT intravenous/JJ route/NN ./.
@@94299135933 RESULTS/NNS :/: Looking/VBG at/IN the/DT question/NN of/IN its/PRP benefits/NNS ,/, we/PRP were/VBD unable/JJ to/IN find/NN any/DT methodologically/RB sound/NN studies/NNS that/WDT have/VBP shown/VBP efficacy/NN for/IN EMDR/NN in/IN eating/JJ disorders/NNS ,/, or/CC ,/, indeed/RB ,/, any/DT psychiatric/JJ disorder/NN ./.
@@77494611276 The/DT 2/CD kb/NN of/IN 5'-flanking/JJ region/NN and/CC the/DT 1/CD ./CD 1/CD kb/NN of/IN the/DT entire/JJ sGTH/NEWGENE alpha/NEWGENE subunit/NEWGENE coding/JJ region/NN were/VBD sequenced/VBN from/IN the/DT genomic/JJ clone/NN ,/, sGTH/NEWGENE alpha-G1/NEWGENE ./.
@@29029274791 Here/RB ,/, we/PRP describe/VBP the/DT isolation/NN of/IN bovine/NEWGENE and/NEWGENE rat/NEWGENE GHF-1/NEWGENE cDNA/NEWGENE clones/NNS ./.
@@89223903165 These/DT data/NN demonstrate/VB that/DT paxillin/NEWGENE localizes/VBZ to/IN focal/JJ adhesions/NNS independent/NN of/IN interactions/NNS with/IN vinculin/NEWGENE and/IN //IN or/IN FAK/NEWGENE ,/, and/CC represents/VBZ the/DT first/JJ definitive/JJ demonstration/NN of/IN LIM/NEWGENE domains/NEWGENE functioning/NN as/IN a/DT primary/JJ determinant/NN of/IN protein/NN subcellular/JJ localization/NN to/IN focal/JJ adhesions/NNS ./.
@@100268243972 Systematic/JJ functional/JJ analysis/NN of/IN V1a/NEWGENE //NEWGENE V2/NEWGENE hybrid/NEWGENE receptors/NEWGENE showed/VBN that/IN the/DT second/JJ intracellular/JJ loop/NN of/IN the/DT V1a/NEWGENE receptor/NEWGENE is/VBZ required/VBN and/CC sufficient/JJ for/IN efficient/JJ coupling/NN to/IN Gq/NEWGENE //NEWGENE 11/NEWGENE ,/, whereas/IN the/DT third/RB intracellular/JJ loop/NN of/IN the/DT V2/NEWGENE receptor/NEWGENE is/VBZ required/VBN and/CC sufficient/JJ for/IN coupling/NN to/IN Gs/NEWGENE ./.
@@98585999879 Both/DT NUP98-HOXA9/NEWGENE chimeras/NEWGENE transformed/VBD NIH/NN 3T3/CD fibroblasts/NNS ,/, and/CC this/DT transformation/NN required/VBD the/DT HOXA9/NEWGENE domains/NEWGENE for/IN DNA/NN binding/JJ and/CC PBX/NEWGENE interaction/NN ./.
@@106985168680 KFC/NEWGENE ,/, a/DT Ste20-like/NEWGENE kinase/NEWGENE with/IN mitogenic/JJ potential/NN and/CC capability/NN to/IN activate/VB the/DT SAPK/NEWGENE //NEWGENE JNK/NEWGENE pathway/NEWGENE ./.
@@92093125809 One/CD RNA/NN construct/NN which/WDT consisted/VBP of/IN 112/CD nucleotides/NNS (/( nt/NN )/SYM from/IN nt/NN 639/CD to/IN nt/NN 750/CD formed/VBN a/DT heterodimeric/NN complex/NN with/IN the/DT RNA/NN which/WDT consisted/VBP of/IN 200/CD nucleotides/NNS from/IN nt/NN 551/CD to/IN nt/NN 750/CD ./.
@@109729909696 Cytogenetic/JJ analysis/NN of/IN LOH/NN mutants/NN by/IN chromosome/NN painting/NN indicated/VBD a/DT mosaic/NN of/IN chromosomal/JJ aberrations/NNS involving/VBG chromosome/NN 17/CD ,/, in/IN which/WDT partial/JJ chromosome/NN deletions/NNS ,/, amplifications/NNS ,/, and/CC multiple/JJ translocations/NNS appeared/VBN heterogeneously/RB in/IN a/DT single/JJ mutant/NN ./.
@@100228587316 In/NN addition/NN ,/, a/DT potent/JJ splicing/JJ enhancer/NN sequence/NN isolated/VBN in/IN the/DT selection/NN specifically/RB binds/VBZ a/DT 20-kDa/NEWGENE SR/NEWGENE protein/NEWGENE ./.
@@72211798466 A/DT dose-dependent/NN fall/NN in/IN GABA/NN content/NN was/VBD observed/VBN ;/: GABA/NN decrease/NN was/VBD evident/JJ 15/CD min/NN after/IN the/DT administration/NN ,/, reached/VBD its/PRP nadir/NN at/IN 60/CD min/NN and/CC disappeared/VBN at/IN 120/CD minutes/NNS ./.
@@77668852469 Within/IN their/PRP polypeptide/NN chain/NN ,/, they/PRP all/DT contain/VB those/DT conserved/VBN features/NNS that/WDT define/VBP a/DT plant/NN CDPK/NEWGENE ;/: kinase/NEWGENE catalytic/NEWGENE sequences/NEWGENE are/VBP linked/JJ to/IN a/DT calmodulin-like/NEWGENE regulatory/NEWGENE domain/NEWGENE through/RB a/DT junction/NN region/NN ./.
@@112133428785 RESULTS/NNS :/: The/DT parameters/NNS SF2/NN and/CC plating/NN efficiency/NN were/VBD stable/JJ throughout/IN the/DT 4-year/JJ test/NN period/NN ./.
@@93156517876 Involvement/NNS of/IN AP-2/NEWGENE in/IN regulation/NN of/IN the/DT R-FABP/NEWGENE gene/NEWGENE in/IN the/DT developing/JJ chick/NN retina/NN ./.
@@37469069244 Two/CD studies/NNS assessed/VBD two/JJ types/NNS of/IN reliability/NN of/IN the/DT student/NN Jenkins/NNP Activity/NNP Survey/NNP (/( JAS/NNP ;/: a/DT questionnaire/NN measure/NN of/IN Type/NN A/NN behavior/NN )/SYM ./.
@@98732919867 Two-way/NNP analysis/NN of/IN variance/NN was/VBD used/VBN to/IN determine/VB whether/IN composite/JJ knowledge/NN score/NN differed/VBN among/IN patient/NN groups/NNS ./.
@@104136076786 We/PRP have/VBP shown/VBP previously/RB that/IN in/IN contrast/NN to/IN other/DT extracellular/JJ matrix/NN molecules/NNS pepsin-solubilized/JJ collagen/NEWGENE VI/NEWGENE (/( CVI/NEWGENE )/SYM can/MD stimulate/VB DNA/NN synthesis/NN of/IN various/JJ mesenchymal/JJ cell/NN types/NNS ,/, apparently/RB independent/NN of/IN integrin-mediated/JJ signal/JJ transduction/NN ./.
@@25689305118 Isolation/NNS and/CC characterization/NN of/IN a/DT cDNA/NN encoding/VBG a/DT putative/JJ cytokine/NN which/WDT is/VBZ induced/VBN by/IN stimulation/NN via/NN the/DT CD2/NEWGENE structure/NEWGENE on/IN human/JJ T/NN lymphocytes/NNS ./.
@@91694753027 In/NN the/DT studies/NNS reported/VBN here/RB ,/, the/DT 5'-flanking/JJ region/NN of/IN the/DT human/NEWGENE gp130/NEWGENE gene/NEWGENE was/VBD isolated/VBN and/CC the/DT transcription/NN initiation/NN sites/NNS were/VBD mapped/VBN ./.
@@106330755131 Preimmune/NEWGENE IgG/NEWGENE ,/, anti-GalT/NEWGENE Fab/NEWGENE fragments/NEWGENE ,/, irrelevant/JJ polymers/NNS and/CC monomeric/JJ N-acetylglucosamine/NN had/VBP no/DT effect/NN ./.
@@91710812399 Cloning/VBG and/CC characterization/NN of/IN a/DT cDNA/NN encoding/VBG a/DT bacteriophage-type/NEWGENE RNA/NEWGENE polymerase/NEWGENE from/IN the/DT higher/JJ plant/NN Chenopodium/NN album/NN ./.
@@66846244910 Female/JJ but/CC not/RB male/JJ mortalities/NNS were/VBD significantly/RB higher/JJ for/IN cake-fed/JJ rats/NNS than/IN for/IN those/DT fed/VBN diet/NN 41B/NN ./.
@@88068178795 Genomic/NN DNA/NN hybridization/NN suggests/VBZ that/IN SpSHR2/NEWGENE is/VBZ a/DT single-copy/JJ gene/NN in/IN the/DT S/NNP ./NNP purpuratus/NN genome/NN ./.
@@112928395499 Its/PRP transcription/NN in/IN vitro/FW by/IN pol/NEWGENE III/NEWGENE requires/VBZ the/DT same/JJ factors/NNS as/IN the/PDT U6/NEWGENE gene/NEWGENE with/IN the/DT major/JJ exception/NN that/IN the/DT modified/JJ TATA-box/NN of/IN this/DT construct/NN only/RB interacts/VBZ with/IN a/DT TATA-binding/NEWGENE protein/NEWGENE (/( TBP/NEWGENE )/SYM mutant/JJ (/( TBP-DR2/NEWGENE )/SYM but/CC not/RB with/IN TBP/NEWGENE wild-type/NEWGENE (/( TBPwt/NEWGENE )/SYM ./.
@@2545373189 How/WRB do/VB graduates/NNS of/IN different/JJ types/NNS of/IN programs/NNS perform/VBP on/IN state/NN boards/NNS ?/.
@@104551439440 Interdomain/NNP signaling/JJ in/IN a/DT two-domain/NN fragment/NN of/IN the/DT human/NEWGENE glucocorticoid/NEWGENE receptor/NEWGENE ./.
@@45395529058 Teratological/JJ studies/NNS on/IN SF-837/NN ./.
@@8750190733 Our/PRP laboratory/NN and/CC others/NNS have/VB shown/VBP alternative/JJ splicing/JJ of/IN up/JJ to/IN ten/CD exons/NNS at/IN a/DT discrete/JJ extracellular/JJ site/NN to/IN be/VB primarily/RB responsible/JJ for/IN the/DT generation/NN of/IN CD44/NEWGENE variant/NEWGENE (/( CD44v/NEWGENE )/SYM isoforms/NNS ./.
@@114791041964 She/PRP has/VBZ since/IN developed/VBN a/DT positive/JJ anti-cardiolipin/NEWGENE antibody/NEWGENE but/CC does/VBP not/RB meet/VB diagnostic/JJ criteria/NNS for/IN systemic/JJ lupus/NN erythematosis/NN ./NN Conclusion/NN :/: The/DT presence/NN of/IN known/VBP autoimmune/JJ disease/NN in/IN a/DT woman/NN with/IN POF/NN should/MD not/RB dissuade/VB the/DT clinician/NN from/IN evaluating/VBG for/IN a/DT potential/JJ genetic/JJ cause/NN ./.
@@115240156909 Forced/VBN expression/NN of/IN BZAP45/NEWGENE strongly/RB stimulates/VBZ H4/NEWGENE promoter/NEWGENE (/( nt/NN -215/CD to/IN -1/CD )/NN //NEWGENE CAT/NEWGENE reporter/NEWGENE gene/NEWGENE activity/NN ./.
@@10042984523 This/DT up-grading/NN of/IN the/DT final/JJ score/NN by/IN the/DT CA/NN component/NN is/VBZ greater/JJR (/( 3-8%/JJ )/SYM in/IN the/DT less/PRP able/JJ students/NNS with/IN scores/NNS below/RB the/DT mean/JJ level/NN ./.
@@19055176521 The/DT ORF/NN was/VBD analyzed/VBN for/IN secondary/JJ structural/JJ features/NNS ,/, and/CC the/DT sequence/NN data/NN bases/NNS were/VBD searched/VBN for/IN homologies/NNS ./.
@@87811442926 The/DT [/NN 18F/NN ]/NN FMISO/NN TMRR/NN is/VBZ a/DT simple/JJ and/CC clinically/RB useful/JJ index/NN for/IN detecting/JJ tumour/NN hypoxia/NN in/IN NPC/NN ./.
@@21698878046 The/DT transcripts/NNS were/VBD equally/RB active/JJ with/IN or/CC without/IN a/DT 5'/CD methylated/JJ capstructure/NN as/IN expected/VBN ,/, since/IN EMCV-RNA/NN is/VBZ one/PRP of/IN the/DT mRNAs/NNS capable/JJ of/IN internal/JJ initiation/NN ./.
@@112117591181 Patients/NNS were/VBD divided/VBN into/IN two/JJ group/NN ;/: Control/NN group/NN A/NN in/NN which/WDT a/DT hot-water/NN circulating/JJ system/NN was/VBD used/VBN and/CC group/NN B/NNP in/IN which/WDT a/DT transtracheal/JJ heating/NN and/CC humidification/NN system/NN by/IN ANAMED/NNP HUMITUBE/NNP was/VBD used/VBN ,/, during/IN gastric/JJ cancer/NN operation/NN ./.
@@108644966242 The/DT equilibrium/NN dissociation/NN binding/JJ constant/NN for/IN the/DT interaction/NN of/IN TnrA/NEWGENE with/IN the/DT nrgAB/NEWGENE promoter/NEWGENE fragment/NEWGENE was/VBD 7/CD ./CD 7/CD nM/NN under/IN the/DT conditions/NNS used/VBN here/RB ./.
@@76664142690 Tissue-specific/NN expression/NN of/IN the/DT tmy-1/NEWGENE gene/NEWGENE was/VBD determined/VBN by/IN microinjection/NN of/IN a/DT promoter/NEWGENE //NEWGENE lacZ/NEWGENE fusion/NEWGENE gene/NEWGENE and/CC with/IN immunohistochemistry/NN by/IN using/VBG affinity-purified/JJ tissue-specific/NEWGENE anti-tropomyosins/NEWGENE ./.
@@87029369009 Radiolabeled/JJ recombinant/NEWGENE TARC/NEWGENE specifically/RB bound/JJ to/IN T/NN cell/NN lines/NNS and/CC peripheral/JJ T/NN cells/NNS but/CC not/RB to/IN monocytes/NNS or/CC granulocytes/NNS ./.
@@10917402737 Intravenous/JJ versus/IN oral/JJ administration/NN of/IN amitriptyline/NN in/IN patients/NNS with/IN major/JJ depression/NN ./.
@@85049322728 One/CD enigmatic/JJ aspect/NN of/IN GATA/NEWGENE factor/NEWGENE expression/NN is/VBZ that/IN several/DT GATA/NEWGENE proteins/NEWGENE ,/, which/WDT ostensibly/RB share/VB the/DT same/JJ DNA-binding/NN site/NN specificity/NN ,/, are/VBP coexpressed/VBN in/IN erythroid/JJ cells/NNS ./.
@@9513759171 Calcitriol/DT therapy/NN was/VBD associated/VBN with/IN a/DT decrease/NN in/IN serum/JJ iPTH/NEWGENE levels/NNS (/( 701/NN +/NN //NN -/NN 103/CD ./CD 9/CD vs/IN ./IN
@@95988949563 In/NN most/RB subjects/VBZ ,/, markers/NNS of/IN bone/NN formation/NN and/CC resorption/NN were/VBD normal/JJ ./.
@@100744259891 Nevertheless/RB ,/, inactivation/NN of/IN the/DT cyclin/NEWGENE E-Cdk2/NEWGENE complex/NEWGENE in/IN response/NN to/IN mitogen/NN starvation/NN occurs/VBZ normally/RB in/IN MEFs/NNS that/WDT have/VBP a/DT homozygous/JJ deletion/NN of/IN the/DT p27/NEWGENE gene/NEWGENE ./.
@@99145184433 Moreover/RB ,/, this/DT enhancement/NN of/IN transcriptional/JJ activation/NN by/IN COUP-TFI/NEWGENE requires/VBZ specifically/RB the/DT AF-1/NEWGENE transactivation/NN function/NN of/IN ER/NEWGENE and/CC can/MD be/VB observed/VBN in/IN the/DT presence/NN of/IN E2/NN or/CC 4-hydroxytamoxifen/JJ but/CC not/RB ICI/NNP 164384/CD ./.
@@64805426280 A/DT pharmacokinetic/JJ study/NN of/IN apalcillin/NN was/VBD performed/VBN in/IN 12/CD patients/NNS in/IN an/DT intensive-care/JJ unit/NN ./.
@@68095866588 Autoimmune/NNP manipulation/NN aids/NNS juvenile/JJ diabetes/NN management/NN ./.
@@7552451168 Effect/NN of/IN indoramin/NN in/IN small/JJ doses/NNS on/IN the/DT central/NN vasomotor/NN loci/NN has/VBZ been/VBN studied/VBN in/IN chloralose/NN anesthetized/JJ cats/NNS by/IN localizing/JJ it/PRP to/IN the/DT central/JJ sites/NNS ./.
@@112948953893 We/PRP also/RB demonstrate/VBP that/IN the/DT spo20/NEWGENE (/NEWGENE +/NEWGENE )/NEWGENE gene/NEWGENE product/NEWGENE is/VBZ structurally/RB homologous/JJ to/IN Saccharomyces/NEWGENE cerevisiae/NEWGENE Sec14/NEWGENE ,/, the/DT major/JJ phosphatidylinositol/NN transfer/NN protein/NN of/IN budding/JJ yeast/NN ./.
@@103201778395 Baseline/NN electrocorticography/NN over/RB the/DT surface/NN of/IN the/DT temporal/JJ lobe/NN and/CC depth/NN electrode/NN recordings/NNS in/IN the/DT amygdala/NN and/CC hippocampus/NN were/VBD obtained/VBN ,/, followed/VBN by/IN 10/CD min/NN of/IN recording/JJ before/IN and/CC after/IN the/DT i/CD ./CD v/CD ./. administration/NN of/IN both/DT alfentanil/NN 50/CD microg/NN //NN kg/NN and/CC fentanyl/NN 10/NN microg/NN //NN kg/NN ./.
@@80435238211 Although/IN elevated/VBN serum/JJ levels/NNS of/IN antibodies/NNS to/IN the/DT nicotinic/NEWGENE acetylcholine/NEWGENE receptor/NEWGENE (/( nAChR/NEWGENE )/SYM have/VB been/VBN reported/VBN in/IN neuroleptic/RB treated/VBN patients/NNS with/IN tardive/JJ dyskinesia/NN ,/, such/JJ antibodies/NNS have/VBP not/RB been/VBN determined/VBN in/IN comparable/JJ nondyskinetic/JJ patients/NNS ./.
@@1305731945 VII/NNP ./.
@@107561003713 Recently/RB ,/, a/DT mutation/NN in/IN the/DT amino-terminus/NN of/IN IB1/NEWGENE was/VBD associated/VBN with/IN diabetes/NN ./.
@@102091192762 In/NN budding/JJ yeast/NN ,/, the/DT protein/NN Skp1p/NEWGENE ,/, the/DT cullin-family/NEWGENE member/NEWGENE Cdc53p/NEWGENE1 ,/, and/CC the/DT F-box/NEWGENE //NEWGENE WD-repeat/NEWGENE protein/NEWGENE Cdc4p/NEWGENE1 form/NN the/DT SCFCdc4p/NEWGENE ubiquitin/NEWGENE1 ligase/NEWGENE complex/NEWGENE ,/, which/WDT targets/VBZ the/DT cyclin-dependent/NEWGENE kinase/NEWGENE (/( Cdk/NEWGENE )/SYM inhibitor/NN Sic1p/NEWGENE for/IN proteolysis/NN [/NN 3/NN ]/NN [/NN 4/NN ]/NN [/NN 5/NN ]/NN [/NN 6/NN ]/NN [/NN 7/NN ]/NN [/NN 8/NN ]/NN ./.
@@111726101354 We/PRP show/VBP that/IN p73/NEWGENE can/MD transcriptionally/RB inhibit/VB a/DT number/NN of/IN cellular/JJ and/CC viral/JJ promoters/NNS ./.
@@110940877761 Induced/JJ expression/NN of/IN Rnd3/NEWGENE is/VBZ associated/VBN with/IN transformation/NN of/IN polarized/JJ epithelial/JJ cells/NNS by/IN the/DT Raf-MEK-extracellular/NEWGENE signal-regulated/NEWGENE kinase/NEWGENE pathway/NEWGENE ./.
@@90255494559 How/WRB does/VBP a/DT nurse/NN go/NN about/RB maintaining/VBG her/PRP level/NN of/IN competence/NN when/CC she/PRP is/VBZ one/PRP of/IN the/DT few/JJ local/JJ practitioners/NNS in/IN her/PRP field/NN ?/. Vancouver/NN sex/NN therapist/NN Bianca/NN Rucker/NN is/VBZ doing/VBG it/PRP by/IN cultivating/JJ a/DT network/NN of/IN colleagues/NNS and/CC mentors/NNS in/IN related/VBN fields/VBZ both/DT at/IN home/JJ and/CC across/IN the/DT continent/NN ./.
@@118661307831 In/NN addition/NN ,/, benzocaine/NN and/CC 2-phenoxyethanol/RB depressed/VBN complement/NN activity/NN and/CC phagocytosis/NN ,/, while/CC MS222/NN and/CC quinaldine/NN sulphate/NN did/VBD not/RB ./.
@@84683205556 (/( 1992/CD )/SYM J/NNP ./NNP
@@89998828621 Expression/NNS of/IN neuronal/JJ traits/NNS in/IN pancreatic/JJ beta/NN cells/NNS ./.
@@106537337270 All/DT four/CD domains/NNS were/VBD linked/JJ via/NN proline-threonine-rich/JJ peptides/NNS ./.
@@16928371734 Both/DT genes/NNS comprise/VBP three/CD exons/NNS ,/, two/JJ introns/NNS and/CC an/DT unusually/RB long/JJ 3'-untranslated/JJ region/NN (/( 3/CD ./CD 2/CD kilobase/NN pairs/NNS )/SYM ,/, specificying/VBG a/DT mRNA/NN of/IN approximately/RB 4/CD ./CD 1/CD kilobases/NNS ./.
@@95875498441 Convulsive/JJ seizure/NN during/IN a/DT treatment/NN with/IN interferon/NEWGENE alpha/NEWGENE for/IN chronic/JJ viral/JJ hepatitis/NNP C/NNP ./NNP
@@79166858289 The/DT ratio/NN of/IN the/DT activity/NN of/IN arogenate/NEWGENE dehydrogenase/NEWGENE to/IN that/DT of/IN prephenate/NEWGENE dehydrogenase/NEWGENE (/( approximately/RB 3/CD :/: 1/CD )/SYM remained/VBN constant/JJ throughout/IN purification/NN ,/, and/CC the/DT two/JJ activities/NNS were/VBD therefore/RB inseparable/JJ ./.
@@68735046668 Pathogenetic/JJ relationships/NNS between/IN renal/JJ tubular/JJ acidosis/NN and/CC sodium/NN metabolism/NN alterations/NNS in/IN liver/NN cirrhosis/NN ./.
@@7406527723 At/NN the/DT end/NN of/IN the/DT experiment/NN the/DT urinary/NN porphyrin/NEWGENE excretion/NN and/CC the/DT porphyrin/NEWGENE content/NN in/IN lijver/NN and/CC skin/NN were/VBD diminished/VBN in/IN HCB-CQ-treated/JJ animals/NNS by/IN about/RB 50%/NN compared/VBN to/IN the/DT HCB/NN controls/NNS ./.
@@86663981613 YAC/NN and/CC cosmid/NN contigs/NNS spanning/VBG the/DT Batten/NEWGENE disease/NEWGENE (/NEWGENE CLN3/NEWGENE )/NEWGENE region/NEWGENE at/IN 16p12/CD ./CD 1-p11/CD ./CD 2/CD ./.
@@82454614316 Hu-Met-1/NEWGENE mRNA/NEWGENE expression/NN in/IN a/DT small/JJ number/NN of/IN human/JJ T/NN cell/NN tumor/NN lines/NNS did/VBD not/RB correlate/VB with/IN any/DT particular/JJ phenotype/NN or/CC stage/NN of/IN development/NN ./.
@@93731558632 Identification/NNP of/IN dynein/NEWGENE heavy/NEWGENE chain/NEWGENE genes/NEWGENE expressed/VBN in/IN human/NN and/CC mouse/NN testis/NN :/: chromosomal/JJ localization/NN of/IN an/DT axonemal/NEWGENE dynein/NEWGENE gene/NEWGENE ./.
@@17620532360 The/DT granules/NNS grew/VBN as/IN the/DT melted/VBN material/NN immersed/VBN into/IN the/DT void/JJ space/NN among/IN the/DT adhered/VBN particles/NNS ./.
@@6555107273 We/PRP conclude/VBP that/DT administration/NN of/IN the/DT calcium/NN antagonist/NN Verapamil/WDT is/NNS of/IN no/DT additional/JJ value/NN in/IN tocolytic/NN treatment/NN with/IN beta-mimetics/NNS ./.
@@12983988608 The/DT method/NN was/VBD adapted/VBN for/IN the/DT determination/NN of/IN nadolol/NN racemate/NN A/NN by/IN a/DT change/NN in/IN mobile/JJ phase/NN composition/NN ./.
@@37773984451 Examples/NNS of/IN its/PRP use/NN in/IN the/DT intensive/JJ therapy/NN unit/NN are/VBP described/VBN ./.
@@96181503639 At/NN physiological/JJ doses/NNS ,/, either/DT insulin-like/NEWGENE growth/NEWGENE factor/NEWGENE I/NEWGENE (/( IGF-I/NEWGENE )/SYM or/CC insulin/NEWGENE turned/VBN out/RB to/RB be/VB as/RB potent/JJ as/IN dibutyryl/NN cAMP/NN (/( dbcAMP/NN )/SYM in/IN increasing/JJ UCP1/NEWGENE gene/NEWGENE transcription/NN rate/NN (/( 1/CD h/NN )/SYM and/CC also/RB UCP1/NEWGENE mRNA/NEWGENE accumulation/NN (/( 3/CD h/NN )/SYM ,/, their/PRP maximal/JJ effect/NN (/( 15-fold/JJ increase/NN )/SYM reached/VBN upon/IN treatment/NN for/IN 24/CD h/CD ./CD
@@16869092285 However/RB ,/, the/DT increase/NN in/IN biliary/JJ excretion/NN did/VBD not/RB compensate/VB for/IN the/DT reduced/VBN elimination/NN of/IN bretylium/NN and/CC hexylsalicylic/JJ acid/NN via/NN the/DT kidney/NN ./.
@@107244836319 Therefore/RB ,/, the/DT positive/JJ cAMP/NN control/NN of/IN the/DT hypoxic/JJ SRP1/NEWGENE and/CC HEM13/NEWGENE genes/NEWGENE was/VBD uncoupled/VBN from/IN the/DT HOG/NN pathway/NN ./.
@@17699191557 Auditory/JJ threshold/NN shifts/NNS ,/, as/IN measured/VBN by/IN the/DT auditory/RB evoked/VBN brainstem/NN response/NN ,/, were/VBD measured/VBN at/IN 2/NN ,/NN 4/NN ,/NN 8/NN ,/NN 12/NN ,/NN 16/NN ,/, 20/CD and/CC 24/CD kHz/NN ./.
@@76785933972 The/DT hybridizing/VBG clone/NN of/IN V/NNP ./NNP vulnificus/NN chromosomal/JJ DNA/NN complemented/VBD a/DT V/NEWGENE ./NEWGENE cholerae/NEWGENE fur/NEWGENE mutant/NEWGENE ./.
@@9858531730 Furthermore/RB ,/, RING1/NEWGENE overexpression/NN results/NNS in/IN enhanced/VBN expression/NN of/IN the/DT proto-oncogenes/NN c-jun/NEWGENE and/CC c-fos/NEWGENE ./.
@@18088292415 TPTA/NN produced/VBD brain/NN congestion/NN ,/, and/CC hepatic/JJ and/CC pulmonary/JJ petechial/JJ and/CC generalized/JJ hemorrhages/NNS ./.
@@29115403616 A/DT patient/NN with/IN an/DT infected/VBN wound/JJ or/CC one/PRP on/IN a/DT primary/JJ area/NN (/( hands/NNS ,/, feet/NNS ,/, face/NN ,/, or/CC perineum/NN )/SYM may/MD have/VB to/IN be/VB hospitalized/VBN to/IN ensure/VB proper/JJ care/NN ./.
@@10740602553 STUDY/NN DESIGN/IN :/: Fine/NNP needle/NN aspiration/NN cytologic/JJ smears/NNS from/IN 21/CD cases/NNS of/IN invasive/JJ lobular/JJ carcinoma/NN (/( ILC/NNS )/SYM of/IN breast/NN were/VBD subjected/VBN to/IN detailed/JJ cytomorphologic/JJ analysis/NN ./.
@@68549576647 Detection/NNS of/IN exercise-induced/JJ asynergy/NN by/IN M-mode/NN echocardiography/NN ./.
@@92497109211 Twenty-one/CD ELISA-positive/NN sera/NNS were/VBD tested/VBN and/CC confirmed/VBN positive/JJ by/IN plaque/NN reduction/NN neutralization/NN testing/NN ./.
@@93767829329 We/PRP have/VBP reviewed/VBN the/DT experience/NN of/IN a/DT major/JJ MMT/NNS general/JJ practice/NN with/IN hepatitis/NN C/NN virus/NN (/( HCV/NN )/SYM infection/NN from/IN 1991/CD to/IN 1995/CD ./.
@@36161744294 An/DT intralobar/JJ change/NN in/IN temperature/NN above/RB or/CC below/RB 36/CD degrees/NNS C/NN decreases/NNS only/RB the/DT lobar/JJ bronchial/JJ blood/NN flow/NN and/CC does/VBP not/RB influence/VB blood/NN flow/NN to/IN other/DT nearby/JJ tissues/NNS including/JJ those/DT vascularized/JJ by/IN the/DT bronchial/JJ circulation/NN ./.
@@21101489300 The/DT cloned/VBN HindIII/NEWGENE fragment/NEWGENE ,/, which/WDT was/VBD shown/VBP by/IN DNA/NN sequence/NN analysis/NN to/IN encode/VB the/DT N-terminal/NN half/NN of/IN the/DT B/NEWGENE ./NEWGENE subtilis/NEWGENE IF2/NEWGENE protein/NEWGENE and/CC 0/CD ./CD 2/CD kb/NN of/IN upstream/RB flanking/JJ sequence/NN ,/, was/VBD utilized/VBN as/IN a/DT homologous/JJ probe/NN to/IN clone/NN an/DT overlapping/JJ 2/NEWGENE ./NEWGENE 76-kb/NEWGENE ClaI/NEWGENE chromosomal/NEWGENE fragment/NEWGENE containing/JJ the/DT entire/NEWGENE IF2/NEWGENE structural/NEWGENE gene/NEWGENE ./.
@@7607669599 The/DT 5'flanking/NN region/NN is/VBZ highly/RB GC/NN rich/JJ ,/, with/IN multiple/JJ CpG/JJ doublets/NNS ,/, and/CC contains/VBZ multiple/JJ binding/JJ sites/NNS for/IN Sp1/NEWGENE ./.
@@1158977972 HTLV-1/NN decreases/NNS Th2/NN type/NN of/IN immune/JJ response/NN in/IN patients/NNS with/IN strongyloidiasis/NN ./.
@@75455107466 The/DT gene/NN product/NN of/IN cotS/NEWGENE was/VBD confirmed/VBN to/IN be/VB identical/JJ to/IN Cot40-2/NEWGENE by/IN SDS-PAGE/NN and/CC immunoblotting/VBG from/IN Escherichia/NN coli/RB transformed/VBD with/IN a/DT plasmid/NN containing/JJ the/DT cotS/NEWGENE region/NEWGENE ./.
@@83835262380 All/DT four/CD of/IN the/DT genes/NNS have/NN a/DT similar/JJ structure/NN ,/, with/IN the/DT receptor/NN protein/NN encoded/VBN in/IN a/DT single/JJ exon/NN ./.
@@10853778662 During/IN surgery/NN bone/NN cysts/NNS were/VBD excised/VBN and/CC filled/VBN by/IN bone/NN grafts/NNS ./.
@@75221635273 Presentation/NN of/IN a/DT horse/NEWGENE cytochrome/NEWGENE c/NEWGENE peptide/NEWGENE by/IN multiple/JJ H-2b/NEWGENE class/NEWGENE I/NEWGENE major/NEWGENE histocompatibility/NEWGENE complex/NEWGENE (/( MHC/NEWGENE )/SYM molecules/NNS to/IN C57BL/NNP //NNP 6-/NNP and/CC bm1-derived/NN cytotoxic/NN T/NN lymphocytes/NNS :/: presence/NN of/IN a/DT single/NN MHC/NEWGENE anchor/NEWGENE residue/NEWGENE may/MD confer/VB efficient/JJ peptide-specific/NN CTL/NN recognition/NN ./.
@@82271299294 The/DT major/JJ myosin-binding/NEWGENE domain/NEWGENE of/IN skeletal/NEWGENE muscle/NEWGENE MyBP-C/NEWGENE (/( C/NEWGENE protein/NEWGENE )/SYM resides/VBZ in/IN the/DT COOH-terminal/NN ,/, immunoglobulin/NEWGENE C2/NEWGENE1 motif/NEWGENE1 ./.
@@114726962441 The/DT differences/NNS in/IN the/DT CPIgG/NEWGENE ,/, CRP/NEWGENE ,/, and/CC fibrinogen/NEWGENE levels/NNS in/IN patients/NNS who/WP were/VBD diagnosed/VBN with/IN ACS/NN versus/IN those/DT who/WP were/VBD not/RB (/( non-ACS/JJ )/SYM were/VBD evaluated/VBN ./.
@@86682031841 FTF/NEWGENE is/VBZ also/RB abundantly/RB expressed/VBN in/IN the/DT pancreas/NN and/CC may/MD exert/VB differentiation/NN functions/NNS in/IN endodermal/JJ sublineages/NNS ,/, similar/JJ to/IN SF-1/NEWGENE in/IN steroidogenic/JJ tissues/NNS ./.
@@109584569088 The/DT 2/CD cDNAs/NNS differed/VBN in/IN the/DT length/NN of/IN their/PRP respective/JJ 3'/CD untranslated/JJ regions/NNS ,/, of/IN 577/CD bp/NN in/IN Cp/NEWGENE ./NEWGENE F6/NEWGENE and/CC 72/CD bp/NN in/IN Cp/NEWGENE ./NEWGENE F10/NEWGENE ,/, in/IN both/DT of/IN which/WDT a/DT putative/JJ polyadenylation/NN signal/NN was/VBD identified/VBN ./.
@@60740935893 Iron/NNP and/CC folate/NN deficiency/NN in/IN pregnancy/NN ./.
@@92759909233 In/NN the/DT first/JJ part/NN of/IN our/PRP study/NN ,/, the/DT highest/JJS mutagenicity/NN was/VBD revealed/VBN by/IN TA98/NN strain/NN without/IN enzymatic/JJ activation/NN ,/, suggesting/VBG a/DT direct-acting/JJ mutagenicity/NN prevalence/NN in/IN diesel/NN particulate/JJ ./.
@@30613014350 However/RB ,/, excretion/NN of/IN 6-keto-prostaglandin/NN F1/NN alpha/NN was/VBD further/RB reduced/VBN in/IN the/DT smokers/NNS who/WP used/VBD oral/JJ contraceptives/NNS (/( 133/CD +/NN //NN -/NN 20/CD to/IN 86/CD +/NN //NN -/NN 9/CD ng/NN //NN gm/NN of/IN creatinine/NN ,/, p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@32532193943 R-wave/NNS voltage/NN in/IN the/DT right/JJ precordial/JJ leads/VBP in/IN anthracycline/NN cardiomyopathy/NN :/: a/DT clinical/JJ study/NN ./.
@@80564741785 A/DT single/NN NMSC/NN was/VBD present/VB in/IN 69/CD ./CD 4%/CD ,/, two/JJ in/IN 16%/JJ ,/, three/CD in/IN 6/CD ./CD 4%/CD ,/, four/CD in/IN 3/CD ./CD 5%/CD ,/, five/CD to/IN nine/CD in/IN 4/CD ./CD 2%/CD ,/, and/CC 0/CD ./CD 5%/CD had/VBP ten/CD or/CC more/RB ./.
@@17401215237 To/TO overcome/VB this/DT problem/NN ,/, we/PRP have/VBP overexpressed/VBN Kex2p/NEWGENE using/VBG the/DT baculovirus/NN //NN insect/NN cell/NN expression/NN system/NN ./.
@@76264695021 Basal/JJ promoter/NN activity/NN is/VBZ enhanced/VBN by/IN a/DT functional/JJ M1/NEWGENE domain/NEWGENE in/IN LHR-expressing/JJ mouse/NN Leydig/NN tumor/NN cells/NNS (/( MLTC/NNS )/SYM but/CC not/RB in/IN non-expressing/JJ CHO/NN cells/NNS ./.
@@100987444235 In/NN contrast/NN ,/, no/DT change/NN was/VBD detected/VBN in/IN the/DT phenotype/NN of/IN 'unstressed'/JJ clones/NNS ,/, with/IN respect/NN to/IN any/DT of/IN the/DT following/NN parameters/NNS :/: proliferation/NN rate/NN in/IN monolayer/JJ ,/, serum-dependence/JJ for/IN proliferation/NN or/CC survival/NN ,/, tumorigenicity/NN ,/, cellular/JJ morphology/NN ,/, or/CC tissue-specific/NN differentiation/NN markers/NN ./.
@@71737296993 In/NN vitro/FW penetration/NN tests/NNS of/IN human/JJ sperm/NN into/IN cervical/JJ mucus/NN were/VBD introduced/VBN in/IN order/NN to/IN study/NN the/DT interaction/NN between/IN sperm/NN and/CC cervical/JJ mucus/NN ./.
@@29763329125 The/DT concentration/NN of/IN PGI2/NN on/IN the/DT newly-formed/JJ luminal/JJ surface/NN remained/VBD low/JJ ./.
@@116768991522 The/DT most/RB important/JJ risk/NN factors/NNS are/VBP :/: 1/NN )/NN genetic/JJ ;/: 2/NN )/NN Epstein-Barr/NNP virus/NN (/( infectious/JJ mononucleosis/NN )/SYM ;/: 3/NN )/NN congenital/JJ and/CC acquired/VBN immunodeficiency/NN ;/: 4/NN )/NN occupational/JJ exposure/NN (/( the/DT wood/JJ industry/NN )/SYM ./.
@@67490726515 Urinary/NNP urate/NN excretion/NN ,/, urate/NN clearance/NN ,/, and/CC fractional/JJ excretion/NN of/IN urate/NN all/DT increased/VBN significantly/RB during/IN water/NN immersion/NN ,/, and/CC decreased/VBD in/IN the/DT hour/NN following/IN water/NN immersion/NN ./.
@@36725324334 Statistically/RB significant/JJ effects/NNS were/VBD noted/VBN at/IN doses/NNS which/WDT did/VBD not/RB appear/VB to/IN be/VB maternally/RB toxic/JJ ./.
@@96494385913 Recently/RB ,/, a/DT human/NEWGENE transcription/NEWGENE elongation/NEWGENE factor/NEWGENE P-TEFb/NEWGENE ,/, consisting/VBG of/IN CDK9/NEWGENE kinase/NEWGENE ,/, cyclin/NEWGENE T/NEWGENE and/CC other/DT associated/VBN factors/NNS ,/, has/VBZ been/VBN shown/VBP to/IN interact/VB with/IN Tat/NEWGENE to/IN restore/VB Tat/NEWGENE activation/NN in/IN HeLa/DT nuclear/JJ extract/NN depleted/VBN of/IN P-TEFb/NEWGENE ./.
@@87279921314 Following/VBG the/DT injection/NN of/IN PGF2/NEWGENE alpha/NEWGENE ,/, heifers/NNS were/VBD observed/VBN visually/RB for/IN signs/NNS of/IN estrus/NN at/IN 0730/CD and/CC 1630/CD (/( 45/CD min/NN each/DT )/SYM ./.
@@10858988667 ECP/NEWGENE and/CC tryptase/NEWGENE levels/NNS in/IN serum/NN were/VBD measured/VBN before/IN and/CC after/IN the/DT last/JJ oral/JJ challenge/NN ./.
@@37593309947 The/DT combination/NN of/IN F1/NN and/CC F2/NN which/WDT was/VBD the/DT best/JJS predictor/NN of/IN CHD/NN in/IN this/DT population/NN (/( G1/NN )/SYM might/MD be/VB interpreted/VBN as/IN reflecting/VBG trunk/NN adiposity/NN mainly/RB abdominal/JJ ./.
@@115520583468 Other/JJ therapies/NNS are/VBP also/RB available/JJ ,/, including/JJ hypertonic/JJ saline/JJ solution/NN ,/, THAM/NN (/( Tris-hydroxy-methyl-aminomethane/CHEM )/SYM buffer/NN ,/, and/CC high-dose/JJ barbiturates/NNS ./.
@@95724289615 Mean+/NNP //NNP -SD/NNP serum/NEWGENE VEGF/NEWGENE concentrations/NNS were/VBD significantly/RB higher/JJ (/( P/NN </SYM 0/CD ./CD 001/CD )/SYM in/IN women/NNS with/IN PCO/NN and/CC PCOS/NN (/( 3/CD ./CD 4+/CD //CD -0/CD ./CD 7/CD and/CC 3/CD ./CD 2+/CD //CD -0/CD ./CD 66/CD ng/NN //NN ml/NN respectively/RB )/SYM compared/VBN with/IN women/NNS with/IN normal/JJ ovaries/NNS (/( 2/CD ./CD 3+/CD //CD -0/CD ./CD 5/CD ng/NN //NN ml/NN )/SYM ./.
@@15067052390 During/IN V-A/NN bypass/NN ,/, hemodynamics/NN were/VBD stable/JJ ./.
@@95855401441 However/RB ,/, a/DT zinc-depleted/JJ enzyme/NN was/VBD obtained/VBN after/IN prolonged/JJ dialysis/NN against/IN the/DT specific/JJ chelating/JJ agent/NN 1/NN ,/NN 10-phenanthroline/NN ./.
@@27671663468 This/DT indicates/VBZ that/DT lipid/NN peroxidation/NN may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN senile/JJ cataract/NN and/CC ,/, as/IN a/DT direct/JJ consequence/NN of/IN retinal/JJ damage/NN ,/, also/RB in/IN the/DT pathogenesis/NN of/IN cataract/NN in/IN diabetes/NN and/CC in/IN severe/JJ myopia/NN ./.
@@26854613353 Major/NNP clinical/JJ symptoms/NNS of/IN the/DT disease/NN were/VBD defined/VBN in/IN this/DT group/NN of/IN patients/NNS ./.
@@36106744278 The/DT effect/NN of/IN dietary/JJ zinc/NN deficiency/NN on/IN the/DT mossy/JJ fiber/NN zinc/NN content/NN of/IN the/DT rat/NN hippocampus/NN ./.
@@104007124166 To/TO investigate/VB the/DT functions/NNS of/IN GE/JJ ,/, IG/NNP ,/, and/CC GS/NN sequences/NN in/IN transcription/NN ,/, we/PRP constructed/VBD plasmids/NNS containing/NN cDNAs/NN of/IN the/DT full-length/JJ SV5/NN genome/NN in/IN which/WDT the/DT gene/NN junction/NN sequences/NNS (/( GE/JJ ,/, IG/NNP ,/, and/CC GS/NN sequences/NN )/SYM located/VBN between/IN the/DT hemagglutinin-neuraminidase/NEWGENE (/( HN/NEWGENE )/SYM and/CC the/DT polymerase/NEWGENE (/NEWGENE L/NEWGENE )/NEWGENE genes/NEWGENE were/VBD replaced/VBN with/IN the/DT counterpart/NN sequences/NNS from/IN other/DT gene/NN junctions/NNS ./.
@@84452998405 Effect/NN of/IN tracheal/JJ insufflation/NN of/IN deferoxamine/NN on/IN acute/JJ ozone/NN toxicity/NN in/IN rats/NNS ./.
@@105185025718 nos-1/NEWGENE and/CC nos-2/NEWGENE ,/, two/JJ genes/NNS related/VBN to/IN Drosophila/NEWGENE nanos/NEWGENE ,/, regulate/VB primordial/JJ germ/NN cell/NN development/NN and/CC survival/NN in/IN Caenorhabditis/NNP elegans/NNS ./.
@@19859245144 The/DT addition/NN of/IN an/DT equimolar/JJ complex/NN of/IN the/DT fourth/NN and/CC seventh/JJ largest/JJS subunits/NNS ,/, purified/VBN from/IN pol/NEWGENE II/NEWGENE holoenzyme/NEWGENE by/IN ion-exchange/NN chromatography/NN in/IN the/DT presence/NN of/IN urea/NN ,/, restored/VBN promoter-directed/JJ initiation/NN activity/NN to/IN pol/NEWGENE II/NEWGENE delta/NEWGENE 4/NEWGENE //NEWGENE 7/NEWGENE ./.
@@111609025488 We/PRP propose/VBP that/WDT TFOs/NN represent/VB a/DT therapeutic/JJ potential/NN to/IN specifically/RB diminish/VB the/DT expression/NN of/IN c-sis/NEWGENE //NEWGENE PDGF-B/NEWGENE proto-oncogene/NEWGENE in/IN various/JJ pathologic/JJ settings/NNS where/CC constitutive/JJ expression/NN of/IN this/DT gene/NN has/VBZ been/VBN observed/VBN ./.
@@84132392707 We/PRP found/VBP that/IN the/DT 3'-end-adjacent/JJ sequence/NN CA/NN (/( N/JJ )/NN 3-10AGTNNAA/NN ,/, conserved/VBN in/IN plant/NN Pol/NEWGENE II-specific/NEWGENE U/NEWGENE snRNA/NEWGENE genes/NEWGENE ,/, is/VBZ essential/JJ for/IN the/DT 3'-end/CD formation/NN of/IN U2/NEWGENE transcripts/NEWGENE and/CC ,/, similar/JJ to/IN the/DT vertebrate/JJ 3'/CD box/NN ,/, is/VBZ highly/RB tolerant/JJ to/IN mutation/NN ./.
@@109325273513 The/DT effectiveness/NN of/IN the/DT haemodialysate/NN Solcoseryl/NN for/IN second-intention/JJ wound/JJ healing/NN in/IN horses/NNS and/CC ponies/NNS ./.
@@39155408427 In/NN addition/NN ,/, the/DT gcd1-101/NEWGENE mutation/NEWGENE suppressed/VBD the/DT low/JJ translational/JJ efficiency/NN of/IN GCN4-lacZ/NEWGENE mRNA/NEWGENE observed/VBN in/IN gcn2-/NEWGENE and/CC gcn3-/NEWGENE cells/NNS ./.
@@76018284566 In/NN this/DT report/NN ,/, we/PRP describe/VBP the/DT characterization/NN of/IN two/JJ early/NN class/NEWGENE II/NEWGENE flagellar/NEWGENE genes/NEWGENE contained/VBN in/IN the/DT orfX-fliP/NEWGENE locus/NEWGENE ./.
@@6795900405 The/DT effect/NN of/IN the/DT fatty/NEWGENE acid/NEWGENE cyclo-oxygenase/NEWGENE inhibitor/NN indomethacin/NN on/IN cerebral/JJ blood/NN flow/NN (/( CBF/NN )/SYM and/CC the/DT metabolic/JJ rate/NN for/IN oxygen/NN (/( CMRO2/NN )/SYM was/VBD studied/VBN in/IN paralyzed/JJ and/CC artificially/RB ventilated/VBN rats/NNS ./.
@@10502434333 From/IN February/NN 1991/CD to/IN August/NN 1997/CD ,/, 124/CD patients/NNS with/IN endometrial/JJ carcinoma/NN were/VBD treated/VBN postoperatively/RB with/IN high-dose-rate/JJ vaginal/JJ vault/NN brachytherapy/NN as/IN the/DT only/RB adjuvant/JJ treatment/NN ./.
@@7558697449 Contingency/NNS contracting/JJ between/IN clients/NNS and/CC their/PRP parents/NNS //NNS caregivers/NNS was/VBD used/VBN to/IN specify/VB consequences/NNS for/IN daily/JJ self-monitoring/NN ,/, reduced/VBN caloric/JJ intake/NN ,/, weight/NN loss/NN ,/, and/CC exercise/NN ./.
@@96127755496 The/DT ParaSight-F/NN test/NN alone/RB was/VBD used/VBN to/IN monitor/NN serum/JJ antigen/NN levels/NNS after/IN treatment/NN in/IN 24/CD patients/NNS ./.
@@105422819341 The/DT expressed/VBN G1-G2/NEWGENE bound/JJ to/IN both/DT hyaluronan/NN and/CC link/NEWGENE protein/NEWGENE indicating/VBG that/IN the/DT immunoglobulin-fold/NEWGENE motif/NEWGENE and/CC proteoglycan/NN tandem/NN repeat/NN loops/NNS of/IN the/DT G1/NEWGENE domain/NEWGENE were/VBD correctly/RB folded/JJ ./.
@@108371261218 Among/IN genes/NNS induced/VBN by/IN added/JJ pMesogenin1/NEWGENE is/VBZ Xwnt-8/NEWGENE ,/, a/DT signaling/NN factor/NN that/WDT induces/VBZ a/DT similar/JJ repertoire/NN of/IN marker/NN genes/NNS and/CC a/DT similar/JJ cellular/JJ phenotype/NN ./.
@@86768586189 A/DT phylogenetic/JJ tree/NN of/IN members/NNS of/IN the/DT T2/NEWGENE //NEWGENE S-RNase/NEWGENE superfamily/NEWGENE in/IN plants/NNS was/VBD obtained/VBN ./.
@@78005056694 Characterization/NNS of/IN the/DT promoter/NN for/IN the/DT human/NEWGENE 85/NEWGENE kDa/NEWGENE cytosolic/NEWGENE phospholipase/NEWGENE A2/NEWGENE gene/NEWGENE ./.
@@92546785186 Gtx/NEWGENE mRNA/NEWGENE accumulates/VBZ in/IN parallel/JJ with/IN the/DT RNAs/NNS encoding/VBG the/DT major/JJ structural/JJ proteins/NNS of/IN myelin/NN ,/, myelin/NEWGENE basic/NEWGENE protein/NEWGENE (/( MBP/NEWGENE )/SYM ,/, and/CC proteolipid/NEWGENE protein/NEWGENE (/( PLP/NEWGENE )/SYM during/IN postnatal/JJ brain/NN development/NN ;/: Gtx/NEWGENE mRNA/NEWGENE decreases/NNS in/IN parallel/JJ with/IN MBP/NEWGENE and/CC PLP/NEWGENE mRNAs/NEWGENE in/IN the/DT brains/NNS of/IN myelin-deficient/JJ rats/NNS ,/, which/WDT have/VBP a/DT point/NN mutation/NN in/IN the/DT PLP/NEWGENE gene/NEWGENE ./.
@@3033283515 Two/CD separate/JJ NF1-binding/NEWGENE loci/NEWGENE were/VBD also/RB found/VB in/IN the/DT equivalent/JJ IE68/NEWGENE gene/NEWGENE of/IN HCMV/NN (/NN Towne/NN )/NN DNA/NN ,/, but/CC in/IN this/DT case/NN the/DT DNA/NN sequence/NN and/CC competition/NN filter/NN binding/JJ experiments/NNS indicated/VBD a/DT maximum/NN of/IN only/RB four/CD to/IN five/CD consensus/NN binding/JJ sites/NNS encompassing/VBG the/DT promoter-enhancer/NN region/NN ./.
@@96401622884 The/DT second/JJ patient/NN had/VBP received/VBN pituitary-derived/NEWGENE growth/NEWGENE hormone/NEWGENE for/IN treatment/NN of/IN growth/NEWGENE hormone/NEWGENE deficiency/NN ,/, secondary/JJ to/IN a/DT third/JJ ventricle/NN teratoma/NN ,/, exised/VBN 13/CD yr/NN earlier/JJR ./.
@@118974494244 The/DT shift/NN in/IN the/DT earliest/JJS activation/NN site/NN after/IN administration/NN of/IN esmolol/NN was/VBD compared/VBN with/IN the/DT shift/NN after/IN RFA/NNP ./NNP The/NNP heart/NN rate/NN at/IN rest/NN and/CC in/IN drug-free/JJ state/NN ranged/VBN between/IN 95/CD and/CC 125/CD beats/NN //NN min/NN (/( mean/JJ 99/CD +/NN //NN -/NN 14/CD beats/NN //NN min/NN )/SYM ./.
@@67638972620 The/DT hypertension/NN with/IN elevated/VBN PRA/NN ,/, however/RB ,/, was/VBD resistant/JJ to/IN the/DT angiotensin/NEWGENE II/NEWGENE (/( AII/NEWGENE )/SYM analog/NN [/NN Sar1/NN ,/, Ile8/NN ]/NN ALL/NN ./.
@@20387842652 Eight/CD patients/NNS with/IN ARC/NNS and/CC renal/JJ failure/NN were/VBD recently/RB evaluated/VBN ./.
@@89430325268 The/DT Escherichia/NEWGENE coli/NEWGENE tet-repressor/NEWGENE (/( TetR/NEWGENE )/SYM operator/NN system/NN was/VBD used/VBN to/IN develop/VB a/DT variation/NN of/IN the/DT yeast/NN two-hybrid/JJ assay/NN in/IN which/WDT disruptions/NNS of/IN protein-protein/JJ interactions/NNS can/MD be/VB identified/VBN by/IN a/DT positive/JJ selection/NN ./.
@@81128709748 Western/JJ blotting/NN (/( immunoblotting/VBG )/SYM with/IN an/DT antiserum/NN to/IN a/DT partial/JJ SOD/NEWGENE expressed/VBN in/IN Escherichia/NN coli/RB revealed/VBD two/JJ proteins/NNS with/IN estimated/VBN molecular/JJ masses/NNS of/IN 19/CD and/CC 29/CD kDa/NN ./.
@@29814579383 D/NN ./NN
@@19420331691 Determination/NNS of/IN an/DT RNA/NN structure/NN involved/VBN in/IN splicing/JJ inhibition/NN of/IN a/DT muscle-specific/JJ exon/NN ./.
@@6966806746 The/DT authors/NNS report/NN the/DT clinicopathologic/JJ findings/NNS in/IN four/CD cases/NNS of/IN adult/JJ women/NNS with/IN rhabdomyosarcomas/NNS that/WDT originated/VBD in/IN the/DT endometrium/NN or/CC cervix/NN ,/, or/CC both/DT ./.
@@21822408224 A/DT total/NN of/IN 112/CD patients/NNS received/VBD anistreplase/NN and/CC 119/CD received/VBN heparin/NN within/IN a/DT mean/JJ period/NN of/IN 188/CD +/NN //NN -/NN 62/CD min/NN following/IN the/DT onset/NN of/IN symptoms/NNS ./.
@@89868125381 Unlike/IN wild-type/NEWGENE p53/NEWGENE ,/, the/DT delta/NEWGENE proAE/NEWGENE mutant/NEWGENE cDNA/NEWGENE can/MD be/VB stably/RB expressed/VBN in/IN tumor/NN derived/VBD cell/NN lines/NNS with/IN few/JJ immediate/JJ detrimental/JJ effects/NNS ./.
@@88256367295 The/DT complete/JJ exon-intron/JJ structure/NN of/IN the/DT 156-kb/NEWGENE human/NEWGENE gene/NEWGENE NFKB1/NEWGENE ,/, which/WDT encodes/VBZ the/DT p105/NEWGENE and/CC p50/NEWGENE proteins/NEWGENE of/IN transcription/NN factors/NN NF-kappa/NEWGENE B/NEWGENE and/CC I/NEWGENE kappa/NEWGENE B-gamma/NEWGENE :/: implications/NNS for/IN NF-kappa/NNP B-mediated/JJ signal/JJ transduction/NN ./.
@@31951673892 The/DT platelet/NN adhesion/NN rate/NN on/IN these/DT layers/NNS were/VBD tested/VBN concerning/VBG the/DT valuation/NN of/IN the/DT haemocompatibility/NN of/IN the/DT basic-polymers/NNS polyurethane/NN (/( PUR/NN )/SYM ,/, polyvinylchloride/NN (/( PVC/NN )/SYM ,/, and/CC polystyrene/NN (/( PS/NN )/SYM in/IN two/JJ different/JJ worked/VBN test/NN chambers/NNS ./.
@@114116231275 Influence/NNS of/IN compression/NN therapy/NN on/IN symptoms/NNS following/IN soft/JJ tissue/NN injury/NN from/IN maximal/JJ eccentric/JJ exercise/NN ./.
@@20330622264 To/TO test/VB promotor/NN function/NN ,/, chimeric/JJ genes/NNS were/VBD constructed/VBN linking/NN fragments/NN of/IN chicken/NN IGF-I/NEWGENE 5'-flanking/JJ DNA/NN to/IN a/DT promoterless/JJ reporter/NN plasmid/NN ./.
@@113366986356 Here/RB ,/, we/PRP identify/VBP Rsc3/NEWGENE and/CC Rsc30/NEWGENE as/IN novel/JJ components/NNS of/IN the/DT essential/JJ yeast/NEWGENE remodeler/NEWGENE RSC/NEWGENE complex/NEWGENE ./.
@@108538508061 Urinary/NN LTE4/NN increased/VBN after/IN both/DT challenges/VBZ the/DT rise/NN being/NN higher/JJ following/IN oral/JJ as/IN compared/VBN to/IN inhalation/NN provocation/NN (/( p/CD =/CD 0/CD ./CD 0001/CD )/SYM ./.
@@28162513516 The/DT subepicardial/JJ lymphatic/JJ capillaries/NNS were/VBD ramified/JJ and/CC anastomosed/VBN with/IN each/DT other/DT to/IN form/NN a/DT relatively/JJ dense/JJ network/NN which/WDT extended/VBD over/RB the/DT entire/JJ surface/NN of/IN both/DT ventricles/NNS ./.
@@99900578007 Recombination/NNS and/CC transcription/NN of/IN the/DT endogenous/NEWGENE Ig/NEWGENE heavy/NEWGENE chain/NEWGENE locus/NEWGENE is/VBZ effected/VBN by/IN the/DT Ig/NEWGENE heavy/NEWGENE chain/NEWGENE intronic/NEWGENE enhancer/NEWGENE core/NEWGENE region/NEWGENE in/IN the/DT absence/NN of/IN the/DT matrix/NN attachment/NN regions/NNS ./.
@@17533177894 These/DT results/NNS strongly/RB suggest/VBP that/IN locally-applied/JJ TTC/NN in/IN combination/NN with/IN FDBA/NN enhances/VBZ new/JJ bone/NN formation/NN in/IN experimental/JJ alveolar/JJ bone/NN defects/NNS ./.
@@75003869503 To/TO confirm/VB the/DT GapIII/NEWGENE protein/NEWGENE activity/NN ,/, constructs/NNS containing/JJ different/JJ GapIII-GRD/NEWGENE domains/NEWGENE were/VBD transformed/VBN into/IN iral/JJ mutant/JJ yeast/NN to/IN determine/VB their/PRP relative/JJ ability/NN to/IN replace/VB IRA1/NEWGENE functionally/RB ./.
@@27768239312 The/DT clinical/JJ tolerance/NN and/CC pharmacokinetics/NN of/IN FCE/NNS 22101/CD (/( sodium/NN (/( 5R/NN ,/, 6S/NN )/NN -6-/NN [/NN (/NN 1R/NN )/NN -hydroxyethyl/NN ]/NN -2-carbamoyloxymethyl-2-penem-3-carboxylate/NN )/NN ,/, a/DT new/JJ penem/NN antibiotic/JJ ,/, have/VB been/VBN studied/VBN after/IN giving/JJ a/DT single/NN i/NN ./NN v/NN ./. dose/NN of/IN 4/CD mg/CD ./CD kg-1/CD to/IN ten/CD healthy/JJ male/JJ volunteers/NNS ./.
@@95942999550 RESULTS/NNS :/: Acetabular/JJ index/NN returned/VBN to/IN normal/JJ gradually/RB as/IN the/DT time/NN went/VBN by/IN and/CC significantly/RB within/IN one/PRP year/NN after/IN the/DT reduction/NN of/IN developmental/JJ dislocation/NN of/IN the/DT hip/NN ./.
@@83865922344 Growth/NEWGENE factor/NEWGENE stimulation/NN rapidly/RB induces/VBZ a/DT reversible/JJ change/NN in/IN the/DT electrophoretic/JJ mobility/NN of/IN the/DT ternary/JJ complex/NN ,/, accompanied/VBN by/IN increased/JJ phosphorylation/NN of/IN the/DT Elk-1/NEWGENE C-terminal/NEWGENE region/NEWGENE and/CC by/IN the/DT activation/NN of/IN a/DT 42/NEWGENE kd/NEWGENE cellular/NEWGENE Elk-1/NEWGENE kinase/NEWGENE ./.
@@8300527774 Inhibition/NNS of/IN erythromycin/NN synthesis/NN by/IN disruption/NN of/IN malonyl-coenzyme/NEWGENE A/NEWGENE decarboxylase/NEWGENE gene/NEWGENE eryM/NEWGENE1 in/IN Saccharopolyspora/NN erythraea/NN ./.
@@77075316810 This/DT experimental/JJ design/NN was/VBD used/VBN to/IN determine/VB the/DT effect/NN of/IN displacement/NN of/IN the/DT alpha/NEWGENE 4-2/NEWGENE binding/NEWGENE site/NEWGENE on/IN the/DT repression/NN of/IN alpha/NEWGENE 4/NEWGENE gene/NEWGENE transcription/NN by/IN ICP4/NEWGENE ./.
@@37692244439 We/PRP analyzed/VBD data/NN from/IN 56/CD patients/NNS with/IN Systemic/JJ Lupus/NNP Erythematosus/NNP (/( SLE/NN )/SYM in/IN whom/WP renal/JJ biopsies/NNS were/VBD done/VBP systematically/RB ./.
@@101903241343 We/PRP have/VBP screened/VBN the/DT elastin/NEWGENE gene/NEWGENE for/IN mutations/NNS responsible/JJ for/IN supravalvular/JJ aortic/JJ stenosis/NN (/( SVAS/NNP )/SYM in/IN two/JJ large/JJ ,/, independently/RB collected/VBN families/NNS with/IN isolated/VBN (/( nonsyndromic/JJ )/SYM SVAS/NNP ./.
@@10872756440 In/NNP NASCIS/NN III/NN ,/, a/DT randomization/NN imbalance/NN occurred/VBN that/WDT allocated/VBD a/DT disproportionate/JJ number/NN of/IN patients/NNS with/IN no/DT motor/JJ deficit/NN (/( and/CC therefore/RB no/DT chance/NN for/IN recovery/NN )/SYM to/IN the/DT lower/JJR dose/NN control/NN group/NN ./.
@@107352723745 Southern/NNP blotting/NN and/CC single/JJ strand/NN conformation/NN polymorphism/NN analyses/NNS did/VBD not/RB show/VB tumor-specific/JJ alterations/NNS of/IN this/DT gene/NN in/IN gliomas/NNS and/CC RT-PCR/NN studies/NNS showed/VBD expression/NN in/IN glioma/NN cell/NN lines/NNS ,/, suggesting/VBG that/DT ANOVA/NEWGENE is/VBZ not/RB the/DT chromosome/NN 19q/NN glioma/NN tumor/NN suppressor/NN gene/NN ./.
@@105254133896 The/DT backbone/NN dynamics/NNS of/IN residues/NNS located/VBN in/IN the/DT folded/JJ part/NN of/IN CRP2/NEWGENE (/NEWGENE LIM2/NEWGENE )/NEWGENE R122A/NEWGENE have/NN been/VBN characterized/VBN by/IN proton-detected/NN (/NN 15/NN )/NN N/NN NMR/NN spectroscopy/NN ./.
@@99311919922 In/NN protocol/NN 2/CD ,/, eight/CD different/JJ subjects/NNS performed/VBD Con/NN and/CC Ecc/NNP arm/NN curls/NNS to/IN fatigue/NN ,/, followed/VBN by/IN postexercise/JJ muscle/NN ischemia/NN ,/, by/IN using/VBG the/DT same/JJ resistance/NN as/IN in/IN protocol/NN 1/CD ./CD
@@112468874044 This/DT study/NN examined/VBD the/DT role/NN of/IN cholesteryl/NN ester/NN transfer/NN (/( CET/NN )/SYM ,/, cholesteryl/NEWGENE ester/NEWGENE transfer/NEWGENE protein/NEWGENE (/( CETP/NEWGENE )/SYM activity/NN ,/, and/CC phospholipid/NEWGENE transfer/NEWGENE protein/NEWGENE (/( PLTP/NEWGENE )/SYM activity/NN in/IN the/DT increased/VBN prevalence/NN of/IN coronary/JJ artery/NN calcification/NN (/( CAC/NNP )/SYM in/IN diabetic/JJ subjects/NNS compared/VBN with/IN nondiabetic/JJ subjects/NNS and/CC in/IN the/DT loss/NN of/IN the/DT sex/NN difference/NN in/IN CAC/NNP in/IN diabetes/NN ./.
@@104551833122 Collectively/RB ,/, these/DT results/NNS show/NN that/IN the/DT differential/JJ utilization/NN of/IN Staf/NEWGENE zinc/NEWGENE finger/NEWGENE 1/NEWGENE represents/VBZ a/DT new/JJ ,/, critical/JJ determinant/NN of/IN the/DT transcriptional/JJ activation/NN mechanism/NN for/IN the/DT Xenopus/NEWGENE tRNA/NEWGENE (/NEWGENE Sec/NEWGENE )/NEWGENE and/CC human/NEWGENE U6/NEWGENE snRNA/NEWGENE genes/NEWGENE ./.
@@86627897281 The/DT corresponding/JJ gene/NN was/VBD identified/VBN in/IN the/DT GenBankTM/NNP data/NN base/NN by/IN sequence/NN alignment/NN and/CC termed/JJ RPS30A/NEWGENE ./.
@@93982672628 Southern/NNP blot/NN analysis/NN of/IN endonuclease-digested/JJ genomic/JJ DNA/NN from/IN primary/JJ chick/NN embryo/NN fibroblasts/NNS (/( CEF/NNP )/SYM suggested/VBN that/IN MEK2/NEWGENE is/VBZ a/DT single-copy/JJ gene/NN in/IN this/DT vertebrate/JJ species/NN ./.
@@86319347727 The/DT members/NNS of/IN the/DT Myb/NEWGENE family/NEWGENE of/NEWGENE transcription/NEWGENE factors/NEWGENE are/VBP defined/VBN by/IN homology/NN in/IN the/DT DNA-binding/NN domain/NN ;/: all/DT bind/NN the/DT Myb-binding/NEWGENE site/NEWGENE (/( MBS/NEWGENE )/SYM sequence/NN (/( YG/NEWGENE (/NEWGENE A/NEWGENE //NEWGENE G/NEWGENE )/NEWGENE C/NEWGENE (/NEWGENE A/NEWGENE //NEWGENE C/NEWGENE //NEWGENE G/NEWGENE )/NEWGENE GTT/NEWGENE (/NEWGENE G/NEWGENE //NEWGENE A/NEWGENE )/NEWGENE )/NEWGENE ./.
@@79354725211 The/DT predominant/JJ binding/JJ activity/NN was/VBD not/RB Ets-1/NEWGENE but/CC rather/RB two/JJ independent/NN DNA-protein/NN complexes/NNS that/WDT comigrated/VBN in/IN mobility/NN shift/NN assays/NNS ./.
@@104545689037 (/( i/NN )/SYM Complete/NNP Grb10/NEWGENE expression/NN from/IN cDNA/NN with/IN an/DT ecdysone-regulated/JJ transient/JJ expression/NN system/NN stimulated/VBN PDGF-BB-/NNP ,/, IGF-I/NEWGENE ,/, and/CC insulin-/JJ but/CC not/RB epidermal/NEWGENE growth/NEWGENE factor/NEWGENE (/( EGF/NEWGENE )/NN -induced/NN DNA/NN synthesis/NN in/IN an/DT ecdysone/NN dose-responsive/JJ fashion/NN ./.
@@28436949639 Chronic/NN E-B/NN virus/NN infection/NN terminated/VBN in/IN malignant/JJ lymphoma/NN :/: a/DT case/NN report/NN ./.
@@111954018618 High/NNP plasma/NEWGENE AVP/NEWGENE levels/NNS observed/VBN in/IN the/DT two/JJ cases/NNS suggest/VBP that/WDT SSRIs/WDT stimulate/VBP AVP/NEWGENE secretion/NN ,/, thereby/RB causing/JJ SIADH/NN ./.
@@9971822759 These/DT data/NN indicate/VB a/DT functional/JJ role/NN for/IN U1/NEWGENE in/IN NRS-mediated/JJ splicing/JJ inhibition/NN ./.
@@105749292546 Based/VBN on/IN subcellular/JJ fractionation/NN ,/, the/DT 47-kDa/NEWGENE P-CIP2/NEWGENE protein/NEWGENE is/VBZ mostly/RB cytosolic/JJ ./.
@@79379653291 Role/NN of/IN c-myc/NEWGENE in/IN simian/JJ virus/NN 40/CD large/JJ tumor/NN antigen-induced/NN DNA/NN synthesis/NN in/IN quiescent/JJ 3T3-L1/CD mouse/NN fibroblasts/NNS ./.
@@111973284807 Binding/NN of/IN cell/NN type-specific/NN nuclear/NN proteins/NN to/IN the/DT 5'-flanking/JJ region/NN of/IN maize/NEWGENE C4/NEWGENE phosphoenolpyruvate/NEWGENE carboxylase/NEWGENE gene/NEWGENE confers/VBZ its/PRP differential/JJ transcription/NN in/IN mesophyll/JJ cells/NNS ./.
@@33407264026 With/IN histology/NN and/CC Evans/NN blue/JJ injections/NNS ,/, blood-brain/JJ barrier/NN alterations/NNS were/VBD seen/VBP as/RB early/RB as/IN 4/CD days/NNS after/IN a/DT dose/NN of/IN 50/CD Gy/NNP ./NNP
@@74994015674 The/DT identity/NN between/IN hnRNPs/NEWGENE H/NEWGENE and/CC H'/NEWGENE is/VBZ 96%/CD ,/, between/IN H/NEWGENE and/CC F/NEWGENE 78%/JJ ,/, and/CC between/IN H'/NEWGENE and/CC F/NEWGENE 75%/JJ ,/, respectively/RB ./.
@@107995908027 Jkappa/NEWGENE DNA-binding/NEWGENE sites/NEWGENE were/VBD not/RB required/VBN for/IN this/DT activation/NN ,/, and/CC a/DT mutant/NEWGENE EBNA-3C/NEWGENE protein/NEWGENE unable/JJ to/IN bind/NN Jkappa/NEWGENE activated/VBN transcription/NN as/RB efficiently/RB as/IN wild-type/NEWGENE EBNA-3C/NEWGENE ,/, indicating/VBG that/IN EBNA-3C/NEWGENE can/MD regulate/VB transcription/NN through/RB a/DT mechanism/NN that/WDT is/VBZ independent/NN of/IN Jkappa/NEWGENE ./.
@@86305838740 As/IN pH/NN and/CC Hb/NEWGENE can/MD also/RB affect/VB mixed/JJ venous/JJ CO2/NN content/NN ,/, the/DT effect/NN on/IN Q/NN was/VBD also/RB assessed/VBN ./.
@@94070315136 Upon/IN UV/NN damage/NN ,/, Crb2/NEWGENE is/VBZ transiently/RB modified/JJ ,/, probably/RB phosphorylated/VBN ,/, with/IN a/DT similar/JJ timing/NN of/IN phosphorylation/NN in/IN Chk1/NEWGENE kinase/NEWGENE ,/, which/WDT is/VBZ reported/VBN to/IN restrain/VB Cdc2/NEWGENE activation/NN ./.
@@83659443409 CONCLUSION/IN :/: This/DT retrospective/JJ analysis/NN does/VBP not/RB confirm/VB the/DT efficacy/NN of/IN one/PRP course/NN of/IN simultaneous/JJ Mitomycin-C/NN and/CC 5-fluorouracil/NN ,/, at/IN least/RB in/IN association/NN with/IN full-dose/JJ radiotherapy/NN incorporating/JJ Iridium-192/NN boost/NN ./.
@@92388502336 Furthermore/RB ,/, ICER/NEWGENE negatively/RB autoregulates/VBZ the/DT alternative/JJ promoter/NN ,/, thus/RB generating/JJ a/DT feedback/NN loop/NN ./.
@@88625229692 Consistent/JJ with/IN this/DT similarity/NN ,/, the/DT cdc28-P8/NEWGENE mutant/NEWGENE accumulates/VBZ unspliced/JJ precursors/NNS at/IN the/DT restrictive/JJ temperature/NN ./.
@@91113093735 Cotransfection/NNS of/IN Ets-2/NEWGENE and/CC p44/NEWGENE mitogen-activated/NEWGENE1 protein/NEWGENE1 (/NEWGENE1 MAP/NEWGENE1 )/NEWGENE1 kinase/NEWGENE1 expression/NN vectors/NNS strongly/RB potentiated/VBN HB-EGF/NEWGENE promoter/NEWGENE activation/NN in/IN response/NN to/IN deltaRaf-1/NEWGENE :/NEWGENE ER/NEWGENE ./.
@@15882702180 A/DT reduction/NN in/IN blood/NN pressure/NN was/VBD only/RB observed/VBN at/IN the/DT end/NN of/IN the/DT study/NN ,/, from/IN 142/CD +/NN //NN -/NN 17/CD //CD 86/CD ./CD 6/CD +/NN //NN -/NN 9/CD ./CD 1/CD to/IN 139/CD +/NN //NN -/NN 13/CD //CD 82/CD ./CD 9/CD +/NN //NN -/NN 8/CD ./CD 9/CD mmHg/NN (/( P/NN less/PRP than/IN 0/CD ./CD 05/CD for/IN DBP/NN )/SYM ./.
@@10671606924 With/IN chemical/JJ shift/NN imaging/JJ ,/, the/DT signal/JJ intensity/NN decreased/VBN on/IN the/DT out-of-phase/JJ images/NNS in/IN six/CD of/IN seven/CD (/( 86%/JJ )/SYM patients/NNS with/IN APA/NN and/CC in/IN eight/CD of/IN nine/CD (/( 89%/CD )/SYM patients/NNS with/IN BAH/NN ./.
@@95416367640 Creatine/NEWGENE kinase/NEWGENE release/NN after/IN hepatic/JJ artery/NN embolization/NN in/IN patients/NNS with/IN carcinoid/NN tumors/NNS ./.
@@116877371536 BACKGROUND/IN :/: Ischemic/NNP heart/NN disease/NN is/VBZ the/DT primary/JJ cause/NN of/IN morbidity/NN and/CC mortality/NN among/IN diabetics/NNS ,/, especially/RB those/DT who/WP became/VBD ill/JJ at/IN a/DT young/JJ age/NN ./.
@@91650047150 SRE/NNS activity/NN is/VBZ dependent/JJ upon/IN the/DT activation/NN by/IN phosphorylation/NN of/IN a/DT ternary/JJ complex/NN factor/NN ;/: included/VBN among/IN the/DT ternary/JJ complex/NN factors/NNS is/VBZ Elk-1/NEWGENE ./.
@@107734553374 Significantly/RB ,/, two/JJ proximal/JJ GATA-1-binding/NEWGENE sites/NEWGENE (/( -118/JJ //JJ -113/JJ and/CC -98/CD //CD -93/CD )/SYM and/CC a/DT region/NN located/VBN within/IN -518/JJ to/IN -315bp/NN of/IN the/DT mouse/NEWGENE ALAS2/NEWGENE promoter/NEWGENE were/VBD essential/JJ for/IN transcriptional/JJ activation/NN during/IN chemically/RB induced/VBN differentiation/NN of/IN MEL/JJ cells/NNS ,/, implying/VBG their/PRP importance/NN in/IN conferring/JJ erythroid/JJ specificity/NN to/IN the/DT ALAS2/NEWGENE transcriptional/JJ activation/NN ./.
@@79267744681 The/DT p73pct1/NEWGENE //NEWGENE p85cdc10/NEWGENE complex/NEWGENE binds/VBZ both/DT in/NN vitro/FW and/CC in/IN vivo/NN to/IN MCB/NEWGENE but/CC not/RB SCB/NEWGENE or/CC E2F/NEWGENE sites/NEWGENE ./.
@@89199073010 Transient/JJ expression/NN of/IN VSF-1/NEWGENE in/IN protoplasts/NNS stimulated/VBN vs-1/NEWGENE dependent/JJ activation/NN of/IN the/DT -76/NEWGENE //NEWGENE grp1/NEWGENE ./NEWGENE 8/NEWGENE minimal/NEWGENE promoter/NEWGENE ./.
@@83767965742 To/TO analyze/VB the/DT VH/NEWGENE regions/NEWGENE of/IN polyreactive/JJ antibodies/NNS ,/, with/IN particular/JJ attention/NN at/IN their/PRP somatically/RB mutated/JJ status/NN ,/, we/PRP generated/VBD five/CD IgG/NEWGENE (/( three/CD IgG1/NEWGENE and/CC two/JJ IgG3/NEWGENE )/SYM mAb/NN (/( using/VBG B/NNP cells/NNS from/IN a/DT healthy/JJ subject/NN ,/, a/DT patient/NN with/IN insulin-dependent/JJ diabetes/NN mellitus/MD and/CC a/DT patient/NN with/IN SLE/NN )/SYM ,/, which/WDT bound/JJ with/IN various/JJ efficiencies/NNS a/DT number/NN of/IN different/JJ self/NN and/CC foreign/JJ Ag/NN ./NN
@@67851136554 Non-complement-dependent/NNP sperm-immobilizing/JJ activity/NN was/VBD also/RB detected/VBN in/IN the/DT cervical/JJ mucus/NN of/IN several/DT patients/NNS ./.
@@94260681208 The/DT c-myc/NEWGENE //NEWGENE TGF-alpha/NEWGENE HCCs/NN were/VBD also/RB characterized/VBN by/IN a/DT particularly/RB strong/JJ expression/NN of/IN TGF-alpha/NEWGENE and/CC very/RB low/JJ apoptotic/JJ index/NN in/IN contrast/NN to/IN high/JJ levels/NNS of/IN apoptosis/NN in/IN peritumorous/JJ tissues/NNS and/CC c-myc/NEWGENE HCCs/NN ./.
@@18648371217 The/DT primary/JJ structure/NN of/IN each/DT of/IN the/DT three/CD proteins/NNS has/VBZ about/RB 70%/CD homology/NN with/IN that/DT of/IN mouse/NEWGENE contrapsin/NEWGENE ,/, in/IN contrast/NN to/IN 43-46%/JJ homology/NN with/IN that/DT of/IN rat/NEWGENE alpha/NEWGENE 1-protease/NEWGENE inhibitor/NN ./.
@@38436764523 Linear/NNP extrapolation/NN is/VBZ used/VBN below/RB the/DT experimental/JJ data/NN range/NN to/IN establish/VB an/DT upper/JJ bound/NN on/IN carcinogenic/JJ risk/NN at/IN low/JJ doses/NNS ./.
@@10427654282 This/DT study/NN was/VBD performed/VBN to/IN assess/VB the/DT role/NN of/IN additional/JJ diagnostic/JJ laparoscopy/NN in/IN the/DT preoperative/JJ staging/NN of/IN patients/NNS with/IN adenocarcinoma/NN of/IN the/DT esophagus/NN ,/, gastric/JJ cancer/NN and/CC pancreatic/JJ cancer/NN prior/NN to/IN intended/VBN curative/JJ surgery/NN ./.
@@112218457692 Treatment/NNP of/IN N18TG-2/NNP cells/NNS with/IN a/DT demethylating/JJ agent/NN ,/, 5-aza-deoxycytidine/JJ ,/, resulted/VBN in/IN an/DT expression/NN of/IN mlt/NEWGENE 1/NEWGENE ,/, indicating/VBG that/IN the/DT repression/NN of/IN mlt/NEWGENE 1/NEWGENE is/VBZ attributable/JJ to/IN methylation/NN Thus/RB ,/, mlt/NEWGENE 1/NEWGENE is/VBZ a/DT novel/JJ target/NN gene/NN that/WDT is/VBZ silenced/VBN by/IN methylation/NN during/IN liver/NN tumorigenesis/NN initiated/VBN by/IN SV40/NEWGENE T/NEWGENE antigen/NEWGENE ./.
@@76895017624 Of/IN these/DT carriers/NNS 149/CD were/VBD diagnosed/VBN to/IN be/VB asymptomatic/JJ clinically/RB ,/, biochemically/RB and/CC echographically/RB ./.
@@10534691396 Animals/NNS were/VBD put/VBN to/IN death/NN 8/NN weeks/NNS later/JJR and/CC the/DT grafts/NNS were/VBD sterilely/RB explanted/VBN and/CC analyzed/VBN via/NN microbiologic/JJ culture/NN and/CC standard/JJ histologic/JJ procedures/NNS for/IN evidence/NN of/IN infection/NN ./.
@@15384018364 A/DT 13/CD base-pair/NN oligonucleotide/NN spanning/VBG nucleotides/NNS +80/CD to/IN +92/NN of/IN the/DT 5/NEWGENE S/NEWGENE RNA/NEWGENE gene/NEWGENE retained/VBD specific/JJ and/CC high-affinity/JJ binding/NN ,/, although/IN the/DT latter/NN was/VBD reduced/VBN sixfold/RB relative/JJ to/IN longer/JJR DNA/NN fragments/NNS ./.
@@75670797459 (/( 1986/CD )/SYM method/NN of/IN separation/NN of/IN Cryptosporidium/DT spp/NNS ./. oocysts/NNS from/IN feces/NNS by/IN using/VBG a/DT percoll/JJ discontinuous/JJ density/NN gradient/NN appeared/VBD a/DT method/NN of/IN choice/JJ for/IN obtaining/JJ large/JJ numbers/NNS of/IN oocysts/NNS of/IN C/NNP ./NNP parvum/NN free/JJ of/IN fecal/JJ contamination/NN ./.
@@26051827244 The/DT deduced/VBN protein/NN sequence/NN is/VBZ characterized/VBN by/IN a/DT putative/JJ 16-residue/JJ amino-terminal/JJ signal/JJ peptide/NN that/WDT is/VBZ cleaved/VBN ,/, resulting/VBG in/IN a/DT 239-residue/CD polypeptide/NN ./.
@@13397737846 The/DT relationships/NNS between/IN the/DT partial/JJ pressures/NNS of/IN O2/NN and/CC CO2/NN as/RB well/VB as/IN between/IN their/PRP gradients/NNS ,/, become/VB stronger/JJR with/IN the/DT increase/NN of/IN the/DT ventilation-perfusion/NN ratio/NN ./.
@@75182573222 Two/CD promoters/NNS were/VBD identified/VBN by/IN S1/NEWGENE nuclease/NEWGENE mapping/NN :/: P1/NN ,/, which/WDT lies/VBZ about/RB 72/CD bp/NN upstream/RB from/IN the/DT structural/JJ gene/NN ;/: and/CC P2/NN ,/, which/WDT lies/VBZ about/RB 35/CD bp/NN upstream/RB ./.
@@94087963012 Multiple/NNP regression/NN analyses/NNS revealed/VBN that/IN WAIS-R/DT factor/NN scores/VBZ Verbal/JJ Comprehension/NNS and/CC Freedom/NNP from/IN Distractibility/NNP accounted/VBD for/IN up/JJ to/IN 42%/NN of/IN the/DT variance/NN in/IN WMS-R/NN and/CC CVLT/NN indices/NNS ./.
@@18458852229 The/DT second/JJ transcriptional/JJ unit/NN ,/, designated/VBN UL26/NEWGENE ./NEWGENE 5/NEWGENE ,/, predicted/VBN to/IN specify/VB a/DT protein/NN of/IN 329/CD amino/JJ acids/NNS ,/, encodes/VBZ the/DT family/NEWGENE 35/NEWGENE proteins/NEWGENE ;/: it/PRP is/VBZ transcribed/VBN by/IN an/DT mRNA/NN which/WDT initiates/VBP at/IN approximately/JJ nucleotide/NN +1000/CD of/IN the/DT UL26/NEWGENE transcription/NN initiation/NN site/NN and/CC is/VBZ translated/VBN from/IN the/DT methionine/NN initiation/NN codon/NN located/VBN at/IN position/NN +1099/CD of/IN the/DT UL26/NEWGENE transcriptional/NEWGENE unit/NEWGENE ./.
@@100760079406 The/DT MSY2/NEWGENE associated/NN kinase/NEWGENE is/VBZ not/RB casein/NEWGENE kinase/NEWGENE 2/NEWGENE ,/, the/DT kinase/NEWGENE believed/VBN to/IN phosphorylate/VB mRNP3+4/NEWGENE in/IN oocytes/NNS ,/, but/CC a/DT yet/RB unidentified/JJ kinase/NEWGENE ./.
@@111684227729 (/( 1997/CD )/SYM Nature/NNP 387/CD ,/, 370-376/NN )/NN ]/NN ,/, we/PRP suggest/VBP that/IN the/DT metal/NN fluoride/NN ions/NNS replaced/VBD phosphate/NN at/IN the/DT two/JJ ATP-binding/NN sites/NN of/IN the/DT iron/NN protein/NN ,/, Kp2/NEWGENE ./.
@@103295862264 Only/RB one/PRP gene/NN ,/, fibronectin/NEWGENE (/( FN/NEWGENE )/SYM ,/, was/VBD highly/RB overexpressed/VBN (/( >/SYM 60-fold/JJ )/SYM in/IN LNCaP-r/NNP cells/NNS ,/, consistent/JJ with/IN previously/RB reported/VBN overexpression/NN of/IN FN/NEWGENE in/IN prostate/NN cancer/NN ./.
@@22833782934 The/DT former/JJ procedure/NN is/VBZ economical/JJ but/CC complicated/VBN ,/, whereas/IN the/DT latter/NN is/VBZ simple/JJ and/CC labour-saving/JJ ,/, but/CC a/DT special/JJ ultrafiltration/NN tube/NN is/VBZ required/VBN ./.
@@7961958371 Rat/NEWGENE kidney/NEWGENE carboxylesterase/NEWGENE ./.
@@98692971767 This/DT suggests/VBZ roles/NNS for/IN both/PDT the/DT CE1/NEWGENE and/CC CE2/NEWGENE elements/NN in/IN regulating/JJ Hoxb1/NEWGENE gene/NEWGENE expression/NN during/IN development/NN ./.
@@84054334673 The/DT human/NEWGENE insulin-like/NEWGENE growth/NEWGENE factor/NEWGENE II/NEWGENE (/( IGF-II/NEWGENE )/SYM gene/NN contains/VBZ four/CD promoters/NNS (/( P1/NN ,/, P2/NN ,/, P3/NN and/CC P4/NN )/SYM ./.
@@74351857307 The/DT symptoms/NNS and/CC objective/JJ findings/NNS were/VBD caused/VBN by/IN a/DT malignant/JJ lymphoma/NN ,/, and/CC the/DT diagnosis/NN was/VBD established/VBN from/IN a/DT drill/NN biopsy/NN ./.
@@23182088882 The/DT cis-acting/JJ element/NN ,/, identified/VBN as/IN CACGTGACCCG/NEWGENE ,/, is/VBZ located/VBN 34/CD bp/NN upstream/RB from/IN the/DT transcription/NN initiation/NN site/NN ,/, and/CC contains/VBZ the/DT core/NN sequence/NN of/IN the/DT upstream/JJ promoter/NN sequence/NN of/IN Ad2MLP/NN ./.
@@88495698821 Two/CD techniques/NNS based/VBN on/IN assay/NN coefficients/NNS of/IN variation/NN were/VBD employed/VBN to/IN characterize/VB a/DT normal/JJ circadian/JJ pattern/NN of/IN cortisol/NN ./.
@@86317608227 This/DT interaction/NN is/VBZ mediated/JJ by/IN the/DT SH2/NEWGENE domain/NEWGENE of/IN Crk/NEWGENE and/CC can/MD be/VB inhibited/VBN with/IN a/DT phosphopeptide/NN containing/JJ the/DT Crk-SH2/NEWGENE binding/NEWGENE motif/NEWGENE ./.
@@89994148949 The/DT differences/NNS among/IN subgenera/NNS of/IN the/DT genus/NN Dermacentor/NN are/VBP more/RB significant/JJ ./.
@@21429212743 Luteinizing/NEWGENE hormone-releasing/NEWGENE hormone/NEWGENE analog/NN therapy/NN of/IN uterine/JJ fibroid/JJ :/: analysis/NN of/IN results/NNS obtained/VBN with/IN buserelin/NN administered/VBN intranasally/RB and/CC goserelin/NN administered/VBN subcutaneously/RB as/IN a/DT monthly/JJ depot/NN ./.
@@100262116908 Proteins/NNPS known/VBP to/IN bind/NN the/DT PEPCK/NEWGENE CRE/NEWGENE1 include/VB the/DT CRE-binding/NEWGENE protein/NEWGENE (/( CREB/NEWGENE )/SYM and/CC members/NNS of/IN the/DT CCAAT/NEWGENE //NEWGENE enhancer-binding/NEWGENE protein/NEWGENE (/( C/NEWGENE //NEWGENE EBP/NEWGENE )/SYM family/NN ./.
@@85127288476 RESULTS/NNS :/: Statistically/RB significant/JJ differences/NNS were/VBD obtained/VBN between/IN group/NN I/PRP and/CC II/NNP concerning/VBG the/DT number/NN of/IN patients/NNS in/IN whom/WP induced/VBD atrial/JJ fibrillation/NN with/IN conduction/NN by/IN the/DT accessory/JJ pathway/NN and/CC RR/NN </SYM or/CC =/SYM 250/CD msec/NN was/VBD found/VBN (/( 0/CD vs/NNP 6/CD ,/, p/NN =/SYM 0/CD ./CD 0045/CD )/SYM ./.
@@25596307327 Other/JJ hemostatic/JJ values/NNS evaluated/VBN were/VBD activated/VBN partial/JJ thromboplastin/NEWGENE times/NNS ,/, prothrombin/NEWGENE times/NNS ,/, thrombin/NEWGENE times/NNS ,/, fibrinogen/NEWGENE ,/, platelet/NN counts/NNS ,/, and/CC fibrin/NEWGENE //NEWGENE fibrinogen/NEWGENE degradation/NN products/NNS ./.
@@89105672361 The/DT human/JJ gene/NN fragment/NN ligated/VBN to/IN the/DT minimal/JJ rat/NN liver/NN glucokinase/NEWGENE promoter/NN was/VBD shown/VBP to/RB work/NN as/IN an/DT enhancer/NN in/IN the/DT hepatocyte/NN transfection/NN system/NN ./.
@@31781613863 Esophageal/JJ brush/NN cytological/JJ screening/NN was/VBD undertaken/VBP and/CC blood/NN concentrations/NNS of/IN micronutrients/NNS (/( vitamin/NN A/DT ,/, E/NN ,/, B12/NN ,/, folic/JJ acid/NN and/CC methionine/NN )/SYM determined/VBN from/IN adults/NNS at/IN risk/NN for/IN esophageal/JJ carcinoma/NN (/( EC/NN )/SYM in/IN Transkei/NNP and/CC Ciskei/NNP ,/, Southern/NNP Africa/NN ./.
@@118837631775 The/DT large/JJ fluxes/NNS of/IN 239+240Pu/NN might/MD be/VB attributed/VBN to/IN episodic/JJ lateral/JJ transport/NN of/IN particles/NNS that/WDT flow/VBP down/NN the/DT continental/JJ slope/NN with/IN the/DT nepheloid/JJ layer/NN which/WDT was/VBD considered/VBN to/IN be/VB significant/JJ for/IN 239+240Pu/CD transport/NN on/IN the/DT continental/JJ slope/NN in/IN the/DT East/NNP China/NNP Sea/NNP ./.
@@1427188245 In/NN only/RB two/JJ patients/NNS were/VBD we/PRP able/JJ to/IN demonstrate/VB changes/NNS suggestive/JJ of/IN pulmonary/JJ metastases/NNS any/DT earlier/JJR with/IN a/DT 99mTc-EHDP/NN scan/NN than/IN with/IN chest/NN radiographs/NNS and/CC one/PRP of/IN these/DT resolved/VBN spontaneously/RB ./.
@@86764563397 A/DT chimeric/NEWGENE VP16-Tat/NEWGENE construct/NEWGENE containing/JJ the/DT leucine/NN mutations/NN showed/VBD no/DT increased/VBN AP-1/NEWGENE responsiveness/NN in/IN comparison/NN with/IN that/DT of/IN the/DT VP16/NEWGENE activation/NEWGENE domain/NEWGENE alone/RB ./.
@@16448315580 An/DT examination/NN of/IN the/DT role/NN of/IN the/DT carboxyl/NN terminus/NN in/IN regulating/JJ NGFI-B/NEWGENE transcriptional/JJ activity/NN revealed/VBN that/IN ,/, in/IN accordance/NN with/IN other/DT nuclear/JJ receptors/NNS ,/, mutants/NNS lacking/JJ portions/NNS of/IN the/DT carboxyl/NN terminus/NN had/VBP greatly/RB decreased/VBN activity/NN ./.
@@23350342986 They/PRP were/VBD then/RB subjected/VBN to/IN whole-body/NN heat/NN stress/NN (/( water-perfused/JJ suits/NNS )/SYM ,/, and/CC the/DT 3/CD minutes/NNS of/IN LBNP/NN was/VBD repeated/JJ ./.
@@117834571886 Preservatives/NN are/VBP an/DT important/JJ component/NN of/IN ophthalmic/JJ preparations/NNS ,/, providing/CC antimicrobial/JJ activity/NN in/IN the/DT bottle/NN and/CC preventing/JJ decomposition/NN of/IN active/JJ drug/NN ./.
@@17274949505 Vaccinia/NN virus/NN (/( VV/JJ )/SYM is/VBZ a/DT potent/JJ immunogen/NN ,/, but/CC the/DT nature/NN of/IN VV/NN proteins/NN involved/VBN in/IN the/DT activation/NN of/IN the/DT immune/JJ response/NN of/IN the/DT host/NN is/VBZ not/RB yet/RB known/VBP ./.
@@10490955979 Beta/NEWGENE 1/NEWGENE integrin-/NEWGENE and/CC proteoglycan-mediated/JJ stimulation/NN of/IN T/NN lymphoma/NN cell/NN adhesion/NN and/CC mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE signaling/JJ by/IN thrombospondin-1/NEWGENE and/CC thrombospondin-1/NEWGENE peptides/NEWGENE ./.
@@76956293174 In/NN addition/NN ,/, an/DT mck1/NEWGENE mds1/NEWGENE1 mrk1/NEWGENE triple/JJ disruptant/NN was/VBD viable/JJ ./.
@@19362132557 Evaluation/NN of/IN antiepileptic/JJ drug/NN effect/NN on/IN membrane/NN fluidity/NN ./.
@@83274883122 One/CD defective/JJ RNA/NN with/IN a/DT large/JJ deletion/NN in/IN the/DT p70/NEWGENE coding/NEWGENE region/NEWGENE was/VBD able/JJ to/IN replicate/VB efficiently/RB ,/, both/DT when/CC inoculated/VBN with/IN the/DT helper/NN genome/NN and/CC when/CC inoculated/VBN with/IN a/DT second/JJ complementing/NN defective/NN RNA/NN that/WDT supplied/VBD a/DT wild-type/NEWGENE p70/NEWGENE ./.
@@108509971006 In/NN contrast/NN ,/, H-NS/NEWGENE negative/JJ regulation/NN operated/VBN only/RB in/IN the/DT absence/NN of/IN Fur/NEWGENE ./.
@@84131862365 Although/IN the/DT molecular/JJ mechanisms/NNS involved/VBN in/IN this/DT regulation/NN are/VBP currently/RB being/VBP elucidated/VBN ,/, very/JJ little/NN is/NNS known/VBP about/RB the/DT trans-acting/JJ factors/NNS that/WDT allow/VBP expression/NN of/IN the/DT nitrate/NEWGENE and/NEWGENE nitrite/NEWGENE reductase/NEWGENE genes/NEWGENE which/WDT code/VBP for/IN the/DT first/JJ enzymes/NNS in/IN the/DT pathway/NN ./.
@@9920775321 The/DT sequence/NN up/JJ to/IN -267/CD bp/NN relative/JJ to/IN the/DT transcription/NN start/NN site/NN was/VBD sufficient/JJ to/IN enhance/VB reporter/NN gene/NN expression/NN depending/VBG on/IN the/DT mesodermal/JJ differentiation/NN of/IN P19/CD cells/NNS ./.
@@3831691062 In/NN this/DT article/NN ,/, the/DT clinical/JJ actions/NNS of/IN the/DT principal/JJ dopamine/NEWGENE receptor/NEWGENE stimulating/JJ agents/NNS (/( apomorphine/NN and/CC its/PRP derivatives/NNS ;/: piribedil/NN ,/, rye-ergot/JJ derivatives/NNS )/SYM are/VBP discussed/VBN on/IN the/DT basis/NN of/IN their/PRP biochemical/JJ and/CC pharmacological/JJ properties/NNS ./.
@@103641597665 To/TO address/VB these/DT questions/NNS ,/, a/DT recombinant/NEWGENE FRAP/NEWGENE //NEWGENE mTOR/NEWGENE protein/NEWGENE and/CC a/DT FRAP/NEWGENE //NEWGENE mTOR/NEWGENE immunoprecipitate/NN were/VBD utilized/VBN in/IN in/IN vitro/NN kinase/NEWGENE assays/NNS to/IN phosphorylate/VB 4E-BP1/NEWGENE ./.
@@75970309925 Here/RB we/PRP report/VBP the/DT cloning/NN ,/, expression/NN ,/, and/CC biochemical/JJ characterization/NN of/IN the/DT 32-kDa/NN subunit/NN of/IN human/JJ (/( h/NN )/SYM TFIID/NEWGENE ,/, termed/JJ hTAFII32/NEWGENE ./.
@@9343432539 The/DT Scm/NEWGENE and/CC ph/NEWGENE proteins/NNS share/VBP a/DT homology/NN domain/NN with/IN 38%/JJ identity/NN over/RB a/DT length/NN of/IN 65/CD amino/JJ acids/NNS ,/, termed/VBD the/DT SPM/NEWGENE domain/NEWGENE ,/, that/WDT is/VBZ located/VBN at/IN their/PRP respective/JJ C/NN termini/NNS ./.
@@107044107774 Clb/NEWGENE //NEWGENE Cdc28/NEWGENE kinases/NEWGENE promote/VBP nuclear/JJ export/NN of/IN the/DT replication/NEWGENE initiator/NEWGENE proteins/NEWGENE Mcm2-7/NEWGENE ./.
@@103364951220 This/DT repression/NN was/VBD reversed/VBN agonists/NNS of/IN either/DT receptor/NN demonstrating/VBG a/DT functional/JJ interaction/NN between/IN NCoR/NEWGENE and/CC PPARalpha/NEWGENE ./NEWGENE RXRalpha/NEWGENE heterodimeric/NEWGENE complexes/NEWGENE in/IN mammalian/JJ cells/NNS ./.
@@8958720318 When/WRB the/DT degree/NN of/IN exercise/NN was/VBD maximal/JJ ,/, mPAP/NN was/VBD maintained/VBN ,/, SVI/NNS decreased/VBN ,/, HR/NN was/VBD unchanged/JJ ,/, and/CC CO/NN and/CC VO2/NN decreased/VBN ./.
@@91441955831 Thus/RB ,/, the/DT association/NN of/IN PS1/NEWGENE fragments/NEWGENE may/MD be/VB maintained/VBN during/IN cycles/NNS of/IN phosphorylation/NN //NN dephosphorylation/NN of/IN the/DT PS1/NEWGENE CTF/NEWGENE ./.
@@87167573091 Microcomputer/NN management/NN of/IN chronic/JJ hepatitis/NN B/NN virus/NN asymptomatic/JJ patients/NNS ./.
@@115708202832 Four/CD casein/NEWGENE kinase/NEWGENE I/NEWGENE isoforms/NEWGENE are/VBP differentially/RB partitioned/VBN between/IN nucleus/NN and/CC cytoplasm/NN ./.
@@102160528560 Furthermore/RB ,/, the/DT validity/NN of/IN this/DT new/JJ subset/NN of/IN questions/NNS was/VBD shown/VBP to/IN be/VB significant/JJ (/( r/NN =/NN 0/NN ./NN 037/NN ,/, p/CD </CD 0/CD ./CD 05/CD )/SYM for/IN the/DT correlation/NN between/IN a/DT measure/NN of/IN the/DT severity/NN of/IN binocular/JJ visual/JJ field/NN loss/NN and/CC the/DT mean/JJ score/NN of/IN the/DT variables/NNS used/VBN in/IN the/DT glaucoma/NN specific/NN subgroup/NN of/IN questions/NNS ./.
@@100856976159 FASEB/NN Federal/NNP Funding/NNP Consensus/NNP Conference/NNP FY/NN 2000/CD ./.
@@95176468972 Azithromycin/WDT is/VBZ a/DT new/JJ generation/NN macrolide/NN antibiotic/JJ with/IN unusual/JJ and/CC favorable/JJ pharmacokinetics/NN ,/, and/CC seems/VBZ to/IN be/VB a/DT very/RB promising/JJ agent/NN for/IN innovative/JJ anti-H/NN ./. pylori/NNS regimens/NNS ./.
@@113332686543 Based/VBN on/IN this/DT analysis/NN ,/, we/PRP propose/VBP that/IN the/DT interactions/NNS of/IN Sos/NEWGENE with/IN the/DT switch/NN 1/CD and/CC switch/NN 2/CD regions/NNS of/IN Ras/NEWGENE have/VBP distinct/JJ functional/JJ consequences/NNS :/: the/DT interaction/NN with/IN switch/NN 2/CD mediates/VBZ the/DT anchoring/JJ of/IN Ras/NEWGENE to/IN Sos/NEWGENE ,/, whereas/IN the/DT interaction/NN with/IN switch/NN 1/CD leads/VBP to/IN disruption/NN of/IN the/DT nucleotide-binding/NN site/NN and/CC GDP/NN dissociation/NN ./.
@@74769633395 Peroxisome/NEWGENE proliferator-activated/NEWGENE receptors/NEWGENE (/( PPARs/NEWGENE )/SYM and/CC retinoid/NEWGENE X/NEWGENE receptors/NEWGENE (/( RXRs/NEWGENE )/SYM are/VBP nuclear/NN hormone/NN receptors/NN that/WDT are/VBP activated/VBN by/IN fatty/JJ acids/NNS and/CC 9-cis-retinoic/NN acid/NN ,/, respectively/RB ./.
@@40184444687 Chenodeoxycholic/NNP acid/NN (/( cheno/NN )/SYM and/CC ursodeoxycholic/JJ acid/NN (/( urso/NN )/SYM dissolve/VB cholesterol/NN gallstones/NNS in/IN man/NN ./.
@@22916282947 The/DT second/JJ part/NN of/IN this/DT paper/NN shows/VBZ some/DT medical/JJ applications/NNS of/IN these/DT two/JJ aspects/NNS of/IN NMR/NN ,/, with/IN help/NN of/IN some/DT examples/NNS ,/, taken/VBP from/IN the/DT literature/NN ,/, according/VBG to/IN what/WP is/VBZ concerned/VBN with/IN endocrinology/NN ./.
@@86911066602 However/RB ,/, D8/NEWGENE binding/NN was/VBD observed/VBN by/IN nuclease/NEWGENE protection/NN with/RB lactotroph-/JJ as/RB well/VB as/IN somatotroph-like/NEWGENE cell/NEWGENE nuclear/NEWGENE protein/NEWGENE ./.
@@86663836259 These/DT findings/NNS suggest/VBP that/IN direct/JJ cDNA/NN mapping/NN using/VBG fluorescence/NN in/IN situ/NN hybridization/NN provides/VBZ an/DT accurate/JJ and/CC rapid/JJ approach/NN to/IN the/DT definition/NN of/IN a/DT transcribed/VBN map/NN of/IN the/DT human/JJ genome/NN ./.
@@57813852723 The/DT significance/NN of/IN the/DT phenolphthalein/NEWGENE sulphatase/NEWGENE test/NN for/IN the/DT differentiation/NN and/CC identification/NN of/IN Nocardia/DT species/NN ./.
@@38657434536 These/DT results/NNS indicate/VBP that/IN T/NNP ./NNP C/NNP ./NNP ,/, LDL-C/NEWGENE ./NNP ,/, HDL-C/NEWGENE ./NNP ,/, HDL2-C/NEWGENE ./NN ,/, apo/NEWGENE B/NEWGENE ,/, apo/NEWGENE A-I/NEWGENE //NEWGENE B/NEWGENE ratio/NN and/CC apo/NEWGENE A-II/NEWGENE //NEWGENE B/NEWGENE ratio/NN are/VBP predictive/JJ risk/NN factors/NNS of/IN the/DT coronary/JJ heart/NN disease/NN ./.
@@22180941974 This/DT last/NN includes/VBZ tissue/NN O2/NN transfer/NN (/( Ft'/NNP )/SYM and/CC mitochondrial/NN O2/NN utilization/NN (/( Fm'/NNP )/SYM ./.
@@91113409894 To/TO identify/VB cis-acting/JJ elements/NNS that/WDT target/VBP c-myc/NEWGENE mRNA/NEWGENE for/IN downregulation/NN during/IN myogenesis/NN ,/, we/PRP stably/RB transfected/VBN C2C12/NNP cells/NNS with/IN mutant/NEWGENE myc/NEWGENE genes/NEWGENE or/CC chimeric/JJ genes/NNS in/IN which/WDT various/JJ myc/NEWGENE sequences/NEWGENE were/VBD fused/VBN to/IN the/DT human/NEWGENE beta-globin/NEWGENE gene/NEWGENE or/CC to/IN the/DT bacterial/NEWGENE chloramphenicol/NEWGENE acetyltransferase/NEWGENE (/( CAT/NEWGENE )/SYM gene/NN ./.
@@77917648123 We/PRP report/VBP here/RB that/IN in/IN cultured/JJ Jurkat/NN T/NN cells/NNS ,/, Cbl/NEWGENE is/VBZ coprecipitated/VBN with/IN antibody/NN against/IN the/DT adapter/NEWGENE protein/NEWGENE Grb2/NEWGENE ./.
@@88164524832 These/DT findings/NNS and/CC the/DT differential/JJ tissue/NN distribution/NN of/IN p54/NEWGENE suggest/VB that/IN this/DT novel/JJ SR/NEWGENE protein/NEWGENE may/MD participate/VB in/IN regulation/NN of/IN alternative/JJ splicing/JJ in/IN a/DT tissue-/JJ and/CC substrate-dependent/JJ manner/NN ./.
@@94598359413 Nine/CD cats/NNS received/VBN PMEA/IN at/IN a/DT dosage/NN of/IN 10/CD mg/CD //CD kg/CD body/NN weight/NN ,/, nine/JJ cats/NNS received/VBD FPMPA/NNP at/IN a/DT dosage/NN of/IN 25/CD mg/CD //CD kg/CD body/NN weight/NN ./.
@@13479447082 Mutational/JJ studies/NNS revealed/VBN that/IN it/PRP was/VBD the/DT homeodomain/NEWGENE binding/NEWGENE site/NEWGENE II/NEWGENE sequence/NEWGENE that/WDT was/VBD required/VBN for/IN this/DT regulation/NN ./.
@@10645921460 BACKGROUND/IN :/: Left/NNP ventricular/JJ hypertrophy/NN is/VBZ a/DT heterogeneous/JJ disorder/NN with/IN distinct/JJ morphologies/NNS ./.
@@113556687833 Proliferative/NNP vasculopathy/NN and/CC cutaneous/JJ hemorrhages/NNS in/IN porcine/JJ neonates/NNS infected/VBN with/IN the/DT porcine/JJ reproductive/JJ and/CC respiratory/JJ syndrome/NN virus/NN ./.
@@111343514573 Additionally/RB ,/, MIP-2A/NEWGENE antagonizes/VBZ cell/NN growth/NN regulatory/JJ role/NN of/IN MBP-1/NEWGENE ./.
@@111625767128 We/PRP also/RB reported/VBD the/DT identification/NN of/IN three/CD corresponding/JJ alternative/JJ first/JJ exons/NNS and/CC an/DT intronic/JJ promoter/NN in/IN the/DT human/NEWGENE PDE5A/NEWGENE gene/NEWGENE ./.
@@11034933871 METHODS/IN AND/CC RESULTS/NNS :/: Studies/NNS were/VBD undertaken/VBP in/IN 9/CD isolated/VBN guinea/NN pig/NN hearts/NNS ,/, which/WDT demonstrated/VBD reverse/JJ use-dependent/JJ prolongation/NN of/IN cardiac/JJ repolarization/NN by/IN 100/CD nmol/NN //NN L/NN domperidone/NN ./.
@@86021694597 In/NN the/DT point/NN mutant/JJ we/PRP observed/VBD normal/JJ repair/NN of/IN endonuclease/NEWGENE III/NEWGENE site/NEWGENE (/( i/CD ./CD e/CD ./. as/IN wild/JJ type/NN )/SYM ,/, but/CC no/DT removal/NN of/IN CPDs/NNS at/IN the/DT MAT/NEWGENE alpha/NEWGENE and/CC HML/NEWGENE alpha/NEWGENE loci/NEWGENE ./.
@@105593209514 The/DT amino-terminal/JJ half/NN of/IN 1a/NEWGENE is/VBZ a/DT distant/JJ homolog/NEWGENE of/NEWGENE alphavirus/NEWGENE nonstructural/NEWGENE protein/NEWGENE nsP1/NEWGENE ,/, which/WDT has/VBZ been/VBN implicated/VBN in/IN capping/NN viral/NN RNAs/NN ./.
@@83944649863 Two/CD putative/JJ Rev/NEWGENE proteins/NEWGENE with/IN apparent/JJ molecular/JJ masses/NNS of/IN 18/CD and/CC 16/CD kDa/NN were/VBD expressed/VBN by/IN p2/NN //NN 2/NN and/CC p176/NN ,/, while/CC p20/NN expressed/VBN only/RB a/DT 16-kDa/JJ species/NN ./.
@@115544691883 These/DT analyses/NNS re-open/VB the/DT question/NN whether/IN all/PDT the/DT CesA/NEWGENE genes/NEWGENE encode/VBP cellulose/NEWGENE synthases/NEWGENE or/CC whether/IN some/DT of/IN the/DT sub-class/NN members/NNS may/MD encode/VB other/DT non-cellulosic/NEWGENE (/NEWGENE 1--/NEWGENE >/NEWGENE 4/NEWGENE )/NEWGENE beta-glycan/NEWGENE synthases/NEWGENE in/IN plants/NNS ./.
@@9963640177 E/NN 50/NN ,/, 843/CD (/( 1994/CD )/NN ]/NN ./.
@@4740642792 In/NN this/DT situation/NN the/DT convlusion/NN threshold/NN for/IN the/DT 8/CD substances/NNS is/VBZ as/IN follows/VBZ :/: pethidine/NN 20/NN mg/NN ./NN kg-1/NN I/NN ./NN V/NN ./NN ,/, piritramide/NN 30/NN ,/, morphine/NN 180/NN ,/, phenoperidine/NN 4/NN ,/, R/NN 39/NN 209/NN 5/NN ,/, fentanyl/NN 4/NN ,/, sufentanil/NN 4/CD and/CC R/NN 34/NN 995/NN 10/NN mg/NN ./NN kg-1/NN I/NN ./NN V/NN ./.
@@71740468824 Vibrio/NN fluvialis/NN (/( group/NN F/NN vibrio/NN )/SYM in/IN Maharashtra/NNP ./.
@@29693163217 To/TO assess/VB the/DT ability/NN of/IN the/DT atria/NNS to/IN maintain/VB elevated/VBN plasma/NN concentrations/NNS of/IN atrial/NEWGENE natriuretic/NEWGENE peptide/NEWGENE (/( ANP/NEWGENE )/SYM ,/, the/DT temporal/JJ changes/NNS in/IN plasma/NEWGENE ANP/NEWGENE concentrations/NNS were/VBD studied/VBN in/IN seven/JJ chloralose-anaesthetized/JJ dogs/NNS during/IN 4/CD h/NN of/IN sustained/JJ rapid/JJ cardiac/JJ pacing/NN ./.
@@90926366768 Our/PRP results/NNS show/VBP that/IN the/DT temperature-sensitive/NEWGENE rad54-3/NEWGENE allele/NEWGENE blocks/NNS mitotic/JJ recombination/NN between/IN tandemly/RB repeated/JJ DYZ3/NEWGENE satellite/NEWGENE sequences/NEWGENE and/CC significantly/RB stabilizes/VBZ a/DT human/NEWGENE DYZ5/NEWGENE satellite-containing/NN YAC/NN clone/NN ./.
@@13881609839 Again/RB residue/NN Glu-381/NNP of/IN beta/NN was/VBD notably/RB reduced/VBN and/CC no/DT missing/JJ residue/NN from/IN the/DT epsilon/NEWGENE peptide/NEWGENE could/MD be/VB identified/VBN ,/, but/CC the/DT peptide/NN sequence/NN limited/VBD the/DT possible/JJ choices/NNS to/IN Ser-106/NNP ,/, Ser-107/NNP ,/, or/CC Ser-108/NNP ./.
@@106444147181 Differential/JJ expression/NN and/CC regulation/NN by/IN 20-hydroxyecdysone/NN of/IN mosquito/NN ultraspiracle/NN isoforms/NNS ./.
@@18518629946 Nucleotide/NN sequences/NNS between/IN the/DT env/NEWGENE gene/NEWGENE and/CC the/DT LTR/NN of/IN SFV-1/NN were/VBD determined/VBN ./.
@@14904932107 As/IN a/DT part/NN of/IN a/DT large/JJ examination/NN ,/, total/JJ and/CC free/JJ serum/JJ cholesterol/NN ,/, total/JJ lipid/NN and/CC triglyceride/NN levels/NNS were/VBD determined/VBN ./.
@@86220704094 Only/RB two/JJ patients/NNS (/( 0/CD ./CD 3%/CD )/SYM had/VBP a/DT CA/NN 125/NN response/NN at/IN the/DT time/NN of/IN clinical/JJ progression/NN ./.
@@67817286552 The/DT alterations/NNS in/IN differentiation/NN of/IN osteoprogenitor/JJ cells/NNS ,/, together/RB with/IN the/DT failure/NN of/IN mineralization/NN ,/, resulted/VBN in/IN significantly/RB lower/JJR rates/NNS of/IN bone/NN formation/NN (/( as/IN measured/VBN by/IN fluorochrome/NN labeling/VBG )/SYM in/IN the/DT magnesium-deficient/JJ rats/NNS ./.
@@36225714301 Radionuclide/NN study/NN and/CC endomyocardial/JJ biopsy/NN revealed/VBD remarkable/JJ degeneration/NN of/IN myocardium/NN ./.
@@115234466571 ICA/NN in/IN the/DT reference/NN solution/NN was/VBD characterised/VBN by/IN LC/NN and/CC time-of-flight/JJ (/( TOF/NN )/SYM MS/NN and/CC quantified/VBN by/IN LC/NN chemiluminescent/JJ nitrogen/NN detection/NN (/( LC-CLND/NNP )/SYM ./.
@@20458098183 In/NN contrast/NN ,/, similar/JJ rates/NNS of/IN B/NNP ./NNP sphaericus/JJ products/NNS ,/, ABG-6184/NN technical/JJ powder/NN and/CC BSP-2/NN flowable/JJ concentrate/NN ,/, produced/VBD no/DT significant/JJ reduction/NN ./.
@@63744181628 The/DT aspirate/NN from/IN a/DT parathyroid/NN cyst/NN was/VBD watery/JJ clear/JJ and/CC contained/VBN high/JJ amount/NN of/IN parathyroid/NEWGENE hormone/NEWGENE ./.
@@36783724343 The/DT number/NN of/IN fecal/JJ pellets/NNS ingested/VBN peaked/VBN at/IN 5/CD to/IN 6/CD weeks/NNS old/JJ (/( 13/CD pellets/NN //NN day/NN )/SYM and/CC gradually/RB decreased/VBN ,/, thereafter/RB (/( 2/CD ./CD 1/CD pellets/NNS at/IN 78/CD weeks/NNS old/JJ ,/, 1/CD ./CD 5/CD pellets/NNS at/IN 104/CD weeks/NNS old/JJ )/SYM ./.
@@110740039950 Our/PRP results/NNS indicate/VBP that/IN Shh/NEWGENE can/MD drive/VB continued/VBN cycling/JJ in/IN immature/JJ ,/, proliferating/JJ CGNPs/NNP ./.
@@77821137755 The/DT roxithromycin/NN doses/NNS that/WDT were/VBD chosen/VBP for/IN these/DT studies/NNS were/VBD less/PRP than/IN achievable/JJ blood/NN levels/NNS ./.
@@13946551332 Urease/NEWGENE activity/NN ,/, judged/VBN as/IN the/DT amount/NN of/IN ammonia/NN production/NN from/IN urea/NN ,/, could/MD be/VB measured/VBN at/IN 25/CD ng/NN per/IN tube/NN (/( S/NN //NN N/NN =/SYM 1/CD ./CD 5/CD )/SYM with/IN Jack/NEWGENE bean/NEWGENE meal/NEWGENE urease/NEWGENE ./.
@@4856155207 These/DT data/NN confirm/VB the/DT existence/NN of/IN hyperlipemic/JJ abdominal/JJ crisis/NN as/IN a/DT distinct/JJ entity/NN and/CC testify/VB to/IN the/DT importance/NN of/IN recognizing/VBG this/DT syndrome/NN in/IN order/NN to/IN avoid/VB the/DT occurrence/NN of/IN acute/JJ pancreatitis/NN and/CC the/DT performance/NN of/IN unnecessary/JJ and/CC potentially/RB harmful/JJ surgery/NN ./.
@@85859946399 Using/VBG reference/NN probes/NNS as/IN internal/JJ standards/NNS ,/, we/PRP show/VBP that/IN the/DT ost/NEWGENE transcription/NEWGENE unit/NEWGENE is/VBZ located/VBN within/IN the/DT cytogenetic/JJ band/NN interval/NN 89A1/NN ,/NN 2/NN on/IN the/DT right/JJ arm/NN of/IN the/DT third/JJ chromosome/NN ,/, and/CC that/IN it/PRP exerts/VBZ diagnostic/JJ segmentation/NN gene/NN expression/NN patterns/NNS in/IN the/DT embryo/NN ./.
@@105293548504 The/DT proteasome/NN is/VBZ a/DT large/JJ complex/NN consisting/VBG of/IN two/JJ multisubunit/JJ structures/NNS ,/, the/DT 20S/NEWGENE and/CC 19S/NEWGENE (/NEWGENE PA700/NEWGENE )/NEWGENE or/CC P28/NEWGENE complexes/NEWGENE ,/, that/WDT combine/VBP to/IN form/NN the/DT 26S/NEWGENE particles/NEWGENE ./.
@@75337587769 The/DT amino/JJ acid/NN sequences/NNS of/IN the/DT predicted/VBN RfbA/NEWGENE and/CC RfbB/NEWGENE homologs/NEWGENE showed/VBD identities/NNS of/IN 75/CD ./CD 7%/CD (/( 87/CD ./CD 9%/CD total/JJ similarity/NN )/SYM and/CC 78/CD ./CD 0%/CD (/( 86/CD ./CD 5%/CD total/JJ similarity/NN )/SYM ,/, respectively/RB ./.
@@113237165772 The/DT UBA/NEWGENE domains/NEWGENE of/IN RAD23/NEWGENE and/CC DDI1/NEWGENE are/VBP required/VBN for/IN these/DT interactions/NNS ./.
@@63104576103 Intracellular/JJ recordings/NNS were/VBD performed/VBN on/IN the/DT optic/JJ tectum/NN of/IN the/DT carp/NN in/IN vitro/FW ./.
@@90713088137 RESULTS/NNS :/: Nodular/JJ opacities/NNS ,/, mainly/RB centrilobular/JJ in/IN distribution/NN ,/, were/VBD the/DT most/RB common/JJ finding/NN ,/, seen/VBP in/IN 21/CD (/( 72%/JJ )/SYM and/CC 15/CD (/( 65%/JJ )/SYM of/IN patients/NNS with/IN MTB/NN and/CC NTMB/NN ,/, respectively/RB ./.
@@19915212604 The/DT results/NNS strengthen/VBP the/DT conclusion/NN that/IN predominantly/RB dynamic/JJ activity/NN increases/VBZ the/DT G4/NEWGENE content/NN of/IN mature/RB innervated/VBN fast/JJ muscles/NNS ./.
@@14732342092 Green/NNP pepper/NN significantly/RB inhibited/VBD N-nitrosothiazolidine-carboxylic/NNP acid/NN formation/NN relative/JJ to/IN ascorbic/JJ acid/NN alone/RB ./.
@@445259284 Serum/NN ferritin/NEWGENE concentration/NN and/CC bone/NN marrow/NN iron/NN stores/NNS ./.
@@111459556783 The/DT mechanism/NN of/IN ligand-activated/NN estrogen/NEWGENE receptor/NEWGENE alpha/NEWGENE (/( ERalpha/NEWGENE )/NN -dependent/NN activation/NN of/IN gene/NN expression/NN through/RB the/DT SRE/NEWGENE was/VBD determined/VBN by/IN mutational/JJ analysis/NN of/IN the/DT promoter/NN ,/, analysis/NN of/IN mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE (/( MAPK/NEWGENE )/SYM pathway/NN activation/NN by/IN E2/NEWGENE ,/, and/CC transforming/NEWGENE growth/NEWGENE factor/NEWGENE alpha/NEWGENE (/( TGF-alpha/NEWGENE )/SYM as/IN a/DT positive/JJ control/NN ./.
@@11382151223 Risk/NN of/IN infection/NN in/IN the/DT treatment/NN of/IN fractures/NNS ./.
@@8622893182 The/DT large/NN subfamily/NN of/IN receptor/NEWGENE tyrosine/NEWGENE kinases/NEWGENE (/( RTKs/NEWGENE )/SYM for/IN which/WDT EPH/NEWGENE is/VBZ the/DT prototype/NN have/NN likely/JJ roles/NNS in/IN intercellular/JJ communication/NN during/IN normal/JJ mammalian/JJ development/NN ,/, but/CC the/DT biochemical/JJ signalling/JJ pathways/NNS utilised/VBN by/IN this/DT family/NN are/VBP poorly/RB characterised/VBN ./.
@@86188827009 Analysis/NNP of/IN RAR/NEWGENE alpha/NEWGENE mutants/NEWGENE in/IN transfection/NN studies/NNS reveals/VBZ that/IN the/DT DNA/NN binding/JJ domain/NN is/VBZ sufficient/JJ for/IN inhibition/NN of/IN BZLF1/NEWGENE activity/NN ./.
@@115545663582 At/NN both/DT companies/NNS sites/NNS Salmonella/NN enteritidis/NN and/CC Salmonella/NN typhimurium/NN Tr104/NN were/VBD also/RB isolated/VBN occasionally/RB from/IN various/JJ locations/NNS ./.
@@89529656642 Comparison/NNS of/IN the/DT proportion/NN of/IN nonsynonymous/JJ (/( pN/NN )/SYM and/CC synonymous/JJ (/( pS/NN )/SYM substitutions/NNS occurring/VBG per/IN site/NN within/IN tamarin/NEWGENE variable/NEWGENE region/NEWGENE genes/NEWGENE demonstrated/VBD a/DT reduction/NN in/IN pN/NN in/IN the/DT framework/NN regions/NNS compared/VBN with/IN pN/NN in/IN the/DT presumed/VBN MHC/NEWGENE contact/NEWGENE regions/NEWGENE (/( CDR1/NEWGENE and/CC CDR2/NEWGENE )/SYM ./.
@@10540915367 Tracheal/JJ transsection/NN combined/JJ with/IN hilar/JJ ligation/NN (/( TL&PL/NNP )/SYM effected/VBN a/DT reduction/NN of/IN 19/CD ./CD 9%/CD (/( n/CD ./CD s/CD ./CD )/SYM ./.
@@34078434105 Papers/NNP of/IN the/DT Society/NNP for/IN Clinical/NNP Vascular/NNP Surgery/NNP ./.
@@94808432097 The/DT COOH-terminal/NN region/NN of/IN the/DT transcripts/NNS contained/VBN fifteen/CD triplet/NN repeats/NNS (/( GCT/NN ;/: alanine/NN )/SYM at/IN nucleotide/NN 465/CD to/IN 509/CD ,/, which/WDT is/VBZ significantly/RB expanded/JJ compared/VBN to/IN the/DT rat/NEWGENE RL14/NEWGENE ./.
@@389838262 Dual/JJ radionuclide/NN subtraction/NN imaging/JJ of/IN the/DT spleen/NN using/VBG 67Ga/CD citrate/NN and/CC 99mTc/NN is/VBZ useful/JJ in/IN further/RB delineating/VBG lesions/NNS that/WDT are/VBP identified/VBN on/IN either/DT a/DT routine/JJ radiogallium/NN survey/NN or/CC on/IN a/DT conventional/JJ sulfur/JJ colloid/NN liver-spleen/JJ image/NN ./.
@@12850099786 Gene/NNP constructs/NNS consisting/VBG of/IN human/NEWGENE growth/NEWGENE hormone/NEWGENE (/( hGH/NEWGENE )/SYM gene/NN driven/VBP by/IN promoter/NN //NN regulatory/NN sequence/NN of/IN mouse/NEWGENE metallothionein/NEWGENE (/( mMT/NEWGENE )/SYM ,/, viral/NEWGENE thymidine/NEWGENE kinase/NEWGENE (/( vTK/NEWGENE )/SYM ,/, rat/NEWGENE cholecystokinin/NEWGENE (/( rCCK/NEWGENE )/SYM ,/, or/CC chicken/NEWGENE beta-actin/NEWGENE (/( cBA/NEWGENE )/SYM gene/NN were/VBD injected/VBN into/IN the/DT cytoplasm/NN of/IN fertilized/JJ medaka/NN eggs/NNS via/NN the/DT micropyle/NN ./.
@@80936165181 DNase/NEWGENE I/NEWGENE footprinting/VBG analysis/NN indicated/VBN that/IN DREF/NEWGENE binds/VBZ to/IN the/DT 24-bp/JJ DRE/NEWGENE region/NN of/IN the/DT DNA/NEWGENE polymerase/NEWGENE alpha/NEWGENE gene/NEWGENE in/IN which/WDT 8-bp/JJ palindromic/JJ sequences/NNS are/VBP centered/VBN ./.
@@107650956914 This/DT study/NN was/VBD carried/VBN out/RB to/IN analyze/VB PRL/NEWGENE secretion/NN in/IN metastatic/JJ prostate/NN cancer/NN patients/NNS both/DT at/IN basal/JJ conditions/NNS and/CC in/IN response/NN to/IN L-Dopa/NN and/CC metoclopramide/NN ,/, which/WDT represents/VBZ the/DT most/RB classical/JJ inhibitory/JJ and/CC stimulatory/JJ tests/NNS for/IN PRL/NEWGENE secretion/NN ,/, respectively/RB ./.
@@94341606056 Expression/NNS of/IN PTPRO/NEWGENE was/VBD also/RB observed/VBN in/IN human/NEWGENE CD34+/NEWGENE bone/NN marrow/NN cells/NNS and/CC 5-FU-treated/JJ murine/JJ primitive/JJ stem/NN cells/NNS ./.
@@88072458788 A/DT 3-yr/JJ retrospective/JJ review/NN is/VBZ effective/JJ and/CC detects/VBZ 94%/CD of/IN the/DT undercalls/NNS ./.
@@10665949475 The/DT partial/JJ farm/NN budget/NN highlighted/VBD the/DT importance/NN of/IN reducing/JJ sub-clinical/JJ lesions/NNS in/IN a/DT feedlot/NN ./.
@@82893399156 Additional/JJ exonuclease/NEWGENE III/NEWGENE protection/NN was/VBD observed/VBN beyond/RB the/DT core/NN region/NN on/IN both/PDT the/DT 5'/CD and/CC 3'/CD sides/NNS ,/, suggesting/VBG that/IN E1/NEWGENE interacted/VBN with/IN more/RB distal/JJ sequences/NNS as/IN well/NN ./.
@@10496161328 Serum/NN antibodies/NNS were/VBD detected/VBN in/IN at/IN least/RB 95%/CD of/IN the/DT infected/VBN guinea/NN pigs/NNS between/IN 4-30/NNP WPI/NNP and/CC rats/NNS between/IN 3-16/CD WPI/NNP ./.
@@88959978851 Physiol/NNP ./.
@@83099578290 Two/CD experiments/NNS were/VBD conducted/VBN to/IN study/NN the/DT vacuous/JJ jaw/NN movements/NNS induced/VBN in/IN rats/NNS by/IN acute/JJ administration/NN of/IN the/DT monoamine-depleting/JJ agent/NN reserpine/NN ./.
@@21437682748 Impaction/NNS of/IN gastrostomy/NN tube/NN in/IN the/DT abdominal/JJ wall/NN ./.
@@115597898659 However/RB ,/, during/IN our/PRP work/NN with/IN a/DT replication-deficient/JJ virus/NN expressing/JJ the/DT ASF/NEWGENE //NEWGENE SF2/NEWGENE splicing/NEWGENE factor/NN from/IN a/DT progesterone/NN antagonist-inducible/JJ gene/NN cassette/NN ,/, we/PRP discovered/VBD that/IN ASF/NEWGENE //NEWGENE SF2/NEWGENE was/VBD expressed/VBN at/IN a/DT significant/JJ level/NN in/IN the/DT 293/CD producer/NN cell/NN line/NN ,/, even/VB in/IN the/DT absence/NN of/IN inducer/NN ./.
@@98910099917 Molecular/NNP cloning/NN of/IN mouse/NEWGENE glycolate/NEWGENE oxidase/NEWGENE ./.
@@65060746297 E2/NN treatments/NNS elevated/VBD hen/NN plasma/NN TG/NN 7/CD ./CD 2X/CD ,/, PL/NN 5/CD ./CD 1X/CD ,/, and/CC C/NN 7/CD ./CD 2X/CD ;/: and/CC pullet/JJ plasma/NN TG/NN 6/CD ./CD 8X/CD ,/, PL/NN 3/CD ./CD 7X/CD ,/, and/CC C/NN 2/CD ./CD 5X/CD ./.
@@18524381980 The/DT MVV-value/NN is/VBZ under/IN the/DT predicted/VBN level/NN in/IN the/DT case/NN of/IN 67-76/JJ percent/NN ./.
@@83199074558 Using/VBG the/DT rap1t/NEWGENE alleles/NEWGENE to/IN generate/VB wild-type/NN cells/NNS differing/JJ only/RB in/IN telomere/NN tract/NN lengths/NNS ,/, we/PRP also/RB show/VBP that/DT telomere/NN position/NN effects/NNS are/VBP highly/RB sensitive/JJ to/IN changes/NNS in/IN the/DT size/NN (/( or/CC structure/NN )/SYM of/IN the/DT telomeric/JJ tract/NN ./.
@@96097203054 Two/CD protease-resistant/JJ fragments/NNS spanning/VBG the/PDT N-/DT and/CC C-terminal/NN halves/NNS of/IN the/DT nuclease/NEWGENE were/VBD identified/VBN using/VBG different/JJ proteases/NEWGENE which/WDT cleave/VBP the/DT protein/NN in/IN the/DT same/JJ region/NN ./.
@@98678555513 Dorsal/JJ root/JJ ganglia/NN neuron-specific/NN promoter/NN activity/NN of/IN the/DT rabbit/NEWGENE beta-galactoside/NEWGENE alpha1/NEWGENE ,/NEWGENE 2-fucosyltransferase/NEWGENE gene/NEWGENE ./.
@@97238967240 Peroxisome/NEWGENE proliferator-activated/NEWGENE receptors/NEWGENE (/( PPAR/NEWGENE )/SYM modulate/VB transcription/NN by/IN binding/JJ to/IN specific/JJ peroxisome/NEWGENE proliferator-response/NEWGENE elements/NEWGENE (/( PPRE/NEWGENE )/SYM through/JJ heterodimerization/NN with/IN the/DT 9-cis/NEWGENE retinoic/NEWGENE acid/NEWGENE receptor/NEWGENE (/( RXR/NEWGENE )/SYM ./.
@@11110528944 A/DT prospectively/RB gated/NN 2D/NN axial/JJ sequence/NN with/IN velocity/NN encoding/VBG in/IN the/DT craniocaudal/JJ direction/NN in/IN the/DT cervical/JJ region/NN was/VBD set/NN at/IN a/DT velocity/NN of/IN +/NN //NN -/NN 10/CD cm/NNS //NNS s/NNS ./.
@@87566422729 Alterations/NNS of/IN the/DT 5q23-q31/NN interval/NN are/VBP frequently/RB observed/VBN in/IN myelodysplasia/NN and/CC myeloid/JJ leukemia/NN ./.
@@102070904445 Mechanistically/RB ,/, the/DT presence/NN of/IN the/DT GRR/NN appears/VBZ to/IN stop/NN further/JJ degradation/NN of/IN p50/NEWGENE and/CC to/IN stabilize/VB the/DT molecule/NN ./.
@@96653619628 Suppressive/JJ therapy/NN for/IN thyroid/JJ nodules/NNS ./.
@@98816926289 Therefore/RB ,/, in/IN order/NN to/IN search/NN for/IN the/DT latent/JJ genes/NNS ,/, we/PRP used/VBD allotype-specific/NN oligonucleotides/NN for/IN b5/NEWGENE ,/, b6/NEWGENE and/CC b9/NEWGENE to/IN probe/NN DNAs/NNS from/IN both/DT normal/JJ and/CC T/NNP ./NNP brucei-infected/JJ rabbits/NNS by/IN Southern/NNP blotting/NN ./.
@@19748769732 A/DT high-frequency/JJ restriction/NN fragment/NN length/NN polymorphism/NN was/VBD evident/JJ in/IN the/DT DNA/NN from/IN 29/CD unrelated/JJ individuals/NNS using/VBG the/DT enzyme/NN BglII/NEWGENE ./.
@@28302654434 RPA190/NEWGENE encodes/VBZ a/DT polypeptide/NN chain/NN of/IN 186/CD ,/CD 270/CD daltons/NNS in/IN a/DT large/JJ uninterrupted/JJ reading/JJ frame/NN ./.
@@69591309810 The/DT arginyl/NN peptide/NN bonds/NNS that/WDT are/VBP cleaved/VBN in/IN the/DT conversion/NN of/IN human/NEWGENE factor/NEWGENE IX/NEWGENE to/IN factor/NEWGENE IXa/NEWGENE by/IN factor/NEWGENE XIa/NEWGENE were/VBD identified/VBN as/IN Arg145-Ala146/NN and/CC Arg180-Val181/NN ./.
@@25437348244 Synthetic/JJ oligonucleotides/NNS representing/VBG the/DT 19/CD bp/NN repeat/NN unit/NN strongly/RB reduced/VBD the/DT activity/NN of/IN the/DT IE1/NEWGENE //NEWGENE 2/NEWGENE enhancer/NEWGENE //NEWGENE promoter/NEWGENE in/IN cotransfection/NN assays/NNS after/IN transient/JJ expression/NN ./.
@@23868953038 Toxicities/NNPS included/VBN :/: nausea/VBG //VBG vomiting/VBG (/( 69%/CD )/SYM ,/, headache/NN (/( 25%/JJ )/SYM ,/, chills/NNS (/( 69%/CD )/SYM ,/, pain/NN at/IN tumor/NN sites/NNS (/( 63%/JJ )/SYM ,/, hypotension/NN (/( 31%/JJ )/SYM ,/, and/CC hypertension/NN (/( 38%/JJ )/SYM ./.
@@83660347581 Despite/IN the/DT existence/NN of/IN 30/CD cysteine/NN residues/NNS ,/, carboxymethylation/NN prevented/VBD the/DT formation/NN of/IN most/RB if/IN not/RB all/DT disulfide/NN bonds/NNS that/WDT otherwise/RB occurred/VBN when/CC the/DT cells/NNS were/VBD sonicated/JJ ./.
@@16397244215 A/DT control/NN group/NN of/IN nine/JJ women/NNS (/( age/NN 23-40/JJ years/NNS )/SYM on/IN oral/JJ contraceptives/NNS (/( Nordette-28/NN )/SYM was/VBD also/RB studied/VBN four/CD times/NNS during/IN a/DT pill/NN cycle/NN ./.
@@82267806770 This/DT motif/NN has/VBZ been/VBN shown/VBP to/IN mediate/VB protein/NN interactions/NNS in/IN the/DT case/NN of/RB ankyrin/NEWGENE as/RB well/VB as/IN several/DT other/DT repeat-bearing/JJ proteins/NNS ./.
@@16136408549 The/DT coating/NN materials/NNS were/VBD poloxamine/NN 904/NN ,/, poloxamine/NN 908/NN ,/, poloxamine/NN 1508/CD ,/, poloxamer/NN 338/NN ,/, and/CC Brij/NNP 35/CD ./CD
@@17561952346 In/NN addition/NN ,/, there/RB was/VBD a/DT significant/JJ increase/NN in/IN postdexamethasone/NN cortical/JJ concentrations/NNS with/IN age/NN (/( p/NN less/PRP than/IN 0/CD ./CD 01/CD ;/: r/JJ =/SYM 0/CD ./CD 31/CD )/SYM ./.
@@30731923794 Mycobacterium/NN avium-intracellulare/NN complex/NN infections/NNS in/IN the/DT acquired/VBN immunodeficiency/NN syndrome/NN ./.
@@90370641824 Recent/JJ application/NN of/IN recombinant/JJ canarypox/NN ALVAC/NN //NN HIV-1/NN vectors/NN as/IN vaccine/NN immunogens/NNS in/IN HIV-1/JJ ,/JJ -noninfected/JJ volunteers/NNS has/VBZ produced/VBN CTL/NN responses/NNS in/IN a/DT significant/JJ number/NN of/IN vaccinees/NNS ./.
@@113800287340 The/DT purpose/NN of/IN this/DT study/NN was/VBD to/IN evaluate/VB simplified/JJ methods/NNS for/IN estimation/NN of/IN Technetium/NN Tc/NN 99m/NN (/( 99mTc/NN )/NN -pentetate/NN and/CC orthoiodohippurate/NN I/NN 131/NN (/( 131I-OIH/NN )/SYM plasma/NN clearance/NN in/IN dogs/NNS and/CC cats/NNS with/IN 1/CD and/CC 2/CD blood/NN samples/NNS ./.
@@90842275949 Hovenitin/NN I/NN and/CC (/( +/SYM )/NN -ampelopsin/NN ,/, both/DT of/IN which/WDT were/VBD principal/JJ ingredients/NNS of/IN the/DT active/JJ fractions/NNS from/IN this/DT natural/JJ medicine/NN ,/, were/VBD found/VBN to/IN show/NN an/DT inhibitory/JJ activity/NN on/IN the/DT ethanol-induced/JJ muscle/NN relaxation/NN in/IN rats/NNS ./.
@@66123735884 This/DT paper/NN brings/VBZ together/RB data/NN ,/, obtained/VBN from/IN a/DT variety/NN of/IN sources/NNS ,/, on/IN the/DT extent/NN of/IN prescription/NN and/CC use/NN of/IN psychotropic/JJ drugs/NNS in/IN the/DT late/JJ 1960s/CD and/CC early/NN 1970s/NN ./.
@@83893658503 This/DT observation/NN suggests/VBZ that/IN the/DT methyl-directed/JJ repair/NN system/NN utilizes/VBZ the/DT proximal/JJ d/NN (/NN GATC/NN )/NN sequence/NN to/IN direct/JJ correction/NN ./.
@@118934031797 Elements/NNS that/WDT are/VBP fundamental/JJ to/IN the/DT safety/NN evaluation/NN of/IN flavor/NN ingredients/NNS include/VBP exposure/NN ,/, structural/JJ analogy/NN ,/, metabolism/NN ,/, pharmacokinetics/NN and/CC toxicology/NN ./.
@@106886399562 This/DT repression/NN does/VBP not/RB require/VB the/DT PU/NEWGENE ./NEWGENE 1/NEWGENE transactivation/NN or/CC PEST/NEWGENE domains/NEWGENE and/CC cannot/MD be/VB reversed/VBN by/IN p300/NEWGENE expression/NN ./.
@@13244064160 Possible/JJ roles/NNS of/IN RAD5/NEWGENE putative/JJ ATPase/NEWGENE //NEWGENE DNA/NEWGENE helicase/NEWGENE activity/NN in/IN DNA/NN repair/NN and/CC in/IN the/DT maintenance/NN of/IN wild-type/NN rates/NNS of/IN instability/NN of/IN simple/JJ repetitive/JJ sequences/NNS are/VBP discussed/VBN ./.
@@30699803791 Factors/NNS influencing/VBG the/DT bond/NN strength/NN between/IN glass/NN polyalkenoate/NN (/( ionomer/NN )/SYM cements/NNS and/CC dentine/NN ./.
@@80706549972 CDC31/NEWGENE is/VBZ required/VBN for/IN SPB/NN duplication/NN and/CC encodes/VBZ a/DT calmodulin-like/NEWGENE protein/NEWGENE that/WDT is/VBZ most/RB closely/RB related/VBN to/IN caltractin/NN //NN centrin/NN ,/, a/DT protein/NN associated/VBN with/IN the/DT Chlamydomonas/NN basal/JJ body/NN ./.
@@87527148738 The/DT occurrence/NN of/IN multiple/JJ malignancy/NN was/VBD studied/VBN in/IN 674/CD patients/NNS with/IN hematologic/JJ malignancies/NNS who/WP were/VBD admitted/VBN to/IN this/DT department/NN during/IN the/DT past/JJ 10/CD years/NNS ./.
@@111729441013 RESULTS/NNS :/: Of/IN the/DT 24/CD patients/NNS ,/, 6/CD had/VBP Grade/NNP 1/CD pneumonitis/NN ,/, and/CC 13/CD had/VBP Grade/NNP 2/CD pneumonitis/NN ./.
@@78461992182 The/DT effect/NN of/IN ethanol/NN on/IN human/NN sensorimotor/NN reactivity/NN was/VBD assessed/VBN by/IN examining/VBG the/DT acoustic/JJ startle/VB response/NN ./.
@@111889936282 Corneal/JJ scrapping/NN and/CC deep/JJ stromal/JJ biopsy/NN were/VBD obtained/VBN and/CC stained/VBN for/IN microscopic/JJ evaluation/NN with/IN periodic/JJ acid-Schiff/NN ,/, Giemsa/JJ ,/, and/CC Gomori's/NNP methenamine/NN silver/NN stains/NNS ./.
@@19788347295 A/DT bovine/NN abomasum/NN lambda/NN gt11/NN cDNA/NN library/NN was/VBD screened/VBN with/IN a/DT monoclonal/JJ antibody/NN raised/VBN against/IN the/DT rabbit/NEWGENE H/NEWGENE ,/NEWGENE K-ATPase/NEWGENE beta/NEWGENE subunit/NEWGENE ./.
@@93860742923 All/DT pigs/NNS had/VBP significant/JJ regional/NN LV/NN dysfunction/NN and/CC reduced/VBN LV/NN ejection/NN fraction/NN (/( 41+/JJ //JJ -11%/JJ )/SYM ./.
@@71140836921 After/IN MOPP/NN therapy/NN ,/, complete/JJ remission/NN of/IN Hodgkin's/NNP disease/NN was/VBD accompanied/VBN by/IN normalization/NN of/IN the/DT glucocerebrosidase/NEWGENE level/NN and/CC disappearance/NN of/IN Gaucher's/NNP cells/NNS ./.
@@104072697841 67/CD 393/CD bp/NN of/IN contiguous/JJ DNA/NN located/VBN between/IN markers/NN cdc18/NEWGENE and/CC cdc14/NEWGENE on/IN the/DT right/JJ arm/NN of/IN fission/NN yeast/NN chromosome/NN II/NN has/VBZ been/VBN sequenced/VBN as/IN part/NN of/IN the/DT European/NNP Union/NNP Schizosaccharomyces/NN pombe/NN genome/NN sequencing/VBG project/NN ./.
@@104911333283 Optical/NNP CD/NN ,/, and/CC spectral/NN and/CC activity/NN analyses/NNS were/VBD used/VBN to/IN examine/VB reactivity/NN of/IN HO/NEWGENE isozymes/NEWGENE with/IN NO/DT species/NN produced/VBN by/IN NO/DT donors/NNS ./.
@@13743311155 Neither/CC gene/NN possesses/VBZ a/DT distinct/JJ transcriptional/JJ start/NN site/NN as/IN shown/VBP by/IN nuclease/NEWGENE S1/NEWGENE analysis/NN ./.
@@81750318147 Treatment/NNP was/VBD well-tolerated/JJ ./.
@@79025328955 Deletion/NNS analyses/NNS of/IN the/DT construct/NN revealed/VBN that/IN the/DT transcription/NN of/IN BOXF1/NEWGENE gene/NEWGENE is/VBZ regulated/VBN by/IN BOX/NEWGENE DNA/NEWGENE ,/, preferentially/RB in/IN undifferentiated/JJ EC/NN cells/NNS versus/IN differentiated/VBN cells/NNS ./.
@@21485081111 Fluid/NNS (/( AVLF/NN )/SYM 31/CD ./CD
@@10369625238 Optimal/JJ monitoring/NN of/IN ODA/NN remains/VBP undefined/JJ ./.
@@84548587889 Ig-alpha/NEWGENE and/CC Ig-beta/NEWGENE contain/VB extended/VBN cytoplasmic/JJ structure/NN (/( 61/CD and/CC 48/CD amino/JJ acids/NNS ,/, respectively/RB )/SYM and/CC associate/VB with/IN cytoplasmic/JJ effectors/NNS indicating/VBG that/IN they/PRP are/VBP directly/RB involved/VBN in/IN signal/JJ transduction/NN ./.
@@108822134817 Topics/NNS reviewed/VBN here/RB include/VB :/: data/NN supporting/JJ the/DT association/NN of/IN myositis/NN with/IN cancer/NN and/CC the/DT appropriate/JJ evaluations/NNS for/IN malignancy/NN in/IN a/DT myositis/NN patient/NN ;/: an/DT approach/NN to/IN the/DT assessment/NN of/IN patients/NNS with/IN dermatomyositis/NN sine/NN myositis/NN ;/: the/DT usefulness/NN of/IN the/DT clinicopathological/JJ and/CC serological/JJ classifications/NNS ;/: a/DT discussion/NN of/IN whether/IN childhood/NN and/CC adult/JJ myositis/NN are/VBP the/DT same/JJ or/CC different/JJ entities/NNS ;/: a/DT review/NN of/IN those/DT prognostic/JJ factors/NNS to/IN consider/VB in/IN the/DT clinical/JJ management/NN of/IN myositis/NN patients/NNS ;/: current/JJ approaches/NNS and/CC their/PRP limitations/NNS for/IN assessing/JJ disease/NN activity/NN and/CC damage/NN ./.
@@29980439288 Examination/NN of/IN the/DT sequence/NN of/IN the/DT Punta/NEWGENE Toro/NEWGENE M/NEWGENE gene/NEWGENE product/NEWGENE reveals/VBZ the/DT presence/NN of/IN multiple/JJ hydrophobic/JJ sequences/NNS including/JJ a/DT 19-amino/NEWGENE acid/NEWGENE ,/NEWGENE carboxy-proximal/NEWGENE ,/NEWGENE hydrophobic/NEWGENE region/NEWGENE (/NEWGENE G2/NEWGENE )/NEWGENE ./.
@@95773652200 In/NN angiodysplasia/NN ,/, ectatic/JJ vessels/NNS in/IN the/DT mucosa/NN appeared/VBN to/IN contain/VB less/PRP collagen/NEWGENE type/NEWGENE IV/NEWGENE than/IN similarly/RB sized/JJ vessels/NNS in/IN the/DT submucosa/NN ,/, and/CC perforating/JJ vessels/NNS appeared/VBN in/IN many/JJ cases/NNS to/IN lose/VB staining/NN at/IN the/DT level/NN of/IN the/DT muscularis/NN mucosae/NNS ./.
@@9478347628 RESULTS/NNS :/: Total/JJ IgE/NEWGENE levels/NNS showed/VBD a/DT tendency/NN to/IN diminish/VB ./.
@@101995396110 In/NN ischemic/JJ and/CC hypoxic/JJ hypoxia/NN ,/, a/DT strong/JJ correlation/NN was/VBD found/VBN between/IN cyt/JJ a/CD ,/CD a3/CD oxidation/NN level/NN and/CC VO2/NN in/IN both/DT ischemic/JJ and/CC hypoxic/JJ hypoxia/NN (/( r2/NN =/CD ./CD 90/CD and/CC ./CD 87/CD ,/, respectively/RB )/SYM ./.
@@83258837487 The/DT sequence/NN of/IN the/DT putative/JJ RBP1/NEWGENE protein/NEWGENE contains/VBZ two/JJ copies/NNS of/IN an/DT RNA/NN recognition/NN motif/NN ,/, two/JJ glutamine/NN stretches/NNS ,/, an/DT asparagine-rich/JJ region/NN ,/, a/DT methionine-rich/JJ region/NN ,/, and/CC two/JJ long/JJ potential/JJ alpha-helixes/NNS ./.
@@93604223829 In/NN a/DT group/NN of/IN 13/CD patients/NNS with/IN obliterative/JJ arteriopathies/NNS of/IN the/DT lower/JJR limbs/NNS the/DT plasma/NN levels/NNS of/IN thrombomodulin/NEWGENE (/( TM/NEWGENE )/SYM ,/, betathromboglobulin/NEWGENE (/( beta-TG/NEWGENE )/SYM ,/, D-dimer/NEWGENE (/( DD/NEWGENE )/SYM and/CC plasminogen/NEWGENE activator-inhibitor/NEWGENE (/( pAI-1/NEWGENE )/SYM were/VBD measured/VBN ,/, and/CC compared/VBD to/IN the/DT values/NNS obtained/VBN from/IN 10/CD healthy/JJ volunteers/NNS ./.
@@3441587502 Research/NNP was/VBD carried/VBN out/RB on/IN the/DT rheumatoid/NEWGENE factors/NEWGENE in/IN the/DT serum/NN of/IN 917/CD patients/NNS by/IN means/NN of/IN two/JJ tests/NNS (/( one/PRP using/VBG polystyrene/NN and/CC one/PRP with/IN erythrocytes/NNS )/SYM and/CC the/DT results/NNS obtained/VBN were/VBD compared/VBN using/VBG a/DT method/NN of/IN reference/NN ./.
@@20835461422 A/DT new/JJ semi-automatic/JJ method/NN for/IN quantifying/JJ regional/JJ cerebral/JJ uptake/NN of/IN 99m/CD technetium-hexamethylpropylene/JJ amine/NN oxime/NN (/( 99mTc-HMPAO/NN )/SYM was/VBD used/VBN to/IN assess/VB single/JJ photon/NN emission/NN tomograms/NNS from/IN 5/CD normal/JJ subjects/NNS ,/, 14/CD patients/NNS with/IN Alzheimer's/NN disease/NN ,/, 14/CD patients/NNS with/IN dementia/NN of/IN frontal/JJ lobe/NN type/NN and/CC 4/CD patients/NNS with/IN dementia/NN with/IN motor/JJ neurone/NN disease/NN ./.
@@16579694952 However/RB ,/, alterations/NNS in/IN electrostatic/JJ and/CC hydrophobic/JJ interactions/NNS created/VBN by/IN the/DT three/CD amino/JJ acid/NN substitutions/NNS prevent/VBP the/DT conformational/JJ change/NN in/IN the/DT enzyme/NN usually/RB produced/VBD by/IN calmodulin/NEWGENE binding/JJ ./.
@@92158913733 The/DT products/NNS of/IN the/DT Saccharomyces/NEWGENE cerevisiae/NEWGENE CIN1/NEWGENE ,/, CIN2/NEWGENE and/CC CIN4/NEWGENE genes/NEWGENE participate/VBP in/IN a/DT nonessential/JJ pathway/NN required/VBN for/IN normal/JJ microtubule/NN function/NN ./.
@@19061112534 This/DT study/NN indicates/VBZ that/IN this/DT dose-intense/JJ regimen/NN can/MD be/VB safely/RB administered/VBN ,/, even/VB with/IN the/DT use/NN of/IN purged/VBN marrow/NN ,/, with/IN an/DT acceptable/JJ toxicity/NN profile/NN ./.
@@87079228262 Transcription/NNS initiation/NN sites/NNS of/IN the/DT rat/NEWGENE II/NEWGENE beta-/NEWGENE ,/NEWGENE III/NEWGENE beta/NEWGENE ,/NEWGENE and/NEWGENE O/NEWGENE beta-globin/NEWGENE genes/NEWGENE were/VBD determined/VBN to/IN be/VB 52/CD base/NN pairs/NNS (/( bp/NN )/SYM 5'-upstream/NN of/IN the/DT translation/NN initiation/NN codon/NN (/( ATG/NN )/SYM ,/, in/IN each/DT gene/NN by/IN primer/NN extension/NN analysis/NN ./.
@@76639986575 Transabdominal/JJ repair/NN of/IN type/NN IV/NN thoraco-abdominal/JJ aortic/JJ aneurysms/NNS ./.
@@110907628943 RESULTS/NNS :/: The/DT main/JJ effect/NN of/IN muscle/NN pain/NN ,/, compared/VBN to/IN non-painful/JJ stimulation/NN ,/, was/VBD a/DT significant/JJ and/CC long-lasting/JJ increase/NN of/IN delta/JJ (/( 1-3/CD Hz/NN )/SYM power/NN and/CC an/DT alpha-1/NN (/( 9-11/CD Hz/NN )/SYM power/NN increase/NN over/RB the/DT contralateral/JJ parietal/JJ locus/NN ./.
@@113500383928 Here/RB we/PRP present/VBP evidence/VBP that/IN the/DT distal/JJ half/NN (/( Stem/NN 2/CD )/SYM of/IN the/DT conserved/VBN base-paired/JJ stem/NN structure/NN found/VB in/IN all/DT hY/NEWGENE RNAs/NEWGENE also/RB plays/VBP a/DT critical/JJ role/NN in/IN the/DT export/NN process/NN ./.
@@37997904486 While/IN the/DT examiner/NN observed/VBD the/DT interior/NN of/IN the/DT eye/NN with/IN indirect/JJ ophthalmoscopy/NN ,/, the/DT point/NN source/NN of/IN light/NN from/IN the/DT fiberoptic/JJ light/NN pipe/NN was/VBD moved/VBN along/IN the/DT margins/NNS of/IN the/DT episcleral/JJ plaque/NN ./.
@@77084881877 In/NN contrast/NN to/IN some/DT results/NNS previously/RB published/VBN for/IN a/DT very/RB close/JJ sequence/NN variant/NN (/( see/VB ref/NN ./.
@@25426121781 S1/NEWGENE nuclease/NEWGENE analysis/NN of/IN RNA/NN from/IN chemically/RB induced/VBN B95-8/CD cells/NNS and/CC from/IN Vero/NNP cells/NNS cotransfected/VBN with/IN NotI/NEWGENE repeat/NEWGENE promoter-CAT/NEWGENE and/CC Z/NEWGENE showed/VBD that/DT Z/NEWGENE transactivation/NN increased/VBD the/DT level/NN of/IN correctly/RB initiated/VBN ,/, stable/JJ RNA/NN transcripts/NNS ./.
@@84834125550 The/DT nifJ/NEWGENE and/CC nifH/NEWGENE promoters/NEWGENE of/NEWGENE Klebsiella/NEWGENE pneumoniae/NEWGENE are/VBP divergently/RB transcribed/VBN sigma/NEWGENE 54-dependent/NEWGENE promoters/NEWGENE that/WDT are/VBP positively/RB activated/VBN by/IN the/DT NifA/NEWGENE protein/NEWGENE ./.
@@117405718901 Both/DT toxins/NNS in/IN a/DT dose/NN 10-fold/JJ surpassimg/NN the/DT maximum/JJ permissible/JJ concentration/NN increased/VBD activity/NN of/IN glutathione/NEWGENE peroxidase/NEWGENE in/IN brain/NN tissue/NN ;/: moreover/RB ,/, toluene/NN increased/VBD chemiluminescence/NN intensity/NN ,/, which/WDT attested/VBD to/IN activation/NN of/IN free/JJ radical/JJ processes/NNS ./.
@@98823488455 To/TO this/DT end/NN ,/, we/PRP analyzed/VBD the/DT phosphorylation/NN status/NN of/IN a/DT universal/JJ tyrosine/NEWGENE kinase/NEWGENE substrate/NN ,/, the/DT transforming/NN Shc/NEWGENE adapter/NEWGENE protein/NEWGENE ,/, in/IN fibroblasts/NNS expressing/JJ the/DT viral/JJ oncogene/NN ./.
@@98264346994 Partial/JJ characterization/NN of/IN the/DT active/JJ site/NN human/NEWGENE platelet/NEWGENE cAMP/NEWGENE phosphodiesterase/NEWGENE ,/, PDE3A/NEWGENE ,/, by/IN site-directed/JJ mutagenesis/NN ./.
@@78290972141 The/DT region/NN between/IN DXS52/NEWGENE and/CC Factor/NEWGENE VIII/NEWGENE gene/NEWGENE in/IN the/DT human/NN Xq28/NN chromosomal/JJ band/NN contains/VBZ a/DT G+C-rich/NNP isochore/NN to/IN which/WDT many/JJ genes/NNS have/VBP been/VBN mapped/VBN ./.
@@81576746221 Biochemical/NNP characterization/NN of/IN valosin-containing/NEWGENE protein/NEWGENE ,/, a/DT protein/NEWGENE tyrosine/NEWGENE kinase/NEWGENE substrate/NN in/IN hematopoietic/JJ cells/NNS ./.
@@25759594349 The/DT latency/NN time/NN for/IN the/DT lactate/NN concentration/NN to/IN reach/NN the/DT top/JJ values/NNS was/VBD reduced/VBN by/IN aerobic/JJ training/NN (/( T2/NN )/SYM ./.
@@92119814776 We/PRP also/RB provide/VBP evidence/NN that/IN gar2/NEWGENE is/VBZ phosphorylated/VBN in/IN vitro/FW by/IN a/DT p13/NEWGENE (/NN suc1/NEWGENE )/NN -Sepharose-bound/NN kinase/NEWGENE from/IN Schizosaccharomyces/NN pombe/NN extracts/NNS that/WDT displays/VBP cell/NN cycle-regulated/JJ activity/NN similar/JJ to/IN that/DT of/IN the/DT p34/NEWGENE (/NEWGENE cdc2/NEWGENE (/NEWGENE kinase/NEWGENE ./.
@@87608726907 Our/PRP results/NNS support/NN a/DT model/NN where/CC both/DT E2F-/NN and/CC CDE-mediated/JJ repression/NN ,/, acting/JJ at/IN different/JJ stages/NNS in/IN the/DT cell/NN cycle/NN ,/, are/VBP dependent/JJ on/IN promoter-specific/NN CHR/NEWGENE elements/NEWGENE ./.
@@8332495568 Indeed/RB ,/, significant/JJ level/NN of/IN CAT/NEWGENE activity/NN was/VBD observed/VBN in/IN human/JJ lung/NN adenocarcinoma/NN (/( A549-1/NNP )/SYM cells/NNS which/WDT had/VBP been/VBN incubated/VBN with/IN a/DT complex/NN of/IN T7/NEWGENE RNA/NEWGENE polymerase/NEWGENE ,/, pT7-EMC-CAT/NEWGENE DNA/NEWGENE and/CC DC-chol/NNP cationic/JJ liposomes/NNS ./.
@@84357948396 CONCLUSIONS/DT ./.
@@15592092164 Preceptorship/NN of/IN CNS/NN students/NNS :/: an/DT exploratory/JJ study/NN ./.
@@113562143601 The/DT difference/NN of/IN hardness/NN over/JJ time/NN of/IN composite/JJ specimens/NNS was/VBD measured/VBN using/VBG Knoop/NN hardness/NN measurements/NNS taken/VBP at/IN the/DT top/NN and/CC bottom/NN surfaces/NNS of/IN resin/NN specimens/NNS made/VBP in/IN a/DT Teflon/NN mold/NN the/DT same/JJ dimensions/NNS as/IN the/DT cavity/NN prepared/VBN in/IN dentin/NEWGENE ./.
@@91620971843 An/DT alternatively/RB spliced/VBN MAdCAM-1/NEWGENE variant/NN was/VBD identified/VBN that/WDT lacks/VBZ exon/NN 4/CD encoding/VBG the/DT mucin/NEWGENE domain/NN ,/, and/CC may/MD mediate/VB leukocyte/NN adhesion/NN to/IN LPAM-1/NEWGENE without/IN adhesion/NN to/IN the/DT alternate/NN receptor/NN ,/, L-selectin/NEWGENE ./.
@@94479179399 The/DT hypothesis/NN of/IN Geisler/NNP (/( Brain/NN Res/NNS ./.
@@10756007243 EM/NN analysis/NN demonstrated/VBN that/IN only/RB one/PRP Rep-DNA/NEWGENE complex/NEWGENE was/VBD formed/VBN on/IN ch-19/NN target/NN DNA/NN ./.
@@36797564345 Epithelial/JJ nerve/NN fiber/NN defects/NNS included/VBD absence/NN or/CC distorted/VBN architecture/NN of/IN the/DT basal/JJ epithelial/JJ plexus/NN and/CC intra-epithelial/JJ terminals/NNS ./.
@@8659545594 In/NN an/DT effort/NN to/IN contribute/VB to/IN the/DT transcript/NN map/NN of/IN human/JJ chromosome/NN 21/CD and/CC the/DT understanding/NN of/IN the/DT pathophysiology/NN of/IN trisomy/NN 21/CD ,/, we/PRP have/VBP used/VBN exon/NN trapping/JJ to/IN identify/VB fragments/NNS of/IN chromosome/NN 21/NN genes/NN ./.
@@9557678324 We/PRP previously/RB demonstrated/VBD that/IN acute/JJ expression/NN of/IN the/DT bovine/JJ papillomavirus/NN type/NN 1/CD (/( BPV1/NN )/SYM E2/NEWGENE protein/NEWGENE in/IN HeLa/DT and/CC HT-3/NN cervical/JJ carcinoma/NN cell/NN lines/NNS greatly/RB reduced/VBN cellular/JJ proliferation/NN by/IN imposing/JJ a/DT specific/JJ G1/NN //NN S/NN phase/NN growth/NN arrest/NN ./.
@@11566317660 The/DT mean/JJ plasma/NN sodium/NN concentration/NN which/WDT was/VBD 135/CD ./CD 95/CD (/( +/NN //NN -/NN SD/NN 4/NN ./NN 14/NN )/SYM mEq/NN //NN kg/NN before/IN diuretic/JJ treatment/NN was/VBD significantly/RB decreased/VBN during/IN treatment/NN to/IN 129/CD ./CD 19/CD (/( +/NN //NN -/NN SD/NN 2/NN ./NN 77/NN )/SYM mEq/NN //NN kg/NN ,/, P/NN less/PRP than/IN 0/CD ./CD 001/CD ./.
@@104389246079 In/NN insulin-responsive/JJ cells/NNS ,/, Akt/NEWGENE phosphorylates/VBZ and/CC inactivates/VBZ the/DT serine/NEWGENE //NEWGENE threonine/NEWGENE kinase/NEWGENE glycogen/NEWGENE1 synthase/NEWGENE1 kinase-3/NEWGENE1 (/( GSK-3/NEWGENE )/SYM ./.
@@100667989626 Cyclin/NEWGENE D1-associated/NEWGENE kinase/NEWGENE activity/NN and/CC protein/NN levels/NNS were/VBD increased/VBN in/IN mammary/JJ tumors/NNS from/IN murine/NEWGENE mammary/NEWGENE tumor/NEWGENE virus-pp60/NEWGENE (/NEWGENE c-src527F/NEWGENE )/NEWGENE transgenic/JJ mice/NNS ./.
@@85806718557 We/PRP conducted/VBD a/DT prospective/NN ,/, randomized/JJ controlled/VBN trial/NN of/IN metoprolol/NN ,/, a/DT selective/JJ beta-blocker/NN for/IN prevention/NN of/IN gastrointestinal/JJ bleeding/NN from/IN portal/JJ hypertension/NN in/IN 29/CD non-selected/JJ patients/NNS with/IN liver/NN disease/NN and/CC previous/JJ gastrointestinal/JJ bleeding/NN ./.
@@96431539415 [/NN Treatment/NN of/IN early/NN T1/NN small/JJ T2N/NNP breast/NN cancers/NNS ./.
@@10871347156 Mutation/NN analysis/NN demonstrates/VBZ that/IN the/DT motif/NN TCCCCT/NEWGENE is/VBZ critical/JJ for/IN PyRo1/NEWGENE interaction/NN ./.
@@91152799347 Cdc2/NEWGENE co-precipitates/VBZ with/IN Pch1/NEWGENE in/IN S/NNP ./NNP pombe/NN cell/NN lysates/NNS ,/, although/IN Cdc2/NEWGENE may/MD not/RB be/VB the/DT major/JJ catalytic/JJ partner/NN of/IN a/DT Pch1/NEWGENE kinase/NEWGENE in/IN vivo/NN ./.
@@25118983157 This/DT paper/NN presents/VBP the/DT reasons/NNS why/RB countries/NNS to/IN which/WDT Chagas/NN disease/NN is/VBZ endemic/NN should/MD carry/VB out/RB the/IN relevant/JJ research/NN themselves/PRP ./.
@@111249028555 Copyright/NNP 2000/CD Academic/NNP Press/NNP ./.
@@86807025097 Despite/IN significant/JJ lethality/NN and/CC cardiovascular/JJ dysfunction/NN ,/, in/IN the/DT septic/JJ group/NN on/IN Days/NN 1/CD and/CC 2/CD ,/, septic/JJ versus/IN control/NN animals/NNS had/VBP no/DT significant/JJ differences/NNS in/IN mean/JJ metabolic/JJ cart/NN measured/VBN (/( Vo2DIR/NN ,/, ml/NN //NN kg/NN //NN min/NN ;/: Day/NN 1/CD :/: 11/CD ./CD 9/CD versus/IN 12/CD ./CD 4/CD ,/, p/NN =/SYM 0/CD ./CD 81/CD ;/: Day/NN 2/CD :/: 14/CD ./CD 2/CD versus/IN 13/CD ./CD 5/CD ,/, p/NN =/SYM 0/CD ./CD 72/CD ,/, respectively/RB )/SYM and/CC intravascular/JJ catheter/NN calculated/VBN (/( Vo2INDIR/NN ,/, ml/NN //NN kg/NN //NN min/NN ;/: Day/NN 1/CD :/: 11/CD ./CD 2/CD versus/IN 11/CD ./CD 2/CD ,/, p/NN =/SYM 0/CD ./CD 99/CD ;/: Day/NN 2/CD :/: 12/CD ./CD 8/CD versus/IN 15/CD ./CD 4/CD ,/, p/NN =/SYM 0/CD ./CD 49/CD ,/, respectively/RB )/SYM ./.
@@27570331492 This/DT would/MD have/NN had/VBP the/DT effect/NN of/IN positioning/VBG the/DT genes/NNS currently/RB on/IN the/DT long/JJ arm/NN adjacent/JJ to/IN the/DT centromeric/NN heterochromatin/NN ,/, perhaps/RB resulting/JJ in/IN a/DT "position/NN effect"/NN on/IN transcription/NN of/IN these/DT genes/NNS ./.
@@10781990591 T1-weighted/JJ MRI/NN on/IN the/DT 49th/CD postoperative/JJ day/NN demonstrated/VBD bilateral/JJ and/CC symmetrical/JJ hyperintense/JJ lesions/NNS in/IN the/DT globus/NN pallidus/NN ./.
@@96107557174 The/DT side-to-side/JJ difference/NN was/VBD statistically/RB significant/JJ at/IN EXT/NN 30/CD degrees/NNS //NNS s/NNS and/CC 60/CD degrees/NNS //NNS s/NNS (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@18815952493 Formalin/NN activated/VBN both/DT SNO/NN NS/NN and/CC NnS/NNP neurones/NNS ,/, but/CC ,/, when/CC they/PRP responded/VBD ,/, NS/NNP neurones/NNS (/( n/NN =/SYM 5/CD )/SYM showed/VBD only/RB the/DT first/JJ phase/NN of/IN activity/NN while/CC NnS/NNP neurones/NNS showed/VBD either/DT one/PRP (/( n/NN =/SYM 13/CD )/SYM or/CC two/JJ phases/NNS (/( n/NN =/SYM 6/CD )/SYM ./SYM
@@14222651554 The/DT IgG/NEWGENE subclass/NN profile/NN of/IN untreated/JJ coeliac/JJ disease/NN was/VBD found/VBN to/IN be/VB the/DT same/JJ as/IN in/IN healthy/JJ controls/NNS (/( IgG1/NEWGENE approximately/JJ IgG2/NEWGENE >/SYM IgG3/NEWGENE >/SYM IgG4/NEWGENE )/SYM ,/, with/IN only/RB the/DT magnitude/NN of/IN the/DT individual/JJ subclass/NN responses/NNS being/VBP increased/VBN in/IN coeliac/JJ patients/NNS ./.
@@67786456548 1/CD ./CD
@@17654079360 An/DT 8-h/JJ exposure/NN to/IN 10/CD mg/NN DMEA/NN //NN m3/NN corresponds/VBZ to/IN a/DT postexposure/JJ plasma/NN concentration/NN and/CC 2-h/JJ postexposure/RB urinary/JJ excretion/NN of/IN 4/CD ./CD 9/CD mumol/NN //NN l/NN and/CC 75/CD mmol/NN //NN mol/NN creatinine/NN ,/, respectively/RB ./.
@@93262463054 Sequence/NN analysis/NN of/IN this/DT region/NN revealed/VBN three/CD eight-bp/JJ repetitive/JJ elements/NNS ,/, the/DT deletion/NN of/IN which/WDT restored/VBD wild-type/NN levels/NNS of/IN luciferase/NEWGENE activity/NN to/IN the/DT -916-bp/CD reporter/NN plasmid/NN ./.
@@104223426225 The/DT radiation/NN burden/NN associated/VBN with/IN the/DT majority/NN of/IN examinations/NNS in/IN nuclear/JJ medicine/NN expressed/VBN as/IN the/DT effective/JJ dose/NN is/VBZ comparable/JJ with/IN the/DT radiation/NN burden/NN of/IN radiodiagnostic/JJ examinations/NNS ,/, only/RB after/IN administration/NN of/IN preparations/NNS with/IN 131I/CD ,/, 201Tl/NN ,/, 67Ga/NN and/CC 111In/NN it/PRP is/VBZ markedly/RB higher/JJ ./.
@@92686386495 Here/RB ,/, we/PRP describe/VBP directional/JJ chromosome/NN walking/NN studies/NNS starting/JJ from/RB D8S260/NEWGENE as/NNP well/VB as/IN D8S285/NEWGENE ./.
@@89234609114 RUSH-1/NEWGENE beta/NEWGENE is/VBZ a/DT 95-kDa/CD truncated/JJ version/NN of/IN RUSH-1/NEWGENE alpha/NEWGENE that/IN results/NNS from/IN alternative/JJ splicing/JJ of/IN a/DT 57-bp/JJ exon/NN as/IN confirmed/VBN by/IN genomic/JJ cloning/NN ./.
@@12451621885 Reduction/NNP in/IN dosage/NN restored/VBD normal/JJ taste/NN sense/NN in/IN all/DT three/CD ,/, but/CC in/IN two/JJ the/DT drug/NN had/VBP to/IN be/VB discontinued/VBN because/IN of/IN persisting/JJ high/JJ transaminase/NEWGENE levels/NNS ./.
@@9177212364 Thus/RB analysis/NN indicated/VBD no/DT reliable/JJ evidence/NN that/IN conscious/JJ presleep/NN suggestions/NNS become/VBP incorporated/VBN into/IN dream/NN content/JJ ./.
@@91489033853 Thus/RB ,/, our/PRP studies/NNS suggest/VBP that/IN pV-mediated/JJ activation/NN of/IN HIV-1/NEWGENE LTR/NEWGENE activity/NN is/VBZ controlled/VBN by/IN the/DT nuclear/JJ translocation/NN of/IN the/DT NF-kappaB/NEWGENE transcription/NEWGENE factor/NEWGENE ,/, which/WDT is/VBZ mediated/JJ by/IN IkappaBalpha/NEWGENE serine/NN phosphorylation/NN and/CC degradation/NN ,/, but/CC also/RB by/IN a/DT still/RB undefined/JJ NF-kappaB-independent/NNP pathway/NN ./.
@@39846834644 Acute/JJ appearance/NN of/IN hemiparesis/NN or/CC hemiplegia/NN with/IN initial/JJ marked/JJ spasticity/NN was/VBD observed/VBN in/IN 8/CD stroke/NN patients/NNS ./.
@@107422168774 Schlegel/NNP ,/, J/NNP ./NNP
@@8921387214 Analysis/NNP of/IN one/PRP cDNA/NN revealed/VBD an/DT unusual/JJ splicing/JJ event/NN involving/VBG EZH1/NEWGENE and/CC a/DT tandemly/RB linked/NN gene/NN GPR2/NEWGENE and/CC suggests/VBZ a/DT potential/JJ mechanism/NN for/IN modifying/JJ the/DT EZH1/NEWGENE protein/NEWGENE in/IN the/DT conserved/VBN C-terminal/NN domain/NN ./.
@@91784911323 We/PRP analysed/VBN two/JJ regions/NNS involved/VBN in/IN preS2/NEWGENE //NEWGENE S/NEWGENE gene/NEWGENE transcription/NN of/IN the/DT HBV/NN adw/NN subtype/NN :/: the/DT diverged/VBN TATA/NN box/NN and/CC a/DT putative/JJ initiator/NN element/NN ./.
@@31728633860 Effect/NN of/IN chronic/JJ undernutrition/NN on/IN susceptibility/NN to/IN cold/JJ stress/NN in/IN young/JJ adult/JJ and/CC aged/VBN rats/NNS ./.
@@39442394606 During/IN this/DT time/NN ,/, the/DT patients/NNS all/DT had/VBP the/DT characteristic/JJ plasma/NN thyroid/JJ hormone/NN changes/NNS associated/VBN with/IN amiodarone/NN therapy/NN ,/, i/NN ./NN e/NN ./. increased/VBN T4/NN ,/, free/JJ T4/NN ,/, and/CC rT3/NN and/CC decreased/VBN T3/NN ,/, while/CC remaining/JJ clinically/RB euthyroid/JJ ./.
@@68869486685 Normal/JJ rates/NNS of/IN weight/NN gain/NN were/VBD seen/VBP once/CC absorbed/VBN energy/NN intakes/NNS reached/VBD 100-110%/NN of/IN requirements/NNS ./.
@@74266042100 The/DT C18/NN :/: 1/CD :/: C10/NN value/NN is/VBZ a/DT convenient/JJ measure/NN of/IN these/DT changes/NNS and/CC can/MD be/VB determined/VBN more/RB rapidly/RB than/IN determining/JJ all/PDT the/DT lower/JJR fatty/JJ acids/NNS ./.
@@27831813479 The/DT cytoprotective/JJ and/CC antiulcer/JJ activities/NNS of/IN the/DT antacid/JJ magaldrate/NN (/( ES/NNP Riopan/NN )/SYM as/RB well/VB as/IN its/PRP effects/NNS on/IN gastric/JJ mucosal/JJ blood/NN flow/NN and/CC mucus/NN secretions/NNS ,/, were/VBD determined/VBN in/IN the/DT rat/NN ./.
@@73925197233 Retinal/NN changes/NNS in/IN pigmentary/JJ retinopathy/NN in/IN children/NNS ./.
@@39317974588 The/DT overall/JJ prevalence/NN of/IN psoriasis/NN was/VBD 4/CD ./CD 79%/CD in/IN men/NNS and/CC 4/CD ./CD 85%/CD in/IN women/NNS ./.
@@84077842214 When/WRB introduced/VBN into/IN recJ+/NEWGENE strains/NNS ,/, srjA/NEWGENE mutations/NN conferred/VBD hyperrecombinational/JJ and/CC hyper-UVr/JJ phenotypes/NNS ./.
@@80949271767 Previous/JJ studies/NNS showed/VBN that/IN mutations/NNS in/IN the/DT 6K/NN protein/NN led/VBN to/IN the/DT slow/JJ release/NN of/IN aberrant/JJ ,/, multi-cored/JJ infectious/JJ virions/NNS ./.
@@91181967346 Performance/NN on/IN two/JJ verbal/JJ measures-the/NNP National/NNP Adult/NN Reading/NNP Test-Revised/JJ (/( NART-R/NN )/SYM and/CC the/DT Vocabulary/NNP subtest/NN from/IN the/DT Wechsler/NN Adult/NN Intelligence/NNP Scale-Revised/NN (/( WAIS-R/IN )/NN -showed/NN strong/JJ correlations/NNS with/IN level/NN of/IN education/NN ./.
@@103490848994 The/DT influence/NN of/IN Epstein-Barr/NNP virus/NN seropositivity/NN on/IN the/DT efficacy/NN of/IN intravenous/JJ immune/NEWGENE globulin/NEWGENE in/IN children/NNS with/IN immune/JJ thrombocytopenic/JJ purpura/NN ./.
@@96537452193 Malaria/NN had/VBP diminished/VBN significantly/RB by/IN the/DT early/NN 1940s/NN ,/, and/CC this/DT paper/NN queries/NNS whether/IN that/DT reduction/NN was/VBD due/NN to/IN the/DT control/NN projects/NNS of/IN the/DT thirties/NNS ,/, and/CC ,/, if/IN so/RB ,/, whether/IN such/JJ projects/NNS should/MD be/VB a/DT model/NN for/IN the/DT current/JJ developing/JJ world/NN ,/, where/CC malaria/NN is/VBZ a/DT growing/JJ problem/NN today/NN ./.
@@63621431620 Plasma/NN renin/NEWGENE activity/NN did/VBD not/RB change/VB in/IN response/NN to/IN head-up/JJ tilt/NN or/CC isoprenaline/NN infusion/NN in/IN the/DT patients/NNS ./.
@@5281445451 On/IN the/DT role/NN of/IN transferrin/NEWGENE in/IN the/DT uptake/NN of/IN gallium/NN by/IN tumor/NN cells/NNS ./.
@@95497839504 Spatial/JJ accuracy/NN of/IN primary/JJ and/CC secondary/JJ memory-guided/JJ saccades/NNS in/IN schizophrenic/JJ patients/NNS ./.
@@74132425216 A/DT 16-year/JJ follow-up/JJ study/NN of/IN 69/CD paraplegics/NNS with/IN complete/JJ lesions/NNS from/IN T1-L3/NN is/VBZ presented/VBN ./.
@@66546866397 Combination/NN of/IN a/DT Shwachman/NN syndrome/NN and/CC a/DT complex/NN granulocyte/NN function/NN disorder/NN in/IN a/DT girl/NN ./.
@@113588014575 This/DT shows/VBZ that/IN in/IN situations/NNS of/IN separated/VBN breaks/NNS ,/, NHEJ/NNP deficiency/NN leads/VBP to/IN genomic/JJ rearrangements/NNS ,/, in/IN agreement/NN with/IN chromosomal/JJ studies/NNS ./.
@@13166805850 Interestingly/RB ,/, the/DT IR5/NEWGENE ORF/NEWGENE of/IN EHV-1/NN possesses/VBZ a/DT sequence/NN of/IN 13/CD amino/JJ acids/NNS (/( CAYWCCLGHAFAC/NEWGENE )/SYM that/WDT is/VBZ a/DT perfect/JJ match/NN to/IN the/DT consensus/NN zinc/NN finger/NN motif/NN (/( C-X2-4-C-X2-15-C/NEWGENE //NEWGENE H-X2-4-C/NEWGENE //NEWGENE H/NEWGENE )/SYM ./.
@@96835769318 Mutating/VBG a/DT potential/JJ cleavage/NN site/NN located/VBD N-terminal/NN to/IN the/DT protease/NEWGENE domain/NEWGENE ,/NEWGENE Gln2526-Asp2527/NEWGENE ,/, diminished/VBN processing/VBG ./.
@@33349502946 The/DT German/NNP Society/NNP of/IN Pediatric/NNP Oncology/NNP in/IN 1981/CD initiated/VBN the/DT Cooperative/NNP Ewing's/NNP Sarcoma/NNP Study/NNP (/( CESS/NN 81/NN )/SYM using/VBG a/DT four-drug/JJ combination/NN of/IN chemotherapy/NN prior/NN to/IN definitive/JJ local/JJ control/NN with/IN surgery/NN and/DT //DT or/DT radiation/NN ./.
@@20768167785 An/DT RME1-independent/NN pathway/NN for/IN sporulation/NN control/NN in/IN Saccharomyces/NN cerevisiae/NN acts/NNS through/RB IME1/NEWGENE transcript/NEWGENE accumulation/NN ./.
@@31265313208 Reversal/NNP of/IN the/DT increase/NN in/IN apomorphine-induced/JJ stereotypy/NN and/CC aggression/NN in/IN REM/NN sleep/NN deprived/VBD rats/NNS by/IN dopamine/NN agonist/NN pretreatments/NNS ./.
@@50001715306 The/DT effect/NN of/IN osmotic/JJ flow/NN on/IN the/DT distribution/NN of/IN horseradish/NEWGENE peroxidase/NEWGENE within/IN the/DT intercellular/JJ spaces/NNS of/IN toad/NN bladder/NN epithelium/NN ./.
@@97066439690 There/EX was/VBD no/DT evident/JJ inciting/JJ agent/NN of/IN the/DT disease/NN ./.
@@979899768 A/DT three-phased/JJ analysis/NN of/IN treatment/NN plans/NNS for/IN 45/CD patients/NNS was/VBD undertaken/VBP ./.
@@80347422342 M/NNP ./NNP ,/, and/CC D/NN ./NN
@@104769704125 Here/RB we/PRP show/VBP that/IN a/DT novel/JJ isoform/NN of/IN Rapl/NEWGENE GTPase-activating/NEWGENE protein/NEWGENE ,/, called/VBN rap1GAPII/NEWGENE ,/, binds/VBZ specifically/RB to/IN the/DT alpha-subunits/NNS of/IN the/DT G/NEWGENE (/NEWGENE i/NEWGENE )/NEWGENE family/NEWGENE of/IN heterotrimeric/NEWGENE G-proteins/NEWGENE ./.
@@23126898060 The/DT kappa/NN coefficient/NN of/IN agreement/NN between/IN the/DT Patho/NNP Dx/NN Kit/NN and/CC the/DT standard/JJ method/NN was/VBD 0/CD ./CD 958/CD ./.
@@88913419807 Transient/JJ transfection/NN assays/NNS using/VBG reporter/NN gene/NN constructs/NNS containing/JJ various/JJ lengths/NNS of/IN the/DT 5'/NEWGENE mdr1b/NEWGENE sequences/NEWGENE revealed/VBN that/IN the/DT sequence/NN located/VBD between-247/JJ to/IN -126/CD bp/NN was/VBD important/JJ for/IN the/DT expression/NN of/IN the/DT reporter/NN gene/NN in/IN many/JJ different/JJ cell/NN lines/NNS ./.
@@4816124106 It/PRP is/VBZ concluded/VBN that/IN opiate/NEWGENE receptors/NEWGENE bordering/VBG the/DT fourth/JJ cerebral/JJ ventricle/NN mediate/VB the/DT cardiovascular/JJ and/CC hypnotic/JJ action/NN of/IN fentanyl/NN ./.
@@82539581586 A/DT number/NN of/IN serological/JJ tests/NNS measuring/JJ the/DT presence/NN of/IN Helicobacter/NN pylori-specific/NN serum/NN immunoglobulin/NEWGENE G/NEWGENE (/( IgG/NEWGENE )/SYM are/VBP now/RB commercially/RB available/JJ ./.
@@76923666626 BACKGROUND/IN :/: Delineation/NNS of/IN the/DT morphologic/JJ aspects/NNS of/IN age-related/JJ macular/JJ degeneration/NN (/( ARMD/NN )/SYM is/VBZ helpful/JJ in/IN correlation/NN with/IN the/DT clinical/JJ features/NNS and/CC may/MD contribute/VB to/IN understanding/VBG the/DT pathogenesis/NN ./.
@@8307564404 Twenty-three/JJ sequence-tagged/NN sites/NN (/( STSs/NN )/SYM were/VBD mapped/VBN within/IN the/DT contig/NN ,/, a/DT density/NN of/IN approximately/RB 1/CD per/IN 200/CD kb/CD ./CD
@@10534402587 RT-PCR/NN and/CC in/IN situ/NN hybridization/NN analyses/NNS of/IN a/DT time/NN course/NN of/IN juvenile/JJ testis/NN development/NN indicate/VB that/IN Spo11/NEWGENE expression/NN begins/VBZ in/IN early/JJ meiotic/JJ Prophase/NNP I/PRP ,/, prior/NN to/IN the/DT pachytene/NN stage/NN ,/, with/IN increasing/JJ accumulation/NN of/IN mRNA/NN through/RB the/DT pachytene/NN stage/NN ./.
@@11590364624 However/RB ,/, the/DT beta5L/NEWGENE splice/NEWGENE variant/NEWGENE was/VBD found/VBN only/RB in/IN the/DT retina/NN ./.
@@87683745181 The/DT P-wr/NEWGENE and/CC P-rr/NEWGENE cDNA/NEWGENE sequences/NEWGENE are/VBP very/RB similar/JJ in/IN their/PRP 5'/CD regions/NNS ./.
@@74741402387 By/IN site-specific/CD mutagenesis/NN ,/, we/PRP also/RB show/VBP that/IN individual/JJ ICP27/NEWGENE C-terminal/NEWGENE amino/NEWGENE acid/NEWGENE residues/NEWGENE that/WDT are/VBP positionally/RB conserved/VBN in/IN ICP27/NEWGENE homologs/NEWGENE in/IN other/DT herpesviruses/NNS (/( D-357/NN ,/, E-358/NN ,/, H-479/NN ,/, C-400/NN ,/, C-483/NN ,/, and/CC C-488/NN )/SYM are/VBP critical/JJ for/IN trans-regulatory/JJ activity/NN ./.
@@99829236763 Electronic/NNP structure/NN of/IN a/DT buried/VBN NiSi2/NN or/CC CoSi2/NN layer/NN in/IN bulk/NN Si/NNP ./NNP
@@93108362989 Six/CD tandem/NN repeats/NNS of/IN the/DT P/NEWGENE element/NEWGENE linked/JJ to/IN the/DT SV40/NEWGENE promoter/NEWGENE responded/VBN to/IN phorbol/NN 12-myristate/JJ 13-acetate/NN ,/, while/CC that/IN of/IN other/DT elements/NNS did/VBD not/RB ./.
@@92026691230 The/DT pWP-19/NEWGENE also/RB encodes/VBZ the/DT AAV/JJ inverted/JJ terminal/JJ repeats/NNS for/IN integration/NN and/CC replication/NN and/CC the/DT herpes/NN virus/NN thymidine/NEWGENE kinase/NEWGENE promoter-driven/NN gene/NN for/IN neomycin/NN resistance/NN (/( neoR/NEWGENE )/SYM ./.
@@79267499518 Binding/NN site/NN selection/NN using/VBG in/IN vitro-synthesized/NN proteins/NN reveals/VBZ that/IN the/DT ROR/NEWGENE alpha/NEWGENE 1/NEWGENE and/CC ROR/NEWGENE alpha/NEWGENE 2/NEWGENE isoforms/NEWGENE bind/VBP DNA/NN as/IN monomers/NNS to/IN hormone/NEWGENE response/NEWGENE elements/NEWGENE composed/VBN of/IN a/DT 6-bp/CD AT-rich/NNP sequence/NN preceding/JJ a/DT half-site/NN core/NEWGENE motif/NEWGENE PuGGTCA/NEWGENE (/( RORE/NEWGENE )/SYM ./.
@@22700962910 Genotoxic/NNP activity/NN of/IN a/DT tobacco-specific/JJ nitrosamine/NN ./.
@@75679795255 Our/PRP findings/NNS also/RB provide/VBP the/DT basis/NN for/IN the/DT development/NN of/IN assays/NNS to/IN screen/NN for/IN the/DT ligands/NNS to/IN testis/NEWGENE receptor/NEWGENE 2/NEWGENE and/CC hERR1/NEWGENE ./.
@@64942159187 The/DT response/NN chain/NN in/IN each/DT component/NN was/VBD maintained/VBN by/IN food/NN presentation/NN under/IN a/DT fixed-ratio/NN schedule/NN ./.
@@89102924947 Signaling/NN from/IN the/DT small/NEWGENE GTP-binding/NEWGENE proteins/NEWGENE Rac1/NEWGENE and/CC Cdc42/NEWGENE to/IN the/DT c-Jun/NEWGENE N-terminal/NEWGENE kinase/NEWGENE //NEWGENE stress-activated/NEWGENE protein/NEWGENE kinase/NEWGENE pathway/NN ./.
@@96985129684 METHODS/IN :/: We/PRP retrospectively/RB reviewed/VBD 242/CD adult/JJ cadaveric/JJ renal/JJ transplant/NN recipients/NNS treated/VBN between/IN 11/CD //CD 91/CD and/CC 5/CD //CD 97/CD ./.
@@78621087866 UV/NN cross-linking/VBG experiments/NNS show/VBP that/DT TEP/NEWGENE has/VBZ an/DT apparent/JJ molecular/JJ mass/NN of/IN approximately/RB 65/CD kDa/NN ./.
@@98585816203 Elevated/NNP expression/NN of/IN a/DT previously/RB uncharacterized/JJ gene/NN ,/, SPP381/NEWGENE ,/, efficiently/RB suppresses/VBZ the/DT growth/NN and/CC splicing/JJ defects/NNS of/IN a/DT temperature-sensitive/JJ (/( Ts/NNS )/SYM mutant/NEWGENE prp38-1/NEWGENE ./.
@@106125051977 Based/VBN on/IN a/DT type/NN I/NN error/NN of/IN 0/CD ./CD 05/CD ,/, our/PRP study/NN had/VBP a/DT power/NN greater/JJR than/IN or/CC equal/NN to/IN 75%/JJ to/IN detect/VB group/NN differences/NNS in/IN treatment/NN effect/NN of/IN greater/JJR than/IN or/CC equal/NN to/IN 15%/JJ to/IN 20%/CD ./.
@@107335916988 Expression/NNS of/IN activated/VBN Cdc42/NEWGENE results/NNS in/IN the/DT translocation/NN of/IN PKClambda/NEWGENE from/IN the/DT nucleus/NN into/IN the/DT cytosol/NN ,/, and/CC Cdc42/NEWGENE and/CC PKClambda/NEWGENE colocalize/VB at/IN the/DT plasma/NN membrane/NN and/CC in/IN the/DT cytoplasm/NN ./.
@@63221831226 NPT/NEWGENE II/NEWGENE synthesis/NN ,/, measured/VBN by/IN agar/NN plate/NN assays/NNS of/IN kanamycin/NN resistance/NN and/CC by/IN immunoprecipitation/NN of/IN the/DT NPT/NEWGENE II/NEWGENE protein/NEWGENE ,/, was/VBD repressed/VBN in/IN the/DT presence/NN of/IN cysteine/NN and/CC derepressed/VBN in/IN its/PRP absence/NN ./.
@@8784787578 Also/RB like/VB the/DT thrombin/NEWGENE receptor/NEWGENE ,/, PAR2/NEWGENE can/MD be/VB activated/VBN by/IN the/DT hexapeptide/NN corresponding/JJ to/IN its/PRP tethered/JJ ligand/NN sequence/NN independent/NN of/IN receptor/NN cleavage/NN ./.
@@14468286584 The/DT 5'/CD region/NN of/IN ADH5/NEWGENE contains/VBZ consensus/NN binding/JJ sites/NNS for/IN the/DT transcriptional/JJ regulatory/JJ proteins/NNS ,/, Sp1/NEWGENE ,/, AP2/NEWGENE ,/, LF-A1/NEWGENE ,/, NF-1/NEWGENE ,/, NF-A2/NEWGENE ,/, and/CC NF-E1/NEWGENE ./.
@@97128981600 Tumor/NEWGENE necrosis/NEWGENE factor/NEWGENE signaling/JJ to/IN stress-activated/NEWGENE protein/NEWGENE kinase/NEWGENE (/( SAPK/NEWGENE )/NN //NEWGENE Jun/NEWGENE NH2-terminal/NEWGENE kinase/NEWGENE (/( JNK/NEWGENE )/SYM and/CC p38/NEWGENE ./.
@@81729053976 The/DT class/NEWGENE II/NEWGENE Escherichia/NEWGENE coli/NEWGENE alanine/NEWGENE tRNA/NEWGENE synthetase/NEWGENE aminoacylates/NEWGENE RNA/NEWGENE miniduplexes/NEWGENE ,/, which/WDT reconstruct/VBP the/DT acceptor/NN end/NN of/IN alanine/NEWGENE tRNA/NEWGENE with/IN the/DT critical/JJ G3/NN :/: U70/NN base/NN pair/NN ./.
@@102318626576 Breast-fed/JJ newborn/JJ infants/NNS synthesize/VBP n-6/NN long-chain/NN polyunsaturated/JJ fatty/JJ acids/NNS already/RB during/IN the/DT first/JJ week/NN of/IN life/NN ,/, but/CC the/DT contribution/NN of/IN endogenous/JJ synthesis/NN to/IN the/DT total/JJ plasma/NN long-chain/JJ polyunsaturated/JJ pool/NN is/VBZ small/JJ ./.
@@110421998022 Elevation/NNS of/IN intracellular/JJ Ca/NN (/NN 2+/NN )/NN levels/NNS are/VBP also/RB involved/VBN because/IN treatment/NN with/IN receptor-associated/NN protein/NN ,/, nifedipine/NN ,/, MK801/NN ,/, removal/NN of/IN Ca/NN (/NN 2+/NN )/NN from/IN the/DT medium/NN and/CC dantrolene/NN all/DT served/VBN to/IN inhibit/VB calcium/NN elevation/NN and/CC attenuate/VB the/DT activation/NN of/IN CREB/NEWGENE ./.
@@70152626796 Ten/CD days/NNS of/IN cefadroxil/NN therapy/NN was/VBD used/VBN to/IN treat/NN 44/CD children/NNS with/IN urinary/JJ tract/NN infection/NN and/CC CRP/NEWGENE values/NNS greater/JJR than/IN or/CC equal/NN to/IN 28/CD microgram/NN //NN ml/NN (/( CRP-positive/NNP group/NN )/SYM ./.
@@85868748562 Studies/NNS on/IN the/DT life/NN cycle/NN of/IN Haplorchis/JJ pumilio/NN (/( Looss/NNP ,/, 1896/CD )/SYM Looss/NNP ,/, 1899/CD with/IN morphological/JJ redescription/NN of/IN larval/JJ and/CC adult/JJ stages/NNS ./.
@@75594303374 R/NNP ./NNP
@@84395648525 The/DT amino/JJ acid/NN sequence/NN alignment/NN of/IN TC/NEWGENE II/NEWGENE with/IN that/DT of/IN other/DT Cbl/NEWGENE binding/NEWGENE proteins/NEWGENE (/( rat/NEWGENE intrinsic/NEWGENE factor/NEWGENE ,/, human/NEWGENE transcobalamin/NEWGENE I/NEWGENE and/CC porcine/NEWGENE haptocorrin/NEWGENE )/SYM revealed/VBN only/RB 33%/JJ overall/JJ homology/NN ./.
@@100082619628 Temperature/NN dependence/NN of/IN the/DT sublattice/JJ spontaneous/JJ magnetization/NN of/IN YBa2Cu3O6/NN ./.
@@68806046673 A/DT reassessment/NN of/IN the/DT prevalence/NN data/NN was/VBD carried/VBN out/RB in/IN the/DT southern/JJ province/NN of/IN Uusimaa/NNP and/CC in/IN the/DT western/JJ province/NN of/IN Vaasa/NNP ,/, the/DT prevalence/NN day/NN being/VBP January/NN 1/CD ,/, 1979/CD ./.
@@33445864031 New/NNP technologies/NNS in/IN diagnosis/NN and/CC classification/NN of/IN malignancy/NN ./.
@@105144939590 Me/NN (/NN 2/NN )/NN SO-induced/NN neuronal/JJ differentiation/NN of/IN N1E-115/NNP neuroblastoma/NN cells/NNS increased/VBD both/PDT the/DT expression/NN of/IN the/DT endogenous/NEWGENE Ntr-1/NEWGENE gene/NEWGENE and/CC reporter/NN genes/NNS driven/VBP by/IN NTR-1/NEWGENE promoter/NEWGENE sequences/NEWGENE by/IN 3-4-fold/NN ./.
@@66540473894 This/DT phenomenon/NN may/MD be/VB regarded/VBN as/IN a/DT variant/NN of/IN selective/JJ individual/JJ cell/NN death/NN ,/, currently/RB referred/VBN to/RB as/IN apoptosis/NN ,/, which/WDT has/VBZ not/RB been/VBN previously/RB reported/VBN in/IN a/DT case/NN of/IN embryonal/JJ rhabdomyosarcoma/NN ./.
@@21706871969 The/DT E6/NEWGENE //NEWGENE E7/NEWGENE promoter/NEWGENE of/IN all/DT genital/JJ human/JJ papillomaviruses/NNS is/VBZ responsible/JJ for/IN expression/NN of/IN the/DT viral/NEWGENE transforming/NEWGENE genes/NEWGENE ./.
@@9869259856 The/DT effect/NN of/IN calcitonin/NEWGENE ,/, a/DT large/JJ amount/NN of/IN calcium/NN given/VBP orally/RB ,/, pentagastrin/NN and/CC glucagon/NN on/IN plasma/NN 47Ca/CD radioactivity/NN curves/NNS in/IN subjects/NNS pretreated/VBN with/IN 47Ca/CD was/VBD examined/VBN ./.
@@54881215563 CO2/NN assimilation/NN by/IN chloroplasts/NNS illuminated/JJ on/IN filter/NN paper/NN ./.
@@117850853571 Comparative/JJ analysis/NN of/IN various/JJ techniques/NNS of/IN prostatic/JJ drainage/NN in/IN patients/NNS with/IN chronic/JJ obstructive/JJ prostatitis/NN The/DT efficacy/NN of/IN prostatic/JJ drainage/NN using/VBG transurethral/JJ vacuum/NN aspiration/NN (/( Introl-4/NN unit/NN )/SYM and/CC transrectal/JJ pneumovibromassage/NN (/( PVM-R-01/NN )/SYM was/VBD compared/VBN in/IN 1511/CD patients/NNS with/IN chronic/JJ obstructive/JJ prostatitis/NN ./.
@@89399668693 As/IN the/DT rate/NN of/IN protein/NN synthesis/NN decreases/NNS during/IN late/JJ embryogenesis/NN ,/, levels/VBZ of/IN SEC-1/NEWGENE and/CC its/PRP cognate/NN mRNA/NN decline/NN precipitously/RB ./.
@@78887886118 The/DT presence/NN of/IN type/NN I/NN hypersensitivity/NN in/IN a/DT subgroup/NN of/IN aspergillomas/NNS suggests/VBZ an/DT immunoallergic/JJ component/NN to/IN this/DT disease/NN which/WDT could/MD contribute/VB to/IN a/DT chronic/JJ inflammatory/JJ response/NN to/IN Aspergillus/NNS in/IN some/DT aspergillomas/NNS ./.
@@100255068938 No/DT TATA/NN or/CC Inr/NEWGENE sequence/NEWGENE was/VBD found/VBN ./.
@@94920381457 In/NN the/DT current/JJ study/NN ,/, the/DT roles/NNS of/IN two/JJ putative/JJ cis-acting/JJ elements/NNS within/IN the/DT -73/CD to/IN +44/CD region/NN in/IN basal/JJ exon/NN 2/NN promoter/NN activity/NN were/VBD evaluated/VBN using/VBG mutagenesis/NN and/CC nuclear/NN protein-DNA/NN binding/JJ assays/NNS ./.
@@6631661556 Radionuclide/NN angiography/NN and/CC static/JJ whole/JJ body/NN imaging/JJ performed/VBN with/IN technetium-99m-labeled/NN particulates/NNS can/MD clearly/RB demonstrate/VB differential/JJ shunting/NN in/IN patients/NNS with/IN patent/JJ ductus/NN arteriosus/NN (/( PDA/NN )/SYM with/IN Eisenmenger/NN physiology/NN ./.
@@107478793439 The/DT evolution/NN of/IN the/DT CCR5/NEWGENE cis-regulatory/NEWGENE region/NEWGENE versus/IN the/DT open/JJ reading/JJ frame/NN as/RB well/VB as/IN among/IN different/JJ domains/NNS of/IN the/DT open/JJ reading/JJ frame/NN differed/VBN from/IN one/PRP another/DT ./.
@@107116743686 PURPOSE/NNS :/: A/DT two-generation/JJ consanguineous/JJ Pakistani/JJ family/NN with/IN autosomal/JJ recessive/JJ Leber/NN congenital/JJ amaurosis/NN (/( LCA/NN ,/, MIM/NN 204/CD ,/CD 000/CD )/SYM and/CC keratoconus/NN was/VBD identified/VBN ./.
@@13763192249 Gene/NNP and/CC pseudogene/NN of/IN the/DT mouse/NN cation-dependent/NN mannose/NEWGENE 6-phosphate/NEWGENE receptor/NEWGENE ./.
@@76671957595 L-735/NN ,/NN 524/NN free/JJ base/NN or/CC sulfate/NN salt/NN was/VBD administered/VBN orally/RB as/IN suspension/NN ,/, solution/NN or/CC in/IN solid/JJ dosage/NN forms/NNS to/IN fasted/VBN or/CC fed/VBN Beagle/NN dogs/NNS ./.
@@26746747493 The/DT results/NNS strongly/RB support/VBP the/DT notion/NN that/IN the/DT OBF1-binding/NEWGENE sites/NEWGENE and/CC the/DT OBF1/NEWGENE protein/NEWGENE are/VBP important/JJ for/IN normal/JJ ARS/NEWGENE function/NN as/IN an/DT origin/NN of/IN replication/NN ./.
@@93566459320 Moreover/RB ,/, in/IN one/PRP patient/NN with/IN a/DT sarcoma/NN who/WP underwent/VBD a/DT leg-sparing/JJ procedure/NN ,/, no/DT sciatic/JJ nerve/NN enlargement/NN was/VBD seen/VBP postoperatively/RB ./.
@@90059792543 The/DT GHR/NEWGENE mRNA/NEWGENE :/: GHBP/NEWGENE mRNA/NEWGENE ratio/NN was/VBD 1/CD ./CD 1/CD +/NN //NN -/NN 0/CD ./CD 12/CD and/CC remained/VBN unchanged/JJ during/IN differentiation/NN ./.
@@41794454843 D/NN ./NN
@@15925452184 After/IN tilting/NN ,/, systolic/JJ blood/NN pressure/NN fell/NN an/DT average/NN of/IN 17%/JJ in/IN patients/NNS who/WP cramped/JJ infrequently/RB (/( p/NN =/SYM 0/CD ./CD 0031/CD )/SYM but/CC only/RB 10%/CD in/IN frequently/RB cramping/VBG patients/NNS ./.
@@17319791719 The/DT tissue/NN specificity/NN of/IN gene/NN expression/NN was/VBD identical/JJ to/IN that/DT described/VBD previously/RB for/IN the/DT CaMV/NEWGENE 35S/NEWGENE domain/NEWGENE B/NEWGENE enhancer/NEWGENE element/NEWGENE ./.
@@95669182373 Substitution/NNS of/IN the/DT Ser-Thr/NNP sites/NNS with/IN the/DT phosphomimetic/JJ Asp/NN generated/VBD a/DT constitutively/RB active/JJ form/NN of/IN IRF-3/NEWGENE that/WDT functioned/VBD as/IN a/DT very/RB strong/JJ activator/NN of/IN promoters/NNS containing/JJ PRDI-PRDIII/NEWGENE or/CC ISRE/NEWGENE regulatory/NEWGENE elements/NEWGENE ./.
@@25193273175 Palindromic/NNP rheumatism/NN ./.
@@83940198595 Precipitation/NNS using/VBG GST/NEWGENE fusion/NEWGENE proteins/NEWGENE containing/NN Fyn/NEWGENE SH2/NEWGENE1 ,/, SH3/NEWGENE ,/, and/CC SH2/NEWGENE //NEWGENE SH3/NEWGENE domains/NEWGENE revealed/VBD that/DT PI/NEWGENE 3-kinase/NEWGENE bound/JJ principally/RB to/IN the/DT SH3/NEWGENE domain/NEWGENE of/IN Fyn/NEWGENE ./.
@@109457812931 Five/CD of/IN the/DT Aeromonas/NNS strains/NNS and/CC one/PRP of/IN V/NN cholerae/NNS non-O1/NN were/VBD positive/JJ for/IN enterotoxin/NEWGENE activity/NN ./.
@@84825399556 Northern/NNP blot/NN analysis/NN of/IN total/JJ cellular/JJ RNA/NN indicated/VBD that/DT xylP/NEWGENE encodes/VBZ a/DT 1/CD ./CD 3-kb/CD transcript/NN which/WDT is/VBZ induced/VBN by/IN xylan/NN ./.
@@110825877481 Effects/NNPS of/IN spatial/JJ and/CC temporal/JJ smoothing/JJ on/IN stimulated/VBN brillouin/NN scattering/JJ in/IN the/DT independent-hot-spot/JJ model/NN limit/NN The/DT influence/NN of/IN laser/NN beam/NN smoothing/JJ on/IN stimulated/VBN Brillouin/NNP backscattering/JJ (/( SBBS/NN )/SYM is/VBZ studied/VBN analytically/RB in/IN the/DT limit/NN of/IN the/DT independent/JJ hot/JJ spot/NN model/NN ./.
@@14335244342 A/DT second/JJ domain/NN ,/, located/VBN in/IN the/DT C-terminal/NN 437/NN amino/JJ acids/NNS of/IN IE1/NEWGENE ,/, is/VBZ required/VBN for/IN inhibitory/JJ and/CC DNA-binding/NN activities/NNS ./.
@@2348225667 Mean/VB (/( +/NN //NN -/NN SE/NN )/SYM measurements/NNS of/IN clearance/NN (/( 24/CD ./CD 5/CD +/NN //NN -/NN 2/CD ./CD 06/CD v/NN 26/CD ./CD 5/CD +/NN //NN -/NN 2/CD ./CD 05/CD mL/NN //NN min/NN //NN m2/NN )/SYM ,/, half-life/NN (/( 5/CD ./CD 7/CD +/NN //NN -/NN 0/CD ./CD 5/CD v/NN 6/CD ./CD 4/CD +/NN //NN -/NN 0/CD ./CD 5/CD hours/NNS )/SYM ,/, and/CC volume/NN of/IN distribution/NN (/( 12/CD ./CD 4/CD +/NN //NN -/NN 1/CD ./CD 1/CD v/NN 13/CD ./CD 7/CD +/NN //NN -/NN 1/CD ./CD 6/CD L/NN //NN m2/NN )/SYM were/VBD not/RB significantly/RB different/JJ in/IN patients/NNS with/IN jaundice/NN when/CC compared/VBN with/IN controls/NNS ./.
@@106789689837 Immunity/NNS acquired/VBN by/IN mice/NNS during/IN I/NNP ./NNP scapularis/NN nymphal/JJ activity/NN in/IN early/JJ summer/NN may/MD exclude/VB a/DT large/JJ proportion/NN of/IN the/DT mouse/NN population/NN from/IN maintaining/VBG E/NNP ./NNP phagocytophila/NN during/IN the/DT period/NN of/IN larval/JJ activity/NN later/JJR in/IN the/DT season/NN ./.
@@72255407052 To/TO evaluate/VB the/DT gas/NN chromatographic/JJ electron/NN capture/NN detection/NN method/NN described/VBN earlier/JJR ,/, 23/CD plasma/NN samples/NNS have/VBP been/VBN analysed/VBN by/IN both/DT techniques/NNS ./.
@@115005714034 Despite/IN abundant/JJ expression/NN of/IN NtmybAS/NEWGENE transcripts/NEWGENE in/IN mature/JJ pollen/NN ,/, gPAL1/NEWGENE transcripts/NEWGENE were/VBD not/RB detectable/JJ in/IN pollen/NN ./.
@@75163378264 Moreover/RB ,/, Lck/NEWGENE was/VBD reversibly/RB co-immunoprecipitated/JJ with/IN p95Vav/NEWGENE ,/, and/CC the/DT stoichiometry/NN of/IN binding/JJ increased/VBN in/IN anti-CD3-treated/JJ Jurkat/NN cells/NNS ./.
@@20278392641 The/DT muscles/NNS from/IN the/DT ischemic/JJ group/NN had/VBP significantly/RB lower/JJR (/( P/NN less/PRP than/IN ./CD 05/CD )/SYM values/NNS for/IN capillary/JJ density/NN and/CC capillary/JJ to/IN fiber/NN ratio/NN and/CC significantly/RB higher/JJ intercapillary/JJ distance/NN than/IN those/DT from/IN the/DT normal/JJ group/NN ./.
@@105860745664 For/IN this/DT purpose/NN ,/, we/PRP used/VBD a/DT series/NN of/IN plasmid/NN constructs/NNS encoding/VBG different/JJ forms/NNS of/IN the/DT envelope/NEWGENE glycoprotein/NEWGENE E/NEWGENE of/NEWGENE the/NEWGENE flavivirus/NEWGENE tick-borne/NEWGENE encephalitis/NEWGENE virus/NEWGENE ./.
@@86282844113 We/PRP constructed/VBD a/DT yeast/NN reporter/NN strain/NN containing/JJ the/DT lacZ/NEWGENE gene/NEWGENE under/IN the/DT control/NN of/IN the/DT CYC1/NEWGENE promoter/NEWGENE associated/VBN with/IN three/CD copies/NNS of/IN TRE-1/NEWGENE ./.
@@83698878328 Differences/NNS in/IN profiles/NNS of/IN viscosity/NN variables/NNS between/IN subgroups/NNS of/IN EAD/NN in/IN RA/NN patients/NNS were/VBD observed/VBN ./.
@@77047307656 Male/JJ contraception/NN :/: ideas/NNS for/IN the/DT future/JJ ./.
@@23430332996 Fifteen/CD light/NN for/IN dates/NNS infants/NNS and/CC their/PRP placentae/NNS were/VBD compared/VBN to/IN 15/CD well-grown/JJ infants/NNS and/CC their/PRP placentae/NNS ./.
@@103488596464 Although/IN it/PRP has/VBZ two/JJ potential/JJ binding/JJ sites/NNS ,/, the/DT purified/VBN MerR/NEWGENE homodimer/NEWGENE binds/VBZ only/RB one/PRP Hg/NN (/NN II/NN )/NN ion/NN ,/, employing/VBG Cys82/NN from/IN one/PRP monomer/NN and/CC Cys117/NNP and/CC Cys126/NNP from/IN the/PDT other/DT ./.
@@60945915979 The/DT envelope/NEWGENE glycoproteins/NEWGENE of/NEWGENE Rous/NEWGENE sarcoma/NEWGENE virus/NEWGENE (/NEWGENE RSV/NEWGENE )/NEWGENE ,/, gp85/NEWGENE and/CC gp37/NEWGENE ,/, are/VBP anchored/VBN in/IN the/DT membrane/NN by/IN a/DT 27-amino/JJ acid/NN ,/, hydrophobic/JJ domain/NN that/IN lies/NNS adjacent/JJ to/IN a/DT 22-amino/JJ acid/NN ,/, cytoplasmic/JJ domain/NN at/IN the/DT carboxy/JJ terminus/NN of/IN gp37/NEWGENE ./.
@@80454314082 HupI/NEWGENE showed/VBD strong/JJ identity/NN to/IN rubredoxin/NEWGENE and/CC rubredoxin-like/NEWGENE proteins/NEWGENE from/IN many/NN other/DT bacteria/NNS ./.
@@67963005608 The/DT already/RB elevated/VBN prolactin/NEWGENE levels/NNS in/IN nursing/JJ women/NNS were/VBD not/RB influenced/VBN by/IN chronic/JJ oestradiol/NN administration/NN ./.
@@34996571944 Osteocalcin/NEWGENE (/( serum/NEWGENE bone-Gla/NEWGENE protein/NEWGENE ,/, sBGP/NEWGENE )/SYM ,/, serum/NEWGENE alkaline/NEWGENE phosphatase/NEWGENE (/( sAP/NEWGENE )/SYM and/CC urinary/JJ hydroxyproline/NN //NN creatinine/NN ratio/NN (/( uOH-Prol/JJ //JJ creatinine/JJ )/SYM have/VB been/VBN measured/VBN in/IN 21/CD patients/NNS with/IN primary/JJ hyperparathyroidism/NN (/( PHPT/IN )/SYM and/CC in/IN nine/JJ patients/NNS with/IN hypercalcaemia/NN of/IN malignancy/NN (/( HM/NN )/SYM ./.
@@94055369361 During/IN the/DT conditioning/JJ procedure/NN ,/, the/DT C-fiber/NN reflex/NN was/VBD facilitated/VBN (/( wind-up/NN )/SYM in/IN a/DT stimulus-dependent/JJ fashion/NN in/IN intact/JJ ,/, anesthetized/JJ animals/NNS during/IN the/DT application/NN of/IN the/DT first/JJ seven/JJ conditioning/JJ stimuli/NNS ;/: thereafter/RB ,/, the/DT magnitude/NN of/IN the/DT responses/NNS reached/VBD a/DT plateau/NN and/CC then/RB decreased/VBN ./.
@@114340843241 In/NN 35/CD of/IN those/DT patients/NNS DD/NN was/VBD measured/VBN also/RB with/IN microlatex/NN tests--Tinaquant/NN and/CC BC/NN d-dimer/NN ./.
@@97085659693 The/DT purpose/NN of/IN this/DT article/NN is/VBZ to/IN discuss/VB the/DT factors/NNS involved/VBN in/IN the/DT selection/NN of/IN antibodies/NNS ,/, radionuclides/NNS and/CC labeling/VBG methods/NNS in/IN the/DT development/NN of/IN radioimmunotherapy/NN (/( RIT/NNP )/SYM for/IN non-Hodgkin's/JJ lymphoma/NN (/( NHL/NN )/SYM from/IN a/DT single/JJ clinical/JJ study/NN site/NN through/RB multicenter/JJ trials/NNS and/CC commercialization/NN ./.
@@36287943831 For/IN patients/NNS with/IN recurrent/JJ or/CC metastatic/JJ disease/NN ,/, the/DT data/NN suggest/VB that/IN I-131/NN MIBG/NN scintigraphy/NN is/VBZ the/DT examination/NN of/IN choice/NN ./.
@@91399101824 In/NN contrast/NN ,/, the/DT Anabaena/NN strain/NN 7120/NN leuA/NEWGENE gene/NN did/VBD not/RB complement/VB the/DT nifV/NEWGENE mutation/NEWGENE of/IN R229I/CD efficiently/RB ./.
@@94143199396 Y15170/NEWGENE (/( Surf-2/NEWGENE ,/, Surf-4/NEWGENE )/SYM ,/, Y15171/NEWGENE (/( Surf-3/NEWGENE ,/, Surf-1/NEWGENE ,/, Surf-6/NEWGENE )/SYM ,/, and/CC Y15172/NEWGENE (/( Surf-5/NEWGENE ./NN )/NN ]/NN
@@49414195249 Yusuf/NNP Dawood/NNP Docrat/NNP L/NNP ./NNP R/NNP ./NNP C/NNP ./NNP P/NNP ./.
@@110203752374 A/DT total/NN of/IN 576/CD 1-day-old/NN Ross/NN broiler/NN chicks/NNS were/VBD housed/VBN in/IN six/CD treatment/NN groups/NNS [/NN six/NN replicates/NNS of/IN 16/CD each/DT ;/: control/NN ,/, CLI/NN (/( 15/CD g/NN kg/NN (/NN -1/NN )/NN diet/NN )/NN ,/, 50/CD parts/NNS per/IN billion/NN (/( ppb/NN )/SYM AF/NNP ,/, 50/CD ppb/NN AF/NNP plus/IN CLI/NN ,/, 100/CD ppb/NN AF/NNP ,/, 100/CD ppb/NN AF/NNP plus/IN CLI/NN ]/) for/IN 42/CD days/NNS ./.
@@19166322538 Anti-HBc/NEWGENE production/NN of/IN PBMC/NN was/VBD enhanced/VBN remarkably/RB in/IN this/DT case/NN ./.
@@92019467079 The/DT RNA-binding/NN and/CC RNA-DNA/NEWGENE helicase/NEWGENE activities/NNS of/IN the/DT Escherichia/NEWGENE coli/NEWGENE transcription/NEWGENE termination/NEWGENE factor/NEWGENE rho/NEWGENE have/NN been/VBN investigated/VBN using/VBG natural/JJ RNA/NN molecules/NNS that/WDT are/VBP 255/CD and/CC 391/CD nucleotide/NN residues/NNS in/IN length/NN and/CC that/DT contain/VB the/DT trp/NEWGENE t'/NEWGENE rho-dependent/NEWGENE termination/NEWGENE sequence/NEWGENE of/IN E/NNP ./NNP coli/JJ ./.
@@4777945148 Effects/NNPS of/IN chronic/JJ descending/JJ tractotomy/NN on/IN the/DT response/NN patterns/NNS of/IN neurons/NNS in/IN the/DT trigeminal/JJ nuclei/NNS principalis/NN and/CC oralis/NN ./.
@@77330754801 Short/JJ therapy/NN with/IN omeprazole/NN 20/CD mg/CD //CD b/CD ./CD i/CD ./CD d/CD ./CD ,/, clarithromycin/NN 500/CD mg/CD //CD b/CD ./CD i/CD ./CD d/CD ./CD ,/, and/CC CBS/NN 120/NN mg/NN //NN q/NN ./NN i/NN ./NN d/NN ./. is/VBZ a/DT safe/NN ,/, well/NN tolerated/VBD combination/NN that/WDT achieves/VBZ a/DT 80/CD ./CD 6%/CD eradication/NN rate/NN of/IN H/NNP ./NNP pylori/NNS and/CC duodenal/JJ ulcer/NN healing/NN rates/NNS as/RB good/JJ as/IN those/DT achieved/VBN by/IN omeprazole/NN 20/CD mg/NN //NN d/NN when/CC given/VBP for/IN 4/CD wk/CD ./CD
@@108610803536 Using/VBG adenoviral/JJ transfer/NN of/IN IkappaBalpha/NEWGENE (/( IkappaBalpha/NEWGENE overexpression/NN )/SYM ,/, the/DT production/NN of/IN TNF-alpha/NEWGENE induced/VBN by/IN whole/JJ GBS/NN was/VBD inhibited/VBN by/IN only/RB 20%/CD ./.
@@9080250750 In/NN the/DT present/NN study/NN ,/, we/PRP have/VBP isolated/VBN and/CC sequenced/VBN several/DT p15E/NEWGENE cDNA/NEWGENE gene/NEWGENE fragments/NEWGENE amplified/VBN by/IN means/NN of/IN polymerase/NEWGENE chain/NN reaction/NN (/( PCR/NN )/SYM from/IN parental/JJ (/( P815/CELL )/SYM and/CC xenogenized/VBN (/( P815/NNP //NNP DTIC/NNP )/SYM tumour/NN cells/NNS ./.
@@38749214534 Documentation/NNP of/IN a/DT successful/JJ intrauterine/JJ fertilization/NN with/IN delivery/NN of/IN a/DT term/NN baby/NN supports/VBP the/DT theoretical/JJ feasibility/NN of/IN the/DT EP/NN ;/: however/RB ,/, anovulation/NN incurred/VBD by/IN our/PRP procedure/NN appears/VBZ to/IN be/VB the/DT major/JJ drawback/NN ./.
@@9135928898 4/CD ./CD 26/CD +/NN //NN -/NN 1/CD ./CD 54/CD mmol/NN //NN l/NN ,/, P/NN </SYM 0/NN ./NN 01/NN )/NN ,/, and/CC systolic/JJ BP/NN responses/NNS to/IN intravenous/JJ norepinephrine/NN and/CC angiotensin/NEWGENE II/NEWGENE were/VBD significantly/RB higher/JJ on/IN glibenclamide/NN than/IN on/IN metformin/NN (/( P/NN </SYM 0/CD ./CD 02/CD and/CC P/NN </SYM 0/CD ./CD 05/CD ,/, respectively/RB )/SYM ./.
@@57962725728 Experimental/JJ chlorpromazine/NN cataracts/NNS ./.
@@59193083180 Interactions/NNS between/IN adrenergics/NNS ,/, adrenolytics/NNS and/CC monoamine/NEWGENE oxidase/NEWGENE inhibitors/NN ./.
@@10614857435 Leukocyte/JJ cultures/NNS ,/, prepared/VBN from/IN blood/NN drawn/VBP from/IN these/DT 18/CD children/NNS at/IN 6/CD months/NNS of/IN age/NN ,/, produced/VBN lower/JJR yields/NNS of/IN IFN/NEWGENE than/IN those/DT of/IN the/DT remaining/JJ 53/CD children/NNS ,/, when/CC stimulated/VBD with/IN adenovirus/NN (/( P/NN </SYM 0/CD ./CD 001/CD )/SYM ,/, coronavirus/NN (/( P/CD </CD 0/CD ./CD 001/CD )/SYM or/CC rhinovirus/NN (/( P/CD =/CD 0/CD ./CD 002/CD )/SYM ./.
@@90322507323 Using/VBG the/DT yeast/NN two-hybrid/JJ system/NN to/IN screen/NN for/IN proteins/NNS which/WDT interact/VBP with/IN Tax1/NEWGENE ,/, we/PRP isolated/VBD the/DT B/NN subunit/NN of/IN the/DT CCAAT/NEWGENE binding/NEWGENE protein/NEWGENE NF-Y/NEWGENE1 from/IN a/DT HeLa/NN cDNA/NN library/NN ./.
@@103500275331 Amisulpride/NN 400/NN mg/NN had/VBP several/DT adverse/JJ effects/NNS on/IN psychomotor/JJ and/CC ,/, although/IN less/PRP severe/JJ ,/, on/IN cognitive/JJ performance/NN on/IN the/DT fifth/JJ day/NN only/RB ./.
@@112104011042 The/DT pharmacokinetic/JJ profiles/NNS of/IN digoxin/NN and/CC warfarin/NN were/VBD not/RB altered/VBN by/IN the/DT simultaneous/JJ and/CC continued/VBN administration/NN of/IN sevelamer/NN ./.
@@76511311907 Band-shift/NNP assays/NNS and/CC DNase/NEWGENE I/NEWGENE footprinting/VBG experiments/NNS using/VBG purified/VBN 42/NN kDa/NN repressor/NN isoform/NN confirmed/VBN that/IN CIRs/NEWGENE 5/NEWGENE and/NEWGENE 6/NEWGENE were/VBD indeed/RB the/DT targets/NNS for/IN binding/NN of/IN this/DT protein/NN ./.
@@77075449908 Immediate-early/NN transcription/NN from/IN the/DT channel/NN catfish/NN virus/NN genome/NN :/: characterization/NN of/IN two/JJ immediate-early/NEWGENE transcripts/NEWGENE ./.
@@74624811989 The/DT average/JJ backscatter/NN coefficient/NN was/VBD six/CD time/NN larger/JJR in/IN regions/NNS of/IN infarct/NN studied/VBN 8--10/NN weeks/NNS after/IN occlusion/NN than/IN that/IN in/NN regions/NNS of/IN infarct/NN studied/VBD 5--6/JJ weeks/NNS after/IN occlusion/NN ./.
@@102050997301 INTERVENTIONS/NNP :/: Study/NNP patients/NNS were/VBD randomly/RB divided/VBN into/IN four/CD parallel/JJ groups/NNS to/IN receive/VB either/DT terbinafine/NN 250/NN mg/NN a/DT day/NN for/IN 12/CD or/CC 16/CD weeks/NNS (/( groups/NNS T12/NN and/CC T16/NN )/SYM or/CC itraconazole/NN 400/CD mg/NN a/DT day/NN for/IN 1/CD week/NN in/IN every/DT 4/CD weeks/NNS for/IN 12/CD or/CC 16/CD weeks/NNS (/( groups/NNS I3/NN and/CC I4/NN )/SYM ./.
@@82520671731 However/RB ,/, limited/VBN comparisons/NNS reveal/VBP domains/NNS in/IN the/DT NH2/NN and/CC COOH/CHEM termini/NNS that/WDT have/VBP a/DT high/JJ degree/NN of/IN similarity/NN suggesting/VBG functional/JJ conservation/NN ./.
@@104545336794 Interaction/NNS of/IN HRI/NEWGENE with/IN Hsc70/NEWGENE was/VBD required/VBN for/IN the/DT transformation/NN of/IN HRI/NEWGENE ,/, as/IN the/PDT Hsc70/NEWGENE antagonist/NN clofibric/JJ acid/NN inhibited/VBD the/DT folding/NN of/IN HRI/NEWGENE into/IN a/DT mature-competent/JJ conformation/NN ./.
@@97652858388 The/DT levels/NNS of/IN transactivation/NN are/VBP correlated/VBN with/IN the/DT respective/JJ binding/JJ affinities/NNS of/IN the/DT response/NN elements/NN (/( IRper-1/NEWGENE >/SYM DR-4/NEWGENE >/SYM IRhsp-1/NEWGENE )/SYM ./.
@@11441311741 Long-term/JJ results/NNS with/IN MACOP-B/NN and/CC radiation/NN therapy/NN for/IN aggressive/JJ lymphomas/NNS BACKGROUND/WDT :/: Long-term/JJ results/NNS are/VBP needed/VBN to/IN evaluate/VB chemotherapy/NN regimens/NNS and/CC prognostic/JJ factors/NNS in/IN non-Hodgkin's/JJ lymphomas/NNS (/( NHL/NN )/SYM ./.
@@9759691756 In/NN analyses/NNS with/IN control/NN for/IN multiple/JJ variables/NNS ,/, relative/JJ risk/NN for/IN microalbuminuria/NN (/( urinary/NN albumin/NEWGENE excretion/NN ,/, 20-199/CD microg/NN //NN min/NN )/SYM in/IN men/NNS and/CC women/NNS was/VBD 2/CD ./CD 51/CD and/CC 1/CD ./CD 62/CD ,/, respectively/RB ,/, with/IN 18/CD mm/NN Hg/NN higher/JJ (/( 1/CD SD/NN )/SYM systolic/JJ blood/NN pressure/NN ;/: 2/CD ./CD 25/CD and/CC 2/CD ./CD 10/CD ,/, respectively/RB ,/, with/IN 1/CD ./CD 0-mmol/CD //CD L/CD (/( 40/CD mg/NN //NN dL/NN )/SYM higher/JJ plasma/NN cholesterol/NN level/NN ;/: 1/CD ./CD 99/CD and/CC 1/CD ./CD 91/CD ,/, respectively/RB ,/, for/IN smokers/NNS vs/NNP nonsmokers/NNS ;/: and/CC 1/CD ./CD 83/CD and/CC 1/CD ./CD 33/CD ,/, respectively/RB ,/, with/IN 4/CD kg/NN //NN m2/NN higher/JJ body/NN mass/JJ index/NN ./.
@@23332392983 Solving/VBG an/DT age/NN old/JJ problem/NN ./.
@@90323285408 DNA/NN sequencing/VBG of/IN a/DT 17-kb/JJ segment/NN encompassing/VBG a/DT gammaherpesvirus/NN divergent/JJ locus/NN (/( DL-B/NN )/SYM between/IN ORF11/NN and/CC ORF17/NN revealed/VBD the/DT presence/NN of/IN nine/JJ viral/JJ ORFs/NNS with/IN predicted/VBN gene/NN products/NNS related/VBN to/IN cellular/JJ proteins/NNS ./.
@@10727247696 Here/RB we/PRP describe/VBP the/DT cloning/NN ,/, tissue-specific/JJ expression/NN pattern/NN ,/, and/CC functional/JJ characterization/NN of/IN two/JJ novel/JJ TEF-1/NEWGENE isoforms/NEWGENE ,/, TEF-1beta/NEWGENE and/CC TEF-1gamma/NEWGENE ./.
@@80960668071 The/DT RFLP/NN patterns/NNS of/IN the/DT isolates/NNS from/IN six/CD of/IN these/DT patients/NNS remained/VBN essentially/RB unchanged/JJ (/( two/JJ strains/NNS showed/VBD one/PRP additional/JJ band/NN )/SYM despite/IN the/DT development/NN of/IN drug/NN resistance/NN ./.
@@17304122380 Max/NEWGENE :/: functional/JJ domains/NNS and/CC interaction/NN with/IN c-Myc/NEWGENE ./.
@@76425444646 Conversely/RB ,/, treatment/NN of/IN human/NEWGENE protein-tyrosine/NEWGENE phosphatase/NEWGENE alpha-overexpressing/JJ cells/NNS with/IN phenylarsine/NN oxide/NN led/VBN to/IN a/DT loss/NN of/IN the/DT constitutive/JJ NF-kappa/NEWGENE B/NEWGENE activity/NN ./.
@@6009435869 2/CD cases/NNS of/IN toxic/JJ lymphomononucleosis/NN ./.
@@54415649995 Studies/NNS on/IN the/DT pathogenicity/NN of/IN ECHO/NN 9/NN (/( HILL/NN )/SYM virus/NN and/CC its/PRP mutants/NNS for/IN suckling/JJ mice/NNS ./.
@@22059705036 1/CD ,/, among/IN which/WDT nine/JJ have/NN been/VBN cloned/VBN and/CC two/JJ (/( potentially/RB functional/JJ )/SYM sequenced/VBN ./.
@@87078408156 Using/VBG immunogold/NN electron/NN microscopy/NN ,/, we/PRP found/VBP that/IN p58/NEWGENE //NEWGENE p45/NEWGENE and/CC p54/NEWGENE are/VBP localized/VBN on/IN both/DT sides/NNS of/IN the/DT nuclear/JJ pore/NN complex/NN ,/, like/JJ p62/NEWGENE ./.
@@95841944375 HEF1/NEWGENE ,/, p130/NEWGENE (/NEWGENE Cas/NEWGENE )/NEWGENE ,/, and/CC Efs/NEWGENE //NEWGENE Sin/NEWGENE constitute/VB a/DT family/NN of/IN multidomain/JJ docking/JJ proteins/NNS that/WDT have/VBP been/VBN implicated/VBN in/IN coordinating/JJ the/DT regulation/NN of/IN cell/NN adhesion/NN ./.
@@46130735050 Role/NN of/IN biocenosis/NN in/IN the/DT manifestation/NN of/IN Shigella/NN virulence/NN ./.
@@107335692571 Among/IN mammalian/NEWGENE HSFs/NEWGENE ,/, HSF1/NEWGENE has/VBZ been/VBN shown/VBP to/IN be/VB important/JJ for/IN regulation/NN of/IN the/DT heat-induced/NEWGENE stress/NEWGENE gene/NEWGENE expression/NN ,/, whereas/IN the/DT function/NN of/IN HSF2/NEWGENE in/IN stress/NN response/NN is/VBZ unclear/JJ ./.
@@95117241438 In/NN all/DT cells/NNS ,/, the/DT accumulation/NN of/IN high/JJ Dsg/NEWGENE protein/NEWGENE levels/NNS required/VBD calcium/NN and/CC was/VBD not/RB observed/VBN in/IN low/JJ calcium/NN (/( 0/CD ./CD 05-0/CD ./CD 07/CD mM/NN )/SYM media/NN ./.
@@79837151033 Point/NNP mutations/NNS that/WDT suppressed/VBD the/DT in/NN vitro/FW binding/NN of/IN NF-Y/NEWGENE to/IN the/DT internal/JJ palindromic/JJ arm/NN reduced/VBD the/DT activity/NN of/IN the/DT resident/JJ P4/NEWGENE promoter/NEWGENE ,/, while/CC those/DT preventing/JJ complex/NN formation/NN with/IN USF/NEWGENE did/VBD not/RB ,/, as/IN determined/VBN by/IN transient/JJ expression/NN assays/NNS using/VBG the/DT luciferase/NEWGENE reporter/NN gene/NN ./.
@@24983228604 Two/CD specific/NN DNA-protein/NN complexes/NNS were/VBD identified/VBN in/IN gel/NN retardation/NN assays/NNS using/VBG HeLa/DT cell/NN nuclear/JJ extracts/NNS and/CC an/DT oligonucleotide/NN probe/NN spanning/VBG the/DT footprinted/VBN region/NN ./.
@@91513766481 We/PRP present/VBP a/DT case/NN of/IN type/NN II/NN hyperbetalipoproteinemia/NN in/IN a/DT patient/NN whose/WP diagnosis/NN had/VBP been/VBN previously/RB unrecognized/JJ ,/, and/CC who/WP had/VBP previously/RB been/VBN misdiagnosed/VBN with/IN rheumatoid/JJ arthritis/NN and/CC later/JJR gout/NN ./.
@@112786108856 We/PRP found/VBP that/IN the/DT SOCS/NEWGENE box/NEWGENE interacted/VBN with/IN Cullin-2/NEWGENE and/CC promoted/VBN ubiquitination/NN of/IN TEL-JAK2/NEWGENE ./.
@@16532385994 TPA/NN and/CC TGF-beta/NEWGENE 1/NEWGENE did/VBD not/RB markedly/RB affect/VB the/DT activities/NNS of/IN the/DT 72-kDa/NN enzyme/NN ./.
@@31120283831 The/DT remaining/JJ six/CD patients/NNS had/VBP slightly/RB decreased/VBN (/( n/NN =/SYM 3/CD )/SYM or/CC normal/JJ (/( n/NN =/SYM 3/CD )/SYM seminal/JJ parameters/NNS ./.
@@97974569996 AMY-1/NEWGENE was/VBD localized/VBN in/IN the/DT cytoplasm/NN in/IN cells/NNS expressing/NN c-myc/NEWGENE at/IN low/JJ levels/NNS ,/, but/CC in/IN the/DT nucleus/NN in/IN the/DT cells/NNS of/IN a/DT high/JJ c-myc/NEWGENE expression/NN in/IN transiently/RB transfected/VBN cells/NNS ./.
@@107104992332 Methysergide/CHEM is/VBZ a/DT serotonin/NN antagonist/NN and/CC has/VBZ been/VBN demonstrated/VBN to/IN reduce/VB wound/JJ blood/NN flow/NN and/CC edema/NN formation/NN ./.
@@1180445584 Imposed/VBN angular/JJ displacements/NNS of/IN monkey's/NN wrist/NN produce/NN three/CD major/JJ peaks/NNS of/IN activity/NN (/( terms/NNS M1/NN ,/, M2/CD ,/, and/CC M3/CD peaks/NNS )/SYM in/IN the/DT averaged/VBN gross/JJ EMG/NN activity/NN ot/NN the/DT stretched/VBN muscles/NNS ./.
@@16177769353 Because/IN the/DT adrenergic/JJ nervous/JJ system/NN influences/VBZ cardiac/JJ arrhythmias/NNS and/CC myocardial/JJ infarction/NN can/MD directly/RB affect/VB sympathetic/JJ innervation/NN in/IN the/DT heart/NN ,/, we/PRP investigated/VBD the/DT role/NN of/IN the/DT sympathetic/JJ nervous/JJ system/NN on/IN reentry/NN in/IN the/DT canine/NN heart/NN 4/NN days/NNS after/IN infarction/NN ./.
@@92303849187 Though/IN the/DT BACTEC/NN 9000/NN MB/NN system/NN is/VBZ recommended/VBN for/IN respiratory/JJ specimens/NNS ,/, we/PRP demonstrated/VBD that/IN it/PRP can/MD be/VB successfully/RB used/VBN also/RB for/IN recovery/NN of/IN mycobacteria/NNS from/IN clinical/JJ specimens/NNS from/IN various/JJ extrapulmonary/JJ sites/NNS ./.
@@66275699354 HL/NN 02/NN type/NN oculomotor/NN stimulator/NN ./.
@@99251209921 OBJECTIVE/IN :/: This/DT meta-analysis/NN of/IN 67/CD controlled/VBN trials/NNS was/VBD performed/VBN to/IN quantify/VB the/DT cholesterol-lowering/JJ effect/NN of/IN major/JJ dietary/JJ fibers/NNS ./.
@@6342141657 Among/IN these/DT are/VBP :/: (/( 1/CD )/SYM Is/VBZ there/RB sufficient/JJ understanding/NN of/IN family/NN pathophysiology/NN ,/, of/IN the/DT sensitivity/NN and/CC specificity/NN of/IN diagnostic/JJ techniques/NNS and/CC of/IN the/DT safety/NN and/CC efficacy/NN of/IN therapeutic/JJ modalities/NNS to/IN make/NN true/JJ family/NN health/NN care/NN possible/JJ ?/. (/( 2/CD )/SYM If/IN this/DT type/NN of/IN care/NN is/VBZ possible/JJ ,/, how/RB are/VBP the/DT needs/NN of/IN the/DT family/NN and/CC its/PRP individual/JJ members/NN met/NN ,/, or/CC value/NN judgements/NNS made/VBP about/RB their/PRP relative/JJ importance/NN ?/. and/CC (/( 3/CD )/SYM What/WP are/VBP the/DT consequences/NNS for/IN the/DT health/NN care/NN delivery/NN system/NN of/IN this/DT type/NN of/IN care/NN ?/. An/DT extensive/JJ literature/NN review/NN is/VBZ used/VBN in/IN an/DT attempt/NN to/IN answer/NN these/DT queries/NNS ,/, from/IN which/WDT questions/NNS for/IN further/JJ study/NN are/VBP posed/VBN ./.
@@107995018621 These/DT studies/NNS suggest/VBP an/DT additional/JJ component/NN or/CC cellular/JJ environment/NN is/VBZ required/VBN for/IN SPRK/NEWGENE activation/NN by/IN Cdc42/NEWGENE ./.
@@3363544672 The/DT response/NN of/IN serum/NEWGENE GH/NEWGENE to/IN arginine/NN infusion/NN was/VBD normal/JJ ,/, while/CC that/IN to/IN insulin-induced/JJ hypoglycemia/NN was/VBD poor/JJ ./.
@@36162374298 Convulsive/JJ status/NN epilepticus/NN after/IN infusion/NN of/IN cisplatin/NN ./.
@@10640683484 NDRF/NEWGENE //NEWGENE NeuroD2/NEWGENE was/VBD co-precipitated/JJ with/IN PKN/NEWGENE from/IN the/DT lysate/NN of/IN COS-7/NNP cells/NNS transfected/VBN with/IN both/DT expression/NN constructs/NNS for/IN NDRF/NEWGENE //NEWGENE NeuroD2/NEWGENE and/CC PKN/NEWGENE ./.
@@10003783781 Effect/NN of/IN trauma/NN on/IN plasma/NEWGENE glucagon/NEWGENE and/CC insulin/NEWGENE concentrations/NNS in/IN sheep/NN ./.
@@16239001987 While/IN blood/NN pressure/NN and/CC noradrenergic/JJ activity/NN ,/, assessed/VBN as/IN changes/NNS in/IN the/DT plasma/NN levels/NNS and/CC urinary/JJ excretion/NN of/IN norepinephrine/NN ,/, remained/VBN unaffected/JJ in/IN the/DT Pl/NN group/NN ,/, a/DT significant/JJ drop/NN in/IN the/DT supine/JJ systolic/JJ and/CC diastolic/JJ blood/NN pressures/NNS ,/, as/RB well/VB as/IN in/IN the/DT resting/JJ venous/JJ norepinephrine/NN level/NN and/CC in/IN urinary/JJ norepinephrine/NN excretion/NN was/VBD found/VBN after/IN the/DT first/JJ month/NN of/IN dF/NN administration/NN ./.
@@98194225297 In/NN vitro/NN protein/NN retention/NN experiments/NNS in/IN which/WDT Hsp90/NEWGENE heterocomplexes/NEWGENE were/VBD precipitated/VBN resulted/VBN in/IN coprecipitation/NN of/IN Cns1/NEWGENE ./.
@@95164726633 We/PRP have/VBP identified/VBN two/JJ functional/JJ elements/NNS ,/, both/DT located/VBN downstream/RB from/IN the/DT TATA/NN motif/NN ,/, that/DT control/NN Id4/NEWGENE promoter/NEWGENE activity/NN ./.
@@16207812207 Four/CD of/IN these/DT five/CD subjects/NNS also/RB performed/VBN mixed/JJ sequences/NNS under/IN conditional/JJ control/NN of/IN the/DT words/NNS (/( e/FW ./FW g/FW ./FW ,/, A1----B2----A3----B4----A5/NN and/CC its/PRP reversal/NN )/SYM ,/, verifying/VBG that/IN the/DT stimuli/NNS which/WDT occupied/VBD the/DT same/JJ position/NN in/IN each/DT sequence/NN were/VBD members/NNS of/IN the/DT same/JJ class/NN ./.
@@90322753206 This/DT inhibitory/JJ domain/NN has/VBZ been/VBN deleted/VBN in/IN all/DT naturally/RB occurring/VBG AHC/NEWGENE deletion/NEWGENE mutants/NEWGENE described/VBN to/IN date/NN ./.
@@114620247329 Zhu/NNP ,/, V/NNP ./NNP
@@81631835297 The/DT xylose/NEWGENE isomerase-encoding/NEWGENE gene/NEWGENE (/( xylA/NEWGENE )/SYM of/IN Clostridium/NN thermosaccharolyticum/NN :/: cloning/NN ,/, sequencing/VBG and/CC phylogeny/NN of/IN XylA/NEWGENE enzymes/NEWGENE ./.
@@94179416933 Two/CD disulphide/NN bridges/NNS ,/, which/WDT are/VBP conserved/VBN in/IN all/DT spermadhesin/NN molecules/NN and/CC many/JJ CUB/NEWGENE domains/NEWGENE ,/, crosslink/NN loop/NN LA/NN and/CC strand/NN beta/NN 4/CD and/CC loops/NNS LE/NN and/CC LG/NN ,/, respectively/RB ,/, at/IN opposite/NN edges/NNS of/IN the/DT same/JJ face/NN of/IN the/DT domain/NN ./.
@@76642783704 A/NNP ./NNP
@@5835225766 Etiopathogenetic/JJ and/CC therapeutic/JJ problems/NNS in/IN acute/JJ orbital/JJ inflammation/NN ./.
@@3319366796 Detection/NNS of/IN anti-lymphocyte/JJ antibodies/NNS using/VBG the/DT immunoperoxidase/NEWGENE antiglobulin/NEWGENE1 technic/NN ./.
@@90124056890 Remarkably/RB ,/, both/DT TTD-A/NN and/CC XP-D/NN defects/NNS are/VBP associated/VBN with/IN subunits/NNS of/IN TFIIH/NEWGENE ,/, a/DT basal/JJ transcription/NN factor/NN with/IN a/DT second/JJ function/NN in/IN DNA/NN repair/NN ./.
@@33120333997 Monotherapy/NNS with/IN ceftazidime/NN was/VBD clinically/RB and/CC bacteriologically/RB as/RB effective/JJ as/IN a/DT combination/NN therapy/NN with/IN cefazolin/NN and/CC tobramycin/NN ./.
@@85242943888 The/DT skp1+/NEWGENE gene/NEWGENE is/VBZ not/RB essential/JJ ./.
@@19179435113 Sequence/NN analysis/NN of/IN the/DT sMtCK/NEWGENE genomic/NEWGENE upstream/NEWGENE sequences/NEWGENE reveals/VBZ a/DT typical/JJ TATAA/NN box/NN within/IN the/DT 80/CD base/NN pairs/NNS (/( bp/NN )/SYM that/IN ,/, by/IN transfection/NN experiments/NNS ,/, are/VBP sufficient/JJ to/IN promote/VB expression/NN of/IN chimeric/JJ plasmids/NNS with/IN the/DT chloramphenicol/NEWGENE acetyltransferase/NEWGENE reporter/NEWGENE ./.
@@39533614749 To/TO evaluate/VB the/DT effects/NNS of/IN propranolol/NN on/IN myocardial/JJ metabolism/NN after/IN coronary/JJ reperfusion/NN ,/, serial/JJ measurements/NNS of/IN myocardial/NEWGENE creatine/NEWGENE kinase/NEWGENE (/( CK/NEWGENE )/SYM and/CC calcium/NN (/( Ca/NN )/SYM contents/NNS and/CC CK/NEWGENE and/CC lactic/JJ acid/NN (/( LA/NN )/SYM concentrations/NNS in/IN coronary/JJ sinus/NN blood/NN were/VBD carried/VBN out/RB in/IN 33/CD open-chest/JJ dogs/NNS ./.
@@88231879335 Titration/NNS of/IN the/DT human/JJ and/CC porcine/NN proteins/NN with/IN 2-nitro-5-thiosulfabenzoate/NN indicates/VBZ that/DT membrane/NEWGENE dipeptidase/NEWGENE additionally/RB possesses/VBZ two/JJ intrachain/JJ disulfide/NN bonds/NNS ./.
@@89851158544 The/DT first/JJ identification/NN of/IN the/DT active/NEWGENE 37LRP/NEWGENE //NEWGENE p40/NEWGENE gene/NEWGENE presented/VBN in/IN this/DT study/NN is/VBZ a/DT critical/JJ step/NN toward/IN the/DT isolation/NN of/IN the/DT corresponding/JJ human/JJ gene/NN and/CC the/DT understanding/NN of/IN the/DT molecular/JJ mechanisms/NNS involved/VBN in/IN the/DT up-regulation/NN of/IN its/PRP expression/NN during/IN tumor/NN invasion/NN and/CC metastasis/NN ./.
@@7954475968 Analyses/NNS of/IN additional/JJ tumors/NNS induced/VBN in/IN mice/NNS from/IN two/JJ reciprocal/JJ crosses/NNS ,/, A/NNP //NNP J/NNP x/NN C3H/NN //NN HeJ/NN F1/NN (/( hereafter/NN called/VBN AC3F1/NN )/SYM and/CC C3H/NN //NN HeJ/NN x/NN A/NN //NN J/NN F1/NN (/( hereafter/NN called/VBN C3AF1/NN )/SYM ,/, provided/VBN evidence/NN for/IN the/DT inactivation/NN of/IN one/PRP allele/NN of/IN the/DT putative/JJ chromosome/NN 4/CD tumor/NN suppressor/NN gene/NN by/IN parental/JJ imprinting/NN ./.
@@34798973691 On/IN the/PDT other/DT hand/NN ,/, if/IN the/DT measured/VBN angle/NN ANB/NNP is/VBZ smaller/JJR than/IN the/DT calculated/VBN angle/NN ,/, the/DT skeletal/JJ relation/NN is/VBZ Class/NN III/NN ./.
@@16907036747 Venkatesan/NNP ,/, and/CC D/NN ./NN
@@81199589376 The/DT lack/NN of/IN the/DT C2/NEWGENE domain/NEWGENE of/IN the/DT Ca/NEWGENE (/NEWGENE 2+/NEWGENE )/NEWGENE -dependent/NEWGENE PKCs/NEWGENE and/CC the/DT presence/NN of/IN a/DT unique/JJ NH2-terminal/NN sequence/NN with/IN a/DT potential/JJ signal/JJ peptide/NN and/CC a/DT transmembrane/JJ domain/NN suggest/VB that/DT PKC/NEWGENE mu/NEWGENE is/VBZ a/DT novel/JJ member/NN of/IN the/DT subgroup/NN of/IN atypical/JJ PKCs/NEWGENE ./.
@@86084473218 However/RB ,/, whether/IN or/CC not/RB nonsense/NN codon/NN recognition/NN within/IN TPI/NEWGENE transcripts/NEWGENE takes/VBP place/NN prior/NN to/IN or/CC after/IN splicing/JJ remained/VBN unresolved/JJ ./.
@@55521495452 18F/NN and/CC 85Sr/NN scintimetry/NN in/IN the/DT study/NN of/IN primary/JJ arthropathies/NNS ./.
@@50930305367 Separation/NN of/IN ninhydrin-positive/JJ compounds/NNS in/IN urine/NN by/IN the/DT combined/JJ methods/NNS of/IN medium-tension/JJ intophoresis/NN and/CC partition/NN chromatography/NN ./.
@@113595688647 Molecular/NNP analysis/NN of/IN the/DT pRA2/NN partitioning/NN region/NN :/: ParB/NEWGENE autoregulates/VBZ parAB/NEWGENE transcription/NN and/CC forms/VBZ a/DT nucleoprotein/NN complex/NN with/IN the/DT plasmid/NN partition/NN site/NN ,/, parS/NEWGENE ./.
@@10226074360 The/DT 5'/CD untranslated/JJ and/CC coding/JJ regions/NNS are/VBP contained/VBN within/IN 12/CD exons/NNS ,/, with/IN the/DT translation/NN start/NN site/NN located/VBN within/IN the/DT first/JJ exon/NN ./.
@@113064639074 A/DT mutation/NN in/IN the/DT C/NN domain/NN of/IN Rb/NEWGENE ,/, L901Q/NN ,/, has/VBZ been/VBN identified/VBN that/WDT completely/RB abolishes/VBZ cdk4/NEWGENE //NEWGENE D1/NEWGENE phosphorylation/NN of/IN the/DT isolated/VBN C/NN domain/NN ./.
@@73865001113 Specific/JJ clotting/JJ factor/NN assays/NNS showed/VBD an/DT isolated/VBN deficiency/NN of/IN factor/NEWGENE X/NEWGENE ranging/VBG from/IN 7/CD to/IN 12/CD per/IN cent/NN on/IN three/CD determinations/NNS ./.
@@27055563917 Thus/RB RV/NN O2/NN demand/NN fell/NN when/CC RC/NN O2/NN supply/NN was/VBD reduced/VBN ,/, although/IN a/DT flow/NN reserve/NN was/VBD available/JJ ./.
@@34996088321 These/DT data/NN should/MD be/VB useful/JJ in/IN developing/JJ reagents/NNS for/IN heterozygote/NN detection/NN and/CC prenatal/JJ diagnosis/NN of/IN 11/NEWGENE beta-hydroxylase/NEWGENE deficiency/NN ,/, the/DT second/JJ most/RB frequent/VB cause/NN of/IN congenital/JJ adrenal/JJ hyperplasia/NN ./.
@@13729008032 These/DT exons/NNS ,/, further/RB identified/VBN as/IN exons/NNS 9/CD ,/, 10/CD ,/, and/CC 11/CD ,/, together/RB encode/VB the/DT 37/CD amino/JJ acid/NN residues/NNS present/VBP in/IN alpha/NEWGENE s1-casein/NEWGENE variant/NEWGENE A/NEWGENE but/CC missing/JJ in/IN variant/NN F/NN ./NN
@@40136045135 Since/IN 1970/CD the/DT frequency/NN of/IN potassium-induced/JJ ulceration/NN has/VBZ been/VBN low--3/NN cases/NNS per/IN 100/CD 000/CD patient-years/NNS of/IN slow-release/NN tablet/NN use/NN ./.
@@7795576868 Examination/NN of/IN neurohumoral/JJ factors/NNS revealed/VBD a/DT hyperactive/JJ sympathetic/JJ nervous/JJ system/NN and/CC an/DT increase/NN in/IN plasma/NN renin/NEWGENE activity/NN ./.
@@81895032826 We/PRP have/VBP used/VBN a/DT full-length/JJ cDNA/NN clone/NN of/IN a/DT mouse/NN hepatitis/NN virus/NN strain/NN A59/CD defective/JJ interfering/JJ (/( DI/JJ )/SYM RNA/NN ,/, pMIDI-C/JJ ,/, and/CC cassette/NN mutagenesis/NN to/IN study/NN the/DT mechanism/NN of/IN coronavirus/NN subgenomic/JJ mRNA/NN synthesis/NN ./.
@@91897839140 This/DT investigation/NN was/VBD undertaken/VBP to/IN determine/VB whether/IN consuming/JJ several/DT small/JJ feedings/NNS of/IN preexercise/NN carbohydrate/NN (/( CHO/NN )/SYM ,/, rather/RB than/IN a/DT single/JJ bolus/NN ,/, would/MD affect/VB blood/VB glucose/NN and/CC insulin/NEWGENE responses/NNS during/IN rest/NN and/CC exercise/NN ./.
@@774236331 A/DT triple/JJ Ser--/NNP >/NNP Ala/NNP mutant/JJ form/NN of/IN yeast/NN eIF-2/NEWGENE alpha/NEWGENE was/VBD found/VBN to/IN be/VB no/RB longer/RB phosphorylated/VBN by/IN either/DT of/IN the/DT yeast/NN (/( or/CC mammalian/JJ )/SYM casein/NEWGENE kinase/NEWGENE activities/NNS in/IN vitro/FW ./.
@@112203069640 HexA71/NEWGENE negatively/RB affects/VBP RpoS/NEWGENE ,/, as/IN the/DT levels/NNS of/IN this/DT alternative/JJ sigma/NEWGENE factor/NEWGENE are/VBP higher/JJ in/IN the/DT HexA-/NEWGENE mutant/NEWGENE than/IN in/IN the/DT HexA+/NEWGENE strain/NN ./.
@@100879939964 Site-directed/JJ mutagenesis/NN of/IN binding/JJ sites/NNS for/IN the/DT repressor/NEWGENE proteins/NEWGENE BP1/NEWGENE and/CC BP2/NEWGENE in/IN the/DT upstream/JJ portion/NN of/IN the/DT beta/NEWGENE globin/NEWGENE gene/NEWGENE flanking/NEWGENE region/NEWGENE led/VBN to/IN a/DT 4-6/CD fold/NN increase/NN in/IN promoter/NN activity/NN ./.
@@1384229701 To/TO study/VB a/DT possible/JJ functional/JJ role/NN of/IN this/DT putative/JJ chicken/NN ICS/NEWGENE ,/, an/DT oligonucleotide/NN spanning/VBG the/DT upstream/JJ sequences/NNS of/IN the/DT BF-IV/NEWGENE gene/NEWGENE (/( -174/CD //CD -194/CD )/SYM was/VBD cloned/VBN singly/RB or/CC in/IN multiple/JJ copies/NNS before/IN the/DT herpes/NN TK/NEWGENE promoter/NEWGENE controlling/JJ the/DT chloramphenicol/NEWGENE acetyl/NEWGENE transferase/NEWGENE (/( CAT/NEWGENE )/SYM gene/NN (/( pBLCAT2/NN )/SYM ./.
@@16604864431 The/DT results/NNS suggested/VBN that/IN ,/, depending/VBG upon/IN the/DT cell/NN type/NN ,/, gene/NN cotransfer/NN using/VBG aminoglycoside/NN resistance/NN as/IN a/DT selectable/JJ marker/NN may/MD seriously/RB perturb/VB important/JJ cellular/JJ control/NN mechanisms/NNS such/JJ as/IN the/DT PKC/NEWGENE pathway/NN leading/JJ to/IN activation/NN of/IN gene/NN expression/NN ./.
@@115360631413 Pulmonary/NNP embolectomy/NN and/CC lung/NN transplantation/NN are/VBP the/DT main/JJ indications/NNS for/IN the/DT use/NN of/IN heart-lung-machine/NN ./.
@@87466052413 With/IN the/DT increasing/JJ use/NN of/IN ACE/NEWGENE inhibitors/NN ,/, the/DT incidence/NN of/IN rare/JJ adverse/JJ effects/NNS such/JJ as/IN potentially/RB lethal/JJ pancreatitis/NN is/VBZ likely/RB to/IN increase/NN ./.
@@77524547716 Staphylococcus/NN aureus/NN and/CC CNS/NN showed/VBD high/JJ or/CC moderate/JJ resistance/NN rates/NNS to/IN methicillin/NN (/( DMPPC/NNP )/SYM ./.
@@25740526394 No/DT significant/JJ differences/NNS were/VBD found/VBN in/IN relation/NN to/IN Type/NN A/NN behaviour/NN and/CC beta-adrenoceptor/NEWGENE blockade/NN ./.
@@17331059680 The/DT genome/NN of/IN Thogoto/ORG virus/NN comprises/VBZ six/CD segments/NNS of/IN single-stranded/JJ ,/, negative/JJ sense/NN RNA/NN ./.
@@91550243064 Overexpression/NNS of/IN EFG1/NEWGENE in/IN C/NNP ./NNP albicans/JJ leads/VBP to/IN enhanced/VBN filamentous/JJ growth/NN in/IN the/DT form/NN of/IN extended/VBN pseudohyphae/NNS in/IN liquid/JJ and/CC on/IN solid/JJ media/NN ./.
@@21674679653 The/DT 26S/NEWGENE rRNA/NEWGENE binding/NEWGENE ribosomal/NEWGENE protein/NEWGENE equivalent/JJ to/IN bacterial/NEWGENE protein/NEWGENE L11/NEWGENE is/VBZ encoded/VBN by/IN unspliced/RB duplicated/VBN genes/NNS in/IN Saccharomyces/NN cerevisiae/NN ./.
@@15365758301 An/DT unexpected/JJ finding/NN was/VBD the/DT presence/NN at/IN position/NN -403/CD to/IN -385/CD of/IN a/DT putative/JJ dioxin/NEWGENE responsive/NEWGENE element/NEWGENE ,/, a/DT sequence/NN found/VB to/IN be/VB responsible/JJ for/IN the/DT induction/NN of/IN transcription/NN of/IN the/DT cytochrome/NEWGENE P450IA1/NEWGENE gene/NEWGENE (/( CYPIA1/NEWGENE )/SYM and/CC other/DT genes/NNS involved/VBN in/IN detoxification/NN //NN activation/NN of/IN polycyclic/JJ aromatic/JJ hydrocarbons/NNS ./.
@@12654431905 Hypertonic/NNP glucose/NN administered/VBN intrajejunally/RB in/IN Heidenhain/NNP pouch/NN dogs/NNS resulted/VBN in/IN an/DT equal/NN inhibition/NN of/IN pentagastrin-induced/JJ acid/NN secretion/NN from/IN the/DT pouch/NN and/CC the/DT main/JJ stomach/NN ,/, whereas/IN hypertonic/JJ saline/JJ had/VBP no/DT effect/NN ./.
@@104304213459 APOE-epsilon4/NEWGENE count/NN predicts/VBZ age/NN when/CC prevalence/NN of/IN AD/NN increases/NNS ,/, then/RB declines/VBZ :/: the/DT Cache/NNP County/NNP Study/NNP ./.
@@93411394152 In/NN contrast/NN ,/, resensitization/NN of/IN a/DT sequestration-impaired/JJ beta2AR/NEWGENE mutant/NEWGENE (/NEWGENE Y326A/NEWGENE )/NEWGENE was/VBD reestablished/VBN following/IN the/DT overexpression/NN of/IN either/DT GRK2/NEWGENE or/CC beta-arrestin/NEWGENE 1/NEWGENE ./CD
@@98240011449 In/NN contrast/NN to/IN hemodynamic/JJ and/CC histopathological/JJ predictors/NNS of/IN survival/NN ,/, vWF/NN :/: Ag/NN does/VBP not/RB require/VB invasive/JJ techniques/NNS to/IN be/VB determined/VBN ./.
@@64686738814 Despite/IN supraphysiologic/JJ E2/NN concentrations/NNS ,/, however/RB ,/, cervical/JJ mucus/NN scores/NNS were/VBD significantly/RB reduced/VBN in/IN the/DT CC-treated/JJ group/NN (/( P/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ./.
@@1003397329 Oscillatory/JJ exchange/NN of/IN atoms/NNS between/IN traps/NNS containing/JJ Bose/NNP condensates/NNS ./.
@@118247015150 Patients/NNS with/IN a/DT secondary/JJ cardiac/JJ event/NN had/VBP more/RB common/JJ Type/NN A/NN behavior/NN patterns/NNS and/CC higher/JJ Bortner/NNP scores/NNS than/IN patients/NNS without/IN a/DT secondary/JJ cardiac/JJ event/NN ./.
@@8382296792 McCann/NN III/NN ,/, F/NN ./NN
@@96139469585 A/DT deproteinization/NN procedure/NN was/VBD coupled/VBN with/IN a/DT reversed-phase/JJ HPLC/NN separation/NN using/VBG a/DT 250x4/CD ./CD 6/CD mm/NN I/NNP ./NNP D/NNP ./.
@@88767015745 Recently/RB ,/, a/DT distantly/RB related/VBN UmuC-homolog/NEWGENE ,/, DinB/NEWGENE ,/, has/VBZ also/RB been/VBN identified/VBN in/IN E/NNP ./NNP coli/JJ ./.
@@99886827202 Molecular/NNP cloning/NN of/IN human/JJ cDNA/NN encoding/VBG a/DT novel/JJ beta1/NEWGENE ,/NEWGENE 6-N-acetylglucosaminyltransferase/NEWGENE forming/JJ core/NN 2/CD and/CC core/NN 4/CD ./CD
@@50655485340 On/IN the/DT constituents/NNS of/IN Dryopteris/NNP polylepis/NN ./.
@@13310866463 The/DT basal/JJ promoter/NN elements/NNS of/IN murine/NEWGENE cytochrome/NEWGENE c/NEWGENE oxidase/NEWGENE subunit/NEWGENE IV/NEWGENE gene/NEWGENE consist/VB of/IN tandemly/RB duplicated/VBN ets/NEWGENE motifs/NEWGENE that/WDT bind/VBP to/IN GABP-related/NEWGENE transcription/NEWGENE factors/NEWGENE ./.
@@17722012375 The/DT alcoholic/JJ patient/NN ,/, his/PRP work/NN and/CC the/DT subjectivity/NN of/IN the/DT period/NN ./.
@@11145563315 Expression/NNS of/IN SREBP-1a/NEWGENE stimulated/VBD StAR/NEWGENE promoter/NEWGENE activity/NN in/IN the/DT context/NN of/IN COS-1/NNP cells/NNS and/CC human/JJ granulosa-lutein/JJ cells/NNS ./.
@@36828052031 Serum/NN levels/NNS of/IN albumin/NEWGENE ,/, globulin/NEWGENE ,/, and/CC coagulation/NEWGENE protein/NEWGENE activity/NN were/VBD measured/VBN preshock/NN ,/, postshock/NN ,/, and/CC daily/JJ for/IN 3/CD days/NNS ;/: skin/NN lymph/NN levels/NNS were/VBD measured/VBN on/IN Day/NN 3/CD ./CD
@@35683114232 In/NN 10/CD patients/NNS with/IN subacute/JJ cardiac/JJ tamponade/NN ,/, pulmonary/JJ wedge/NN pressure/NN (/( PWP/NN )/SYM ,/, RAP/NN ,/, and/CC IPP/NN were/VBD measured/VBN along/IN with/IN indexes/NNS of/IN systolic/JJ function/NN ./.
@@83756511486 The/DT Drosophila/NN clathrin/NEWGENE heavy/NEWGENE chain/NEWGENE gene/NN :/: clathrin/NEWGENE function/NN is/VBZ essential/JJ in/IN a/DT multicellular/JJ organism/NN ./.
@@6460236262 Experimental/JJ studies/NNS on/IN virus/NN excretion/NN and/CC non-arthropod/JJ transmission/NN ./.
@@96021244541 Fregnac/NNP ,/, M/NNP ./NNP
@@84602708431 However/RB ,/, after/IN repeated/JJ infections/NNS ,/, hypobiotic/JJ larvae/NNS were/VBD numerous/JJ ./.
@@14598852070 After/IN 28/CD days/NNS of/IN haloperidol/NN treatment/NN ,/, similar/JJ changes/NNS were/VBD observed/VBN for/IN delta/JJ ,/, together/RB with/IN an/DT increase/NN of/IN alpha/NN 1/NN ,/, and/CC a/DT decrease/NN of/IN fast/JJ beta/NN ./.
@@37657312379 Incidences/NNS of/IN nonfatal/JJ stroke/NN ,/, myocardial/JJ infarction/NN ,/, angina/NN pectoris/NN und/NN left/NN ventricular/JJ hypertrophy/NN could/MD also/RB be/VB lowered/VBN ./.
@@10770041583 Kidney/NNS length/NN did/VBD not/RB significantly/RB differ/VB between/IN right/NN and/CC left/NN ,/, however/RB ,/, kidney/NN width/NN ,/, cortical/JJ thickness/NN and/CC size/NN did/VBD (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@98646897619 These/DT findings/NNS suggest/VBP that/IN late/JJ MYO/NN //NN M/NN is/VBZ more/RB useful/JJ than/IN washout/NN rate/NN to/IN assess/VB the/DT effect/NN of/IN treatment/NN on/IN heart/NN failure/NN due/NN to/IN DCM/NN ./.
@@24439243108 Rarely/RB ,/, patients/NNS with/IN locally/RB advanced/JJ ,/, uncontrollable/JJ ,/, non-metastatic/JJ prostatic/JJ cancer/NN enjoy/VB prolonged/JJ survival/NN ./.
@@110294582891 Cells/NNS differentiate/VBP in/IN response/NN to/IN various/JJ extracellular/JJ stimuli/NNS ./.
@@29643296609 The/DT pathogenesis/NN of/IN Limited/NNP Joint/NNP Mobility/NN (/( LJM/NN )/SYM in/IN diabetes/NN is/VBZ unknown/JJ ,/, but/CC the/DT abnormality/NN is/NNS said/VBP to/IN be/VB associated/VBN with/IN an/DT increased/VBN incidence/NN of/IN microangiopathy/NN ./.
@@11278604666 Radiolabeled/JJ biantennary/JJ N-glycans/NNS synthesized/VBN by/IN Pro/NEWGENE (/NEWGENE -/NEWGENE )/NEWGENE 5Lec20/NEWGENE were/VBD proportionately/RB less/PRP ricin-bound/JJ than/IN similar/JJ species/NN from/IN parental/JJ CHO/NN cells/NNS ,/, and/CC Lec20/NNP cell/NN extracts/NNS had/VBP a/DT markedly/RB reduced/VBN ability/NN to/IN transfer/NN Gal/NN to/IN GlcNAc-terminating/VBG acceptors/NNS ./.
@@104136047994 In/NN Saccharomyces/NN cerevisiae/NN the/DT cAMP-dependent/NEWGENE kinases/NEWGENE (/( PKAs/NEWGENE )/SYM promote/VB cytoplasmic/JJ growth/NN and/CC modulate/VB the/DT growth-regulated/JJ mechanism/NN triggering/JJ the/DT begin/VB of/IN DNA/NN synthesis/NN ./.
@@106695942564 In/NN marked/JJ contrast/NN to/IN AgfA/NEWGENE ,/, none/NN of/IN the/DT chimeric/NEWGENE SefA/NEWGENE proteins/NEWGENE were/VBD expressed/VBN or/CC assembled/VBN into/IN fimbriae/NNS ./.
@@21809351799 Kinetic/JJ experiments/NNS revealed/VBN that/IN within/IN 10/CD min/NN this/DT radiolabeled/JJ precursor/NN protein/NN was/VBD converted/VBN in/IN HL-60/NN cells/NNS into/IN an/DT Mr/NNP approximately/RB 150/NN ,/NN 000/NN chondroitin/NN sulfate/NN proteoglycan/NN intermediate/JJ ./.
@@80511027070 Heparin/NNS had/VBP no/DT effect/NN on/IN rAC-st/NEWGENE myosin/NEWGENE light/NEWGENE chain/NEWGENE phosphatase/NEWGENE activity/NN ,/, while/CC the/DT B/NNP subunit-containing/JJ forms/NNS were/VBD stimulated/VBN 2-3-fold/JJ ./.
@@97018951832 Randomly/RB selected/VBN 300/CD children/NNS aged/VBN 3/CD months-3/NN yr/NN were/VBD analysed/VBN over/RB a/DT period/NN of/IN one/PRP year/NN for/IN estimating/VBG prevalence/NN of/IN nutritional/JJ anaemia/NN ./.
@@97317055042 Studies/NNS using/VBG the/DT yeast/NN two-hybrid/JJ system/NN also/RB did/VBD not/RB provide/VB evidence/NN for/IN the/DT formation/NN of/IN a/DT VDR-TR/NEWGENE protein-protein/NN interaction/NN ./.
@@39898274653 The/DT frequency/NN of/IN lactase/NEWGENE phenotypes/NEWGENE in/IN Aymara/NNS children/NNS ./.
@@109381093449 (/( iii/NN )/SYM In/NN these/DT cells/NNS ,/, PKCbeta/NEWGENE plays/VBP a/DT unique/JJ Ras-independent/NNP role/NN in/IN mediating/JJ insulin/NEWGENE but/CC not/RB EGF/NEWGENE or/CC other/DT growth/NEWGENE factor/NEWGENE mitogenic/JJ signals/NNS ./.
@@31828728098 Chem/NNP ./.
@@19899991347 Adenylosuccinate/NEWGENE synthetase/NEWGENE (/( IMP/NN :/: L-aspartate/NEWGENE ligase/NEWGENE (/( GDP/NN )/SYM ,/, EC/NN 6/NN ./NN 3/NN ./NN 4/NN ./NN 4/NN )/NN plays/VBP an/DT important/JJ role/NN in/IN purine/NN biosynthesis/NN catalyzing/VBG the/DT GTP-dependent/NNP conversion/NN of/IN IMP/NN to/IN AMP/NN ./.
@@37764388231 Glucocorticoid/NN induced/VBD hypertension/NN has/VBZ been/VBN regarded/VBN as/IN independent/NN of/IN sodium/NN (/( Na/NN )/SYM ,/, in/IN contrast/NN to/IN mineralocorticoid/RB induced/VBN hypertension/NN ,/, which/WDT is/VBZ Na+-dependent/JJ ./.
@@16493182875 These/DT experiments/NNS delineate/VBP a/DT 186-bp/NN ,/, EBNA-2-responsive/NNP cell/NN DNA/NN fragment/NN and/CC provide/VB firm/JJ evidence/NN that/IN EBNA-2/NEWGENE transactivates/VBZ transcription/NN of/IN cell/NN genes/NNS ./.
@@109973309720 Northern/NNP blot/NN analysis/NN demonstrated/VBN that/IN the/DT STORP/NEWGENE gene/NEWGENE has/VBZ a/DT ubiquitous/JJ pattern/NN of/IN expression/NN similar/JJ to/IN that/DT of/IN the/DT PML/NEWGENE gene/NEWGENE ./.
@@89319916969 These/DT data/NN provide/VB strong/JJ evidence/NN that/IN E2F/NEWGENE or/CC an/DT E2F-related/NEWGENE transcription/NEWGENE factor/NEWGENE is/VBZ involved/VBN in/IN the/DT regulation/NN of/IN nonmuscle/NEWGENE myosin/NEWGENE expression/NN ./.
@@114085759440 In/NN Saccharomyces/NN cerevisiae/NN ,/, entry/NN into/IN mitosis/NN requires/VBZ activation/NN of/IN the/DT cyclin-dependent/NEWGENE kinase/NEWGENE Cdc28/NEWGENE in/IN its/PRP cyclin/NEWGENE B/NEWGENE (/( Clb/NEWGENE )/NN -associated/NN form/NN ./.
@@115537044906 Similar/JJ data/NN were/VBD also/RB obtained/VBN when/CC either/DT dominant/NEWGENE negative/NEWGENE EGFR-CD533/NEWGENE or/CC dominant/NEWGENE negative/NEWGENE Ras/NEWGENE N17/NEWGENE were/VBD used/VBN to/IN block/NN MAPK/NEWGENE activation/NN ./.
@@10120952398 HANYS/NN criticizes/VBZ laparoscopic/JJ gall/NN bladder/NN guidelines/NNS ./.
@@9346935383 By/IN far-Western/CD analysis/NN and/CC coimmunoprecipitation/NN studies/NNS ,/, we/PRP demonstrate/VBP that/IN ZNF74/NEWGENE interacts/VBZ ,/, via/NN its/PRP zinc/NN finger/NN domain/NN ,/, with/IN the/DT hyperphosphorylated/JJ largest/JJS subunit/NN of/IN RNA/NEWGENE polymerase/NEWGENE II/NEWGENE (/( pol/NEWGENE IIo/NEWGENE )/SYM but/CC not/RB with/IN the/DT hypophosphorylated/JJ form/NN ./.
@@28177242190 The/DT examination/NN must/MD include/VB T1/NN and/CC T2/NN sequences/NN and/CC scans/NNS in/IN three/CD planes/NNS ./.
@@13752249960 Genetic/NNP and/CC biochemical/JJ evidence/NN suggests/VBZ that/DT v-Crk/NEWGENE can/MD induce/VB transformation/NN of/IN chicken/NN embryo/NN fibroblasts/NNS by/IN influencing/VBG the/DT activity/NN of/IN cellular/JJ proteins/NNS involved/VBN in/IN growth/NN regulation/NN ./.
@@27615377112 Heating/NN cells/NNS to/IN 43/CD degrees/NNS C/NN decreased/VBD the/DT amount/NN of/IN newly/RB synthesized/VBN rRNA/NEWGENE to/IN less/PRP than/IN 5%/NN of/IN the/DT control/NN level/NN and/CC led/VBN to/IN greater/JJR than/IN 95%/CD inhibition/NN of/IN transcription/NN termination/NN at/IN a/DT region/NN 355/NN to/IN 362/CD nucleotides/NNS downstream/RB of/IN the/DT 3'/CD end/NN of/IN 28S/NEWGENE rRNA/NEWGENE ,/, with/IN readthrough/NN continuing/JJ into/IN the/DT next/JJ transcription/NN unit/NN ./.
@@28702493552 Intravesical/JJ chemotherapy/NN ./.
@@75084417663 Antibodies/NNS affinity-purified/JJ using/VBG the/DT bacterially/RB expressed/VBN recombinant/JJ protein/NN recognized/VBD the/DT 56K/NEWGENE autoantigen/NEWGENE in/IN a/DT HeLa/DT cell/NN extract/NN ./. cDNA/NN sequencing/VBG revealed/VBN that/IN the/DT 56K/NEWGENE cDNA/NEWGENE shares/VBP a/DT high/JJ degree/NN of/IN homology/NN in/IN both/DT nucleotide/NN (/( 87%/JJ )/SYM and/CC amino/JJ acid/NN sequence/NN (/( 92/CD ./CD 5%/CD )/SYM with/IN bovine/NEWGENE annexin/NEWGENE XI/NEWGENE ,/, indicating/VBG that/IN the/DT 56K/NEWGENE cDNA/NEWGENE encodes/VBZ the/DT human/NEWGENE homologue/NEWGENE of/NEWGENE annexin/NEWGENE XI/NEWGENE ,/, a/DT member/NN of/IN the/DT Ca/NEWGENE (/NEWGENE 2+/NEWGENE )/NEWGENE -dependent/NEWGENE phospholipid/NEWGENE binding/NEWGENE protein/NEWGENE family/NEWGENE ./.
@@78065326973 Protein/NEWGENE cHMGI/NEWGENE binds/VBZ preferentially/RB to/IN AT-rich/NNP DNA/NN with/IN a/DT half-saturation/NN value/NN of/IN 1/CD ./CD 1/CD nM/CD ./CD
@@2240138661 Total/JJ VO2/NN was/VBD decreased/VBN in/IN both/DT groups/NNS during/IN severe/JJ hypoxia/NN but/CC limb/NN VO2/NN was/VBD maintained/VBN in/IN the/DT beta-block/JJ group/NN ./. beta-Block/RB prevented/VBN the/DT fall/NN in/IN total/NN and/CC limb/NN peripheral/JJ resistance/NN seen/VBP in/IN severe/JJ hypoxia/NN but/CC did/VBD not/RB alter/VB the/DT consistently/RB more/RB efficient/JJ utilization/NN of/IN total/JJ O2/NN delivery/NN shown/VBP by/IN the/DT limb/NN in/IN comparison/NN to/IN the/DT whole/JJ body/NN by/IN higher/JJ O2/NN extraction/NN ratios/NNS and/CC lower/JJR venous/JJ O2/NN pressure/NN ./. beta-Vasodilator/NEWGENE receptors/NEWGENE evidently/RB played/VBN an/DT active/JJ part/NN in/IN the/DT vasodilatation/NN seen/VBP during/IN severe/JJ hypoxia/NN ./.
@@30277793236 SPECT/NN examination/NN of/IN the/DT TMJ/NN using/VBG 99m/NN Tc-MDP/NN was/VBD performed/VBN in/IN 43/CD patients/NNS with/IN arthrographically/RB proven/VBP anterior/JJ dislocation/NN of/IN the/DT disc/NN and/CC in/IN 30/CD normals/NNS ./.
@@105061604926 J/NNP ./NNP
@@33228299878 The/DT size/NN of/IN the/DT group/NN allocated/VBN to/IN the/DT good/JJ compliance/NN category/NN by/IN the/DT use/NN of/IN the/DT digoxin/NN marker/NN was/VBD equivalent/JJ in/IN size/NN to/IN a/DT group/NN of/IN patients/NNS who/WP had/VBP returned/VBN less/PRP than/IN 15%/NN of/IN their/PRP prescribed/VBN dose/NN or/CC reported/VBD a/DT deviation/NN of/IN less/PRP than/IN 6%/JJ from/IN their/PRP prescription/NN ./.
@@105675823903 In/NN the/DT mouse/NN ,/, CtBP1/NEWGENE is/VBZ expressed/VBN from/IN embryo/NN to/IN adult/JJ ,/, but/CC CtBP2/NEWGENE is/VBZ mainly/RB expressed/VBN during/IN embryogenesis/NN ./.
@@44076498910 Intracranial/JJ arachnoid/NN cyst/NN of/IN the/DT middle/JJ fossa/NN demonstrated/VBN by/IN positive/JJ 99mTc/NN brainscintigraphy/NN ./.
@@89295639503 Rat/NEWGENE liver/NEWGENE catalase/NEWGENE is/VBZ sorted/VBN to/IN peroxisomes/NNS by/IN its/PRP C-terminal/NN tripeptide/NN Ala-Asn-Leu/NEWGENE ,/, not/RB by/IN the/DT internal/NEWGENE Ser-Lys-Leu/NEWGENE motif/NEWGENE ./.
@@29833319412 Evidence/NN for/IN a/DT role/NN of/IN endogenous/NEWGENE corticotropin-releasing/NEWGENE factor/NEWGENE in/IN cold/JJ ,/, ether/NN ,/, immobilization/NN ,/, and/CC traumatic/JJ stress/NN ./.
@@106715546366 The/DT encoded/VBN amino/JJ acid/NN sequences/NNS in/IN the/DT full-length/JJ bovine/JJ and/CC porcine/NN cDNAs/NN were/VBD identical/JJ ,/, consisting/VBG of/IN 209/CD amino/JJ acid/JJ residues/NNS ,/, and/CC were/VBD nearly/RB the/DT same/JJ as/IN the/DT published/VBN sequence/NN determined/VBN by/IN Edman/NN degradation/NN ./.
@@21494872760 The/DT 4/CD days/NNS dexamethasone/NN suppression/NN test/NN showed/VBD more/RB than/IN 80%/CD suppression/NN of/IN dehydroepiandrosterone-sulphate/NN and/CC a/DT variable/JJ (/( 40-60%/JJ )/SYM reduction/NN of/IN testosterone/NN and/CC androstenedione/NN levels/NNS ./.
@@18645105410 Dd/NEWGENE PK1/NEWGENE RNA/NEWGENE decreases/NNS after/IN 6/CD h/NN of/IN starvation/NN to/IN re-accumulate/NN once/CC the/DT cells/NNS have/NN aggregated/VBN ./.
@@37632414429 She/PRP also/RB had/VBP slight/JJ weakness/NN of/IN the/DT upper/JJ extremities/NNS ./.
@@106013356775 Redistribution/NNS of/IN mannosidase/NEWGENE I/NEWGENE was/VBD also/RB observed/VBN in/IN cells/NNS incubated/VBN at/IN 15/CD degrees/NNS C/NNP ./NNP
@@95288582051 In/NN some/DT cases/NNS ,/, the/DT aberrant/JJ methylation/NN of/IN CpGs/NNS within/IN 5'/CD regulatory/JJ regions/NNS has/VBZ led/VBN to/IN suppression/NN of/IN gene/NN activity/NN ./.
@@9447962805 The/DT second/JJ transcript/NN ,/, rhis4l/NEWGENE ,/, is/VBZ bicistronic/JJ ./.
@@25111503156 Current/JJ status/NN and/CC future/JJ perspectives/NNS ./.
@@93006984976 In/NN support/NN of/IN this/DT interpretation/NN we/PRP demonstrate/VBP that/IN MQ9b/NEWGENE binds/VBZ strongly/RB 5/CD of/IN 17/CD motif-positive/JJ ,/, pathogen-derived/JJ synthetic/JJ peptides/NNS ./.
@@10409699826 Human/NNP expressed/VBD sequence/NN tag/NN clones/NNS were/VBD identified/VBN by/IN sequence/NN similarity/NN to/IN mammalian/NEWGENE and/NEWGENE yeast/NEWGENE oligosaccharide-processing/NEWGENE mannosidases/NEWGENE ,/, and/CC the/DT full-length/JJ coding/JJ region/NN of/IN the/DT putative/JJ mannosidase/NEWGENE homolog/NEWGENE was/VBD isolated/VBN by/IN a/DT combination/NN of/IN 5'-rapid/JJ amplification/NN of/IN cDNA/NN ends/NNS and/CC direct/JJ polymerase/NEWGENE chain/NN reaction/NN from/IN human/JJ placental/JJ cDNA/NN ./.
@@5346133420 Irradiation/NN of/IN human/JJ blood/NN platelets/NNS with/IN UV-A/NN in/IN vitro/FW impairs/VBZ their/PRP ability/NN to/IN aggregate/NN after/IN challenge/NN with/IN collagen/NEWGENE ./.
@@117892161647 Exploration/NNP on/IN the/DT effects/NNS of/IN activating/JJ blood/NN circulation/NN to/IN remove/VB blood/NN stasis/NN on/IN barrier/NN action/NN of/IN gastric/JJ wall/NN in/IN chronic/JJ atrophic/JJ gastritis/NN
@@77453113838 Diagnosis/NNP of/IN FHCS/NN has/VBZ been/VBN weighed/VBN upon/IN laparoscopic/JJ findings/NNS ./.
@@109100737912 Because/IN all/DT PDGFbetaR/NEWGENE fusions/NEWGENE described/VBN thus/RB far/JJ result/NN in/IN splicing/JJ to/IN a/DT common/JJ exon/NN of/IN this/DT gene/NN ,/, we/PRP performed/VBD 5'-rapid/JJ amplification/NN of/IN cDNA/NN ends/NNS PCR/NN on/IN patient/NN RNA/NN ./.
@@98379209017 Here/RB we/PRP have/VBP investigated/VBN the/DT structural/JJ requirements/NNS and/CC consequences/NNS of/IN regulatory/JJ phosphorylation/NN for/IN the/DT interaction/NN between/IN c-Jun/NEWGENE and/CC JNK/NEWGENE in/IN vivo/NN ./.
@@20525924845 To/TO determine/VB whether/IN mononuclear/JJ cell/NN secretory/JJ products/NNS contribute/VBP to/IN the/DT changes/NNS in/IN bone/NN turnover/NN that/WDT characterize/VBP the/DT development/NN of/IN postmenopausal/JJ osteoporosis/NN ,/, we/PRP evaluated/VBD the/DT effects/NNS of/IN oophorectomy/NN and/CC subsequent/JJ estrogen/NN replacement/NN on/IN the/DT spontaneous/JJ secretion/NN of/IN interleukin/NEWGENE 1/NEWGENE (/( IL-1/NEWGENE )/SYM and/CC tumor/NEWGENE necrosis/NEWGENE factor/NEWGENE alpha/NEWGENE (/( TNF-alpha/NEWGENE )/SYM and/CC on/IN the/DT phytohemagglutinin/NN A-induced/JJ secretion/NN of/IN granulocyte-macrophage/NEWGENE colony-stimulating/NEWGENE factor/NEWGENE (/( GM-CSF/NEWGENE )/SYM from/IN peripheral/JJ blood/NN mononuclear/JJ cells/NNS ./.
@@111584561000 METHODS/IN :/: A/DT structured/JJ interview/NN was/VBD undertaken/VBP at/IN the/DT time/NN of/IN initial/JJ consultation/NN and/CC at/IN subsequent/JJ 1-year/JJ intervals/NNS regarding/IN type/NN of/IN BHS/DT ,/, frequency/NN of/IN spells/NNS ,/, associated/VBN phenomenon/NN ,/, sequelae/NNS ,/, family/NN history/NN ,/, and/CC age/NN at/IN termination/NN of/IN spells/NNS ./.
@@62456726048 Selective/JJ macrophage/NN inhibition/NN abolishes/VBZ warfarin-induced/JJ reduction/NN of/IN metastasis/NN ./.
@@1860846244 The/DT human/JJ cDNA/NN was/VBD used/VBN to/IN demonstrate/VB that/DT tumor/NEWGENE necrosis/NEWGENE factor-alpha/NEWGENE could/MD rapidly/RB stimulate/VB MARCKS/NEWGENE gene/NEWGENE transcription/NN in/IN the/DT human/JJ promyelocytic/JJ leukemia/NN cell/NN line/NN HL60/JJ ./.
@@111455904191 We/PRP have/VBP therefore/RB studied/VBN the/DT molecular/JJ mechanisms/NNS of/IN TGF-beta1/NEWGENE action/NN on/IN thyroglobulin/NEWGENE (/( TG/NEWGENE )/SYM gene/NN expression/NN by/IN focusing/VBG our/PRP attention/NN on/IN TGF-beta1/NEWGENE regulation/NN of/IN thyroid-specific/NN transcription/NN factors/NN ./.
@@13108992724 The/DT predicted/VBN receptor/NN structure/NN includes/VBZ a/DT cysteine-rich/JJ extracellular/JJ domain/NN ,/, a/DT single/JJ hydrophobic/JJ transmembrane/JJ domain/NN ,/, and/CC a/DT predicted/VBN cytoplasmic/NEWGENE serine/NEWGENE //NEWGENE threonine/NEWGENE kinase/NEWGENE domain/NEWGENE ./.
@@114284352101 DESIGN/IN :/: A/DT retrospective/JJ chart/NN review/NN of/IN 9/NN ,/NN 322/NN patients/NNS undergoing/VBG surgical/JJ procedures/NNS in/IN the/DT period/NN January/NN 1993/CD to/IN December/NN 1998/CD ./.
@@107903901947 Genetic/NNP and/CC molecular/JJ complexity/NN of/IN the/DT position/NN effect/NN variegation/NN modifier/NN mod/NEWGENE (/NEWGENE mdg4/NEWGENE )/NEWGENE in/IN Drosophila/NN ./. mod/NEWGENE (/NEWGENE mdg4/NEWGENE )/NEWGENE ,/, also/RB known/VBP as/IN E/NEWGENE (/NEWGENE var/NEWGENE )/NEWGENE 3-93D/NEWGENE ,/, is/VBZ involved/VBN in/IN a/DT variety/NN of/IN processes/NNS ,/, such/JJ as/IN gene/NN silencing/VBG in/IN position/NN effect/NN variegation/NN (/( PEV/NNS )/SYM ,/, the/DT control/NN of/IN gypsy/NEWGENE insulator/NEWGENE sequences/NEWGENE ,/, regulation/NN of/IN homeotic/NEWGENE gene/NEWGENE expression/NN ,/, and/CC programmed/JJ cell/NN death/NN ./.
@@1883872500 Studies/NNS of/IN lipoproteins/NNS should/MD ,/, however/RB ,/, be/VB made/VBP in/IN children/NNS from/IN families/NNS known/VBP to/IN have/NN FH/NN or/CC early/JJ coronary/JJ heart/NN disease/NN ./.
@@9328476560 U4/NEWGENE //NEWGENE U6/NEWGENE snRNP/NEWGENE is/VBZ one/PRP of/IN four/CD essential/JJ small/NEWGENE nuclear/NEWGENE ribonucleoprotein/NEWGENE (/NEWGENE snRNP/NEWGENE )/NEWGENE particles/NEWGENE (/NEWGENE U1/NEWGENE ,/NEWGENE U2/NEWGENE ,/NEWGENE U5/NEWGENE and/NEWGENE U4/NEWGENE //NEWGENE U6/NEWGENE )/SYM present/VB in/IN the/DT spliceosome/NEWGENE ./.
@@10785294604 Eight/CD of/IN the/DT non-acceptable/JJ inlays/NNS //NNS onlays/NNS and/CC five/CD of/IN the/DT direct/JJ restorations/NNS were/VBD replaced/VBN ,/, while/CC the/PDT other/DT ones/NNS were/VBD repaired/VBN with/IN resin/NN composite/JJ ./.
@@11689568803 Before/IN this/DT date/NN ,/, the/DT drug/NN directly/RB inhibits/VBZ fetal/JJ weight/NN gain/NN ,/, whereas/IN the/DT sensitivity/NN of/IN the/DT placenta/NN is/VBZ only/RB transient/JJ at/IN day/NN 16/CD resulting/JJ in/IN maximum/JJ weight/NN decrease/NN of/IN this/DT organ/NN 24/CD h/NN later/JJR ./.
@@110240363757 When/WRB cotransfected/VBN in/IN fibroblasts/NNS with/IN a/DT C/NEWGENE //NEWGENE EBP/NEWGENE alpha/NEWGENE expression/NN vector/NN ,/, reporter/NN gene/NN expression/NN increased/VBN 3-fold/CD only/RB in/IN the/DT wild-type/NN constructs/NN ./.
@@78295193482 This/DT utilization/NN of/IN an/DT intronic/JJ polyadenylation/NN site/NN without/IN alternative/JJ exon/NN usage/NN is/VBZ comparable/JJ to/IN the/DT mechanism/NN whereby/RB both/DT secreted/VBN and/CC membrane-bound/JJ forms/NNS of/IN the/DT immunoglobulin/NEWGENE mu/NEWGENE heavy/NEWGENE chain/NEWGENE are/VBP made/VBP from/IN a/DT single/JJ genetic/JJ locus/NN ./.
@@21790529326 The/DT characterized/VBN Y'/NEWGENE repeated/NEWGENE sequence/NEWGENE families/NEWGENE provide/VBP an/DT experimental/JJ system/NN in/IN which/WDT repeated/JJ sequence/NN interactions/NNS and/CC subsequent/JJ evolution/NN can/MD be/VB studied/VBN ./.
@@60858395908 Also/RB discussed/VBN is/VBZ the/DT possibility/NN of/IN a/DT combined/JJ genetic/JJ and/CC environmental/JJ etiology/NN ./.
@@85897355732 In/NN these/DT constructs/NNS ,/, GUS/NEWGENE expression/NN was/VBD driven/VBP by/IN promoter/NN regions/NNS derived/VBN from/IN the/DT Arabidopsis/NEWGENE alcohol/NEWGENE dehydrogenase/NEWGENE (/( Adh1/NEWGENE )/SYM ,/, maize/NEWGENE ubiquitin/NEWGENE (/( Ubi1/NEWGENE )/SYM ,/, rice/NEWGENE actin/NEWGENE (/( Act1/NEWGENE )/SYM and/CC CaMV/NEWGENE 35S/NEWGENE genes/NEWGENE ./.
@@81157448090 The/DT films/NNS were/VBD analyzed/VBN using/VBG a/DT scanning/JJ helium-neon/JJ laser/NN densitometer/NN with/IN a/DT small/JJ aperture/NN of/IN 5-10/CD microns/NNS ./.
@@17404484245 While/IN no/DT obvious/JJ transmembrane/JJ regions/NNS were/VBD identified/VBN ,/, several/DT short/JJ hydrophobic/JJ amino/JJ acid/NN stretches/NNS were/VBD found/VBN to/IN be/VB localized/VBN in/IN and/CC around/IN the/DT Pro/NEWGENE II/NEWGENE region/NEWGENE ,/, and/CC these/DT may/MD be/VB responsible/JJ for/IN attachment/NN of/IN precursors/NNS to/IN membranes/NNS ./.
@@88927554902 In/NN addition/NN ,/, carp/NEWGENE JAK1/NEWGENE shows/VBZ higher/JJ sequence/NN homology/NN to/IN mammalian/NEWGENE JAK1/NEWGENE in/IN both/PDT the/DT kinase-like/NEWGENE (/( JH2/NEWGENE )/SYM and/CC kinase/NEWGENE (/( JH1/NEWGENE )/SYM domains/NNS (/( approximately/RB 70%/CD identity/NN )/SYM ./.
@@95733784336 U73/NEWGENE contains/VBZ C/NN ,/, D/NN and/CC D'/NNS boxes/NNS and/CC a/DT 12-nucleotide/JJ antisense/NN complementarity/NN to/IN the/DT 28S/NEWGENE ribosomal/NEWGENE RNA/NEWGENE ./.
@@88544598827 This/DT paper/NN gives/VBZ an/DT overview/NN of/IN the/DT global/JJ pattern/NN of/IN casualties/NNS in/IN earthquakes/NNS which/WDT occurred/VBD during/IN the/DT 30-month/CD period/NN from/IN 1/CD September/NN 1993/CD to/IN 29/CD February/NN 1996/CD ./.
@@77999484865 By/IN contrast/NN ,/, deletion/NN of/IN this/DT Ras-binding/NEWGENE site/NEWGENE did/VBD not/RB diminish/VB activation/NN of/IN Raf-1/NEWGENE kinase/NEWGENE by/IN Src/NEWGENE ,/, implying/VBG that/IN Src/NEWGENE and/CC Ras/NEWGENE can/MD activate/VB Raf-1/NEWGENE through/RB independent/JJ mechanisms/NNS ./.
@@29582333662 The/DT clinical/JJ picture/NN and/CC laboratory/NN parameters/NNS were/VBD consistent/JJ with/IN a/DT serum/JJ sickness/NN reaction/NN ./.
@@75680264257 The/DT Stat5b/NEWGENE mRNA/NEWGENE has/VBZ a/DT size/NN of/IN 5/CD ./CD 6/CD kb/NN and/CC encodes/VBZ a/DT protein/NN of/IN 786/CD amino/JJ acids/NNS ./.
@@16627941582 Expression/NNS of/IN the/DT wt1/NEWGENE gene/NEWGENE via/NN transient/JJ transfection/NN in/IN COS-1/NNP cells/NNS revealed/VBD a/DT 52/NN kDa/NN protein/NN which/WDT was/VBD immunoprecipitated/VBN by/IN both/PDT the/DT N-terminal-/NNP and/CC C-terminal-specific/NNP antisera/NNS ./.
@@2479635232 Cotransfection/NNS of/IN either/DT construct/NN with/IN plasmids/NNS encoding/VBG PKI/NEWGENE (/NEWGENE 1-31/NEWGENE )/NEWGENE inhibits/VBZ cAMP-stimulated/JJ but/CC not/RB basal-/DT or/CC phorbol/NN ester-stimulated/JJ expression/NN ./.
@@106428898097 Sequence/NN analysis/NN showed/VBN that/IN the/DT 5'-flanking/JJ region/NN upstream/RB to/IN the/DT ATG/NN codon/NN did/VBD not/RB contain/VB a/DT conventional/JJ TATA/NN box/NN ./.
@@96630624156 Tensile/JJ bond/NN strengths/NNS between/IN resin/NN composite/JJ and/CC bovine/NEWGENE dentin/NEWGENE using/VBG dentin/NEWGENE adhesive/JJ systems/NNS (/( Clearfil/NNP Liner/NNP Bond/NNP II/NNP :/: LB/NN II/NNP ;/: Scotchbond/NNP Multi-Purpose/NNP :/: MP/NN )/SYM bonding/JJ systems/NNS showed/VBD a/DT large/JJ scatter/NN among/IN students/NNS and/CC dentists/NNS ./.
@@112850549472 Regression/NNS analyses/NNS showed/VBD that/DT SOREMP/NN dream/NN occurrences/NNS were/VBD significantly/RB related/VBN to/IN the/DT amount/NN of/IN REM/NN sleep/NN ,/, while/CC NREMP/NN dream/NN occurrences/NNS were/VBD related/VBN to/IN arousals/NNS from/IN NREM/NN sleep/NN ./.
@@114419744432 At/NN the/DT end/NN of/IN each/DT day/NN of/IN migration/NN the/DT pulmonary/JJ hemolymph/NN PO2/NN decreased/VBN by/IN 1-2/CD ./CD 5/CD kPa/NN ,/, but/CC the/DT hemocyanin/NN remained/VBD saturated/JJ with/IN O2/NN and/CC the/DT venous/JJ reserve/NN was/VBD largely/RB unchanged/JJ (/( O2/NN >/SYM 0/CD ./CD 4/CD mmol/NN x/NN l/NN (/NN -1/NN )/NN )/NN ./.
@@92346969080 Prominent/JJ protein/NEWGENE kinase/NEWGENE cascades/NEWGENE are/VBP those/DT that/WDT activate/VBP mitogen-activated/NEWGENE protein/NEWGENE (/NEWGENE MAP/NEWGENE )/NEWGENE kinases/NEWGENE ./.
@@8057356372 A/DT constitutive/JJ mutant/JJ form/NN with/IN a/DT single/JJ substitution/NN (/( V88A/NNP )/SYM in/IN the/DT amino-terminal/JJ (/( response/NN regulator/NN )/SYM region/NN was/VBD used/VBN ./.
@@28456547165 Substitution/NNS of/IN a/DT threonine/NN residue/NN by/IN an/DT alanine/NN residue/NN at/IN position/NN -2/CD (/( P2/NN )/SYM of/IN this/DT cleavage/NN site/NN abolished/VBD cleavage/NN ,/, whereas/IN substitution/NN of/IN a/DT tyrosine/NN residue/NN by/IN a/DT phenylalanine/NN residue/NN at/IN amino/JJ acid/NN position/NN -1/CD (/( P1/NN )/SYM of/IN the/DT cleavage/NN site/NN did/VBD not/RB influence/VB processing/VBG ./.
@@35368648139 In/NN previous/JJ work/NN (/( E/NNP ./NNP
@@108110796303 In/NN the/DT SPP2/NN screening/JJ test/NN ,/, a/DT few/JJ plates/NNS were/VBD not/RB seen/VBP in/IN both/DT groups/NNS ./.
@@40148334676 Hydrocortisone/NNP caused/VBD lymphopenia/NN and/CC inhibited/VBD the/DT blastogenic/JJ response/NN of/IN peripheral/JJ blood/NN lymphocytes/NNS to/IN phytohemagglutinin/NEWGENE and/CC concanavalin/NEWGENE A/NEWGENE mitogens/NNS ./.
@@188889688 A/DT deletion/NN series/NN of/IN the/DT 5'/CD flanking/JJ region/NN was/VBD created/VBN from/IN position/NN -1329/CD to/IN -74/NN relative/JJ to/IN the/DT transcriptional/JJ initiation/NN site/NN and/CC similarly/RB examined/VBN in/IN transgenic/JJ tobacco/NN ./.
@@88876745083 A/DT subset/NN of/IN these/DT DMP1/NEWGENE recognition/NEWGENE sequences/NEWGENE containing/JJ a/DT GGA/DT trinucleotide/NN core/NN can/MD also/RB function/VB as/IN Ets-responsive/NEWGENE elements/NEWGENE ./.
@@107755854951 Ab-MLV/NNP strains/NNS expressing/JJ P70/NEWGENE //NEWGENE S2/NEWGENE failed/VBN to/IN transform/VB NIH/NN 3T3/CD cells/NNS and/CC demonstrated/VBD a/DT greatly/RB reduced/VBN capacity/NN to/IN mediate/VB signaling/JJ events/NNS associated/VBN with/IN the/DT Ras-dependent/NEWGENE mitogen-activated/NEWGENE protein/NEWGENE (/NEWGENE MAP/NEWGENE )/NEWGENE kinase/NEWGENE pathway/NN ./.
@@18515279433 The/DT promoter/NN activity/NN of/IN the/DT gene/NEWGENE encoding/NEWGENE Alzheimer/NEWGENE beta-amyloid/NEWGENE precursor/NEWGENE protein/NEWGENE (/( APP/NEWGENE )/SYM is/VBZ regulated/VBN by/IN two/JJ blocks/NNS of/IN upstream/JJ sequences/NNS ./.
@@100267841401 High-affinity/NNP site-specific/NN DNA/NN binding/JJ by/IN POU/NEWGENE domain/NEWGENE transcription/NN factors/NNS requires/VBZ both/PDT the/DT POU-specific/NNP and/CC the/DT POU-homeodomain/NEWGENE ./.
@@116934618189 These/DT utilisation/NN data/NN imply/VB annual/JJ drug/NN costs/NNS in/IN the/DT range/NN of/IN $US/NN 480/CD ,/CD 000/CD to/IN $US/NN 3/CD ,/CD 600/CD ,/CD 000/CD for/IN TNF/NEWGENE antagonists/NNS for/IN RA/NN per/IN 1/CD million/NN population/NN ./.
@@34138904106 Prognosis/NNS in/IN Bowen's/NNP disease/NN localized/VBN to/IN the/DT ano-genital/JJ region/NN ./.
@@13099108804 Nucleotide/NN sequence/NN analysis/NN revealed/VBN that/IN TAR-binding/NEWGENE protein/NEWGENE is/VBZ very/RB similar/JJ to/IN the/DT CREB2/NEWGENE protein/NEWGENE ./.
@@66743744015 Hepatitis/NN B/NN vaccination/NN strategy/NN for/IN health-care/JJ workers/NNS in/IN a/DT country/NN of/IN intermediate/JJ hepatitis/NNP B/NNP endemicity/NN ./.
@@33964374091 So/RB far/RB no/DT problems/NNS with/IN multiply/RB resistant/JJ strains/NNS have/VBP developed/VBN ./.
@@9309479269 These/DT observed/VBN drug/NN interactions/NNS ,/, plus/IN the/DT known/VBP effect/NN of/IN probenecid/NN to/IN block/NN secretion/NN of/IN PZA/NN ,/, have/VB to/IN be/VB considered/VBN in/IN evaluating/VBG the/DT effect/NN of/IN the/DT two/JJ drugs/NNS given/VBP together/RB ,/, compared/VBN to/IN the/DT effect/NN of/IN each/DT drug/NN given/NN separately/RB ./.
@@1067978112 A/DT 385/NEWGENE bp/NEWGENE Glucocorticoid/NEWGENE Response/NEWGENE Unit/NEWGENE (/( GRU/NEWGENE )/SYM was/VBD identified/VBN whose/WP glucocorticoid/NN induction/NN was/VBD enhanced/VBN by/IN dibutyryl-cAMP/NN and/CC reduced/VBN by/IN phorbol/NN esters/NNS ./.
@@112658538734 The/DT Novacor/NNP Left/NNP Ventricular/NNP Assist/NNP System/NNP (/( LVAS/NN )/SYM (/( Novacor/NNP Corp/NNP ,/, Oakland/NNP ,/, CA/NN )/SYM was/VBD initially/RB console-based/JJ and/CC has/VBZ been/VBN available/JJ since/IN 1993/CD in/IN a/DT wearable/JJ configuration/NN ./.
@@96657209264 In/NN the/DT absence/NN of/IN Mg2+/NN ,/, a/DT hydrophobic/JJ exonuclease/NEWGENE site/NEWGENE dominates/VBZ over/RB the/DT polymerase/NEWGENE site/NEWGENE for/IN possession/NN of/IN the/DT primer/NN terminus/NN ./.
@@103626529040 Both/DT carbachol/NN (/( 100/CD microM/NN )/SYM and/CC EGF/NEWGENE (/( 10/CD nM/NN )/SYM induced/VBN Ras/NEWGENE activation/NN ./.
@@69115591963 Statistics/NNP for/IN nurse/NN managers--3/NN ./.
@@75965585590 These/DT results/NNS suggest/VBP that/IN low/JJ concentrations/NNS of/IN IL-1/NEWGENE beta/NEWGENE may/MD be/VB useful/JJ for/IN nonsurgical/JJ treatment/NN of/IN human/NN vitreous/NN hemorrhage/NN ./.
@@51701065414 Results/NNS of/IN the/DT official/JJ inspection/NN of/IN the/DT commercial/JJ anti-inflammatory/JJ enzyme/NN preparations/NNS containing/NN chymotrypsin/NEWGENE and/CC trypsin/NEWGENE by/IN means/NN of/IN modified/JJ NF/NN 13/NN methods/NNS ./.
@@8642313866 T/NN cell/NN leukemia-associated/JJ human/NN Notch/VBD //VBD translocation-associated/VBD Notch/NEWGENE homologue/NEWGENE has/VBZ I/NN kappa/NN B-like/NN activity/NN and/CC physically/RB interacts/VBZ with/IN nuclear/NEWGENE factor-kappa/NEWGENE B/NEWGENE proteins/NEWGENE in/IN T/NN cells/NNS ./.
@@95997243744 A/DT stratified/JJ random/JJ sample/NN of/IN 20/CD active/JJ employees/NNS from/IN a/DT cohort/NN of/IN phenoxy/JJ herbicide/NN workers/NNS was/VBD selected/VBN in/IN 1995/CD for/IN determining/VBG PCDD/NN and/CC PCDF/NN congeners/NNS in/IN blood/NN lipids/NNS to/IN assess/VB the/DT extent/NN of/IN past/JJ PCDD/NN and/CC PCDF/NN exposure/NN in/IN this/DT cohort/NN and/CC whether/IN that/DT exposure/NN might/MD explain/VB site-specific/JJ cancer/NN findings/NNS in/IN the/DT total/JJ cohort/NN ./.
@@95823061840 A/DT point/NN mutation/NN in/IN Galphao/NEWGENE and/CC Galphai1/NEWGENE blocks/NNS interaction/NN with/IN regulator/NN of/IN G/NEWGENE protein/NEWGENE signaling/NN proteins/NN ./.
@@18699688562 Linear/NNP regression/NN analysis/NN was/VBD performed/VBN and/CC the/DT following/JJ result/NN was/VBD obtained/VBN :/: clearance/NN (/( HMPAO/NN )/SYM =/SYM 0/CD ./CD 07/CD +/SYM 0/CD ./CD 43/CD ./. rCBF/NN with/IN a/DT high/JJ significance/NN (/( p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ./.
@@11161720991 Copyright/NNP 2001/CD Academic/NNP Press/NNP ./.
@@114199385442 Conformational/JJ changes/NNS of/IN the/DT ferric/JJ uptake/NN regulation/NN protein/NN upon/IN metal/NN activation/NN and/CC DNA/NN binding/JJ ;/: first/JJ evidence/NN of/IN structural/JJ homologies/NNS with/IN the/DT diphtheria/NEWGENE toxin/NEWGENE repressor/NEWGENE ./.
@@106626145508 The/DT genome/NN organization/NN of/IN the/DT mite-transmitted/JJ wheat/NN streak/NN mosaic/NN virus/NN (/( WSMV/NN )/SYM appears/VBZ to/IN parallel/JJ that/IN of/IN members/NNS of/IN the/DT Potyviridae/NN with/IN monopartite/JJ genomes/NNS ,/, but/CC there/RB are/VBP substantial/JJ amino/JJ acid/NN dissimilarities/NNS with/IN other/DT potyviral/NN polyproteins/NN ./.
@@80822868060 Acupuncture/NNS effect/NN on/IN deep/JJ receptors/NNS was/VBD not/RB limited/VBN to/IN one/PRP point/NN but/CC within/IN a/DT certain/JJ area/NN ,/, namely/RB distant/JJ effect/NN existed/VBN ./.
@@87103779291 Cbl/NEWGENE constitutively/RB interacts/VBZ with/IN the/DT SH3/NEWGENE domains/NEWGENE of/IN Grb2/NEWGENE ,/, with/IN a/DT preference/NN for/IN the/DT amino-terminal/JJ domain/NN ,/, and/CC is/VBZ in/IN this/DT way/NN recruited/VBN to/IN Shc/NEWGENE upon/IN BCR/NEWGENE stimulation/NN ./.
@@92142749173 Colorectal/JJ carcinoma/NN :/: therapeutic/JJ approach/NN in/IN patients/NNS already/RB treated/VBN with/IN metastasis/NN resection/NN ./.
@@62877379716 The/DT frequency/NN of/IN previous/JJ transfusion/NN in/IN chronic/JJ hepatitis/NN ,/, cirrhosis/NN and/CC hepatocellular/JJ carcinoma/NN of/IN type/NN NANB/NN was/VBD 42/CD ./CD 8/CD ,/, 37/CD ./CD 1/CD and/CC 15/CD ./CD 1%/CD ,/, respectively/RB ,/, whereas/IN the/DT incidence/NN of/IN early/JJ posttransfusion/JJ hepatitis/NN was/VBD 8/CD ./CD 5/CD ,/, 8/CD ./CD 6/CD and/CC 7/CD ./CD 5%/CD ,/, respectively/RB ./. in/IN chronic/JJ liver/NN diseases/NNS with/IN a/DT history/NN of/IN jaundice/NN and/DT //DT or/DT hepatitis/NN ,/, previous/JJ transfusions/NNS are/VBP more/RB frequently/RB associated/VBN with/IN type/NN NANB/NN than/IN with/IN type/NN B/NN disease/NN ./.
@@14707412087 Distribution/NNP and/CC changing/JJ morphological/JJ course/NN ./.
@@110594923789 Bacteriol/NNP ./.
@@77395667983 By/IN creating/VBG Pax-6-BSAP/NEWGENE fusion/NEWGENE proteins/NEWGENE ,/, we/PRP were/VBD able/JJ to/IN identify/VB a/DT short/JJ amino/JJ acid/NN stretch/NN in/IN the/DT N-terminal/NN part/NN of/IN the/DT paired/JJ domain/NN which/WDT is/VBZ responsible/JJ for/IN these/DT differences/NNS in/IN DNA-binding/NN specificity/NN ./.
@@20662462670 This/DT computerized/JJ list/NN was/VBD linked/JJ to/IN the/DT central/JJ files/NNS of/IN the/DT Massachusetts/NNP Cancer/NNP Registry/NNP and/CC cases/NNS diagnosed/VBN between/IN 1982/CD and/CC 1988/CD were/VBD identified/VBN ./.
@@26219833298 Significance/NN of/IN delta-aminolevulinic/JJ acid/NN analysis/NN in/IN clinical/JJ tests/NNS ./.
@@73859331410 Following/VBG iv/NN injection/NN of/IN 0/CD ./CD 5/CD g/NN galactose/NN per/IN kg/NN body/NN weight/NN ,/, together/RB with/IN 2/CD mu/NN Ci/NN generally/RB 14C-labelled/JJ galactose/NN ,/, 14CO2/NN is/VBZ collected/VBN in/IN regular/JJ intervals/NNS during/IN one/PRP hour/NN ./.
@@11289851125 A/DT clinically/RB useful/JJ diagnostic/JJ method/NN has/VBZ been/VBN developed/VBN for/IN detecting/JJ and/CC quantitating/JJ periods/NNS of/IN apnea/NN in/IN pediatric/JJ patients/NNS ./.
@@27735073469 A/DT value/NN of/IN 1/CD ./CD 1/CD l/NN //NN kg/NN was/VBD used/VBN for/IN V/NN in/IN calculating/JJ all/DT single/JJ sample/NN estimates/NNS of/IN clearance/NN (/( CL/NN )/SYM ,/, and/CC a/DT value/NN of/IN 4/CD ./CD 3/CD l/NN //NN kg/NN was/VBD used/VBN to/IN calculate/VB single/JJ sample/NN estimates/NNS of/IN clearance/NN of/IN plasma/NN unbound/JJ drug/NN (/( CLunb/NNP )/SYM ./.
@@78906748197 The/DT catenins/NEWGENE bind/VBP to/IN APC/NEWGENE and/CC E-cadherin/NEWGENE in/IN a/DT similar/JJ fashion/NN ,/, but/CC APC/NEWGENE and/CC E-cadherin/NEWGENE do/NN not/RB associate/VB with/IN each/DT other/DT either/DT in/NN the/DT presence/NN or/CC absence/NN of/IN catenins/NEWGENE ./.
@@83961206802 The/DT rhaB/NEWGENE transcription/NEWGENE start/NEWGENE site/NEWGENE was/VBD mapped/VBN to/IN -24/NN relative/JJ to/IN the/DT start/NN of/IN translation/NN ./.
@@77608195025 Despite/IN the/DT activation/NN of/IN these/DT intracellular/JJ signaling/NN molecules/NN ,/, PDGF/NEWGENE beta/NEWGENE receptor/NEWGENE activation/NN elicited/VBD no/DT detectable/JJ effect/NN on/IN cell/NN proliferation/NN or/CC differentiation/NN ./.
@@94466001033 A/DT fusion/NN protein/NN composed/VBN of/IN beta-galactosidase/NEWGENE and/CC full-length/NEWGENE Ahr/NEWGENE translocates/VBZ from/IN the/DT cytoplasm/NN to/IN the/DT nucleus/NN in/IN a/DT ligand-dependent/JJ manner/NN ./.
@@11238405374 In/NN strains/NNS lacking/JJ tup11/NEWGENE and/CC tup12/NEWGENE ,/, the/DT atf1-pcr1/NEWGENE transcriptional/NEWGENE activator/NEWGENE continues/VBZ to/IN play/NN a/DT central/JJ role/NN in/IN fbp1-lacZ/NEWGENE expression/NN ;/: however/RB ,/, spc1/NEWGENE MAPK/NEWGENE phosphorylation/NN of/IN atf1/NEWGENE is/VBZ no/RB longer/RB essential/JJ for/IN its/PRP activation/NN ./.
@@109185993598 In/NN contrast/NN to/IN full-length/NEWGENE E2F-3/NEWGENE ,/, which/WDT is/VBZ expressed/VBN only/RB at/IN the/DT G1/NN //NN S/NN boundary/NN ,/, E2F-3B/NEWGENE is/VBZ detected/VBN throughout/IN the/DT cell/NN cycle/NN with/IN peak/NN levels/NNS in/IN GO/VB where/CC it/PRP is/VBZ associated/VBN with/IN Rb/NN ./NN
@@24468714909 A/DT 5/NEWGENE ./NEWGENE 8S-like/NEWGENE structure/NEWGENE is/VBZ present/VB within/IN the/DT 5'-terminal/NN region/NN of/IN all/DT three/CD fungal/NEWGENE mitochondrial/NEWGENE LSU/NEWGENE rRNAs/NEWGENE ;/: in/IN contrast/NN ,/, no/DT 4/NEWGENE ./NEWGENE 5S-like/NEWGENE structure/NEWGENE is/VBZ evident/JJ at/IN the/DT 3'/CD end/NN of/IN these/DT molecules/NNS ./.
@@90001465863 Phenotypic/NNP changes/NNS induced/VBN by/IN wild/NEWGENE type/NEWGENE and/NEWGENE variant/NEWGENE c-src/NEWGENE genes/NEWGENE carrying/VBG C-terminal/NN sequence/NN alterations/NNS ./.
@@103959203659 These/DT results/NNS suggest/VBP that/IN members/NNS of/IN the/DT ATF/NEWGENE family/NEWGENE are/VBP involved/VBN in/IN mediating/JJ the/DT transcriptional/JJ regulation/NN of/IN the/DT KGF/NEWGENE gene/NEWGENE in/IN response/NN to/IN extracellular/JJ stimuli/NNS via/NN a/DT novel/JJ CRE/NEWGENE regulatory/NEWGENE element/NEWGENE ./.
@@112812685865 Unusual/JJ two-domain/NEWGENE arginine/NEWGENE kinases/NEWGENE (/( AKs/NEWGENE )/SYM arose/VBD independently/RB at/IN least/RB two/JJ times/NNS during/IN molecular/JJ evolution/NN of/IN phosphagen/NEWGENE kinases/NEWGENE :/: AKs/NEWGENE from/IN the/DT primitive/JJ sea/NN anemone/NNP Anthopleurura/NNP japonicus/NN and/CC from/IN the/DT clam/NN Pseudocardium/NNP sachalinensis/NN ./.
@@16929629526 Stable/NN expression/NN of/IN the/DT chimeric/JJ alpha/NN i/NN (/NN 54/NN )/NN //NN s/NN polypeptide/NN in/IN Chinese/JJ hamster/NN ovary/NN (/( CHO/NN )/SYM cells/NNS constitutively/RB increased/VBN both/DT cAMP/NN synthesis/NN and/CC cAMP-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE activity/NN ./.
@@86452192674 Ca2+/NN decreased/VBD Zn2+/NN binding/JJ in/IN S100/NEWGENE beta/NEWGENE but/CC it/PRP did/VBD not/RB influence/VB binding/JJ to/IN MRP14/NEWGENE ,/, suggesting/VBG that/IN the/DT Zn2+/NN binding/NN site/NN was/VBD distinct/JJ from/IN and/CC independent/NN of/IN the/DT two/JJ Ca2+/NN binding/JJ domains/NNS ./.
@@79575597440 However/RB ,/, rapamycin/NN inhibited/VBD proliferation/NN of/IN Ba/NN //NN F3-EpoRgp55/NN but/CC not/RB of/IN MEL/NN cells/NNS despite/IN inhibition/NN of/IN p70/NEWGENE S6/NEWGENE kinase/NEWGENE activity/NN in/IN both/DT cells/NNS ./.
@@89813716924 Further/RB ,/, the/DT PIP2/NN content/NN of/IN the/DT 85-90/NN kDa/NN protein/NN appeared/VBN to/IN decrease/NN with/IN CSF-1/NEWGENE treatment/NN ./.
@@6068491535 Experimental/JJ ischemic/JJ heart/NN disease/NN induced/VBN by/IN thromboxane/NEWGENE A2/NEWGENE in/IN rabbits/NNS ./.
@@86016166998 This/DT spindle/NN defect/NN of/IN pds1/NEWGENE mutants/NEWGENE results/NNS from/IN a/DT temperature-sensitive/JJ step/NN that/WDT occurs/VBZ around/IN the/DT G1/NN //NN S/NN boundary/NN about/RB the/DT time/NN of/IN spindle/NN assembly/NN ./.
@@1103390870 The/DT discordant/JJ behaviour/NN in/IN weakly/RB infected/VBN mice/NNS was/VBD due/NN to/IN the/DT occurrence/NN in/IN some/DT animals/NNS of/IN a/DT second/JJ phase/NN of/IN more/RB rapid/JJ increase/NN of/IN the/DT parasitemia/NN ./.
@@68909356688 Behcet's/NNP syndrome/NN ./.
@@66710656433 Serum/NN lipids/NNS and/CC lipoproteins/NNS of/IN 29/NN insulin/NEWGENE dependent/JJ diabetic/JJ children/NNS have/VBP been/VBN determined/VBN and/CC related/VBN to/IN the/DT metabolic/JJ status/NN of/IN the/DT patients/NNS ./.
@@21965659827 Since/IN general/NEWGENE regulatory/NEWGENE factor/NEWGENE I/NEWGENE (/( GRFI/NEWGENE )/NN //NEWGENE repressor/NEWGENE //NEWGENE activator/NEWGENE site/NEWGENE binding/NEWGENE protein/NEWGENE 1/NEWGENE (/( RAP1/NEWGENE )/NN //NEWGENE translation/NEWGENE upstream/NEWGENE factor/NEWGENE (/( TUF/NEWGENE )/SYM is/VBZ believed/VBN to/IN be/VB an/DT activator/NN of/IN MAT/NEWGENE alpha/NEWGENE expression/NN ,/, we/PRP examined/VBD whether/IN PYK1/NEWGENE ,/, which/WDT is/NNS known/VBP to/IN be/VB regulated/VBN by/IN GRFI/NEWGENE //NEWGENE RAP1/NEWGENE //NEWGENE TUF/NEWGENE ,/, is/VBZ also/RB affected/VBN by/IN the/DT gal11/NEWGENE mutation/NEWGENE ./.
@@22782172927 In/NN both/DT groups/NNS there/RB were/VBD 5/CD management/NN failure/NN of/IN therapy/NN ,/, so/RB that/IN alternative/JJ medication/NN or/CC a/DT cesarean/JJ section/NN lead/NN to/IN delivery/NN ./.
@@105517889794 LHbeta/NEWGENE is/VBZ expressed/VBN in/IN pituitary/JJ gonadotrope/NN cells/NNS and/CC CGbeta/NEWGENE is/VBZ expressed/VBN in/IN placental/JJ trophoblast/NN cells/NNS ./.
@@3371024056 Williams/NN ,/, 2/CD August/NN 1977/CD ./.
@@94164673548 These/DT results/NNS suggest/VBP that/IN ,/, in/IN this/DT experimental/JJ model/NN ,/, ACE/NEWGENE inhibitors/NN limit/NN the/DT arrhythmias/NNS following/IN ischemia-reperfusion/NN and/CC free/JJ radical/JJ scavenging/JJ action/NN of/IN these/DT drugs/NNS does/VBP not/RB have/VB a/DT major/JJ contributory/JJ role/NN in/IN their/PRP protective/JJ effect/NN ./.
@@117449531590 Skin/VBP cancers/NNS ,/, followed/VBN by/IN gastrointestinal/JJ tract/NN and/CC male/JJ genital/JJ system/NN affected/VBN mostly/RB older/JJR age/NN patients/NNS ./.
@@115786855659 ICAM-1/NEWGENE has/VBZ been/VBN suggested/VBN a/DT predictor/NN of/IN the/DT onset/NN of/IN GO/NNP ./NNP
@@11067797900 CONCLUSIONS/IN :/: EBCT/NN technology/NN allows/VBZ minimally/RB invasive/JJ evaluation/NN of/IN intramyocardial/JJ microcirculatory/JJ function/NN and/CC permits/VBP assessment/NN of/IN microvascular/JJ BV/NN distribution/NN in/IN different/JJ functional/JJ components/NNS ./.
@@61655515995 (/( 2/CD )/SYM The/DT inappropriateness/NN of/IN adaptive/JJ segmentation/NN for/IN the/DT isolation/NN of/IN spikes/NNS and/CC sharp/JJ waves/NNS ,/, which/WDT had/VBP been/VBN anticipated/VBN in/IN view/NN of/IN the/DT short/JJ duration/NN of/IN such/JJ transients/NNS in/IN relation/NN to/IN the/DT length/NN of/IN the/DT window/NN (/( 1/CD ./CD 2/CD sec/NN )/SYM used/VBN for/IN the/DT autocorrelation/NN functions/NNS employed/VBN in/IN the/DT segmentation/NN algorithm/NN ,/, was/VBD confirmed/VBN ./.
@@8729228712 The/DT acids/NNS were/VBD obtained/VBN by/IN hydrolysis/NN of/IN the/DT corresponding/JJ esters/NNS ,/, and/CC their/PRP anti-inflammatory/JJ activity/NN was/VBD tested/VBN ./.
@@91782699105 All/DT six/CD genes/NNS were/VBD cloned/VBN and/CC characterised/VBN ./.
@@38298485359 Autotransplantation/NNS of/IN a/DT vein/NN segment/NN with/IN valve/NN in/IN the/DT treatment/NN of/IN deep/JJ vein/NN valvular/JJ insufficiency/NN of/IN the/DT lower/JJR extremity/NN ./.
@@85917008566 The/DT mean/JJ body/NN mass/JJ index/NN (/( BMI/NN )/SYM was/VBD 31/CD ./CD 8/CD +/NN //NN -/NN 6/CD ./CD 3/CD kg/NN //NN m2/NN and/CC 28/NN ./NN 5/NN +/NN //NN -/NN 6/CD ./CD 3/CD kg/NN //NN m2/NN in/IN women/NNS and/CC men/NNS ,/, respectively/RB ./.
@@96110169579 CONCLUSION/IN :/: In/NN women/NNS who/WP want/VBP or/CC require/VB conservative/JJ management/NN of/IN grade/NN 4/CD prolapse/NN and/CC are/VBP unable/JJ to/IN retain/VB a/DT single/JJ pessary/NN ,/, the/DT placement/NN of/IN two/JJ pessaries/NNS often/RB will/MD be/VB successful/JJ ./.
@@101349777725 JCAHO/NN asks/VBZ for/IN hospitals'/JJ patience/NN ./.
@@111606834860 This/DT interaction/NN is/VBZ reciprocal/JJ ,/, since/IN C/NEWGENE //NEWGENE EBP/NEWGENE dimer/NEWGENE binding/JJ to/IN a/DT strong/JJ C/NEWGENE //NEWGENE EBP/NEWGENE site/NEWGENE leads/VBP to/IN enhanced/VBN CREB-1/NEWGENE recruitment/NN to/IN ATF/NEWGENE //NEWGENE CREB/NEWGENE sites/NEWGENE that/WDT are/VBP weakly/RB bound/JJ by/IN CREB/NEWGENE ./.
@@87233658702 Possible/JJ relationship/NN between/IN hyperinsulinemia/NN and/CC glomerular/JJ hypertrophy/NN in/IN nephrosclerosis/NN ./.
@@8599945276 Mutations/NNS in/IN the/DT alpha-amanitin/NEWGENE conserved/VBN domain/NN of/IN the/DT largest/JJS subunit/NN of/IN yeast/NEWGENE RNA/NEWGENE polymerase/NEWGENE III/NEWGENE affect/VB pausing/NN ,/, RNA/NN cleavage/NN and/CC transcriptional/JJ transitions/NNS ./.
@@240445145 Since/IN very/RB recent/JJ scanning-deletion/JJ analysis/NN indicates/VBZ that/WDT there/RB is/VBZ a/DT critical/JJ region/NN for/IN activity/NN near/IN Cys-118/NNP and/CC that/IN Cys-118/NN is/VBZ necessary/JJ for/IN maximal/JJ activity/NN ,/, we/PRP conclude/VBP that/IN the/DT Cys-118/NN residue/NN is/VBZ necessary/JJ for/IN proper/JJ glycosylation/NN and/CC maximal/JJ biologic/JJ activity/NN of/IN GM-CSF/NEWGENE ./.
@@77259807682 1972/CD ./.
@@23705713028 The/DT findings/NNS suggest/VBP that/IN ,/, although/IN iodine/NN deficiency/NN is/VBZ the/DT most/RB probable/JJ cause/NN of/IN goiter/NN among/IN immigrants/NNS of/IN the/DT 1928/NN cohort/NN ,/, where/CC the/DT native/JJ population/NN is/VBZ concerned/VBN (/( both/DT men/NNS and/CC women/NNS )/SYM ,/, some/DT other/DT goitrogenic/JJ factor/NN (/NN s/NN )/NN must/MD be/VB involved/VBN ./.
@@4351874944 "Let/VBG the/DT hundred/JJ flowers/NNS bloom"/NN ./.
@@87421353393 Fragments/NNS and/CC analogs/NNS of/IN the/DT hormone/NN ACTH/NEWGENE were/VBD previously/RB shown/VBP to/IN have/NN beneficial/JJ effect/NN on/IN the/DT outcome/NN of/IN head/JJ injury/NN ,/, while/CC elevated/VBD levels/NNS of/IN corticosterone/NN (/( CS/NN )/SYM exacerbate/VB it/CD ./CD
@@61130843511 Cardiac/NNP taurine/NN levels/NNS and/CC sarcolemmal/JJ calcium/NN binding/JJ activity/NN in/IN furazolidone-induced/JJ cardiomyopathy/NN ./.
@@87902884493 This/DT is/VBZ concluded/VBN from/IN the/DT isolation/NN of/IN cDNAs/NNS from/IN spinach/NN (/( Spinacia/NNP oleracea/NN )/SYM and/CC barley/NN (/( Hordeum/NN vulgare/JJ cv/CD ./CD
@@97993627713 Over-expression/NNS of/IN Azf1p/NEWGENE in/IN the/DT yeast/NN cell/NN does/VBP not/RB influence/VB the/DT expression/NN level/NN of/IN the/DT mitochondrial/NEWGENE transcription/NEWGENE factor/NEWGENE Mtf1p/NEWGENE ,/, indicating/VBG that/IN the/DT influence/NN of/IN Azf1p/NEWGENE on/IN the/DT suppression/NN of/IN the/DT special/JJ mitochondrial/NEWGENE RNA/NEWGENE polymerase/NEWGENE mutant/NEWGENE is/VBZ an/DT indirect/JJ one/PRP ./.
@@13148415312 Treatment/NNP with/IN MK-801/NN induced/VBN a/DT burst/NN suppression/NN in/IN the/DT EEG/NN and/CC a/DT transient/JJ drop/NN (/( 11/CD ./CD 4/CD +/NN //NN -/NN 6/CD ./CD 5/CD mm/NN Hg/NN )/SYM in/IN the/DT mean/JJ arterial/JJ pressure/NN ./.
@@28261275570 We/PRP have/VBP also/RB found/VB that/IN the/DT in/NN vitro/FW interaction/NN between/IN the/DT SV40/NN octamer/NN motif/NN and/CC the/DT lymphoid/NEWGENE cell-specific/NEWGENE protein/NEWGENE oct-B2/NEWGENE was/VBD negatively/RB modulated/VBN by/IN a/DT component/NN present/NN in/IN the/DT nuclear/JJ extracts/NNS from/IN several/DT lymphoid/JJ cell/NN lines/NNS ./.
@@11719355016 The/DT appearance/NN of/IN dyskinetic/JJ movement/NN disorders/NNS in/IN humans/NNS following/IN the/DT chronic/JJ use/NN of/IN levodopa/NN or/CC amphetamine/NN may/MD be/VB a/DT manifestation/NN of/IN similarly/RB increased/VBN dopamine/NEWGENE receptor/NEWGENE site/NEWGENE sensitivity/NN within/IN the/DT striatum/NN ./.
@@13045151943 The/DT obtained/VBN results/NNS were/VBD compared/VBN with/IN control/NN group/NN (/( 10/CD female/JJ volunteers/NNS )/SYM ./.
@@86422856298 DNA-STAT/NEWGENE complexes/NEWGENE were/VBD detected/VBN in/IN all/DT Bcr/JJ //JJ Abl-transformed/JJ cell/NN lines/NNS and/CC they/PRP were/VBD supershifted/VBN by/IN antibodies/NNS against/IN STAT1/NEWGENE and/CC STAT5/NEWGENE ./.
@@16264402217 But/CC the/DT application/NN solutions/NNS of/IN instrument/NN disinfectants/NNS should/MD not/RB be/VB used/VBN longer/JJR than/IN one/PRP day/NN ./.
@@100979322352 Four/CD CsA-treated/JJ patients/NNS developed/VBN persistently/RB elevated/VBN UAER/NN >/SYM 30/CD mg/CD //CD 24/CD h/NN (/( n/NN =/SYM 3/CD with/IN microalbuminuria/NN )/SYM ,/, whereas/IN all/PDT the/DT 17/CD placebo-treated/JJ patients/NNS had/VBP normal/JJ UAER/NN (/( </SYM 30/CD mg/CD //CD 24/CD h/NN )/SYM after/IN 7/CD years/NNS of/IN follow-up/NN ./.
@@9060045584 This/DT brief/JJ review/NN analyses/VBZ these/DT interactions/NNS and/CC defines/VBZ clinical/JJ settings/NNS where/CC antibiotic-induced/NN endotoxin/NEWGENE release/NN may/MD prove/VB to/IN be/VB clinically/RB relevant/JJ ./.
@@93652018644 These/DT studies/NNS serve/NN as/IN the/DT basis/NN for/IN the/DT further/JJ characterization/NN of/IN the/DT regulatory/JJ mechanism/NN of/IN aromatase/NEWGENE expression/NN in/IN human/JJ breast/NN cancer/NN and/CC ASCs/NNS ./.
@@76291238655 However/RB ,/, a/DT similar/JJ mutation/NN of/IN a/DT leucine/NN residue/NN to/IN arginine/NN at/IN position/NN 422/CD showed/VBD no/DT alteration/NN of/IN heterodimerization/NN ,/, DNA/NN binding/JJ ,/, or/CC transcriptional/JJ activation/NN ./.
@@57348475686 Studies/NNS carried/VBN out/RB with/IN the/DT Glossina/NN morsitans/NNS colony/NN of/IN Lisbon/NNP ./.
@@119040178794 Steal/NN is/VBZ a/DT pathophysiological/JJ process/NN in/IN which/WDT increased/VBD blood/NN flow/NN through/RB a/DT low-resistance/JJ vascular/JJ bed/NN is/VBZ sufficient/JJ to/IN divert/VB flow/NN away/RB from/IN a/DT region/NN of/IN the/DT central/JJ nervous/JJ system/NN ./.
@@107029267809 Cross-reaction/NNS between/IN a/DT monoclonal/JJ antibody/NN and/CC two/JJ alpha/NEWGENE beta/NEWGENE T/NEWGENE cell/NEWGENE receptors/NEWGENE ./.
@@106025073589 The/DT coordinate/JJ increase/NN in/IN cyclin/NEWGENE D1/NEWGENE and/CC p21/NEWGENE had/VBP the/DT effect/NN of/IN decreasing/JJ the/DT specific/JJ but/CC not/RB absolute/JJ activity/NN of/IN cyclin/NEWGENE D1/NEWGENE //NEWGENE cdk4/NEWGENE ./. p53/NEWGENE was/VBD not/RB involved/VBN since/IN CSF-1/NEWGENE induction/NN of/IN p21/NEWGENE was/VBD unaffected/JJ by/IN dominant-negative/NEWGENE p53/NEWGENE expression/NN ./.
@@106662536317 We/PRP show/VBP that/DT stabilization/NN of/IN the/DT hairpin/NN reduced/VBD the/DT amount/NN of/IN tRNA/NN primer/NN that/WDT is/VBZ annealed/VBN to/IN the/DT PBS/NNP ./.
@@2761492985 Our/PRP findings/NNS support/NN the/DT view/NN of/IN a/DT multifactorial/NN genesis/NN of/IN the/DT cardiac/JJ involvement/NN in/IN uremic/JJ patients/NNS ./.
@@104489025820 Myocardial/JJ antioxidant/JJ enzymes/NNS ,/, catalase/NEWGENE ,/, glutathione/NEWGENE peroxidase/NEWGENE and/CC superoxide/NEWGENE dismutase/NEWGENE ,/, in/IN the/DT MCT-treated/JJ rats/NNS were/VBD not/RB different/JJ compared/VBN to/IN control/NN rats/NNS ./.
@@7565117456 Dietetics/NNS of/IN childhood-/JJ and/CC juvenile/JJ diabetes/NN ./.
@@12840323281 AP/NN was/VBD induced/VBN by/IN intraductal/JJ infusion/NN of/IN two/JJ different/JJ concentrations/NNS of/IN glycodeoxycholic/JJ acid/NN (/( GDOC/NN 17/NN mmol/NN and/CC 34/CD mmol/NN )/SYM ./.
@@29435625384 Penicillinase/NEWGENE production/NN in/IN Staphylococcus/NN aureus/NN strains/NNS of/IN clinical/JJ importance/NN ./.
@@97256519706 The/DT PC-based/JJ RTPS/NN is/VBZ designed/VBN to/IN run/NN in/IN the/DT Microsoft/NNP Windows/NNP 3/CD ./CD 11/CD environment/NN (/( and/CC later/JJR versions/NNS )/SYM ,/, for/IN computers/NNS equipped/VBN with/IN 486/CD or/CC Pentium/NNP processors/NNS ./.
@@10798607612 Our/PRP data/NN show/NN also/RB that/IN phagocytic/JJ killing/NN of/IN meningococci/NNS is/VBZ probably/RB a/DT more/RB consistent/JJ assay/NN than/IN antibody/NN titer/NN levels/NNS for/IN antimeningococcal/JJ immunity/NN ,/, especially/RB in/IN LCC-deficient/NNP patients/NNS ./.
@@49598165271 Human/NNP synovial/JJ fluid/NN :/: detection/NN of/IN a/DT new/JJ component/NN ./.
@@106585882952 Desmethylferrochloroquine/NN 1a/NN and/CC didesmethylferrochloroquine/NN 2/NN would/MD be/VB more/RB potent/JJ against/IN schizontocides/NNS than/IN CQ/DT in/NN vitro/FW against/IN two/JJ strains/NNS (/( HB3/NN and/CC Dd2/NN )/SYM of/IN Plasmodium/NN falciparum/NN ./.
@@10885731710 Furthermore/RB ,/, this/DT study/NN looks/NNS at/IN the/DT impact/NN of/IN synthesis/NN conditions/NNS on/IN block/NN length/NN and/CC crystallinity/NN ,/, and/CC the/DT impact/NN of/IN the/DT blocking/NN on/IN both/DT ,/, crystallinity/NN and/CC solubility/NN of/IN the/DT polymers/NNS ./.
@@86493729456 The/DT carboxy/JJ terminus/NN of/IN Mbp1/NEWGENE is/VBZ sufficient/JJ for/IN interaction/NN with/IN Swi6/NEWGENE ,/, and/CC the/DT carboxy/JJ terminus/NN of/IN Swi6/NEWGENE is/VBZ required/VBN for/IN interaction/NN with/IN Mbp1/NEWGENE ./.
@@6694778288 10/CD long-term/JJ hemodialysis/NN patients/NNS had/VBP immediate/JJ and/CC redistribution/NN thallium-201/NN myocardial/JJ imaging/NN performed/VBN after/IN a/DT course/NN of/IN hemodialysis/NN ./.
@@84289528 However/RB ,/, L-plastin/NEWGENE has/VBZ been/VBN found/VB in/IN many/JJ types/NNS of/IN malignant/JJ human/JJ cells/NNS of/IN non-hemopoietic/JJ origin/NN suggesting/VBG that/IN its/PRP expression/NN is/VBZ induced/VBN accompanying/JJ tumorigenesis/NN in/IN solid/JJ tissues/NNS ./.
@@108968594797 Neither/CC is/VBZ it/PRP a/DT major/JJ cause/NN of/IN rehydration-induced/NN renal/NN Na/NN retention/NN ./.
@@94157115034 Gel/NNP mobility/NN shift/NN and/CC super-shift/JJ assays/NNS using/VBG liver/NN nuclear/JJ extracts/NNS from/IN either/DT rat/NN liver/NN or/CC DDT1MF-2/NNP cells/NNS demonstrated/VBN that/IN the/DT CRE/NEWGENE in/IN the/DT alpha/NEWGENE 1B-AR/NEWGENE gene/NEWGENE bound/JJ CRE/NEWGENE binding/NEWGENE protein/NEWGENE ./.
@@108283199227 Therefore/RB ,/, analogs/NNS of/IN vitamin/NN D3/NN have/VB been/VBN investigated/VBN in/IN a/DT number/NN of/IN trials/NNS showing/VBG improvement/NN of/IN psoriasis/NN ./.
@@18462067403 A/DT larger/JJR region/NN upstream/RB of/IN human/NEWGENE CMV/NEWGENE dbp/NEWGENE also/RB mediated/JJ replication/NN in/IN transient/JJ assays/NNS ./.
@@19820618802 There/EX is/VBZ no/DT TATA/NN box/NN appropriately/RB spaced/VBN upstream/RB from/IN the/DT transcription/NN initiation/NN site/NN ./.
@@79371276882 Using/VBG this/DT method/NN ,/, we/PRP were/VBD able/JJ to/IN select/VB strong/JJ enhancer-type/NN activation/NN domains/NN from/IN the/DT immediate/NEWGENE early/NEWGENE regions/NEWGENE of/IN two/JJ herpesviruses/NNS ,/, namely/RB pseudorabies/NN virus/NN and/CC bovine/JJ herpesvirus/NN 1/CD ./CD
@@113065115103 An/DT association/NN was/VBD demonstrated/VBN between/IN the/DT expression/NN of/IN aberrantly/RB and/IN //IN or/IN alternatively/RB spliced/VBN mdm2/NEWGENE mRNAs/NEWGENE and/CC a/DT lack/NN of/IN progesterone/NEWGENE receptor/NEWGENE ./.
@@10644760567 The/DT differentiation/NN and/CC maintenance/NN of/IN a/DT neurotransmitter/NN phenotype/NN is/VBZ guided/VBN by/IN the/DT interaction/NN of/IN exogenous/JJ cues/NNS with/IN intrinsic/JJ genetic/JJ machinery/NN ./.
@@88160528575 Data/NNP supported/VBD the/DT brevity/NN of/IN the/DT WISC-III/NN short/JJ form/NN and/CC the/DT criterion-related/JJ validity/NN of/IN both/PDT the/DT K-FAST/NNP and/CC and/CC Kaufman/NNP Short/NNP Neuropsychological/NNP Assessment/NNP Procedure/NN (/( K-SNAP/NN )/SYM ./.
@@8454077210 In/NN contrast/NN ,/, rats/NNS receiving/JJ U74500A/NNP (/( 2/CD mg/CD //CD kg/CD i/CD ./CD v/CD ./. infusion/NN commencing/VBG 30/CD min/NN prior/NN to/IN revascularisation/NN )/SYM exhibited/VBN enhanced/VBN GMBF/NN throughout/IN reperfusion/NN [/NN PI/NN 10/CD min/NN :/: 3/CD ./CD 26/CD (/( 2/CD ./CD 56-3/CD ./CD 63/CD )/SYM ;/: 120/CD min/NN :/: 2/CD ./CD 03/CD (/( 1/CD ./CD 73-2/CD ./CD 25/CD )/SYM ;/: 240/CD min/NN :/: 2/CD ./CD 13/CD (/( 1/CD ./CD 75-2/CD ./CD 44/CD )/SYM ,/, p/NN </SYM 0/CD ./CD 01/CD vs/IN ./IN controls/NNS and/CC normals/NN ]/NN with/IN complete/JJ muscle/NN salvage/NN [/NN GMV/NN 100%/CD in/IN all/DT reperfused/JJ muscles/NNS ,/, p/NN </SYM 0/CD ./CD 01/CD vs/IN ./IN controls/NNS ,/, not/RB significant/JJ (/( NS/NNP )/SYM vs/IN ./IN normals/NNS and/CC 6/CD h/NN ischaemia/NN ]/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@115791003405 Phosphotyrosyl/NEWGENE peptides/NEWGENE block/NN Stat3-mediated/NN DNA-binding/NN activity/NN ,/, gene/NN regulation/NN and/CC cell/NN transformation/NN ./.
@@109472741414 The/DT therapy/NN time/NN to/IN deliver/VB the/DT NCS/NNS therapeutic/JJ dose/NN of/IN 10000/CD RBE-cGy/NN ,/, is/VBZ 27/CD times/NNS longer/JJR when/CC 157Gd/NN is/VBZ used/VBN instead/RB of/IN 10B/NN ./.
@@10407985418 G-CSF/NEWGENE (/( 480/CD micrograms/NNS subcutaneously/RB (/( s/CD ./CD c/CD ./CD )/NN )/NN were/VBD used/VBN in/IN 55/CD and/CC GM-CSF/NEWGENE (/( 400/CD micrograms/NNS s/CD ./CD c/CD ./CD )/SYM in/IN 28/CD chemotherapeutic/JJ cycles/NNS ./.
@@27045792080 A/DT significant/JJ relationship/NN existed/VBN during/IN the/DT evolution/NN of/IN the/DT disease/NN between/IN CRS/NNP //NNP BW/NNP and/CC gas/NN exchange/NN parameters/NNS (/( FIO2/NN and/CC a/NN //NN AO2/NN ratio/NN )/SYM (/( P/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ,/, but/CC gas/NN exchange/NN improved/VBN earlier/JJR than/IN lung/NN mechanics/NN ./.
@@69721798382 Specific/NN IgE/NEWGENE levels/NNS decreased/VBN slightly/RB ,/, but/CC always/RB remained/VBN within/IN the/DT pathological/JJ range/NN ./.
@@89998575193 Mutating/VBG the/DT E-box/NNS in/IN the/DT context/NN of/IN the/DT 3'-flanking/JJ region/NN confirmed/VBN that/IN it/PRP contributes/VBZ to/IN the/DT enhancement/NN of/IN transcriptional/JJ activity/NN of/IN the/DT alpha1/NEWGENE (/NEWGENE I/NEWGENE )/NEWGENE collagen/NEWGENE gene/NEWGENE promoter/NEWGENE ./.
@@77625047733 The/DT study/NN was/VBD repeated/JJ after/IN administration/NN of/IN oral/JJ amiodarone/NN ,/, 50/CD mg/NN //NN kg/NN //NN day/NN for/IN 2/CD days/NNS in/IN 8/CD divided/VBN doses/NNS (/( mean/JJ dose/NN 6/CD ./CD 9/CD +/NN //NN -/NN 0/CD ./CD 4/CD g/NN )/SYM ./SYM
@@48262725194 VII/NNP ./.
@@34136814687 Ischemic/NNP heart/NN disease/NN ,/, age/NN of/IN more/RB than/IN 75/CD years/NNS ,/, and/CC the/DT fact/NN that/IN the/DT patient/NN was/VBD a/DT woman/NN were/VBD independent/NN predictors/NN of/IN poor/JJ cardiac/JJ function/NN ./.
@@12793525429 To/TO determine/VB if/IN the/DT NF/NEWGENE (/NEWGENE H/NEWGENE )/NEWGENE promoter/NEWGENE can/MD be/VB activated/VBN in/IN a/DT tissue/NN specific/JJ manner/NN during/IN development/NN transgenic/JJ mice/NNS containing/JJ the/DT promoter/NN region/NN linked/JJ to/IN a/DT beta-galactosidase/NEWGENE reporter/NEWGENE gene/NEWGENE were/VBD generated/VBN ./.
@@69463148947 Serum/NEWGENE IgE/NEWGENE levels/NNS in/IN Tauranga/NNP children/NNS ./.
@@41142114800 Renal/JJ excretion/NN of/IN sulphadimidine/NN in/IN normal/JJ and/CC uraemic/JJ subjects/NNS ./.
@@85313732997 It/PRP is/VBZ considered/VBN that/IN the/DT recurrent/JJ annular/JJ erythema/NN is/VBZ a/DT specific/JJ skin/NN manifestation/NN of/IN SjS/NNP with/IN anti/NEWGENE SS-A/NEWGENE //NEWGENE SS-B/NEWGENE antibodies/NEWGENE ./.
@@5066495349 Changes/NNS of/IN thirtynine/NN serum/NN protein/NN components/NN following/IN surgical/JJ stress/NN ./.
@@76777157612 The/DT TAF/NN factor/NN appears/VBZ to/IN be/VB particularly/RB significant/JJ in/IN OCD/NN ./.
@@86286813461 A/DT developmentally/RB regulated/VBN 4/CD ./CD 6/CD kb/NN mRNA/NN is/VBZ recognized/VBN on/IN Northern/NNP blots/NNS of/IN oocyte/NN RNA/NN using/VBG the/DT X/NN ./NN laevis/NN cDNA/NN ./.
@@36006331463 Cell/NNP ./.
@@89861908930 Reperfusion/NNS caused/VBD a/DT transient/JJ reduction/NN in/IN lactate/NN production/NN and/CC a/DT significant/JJ increase/NN in/IN LDH/NEWGENE release/NN ./.
@@7873831130 Secondary/JJ pancreatic/JJ involvement/NN of/IN mycosis/NN fungoides/NNS detected/VBN by/IN a/DT clinically/RB palpable/JJ mass/NN ./.
@@30572593769 The/DT relationship/NN between/IN primary/JJ malignant/JJ lymphoma/NN of/IN the/DT thyroid/JJ and/CC chronic/JJ thyroiditis/NN is/VBZ discussed/VBN ./.
@@90273465205 Finally/RB ,/, antibody/NN binding/JJ to/IN site/NN IIIa/NN on/IN the/DT hCG-ectodomain/NEWGENE complex/NEWGENE was/VBD also/RB hindered/VBN by/IN an/DT anti-peptide/NEWGENE mAb/NEWGENE directed/VBN against/IN a/DT peptide/NN encoded/VBN by/IN the/DT eighth/JJ exon/NN (/( pE/NN x/NN 8/CD )/SYM of/IN the/DT LHR/NEWGENE ./.
@@96818227990 Identical/JJ c-erbB3/NEWGENE transcripts/NEWGENE are/VBP expressed/VBN in/IN normal/JJ human/JJ placental/JJ tissues/NNS ./.
@@75657095154 T-cell/NN hybridomas/NNS ,/, thymocytes/NNS ,/, and/CC T/NN cells/NNS can/MD be/VB induced/VBN to/IN undergo/VB apoptotic/JJ cell/NN death/NN by/IN activation/NN through/RB the/DT T-cell/NEWGENE receptor/NEWGENE ./.
@@89223901378 These/DT data/NN demonstrate/VB the/DT presence/NN of/IN a/DT single/JJ binding/JJ site/NN for/IN vinculin/NEWGENE ,/, and/CC at/IN least/RB two/JJ binding/JJ sites/NNS for/IN FAK/NEWGENE that/WDT are/VBP separated/VBN by/IN an/DT intervening/JJ stretch/NN of/IN 100/CD amino/JJ acids/NNS ./.
@@10833218639 As/IN stands/NNS shifted/VBN in/IN dominance/NN from/IN pine/NN to/IN fir/NN with/IN age/NN ,/, subalpine/NN fir/NN appeared/VBN to/IN maintain/VB gradually/RB increasing/JJ rates/NNS of/IN whole-forest/JJ productivity/NN until/IN stands/NNS were/VBD approximately/RB 400/CD years/NNS old/JJ ./.
@@29356383502 We/PRP have/VBP identified/VBN and/CC characterized/VBD the/DT structure/NN of/IN the/DT Spec1/NEWGENE gene/NEWGENE in/IN the/DT sea/NN urchin/NN Strongylocentrotus/NNP purpuratus/NN ./.
@@18711357439 The/DT cDNA/NN contained/VBD an/DT open/JJ reading/JJ frame/NN of/IN 1392/CD bp/NN that/WDT predicted/VBD a/DT protein/NN of/IN 464/CD amino/JJ acids/NNS and/CC a/DT molecular/JJ mass/NN of/IN 52/CD kDa/NN ;/: this/DT protein/NN has/VBZ 97%/NN identity/NN to/IN rat/NEWGENE liver/NEWGENE glucokinase/NEWGENE ./.
@@10828751634 The/DT real/JJ challenge/NN for/IN the/DT future/JJ will/MD be/VB the/DT management/NN of/IN patients/NNS who/WP do/VBP not/RB respond/VB to/IN first-line/NN treatment/NN ./.
@@68071497278 This/DT study/NN was/VBD designed/VBN to/IN assess/VB and/CC compare/VB the/DT ability/NN of/IN three/CD different/JJ forms/NNS of/IN DSG/NN to/IN block/NN EIB/NN ./.
@@103577519918 In/NN the/DT whole/JJ group/NN of/IN infected/VBN children/NNS ,/, an/DT age-specific/NN z/NN score/NN </SYM -2/CD for/IN weight/NN and/CC for/IN FFM/NN was/VBD significantly/RB associated/VBN with/IN an/DT increased/VBN risk/NN of/IN death/NN [/NN relative/NN risk/NN (/( 95%/CD CI/NN )/SYM =/SYM 11/CD ./CD 4/CD (/( 3/CD ./CD 1/CD ,/, 41/CD ./CD 0/CD )/SYM and/CC 5/CD ./CD 1/CD (/( 1/CD ./CD 5/CD ,/, 18/CD ./CD 2/CD )/SYM ,/, respectively/NN ]/NN ;/: when/CC only/JJ children/NNS with/IN more/RB severe/JJ disease/NN were/VBD considered/VBN ,/, only/JJ z/NN score/NN for/IN weight/NN was/VBD significantly/RB associated/VBN with/IN an/DT increased/VBN risk/NN [/NN 4/NN ./NN 6/NN (/( 1/CD ./CD 4/CD ,/, 14/CD ./CD 9/CD )/NN ]/NN ./.
@@77518484691 His/NN carnitine/NEWGENE palmitoyltransferase/NEWGENE (/NEWGENE CPT/NEWGENE )/NEWGENE I/NEWGENE and/NEWGENE II/NEWGENE activities/NNS were/VBD 0/CD ./CD 06/CD and/CC 0/CD ./CD 12/CD nmol/NN //NN min/NN //NN mg/NN protein/NN ,/, as/IN compared/VBN with/IN a/DT mean/JJ value/NN of/IN 0/CD ./CD 22/CD +/NN //NN -/NN 0/CD ./CD 14/CD and/CC 0/CD ./CD 27/CD +/NN //NN -/NN 0/CD ./CD 07/CD nmol/NN //NN min/NN //NN mg/NN protein/NN ,/, respectively/RB ,/, in/IN control/NN subjects/NNS ./.
@@103580797909 However/RB ,/, neu/NEWGENE differentiation/NN factor-induced/NN heterodimers/NN of/IN ErbB2/NEWGENE and/CC ErbB4/NEWGENE activated/VBN Stat5/NEWGENE ./.
@@111713204648 Coexpression/NNS of/IN the/DT p120/NEWGENE (/NEWGENE ctn/NEWGENE )/NEWGENE protein/NEWGENE with/IN an/DT N-terminal/NN deletion/NN ,/, which/WDT eliminates/VBZ some/DT potential/JJ tyrosine/NN phosphorylation/NN sites/NN ,/, or/CC the/DT protein/NN with/IN a/DT single/JJ amino/JJ acid/NN substitution/NN (/( tyrosine/NN at/IN 217/CD to/IN phenylalanine/NN )/SYM resulted/VBN in/IN an/DT increase/NN in/IN the/DT aggregation/NN of/IN v-Src-transformed/JJ EL/NNS and/CC EalphaCL/NNP cells/NNS ./.
@@74367947311 In/NN a/DT control/NN group/NN both/DT common/JJ carotid/JJ arteries/NNS (/( CCA/NN )/SYM were/VBD ligated/VBN ./.
@@83569448320 Thus/RB ,/, it/PRP was/VBD confirmed/VBN that/IN the/DT sodium/NN lauryl/NN sulfate/NN method/NN of/IN estimating/VBG hemoglobin/NEWGENE concentration/NN is/VBZ an/DT appropriate/JJ alternative/NN to/IN the/DT cyanmethemoglobin/NN method/NN and/CC avoids/VBZ the/DT generation/NN of/IN toxic/JJ wastes/NNS ./.
@@91396941343 CTF1alpha/NEWGENE ,/, expressed/VBN in/IN Escherichia/NN coli/JJ ,/, showed/VBD specific/JJ binding/NN to/IN the/DT palindrome/NN 2/NN DNA/NN fragment/NN but/CC not/RB to/IN palindrome/NN 1/NN or/CC mutant/NN palindrome/NN 2/NN DNA/NN fragments/NN ,/, suggesting/VBG specific/JJ binding/NN of/IN CTF1alpha/NEWGENE to/IN palindrome/NN 2/CD ./CD
@@17377412194 BACKGROUND/IN :/: The/DT effectiveness/NN of/IN monoamine/NEWGENE oxidase/NEWGENE inhibitors/NN (/( MAOIs/NN )/SYM in/IN tricyclic/JJ resistant/JJ depression/NN has/VBZ received/VBN surprisingly/RB little/JJ systematic/JJ study/NN ./.
@@29628592483 Monospecific/NNP antibodies/NNS ,/, eluted/VBN from/IN the/DT beta-galactosidase/NEWGENE fusion/NN protein/NN of/IN either/DT clone/NN reacted/VBN with/IN the/DT U1/NEWGENE snRNP-specific/NEWGENE A/NEWGENE antigen/NEWGENE ./.
@@23760232059 However/RB ,/, at/IN 18/CD months/NNS of/IN age/NN ,/, significantly/RB higher/JJ levels/NNS of/IN IgG1/NEWGENE (/( P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM and/CC of/IN IgG4/NEWGENE (/( P/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM were/VBD found/VBN in/IN infants/NNS with/IN an/DT elevated/VBN IgE/NEWGENE (/( greater/JJR than/IN or/CC equal/NN to/IN 8/CD ./CD 0/CD kU/NN //NN l/NN )/SYM than/IN in/IN those/DT with/IN a/DT lower/JJR level/NN ./.
@@19369979531 RNA/NN gel/NN retardation/NN and/CC competition/NN analyses/NNS indicate/VBP that/IN TRP-185/NEWGENE binding/NN is/VBZ strongly/RB dependent/JJ on/IN the/DT TAR/NEWGENE RNA/NEWGENE loop/NEWGENE sequences/NEWGENE ./.
@@77447764636 Transcript/NNS analysis/NN reveals/VBZ that/IN lethal/NN B/NEWGENE block/NEWGENE substitutions/NNS reduce/VBP U6/NEWGENE RNA/NEWGENE synthesis/NN at/IN least/RB 10-fold/JJ in/IN vivo/NN and/CC 20-fold/JJ in/IN vitro/FW ./.
@@1008538385 KEY/JJ WORDS/NNP :/: Melaleuca/NNP ;/: Lake/NNP Okeechobee/NNP ;/: Littoral/NN zone/NN ;/: Water/NNP level/NN ;/: Regulation/NN schedule/NN
@@97537696610 The/DT primers/NNS were/VBD degenerate/JJ sets/NNS of/IN oligonucleotides/NNS derived/VBN from/IN known/VBP amino/JJ acid/NN sequences/NNS of/IN the/PDT PBAN/NEWGENE precursor/NEWGENE ./.
@@108807024839 Therefore/RB ,/, the/DT results/NNS indicate/VBP that/IN repeated/JJ exposure/NN to/IN amphetamine/NN or/CC apomorphine/NN overcomes/VBZ the/DT context-dependent/NN component/NN of/IN sensitization/NN of/IN amphetamine-/JJ or/CC apomorphine-induced/JJ stereotyped/JJ behavior/NN ./.
@@10326856191 An/DT end-to-end/JJ pancreaticojejunostomy/NN using/VBG a/DT mechanical/JJ purse-string/NN device/NN ./.
@@33609485333 Because/IN the/DT CAP/NN measures/NNS variables/NNS predictive/JJ of/IN abusive/JJ behavior/NN ,/, a/DT substantial/JJ relationship/NN was/VBD expected/VBN between/IN the/DT CAP/NN and/CC the/DT MHI/NN Loss/NN of/IN Behavioral/NNP //NNP Emotional/NNP Control/NNP scale/NN ./.
@@99133081223 Soft-x-ray/NNP lasing/JJ at/IN 32/CD ./CD 6/CD nm/NN in/IN Ne-like/NN Ti/NN ions/NNS driven/VBP by/IN 40/CD J/NN of/IN energy/NN from/IN two/JJ 650-ps/NN laser/NN pulses/NNS ./.
@@97780069425 After/IN measuring/JJ baseline/NN Vmca/NNP at/IN a/DT partial/JJ pressure/NN of/IN carbon/NN dioxide/NN in/IN arterial/JJ blood/NN (/( PaCO2/NN )/SYM of/IN 37/CD ./CD 7/CD +/NN //NN -/NN 4/CD ./CD 5/CD mmHg/NN (/( mean/JJ +/NN //NN -/NN SD/NN )/SYM ,/, measurements/NNS were/VBD repeated/JJ at/IN a/DT PaCO/NNP of/IN 44/CD ./CD 2/CD +/NN //NN -/NN 3/CD ./CD 8/CD mmHg/NN ,/, and/CC the/DT carbon/NN dioxide/NN reactivity/NN (/( absolute/JJ value/NN :/: cm/NN x/NN s/NN (/NN -1/NN )/SYM x/NN mmHg/NN (/NN -1/NN )/NN ;/: relative/JJ value/NN :/: percentage/NN of/IN baseline/NN Vmca/NN //NN mmHg/NN )/NN was/VBD calculated/VBN ./.
@@78364062954 Isoelectric/NNP focusing/NN of/IN tryptic/JJ peptides/NNS generated/VBN from/IN MHC-B/NEWGENE phosphorylated/VBN with/IN cdc2/NEWGENE kinase/NEWGENE revealed/VBN one/PRP major/JJ phosphopeptide/NN that/WDT was/VBD purified/VBN by/IN reverse-phase/JJ high/JJ performance/NN liquid/JJ chromatography/NN and/CC sequenced/VBN ./.
@@79571066042 Such/JJ an/DT interaction/NN could/MD be/VB detected/VBN using/VBG a/DT GST-POU/NEWGENE fusion/NEWGENE protein/NEWGENE bound/JJ to/IN glutathione-agarose/JJ beads/NNS ./.
@@107217269641 Molecular/NNP cloning/NN of/IN mouse/NEWGENE thioredoxin/NEWGENE reductases/NEWGENE ./.
@@37143485125 Factors/NNS that/WDT showed/VBD significant/JJ correlation/NN to/IN elevated/VBN CIC's/NNS in/IN the/DT highly/RB elevated/VBN portion/NN of/IN our/PRP CIC/NN population/NN were/VBD poor/JJ NIH/NN score/NN ,/, increased/VBN patient/NN age/NN ,/, low/JJ peak/NN expiratory/JJ flow/NN rate/NN ,/, and/CC elevated/VBD total/JJ serum/NEWGENE IgG/NEWGENE ./.
@@114447621324 There/EX are/VBP many/JJ different/JJ proposals/NNS for/IN the/DT statistical/JJ analysis/NN of/IN data/NN to/IN determine/VB early/JJ onset/NN of/IN action/NN ./.
@@85235667796 A/DT chaotropic/JJ detergent/NN ,/, 0/NN ./NN 1%/NN Nonidet/NNP P-40/NN ,/, also/RB abolished/VBN the/DT interaction/NN ,/, further/RB supporting/JJ the/DT hydrophobic/JJ nature/NN of/IN the/DT interaction/NN ./.
@@3854574526 Thus/RB ,/, the/DT inhibition/NN of/IN pepsin/NEWGENE in/IN human/JJ gastric/JJ juice/NN does/VBP not/RB appear/VB to/IN have/NN a/DT major/JJ influence/NN on/IN the/DT healing/NN of/IN duodenal/JJ ulcer/NN ./.
@@71324086941 Restarting/VBG time/NN was/VBD not/RB affected/VBN by/IN magnesium/NN cardioplegia/NN ./.
@@85214146832 These/DT cell/NN lines/NNS displayed/VBD methylation/NN of/IN the/DT CpG/NN island/NN surrounding/JJ the/DT first/JJ exon/NN of/IN p16INK4A/NEWGENE and/CC expressed/VBN abundant/JJ levels/NNS of/IN a/DT nontranslated/JJ mRNA/NN containing/JJ an/DT alternative/JJ first/JJ exon/NN (/( E1/NEWGENE beta/NEWGENE )/SYM ,/, as/IN did/VBD all/PDT other/DT cell/NN lines/NNS in/IN which/WDT the/DT p16INK4A/NEWGENE locus/NEWGENE was/VBD not/RB deleted/VBN ./.
@@108610868442 In/NN reconstitution/NN experiments/NNS ,/, we/PRP first/NN showed/VBD that/DT expression/NN in/IN the/DT RAW/NNP 264/CD ./CD 7/CD cell/NN line/NN of/IN C-terminal/NEWGENE Src/NEWGENE kinase/NEWGENE (/( Csk/NEWGENE )/SYM inhibited/VBN and/CC that/IN of/IN a/DT membrane-anchored/NN ,/, gain-of-function/NNP Csk/NEWGENE abolished/VBD the/DT Fc/NN gamma/NN R-mediated/NN signaling/JJ that/WDT leads/VBP to/IN phagocytosis/NN in/IN a/DT kinase-dependent/JJ manner/NN ./.
@@95400622005 These/DT mutants/NNS were/VBD tested/VBN for/IN ability/NN to/IN bind/NN each/DT of/IN the/DT Site/NEWGENE II/NEWGENE cognate/NEWGENE proteins/NEWGENE ,/, and/CC subsequently/RB evaluated/VBN for/IN ability/NN to/IN confer/VB H4/NEWGENE transcriptional/JJ activity/NN using/VBG chimeric/JJ H4/NEWGENE promoter/NN //SYM CAT/NEWGENE fusion/NN constructs/NN in/IN different/JJ cell/NN types/NNS ./.
@@11107637940 The/DT determination/NN of/IN the/DT double/JJ bounds/NNS in/IN blood/NN serum/JJ lipids/NNS by/IN titration/NN with/IN ozone/NN :/: the/DT pathophysiology/NN and/CC diagnostic/JJ significance/NN In/NN this/DT article/NN the/DT method/NN of/IN definition/NN of/IN double/JJ binders/NNS in/IN lipids/NNS of/IN blood/NN serum/JJ in/IN patients/NNS with/IN different/JJ diseases/NNS basically/RB atherosclerosis/NN and/CC ischemic/JJ heart/NN disease/NN ,/, with/IN use/NN titration/NN by/IN ozone/NN is/NNS given/VBP ./.
@@15126545878 On/IN the/PDT other/DT hand/NN ,/, neither/DT phosphate/NN buffered/JJ saline/JJ injection/NN into/IN the/DT ES/NNP nor/CC primary/NN KLH/NEWGENE challenges/NNS of/IN the/DT ES/NNP were/VBD capable/JJ of/IN elevating/JJ the/DT threshold/NN level/NN and/CC changing/JJ the/DT latency/NN ./.
@@118641738034 Viral/JJ and/CC atypical/JJ pathogens/NNS as/IN causes/NNS of/IN type/NN 1/NN acute/JJ exacerbations/NNS of/IN chronic/JJ bronchitis/NN ./.
@@91159892583 Thus/RB ,/, depending/VBG on/IN their/PRP location/NN ,/, psoralen/NEWGENE cross-links/NNS affected/VBD different/JJ steps/NNS in/IN the/DT initiation/NN process/NN ./.
@@94202697801 The/DT 5'/CD end/NN of/IN the/DT genomic/JJ RNA/NN of/IN rubella/NN virus/NN (/( RUB/NN )/SYM contains/VBZ a/DT 14-nucleotide/JJ (/( nt/NN )/SYM single-stranded/JJ leader/NN (/( ss-leader/JJ )/SYM followed/VBN by/IN a/DT stem-and-loop/JJ structure/NN [/NN 5'/NN (/NN +/NN )/NN SL/NN ]/NN (/( nt/NN 15/CD to/IN 65/CD )/SYM ,/, the/DT complement/NN of/IN which/WDT at/IN the/DT 3'/CD end/NN of/IN the/DT minus-strand/NN RNA/NN [/NN 3'/NN (/NN -/NN )/NN SL/NN ]/NN has/VBZ been/VBN proposed/VBN to/RB function/NN as/IN a/DT promoter/NN for/IN synthesis/NN of/IN genomic/JJ plus/IN strands/NNS ./.
@@17792992390 We/PRP examined/VBD behavioral/JJ alterations/NNS in/IN the/DT brown/JJ cockroach/NN ,/, Periplaneta/NNP brunnea/NN ,/, infected/VBN with/IN the/DT acanthocephalan/NN ,/, Moniliformis/NNP moniliformis/NN ./.
@@90835631039 The/DT prominent/JJ lesions/NNS were/VBD confined/VBN to/IN the/DT cerebral/JJ surface/NN layer/NN and/CC leptomeningeal/JJ tissue/NN including/JJ the/DT arachnoid/JJ vessels/NNS ,/, which/WDT were/VBD all/DT bathed/VBN in/IN the/DT cerebrospinal/JJ fluid/NN ,/, suggesting/VBG that/IN some/DT necrotizing/JJ toxins/NNS had/VBP been/VBN secreted/VBN into/IN the/DT fluid/JJ by/IN the/DT B/NNP ./NNP cereus/NN ./.
@@104287594195 A/DT decrease/NN in/IN insulin-induced/NN receptor/NEWGENE kinase/NEWGENE activity/NN was/VBD observed/VBN for/IN solubilized/VBN chimeric/JJ receptors/NNS ./.
@@82074051434 BYV/NNP ,/, citrus/NN tristeza/NN virus/NN (/( CTV/NN )/SYM ,/, beet/NN yellow/JJ stunt/NN virus/NN (/( BYSV/NNP )/SYM and/CC carnation/NN necrotic/JJ fleck/NN virus/NN templates/NNS produced/VBN 1/CD kb/NN amplification/NN products/NNS ,/, which/WDT were/VBD shown/VBP by/IN sequencing/VBG to/IN represent/VB fragments/NNS of/IN the/DT respective/JJ HSP70/NEWGENE genes/NEWGENE ./.
@@96774107110 At/NN the/DT same/JJ time/NN ,/, the/DT results/NNS indicate/VBP that/IN p53/NEWGENE plays/VBP a/DT defensive/JJ role/NN against/IN HBV/NN by/IN transcriptionally/RB repressing/JJ the/DT HBV/NEWGENE core/NEWGENE promoter/NEWGENE through/RB liver-specific/NEWGENE enhancer/NEWGENE II/NEWGENE and/CC HBx/NEWGENE is/VBZ required/VBN to/IN counteract/VB this/DT inhibitory/JJ function/NN of/IN p53/NEWGENE ./.
@@19377902562 The/DT vaccine/NN used/VBN was/VBD known/VBP to/IN be/VB immunogenic/JJ for/IN older/JJR children/NNS and/CC adults/NNS ./.
@@83217418494 The/DT first/JJ group/NN of/IN sequential/JJ BMB/NN showed/VBD a/DT significant/JJ progress/NN to/IN myelofibrosis/NN in/IN so-called/JJ "Chronic/NNP Megakaryocytic-Granulocytic/NNP Myelosis"--CMGM-/NNP ,/, which/WDT corresponds/VBZ to/IN Agnogenic/NNP Myeloid/NNP Metaplasia-AMM-in/NNP 72/CD ./CD 4%/CD (/( 21/CD //CD 29/CD patients/NNS )/SYM ,/, as/RB well/VB as/IN in/IN CML/NN with/IN megakaryocytic/JJ increase-CML/CD ./CD MI-in/CD 39/CD ./CD 2%/CD (/( 20/CD //CD 51/CD )/SYM ./.
@@10223338698 Our/PRP results/NNS indicate/VBP that/IN V3/NEWGENE peptides/NN from/IN all/DT major/JJ clades/NNS of/IN HIV-1/NNP carried/VBD by/IN HIV-2/NEWGENE gag/NEWGENE can/MD be/VB used/VBN as/IN a/DT potential/JJ HIV/DT //DT AIDS/DT vaccine/NN ./.
@@26959143369 The/DT stereoselectivity/NN of/IN drug/NN action/NN ./.
@@39239769726 Thrombophlebitis/NNS and/CC pulmonary/JJ embolism/NN in/IN congenital/JJ factor/NEWGENE XII/NEWGENE deficiency/NN ./.
@@113976521255 Guidelines/NNS for/IN performing/JJ a/DT routine/JJ spiral/JJ assay/NN are/VBP presented/VBN ,/, and/CC alternative/JJ test/NN methods/NNS intended/VBN to/IN overcome/VB a/DT variety/NN of/IN technical/JJ difficulties/NNS (/( such/JJ as/IN restricted/VBN sample/NN availability/NN ,/, sample/NN viscosity/NN or/CC volatility/NN ,/, etc/FW ./FW )/SYM are/VBP recommended/VBN ./.
@@20159215741 A/DT further/JJ subdivision/NN of/IN Category/JJ pN1/NN into/IN pN1a/NN (/( metastasis/NN in/IN single/JJ node/NN )/SYM and/CC pN1b/NN (/( two/JJ or/CC more/JJ nodes/NNS )/SYM is/VBZ recommended/VBN ./.
@@21472231873 In/NN contrast/NN ,/, the/DT CRE/NEWGENE of/IN the/DT human/NEWGENE c-fos/NEWGENE promoter/NEWGENE located/VBN at/IN -60/CD was/VBD weakly/RB induced/VBN by/IN cAMP/NN and/CC E1a/NEWGENE in/IN both/DT HeLa/NN and/CC PC12/NNP cells/NNS ./.
@@75462941613 The/DT RAD6/NEWGENE //NEWGENE UBC2/NEWGENE gene/NEWGENE from/IN Saccharomyces/NN cerevisiae/NN encodes/VBZ a/DT ubiquitin-conjugating/NEWGENE enzyme/NEWGENE involved/VBN in/IN DNA/NN repair/NN ,/, induced/VBN mutagenesis/NN ,/, and/CC sporulation/NN ./.
@@83701192212 Deletion/NNS of/IN a/DT 53-bp/JJ early/JJ promoter/NN region/NN containing/JJ the/DT transcription/NN start/NN site/NN and/CC a/DT putative/JJ TATA/NN box/NN completely/RB abolishes/VBZ the/DT ability/NN of/IN upstream/JJ elements/NNS to/IN drive/NN transcription/NN of/IN the/DT luciferase/NEWGENE cDNA/NEWGENE ./.
@@75983037498 However/RB ,/, the/DT few/JJ studies/NNS that/WDT address/VBP antimicrobial/JJ prophylaxis/NN in/IN bone/NN marrow/NN transplantation/NN have/NN not/RB always/RB shown/VBP a/DT survival/NN benefit/NN ./.
@@87548027228 Transcriptional/JJ control/NN of/IN a/DT nuclear/JJ gene/NN encoding/VBG a/DT mitochondrial/JJ fatty/JJ acid/NN oxidation/NN enzyme/NN in/IN transgenic/JJ mice/NNS :/: role/NN for/IN nuclear/JJ receptors/NNS in/IN cardiac/JJ and/CC brown/JJ adipose/JJ expression/NN ./.
@@103297361906 Insulin/NEWGENE stimulation/NN promoted/VBD the/DT association/NN of/IN mIRS3/NEWGENE with/IN p85/NEWGENE ,/, SHP2/NEWGENE ,/, Nck/NEWGENE ,/, and/CC Shc/NEWGENE ./.
@@62178597161 Experience/NN with/IN the/DT tensor/NN fasciae/NNS latae/NNS free/JJ flap/NN ./.
@@22940487670 In/NN particular/JJ ,/, 71/CD and/CC 69%/NN amino/JJ acid/NN sequence/NN similarities/NNS were/VBD identified/VBN with/IN hsp70/NEWGENE of/NEWGENE Escherichia/NEWGENE coli/NEWGENE and/NEWGENE Bacillus/NEWGENE megaterium/NEWGENE ,/, respectively/RB ./.
@@74310597297 Thirty/CD cadaver/NN brains/NNS were/VBD examined/VBN under/IN X/NN 6/CD to/IN 16/CD magnification/NN in/IN order/NN to/IN define/VB the/DT microsurgical/JJ anatomy/NN of/IN the/DT pineal/JJ region/NN ,/, particularly/RB the/DT relationship/NN of/IN the/DT pineal/JJ body/NN ,/, posterior/JJ cerebral/JJ artery/NN ,/, superior/JJ cerebellar/JJ artery/NN ,/, vein/NN of/IN Galen/NN ,/, basal/NN vein/NN of/IN Rosenthal/NN ,/, internal/JJ cerebral/JJ vein/NN ,/, straight/JJ sinus/NN ,/, bridging/JJ vein/NN ,/, the/DT size/NN of/IN the/DT tentorial/JJ notch/NN ,/, and/CC the/DT third/RB and/CC the/DT fourth/JJ cranial/JJ nerves/NNS ./.
@@111684464237 Increased/VBN erythropoietin/NEWGENE synthesis/NN in/IN patients/NNS with/IN COLD/NN or/CC left/NN heart/NN failure/NN is/VBZ related/VBN to/IN alterations/NNS in/IN renal/JJ haemodynamics/NN ./.
@@85305036248 Unlike/IN ARF/NEWGENE ,/, the/DT ARP/NEWGENE immunoreactivity/NN was/VBD detected/VBN in/IN plasma/NN membranes/NNS but/CC not/RB in/IN cytosol/NN of/IN fractionated/VBN 3T3-L1/CD cells/NNS ./.
@@21568287149 The/DT deduced/VBN amino/JJ acid/NN sequence/NN of/IN destrin/NEWGENE is/VBZ 165/CD residues/NNS long/JJ and/CC is/VBZ very/RB similar/JJ (/( 71%/JJ identical/JJ )/SYM to/IN that/DT of/IN cofilin/NEWGENE ,/, a/DT widely/RB distributed/VBN ,/, pH-sensitive/JJ actin-modulating/JJ protein/NN ./.
@@54977935568 Effects/NNPS of/IN chronic/JJ metaraminol/NN treatment/NN on/IN the/DT sympathetic/JJ activity/NN of/IN intact/JJ and/CC adrenal/JJ demedullated/JJ rats/NNS kept/VBP in/IN warm/JJ or/CC cold/JJ environments/NNS ./.
@@63674141500 Bepridil/NNP ,/, a/DT calcium/NN antagonist/NN with/IN a/DT half-life/NN of/IN approximately/RB 42/CD hours/NNS ,/, was/VBD compared/VBN with/IN placebo/NN in/IN a/DT double-blind/JJ ,/, randomized/JJ ,/, crossover/JJ trial/NN ./.
@@14203637328 Involvement/NNS of/IN AP1/NEWGENE and/CC PEA3/NEWGENE binding/NEWGENE sites/NEWGENE in/IN the/DT regulation/NN of/IN murine/NEWGENE tissue/NEWGENE inhibitor/NEWGENE of/NEWGENE metalloproteinases-1/NEWGENE (/( TIMP-1/NEWGENE )/SYM transcription/NN ./.
@@88560775916 Alternative/JJ processing/NN of/IN the/DT tryptophanyl-tRNA/NEWGENE synthetase/NEWGENE mRNA/NEWGENE from/IN interferon-treated/JJ human/JJ cells/NNS ./.
@@82646284090 Oligonucleotide/NN competitors/NNS were/VBD used/VBN to/IN evaluate/VB the/DT accessibility/NN of/IN the/DT TATA-binding/NN site/NN in/IN TIF-IB/NEWGENE ,/, TFIID/NEWGENE ,/, and/CC TFIIIB/NEWGENE ./.
@@29043223608 The/DT East/JJ African/JJ dik-dik/NN antelope/NN represents/VBZ a/DT miniature/NN model/NN ruminant/JJ for/IN comparative/JJ studies/NNS ./.
@@84916838456 Three/CD patients/NNS had/VBP well-/JJ ,/, 6/CD patients/NNS had/VBP moderately-/JJ ,/, and/CC 5/CD patients/NNS had/VBP poorly-differentiated/JJ adenocarcinoma/NN of/IN the/DT prostate/NN ./.
@@54106415548 The/DT "28/NN percent"/NNP Venturi/NNP mask/NN in/IN obstructive/JJ airway/NN disease/NN ./.
@@85554989557 Human/NEWGENE LAF-4/NEWGENE readily/RB hybridized/VBN with/IN genes/NNS in/IN mouse/NN and/CC chicken/NN ,/, thus/RB showing/VBG that/IN this/DT gene/NN family/NN has/VBZ been/VBN highly/RB conserved/VBN during/IN vertebrate/JJ evolution/NN ./.
@@8181755404 Northern/NNP analysis/NN ,/, to/IN search/NN for/IN a/DT pcbAB/NEWGENE transcript/NEWGENE ,/, showed/VBD no/DT distinct/JJ transcript/NN and/CC indicated/VBN severely/RB degraded/VBN mRNA/NN ./.
@@82313987740 RESULTS/NNS :/: In/NN an/DT 18/CD moth/NN period/NN and/CC out/RB of/IN a/DT total/NN of/IN 284/CD positive/JJ blood/NN cultures/NNS (/( 154/CD significant/JJ isolations/NNS )/SYM 14/CD episodes/NNS of/IN bacteremia/NN by/IN M/NNP ./NNP tuberculosis/NN were/VBD studied/VBN in/IN 12/CD prison/NN patients/NNS coinfected/VBN by/IN the/DT human/JJ immunodeficiency/NN virus/NN with/IN associated/VBN severe/JJ immunosuppression/NN (/( mean/NN of/IN CD4/NEWGENE =/SYM 0/CD ./CD 068/CD x/NN 10/NN (/NN 9/NN )/NN //NN l/NN )/NN ./.
@@75415897410 Morphologic/NNP variables/NNS included/VBD cancer/NN volume/NN ,/, histologic/JJ grade/NN ,/, capsular/JJ penetration/NN ,/, seminal/JJ vesicle/NN invasion/NN ,/, and/CC lymph/NN node/NN metastasis/NN ./.
@@90460909301 The/DT genes/NNS encoding/VBG the/DT transcription/NEWGENE factor/NEWGENE yTAFII60/NEWGENE ,/, the/DT G4p1/NEWGENE protein/NEWGENE and/CC a/DT putative/JJ glucose/NEWGENE transporter/NEWGENE are/VBP contained/VBN in/IN a/DT 12/CD ./CD 3/CD kb/NN DNA/NN fragment/NN on/IN the/DT left/NN arm/NN of/IN Saccharomyces/NN cerevisiae/NN chromosome/NN VII/NN ./.
@@8757781574 Evaluation/NN of/IN the/DT new/JJ Gravigard/NNP IUCD/NN inserter/NN ./.
@@79184945521 In/NN the/DT presence/NN of/IN the/DT in/NN vivo/NN reducing/JJ system/NN (/( thioredoxin/NEWGENE ,/, thioredoxin/NEWGENE reductase/NEWGENE ,/, and/CC NADPH/NN )/SYM ,/, however/RB ,/, each/DT of/IN these/DT mutants/NNS catalyzed/VBN the/DT formation/NN of/IN only/RB 0/CD ./CD 6-0/CD ./CD 8/CD dCTPs/NNS per/IN mole/NN of/IN enzyme/NN ./.
@@116261101504 Not/RB Available/JJ
@@92045664241 Functional/JJ and/CC regulatory/JJ analysis/NN of/IN the/DT two/JJ copies/NNS of/IN the/DT fixNOQP/NEWGENE operon/NEWGENE of/IN Rhizobium/NN leguminosarum/NN strain/NN VF39/CD ./.
@@9305592653 The/DT 9/CD ;/: 22/NN chromosomal/NN translocation/NN characteristic/NN of/IN CML/NN results/NNS in/IN a/DT fused/NEWGENE bcr/NEWGENE //NEWGENE abl/NEWGENE gene/NEWGENE and/CC an/DT abnormal/JJ fusion/NN protein/NN ,/, p210bcr/NEWGENE //NEWGENE abl/NEWGENE ./.
@@90420785293 We/PRP have/VBP measured/VBN the/DT MBF/NN on/IN incisors/NNS and/CC its/PRP direction/NN in/IN three/CD dimensions/NNS for/IN different/JJ jaw/NN openings/NNS in/IN ten/CD subjects/NNS ./.
@@95510963349 RNAs/NNS are/VBP not/RB only/RB essential/JJ components/NNS of/IN both/DT ribosomal/JJ subunits/NNS but/CC also/RB transiently/RB interacting/VBG factors/NNS during/IN particle/NN formation/NN ./.
@@86436826893 Subcellular/JJ localizations/NNS of/IN the/DT wild-type/NEWGENE CBFbeta/NEWGENE and/CC the/DT CBFbeta-SMMHC/NEWGENE fusion/NEWGENE protein/NEWGENE were/VBD determined/VBN by/IN immunofluorescence/NN of/IN NIH/NN 3T3/CD cells/NNS that/WDT overexpress/VBP wild-type/VBG or/CC fusion/NN protein/NN ./.
@@86057058583 In/NN conclusion/NN ,/, IgM/NEWGENE class/NN CIC/NN is/VBZ the/DT predominant/JJ CIC/NN in/IN acute/NN hepatitis/NN A/NN and/CC correlated/VBN with/IN disease/NN activity/NN ./.
@@95747997885 Echinostomiasis/NN is/VBZ aggravated/VBN by/IN socioeconomic/JJ factors/NNS such/JJ as/IN poverty/NN ,/, malnutrition/NN ,/, an/DT explosively/RB growing/JJ free-food/JJ market/NN ,/, a/DT lack/NN of/IN supervised/JJ food/NN inspection/NN ,/, poor/JJ or/CC insufficient/JJ sanitation/NN ,/, other/DT helminthiases/NNS ,/, and/CC declining/JJ economic/JJ conditions/NNS ./.
@@103270512241 We/PRP further/RB demonstrate/VBP that/IN the/DT Stress-Activated-Protein-Kinase/NEWGENE (/( SAPK/NEWGENE )/SYM target/NN sites/NNS of/IN ATF2/NEWGENE ,/, Thr69/NN and/CC Thr71/NN are/VBP not/RB required/VBN for/IN the/DT formation/NN of/IN the/DT p300/NEWGENE //NEWGENE CBP-ATF2/NEWGENE multiprotein/NN complex/NN ./.
@@106648762596 Patch/NNP test/NN results/NNS obtained/VBN with/IN corticosteroid/NN allergic/JJ patients/NNS tested/VBN with/IN a/DT large/JJ corticosteroid/NN series/NN validated/VBN the/DT earlier/JJR classification/NN of/IN corticosteroid/NN molecules/NN in/IN four/CD groups/NNS of/IN cross-reacting/VBG molecules/NNS :/: i/FW ./FW e/FW ./FW ,/, group/NN A/DT (/( hydrocortisone/NN type/NN )/SYM ,/, group/NN B/NNP (/( acetonides/NNS )/SYM ,/, group/NN C/NN (/( betamethasone/NN type-non/JJ esterified/JJ )/SYM and/CC group/NN D/NN (/( esters/NNS )/SYM ./.
@@54560025548 Mae/NN West/NN and/CC the/DT doctor/NN shortage/NN ./.
@@78091285962 Oncogenic/NNP capacity/NN of/IN the/DT E2F1/NEWGENE gene/NEWGENE ./.
@@95394212581 Thus/RB ,/, Sir/NEWGENE proteins/NEWGENE from/IN K/NNP ./NNP lactis/NN have/NN roles/NNS in/IN both/DT silencing/VBG and/CC telomere/NN length/NN maintenance/NN ,/, reflecting/JJ conserved/VBN functional/JJ themes/NNS ./.
@@79331164092 The/DT p55/NEWGENE mRNA/NEWGENE is/VBZ undetectable/JJ in/IN non-EBV-infected/VBD B-/DT and/CC T-cell/NN lines/NNS or/CC in/IN a/DT myelomonocytic/JJ cell/NN line/NN (/( U937/CD )/SYM ./.
@@95011694770 Histone/NN acetylation/NN levels/NNS in/IN cells/NNS result/NN from/IN a/DT dynamic/JJ equilibrium/NN between/IN competing/JJ histone/NEWGENE acetylases/NEWGENE and/CC deacetylases/NEWGENE ./.
@@21429552746 In/NN Experiments/NNS 1/CD and/CC 2/CD ,/, infants/NNS ,/, like/JJ adults/NNS ,/, initially/RB categorized/VBN novel/JJ objects/NNS on/IN the/DT basis/NN of/IN physical/JJ appearance/NN ,/, but/CC only/RB if/IN trained/VBN with/IN multiple/JJ exemplars/NNS ,/, after/IN delays/NNS of/IN 1/CD and/CC 7/CD days/NNS ./.
@@29290563637 Successful/JJ use/NN of/IN transureteroureterostomy/NN to/IN salvage/NN ureterosigmoidostomy/NN after/IN anastomotic/JJ failure/NN ./.
@@97992374379 SRF-deficient/NNP embryos/NNS (/( Srf/NEWGENE -/JJ //JJ -/JJ )/SYM have/VB a/DT severe/JJ gastrulation/NN defect/NN and/CC do/VB not/RB develop/VB to/IN term/NN ./.
@@26039235058 Four/CD full-thickness/NN skin/NN incisions/NNS were/VBD made/VBP in/IN the/DT back/NN of/IN 10/CD female/JJ pigs/NNS that/WDT treated/VBD twice/RB a/DT day/NN for/IN 14/CD days/NNS with/IN 2/CD ml/NN of/IN epidermal/NEWGENE growth/NEWGENE factor/NEWGENE (/( 300/CD ng/NN //NN ml/NN )/SYM or/CC 2/CD ml/NN of/IN Ringer's/DT lactate/NN solution/NN in/IN a/DT single-blind/NN ,/, randomized/JJ fashion/NN ./.
@@15646532166 Various/JJ companies/NNS produce/VBP this/DT type/NN of/IN lens/NN ./.
@@112267527753 In/NN mammalian/JJ tissue/NN culture/NN cells/NNS ,/, overexpression/NN of/IN any/DT of/IN the/DT four/CD mouse/NN deltex/NN homologs/NNS suppressed/VBD the/DT transcriptional/JJ activity/NN of/IN E47/NEWGENE ,/, a/DT basic/NEWGENE helix-loop-helix/NEWGENE (/NEWGENE bHLH/NEWGENE )/NEWGENE protein/NEWGENE ,/, in/IN a/DT manner/NN similar/JJ to/IN suppression/NN by/IN an/DT activated/JJ form/NN of/IN human/NEWGENE Notch1/NEWGENE or/CC human/NEWGENE DTX1/NEWGENE ./.
@@39790844641 However/RB ,/, kidneys/NNS perfused/VBN for/IN 72/CD hr/NN demonstrated/VBN more/RB similar/JJ renal/JJ functions/NNS when/CC tested/VBN by/IN either/DT IMPK/NN or/CC IBPK/NN ./.
@@115741056923 Patients/NNS with/IN antibody/NN peaks/NNS ,/, defined/VBN as/IN fivefold/RB or/CC higher/JJ increase/NN in/IN antibody/NN titer/NN compared/VBN to/IN the/DT lowest/JJS antibody/NN titer/NN over/RB the/DT course/NN of/IN GBS/NN ,/, had/VBP higher/JJ disability/NN scores/NNS during/IN the/DT first/JJ two/JJ weeks/NNS of/IN GBS/NN and/CC a/DT worse/JJ clinical/JJ outcome/NN (/( anti-GM1/NEWGENE IgG/NEWGENE and/CC anti-GD1a/NEWGENE IgM/NEWGENE antibody/NEWGENE peaks/NNS )/SYM and/CC axonal/JJ damage/NN (/( anti-GD1a/NEWGENE IgM/NEWGENE antibody/NEWGENE peaks/NNS )/SYM ,/, compared/VBN to/IN patients/NNS without/IN peak/NN antibody/NN titers/NNS ./.
@@98266587067 This/DT core/NN sequence/NN ,/, along/IN with/IN additional/JJ nonspecific/JJ downstream/JJ nucleotides/NNS ,/, is/VBZ sufficient/JJ for/IN partial/JJ suppression/NN of/IN spliceosome/NN assembly/NN and/CC splicing/JJ of/IN BPV-1/NN pre-mRNAs/NN ./.
@@103710974872 CONCLUSIONS/IN :/: Turbutest/NN is/VBZ a/DT valuable/NN tool/NN in/IN asthmatic/JJ patients'/NN training/NN ,/, allowing/VBG identification/NN and/CC improvement/NN of/IN an/DT inadequate/JJ inhalation/NN technique/NN with/IN Turbuhaler/NN ./.
@@113508129012 Inhibition/NNS of/IN the/DT Raf-1/NEWGENE target/NEWGENE ERK/NEWGENE1 kinase/NEWGENE1 (/( MEK/NEWGENE )/SYM either/DT attenuated/VBN or/CC abolished/VBN Rp-cAMPS-/NNP and/CC PKI-induced/NN ERK/NEWGENE activation/NN ,/, caldesmon/NEWGENE phosphorylation/NN ,/, and/CC stress/NN fiber/NN formation/NN ./.
@@111057172250 METHODS/IN :/: T2*-weighted/NN ,/, three-dimensional/JJ gradient-echo/JJ images/NNS were/VBD acquired/VBN by/IN exploiting/VBG the/DT magnetic/JJ susceptibility/NN difference/NN between/IN oxygenated/JJ and/CC deoxygenated/JJ hemoglobin/NEWGENE in/IN the/DT vasculature/NN and/CC microvasculature/NN ./.
@@7865895467 In/NN a/DT second/JJ experiment/NN involving/VBG an/DT 18-h/JJ lung/NN clearance/NN assay/NN ,/, we/PRP used/VBD the/DT mAb/NN 3/NN ./NN 2/NN ./NN 3/NN to/IN deplete/VB rats/NNS of/IN LGL/NNP //NNP NK/NNP cells/NNS with/IN the/DT following/JJ rationale/NN :/: if/IN LGL/NNP //NNP NK/NNP cells/NNS are/VBP necessary/JJ to/IN mediate/VB an/DT event/NN ,/, then/RB in/IN their/PRP absence/NN ,/, that/DT event/NN should/MD not/RB occur/VB ./.
@@30656107782 The/DT rci/NEWGENE gene/NEWGENE was/VBD fused/VBN with/IN lacZ/NEWGENE and/CC its/PRP gene/NN product/NN was/VBD identified/VBN by/IN Western/JJ blot/NN analysis/NN ./.
@@28289268279 Thus/RB ,/, multiple/JJ myogenic/JJ factors/NNS that/WDT vary/VBP qualitatively/RB and/CC quantitatively/RB may/MD be/VB responsible/JJ for/IN the/DT different/JJ and/CC complex/NN modulatory/JJ programs/NNS of/IN actin/NEWGENE gene/NEWGENE expression/NN observed/VBN during/IN in/IN vivo/NN muscle/NN differentiation/NN ./.
@@32275683911 Variety/NNP of/IN cows/NNS and/CC sires/NNS according/VBG to/IN types/NNS of/IN dermatoglyphics/NN (/( patterns/NNS )/SYM of/IN the/DT nose-labial/JJ mirror/NN of/IN cattle/NNS ./.
@@1806314267 Many/JJ cells/NNS were/VBD negative/JJ for/IN endothelial-cell/NN markers/NN ,/, and/CC they/PRP reacted/VBD with/IN a/DT monoclonal/JJ antibody/NN against/IN muscle/NN actin/NEWGENE ./.
@@72498953725 We/PRP studied/VBD the/DT role/NN of/IN prostaglandins/NNS in/IN acid-induced/JJ esophagitis/NN and/CC the/DT associated/VBN LES/NN hypotension/NN by/IN simultaneous/JJ treatment/NN of/IN some/DT animals/NNS with/IN indomethacin/NN (/( 150/CD micrograms/NN //NN kg/NN intravenous/JJ )/SYM ,/, a/DT specific/JJ inhibitor/NN of/IN prostaglandin/NN synthesis/NN ,/, either/DT during/IN production/NN of/IN esophagitis/NN or/CC during/IN recovery/NN ./.
@@95376514019 Of/IN these/DT sites/NNS ,/, PEA3/NEWGENE and/CC STAT/NEWGENE contributed/VBN specifically/RB to/IN induction/NN by/IN v-src/NEWGENE ,/, whereas/IN the/DT remaining/JJ elements/NNS were/VBD also/RB involved/VBN in/IN induction/NN by/IN the/DT phorbol/NN ester/NN phorbol/NN myristate/NN acetate/NN (/( PMA/NN )/SYM ./.
@@111283126936 There/EX were/VBD significant/JJ differences/NNS (/( p/CD </CD 0/CD ./CD 05/CD )/SYM between/IN the/DT fracture/NN and/CC nonfracture/JJ groups/NNS in/IN the/DT total/JJ femur/NN BMD/NN (/( 13%/JJ )/SYM ,/, trabecular/JJ BMD/NN in/IN the/DT distal/JJ radius/NN (/( 4%/JJ )/SYM ,/, and/CC the/DT fractal/JJ dimension/NN in/IN the/DT radiographs/NNS (/( FD2/NN )/SYM (/( 3%/JJ )/SYM ./.
@@19214632500 An/DT ASSEMBLER/NN routine/JJ for/IN on-line/JJ graphic/JJ display/NN and/CC averaging/JJ of/IN data/NN acquired/VBN on/IN a/DT personal/JJ microcomputer/NN ./.
@@98336101404 The/DT exodomain/NN alone/RB has/VBZ the/DT high/NN affinity/NN hormone/NN binding/NN site/NN but/CC is/VBZ not/RB capable/JJ of/IN generating/JJ hormonal/JJ signal/NN ./.
@@118519412243 We/PRP therefore/RB applied/VBD a/DT radiolabelled/JJ serumalbumin/NN method/NN to/IN determine/VB blood/NN volume/NN after/IN haemodilution/NN with/IN crosslinked/JJ or/CC conjugated/NN haemoglobin/NEWGENE ,/, in/IN comparison/NN with/IN a/DT reference/NN solution/NN of/IN hydroxyethyl/NN starch/NN (/( HES/NNS )/SYM ./.
@@65033297041 The/DT average/JJ birth/NN mass/NN of/IN these/DT newborns/NNS was/VBD 3491/CD ./CD 9/CD +/NN //NN -/NN 2/NN SD/NN 780/CD ./CD 5/CD g/NN and/CC that/IN in/IN the/DT control/NN group/NN 3/CD ,/CD 767/CD ./CD 5/CD +/NN //NN -/NN 2/NN SD/NN 824/CD ./CD 2/CD g/NN (/( P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@26051604406 The/DT effect/NN of/IN iron/NN intake/NN on/IN 59Fe/NN absorption/NN throughout/IN pregnancy/NN ,/, and/CC on/IN maternal/JJ and/CC fetal/JJ Fe/NN status/NN towards/IN the/DT end/NN of/IN pregnancy/NN ,/, was/VBD investigated/VBN in/IN rats/NNS ./.
@@16940099799 This/DT exon/NN ,/, here/RB named/VBN exon/NN 0/CD ,/, contained/VBD the/DT entire/JJ 5'/CD untranslated/JJ region/NN and/CC the/DT N-terminal/NN signal/NN sequence/NN of/IN the/DT polypeptide/NN ./.
@@63180789799 Expression/NNS of/IN herpes/NEWGENE simplex/NEWGENE virus/NEWGENE beta/NEWGENE and/NEWGENE gamma/NEWGENE genes/NEWGENE integrated/JJ in/IN mammalian/JJ cells/NNS and/CC their/PRP induction/NN by/IN an/DT alpha/NEWGENE gene/NEWGENE product/NEWGENE ./.
@@112606621095 A/NNP ./NNP ,/, Slatkin/NNP ,/, D/NN ./NN
@@26056798272 Analysis/NNP of/IN the/DT rate/NN constants/NNS indicated/VBN that/IN the/DT isomerization/NN rate/NN k12/NN was/VBD approximately/RB equal/VB to/IN the/DT apparent/JJ degradation/NN rate/NN of/IN the/DT delta/NN 3/NN ester/NN kdeg/NN ,/, and/CC slower/JJR than/IN the/DT hydrolysis/NN rate/NN of/IN the/DT delta/NN 2/NN ester/NN k24/CD ./.
@@115005126976 The/DT human/NEWGENE ABCG1/NEWGENE gene/NEWGENE encodes/VBZ a/DT member/NN of/IN the/DT ATP-binding/NEWGENE cassette/NEWGENE (/( ABC/NEWGENE )/SYM superfamily/NN of/IN transporter/NEWGENE proteins/NEWGENE and/CC is/VBZ highly/RB induced/VBN when/CC macrophages/NNS are/VBP incubated/VBN with/IN oxysterols/NNS ./.
@@98571975448 Yap1p/NEWGENE is/VBZ constitutively/RB nuclear/JJ in/IN a/DT crm1/NEWGENE mutant/NEWGENE ,/, and/CC Crm1p/NEWGENE binds/VBZ to/IN a/DT nuclear/NN export/NN sequence/NN (/( NES/NN )/NN -like/NN sequence/NN in/IN Yap1p/NEWGENE in/IN the/DT presence/NN of/IN RanGTP/NEWGENE ./.
@@33040153992 Clinical/NNP chemistry/NN ./.
@@48036295184 Hematopoietic/JJ system/NN in/IN streptococcal/JJ allergy/NN ./.
@@92094388948 However/RB ,/, using/VBG ATL-16T/NNP nuclear/JJ extract/NN ,/, we/PRP demonstrated/VBD that/IN GATA-4/NEWGENE is/VBZ the/DT only/RB GATA-binding/NEWGENE protein/NEWGENE that/IN forms/NNS specific/NN DNA-protein/NN complex/NN with/IN the/DT -70/NEWGENE GATA/NEWGENE site/NEWGENE ./.
@@92238808695 We/PRP suppose/VBP that/IN this/DT injection/NN speed/NN (/( 0/CD ./CD 1-0/CD ./CD 2/CD ml/NN ./NN s-1/NN )/SYM is/VBZ suitable/JJ for/IN spinal/JJ anesthesia/NN ./.
@@19609747498 Toluene/NN is/VBZ the/DT chemical/JJ most/RB frequently/RB present/VB in/IN cases/NNS involving/VBG volatile/JJ solvents/NNS ./.
@@78646526341 Thus/RB ,/, we/PRP have/VBP produced/VBN lipoyl/NN domain/NN constructs/NNS that/WDT can/MD be/VB employed/VBN in/IN sorting/JJ the/DT specific/JJ roles/NNS of/IN E2L1/NEWGENE and/CC E2L2/NEWGENE in/IN facilitating/JJ catalytic/JJ and/CC regulatory/JJ processes/NNS ./.
@@16498357047 Transfecting/VBG the/DT cloned/NEWGENE bovine/NEWGENE PBR/NEWGENE //NEWGENE IBP/NEWGENE cDNA/NEWGENE into/IN COS-7/NNP cells/NNS resulted/VBN in/IN an/DT 11-fold/JJ increase/NN in/IN the/DT density/NN of/IN high/JJ affinity/NN [/NN 3H/NN ]/NN PK/NN 11195/NN binding/NN sites/NN which/WDT had/VBP only/RB low/JJ affinity/NN for/IN Ro5-4864/NN ./.
@@81446158691 Digestion/NNS of/IN NF-IL6/NEWGENE with/IN endoprotease/NEWGENE Asp-N/NEWGENE produced/VBN a/DT domain/NN smaller/JJR than/IN the/DT TCD/NEWGENE (/( NF-IL6/NEWGENE bZIP/NEWGENE domains/NEWGENE (/( NFBD/NEWGENE )/SYM (/( 272-345/JJ )/NN )/NN ,/, a/DT domain/NN identified/VBD either/DT in/NN the/DT absence/NN or/CC the/DT presence/NN of/IN DNA/NN ./.
@@13331252170 A/DT combination/NN of/IN comparative/JJ sequence/NN analysis/NN and/CC thermodynamic/JJ methods/NNS reveals/VBZ the/DT conservation/NN of/IN tertiary/JJ structure/NN elements/NNS in/IN the/DT 5'/CD untranslated/JJ region/NN (/( UTR/NNS )/SYM of/IN human/JJ enteroviruses/NNS and/CC rhinoviruses/NNS ./.
@@41609804828 Hypothalamic/JJ control/NN of/IN coronary/JJ circulation/NN in/IN the/DT dog/NN ./.
@@38285004508 Intensification/NN of/IN human/JJ myocardial/JJ contractile/JJ activity/NN as/IN affected/VBN by/IN blood/NN serum/JJ ./.
@@74741247489 These/DT results/NNS demonstrate/VBP that/IN although/IN PI2/NN and/CC PI3/NN viruses/NNS belong/VBP to/IN the/DT same/JJ parainfluenza/NN virus/NN genus/NN ,/, these/DT viruses/NNS show/NN marked/JJ differences/NNS with/IN respect/NN to/IN functional/JJ requirements/NNS for/IN the/DT cytoplasmic/JJ tail/NN of/IN the/DT F/NEWGENE glycoprotein/NEWGENE ./.
@@112643759501 The/DT human/NEWGENE cytomegalovirus/NEWGENE (/NEWGENE HCMV/NEWGENE )/NEWGENE major/NEWGENE immediate-early/NEWGENE protein/NEWGENE IE2/NEWGENE is/VBZ a/DT nuclear/NEWGENE phosphoprotein/NEWGENE that/WDT is/VBZ believed/VBN to/IN be/VB a/DT key/NN regulator/NN in/IN both/DT lytic/JJ and/CC latent/JJ infections/NNS ./.
@@14284902052 The/DT highest/JJS prevalence/NN of/IN reported/VBN pet/NN allergy/NN ,/, chronic/JJ cough/NN ,/, wheeze/NN ,/, attacks/VBZ of/IN shortness/NN of/IN breath/NN with/IN wheezing/NN ,/, and/CC doctor-diagnosed/JJ asthma/NN was/VBD found/VBN in/IN children/NNS who/WP had/VBP pets/NNS in/IN the/DT past/JJ but/CC not/RB anymore/RB ./.
@@92630941256 MEASUREMENTS/NNP AND/CC MAIN/NNP RESULTS/NNS :/: Lung/NNP elastance/NN (/( EL/NNS )/SYM and/CC resistance/NN (/( RL/NN )/SYM were/VBD calculated/VBN from/IN measurements/NNS of/IN airway/NN pressure/NN ,/, esophageal/JJ pressure/NN ,/, and/CC airway/NN flow/NN in/IN five/CD anesthetized/JJ ,/, paralyzed/JJ dogs/NNS during/IN sinusoidal/JJ forcing/VBG at/IN a/DT constant/JJ mean/JJ airway/NN pressure/NN of/IN 10/CD cmH2O/NN in/IN a/DT wide/JJ range/NN of/IN breathing/JJ frequencies/NNS (/( 0/CD ./CD 2/CD to/IN 1/CD ./CD 0/CD Hz/NN in/IN intervals/NNS of/IN 0/CD ./CD 2/CD )/SYM and/CC tidal/JJ volumes/NNS (/( 50/CD ,/, 100/CD ,/, 200/CD ,/, and/CC to/IN 300/CD mL/NN )/SYM ./.
@@83427032371 The/DT mean/JJ power/NN (/( in/IN mu/NN W/NN )/SYM required/VBN to/IN produce/NN the/DT observed/VBN flow/NN rate/NN was/VBD estimated/VBN at/IN each/DT outflow/NN pressure/NN as/IN the/DT product/NN of/IN the/DT flow/NN rate/NN and/CC the/DT pressure/NN across/IN the/DT lymphatic/JJ vessel/NN ./.
@@86543759629 A/DT mutational/JJ analysis/NN has/VBZ resolved/VBN a/DT region/NN of/IN seven/JJ amino/JJ acids/NNS (/( amino/JJ acids/NNS 26-32/CD )/SYM in/IN the/DT N-terminus/NN of/IN Bob1/NEWGENE that/WDT are/VBP important/JJ for/IN contacting/JJ the/DT DNA/NN binding/JJ POU/NEWGENE domain/NEWGENE of/IN Oct-1/NEWGENE or/CC Oct-2/NEWGENE ./.
@@3109147147 Ethylene/NNP glycol/NN and/CC diethylene/NN glycol/NN were/VBD each/DT administered/VBN once/CC weekly/JJ subcutaneously/RB to/IN groups/NNS of/IN 100/CD female/JJ NMRI/NN mice/NNS at/IN 3/CD dosages/NNS (/( 30/CD ;/: 10/NN und/NN 3/NN mg/NN single/JJ dose/NN per/IN mouse/NN )/SYM ./.
@@93145377594 These/DT findings/NNS show/NN that/IN EBP50/NEWGENE is/VBZ a/DT physiologically/RB relevant/JJ ezrin/NEWGENE binding/NEWGENE protein/NEWGENE ./.
@@111760981016 METHODS/IN :/: Sixteen/CD pigs/NNS were/VBD assigned/VBN randomly/RB to/IN control/NN and/CC shock/NN groups/NNS ./.
@@79354716987 Because/IN endogenous/JJ HSF/NEWGENE DNA-binding/NN activity/NN is/VBZ low/JJ and/CC anti-hHSF1/NEWGENE antibody/NEWGENE does/VBP not/RB recognize/VB Xenopus/NEWGENE HSF/NEWGENE ,/, we/PRP employed/VBD this/DT system/NN for/IN mapping/NN regions/NNS in/IN hHSF1/NEWGENE that/WDT are/VBP required/VBN for/IN the/DT maintenance/NN of/IN the/DT monomeric/JJ state/NN ./.
@@96951949673 On/IN the/DT comparison/NN of/IN correlated/VBN proportions/NNS for/IN clustered/VBN data/NN ./.
@@13398154221 No/DT significant/JJ correlations/NNS of/IN peak/NN VO2/NN were/VBD observed/VBN between/IN the/DT 3/CD tests/NNS ./.
@@89938365950 We/PRP discuss/VBP these/DT results/NNS with/IN respect/NN to/IN the/DT transcriptional/JJ induction/NN of/IN the/DT HNF-3/NEWGENE alpha/NEWGENE gene/NEWGENE in/IN respiratory/JJ epithelium/NN during/IN embryogenesis/NN ./.
@@3263357469 We/PRP were/VBD interested/VBN in/IN studying/VBG the/DT relationship/NN between/IN the/DT circadian/JJ rhythm/NN in/IN body/NN temperature/NN and/CC 24-h/JJ variations/NNS in/IN plasma/NN concentrations/NNS of/IN iron/NN ,/, zinc/NN ,/, circulating/JJ leukocyte/NN counts/NNS ,/, and/CC plasma/NN interleukin/NEWGENE 1/NEWGENE (/( IL-1/NEWGENE )/SYM activity/NN ./.
@@109240615193 Activation/NNS was/VBD biphasic/JJ ;/: peaking/VBG at/IN 5-10/CD min/NN and/CC 24/CD h/NN after/IN treatment/NN ./.
@@82434764655 Three/CD cysteine/NN and/CC four/CD tryptophan/NN residues/NNS ,/, previously/RB identified/VBN as/IN conserved/VBN amongst/IN nitrous-oxide/NEWGENE reductases/NEWGENE ,/, are/VBP found/VB in/IN the/DT Paracoccus/NNP enzyme/NN ./.
@@829176180 Animal/NN age/NN and/CC sex/NN had/VBP no/DT significant/JJ effects/NNS on/IN CSF/NN composition/NN ,/, but/CC serum/JJ IgG/NEWGENE concentration/NN increased/VBN with/IN age/NN ./.
@@90925802803 These/DT studies/NNS point/NN to/IN the/DT involvement/NN of/IN the/DT MAP/NEWGENE kinase/NEWGENE pathway/NN in/IN the/DT activation/NN of/IN monocytic/JJ cells/NNS during/IN transmigration/NN to/IN inflammatory/JJ sites/NNS ./.
@@85859579253 This/DT gene/NN encodes/VBZ a/DT putative/JJ transcription/NN factor/NN with/IN regions/NNS of/IN homology/NN to/IN several/DT other/DT proteins/NNS including/JJ the/DT zinc/NN fingers/NNS and/CC other/DT domains/NNS of/IN the/DT Drosophila/NEWGENE trithorax/NEWGENE gene/NEWGENE product/NEWGENE ,/, and/CC the/DT "AT-hook"/NEWGENE DNA-binding/NEWGENE motif/NEWGENE of/IN high/NEWGENE mobility/NEWGENE group/NEWGENE proteins/NEWGENE ./.
@@3522105926 High/NNP trough/NN serum/JJ TOB/NN concentrations/NNS were/VBD associated/VBN with/IN death/NN and/CC very/RB low/JJ levels/NNS with/IN recovery/NN ./.
@@112820883541 Baseline/NN MBF/NN in/IN females/NNS was/VBD significantly/RB (/( P/CD </CD 0/CD ./CD 001/CD )/SYM higher/JJ than/IN in/IN males/NNS ./.
@@72954177154 Delayed/JJ or/CC paradoxically/RB emptying/VBG regions/NNS of/IN the/DT left/NN ventricle/NN were/VBD detected/VBN by/IN a/DT relatively/JJ new/JJ nuclear/NN technique--phase/NN imaging/NN ./.
@@95780421448 To/TO clarify/VB whether/IN seizure-offset/JJ patterns/NNS are/VBP reliable/JJ in/IN predicting/JJ seizure/NN outcome/NN ,/, we/PRP studied/VBD SEEG/NN //NN ECoG/NN in/IN a/DT similar/JJ group/NN of/IN patients/NNS with/IN temporal/JJ lobe/NN epilepsy/NN (/( TLE/NNS )/SYM ./.
@@85163245552 The/DT 11/CD ;/: 22/NN chromosomal/NN translocation/NN specifically/RB linked/JJ to/IN Ewing/NN sarcoma/NN and/CC primitive/JJ neuroectodermal/JJ tumor/NN results/NNS in/IN a/DT chimeric/JJ molecule/NN fusing/JJ the/DT amino-terminal-encoding/JJ portion/NN of/IN the/DT EWS/NEWGENE gene/NEWGENE to/IN the/DT carboxyl-terminal/NN DNA-binding/NN domain/NN encoded/VBN by/IN the/DT FLI1/NEWGENE gene/NEWGENE ./.
@@101942309464 Immediately/RB after/IN surgery/NN ,/, dialysate/NN PGE2/NN and/CC adenosine/NN concentrations/NNS were/VBD 3/CD ./CD 7/CD +/NN //NN -/NN 0/CD ./CD 7/CD and/CC 296/CD +/NN //NN -/NN 127/CD nM/NN ,/, respectively/RB ./.
@@114816254803 We/PRP randomly/RB assigned/VBD 1/NN ,/NN 219/NN subjects/NNS to/IN receive/VB either/DT the/DT standard/JJ three-times-weekly/JJ (/( TIW/NNP )/SYM interferon/NEWGENE alfa-2b/NEWGENE dose/NN (/( 3/CD MIU/NNS )/SYM or/CC the/DT once-weekly/JJ (/( QW/NNP )/SYM peginterferon/NN alfa-2b/NN (/( 0/CD ./CD 5/CD ,/, 1/CD ./CD 0/CD ,/, or/CC 1/CD ./CD 5/CD microg/NN //NN kg/NN )/SYM ./.
@@78780297936 We/PRP show/VBP that/IN CBF-A/NEWGENE and/CC CBF-C/NEWGENE interact/VB with/IN each/DT other/DT to/IN form/NN a/DT CBF-A-CBF-C/NEWGENE complex/NEWGENE and/CC that/IN CBF-B/NEWGENE does/VBP not/RB interact/VB with/IN CBF-A/NEWGENE or/CC CBF-C/NEWGENE individually/RB but/CC that/IN it/PRP associates/VBP with/IN the/DT CBF-A-CBF-C/NEWGENE complex/NEWGENE ./.
@@76582625427 Protein/NEWGENE S/NEWGENE levels/NNS were/VBD virtually/RB undetectable/JJ at/IN the/DT time/NN of/IN admission/NN and/CC failed/VBN to/IN respond/NN to/IN infusions/NNS of/IN fresh/JJ frozen/JJ plasma/NN ,/, despite/IN correction/NN of/IN other/DT procoagulant/JJ and/CC anticoagulant/JJ factors/NNS ./.
@@28182603519 Low-grade/NNP glioma/NN ./.
@@110297001080 While/IN Pt/NEWGENE ;/NEWGENE cycH/NEWGENE ;/NEWGENE 1/NEWGENE and/CC Os/NEWGENE ;/NEWGENE cycH/NEWGENE ;/NEWGENE 1/NEWGENE were/VBD expressed/VBN in/IN all/DT tissues/NNS examined/VBN ,/, the/DT transcripts/NNS accumulated/VBN abundantly/RB in/IN dividing/JJ cells/NNS ./.
@@6345840270 In/NN patients/NNS in/IN group/NN A/DT (/( "normal"/NN CI/NN )/SYM ,/, the/DT CI/NN ,/, heart/NN rate/NN and/CC the/DT mean/JJ circumferential/JJ fiber/NN shortening/NN velocity/NN (/( mVCF/NN )/SYM were/VBD normal/JJ ,/, but/CC the/DT TPR/NN was/VBD increased/VBN significantly/RB ./.
@@25170083162 The/DT other/DT patients/NNS continued/VBD the/DT trial/NN with/IN single/JJ daily/JJ doses/NNS of/IN monotherapy/NN ./.
@@108718424846 Our/PRP results/NNS suggest/VBP that/DT proteasome/NN inhibition/NN leads/VBP to/IN upregulation/NN of/IN specific/JJ members/NNS of/IN transcription/NN factor/NN families/NNS controlling/JJ cellular/JJ stress/NN response/NN and/CC proliferation/NN ./.
@@6461936268 Potency/NNS of/IN enflurane/NN in/IN dogs/NNS :/: comparison/NN with/IN halothane/NN and/CC isoflurane/NN ./.
@@29348899962 Oxfendazole/NNP ,/, which/WDT was/VBD active/JJ for/IN the/DT shortest/JJS time/NN (/( about/RB 65/CD days/NNS )/SYM from/IN the/DT start/NN of/IN grazing/JJ (/( May/NN 1/CD )/SYM ,/, produced/VBD a/DT 78/CD ./CD 1/CD per/IN cent/NN reduction/NN in/IN Ostertagia/NNP species/NN and/CC an/DT 84/CD ./CD 4/CD per/IN cent/NN reduction/NN in/IN D/NN viviparus/NN ./.
@@114966178775 METHODS/IN :/: 93/CD female/JJ and/CC 43/CD male/JJ patients/NNS undergoing/VBG thyroid/JJ surgery/NN were/VBD stratified/JJ according/VBG to/IN gender/NN and/CC then/RB randomised/JJ to/IN receive/VB double-blind/JJ one/PRP of/IN four/CD antiemetic/JJ regimes/NNS :/: 50/CD mg/NN dolasetron/NN given/VBP orally/RB 45/CD minutes/NNS prior/NN to/IN induction/NN of/IN anaesthesia/NN (/( group/NN I/PRP )/SYM ,/, 12/CD ./CD 5/CD mg/NN dolasetron/NN given/VBP intravenously/RB during/IN induction/NN of/IN anaesthesia/NN (/( group/NN II/NNP )/SYM ,/, 1/CD ./CD 25/CD mg/NN DHB/NEWGENE given/VBP intravenously/RB during/IN induction/NN of/IN anaesthesia/NN (/( group/NN III/NNP )/SYM or/CC placebo/NN (/( group/NN IV/NN )/SYM ./.
@@19924594503 The/DT specific/JJ interaction/NN between/IN a/DT defined/VBN structural/JJ element/NN of/IN the/DT human/JJ immunodeficiency/NN virus/NN mRNA/NN (/( RRE/NEWGENE ,/, the/DT Rev/NEWGENE response/NEWGENE element/NEWGENE )/SYM and/CC the/DT virus-encoded/NEWGENE protein/NEWGENE Rev/NEWGENE has/VBZ been/VBN implicated/VBN in/IN the/DT regulation/NN of/IN the/DT export/NN of/IN unspliced/JJ or/CC singly/RB spliced/VBN mRNA/NN from/IN the/DT nucleus/NN to/IN the/DT cytoplasm/NN ./.
@@104529911794 These/DT cells/NNS were/VBD able/JJ to/IN present/NN influenza/NN virus/NN particles/NNS to/IN HLA-DR1-restricted/JJ T/NN cell/NN clones/NNS ./.
@@34280846677 The/DT 4/CD degrees/NNS stimuli/NNS were/VBD found/VBN to/IN elicit/VB scalp/NN distributions/NNS for/IN the/DT pattern/NN reversal/NN P100/NN and/CC the/DT pattern/NN onset/NN C1/NN consistent/JJ with/IN striate/JJ and/CC extrastriate/NN visual/NN cortical/JJ origins/NNS respectively/RB ./.
@@85079211662 In/NN conclusion/NN ,/, these/DT observations/NNS demonstrated/VBD that/DT stratification/NN of/IN acute/NN MI/NN patients/NNS by/IN plasma/NN ANF/NEWGENE level/NN is/VBZ a/DT useful/JJ non-invasive/JJ method/NN for/IN predicting/JJ prognosis/NN and/CC for/IN identifying/JJ individuals/NNS at/IN high/JJ risk/NN of/IN cardiac/JJ death/NN ./.
@@17360937534 Heat-inducible/NNP CAT/NEWGENE activity/NN was/VBD detectable/JJ when/CC additional/JJ sequences/NNS from/IN the/DT native/JJ promoter/NN containing/JJ three/CD CCAAT/NNP boxes/NNS and/CC a/DT single/JJ HSE/NEWGENE were/VBD present/VB in/IN the/DT constructions/NNS ./.
@@110690753936 Characterization/NNS of/IN a/DT Xenopus/NEWGENE laevis/NEWGENE CXC/NEWGENE chemokine/NEWGENE receptor/NEWGENE 4/NEWGENE :/: implications/NNS for/IN hematopoietic/JJ cell/NN development/NN in/IN the/DT vertebrate/JJ embryo/NN ./.
@@116784372254 The/DT effect/NN of/IN crude/JJ oil/NN spillage/NN on/IN growth/NN ,/, productivity/NN and/CC nutrient/JJ uptake/NN of/IN maize/NN (/( Zea/NN mays/VBZ L/NNP ./NNP )/SYM was/VBD assessed/VBN in/IN a/DT pot/NN experiment/NN using/VBG an/DT Evwreni/NNP manifold/JJ sample/NN of/IN a/DT petroleum/NN development/NN company/NN ,/, which/WDT had/VBP a/DT specific/JJ gravity/NN of/IN 0/CD ./CD 8778/CD ./.
@@78917085379 Moreover/RB ,/, the/DT hypoxia-induced/JJ expression/NN of/IN the/DT endogenous/JJ Epo/NEWGENE gene/NEWGENE was/VBD significantly/RB inhibited/VBN in/IN Hep3B/NNP cells/NNS stably/RB transfected/VBN with/IN HNF-4/NEWGENE delta/NEWGENE C/NEWGENE ./.
@@119134271829 The/DT subjects/NNS were/VBD shown/VBP to/IN be/VB capable/JJ of/IN assessing/JJ integrally/RB the/DT value/NN of/IN accelerations/NNS and/CC estimating/VBG it/PRP with/IN an/DT error/NN of/IN 0/CD ./CD 1-0/CD ./CD 12/CD g/CD ./CD
@@86327796918 Two/CD XPG/NEWGENE regions/NEWGENE with/IN putative/JJ NLS/NN [/NN amino/NN acid/NN (/( AA/NN )/SYM coordinates/NNS :/: NLS-B/NN (/( AA/NN 1057-1074/JJ )/SYM and/CC NLS-C/NNP (/( AA/NN 1171-1185/JJ )/NN ]/NN were/VBD each/DT shown/VBP to/IN independently/RB localize/VB the/DT beta-gal/NEWGENE extensively/RB (/( >/SYM 80%/NN )/SYM to/IN the/DT nucleus/NN of/IN HeLa/DT cells/NNS ./.
@@115168908450 Although/IN metabolized/VBN by/IN the/DT cytochrome/NEWGENE P-450/NEWGENE (/( CYP/NEWGENE )/SYM system/NN ,/, venlafaxine/NN inhibits/VBZ CYP/NEWGENE 2D6/NEWGENE and/NEWGENE 3A4/NEWGENE to/IN a/DT far/RB lesser/JJ extent/NN than/IN do/NN the/DT SSRIs/NN ./.
@@81446317157 Signaling/NN by/IN tyrosine/NEWGENE kinases/NEWGENE involves/VBZ direct/JJ associations/NNS between/IN proteins/NNS with/IN Src/NEWGENE homology/NEWGENE 2/NEWGENE (/( SH2/NEWGENE )/SYM domains/NNS and/CC sites/NNS of/IN tyrosine/NN phosphorylation/NN ./.
@@96948698867 In/NN addition/NN ,/, and/CC in/IN support/NN of/IN a/DT mediating/JJ role/NN of/IN STATs/NEWGENE in/IN the/DT activation/NN of/IN the/DT p21/NEWGENE promoter/NEWGENE ,/, overexpression/NN of/IN Stat3/NEWGENE potentiated/VBN the/DT cytokine/NN effect/NN on/IN the/DT p21/NEWGENE promoter/NEWGENE ;/: whereas/IN a/DT dominant/NEWGENE negative/NEWGENE Stat3/NEWGENE ,/, or/CC a/DT mutation/NN of/IN the/DT STAT/NEWGENE response/NEWGENE element/NEWGENE on/IN the/DT promoter/NN ,/, significantly/RB reduced/VBN the/DT cytokine/NN effect/NN ./.
@@17929142408 Extramedullary/NNP relapse/NN in/IN childhood/NN leukemia/NN ./.
@@108812757783 Testing/NN for/IN serum/NEWGENE IgM/NEWGENE binding/JJ to/IN GM1/NN ganglioside/NN in/IN clinical/JJ practice/NN ./.
@@94006133486 Using/VBG GST-PKR/NEWGENE fusion/NEWGENE chromatography/NN ,/, direct/JJ physical/JJ interaction/NN between/IN the/DT mouse/NN and/CC human/NEWGENE PKR/NEWGENE homologs/NEWGENE was/VBD established/VBN ./.
@@103316465835 In/NN contrast/NN ,/, the/DT deduced/VBN amino/JJ acid/NN sequence/NN of/IN a/DT second/JJ family/NN (/( ART5/NEWGENE )/SYM of/IN transferases/NEWGENE ,/, cloned/VBN from/IN murine/JJ lymphoma/NN cells/NNS and/CC expressed/VBN in/IN high/JJ abundance/NN in/IN testis/NN ,/, displays/VBP a/DT hydrophobic/JJ amino/JJ terminus/NN ,/, consistent/JJ with/IN a/DT signal/JJ sequence/NN ,/, but/CC lacks/VBZ a/DT hydrophobic/JJ signal/JJ sequence/NN at/IN its/PRP carboxyl/NN terminus/NN ,/, suggesting/VBG that/IN the/DT protein/NN is/VBZ destined/VBN for/IN export/NN ./.
@@9915860821 Sp1's/NNP role/NN in/IN transactivation/NN of/IN the/DT pgp2/NEWGENE //NEWGENE mdr1b/NEWGENE promoter/NEWGENE was/VBD tested/VBN in/IN Drosophila/NN Schneider/NN cells/NNS ./.
@@27567313454 Prostaglandins/NNS and/CC gallstones/NNS ./.
@@28799063586 Studies/NNS were/VBD performed/VBN on/IN several/DT superficial/JJ veins/NNS from/IN the/DT rabbit/NN face/NN to/IN examine/VB the/DT relationship/NN between/IN beta/NEWGENE adrenoceptor/NEWGENE subtype/NEWGENE distribution/NN ,/, intrinsic/JJ myogenic/JJ tone/NN and/CC sympathetic/JJ nerve/NN innervation/NN ./.
@@83962611162 Several/JJ lines/NNS of/IN evidence/NN demonstrate/VB that/IN this/DT growth/NN inhibition/NN requires/VBZ active/JJ PKA/NEWGENE subunits/NEWGENE and/CC cAMP/NN :/: (/( i/NN )/SYM this/DT phenotype/NN is/VBZ dependent/JJ on/IN cAMP/NN since/IN it/PRP is/VBZ not/RB seen/VBP in/IN a/DT strain/NN lacking/JJ adenylyl/NEWGENE cyclase/NEWGENE activity/NN ,/, but/CC the/DT growth/NN rate/NN of/IN these/DT transformants/NNS is/VBZ slower/JJR when/CC exogenous/JJ cAMP/NN is/VBZ added/VBN ;/: (/( ii/NN )/SYM normal/JJ growth/NN occurs/VBZ when/CC wild-type/NN RI/NEWGENE cDNA/NN is/VBZ replaced/VBN by/IN a/DT mutant/NEWGENE RI/NEWGENE cDNA/NEWGENE encoding/VBG a/DT RI/NEWGENE protein/NEWGENE with/IN reduced/VBN cAMP/NN binding/JJ ;/: and/CC (/( iii/NN )/SYM the/DT growth-inhibited/JJ phenotype/NN of/IN the/DT transformed/VBN BL21/NN (/NN DE3/NN )/NN cells/NNS requires/VBZ soluble/JJ ,/, active/JJ C/NEWGENE alpha/NEWGENE protein/NEWGENE ./.
@@21158898812 In/NN this/DT paper/NN ,/, we/PRP have/VBP analyzed/VBN the/DT structure/NN of/IN human/JJ gene/NN for/IN Gx/NEWGENE alpha/NEWGENE ,/, which/WDT spans/VBZ more/RB than/IN 60/CD kilobases/NNS ./.
@@93773559330 The/DT author/NN analyzes/VBZ extensive/JJ own/VB data/NN based/VBN on/IN study/NN into/IN particular/JJ features/NNS of/IN cardiovascular/JJ disorders/NNS in/IN chronic/JJ renal/JJ impairement/NN with/IN making/VBG use/NN of/IN modern/JJ diagnostic/JJ tools/NNS ./.
@@83863178615 Nuclear/NEWGENE protein/NEWGENE phosphatase/NEWGENE 2A/NEWGENE dephosphorylates/VBZ protein/NEWGENE kinase/NEWGENE A-phosphorylated/JJ CREB/NEWGENE and/CC regulates/VBZ CREB/NEWGENE transcriptional/JJ stimulation/NN ./.
@@22930193826 Antileukoproteinase/NEWGENE (/( ALP/NEWGENE )/SYM is/VBZ a/DT low/JJ mol/NN wt/NN mucosal/JJ secretory/JJ protein/NN which/WDT ,/, in/IN human/JJ tissues/NNS ,/, inhibits/VBZ the/DT activities/NNS of/IN the/DT neutral/JJ serine/NEWGENE lysosomal/NEWGENE proteinases/NEWGENE elastase/NEWGENE1 and/CC cathepsin-G/NEWGENE ./.
@@114105631702 No/DT dominant/JJ clinical/JJ factor/NN of/IN risk/NN was/VBD found/VBN ,/, but/CC multiple/JJ regression/NN analysis/NN identified/VBD age/NN ,/, body/NN surface/NN area/NN ,/, valve/NN size/NN ,/, shop/NN order/NN fracture/NN rate/NN ,/, and/CC manufacturing/JJ period/NN as/IN risk/NN factors/NNS for/IN OSF/NN ./.
@@113483181199 It/PRP is/VBZ useful/JJ as/IN an/DT adjunct/NN to/IN mammography/NN in/IN those/DT patients/NNS with/IN radiographically/RB dense/JJ breasts/NNS for/IN the/DT characterization/NN of/IN palpable/JJ masses/NNS ./.
@@15361536433 There/EX was/VBD however/RB ,/, no/DT significant/JJ difference/NN in/IN the/DT prevalence/NN of/IN chronic/JJ respiratory/JJ symptoms/NNS between/IN animal/NN food/NN workers/NNS with/IN positive/JJ and/CC negative/JJ skin/NN tests/NNS to/IN house/JJ dust/NN or/CC to/IN fish/NN flour/NN or/CC among/IN those/DT with/IN increased/VBN or/CC normal/JJ IgE/NEWGENE (/( except/VB for/IN dyspnea/NN )/SYM ./.
@@86631727325 This/DT protein/NN with/IN a/DT hydrophobic/JJ amino/JJ terminus/NN appears/VBZ to/IN be/VB a/DT secreted/VBN protein/NN ./.
@@8707516166 Initial/JJ estimates/NNS indicate/VBP that/IN 27/NN ,/NN 193/NN people/NN are/VBP either/DT in/NN receipt/NN of/IN or/CC in/IN need/NN of/IN mental/JJ handicap/NN services/NNS ./.
@@14202232039 Significance/NN of/IN the/DT biopsy/NN site/NN of/IN the/DT latissimus/NN dorsi/NN muscle/NN for/IN fiber/NN typing/NN ./.
@@17833756106 Our/PRP mapping/NN results/NNS did/VBD not/RB suggest/VB involvement/NN of/IN this/DT gene/NN in/IN previously/RB mapped/VBN genetic/JJ disorders/NNS or/CC in/IN known/VBP neoplasia-associated/NN translocation/NN breakpoints/NNS ./.
@@92062309159 OBJECTIVE/IN :/: This/DT study/NN was/VBD designed/VBN to/IN analyze/VB the/DT common/JJ cause/NN of/IN asthenopia/NN ,/, mixed/JJ astigmatism/NN ./.
@@103408836247 The/DT 5-year/JJ OS/NNS for/IN stage/NN IIIB/NN was/VBD 30/CD ./CD 9%/CD ,/, compared/VBN to/IN 7/CD ./CD 8%/CD for/IN stage/NN IV/DT ./DT
@@8363332659 The/DT simultaneous/JJ recording/NN of/IN electrical/JJ activity/NN from/IN the/DT surface/NN electrocardiogram/NN ,/, right/JJ ventricular/JJ apex/NN ,/, His/NN bundle/NN ,/, high/JJ right/JJ atrium/NN ,/, coronary/JJ sinus/NN ,/, with/IN or/CC without/IN a/DT roving/JJ mapping/NN catheter/NN ,/, enables/VBZ us/PRP to/IN precisely/RB map/VBP the/DT electrical/JJ activation/NN sequence/NN in/IN the/DT heart/NN ./.
@@92232293404 As/IN with/IN the/DT murine/NEWGENE and/NEWGENE human/NEWGENE mb-1/NEWGENE genes/NEWGENE ,/, the/DT 5'/CD region/NN of/IN the/DT bovine/NEWGENE mb-1/NEWGENE gene/NEWGENE lacked/VBD a/DT TATA/NN box/NN ./.
@@107253829848 Sequence/NN analyses/NNS of/IN sos2/NEWGENE mutant/NEWGENE alleles/NEWGENE reveal/VBP that/IN both/PDT the/DT N-terminal/NN catalytic/JJ domain/NN and/CC the/DT C-terminal/NN regulatory/JJ domain/NN of/IN SOS2/NEWGENE are/VBP functionally/RB essential/JJ ./.
@@21646044272 Furthermore/RB ,/, analysis/NN of/IN the/DT E2/NEWGENE proteins/NEWGENE present/VBP in/IN various/JJ cell/NN lines/NNS harboring/VBG specific/NN BPV-1/NN mutants/NN ,/, including/JJ the/DT 2558/NEWGENE acceptor/NEWGENE mutant/NEWGENE ,/, proves/VBZ that/IN alternate/JJ modes/NNS of/IN E2/NEWGENE expression/NN exist/VB ./.
@@27039257127 When/WRB statistically/RB analyzed/VBN in/IN various/JJ subgroupings/NNS ,/, the/DT obtained/VBN average/JJ sedimentation/NN coefficients/NNS and/CC polydispersity/JJ profiles/NNS supported/VBD the/DT following/NN conclusions/NNS :/: (/( a/DT )/SYM loss/NN of/IN proteoglycan/NN aggregation/NN and/CC sedimentability/NN is/VBZ confirmed/VBN to/IN be/VB a/DT primary/JJ sign/NN of/IN cartilage/NN matrix/NN degradation/NN ;/: (/( b/NN )/SYM higher/JJ S/NNP values/NNS for/IN proteoglycans/NNS of/IN the/DT high/JJ weight/NN (/( HW/JJ )/NN -bearing/NN areas/NNS and/CC lower/JJR values/NNS for/IN those/DT of/IN the/DT low/JJ weight/NN (/( LW/JJ )/NN -bearing/NN areas/NNS were/VBD a/DT typical/JJ finding/NN in/IN normal/JJ cartilage/NN samples/NNS ;/: (/( c/NN )/SYM inversion/NN of/IN this/DT pattern/NN was/VBD indicative/NN of/IN matrix/NN degradation/NN ,/, suggesting/VBG that/IN the/DT HW/NN regions/NN are/VBP more/RB affected/VBN than/IN the/DT LW-bearing/VBG areas/NNS ;/: (/( d/NN )/SYM the/DT average/JJ S/NNP value/NN distribution/NN across/IN cartilage/NN thickness/NN tended/VBN to/IN resemble/VB the/DT corresponding/JJ proteoglycan/NN content/NN versus/IN distance/NN from/IN articular/JJ surface/NN ;/: and/CC (/( e/NN )/SYM the/DT deepest/JJS cartilage/NN layer/NN had/VBP ,/, in/IN most/RB cases/VBZ ,/, the/DT smallest/JJS amount/NN of/IN aggregates/NNS while/CC the/DT highest/JJS average/JJ sedimentability/NN was/VBD observed/VBN at/IN the/DT middle/JJ zone/NN of/IN the/DT normal/JJ samples/NNS ./.
@@113140463441 Cyclins/NEWGENE are/VBP one/PRP of/IN the/DT pivotal/JJ determinants/NNS regulating/JJ cell/NN cycle/NN progression/NN ./.
@@30321434659 A/DT centromere/NN in/IN S/NNP ./NNP cerevisiae/NN consists/VBZ of/IN a/DT region/NN of/IN DNA/NN ,/, approximately/RB 150/CD bp/NN in/IN length/NN ,/, containing/JJ three/CD important/JJ sequence/NN elements/NNS ,/, which/WDT are/VBP folded/JJ with/IN proteins/NNS into/IN a/DT specific/JJ conformation/NN in/IN the/DT chromatin/NN (/( the/DT yeast/NN kinetochore/NN )/SYM ./.
@@1505488332 The/DT first/JJ 146/CD consecutive/JJ patients/NNS treated/VBN with/IN EVL/NN during/IN the/DT period/NN from/IN August/NN ,/, 1986/CD to/IN July/NN ,/, 1989/CD are/VBP reported/VBN ./.
@@34392481391 Two/CD scintigraphic/JJ methods/NNS ,/, resting/JJ dipyridamole/NN and/CC exercise/NN thallium-201/NN myocardial/JJ perfusion/NN imaging/JJ ,/, to/IN detect/VB and/CC localize/VB coronary/JJ artery/NN stenosis/NN were/VBD compared/VBN in/IN 32/CD patients/NNS suffering/VBG from/IN coronary/JJ artery/NN disease/NN ./.
@@25091234611 In/NN all/DT sessions/NNS under/IN IFN/NEWGENE ,/, the/DT latency/NN of/IN the/DT P100/NN component/NN of/IN the/DT VEP/NN was/VBD shortened/VBN as/IN compared/VBN to/IN baseline/NN conditions/NNS ./.
@@114016111260 CONCLUSIONS/IN :/: Our/PRP meta-analysis/NN of/IN randomized/JJ controlled/VBN trials/NNS of/IN HRT/NN noted/VBD a/DT statistically/RB significant/JJ reduction/NN in/IN nonvertebral/JJ fractures/NNS ./.
@@73300737188 Prevention/NNP of/IN transfusion/NN reactions/NNS by/IN the/DT use/NN of/IN saline/RB washed/VBN red/JJ blood/NN cells/NNS ./.
@@7622060359 In/NN human/JJ proliferative/JJ cells/NNS ,/, the/DT NADP-dependent/NNP ME/NEWGENE activity/NN is/VBZ poorly/RB expressed/VBN and/CC barely/RB inducible/JJ by/IN thyroid/JJ hormones/NNS ./.
@@108619068762 The/DT delta/NEWGENE srb10/NEWGENE mutation/NEWGENE also/RB influenced/VBD on/IN the/DT transcript/NN levels/NNS of/IN meiosis-inducing/JJ genes/NNS called/VBN IME1/NEWGENE and/CC IME2/NEWGENE :/: the/DT mutation/NN elevated/VBD the/DT transcript/NN level/NN of/IN IME1/NEWGENE but/CC reduced/VBN that/IN of/IN IME2/NEWGENE ,/, resulting/VBG in/IN partial/JJ defects/NNS in/IN premeiotic/JJ DNA/NN synthesis/NN and/CC meiosis/NN ./.
@@108991426386 After/IN screening/JJ the/DT Berkeley/NNP Drosophila/NN Genome/NNP Project/NNP database/NN with/IN sequences/NNS from/IN a/DT recently/RB characterized/VBN Leu-rich/NEWGENE repeats-containing/NEWGENE G/NEWGENE protein-coupled/NEWGENE receptor/NEWGENE (/( LGR/NEWGENE )/SYM from/IN Drosophila/NN (/( DLGR-1/NEWGENE )/SYM ,/, we/PRP identified/VBD a/DT second/JJ gene/NN for/IN a/DT different/JJ LGR/NEWGENE (/( DLGR-2/NEWGENE )/SYM and/CC cloned/VBN its/PRP cDNA/NN ./.
@@93011149191 Takahashi/NNP ,/, H/NNP ./NNP
@@114547034695 The/DT telomerase/NEWGENE RNA-protein/NEWGENE complex/NEWGENE responsible/JJ for/IN maintenance/NN of/IN telomeric/NN DNA/NN at/IN chromosome/NN ends/NNS ,/, is/VBZ usually/RB inactive/JJ in/IN most/RB primary/JJ somatic/JJ human/JJ cells/NNS ,/, but/CC is/VBZ specifically/RB activated/VBN with/IN in/IN vitro/FW immortalization/NN and/CC during/IN tumorigenesis/NN ./.
@@23405951762 Sequence/NN analysis/NN of/IN these/DT genes/NNS and/CC their/PRP surrounding/JJ sequences/NNS are/VBP presented/VBN and/CC compared/VBN with/IN other/DT known/VBP tRNA/NN genes/NNS from/IN plant/NN mitochondria/NNS ./.
@@14418187400 Interferon/NEWGENE type/NEWGENE I/NEWGENE in/IN protective/JJ body/NN reactions/NNS in/IN an/DT experimental/JJ Klebsiella/NN infection/NN ./.
@@112232553404 In/NN addition/NN ,/, the/DT consensus/NN amino/JJ acid/NN motif/NN for/IN serine/NEWGENE threonine/NEWGENE receptor/NEWGENE kinases/NEWGENE was/VBD also/RB present/VB ./.
@@84744644686 However/RB ,/, despite/IN its/PRP relationship/NN to/IN the/DT TR/NEWGENE ,/, Rev-Erb/NEWGENE bound/JJ poorly/RB to/IN TR/NEWGENE binding/NEWGENE sites/NEWGENE ./.
@@28243347818 These/DT data/NN suggest/VB that/IN the/DT G-protein/NEWGENE gene/NEWGENE family/NEWGENE may/MD be/VB distributed/VBN over/RB at/IN least/RB two/JJ human/JJ chromosomes/NNS ./.
@@62447321157 Radioimmunoassay/NNS of/IN serum/JJ creatine/NEWGENE kinase/NEWGENE B/NEWGENE isoenzyme/NEWGENE in/IN the/DT diagnosis/NN of/IN acute/JJ myocardial/JJ infarction/NN ./.
@@17675927175 Two/CD potential/JJ regulatory/JJ sequences/NNS for/IN DNA/NN binding/JJ proteins/NNS were/VBD found/VBN in/IN the/DT non-coding/JJ 5'/CD region/NN :/: a/DT HAP2/NEWGENE //NEWGENE HAP3/NEWGENE consensus/NEWGENE recognition/NEWGENE sequence/NEWGENE at/IN nucleotide-154/JJ and/CC a/DT BAF1/NEWGENE consensus/NEWGENE recognition/NEWGENE sequence/NEWGENE at/IN nucleotide-136/NN ./.
@@91533193075 Transfection/NNS experiments/NNS using/VBG preformed/JJ triplexes/NNS with/IN a/DT reporter/NN plasmid/NN containing/JJ the/DT collagen/NEWGENE promoter/NEWGENE sequence/NEWGENE showed/VBD significant/JJ inhibition/NN of/IN transcription/NN when/CC compared/VBN with/IN a/DT control/NN phosphorothioate/NN ODN/NNS ./.
@@16583757502 The/DT nucleotide/NN sequences/NNS at/IN the/DT 5'/CD and/CC 3'/CD ends/NNS of/IN these/DT introns/NNS are/VBP characteristic/NN of/IN spliced/VBN transcripts/NNS from/IN eukaryotic/NN protein-encoding/NN genes/NN ,/, with/IN one/PRP significant/JJ difference/NN ;/: i/FW ./FW e/FW ./FW ,/, the/DT 5'/CD end/NN of/IN the/DT LAT/NEWGENE intron/NEWGENE is/VBZ GC/NN instead/RB of/IN the/DT consensus/NN sequence/NN GT/NNP ./NNP
@@7935451707 Human/NNP T-cell/NN leukemia/NN virus/NN type/NN I/NN Tax/NEWGENE activation/NN of/IN NF-kappa/NEWGENE B/NEWGENE //NEWGENE Rel/NEWGENE involves/VBZ phosphorylation/NN and/CC degradation/NN of/IN I/NEWGENE kappa/NEWGENE B/NEWGENE alpha/NEWGENE and/CC RelA/NEWGENE (/( p65/NEWGENE )/NN -mediated/NN induction/NN of/IN the/DT c-rel/NEWGENE gene/NEWGENE ./.
@@40403071917 Before/IN birth/NN ,/, there/RB were/VBD a/DT few/JJ perivascular/JJ adrenergic/JJ nerves/NNS and/CC correspondingly/RB low/JJ ovarian/JJ NE/NN levels/NNS ./.
@@19227342542 Habituation/NNS of/IN completely/RB isolated/VBN neurons/NNS of/IN the/DT edible/JJ snail/NN to/IN electrical/JJ stimulation/NN ./.
@@98226527532 A/DT synergistic/JJ effect/NN on/IN HCK/NEWGENE promoter/NEWGENE activity/NN was/VBD observed/VBN at/IN high/JJ concentrations/NNS of/IN Sp1/NEWGENE ./.
@@109425992494 Further/JJ characterization/NN of/IN these/DT putative/JJ Hoxa-1/NEWGENE target/NEWGENE genes/NEWGENE will/MD aid/VB in/IN delineating/VBG the/DT functions/NNS of/IN the/DT Hoxa-1/NEWGENE protein/NEWGENE in/IN the/DT differentiation/NN processes/NNS which/WDT occur/VBP during/IN embryogenesis/NN ./.
@@21878715993 The/DT ANB1/NEWGENE locus/NEWGENE of/IN Saccharomyces/NN cerevisiae/NN encodes/VBZ the/DT protein/NEWGENE synthesis/NEWGENE initiation/NEWGENE factor/NEWGENE eIF-4D/NEWGENE ./.
@@78592387846 No/DT serious/JJ side/JJ effects/NNS were/VBD observed/VBN ./.
@@10422468278 Although/IN the/DT risk/NN of/IN malformation/NN in/IN children/NNS born/JJ after/IN ICSI/NN is/VBZ not/RB increased/VBN there/RB is/VBZ an/DT increased/VBN risk/NN to/IN transmit/VB genetic/JJ abnormalities/NNS in/IN case/NN of/IN NOA/NN (/( such/JJ as/IN the/DT rate/NN of/IN sex/NN chromosome/NN ,/, or/CC microdeletions/NNS of/IN the/DT Y/NN chromosome/NN )/SYM and/CC in/IN case/NN of/IN congenital/JJ OA/NN (/( mutations/NNS of/IN the/DT cystic/NEWGENE fibrosis/NEWGENE gene/NEWGENE )/SYM ./.
@@85551683561 Mg2+/NN and/CC Mn2+/NN compete/VB for/IN binding/JJ sites/NNS ,/, with/IN the/DT former/JJ having/VBG lower/JJR affinity/NN ./.
@@21028237727 Promoter/NNS activities/NNS were/VBD estimated/VBN using/VBG beta-glucuronidase/NEWGENE and/CC neomycin/NEWGENE phosphotransferase/NEWGENE II/NEWGENE reporter/NEWGENE gene/NEWGENE systems/NEWGENE ./.
@@36007054256 Timing/NN of/IN symptoms/NNS and/CC oocyst/NN excretion/NN in/IN human/JJ cryptosporidiosis/NN ./.
@@75373622471 In/NN vivo/NN association/NN between/IN Shb-SH3/NEWGENE domain/NEWGENE proteins/NNS v-Src/NEWGENE and/CC Eps8/NEWGENE was/VBD detected/VBN by/IN coimmunoprecipitation/NN ./.
@@83341586836 The/DT first/JJ gene/NN codes/NNS for/IN a/DT protein/NN containing/NN 11/NN cystein/NN residues/NNS in/IN an/DT arrangement/NN typical/JJ for/IN Fe/NEWGENE //NEWGENE S/NEWGENE proteins/NEWGENE ./.
@@13011715891 In/NN 7/CD of/IN 9/CD cases/NNS ,/, the/DT enhancer/NN is/VBZ fused/VBN to/IN the/DT c-myc/NEWGENE bearing/NEWGENE sequences/NEWGENE of/IN chromosome/NN 8/CD ./CD
@@94202395571 The/DT critical/JJ mutations/NNS were/VBD likely/RB to/IN have/NN been/VBN multiple/JJ and/CC dispersed/VBN ,/, including/JJ elongation/NN of/IN the/DT TM/NEWGENE and/CC Nef/NEWGENE coding/NEWGENE sequences/NEWGENE ;/: changes/NNS in/IN RNA/NN splice/NN donor/NN and/CC acceptor/NN sites/NNS ,/, TATA/NN box/NN sites/NN ,/, and/CC Sp1/NEWGENE sites/NEWGENE ;/: multiple/JJ changes/NNS in/IN the/DT V2/NEWGENE region/NEWGENE of/IN SU/NEWGENE ,/, including/JJ a/DT consensus/NN neutralization/NN epitope/NN ;/: and/CC five/CD new/JJ N-linked/NN glycosylation/NN sites/NN in/IN SU/NEWGENE ./.
@@95800624104 These/DT patients/NNS failed/VBN to/IN respond/NN to/IN intravenous/JJ cyclophosphamide/NN and/CC steroids/NNS and/CC were/VBD then/RB changed/VBN to/IN receive/VB oral/JJ cyclosporine/NN A/NN ,/, at/IN a/DT dose/NN of/IN 5/CD mg/NN //NN kg/NN //NN day/NN ./.
@@76547122353 The/DT yeast/NN enzyme/NN was/VBD 6-fold/CD slower/JJR than/IN the/DT mammalian/JJ enzymes/NNS ,/, which/WDT made/VBP it/PRP amenable/JJ to/IN pre-steady-state/JJ stopped-flow/JJ spectroscopic/JJ kinetic/JJ analysis/NN at/IN 30/CD degrees/NNS C/NN and/CC pH/NN 6/CD ./CD 0/CD ./.
@@86436337013 Each/DT immunoprecipitate/NN contained/VBD a/DT complex/NN of/IN N1/NEWGENE (/NEWGENE deltaEC/NEWGENE )/NEWGENE and/CC CBF1/NEWGENE ./.
@@60725125892 In/NN vitro/FW evaluation/NN of/IN the/DT mucolytic/JJ action/NN of/IN urea/NN ./.
@@9754571597 The/DT hBRAG/NEWGENE gene/NEWGENE was/VBD localized/VBN to/IN the/DT long/JJ arm/NN of/IN chromosome/NN 10/CD (/( 10q26/CD )/SYM ./.
@@2391699857 Dopamine/NEWGENE receptor/NEWGENE blockade/NN and/CC the/DT neuroleptics/NNS ,/, a/DT crystallographic/JJ study/NN ./.
@@18992876700 Expression/NNS was/VBD cell/NN cycle/NN controlled/VBN ,/, with/IN steady-state/JJ RNA/NN levels/NNS significantly/RB higher/JJ in/IN growth-arrested/JJ than/IN in/IN growth-stimulated/JJ cells/NNS ./.
@@81718141 Pharmacologic/NNP aspects/NNS of/IN neonatal/JJ hyperbilirubinemia/NN ./.
@@11113822947 Of/IN the/DT 21/CD quadrants/NNS positive/JJ in/IN the/DT controls/NNS ,/, 17/CD were/VBD correlated/VBN with/IN previously/RB detected/VBN jaw/NN pathoses/NNS ./.
@@110697882655 In/NN 15/CD ventilator-dependent/JJ ,/, SB/NN ,/, and/CC actively/RB expiring/VBG patients/NNS ,/, we/PRP found/VBP that/IN the/DT difference/NN PEEP/NN (/NN i/NN )/NN ,/NN dyn/NN -/: Pga/NN ,/, total/JJ decay/NN (/( mean/JJ +/NN //NN -/NN SD/NN ,/, 5/NN ./NN 7/NN +/NN //NN -/NN 1/CD ./CD 9/CD cm/NN H/NN (/NN 2/NN )/NN O/NN )/NN was/VBD quite/RB similar/JJ to/IN PEEP/NN (/NN i/NN )/NN ,/NN dyn/NN ref/NN (/( 5/CD ./CD 3/CD +/NN //NN -/NN 1/CD ./CD 9/CD cm/NN H/NN (/NN 2/NN )/NN O/NN )/NN ./.
@@111469612706 Perfusion/NNS technique/NN for/IN perfusion-assisted/JJ direct/JJ coronary/JJ artery/NN bypass/NN (/( PADCAB/NN )/SYM ./.
@@65076296300 By/IN contrast/NN ,/, kidneys/NNS from/IN rats/NNS with/IN chronic/JJ metabolic/JJ acidosis/NN produced/VBN significantly/RB more/RB NH3/NN than/IN both/PDT these/DT groups/NNS (/( 2/CD ./CD 73/CD +/NN //NN -/NN 0/CD ./CD 29/CD mumol/NN X/NN min-1/NN X/NN g-1/NN )/SYM ./.
@@102070927168 This/DT phosphorylation/NN can/MD be/VB catalyzed/VBN by/IN a/DT break-ended/JJ double-stranded/JJ DNA-activated/NN protein/NEWGENE kinase/NEWGENE activity/NN from/IN the/DT sea/NN urchin/NN nucleus/NN in/IN vitro/FW ./.
@@100248826761 In/NN addition/NN ,/, we/PRP also/RB show/VBP that/IN cdk7/NEWGENE may/MD phosphorylate/VB the/DT carboxy-terminal/JJ domain/NN (/( CTD/NN )/SYM of/IN RNA/NEWGENE pol/NEWGENE II/NEWGENE in/IN the/DT absence/NN of/IN promoter/NN opening/NN ./.
@@3180595861 Delayed/JJ gallbladder/NN visualization/NN and/CC reduction/NN in/IN ejection/NN fraction/NN were/VBD sensitive/JJ but/CC nonspecific/NN indicators/NN of/IN biliary/JJ disease/NN ./.
@@116032711495 Managing/NNP vertigo/NN and/CC vertigo/NN syndromes/NNS in/IN the/DT elderly/JJ
@@1974550188 After/IN base-line/NN CBF/NN was/VBD established/VBN ,/, hexamethonium/NN bromide/NN (/( 2/CD mg/CD //CD kg/CD iv/NN )/SYM ,/, ipratropium/NN bromide/NN (/( 0/CD ./CD 5/CD microgram/NN //NN kg/NN iv/NN )/SYM ,/, indomethacin/NN (/( 2/CD mg/CD //CD kg/CD iv/NN )/SYM ,/, or/CC intravenous/JJ 0/CD ./CD 9%/CD saline/NN was/VBD administered/VBN ./.
@@98572656980 Mean/VB intake/NN of/IN vitamin/NN A/DT amounted/VBN to/IN 1/CD ./CD 1/CD and/CC 0/CD ./CD 9/CD mg/NN RE/NN //NN day/NN for/IN men/NNS and/CC women/NNS ,/, respectively/RB ;/: the/DT contributions/NNS of/IN meat/NN ,/, fats/NNS and/CC oils/NNS ,/, vegetables/NNS and/CC dairy/NN products/NNS to/IN total/JJ intake/NN were/VBD 35%/JJ ,/, 24%/JJ ,/, 16%/JJ ,/, and/CC 16%/JJ ,/, respectively/RB ./.
@@38118524473 The/DT risk/NN for/IN these/DT complications/NNS is/VBZ increased/VBN by/IN the/DT following/NN factors/NNS :/: multiple/JJ gestation/NN ,/, the/DT combination/NN of/IN magnesium/NN sulfate/NN and/CC beta-adrenergic/NN agonist/NN ,/, and/CC the/DT use/NN of/IN adrenocortico-steroids/NNS to/IN hasten/VB fetal/JJ pulmonary/JJ maturity/NN ./.
@@31274634650 Human/NEWGENE rIL-3/NEWGENE expressed/VBN in/IN COS7/NNP cells/NNS has/VBZ multipotential/JJ CSF/NEWGENE activity/NN in/IN semisolid/JJ cultures/NNS of/IN bone/NN marrow/NN cells/NNS ,/, and/CC selectively/RB induced/VBN the/DT proliferation/NN of/IN My-10+/NNP marrow/NN or/CC cord/NN blood/NN cells/NNS in/IN liquid/JJ cultures/NNS ./.
@@92425512122 EBER1/NEWGENE mRNA/NEWGENE ,/, a/DT consistent/JJ marker/NN of/IN viral/JJ latency/NN ,/, was/VBD positive/JJ in/IN all/DT PEL/JJ cases/NNS ,/, although/IN at/IN lower/JJR levels/NNS than/IN in/IN the/DT non-PEL/JJ controls/NNS due/NN to/IN EBER1/NEWGENE expression/NN by/IN only/RB a/DT variable/JJ subset/NN of/IN lymphoma/NN cells/NNS ./.
@@77595296206 We/PRP used/VBD two/JJ approaches/NNS to/IN ascertain/VB whether/IN CDP/NEWGENE //NEWGENE cut/NEWGENE serves/VBP as/IN a/DT repressor/NN of/IN gp91-phox/NEWGENE gene/NEWGENE expression/NN ./.
@@75072078417 Interestingly/RB ,/, one/PRP IRF/NEWGENE binding/NEWGENE site/NEWGENE was/VBD found/VBN within/IN the/DT IRF-2/NEWGENE promoter/NEWGENE ,/, and/CC expression/NN of/IN the/DT IRF-2/NEWGENE gene/NEWGENE was/VBD affected/VBN by/IN both/DT transient/JJ and/CC stable/JJ IRF-1/NEWGENE expression/NN ./.
@@18850061346 The/DT domains/NNS involved/VBN in/IN superactivation/NN appear/VB to/IN be/VB a/DT subset/NN of/IN those/DT necessary/JJ to/IN achieve/VB synergistic/JJ activation/NN ./.
@@86151838589 Effects/NNPS of/IN posteroventral/JJ pallidotomy/NN on/IN Parkinson's/NNP disease/NN ./.
@@91533196710 We/PRP also/RB demonstrate/VBP that/IN preformed/JJ triplexes/NNS are/VBP quite/RB stable/JJ when/CC precipitated/VBN with/IN ethanol/NN and/CC resuspended/VBN in/IN water/NN ./.
@@93729245947 Furthermore/RB ,/, both/DT rhHR23/NEWGENE proteins/NEWGENE function/NN in/IN a/DT defined/VBN NER/NNS system/NN reconstituted/VBN with/IN purified/VBN proteins/NNS ,/, indicating/VBG direct/JJ involvement/NN of/IN hHR23/NEWGENE proteins/NEWGENE in/IN the/DT DNA/NN repair/NN reaction/NN via/NN interaction/NN with/IN XPC/NEWGENE ./.
@@77388567685 2/CD ./CD
@@65410196328 All/DT patients/NNS were/VBD evaluable/JJ for/IN toxicity/NN and/CC 9/CD for/IN response/NN ./.
@@10970048249 It/PRP was/VBD found/VBN that/DT increase/NN in/IN the/DT RH/NN level/NN boosts/VBZ the/DT current/JJ values/NNS by/IN 2-3/CD orders/NNS of/IN magnitude/NN ;/: contrariwise/NN ,/, the/DT voltage/NN values/NNS rise/NN by/IN about/RB three/CD times/NNS with/IN drop/NN in/IN the/DT RH/NN ./NN
@@88313648851 Both/DT verapamil/NN and/CC propranolol/NN can/MD exhibit/VB additive/JJ effects/NNS with/IN adenosine/NN in/IN prolonging/JJ AV/NN nodal/NN conduction/NN time/NN ;/: however/RB ,/, only/JJ verapamil/NN can/MD reduce/VB the/DT dose/NN of/IN adenosine/NN required/VBN to/IN produce/NN AV/NN nodal/NN block/NN ./.
@@106171441003 The/DT extents/NNS of/IN phosphorylation/NN of/IN Ser44/NN and/CC Ser64/NN were/VBD 1/CD :/: 1/CD ,/, whereas/IN those/DT of/IN the/DT four/CD minor/JJ sites/NNS all/DT together/RB were/VBD </SYM 30%/CD of/IN the/DT major/JJ one/PRP ./.
@@27777976346 DNA/NN blot/NN hybridization/NN suggests/VBZ that/IN the/DT rat/NN genome/NN may/MD contain/VB more/RB than/IN one/PRP gene/NN encoding/VBG PtdIns/NEWGENE transfer/NEWGENE protein/NEWGENE ./.
@@7836471213 The/DT deduced/VBN protein/NN sequence/NN was/VBD 88%/JJ homologous/JJ to/IN that/DT of/IN hNUC/NEWGENE I/NEWGENE ,/, isolated/VBN from/IN human/JJ osteosarcoma/NN cells/NNS ./.
@@29666713678 The/DT experimental/JJ end/NN points/NNS were/VBD the/DT time/NN required/VBN for/IN treated/VBN tumors/NNS to/IN reach/NN 3/CD times/NNS their/PRP treatment/NN size/NN ,/, the/DT survival/NN of/IN stem/NN cells/NNS in/IN the/DT duodenal/JJ crypts/NNS ,/, and/CC the/DT breathing/JJ rate/NN measured/VBD early/JJ (/( 19-23/CD weeks/NNS )/SYM and/CC late/JJ (/( 41-46/JJ weeks/NNS )/SYM after/IN treatment/NN ./.
@@111582886212 Recruitment/NNS of/IN an/DT RNA/NEWGENE polymerase/NEWGENE II/NEWGENE complex/NEWGENE is/VBZ mediated/JJ by/IN the/DT constitutive/JJ activation/NN domain/NN in/IN CREB/NEWGENE ,/, independently/RB of/IN CREB/NEWGENE phosphorylation/NN ./.
@@105949038405 The/DT potential/NN for/IN highly/RB reactive/VBP nanoparticles/NNS (/( RNP/NN )/SYM to/IN absorb/VB destructively/RB ,/, i/NN ./NN e/NN ./. to/IN neutralize/VB highly/RB toxic/JJ substances/NNS such/JJ as/IN the/DT warfare/NN agents/NNS GA/NN ,/, GB/NN ,/, HD/NN and/CC VX/NN ,/, has/VBZ been/VBN demonstrated/VBN in/IN the/DT laboratory/NN ./.
@@117181971559 The/DT procedure/NN is/VBZ less/PRP aggressive/JJ and/CC painful/JJ than/IN sternotomy/NN ./.
@@8621384731 Treatment/NNP of/IN keratinocytes/NNS expressing/JJ a/DT normal/JJ epidermal/NEWGENE growth/NEWGENE factor/NEWGENE receptor/NEWGENE (/( EGFR/NEWGENE )/SYM with/IN TGFalpha/NEWGENE or/CC epidermal/NEWGENE growth/NEWGENE factor/NEWGENE for/IN 5/CD min/NN induced/VBN PKCdelta/NEWGENE tyrosine/NN phosphorylation/NN ./.
@@1596002186 SV/NN increased/VBN less/PRP in/IN SHR/NN ,/, mainly/RB reflecting/JJ the/DT reduced/VBN diastolic/JJ compliance/NN of/IN the/DT hypertrophied/JJ SHR/NN left/NN ventricle/NN and/CC the/DT consequent/JJ rightward/JJ shift/NN of/IN its/PRP Frank-Starling/JJ curve/NN ./.
@@17256229808 The/DT first/JJ transfusion/NN resulted/VBN in/IN a/DT platelet/NN increment/NN to/IN 32/CD Gpt/NN //NN l/NN (/( CCI/NN 11/NN )/SYM ./.
@@97951701386 We/PRP also/RB mapped/VBD a/DT 3'-polyadenylation/NN site/NN 504bp/NN downstream/RB of/IN the/DT TGA/NN stop/NN codon/NN ,/, consistent/JJ with/IN the/DT 2/NN ./NN 5kb/NN transcript/NN size/NN ./.
@@8420995921 265/CD ,/, 1102-1110/NN )/NN ./.
@@112223878451 As/IN an/DT oral/NN ,/, nontoxic/JJ compound/NN with/IN a/DT mechanism/NN of/IN action/NN distinct/JJ from/IN that/DT of/IN ABL/NEWGENE tyrosine/NEWGENE kinase/NEWGENE inhibition/NN ,/, FTI/NN SCH66336/NN shows/VBZ promise/VB for/IN the/DT treatment/NN of/IN BCR/JJ //JJ ABL-induced/JJ leukemia/NN ./.
@@89155598876 REM/NN sleep/NN deprivation/NN was/VBD performed/VBN using/VBG the/DT platform/NN technique/NN ./.
@@97568953275 Genomic/NN locus/NN of/IN chCTCF/NEWGENE contains/VBZ a/DT GC-rich/NNP untranslated/JJ exon/NN separated/VBN from/IN seven/JJ coding/JJ exons/NNS by/IN a/DT long/JJ intron/NN ./.
@@10074135974 Primary/JJ and/CC secondary/JJ structural/JJ elements/NNS required/VBN for/IN synthesis/NN of/IN barley/NN yellow/JJ dwarf/NN virus/NN subgenomic/JJ RNA1/NN ./.
@@118769372996 Heparin/NNS (/( 100/CD Ucenter/NNP dotkg/NN (/NN minus/NN sign1/NN )/NN center/NN dotday/NN (/NN minus/NN sign1/NN )/NN )/NN was/VBD injected/VBN subcutaneously/RB to/IN the/DT rats/NNS in/IN H/NN group/NN while/CC normal/JJ saline/NN to/IN those/DT in/NN N/JJ group/NN once/CC a/DT day/NN ./.
@@10628748935 Deletion/NNS and/CC site-directed/JJ mutagenesis/NN localized/VBN a/DT novel/JJ SF-1/NEWGENE regulatory/NEWGENE element/NEWGENE (/( TCA/NEWGENE GGGCCA/NEWGENE ;/: -137/CD to/IN -129/CD )/SYM adjacent/JJ to/IN a/DT variant/NN cAMP-response/NEWGENE element/NEWGENE (/( CRE/NEWGENE ;/: -120/CD to/IN -114/CD )/SYM ./.
@@88548446455 If/IN we/PRP apply/VBP the/DT finding/NN of/IN non-visualization/NN of/IN the/DT GB/NN at/IN 4/CD h/NN post/JJ injection/NN as/IN the/DT criterion/NN for/IN the/DT diagnosis/NN of/IN AC/NN ,/, the/DT diagnostic/JJ accuracy/NN was/VBD only/RB 40/CD ./CD 7%/CD (/( 11/CD //CD 27/CD )/SYM ./.
@@104831242099 Regional/NNP insertional/JJ mutagenesis/NN of/IN specific/JJ genes/NNS on/IN the/DT CIC5F11/NEWGENE //NEWGENE CIC2B9/NEWGENE locus/NEWGENE of/IN Arabidopsis/NN thaliana/NN chromosome/NN 5/CD using/VBG the/DT Ac/NEWGENE //NEWGENE Ds/NEWGENE transposon/NEWGENE in/IN combination/NN with/IN the/DT cDNA/NN scanning/JJ method/NN ./.
@@113689142102 Two/CD remotely/RB situated/VBN exons/NNS within/IN the/DT complement/NEWGENE C3/NEWGENE gene/NN locus/NN encode/VB an/DT alternate/JJ 5'/CD end/NN and/CC proximal/JJ ORF/NN under/IN the/DT control/NN of/IN a/DT bidirectional/JJ promoter/NN ./.
@@2183467953 Three/CD of/IN the/DT short/JJ ORFs/NNS in/IN the/DT central/JJ region/NN of/IN BIV/NN have/NN been/VBN identified/VBN by/IN location/NN and/CC structural/JJ similarity/NN to/IN the/DT nonstructural/NN //NN regulatory/NN genes/NN (/( vif/NEWGENE ,/, tat/NEWGENE ,/, and/CC rev/NEWGENE )/SYM of/IN other/DT lentiviruses/NNS ;/: we/PRP also/RB discovered/VBD two/JJ unique/JJ ORFs/NNS ,/, termed/JJ W/NEWGENE and/CC Y/NEWGENE ,/, which/WDT may/MD serve/VB as/IN exons/NNS for/IN novel/JJ genes/NNS ./.
@@99346119931 This/DT dependence/NN ,/, however/RB ,/, can/MD be/VB overcome/VB to/IN a/DT large/JJ extent/NN by/IN dividing/JJ min/NN LVdP/NNP //NNP dt/NNP by/IN mean/JJ aortic/JJ pressure/NN ./.
@@3787359833 A/DT randomized/JJ clinical/JJ trial/NN in/IN sixty-two/NN adult/JJ patients/NNS suffering/VBG from/IN typhoid/JJ fever/NN ,/, proved/VBN by/IN blood/NN and/CC marrow/NN culture/NN ,/, showed/VBD that/DT amoxycillin/NN in/IN a/DT dosage/NN schedule/NN of/IN 1/CD g/NN 8-hourly/JJ orally/RB for/IN fourteen/CD days/NNS was/VBD better/JJR than/IN chloramphenicol/NN with/IN regard/NN to/IN clinical/JJ and/CC temperature/NN response/NN and/CC in/IN respect/NN of/IN carriers/NNS and/CC relapse/NN rates/NNS ./.
@@4457209687 The/DT systolic/JJ pressure/NN gradient/NN (/( SPG/NN )/SYM between/IN the/DT left/NN ventricle/NN (/( LV/JJ )/SYM and/CC left/NN atrium/NN (/( LA/NN )/SYM was/VBD obtained/VBN from/IN high-fidelity/NN pressure/NN transducers/NNS ./.
@@11157334998 Serum/NEWGENE PTH/NEWGENE tended/VBN to/IN increase/NN in/IN the/DT WL/NN group/NN but/CC not/RB in/IN the/DT WM/NN group/NN (/( P/NN </SYM 0/CD ./CD 06/CD )/SYM ./.
@@84132237541 When/WRB multiple/JJ copies/NNS of/IN the/DT IL-1/NEWGENE beta/NEWGENE NF-kappa/NEWGENE1 B/NEWGENE1 site/NEWGENE1 were/VBD linked/JJ to/IN an/DT enhancerless/JJ simian/JJ virus/NN 40/CD promoter/NN ,/, this/DT element/NN was/VBD able/JJ to/IN mediate/VB phorbol/NN ester-/JJ or/CC lipopolysaccharide-inducible/JJ gene/NN expression/NN ./.
@@86497734899 The/DT ability/NN of/IN BCL-6/NEWGENE to/RB function/NN as/IN a/DT transcriptional/JJ repressor/NN may/MD contribute/VB to/IN its/PRP ability/NN to/IN transform/VB B/NNP lymphocytes/NNS in/IN diffuse/JJ large/JJ cell/NN lymphoma/NN ./.
@@83908318354 Recipients/NNS with/IN acute/JJ leukaemia/NN in/IN first/JJ remission/NN or/CC chronic/JJ myeloid/JJ leukaemia/NN in/IN first/JJ chronic/JJ phase/NN were/VBD analysed/VBN as/IN good/JJ risk/NN ,/, and/CC those/DT beyond/RB these/DT stages/NNS ,/, as/IN poor/JJ risk/NN patients/NNS ./.
@@96490699620 It/PRP can/MD also/RB be/VB used/VBN to/IN examine/VB various/JJ laryngeal/JJ parameters/NNS obtained/VBN from/IN videotaped/VBN endoscopic/JJ and/CC stroboscopic/JJ examinations/NNS ./.
@@38416274515 Chemotherapy/NNS of/IN metastasizing/JJ breast/NN cancer/NN ./.
@@68164426598 Diagnostic/NNP value/NN of/IN serum/NEWGENE myoglobin/NEWGENE in/IN cases/NNS of/IN neuromuscular/JJ disease/NN ./.
@@96288909783 We/PRP found/VBP the/DT following/NN :/: Specific/JJ mutations/NNS affected/VBD the/DT precise/JJ carbohydrate/NN structure/NN and/CC folding/NN of/IN the/DT HA/NEWGENE trimer/NEWGENE ./.
@@7563994159 The/DT patients/NNS undergoing/VBG VTLB/NN had/VBP significantly/RB shorter/RBR operative/JJ times/NNS (/( VTLB/NN ,/, 100/NN ./NN 2/NN +/NN //NN -/NN 27/CD ./CD 2/CD min/NN ./. vs/NNP OLB/NN ,/, 119/NN ./NN 8/NN +/NN //NN -/NN 42/CD ./CD 6/CD min/NN ;/: p/NN </SYM 0/CD ./CD 01/CD )/SYM and/CC less/PRP blood/NN loss/NN (/( VTLB/NN ,/, 4/NN ./NN 7/NN +/NN //NN -/NN 14/CD ./CD 6/CD ml/NN vs/NNP OLB/NN ,/, 65/NN ./NN 7/NN +/NN //NN -/NN 77/CD ./CD 0/CD ml/NN ;/: p/NN </SYM 0/CD ./CD 001/CD )/SYM ./.
@@107612633941 The/DT 'Newcastle'/NN model/NN ,/, which/WDT is/VBZ based/VBN on/IN Hotelling's/NNP T2/NN statistic/NN ,/, proved/VBN to/IN be/VB more/RB sensitive/JJ and/CC diagnosed/VBD a/DT systematic/JJ displacement/NN for/IN three/CD prostate/NN patients/NNS ./.
@@14324532054 Validation/NNS of/IN automated/JJ systems--system/JJ definition/NN ./.
@@77450081682 Radioligand/NN binding/NN was/VBD indistinguishable/JJ for/IN both/DT transiently/RB expressed/VBN constructs/NNS ./.
@@62703477777 A/DT 22K/CD polypeptide/NN was/VBD detected/VBN as/IN a/DT translation/NN product/NN of/IN late/JJ RNA/NN that/IN hybridized/VBN to/IN this/DT DNA/NN fragment/NN ./.
@@55328545579 Gastrointestinal/JJ manifestations/NNS of/IN systemic/JJ sclerosis/NN ./.
@@84132057167 Transient/JJ transfection/NN experiments/NNS revealed/VBN that/IN Pax-8/NEWGENE isoforms/NEWGENE a/NEWGENE and/NEWGENE b/NEWGENE ,/, but/CC not/RB c/NN and/CC d/NN ,/, strongly/RB stimulate/VB transcription/NN from/IN a/DT promoter/NN containing/JJ six/CD copies/NNS of/IN a/DT paired-domain/NEWGENE recognition/NEWGENE sequence/NEWGENE ./.
@@115194661395 Low-selenium/NN diet/NN has/VBZ a/DT human/JJ unfavourable/NN impact/NN ./.
@@107795085552 In/NN DNase/NEWGENE I/NEWGENE footprinting/VBG protection/NN analysis/NN ,/, both/DT SFRE/NEWGENE and/CC ERE/NEWGENE regions/NEWGENE were/VBD protected/VBN by/IN glutathione/NEWGENE S-transferase-ERRalpha1/NEWGENE fusion/NEWGENE protein/NEWGENE ./.
@@10616948871 In/NN the/DT BF/NN ECT/NN group/NN the-age/NN based/VBD dose/NN would/MD have/VB been/VBN similarly/RB dependent/JJ on/IN the/DT initial/JJ seizure/NN threshold/NN level/NN ./.
@@117892063258 CONCLUSIONS/IN :/: The/DT mechanism/NN of/IN MIRI/NN is/VBZ Qi/VBG deficiency/NN and/CC blood/NN stasis/NN in/IN TCM/NN ,/, its/PRP treating/JJ principles/NNS should/MD be/VB promoting/NN Qi/NN and/CC removing/JJ the/DT blood/NN stasis/NN ./.
@@8417117707 Instead/RB ,/, mRNA/NN of/IN 2/CD ./CD 0/CD and/CC 2/CD ./CD 8/CD kb/NN are/VBP detected/VBN in/IN varying/JJ abundance/NN ./.
@@86370063489 Transcription/NNS from/IN adenovirus/NEWGENE E2-early/NEWGENE promoter/NEWGENE is/VBZ controlled/VBN by/IN a/DT unique/JJ array/NN of/IN four/CD cis-acting/JJ elements/NNS which/WDT include/VBP an/DT atypical/JJ TBP/NEWGENE site/NEWGENE ,/, two/JJ E2F/NEWGENE sites/NEWGENE present/VBP in/IN an/DT inverted/JJ orientation/NN relative/JJ to/IN each/DT other/DT ,/, and/CC an/DT ATF/NEWGENE site/NEWGENE ./.
@@90910109041 Three/CD women/NNS have/VBP had/VBP abnormal/JJ endocervical/JJ follow/VB up/RP cytology/NN suggestive/JJ of/IN residual/JJ disease/NN ./.
@@13980984633 Clone/NN pSRc200/NN hybrid/RB selected/VBN an/DT mRNA/NN that/IN on/IN cell-free/JJ translation/NN produced/VBD a/DT 38-kDa/JJ polypeptide/NN ./.
@@22095401638 More/RBR generally/RB ,/, Ets1/NEWGENE and/CC Ets2/NEWGENE could/MD regulate/VB transcription/NN of/IN cellular/JJ genes/NNS ./.
@@20047055036 The/DT cdr1/NEWGENE sequence/NEWGENE includes/VBZ an/DT additional/JJ 237/CD amino/JJ acids/NNS of/IN the/DT contiguous/JJ fragment/NN and/CC encodes/VBZ a/DT product/NN of/IN predicted/VBN Mr/NNP 67/CD ,/CD 000/CD ./.
@@34848944907 In/NN 14/CD cases/NNS ,/, isolates/NNS were/VBD biotyped/VBN yielding/VBG eight/CD with/IN biotype/NN II/NN ,/, four/CD with/IN biotype/NN III/NN ,/, and/CC one/PRP each/DT with/IN biotypes/NNS IV/NN and/CC V/NNP ./NNP
@@17631062364 In/NN one/PRP ,/, exploratory/JJ behavior/NN (/( assessed/VBN by/IN hole/NN pokes/NNS )/SYM and/CC locomotion/NN were/VBD assessed/VBN during/IN a/DT 10-min/JJ test/NN session/NN ./.
@@75419124053 Sequence/NN analysis/NN of/IN these/DT regions/NNS showed/VBD a/DT CAAT/NN box/NN upstream/RB of/IN exon/NN 1a/CD and/CC high/JJ G-C/NN content/NN regions/NNS within/IN both/DT P1/NEWGENE and/CC P2/NEWGENE ./.
@@5244515434 Both/DT reduced/VBN spontaneous/JJ locomotor/JJ activity/NN in/IN mice/NNS ,/, protected/VBD them/PRP from/IN death/NN from/IN amphetamine/NN induced/VBD toxicity/NN ,/, prolonged/JJ hexobarbitone/NN sleeping/JJ time/NN and/CC caused/VBD a/DT depletion/NN of/IN catecholamines/NNS from/IN various/JJ organs/NNS of/IN the/DT rat/NN ./.
@@100262118835 This/DT construct/NN ,/, termed/JJ pDeltaCREC/NEWGENE //NEWGENE EBP/NEWGENE ,/, binds/VBZ C/NEWGENE //NEWGENE EBPalpha/NEWGENE and/NEWGENE beta/NEWGENE but/CC not/RB CREB/NEWGENE ,/, yet/RB it/PRP confers/VBZ a/DT nearly/RB complete/JJ glucocorticoid/NN response/NN when/CC transiently/RB transfected/VBN into/IN H4IIE/NNP rat/NN hepatoma/NN cells/NNS ./.
@@111582908416 The/DT region/NN containing/JJ both/DT serines/NNS is/VBZ homologous/JJ to/IN the/DT N-terminal/NN destruction/NN box/NN of/IN IkappaBalpha/NEWGENE ,/NEWGENE -beta/NEWGENE ,/NEWGENE and/NEWGENE -epsilon/NEWGENE ./.
@@19548351046 Echinococcus/NNS granulosus/NN was/VBD diagnosed/VBN by/IN fine-needle/NN aspiration/NN cytology/NN of/IN a/DT lung/NN cyst/NN in/IN a/DT 6-yr-old/CD white/JJ female/NN in/IN central/JJ Missouri/NN ./.
@@108909119426 Herein/IN ,/, we/PRP show/VBP that/IN Smad3/NEWGENE physically/RB interacts/VBZ with/IN the/DT HMG/NEWGENE box/NEWGENE domain/NEWGENE of/IN LEF1/NEWGENE and/CC that/DT TGFbeta/NEWGENE and/CC Wnt/NEWGENE pathways/NEWGENE synergize/VBP to/IN activate/VB transcription/NN of/IN the/DT Xenopus/NEWGENE homeobox/NEWGENE gene/NEWGENE twin/NEWGENE1 (/( Xtwn/NEWGENE )/SYM ./.
@@55009575572 The/DT association/NN of/IN clopamide/NN and/CC hydergine/NN (/( Brinedine/NNP )/SYM in/IN the/DT treatment/NN of/IN the/DT vasculo-renal/JJ syndromes/NNS of/IN pregnancy/NN ./.
@@110498896107 Thromboelastography/NN is/VBZ a/DT test/NN that/WDT could/MD potentially/RB correlate/VB with/IN the/DT degree/NN of/IN anticoagulation/NN produced/VBN by/IN low/JJ molecular/JJ weight/NN heparin/NN ./.
@@114156331282 Using/VBG the/DT postural/JJ and/CC force/NN data/NN as/IN input/NN to/IN a/DT 3-D/JJ biomechanical/JJ model/NN ,/, the/DT lumbosacral/JJ spinal/JJ compression/NN was/VBD calculated/VBN ./.
@@81363838111 Within/IN 12/CD hours/NNS after/IN MR/NN tomography/NN the/DT patients/NNS were/VBD surgically/RB explored/VBN ,/, biopsied/VBN and/CC if/IN necessary/JJ orchiectomised/VBN ./.
@@113683632638 The/DT human/JJ protein/NN sequence/NN exhibits/VBP a/DT putative/JJ DNA-binding/NN domain/NN similar/JJ to/IN that/DT seen/VBP in/IN rat/NEWGENE HBP1/NEWGENE and/CC shows/VBZ homology/NN with/IN the/DT activation/NN and/CC repressor/NN domains/NNS previously/RB demonstrated/VBN in/IN the/DT rat/NN protein/NN ./.
@@78239515688 These/DT results/NNS demonstrate/VBP that/IN EKLF/NEWGENE provides/VBZ a/DT crucial/JJ transactivation/NN function/NN for/IN globin/NEWGENE expression/NN and/CC further/RB reinforce/VB the/DT idea/NN that/IN EKLF/NEWGENE is/VBZ an/DT important/JJ regulator/NN of/IN CACCC/NN element-directed/NN transcription/NN in/IN erythroid/JJ cells/NNS ./.
@@86828681911 Although/IN the/DT DSK2-1/NEWGENE mutation/NEWGENE alters/VBZ a/DT conserved/VBN residue/NN in/IN the/DT Dsk2p/NEWGENE ubiquitin-like/NEWGENE1 domain/NEWGENE1 ,/, we/PRP detect/VBP no/DT differences/NNS in/IN Dsk2p/NEWGENE or/CC Cdc31p/NEWGENE stability/NN ./.
@@299533296 Characteristics/NNS of/IN lipase/NEWGENE activity/NN ./.
@@107647296676 The/DT complete/JJ cDNA/NN sequence/NN of/IN human/NEWGENE betaV/NEWGENE spectrin/NEWGENE is/VBZ available/JJ from/RB GenBank/NN (/NN TM/NN )/NN as/IN accession/NN number/NN ./.
@@13781272684 Although/IN the/DT effects/NNS of/IN the/DT calcium/NN supplement/NN or/CC calcium/NN antagonist/NN alone/RB were/VBD significant/JJ ,/, such/JJ hypotensive/JJ responses/NNS were/VBD not/RB optimal/JJ or/CC predictable/JJ or/CC clearly/RB dose-dependent/VB ./.
@@82386268222 At/NN a/DT PaCO2/NN of/IN 40/CD mmHg/NN ,/, baseline/NN brain/NN pHi/NN measured/VBN 7/CD ./CD 03/CD +/NN //NN -/NN 0/CD ./CD 04/CD ,/, while/CC regional/JJ cortical/JJ blood/NN flow/NN was/VBD 47/CD ./CD 0/CD +/NN //NN -/NN 4/CD ./CD 3/CD ml/CD ./CD 100/CD g-1/CD ./CD min-1/CD ./.
@@25658071941 In/NN contrast/NN ,/, the/DT neu/NEWGENE proto-oncogene/NEWGENE did/VBD not/RB show/VB kinase/NN activity/NN or/CC transforming/JJ properties/NNS when/CC expressed/VBN at/IN similar/JJ levels/NNS in/IN NIH/NN 3T3/CD cells/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@76597467 The/DT CVA16/NEWGENE ./NEWGENE 4/NEWGENE proteolipid/NEWGENE transcript/NEWGENE is/VBZ the/DT most/JJ prevalent/NN of/IN the/DT two/JJ proteolipid/NN messages/NN in/IN expanding/JJ ovules/NNS harvested/VBN 10/CD d/NN post-anthesis/NN ./.
@@95473111236 Furthermore/RB ,/, interactions/NNS were/VBD identified/VBN between/IN endogenous/NEWGENE E-cadherin/NEWGENE and/CC the/DT chimera/NN containing/JJ the/DT E-cadherin/NEWGENE extracellular/NEWGENE domain/NEWGENE and/CC the/DT desmoglein/NEWGENE 1/NEWGENE intracellular/NEWGENE domain/NEWGENE providing/CC in/IN vivo/NN evidence/NN for/IN previously/RB predicted/VBN lateral/JJ interactions/NNS of/IN E-cadherin/NEWGENE extracellular/NEWGENE domains/NEWGENE ./.
@@31944104369 No/DT UOxase/NEWGENE mRNA/NEWGENE was/VBD detected/VBN in/IN 11/CD nonhepatic/JJ tissues/NNS of/IN rat/NN ,/, suggesting/VBG tissue/NN specificity/NN of/IN expression/NN of/IN this/DT UOxase/NEWGENE gene/NEWGENE ./.
@@98240219812 CONCLUSION/IN :/: We/PRP were/VBD unable/JJ to/IN identify/VB features/NNS of/IN disease/NN likely/RB to/IN be/VB associated/VBN with/IN a/DT clinically/RB useful/JJ response/NN to/IN inhaled/JJ NO/DT therapy/NN using/VBG the/DT parameters/NNS studied/VBN ./.
@@68692156667 High/NNP levels/NNS of/IN IC/NN coincided/VBN with/IN relative/JJ hypocomplementemia/NN ./.
@@94679002607 The/DT CAPLC1/NEWGENE protein/NEWGENE also/RB exhibited/VBD several/DT unique/JJ features/NNS ,/, including/JJ a/DT novel/JJ stretch/NN of/IN 18-19/CD amino/JJ acid/NN residues/NNS within/IN the/DT X/NEWGENE domain/NEWGENE and/CC an/DT unusually/RB long/JJ N-terminus/NN which/WDT did/VBD not/RB contain/VB a/DT recognizable/JJ EF-hand/NEWGENE Ca/NEWGENE (/NEWGENE 2+/NEWGENE )/NEWGENE -binding/NEWGENE domain/NEWGENE ./.
@@97566879745 Besides/IN the/DT characterization/NN and/CC discussion/NN of/IN the/DT experimental/JJ setup/NN used/VBN ,/, the/DT rate/NN constants/NNS obtained/VBN are/VBP discussed/VBN and/CC compared/VBN with/IN estimated/VBN values/NNS ./.
@@3911052380 We/PRP consider/VBP that/IN DIL-CP/NN is/VBZ a/DT safe/JJ and/CC excellent/JJ CP/NN in/IN CABG/NN surgery/NN and/CC we/PRP are/VBP now/RB utilizing/VBG this/DT CP/NN in/IN all/DT patients/NNS requiring/JJ CABG/NN surgery/NN ./.
@@22046219040 Isolation/NNS of/IN a/DT temperature-sensitive/JJ mutant/NN with/IN an/DT altered/VBN tRNA/NEWGENE nucleotidyltransferase/NEWGENE and/CC cloning/NN of/IN the/DT gene/NEWGENE encoding/NEWGENE tRNA/NEWGENE nucleotidyltransferase/NEWGENE in/NEWGENE the/NEWGENE yeast/NEWGENE Saccharomyces/NEWGENE cerevisiae/NEWGENE ./.
@@46542493177 Measurement/NNP of/IN open-loop/JJ responses/NNS to/IN electrical/JJ stimulation/NN in/IN olfactory/NN bulb/NN of/IN cat/NN ./.
@@84289527710 Finally/RB ,/, we/PRP present/VBP evidence/VBP that/DT fimbrin/NEWGENE is/VBZ a/DT third/RB distinct/JJ plastin/NEWGENE isoform/NEWGENE which/WDT is/VBZ specifically/RB expressed/VBN at/IN high/JJ levels/NNS in/IN the/DT small/JJ intestine/NN ./.
@@90988995289 The/DT UV/NN absorption/NN spectrum/NN revealed/VBD a/DT shoulder/NN at/IN 250/CD nm/NN ,/, characteristic/NN of/IN CysS-Cd/NN (/NN II/NN )/NN ligand-to-metal/JJ charge-transfer/JJ transitions/NNS ,/, and/CC the/DT difference/NN absorption/NN coefficient/NN after/IN acidification/NN (/( delta/NN epsilon/NN 248/NN ,/, 24/CD mM-1/NN cm-1/NN )/SYM indicated/VBN the/DT presence/NN of/IN a/DT Cd/NN (/NN Cys-S/NN )/NN 4/NN center/NN ./.
@@117069497624 Growth/NEWGENE hormone/NEWGENE and/CC insulin-like/NEWGENE growth/NEWGENE factor/NEWGENE I/NEWGENE receptors/NEWGENE in/IN the/DT temporomandibular/JJ joint/NN of/IN the/DT rat/NN ./.
@@17740931203 Adverse/JJ foetal/JJ outcome/NN in/IN specific/NN IgM/NEWGENE positive/JJ Chlamydia/NN trachomatis/JJ infection/NN in/IN pregnancy/NN ./.
@@107579838797 On/IN the/DT basis/NN of/IN size/NN ,/, the/DT CRS/NEWGENE sequence/NEWGENE to/IN which/WDT it/PRP binds/VBZ ,/, and/CC its/PRP tentative/JJ identification/NN as/IN a/DT zinc/NEWGENE finger/NEWGENE protein/NEWGENE ,/, Adx/NEWGENE factor/NEWGENE has/VBZ been/VBN identified/VBN as/IN a/DT Kruppel-like/NEWGENE zinc/NEWGENE finger/NEWGENE protein/NEWGENE (/( a/DT mouse/NEWGENE ZBP-89/NEWGENE homologue/NEWGENE )/SYM ./.
@@15889611451 STP1/NEWGENE is/VBZ an/DT unessential/JJ yeast/NN gene/NN involved/VBN in/IN the/DT removal/NN of/IN intervening/JJ sequences/NNS from/IN some/DT ,/, but/CC not/RB all/DT ,/, families/NNS of/IN intervening/JJ sequence-containing/NN pre-tRNAs/NN ./.
@@98540343095 The/DT downstream/RB ,/, TATA-less/NN promoter/NN has/VBZ high/JJ G+C/NN content/NN ,/, and/CC exon/NN 1b/NN predominates/VBZ among/IN abundantly/RB expressed/VBN mRNA/NN species/NN ./.
@@86216614185 Both/DT P5CDh/NEWGENE cDNA/NEWGENE clones/NNS detect/VBP a/DT single/JJ 3/CD ./CD 2-kb/CD transcript/NN on/IN Northern/NNP blots/NNS of/IN multiple/JJ human/JJ tissues/NNS ,/, indicating/VBG the/DT long/JJ cDNA/NN containing/JJ the/DT 3'-untranslated/JJ intron/NN represents/VBZ the/DT predominant/JJ transcript/NN ./.
@@21430237626 Although/IN there/RB are/VBP no/DT octamer/NN elements/NNS in/IN the/DT adenovirus/NN genome/NN that/WDT are/VBP known/VBP to/IN be/VB important/JJ for/IN transcription/NN ,/, there/RB are/VBP octamer/NN elements/NNS in/IN the/DT viral/JJ terminal/JJ repeat/NN sequences/NNS ./.
@@7806397781 Carcinoembryonic/NEWGENE antigen/NEWGENE (/( CEA/NEWGENE )/SYM procedures/NNS and/CC clinical/JJ evaluation/NN ./. pp/NNS ./NNS
@@109839794006 Functional/JJ recognition/NN of/IN 5'/CD splice/NN site/NN by/IN U4/NEWGENE //NEWGENE U6/NEWGENE ./NEWGENE U5/NEWGENE tri-snRNP/NEWGENE defines/VBZ a/DT novel/JJ ATP-dependent/JJ step/NN in/IN early/JJ spliceosome/NN assembly/NN ./.
@@82069912590 Acylation/NNS with/IN the/DT palmitate/NN analog/NN was/VBD prevented/VBN when/CC Gly-2/NN was/VBD mutated/JJ to/IN alanine/NN ,/, implying/VBG that/IN N-myristylation/NNS is/VBZ required/VBN for/IN palmitylation/JJ ,/, and/CC when/CC either/DT Cys-3/NN or/CC Cys-6/NN was/VBD mutated/JJ to/IN serine/NN ./.
@@3774662480 Follow-up/JJ controls/NNS of/IN luteinizing/NEWGENE hormone/NEWGENE (/( LH/NEWGENE )/SYM ,/, follicle/NEWGENE stimulating/NEWGENE hormone/NEWGENE (/( FSH/NEWGENE )/SYM ,/, prolactin/NEWGENE (/( HPRL/NEWGENE )/SYM ,/, oestradiol/NN (/( E2/NN )/SYM ,/, progesterone/NN (/( P/NN )/SYM and/CC testosterone/NN (/( T/NN )/SYM in/IN the/DT catabolic/JJ and/CC healing/NN phase/NN of/IN burn/NN disease/NN ./.
@@92354249193 Confirming/VBG measures/NNS made/VBP by/IN nurses/NNS and/CC additionally/RB ,/, ABPM/IN for/IN women/NNS ,/, seem/VB to/IN lessen/VB this/DT effect/NN ./.
@@63276388673 The/DT gene/NEWGENE cat-86/NEWGENE ,/, specifying/VBG chloramphenicol-inducible/NEWGENE chloramphenicol/NEWGENE acetyltransferase/NEWGENE ,/, is/VBZ located/VBN on/IN the/DT 1/CD ./CD 1-kilobase/CD cloned/VBN DNA/NN ./.
@@11576143852 Effects/NNPS of/IN perceptual/JJ salience/NN on/IN the/DT matrix/NN task/NN performance/NN of/IN four-/DT and/CC six-year-old/JJ children/NNS ./.
@@95798082765 UDP-GlcNAc/NEWGENE :/: alpha-6-D-mannoside/NEWGENE beta-1/NEWGENE ,/NEWGENE 2-N-acetylglucosaminyltransferase/NEWGENE II/NEWGENE (/( GnT/NEWGENE II/NEWGENE ;/: EC/NEWGENE 2/NEWGENE ./NEWGENE 4/NEWGENE ./NEWGENE 1/NEWGENE ./NEWGENE 143/NEWGENE )/SYM is/VBZ essential/JJ for/IN the/DT normal/JJ assembly/NN of/IN complex/NN Asn-linked/JJ glycans/NNS ./.
@@1549123490 The/DT MET4/NEWGENE gene/NN was/VBD cloned/VBN ,/, and/CC its/PRP sequence/NN reveals/VBZ that/IN it/PRP encodes/VBZ a/DT protein/NN related/VBN to/IN the/DT family/NN of/IN the/DT bZIP/NEWGENE transcriptional/NEWGENE activators/NEWGENE ./.
@@99157986010 This/DT region/NN of/IN hsp90/NEWGENE mediates/VBZ ATP-independent/NN chaperone/NEWGENE activity/NN ,/, overlaps/VBP the/DT hsp90/NEWGENE dimerization/NEWGENE domain/NEWGENE ,/, and/CC includes/VBZ structural/JJ elements/NNS important/JJ for/IN steroid/NEWGENE receptor/NEWGENE interaction/NN ./.
@@79180976532 The/DT novel/JJ Notch/NEWGENE homologue/NEWGENE mouse/NEWGENE1 Notch/NEWGENE1 3/NEWGENE1 lacks/VBZ specific/JJ epidermal/NEWGENE growth/NEWGENE factor-repeats/NEWGENE and/CC is/VBZ expressed/VBN in/IN proliferating/JJ neuroepithelium/NN ./.
@@8223613420 GGS1/NEWGENE is/VBZ the/DT same/JJ gene/NN as/IN TPS1/NEWGENE which/WDT was/VBD identified/VBN as/IN encoding/VBG a/DT subunit/NN of/IN the/DT trehalose-6-phosphate/NEWGENE synthase/NEWGENE //NEWGENE phosphatase/NEWGENE complex/NEWGENE and/CC it/PRP is/VBZ allelic/JJ to/IN the/DT fdp1/NEWGENE ,/, byp1/NEWGENE ,/, glc6/NEWGENE and/CC cif1/NN mutations/NN ./.
@@81456462272 Structure/NNS and/CC expression/NN of/IN the/DT alternative/JJ sigma/NN factor/NN ,/, RpoN/NEWGENE ,/, in/IN Rhodobacter/NN capsulatus/NN ;/: physiological/JJ relevance/NN of/IN an/DT autoactivated/JJ nifU2-rpoN/NEWGENE superoperon/NN ./.
@@52107915432 Pneumonia/NNS in/IN children/NNS ./.
@@30807932805 Statement/NN on/IN the/DT development/NN of/IN guidelines/NNS for/IN the/DT prevention/NN of/IN AIDS/NN transmission/NN in/IN the/DT workplace/NN ./.
@@104461495172 M-Ras/NEWGENE interacted/VBN poorly/RB in/IN a/DT yeast/NN two-hybrid/JJ assay/NN with/IN multiple/JJ Ras/NEWGENE effectors/NN ,/, including/JJ c-Raf-1/NEWGENE ,/, A-Raf/NEWGENE ,/, B-Raf/NEWGENE ,/, phosphoinositol-3/NEWGENE kinase/NEWGENE delta/NEWGENE ,/, RalGDS/NEWGENE ,/, and/CC Rin1/NEWGENE ./.
@@81039353016 Isolation/NNS and/CC characterization/NN of/IN SRF/NEWGENE accessory/NEWGENE proteins/NEWGENE ./.
@@99253725569 The/DT 3/CD ./CD 3-fold/CD higher/JJ expression/NN in/IN the/DT fetal/JJ heart/NN than/IN in/IN the/DT adult/JJ heart/NN suggests/VBZ that/IN HFHZ/NEWGENE mRNA/NEWGENE is/VBZ downregulated/VBN in/IN the/DT process/NN of/IN development/NN ./.
@@22236522858 On/IN an/DT antithrombin/NN unit/NN basis/NN ,/, CY/NN 216/NN and/CC CY/NN 222/NN were/VBD equivalent/JJ and/CC more/RB potent/JJ than/IN UH/NNP ./NNP
@@10214610155 Marked/JJ racial/JJ variation/NN in/IN birthweight/NN percentiles/NNS by/IN gestational/JJ age/NN was/VBD evident/JJ ./.
@@12174501861 2/CD -/: Chemical/NNP occlusion/NN of/IN vas/NN is/VBZ quite/RB effective/JJ in/IN producing/JJ a/DT block/NN in/IN the/DT vas/NN deferens/NN of/IN dogs/NNS ./.
@@33805474748 SPA/NN from/IN PAG/NN sites/NN was/VBD associated/VBN with/IN aversion/NN ./.
@@38354134513 The/DT observation/NN of/IN late/JJ effects/NNS after/IN irradiations/NNS or/CC after/IN space/NN flights/NNS show/VBP the/DT difficulties/NNS encountered/VBN in/IN assessing/JJ radiative/JJ risks/NNS during/IN long/JJ duration/NN space/NN flights/NNS ./.
@@68123891190 TEMTU/NN and/CC DPTU/NN were/VBD the/DT most/RB potent/JJ teratogens/NNS ./.
@@66745163367 An/DT intravenous/JJ drip/NN infusion/NN of/IN AMK/NN in/IN adequate/JJ dosage/NN would/MD be/VB beneficial/JJ to/IN use/NN against/IN some/DT infectious/JJ diseases/NNS of/IN otorhinolaryngologic/JJ field/NN ./.
@@10897973724 Antithrombin/NEWGENE III/NEWGENE deficiency/NN :/: when/CC substitute/NN ,/, when/CC heparin/NN ?/. Thrombosis/NNS ABC/NN ,/, 3/CD :/: The/DT role/NN of/IN antithrombin/NEWGENE III/NEWGENE ./.
@@18768365040 Identification/NNP of/IN Ets-/NEWGENE and/NEWGENE notch-related/NEWGENE subunits/NEWGENE in/IN GA/NEWGENE binding/NEWGENE protein/NEWGENE ./.
@@4255477998 40/CD patients/NNS with/IN chronic/JJ osteomyelitis/NN were/VBD treated/VBN per/IN os/NN with/IN the/DT bactericidal/JJ beta-lactam-antibiotic/NN cephalexin/NN during/IN 3/CD to/IN 60/CD weeks/NNS ./.
@@5996015867 It/PRP was/VBD concluded/VBN that/IN both/DT of/IN these/DT surgical/JJ procedures/NNS were/VBD as/RB effective/JJ as/IN pinealectomy/NN in/IN reversing/JJ the/DT pineal-induced/JJ alterations/NNS in/IN the/DT reproductive/JJ physiology/NN of/IN the/DT blind-anosmic/JJ female/JJ rat/NN ./.
@@67142983626 Is/VBZ nisoldipine/NN capable/JJ of/IN reducing/JJ left/NN ventricular/JJ preload/NN ?/. In/NN ten/CD anesthetized/JJ pigs/NNS ,/, nisoldipine/NN (/( 2-4/CD micrograms/NNS X/NN kg-1/NN X/NN min-1/NN )/SYM ,/, a/DT calcium/NN channel/NN blocker/NN structurally/RB related/VBD to/IN nifedipine/NN ,/, reduced/VBN left/NN ventricular/JJ systolic/JJ pressure/NN (/( 40%/CD )/SYM and/CC systemic/JJ vascular/JJ resistance/NN (/( 35%/JJ )/SYM ,/, whereas/IN maxLVdP/NN //NN dt/NN decreased/VBN by/IN 20%/CD and/CC cardiac/JJ output/NN was/VBD unchanged/JJ ./.
@@103932015924 In/NN a/DT reconstituted/VBN human/JJ DNA/NN repair/NN system/NN containing/NN DNA/NEWGENE polymerase/NEWGENE beta/NEWGENE and/CC DNA/NEWGENE ligase/NEWGENE III-XRCC1/NEWGENE ,/, accurate/JJ rejoining/NN of/IN a/DT 3'/CD mismatched/JJ base/NN residue/NN at/IN a/DT single-strand/JJ break/NN is/VBZ dependent/JJ on/IN addition/NN of/IN the/DT exonuclease/NEWGENE ./.
@@94809292336 Soluble/NNP FasR/NEWGENE ligand-binding/NN domain/NN :/: high-yield/JJ production/NN of/IN active/JJ fusion/NN and/CC non-fusion/JJ recombinant/JJ proteins/NNS using/VBG the/DT baculovirus/NN //NN insect/NN cell/NN system/NN ./.
@@8937981999 Furthermore/RB ,/, co-expression/NN of/IN both/DT p46/NEWGENE and/CC p54/NEWGENE subunits/NEWGENE markedly/RB altered/VBN the/DT subcellular/JJ distribution/NN of/IN p46/NEWGENE ;/: co-expressed/NN p46/NEWGENE was/VBD transported/VBN into/IN the/DT nucleus/NN as/RB efficiently/RB as/IN p54/NEWGENE ./.
@@91831459991 Evaluation/NN of/IN myocardial/JJ perfusion/NN by/IN 99mTc-tetrofosmin/NN SPECT/NN before/IN and/CC after/IN emergent/JJ percutaneous/JJ transluminal/JJ coronary/JJ angioplasty/NN for/IN acute/JJ myocardial/JJ infarction/NN ./.
@@109729909810 These/DT results/NNS support/NN a/DT model/NN in/IN which/WDT p53/NEWGENE protein/NEWGENE contributes/VBZ to/IN the/DT maintenance/NN of/IN genomic/JJ integrity/NN through/RB recombinational/JJ repair/NN ./.
@@9566871962 Posttranslational/JJ regulation/NN of/IN Ty1/NEWGENE retrotransposition/JJ by/IN mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE Fus3/NEWGENE ./.
@@102158507957 Finally/RB ,/, we/PRP determined/VBD the/DT genomic/JJ organization/NN of/IN the/DT human/NEWGENE TrxR2/NEWGENE gene/NEWGENE ,/, which/WDT consists/VBZ of/IN 18/CD exons/NNS spanning/VBG about/RB 67/CD kb/NN ,/, and/CC its/PRP chromosomal/JJ localization/NN at/IN position/NN 22q11/CD ./CD 2/CD ./.
@@93057557180 The/DT 5'/CD flanking/JJ region/NN contains/VBZ potential/JJ binding/JJ sites/NNS for/IN TATA-binding/NEWGENE protein/NEWGENE ,/, Sp1/NEWGENE ,/, nuclear/NEWGENE factor/NEWGENE 1/NEWGENE (/( NF1/NEWGENE )/SYM ,/, CAAT-box/NEWGENE binding/NEWGENE protein/NEWGENE (/( C/NEWGENE //NEWGENE EBP/NEWGENE )/SYM ,/, hepatocyte/NEWGENE nuclear/NEWGENE factors/NEWGENE 1/NEWGENE and/NEWGENE 5/NEWGENE (/( HNF1/NEWGENE ,/, HNF5/NEWGENE )/SYM and/CC activator/NEWGENE proteins/NEWGENE 1/NEWGENE and/NEWGENE 2/NEWGENE (/( AP1/NEWGENE ,/, AP2/NEWGENE )/SYM ./.
@@76475708201 The/DT most/RB likely/JJ explanation/NN for/IN this/DT is/VBZ that/DT gold/NN principally/RB accumulates/VBZ in/IN the/DT Kupffer/NN cells/NNS and/CC renal/JJ cortex/NN and/CC these/DT cells/NNS do/NN not/RB express/VB Type/NEWGENE I/NEWGENE deiodinase/NEWGENE ./.
@@10973151807 The/DT importance/NN of/IN this/DT new/JJ epidemiological/JJ profile/NN of/IN schistosomiasis/NN in/IN the/DT State/NNP of/IN Pernambuco/NN relies/VBZ on/IN the/DT fact/NN that/IN it/PRP can/MD be/VB related/VBN with/IN the/DT drastic/JJ human/JJ interference/NN on/IN the/DT environment/NN ./.
@@79677251541 All/DT nuclear/JJ receptors/NNS have/VBP several/DT well-characterized/JJ structural/JJ domains/NNS ,/, including/JJ a/DT conserved/VBN DNA-binding/NN domain/NN ,/, and/CC a/DT ligand/NN binding/JJ domain/NN at/IN the/DT carboxyl/NN terminus/NN of/IN the/DT receptor/NN ./.
@@51351686155 New/NNP alkaloids/NNS from/IN bark/NN of/IN Erythrophleum/NN ivorense/NN ./.
@@83823599313 In/NN order/NN to/IN investigate/VB to/IN what/WP extent/NN this/DT interaction/NN might/MD contribute/VB to/IN tumor/NN induction/NN by/IN the/DT virus/NN ,/, we/PRP have/VBP introduced/VBN two/JJ different/JJ point/NN mutations/NNS within/IN the/DT putative/JJ pRb-binding/NEWGENE sequence/NEWGENE of/IN large/NEWGENE T/NEWGENE antigen/NEWGENE ,/, and/CC as/IN a/DT preliminary/NN to/IN in/IN vivo/NN experiments/NNS we/PRP have/VBP studied/VBN their/PRP effects/NNS in/IN vitro/FW on/IN some/DT biological/JJ activities/NNS relevant/JJ to/IN tumor/NN induction/NN ./.
@@106306301629 However/RB ,/, calphostin/NN C/NN ,/, a/DT specific/JJ inhibitor/NN of/IN PKC/NEWGENE ,/, abolished/VBD the/DT TPA-induced/JJ increase/NN in/IN CFI/NEWGENE mRNA/NEWGENE levels/NNS ./.
@@5132845283 An/DT intravenous/JJ preparation/NN of/IN doxycycline/NN (/( DOTC/NN ,/, Vibramycin/NN 'Pfizer'/NN )/SYM ,/, a/DT long-lasting/JJ tetracycline/NN ,/, was/VBD administered/VBN mainly/RB by/IN drip/NN infusion/NN for/IN a/DT series/NN of/IN study/NN in/IN the/DT pediatrics/NN field/NN ,/, and/CC the/DT results/NNS were/VBD as/IN follows/VBZ :/: 1/NN )/NN DOTC/NN (/( 100/CD mg/NN )/SYM was/VBD dissolved/VBN in/IN a/DT 100/CD ml/NN of/IN glucose/NN solution/NN and/CC 2--3/CD mg/CD //CD kg/CD was/VBD administered/VBN intravenously/RB ./.
@@111792723499 Cytomegalovirus/NNS ,/, Chlamydia/JJ pneumoniae/NNS ,/, and/CC Helicobacter/NN pylori/NNS IgG/NEWGENE antibodies/NEWGENE and/CC restenosis/NN after/IN stent/NN implantation/NN :/: an/DT angiographic/JJ and/CC intravascular/JJ ultrasound/JJ study/NN ./.
@@28397162435 The/DT mechanism/NN by/IN which/WDT E2-C/NEWGENE represses/VBZ E2-dependent/NEWGENE enhancer/NEWGENE activity/NN most/RB likely/RB involves/VBZ competition/NN with/IN E2/NEWGENE for/IN binding/JJ to/IN a/DT common/JJ transcriptional/JJ regulatory/JJ site/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 400/CD WORDS/NN )/NN
@@89709915685 Upon/IN serum/JJ withdrawal/NN at/IN the/DT permissive/JJ temperature/NN ,/, p53-mediated/JJ apoptosis/NN was/VBD induced/VBN in/IN 50/CD to/IN 60%/CD of/IN the/DT cells/NNS ./.
@@21445582756 A/DT needs/NN assessment/NN of/IN these/DT families/NNS was/VBD also/RB done/VBP ./.
@@72429297071 Recording/NNP of/IN the/DT digital/JJ sphygmic/JJ activity/NN in/IN the/DT lower/JJR extremities/NNS with/IN the/DT photoplethysmographic/JJ and/CC strain-gauge/NN methods/NNS ./.
@@20127892624 No/DT positive/JJ family/NN history/NN was/VBD obtained/VBN ./.
@@85325169436 In/NN this/DT paper/NN we/PRP describe/VBP properties/NNS of/IN the/DT cdc10-C4/NEWGENE mutant/NEWGENE of/NEWGENE the/NEWGENE fission/NEWGENE yeast/NEWGENE Schizosaccharomyces/NEWGENE pombe/NEWGENE ./.
@@86317977179 Consistent/JJ with/IN ErbB-2/NEWGENE being/VBP a/DT shared/VBN receptor/NN subunit/NN ,/, its/PRP tyrosine/NN phosphorylation/NN was/VBD increased/VBN by/IN both/DT heterologous/JJ ligands/NNS and/CC it/PRP mediated/JJ a/DT trans-inhibitory/JJ effect/NN of/IN NDF/NEWGENE on/IN EGF/NEWGENE binding/JJ ./.
@@91447707179 This/DT conformer/NN features/VBZ a/DT Type/NN I/NN beta-turn/NN and/CC has/VBZ extensive/JJ hydrophobic/JJ contacts/NNS with/IN the/DT FKBP12/NEWGENE binding/JJ surface/NN ./.
@@7565740283 Endocytosis/NNS and/CC vacuolar/JJ degradation/NN of/IN the/DT plasma/NN membrane-localized/NN Pdr5/NEWGENE ATP-binding/NEWGENE cassette/NEWGENE multidrug/NEWGENE transporter/NEWGENE in/IN Saccharomyces/NN cerevisiae/NN ./.
@@31157877214 Of/IN 7/CD patients/NNS treated/VBN with/IN cyclophosphamide/NN ,/, hexamethylmelamine/NN ,/, adriamycin/NN and/CC cisplatin/NN (/( CHAP-5/NN )/SYM ,/, 6/CD had/VBP measurable/JJ disease/NN ,/, of/IN whom/WP 5/CD yielded/VBN a/DT response/NN (/( 2/CD complete/JJ responses/NNS for/IN 19+/CD and/CC 40/CD months/NNS and/CC 3/CD partial/JJ responses/NNS for/IN 4/CD ,/, 7/CD and/CC 8/CD months/NNS )/SYM ./.
@@83320338309 Morphometrical/JJ quantification/NN of/IN brain/NN edema/NN related/VBN to/IN experimental/JJ multiple/JJ micro-infarcts/NNS in/IN mice/NNS :/: assessment/NN of/IN neurotropin/NN effect/NN ./.
@@8148756106 The/DT degree/NN of/IN lung/NN destruction/NN ,/, reflected/VBN by/IN interstitial/JJ hemorrhage/NN was/VBD assessed/VBN by/IN measuring/JJ hemoglobin/NEWGENE content/NN in/IN the/DT fluid/NN of/IN the/DT lavaged/VBN lungs/NNS ./.
@@85800833496 To/TO elucidate/VB the/DT functional/JJ significance/NN of/IN Fyn/NEWGENE in/IN the/DT expression/NN of/IN viral/JJ promoters/NNS ,/, we/PRP transfected/VBN a/DT Fyn-expression/NN vector/NN together/RB with/IN a/DT reporter/NN plasmid/NN containing/JJ the/DT chloramphenicol/NEWGENE acetyltransferase/NEWGENE gene/NEWGENE driven/VBP by/IN HIV/NEWGENE LTR/NEWGENE into/IN a/DT human/JJ T/NN cell/NN line/NN ,/, Jurkat/NN ./.
@@114599608874 They/PRP consist/VBP of/IN at/IN least/RB two/JJ separable/JJ components/NNS ,/, one/PRP heat/NN stable/JJ and/CC the/PDT other/DT heat/NN labile/JJ ./.
@@83732741784 Polymyxin/NN B/NN was/VBD given/VBP intravenously/RB for/IN 1/CD week/NN postburn/JJ in/IN doses/NNS designed/VBN to/IN neutralize/VB circulating/JJ endotoxemia/NN ./.
@@82882401791 These/DT data/NN are/VBP consistent/JJ with/IN the/DT idea/NN that/IN the/DT neuron-specific/NEWGENE SCG10/NEWGENE gene/NEWGENE evolved/VBN by/IN duplication/NN and/CC modification/NN of/IN the/DT more/RB broadly/RB expressed/VBN stathmin/NEWGENE //NEWGENE Lap18/NEWGENE gene/NEWGENE ./.
@@83018413312 We/PRP studied/VBD GSH-Px/NEWGENE enzyme/NEWGENE activity/NN in/IN serum/JJ after/IN acute/JJ myocardial/JJ infarction/NN (/( AMI/NN )/SYM and/CC unstable/JJ angina/NN pectoris/JJ (/( UAP/NNP )/SYM ./.
@@21110157884 The/DT N-terminal/NN 115/NN amino/JJ acids/NNS correspond/VBP to/IN a/DT putative/JJ DNA-binding/NN domain/NN and/CC show/VB significant/JJ sequence/NN similarity/NN with/IN other/DT cloned/VBN IFN/NEWGENE response/NEWGENE factors/NEWGENE (/( IRF-1/NEWGENE and/CC IRF-2/NEWGENE )/SYM ./.
@@15520522160 OBJECTIVE/IN :/: The/DT study/NN was/VBD designed/VBN to/IN investigate/VB the/DT frequency/NN of/IN alterations/NNS in/IN serum/JJ creatinine/NN in/IN patients/NNS with/IN psoriasis/NN receiving/JJ 5/CD mg/NN //NN kg/NN //NN day/NN of/IN cyclosporine/NN ./.
@@63334339032 Thirty/CD isolates/NNS of/IN Haemophilus/NN influenzae/NNS type/NN b/NN were/VBD obtained/VBN during/IN an/DT outbreak/NN of/IN invasive/JJ H/NNP ./NNP influenzae/NNS type/NN b/NN disease/NN and/CC were/VBD classified/VBN by/IN the/DT electrophoretic/JJ profile/NN of/IN their/PRP lipopolysaccharide/NN (/( LPS/NN )/SYM ./.
@@27025667337 A/DT combination/NN of/IN cisplatin/NN and/CC 5-fluorouracil/NN ,/, both/DT administered/VBN 4/CD days/NNS continuously/RB as/IN infusion/NN ,/, was/VBD assessed/VBN in/IN advanced/JJ head/NN and/CC neck/NN cancer/NN ./.
@@15188494496 NE/NEWGENE and/CC PR3/NEWGENE assist/VB in/IN the/DT destruction/NN of/IN phagocytosed/VBN microorganisms/NNS ,/, cleave/VB the/DT important/JJ connective-tissue/NEWGENE protein/NEWGENE elastin/NEWGENE ,/, and/CC generate/VB chemotactic/JJ activities/NNS by/IN forming/NN alpha/NEWGENE 1-proteinase/NEWGENE inhibitor/NEWGENE complexes/NEWGENE and/CC elastin/NEWGENE peptides/NEWGENE ./.
@@88962806755 They/PRP suggest/VBP that/WDT decreased/VBD steady-state/JJ levels/NNS of/IN IME1/NEWGENE and/CC IME2/NEWGENE mRNA/NEWGENE were/VBD not/RB merely/RB the/DT result/NN of/IN non-specific/JJ adverse/JJ affects/VBP on/IN nucleic/JJ acid/NN metabolism/NN caused/VBN by/IN the/DT yvh1/NEWGENE disruption/NN ./.
@@141007196 Blood/NNP levels/NNS of/IN melatonin/NN ,/, serotonin/NN ,/, cortisol/NN ,/, and/CC prolactin/NEWGENE in/IN relation/NN to/IN the/DT circadian/JJ rhythm/NN of/IN platelet/NN serotonin/NN uptake/NN ./.
@@91909403134 Induction/NNS of/IN correctly/RB spliced/VBN germline/NN transcripts/NN is/VBZ necessary/JJ to/IN target/NN a/DT switch/NN region/NN for/IN recombination/NN and/CC switching/NN ./.
@@73235737185 A/DT narrow/JJ zone/NN of/IN myelin-axonal/JJ dissociation/NN was/VBD also/RB observed/VBN ./.
@@110966623633 Tranilast/NN in/IN the/DT Therapy/NNP of/IN Coronary/NNP Artery/NNP Disease/NNP ./.
@@76011211011 Analysis/NNP of/IN this/DT sequence/NN combined/JJ with/IN that/DT previously/RB reported/VBN for/IN the/DT 5'-flanking/JJ region/NN directly/RB proximal/JJ to/IN the/DT start/NN of/IN transcription/NN revealed/VBD several/DT putative/JJ regulatory/JJ sequences/NNS ./.
@@17002724937 Polyadenylation/NNS of/IN B4/NEWGENE RNA/NEWGENE ,/, which/WDT occurs/VBZ very/RB early/RB during/IN maturation/NN ,/, is/VBZ limited/VBN to/IN 150/CD residues/NNS ,/, and/CC it/PRP is/VBZ this/DT number/NN that/WDT is/VBZ required/VBN for/IN polysomal/JJ recruitment/NN ./.
@@7579164674 In/NN comparison/NN of/IN cDNA/NN and/CC genomic/JJ sequences/NNS four/CD RNA/NN editing/VBG events/NNS were/VBD found/VBN in/IN both/DT atp9/NEWGENE genes/NEWGENE ./.
@@77134214647 We/PRP show/VBP that/IN these/DT three/CD gain-of-function/NN mutants/NNS differ/VBP considerably/RB in/IN their/PRP ability/NN to/IN bypass/NN the/DT sex/NN determination/NN signal/JJ ,/, with/IN SxlM4/NEWGENE being/VBP the/DT strongest/JJS and/CC SxlM1/NEWGENE the/DT weakest/JJS ./.
@@86053264410 Overlapping/NN cDNA/NN clones/NNS were/VBD isolated/VBN and/CC sequenced/VBN ./.
@@68160536596 Of/IN 270/CD patients/NNS with/IN well-defined/JJ drug/NN reactions/NNS ,/, 190/CD (/( 70/CD per/IN cent/NN )/SYM gave/VBD a/DT positive/JJ response/NN to/IN the/DT mast/NN cell/NN test/NN ./.
@@19474494505 (/( 2/CD )/SYM Diffusion/NNS limitation/NN in/IN the/DT heterogeneous/JJ model/NN sets/NNS in/IN at/IN a/DT lower/JJR O2/NN requirement/NN value/NN ,/, and/CC increases/NNS more/RB gradually/RB with/IN increasing/JJ O2/NN requirement/NN ,/, than/IN in/IN the/DT corresponding/JJ homogeneous/JJ models/NNS with/IN the/DT same/JJ average/JJ cylinder/NN diameter/NN ./.
@@114655181340 BACKGROUND/IN :/: There/EX is/VBZ increasing/JJ interest/NN on/IN the/DT part/NN of/IN investigators/NNS and/CC the/DT public/NN at/IN large/JJ in/IN finding/NN ways/NNS to/IN study/NN and/CC improve/VB treatments/NNS for/IN the/DT seriously/RB mentally/RB ill/JJ without/IN exposing/JJ such/JJ individuals/NNS to/IN unnecessary/JJ risks/NNS ./.
@@96202738356 In/JJ mammals/NNS ,/, the/DT Rb/NEWGENE protein/NEWGENE interacts/VBZ specifically/RB with/IN D-type/NEWGENE cyclins/NEWGENE and/CC regulates/VBZ cell/NN proliferation/NN by/IN binding/JJ and/CC inhibiting/NN E2F/NEWGENE transcription/NEWGENE factors/NEWGENE ./.
@@104309443364 The/DT data/NN imply/VB that/IN JAK/NEWGENE //NEWGENE STAT/NEWGENE signaling/NN has/VBZ a/DT role/NN in/IN EBV-associated/JJ malignancies/NNS ./.
@@8510320356 Against/IN 200/CD strains/NNS of/IN methicillin-resistant/JJ Staphylococcus/NN aureus/NN (/( MRSA/NN )/SYM isolated/VBN from/IN 1990/CD to/IN 1991/CD ,/, minimum/JJ inhibitory/JJ concentrations/NNS (/( MICs/NNS )/SYM of/IN a/DT total/NN of/IN 15/CD antibacterial/JJ agents/NNS including/JJ arbekacin/NN (/( ABK/NN )/SYM were/VBD determined/VBN ./.
@@91019109045 The/DT perioperative/JJ mortality/NN of/IN all/DT patients/NNS was/VBD 1/CD ./CD 9%/CD ,/, the/DT mortality/NN of/IN patients/NNS older/JJR than/IN 70/CD years/NNS was/VBD 4/CD ./CD 3%/CD ./.
@@105684558675 We/PRP determined/VBD whether/IN a/DT single/JJ injection/NN of/IN slow-release/NN estradiol-17beta/NN (/( SRE2/NN )/SYM would/MD induce/VB pseudopregnancy/NN in/IN gilts/NNS and/CC whether/IN PGF2alpha/NN would/MD regress/VB the/DT corpora/NNS lutea/NN (/( CL/NN )/SYM of/IN pseudopregnancy/NN ./.
@@111135466345 Fecal/JJ samples/NNS were/VBD collected/VBN at/IN the/DT beginning/NN and/CC end/NN of/IN each/DT trial/NN period/NN and/CC were/VBD analyzed/VBN for/IN gastrointestinal/JJ nematode/JJ eggs/NNS and/CC Giardia/NN cyst/NN ./.
@@90896539509 Analysis/NNP for/IN DNA-protein/NN interactions/NNS by/IN in/IN vitro/NN DNase-I/NEWGENE footprinting/VBG identified/VBN a/DT broad/JJ region/NN of/IN protection/NN extending/VBG from/IN nt/NN -12/CD to/IN +38/CD ./.
@@94662678498 Using/VBG himA/NEWGENE mutants/NEWGENE ,/, we/PRP confirmed/VBD that/DT IHF/NEWGENE plays/VBP a/DT role/NN in/IN the/DT molybdate-dependent/JJ regulation/NN of/IN dmsA-lacZ/NEWGENE expression/NN in/IN vivo/NN ./.
@@90248056401 A/DT heterologous/JJ promoter/NN construct/NN containing/JJ three/CD repeats/NNS of/IN a/DT consensus/NN Sp1/NEWGENE site/NEWGENE ,/, cloned/VBN upstream/RB of/IN a/DT single/JJ copy/NN of/IN the/DT ZII/NEWGENE (/( CREB/NEWGENE //NEWGENE AP1/NEWGENE )/SYM element/NN from/IN the/DT BZLF1/NEWGENE promoter/NEWGENE linked/JJ to/IN the/DT beta-globin/NEWGENE TATA/NN box/NN ,/, exhibited/VBN phorbol/NN ester/NN inducibility/NN ./.
@@100375762712 Early-onset/NNP scleral/JJ necrosis/NN after/IN iodine/NN I/NN 125/NN plaque/NN radiotherapy/NN for/IN ciliochoroidal/JJ melanoma/NN ./.
@@44882714993 Treatment/NNP and/CC care/NN of/IN adult/JJ diabetes/NN mellitus/MD without/IN coma/NN ./.
@@103799426361 Identification/NNP and/CC structure/NN of/IN the/DT Marek's/NEWGENE disease/NEWGENE virus/NEWGENE serotype/NEWGENE 2/NEWGENE glycoprotein/NEWGENE M/NEWGENE gene/NEWGENE :/: comparison/NN with/IN glycoprotein/NEWGENE M/NEWGENE genes/NEWGENE of/IN Herpesviridae/NN family/NN ./.
@@15824136783 Dimerization/NNS of/IN Myf-5/NEWGENE with/IN the/DT ubiquitously/RB expressed/VBN bHLH/NEWGENE protein/NEWGENE E12/NEWGENE1 not/RB only/RB increases/VBZ the/DT affinity/NN for/IN DNA/NN but/CC also/RB stimulates/VBZ transactivation/NN independently/RB of/IN DNA/NN binding/JJ ./.
@@24866343143 Myocardial/JJ perfusion/NN was/VBD evaluated/VBN using/VBG the/DT enhanced/VBN gray/JJ level/NN after/IN contrast/NN injection/NN ,/, and/CC the/DT level/NN was/VBD compared/VBN with/IN the/DT morphology/NN and/CC degree/NN of/IN collateral/JJ development/NN ./.
@@3167233859 Changes/NNS in/IN body/NN weight/NN and/CC agonistic/JJ behavior/NN were/VBD also/RB recorded/VBN ./.
@@83500617933 The/DT mechanisms/NNS that/WDT govern/VBP the/DT activation/NN or/CC suppression/NN of/IN the/DT CD8/NEWGENE gene/NEWGENE are/VBP likely/RB to/IN be/VB central/JJ to/IN the/DT T/NN cell/NN development/NN program/NN ./.
@@17162926594 A/DT segmental/JJ analysis/NN of/IN the/DT key/NN regions/NNS of/IN HLA-DR1/NEWGENE that/DT control/NN T/NN cell/NN allorecognition/NN was/VBD performed/VBN by/IN using/VBG a/DT series/NN of/IN transfected/VBN cell/NN lines/NNS expressing/JJ the/DT products/NNS of/IN recombinant/NEWGENE DRB/NEWGENE //NEWGENE H-2Eb/NEWGENE genes/NEWGENE ,/, paired/JJ with/IN either/DT DR/NEWGENE alpha/NEWGENE or/CC H-2E/NEWGENE alpha/NEWGENE ./.
@@4732295126 Effects/NNPS of/IN methylene/NN chloride/NN ,/, trichloroethane/NN ,/, trichloroethylene/NN ,/, tetrachloroethylene/NN and/CC toluene/NN on/IN the/DT development/NN of/IN chick/NN embryos/NNS ./.
@@114160127811 To/TO assess/VB more/RB specific/JJ PKA-dependent/NNP mediation/NN of/IN LH's/NEWGENE contribution/NN to/IN combined/JJ hormonal/JJ drive/NN ,/, the/DT LDL/NEWGENE receptor/NEWGENE (/NEWGENE -1076/NEWGENE to/NEWGENE +11/NEWGENE bp/NEWGENE )/NEWGENE reporter/NEWGENE plasmid/NN was/VBD cotransfected/VBN with/IN a/DT full-sequence/NEWGENE rabbit/NEWGENE muscle/NEWGENE protein/NEWGENE kinase/NEWGENE inhibitor/NEWGENE (/( PKI/NEWGENE )/SYM minigene/NN driven/VBP constitutively/RB by/IN a/DT Rous/NN sarcoma/NN virus/NN promoter/NN ./.
@@17132136402 A/DT full-length/NEWGENE human/NEWGENE pim-1/NEWGENE cDNA/NEWGENE was/VBD subcloned/JJ into/IN the/DT bacterial/JJ vector/NN pGEX-2T/JJ and/CC the/DT Pim-1/NEWGENE protein/NEWGENE expressed/VBN as/IN a/DT fusion/NN product/NN with/IN bacterial/NEWGENE glutathione/NEWGENE S-transferase/NEWGENE (/( GST/NEWGENE )/SYM ./.
@@31376013852 Although/IN L-threo-dihydroxyphenylserine/CHEM (/( DOPS/NN )/SYM ,/, an/DT artificial/JJ norepinephrine/NN (/( NE/NN )/SYM precursor/NN ,/, did/VBD not/RB change/VB immobility/NN in/IN intact/JJ mice/NNS ,/, DOPS/NN significantly/RB reduced/VBN immobility/NN in/IN mice/NNS pretreated/VBN with/IN the/DT selective/JJ NE/NN neurotoxin/NN DSP4/NN ./.
@@77849429389 Circulating/VBG thrombomodulin/NEWGENE :/: current/JJ knowledge/NN and/CC future/JJ prospects/NNS ./.
@@74089707251 Six/CD hours/NNS after/IN the/DT last/NN administration/NN ,/, uterus/NN of/IN Gf/NNP and/CC Cv/NNS mice/NNS were/VBD weight/NN 337/CD ./CD 6/CD mg%/NN and/CC 423/CD ./CD 5/CD mg%/NN respectively/RB ,/, the/DT difference/NN was/VBD statistically/RB significant/JJ (/( p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ./.
@@83866373533 In/NN contrast/NN to/IN the/DT situation/NN in/IN mammalian/JJ cells/NNS ,/, prolonged/JJ exposure/NN of/IN the/DT agonist/NN (/( 24/CD h/NN )/SYM does/VBP not/RB result/VB in/IN down/NN regulation/NN of/IN the/DT remaining/JJ 70%/CD of/IN the/DT receptors/NNS ./.
@@95382205540 The/DT mitochondrial/NEWGENE regulatory/NEWGENE region/NEWGENE (/( mrr/NEWGENE )/SYM located/VBN between/IN the/DT tRNAPhe/NEWGENE and/CC tRNAPro/NEWGENE genes/NEWGENE of/IN mitochondrial/JJ DNA/NN (/( mtDNA/NN )/SYM is/VBZ essential/JJ for/IN regulation/NN of/IN replication/NN and/CC transcription/NN of/IN the/DT mitochondrial/JJ genome/NN ./.
@@95198306922 In/NN order/NN to/IN examine/VB the/DT potential/JJ role/NN of/IN transcriptional/JJ silencing/VBG during/IN productive/JJ HSV-1/NN infection/NN ,/, recombinant/JJ viruses/NNS were/VBD generated/VBN in/IN which/WDT wild-type/NEWGENE or/NEWGENE mutant/NEWGENE ICP34/NEWGENE ./NEWGENE 5/NEWGENE promoters/NEWGENE controlling/VBG the/DT expression/NN of/IN a/DT chloramphenicol/NEWGENE acetyltransferase/NEWGENE reporter/NEWGENE gene/NEWGENE were/VBD inserted/VBN into/IN the/DT thymidine/NEWGENE kinase/NEWGENE gene/NEWGENE of/IN the/DT viral/JJ genome/NN ./.
@@102310267908 The/DT gene/NN structure/NN of/IN Elk1/NEWGENE spans/NNS 15/CD ./CD 2/CD kb/NN and/CC consists/VBZ of/IN seven/JJ exons/NNS and/CC six/CD introns/NNS ./.
@@58224995755 The/DT structure/NN of/IN digiprogenin/NN ./.
@@13718636698 We/PRP have/VBP isolated/VBN and/CC characterised/VBN a/DT differentially-regulated/NN gene/NN family/NN in/IN the/DT protozoan/JJ parasite/NN Leishmania/NN major/JJ ./.
@@73401967192 The/DT quantitative/JJ determination/NN of/IN HBSAG--a/NNP valuable/NN aid/NN in/IN evaluating/VBG the/DT infectiousness/NN of/IN hepatitis/NN B/NN virus/NN carriers/NNS ./.
@@110180285325 We/PRP could/MD demonstrate/VB the/DT involvement/NN of/IN cAMP-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE (/( PKA/NEWGENE )/SYM in/IN the/DT phosphorylation/NN of/IN CDC25Mm/NEWGENE in/IN fibroblasts/NNS overexpressing/JJ this/DT RasGEF/NEWGENE as/RB well/NN as/IN in/IN mouse/NN brain/NN synaptosomal/JJ membranes/NNS ./.
@@113568356149 Saccharomyces/NN cerevisiae/NN activates/VBZ a/DT regulatory/JJ network/NN called/VBN "general/JJ control"/NN that/WDT provides/VBZ the/DT cell/NN with/IN sufficient/JJ amounts/NNS of/IN protein/NN precursors/NNS during/IN amino/JJ acid/NN starvation/NN ./.
@@15457929063 The/DT cardiac/NEWGENE myosin/NEWGENE light/NEWGENE chain-2/NEWGENE (/( MLC-2/NEWGENE )/SYM gene/NN promoter/NN contains/VBZ several/DT positive/JJ and/CC negative/JJ cis-acting/JJ sequences/NNS that/WDT are/VBP involved/VBN in/IN the/DT regulation/NN of/IN its/PRP expression/NN ./.
@@94443169397 No/DT apparent/JJ clinical/JJ signs/NNS indicative/NN of/IN systemic/JJ toxicity/NN were/VBD observed/VBN in/IN the/DT F0/NN and/CC F1/NN animals/NNS of/IN either/DT sex/NN ./.
@@10831972184 CONCLUSION/IN :/: Our/PRP findings/NNS suggest/VBP that/IN endometriosis/NN increases/NNS soluble/NN CD23/NEWGENE levels/NNS ,/, which/WDT can/MD be/VB suppressed/VBN with/IN either/DT danazol/NN or/CC leuprolide/NN acetate/NN injection/NN ./.
@@38808384535 Diagnosis/NNP of/IN unilateral/JJ renal/JJ artery/NN lesions/NNS after/IN captopril/NN administration/NN ./.
@@105624181151 Insulin-regulated/JJ events/NNS ,/, however/RB ,/, occur/VB in/IN all/DT cells/NNS ./.
@@4946595254 The/DT major/JJ urinary/JJ metabolites/NNS were/VBD 3-/NN (/NN 3-carboxyphenyl/NN )/NN -5-hydroxymethyl-2-oxazolidinone/NN and/CC a/DT glucuronide/NN of/IN toloxatone/NN ./.
@@27485953020 This/DT suggested/VBN that/DT baboon/NEWGENE liver/NEWGENE class/NEWGENE I/NEWGENE ADH/NEWGENE is/NNS of/IN the/DT same/JJ ancestral/JJ lineage/NN as/IN the/DT human/NEWGENE ADH-beta/NEWGENE ./.
@@109130942695 Nine/CD DNA/NN fragments/NNS that/WDT were/VBD specifically/RB recognized/VBN and/CC bound/JJ by/IN histidine-tagged/JJ AdpA/NEWGENE were/VBD isolated/VBN by/IN cycles/NNS of/IN a/DT gel/NN mobility/NN shift-PCR/JJ method/NN ./.
@@75966977497 We/PRP conclude/VBP that/IN pancreatic/NEWGENE polypeptide/NEWGENE and/CC motilin/NEWGENE responses/NNS to/IN a/DT meal/NN are/VBP different/JJ in/IN encopretic/JJ children/NNS than/IN in/IN children/NNS in/IN the/DT control/NN group/NN ./.
@@21545999935 The/DT zta/NEWGENE transactivator/NEWGENE involved/VBN in/IN induction/NN of/IN lytic/JJ cycle/NN gene/NN expression/NN in/IN Epstein-Barr/NNP virus-infected/JJ lymphocytes/NNS binds/VBZ to/IN both/DT AP-1/NEWGENE and/CC ZRE/NEWGENE sites/NEWGENE in/IN target/NN promoter/NN and/CC enhancer/NN regions/NNS ./.
@@93680977675 The/DT pen/NN can/MD heal/VB ./.
@@21247104291 The/DT nuclear/JJ proteins/NNS encoded/VBN by/IN the/DT c-fos/NEWGENE and/CC c-jun/NEWGENE protooncogenes/NEWGENE are/VBP expressed/VBN during/IN the/DT proliferation/NN period/NN of/IN osteoblast/NN phenotype/NN development/NN ./.
@@25222979236 The/DT effect/NN of/IN the/DT thromboxane/NEWGENE A2/NEWGENE (/NEWGENE TXA2/NEWGENE )/NEWGENE //NEWGENE prostaglandin/NEWGENE endoperoxide/NEWGENE receptor/NEWGENE antagonist/NN ,/, SQ/NN 29/CD ,/CD 548/CD on/IN pacing-induced/CD ischemia/NN was/VBD determined/VBN in/IN anesthetized/JJ open-chest/JJ dogs/NNS ./.
@@10703633518 Strontium/NNP nitrate/NN mixed/JJ with/IN glycolic/JJ acid/NN ,/, in/IN comparison/NN with/IN glycolic/JJ acid/NN alone/RB ,/, markedly/RB (/( p/CD </CD 0/CD ./CD 01/CD )/SYM shortened/VBN the/DT duration/NN of/IN the/DT irritation/NN sensation/NN from/IN 24/CD ./CD 4+/CD //CD -4/CD ./CD 1/CD (/( mean+/NN //NN -SEM/NN )/SYM min/NN to/IN 8/CD ./CD 9+/CD //CD -3/CD ./CD 7/CD (/( mean+/NN //NN -SEM/NN )/SYM min/NN ,/, and/CC significantly/RB (/( p/CD </CD 0/CD ./CD 05/CD )/SYM reduced/VBN the/DT mean/JJ magnitude/NN of/IN the/DT irritation/NN sensation/NN at/IN all/DT time/NN points/NNS (/( overall/JJ )/SYM ./.
@@95359087228 Two/CD differentially/RB expressed/VBN LNX/NEWGENE messages/NEWGENE encode/VBP overlapping/JJ proteins/NNS with/IN predicted/VBN molecular/JJ masses/NNS of/IN 80/NEWGENE kDa/NEWGENE (/NEWGENE LNX/NEWGENE )/NEWGENE and/CC 70/NEWGENE kDa/NEWGENE (/NEWGENE LNX-b/NEWGENE )/NEWGENE ./.
@@2511069162 Recessive/JJ lethal/JJ mutations/NNS were/VBD isolated/VBN based/VBN upon/IN failure/NN to/IN complement/NN the/DT recessive/JJ lethality/NN of/IN Df/NN (/NN 3L/NN )/NN RR2/NN ,/, a/DT deletion/NN of/IN the/DT DRE/NEWGENE region/NEWGENE that/WDT removes/VBZ 16-18/JJ polytene/JJ chromosome/NN bands/NNS ./.
@@14801833532 Therefore/RB ,/, the/DT molecular/JJ mechanisms/NNS of/IN the/DT estrogen/NN action/NN that/WDT govern/VBP the/DT lactoferrin/NEWGENE gene/NEWGENE expression/NN differ/VB between/IN mouse/NN and/CC human/JJ ./.
@@33351274014 The/DT program/NN has/VBZ been/VBN written/VBP in/IN a/DT generic/NN BASIC/IN in/IN order/NN to/IN make/NN the/DT procedure/NN user-friendly/JJ ./.
@@32613317213 SPECT/NN is/VBZ an/DT important/JJ aid/NN in/IN the/DT diagnosis/NN of/IN AIDS/NN dementia/NN complex/NN and/CC contributes/VBZ to/IN the/DT understanding/NN of/IN the/DT pathophysiological/JJ mechanisms/NNS of/IN this/DT disorder/NN ./.
@@78917133167 Small/NEWGENE Maf/NEWGENE proteins/NEWGENE heterodimerize/VBP with/IN Fos/NEWGENE and/CC may/MD act/VB as/IN competitive/JJ repressors/NNS of/IN the/DT NF-E2/NEWGENE transcription/NEWGENE factor/NEWGENE ./.
@@111186199106 These/DT and/CC other/DT data/NN presented/VBN suggest/VB that/DT TAg/NEWGENE 're-models'/JJ host/NN cell/NN transcription/NN factors/NNS that/WDT are/VBP used/VBN early/RB in/IN viral/JJ infection/NN ,/, and/CC thereby/RB mimics/VBP an/DT event/NN that/WDT naturally/RB occurs/VBZ during/IN transformation/NN ./.
@@91489293712 One/CD P1/NN genomic/JJ clone/NN and/CC six/CD subsequent/JJ plasmid/NN subclones/NNS were/VBD isolated/VBN and/CC analyzed/VBN for/IN the/DT exon-intron/JJ organization/NN of/IN the/DT Ctpct/NEWGENE gene/NEWGENE ./.
@@81736936441 A/DT second/JJ study/NN group/NN ,/, with/IN intact/JJ cardiac/JJ innervation/NN ,/, consisted/VB of/IN 19/CD patients/NNS with/IN stable/JJ angina/NN pectoris/NN class/NN I/NN to/IN III/NNP ./.
@@60963809463 Mature/NN mRNA/NN for/IN cytosolic/NEWGENE phosphoenolpyruvate/NEWGENE carboxykinase/NEWGENE of/NEWGENE the/NEWGENE chicken/NEWGENE is/VBZ 2/CD ./CD 8/CD kilobases/NNS in/IN length/NN ,/, similar/JJ to/IN that/DT previously/RB noted/VBN for/IN mRNA/NN coding/JJ for/IN the/DT same/JJ enzyme/NN in/IN the/DT rat/NN ./.
@@21422406309 No/DT significant/JJ differences/NNS could/MD be/VB seen/VBP in/IN response/NN rates/NNS according/VBG to/IN the/DT concentration/NN of/IN estrogen/NEWGENE receptors/NEWGENE or/CC presence/NN of/IN progesteron/NEWGENE receptors/NEWGENE in/IN this/DT group/NN of/IN patients/NNS ./.
@@80694818054 Surface-coil/NNP experiments/NNS on/IN phantoms/NNS and/CC on/IN human/JJ calf/NN muscles/NNS in/IN vivo/NN are/VBP presented/VBN ./.
@@7039326814 Six/CD patients/NNS with/IN glomerulonephritis/NN in/IN association/NN with/IN a/DT ventriculovascular/JJ shunt/NN were/VBD treated/VBN with/IN three/CD basic/JJ modes/NNS of/IN therapy/NN ./.
@@12426361880 The/DT results/NNS obtained/VBN tend/VB to/IN prove/VB that/IN the/DT reticuloendothelial/JJ system/NN mainly/RB participated/VBD in/IN beryllium/NN retention/NN ./.
@@94887257529 Molecular/NNP characterization/NN of/IN the/DT 50-/CD and/CC 57-kDa/NN subunits/NN of/IN the/DT bovine/NEWGENE vacuolar/NEWGENE proton/NEWGENE pump/NEWGENE ./.
@@74344567306 One/CD hundred/JJ twenty/CD units/NNS of/IN deglycerolized/VBN red/JJ blood/NN cells/NNS ,/, some/DT with/JJ glycerol/NN added/VBN so/RB as/IN to/IN exceed/VB an/DT acceptable/JJ 1%/JJ glycerol/NN content/NN ,/, had/VBP measurements/NNS made/VBP of/IN the/DT post-wash/JJ supernatant/JJ fluid/NN by/IN refractive/JJ index/NN and/CC osmometry/NN ./.
@@90030012041 The/DT E-box/NN sequence/NN in/IN the/DT SE2/NEWGENE fragment/NEWGENE of/IN the/DT transferrin/NEWGENE promoter/NEWGENE was/VBD CATCTG/NNP and/CC was/VBD similar/JJ in/IN gel/NN shifts/NNS to/IN the/DT consensus/NN E-box/NN elements/NN (/( CANNTG/NN )/SYM previously/RB characterized/VBN ./.
@@18859152503 Although/IN human/JJ infections/NNS with/IN bacteraemia/NN due/NN to/IN Pasteurella/NNP multocida/NN are/VBP not/RB uncommon/JJ ,/, endocarditis/NN associated/VBD with/IN P/NNP ./NNP haemolytica/NN is/VBZ rare/JJ ./.
@@112554231034 OBJECTIVE/IN :/: To/TO determine/VB the/DT association/NN of/IN depressive/JJ symptoms/NNS with/IN HIV-related/JJ mortality/NN and/CC decline/NN in/IN CD4/NEWGENE lymphocyte/NN counts/NNS among/IN women/NNS with/IN HIV/NN ./.
@@17394391855 Complex/NNP repetitive/JJ discharges/NNS were/VBD observed/VBN in/IN muscles/NNS of/IN mdx/NN mice/NNS but/CC no/DT complex/JJ repetitive/JJ discharges/NNS or/CC other/DT abnormalities/NNS were/VBD observed/VBN in/IN muscles/NNS of/IN normal/JJ control/NN mice/NNS ./.
@@90770769366 Positive/JJ CRP/NEWGENE test/NN were/VBD seen/VBP ./.
@@97152781441 RA-treatment/NNS of/IN these/DT transfectants/NNS induced/VBD morphologic/JJ and/CC immunophenotypic/JJ maturation/NN ,/, changes/VBZ in/IN RA-regulated/NN genes/NN ,/, and/CC a/DT G1/NN cell/NN cycle/NN arrest/NN in/IN a/DT manner/NN similar/JJ to/IN parental/JJ NT2/NNP //NNP D1/NNP cells/NNS ./.
@@81646619462 Surprisingly/RB ,/, TFIIIC/NEWGENE alpha/NEWGENE has/VBZ no/DT homology/NN to/IN any/DT of/IN the/DT yeast/NEWGENE TFIIIC/NEWGENE subunits/NEWGENE already/RB cloned/VBN ,/, suggesting/VBG a/DT significant/JJ degree/NN of/IN evolutionary/JJ divergence/NN for/IN RNA/NEWGENE polymerase/NEWGENE III/NEWGENE factors/NEWGENE ./.
@@61624195983 When/WRB used/VBN subcutaneously/RB or/CC intravenously/RB in/IN maximum/RB tolerated/VBN doses/NNS the/DT antibiotic/RB inhibited/VBN the/DT development/NN of/IN lymphadenosis/NN NK/NNP //NNP Li/NNP by/IN 90/CD and/CC 70/CD per/IN cent/NN respectively/RB ./.
@@16201292696 The/DT sequence-specific/JJ interaction/NN of/IN nuclear/NEWGENE factor/NEWGENE HiNF-D/NEWGENE with/IN this/DT key/JJ proximal/JJ promoter/NN element/NN of/IN the/DT H4-FO108/NEWGENE gene/NEWGENE is/VBZ cell/NN cycle/NN regulated/VBN in/IN normal/JJ diploid/JJ cells/NNS (/( J/NNP ./NNP
@@19398272567 Only/RB after/IN a/DT pretreatment/RB aimed/VBN at/IN increasing/JJ its/PRP oxide/NN surface/NN layer/NN was/VBD titanium/NN powder/NN found/VB to/IN accelerate/VB the/DT precipitation/NN from/IN solutions/NNS containing/JJ 2/CD mmol/NN //NN L/NN CaCl2/NN ,/, 2/CD mmol/NN //NN L/NN KH2PO4/NN ,/, 50/CD mmol/NN //NN L/NN Hepes/IN ,/, pH/NN 7/CD ./CD 2/CD ,/, and/CC to/IN induce/VB precipitation/NN from/IN metastable/JJ solutions/NNS containing/JJ 1/CD ./CD 2/CD mmol/NN //NN L/NN CaCl2/NN ,/, 1/CD ./CD 2/CD mmol/NN //NN L/NN KH2PO4/NN ,/, 50/CD mmol/NN //NN L/NN Hepes/IN ,/, pH/NN 7/CD ./CD 2/CD ,/, at/IN 37/CD degrees/NNS C/NNP ./NNP
@@81072089264 The/DT approach/NN derives/VBZ from/IN a/DT recently/RB described/VBN strategy/NN for/IN making/VBG recombinants/NNS from/IN five/CD overlapping/JJ EBV/NN cosmid-cloned/JJ DNAs/NNS (/( B/NNP ./NNP
@@97353664721 Using/VBG homology/NN cloning/NN techniques/NNS ,/, we/PRP identified/VBD a/DT mouse/NN homologue/NN of/IN E/NEWGENE (/NEWGENE Pc/NEWGENE )/NEWGENE ,/, termed/JJ Epc1/NEWGENE ,/, a/DT yeast/NN protein/NN that/IN we/PRP name/VBP EPL1/NEWGENE ,/, and/CC as/RB well/VB as/IN additional/JJ ESTs/NNS from/IN Caenorhabditis/NNP elegans/NNS ,/, mice/NNS and/CC humans/NNS ./.
@@99158608975 The/DT promoter/NN of/IN the/DT rat/NEWGENE pgp2/NEWGENE //NEWGENE mdr1b/NEWGENE gene/NEWGENE has/VBZ a/DT GC-rich/NNP region/NN (/( pgp2GC/NEWGENE )/SYM that/WDT is/VBZ highly/RB conserved/VBN in/IN mdr/NEWGENE genes/NEWGENE and/CC contains/VBZ an/DT consensus/NN Sp1/NEWGENE site/NEWGENE ./.
@@43925844956 Natural/NNP and/CC induced/VBN malarias/NNS in/IN western/JJ hemisphere/NN monkeys/NNS ./.
@@69940496774 Detection/NNS of/IN congenital/JJ hypothyroidism/NN in/IN 26/CD ,/CD 282/CD newborn/JJ infants/NNS ./.
@@76555096612 A/DT polymorphic/JJ bipartite/JJ motif/NN signals/NNS nuclear/JJ targeting/NN of/IN early/JJ auxin-inducible/JJ proteins/NNS related/VBN to/IN PS-IAA4/NEWGENE from/NEWGENE pea/NEWGENE (/NEWGENE Pisum/NEWGENE sativum/NEWGENE )/NEWGENE ./.
@@18101087171 A/DT two/JJ phase/NN slug/NN flow/NN tubular/JJ heat/NN exchanger/NN was/VBD used/VBN for/IN the/DT thermal/JJ inactivation/NN of/IN Listeria/NN monocytogenes/NNS in/IN natural/RB infected/VBN milk/NN from/IN seven/JJ cows/NNS ./.
@@80161892431 Granisetron/NN ,/, but/CC not/RB saline/JJ ,/, abolished/VBN vomiting/NN and/CC nausea/NN when/CC given/VBP as/IN intervention/NN after/IN this/DT combined/JJ emetic/JJ regimen/NN ./.
@@107811091264 Specific/JJ and/CC heritable/JJ genetic/JJ interference/NN by/IN double-stranded/JJ RNA/NN in/IN Arabidopsis/NN thaliana/NN ./.
@@85626885407 Upstream/NNS of/IN -37/CD ,/, the/DT 5'/CD untranslated/JJ sequences/NNS of/IN the/DT isolates/NNS differ/VBP in/IN both/DT length/NN and/CC sequence/NN ./.
@@94265957722 Lysine-ketoglutarate/NEWGENE reductase/NEWGENE and/CC saccharopine/NEWGENE dehydrogenase/NEWGENE from/IN Arabidopsis/NN thaliana/NN :/: nucleotide/NN sequence/NN and/CC characterization/NN ./.
@@40148612307 To/TO test/VB the/DT feasibility/NN of/IN using/VBG liposomes/NNS to/IN deliver/VB therapeutic/JJ agents/NNS to/IN the/DT lungs/NNS ,/, the/DT effect/NN of/IN liposome-encapsulated/JJ superoxide/NEWGENE dismutase/NEWGENE (/( SOD/NEWGENE )/SYM or/CC catalase/NEWGENE on/IN pulmonary/JJ oxygen/NN toxicity/NN was/VBD studied/VBN in/IN rats/NNS ./.
@@12564101125 3/CD activities/NNS of/IN the/DT factor/NEWGENE II/NEWGENE molecule/NN in/IN the/DT newborn/JJ infant/NN at/IN term/NN ./.
@@112954703060 There/EX was/VBD no/DT evidence/NN of/IN linkage/NN disequilibrium/NN between/IN the/DT polymorphic/JJ site/NN in/IN the/DT B/NN cell/NN specific/NN promoter/NN and/CC those/DT in/NN the/DT 3'/CD UTR/NNS ./.
@@11073870907 Patients/NNS with/IN lesions/NNS affecting/VBG the/DT PRC/NN but/CC sparing/JJ the/DT PHC/NN ,/, and/CC patients/NNS with/IN lesions/NNS affecting/VBG both/DT PRC/NN and/CC PHC/NN ,/, performed/VBD an/DT oculomotor/NN delayed/NN response/NN task/NN with/IN unpredictably/RB varied/VBN memory/NN delays/NNS of/IN up/JJ to/IN 30/CD s/CD ./CD
@@41452444817 Relaxation/NNS of/IN catch/NN in/IN a/DT molluscan/JJ smooth/JJ muscle/NN ./.
@@108524852733 Chinese/NNP Spring/NNP (/( CS/NN )/SYM carrying/JJ the/DT Q/NEWGENE gene/NEWGENE to/IN those/DT of/IN a/DT chromosome/NN deletion/NN line/NN of/IN CS/NN ,/, namely/RB ,/, q5/CD ,/, which/WDT lacks/VBZ 15%/NN of/IN 5AL/CD including/JJ the/DT Q/NEWGENE gene/NEWGENE ./.
@@74740857230 The/DT resulting/VBG R/NEWGENE protein/NEWGENE terminates/VBZ five/CD codons/NNS downstream/RB of/IN the/DT frameshift/JJ site/NN at/IN the/DT V/NEWGENE protein/NEWGENE stop/NN codon/NN ./.
@@89867704246 Here/RB we/PRP report/VBP that/DT expression/NN of/IN the/DT I-POU/NEWGENE //NEWGENE tI-POU/NEWGENE message/NEWGENE is/VBZ maximal/JJ late/RB in/IN the/DT embryonic/JJ phase/NN of/IN Drosophila/NN development/NN ,/, and/CC I-POU/NEWGENE is/VBZ the/DT preferred/VBN splice/NN variant/NN ./.
@@19999992614 Perilunar/JJ luxation--an/JJ unusual/JJ injury/NN demanding/JJ immediate/JJ and/CC correct/JJ treatment/NN ./.
@@7693708731 Insulin-like/NEWGENE growth/NEWGENE factor-binding/NEWGENE protein-2/NEWGENE (/( IGF-BP-2/NEWGENE )/SYM transcription/NN in/IN rat/NN liver/NN varies/VBZ with/IN developmental/JJ age/NN and/CC fasting/JJ ./.
@@38434962260 In/NN recent/JJ years/NNS ,/, successful/JJ physiological/JJ models/NNS have/VBP been/VBN developed/VBN for/IN a/DT variety/NN of/IN volatile/JJ and/CC nonvolatile/JJ chemicals/NNS ,/, and/CC their/PRP ability/NN to/IN perform/VB the/DT extrapolations/NNS needed/VBN in/IN risk/NN assessment/NN has/VBZ been/VBN demonstrated/VBN ./.
@@95648609485 These/DT data/NN indicate/VB that/IN the/DT third/RB intracellular/JJ loop/NN of/IN the/DT rat/NEWGENE GnRH-R/NEWGENE is/VBZ involved/VBN in/IN receptor/NEWGENE G/NEWGENE (/NEWGENE q/NEWGENE //NEWGENE 11/NEWGENE )/NEWGENE protein/NEWGENE coupling/VBG and/DT //DT or/DT selectivity/NN ,/, and/CC in/IN the/DT GGH/NN (/NN 3/NN )/NN 1'/NN cell/NN line/NN ,/, this/DT loop/NN is/VBZ also/RB involved/VBN in/IN signal/JJ transduction/NN mediated/JJ through/RB the/DT Gs/NEWGENE protein/NEWGENE pathway/NEWGENE ./.
@@14488062063 Administration/NNP of/IN growth/NEWGENE hormone/NEWGENE leads/VBP to/IN faster/JJR growth/NN ,/, but/CC also/RB faster/JJR bone/NN maturation/NN ./.
@@2744490140 Evidence/NN from/IN the/DT structure/NN of/IN a/DT number/NN of/IN cDNA/NN clones/NNS ,/, as/RB well/VB as/IN S1/NEWGENE nuclease/NEWGENE and/CC primer/NN extension/NN studies/NNS supports/VBP the/DT hypothesis/NN that/IN the/DT PTHrP/NEWGENE gene/NEWGENE contains/VBZ at/IN least/RB two/JJ mRNA/NN transcription/NN start/NN points/NNS that/WDT define/VBP two/JJ putative/JJ regulatory/JJ domains/NNS ./.
@@107883208295 Since/IN proteins/NN containing/NN TPR/NEWGENE elements/NEWGENE are/VBP typically/RB involved/VBN in/IN multiple/JJ protein-protein/JJ interactions/NNS ,/, we/PRP suggest/VBP that/IN the/DT 102kD/NN protein/NN interacts/VBZ within/IN the/DT tri-snRNP/NEWGENE with/IN both/PDT the/DT U5/NEWGENE and/NEWGENE U4/NEWGENE //NEWGENE U6/NEWGENE snRNPs/NEWGENE ,/, thus/RB bridging/JJ the/DT two/JJ particles/NNS ./.
@@107292214312 The/DT comparison/NN of/IN the/DT expression/NN patterns/NNS of/IN the/DT known/VBP Kv4/NEWGENE family/NEWGENE members/NEWGENE shows/VBZ subtype/NN specificity/NN with/IN significant/JJ overlaps/VBP ./.
@@74772457373 Some/DT strains/NNS of/IN A/NNP ./NNP parasiticus/NN produced/VBD all/DT four/CD aflatoxins/NEWGENE B1/NEWGENE B2/NEWGENE G1/NEWGENE G2/NEWGENE ,/, while/CC the/PDT other/DT ones/NNS produced/VBD AF/NEWGENE B1/NEWGENE +/SYM G1/NEWGENE only/RB ,/, with/IN concentrations/NNS of/IN aflatoxins/NEWGENE from/IN 0/CD ./CD 1/CD to/IN 450/CD mg/CD //CD kg/CD ./.
@@97106217428 We/PRP have/VBP tested/VBN this/DT possibility/NN by/IN constructing/JJ a/DT consecutive/JJ series/NN of/IN cysteine/NN substitutions/NNS in/IN the/DT Neu/NEWGENE juxtamembrane/NEWGENE domain/NEWGENE in/IN order/NN to/IN force/NN dimerization/NN along/IN a/DT series/NN of/IN interreceptor/NN faces/NNS ./.
@@30445923762 4/CD ./CD
@@84132155280 We/PRP have/VBP examined/VBN the/DT ability/NN of/IN various/JJ NF-kappa/NEWGENE B/NEWGENE subunits/NEWGENE to/IN bind/NN to/IN ,/, and/CC activate/VB transcription/NN from/IN ,/, the/DT IL-8/NEWGENE promoter/NEWGENE ./.
@@10492127295 In/NN another/DT study/NN ,/, intravenous/JJ administration/NN of/IN devazepide/NN ,/, a/DT specific/JJ cholecystokinin-A/NEWGENE receptor/NEWGENE antagonist/NN ,/, at/IN a/DT dose/NN of/IN 0/CD ./CD 1/CD mg/NN //NN kg/NN //NN hr/NN was/VBD begun/VBP 15/CD min/NN before/IN postprandial/JJ saline/JJ intake/NN and/CC continued/VBN for/IN 1/CD hr/NN ./NN
@@107291554039 In/NN the/DT icosahaedral/NNP MVMi/NNP capsid/NN ,/, this/DT sequence/NN forms/VBZ the/DT carboxy/JJ end/NN of/IN the/DT amphipathic/JJ beta-strand/NEWGENE I/NEWGENE (/( betaI/NEWGENE )/SYM ,/, and/CC all/DT its/PRP basic/JJ residues/NNS are/VBP contiguously/RB positioned/VBN at/IN the/DT face/NN that/IN in/IN the/DT unassembled/JJ subunit/NN would/MD be/VB exposed/VBN to/IN solvent/NN ./.
@@77608414290 UAS1/NEWGENE is/VBZ the/DT binding/JJ site/NN for/IN the/DT transcriptional/NN regulator/NN Adr1p/NEWGENE ./.
@@106256838112 Both/DT receptors/NNS utilize/VBP protein/NEWGENE tyrosine/NEWGENE kinases/NEWGENE (/( PTKs/NEWGENE )/SYM for/IN the/DT phosphorylation/NN of/IN various/JJ signaling/NN molecules/NN ,/, a/DT process/NN that/WDT is/VBZ critical/JJ for/IN the/DT function/NN of/IN both/DT receptors/NNS ./.
@@105854537782 Because/IN the/DT Pit-1/NEWGENE sites/NEWGENE in/IN the/DT hGH-N/NEWGENE gene/NEWGENE promoter/NEWGENE are/VBP insufficient/JJ for/IN such/JJ gene/NN activation/NN in/IN vivo/NN ,/, these/DT data/NN suggested/VBD a/DT unique/JJ chromatin-mediated/JJ developmental/JJ role/NN for/IN Pit-1/NEWGENE in/IN the/DT hGH/NEWGENE LCR/NEWGENE ./.
@@99958479993 Optical-absorption/NNP spectra/NNS ,/, crystal-field/JJ energy/NN levels/NNS ,/, and/CC transition/NN line/NN strengths/NNS of/IN holmium/NN in/IN trigonal/JJ Na3/NN [/NN Ho/NN (/NN C4H4O5/NN )/NN 3/NN ]/NN [/NN sdot/NN ]/NN 2NaClO4/NN [/NN sdot/NN ]/NN 6H2O/NN ./.
@@94865311503 During/IN organogenesis/NN ,/, HFH-8/NEWGENE expression/NN is/VBZ found/VBN in/IN the/DT splanchnic/JJ mesoderm/NN in/IN close/JJ apposition/NN of/IN the/DT gut/JJ endoderm/NN ,/, suggesting/VBG a/DT role/NN in/IN mesenchymal-epithelial/JJ induction/NN of/IN lung/NN and/CC gut/JJ morphogenesis/NN ./.
@@78469427822 Atrial/JJ fibrillation/NN and/CC the/DT autonomic/JJ nervous/JJ system/NN ./.
@@73265967186 The/DT IgA/NEWGENE deficiency/NN is/VBZ combined/JJ with/IN the/DT IgE/NEWGENE one/PRP ./.
@@105323546912 Our/PRP results/NNS suggest/VBP that/IN Anu2p/NEWGENE is/VBZ the/DT yeast/NEWGENE homologue/NEWGENE of/NEWGENE mammalian/NEWGENE epsilon-COP/NEWGENE and/CC the/DT abrupt/JJ accumulation/NN of/IN the/DT ER/NN membrane/NN caused/VBN by/IN a/DT blockage/NN of/IN the/DT early/JJ protein/NN transport/NN pathway/NN leads/VBP to/IN alteration/NN of/IN nuclear/JJ morphology/NN of/IN the/DT budding/JJ yeast/NN cells/NNS ./.
@@10383966423 The/DT penicillin/NEWGENE binding/NEWGENE proteins/NEWGENE (/( PBPs/NEWGENE )/SYM synthesize/VB and/CC remodel/VB peptidoglycan/NN ,/, the/DT structural/JJ component/NN of/IN the/DT bacterial/JJ cell/NN wall/NN ./.
@@23390052992 Effect/NN of/IN hyperglycemia/NN on/IN pain/NN threshold/NN in/IN alloxan-diabetic/JJ rats/NNS ./.
@@22046239358 The/DT juxtamembrane/NN region/NN of/IN the/DT insulin/NEWGENE receptor/NEWGENE (/NEWGENE IR/NEWGENE )/NEWGENE beta-subunit/NEWGENE contains/VBZ an/DT unphosphorylated/JJ tyrosyl/NN residue/NN (/( Tyr960/CD )/SYM that/WDT is/VBZ essential/JJ for/IN insulin-stimulated/JJ tyrosyl/NN phosphorylation/NN of/IN some/DT endogenous/JJ substrates/NNS and/CC certain/JJ biological/JJ responses/NNS (/( White/NN ,/, M/NNP ./NNP F/NNP ./NNP ,/, Livingston/NNP ,/, J/NNP ./NNP N/NNP ./NNP ,/, Backer/NNP ,/, J/NNP ./NNP M/NNP ./NNP ,/, Lauris/NNP ,/, V/NNP ./NNP ,/, Dull/JJ ,/, T/NNP ./NNP J/NNP ./NNP ,/, Ullrich/NN ,/, A/NNP ./NNP ,/, and/CC Kahn/NNP ,/, C/NN ./NN R/NN ./.
@@20248167600 Using/VBG an/DT ELISA/NN ,/, we/PRP found/VBP that/IN surfactant/NEWGENE protein/NEWGENE A/NEWGENE (/( SP-A/NEWGENE )/SYM was/VBD markedly/RB elevated/VBN in/IN the/DT pneumonia/NN patients/NNS ./.
@@109023483549 Resistance/NNP ratios/NNS for/IN the/PDT other/DT field/NN strains/NNS obtained/VBN by/IN comparison/NN with/IN the/DT R5/NN strain/NN ranged/VBN from/IN 24/CD ./CD 5/CD to/IN 239/CD for/IN topical/JJ application/NN and/CC from/IN 1/CD ./CD 2/CD to/IN 9/CD ./CD 8/CD for/IN the/DT glass/NN jar/NN method/NN ./.
@@3016301864 Among/IN the/DT v-myc/NEWGENE codons/NNS ,/, the/DT first/JJ 5/CD are/VBP derived/VBN from/IN the/DT noncoding/JJ 5'/CD terminus/NN of/IN the/DT second/JJ c-myc/NEWGENE exon/NN ,/, and/CC 412/CD codons/NNS correspond/VBP to/IN the/DT c-myc/NEWGENE coding/JJ region/NN ./.
@@79599522644 A/DT cDNA/NN for/IN a/DT newly/RB discovered/VBN pseudogene/NN ,/, closely/RB related/VBN to/IN the/DT mouse/NEWGENE mast/NEWGENE cell/NEWGENE chymases/NEWGENE was/VBD isolated/VBN by/IN polymerase/NEWGENE chain/NN reaction/NN amplification/NN from/IN a/DT mouse/NN connective/JJ tissue-like/JJ mast/NN cell/NN line/NN ./.
@@92838289240 Their/PRP circadian/JJ responses/NNS to/IN both/DT photic/JJ and/CC non-photic/JJ cues/NNS were/VBD then/RB tested/VBN ./.
@@19220826577 Expression/NNS of/IN the/DT mouse/NEWGENE TSH/NEWGENE beta/NEWGENE gene/NEWGENE ,/, therefore/RB ,/, gives/VBZ rise/NN to/IN multiple/JJ mRNAs/NNS ,/, each/DT with/IN a/DT unique/JJ 5'-untranslated/JJ region/NN ./.
@@17122968504 The/DT nucleotide/NN sequences/NNS of/IN these/DT genes/NNS differ/VBP at/IN only/RB nine/JJ positions/NNS ,/, resulting/VBG in/IN three/CD amino/JJ acid/NN differences/NNS ./.
@@6939876715 Thromboplastic/JJ and/CC fibrynolytic/JJ activity/NN of/IN the/DT blood/NN after/IN administration/NN of/IN intralipid/NN in/IN men/NNS with/IN history/NN of/IN myocardial/JJ infarction/NN up/JJ to/IN 45/CD year/NN of/IN life/NN ./.
@@114861419123 Many/JJ factors/NNS do/VBP influence/NN the/DT educational/JJ outcome/NN in/IN students/NNS and/CC large/JJ statistical/JJ power/NN (/( such/JJ as/IN meta/NN analysis/NN )/SYM should/MD be/VB helpful/JJ to/IN eliminate/VB many/JJ souces/NNS of/IN error/NN ./.
@@20330381350 Most/JJS of/IN the/DT expressed/VBN human/NEWGENE E3/NEWGENE polypeptides/NEWGENE (/( five/CD bands/NNS )/SYM were/VBD found/VBN in/IN the/DT insoluble/JJ pellet/NN while/CC primarily/RB full-length/NEWGENE mature/NEWGENE E3/NEWGENE was/VBD found/VBN in/IN the/DT soluble/JJ fraction/NN ./.
@@103774383952 We/PRP show/VBP that/IN a/DT protein/NN ,/, UBC9/NEWGENE ,/, interacts/VBZ specifically/RB with/IN TEL/NEWGENE in/IN vitro/FW and/CC in/IN vivo/NN ./.
@@24030356729 Thus/RB ,/, this/DT reading/JJ frame/NN was/VBD concluded/VBN to/IN encode/VB the/DT precursor/NN of/IN mitochondrial/NEWGENE fumarase/NEWGENE ./.
@@76939755827 By/IN contrast/NN ,/, all/DT proteins/NNS initiated/VBN with/IN a/DT methionine/NN placed/VBN one/PRP residue/NN upstream/RB of/IN the/DT natural/NN N/NN terminus/NN of/IN PR/NEWGENE failed/VBD to/IN show/NN specific/JJ proteolysis/NN ./.
@@9377374300 In/NN this/DT paper/NN ,/, characterization/NN is/NNS given/VBP of/IN clinical/JJ and/CC biochemical/JJ features/NNS of/IN VH/NN B/NN course/NN against/IN the/DT background/NN of/IN narcomania/NN ./.
@@36598058419 The/DT statistical/JJ significance/NN of/IN the/DT prognosis/NN factors/NNS was/VBD studied/VBN by/IN uni-/JJ and/CC multivariative/JJ methods/NNS ,/, according/VBG to/IN the/DT model/NN of/IN Cox/NN ,/, with/IN the/DT help/NN of/IN an/DT IMB/NN computer/NN ./.
@@111237012719 Current/JJ evidence/NN for/IN this/DT type/NN of/IN DNA/NN supercoiling-dependent/JJ transcriptional/JJ coupling/NN ,/, based/VBD largely/RB on/IN the/DT in/NN vivo/NN activities/NNS of/IN promoters/NNS contained/VBN in/IN engineered/VBN DNA/NN constructs/NNS ,/, suggests/VBZ that/IN the/DT transcription/NN complex/NN must/MD be/VB physically/RB hindered/VBN to/IN generate/VB DNA/NN supercoils/NNS and/CC to/IN prevent/VB their/PRP diffusion/NN throughout/IN the/DT DNA/NN duplex/JJ ./.
@@100381936 With/IN the/DT help/NN of/IN a/DT nomogram/NN one/PRP can/MD read/VB off/RB the/DT refraction/NN ,/, when/CC axis/NN length/NN and/CC corneal/JJ curvature/NN are/VBP known/VBP ./.
@@112370383261 A/DT subset/NN of/IN patients/NNS (/( n/CD =/CD 30/CD )/SYM underwent/VBD multichannel/JJ pressure/NN flow/NN studies/NNS ,/, which/WDT demonstrated/VBD that/IN transrectal/JJ HIFU/NN reduces/VBZ bladder/NN outflow/NN obstruction/NN ./.
@@8879237477 Two/CD of/IN seven/CD initiation/NN sites/NNS were/VBD flanked/VBN by/IN a/DT sequence/NN homologous/JJ to/IN the/DT consensus/NN promoter/NN motif/NN that/WDT includes/VBZ the/DT CRTA/NN motif/NN (/( where/CC R/NN is/VBZ A/DT or/CC G/NN )/SYM of/IN the/DT rice/NN mitochondrion/NN ./.
@@104717215703 Recent/JJ molecular/JJ analysis/NN has/VBZ revealed/VBN that/IN the/DT S/NEWGENE locus/NEWGENE is/VBZ highly/RB polymorphic/JJ and/CC contains/VBZ several/DT genes/NNS ,/, i/FW ./FW e/FW ./FW ,/, SLG/NEWGENE ,/, SRK/NEWGENE ,/, the/DT as-yet-unidentified/JJ pollen/NEWGENE S/NEWGENE gene/NEWGENE (/NEWGENE s/NEWGENE )/NEWGENE ,/, and/CC other/DT linked/NN genes/NN ./.
@@96376895358 The/DT major/JJ type/NN involves/VBZ activator/NN proteins/NNS that/WDT bind/VBP to/IN DNA/NN adjacent/JJ to/IN where/CC the/DT RNA/NEWGENE polymerase/NEWGENE (/( RNAP/NEWGENE )/SYM holoenzyme/NN binds/VBZ ,/, usually/RB assisting/JJ in/IN recruitment/NN of/IN the/DT RNAP/NEWGENE to/IN the/DT promoter/NN ./.
@@5065595343 The/DT sub-acute/JJ inhalation/NN toxicity/NN of/IN furfural/NN was/VBD studied/VBN in/IN Syrian/JJ golden/JJ hamsters/NNS ./.
@@26017079534 Gel/NNP retardation/NN assays/NNS combined/JJ with/IN DNase/NEWGENE I/NEWGENE footprinting/VBG and/CC diethyl/JJ pyrocarbonate/NN interference/NN showed/VBN that/IN a/DT nuclear/JJ factor/NN from/IN differentiated/VBN C2/NN myotubes/NNS and/CC BC3H1/NN myocytes/NNS recognized/VBD a/DT conserved/VBN A/DT +/SYM T-rich/NNP sequence/NN within/IN the/DT peripheral/NN activating/NN region/NN ./.
@@19895612601 The/DT application/NN of/IN these/DT instruments/NNS allows/VBZ occlusion/NN of/IN the/DT ascending/JJ aorta/NN traversed/VBN by/IN the/DT perfusion/NN cannula/NN inserted/VBN directly/RB or/CC through/RB the/DT apex/NN of/IN the/DT heart/NN as/RB well/NN as/IN simultaneous/JJ left/NN ventricular/JJ venting/NN ./.
@@91021139046 Chronic/NN renal/JJ failure/NN patients/NNS essentially/RB die/VBP from/IN cardiovascular/JJ causes/NNS ,/, and/CC the/DT frequency/NN of/IN malignant/JJ disease/NN responsible/JJ for/IN death/NN is/VBZ estimated/VBN to/IN be/VB 10%/CD ./.
@@25374853180 In/NN the/DT formalin/NN test/NN ,/, however/RB ,/, naloxone/NN attenuated/VBN morphine/NN analgesia/NN at/IN the/DT lower/JJR doses/NNS (/( 0/CD ./CD 1/CD and/CC 0/CD ./CD 3/CD mg/CD //CD kg/CD )/SYM and/CC potentiated/VBN morphine/NN analgesia/NN at/IN the/DT highest/JJS dose/NN (/( 10/CD mg/CD //CD kg/CD )/SYM ./.
@@110270275393 5/CD (/( Sunset/NNP Yellow/NNP FCF/NN )/SYM were/VBD determined/VBN using/VBG liquid/JJ chromatography/NN //NN mass/NN spectrometry/NN (/( LC/NNS //NNS MS/NNS )/SYM with/IN electrospray/NN ionization/NN ./.
@@95797895867 The/DT present/NN results/NNS demonstrate/VBP that/IN rats/NNS with/IN relatively/JJ small/JJ remnants/NNS of/IN one/PRP olfactory/NN bulb/NN can/MD perform/VB a/DT variety/NN of/IN odor/NN detection/NN and/CC discrimination/NN tasks/NNS as/IN well/NN or/CC nearly/RB as/RB well/VB as/IN controls/NNS ./.
@@2971603280 Most/JJS patients/NNS preferred/VBD tablets/NNS to/IN injection/NN both/DT on/JJ day/NN 1/CD (/( 313/NN v/NN 200/NN )/SYM and/CC at/IN follow/VB up/JJ (/( 373/NN v/NN 104/NN )/SYM ./.
@@36883011967 Two/CD of/IN these/DT six/CD cases/NNS showed/VBD mucosal/JJ spread/NN without/IN stromal/JJ invasion/NN (/( type/NN A/NN )/SYM ;/: the/DT remaining/JJ four/CD cases/NNS presented/VBD a/DT direct/JJ extension/NN (/( type/NN B/NN )/SYM from/IN muscle-invasive/JJ carcinomas/NNS of/IN the/DT bladder/NN ./.
@@59087625817 IV/DT ./DT
@@103428296635 Competitive/JJ mobility/NN shift/NN assays/NNS using/VBG either/DT alphaT3-1/NN nuclear/JJ extract/NN or/CC recombinant/NEWGENE SF-1/NEWGENE protein/NEWGENE clearly/RB indicated/VBD that/IN SF-1/NEWGENE is/VBZ able/JJ to/IN interact/VB specifically/RB with/IN this/DT GSE/NEWGENE element/NEWGENE positioned/VBN at/IN -134/CD ./.
@@10367385236 A/DT liquid/JJ chromatographic/JJ method/NN is/VBZ described/VBN for/IN analysis/NN of/IN beta-carotene/NN in/IN medical/JJ food/NN ./.
@@12820143231 Animals/NNS that/WDT received/VBD DSP-4/NN were/VBD significantly/RB retarded/VBN in/IN motor/JJ recovery/NN compared/VBN with/IN the/DT saline/JJ group/NN ./.
@@10393910974 Site-directed/JJ mutagenesis/NN of/IN the/DT R2/NEWGENE protein/NEWGENE was/VBD used/VBN to/IN provide/VB evidence/NN that/IN this/DT motif/NN is/VBZ also/RB part/VBP of/IN the/DT active/JJ site/NN of/IN the/DT endonuclease/NEWGENE encoded/VBN by/IN this/DT element/NN ./.
@@11145563163 We/PRP determined/VBD whether/IN the/DT human/NEWGENE StAR/NEWGENE promoter/NEWGENE is/VBZ responsive/JJ to/IN sterol/NEWGENE regulatory/NEWGENE element-binding/NEWGENE proteins/NEWGENE (/( SREBPs/NEWGENE )/SYM ./.
@@102296681529 We/PRP show/VBP that/IN other/DT cdc33/NEWGENE mutants/NEWGENE also/RB arrest/VBP in/IN G1/NNP ./NNP
@@10830395636 The/DT network/NN evolution/NN was/VBD interpreted/VBN by/IN an/DT approach/NN based/VBN on/IN the/DT Flory/NNP model/NN ./.
@@10938556758 In/NN addition/NN ,/, the/DT ketamine-treated/JJ rats/NNS had/VBP more/JJ neurons/NNS and/CC glial/JJ cells/NNS surrounding/JJ the/DT ventricles/NNS ./.
@@10699896511 RESULTS/NNS :/: In/NN this/DT group/NN of/IN patients/NNS ,/, male/JJ gender/NN (/( P/NN =/SYM 0/CD ./CD
@@32004883350 The/DT results/NNS presented/VBN suggest/VB that/DT TIQ/NN reduces/VBZ the/DT turnover/NN rate/NN of/IN the/DT nigrostriatal/JJ dopamine/NN neurons/NNS after/IN repeated/JJ administration/NN for/IN a/DT long/JJ period/NN in/IN mice/NNS ./.
@@16082392193 And/CC the/DT natural/JJ barriers/NNS ?/.
@@97032131206 In/NN experiments/NNS with/IN the/DT D1/NEWGENE antagonist/NN SCH/NN 23390/CD ,/, buprenorphine-induced/JJ depression/NN was/VBD consistently/RB blocked/VBN ,/, but/CC facilitation/NN was/VBD unaffected/JJ ./.
@@27510803447 Each/DT individual/JJ shot/NN 25/NN bullets/NNS in/IN about/RB 5/CD minutes/NNS ,/, at/IN an/DT intensity/NN level/NN calculated/VBN at/IN 163/CD dB/CD ./CD
@@86498411041 Positioning/VBG this/DT uORF/NN ,/, together/RB with/IN its/PRP accompanying/JJ Kozak/NNP sequences/NNS ,/, between/IN a/DT heterologous/JJ promoter/NN from/IN SV40/NN and/CC a/DT CAT/NEWGENE reporter/NEWGENE gene/NEWGENE resulted/VBN in/IN marked/JJ inhibition/NN of/IN CAT/NEWGENE protein/NEWGENE production/NN without/IN a/DT decrease/NN in/IN CAT/NEWGENE mRNA/NEWGENE ./.
@@67440246511 Morphine/IN injected/VBN into/IN the/DT lateral/JJ ventricle/NN of/IN the/DT rat/NN produced/VBD unilateral/JJ analgesia/NN in/IN the/DT formalin/NN test/NN ,/, which/WDT involves/VBZ continuous/JJ ,/, moderate/JJ pain/NN ./.
@@85342172118 The/DT subjects/NNS from/IN the/DT two/JJ regions/NNS with/IN a/DT higher/JJ pollution/NN level/NN had/VBP lower/JJR FVC/NN and/CC FEV1/NN values/NNS than/IN those/DT from/IN the/DT Viskovo/NN region/NN ./.
@@21942732813 Specific/JJ hyperimmune/NEWGENE globulins/NEWGENE to/IN pathogens/NNS such/JJ as/IN Haemophilus/NN influenzae/NNS and/CC Streptococcus/NN pneumoniae/NNS have/VBP also/RB been/VBN studied/VBN ./.
@@27111672861 From/IN day/NN 30/CD after/IN turnout/NN ,/, the/DT PFB-group/NN had/VBP significantly/RB lower/JJR serum/NEWGENE pepsinogen/NEWGENE levels/NNS ,/, which/WDT reflects/VBZ the/DT low/JJ degree/NN of/IN abomasal/JJ damage/NN in/IN these/DT animals/NNS ./.
@@79959107986 This/DT technique/NN has/VBZ a/DT sensitivity/NN and/CC a/DT specificity/NN of/IN almost/RB 100%/CD ,/, and/CC is/VBZ currently/RB the/DT best/JJS way/NN to/IN diagnose/VB nodal/JJ involvement/NN ,/, apart/RB from/IN laparotomy/NN ./.
@@1581965420 At/NN the/DT C-terminus/NN of/IN the/DT protein/NN is/VBZ a/DT domain/NN that/WDT contains/VBZ sequences/NNS very/RB similar/JJ to/IN those/DT found/VB in/IN the/DT breakpoint/NN cluster/NN region/NN gene/NN product/NN ,/, n-chimerin/NEWGENE ,/, and/CC rho/NEWGENE GAP/NEWGENE ,/, all/DT of/IN which/WDT have/VBP been/VBN shown/VBP to/IN possess/VB intrinsic/JJ GAP/NEWGENE activity/NN on/IN small/NEWGENE GTPases/NEWGENE ./.
@@84121202377 Skin/VBP and/CC bowel/NN TPO2/NN varied/VBN with/IN DO2/NN and/CC each/DT other/DT (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@2795923259 In/NN order/NN to/IN identify/VB and/CC classify/VB the/DT basic/NN CT/NN appearances/NNS of/IN interstitial/JJ pneumonia/NN ,/, radiologic/JJ -pathologic/CD correlative/JJ study/NN was/VBD performed/VBN using/VBG inflated/VBN and/CC fixed/JJ lungs/NNS from/IN autopsy/NN and/CC surgery/NN ./.
@@81927958169 Thrombotic/JJ thrombocytopenic/JJ purpura/NN in/IN systemic/JJ lupus/NN erythematosus/NN ./.
@@105189375093 The/DT expression/NN analysis/NN of/IN the/DT KlHIS4/NEWGENE gene/NEWGENE under/IN phosphate/NN starvation/NN or/CC high/JJ adenine/NN supply/NN shows/VBZ that/IN factors/NNS ,/, such/JJ as/IN Bas1/NEWGENE or/CC Bas2/NEWGENE ,/, involved/VBN in/IN the/DT basal/JJ control/NN may/MD also/RB operate/VB in/IN a/DT different/JJ way/NN in/IN K/NNP ./NNP lactis/NN ./.
@@45986705047 Local/JJ graft/NN irradiation/NN as/IN an/DT adjunct/NN to/IN pharmacologic/JJ immunosuppression/NN ./.
@@98450439970 The/DT US/NNP National/NNP Institute/NNP on/IN Alcohol/NNP Abuse/NNP and/CC Alcoholism/IN (/( NIAAA/NN )/SYM recognizes/VBZ two/JJ forms/NNS of/IN problematic/JJ drinking/JJ :/: 'willful/JJ alcohol/NN abuse'/NN ,/, a/DT behavioural/JJ problem/NN ,/, and/CC 'alcohol/NN dependence'/NN ,/, a/DT true/JJ medical/JJ disorder/NN ,/, which/WDT includes/VBZ a/DT genetic/JJ component/NN ,/, that/WDT can/MD be/VB scientifically/RB understood/VBP and/CC medically/RB treated/VBN ./.
@@97269889139 Oleate/NN induced/VBD steady-state/JJ levels/NNS of/IN M-CPT/NEWGENE I/NEWGENE mRNA/NEWGENE 4/CD ./CD 5-fold/CD ./.
@@90381924987 A/DT MEK-specific/NN inhibitor/NN (/( PD098059/NN )/SYM (/( Dudley/NNP ,/, D/NN ./NN
@@79588654203 Homozygous/JJ null/JJ embryos/NNS also/RB displayed/VBN abnormalities/NNS in/IN heart/NN development/NN ,/, consistent/JJ with/IN the/DT conclusion/NN that/IN Tek/NEWGENE is/VBZ necessary/JJ for/IN endocardial/JJ //JJ myocardial/JJ interactions/NNS during/IN development/NN ./.
@@117261641569 Of/IN major/JJ concern/NN to/IN food/NN processors/NNS is/VBZ the/DT inadvertent/JJ cross-contact/NN of/IN food/NN products/NNS with/IN allergenic/JJ residues/NNS ,/, which/WDT could/MD result/VB in/IN potentially/RB life-threatening/JJ reactions/NNS in/IN those/DT with/IN a/DT food/NN allergy/NN ./.
@@77395205636 No/DT homologs/NNS of/IN other/DT members/NNS of/IN the/DT Surfeit/NEWGENE gene/NEWGENE cluster/NEWGENE were/VBD detected/VBN in/IN close/JJ proximity/NN to/IN the/DT D/NEWGENE ./NEWGENE melanogaster/NEWGENE Surf-3/NEWGENE //NEWGENE rpL7a/NEWGENE gene/NEWGENE ./NEWGENE (/NEWGENE ABSTRACT/NEWGENE TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@24731983128 Dopamine/IN caused/VBN a/DT prominent/JJ potassium/NN efflux/NN measured/VBN as/IN 86Rb+/CD efflux/NN from/IN control/JJ glands/NNS ,/, but/CC was/VBD without/IN effect/NN in/IN denervated/JJ glands/NNS ./.
@@109343108954 DATA/NNP SYNTHESIS/NNP :/: Intracoronary/NN ultrasound/NN has/VBZ been/VBN shown/VBP to/IN improve/VB upon/IN demonstrated/VBN weaknesses/NNS of/IN coronary/JJ angiography/NN ./.
@@13315163867 These/DT mutants/NNS grow/VBP normally/RB in/IN 3T6/CD mouse/NN fibroblast/NN cells/NNS ,/, and/CC they/PRP do/VBP not/RB complement/VB the/DT wild-type/NN virus/NN in/IN coinfection/NN experiments/NNS of/IN C2/NN myoblasts/NNS ./.
@@81299551153 Serial/JJ levels/NNS of/IN troponin/NEWGENE T/NEWGENE and/CC the/DT activity/NN of/IN CK-MB/NEWGENE were/VBD measured/VBN 6/CD ,/, 12/CD ,/, 24/CD and/CC 48/CD h/NN after/IN aortic/JJ unclamping/VBG ./.
@@105422743229 We/PRP also/RB show/VBP that/DT activation/NN of/IN protein/NEWGENE kinase/NEWGENE A/NEWGENE (/( PKA/NEWGENE )/SYM signaling/NN is/VBZ sufficient/JJ to/IN down-regulate/DT caveolin-1/NEWGENE protein/NEWGENE expression/NN and/CC promoter/NN activity/NN ./.
@@86150258228 As/IN expected/VBN ,/, glycosylation/NN of/IN Env/NEWGENE produced/VBN from/IN mutants/NNS was/VBD affected/VBN but/CC ,/, irrespective/JJ of/IN the/DT glycosylation/NN phenotype/NN ,/, (/( i/NN )/SYM similar/JJ quantities/NNS of/IN Env/NEWGENE were/VBD synthesized/VBN ,/, (/( ii/NN )/SYM the/DT immunoreactivity/NN of/IN V3/NN was/VBD similar/JJ ,/, (/( iii/NN )/SYM gp160/NEWGENE was/VBD efficiently/RB cleaved/VBN into/IN gp120/NEWGENE and/CC gp41/NEWGENE ,/, (/( vi/NN )/SYM Env/NEWGENE was/VBD exposed/VBN at/IN the/DT cell/NN membrane/NN ,/, (/( v/NN )/SYM secreted/VBN gp120/NEWGENE bound/JJ CD4/NEWGENE ,/, and/CC (/( vi/NN )/SYM membrane/NN gp41/NEWGENE was/VBD able/JJ to/IN induce/VB membrane/NN fusion/NN with/IN CD4+/NEWGENE cells/NNS ./.
@@27083538366 Significantly/RB ,/, the/DT polymerase/NN chain/NN reaction/NN results/NNS demonstrated/VBD that/DT gene/NEWGENE IV/NEWGENE transcripts/NEWGENE were/VBD associated/VBN with/IN hepatic/JJ polysome/NN fractions/NNS ,/, indicating/VBG their/PRP active/JJ utilization/NN in/IN this/DT tissue/NN ./.
@@94085169364 Stability/NNS of/IN pyrimethamine/NN in/IN a/DT liquid/JJ dosage/NN formulation/NN stored/VBN for/IN three/CD months/NNS ./.
@@37458337827 On/IN transition/NN from/IN high/JJ to/IN low/JJ voltage/NN there/RB was/VBD a/DT significant/JJ fall/NN in/IN arterial/JJ pressure/NN (/( 7%/JJ )/SYM and/CC an/DT increase/NN in/IN flow/NN (/( 19-38%/NN )/SYM to/IN areas/NNS of/IN the/DT brain/NN corresponding/JJ to/IN the/DT arborization/NN of/IN the/DT reticular/JJ formation/NN ,/, i/NN ./NN e/NN ./. excluding/JJ the/DT cerebrum/NN and/CC cerebellum/NN ./.
@@32561503950 The/DT results/NNS indicate/VBP that/IN the/DT pooling/VBG requirements/NNS are/VBP task/NN dependent/JJ ./.
@@9525105863 Also/RB ,/, the/DT anti-inflammatory/JJ activities/NNS of/IN an/DT aqueous/JJ extract/NN of/IN Buddleia/NNP cordata/NN and/CC its/PRP principal/JJ glycoside/NN linarin/NN were/VBD evaluated/VBN ./.
@@17778412388 The/DT possible/JJ mechanisms/NNS underlying/JJ differences/NNS in/IN post-tetanic/JJ effects/NNS from/IN muscle/NN and/CC cutaneous/JJ afferents/NNS in/IN adults/NNS and/CC neonates/NNS are/VBP discussed/VBN ./.
@@11196340631 For/IN immunological/JJ methods/NNS ,/, identification/NN of/IN such/JJ antigens/NNS with/IN intermolecular/JJ variability/NN ,/, e/FW ./FW g/FW ./FW ,/, the/DT structural/NN aescin/NN analogs/NNS ,/, is/VBZ of/IN unknown/JJ validity/NN ./.
@@89131863507 This/DT report/NN provides/VBZ further/JJ evidence/NN for/IN the/DT riMLF/NN in/IN the/DT control/NN of/IN downgaze/NN ,/, and/CC a/DT synkinesis/NN is/VBZ postulated/VBN for/IN the/DT development/NN of/IN the/DT convergence/NN retraction/NN nystagmus/NN ./.
@@8320968300 Abnormal/JJ calcium/NN metabolism/NN in/IN normocalcaemic/JJ sarcoidosis/NN [/NN letter/NN ]/NN ./.
@@95862851966 All/DT patients/NNS diagnosed/VBN of/IN H/NNP ./NNP influenza/NN type/NN b/NN meningitis/NN were/VBD less/PRP than/IN 3/CD years/NNS old/JJ ./.
@@37810004464 This/DT lack/NN of/IN correlation/NN may/MD be/VB due/NN to/IN variations/NNS in/IN the/DT metabolic/JJ activity/NN of/IN the/DT endometriotic/JJ implants/NNS present/VBP at/IN different/JJ stages/NNS of/IN the/DT disease/NN ./.
@@23174134499 Patients/NNS with/IN acute/JJ myocardial/JJ infarction/NN had/VBP higher/JJ plasma/NN concentrations/NNS of/IN neutrophil/NEWGENE elastase/NEWGENE and/CC the/DT non-peroxide/NN diene/NN conjugated/NN isomer/NN of/IN linoleic/JJ acid/NN than/IN normal/JJ volunteers/NNS or/CC patients/NNS with/IN stable/JJ ischaemic/JJ heart/NN disease/NN ./.
@@24378954382 A/DT probe/NN evoked/VBD potentials/NNS procedure/NN was/VBD used/VBN to/IN assess/VB the/DT relative/JJ engagement/NN of/IN both/DT cerebral/JJ hemispheres/NNS during/IN a/DT language/NN task/NN in/IN the/DT following/NN four/CD groups/NNS of/IN dextral/JJ adults/NNS :/: left/NN hemisphere/NN (/( LH/NN )/NN -damaged/NN aphasics/NNS recovering/VBG from/IN stroke/NN ,/, dysarthrics/NNS ,/, right/JJ hemisphere/NN (/( RH/NN )/NN -damaged/NN nonaphasic/JJ patients/NNS ,/, and/CC normal/JJ control/NN subjects/NNS ./.
@@97981007739 On/IN Day/NN 8/CD ,/, the/DT CIDR-B/NN was/VBD removed/VBN and/CC 500/CD micrograms/NNS cloprostenol/NN injected/VBN ,/, IM/NNP ./NNP
@@102014685573 Plasma/NN glucose/NN ,/, immunoreactive/NEWGENE insulin/NEWGENE (/( IRI/NEWGENE )/SYM ,/, C-peptide/NEWGENE ,/, glucagon/NEWGENE ,/, and/CC GLP-1/NEWGENE levels/NNS at/IN each/DT time/NN point/NN during/IN OGTT/NN were/VBD measured/VBN ./.
@@76284385099 The/DT Drosophila/NEWGENE insulin/NEWGENE receptor/NEWGENE homolog/NEWGENE :/: a/DT gene/NN essential/JJ for/IN embryonic/JJ development/NN encodes/VBZ two/JJ receptor/NN isoforms/NNS with/IN different/JJ signaling/JJ potential/NN ./.
@@99436519938 Internal/NNP modes/NNS of/IN a/DT soliton/NN ./.
@@92160175594 Vitrectomy/NN was/VBD still/RB a/DT significant/JJ risk/NN factor/NN when/CC macular/JJ holes/NNS were/VBD excluded/VBN ./.
@@35972182667 The/DT absolute/JJ concentrations/NNS of/IN alpha/NEWGENE 2-plasmin/NEWGENE inhibitor/NN ,/, alpha/NEWGENE 2-macroglobulin/NEWGENE ,/, and/CC antithrombin/NEWGENE III/NEWGENE increased/VBD with/IN exercise/NN (/( all/DT P/NN less/PRP than/IN 0/CD ./CD 005/CD )/SYM ,/, but/CC when/CC concentrations/NNS were/VBD corrected/VBN for/IN acute/JJ shifts/NNS of/IN plasma/NN water/NN during/IN exercise/NN ,/, the/DT quantity/NN of/IN these/DT inhibitors/NNS actually/RB decreased/VBN (/( all/DT P/NN less/PRP than/IN 0/CD ./CD 005/CD )/SYM ./.
@@81395393284 In/NNP Rat/NNP 1a/CD cells/NNS ,/, m1R/NEWGENE stimulation/NN of/IN phospholipase/NEWGENE C/NEWGENE beta/NEWGENE and/CC the/DT marked/JJ rise/NN in/IN intracellular/JJ calcium/NN stimulated/VBD cyclic/JJ AMP/NN (/( cAMP/NN )/SYM synthesis/NN ,/, resulting/JJ in/IN the/DT activation/NN of/IN protein/NEWGENE kinase/NEWGENE A/NNP ./NNP
@@106520937232 Electron/NNP microscopic/JJ and/CC enzymatic/JJ analyses/NNS revealed/VBN that/IN the/DT A118/NN genome/NN is/VBZ a/DT linear/JJ ,/, circularly/RB permuted/VBN ,/, terminally/RB redundant/JJ collection/NN of/IN double-stranded/JJ DNA/NN molecules/NNS ./.
@@108507197721 Vbeta/NEWGENE segments/NEWGENE are/VBP appended/VBN to/IN DJbeta/NEWGENE rearrangements/NEWGENE ,/, with/IN little/JJ or/CC no/DT direct/JJ Vbeta/NEWGENE to/IN Jbeta/NEWGENE joining/VBG ,/, despite/IN 12/CD //CD 23/CD compatibility/NN of/IN Vbeta/NEWGENE 23-RSSs/NEWGENE and/CC Jbeta12-RSSs/NEWGENE ./.
@@19902541013 Immunophenotyping/NN in/IN four/CD cases/NNS ,/, demonstrated/VBN non-B/NN ,/, non-T/NN cell/NN origin/NN in/IN three/CD and/CC pre-B/NN cell/NN origin/NN in/IN one/PRP ./.
@@68487296638 Of/IN 254/CD children/NNS with/IN neuroblastoma/NN treated/VBN at/IN St/NN ./NN
@@113414058120 SAMPLE/NNP POPULATION/NNP :/: MCB/NN from/IN 7/CD racing/JJ Greyhounds/NNS euthanatized/VBN for/IN reasons/NNS unrelated/JJ to/IN MCB/NN abnormalities/NNS ./.
@@16244254878 Wild-type/NN protein/NN bound/JJ azido-ATP/NN well/NN ,/, but/CC mutants/NNS with/IN substitutions/NNS in/IN the/DT consensus/NN amino/JJ acids/NNS were/VBD unable/JJ to/IN bind/NN azido-ATP/NN ./.
@@7758459265 The/DT UAS/NEWGENE of/IN the/DT AAC2/NEWGENE gene/NEWGENE contains/VBZ at/IN least/RB two/JJ distinct/JJ motifs/NNS for/IN DNA-binding/NEWGENE transcriptional/NEWGENE activators/NEWGENE ,/, including/JJ one/PRP which/WDT is/VBZ identical/JJ with/IN the/DT core/NN HAP2/NEWGENE //NEWGENE 3/NEWGENE //NEWGENE 4/NEWGENE binding/NEWGENE motif/NEWGENE ,/, and/CC a/DT second/JJ one/PRP with/IN the/DT ABF1/NEWGENE consensus/NEWGENE binding/NEWGENE sequence/NEWGENE ./.
@@30013535944 At/NN temperatures/NNS permissive/JJ for/IN transformation/NN ,/, 6m2/NNP cells/NNS contain/VBP P58gag/NEWGENE produced/VBD from/IN the/DT 4/CD ./CD 0-kilobase/CD (/( kb/NN )/SYM viral/JJ RNA/NN genome/NN and/CC P85gag-mos/NEWGENE translated/VBD from/IN a/DT 3/CD ./CD 5-kb/CD spliced/VBN mRNA/NN ./.
@@88619631645 The/DT reconstituted/VBN RNA/NEWGENE polymerases/NEWGENE containing/JJ the/DT mutant/NN alpha/NN subunits/NN were/VBD examined/VBN for/IN their/PRP response/NN to/IN transcription/NN activation/NN by/IN cAMP-CRP/NEWGENE and/CC the/DT rrnBP1/NEWGENE UP/NEWGENE element/NEWGENE ./.
@@112547527334 2001/CD ./.
@@18474645735 In/NN short-term/JJ cotransfections/NNS ,/, a/DT pFRTK-CAT/NEWGENE target/NN containing/NN EBNA-1-binding/NEWGENE sites/NEWGENE from/IN the/DT EBV/NN origin/NN of/IN plasmid/NN replication/NN ,/, ori-P/NEWGENE ,/, was/VBD transactivated/VBN by/IN a/DT carboxy-terminal/NEWGENE EBNA-1/NEWGENE construction/NEWGENE (/( amino/JJ acids/NNS 450/CD to/IN 641/CD )/SYM that/IN also/RB carried/VBN a/DT c-myc/NEWGENE nuclear/NEWGENE localization/NEWGENE signal/NEWGENE ./.
@@91320611453 The/DT atp/NEWGENE 1/NEWGENE and/CC atp/NEWGENE 2/NEWGENE types/NNS of/IN cDNA/NN sequences/NNS were/VBD the/DT most/RB redundant/JJ among/IN the/DT 28/CD different/JJ isoperoxidases/NEWGENE identified/VBN among/IN about/RB 200/CD peroxidase/NEWGENE encoding/NEWGENE ESTs/NEWGENE ./.
@@69842251495 REV/NN I/NN :/: All/DT vessels/NNS up/JJ to/IN 50%/CD stenosed/JJ have/NN a/DT patent/JJ graft/NN ./.
@@96715766466 One/CD is/VBZ to/IN act/NN within/IN the/DT visceral/JJ endoderm/NN to/IN promote/VB proper/JJ streak/NN morphogenesis/NN ./.
@@95464249406 Interestingly/RB ,/, the/DT activated/VBN PDGF/NEWGENE beta-receptor/NEWGENE was/VBD found/VBN not/RB to/IN bind/NN Crk/NEWGENE proteins/NEWGENE ./.
@@79346665786 The/DT transverse/JJ magnetization/NN decays/VBZ mentioned/VBN above/RB exhibited/VBN two/JJ components/NNS ,/, a/DT T2/NN fast/JJ (/( T2f/NNP )/SYM and/CC a/DT T2/NN slow/JJ (/( T2s/NNS )/SYM component/NN ./.
@@31925371412 The/DT deduced/VBN 96-residue/CD amino/JJ acid/NN coding/JJ sequence/NN of/IN the/DT murine/JJ HMG-I/NEWGENE (/NEWGENE Y/NEWGENE )/NEWGENE cDNA/NN is/VBZ very/RB similar/JJ to/IN the/DT reported/VBN amino/JJ acid/NN sequence/NN of/IN human/NN HMG-I/NEWGENE ,/, except/VB that/IN it/PRP lacks/VBZ 11/CD internal/JJ amino/JJ acids/NNS reported/VBN in/IN the/DT human/JJ protein/NN ./.
@@112788489937 Furthermore/RB ,/, SB203580/NN inhibited/VBN LPS-induced/JJ activation/NN of/IN Sp1/NEWGENE ,/, as/RB well/VB as/IN the/DT promoter/NN activity/NN in/IN cells/NNS transfected/VBN with/IN a/DT plasmid/NN containing/JJ the/DT Sp1/NEWGENE consensus/NN sequence/NN ./.
@@78762105630 It/PRP is/VBZ now/RB recognized/VBN that/IN essentially/RB all/DT eukaryotic/JJ and/CC prokaryotic/JJ genes/NNS whose/WP 5'-flanking/JJ regions/NNS are/VBP known/VBP and/CC that/DT encode/VB barbiturate-inducible/JJ proteins/NNS contain/VBP the/DT Barbie/NEWGENE box/NEWGENE element/NEWGENE ./.
@@23363382988 The/DT effects/NNS of/IN mean/JJ luminance/NN were/VBD also/RB measured/VBN and/CC a/DT general/JJ expression/NN that/WDT would/MD take/VB them/PRP into/IN account/NN was/VBD derived/VBN ./.
@@107944057239 The/DT structural/JJ study/NN of/IN peptides/NNS belonging/NN to/IN the/DT terminal/JJ domains/NNS of/IN histone/NEWGENE H1/NEWGENE can/MD be/VB considered/VBN as/IN a/DT step/NN toward/IN the/DT understanding/NN of/IN the/DT function/NN of/IN H1/NEWGENE in/IN chromatin/NN ./.
@@47982935171 3/CD ./CD
@@10622576447 Clear/NNP and/CC evidenced-based/JJ information/NN should/MD be/VB provided/VBN to/RB patients/NNS as/IN to/IN the/DT means/NN of/IN prevention/NN with/IN special/JJ attention/NN to/IN individual/JJ risk/NN groups/NNS such/JJ as/IN IV/NN drug/NN abusers/NNS ./.
@@16150492196 The/DT eating/JJ and/CC drinking/JJ patterns/NNS of/IN pygmy/NN goats/NNS fed/VBD ad/NN lib/NN and/CC kept/VBP on/IN a/DT 12/CD h/NN light/NN //NN 12/NN h/NN dark/JJ cycle/NN were/VBD recorded/VBN and/CC analyzed/VBN ./.
@@99853029984 Chaotic/JJ electron/NN dynamics/NNS around/IN a/DT single/JJ elliptically/RB shaped/JJ antidot/NN ./.
@@84499435180 In/NN the/DT present/NN study/NN we/PRP demonstrated/VBD a/DT unique/JJ mechanism/NN of/IN action/NN of/IN 8-Cl-cAMP/JJ in/IN the/DT regulation/NN of/IN these/DT kinase/NEWGENE isozymes/NEWGENE in/IN HL-60/NN human/JJ promyelocytic/JJ leukemia/NN cells/NNS ./.
@@40675403670 The/DT comparisons/NNS revealed/VBN that/IN female/JJ homicide-suicide/NN perpetrators/NNS were/VBD more/RB likely/RB than/IN female/JJ homicide-suicide/NN victims/NN to/IN live/VB in/IN mobile/JJ homes/NNS ,/, kill/VB their/PRP lover/NN or/CC ex-lover/JJ ,/, have/VB their/PRP crime/NN accidentally/RB discovered/VBD ,/, leave/VB a/DT suicide/NN note/NN ,/, kill/NN on/IN a/DT weekend/NN ,/, and/CC be/VB depressed/VBN ,/, but/CC are/VBP less/PRP likely/RB than/IN female/JJ homicide-suicide/NN victims/NN to/IN live/VB with/IN a/DT spouse/NN ./.
@@118014591666 Efficacy/NNS and/CC safety/NN of/IN aspirin/NN in/IN the/DT long-term/JJ management/NN of/IN atherothrombosis/NN ./.
@@89553062172 Northern/NNP (/( RNA/NN )/SYM blot/NN analyses/NNS indicated/VBN that/IN the/DT cdh/NEWGENE genes/NEWGENE encoding/VBG the/DT five/CD subunits/NNS and/CC an/DT open/JJ reading/JJ frame/NN (/( ORF1/NN )/SYM with/IN unknown/JJ function/NN are/VBP cotranscribed/VBN during/IN growth/NN on/IN acetate/NN ./.
@@12855541927 Prospects/NNS for/IN controlled-delivery/NN systems/NNS ./.
@@10585808413 Mycoplasma/NN hominis/JJ infections/NNS are/VBP easily/RB missed/VBN because/IN conventional/JJ methods/NNS for/IN bacterial/JJ detection/NN may/MD fail/VB ./.
@@108557964923 Finally/RB ,/, in/IN situ/NN RNA/NN hybridization/NN studies/NNS revealed/VBD a/DT very/RB specific/JJ pattern/NN of/IN EphA8/NEWGENE gene/NEWGENE expression/NN restricted/VBN to/IN the/DT rostral/JJ region/NN of/IN midbrain/NN tectum/NN during/IN embryonic/JJ development/NN ./.
@@15607747861 The/DT 1/CD ./CD 7/CD kb/NN cloned/VBN fragment/NN was/VBD sequenced/VBN and/CC shown/VBP to/IN contain/VB the/DT entire/JJ fliA/NEWGENE gene/NEWGENE ./.
@@16367142239 The/DT results/NNS indicate/VBP that/IN the/DT carbon-perfused/JJ areas/NNS and/CC MBF/NN in/IN the/DT liver/NN ,/, renal/JJ cortex/NN ,/, spleen/NN ,/, and/CC small/JJ intestinal/JJ serosa/NN (/( only/RB MBF/NN )/SYM increased/VBN significantly/RB 5/CD h/NN after/IN CLP/NN ./.
@@76875415067 Since/IN RCC1p/NEWGENE acts/NNS as/IN GNRP/NEWGENE for/IN Ran/NEWGENE ,/, a/DT small/NEWGENE nuclear/NEWGENE GTPase/NEWGENE of/IN the/DT ras/NEWGENE superfamily/NEWGENE ,/, we/PRP have/VBP identified/VBN two/JJ homologs/NNS of/IN Ran/NEWGENE in/IN S/NN ./NN cerevisiae/NN (/( CNR1/NEWGENE and/CC CNR2/NEWGENE )/SYM ./.
@@16201188765 These/DT mutant/JJ proteins/NNS retained/VBD the/DT ability/NN to/IN competitively/RB inhibit/VB kappa/NN B-mediated/JJ transcriptional/JJ activation/NN of/IN the/DT human/JJ immunodeficiency/NN virus/NN long/JJ terminal/JJ repeat/NN but/CC failed/VBN to/IN efficiently/RB transform/VB chicken/NN lymphoid/JJ cells/NNS both/DT in/NN vitro/FW and/CC in/IN vivo/NN ./.
@@91460271547 A/DT patient/NN of/IN Group/NNP B/NNP had/VBP severe/JJ athetoid/NN CP/NN with/IN spasticity/NN ,/, being/VBP unable/JJ to/IN right/JJ his/PRP trunk/NN and/CC neck/NN ./.
@@100497754089 Mapping/NN of/IN the/DT human/NEWGENE Voltage-Dependent/NEWGENE Anion/NEWGENE Channel/NEWGENE isoforms/NEWGENE 1/NEWGENE and/NEWGENE 2/NEWGENE reconsidered/VBN ./.
@@83719368336 The/DT Functional/NNP Independence/NNP Measure/NN :/: a/DT comparative/JJ study/NN of/IN clinician/NN and/CC self/NN ratings/NNS ./.
@@62954292992 The/DT combination/NN of/IN MISO/DT and/CC WR-2721/NN gave/VBD an/DT intermediate/JJ response/NN compared/VBN with/IN either/DT drug/NN used/VBN alone/RB ,/, resulting/JJ in/IN some/DT sensitization/NN with/IN single/JJ doses/NNS and/CC an/DT overall/JJ protection/NN with/IN repeated/JJ small/JJ doses/NNS ./.
@@80916695923 To/TO determine/VB whether/IN P35/NEWGENE could/MD activate/VB the/DT 39k/NN promoter/NN in/IN the/DT absence/NN of/IN IE1/NEWGENE ,/, the/DT p35/NEWGENE open/JJ reading/JJ frame/NN was/VBD cloned/VBN under/IN the/DT control/NN of/IN the/DT ie1/NEWGENE promoter/NEWGENE ./.
@@90735822863 A/DT previous/JJ report/NN described/VBN that/IN a/DT 548-bp/NEWGENE BglII-SmaI/NEWGENE fragment/NEWGENE has/VBZ an/DT SSO/NNS activity/NN (/( ori2/NN ;/: Kataoka/NN et/FW al/NNS ./NNS ,/, Mol/JJ ./.
@@13728024574 In/NN summary/NN ,/, the/DT segments/NNS of/IN C3/NEWGENE represented/VBN by/IN amino/JJ acid/NN residues/NNS 1082-1118/JJ ,/, 1117-1155/JJ ,/, 1234-1294/CD and/CC 1312-1404/JJ accommodate/VB C3/NEWGENE (/NEWGENE D/NEWGENE )/NEWGENE epitopes/NEWGENE that/WDT are/VBP expressed/VBN by/IN erythrocyte-bound/NN C3/NEWGENE fragments/NEWGENE ,/, but/CC not/RB by/IN the/DT corresponding/JJ fluid-phase/NN fragment/NN ,/, whereas/IN the/DT segments/NNS spanning/VBG residues/NNS 973-1026/CD and/CC 1477-1510/JJ contain/VB C3/NEWGENE (/NEWGENE D/NEWGENE )/NEWGENE epitopes/NEWGENE that/WDT are/VBP exposed/VBN exclusively/RB in/IN denatured/JJ C3/NEWGENE and/CC therefore/RB hidden/JJ in/IN physiological/JJ fragments/NNS of/IN the/DT protein/NN ./.
@@9712898627 Thus/RB ,/, TRAF2/NEWGENE initiates/VBP SAPK/NEWGENE and/CC p38/NEWGENE activation/NN by/IN binding/JJ two/JJ proximal/JJ protein/NEWGENE kinases/NEWGENE :/: GCK/NEWGENE and/CC RIP/NEWGENE ./.
@@32272888662 Of/IN the/DT 43/CD infants/NNS with/IN a/DT (/( probable/JJ )/SYM loss/NN 18/NN were/VBD examined/VBN again/RB at/IN 3/CD months/NNS corrected/VBD age/NN ./.
@@19016642526 3/CD cases/NNS ./.
@@30205134388 The/DT 52-protein/NN subunit/NN of/IN T4/NEWGENE DNA/NEWGENE topoisomerase/NEWGENE is/VBZ homologous/JJ to/IN the/DT gyrA-protein/NEWGENE of/IN gyrase/NEWGENE ./.
@@105405532045 Intensive/JJ synthesis/NN of/IN PNA/NEWGENE in/IN the/DT cells/NNS of/IN microvascular/JJ wall/NN evidenced/VBN of/IN their/PRP high/JJ functional/JJ activity/NN ,/, and/CC the/DT synthesis/NN of/IN DNA/NN in/IN them/PRP showed/VBD their/PRP ability/NN for/IN proliferation/NN ,/, i/NN ./NN g/NN ./NN --for/NN growth/NN ./.
@@66707322816 In/NN a/DT randomized/JJ study/NN on/IN 150/CD patients/NNS (/( ASA/NN 1/NN )/SYM undergoing/VBG induction/NN of/IN anaesthesia/NN ,/, the/DT effects/NNS of/IN Fentanyl/DT (/( 0/CD ./CD 1/CD mg/NN )/SYM ,/, the/DT combination/NN of/IN Fentanyl/DT (/( 0/CD ./CD 1/CD mg/NN )/SYM and/CC Droperidol/CHEM (/( 5/CD mg/NN )/SYM (/( Innovar/NN ,/, Thalamonal/JJ )/SYM and/CC Atropine/IN (/( 0/CD ./CD 01/CD mg/CD //CD kg/CD b/CD ./CD w/CD ./CD )/SYM alone/RB on/IN cardiocirculatory/JJ parameters/NNS were/VBD studied/VBN ./.
@@81528001516 Since/IN the/DT ETS/NEWGENE domain/NEWGENE ,/, which/WDT is/VBZ localized/VBN in/IN the/DT carboxy/NN terminal/NN region/NN of/IN the/DT encoded/VBN protein/NN ,/, is/VBZ 95%/NN and/CC 96%/NN identical/JJ to/IN that/DT of/IN PEA3/NEWGENE and/CC ER81/NEWGENE ,/, respectively/RB ,/, we/PRP named/VBD this/DT new/JJ member/NN 'Ets/NEWGENE Related/NEWGENE Molecule/NEWGENE PEA3-like'/NEWGENE (/( ERM/NEWGENE )/SYM ./.
@@106017473452 Relative/JJ to/IN coherent/JJ control/NN words/NNS (/( e/FW ./FW g/FW ./FW ,/, quick/JJ )/SYM ,/, these/DT discourse-dependent/JJ semantic/JJ anomalies/NNS elicited/VBD a/DT large/NN N400/NN effect/NN that/WDT began/VBD at/IN about/RB 200/CD to/IN 250/CD msec/NN after/IN word/NN onset/NN ./.
@@91908218808 The/DT second/JJ primary/JJ mutant/RB contained/VBN a/DT proline-to-leucine/JJ change/NN at/IN position/NN 243/CD (/( P243L/NN )/SYM ./.
@@40555936790 The/DT fast/JJ real-time/NN digital/JJ processing/NN of/IN the/DT N2/NN and/CC flow/NN signals/NNS incorporated/VBD filtering/JJ ,/, delay/NN compensation/NN ,/, and/CC corrections/NNS for/IN the/DT effects/NNS of/IN changes/NNS in/IN gas/NN composition/NN and/CC temperature/NN ./.
@@95035269465 In/NN patients/NNS with/IN myalgia/NN ,/, Raynaud's/NNP syndrome/NN ,/, skin/NN vasculitis/NN and/CC vascular/JJ diseases/NNS WFAg/NEWGENE concentrations/NNS were/VBD higher/JJ than/IN in/IN patients/NNS without/IN them/PRP ./.
@@79166891306 The/DT Y/NNP ./NNP lipolytica/NN genomic/JJ POT1/NEWGENE gene/NN was/VBD disrupted/VBN by/IN replacing/VBG 120/CD bp/NN of/IN its/PRP coding/JJ sequence/NN with/IN 2/CD ./CD 7/CD kbp/NN of/IN DNA/NN including/JJ the/DT Y/NNP ./NNP lipolytica/NN LEU2/NEWGENE gene/NEWGENE ./.
@@85761792079 Activated/NN PKR/NEWGENE may/MD exist/VB as/IN a/DT dimer/NN and/CC phosphorylates/VBZ the/DT eukaryotic/NEWGENE translation/NEWGENE initiation/NEWGENE factor/NEWGENE 2/NEWGENE alpha/NEWGENE subunit/NEWGENE (/( cIF-2/NEWGENE alpha/NEWGENE )/SYM to/IN inhibit/VB polypeptide/NN chain/NN initiation/NN ./.
@@7723247179 After/IN 24/CD hour/NN incubation/NN ,/, total/JJ cell-associated/NN IL-1Ra/NEWGENE and/CC IL-1/NEWGENE beta/NEWGENE were/VBD measured/VBN by/IN specific/JJ radioimmunoassay/NN ./.
@@309374943 SGPT/NEWGENE ,/, SGOT/NEWGENE ,/, and/CC alkaline/NEWGENE phosphatase/NEWGENE concentrations/NNS were/VBD essentially/RB normal/JJ in/IN all/DT subjects/NNS ./.
@@77195277673 Weak/JJ allergenicity/NN of/IN recombinant/NEWGENE hirudin/NEWGENE CGP/NEWGENE 39393/NEWGENE (/( REVASC/NNP )/SYM in/IN immunocompetent/JJ volunteers/NNS ./.
@@9599664821 The/DT DNA/NN sequencing/VBG of/IN the/DT recombinant/JJ clones/NNS revealed/VBD the/DT expression/NN of/IN RXR/NEWGENE alpha/NEWGENE and/CC RXR/NEWGENE beta/NEWGENE ./.
@@111564845610 TBARS/NNS levels/NNS ,/, oxygen-radical/JJ absorbing/JJ capacity/NN assay/NN and/CC AFR/NN release/NN assessed/VBN by/IN electron/NN paramagnetic/JJ resonance/NN (/( EPR/NN )/SYM were/VBD used/VBN to/IN explore/VB the/DT existence/NN of/IN oxidative/JJ stress/NN in/IN diabetes/NN ./.
@@94860353975 METHODS/IN :/: A/DT population/NN survey/NN was/VBD undertaken/VBP in/IN 10/NN ,/NN 148/NN individuals/NNS to/IN measure/NN the/DT prevalence/NN and/CC identify/VB the/DT causes/NNS of/IN blindness/NN in/IN Lebanon/NN ./.
@@77871798654 A/DT 73/NEWGENE bp/NEWGENE fragment/NEWGENE (/NEWGENE X1/NEWGENE region/NEWGENE )/NEWGENE of/IN the/DT PRB-1b/NEWGENE promoter/NEWGENE ,/, located/VBN between/IN positions/NNS -213/CD and/CC -141/CD ,/, was/VBD sufficient/JJ to/IN confer/VB ethylene/NN responsiveness/NN to/IN the/DT reporter/NN gene/NN ./.
@@91685119117 More/RBR recently/RB ,/, however/RB ,/, a/DT number/NN of/IN developments/NNS such/JJ as/IN the/DT successful/JJ use/NN of/IN the/DT inhaled/JJ steroid/JJ budesonide/NN and/CC oral/JJ dexamethasone/NN have/NN reinforced/VBD the/DT argument/NN for/IN using/VBG steroids/NNS ./.
@@30036957636 Comparison/NNS with/IN a/DT recently/RB described/VBN c-sis/NEWGENE cDNA/NEWGENE clone/NEWGENE (/( Collins/NN et/FW al/NNS ./NNS ,/, Nature/NNP 316/CD ,/, 748-750/JJ (/( 1985/CD )/NN )/NN revealed/VBN that/IN the/DT 1/CD ./CD 9/CD kbp/NN DNA/NN region/NN contained/VBD a/DT large/JJ 5'/NEWGENE c-sis/NEWGENE exon/NEWGENE of/IN at/IN least/RB 1050/CD bp/CD ./CD
@@104921694142 This/DT cluster/NN consisted/VB of/IN four/CD apparently/RB unrelated/JJ ESTs/NNS and/CC two/JJ genes/NNS ,/, pregnancy-associated/NEWGENE plasma/NEWGENE protein-A/NEWGENE (/( PAPP-A/NEWGENE )/SYM and/CC a/DT novel/JJ gene/NN (/( tentatively/RB named/VBN EST-YD1/NEWGENE )/SYM ./.
@@81517907282 The/DT revertant/JJ TATA/NN boxes/NNS accelerated/VBD the/DT kinetics/NN of/IN HIV/NN replication/NN when/CC present/VB in/IN the/DT context/NN of/IN an/DT LTR/NN containing/NN a/NN Sp1/NEWGENE mutation/NN (/( deletion/NN or/CC site/NN specific/JJ )/SYM ;/: no/DT effect/NN was/VBD observed/VBN on/IN the/DT infectivity/NN of/IN wild-type/NN HIV/NN ./.
@@106001719630 Higher/JJR CYP3A23/NEWGENE basal/JJ activity/NN appears/VBZ to/IN be/VB due/NN to/IN an/DT E-box/NNS in/IN 3A23SiteA/NEWGENE that/WDT interacts/VBZ with/IN USF1/NEWGENE ,/, a/DT ubiquitous/JJ bHLH/NEWGENE //NEWGENE leucine/NEWGENE zipper/NEWGENE transcription/NEWGENE factor/NEWGENE ./.
@@92235061866 Transcription/NNS factor/NN binding/JJ sites/NNS downstream/RB of/IN the/DT human/JJ immunodeficiency/NN virus/NN type/NN 1/NN transcription/NN start/NN site/NN are/VBP important/JJ for/IN virus/NN infectivity/NN ./.
@@91084516528 Results/NNS from/IN our/PRP and/CC other/DT laboratories/NNS have/NN suggested/VBN that/IN UCN-01/NN induces/VBZ preferential/JJ G1-phase/NN accumulation/NN in/IN several/DT human/JJ tumor/NN cell/NN lines/NNS tested/VBN ./.
@@106012905907 To/TO understand/VB the/DT basis/NN for/IN the/DT increased/VBN cell/NN surface/NN stability/NN compared/VBN with/IN wild-type/NN peptide/NN and/CC to/IN understand/VB the/DT differences/NNS in/IN T/NN cell/NN recognition/NN between/IN I1Y/NEWGENE and/CC I1F/NEWGENE ,/, we/PRP determined/VBD the/DT x-ray/NN crystal/NN structures/NNS of/IN the/DT two/JJ class/NEWGENE I/NEWGENE MHC-peptide/NEWGENE complexes/NEWGENE ./.
@@15883158394 AgMNPV/NNP and/CC Orgyia/NNP pseudotsugata/NN MNPV/NNS (/( OpMNPV/NNP )/SYM are/VBP similar/JJ in/IN terms/NNS of/IN promoter/NN structure/NN and/CC polyhedrin/NEWGENE primary/NEWGENE sequence/NEWGENE ,/, and/CC the/DT polyhedrin/NEWGENE gene/NEWGENE of/IN both/DT viruses/NNS is/VBZ transcribed/VBN in/IN the/DT anti-clockwise/JJ direction/NN in/IN relation/NN to/IN their/PRP physical/JJ maps/NNS ./.
@@6216262772 Stress/NN effects/NNS on/IN affiliation/NN preferences/NNS among/IN subjects/NNS possessing/VBG the/DT type/NN A/NN coronary-prone/JJ behavior/NN pattern/NN ./.
@@117412591588 The/DT performance/NN of/IN pH-sensitive/JJ particles/NNS is/VBZ attributed/VBN to/IN their/PRP ability/NN to/IN release/NN the/DT drug/NN selectively/RB in/IN the/DT upper/JJ part/NN of/IN the/DT intestine/NN in/IN a/DT molecular/JJ or/CC amorphous/JJ form/NN ./.
@@11150114987 Chlamydia/NN and/CC cervical/JJ cancer/NN :/: a/DT real/JJ association/NN ?/.
@@95159244002 From/IN 250/CD g/NN of/IN cells/NNS ,/, we/PRP isolated/VBD 1/CD mg/NN of/IN PDH/NEWGENE complex/NEWGENE with/IN a/DT specific/JJ activity/NN of/IN 12/CD ./CD 6/CD U/NNS //NNS mg/NNS of/IN protein/NN ./.
@@10375107247 Progression/NNS after/IN first-line/NN chemotherapy/NN was/VBD associated/VBN with/IN significantly/RB worse/JJ survival/NN for/IN patients/NNS with/IN metastasis/NN ./.
@@97152784793 The/DT histopathology/NN and/CC neovascularization/NN did/VBD not/RB appreciably/RB differ/VB between/IN xenograft/NN tumors/NNS derived/VBN from/IN FGF4/NEWGENE over-expressing/JJ versus/IN control/NN transfectants/NNS ./.
@@79277118194 ORF/NN 2/NN potentially/RB encoded/VBN a/DT hydrophobic/JJ protein/NN of/IN 29/CD ,/CD 705/CD Da/NNP with/IN six/CD potential/JJ membrane-spanning/NN regions/NN ./.
@@76728221602 Genomic/NN structure/NN and/CC chromosomal/JJ location/NN of/IN the/DT mouse/NEWGENE pre-T-cell/NEWGENE receptor/NEWGENE alpha/NEWGENE gene/NEWGENE ./.
@@108122941097 When/WRB the/DT entire/JJ diet/NN consisted/VB of/IN SBF/NN ,/, voluntary/JJ feed/JJ intake/NN was/VBD reduced/VBN ,/, indicating/VBG that/IN SBF/NN should/MD not/RB be/VB fed/VBN to/RB ponies/NNS as/IN the/DT sole/JJ dietary/JJ ingredient/NN ./.
@@114964951380 The/DT authors/NNS made/VBP an/DT analysis/NN of/IN social-economical/JJ conditions/NNS limiting/JJ the/DT possibilities/NNS of/IN rendering/VBG cardiosurgical/JJ care/NN to/IN children/NNS ./.
@@77999313847 Therefore/RB ,/, it/PRP is/VBZ hoped/VBN that/IN by/IN defining/VBG the/DT transcriptional/JJ control/NN of/IN the/DT L7/NEWGENE gene/NEWGENE insights/NNS into/IN the/DT mechanisms/NNS that/WDT control/VBP functional/JJ fate/NN and/CC organization/NN in/IN the/DT nervous/JJ system/NN can/MD be/VB gained/VBN ./.
@@75475007395 We/PRP showed/VBD previously/RB that/IN a/DT fusion/NN protein/NN (/( GAL4-p40/NEWGENE )/SYM containing/JJ the/DT DNA-binding/NN domain/NN of/IN GAL4/NEWGENE and/CC sequences/NNS of/IN chicken/NEWGENE l/NEWGENE kappa/NEWGENE B-alpha/NEWGENE (/( p40/NEWGENE )/SYM inhibits/VBZ growth/NN in/IN the/DT yeast/NN Saccharomyces/NN cerevisiae/NN ./.
@@75137035987 Activation/NNS of/IN the/DT SH2-containing/NEWGENE protein/NEWGENE tyrosine/NEWGENE phosphatase/NEWGENE ,/, SH-PTP2/NEWGENE ,/, by/IN phosphotyrosine-containing/NN peptides/NN derived/VBN from/IN insulin/NEWGENE receptor/NEWGENE substrate-1/NEWGENE ./.
@@91441653564 We/PRP thus/RB conclude/VBP that/IN the/DT NFAT/NEWGENE RIR/NEWGENE plays/VBP an/DT essential/JJ dual/JJ role/NN in/IN DNA/NN recognition/NN and/CC cooperative/JJ binding/NN to/IN AP-1/NEWGENE family/NEWGENE transcription/NEWGENE factors/NEWGENE ./.
@@112661845890 Atheroma/NNS appears/VBZ as/IN a/DT very/RB low/JJ signal/JJ intensity/NN area/NN on/IN 2-dimensional/JJ time-of-flight/JJ (/( TOF/NN )/SYM magnetic/JJ resonance/NN (/( MR/NN )/SYM images/NNS ,/, and/CC its/PRP components/NNS have/VBP various/JJ signal/JJ intensities/NNS on/IN spin-echo/NN (/( SE/NN )/SYM images/NNS ./.
@@97148352319 After/IN that/DT report/NN ,/, carboxypeptidase/NEWGENE D/NEWGENE (/( CPD/NEWGENE )/SYM was/VBD subsequently/RB purified/VBN from/IN bovine/JJ pituitary/JJ and/CC characterized/VBN as/IN a/DT novel/JJ carboxypeptidase/NEWGENE E/NEWGENE (/( CPE/NEWGENE )/NN -like/NN enzyme/NN ,/, with/IN many/JJ characteristics/NNS in/IN common/JJ with/IN duck/NN gp180/NEWGENE (/( Song/NNP ,/, L/NNP ./NNP ,/, Fricker/NNP ,/, L/NNP ./NNP D/NNP ./NNP ,/, 1995/CD ./.
@@65163696304 Proteinuria--selected/JJ physiopathological/JJ and/CC clinical/JJ problems/NNS ./.
@@21482192757 Although/IN popular/JJ this/DT hypothesis/NN is/VBZ far/RB from/IN explaining/VBG all/PDT the/DT clinical/JJ facts/NNS ,/, namely/RB that/DT rigidity/NN is/VBZ equal/NN in/IN extensor/NN and/CC flexor/NN ,/, proximal/JJ and/CC distal/JJ muscles/NNS ./.
@@17180438860 In/NN patients/NNS with/IN osteomyelitis/NN and/CC joint/JJ empyema/NN (/( n/NN =/SYM 48/CD )/SYM PMN/NEWGENE elastase/NEWGENE had/VBP a/DT sensitivity/NN of/IN 77%/JJ ,/, which/WDT was/VBD only/RB exceeded/VBN by/IN that/DT of/IN the/DT unspecific/JJ erythrocyte/NN sedimentation/NN rate/NN (/( sensitivity/NN 89%/CD )/SYM ./.
@@79295591143 Cytoplasmic/NEWGENE dynein/NEWGENE is/VBZ a/DT multisubunit/JJ ,/, microtubule-dependent/JJ mechanochemical/JJ enzyme/NN that/WDT has/VBZ been/VBN proposed/VBN to/IN function/NN in/IN a/DT variety/NN of/IN intracellular/JJ movements/NNS ,/, including/JJ minus-end-directed/JJ transport/NN of/IN organelles/NNS ./.
@@112412436443 The/DT authors/NNS undertook/VBD a/DT retrospective/JJ analysis/NN of/IN pathology/NN with/IN quantification/NN of/IN the/DT percentage/NN of/IN papillary/JJ serous/JJ component/NN (/( %/NN PSC/NN )/SYM and/CC p53/NEWGENE expression/NN ./.
@@77651182211 The/DT maximum/JJ induction/NN of/IN ACC-oxidase/NEWGENE transcripts/NEWGENE occurred/VBN at/IN about/RB 6/CD h/NN after/IN excision/NN ,/, while/CC the/DT maximum/JJ enzyme/NN activity/NN was/VBD observed/VBN at/IN 24/CD h/CD ./CD
@@99903155562 TPO/NEWGENE by/IN itself/PRP did/VBD not/RB activate/VB ERK1/NEWGENE ,/, ERK2/NEWGENE and/CC protein/NEWGENE kinase/NEWGENE C/NEWGENE (/( PKC/NEWGENE )/SYM ,/, whereas/IN TPO/NEWGENE directly/RB enhanced/VBD the/DT PKC-dependent/NNP activation/NN of/IN ERKs/NEWGENE induced/VBN by/IN other/DT agonists/NNS including/JJ thrombin/NEWGENE and/CC phorbol/NN esters/NNS ,/, without/IN affecting/VBG the/DT PKC/NEWGENE activation/NN by/IN those/DT agonists/NNS ./.
@@10496388889 Except/IN for/IN nonperfusion/NN of/IN neurosensory/JJ retinal/JJ vessels/NNS at/IN a/DT light/NN dose/NN of/IN 150/CD J/NN //NN cm2/NN ,/, no/DT other/DT adverse/JJ events/NNS were/VBD of/IN concern/NN ./.
@@96945147866 The/DT complement/NEWGENE C3a/NEWGENE anaphylatoxin/NEWGENE receptor/NEWGENE (/( C3aR/NEWGENE )/SYM is/VBZ a/DT seven-transmembrane/NEWGENE G-protein/NEWGENE coupled/NEWGENE chemoattractant/NEWGENE receptor/NEWGENE that/IN on/IN binding/JJ the/DT C3a/NEWGENE peptide/NEWGENE ligand/NEWGENE mediates/VBZ numerous/JJ cellular/JJ responses/NNS ,/, including/JJ histamine/NN release/NN from/IN mast/NN cells/NNS ./. smooth/JJ muscle/NN contraction/NN ,/, and/CC the/DT directed/VBN migration/NN of/IN eosinophils/NNS ./.
@@105644843610 With/IN constructs/NNS containing/JJ the/DT binding/JJ site/NN of/IN one/PRP gene/NN fused/VBN to/IN the/DT promoter/NN of/IN the/PDT other/DT ,/, we/PRP demonstrated/VBD that/IN the/DT positional/JJ requirements/NNS are/VBP a/DT function/NN of/IN the/DT specific/JJ binding/JJ site/NN ,/, not/RB the/DT promoter/NN ./.
@@3257146795 These/DT results/NNS indicate/VBP that/IN CSFHU/NEWGENE can/MD increase/VB neutrophil/JJ counts/NNS by/IN increasing/JJ the/DT number/NN and/CC maturity/NN of/IN the/DT marrow/NN neutrophil/JJ precursors/NNS in/IN some/DT types/NNS of/IN childhood/NN chronic/JJ neutropenia/NN ./.
@@2223928104 Initial/JJ experience/NN with/IN a/DT serotonin/NN agonist/NN ./.
@@104642508685 (/( 1998/CD )/SYM FASEB/NN J/NNP ./NNP
@@63814386870 Lung/NN prostacyclin/NN production/NN may/MD be/VB related/VBN to/IN flow/NN ./.
@@93356191790 Nucleotide/NN sequence/NN analysis/NN of/IN R/NEWGENE has/VBZ revealed/VBN similarities/NNS to/IN the/DT R1/NN plasmid/NN found/VB in/IN some/DT South/JJ American/JJ maize/NN races/NNS with/IN RU/NNP cytoplasm/NN ,/, to/IN the/DT M1/NN plasmid/NN found/VB in/IN one/PRP source/NN of/IN Zea/NNP luxurians/NNS teosinte/NN ,/, to/IN the/DT atp9/NEWGENE mitochondrial/NEWGENE gene/NEWGENE and/CC its/PRP 3'/CD flanking/JJ sequence/NN ,/, and/CC also/RB to/IN a/DT region/NN 3'/CD to/IN the/DT orf221/NEWGENE gene/NEWGENE ./.
@@89804139744 The/DT P13/NN and/CC N22/NN of/IN ppSEPs/NNS had/VBP phase/NN reversal/NN relationship/NN with/IN the/DT P2/NN and/CC N2/NN recorded/VBN from/IN the/DT PES/NN ,/, respectively/RB ./.
@@78982757874 Three/CD classes/NNS of/IN test/NN objects/NNS were/VBD considered/VBN :/: (/( 1/CD )/SYM a/DT multicompartment/JJ test/NN object/NN for/IN 31P/NN MRS/NN measurements/NNS performed/VBN with/IN slice-selective/JJ sequences/NNS ;/: (/( 2/CD )/SYM a/DT two-compartment/JJ test/NN object/NN for/IN volume-selection/JJ 1H/NN MRS/NN ;/: and/CC (/( 3/CD )/SYM two-compartment/JJ test/NN objects/NNS for/IN assessing/JJ the/DT performance/NN of/IN experimental/JJ systems/NNS using/VBG ISIS/NN as/IN volume/NN localization/NN sequence/NN in/IN 31P/NN MRS/NN ./.
@@87986355481 Purified/VBN spleen/NN GAP/NEWGENE accelerated/JJ hydrolysis/NN of/IN GTP/NN bound/JJ to/IN recombinant/NEWGENE ARF1/NEWGENE ,/, ARF3/NEWGENE ,/, ARF5/NEWGENE ,/, and/CC ARF6/NEWGENE ;/: no/DT effect/NN of/IN NH2-terminal/NN myristoylation/NN was/VBD observed/VBN ./.
@@95769157538 Specifically/RB ,/, recombination/NN at/IN HMR/NEWGENE was/VBD used/VBN to/IN produce/NN rings/NNS that/WDT lacked/VBD the/DT E/NEWGENE and/NEWGENE I/NEWGENE silencers/NEWGENE ./.
@@73651831780 Twenty/CD patients/NNS aged/VBN 45/CD or/CC older/JJR with/IN the/DT diagnosis/NN of/IN endogenous/JJ depression/NN were/VBD evaluated/VBN in/IN terms/NNS of/IN safety/NN and/CC efficacy/NN in/IN their/PRP response/NN to/IN multiple/RB monitored/VBN electroconvulsive/JJ therapy/NN (/( MMECT/NNP )/SYM versus/IN single/JJ electroconvulsive/JJ therapy/NN (/( SECT/NN )/SYM ./.
@@10234698174 Despite/IN the/DT reported/VBN detrimental/JJ effects/NNS on/IN CNS/NN development/NN ,/, a/DT number/NN of/IN animal/NN studies/NNS have/VBP shown/VBP that/IN pretreatment/JJ with/IN corticosteroids/NNS nevertheless/RB protect/VBP the/DT brain/NN from/IN hypoxia-ischemic/JJ injury/NN ;/: however/RB ,/, clinically/RB such/JJ treatment/NN is/VBZ no/RB longer/RB favored/VBN ./.
@@2400163063 V/NNP ./NNP
@@33370244022 No/DT previous/JJ studies/NNS have/VBP determined/VBN the/DT pharmaco-dynamics/NNS of/IN intravenous/JJ procainamide/NN when/CC administered/VBN in/IN a/DT dose/NN of/IN 15/CD mg/CD //CD kg/CD and/CC at/IN a/DT rate/NN of/IN 50/CD mg/NN //NN min/NN ,/, as/IN is/VBZ common/JJ practice/NN during/IN electropharmacologic/JJ testing/NN ./.
@@88964738852 The/DT objective/NN of/IN this/DT study/NN was/VBD to/IN examine/VB the/DT influence/NN of/IN HHCA/NNP and/CC other/DT serological/JJ factors/NNS upon/IN the/DT development/NN of/IN VGS/NNP ./.
@@36287132766 Separate/JJ experiments/NNS measured/VBD AIB/NN and/CC 86RbCl/CD uptake/NN in/IN 36B-10/NNP cells/NNS in/IN vitro/NN 1/NN and/CC 2/CD days/NNS following/IN 20/CD Gy/JJ irradiation/NN to/IN assess/VB whether/IN this/DT radiation/NN dose/NN reduced/VBD the/DT capacity/NN of/IN tumor/NN cells/NNS to/IN trap/NN AIB/NN or/CC Rb+/NN ./.
@@8663127369 Hydropathy/NNP analysis/NN of/IN KCC1/NEWGENE indicates/VBZ structural/JJ homology/NN to/IN NKCC/NEWGENE ,/, including/JJ 12/NN transmembrane/NN domains/NN ,/, a/DT large/JJ extracellular/JJ loop/NN with/IN potential/JJ N-linked/NN glycosylation/NN sites/NN ,/, and/CC cytoplasmic/JJ N-/DT and/CC C-terminal/NN regions/NN ./.
@@89755328921 Liver/NN injuries/NNS ./.
@@91113673251 Furthermore/RB ,/, experiments/NNS with/IN 32D/CD temperature-sensitive/JJ p53/NEWGENE cells/NNS indicate/VBP that/IN aberrant/JJ tal-1/NEWGENE expression/NN at/IN the/DT permissive/JJ temperature/NN does/VBP not/RB exert/VB a/DT proliferative/JJ effect/NN but/CC causes/NNS p53-mediated/JJ apoptosis/NN ,/, i/FW ./FW e/FW ./FW ,/, the/DT tal-1/NEWGENE proliferative/JJ effect/NN depends/VBZ on/IN the/DT integrity/NN of/IN the/DT cell/NN cycle/NN checkpoints/NNS of/IN the/DT host/NN cell/NN ,/, as/IN observed/VBN for/IN c-myc/NEWGENE and/CC other/DT oncogenes/NNS ./. tal-1/NEWGENE mutant/NEWGENE experiments/NNS indicate/VBP that/IN ectopic/JJ tal-1/NEWGENE effects/NNS are/VBP mediated/JJ by/IN both/PDT the/DT DNA-binding/NN and/CC the/DT heterodimerization/NN domains/NN ,/, while/CC the/DT N-terminally/NEWGENE truncated/NEWGENE tal-1/NEWGENE variant/NEWGENE (/( M3/NEWGENE )/SYM expressed/VBN in/IN T-ALL/JJ malignant/JJ cells/NNS mimics/VBP the/DT effects/NNS of/IN the/DT wild-type/NN protein/NN ./.
@@80355177239 However/RB ,/, each/DT promoter/NN activated/VBN by/IN IEP86/NEWGENE was/VBD synergistically/RB affected/VBN by/IN the/DT addition/NN of/IN IEP72/NEWGENE ./.
@@91768379595 Computer/NNP software/NN assisted/JJ ordering/NN (/( CSAO/NNP )/SYM was/VBD developed/VBN to/IN integrate/VB PN/NN Ca/NN :/: P/NN solubility/NN with/IN clinical/JJ data/NN to/IN improve/VB parenteral/JJ Ca/NN and/CC P/NN administration/NN ./.
@@20809022689 In/NN adulthood/NN these/DT rats/NNS were/VBD hyperactive/JJ and/CC learned/VBD the/DT active/JJ avoidance/NN response/NN later/JJR than/IN the/DT controls/NNS ./.
@@109038779558 Activation/NNS of/IN PKA/NEWGENE by/IN 8-bromo-cyclic/JJ AMP/NN or/CC forskolin/NN ,/, and/CC inhibition/NN of/IN PKC/NEWGENE by/IN calphostin/NN C/NN ,/, resulted/VBN in/IN a/DT significant/JJ decrease/NN in/IN 3TP/NEWGENE activity/NN as/RB well/VB as/IN in/IN vitro/NN ERK/NEWGENE kinase/NEWGENE activity/NN in/IN CRAC/NNP ./.
@@94829021438 When/WRB tested/VBN with/IN wild-type/NN (/( DBA/NN //NN 2/NN )/SYM p16/NEWGENE ,/, both/DT A134C/NN and/CC G232A/NN BALB/NN //NN c-specific/NN variants/NN of/IN p16/NEWGENE were/VBD inefficient/JJ in/IN their/PRP ability/NN to/IN inhibit/VB the/DT activity/NN of/IN cyclin/NEWGENE D2/NEWGENE //NEWGENE CDK4/NEWGENE in/IN kinase/NN assays/NNS with/IN retinoblastoma/NEWGENE protein/NEWGENE ,/, suggesting/VBG this/DT defective/NN ,/, inherited/JJ allele/NN plays/VBP an/DT important/JJ role/NN in/IN the/DT genetic/JJ susceptibility/NN of/IN BALB/NN //NN c/NN mice/NNS for/IN plasmacytoma/NN induction/NN and/CC that/IN p16/NEWGENE (/NEWGENE INK4a/NEWGENE )/NEWGENE is/VBZ a/DT strong/JJ candidate/NN for/IN the/DT Pctr1/NEWGENE locus/NEWGENE ./.
@@9786926716 We/PRP previously/RB delineated/VBN a/DT region/NN in/IN the/DT fatty-acid/NEWGENE synthase/NEWGENE promoter/NEWGENE ,/, which/WDT was/VBD responsible/JJ for/IN obesity-related/JJ overexpression/NN of/IN the/DT fatty-acid/NEWGENE synthase/NEWGENE (/( FAS/NEWGENE )/SYM gene/NN ,/, by/IN negatively/RB regulating/JJ the/DT activity/NN of/IN the/DT downstream/JJ promoter/NN in/IN lean/JJ but/CC not/RB obese/JJ rat/NN fat/JJ cells/NNS ./.
@@87936938776 DESIGN/IN :/: A/DT cross-sectional/JJ study/NN ./.
@@118344765465 Therefore/RB ,/, in/IN a/DT large/JJ animal/NN model/NN of/IN permanent/JJ focal/JJ ischemia/NN in/IN which/WDT transfusion/NN starts/VBP 30/CD min/NN after/IN ischemia/NN ,/, tetrameric/RB cross-linked/VBN hemoglobin/NEWGENE transfusion/NN can/MD augment/VB oxygen/NN transport/NN to/IN the/DT ischemic/JJ cortex/NN ,/, but/CC the/DT increase/NN can/MD be/VB delayed/JJ and/CC not/RB necessarily/RB provide/VB protection/NN ./.
@@101947693675 One/CD such/JJ element/NN ,/, 1P/NEWGENE ,/, was/VBD employed/VBN to/IN clone/NN from/IN a/DT rat/NN pituitary/JJ cDNA/NN expression/NN library/NN a/DT novel/JJ 417-amino/NEWGENE acid/NEWGENE WD/NEWGENE protein/NEWGENE ,/, designated/VBN PREB/NEWGENE (/NEWGENE PRL/NEWGENE regulatory/NEWGENE element/NEWGENE binding/NEWGENE )/NEWGENE protein/NEWGENE ./.
@@86435576172 Thus/RB ,/, a/DT critical/JJ question/NN is/VBZ how/RB HOX/NEWGENE proteins/NEWGENE select/VBP the/DT correct/JJ sets/NNS of/IN target/NN genes/NNS in/IN vivo/NN ./.
@@20346763631 Two/CD homologues/NNS of/IN the/DT rhombotin/NEWGENE gene/NEWGENE have/NN now/RB been/VBN isolated/VBN ./.
@@15574116929 Thus/RB ,/, the/DT human/NEWGENE D1A/NEWGENE gene/NEWGENE belongs/VBZ to/IN the/DT category/NN of/IN tissue-specific/JJ ,/, regulated/VBN genes/NNS that/WDT have/VBP housekeeping-type/NN promoters/NN ./.
@@97704932418 As/IN PP2A/NEWGENE exerts/VBZ a/DT range/NN of/IN cellular/JJ functions/NNS including/JJ cell/NN cycle/NN regulation/NN and/CC cell/NN fate/NN determination/NN ,/, we/PRP were/VBD surprised/VBN to/IN find/NN that/IN these/DT embryos/NNS develop/VBP normally/RB until/IN postimplantation/JJ ,/, around/IN embryonic/JJ day/NN 5/CD ./CD 5/CD //CD 6/CD ./CD 0/CD ./.
@@10373029242 The/DT femoral/JJ artery/NN //NN vein/NN and/CC the/DT soleus/NN and/CC gastrocnemius/NN muscles/NNS were/VBD examined/VBN in/IN healthy/JJ human/JJ male/JJ volunteers/NNS ./.
@@107053809104 We/PRP also/RB show/VBP that/IN zygotically/RB activated/VBN Xretpos/NNP transcripts/NNS are/VBP restricted/VBN to/IN ventro-posterior/NN specific/NN regions/NN and/CC induced/VBN by/IN UV-irradiation/NNS and/CC BMP-4/NEWGENE overexpression/NN in/IN cycloheximide-dependent/JJ way/NN ./. genesis/NN 26/CD :/: 198-207/CD ,/, 2000/CD ./.
@@40750614762 All/DT runners/NNS drank/VBD a/DT total/NN of/IN 1/CD ./CD 4/CD L/NN of/IN water/NN during/IN the/DT race/NN ./.
@@76926681060 An/DT abundant/JJ 1/CD ./CD 1-kb/CD virion-sense/JJ polyadenylated/JJ RNA/NN and/CC four/CD complementary-sense/JJ polyadenylated/JJ RNAs/NNS of/IN 1/CD ./CD 7/CD ,/, 1/CD ./CD 5/CD ,/, 1/CD ./CD 3/CD ,/, and/CC 0/CD ./CD 7/CD kb/NN have/NN been/VBN identified/VBN by/IN northern/JJ blot/NN hybridization/NN ,/, confirming/VBG the/DT bidirectional/JJ transcription/NN strategy/NN implied/VBN by/IN the/DT arrangement/NN of/IN ORFs/NNS ./.
@@67093102810 A/DT case/NN of/IN manifest/NN latent/JJ nystagmus/NN of/IN late/JJ onset/NN in/IN a/DT 13-year-old/NN girl/NN is/VBZ reported/VBN ./.
@@110731639200 Tightly/RB ordered/JJ proteasomal/JJ degradation/NN of/IN proteins/NNS critical/JJ for/IN cell/NN cycle/NN control/NN implies/VBZ a/DT role/NN of/IN the/DT proteasome/NN in/IN maintaining/VBG cell/NN proliferation/NN and/CC cell/NN survival/NN ./.
@@117034647505 We/PRP found/VBP in/IN the/DT control/NN subjects/NNS rCBF/NN increases/NNS in/IN regions/NNS associated/VBN with/IN the/DT meso-striatal/JJ and/CC meso-corticolimbic/JJ circuits/NNS in/IN response/NN to/IN both/DT monetary/JJ reward/NN and/CC nonmonetary/JJ reinforcement/NN ./.
@@34021834098 The/DT TA/NN muscle/NN was/VBD fatigued/JJ by/IN four/CD forms/NNS of/IN repeated/JJ isometric/JJ contractions/NNS :/: (/( 1/CD )/SYM maximal/JJ voluntary/JJ contractions/NNS (/( MVC/NN )/SYM ,/, (/( 2/CD )/SYM MVC/NN with/IN circulation/NN occluded/VBN ,/, (/( 3/CD )/SYM electrically/RB evoked/VBN contractions/NNS with/IN 20/CD Hz/NN supramaximal/JJ voltage/NN stimulation/NN and/CC (/( 4/CD )/SYM electrically/RB evoked/VBN contractions/NNS with/IN circulation/NN occluded/VBN ./.
@@25063903153 Growth/NN of/IN tracheal/JJ anastomoses/NNS in/IN growing/JJ animals/NNS ./.
@@27845078355 The/DT human/JJ immunodeficiency/NN virus/NN type/NN 1/CD (/( HIV-1/NNP )/SYM preferentially/RB infects/VBZ CD4+/NEWGENE T/NN lymphocytes/NNS and/CC may/MD exist/VB as/IN a/DT latent/JJ provirus/NN within/IN these/DT cells/NNS for/IN extended/VBN periods/NNS ./.
@@96422002687 However/RB ,/, it/PRP is/VBZ only/JJ one-half/NN and/CC one-third/NN the/DT size/NN of/IN the/DT proteolipids/NNS from/IN M/NNP ./NNP thermoautotrophicum/NN and/CC M/NNP ./NNP jannaschii/NN ,/, respectively/RB ./. ahaK/NEWGENE is/VBZ expressed/VBN in/IN Escherichia/NN coli/JJ ,/, and/CC it/PRP is/VBZ incorporated/VBN into/IN the/DT cytoplasmic/JJ membrane/NN despite/IN the/DT different/JJ chemical/JJ natures/NNS of/IN lipids/NNS from/IN archaea/NNS and/CC bacteria/NNS ./.
@@5649435294 Calves/NNS fed/VBD MCT-milk/NN had/VBP significantly/RB lower/JJR blood/NN cholesterol/NN than/IN calves/NNS fed/VBN T-/IN or/CC SBO-milk/NNP ./.
@@108786062356 It/PRP is/VBZ mainly/RB transcribed/VBN in/IN neural/JJ structures/NNS and/CC in/IN developing/JJ organs/NNS characterized/VBN by/IN epithelial-mesenchymal/JJ interactions/NNS ./.
@@77893425120 Although/IN the/DT extracellular/JJ domain/NN of/IN the/DT TSH-R/NEWGENE is/VBZ sufficient/JJ for/IN high/JJ affinity/NN binding/NN of/IN TSH/NEWGENE ,/, we/PRP conclude/VBP that/IN the/DT hyt/NN mutation/NN in/IN the/DT fourth/JJ transmembrane/JJ domain/NN eliminates/VBZ TSH/NEWGENE binding/JJ ./.
@@92187751938 Pseudomonas/NNS aeruginosa/NN strains/NNS infecting/JJ patients/NNS with/IN cystic/JJ fibrosis/NN (/( CF/NN )/SYM acquire/VB a/DT mucoid/NN phenotype/NN due/NN to/IN overproduction/NN of/IN alginate/NN ./.
@@92659322076 All/PDT the/DT women/NNS received/VBN 13/CD ./CD 5/CD mg/NN plain/JJ bupivacaine/NN via/NN subarachnoid/JJ injection/NN at/IN the/DT L2-3/NN interspace/NN ./.
@@10658425472 The/DT level/NN of/IN subclinical/JJ infection/NN was/VBD 75%/JJ among/IN seropositive/JJ dogs/NNS ./.
@@64024806201 The/DT susceptibility/NN of/IN the/DT PPNG/NN strains/NNS to/IN clinically/RB relevant/JJ antibiotics/NNS varied/VBN with/IN the/DT plasmid/NN pattern/NN ;/: this/DT stresses/VBZ the/DT necessity/NN of/IN permanent/JJ surveillance/NN of/IN gonococcal/JJ infections/NNS and/CC of/IN regular/JJ evaluation/NN of/IN the/DT recommendations/NNS for/IN antimicrobial/JJ treatment/NN ./.
@@10770471584 Benztropine/NNP for/IN venlafaxine-induced/JJ night/NN sweats/NNS ./.
@@79292386164 (/( 1992/CD )/SYM Genomics/NNP 12/CD ,/, 58-62/NN )/NN ./.
@@32962123983 The/DT future/JJ of/IN research/NN with/IN interferon/NEWGENE may/MD be/VB divided/VBN into/IN three/CD areas/NNS :/: Efforts/NNS must/MD be/VB made/VBP to/IN determine/VB how/RB best/JJS to/IN translate/VB the/DT in/NN vitro/FW synergy/NN into/IN clinically/RB meaningful/JJ terms/NNS ;/: in/IN order/NN to/IN exploit/NN the/DT fullest/JJS potential/NN of/IN IFN/NEWGENE ,/, research/NN is/VBZ moving/JJ toward/IN using/VBG this/DT agent/NN earlier/JJR in/IN disease/NN either/DT as/IN an/DT adjuvant/NN after/IN tumor/NN debulking/JJ or/CC after/IN initial/JJ diagnosis/NN ;/: the/DT medical/JJ community/NN must/MD rethink/VB the/DT natural/JJ history/NN of/IN some/DT diseases/NNS ,/, because/IN the/DT fullest/JJS potential/NN of/IN the/DT biologic/JJ agents/NNS will/MD most/RB likely/RB manifest/VB itself/PRP when/CC these/DT agents/NNS are/VBP used/VBN together/RB ./.
@@93006974050 Proteasomes/NEWGENE are/VBP the/DT multisubunit/JJ protease/NEWGENE involved/VBN in/IN the/DT generation/NN of/IN peptides/NNS presented/VBN by/IN MHC/NEWGENE class/NEWGENE I/NEWGENE molecules/NEWGENE ./.
@@109001298533 Degenerate/JJ primers/NNS homologous/JJ to/IN highly/RB conserved/VBN regions/NNS of/IN known/VBP CYP3A/NEWGENE sequences/NEWGENE were/VBD used/VBN for/IN initial/JJ RT-PCRs/NNP ./.
@@99334287853 IFN-gamma/NEWGENE was/VBD elevated/VBN during/IN active/JJ TB/NN when/CC compared/VBN with/IN healthy/JJ controls/NNS ,/, declining/JJ during/IN and/CC after/IN treatment/NN ./.
@@15457878157 Within/IN the/DT human/JJ enhancer/NN ,/, these/DT two/JJ sites/NNS are/VBP located/VBN within/IN the/DT previously/RB defined/VBN DNase/NEWGENE I/NEWGENE footprints/NEWGENE ,/, NFAT-1/NEWGENE and/CC NFIL-2B/NEWGENE ,/, respectively/RB ./.
@@103193277528 Analysis/NNP of/IN SRE/NNS oligonucleotide/NN gel/NN mobility/NN shift/NN assays/NNS with/IN nuclear/JJ extracts/NNS from/IN Sertoli/NN cells/NNS demonstrated/VBD the/DT presence/NN of/IN both/PDT the/DT SRF/NEWGENE and/CC the/DT ubiquitously/RB expressed/VBN bHLH/NEWGENE protein/NEWGENE E12/NEWGENE1 //NEWGENE1 E47/NEWGENE1 ./.
@@13980732928 These/DT results/NNS lead/NN us/PRP to/IN hypothesize/VB that/IN a/DT single/NN multisubunit/NEWGENE TFIID/NEWGENE protein/NEWGENE supports/VBP transcriptional/JJ stimulation/NN by/IN diverse/JJ activation/NN domains/NN and/CC from/IN a/DT TATA-less/NNP promoter/NN ./.
@@108385312001 Tumor/NNP stages/NNS were/VBD IIB/NN (/( T3/NN N0/NN )/SYM in/IN 52%/JJ ,/, IIIA/VBZ in/IN 15%/JJ ,/, and/CC IIIB/NN in/IN 27%/NN of/IN patients/NNS ./.
@@93805047418 The/DT ZnF20/NEWGENE cDNA/NEWGENE hybridized/VBN to/IN multiple/JJ transcripts/NNS in/IN a/DT thyroid/JJ cancer/NN cell/NN line/NN (/( 8/CELL ./CELL 0/CELL ,/, 4/CD ./CD 5/CD and/CC 2/CD kb/NN )/SYM that/WDT increased/VBD after/IN cycloheximide/NN treatment/NN and/CC decayed/VBN </SYM 2/CD h/NN after/IN addition/NN of/IN actinomycin/NN D/NN ./NN
@@90841748108 This/DT fragment/NN contained/VBD the/DT C-terminal/NN 47/NN nucleotides/NN of/IN leuB/NEWGENE ,/, encoding/VBG 3-isopropylmalate/NEWGENE dehydrogenase/NEWGENE ;/: asd/NEWGENE ,/, encoding/VBG aspartate-beta-semialdehyde/NEWGENE dehydrogenase/NEWGENE (/( Asd/NEWGENE )/SYM ;/: and/CC orfA/NN ,/, whose/WP product/NN showed/VBD similarity/NN to/IN the/DT Asd/NEWGENE proteins/NEWGENE from/NEWGENE Vibrio/NEWGENE spp/NEWGENE ./.
@@94884412496 Sp1/NEWGENE can/MD activate/VB transcription/NN through/JJ immunoglobulin/NEWGENE kappa-chain/NEWGENE enhancer/NEWGENE or/CC P-selectin/NEWGENE promoter/NEWGENE NF-kappaB/NEWGENE1 sites/NEWGENE1 ./. p50/NEWGENE homodimers/NEWGENE replace/VBP Sp1/NEWGENE from/IN the/PDT P-selectin/NEWGENE promoter/NEWGENE by/IN binding/JJ site/NN competition/NN and/CC thereby/RB either/DT inhibit/VB basal/JJ Sp1-driven/NN expression/NN or/CC ,/, in/IN concert/NN with/IN Bcl-3/NEWGENE ,/, stimulate/VB expression/NN ./.
@@107326699241 Results/NNS of/IN two-hybrid/JJ assays/NNS and/CC electrophoretic/JJ mobility/NN shift/NN assays/NNS strongly/RB suggest/VBP that/IN all/DT HD-Zip/NEWGENE proteins/NEWGENE of/IN families/NNS I/PRP and/CC II/NNP can/MD form/VB homodimers/NNS and/CC also/RB heterodimers/NNS with/IN all/DT HD-Zip/NEWGENE proteins/NEWGENE of/IN the/DT same/JJ family/NN ./.
@@79320957901 Nine/CD new/JJ naphthalene/NN related/VBD compounds/NNS (/( I/PRP ,/, IV/NN ,/, V/NN ,/, VII-XII/NN )/SYM together/RB with/IN four/CD known/VBP compounds/NNS (/( II/NNP ,/, III/NNP ,/, VI/NN ,/, XIII/NNP )/SYM were/VBD isolated/VBN from/IN the/DT root/JJ bark/NN of/IN Oroxylum/NNP indicum/NN Vent/NN ./.
@@28317963527 Simian/JJ immunodeficiency/NN virus/NN (/( SIV/NN )/SYM is/VBZ a/DT lentivirus/NN with/IN morphological/JJ and/CC antigenic/JJ similarities/NNS to/IN human/JJ immunodeficiency/NN virus/NN ,/, the/DT causative/JJ agent/NN of/IN acquired/VBN immunodeficiency/NN syndrome/NN (/( AIDS/NN )/SYM of/IN humans/NNS ./.
@@93580554453 This/DT sequence/NN possessed/VBD homology/NN with/IN a/DT methylation-sensitive/JJ promoter/NN element/NN ,/, Enh2/NEWGENE ,/, present/VB in/IN the/DT LTR/NN of/IN mouse/NN intractisternal/JJ A-particles/NNS ./.
@@21389158019 The/DT p36/NEWGENE gene/NEWGENE is/VBZ at/IN least/RB 22/CD kb/NN in/IN length/NN and/CC has/VBZ a/DT coding/JJ sequence/NN of/IN approximately/RB 1/CD kb/NN ,/, representing/VBG only/RB 4/CD ./CD 5%/CD of/IN the/DT gene/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@103188068415 Members/NNS of/IN the/DT mitogen/NEWGENE activated/NEWGENE protein/NEWGENE (/NEWGENE MAP/NEWGENE )/NEWGENE kinase/NEWGENE family/NEWGENE ,/, extracellular/NEWGENE signal-regulated/NEWGENE kinase/NEWGENE ,/, stress-activated/NEWGENE protein/NEWGENE kinase-1/NEWGENE //NEWGENE c-Jun/NEWGENE NH2-terminal/NEWGENE kinase/NEWGENE ,/, and/CC p38/NEWGENE ,/, are/VBP central/JJ elements/NNS that/WDT transduce/VBP the/DT signal/RB generated/VBN by/IN growth/NEWGENE factors/NEWGENE ,/, cytokines/NNS ,/, and/CC stressing/VBG agents/NNS ./.
@@77892756938 To/TO assess/VB the/DT function/NN (/NN s/NN )/NN of/IN E74/NEWGENE during/IN metamorphosis/NN ,/, we/PRP have/VBP isolated/VBN and/CC characterized/VBN recessive/JJ loss-of-function/NN mutations/NNS specific/JJ to/IN each/DT transcription/NN unit/NN ./.
@@3335923475 Fifty-four/NNS patients/NNS were/VBD divided/VBN into/IN groups/NNS according/VBG to/IN their/PRP clinical/JJ presentation/NN ;/: seven/JJ asymptomatic/JJ volunteers/NNS ,/, 20/CD patients/NNS with/IN duodenal-gastric/JJ reflux/JJ gastropathy/NN (/( DRG/NN )/SYM ,/, 16/CD patients/NNS with/IN recurrent/JJ ulcers/NNS of/IN the/DT duodenal/JJ bulb/NN (/( RUD/NN )/SYM ,/, and/CC 11/CD patients/NNS with/IN Moynihan's/NNP disease/NN ./.
@@33208755925 If/IN this/DT is/VBZ unavailable/JJ ,/, then/RB Supramid/NN has/VBZ a/DT proven/VBP record/NN for/IN good/JJ tissue/NN compatibility/NN and/CC resistance/NN to/IN infection/NN ./.
@@86885561394 Recently/RB ,/, our/PRP laboratory/NN developed/VBD a/DT screen/NN that/WDT identified/VBD five/CD multicopy/JJ suppressors/NNS that/WDT can/MD rescue/VB lethal/JJ strains/NNS of/IN clathrin/NEWGENE heavy/NN chain-deficient/NN yeast/NN (/( Chc/NEWGENE -/NEWGENE scd1-i/NEWGENE )/SYM to/IN viability/NN ./.
@@38731413378 In/NN 19/CD patients/NNS vagotomy/NN not/RB only/RB curbed/VBN the/DT bleeding/NN but/CC provided/VBN definitive/JJ therapy/NN (/( Visick/NN I-II/NN )/SYM ;/: 4/CD patients/NNS died/VBN (/( mortality/NN rate/NN 16%/JJ )/SYM ./.
@@117408061586 Saunders/NNP Company/NNP ./.
@@10477620865 Cytokine-induced/NN NF-kappa/NEWGENE B/NEWGENE DNA/NN binding/JJ activity/NN ,/, RelA/NEWGENE nuclear/NN translocation/NN ,/, I/NEWGENE kappa/NEWGENE B/NEWGENE alpha/NEWGENE degradation/NN ,/, I/NEWGENE kappa/NEWGENE B/NEWGENE serine/NN 32/NN phosphorylation/NN ,/, and/CC I/NEWGENE kappa/NEWGENE B/NEWGENE kinase/NEWGENE (/( IKK/NEWGENE )/SYM activity/NN were/VBD blocked/VBN by/IN curcumin/NN treatment/NN ./.
@@108119089969 HPLC/NN phosphopeptide/NN mapping/NN ,/, amino/JJ acid/NN sequencing/VBG ,/, and/CC site-directed/JJ mutagenesis/NN determined/VBN that/IN NCLK/NEWGENE phosphorylates/VBZ Ser/NN (/NN 67/NN )/NN of/IN I-1/NEWGENE ./.
@@86318178609 Identification/NNP of/IN a/DT consensus/NN cyclin-dependent/NEWGENE kinase/NEWGENE phosphorylation/NEWGENE site/NEWGENE unique/JJ to/IN the/DT nuclear/JJ form/NN of/IN human/NEWGENE deoxyuridine/NEWGENE triphosphate/NEWGENE nucleotidohydrolase/NEWGENE ./.
@@98866029882 OBJECTIVES/NNS :/: To/TO assess/VB the/DT ability/NN of/IN pretreatment/JJ and/CC post-treatment/JJ prostate-specific/NEWGENE antigen/NEWGENE (/( PSA/NEWGENE )/SYM measurements/NNS ,/, clinical/JJ tumor/NN stage/NN ,/, tumor/NN grade/NN ,/, Gleason/NN sum/NN ,/, race/NN ,/, age/NN ,/, and/CC radiation/NN dose/NN to/IN predict/VB the/DT recurrence/NN of/IN prostate/NN cancer/NN following/IN external/NN beam/NN radiation/NN therapy/NN (/( XRT/NNS )/SYM since/IN the/DT introduction/NN of/RB PSA/NEWGENE as/IN a/DT tumor/NN marker/NN at/IN one/PRP tertiary/JJ care/NN center/NN ./.
@@110343924030 Taken/VBN together/RB ,/, our/PRP data/NN indicate/VB that/IN multiple/JJ survival/NN pathways/NNS are/VBP triggered/VBN via/NN this/DT receptor/NN ,/, whereas/IN NF-kappaB/NEWGENE //NEWGENE Rel/NEWGENE and/CC PI-3K/NEWGENE are/VBP crucial/JJ for/IN CD40-induced/JJ proliferation/NN ./.
@@114709146633 The/DT activity/NN of/IN Rac1/NEWGENE leads/VBP to/IN STAT3/NEWGENE translocation/NN to/IN the/DT nucleus/NN coincident/JJ with/IN STAT3-dependent/NN gene/NN expression/NN ./.
@@107560325426 In/NN vivo/NN dimethyl/JJ sulfate/NN footprinting/VBG of/IN the/DT cyclin/NEWGENE E/NEWGENE promoter/NEWGENE revealed/VBD several/DT regions/NNS of/IN protection/NN and/CC hypersensitivity/NN that/WDT were/VBD unique/JJ to/IN infected/VBN cells/NNS ./.
@@104932034267 Prognostic/JJ value/NN of/IN a/DT treadmill/NN exercise/NN score/NN in/IN symptomatic/JJ patients/NNS with/IN nonspecific/NN ST-T/NN abnormalities/NNS on/IN resting/JJ ECG/NN ./.
@@24069923074 Nonvascular/JJ ophthalmic/JJ and/CC neurologic/JJ disorders/NNS that/WDT can/MD be/VB confused/VBN with/IN amaurosis/NN fugax/NN are/VBP listed/VBN ,/, and/CC an/DT algorithm/NN for/IN evaluation/NN (/( which/WDT includes/VBZ ophthalmic/JJ examination/NN ,/, laboratory/NN studies/NNS ,/, and/CC noninvasive/JJ carotid/JJ artery/NN studies/NNS )/SYM is/NNS given/VBP ./.
@@86393108077 OND/NN 8/NN mg/NN tid/RB days/NNS 2-3/CD ,/, and/CC 8/CD mg/NN tid/RB prn/VBP days/NNS 4-5/CD and/CC prednisolone/NN 75-100/JJ mg/NN qds/NNS days/NNS 2-5/CD and/CC 2/NN )/NN MCP/NN 30/NN mg/NN //NN metylprednisolone/NN 80/NN mg/NN i/CD ./CD v/CD ./. before/IN CT/NN and/CC MCP/NN 20/NN mg/NN p/CD ./CD r/CD ./. after/IN 4/CD and/CC 8/CD h/NN respectively/RB ./.
@@1005402990 Aspirin/NNP intolerance/NN :/: unaltered/JJ susceptibility/NN of/IN platelet/NEWGENE cyclo-oxygenase/NEWGENE to/IN inhibition/NN by/IN aspirin/NN in/IN vitro/FW ./.
@@30316026735 The/DT second/JJ group/NN of/IN homologous/JJ elements/NNS is/VBZ present/VB in/IN the/DT upstream/JJ region/NN of/IN both/DT genes/NNS ./.
@@112782863046 In/NNP SN-48/NNP neuronal/JJ cells/NNS that/WDT express/VBP MR/NEWGENE ,/, GR/NEWGENE ,/, and/CC 5-HT1A/NEWGENE receptors/NEWGENE ,/, deletion/NN or/CC inactivation/NN of/IN the/DT nGRE/NEWGENE (/( negative/NEWGENE GRE/NEWGENE )/SYM eliminated/VBN negative/JJ regulation/NN of/IN the/DT rat/NEWGENE 5-HT1A/NEWGENE or/CC heterologous/JJ promoters/NNS by/IN corticosteroids/NNS ,/, whereas/IN its/PRP inclusion/NN conferred/VBD corticosteroid-induced/JJ inhibition/NN to/IN a/DT heterologous/JJ promoter/NN ./.
@@21095444769 To/TO evaluate/VB the/DT cost/NN and/CC benefits/NNS of/IN screening/JJ tests/NNS for/IN Chlamydia/NN trachomatis/JJ in/IN adolescent/JJ males/NNS ,/, we/PRP developed/VBD a/DT decision/NN analysis/NN model/NN and/CC compared/VBD the/DT leukocyte/NEWGENE esterase/NEWGENE urine/NN dipstick/NN test/NN with/IN culture/NN ,/, with/IN direct-smear/JJ fluorescent/JJ antibody/NN (/( DFA/NN )/SYM ,/, and/CC with/IN the/DT option/NN of/IN no/DT screening/JJ (/( no/DT treatment/NN )/SYM ./.
@@8923535228 No/DT hypotension/NN was/VBD noted/VBN in/IN patients/NNS with/IN toxemia/NN and/CC only/RB 2/NN ran/NN a/DT fever/NN above/RB 37/CD ./CD 5/CD degrees/NNS C/NNP ./NNP
@@19859202206 Initial/JJ screening/NN of/IN a/DT rat/NN liver/NN cDNA/NN library/NN with/IN an/DT oligonucleotide/NN probe/NN derived/VBN from/IN the/DT rat/NN SCP2/NEWGENE protein/NN sequence/NN revealed/VBD an/DT 825-base/JJ pair/NN cDNA/NN clone/NN coding/JJ for/IN the/DT complete/JJ SCP2/NEWGENE protein/NN sequence/NN ./.
@@3031893747 It/PRP seems/VBZ that/IN the/DT way/NN in/IN which/WDT drugs/NNS modify/VBP a/DT patient's/VBZ serum/JJ chemistry/NN may/MD be/VB used/VBN to/IN assess/VB the/DT efficacy/NN with/IN which/WDT they/PRP control/NN the/DT inflammatory/JJ process/NN ./.
@@92776299236 Two/CD experiments/NNS (/( N/JJ =/SYM 20/CD each/DT )/SYM were/VBD carried/VBN out/RB to/IN explore/VB the/DT nature/NN of/IN ERP/NN negativities/NNS in/IN a/DT visuospatial/JJ memory/NN task/NN and/CC in/IN an/DT auditory/JJ spatial/JJ memory/NN task/NN ,/, respectively/RB ./.
@@14643295067 A/DT coiled-coil/NN related/NN protein/NN specific/JJ for/IN synapsed/VBN regions/NNS of/IN meiotic/JJ prophase/NN chromosomes/NNS ./.
@@95242229076 The/DT COOH-terminus/NN of/IN this/DT new/JJ isoform/NN ,/, which/WDT we/PRP designate/VBP beta/NEWGENE 4/NEWGENE ,/, lacks/VBZ a/DT 22/CD amino/JJ acid/NN lysine-rich/JJ sequence/NN common/JJ to/IN both/PDT the/DT human/NEWGENE red/NEWGENE cell/NEWGENE alpha-/NEWGENE and/NEWGENE beta-adducin/NEWGENE subunits/NEWGENE and/CC homologous/JJ to/IN a/DT highly/RB conserved/VBN region/NN in/IN MARCKS/NEWGENE ,/, a/DT filamentous/JJ actin-cross/NN linking/NN protein/NN regulated/VBN by/IN protein/NEWGENE kinase/NEWGENE C/NEWGENE and/CC calcium/NN //NN calmodulin/NN ./. beta/NEWGENE 4-adducin/NEWGENE preserves/VBP a/DT previously/RB identified/VBN calmodulin/NEWGENE binding/NEWGENE domain/NEWGENE ./.
@@89967308946 Lack/NN of/IN sufficient/JJ data/NN on/IN vibration/NN measurements/NNS and/CC employment/NN durations/NNS add/VBP to/IN the/DT uncertainty/NN ,/, as/IN do/NN variations/NNS in/IN tool/NN conditions/NNS (/( grinder/NN wheels/NNS ,/, etc/NN )/SYM and/CC inherent/JJ difficulties/NNS in/IN measurement/NN ./.
@@9751114652 These/DT results/NNS suggest/VBP that/IN Thr115/NN may/MD play/VB an/DT important/JJ role/NN in/IN the/DT regulation/NN of/IN MyoD/NEWGENE function/NN under/IN conditions/NNS of/IN high/JJ mitogenesis/NN ./.
@@21660404777 To/TO determine/VB whether/IN vanadate/NN could/MD inhibit/VB PEPCK/NEWGENE gene/NEWGENE transcription/NN ,/, a/DT series/NN of/IN chimeric/JJ genes/NNS containing/JJ several/DT deletions/NNS in/IN the/DT P-enolypyruvate/NEWGENE carboxykinase/NEWGENE promoter/NEWGENE between/IN -550/JJ and/CC -68/CD was/VBD linked/JJ to/IN the/DT structural/JJ genes/NNS for/IN either/DT amino-3-glycosyl/NEWGENE phosphotransferase/NEWGENE (/( neo/NEWGENE )/SYM or/CC chloramphenicol/NEWGENE acetyltransferase/NEWGENE and/CC introduced/VBN into/IN hepatoma/NN cells/NNS using/VBG three/CD methods/NNS :/: (/( a/DT )/SYM infection/NN with/IN a/DT Moloney/NN murine/JJ leukemia/NN virus-based/JJ retrovirus/NN ,/, (/( b/NN )/SYM transfection/NN and/CC stable/JJ selection/NN for/IN neo/JJ expression/NN ,/, or/CC (/( c/NN )/SYM transient/JJ expression/NN of/IN chloroamphenicol/NEWGENE acetyltransferase/NEWGENE ./.
@@95841796346 Peptide/NN sequences/NNS of/IN the/DT zinc/NEWGENE finger/NEWGENE protein/NEWGENE Ttk/NEWGENE and/CC the/DT transcription/NEWGENE factor/NEWGENE Adf-1/NEWGENE were/VBD obtained/VBN ./.
@@97532415755 Endoscopic/NNP examinations/NNS ,/, peripheral/NN white/NN blood/NN cell/NN (/( WBC/NN )/SYM counts/NNS ,/, and/CC assays/NNS of/IN myeloperoxidase/NEWGENE activity/NN (/( MPO/NEWGENE )/SYM in/IN homogenates/NNS of/IN colon/NN mucosa/NN were/VBD performed/VBN after/IN one/PRP week/NN (/( 4%/JJ DSS/NN model/NN )/SYM and/CC eight/CD weeks/NNS (/( 1%/JJ DSS/NN model/NN )/SYM ./.
@@70161416797 Both/DT resting/JJ blood/NN flow/NN (/( RBF/NN )/SYM and/CC maximal/JJ blood/NN flow/NN (/( NBF/NN )/SYM were/VBD studied/VBN by/IN Xenon/VB 133/CD clearance/NN ./.
@@80124486603 INO2/NEWGENE ,/, a/DT regulatory/JJ gene/NN in/IN yeast/NN phospholipid/NN biosynthesis/NN ,/, affects/VBP nuclear/JJ segregation/NN and/CC bud/NN pattern/NN formation/NN ./.
@@92910988455 We/PRP established/VBD that/IN the/DT 2/NEWGENE ./NEWGENE 6/NEWGENE kb/NEWGENE mRNA/NEWGENE V-1/NEWGENE and/CC the/DT 2/NEWGENE ./NEWGENE 3/NEWGENE kb/NEWGENE GGT/NEWGENE mRNA/NEWGENE V-2/NEWGENE derive/VB ,/, by/IN alternate/JJ splicing/JJ ,/, from/IN a/DT primary/JJ transcript/NN initiated/VBN on/IN a/DT distal/JJ promoter/NN on/IN the/DT rat/NEWGENE GGT/NEWGENE gene/NEWGENE ./.
@@17565392347 Pulmonary/NNP hypertension/NN ,/, with/IN or/CC without/IN coronary/JJ arterial/JJ narrowing/NN ,/, is/VBZ the/DT major/JJ condition/NN leading/JJ to/IN isolated/VBN atrial/JJ infarction/NN ./.
@@75592332998 Citrate/NEWGENE synthase/NEWGENE activity/NN was/VBD increased/VBN in/IN the/DT medial/JJ head/JJ (/( 81%/JJ ,/, P/NN </SYM 0/CD ./CD 001/CD )/SYM and/CC the/DT red/JJ long/JJ head/JJ (/( 88%/JJ ,/, P/NN </SYM 0/CD ./CD 001/CD )/SYM of/IN the/DT triceps/NN brachii/NNS muscle/NN in/IN R/NN rats/NNS but/CC not/RB in/IN the/DT white/JJ long/JJ head/JJ (/( 25%/JJ ,/, P/NN =/SYM 0/CD ./CD 06/CD )/SYM ./.
@@103291354992 These/DT results/NNS suggest/VBP that/IN mitochondrial/JJ presequences/NNS interact/VBP with/IN the/DT mt-hsp70/NEWGENE during/IN or/CC after/IN mitochondrial/JJ protein/NN import/NN ./.
@@81247859768 METHODS/IN AND/CC RESULTS/NNS :/: In/NN 25/CD open-chest/JJ ,/, anesthetized/JJ dogs/NNS ,/, progressive/JJ circumflex/JJ artery/NN stenosis/NN led/VBN to/IN a/DT concordant/JJ decrease/NN of/IN circumflex/JJ artery/NN resting/JJ and/CC hyperemic/JJ flow/NN ,/, coronary/JJ flow/NN reserve/NN ,/, and/CC inverse/JJ angiographic/JJ mean/JJ transit/NN time/NN Tmicro-1/NN (/( P/NN </SYM ./CD 01/CD )/SYM ./.
@@95565578636 Conversely/RB ,/, the/DT central/JJ regions/NNS are/VBP highly/RB variable/JJ ./.
@@107750389453 In/NN an/DT attempt/NN to/IN understand/VB Wee1/NEWGENE regulation/NN during/IN cell/NN cycle/NN ,/, yeast/NN two-hybrid/JJ screening/NN was/VBD used/VBN to/IN identify/VB Wee1-binding/NEWGENE protein/NEWGENE (/NEWGENE s/NEWGENE )/NEWGENE ./.
@@97258543267 Alternatively/RB ,/, the/DT similarity/NN in/IN apparent/JJ regulatory/JJ action/NN of/IN the/DT genes/NNS may/MD indicate/VB allelic/JJ differences/NNS wherein/CC the/DT IS1112C/NEWGENE Rf3/NEWGENE1 allele/NEWGENE1 may/MD differ/VB from/IN alleles/NNS of/IN maintainer/NN lines/NNS by/IN the/DT capability/NN to/IN regulate/VB both/DT orf107/NEWGENE and/CC urf209/NEWGENE processing/VBG activities/NNS ./.
@@11125872240 This/DT philosophy/NN was/VBD instituted/VBN for/IN the/DT compound/NN RP/NN 73401/CD ,/, a/DT specific/NN phosphodiesterase/NEWGENE IV/NEWGENE inhibitor/NN ,/, that/WDT was/VBD being/VBP developed/VBN simultaneously/RB for/IN delivery/NN by/IN both/DT oral/JJ and/CC pulmonary/JJ routes/NNS of/IN administration/NN ./.
@@106743957588 We/PRP have/VBP previously/RB demonstrated/VBN that/DT expression/NN of/IN the/DT gene/NN for/IN the/DT reproductive/JJ neuropeptide/NN ,/, GnRH/NEWGENE ,/, is/VBZ repressed/VBN by/IN the/DT glutamate/NN //NN NO/NN //NN cyclic/NN GMP/NN (/( cGMP/NN )/SYM signal/JJ transduction/NN pathway/NN through/RB cGMP-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE in/IN the/DT hypothalamic/JJ GnRH-secreting/JJ neuronal/JJ cell/NN line/NN GT1-7/NNP ./.
@@11071974902 To/TO evaluate/VB the/DT effects/NNS of/IN HRT/NN on/IN those/DT factors/NNS in/IN end-stage/JJ renal/JJ disease/NN (/( ESRD/NN )/SYM patients/NNS ,/, we/PRP evaluated/VBD the/DT changes/NNS of/IN lipid/NN profile/NN ,/, coagulation/NN and/CC fibrinolysis/NN markers/NNS ,/, and/CC plasma/NN homocysteine/NN levels/NNS after/IN treatment/NN ./.
@@111982892635 Decreased/JJ serum/NEWGENE ceruloplasmin/NEWGENE and/CC copper/JJ levels/NNS in/IN cervical/JJ dystonia/NN ./.
@@19239857152 Symptoms/NNS due/NN to/IN the/DT action/NN of/IN mastocyte/NN mediators/NN were/VBD observed/VBN ./.
@@20832304116 The/DT encoded/VBN sequence/NN revealed/VBD a/DT typical/JJ signal/JJ peptide/NN ,/, a/DT predominantly/RB hydrophilic/JJ 707/CD amino/JJ acid/NN residue/NN domain/NN with/IN 8/NN N-glycosylation/NN sites/NN ,/, a/DT transmembrane/JJ domain/NN ,/, and/CC a/DT C-terminal/NN domain/NN of/IN 52/CD amino/JJ acids/NNS ./.
@@111018471238 Oncogenic/NNP signalling/JJ by/IN E2F1/NEWGENE has/VBZ recently/RB been/VBN linked/JJ to/IN stabilization/NN and/CC activation/NN of/IN the/DT tumour/NN suppressor/NN p53/NEWGENE (/( refs/NNS 1/CD ,/CD 3/CD ,/CD 4/CD )/SYM ./.
@@83432167081 PPD-specific/NEWGENE IgG/NEWGENE subclass/NN responses/NNS were/VBD evident/JJ to/IN all/DT four/CD IgG/NEWGENE subclasses/NNS ./.
@@12674461910 Biohydrogenation/NNS of/IN linoleic/JJ acid/NN into/IN octadecenoic/JJ acid/JJ was/VBD observed/VBN ./.
@@75796954285 Similarly/RB ,/, we/PRP observed/VBD synthetic/JJ phenotypes/NNS between/IN mutations/NNS in/IN MIF2/NEWGENE and/CC trans-acting/JJ mutations/NNS in/IN three/CD known/VBP yeast/NEWGENE centromere/NEWGENE protein/NEWGENE genes-CEP1/NEWGENE //NEWGENE CBF1/NEWGENE //NEWGENE CPF1/NEWGENE ,/, NDC10/NEWGENE //NEWGENE CBF2/NEWGENE ,/, and/CC CEP3/NEWGENE //NEWGENE CBF3B/NEWGENE ./.
@@28528053541 (/( total/JJ soluble/JJ solids/NNS )/SYM and/CC organoleptic/JJ characteristics/NNS under/IN the/DT influence/NN of/IN different/JJ treatments/NNS ./.
@@105939391599 Furthermore/RB ,/, in/IN vivo/NN and/CC in/IN vitro/NN protein-protein/NN interaction/NN experiments/NNS have/VBP shown/VBP that/IN SR33/NEWGENE protein/NEWGENE interacts/VBZ with/IN itself/PRP and/CC with/IN SR45/NEWGENE protein/NEWGENE but/CC not/RB with/IN two/JJ other/DT members/NNS (/( SRZ21/NEWGENE and/CC SRZ22/NEWGENE )/SYM of/IN the/DT SR/NEWGENE family/NEWGENE that/WDT are/VBP known/VBP to/IN interact/VB with/IN the/DT Arabidopsis/NN full-length/JJ U-70K/NEWGENE only/RB ./.
@@12826381926 The/DT prophylactic/JJ use/NN of/IN new/JJ medication/NN for/IN patients/NNS between/IN the/DT first/JJ and/CC second/JJ cycle/NN of/IN chemotherapy/NN ,/, in/IN agreement/NN with/IN the/DT estimates/NNS calculated/VBN ,/, does/VBP not/RB save/VB health/NN care/NN costs/NNS but/CC may/MD improve/VB the/DT quality/NN of/IN life/NN in/IN these/DT patients/NNS and/CC permit/NN the/DT continuation/NN of/IN a/DT therapeutic/JJ schedule/NN without/IN interruption/NN which/WDT may/MD improve/VB the/DT life/NN expectancy/NN of/IN the/DT patient/NN ./.
@@30004893720 Alveolar/JJ lymphocytes/NNS were/VBD surprisingly/RB increased/VBN in/IN most/JJ patients/NNS with/IN AIDS/NN (/( mean/JJ 26/CD ./CD 1/CD +/NN //NN -/NN 21/CD ./CD 9%/CD ;/: range/NN 1-76%/JJ )/SYM and/CC CGL/IN (/( mean/JJ 26/CD ./CD 6/CD +/NN //NN -/NN 22/CD ./CD 6%/CD ;/: range/NN 3-76%/JJ )/SYM with/IN criteria/NNS of/IN activation/NN contrasting/JJ with/IN the/DT blood/NN lymphopenia/NN ./.
@@15555565162 Control/NNP Tmuscle/NNP was/VBD 35/CD ./CD 8/CD +/NN //NN -/NN 0/CD ./CD 7/CD degrees/NNS C/NN ,/, with/IN control/NN Wi/NN ,/NN max/NN being/VBP 51/CD ./CD 6/CD (/( SD/NN 8/NN ./NN 7/NN )/SYM W/CD ./CD kg-1/CD ./.
@@75657137672 Overexpression/NNS of/IN SCS1/NEWGENE could/MD not/RB complement/VB an/DT HSP60-null/NEWGENE allele/NEWGENE ,/, indicating/VBG that/DT suppression/NN was/VBD not/RB due/NN to/IN the/DT bypassing/VBG of/IN Hsp60/NEWGENE activity/NN ./.
@@106372385010 Eastern/NNP Cooperative/NNP Oncology/NNP Group/NNP trial/NN E3186/NN was/VBD initiated/VBN to/IN explore/VB this/DT question/NN ./.
@@13871059118 Through/IN Southern/NNP blot/NN analyses/NNS of/IN DNA/NN from/IN backcross/NN and/CC cogenic/JJ mice/NNS ,/, recombinant/JJ inbred/JJ strains/NNS ,/, and/CC somatic/JJ cell/NN hybrids/NNS ,/, the/DT genetic/JJ loci/NNS that/WDT produce/VBP the/DT cyclin/NEWGENE B1-related/NEWGENE sequences/NEWGENE (/( designated/VBN loci/NEWGENE Cycb1-rs1/NEWGENE to/IN Cycb1-rs9/NEWGENE )/SYM were/VBD mapped/VBN on/IN mouse/NN chromosomes/NNS 5/CD ,/, 1/CD ,/, 17/CD ,/, 4/CD ,/, 14/CD ,/, 13/CD ,/, 7/CD ,/, X/NN ,/, and/CC 8/CD ,/, respectively/RB ./.
@@116835581531 The/DT diet/NN of/IN migrants/NNS showed/VBD both/DT positive/JJ (/( macronutrients/NNS )/SYM and/CC negative/JJ (/( micronutrients/NNS )/SYM differences/NNS with/IN the/DT general/JJ Dutch/JJ diet/NN ./.
@@118380581703 METHODS/IN :/: 9/CD cases/NNS of/IN conventional/JJ intermittent/JJ tissue/NN expansion/NN (/( CITE/NNP )/SYM and/CC 9/CD cases/NNS of/IN continuous/JJ pressure-controlled/JJ tissue/NN expansion/NN (/( CPTE/NNP )/SYM were/VBD chosen/VBP for/IN the/DT study/NN ./.
@@15067462123 Greater/NNP rupture/NN force/NN was/VBD required/VBN in/IN the/DT adult/JJ pigs/NNS than/IN in/IN the/DT young/JJ pigs/NNS ./.
@@115027386060 Identical/JJ effects/NNS were/VBD obtained/VBN when/CC inhibitors/NNS and/CC dominant/JJ negative/JJ mutants/NNS were/VBD tested/VBN on/IN the/DT -29/CD to/IN +139/CD bp/NN region/NN of/IN the/DT cyclin/NEWGENE D1/NEWGENE promoter/NEWGENE ./.
@@85838468560 Recent/JJ literature/NN has/VBZ suggested/VBN that/IN beta-2/NEWGENE transferrin/NEWGENE can/MD also/RB be/VB used/VBN as/IN a/DT clinical/JJ marker/NN for/IN perilymph/NN ./.
@@91153657058 Expression/NNS of/IN the/DT human/NEWGENE heat/NEWGENE shock/NEWGENE protein/NEWGENE 70/NEWGENE gene/NEWGENE (/( hsp70/NEWGENE )/SYM is/VBZ induced/VBN by/IN various/JJ kinds/NNS of/IN stress/NN and/CC by/IN oncogenes/NNS ./.
@@62421136043 Cultivation/NNS technics/NNS for/IN Codonopsis/NNP pilosula/NN ./.
@@62784248389 We/PRP have/VBP investigated/VBN the/DT requirements/NNS of/IN the/DT CH/NEWGENE gene/NEWGENE switch/NN by/IN characterizing/VBG two/JJ rearranged/NEWGENE gamma/NEWGENE 2b/NEWGENE genes/NEWGENE from/IN a/DT gamma/NEWGENE 2b/NEWGENE producing/JJ mouse/NN myeloma/NN (/( MPC-11/NN )/SYM ./.
@@112785944877 Exchanging/VBD the/DT human/JJ propeptide/NN in/IN this/DT chimera/NN with/IN either/DT the/DT murine/NEWGENE MIC-1/NEWGENE or/CC TGF-beta1/NEWGENE propeptide/NEWGENE resulted/VBN in/IN secretion/NN of/IN the/DT unprocessed/JJ ,/, monomeric/JJ chimera/NN ,/, suggesting/VBG a/DT specific/JJ interaction/NN between/IN the/DT human/NEWGENE MIC-1/NEWGENE propeptide/NEWGENE and/CC mature/JJ peptide/NN ./.
@@97252924788 CONCLUSION/IN :/: Although/IN quantitative/JJ and/CC qualitative/JJ criteria/NNS for/IN diagnosing/JJ fatty/JJ liver/NN on/IN helical/JJ CT/NN can/MD be/VB determined/VBN ,/, they/PRP are/VBP protocol-specific/JJ ./.
@@90796258829 Syndecan-4/NEWGENE is/VBZ a/DT focal/JJ adhesion/NN component/NN ,/, and/CC this/DT interaction/NN may/MD both/DT localize/VB PKC/NEWGENE and/CC amplify/VB its/PRP activity/NN at/IN sites/NNS of/IN forming/JJ adhesions/NNS ./.
@@1047417227 Who/WP says/VBZ 'National/NN Health/NNP Dis-service'/NNP ./.
@@82017588174 A-69-year-old/CD patient/NN with/IN postoperative/JJ small-bowel/NN obstruction/NN underwent/VBD laparotomy/NN three/CD times/NNS ./.
@@106138636631 The/DT VirR/NEWGENE response/NEWGENE regulator/NEWGENE from/IN Clostridium/NN perfringens/NNS binds/VBZ independently/RB to/IN two/JJ imperfect/JJ direct/JJ repeats/NNS located/VBN upstream/RB of/IN the/DT pfoA/NEWGENE promoter/NEWGENE ./.
@@58072225747 Ion/NNP injection/NN ./.
@@39878185601 These/DT data/NN suggest/VB that/IN AP-A/NEWGENE may/MD be/VB potentially/RB useful/JJ in/IN the/DT management/NN of/IN heart/NN failure/NN ./.
@@22828152931 Significance/NN of/IN thin/JJ glomerular/JJ basement/NN membranes/NNS in/IN hematuric/JJ children/NNS ./.
@@98132033286 The/DT effect/NN of/IN low-profile/JJ serine/NN substitutions/NNS in/IN the/DT V3/NN loop/NN of/IN HIV-1/NEWGENE gp120/NEWGENE IIIB/NEWGENE //NEWGENE LAI/NEWGENE on/IN the/DT immunogenicity/NN of/IN the/DT envelope/NEWGENE protein/NEWGENE ./.
@@39283577269 Laboratory/NNP pyrolyses/NNS have/VBP indeed/RB shown/VBP that/IN PCBs/NNS give/VBP significant/JJ yields/NNS of/IN PCDFs/NN ,/, and/CC chlorobenzenes/NNS give/VB both/DT PCDFs/NN and/CC PCDDs/NN ./.
@@111455623311 A/DT marked/JJ decrease/NN in/IN the/DT type/NEWGENE 1/NEWGENE insulin-like/NEWGENE growth/NEWGENE factor/NEWGENE (/NEWGENE IGF/NEWGENE )/NEWGENE receptor/NEWGENE (/( IGF-IR/NEWGENE )/SYM occurs/VBZ in/IN prostate/NN epithelial/JJ cells/NNS during/IN transformation/NN from/IN the/DT benign/JJ to/IN the/DT metastatic/JJ state/NN ./.
@@99249876431 Pokeweed/NEWGENE antiviral/NEWGENE protein/NEWGENE (/( PAP/NEWGENE )/SYM from/IN Phytolacca/NN americana/NN is/VBZ a/DT highly/RB specific/NN N-glycosidase/NEWGENE removing/JJ adenine/NN residues/NNS (/( A4324/NN in/IN 28S/NEWGENE rRNA/NEWGENE and/CC A2660/NNP in/IN 23S/NEWGENE rRNA/NEWGENE )/SYM from/IN intact/JJ ribosomes/NNS of/IN both/DT eukaryotes/NNS and/CC prokaryotes/NNS ./.
@@93411937235 We/PRP also/RB identified/VBD Sp1/NEWGENE ,/, Sp3/NEWGENE ,/, and/CC NGFI-A/NEWGENE //NEWGENE Egr-1/NEWGENE as/IN the/DT primary/JJ nuclear/JJ transcription/NN factors/NNS binding/JJ to/IN TRE1/NEWGENE which/WDT mediate/VBP Tax/NEWGENE responsiveness/NN ./.
@@40394394661 This/DT study/NN indicated/VBN that/IN the/DT Japanese/JJ quail/NN was/VBD less/PRP sensitive/JJ to/IN particulate/JJ Mn3O4/NN exposure/NN than/IN rodents/NNS treated/VBN comparably/RB ./.
@@28201285804 The/DT significance/NN of/IN these/DT palindromic/JJ domains/NNS in/IN this/DT ORF/NN is/VBZ unclear/JJ but/CC the/DT coincidence/NN of/IN the/DT end/NN of/IN one/PRP larger/JJR palindrome/NN with/IN the/DT end/NN of/IN the/DT translated/VBN protein/NN sequence/NN that/WDT has/VBZ homology/NN with/IN the/DT B/NEWGENE chain/NEWGENE of/IN insulin/NEWGENE suggests/VBZ that/IN the/DT palindromes/NNS may/MD divide/NN the/DT T2/NEWGENE protein/NEWGENE into/IN several/DT functional/JJ units/NNS ./.
@@86319449609 In/NN contrast/NN ,/, when/CC the/DT isoform/NN containing/JJ the/DT C/NEWGENE epsilon4/NEWGENE domain/NEWGENE joined/VBN directly/RB to/IN the/DT M2/NEWGENE exon/NEWGENE (/( IgE/NEWGENE grande/NEWGENE )/SYM is/VBZ expressed/VBN in/IN the/DT J558L/NNP cell/NN line/NN ,/, it/PRP is/VBZ degraded/VBN intracellularly/RB ,/, suggesting/VBG a/DT cell/NN line-dependent/JJ regulation/NN of/IN secretion/NN ./.
@@98610998456 Positive/JJ correlations/NNS were/VBD seen/VBP between/IN the/DT measurements/NNS for/IN protein/NN intake/NN (/( r/JJ =/CD ./CD 58/CD ,/, P/NN =/CD ./CD 0026/CD )/SYM energy/NN intake/NN (/( r/JJ =/CD ./CD 78/CD ,/, P/NN </SYM ./CD 00001/CD )/SYM ,/, with/IN mean/JJ differences/NNS of/CD ./CD 066/CD g/NN //NN kg/NN //NN d/NN (/( SD/CD ./CD 38/CD )/SYM 2/CD ./CD 04/CD kcal/NN //NN kg/NN //NN day/NN (/( SD/NN 6/NN ./NN 67/NN )/SYM ,/, respectively/RB ./.
@@63407036133 Grimelius/NNP stain/NN was/VBD positive/JJ ,/, Masson/NNP Fontana/NNP stain/NN negative/JJ ./.
@@80054387836 SPP41/NEWGENE was/VBD cloned/VBN and/CC sequenced/VBN and/CC found/VB to/IN be/VB essential/JJ ./. spp43/NEWGENE is/VBZ allelic/JJ to/IN the/DT previously/RB identified/VBN suppressor/NEWGENE srn1/NEWGENE ,/, which/WDT encodes/VBZ a/DT negative/JJ regulator/NN of/IN gene/NN expression/NN ./.
@@2482511408 Thus/RB ,/, phosphodiesterase/NEWGENE inhibitors/NN that/WDT produce/VBP an/DT opiate/JJ quasi-withdrawal/JJ syndrome/NN potentiate/VB interoceptive/JJ stimuli/NNS and/CC weight/NN loss/NN associated/VBN with/IN the/DT withdrawal/NN syndrome/NN precipitated/VBN by/IN naltrexone/NN in/IN morphine-dependent/JJ rats/NNS ./.
@@31186313838 No/DT differences/NNS in/IN fixation/NN quality/NN were/VBD observed/VBN between/IN cochleas/NNS fixed/JJ by/IN intravascular/JJ perfusion/NN and/CC cochleas/NNS fixed/JJ by/IN intralabyrinthine/NN perfusion/NN ./.
@@82395868224 Effects/NNPS of/IN diltiazem/NN on/IN netilmicin-induced/JJ nephrotoxicity/NN in/IN rabbits/NNS ./.
@@114376604613 Substitution/NNS of/IN serine/NN residues/NNS at/IN the/DT C-terminus/NN indicated/VBD that/DT loss/NN of/IN phosphorylation/NN sites/NNS did/VBD not/RB appear/VB to/IN have/NN any/DT effect/NN on/IN transcription/NN and/CC replication/NN ./.
@@113020728206 The/DT results/NNS show/NN that/IN cognitive/JJ stimulation/NN enhanced/VBD performance/NN on/IN the/DT Boston/NNP Naming/NNP Test/NNP and/CC a/DT Word/NNP List/NNP Recognition/NN Task/NN ;/: physical/JJ intervention/NN ,/, however/RB ,/, did/VBD not/RB reach/VB statistical/JJ significance/NN ./.
@@78831935902 A/DT DNA/NN fragment/NN encoding/VBG the/DT DNA-binding/NN domain/NN (/( amino/JJ acids/NNS 1-60/JJ )/SYM of/IN the/DT Escherichia/NEWGENE coli/NEWGENE fru/NEWGENE transcriptional/NEWGENE regulator/NEWGENE was/VBD cloned/VBN into/IN the/DT pGEX-KT/JJ vector/NN and/CC expressed/VBN in/IN frame/NN with/IN the/DT fused/VBN gene/NN encoding/VBG glutathione/NEWGENE S-transferase/NEWGENE ./.
@@15491297941 It/PRP is/VBZ believed/VBN that/IN these/DT domains/NNS are/VBP important/JJ for/IN directing/VBG specific/NN protein-protein/NN interactions/NNS necessary/JJ for/IN the/DT proper/JJ functioning/NN of/IN Src/NEWGENE ./.
@@27583828545 Obesity/NN was/VBD strongly/RB associated/VBN with/IN the/DT proportions/NNS of/IN nonprotein-bound/JJ and/CC albumin-bound/JJ estradiol/NN ,/, and/CC inversely/RB associated/VBN with/IN sex/NEWGENE hormone/NEWGENE binding/NEWGENE globulin/NEWGENE (/( SHBG/NEWGENE )/SYM levels/NNS and/CC the/DT proportion/NN of/IN SHBG-bound/NNP estradiol/NN ./.
@@79691521472 Although/IN a/DT carboxyl-terminal/NN HSF/NEWGENE transcriptional/JJ activation/NN domain/NN is/VBZ critical/JJ for/IN the/DT activation/NN of/IN CUP1/NEWGENE transcription/NN in/IN response/NN to/IN both/DT heat/NN shock/NN stress/NN and/CC glucose/NN starvation/NN ,/, this/DT region/NN is/VBZ dispensable/JJ for/IN transient/JJ heat/NN shock/NN activation/NN of/IN at/IN least/RB two/JJ genes/NNS encoding/VBG members/NNS of/IN the/DT S/NNP ./NNP cerevisiae/NN hsp70/NEWGENE family/NEWGENE ./.
@@75678307463 METHODS/IN :/: We/PRP obtained/VBD maximal/JJ inspiratory/JJ and/CC expiratory/JJ flow-volume/NN curves/NNS in/IN 41/CD unselected/JJ patients/NNS with/IN essential/JJ tremor/NN (/( 14/CD males/NNS ,/, 27/CD females/NNS ,/, age/NN 61/CD ./CD 7/CD +/NN //NN -/NN 2/CD ./CD 14/CD years/NNS )/SYM ./.
@@89709513379 This/DT correlated/VBN with/IN reduced/VBN levels/NNS of/IN secreted/VBN hepatitis/NEWGENE B/NEWGENE e/NEWGENE antigen/NEWGENE and/CC increased/VBN intracellular/JJ levels/NNS of/IN core/NEWGENE and/CC Pol/NEWGENE proteins/NEWGENE and/CC replicative/JJ HBV/NN DNA/NN intermediates/NNS ./.
@@52745265446 Relapse/NNS of/IN leukemia/NN after/IN prolonged/JJ remission/NN ./.
@@29026155637 A/DT new/JJ physiopathological/JJ treatment/NN of/IN HBV-related/JJ polyarteritis/NN inspired/JJ by/IN advances/NNS in/IN the/DT treatment/NN of/IN chronic/JJ active/JJ hepatitis/NN B/NN was/VBD tested/VBN in/IN 7/CD patients/NNS ./.
@@94670447604 The/DT ipsilateral/JJ breast/NN tumor/NN relapse/NN rate/NN was/VBD similar/JJ between/IN the/DT PALP/NN and/CC MGDET/NN groups/NNS ./.
@@47844325158 Possibilities/NNS of/IN needleless/JJ administration/NN of/IN various/JJ substances/NNS to/IN animals/NNS ./.
@@63270395973 No/DT significant/JJ correlation/NN was/VBD found/VBN between/IN LVM/NN or/CC wall/NN thickness/NN and/CC body/NN surface/NN area/NN ,/, age/NN ,/, blood/NN pressure/NN ,/, heart/NN rate/NN ,/, cardiac/JJ output/NN ,/, total/JJ peripheral/JJ resistance/NN and/CC left/NN ventricular/JJ systolic/JJ wall/NN stress/NN ,/, whereas/IN CD25/NN was/VBD correlated/VBN with/IN urinary/JJ catecholamines/NNS only/RB in/IN hypertensive/JJ patients/NNS (/( r/JJ =/SYM 0/CD ./CD 606/CD ,/, p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ./.
@@21177992715 Uses/NNS of/IN orthoclone/NN OKT3/NN for/IN prophylaxis/NN of/IN rejection/NN and/CC induction/NN in/IN initial/JJ nonfunction/NN in/IN kidney/NN transplantation/NN ./.
@@7821790322 (/( iv/NN )/SYM Although/IN UCRBP/NEWGENE has/VBZ been/VBN previously/RB shown/VBP to/RB act/NN as/IN a/DT transcriptional/JJ repressor/NN ,/, we/PRP show/VBP here/RB that/IN UCRBP/NEWGENE can/MD also/RB act/VB as/IN a/DT positive/JJ transactivator/NN of/IN a/DT reporter/NN driven/VBP by/IN UCR/NEWGENE elements/NEWGENE when/CC used/VBN in/IN co-transfection/NN assays/NNS ./.
@@22040295431 RNase/NEWGENE protection/NN assays/NNS reveal/VBP that/IN this/DT gene/NN ,/, unr/NEWGENE ,/, is/VBZ transcribed/VBN in/IN the/DT same/JJ direction/NN as/IN N-ras/NEWGENE and/CC that/IN its/PRP 3'/NN end/NN is/VBZ located/VBN just/RB 130/CD base/NN pairs/NNS away/RB from/IN the/DT point/NN at/IN which/WDT N-ras/NEWGENE transcription/NN begins/VBZ ./.
@@86626178980 Collectively/RB ,/, these/DT data/NN indicate/VB that/IN HIP/NEWGENE is/VBZ a/DT membrane-associated/NN HP-binding/NN protein/NN expressed/VBN on/IN the/DT surface/NN of/IN normal/JJ human/JJ uterine/JJ epithelia/NNS and/CC uterine/JJ epithelial/JJ cell/NN lines/NNS ./.
@@74987919566 The/DT second/JJ mutation/NN present/NN in/IN the/DT original/JJ mutant/RB proved/VBN to/IN be/VB an/DT allele/NN of/IN a/DT known/VBP gene/NN ,/, PBS2/NEWGENE ,/, which/WDT encodes/VBZ a/DT putative/JJ protein/NEWGENE kinase/NEWGENE that/IN functions/NNS in/IN the/DT high/JJ osmolarity/NN stress/NN pathway/NN ./.
@@96616767454 Clinical/NNP implication/NN of/IN protein/NN levels/NNS of/IN IL-5/NEWGENE in/IN induced/VBN sputum/NN in/IN asthmatic/JJ patients/NNS ./.
@@104173318164 The/DT enzyme/NN displays/VBP optimal/JJ activity/NN at/IN about/RB 0/CD ./CD 5/CD mM/NN pantoate/NN (/( k/NN (/NN cat/NN )/SYM 0/CD ./CD 63/CD s/NN (/NN -1/NN )/NN )/NN and/CC at/IN pH/NN 7/CD ./CD 8/CD ./.
@@87986418125 Biol/NNP ./.
@@88480526946 These/DT properties/NNS indicate/VBP that/IN Gle1/NEWGENE is/VBZ an/DT RNA-export/NN factor/NN and/CC that/IN Rev/NEWGENE may/MD mediate/VB viral/JJ RNA/NN export/NN by/IN mimicking/VBG the/DT function/NN of/IN Gle1/NEWGENE ./.
@@118008781665 Dynamic/NNP imaging/NN of/IN nuclear/JJ wave/NN functions/NNS with/IN ultrashort/JJ UV/NN laser/NN pulses/NNS ./.
@@23724964956 Co-administration/NNS of/IN 5FU/NN ,/, angiotensin/NEWGENE II/NEWGENE and/CC microspheres/NNS via/NN the/DT hepatic/JJ artery/NN may/MD reduce/VB drug/VB exposure/NN in/IN the/DT systemic/JJ compartment/NN and/CC therefore/RB may/MD increase/VB the/DT therapeutic/JJ ratio/NN of/IN 5FU/CD administration/NN via/NN the/DT hepatic/JJ artery/NN ./.
@@21594706813 Specific/JJ binding/NN of/IN the/DT protein/NN factors/NNS to/IN the/DT sites/NNS ,/, possibly/RB to/IN the/DT three/CD Mt/NEWGENE sequences/NEWGENE ,/, may/MD play/VB an/DT important/JJ role/NN in/IN the/DT coordinate/JJ regulation/NN of/IN the/DT transcription/NN of/IN nuclear/JJ genes/NNS encoding/VBG subunits/NNS responsible/JJ for/IN mitochondrial/JJ oxidative/JJ phosphorylation/NN ./.
@@23958687088 The/DT pattern/NN for/IN catalytic/JJ zinc/NN sites/NNS included/VBD two/JJ ligands/NNS close/JJ in/IN sequence/NN ,/, a/DT sequence-distant/NN ligand/NN ,/, and/CC a/DT main-chain/NN hydrogen/NN bond/NN joining/VBG two/JJ ligands/NNS ./.
@@118819231596 Neutrophil/NN :/: lymphocyte/NN ratio/NN ,/, plasma/NN haptoglobin/NEWGENE ,/, and/CC CBG/NEWGENE levels/NNS were/VBD greater/JJR (/( P/NN </SYM 0/CD ./CD 01/CD )/SYM during/IN the/DT INITIAL/NNP period/NN than/IN during/IN the/DT PRE/NN or/CC POST/NN periods/NNS but/CC did/VBD not/RB differ/VB between/IN treatments/NNS ./.
@@10403690528 In/NN a/DT prospective/JJ randomized/JJ study/NN ,/, 287/CD patients/NNS with/IN advanced/JJ non-small/JJ cell/NN lung/NN cancer/NN (/( NSCLC/NN )/SYM stage/NN IIIb/NNS or/CC IV/NN with/IN ECOG/NN performance/NN status/NN (/( PS/NN )/SYM 0-1/CD or/CC 2/CD were/VBD randomly/RB assigned/VBN to/IN receive/VB either/DT best/JJS supportive/JJ care/NN (/( BSC/NN )/SYM or/CC supportive/JJ care/NN plus/IN combination/NN chemotherapy/NN (/( IEP/NN regimen/NN :/: ifosfamide/NN 3/CD gm/NN //NN m2/NN IV/NN with/IN mesna/NNS uroprotection/NN ,/, epirubicin/NN 60/CD mg/NN //NN m2/NN IV/NN on/IN day/NN 1/CD and/CC cisplatin/NN 60/CD mg/NN //NN m2/NN IV/NN on/IN day/NN 2/CD ;/: or/CC MVP/NN regimen/NN :/: mitomycin-C/NN 8/CD mg/NN //NN m2/NN ,/, cisplatin/NN 100/CD mg/NN //NN m2/NN IV/NN on/IN day/NN 1/CD ,/, vinblastine/NN 4/CD mg/NN //NN m2/NN IV/NN on/IN days/NNS 1/CD and/CC 15/CD )/SYM ./.
@@105854919779 In/NN gel/NN mobility/NN shift/NN assays/NNS ,/, low/JJ binding/JJ activity/NN of/IN CBF/NEWGENE to/IN the/DT wild-type/NEWGENE AtpC/NEWGENE promoter/NEWGENE sequence/NEWGENE was/VBD observed/VBN with/IN nuclear/JJ extracts/NNS from/IN tissue/NN with/IN low/JJ AtpC/NEWGENE expression/NN levels/NNS ,/, i/CD ./CD e/CD ./. extracts/NNS from/IN etiolated/JJ and/CC photobleached/VBN seedlings/NNS ,/, whereas/IN high/JJ binding/JJ activity/NN was/VBD detectable/JJ with/IN extracts/NNS from/IN tissues/NNS with/IN high/JJ AtpC/NEWGENE expression/NN levels/NNS ,/, i/CD ./CD e/CD ./. extracts/NNS from/IN light-grown/JJ seedlings/NNS and/CC etiolated/JJ seedlings/NNS treated/VBN with/IN cytokinin/NEWGENE ./.
@@25572179265 The/DT data/NN indicate/VB that/DT calcitonin/NEWGENE induced/NN a/NN beta-endorphin/NEWGENE increase/NN independent/NN of/IN enhanced/VBN corticotrophin-cortisol/JJ release/NN ./.
@@27891803481 Electrocardiographic/NNP right/JJ ventricular/JJ hypertrophy/NN was/VBD seen/VBP in/IN 4/CD ,/, and/CC biventricular/JJ hypertrophy/NN in/IN 5/CD patients/NNS ./.
@@76656058958 The/DT plasmin-derived/NEWGENE D/NEWGENE (/NEWGENE approximately/NEWGENE 105-kDa/NEWGENE )/NEWGENE product/NEWGENE ,/, however/RB ,/, could/MD be/VB cross-linked/VBN into/IN DD/NEWGENE dimers/NEWGENE ./.
@@95373783757 Furthermore/RB ,/, the/DT deletion/NN of/IN bcp/NEWGENE from/IN the/DT chromosome/NN had/VBP no/DT effect/NN on/IN gcv-lacZ/NEWGENE expression/NN ./.
@@8891337409 The/DT amino-terminal/NN region/NN of/IN E1A/NEWGENE binds/VBZ several/DT high/JJ molecular/JJ weight/NN proteins/NNS and/CC inhibits/VBZ the/DT transcriptional/NN coactivator/NN function/NN of/IN p300/NEWGENE and/CC the/DT homologous/JJ cAMP/NEWGENE response/NEWGENE element/NEWGENE (/NEWGENE CRE/NEWGENE )/NEWGENE -binding/NEWGENE protein/NEWGENE ./.
@@111787651021 To/TO investigate/VB the/DT effects/NNS of/IN exogenous/JJ hyaluronic/JJ acid/NN ,/, the/DT development/NN of/IN port-site/NN metastasis/NN was/VBD examined/VBN using/VBG mouse/NN adenocarcinoma/NN cell-line/NN colon/NN 26/CD cells/NNS ./.
@@86616138638 Some/DT users/NNS will/MD willingly/RB comply/VB with/IN management/NN measures/NNS ,/, other/DT users/NNS will/MD comply/VB in/IN response/NN to/IN education/NN ,/, but/CC there/RB will/MD be/VB another/DT group/NN who/WP will/MD only/RB respond/VB to/IN enforcement/NN activities/NNS ./.
@@11092770286 The/DT extraction/NN was/VBD subsequently/RB rated/JJ as/IN 'easy'/NN or/CC 'difficult'/CD ./CD Taking/CD Pell-Gregory/JJ class/NN C/NN as/IN a/DT predictor/NN of/IN a/DT 'difficult'/NN extraction/NN ,/, specificity/NN was/VBD 88%/JJ but/CC sensitivity/NN was/VBD low/JJ at/IN 15%/NN ./.
@@78461539655 Chrispeels/NNP [/NN 1993/NN ]/NN EMBO/NNP J/NN 12/CD :/: 2241-2247/NN )/NN ./.
@@117050934747 Therefore/RB ,/, vitamin/NN D3/NN analogues/NNS have/VBP a/DT substantial/JJ antipsoriatic/JJ effect/NN ./.
@@85696804474 A/DT mutant/NEWGENE areA/NEWGENE product/NEWGENE truncated/JJ immediately/RB after/IN the/DT last/NN residue/NN of/IN the/DT highly/RB conserved/VBN GATA/NEWGENE (/( DNA-binding/NN )/SYM domain/NN retains/VBZ partial/JJ function/NN ./.
@@93283499149 Thus/RB ,/, the/DT CCAAT/NN box/NN also/RB has/VBZ tissue-specific/JJ characteristics/NNS that/WDT assist/VBP in/IN targeting/JJ expression/NN of/IN the/DT alpha-subunit/NEWGENE gene/NEWGENE to/IN trophoblasts/NNS ./.
@@89789962783 The/DT identification/NN of/IN the/DT hepatitis/NN C/NN virus/NN as/IN the/DT major/JJ cause/NN of/IN liver/NN disease/NN both/DT in/NN dialysis/NN patients/NNS and/CC in/IN transplant/NN patients/NNS has/VBZ focused/VBN attention/NN on/IN the/DT epidemiology/NN and/CC the/DT impact/NN of/IN continuing/JJ infection/NN in/IN these/DT patient/NN groups/NNS ./.
@@104389503705 IL-1/NEWGENE and/CC TNF/NEWGENE increase/NN AND-34/NEWGENE transcript/NEWGENE levels/NNS in/IN thymic/JJ cortical/JJ reticular/JJ ,/, thymic/JJ nurse/NN ,/, and/CC fibroblast/NN cell/NN lines/NNS ./.
@@91930809025 Sequence/NN divergence/NN is/VBZ observed/VBN in/IN untranslated/JJ regions/NNS which/WDT allows/VBZ the/DT definition/NN of/IN gene-specific/JJ probes/NNS ./.
@@90940936255 This/DT site/NN is/VBZ upstream/RB from/IN the/DT TATA/NN box/NN used/VBN in/IN somatic/JJ cells/NNS ./.
@@84972802809 It/PRP also/RB suggests/VBZ that/WDT there/RB is/VBZ another/DT pathway/NN which/WDT can/MD activate/VB SWI4/NEWGENE transcription/NN in/IN the/DT absence/NN of/IN SWI6/NEWGENE ./.
@@77614205971 Furthermore/RB ,/, 45Ca-binding/JJ assays/NNS revealed/VBN that/IN CCaMK/NEWGENE directly/RB binds/VBZ Ca2+/NN ./.
@@109315241469 To/TO analyze/VB the/DT regulatory/JJ activity/NN of/IN Gtx/NEWGENE ,/, we/PRP first/RB identified/VBD the/DT optimal/JJ Gtx-binding/NEWGENE sequence/NEWGENE using/VBG an/DT in/NN vitro/FW DNA-binding/NN assay/NN ./.
@@73088497174 Generally/RB the/DT differences/NNS between/IN short/JJ gut/NN and/CC sham/NN operation/NN animals/NNS disappeared/VBN when/CC the/DT data/NN were/VBD normalised/VBN for/IN mucosal/JJ weight/NN ./.
@@100964699884 Dopaminergic/NNP modulation/NN of/IN transcallosal/JJ activity/NN of/IN cat/NN motor/JJ cortical/JJ neurons/NNS ./.
@@115879801481 In/NN children/NNS unable/JJ to/IN perform/VB forced/JJ expiratory/JJ maneuvers/NNS (/( n/NN =/SYM 25/CD )/SYM ,/, FOT/NNP ,/, contrary/NN to/IN the/DT interrupter/NN technique/NN ,/, clearly/RB identified/VBN a/DT subgroup/NN of/IN young/JJ children/NNS with/IN high/JJ resistance/NN values/NNS at/IN baseline/NN ,/, which/WDT returned/VBD to/IN normal/JJ after/IN bronchodilation/NN ./.
@@1006841868 An/DT increase/NN in/IN bone/NN mineral/JJ density/NN at/IN the/DT spine/NN ,/, total/JJ hip/NN ,/, and/CC total/JJ body/NN has/VBZ been/VBN reported/VBN with/IN raloxifene/NN but/CC seems/VBZ to/IN be/VB less/PRP than/IN that/DT seen/VBP with/IN estrogen/NN or/CC alendronate/NN therapy/NN ./.
@@88167595725 The/DT retinoid/NEWGENE Z/NEWGENE receptor/NEWGENE beta/NEWGENE (/( RZR/NEWGENE beta/NEWGENE )/SYM ,/, an/DT orphan/NEWGENE receptor/NEWGENE ,/, is/VBZ a/DT member/NN of/IN the/DT retinoic/NEWGENE acid/NEWGENE receptor/NEWGENE (/( RAR/NEWGENE )/NEWGENE1 //NEWGENE1 thyroid/NEWGENE1 hormone/NEWGENE1 receptor/NEWGENE1 (/( TR/NEWGENE )/SYM subfamily/NN of/IN nuclear/JJ receptors/NNS ./.
@@85009387899 We/PRP conclude/VBP that/DT grade/NN III/NN BGCT/NN can/MD be/VB treated/VBN by/IN modified/JJ intralesional/JJ excision/NN provided/VBD the/DT articular/JJ surfaces/NNS and/CC part/NN of/IN the/DT metaphysis/NN are/VBP intact/JJ ./.
@@91724149183 A/DT reversed-phase/JJ high-performance/JJ liquid/JJ chromatographic/JJ (/( HPLC/NN )/SYM method/NN for/IN the/DT determination/NN of/IN cocaine/NN metabolites/NNS produced/VBN in/IN vitro/FW by/IN serum/NEWGENE and/NEWGENE liver/NEWGENE esterases/NEWGENE is/VBZ described/VBN ./.
@@15491253191 The/DT functions/NNS of/IN isolated/VBN portions/NNS of/IN the/DT insulin/NEWGENE ,/, IAPP/NEWGENE ,/, and/CC beta/NEWGENE GK/NEWGENE promoters/NEWGENE were/VBD studied/VBN by/IN using/VBG transient/JJ expression/NN and/CC DNA/NN binding/JJ assays/NNS ./.
@@57606655709 Caries/NNS prevention/NN in/IN the/DT dental/JJ office/NN ./.
@@79495511773 Use/VB of/IN the/DT vena/NN cava/NN to/IN extend/VB the/DT right/JJ renal/NN vein/NN for/IN cadaver/NN transplantation/NN is/VBZ controversial/JJ ./.
@@33966287808 During/IN the/DT observation/NN period/NN of/IN 0/CD ./CD 4-30/CD weeks/NNS ,/, cardiac/NN white/NN spots/NNS on/IN the/DT right/JJ ventricle/NN of/IN BALB/NN //NN c/NN mice/NNS were/VBD first/RB detected/VBN at/IN three/CD weeks/NNS (/( 6/CD of/IN 20/CD mice/NNS ;/: 30%/CD )/SYM ,/, and/CC the/DT maximal/JJ incidence/NN of/IN cardiac/NN white/NN spots/NNS was/VBD obtained/VBN at/IN nine/JJ weeks/NNS (/( 39/CD of/IN 44/CD mice/NNS ;/: 88%/JJ )/SYM ./.
@@96495012636 We/PRP have/VBP used/VBN the/DT hydrophobic/JJ repeats/NNS of/IN the/DT HSF1/NEWGENE trimerization/NEWGENE domain/NEWGENE in/IN the/DT yeast/NN two-hybrid/JJ protein/NN interaction/NN assay/NN to/IN identify/VB heat/NEWGENE shock/NEWGENE factor/NEWGENE binding/NEWGENE protein/NEWGENE 1/NEWGENE (/( HSBP1/NEWGENE )/SYM ,/, a/DT novel/NN ,/, conserved/VBN ,/, 76-amino-acid/JJ protein/NN that/WDT contains/VBZ two/RB extended/VBN arrays/NNS of/IN hydrophobic/JJ repeats/NNS that/WDT interact/VBP with/IN the/DT HSF1/NEWGENE heptad/NEWGENE repeats/NEWGENE ./.
@@93532968616 The/DT CNXA/NEWGENE domain/NEWGENE is/VBZ similar/JJ at/IN the/DT amino/JJ acid/NN level/NN to/IN the/DT Escherichia/NEWGENE coli/NEWGENE moaA/NEWGENE gene/NEWGENE product/NEWGENE ,/, while/CC CNXC/NEWGENE is/VBZ similar/JJ to/IN the/DT E/NEWGENE ./NEWGENE coli/NEWGENE moaC/NEWGENE product/NEWGENE ,/, with/IN both/DT E/NNP ./NNP coli/JJ products/NNS encoded/VBN by/IN different/JJ cistrons/NNS ./.
@@98516148496 One/CD of/IN its/PRP unique/JJ features/NNS appears/VBZ to/IN be/VB the/DT unusually/RB short/JJ 5'-untranslated/JJ regions/NNS (/( UTR/NNS )/SYM (/( 1-6/JJ nucleotides/NNS (/( nts/NNS )/NN )/NN and/CC the/DT apparent/JJ absence/NN of/IN 5'-cap/NN structures/NNS from/IN its/PRP mRNAs/NNS ./.
@@71169626928 The/DT COP-PAWP/NN gradient/NN was/VBD markedly/RB decreased/VBN in/IN both/DT shock/NN and/CC non-shock/JJ patients/NNS with/IN pulmonary/JJ edema/NN ./.
@@22237736266 Chick/NEWGENE brain/NEWGENE actin/NEWGENE depolymerizing/NEWGENE factor/NEWGENE (/( ADF/NEWGENE )/SYM is/VBZ a/DT 19-kDa/NN protein/NN that/WDT severs/VBZ actin/NEWGENE filaments/NEWGENE and/CC binds/VBZ actin/NEWGENE monomers/NEWGENE ./.
@@77836412680 CodY/NEWGENE does/VBP not/RB have/VB any/DT homologues/NNS in/IN the/DT data-bases/NNS ./.
@@79417397108 A/DT 15/CD ./CD 1/CD kb/NN fragment/NN of/IN the/DT yeast/NN genome/NN was/VBD allocated/VBN to/IN the/DT centromeric/JJ region/NN of/IN chromosome/NN XIV/NN by/IN genetic/JJ mapping/NN ./.
@@3190481642 The/DT test/NN for/IN alpha-naphthyl/NEWGENE esterase/NEWGENE and/CC quantitation/NN of/IN macrophages/NNS (/( absolute/JJ number/NN )/SYM per/IN infiltration/NN area/NN unit/NN adjacent/JJ to/IN the/DT abscess/NN suggest/VB a/DT direct/JJ correlation/NN between/IN the/DT absolute/JJ number/NN of/IN macrophages/NNS and/CC the/DT width/NN of/IN the/DT capsule/NN ./.
@@85109247156 Here/RB ,/, we/PRP have/VBP more/RB closely/RB investigated/VBN transactivation/NN of/IN the/DT human/NEWGENE HSP70/NEWGENE promoter/NEWGENE by/IN Myb/NEWGENE proteins/NEWGENE ./.
@@81383648113 Varieties/NNS of/IN envious/JJ experience/NN ./.
@@13009148204 In/NN the/DT absence/NN of/IN histological/JJ criteria/NNS ,/, which/WDT it/PRP is/VBZ difficult/JJ to/IN demand/NN in/IN view/NN of/IN the/DT variability/NN of/IN results/NNS and/CC potential/JJ dangers/NNS of/IN endomyocardial/JJ biopsy/NN involving/VBG such/JJ thin/JJ and/CC fragile/JJ ventricular/JJ walls/NNS ,/, the/DT diagnosis/NN of/IN ACRV/NN is/VBZ based/VBN upon/IN the/DT concomitant/JJ existence/NN of/IN :/: (/( 1/CD )/SYM electrophysiological/JJ criteria/NNS :/: ventricular/JJ arrhythmias/NNS ,/, in/IN particular/JJ sustained/JJ monomorphous/JJ VT/NN ,/, with/IN the/DT particular/JJ feature/NN of/IN a/DT very/RB high/JJ degree/NN of/IN sensitivity/NN to/IN adrenergic/JJ stimulation/NN (/( exercise/NN )/SYM ,/, the/DT existence/NN of/IN late/JJ potentials/NNS on/IN the/DT high/JJ amplification/NN ECG/NN ,/, a/DT highly/RB specific/JJ sign/NN ,/, though/CC unfortunately/RB of/IN poor/JJ sensitivity/NN in/IN localized/VBN froms/NNS ,/, those/DT which/WDT are/VBP most/RB difficult/JJ to/IN identify/VB (/( 2/CD )/SYM ;/: segmentary/JJ morphological/JJ and/CC kinetic/JJ RV/NN abnormalities/NNS ,/, most/RB often/RB resulting/JJ in/IN localized/VBN akinetic/JJ or/CC dyskinetic/JJ parietal/JJ vaulting/NN ,/, with/IN stasis/NN "in/NN situ"/NN ./.
@@83617615120 We/PRP show/VBP here/RB that/DT v-Rel/NEWGENE specifically/RB increased/VBD expression/NN from/IN a/DT reporter/NN plasmid/NN containing/JJ multiple/JJ Sp1/NEWGENE binding/NEWGENE sites/NEWGENE approximately/RB sixfold/RB in/IN chicken/NN embryo/NN fibroblasts/NNS (/( CEFs/IN )/SYM ,/, even/VB though/CC v-Rel/NEWGENE did/VBD not/RB bind/VB directly/RB to/IN these/DT sites/NNS ./. v-Rel/NEWGENE also/RB increased/VBD expression/NN from/IN a/DT reporter/NN plasmid/NN containing/JJ a/DT human/NEWGENE immunodeficiency/NEWGENE virus/NEWGENE type/NEWGENE 1/NEWGENE (/NEWGENE HIV-1/NEWGENE )/NEWGENE long/NEWGENE terminal/NEWGENE repeat/NEWGENE (/( LTR/NEWGENE )/SYM in/IN which/WDT the/DT kappa/NEWGENE B/NEWGENE binding/NEWGENE sites/NEWGENE were/VBD mutated/JJ but/CC which/WDT still/RB contained/VBN intact/JJ Sp1/NEWGENE binding/NEWGENE sites/NEWGENE ./.
@@80792685392 Use/VB of/IN Medi-Jector/NN EZ/NN dermojet/NN for/IN anesthesia/NN in/IN minor/JJ surgery/NN ./.
@@86763835005 Each/DT half/NN molecule/NN contains/VBZ four/CD disulfide/NN linkages/NNS and/CC four/CD cis/NN peptides/NN ./.
@@84913837285 The/DT alpha-subunit/NN by/IN itself/PRP binds/VBZ to/IN telomeric/NN DNA/NN ./.
@@83162096965 The/DT positive-acting/JJ global/JJ sulfur/JJ regulatory/JJ protein/NN ,/, CYS3/NEWGENE ,/, of/IN Neurospora/NN crassa/NN turns/NNS on/IN the/DT expression/NN of/IN a/DT family/NN of/IN unlinked/NN structural/NN genes/NN that/WDT encode/VBP enzymes/NNS of/IN sulfur/JJ catabolism/NN ./.
@@46248635057 Mechanism/NNS of/IN immunogenesis/NN in/IN vaccination/NN with/IN streptomycin-dependent/JJ mutants/NNS of/IN salmonellae/NNS and/CC shigellae/NNS ./.
@@39566954610 Cortisol/CHEM excretion/NN ,/, appeared/VBN to/IN be/VB markedly/RB affected/VBN by/IN the/DT season/NN although/IN other/DT factors/NNS such/JJ as/IN social/JJ and/CC environmental/JJ stress/NN cannot/MD be/VB discounted/VBN ./.
@@13329642994 The/DT minimal/JJ promoter/NN of/IN the/DT RII/NEWGENE beta/NEWGENE gene/NEWGENE was/VBD composed/VBN of/IN two/JJ adjacent/JJ functional/JJ elements/NNS ./.
@@11046517890 Our/PRP results/NNS ,/, however/RB ,/, were/VBD obtained/VBN for/IN Z/NN itself/PRP and/CC not/RB for/IN [/NN Z/NN ]/NN ./.
@@104254455857 Structure/NNS and/CC expression/NN of/IN the/DT mouse/NEWGENE growth/NEWGENE hormone/NEWGENE receptor/NEWGENE //NEWGENE growth/NEWGENE hormone/NEWGENE binding/NEWGENE protein/NEWGENE gene/NEWGENE ./.
@@114227572238 Among/IN individuals/NNS ,/, however/RB ,/, changes/NNS were/VBD strongly/RB correlated/VBN with/IN ACR/NN levels/NNS at/IN baseline/NN ./.
@@108529531054 Investigations/NNS using/VBG hippocampal/JJ slices/NNS maintained/VBN in/IN vitro/FW have/NN demonstrated/VBN that/IN bursts/NNS of/IN oscillatory/JJ field/NN potentials/NNS in/IN the/DT gamma/JJ frequency/NN range/NN (/( 30-80/JJ Hz/NN )/SYM are/VBP followed/VBN by/IN a/DT slower/JJR oscillation/NN in/IN the/DT beta/NN 1/NN range/NN (/( 12-20/JJ Hz/NN )/SYM ./.
@@82212518191 We/PRP suggest/VBP that/DT CT/NN scan/NN be/VB preferable/JJ in/IN diagnosis/NN of/IN tumors/NNS in/IN that/DT area/NN ./.
@@82948654622 Several/JJ features/NNS of/IN 10/CD ./CD 24/CD ./CD 6/CD cells/NNS suggest/VBP that/IN the/DT mutation/NN disrupts/VBZ normal/JJ intracellular/JJ formation/NN of/IN peptide/NEWGENE //NEWGENE DR/NEWGENE complexes/NEWGENE ./.
@@58903515792 Human/NNP antitetanus/NN serum/JJ :/: an/DT unused/JJ wealth/NN ./.
@@111320631619 Depending/VBG on/IN treatment/NN exposures/NNS ,/, this/DT at-risk/JJ population/NN may/MD experience/VB life-threatening/JJ late/JJ effects/NNS ,/, such/JJ as/IN cirrhosis/NN secondary/JJ to/IN hepatitis/NN C/NN or/CC late-onset/NN anthracycline-induced/JJ cardiomyopathy/NN ,/, or/CC life-changing/JJ late/JJ effects/NNS ,/, such/JJ as/IN cognitive/JJ dysfunction/NN ./.
@@4295031755 Their/PRP effect/NN on/IN the/DT guinea/NN pig/NN vas/NN deferens/NN ./.
@@109201866374 This/DT enabled/VBN the/DT formation/NN of/IN stem-loop/NN templates/NNS with/IN the/DT fusion/NN point/NN of/IN the/DT chimeric/JJ transcript/NN in/IN the/DT loop/NN and/CC the/DT use/NN of/IN MLL/NEWGENE primers/NN in/IN two-sided/JJ PCR/NN ./.
@@97482864692 We/PRP recently/RB reported/VBD a/DT placenta-specific/NN enhancer/NN in/IN the/DT human/NEWGENE leukemia/NEWGENE inhibitory/NEWGENE factor/NEWGENE receptor/NEWGENE (/( LIFR/NEWGENE )/SYM gene/NN and/CC now/RB show/VB detailed/JJ characterization/NN of/IN the/DT 226-base/JJ pair/NN enhancer/NN (/( -4625/JJ //JJ -4400/JJ nucleotides/NNS )/SYM ./.
@@40742144756 Factors/NNS influencing/VBG semen/NN characteristics/NNS in/IN young/JJ boars/NNS reared/VBN in/IN a/DT subtropical/JJ environment/NN were/VBD studied/VBN ./.
@@36683964333 These/DT equilibrium/NN solutions/NNS are/VBP then/RB shown/VBP to/IN arise/VB from/IN the/DT vertices/NNS of/IN a/DT particular/JJ convex/JJ polyhedron/NN ./.
@@103697753825 The/DT studied/VBN protein/NN fragments/NNS consist/VBP of/IN residues/NNS Arg183-His267/NN of/IN the/DT human/NEWGENE ER/NEWGENE and/CC residues/NNS Lys438-Gln520/NN of/IN the/DT rat/NEWGENE GR/NNP ./NNP
@@73201537182 Micro/NNP high-performance/JJ liquid/JJ chromatographic/JJ system/NN with/IN micro/NN precolumn/NN and/CC dual/JJ electrochemical/JJ detector/NN for/IN direct/JJ injection/NN analysis/NN of/IN catecholamines/NNS in/IN body/NN fluids/NNS ./.
@@86319585383 Human/NEWGENE cytomegalovirus/NEWGENE immediate-early/NEWGENE protein/NEWGENE IE2/NEWGENE tethers/NNS a/DT transcriptional/JJ repression/NN domain/NN to/IN p53/NEWGENE ./.
@@29184743624 Neither/CC verapamil/NN nor/CC nifedipine/NN changed/VBD collateral/JJ myocardial/JJ blood/NN flow/NN from/IN 0/CD ./CD 10/CD +/NN //NN -/NN 0/CD ./CD 02/CD in/IN the/DT subendocardium/NN and/CC 0/CD ./CD 17/CD +/NN //NN -/NN 0/CD ./CD 03/CD ml/NN //NN min/NN //NN g/NN in/IN the/DT subepicardium/NN ./.
@@91681341802 Sequence/NN comparison/NN of/IN the/DT 0/CD ./CD 38/CD kb/NN promoter/NN sequence/NN with/IN the/DT promoters/NNS of/IN the/DT Sm-E/NEWGENE gene/NN and/CC U1/NEWGENE snRNA/NEWGENE genes/NEWGENE revealed/VBD several/DT homologous/JJ motifs/NNS ,/, suggesting/VBG that/IN genes/NNS encoding/VBG the/DT snRNP/NEWGENE components/NN may/MD be/VB coordinately/RB regulated/VBN ./.
@@9262729217 The/DT most/RB common/JJ cause/NN of/IN renal/JJ deterioration/NN in/IN the/DT spinal/JJ cord/NN injured/JJ patient/NN is/VBZ irreversible/JJ vesicoureteral/JJ reflux/NN ./.
@@10488147409 Identification/NNP of/IN eotaxin-3/NEWGENE will/MD further/RB promote/VB our/PRP understanding/NN of/IN the/DT control/NN of/IN eosinophil/JJ trafficking/NN and/CC other/DT CCR3-mediated/JJ biological/JJ phenomena/NNS ./.
@@81821718154 The/DT efficacy/NN of/IN a/DT Propionibacterium/NNP acnes/NNS product/NN for/IN treatment/NN of/IN coliform/JJ mastitis/NN was/VBD evaluated/VBN following/IN intramammary/JJ infusion/NN of/IN Escherichia/NN coli/JJ ./.
@@11069223901 Patients/NNS had/VBP to/IN have/NN adequate/JJ liver/NN ,/, renal/JJ ,/, and/CC marrow/NN functions/NNS ./.
@@80864507967 Comparison/NNS with/IN the/DT bovine/NN gene/NN showed/VBN that/IN the/DT 5'-flanking/JJ region/NN of/IN the/DT hATP1/NEWGENE gene/NEWGENE has/VBZ an/DT unconserved/JJ guanine-cytosine/JJ (/( GC/NN )/SYM rich/NN region/NN ,/, including/JJ several/DT binding/JJ motifs/NNS of/IN transcriptional/JJ factors/NNS ,/, such/JJ as/IN Sp1/NEWGENE ,/, AP-2/NEWGENE ,/, and/CC GCF/NEWGENE ./.
@@94466162881 Reconstitution/NNS of/IN Raf-1/NEWGENE activity/NN was/VBD observed/VBN only/RB with/IN kinase/NEWGENE active/JJ Jak1/NEWGENE in/IN both/DT cell/NN lines/NNS ./.
@@77139365923 Binding/NN of/IN meAda/NEWGENE is/VBZ necessary/JJ to/IN activate/VB transcription/NN of/IN the/DT adaptive/JJ response/NN genes/NN ;/: accordingly/RB ,/, in/IN vitro/FW transcription/NN of/IN aidB/NEWGENE is/VBZ dependent/JJ on/IN the/DT presence/NN of/IN meAda/NEWGENE ./.
@@10191090411 Spatiotemporal/JJ expression/NN of/IN the/DT PAX3/NEWGENE gene/NEWGENE is/VBZ tightly/RB regulated/VBN during/IN development/NN ./.
@@92465859209 Neural/JJ blockade/NN in/IN chronic/NN and/CC cancer/NN pain/NN ./.
@@78630473617 OBJECTIVES/NNS :/: 1/NN )/NN to/IN determine/VB serum/NEWGENE ACE/NEWGENE activity/NN in/IN patients/NNS with/IN COPD/NN treated/VBN with/IN and/CC without/IN continuous/JJ ambulatory/JJ oxygen/NN therapy/NN (/( CAOT/NNP )/SYM ;/: 2/NN )/NN to/IN verify/VB whether/IN there/RB is/VBZ a/DT correlation/NN between/IN ACE/NEWGENE and/CC any/DT hematological/JJ ,/, spirometric/JJ or/CC gasometric/JJ parameter/NN ./.
@@17033359916 Lymphoproliferative/NNP disorders/NNS arising/VBG under/IN immunosuppression/NN with/IN FK/NN 506/NN :/: initial/JJ observations/NNS in/IN a/DT large/JJ transplant/NN population/NN ./.
@@207662014 Furthermore/RB ,/, plasma/NN fibrinogen/NEWGENE levels/NNS increased/VBN by/IN a/DT mean/NN of/IN 17/CD ./CD 6%/CD ,/, a/DT potentially/RB adverse/JJ effect/NN of/IN gemfibrozil/NN that/WDT has/VBZ not/RB been/VBN previously/RB reported/VBN ./.
@@85667543882 This/DT 5'/CD splice/NN site/NN sequence/NN was/VBD required/VBN for/IN enhanced/VBN polyadenylation/NN and/CC was/VBD recognized/VBN by/IN both/DT U1/NEWGENE small/NEWGENE nuclear/NEWGENE ribonucleoproteins/NEWGENE (/( snRNPs/NEWGENE )/SYM and/CC alternative/NEWGENE splicing/NEWGENE factor/NEWGENE //NEWGENE splicing/NEWGENE factor/NEWGENE 2/NEWGENE (/( ASF/NEWGENE //NEWGENE SF2/NEWGENE )/SYM ./.
@@94180577323 One/CD R-EST/NN and/CC one/PRP Pto-like/NEWGENE sequence/NEWGENE each/DT mapped/VBN to/IN two/JJ locations/NNS ./.
@@110240474170 Expression/NNS of/IN a/DT dominant/NEWGENE negative/NEWGENE Smad2/NEWGENE significantly/RB reduces/VBZ the/DT level/NN of/IN luciferase/NEWGENE reporter/NEWGENE activity/NN induced/VBN by/IN nodal/JJ treatment/NN ./.
@@107964655670 SELECTION/NN CRITERIA/NNP :/: Randomised/JJ and/CC possibly/RB randomised/JJ trials/NNS using/VBG acupuncture/NN to/IN treat/NN asthma/NN and/CC asthma-like/JJ symptoms/NNS ./.
@@1735447143 The/DT size/NN of/IN the/DT mutant/JJ molecule/NN corresponds/VBZ to/IN the/DT unprocessed/JJ cytoplasmic/JJ precursor/NN (/( pre-super-pro-PrB/NEWGENE )/SYM ,/, as/IN detected/VBN in/IN sec61/NEWGENE mutants/NEWGENE ,/, when/CC translocation/NN into/IN the/DT endoplasmic/JJ reticulum/NN is/VBZ blocked/VBN ./.
@@91287304010 Malonate/NN decarboxylation/NN in/IN Malonomonas/NNP rubra/NN involves/VBZ the/DT formation/NN of/IN malonyl-S-/NEWGENE [/NEWGENE acyl-carrier/NEWGENE protein/NEWGENE ]/NEWGENE from/IN acetyl-S-/NEWGENE [/NEWGENE acyl-carrier/NEWGENE protein/NEWGENE ]/NEWGENE and/CC malonate/NN ,/, carboxyltransfer/NN to/IN a/DT biotin/NEWGENE protein/NEWGENE and/CC its/PRP decarboxylation/NN that/WDT is/VBZ coupled/VBN to/IN delta/NN mu/NN Na+/NN generation/NN ./.
@@67841236085 Production/NN of/IN C/NEWGENE mu/NEWGENE RNAs/NEWGENE ,/, unlike/IN mu/NEWGENE mRNAs/NEWGENE ,/, does/VBP not/RB require/VB recombination/NN with/IN the/DT joining/NEWGENE region/NEWGENE (/NEWGENE JH/NEWGENE )/NEWGENE locus/NEWGENE ./.
@@95751874304 Finally/RB ,/, a/DT role/NN for/IN NF-kappaB/NEWGENE in/IN preventing/JJ apoptosis/NN induced/VBN by/IN ER/NN calcium/NN release/NN was/VBD demonstrated/VBN by/IN data/NN showing/VBG that/DT sAPPalpha/NEWGENE prevents/VBZ thapsigargin-induced/JJ apoptosis/NN ,/, an/DT effect/NN blocked/VBN by/IN kappaB/NEWGENE decoy/NN DNA/NN ./.
@@87572658741 Neurons/NNS were/VBD held/VBP at/IN -67/NN mV/NN to/IN equate/VB voltage-dependent/JJ effects/NNS ./.
@@636806165 Prenatal/JJ diagnosis/NN of/IN galactosaemia/NN [/NN letter/NN ]/NN ./.
@@30243433737 All/DT tumors/NNS proved/VBN histologically/RB to/IN be/VB neuroendocrine/JJ in/IN origin/NN ./.
@@10665308473 Mechanisms/NNPS of/IN tachyphylaxis/NN in/IN regional/JJ anesthesia/NN of/IN long/JJ duration/NN ./.
@@75313217744 Patients/NNS with/IN more/RB than/IN 250/CD PVC/NN //NN 24/NN hours/NNS were/VBD selected/VBN for/IN distribution/NN of/IN PVC/NN and/CC CI/NN evaluation/NN ./.
@@110700781973 This/DT dynamic/JJ response/NN strongly/RB suggests/VBZ that/IN the/DT p53/NEWGENE and/CC Rb/NEWGENE tumor/NN suppressor/NN pathways/NNS are/VBP intact/JJ in/IN HeLa/DT cells/NNS and/CC that/DT repression/NN of/IN HPV/NEWGENE E6/NEWGENE and/CC E7/NEWGENE mobilizes/VBZ these/DT pathways/NNS in/IN an/DT orderly/JJ fashion/NN to/IN deliver/VB growth/NN inhibitory/JJ signals/NNS to/IN the/DT cells/NNS ./.
@@108504534389 Taken/VBN together/RB ,/, our/PRP data/NN suggest/VB that/IN prostate/NN carcinomas/NNS with/IN the/DT Ras/NEWGENE //NEWGENE MAPK/NEWGENE pathway/NN activation/NN might/MD have/VB a/DT selective/JJ growth/NN advantage/NN by/IN autocrine/JJ TGF-beta1/NEWGENE production/NN ./.
@@7948921434 Optima/NN )/NN genomic/JJ library/NN by/IN hybridizing/VBG with/IN elicitor-induced/JJ stilbene/NEWGENE synthase/NEWGENE cDNA/NEWGENE as/IN a/DT probe/NN ./.
@@85147667862 The/DT GTPase/NEWGENE activity/NN of/IN CDC42Ce/NEWGENE is/VBZ moderately/RB stimulated/VBN by/IN human/NEWGENE n-chimaerin/NEWGENE ,/, a/DT GTPase-activating/NEWGENE protein/NEWGENE for/IN the/DT related/VBN p21/NEWGENE rac1/NEWGENE ./.
@@3784925873 Renin/IN studies/NNS performed/VBN in/IN 34/CD hypertensive/JJ patients/NNS and/CC in/IN a/DT control/NN group/NN of/IN 11/CD recipients/NNS showed/VBD that/DT elevation/NN of/IN plasma/NEWGENE renin/NEWGENE activity/NN and/CC of/IN plasma/NN aldosterone/NN level/NN is/VBZ frequent/VB but/CC difficult/JJ to/IN interpret/VB ,/, particularly/RB when/CC a/DT renal/JJ artery/NN stenosis/NN is/VBZ observed/VBN ./.
@@106878623723 The/DT CCAAT/NEWGENE core/NEWGENE sequence/NEWGENE mutants/NEWGENE in/IN which/WDT both/DT CIII/NEWGENE and/CC CI/NEWGENE //NEWGENE CII/NEWGENE were/VBD abolished/VBN ,/, also/RB increased/VBN the/DT promoter/NN activity/NN ./.
@@83838502981 In/NN the/DT present/NN study/NN ,/, beta-funaltrexamine/NN (/( beta-FNA/NN )/SYM and/CC naltrindole/NN (/( NTI/IN )/SYM (/( nonequilibrium/NN mu-/NN and/CC delta-antagonist/NN ,/, respectively/RB )/SYM were/VBD used/VBN to/IN precipitate/NN withdrawal/NN in/IN butorphanol-dependent/JJ rats/NNS ./.
@@94740017345 The/DT frequency/NN of/IN SPs/NNS for/IN both/PDT the/DT moderate/JJ and/CC severe/JJ groups/NNS was/VBD significantly/RB higher/JJ than/IN that/IN in/NN patients/NNS with/IN a/DT normal/JJ MMFCV/NNP (/( p/NN </SYM ./CD 01/CD )/SYM ;/: of/IN 154/CD arms/NNS with/IN a/DT normal/JJ MMFCV/NN ,/, only/RB 9/CD (/( 6%/JJ )/SYM had/VBP an/DT SP/NNP ./NNP
@@92784412877 The/DT pattern/NN and/CC timing/NN of/IN CARP/NEWGENE mRNA/NEWGENE expression/NN ,/, including/JJ transient/JJ expression/NN in/IN the/DT tongue/NN at/IN 14/CD ./CD 5/CD days/NNS p/NN ./NN c/NN ./NN ,/, coincides/VBZ with/IN that/DT of/IN Nkx2/NEWGENE ./NEWGENE 5/NEWGENE //NEWGENE Csx/NEWGENE (/( a/DT putative/JJ homolog/NN of/IN tinman/NEWGENE ,/, the/DT Drosophila/NN melanogaster/NN gene/NN responsible/JJ for/IN cardiac/JJ development/NN )/SYM ./.
@@6330478310 188/CD patients/NNS received/VBD cimetidine/NN 400/NN mg/NN q/CD ./CD i/CD ./CD d/CD ./. intravenously/RB and/CC 1/CD ,/CD 000/CD mg/NN daily/JJ orally/RB in/IN divided/VBN doses/NNS ./.
@@20698731075 Mechanism/NNS of/IN activation/NN of/IN the/DT vav/NEWGENE protooncogene/NEWGENE ./. vav/NEWGENE is/VBZ a/DT human/JJ locus/NN that/WDT appears/VBZ to/IN be/VB specifically/RB expressed/VBN in/IN cells/NNS of/IN hematopoietic/JJ origin/NN regardless/RB of/IN their/PRP differentiation/NN lineage/NN ./.
@@32299173922 Not/RB even/VB extensive/JJ pancreatic/JJ resection/NN could/MD prevent/VB pancreatic/JJ remnant/NN infection/NN ./.
@@788882891 This/DT concept/NN is/VBZ supported/VBN by/IN the/DT identification/NN of/IN RH-like/NEWGENE genes/NEWGENE in/IN non/FW human/JJ primates/NNS ./.
@@33263811481 The/DT ultrastructural/JJ findings/NNS ,/, as/RB well/VB as/IN the/DT urinary/JJ C-peptide/NEWGENE excretion/NN ,/, confirmed/VBN that/IN the/DT glycemic/JJ effects/NNS should/MD not/RB be/VB thought/VBP to/IN be/VB due/NN to/IN a/DT direct/JJ action/NN of/IN the/DT drugs/NNS used/VBN on/IN the/DT endocrine/JJ pancreas/NN ./.
@@118730031764 HIV-1/NNP infection/NN in/IN rural/JJ Africa/NN :/: is/VBZ there/RB a/DT difference/NN in/IN median/JJ time/NN to/IN AIDS/NN and/CC survival/NN compared/VBN with/IN that/DT in/NN industrialized/JJ countries/NNS ?/. OBJECTIVES/NNS :/: To/TO describe/VB the/DT progression/NN times/NNS of/IN HIV-1/NNP infection/NN from/IN seroconversion/NN to/IN AIDS/NN and/CC to/IN death/NN ,/, and/CC time/NN from/IN first/JJ developing/JJ AIDS/NN to/IN death/NN in/IN rural/JJ Uganda/NN ./.
@@103580835790 Both/DT functional/JJ analyses/NNS in/IN undifferentiated/JJ and/CC differentiated/VBN F9/NN cells/NNS and/CC characterization/NN of/IN DNA-protein/NN complexes/NNS in/IN vitro/FW have/NN identified/VBD the/DT sequence/NEWGENE motifs/NEWGENE GTGACT/NEWGENE (/NEWGENE C/NEWGENE )/NEWGENE ,/, ATTGT/NEWGENE ,/, and/CC GATA/NEWGENE as/IN the/DT key/NN transcription/NN factor/NN binding/JJ sites/NNS ./.
@@15337604256 Estrogen/NN replacement/NN therapy/NN and/CC risk/NN of/IN breast/NN cancer/NN :/: results/NNS of/IN two/JJ meta-analyses/NNS ./.
@@78004791793 The/DT first/JJ gene/NN ,/, NSR1/NEWGENE ,/, a/DT previously/RB identified/VBN gene/NN ,/, encodes/VBZ a/DT protein/NN involved/VBN in/IN ribosomal/JJ RNA/NN maturation/NN and/CC possibly/RB in/IN transport/NN of/IN proteins/NNS into/IN the/DT nucleus/NN ./.
@@81725989823 Northern-blot/NN analysis/NN of/IN mRNA/NN from/IN Avicel-grown/NNP N/NNP ./NNP patriciarum/NN showed/VBN that/IN xynB/NEWGENE hybridized/VBN to/IN a/DT 3/CD ./CD 4/CD kb/NN mRNA/NN species/NN ./.
@@79424486480 There/EX were/VBD 9/CD patients/NNS in/IN NYHA/NN class/NN III/NN and/CC 8/CD in/IN class/NN IV/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@107022858025 To/TO assess/VB the/DT relationship/NN between/IN G/NN (/NN q/NN )/NN //NN G/NN (/NN 11/NN )/NN function/NN with/IN the/DT phosphatidylinositol/NEWGENE 3-kinase/NEWGENE dependent/JJ pathway/NN ,/, expression/NN of/IN a/DT dominant-interfering/JJ p85/NEWGENE regulatory/NEWGENE subunit/NEWGENE ,/, as/RB well/VB as/IN wortmannin/NN treatment/NN inhibited/VBD insulin-stimulated/JJ but/CC not/RB G/NN (/NN q/NN )/NN //NN Q209L-stimulated/NN GLUT4-EGFP/NEWGENE translocation/NN ./.
@@113501652071 Changes/NNS of/IN the/DT DB/NEWGENE sequence/NEWGENE without/IN affecting/VBG the/DT postulated/VBN stem/NN structure/NN led/VBN to/IN drastic/JJ losses/NNS of/IN translation/NN efficiency/NN ./.
@@90492707689 Northern/NNP blot/NN analysis/NN of/IN LeMT/NEWGENE (/NEWGENE A/NEWGENE )/NEWGENE and/CC LeMT/NEWGENE (/NEWGENE B/NEWGENE )/NEWGENE showed/VBD that/IN transcripts/NNS of/IN both/DT MT-like/NEWGENE genes/NEWGENE were/VBD more/RB abundant/JJ in/IN leaves/NNS than/IN roots/NNS in/IN tomato/NN plants/NNS grown/VBP without/IN addition/NN of/IN extra/JJ metal/NN ions/NNS ,/, a/DT characteristic/NN of/IN type/NEWGENE II/NEWGENE MTs/NEWGENE ./.
@@73872421073 Blood/NNP variables/NNS measured/VBN at/IN eight/CD intervals/NNS before/RB ,/, during/IN ,/, and/CC after/IN operation/NN were/VBD as/IN follows/VBZ :/: seven/JJ plasma/NN proteins/NNS ,/, free/JJ hemoglobin/NEWGENE ,/, formed/VBN elements/NNS ,/, and/CC clotting/JJ functions/NNS ./.
@@37638364430 Results/NNS of/IN electron/NN therapy/NN of/IN tumors/NNS in/IN different/JJ sites/NNS ./.
@@100013339147 Echo/NNP modulation/NN in/IN Pr3+/NNP :/: YAlO3/NN ./.
@@18648212984 The/DT various/JJ forms/NNS of/IN sickle/JJ cell/NN disease/NN share/NN the/DT common/JJ feature/NN of/IN an/DT abnormal/JJ globin/NEWGENE chain/NEWGENE that/IN ,/, under/IN certain/JJ conditions/NNS such/JJ as/IN hypoxia/NN ,/, results/VBZ in/IN the/DT sickling/NN of/IN red/JJ blood/NN cells/NNS and/CC obstruction/NN of/IN blood/NN vessels/NNS ./.
@@94985538438 No/DT TATA/NN box/NN was/VBD found/VBN in/IN the/DT putative/JJ promoter/NN region/NN ,/, but/CC multiple/JJ GC/NN boxes/NNS were/VBD found/VBN around/IN the/DT cap/NN sites/NNS ,/, supporting/VBG the/DT previously/RB inferred/VBN housekeeping/NN nature/NN of/IN CYP51/NEWGENE gene/NEWGENE and/CC the/DT existence/NN of/IN the/DT multiple/JJ transcription/NN initiation/NN sites/NNS ./.
@@2110145536 Sequencing/VBG the/DT gene/NN for/IN an/DT imipenem-cefoxitin-hydrolyzing/JJ enzyme/NN (/( CfiA/NEWGENE )/SYM from/IN Bacteroides/NN fragilis/ORG TAL2480/NN reveals/VBZ strong/JJ similarity/NN between/IN CfiA/NEWGENE and/CC Bacillus/NEWGENE cereus/NEWGENE beta-lactamase/NEWGENE II/NEWGENE ./NNS
@@18290606540 The/DT ED30/NN values/NNS were/VBD 2/CD ./CD 4/CD and/CC 2/CD ./CD 2/CD mg/CD //CD kg/CD and/CC similar/JJ to/IN the/DT respective/JJ values/NNS of/IN nifedipine/NN (/( ED/NN 30/CD :/: 2/CD ./CD 4/CD ,/CD 2/CD ./CD 1/CD mg/CD //CD kg/CD )/SYM ./.
@@100668151918 The/DT SH2/NEWGENE domain-containing/NEWGENE inositol/NEWGENE 5'-phosphatase/NEWGENE (/( SHIP/NEWGENE )/SYM recruits/VBZ the/DT p85/NEWGENE subunit/NEWGENE of/IN phosphoinositide/NEWGENE 3-kinase/NEWGENE during/IN FcgammaRIIb1-mediated/CD inhibition/NN of/IN B/NEWGENE cell/NEWGENE receptor/NEWGENE signaling/JJ ./.
@@10475972314 In/NN the/DT face/NN of/IN the/DT outbreak/NN ,/, there/RB was/VBD a/DT delay/NN before/IN vaccination/NN was/VBD able/JJ to/IN stop/NN deaths/NNS ./.
@@64793621300 Hydrocortisone/NN seems/VBZ to/IN be/VB unable/JJ to/IN hinder/VB the/DT postdenervation/NN changes/NNS in/IN the/DT muscle/NN membrane/NN whereas/IN high/JJ doses/NNS of/IN the/DT hormone/NN are/VBP able/JJ to/IN induce/VB changes/NNS in/IN the/DT muscle/NN membrane/NN ./.
@@9681819656 The/DT recovered/VBN calves/NNS were/VBD tested/VBN for/IN immunity/NN to/IN homologous/JJ severe/JJ challenge/NN ,/, 50/CD or/CC 73/CD days/NNS after/IN the/DT first/JJ infection/NN ./.
@@76551846505 The/DT transport/NN of/IN a/DT genetically/RB engineered/VBN chimeric/JJ transmembrane/JJ protein/NN connected/VBN to/IN this/DT ER/NN leader/NN sequence/NN was/VBD as/RB efficient/JJ as/IN that/DT of/IN the/DT original/JJ protein/NN from/IN which/WDT the/DT ER/NN sequence/NN has/VBZ been/VBN derived/VBN ./.
@@1894696151 J/NNP ./NNP
@@79054532084 Results/NNS from/IN in/IN vitro/FW transcription-translation/NN analysis/NN and/CC maxicell/JJ experiments/NNS suggested/VBN that/IN the/DT 447-bp/JJ ORF/NN was/VBD the/DT one/PRP being/NN actively/RB expressed/VBD ./.
@@80653276535 Extensive/JJ DNA/NN rearrangement/NN occurs/VBZ during/IN the/DT development/NN of/IN the/DT somatic/JJ macronucleus/NN from/IN the/DT germ/NN line/NN micronucleus/NN in/IN ciliated/JJ protozoans/NNS ./.
@@93896697143 Thus/RB ,/, dpp/NEWGENE and/CC omb/NEWGENE promote/VB both/DT dorsal/JJ leg/NN cell/NN fate/NN as/RB well/VB as/IN transdetermination-competent/JJ leg/NN disc/NN cells/NNS ./.
@@40686634745 Germ-free/NNP rabbits/NNS given/VBP mouse/NN CRF-flora/NNP showed/VBD values/NNS quite/RB different/JJ from/IN control/NN animals/NNS for/IN most/JJ parameters/NNS ,/, indicating/VBG unsuitability/NN of/IN mouse/NN CRF/NN flora/NN to/IN 'normalize'/NN rabbits/NNS ./.
@@112789282893 Based/VBN on/IN mutational/JJ data/NN and/CC possible/JJ mRNA/NN structure/NN ,/, we/PRP hypothesized/VBN about/RB the/DT effect/NN of/IN mRNA/NN structure/NN on/IN translation/NN of/IN the/DT two/JJ major/JJ C/NEWGENE //NEWGENE EBPepsilon/NEWGENE isoforms/NEWGENE :/: p32/NEWGENE and/CC p30/NEWGENE ./.
@@34274744127 Moreover/RB ,/, unlike/IN control/NN rats/NNS operated/VBD animals/NNS did/VBD not/RB show/VB aversion/NN to/IN the/DT highest/JJS concentrations/NNS of/IN saccharin/NN solutions/NNS ./.
@@83520663820 We/PRP recently/RB found/VBP that/IN 17/CD beta-estradiol/NN (/( E2/NN )/SYM not/RB only/RB suppresses/VBZ bone/NN resorption/NN but/CC also/RB stimulates/VBZ bone/NN formation/NN in/IN the/DT cancellous/JJ bone/NN of/IN female/JJ rats/NNS ./.
@@13290399686 Although/IN the/DT E-box/NNS consensus/NN is/VBZ minimally/RB defined/VBN as/IN CANNTG/NEWGENE ,/, the/DT adjacent/JJ nucleotides/NNS of/IN functional/JJ E-boxes/NN are/VBP variable/JJ for/IN genes/NNS regulated/VBN by/IN the/DT bHLH/NEWGENE proteins/NEWGENE ./.
@@25206222760 Forty/CD patients/NNS ,/, divided/VBN according/VBG to/IN their/PRP initial/JJ total/JJ gastrointestinal/JJ transit/NN times/NNS and/CC presenting/VBG symptoms/NNS ,/, were/VBD treated/VBN with/IN cimetropium/NN bromide/NN 50/NN mg/NN t/NNS ./NNS d/NNS ./NNS s/NNS ./. or/CC placebo/NN for/IN 1/CD month/NN according/VBG to/IN a/DT double-blind/JJ ,/, parallel/JJ group/NN design/NN ./.
@@11323411410 Far/NNP Western/JJ blot/NN analysis/NN suggested/VBN that/IN the/DT tandem/NN SH2/NEWGENE domains/NEWGENE of/IN SHP2/NEWGENE bind/NN to/IN Gab1/NEWGENE in/IN a/DT specific/JJ orientation/NN ,/, in/IN which/WDT the/DT N-SH2/NEWGENE domain/NEWGENE binds/VBZ to/IN phosphotyrosine/NN (/( Tyr/NN (/NN P/NN )/NN )/NN -627/NN and/CC the/DT C-SH2/NEWGENE domain/NEWGENE binds/VBZ to/IN Tyr/NN (/NN P/NN )/NN -659/NN ./.
@@75681182618 These/DT results/NNS suggest/VBP that/DT G/NN beta/NN gamma-stimulated/NN Shc/NEWGENE phosphorylation/NN represents/VBZ an/DT early/JJ step/NN in/IN the/DT pathway/NN leading/JJ to/IN p21ras/NEWGENE activation/NN ,/, similar/JJ to/IN the/DT mechanism/NN utilized/VBN by/IN growth/NEWGENE factor/NEWGENE tyrosine/NEWGENE kinase/NEWGENE receptors/NEWGENE ./.
@@80653387599 The/DT Oct-2/NEWGENE glutamine-rich/JJ and/CC proline-rich/JJ activation/NN domains/NN can/MD synergize/VB with/IN each/DT other/DT or/CC duplicates/NNS of/IN themselves/PRP to/IN activate/VB transcription/NN ./.
@@104064659101 This/DT sequence/NN also/RB confers/VBZ VDR/NEWGENE and/CC vitamin/NN D/NN responsiveness/NN to/IN a/DT heterologous/JJ promoter/NN ./.
@@8510417851 A/DT follow-up/JJ study/NN of/IN 22/CD patients/NNS with/IN Ebstein's/NN anomaly/NN has/VBZ been/VBN performed/VBN ./.
@@93433984901 Processivity/NNS of/IN DNA/NN synthesis/NN by/IN the/DT mutant/NN holoenzyme/NN containing/NN pcna-79/NEWGENE was/VBD unaffected/JJ on/IN poly/NN (/NN dA/NN )/NN x/NN oligo/NN (/NN dT/NN )/NN but/CC was/VBD dramatically/RB reduced/VBN on/IN a/DT natural/JJ template/NN with/IN secondary/JJ structure/NN ./.
@@79099369853 The/DT present/NN treatment/NN strategy/NN in/IN progressive/JJ disorders/NNS is/VBZ mainly/RB based/VBN on/IN the/DT complementary/JJ effect/NN of/IN intensive/JJ radiochemotherapy/NN ,/, autologous/JJ stem-cell/NN transplantation/NN and/CC the/DT rational/JJ use/NN of/IN cytokines/NNS ,/, mostly/RB colony-stimulating/NEWGENE factors/NEWGENE ./.
@@115045454335 Competition/NN electrophoretic/JJ mobility/NN shift/NN and/CC immunoshift/NN assays/NNS confirmed/VBN that/IN NF1/NEWGENE factors/NEWGENE present/VBP in/IN nuclear/JJ extracts/NNS of/IN HeLa/DT and/CC CV-1/NNP cells/NNS bind/VBP to/IN the/DT BKV-MLP/NEWGENE ./.
@@93954703986 CKbeta4GT-II/NEWGENE is/VBZ predicted/VBN to/IN encode/VB a/DT type/NEWGENE II/NEWGENE transmembrane/NEWGENE glycoprotein/NEWGENE of/IN 43/CD kDa/NN with/IN five/CD potential/JJ N-linked/NN glycosylation/NN sites/NN ./.
@@85087744086 Analysis/NNP of/IN the/DT binding/NN of/IN Lrp/NEWGENE to/IN a/DT set/NN of/IN circularly/RB permuted/VBN DNA/NN fragments/NNS from/IN this/DT region/NN indicates/VBZ that/IN Lrp/NEWGENE induces/VBZ DNA/NN bending/NN ./.
@@79294313756 Plasmids/NNS were/VBD constructed/VBN with/IN the/DT mouse/NN promoter/NN region/NN linked/JJ to/IN the/DT reporter/NEWGENE gene/NEWGENE chloramphenicol/NEWGENE acetyltransferase/NEWGENE (/( CAT/NEWGENE )/SYM ,/, and/CC transiently/RB and/CC stably/RB transfected/VBN in/IN the/DT INS-1/NN cells/NNS ./.
@@100809012940 A/DT set/NN of/IN peptides/NNS corresponding/JJ to/IN the/DT individual/JJ elements/NNS of/IN secondary/JJ structure/NN derived/VBN from/IN the/DT N-terminal/NN domain/NN of/IN the/DT ribosomal/NEWGENE protein/NEWGENE L9/NEWGENE have/VB been/VBN synthesized/VBN ./.
@@78068204252 Both/DT can/MD be/VB elevated/VBN on/IN a/DT single/JJ vascular/JJ pedicle/NN based/VBN on/IN the/DT superficial/JJ temporal/JJ artery/NN ,/, the/DT double-layered/JJ temporal/NN fascia/NN flap/NN ./.
@@118374097702 The/DT two-wave/NN ,/, 1995-1996/CD National/NNP Longitudinal/NNP Study/NNP of/IN Adolescent/NN Health/NNP uses/VBZ a/DT measure/NN of/IN depressive/JJ symptomatology/NN across/IN a/DT 12-month/JJ interval/NN ./.
@@85675563528 Although/IN the/DT consumption/NN of/IN myoglobin-bound/JJ O2/NN (/( MbO2/NN )/SYM stores/NNS in/IN seal/NN muscles/NNS has/VBZ been/VBN demonstrated/VBN in/IN seal/NN muscles/NNS during/IN laboratory/NN simulations/NNS of/IN diving/NN ,/, this/DT may/MD not/RB be/VB a/DT feature/NN of/IN normal/JJ field/NN diving/NN in/IN which/WDT measurements/NNS of/IN heart/NN rate/NN and/CC lactate/NN production/NN show/NN marked/JJ differences/NNS from/IN the/DT profound/JJ diving/NN response/NN induced/VBN by/IN forced/JJ immersion/NN ./.
@@67352475271 Postprandial/JJ plasma/NEWGENE enteroglucagon/NEWGENE concentration/NN after/IN 90/CD minutes/NNS in/IN untreated/JJ patients/NNS correlated/VBN positively/RB to/IN the/DT faecal/JJ fat/JJ excretion/NN (/( r/JJ =/SYM 0/CD ./CD 58/CD ,/, p/NN less/PRP than/IN 0/CD ./CD 02/CD )/SYM ./.
@@808918494 In/NN addition/NN ,/, the/DT megabase/NN region/NN surrounding/JJ the/DT dagA/NEWGENE locus/NEWGENE was/VBD mapped/VBN ./.
@@87717814124 In/NN an/DT attempt/NN to/IN investigate/VB whether/IN the/DT intergenic/JJ region/NN between/IN the/DT oleosin/NEWGENE and/CC a/DT second/JJ open/JJ reading/JJ frame/NN (/( ORFII/NN )/SYM in/IN Brassica/NNP napus/NN (/( L/NNP ./NNP )/SYM is/VBZ a/DT divergent/JJ promoter/NN ,/, and/CC also/RB to/IN characterize/VB the/DT ORFII/NEWGENE ,/, cDNA/NEWGENE clones/NEWGENE homologous/NEWGENE to/NEWGENE ORFII/NEWGENE were/VBD isolated/VBN from/IN a/DT leaf/NN cDNA/NN library/NN ./.
@@77449541561 The/DT protein/NN is/VBZ composed/VBN of/IN a/DT central/NN alpha-helical/NN portion/NN with/IN globular/JJ domains/NNS at/IN both/DT NH2/NN and/CC COOH/CHEM termini/NNS ,/, and/CC the/DT epitope/NN to/IN the/DT monoclonal/JJ antibody/NN resides/VBZ in/IN the/DT central/NN alpha-helical/NN stalk/NN ./.
@@98824997830 Furthermore/RB ,/, using/VBG transgenic/JJ mouse/NN technology/NN we/PRP localized/VBN independent/NN cis-regulatory/NN elements/NN controlling/VBG the/DT tissue-specific/JJ expression/NN of/IN Pax6/NEWGENE ./.
@@10963735790 Indirect/JJ plasma/NN parameters/NNS such/JJ as/IN vitamin/NN E/NN ,/, thiol/NN and/CC uric/JJ acid/NN levels/NNS were/VBD also/RB quantified/VBN ./.
@@112823954456 In/NN addition/NN ,/, we/PRP did/VBD not/RB detect/VB significant/JJ differences/NNS in/IN CDR3/NEWGENE sequences/NEWGENE of/IN endogenous/NEWGENE Ig/NEWGENE lambdaL/NEWGENE and/CC kappaL/NEWGENE chain/NEWGENE gene/NEWGENE loci/NEWGENE cloned/VBN from/IN peripheral/JJ blood/NN lymphocytes/NNS of/IN an/DT NBS/NNP patient/NN and/CC of/IN healthy/JJ individuals/NNS ./.
@@114160129986 To/TO investigate/VB the/DT convergent/JJ role/NN of/IN the/DT insulin/NEWGENE //NEWGENE IGF-I/NEWGENE effector/NN pathway/NN mediating/JJ bihormonal/JJ stimulation/NN of/IN LDL/NEWGENE receptor/NEWGENE promoter/NEWGENE expression/NN ,/, transfected/VBN granulosa-luteal/JJ cells/NNS were/VBD pretreated/VBN for/IN 30/CD min/NN with/IN two/JJ specific/JJ inhibitors/NNS of/IN phophatidylinositol/NEWGENE 3-kinase/NEWGENE ,/, wortmannin/NN (/( 100/CD nM/NN )/SYM and/CC LY/NN 294002/CD (/( 10/CD microM/NN )/SYM ,/, or/CC of/IN mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE kinase/NEWGENE ,/, PD/NN 98059/CD (/( 50/CD microM/NN )/SYM ,/, U0126/NNP (/( 10/CD microM/NN )/SYM ,/, or/CC the/DT latter's/NNS inactive/JJ derivative/NN ,/, U0124/NN (/( 10/CD microM/NN )/SYM ./.
@@85520458325 Thus/RB ,/, the/DT consensus/NN sequences/NNS for/IN phosphatase/NEWGENE regulation/NN are/VBP 5'-GCACGTGGG-3'/NEWGENE and/CC 5'-GCACGTTTT-3'/NEWGENE which/WDT differ/VBP from/IN the/DT binding/JJ sequences/NNS for/IN the/DT Cpflp/NEWGENE protein/NN required/VBN for/IN transcription/NN of/IN the/DT genes/NNS in/IN methionine/NN biosynthesis/NN and/CC for/IN centromere/NN function/NN ./.
@@110345476839 We/PRP conclude/VBP from/IN this/DT study/NN that/IN Arix/NEWGENE and/CC NBPhox/NEWGENE exhibit/VB indistinguishable/JJ and/CC independent/JJ transcriptional/JJ regulatory/JJ properties/NNS on/IN the/DT DBH/NEWGENE promoter/NEWGENE ./.
@@107447494009 The/DT human/NEWGENE T/NEWGENE cell/NEWGENE leukemia/NEWGENE //NEWGENE lymphotropic/NEWGENE virus/NEWGENE type/NEWGENE 1/NEWGENE Tax/NEWGENE protein/NEWGENE represses/VBZ MyoD-dependent/NN transcription/NN by/IN inhibiting/JJ MyoD-binding/NN to/IN the/DT KIX/NEWGENE domain/NEWGENE of/IN p300/NEWGENE ./.
@@85838469816 With/IN current/JJ methodology/NN beta-2/NEWGENE transferrin/NEWGENE does/VBP not/RB appear/VB to/IN be/VB a/DT reliable/JJ clinical/JJ marker/NN for/IN perilymph/NN in/IN the/DT operative/JJ setting/NN ./.
@@11506587348 This/DT sequence/NN is/VBZ almost/RB identical/JJ with/IN that/DT of/IN human/NEWGENE luteinizing/NEWGENE hormone/NEWGENE (/( Sairam/NNP ,/, M/NNP ./NNP
@@96624435059 However/RB ,/, little/NN is/NNS known/VBP regarding/IN the/DT genomic/JJ organization/NN and/CC developmental/JJ expression/NN of/IN the/DT caveolin/NEWGENE gene/NEWGENE family/NEWGENE ./.
@@7717297668 Avian/JJ reproductive/JJ system/NN :/: daily/JJ variations/NNS in/IN responses/NNS to/IN hormones/NNS ./. pp/NNS ./NNS
@@28468523115 The/DT number/NN of/IN polymerases/NEWGENE active/JJ in/IN vitro/FW at/IN the/DT E/NEWGENE strand/NEWGENE promoter/NEWGENE was/VBD similar/JJ to/IN the/DT number/NN of/IN polymerases/NEWGENE at/IN the/DT L/NEWGENE strand/NEWGENE promoter/NEWGENE ./.
@@31022892627 Our/PRP data/NN suggest/VB that/IN it/PRP may/MD be/VB possible/JJ to/IN individualize/VB hCG/NEWGENE administration/NN at/IN midcycle/NN by/IN determining/JJ the/DT number/NN of/IN follicles/NNS greater/JJR than/IN 1/CD cm/NN by/IN ultrasound/JJ on/IN cycle/NN day/NN 12/CD or/CC 13/CD and/CC giving/JJ hCG/NEWGENE when/CC serum/JJ E2/NN levels/NNS reach/VBP 1100/CD to/IN 1200/CD pmol/NN //NN l/NN per/IN follicle/NN ./.
@@97953412693 An/DT electrophoretic/JJ mobility/NN shift/NN assay/NN was/VBD performed/VBN to/IN characterize/VB the/DT binding/JJ property/NN of/IN TR2/NEWGENE and/CC its/PRP truncated/JJ isoform/NN ./.
@@59676105846 Adrenergic/JJ nerve/NN function/NN ,/, noradrenaline/NN level/NN and/CC noradrenaline/NN uptake/NN in/IN cat/NN nictitating/JJ membrane/NN after/IN reserpine/NN treatment/NN ./.
@@114131481310 STAT5A/NEWGENE mutations/NN in/IN the/PDT Src/NEWGENE homology/NEWGENE 2/NEWGENE (/( SH2/NEWGENE )/SYM and/CC SH3/NEWGENE domains/NEWGENE did/VBD not/RB alter/VB the/DT BTK-mediated/NN tyrosine/NN phosphorylation/NN ./.
@@76538929124 After/IN determining/VBG isoflurane/NN MAC/NN in/IN triplicate/JJ ,/, birds/NNS were/VBD given/VBP a/DT mu-opioid/NN agonist/NN (/( morphine/NN ,/, n/NN =/SYM 9/CD )/SYM or/CC a/DT kappa-opioid/NN agonist/NN (/( U50488H/NN ,/, n/NN =/SYM 9/CD )/SYM ./SYM
@@58477725776 Functional/JJ disorders/NNS of/IN the/DT ureter/NN following/IN gynecologic/JJ surgery/NN ./.
@@9753774691 Based/VBN on/IN the/DT comparison/NN of/IN the/DT predicted/VBN amino/JJ acid/NN sequences/NNS of/IN 1-sst/NEWGENE and/CC 1-fft/NEWGENE with/IN those/DT of/IN other/DT plant/NN fructosyl/NEWGENE transferase/NEWGENE genes/NEWGENE ,/, we/PRP postulate/VBP that/IN both/DT plant/NN fructan/NEWGENE genes/NEWGENE have/VBP evolved/VBN from/IN plant/NN invertase/NEWGENE genes/NN ./.
@@37556231349 Further/JJ investigations/NNS are/VBP necessary/JJ to/IN elucidate/VB the/DT biochemical/JJ and/CC physiological/JJ properties/NNS of/IN DLIS/NN ./.
@@30609533770 Animals/NNS may/MD be/VB immunized/VBN by/IN oral/JJ vaccination/NN ,/, but/CC natural/JJ mechanisms/NNS that/WDT also/RB can/MD terminate/VB outbreaks/NNS are/VBP discussed/VBN ./.
@@83834923081 Together/RB with/IN a/DT considerably/RB shortened/VBN and/CC interrupted/VBN aromatic/JJ aa/NNS stretch/NN in/IN this/DT region/NN ,/, these/DT differences/NNS are/VBP discussed/VBN in/IN terms/NNS of/IN the/DT peculiar/JJ affinity/NN of/IN cyanobacterial/NEWGENE cytochrome/NEWGENE oxidases/NEWGENE for/IN acidic/NN c-type/NEWGENE cytochromes/NEWGENE ./.
@@107814235151 Comparison/NNS of/IN sequences/NNS from/IN -215/CD to/IN +1/NN bp/NN identified/VBD consensus/NN binding/JJ sites/NNS for/IN the/DT homeodomain/NEWGENE transcription/NEWGENE factor/NEWGENE thyroid/NEWGENE1 transcription/NEWGENE1 factor-1/NEWGENE1 (/( TTF-1/NEWGENE )/SYM ./.
@@74889597379 An/DT approach/NN to/IN a/DT biomathematical/JJ model/NN of/IN lymphocytopoiesis/NN ./.
@@8366378327 A/DT five-phase/JJ experiment/NN was/VBD designed/VBN to/IN investigate/VB (/( a/DT )/SYM whether/IN contingent/JJ music-listening/NN would/MD act/VB as/IN a/DT reinforcer/NN to/IN increase/NN arithmetic/JJ performance/NN of/IN EMR/NNS children/NNS and/CC (/( b/NN )/SYM whether/IN this/DT contingent/JJ reinforcement/NN would/MD affect/VB preference/NN for/IN that/DT reinforcer/NN ./.
@@85225112050 Purified/VBN PLB/NEWGENE showed/VBD optimal/JJ lyase/NEWGENE activity/NN at/IN pH/NN 10/CD ./CD 0/CD ./.
@@99275706334 We/PRP now/RB show/VBP that/IN RNU2/NEWGENE fragility/NN can/MD be/VB induced/VBN by/IN transfection/NN with/IN an/DT expression/NN vector/NN encoding/VBG Ad12/NEWGENE E1B/NEWGENE 55/NN kDa/NN alone/RB but/CC not/RB by/IN an/DT E1/NEWGENE vector/NN encoding/VBG all/DT E1/NEWGENE products/NEWGENE (/( 3/NN E1A/NEWGENE proteins/NEWGENE ,/, as/RB well/VB as/IN the/DT E1B/NEWGENE 19/NN kDa/NN and/CC 55/NN kDa/NN proteins/NN )/SYM ./.
@@59173155820 A/DT case/NN report/NN with/IN angiographic/JJ follow-up/JJ study/NN ./.
@@88988939398 The/DT PAI-2/NEWGENE gene/NEWGENE is/VBZ one/PRP of/IN the/DT most/RB TNF-responsive/NEWGENE genes/NEWGENE known/VBP and/CC is/VBZ also/RB highly/RB induced/VBN by/IN the/DT phorbol/NN ester/NN phorbol/NN 12-myristate/JJ 13-acetate/JJ (/( PMA/NN )/SYM and/CC the/DT phosphatase/NEWGENE inhibitor/NN ,/, okadaic/JJ acid/NN ,/, in/IN both/DT HT-1080/NNP fibrosarcoma/NN and/CC U-937/CD histiocytic/JJ cells/NNS ./.
@@108460541498 Mutational/JJ analyses/NNS showed/VBD that/DT in-frame/NN stop/NN codons/NNS introduced/VBN into/IN five/CD of/IN seven/CD RNA/NEWGENE 2/NEWGENE ORFs/NEWGENE did/VBD not/RB affect/VB accumulation/NN of/IN progeny/NN LIYV/NEWGENE RNA/NEWGENE 1/NEWGENE or/CC RNA/NEWGENE 2/NEWGENE ,/, confirming/VBG that/DT RNA/NEWGENE 2/NEWGENE does/VBP not/RB encode/VB proteins/NNS necessary/JJ for/IN LIYV/NEWGENE RNA/NEWGENE replication/NN ./.
@@77868202092 CPT-11/NN was/VBD administered/VBN as/IN a/DT 30-minute/CD i/CD ./CD v/CD ./. infusion/NN at/IN a/DT dose/NN of/IN 350/CD mg/NN //NN m2/NN diluted/VBN in/IN 250/CD ml/NN normal/JJ saline/JJ every/DT 3/CD weeks/NNS ./.
@@11543154672 Responses/NNS of/IN TLD/NN Mg2SiO4/NN :/: Tb/NN and/CC radiophotoluminescent/NN glass/NN to/IN heavy/RB charged/VBN particles/NNS and/CC space/NN radiation/NN ./.
@@12755413371 Because/IN of/IN the/DT increased/VBN CPK/NEWGENE activity/NN found/VB in/IN normal/JJ newborns/NNS ,/, screening/JJ for/IN Duchenne-type/NNP muscular/JJ dystrophy/NN should/MD be/VB postponed/VBN for/IN a/DT few/JJ weeks/NNS after/IN delivery/NN ./.
@@107226613636 CYC2/NEWGENE encodes/VBZ a/DT 24-kDa/NN protein/NN that/WDT has/VBZ sequence/NN identity/NN to/IN the/DT Neurospora/NEWGENE crassa/NEWGENE PREG1/NEWGENE and/CC the/DT S/NEWGENE ./NEWGENE cerevisiae/NEWGENE PHO80/NEWGENE cyclin/NEWGENE ./.
@@91712356704 Similarly/RB ,/, overexpression/NN of/IN increasing/JJ concentration/NN of/IN COUP-TFI/NEWGENE ,/, but/CC not/RB COUP-TFI/NEWGENE delta35/NEWGENE ,/, can/MD squelch/VB the/DT silencing/VBG activity/NN of/IN the/DT unliganded/JJ TRbeta/NEWGENE ./.
@@4114651542 It/PRP was/VBD concluded/VBN ,/, that/IN on/IN a/DT given/NN section/NN ,/, 75/NN ,/NN 7/NN per/IN cent/NN of/IN the/DT trabeculae/NNS were/VBD in/IN contact/NN with/IN vascular/JJ cavities/NNS ./.
@@60848106374 The/DT immuno-purified/JJ mRNA/NN in/IN the/DT polysome/NN complex/NN was/VBD used/VBN to/IN prepare/VB cDNA/NN with/IN which/WDT to/IN probe/NN a/DT D/NN ./NN melanogaster/NN genomic/JJ library/NN ./.
@@81673968138 Retrogradely/RB labelled/JJ neurons/NNS significantly/RB prevailed/VBN in/IN the/DT ipsilateral/JJ substantia/NN nigra/NN pars/NN compacta/NN ./.
@@31049141423 Mechanism/NNS of/IN the/DT t/NN (/NN 14/NN ;/: 18/NN )/NN chromosomal/JJ translocation/NN :/: structural/JJ analysis/NN of/IN both/DT derivative/NN 14/CD and/CC 18/CD reciprocal/JJ partners/NNS ./.
@@113286991181 In/NN the/DT free-swimming/JJ rotatory/JJ test/NN mice/NNS spend/VBP most/RB of/IN the/DT time/NN swimming/JJ close/RB to/IN the/DT wall/NN of/IN the/DT container/NN attempting/VBG to/IN escape/NN from/IN an/DT aversive/JJ test/NN situation/NN ./.
@@80510741690 We/PRP have/VBP examined/VBN by/IN in/IN vitro/FW footprinting/VBG a/DT region/NN located/VBN downstream/RB of/IN the/DT human/JJ immunodeficiency/NN virus/NN ,/, type/NN 1/CD (/( HIV-1/NNP )/SYM promoter/NN found/VB to/IN be/VB hypersensitive/JJ to/IN DNase/NEWGENE I/NEWGENE digestion/NN in/IN vivo/NN ./.
@@91698529457 Sequencing/NN of/IN the/DT three/CD pag-3/NEWGENE alleles/NEWGENE showed/VBN that/IN two/JJ apparent/JJ null/JJ alleles/NNS encode/VBP a/DT nonsense/NN mutation/NN before/IN the/DT zinc/NN fingers/NNS and/CC a/DT missense/JJ mutation/NN in/IN the/DT fourth/NN zinc/NN finger/NN that/WDT changes/VBZ a/DT coordinating/JJ histidine/NN to/IN a/DT tyrosine/NN ./.
@@2901763834 Codon/VBP usage/NN in/IN C/NNP ./NNP reinhardtii/NN mitochondria/NNS is/VBZ highly/RB biased/VBN ,/, with/IN eight/CD codons/NNS entirely/RB absent/VBP from/IN all/DT protein-coding/NN genes/NN ;/: however/RB ,/, even/VB though/CC codon/NN usage/NN is/VBZ restricted/VBN ,/, it/PRP appears/VBZ that/IN C/NNP ./NNP reinhardtii/NN mtDNA/NN cannot/MD encode/VB the/DT minimum/JJ number/NN of/IN tRNAs/NNS needed/VBN to/IN support/NN mitochondrial/JJ protein/NN synthesis/NN ./.
@@8121837491 Dialyzable/NNP transfer/NEWGENE factor/NEWGENE ./.
@@110401016727 Together/RB ,/, these/DT results/NNS indicate/VBP that/DT IL-1/NEWGENE beta/NEWGENE induces/VBZ VEGF/NEWGENE gene/NEWGENE expression/NN at/IN both/DT transcriptional/JJ and/CC post-transcriptional/JJ levels/NNS ,/, and/CC IL-1/NEWGENE beta/NEWGENE evokes/VBZ p38/NEWGENE MAPK/NEWGENE and/CC JNK/NEWGENE signalings/NNS ,/, which/WDT in/IN turn/NN stimulate/VB the/DT transcription/NN of/IN the/DT VEGF/NEWGENE gene/NEWGENE through/RB Sp1-binding/NEWGENE sites/NEWGENE ./.
@@5890732058 We/PRP measured/VBD basal/JJ plasma/NN prolactin/NEWGENE concentrations/NNS (/( in/IN samples/NNS obtained/VBN during/IN the/DT early/JJ follicular/JJ phase/NN )/SYM in/IN 25/CD normal/JJ (/( control/NN )/SYM women/NNS and/CC in/IN a/DT similar/JJ group/NN of/IN 40/CD patients/NNS with/IN a/DT long-standing/JJ history/NN of/IN infertility/NN ./.
@@8840501652 We/PRP report/VBP here/RB the/DT discovery/NN of/IN a/DT new/JJ actin-related/NEWGENE gene/NEWGENE in/IN this/DT organism/NN ,/, which/WDT we/PRP have/VBP named/VBN ACT4/NEWGENE ./.
@@90193022504 In/NN this/DT method/NN ,/, PLP/NN in/IN plasma/NN can/MD be/VB determined/VBN with/IN high/JJ sensitivity/NN using/VBG derivatization/NN with/IN sodium/NN bisulfite/NN in/IN the/DT mobile/JJ phase/NN ./.
@@75761789573 Polypeptide/NEWGENE growth/NEWGENE factors/NEWGENE and/CC cytokines/NNS mediate/VB their/PRP biochemical/JJ functions/NNS through/RB their/PRP responsive/NN receptors/NN ./.
@@10402022267 Auditory/JJ clicks/NNS were/VBD given/VBP at/IN a/DT rate/NN of/IN 20/CD s/NN (/NN -1/NN )/NN ./.
@@89234708579 PPAR/NEWGENE gamma/NEWGENE mRNA/NEWGENE levels/NNS were/VBD reduced/VBN by/IN 95%/CD with/IN 3/CD nM/NN TNF/NEWGENE alpha/NEWGENE treatment/NN for/IN 24/CD h/CD ./CD
@@84556111064 We/PRP studied/VBD the/DT functional/JJ interaction/NN between/IN human/NN embryonic/NN zeta/NEWGENE 2/NEWGENE globin/NEWGENE promoter/NN and/CC the/DT alpha/NEWGENE globin/NEWGENE regulatory/NEWGENE element/NEWGENE (/( HS-40/NEWGENE )/SYM located/VBN 40/CD kb/NN upstream/RB of/IN the/DT zeta/NEWGENE 2/NEWGENE globin/NEWGENE gene/NEWGENE ./.
@@8876167800 The/DT HiNF-D/NEWGENE (/NEWGENE CDP/NEWGENE //NEWGENE cut/NEWGENE )/NEWGENE complex/NEWGENE with/IN the/DT H4/NEWGENE promoter/NEWGENE is/VBZ immunoreactive/JJ with/IN antibodies/NNS against/IN CDP/NEWGENE //NEWGENE cut/NEWGENE and/CC pRB/NEWGENE but/CC not/RB p107/NEWGENE ,/, whereas/IN the/DT CDP/NEWGENE //NEWGENE cut/NEWGENE complex/NEWGENE with/IN a/DT nonhistone/NEWGENE promoter/NEWGENE (/( gp91-phox/NEWGENE )/SYM reacts/VBZ only/RB with/IN CDP/NEWGENE and/CC p107/NEWGENE antibodies/NNS ./.
@@86342901245 The/DT genome/NN of/IN all/DT retroviruses/NNS consists/VBZ of/IN two/JJ identical/JJ RNAs/NNS noncovalently/RB linked/JJ near/IN their/PRP 5'/CD end/NN ./.
@@88139008792 Adding/VBG phytase/NEWGENE and/CC nP/NN improved/VBD the/DT orderliness/NN of/IN development/NN ,/, mineralization/NN and/CC arrangement/NN of/IN cartilage/NN and/CC bone/NN cells/NNS ,/, and/CC alleviated/VBN the/DT effects/NNS of/IN P/NN deficiency/NN on/IN the/DT histological/JJ and/CC gross/JJ structure/NN of/IN the/DT tibias/NNS ./.
@@111127002153 Characterization/NNS of/IN the/DT microtubule/NEWGENE binding/NEWGENE domain/NEWGENE of/IN microtubule/NEWGENE actin/NEWGENE crosslinking/NEWGENE factor/NEWGENE (/( MACF/NEWGENE )/SYM :/: identification/NN of/IN a/DT novel/JJ group/NN of/IN microtubule/NEWGENE associated/NEWGENE proteins/NEWGENE ./.
@@25666135696 Somatostatin/NEWGENE gene/NEWGENE expression/NN in/IN pancreatic/JJ islet/NN cells/NNS is/VBZ directed/VBN by/IN cell-specific/NN DNA/NN control/NN elements/NN and/CC DNA-binding/NN proteins/NN ./.
@@12117541859 In/NN about/RB one/PRP third/RB of/IN the/DT cases/VBZ this/DT operation/NN results/NNS in/IN tonal/JJ and/CC vocal/JJ improvement/NN for/IN patients/NNS suffering/VBG from/IN progressive/JJ perceptive/JJ deafness/NN ./.
@@90799048011 Apart/RB from/IN iron/NN regulation/NN ,/, sodA/NEWGENE expression/NN was/VBD affected/VBN by/IN changes/NNS in/IN DNA/NN topology/NN induced/VBN by/IN coumermycin/NN A/DT but/CC not/RB by/IN the/DT global/JJ virulence/NN regulatory/NN Bvg/NEWGENE system/NEWGENE ./.
@@16050382190 Influence/NNS of/IN neural/JJ regulation/NN on/IN anti-arrhythmic/JJ effects/NNS of/IN GABA/NN in/IN rats/NNS ./.
@@78973597475 The/DT wild-type/NN and/CC altered/VBN forms/NNS of/IN the/DT F/NEWGENE protein/NEWGENE were/VBD expressed/VBN in/IN BHK-21/NNP and/CC HeLa/DT T4/NN cells/NNS by/IN use/NN of/IN the/DT recombinant/NEWGENE vaccinia/NEWGENE virus-encoding/NEWGENE T7/NEWGENE polymerase/NEWGENE system/NN ./.
@@83950046504 Nuclear/NNP localization/NN and/CC protein/NN sequence/NN similarities/NNS suggested/VBN that/IN the/DT SPT2/NEWGENE //NEWGENE SIN1/NEWGENE protein/NEWGENE may/MD be/VB related/VBN to/IN the/DT nonhistone/NEWGENE chromosomal/NEWGENE protein/NEWGENE HMG1/NEWGENE ./.
@@89889138942 In/NN contrast/NN with/IN previous/JJ two-pool/JJ models/NNS ,/, provisions/NNS were/VBD made/VBP for/IN folate/NN turnover/NN by/IN urinary/JJ folate/NN excretion/NN (/( as/IN measured/VBN here/RB )/SYM and/CC by/IN fecal/JJ excretion/NN and/CC catabolic/JJ processes/NNS ./.
@@104545576184 These/DT results/NNS suggest/VBP that/IN ,/, for/IN the/DT HML/NEWGENE ARS/NEWGENE1 cluster/NEWGENE1 (/( ARS303/NEWGENE ,/, ARS320/NEWGENE ,/, and/CC ARS302/NEWGENE )/SYM ,/, inactivity/NN of/IN origins/NNS is/VBZ independent/NN of/IN local/JJ transcriptional/JJ silencing/VBG ,/, even/VB though/CC origins/NNS and/CC silencers/NNS share/VB key/NN cis-/JJ and/CC trans-acting/JJ components/NNS ./.
@@75657361152 Finally/RB ,/, we/PRP demonstrate/VBP that/DT C/NEWGENE //NEWGENE EBP/NEWGENE alpha/NEWGENE can/MD also/RB active/JJ the/DT GM-CSF/NEWGENE receptor/NEWGENE alpha/NEWGENE promoter/NN in/IN nonmyeloid/JJ cells/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 400/CD WORDS/NN )/NN
@@76204917542 Resources/NNS for/IN helping/JJ patients/NNS to/IN quit/NN smoking/NN ./.
@@46794385091 Antibiotic/NN effect/NN of/IN the/DT mud/NN from/IN heviz/NN ./.
@@12646401899 A/DT case/NN observed/VBN in/IN Saigon/NNP ./.
@@93983322836 Sequences/NNS required/VBN for/IN interaction/NN of/IN mu2/NEWGENE and/CC CTLA-4/NEWGENE were/VBD localized/VBN to/IN residues/NNS ,/, 161TTGVY/NEWGENE in/IN CTLA-4/NEWGENE ;/: this/DT sequence/NN is/VBZ N-terminal/NN to/IN ,/, but/CC overlaps/VBP with/IN ,/, a/DT previously/RB identified/VBN SH2/NEWGENE binding/NEWGENE motif/NEWGENE ,/, 165YVKM/NEWGENE ,/, involved/VBN in/IN CTLA-4/NEWGENE signaling/JJ ./.
@@28109113509 The/DT accuracies/NNS of/IN presence/NN or/CC absence/NN of/IN neuroblastoma/NN were/VBD compared/VBN between/IN 131I-MIBG/JJ imaging/NN and/CC several/DT tumor/NN markers/NNS ./.
@@7784197428 Cytosolic/NNP extracts/NNS from/IN a/DT variety/NN of/IN mammalian/JJ cell/NN lines/NNS (/( monkey/NN Cos7/NNP ,/, several/DT mouse/NN fibrosarcomas/NNS and/CC human/NN HeLa/NN S3/NN )/SYM demonstrated/VBN similar/JJ TGF-beta/NEWGENE 1/NEWGENE dependent/NN RNA-protein/NN band/NN shifts/NNS as/IN cell/NN extract/NN from/IN BALB/NN //NN c/NN 3T3/CD mouse/NN fibroblasts/NNS ./.
@@75194636706 We/PRP determined/VBD whether/IN regional/JJ myocardial/JJ work/NN efficiency/NN (/( segment/NN work/NN //NN regional/NN O2/NN consumption/NN )/SYM would/MD be/VB elevated/VBN by/IN surgically-augmented/JJ inflow/NN ./.
@@110034719506 Phylogenetic/JJ analysis/NN showed/VBN that/IN the/DT ToLCV/NNP isolates/NNS from/IN Bangalore/NNP constitute/VB a/DT group/NN of/IN viruses/NNS separated/VBN from/IN those/DT of/IN Northern/NNP India/NNP ./.
@@95456385553 Recombinant/NEWGENE HRMT1L2/NEWGENE protein/NEWGENE encoded/VBN by/IN the/DT most/RB common/JJ 5'-variant/RB exhibited/VBN methyltransferase/NEWGENE activity/NN in/IN vitro/FW ./.
@@37016404207 These/DT results/NNS indicate/VBP that/IN the/DT effect/NN of/IN the/DT isomers/NNS of/IN pentobarbital/NN and/CC secobarbital/NN on/IN mult/NN FR30/NN FI600/NN responding/VBG and/CC on/IN suppressed/VBN responding/VBG are/VBP qualitatively/RB similar/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@69165886693 The/DT infection/NN rate/NN was/VBD five/CD times/NNS greater/JJR in/IN patients/NNS with/IN Hickman/NNP catheters/NNS than/IN in/IN those/DT with/IN Broviac/NNP catheters/NNS (/( p/NN =/SYM 0/CD ./CD 01/CD )/SYM ./.
@@113872087107 SKP1-SnRK/NEWGENE protein/NEWGENE kinase/NEWGENE interactions/NNS mediate/VBP proteasomal/JJ binding/NN of/IN a/DT plant/NN SCF/NEWGENE ubiquitin/NEWGENE ligase/NEWGENE ./.
@@20890547219 IdB/NN 1031/CD was/VBD first/RB extracted/VBN by/IN liquid-solid/JJ partition/NN and/CC the/DT extracts/NNS were/VBD evaporated/VBN and/CC analysed/VBN on/IN a/DT reversed-phase/JJ column/NN under/IN isocratic/JJ conditions/NNS ,/, using/VBG either/DT an/DT electrochemical/JJ or/CC a/DT UV/NN detector/NN ./.
@@67813396549 This/DT study/NN represents/VBZ the/DT first/RB published/VBN long-term/JJ follow-up/NN regarding/IN this/DT mode/NN of/IN treatment/NN in/IN patients/NNS with/IN alveolar/JJ hypoventilation/NN ./.
@@89345331803 Moreover/RB ,/, the/DT same/JJ mutations/NNS alter/VBP the/DT structure/NN of/IN junB/NEWGENE 5'/CD flanking/JJ DNA/NN within/IN chromatin/NN ./.
@@1063860724 These/DT articles/NNS both/DT report/NN the/DT results/NNS of/IN multi-institutional/JJ ,/, randomized/JJ ,/, phase/NN 3/CD trials/NNS for/IN the/DT treatment/NN of/IN patients/NNS with/IN localized/VBN (/( T1-3/NN N0-1/NN M0/NN )/SYM esophageal/JJ squamous/JJ cell/NN carcinoma/NN (/( SCC/NN )/SYM or/CC esophageal/JJ adenocarcinoma/NN ./.
@@3693976285 Basal/NN FSH/NEWGENE and/CC LH/NEWGENE levels/NNS were/VBD significantly/RB lower/JJR in/IN addicts/NNS ;/: after/IN GnRH/NEWGENE stimulation/NN the/DT addicts'/NN FSH/NEWGENE and/CC LH/NEWGENE values/NNS increased/VBN but/CC not/RB significantly/RB compared/VBN to/IN controls/NNS ./.
@@32875973975 Secretory/JJ function/NN of/IN the/DT prostate/NN gland/NN ./.
@@108118042446 Mitogen-activated/NEWGENE protein/NEWGENE (/NEWGENE MAP/NEWGENE )/NEWGENE kinase/NEWGENE phosphatase-3/NEWGENE (/( MKP-3/NEWGENE )/SYM is/VBZ a/DT dual/JJ specificity/NN phosphatase/NEWGENE that/WDT inactivates/VBZ extracellular/NEWGENE signal-regulated/NEWGENE kinase/NEWGENE (/( ERK/NEWGENE )/SYM MAP/NEWGENE1 kinases/NEWGENE1 ./.
@@10232872809 It/PRP is/VBZ clear/JJ that/IN subclinical/JJ and/CC silent/JJ CD/NN exist/VB in/IN a/DT large/NN subgroup/NN of/IN the/DT celiac/JJ population/NN ./.
@@103912464600 Furthermore/RB ,/, MOM-4/NEWGENE and/CC TAK1/NEWGENE bind/VB related/VBN proteins/NNS that/WDT promote/VBP their/PRP kinase/NEWGENE activities/NNS ./.
@@113424791191 METHODS/IN AND/CC RESULTS/NNS :/: Palmaz-Schatz/NNP stents/NNS were/VBD dip-coated/JJ with/IN paclitaxel/NN (/( 0/CD ,/, 0/CD ./CD 2/CD ,/, 15/CD ,/, or/CC 187/CD microgram/NN //NN stent/NN )/SYM by/IN immersion/NN in/IN ethanolic/JJ paclitaxel/NN and/CC evaporation/NN of/IN the/DT solvent/NN ./.
@@81952161515 Furthermore/RB ,/, unlike/IN the/DT case/NN for/IN HIS3/NEWGENE where/CC only/RB a/DT limited/VBN subset/NN of/IN TATA-like/NEWGENE sequences/NEWGENE can/MD activate/VB transcription/NN in/IN conjunction/NN with/IN GCN4p/NEWGENE ,/, many/JJ divergent/JJ TATA-like/NEWGENE sequences/NEWGENE allowed/VBN GCN4p/NEWGENE activation/NN of/IN TRP3/NEWGENE ./.
@@75656853164 The/DT peptide/NN sequences/NNS reveal/VBP that/IN the/DT factor/NN consists/VBZ of/IN GABP/NEWGENE alpha/NEWGENE and/CC GABP/NEWGENE beta/NEWGENE 1/NEWGENE with/IN Ets/NEWGENE and/CC Notch/NEWGENE motifs/NEWGENE ,/, respectively/RB ./.
@@76590855305 The/DT ubiquitous/JJ transcription/NN factor/NN Oct-1/NEWGENE forms/NNS complexes/NNS with/IN an/DT octamer/NN motif/NN present/NN within/IN FPIV/NNP by/IN gel/NN shift/NN analysis/NN with/IN liver/NN and/CC kidney/NN extracts/NNS ,/, making/VBG Oct-1/NEWGENE an/DT intriguing/JJ candidate/NN for/IN partnership/NN in/IN androgen/NN regulation/NN ./.
@@10863048671 The/DT effect/NN of/IN acute/JJ ,/, mid-cervical/JJ spinal/JJ cord/NN lesions/NNS on/IN neuronal/JJ and/CC reflex/NN activity/NN evoked/VBN by/IN the/DT noxious/JJ visceral/JJ stimulus/NN ,/, colorectal/JJ distension/NN (/( CRD/NN ;/: 80/CD mmHg/NN ,/, 20/CD s/NN )/SYM ,/, was/VBD determined/VBN in/IN halothane-anesthetized/JJ rats/NNS ./.
@@95732441384 These/DT two/JJ mRNA/NN species/NN are/VBP produced/VBN by/IN differential/JJ polyadenylation/NN site/NN usage/NN ./.
@@115616261375 When/WRB mixed/JJ with/IN aqueous/JJ solutions/NNS of/IN TMT-55/NN ,/, aqueous/JJ solutions/NNS of/IN either/DT reagent-grade/JJ zinc/NN ,/, cadmium/NN ,/, or/CC lead/VB salts/NNS precipitate/VBP crystalline/JJ "Zn-TMT"/NN ,/, amorphous/JJ or/CC crystalline/JJ "Cd-TMT"/JJ or/CC amorphous/JJ "Pb-TMT"/JJ (/( M3/NN [/NN S3C3N3/NN ]/NN 2/NN ./NN nH2O/NN ,/, where/CC M/NNP =/NNP Cd2+/NNP ,/, Pb2+/NN ,/, and/CC Zn2+/NN and/CC n/NN >/NN or/CC =/SYM 0/CD )/SYM that/WDT may/MD eventually/RB crystallize/VB if/IN stored/VBN in/IN air/NN ./.
@@16732208068 We/PRP report/VBP the/DT isolation/NN of/IN genomic/JJ and/CC cDNA/NN clones/NNS of/IN the/DT light-independent/NN Sn/NEWGENE :/NEWGENE bol3/NEWGENE allele/NEWGENE ./.
@@1721261851 Pharmacokinetics/NNS of/IN FK/NN 506/NN in/IN transplant/NN patients/NNS ./.
@@79999954450 A/DT receptor-like/NEWGENE protein/NEWGENE kinase/NEWGENE ,/, OsPK10/NEWGENE ,/, has/VBZ been/VBN cloned/VBN from/IN rice/NN (/( Oryza/NNP sativa/NN )/SYM ./.
@@16613697585 Therefore/RB ,/, the/DT strD/NEWGENE and/CC strE/NEWGENE genes/NEWGENE could/MD serve/VB as/IN universal/JJ probes/NNS indicative/NN of/IN the/DT presence/NN of/IN biosynthetic/JJ capacity/NN for/IN 6-deoxyhexose/CD moieties/NNS ./.
@@38368534514 The/DT 1/CD ,/, 2/CD ,/, 3/CD and/CC 4/CD year/NN survival/NN rates/NNS were/VBD 94%/CD ,/, 84%/JJ ,/, 76%/JJ and/CC 63%/JJ ,/, respectively/RB ./.
@@74194857275 For/IN the/DT study/NN of/IN the/DT transition/NN of/IN long/RB to/IN short/JJ waves/NNS (/( deep-water/JJ waves/NNS )/SYM a/DT closed-form/JJ solution/NN is/VBZ advantageous/JJ ;/: this/DT can/MD ,/, however/RB ,/, only/RB be/VB obtained/VBN at/IN the/DT cost/NN of/IN further/JJ simplification/NN ./.
@@78878591334 TcPO2/NN measurement/NN appears/VBZ to/IN be/VB a/DT reliable/JJ technique/NN that/WDT can/MD influence/VB ischaemic/JJ ulcer/NN management/NN ./.
@@16344002231 Production/NN costs/NNS included/VBD feed/JJ ,/, non-feed/JJ operating/NN ,/, fixed/JJ ,/, and/CC replacement/NN stock/NN costs/NNS ./.
@@95815527566 Molecular/NNP modelling/NN suggested/VBN that/IN the/DT tetramerization/NN domain/NN was/VBD a/DT four-helix/JJ bundle/NN ,/, stabilized/VBN by/IN interactions/NNS of/IN seven/RB conserved/VBN aromatic/JJ amino/JJ acids/NNS ./.
@@3045725931 It/PRP is/VBZ concluded/VBN that/DT suppression/NN of/IN elevated/VBN prolactin/NEWGENE levels/NNS in/IN progressive/JJ metastatic/JJ breast/NN cancer/NN patients/NNS is/VBZ not/RB effective/JJ in/IN restoring/JJ tumor/NN sensitivity/NN to/IN chemotherapy/NN ./.
@@86265298520 Apart/RB from/IN two/JJ proline-rich/JJ regions/NNS (/( amino/JJ acids/NNS 1-117/JJ and/CC 239-270/CD )/SYM ,/, p230/NEWGENE contains/VBZ a/DT very/RB high/JJ frequency/NN of/IN heptad/NN repeats/NNS ,/, characteristic/NN of/IN alpha-helices/VBZ that/DT form/JJ dimeric/JJ coiled-coil/NN structures/NNS ./. p230/NEWGENE also/RB includes/VBZ the/DT sequence/NEWGENE ESLALEELEL/NEWGENE (/NEWGENE amino/NEWGENE acids/NEWGENE 538-546/NEWGENE )/NEWGENE ,/, a/DT motif/NN found/VB in/IN the/DT granin/NEWGENE family/NEWGENE of/IN acidic/NN proteins/NNS present/VBP in/IN secretory/JJ granules/NNS of/IN neuroendocrine/JJ cells/NNS ./.
@@9923168134 Constantly/RB rectilinear/JJ pressure/NN curves/NNS without/IN uterine/NN activities/NNS are/VBP interpreted/VBN as/IN characteristic/JJ tocographic/JJ criteria/NNS of/IN an/DT advanced/JJ ectopic/JJ gravidity/NN ./.
@@93851695163 Ask/VB AONE's/NNP experts/NNS ./: ./: ./: about/JJ productivity/NN indicators/NN ./.
@@115723771449 Use/VB of/IN a/DT dual-pulse/JJ lithotripter/NN to/IN generate/VB a/DT localized/VBN and/CC intensified/VBN cavitation/NN field/NN ./.
@@21504732766 Critical/NNP study/NN ./.
@@1500662115 No/DT post-operative/JJ haemorrhages/NNS from/IN the/DT prostheses/NNS were/VBD observed/VBN ./.
@@113690668180 CONCLUSIONS/IN :/: Adding/VBG MMF/NN ,/, a/DT potent/JJ topical/JJ corticosteroid/NN ,/, to/IN an/DT emollient/JJ cream/NN is/VBZ statistically/RB significantly/RB more/RB effective/JJ than/IN emollient/JJ cream/NN alone/RB in/IN reducing/JJ acute/JJ radiation/NN dermatitis/NN ./.
@@107436085176 TbRAB31/NEWGENE behaviour/NN was/VBD also/RB studied/VBN during/IN the/DT cell/NN cycle/NN ;/: TbRAB31/NEWGENE always/RB localised/VBN to/IN a/DT discrete/JJ structure/NN that/IN duplicated/VBN very/RB early/RB in/IN mitosis/NN and/CC relocated/VBN to/IN daughter/JJ cells/NNS in/IN a/DT coordinate/JJ manner/NN with/IN the/DT basal/JJ body/NN and/CC kinetoplast/NN ,/, suggesting/VBG the/DT involvement/NN of/IN microtubules/NNS ./.
@@21965658500 Yeast/NEWGENE Gal11/NEWGENE protein/NEWGENE mediates/VBZ the/DT transcriptional/JJ activation/NN signal/NN of/IN two/JJ different/JJ transacting/JJ factors/NNS ,/, Gal4/NEWGENE and/CC general/NEWGENE regulatory/NEWGENE factor/NEWGENE I/NEWGENE //NEWGENE repressor/NEWGENE //NEWGENE activator/NEWGENE site/NEWGENE binding/NEWGENE protein/NEWGENE 1/NEWGENE //NEWGENE translation/NEWGENE upstream/NEWGENE factor/NEWGENE ./.
@@1389585783 It/PRP was/VBD concluded/VBN that/IN Scotchbond/NNP 2/CD and/CC Prisma/NN Universal/NNP Bond/NNP 2/CD are/VBP effective/JJ and/CC are/VBP the/DT dentine/NN bonding/JJ agents/NNS of/IN choice/NN ./.
@@17239625844 The/DT activity/NN of/IN serum/NEWGENE lipase/NEWGENE and/CC amylase/NEWGENE distinctly/RB increased/VBD at/IN 3/CD h/NN and/CC went/VBD up/JJ to/IN the/DT maximum/NN at/IN 12/CD h/NN after/IN injection/NN of/IN Na-Tc/NNP ./.
@@108557936556 Characterization/NNS of/IN polymorphic/JJ TNRs/NEWGENE in/IN novel/JJ and/CC even/VB known/VBP genes/NNS expressed/VBN in/IN human/JJ spinal/JJ cord/NN is/VBZ likely/RB to/IN help/NN in/IN the/DT identification/NN of/IN new/JJ candidates/NNS for/IN genes/NNS involved/VBN in/IN neurodegenerative/JJ disorders/NNS ./.
@@11498795641 This/DT slow/JJ progression/NN through/RB the/DT early/NN G1-phase/NN resulted/VBN in/IN decreased/VBN phosphorylation/NN of/IN the/DT RB/NEWGENE protein/NEWGENE and/CC subsequent/JJ delay/NN into/IN the/DT S/NNP phase/NN transition/NN ./.
@@29700616900 The/DT RAD18/NEWGENE gene/NEWGENE open/NEWGENE reading/NEWGENE frame/NEWGENE encodes/VBZ a/DT protein/NN of/IN 487/CD amino/JJ acids/NNS ,/, with/IN a/DT calculated/VBN molecular/JJ weight/NN of/IN 55/NN ,/NN 512/NN ./.
@@40113384669 In/NN the/DT 10/CD patients/NNS with/IN a/DT more/RB severe/JJ degree/NN of/IN steatorrhea/NN the/DT decrease/NN in/IN fat/JJ loss/NN approached/VBN 20%/CD and/CC a/DT close/JJ relationship/NN was/VBD found/VBN (/( r/JJ =/SYM 0/CD ./CD 84/CD ,/, p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM between/IN the/DT extent/NN of/IN the/DT fatty/JJ acid/NN loss/NN on/IN placebo/NN and/CC the/DT decrease/NN of/IN this/DT loss/NN on/IN taurine/NN ./.
@@38282094506 Laryngographic/NNP changes/NNS following/IN endotracheal/JJ intubation/NN in/IN adults/NNS ./.
@@32008443882 The/DT partial/JJ sequence/NN of/IN the/DT 62-kDa/NEWGENE nuclear/NEWGENE pore/NEWGENE glycoprotein/NEWGENE shows/VBZ little/JJ similarity/NN to/IN other/DT characterized/VBN proteins/NNS and/CC elucidates/VBZ structural/JJ features/NNS of/IN a/DT member/NN of/IN the/DT family/NN of/IN nuclear/NEWGENE pore/NEWGENE glycoproteins/NEWGENE ./.
@@20937415903 Data/NNP collection/NN was/VBD made/VBP with/IN a/DT query/NN language/NN ,/, and/CC data/NN analysis/NN performed/VBN with/IN an/DT interactive/JJ knowledge-based/JJ statistical/JJ tool/NN ,/, MAXITAB/NN ,/, employing/VBG a/DT multivariate/JJ tabular/JJ analysis/NN technique/NN ./.
@@84433409974 In/NN order/NN to/IN investigate/VB how/RB these/DT expression/NN patterns/NNS are/VBP established/VBN ,/, we/PRP fused/VBD promoter/NN regions/NNS of/IN an/DT acidic/NN and/CC a/DT basic/NN glucanase/NEWGENE gene/NEWGENE to/IN the/DT beta-glucuronidase/NEWGENE (/( GUS/NEWGENE )/SYM reporter/NN gene/NN and/CC examined/VBN expression/NN of/IN these/DT constructs/NNS in/IN transgenic/JJ tobacco/NN plants/NNS ./.
@@85840748561 Sixty-five/JJ patients/NNS (/( aged/VBN between/IN 3/CD years/NNS 5/CD months/NNS and/CC 60/CD years/NNS )/SYM suffering/VBG from/IN medically/RB resistant/JJ temporal/JJ lobe/NN epilepsy/NN (/( TLE/NNS )/SYM were/VBD operated/VBN on/IN over/RB a/DT period/NN of/IN 33/CD months/NNS in/IN Bethel/NNP Epilepsy/NNP Center/NNP ./.
@@100821377431 The/DT results/NNS showed/VBD that/DT IFN-gamma/NEWGENE stimulated/VBD the/DT rapid/JJ accumulation/NN of/IN interferon/NEWGENE regulated/NEWGENE factor/NEWGENE (/NEWGENE IRF/NEWGENE )/NEWGENE -1/NEWGENE mRNA/NEWGENE ,/, followed/VBN by/IN a/DT delayed/JJ and/CC dose-dependent/NN inhibition/NN of/IN alpha1/NEWGENE (/NEWGENE I/NEWGENE )/NEWGENE procollagen/NEWGENE mRNA/NEWGENE expression/NN in/IN skin/NN fibroblasts/NNS from/IN several/DT different/JJ donors/NNS ./.
@@115668745677 A/DT split/JJ motor/JJ domain/NN in/IN a/DT cytoplasmic/NEWGENE dynein/NEWGENE ./.
@@57942478490 Effect/NN of/IN heparin/NN on/IN the/DT inactivation/NN of/IN serum/NEWGENE lipoprotein/NEWGENE lipase/NEWGENE by/IN the/DT liver/NN in/IN unanesthetized/JJ dogs/NNS ./.
@@105562638692 CONCLUSIONS/IN :/: The/DT largest/JJS value/NN of/IN the/DT joint/JJ space/NN may/MD be/VB used/VBN when/CC evaluating/VBG rheumatoid/NN AC/NN joint/JJ space/NN ./.
@@86144036130 We/PRP then/RB demonstrated/VBD that/IN 1/NN )/NN GAL4-REV-erbA/NEWGENE alpha/NEWGENE chimeras/NEWGENE that/WDT contain/VBP the/DT 'AB'/NEWGENE region/NEWGENE and/CC lack/VB the/DT 'E'/NEWGENE region/NEWGENE activated/VBN transcription/NN of/IN GAL4/NEWGENE response/NEWGENE elements/NEWGENE in/IN the/DT presence/NN of/IN 8-Br-cAMP/JJ and/CC 2/NN )/NN the/DT ligand-binding/NN domain/NN (/( LBD/NNS )/SYM contains/VBZ an/DT active/JJ transcriptional/JJ silencer/NN ./.
@@18405132909 When/WRB transfected/VBN into/IN Drosophila/NN SL-2/NNP cells/NNS ,/, pCAT/NN plasmid/NN containing/JJ 2/CD ,/CD 090/CD bp/NN of/IN 5'-flanking/JJ region/NN shows/VBZ a/DT 3/CD ./CD 0-/CD to/IN 3/CD ./CD 5-fold/CD increase/NN in/IN chloramphenicol/NEWGENE acetyltransferase/NEWGENE activity/NN after/IN induction/NN with/IN retinoic/JJ acid/NN and/DT //DT or/DT 8-bromo-cAMP/NN ./.
@@113683637879 In/NN the/DT course/NN of/IN screening/JJ for/IN transcription/NN factors/NNS which/WDT interact/VBP with/IN the/DT human/NEWGENE myeloperoxidase/NEWGENE (/( MPO/NEWGENE )/SYM promoter/NN we/PRP ,/, for/IN the/DT first/JJ time/NN ,/, identified/VBN and/CC cloned/VBN the/DT cDNA/NN and/CC genomic/JJ DNA/NN for/IN human/NEWGENE HBP1/NEWGENE (/( HMG-Box/NEWGENE containing/NEWGENE protein/NEWGENE 1/NEWGENE )/SYM ,/, a/DT member/NN of/IN the/DT high/NEWGENE mobility/NEWGENE group/NEWGENE of/NEWGENE non-histone/NEWGENE chromosomal/NEWGENE proteins/NEWGENE ./.
@@85667564313 This/DT analysis/NN revealed/VBD that/DT SAP/NEWGENE 145/NEWGENE ,/, together/RB with/IN four/CD other/DT SF3a/NEWGENE //NEWGENE SF3b/NEWGENE subunits/NEWGENE ,/, UV/NN cross-links/NNS to/IN pre-mRNA/NN in/IN a/DT 20-nucleotide/NN region/NN upstream/RB of/IN the/DT BPS/NEWGENE ./.
@@78651294613 The/DT first/NN contains/VBZ ATF/NEWGENE //NEWGENE CRE/NEWGENE and/CC TBP/NEWGENE //NEWGENE TATA/NEWGENE sequence/NEWGENE motifs/NEWGENE within/IN an/DT 87-bp/JJ region/NN ./.
@@98854319881 OBJECTIVE/IN :/: To/TO evaluate/VB the/DT accuracy/NN of/IN working/JJ casts/NNS for/IN crown/NN and/CC bridge/NN restorations/NNS made/VBP from/IN twin/NN mix/NN putty/NN //NN wash/NN silicone/NN elastomeric/JJ impression/NN materials/NNS using/VBG different/JJ types/NNS of/IN stock/NN tray/NN ./.
@@88385855753 The/DT final/RB predicted/VBN structure/NN has/VBZ an/DT overall/JJ backbone/NN deviation/NN of/IN 0/CD ./CD 7/CD A/DT from/IN that/DT of/IN ras-p21/NEWGENE ./.
@@14333912055 As/IN a/DT consequence/NN of/IN dark/JJ rearing/NN ,/, the/DT numerical/JJ density/NN of/IN cortical/JJ neurons/NNS in/IN area/NN 17/CD amounted/VBN to/IN about/JJ double/NN of/IN the/DT value/NN observed/VBN in/IN normally/RB reared/VBN kittens/NNS and/CC was/VBD also/RB significantly/RB higher/JJ in/IN area/NN 18/CD ./CD
@@54105905527 The/DT role/NN of/IN ascorbic/JJ acid/NN in/IN the/DT prevention/NN of/IN bladder/NN tumor/NN formation/NN ./.
@@17830881010 Ten/CD out/RB of/IN 10/CD patients/NNS with/IN progressive/JJ disease/NN had/VBP mast/NN cells/NNS greater/JJR than/IN or/CC equal/NN to/IN 0/CD ./CD 5%/CD ,/, hyaluronan/NN greater/JJR than/IN or/CC equal/NN to/IN 50/CD micrograms/CD ./CD l-1/CD and/CC fibronectin/NEWGENE greater/JJR than/IN or/CC equal/NN to/IN 350/CD micrograms/NN ./NN l-1/NN compared/VBN to/IN eight/CD out/RB of/IN 41/CD patients/NNS with/IN stable/JJ or/CC regressive/JJ disease/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@78881566434 Since/IN 1990/CD the/DT University/NNP Hospital/NNP of/IN Tromso/NN has/VBZ provided/VBN local/JJ hospitals/NNS in/IN northern/JJ Norway/NN with/IN a/DT remote/JJ frozen/JJ section/NN service/NN and/CC with/IN access/NN to/IN video/JJ conferences/NNS for/IN the/DT review/NN of/IN microscopic/JJ findings/NNS and/CC for/IN the/DT discussion/NN of/IN major/JJ diagnostic/JJ issues/NNS ./.
@@13282197378 NSCL-1/NEWGENE is/VBZ expressed/VBN in/IN a/DT larger/JJR number/NN of/IN these/DT cell/NN lines/NNS ./.
@@92396351274 Both/DT of/IN these/DT dogs/NNS had/VBP low/JJ serum/JJ IgG/NEWGENE (/( 3/CD ./CD 5/CD to/IN 7/CD ./CD 2/CD mg/NN //NN ml/NN )/SYM and/CC the/DT second/JJ littermate/NN also/RB had/VBP reduced/VBN serum/JJ IgA/NEWGENE (/( </SYM 0/CD ./CD 1/CD to/IN 0/CD ./CD 15/CD mg/NN //NN ml/NN )/SYM ./.
@@89762534372 However/RB ,/, we/PRP did/VBD not/RB observe/VB a/DT correlation/NN between/IN serum/JJ and/CC seminal/NEWGENE plasma/NEWGENE PSA/NEWGENE levels/NNS ./.
@@24195881388 A/NNP ./NNP
@@93828864107 Direct/JJ proof/NN that/IN the/DT heightened/JJ renal/JJ cellular/JJ apoptosis/NN in/IN PKD/DT is/VBZ not/RB occurring/VBG through/RB p53/NEWGENE was/VBD obtained/VBN by/IN successive/JJ matings/NNS between/IN SBM/DT and/CC p53/NEWGENE (/NEWGENE -/NEWGENE //NEWGENE -/NEWGENE )/NEWGENE mice/NNS ./.
@@79066167885 Evoked/JJ electromyographic/JJ response/NN to/IN indirect/JJ supramaximal/JJ stimulation/NN at/IN 1/CD Hz/NN was/VBD monitored/VBN in/IN ten/CD adult/JJ goats/NNS under/IN thiopentone-halothane/JJ anaesthesia/NN ./.
@@97106415062 It/PRP has/VBZ been/VBN demonstrated/VBN previously/RB that/IN Pax-6/NEWGENE ,/, a/DT paired/NEWGENE domain/NEWGENE (/NEWGENE PD/NEWGENE )/NEWGENE //NEWGENE homeodomain/NEWGENE (/NEWGENE HD/NEWGENE )/NEWGENE transcription/NEWGENE factor/NEWGENE critical/JJ for/IN eye/NN development/NN ,/, contributes/VBZ to/IN the/DT activation/NN of/IN the/DT alphaB-/NEWGENE ,/, alphaA-/NEWGENE ,/, delta1-/NEWGENE ,/, and/CC zeta-crystallin/NEWGENE genes/NEWGENE in/IN the/DT lens/NN ./.
@@21446102096 TCR/NEWGENE alpha/NEWGENE and/NEWGENE beta/NEWGENE gene/NEWGENE expression/NN may/MD be/VB regulated/VBN by/IN a/DT common/JJ set/NN of/IN T-cell/NEWGENE nuclear/NEWGENE proteins/NEWGENE in/IN that/DT the/DT T/NEWGENE beta/NEWGENE 2/NEWGENE element/NEWGENE binding/JJ a/DT set/NN of/IN cyclic/NEWGENE AMP/NEWGENE response/NEWGENE element-binding/NEWGENE proteins/NEWGENE that/WDT are/VBP also/RB bound/JJ by/IN the/DT T/NEWGENE alpha/NEWGENE 1/NEWGENE element/NEWGENE of/IN the/DT human/NN TCR/NEWGENE alpha/NEWGENE enhancer/NN and/CC the/DT decamer/NN element/NN present/NN in/IN a/DT large/JJ number/NN of/IN human/JJ and/CC murine/NN TCR/NEWGENE beta/NEWGENE promoters/NN ./.
@@83747531444 The/DT transverse/JJ relaxation/NN time/NN (/( T2/NN )/SYM and/CC apparent/JJ diffusion/NN coefficient/NN of/IN water/NN were/VBD determined/VBN ./.
@@6698006454 Female/JJ mice/NNS were/VBD significantly/RB more/RB resistant/JJ to/IN infection/NN than/IN males/NNS ./.
@@8686381279 Three/CD ORFs/NNS (/( 9765orfR002/NEWGENE ,/, 9765orfR011/NEWGENE and/CC 9765orfR013/NEWGENE )/SYM were/VBD found/VBN to/IN be/VB homologous/JJ with/IN Schizosaccharomyces/NN pombe/NN polyadenylate/NEWGENE binding/NEWGENE protein/NEWGENE ,/, Escherichia/NN coli/JJ hypothetical/JJ 38/NN ./NN 1-kDa/NN protein/NN in/IN the/DT BCR/NEWGENE 5'/CD region/NN ,/, and/CC transcription/NN regulatory/NN protein/NN Swi3/NEWGENE ,/, respectively/RB ./.
@@16493185715 EBNA-2/NEWGENE and/CC the/DT cis-acting/JJ CD23/NEWGENE element/NEWGENE increased/VBD TK-promoted/JJ mRNA/NN and/CC did/VBD not/RB alter/VB the/DT herpes/NEWGENE simplex/NEWGENE virus/NEWGENE TK/NEWGENE promoter/NEWGENE transcription/NEWGENE start/NEWGENE site/NEWGENE ./.
@@112595932370 Analysis/NNP of/IN ace2Delta/NNP cells/NNS reveals/VBZ that/IN Ace2p/NEWGENE is/VBZ required/VBN for/IN cell/NN separation/NN but/CC not/RB for/IN polarized/JJ growth/NN ./.
@@14992135357 The/DT case/NN described/VBN is/VBZ that/IN of/IN a/DT 72-year-old/JJ man/NN with/IN ochronosis/NN who/WP suffered/VBD a/DT hyperextension/NN injury/NN to/IN his/PRP spine/NN in/IN a/DT fall/NN ,/, resulting/JJ in/IN a/DT fracture/NN through/RB an/DT ankylosed/JJ L2-L3/NN disk/NN space/NN ./.
@@74100377252 Although/IN stone-formers/NNS were/VBD not/RB found/VB to/IN display/NN any/DT features/NNS of/IN magnesium/NN metabolism/NN that/WDT were/VBD different/JJ from/IN those/DT in/NN the/DT control/NN group/NN ,/, their/PRP lower/JJR urinary/JJ excretion/NN of/IN magnesium/NN in/IN relation/NN to/IN calcium/NN may/MD be/VB a/DT factor/NN in/IN their/PRP increased/VBN stone-forming/JJ propensity/NN ./.
@@75287465698 Phosphoamino/NNP acid/NN analysis/NN of/IN radiolabeled/JJ ASGPR/NEWGENE subunits/NEWGENE identified/VBD Ser/NN (/NN P/NN )/NN as/IN the/DT predominant/JJ (/( approximately/RB 95%/CD )/SYM and/CC Thr/NN (/NN P/NN )/NN as/IN a/DT minor/JJ (/( approximately/RB 5%/JJ )/SYM phosphoamino/JJ acid/NN in/IN each/DT polypeptide/NN and/CC confirmed/VBD the/DT presence/NN of/IN Tyr/NN (/NN P/NN )/NN (/( approximately/RB 1%/JJ )/SYM in/IN RHL1/NEWGENE ./.
@@85504617610 Cheung/NNP and/CC S/NNP ./NNP
@@1126271096 Pentobarbital/NN (/( 1/CD ,/, 3/CD ,/, 10/CD ,/, and/CC 17/CD ./CD 5/CD mg/CD //CD kg/CD )/SYM was/VBD also/RB tested/VBN in/IN combination/NN with/IN rate-decreasing/JJ doses/NNS of/IN normeperidine/NN (/( 17/CD ./CD 5/CD mg/CD //CD kg/CD )/SYM ,/, anileridine/NN (/( 10/CD mg/CD //CD kg/CD )/SYM ,/, alphaprodine/NN (/( 10/CD mg/CD //CD kg/CD )/SYM ,/, and/CC fentanyl/NN (/( 0/CD ./CD 3/CD mg/CD //CD kg/CD )/SYM ./.
@@32742048529 Dentalplaque/NNP was/VBD controlled/VBN by/IN the/DT oral/JJ higienic/JJ index/NN of/IN the/DT whole/JJ dentition/NN daily/JJ ,/, after/IN staining/NN with/IN 1/CD per/IN cent/NN alkaline/NN fuxin/NN ./.
@@21606228145 The/DT antinociceptive/JJ properties/NNS ,/, as/IN measured/VBN by/IN the/DT tail-flick/NN and/CC hot-plate/JJ tests/NNS ,/, and/CC the/DT motor/JJ effects/NNS of/IN an/DT intrathecally-administered/JJ benzodiazepine/NN agonist/NN midazolam/NN ,/, alone/RB ,/, and/CC in/IN combination/NN with/IN morphine/NN ,/, was/VBD examined/VBN in/IN rats/NNS ./.
@@8919289680 This/DT is/VBZ the/DT first/JJ report/NN of/IN the/DT successful/JJ resection/NN of/IN a/DT MFH/NN originating/VBG in/IN the/DT renal/JJ capsular/JJ tissue/NN and/CC extending/VBG into/IN the/DT inferior/JJ vena/NN cava/NN ./.
@@95818725292 In/NN connective/JJ tissue/NN ,/, cell/NN structure/NN contributes/VBZ to/IN type/NEWGENE I/NEWGENE collagen/NEWGENE expression/NN ./.
@@84513318409 Pathways/NNS linking/JJ the/DT olfactory/JJ bulbs/NNS with/IN the/DT medial/JJ preoptic/JJ anterior/JJ hypothalamus/NN are/VBP important/JJ for/IN intermale/NN aggression/NN in/IN mice/NNS ./.
@@86633921058 In/NN this/DT study/NN ,/, we/PRP have/VBP cloned/VBN the/DT human/NEWGENE DSG3/NEWGENE gene/NEWGENE and/CC examined/VBD the/DT transcriptional/JJ regulation/NN of/IN its/PRP expression/NN ./.
@@10559207696 In/NN simpler/JJR organisms/NNS ,/, the/DT ATP/NEWGENE sulfurylase/NEWGENE and/CC APS/NEWGENE kinase/NEWGENE reactions/NNS are/VBP catalyzed/VBN by/IN separate/JJ enzymes/NNS encoded/VBN by/IN two/JJ or/CC three/CD genes/NNS ,/, suggesting/VBG that/IN a/DT fusion/NN of/IN separate/JJ genes/NNS during/IN the/DT course/NN of/IN evolution/NN generated/VBD the/DT bifunctional/JJ enzyme/NN ./.
@@17132135304 The/DT protein/NN predicted/VBN by/IN the/DT sequence/NN of/IN the/DT human/NEWGENE pim-1/NEWGENE proto-oncogene/NEWGENE shares/VBP extensive/JJ homology/NN with/IN known/VBP serine/NEWGENE //NEWGENE threonine/NEWGENE protein/NEWGENE kinases/NEWGENE ,/, and/CC yet/RB the/DT human/NEWGENE Pim-1/NEWGENE enzyme/NEWGENE has/VBZ previously/RB been/VBN reported/VBN to/IN exhibit/NN protein/NEWGENE tyrosine/NEWGENE kinase/NEWGENE activity/NN both/DT in/NN vitro/FW and/CC in/IN vivo/NN ./.
@@23909897850 Compared/VBN to/IN its/PRP counterpart/NN in/IN the/DT GPB/NEWGENE gene/NEWGENE ,/, exon/NN 3/CD of/IN the/DT GPE/NEWGENE gene/NEWGENE contains/VBZ several/DT point/NN mutations/NNS ,/, an/DT insertion/NN of/IN 24/CD bp/NN ,/, and/CC a/DT stop/NN codon/NN which/WDT shortens/VBZ the/DT reading/JJ frame/NN ./.
@@75796959655 Taken/VBN together/RB ,/, these/DT data/NN suggest/VB that/IN the/DT Mif2/NEWGENE protein/NEWGENE interacts/VBZ with/IN Cep1p/NEWGENE at/IN the/DT centromere/NN and/CC that/IN the/DT yeast/NN centromere/NN indeed/RB exists/VBZ as/IN a/DT higher/JJ order/NN protein-DNA/NN complex/NN ./.
@@102066981651 These/DT findings/NNS demonstrate/VBP that/IN signature-tagged/JJ mutagenesis/NN is/VBZ a/DT viable/JJ approach/NN to/IN identify/VB bacterial/JJ genes/NNS associated/VBN with/IN the/DT ability/NN to/IN infect/VB the/DT urinary/JJ tract/NN ./.
@@17601662476 CONCLUSION/IN :/: Monitoring/NN SpO2/NN at/IN the/DT nasal/JJ septum/NN site/NN is/VBZ more/RB reliable/JJ than/IN monitoring/VBG it/PRP at/IN the/DT finger/NN site/NN in/IN hypothermic/JJ patients/NNS ./.
@@20565532663 Hemorrhagic/NNP shock/NN and/CC bacterial/JJ translocation/NN in/IN a/DT swine/NN model/NN ./.
@@102280093952 Induction/NNS of/IN the/DT CINC/NEWGENE promoter/NEWGENE by/IN IL-17/NEWGENE in/IN IEC-6/NNP cells/NNS was/VBD TNF/NEWGENE receptor-associated/NEWGENE factor-6/NEWGENE (/( TRAF6/NEWGENE )/SYM ,/, but/CC not/RB TRAF2/NEWGENE ,/, dependent/JJ ./.
@@96809944467 This/DT study/NN reports/VBZ the/DT isolation/NN of/IN a/DT P/NNP ./NNP hybrida/NN gene/NN ,/, jaf13/NEWGENE ,/, encoding/VBG a/DT basic/NEWGENE helix-loop-helix/NEWGENE protein/NEWGENE that/IN ,/, on/IN the/DT basis/NN of/IN sequence/NN homology/NN and/CC intron/NN //NN exon/NN structure/NN ,/, represents/VBZ the/DT P/NNP ./NNP hybrida/NN orthologue/NN of/IN the/DT Z/NEWGENE ./NEWGENE mays/NEWGENE r/NEWGENE genes/NEWGENE ./.
@@97598654126 However/RB ,/, while/CC IL-1beta/NEWGENE and/CC TNF-alpha/NEWGENE both/DT induced/VBN nuclear/JJ binding/NN of/IN the/DT Rel/NEWGENE proteins/NEWGENE p50/NEWGENE1 and/CC p65/NEWGENE to/IN an/DT NF-kappaB/NEWGENE consensus/NEWGENE oligonucleotide/NEWGENE in/IN gel/NN shift/NN assays/NNS and/CC caused/VBN transient/JJ degradation/NN of/IN inhibitor/NEWGENE of/NEWGENE NF-kappaB-alpha/NEWGENE (/( IkappaB-alpha/NEWGENE )/SYM in/IN the/DT cytoplasm/NN of/IN myofibroblasts/NNS ,/, only/RB IL-1beta/NEWGENE upregulated/VBN PDGF-Ralpha/NEWGENE ./.
@@18573266383 Oculus-500/NN is/VBZ a/DT group/NN of/IN high/JJ resolution/NN imaging/JJ boards/NNS for/IN use/NN with/IN IBM-AT/NN and/CC compatible/JJ computers/NNS ./.
@@91507288055 The/DT mRNA/NN from/IN this/DT gene/NN ,/, termed/JJ HES1/NEWGENE ,/, is/VBZ ubiquitously/RB expressed/VBN ,/, but/CC strongly/RB so/RB in/IN heart/NN and/CC skeletal/JJ muscle/NN ./.
@@84413793200 When/WRB ligated/VBN to/IN the/DT proIL-1/NEWGENE beta/NEWGENE cap/NEWGENE site-proximal/NEWGENE region/NEWGENE (/( located/VBN between/IN -131/CD to/IN +12/NN )/SYM ,/, both/PDT the/DT proIL-1/NEWGENE beta/NEWGENE and/CC the/DT simian/NEWGENE virus/NEWGENE 40/NEWGENE enhancer/NEWGENE elements/NEWGENE functioned/VBN more/RB efficiently/RB in/IN monocytes/NNS than/IN in/IN HeLa/DT cells/NNS ,/, which/WDT are/VBP not/RB normally/RB competent/JJ for/IN IL-1/NEWGENE beta/NEWGENE expression/NN ./.
@@3296254843 Minor/NNP differences/NNS were/VBD noted/VBN with/IN latamoxef/NN producing/JJ mild/JJ persistant/JJ elevation/NN of/IN prothrombin/NEWGENE time/NN (/( 0/CD ./CD 7/CD second/JJ )/SYM associated/VBN with/IN depression/NN of/IN factor/NEWGENE II/NEWGENE and/CC factor/NEWGENE VII/NEWGENE ./.
@@19014432075 We/PRP report/VBP two/JJ patients/NNS receiving/JJ maintenance/NN valproate/NN ,/, one/PRP with/IN resolving/JJ acute/NN hepatitis/NN C/NN and/CC the/PDT other/DT with/IN chronic/JJ persistent/JJ hepatitis/NN C/NN ,/, with/IN incidental/JJ microvesicular/JJ steatosis/NN demonstrated/VBN on/IN oil-red/JJ O/NN stains/NNS ./.
@@28504728495 One/CD of/IN these/DT ,/, the/DT origin/NN core/NN ,/, is/VBZ required/VBN only/RB for/IN DNA/NN replication/NN ./.
@@98192881304 Levels/NNS of/IN serum/JJ IgE/NEWGENE were/VBD measured/VBN monthly/JJ ,/, and/CC nasal/JJ IgE/NEWGENE was/VBD measured/VBN at/IN the/DT height/NN and/CC end/NN of/IN the/DT season/NN ./.
@@104461318974 PDGF/NEWGENE A-chain/NEWGENE levels/NNS increase/NN in/IN cultured/JJ vascular/JJ smooth/JJ muscle/NN cells/NNS (/( SMCs/NNS )/SYM exposed/VBN to/IN ATII/NEWGENE ./.
@@22125402845 Standardized/JJ gastric/JJ wall/NN specimens/NNS from/IN the/DT area/NN of/IN grossly/RB healed/VBN ulcers/NNS were/VBD obtained/VBN ,/, processed/VBN ,/, and/CC evaluated/VBD by/IN light/NN microscopy/NN and/CC by/IN transmission/NN electron/NN microscopy/NN ./.
@@97313549988 Likewise/RB ,/, at/IN 150/CD degrees/NNS C/NN with/IN 2%/NNP APS/NNP the/DT surface/NN density/NN of/IN NH2/NN groups/NNS reached/VBD a/DT maximum/NN at/IN 24/CD hr/NN and/CC remained/VBN relatively/JJ constant/JJ up/NN to/IN 96/CD hr/NN ./NN
@@20244887089 HeLa/IN and/CC Jurkat/NN cell/NN lines/NNS carrying/JJ the/DT nef/NEWGENE gene/NEWGENE linked/JJ to/IN the/DT CMV/NN promoter/NN or/CC the/DT HIV-1/NN LTR/NN were/VBD isolated/VBN by/IN coselection/NN for/IN neomycin/NN resistance/NN ./.
@@8441423620 We/PRP have/VBP isolated/VBN and/CC characterized/VBD the/DT GCD6/NEWGENE and/CC GCD7/NEWGENE genes/NEWGENE and/CC shown/VBP that/IN their/PRP products/NNS are/VBP required/VBN to/IN repress/VB GCN4/NEWGENE translation/NN under/IN nonstarvation/JJ conditions/NNS ./.
@@95279216113 We/PRP have/VBP visualized/VBN DNA-protein/NN complexes/NNS by/IN electron/NN microscopy/NN and/CC a/DT high-affinity/JJ binding/JJ site/NN of/IN WDV/NEWGENE Rep/NEWGENE protein/NEWGENE within/IN the/DT core/NN element/NN has/VBZ been/VBN mapped/VBN to/IN approximately/RB 144/CD +/NN //NN -/NN 18/CD bp/NN upstream/RB from/IN the/DT initiation/NN site/NN ,/, between/IN the/DT start/NN site/NN for/IN complementary-sense/JJ transcription/NN and/CC the/DT TATA/NN box/NN ./.
@@13164619076 Both/DT in/NN vitro-synthesized/NN S2/NEWGENE protein/NEWGENE and/CC synthetic/JJ peptides/NNS corresponding/JJ to/IN S2/NEWGENE are/VBP shown/VBP to/IN react/VB positively/RB with/IN sera/NNS obtained/VBN from/IN EIAV-infected/JJ horses/NNS ,/, providing/CC the/DT first/JJ direct/JJ evidence/NN of/IN expression/NN of/IN this/DT protein/NN in/IN infected/VBN animals/NNS ./.
@@117084311550 For/IN these/DT patients/NNS the/DT introduction/NN of/IN a/DT separate/JJ category/NN "extended/VBD oligoarthritis/NN at/IN onset"/NN should/MD be/VB considered/VBN to/IN establish/VB comparable/JJ patient/NN groups/NNS ./.
@@83360128884 The/DT number/NN of/IN bacteria/NNS in/IN the/DT lung/NN ,/, peripheral/NN white/NN blood/NN cell/NN and/CC BAL/NN fluid/NN cell/NN also/RB decreased/VBD by/IN the/DT administration/NN of/IN FN/NEWGENE ./.
@@111815315697 A/DT major/JJ mechanism/NN by/IN which/WDT estrogens/NNS prevent/VBP osteoporosis/NN seems/VBZ to/IN be/VB repression/NN of/IN transcription/NN of/IN NF-kappa/NEWGENE B/NEWGENE target/NEWGENE genes/NEWGENE ,/, such/JJ as/IN the/DT osteoclast-activating/JJ cytokines/NNS interleukin-6/NEWGENE and/CC interleukin-1/NEWGENE ./.
@@85826332936 Suppressors/NNS of/IN defective/JJ silencing/VBG in/IN yeast/NN :/: effects/NNS on/IN transcriptional/JJ repression/NN at/IN the/DT HMR/NEWGENE locus/NEWGENE ,/, cell/NN growth/NN and/CC telomere/NN structure/NN ./.
@@72363516990 Following/VBG extended/VBN recovery/NN hippocampal/JJ EEG/NN was/VBD normal/JJ despite/IN extensive/JJ cellular/JJ loss/NN in/IN areas/NNS CA3/NN and/CC CA4/NN ./.
@@92505546459 Patients/NNS received/VBD either/DT diltiazem/NN CD/NN 180/NN mg/NN or/CC placebo/NN once/NN //NN day/NN in/IN combination/NN with/IN existing/JJ antianginal/JJ therapy/NN ./.
@@62528836052 A/DT haemolytic/JJ enterotoxigenic/JJ strain/NN of/IN E/NNP ./NNP coli/JJ (/( O149/CD :/: K88/NN :/: H10/NN )/SYM was/VBD regularly/RB recovered/VBN from/IN piglets/NNS with/IN PWD/NNP while/CC rotavirus/NN was/VBD demonstrated/VBN on/IN a/DT number/NN of/IN occasions/NNS ./.
@@23512398563 These/DT findings/NNS indicate/VBP that/DT hypergastrinemia/NN induced/VBN by/IN surgical/JJ removal/NN of/IN acid-producing/JJ mucosa/NN in/IN the/DT rat/NN has/VBZ the/DT same/JJ effects/NNS on/IN oxyntical/JJ mucosal/NEWGENE HDC/NEWGENE activity/NN ,/, histamine/NN concentration/NN and/CC ECL/JJ cell/NN density/NN as/IN hypergastrinemia/NN induced/VBN by/IN continuous/JJ gastrin/NEWGENE infusion/NN or/CC by/IN long-term/JJ treatment/NN with/IN effective/JJ antisecretagogues/NNS ./.
@@86493895727 We/PRP have/VBP isolated/VBN and/CC analyzed/VBN human/NEWGENE CTCF/NEWGENE cDNA/NEWGENE clones/NNS and/CC show/VB here/RB that/IN the/DT ubiquitously/RB expressed/VBN 11-zinc-finger/NEWGENE factor/NEWGENE CTCF/NEWGENE is/VBZ an/DT exceptionally/RB highly/RB conserved/VBN protein/NN displaying/VBG 93%/CD identity/NN between/IN avian/JJ and/CC human/JJ amino/JJ acid/NN sequences/NNS ./.
@@79649187955 The/DT influence/NN of/IN patient-related/NN factors/NN on/IN inter-observer/NN variability/NN in/IN the/DT evaluation/NN of/IN neurological/JJ signs/NNS was/VBD investigated/VBN ./.
@@35459554889 The/DT glucose/NN areas/NNS following/IN the/DT ingestion/NN of/IN the/DT foods/NNS were/VBD :/: Study/NNP 1/CD :/: glucose/NN 11/CD ./CD 7/CD ,/, orange/JJ juice/NN 7/CD ./CD 3/CD ,/, sucrose/NN 5/NN ./NN 2/NN ,/, glucose/NN +/SYM fructose/NN 6/NN ./NN 3/NN ,/, and/CC fructose/NN 0/CD ./CD 7/CD mmol/NN X/NN h/NN //NN l/NN ;/: Study/NNP 2/CD :/: glucose/NN 14/CD ./CD 6/CD ,/, orange/JJ juice/NN 7/CD ./CD 3/CD ,/, apples/NNS 5/CD ./CD 5/CD ,/, and/CC apple/NN juice/NN 4/CD ./CD 7/CD mmol/NN X/NN h/NN //NN l/NN ;/: Study/NNP 3/CD :/: glucose/NN 12/CD ./CD 6/CD ,/, ice/NN cream/NN 8/CD ./CD 1/CD ,/, milk/NN 3/CD ./CD 7/CD ,/, and/CC lactose/NN 4/NN ./NN 1/NN mmol/NN X/NN h/NN //NN l/NN ./.
@@110928864804 Nevertheless/RB ,/, protein/NEWGENE kinase/NEWGENE A/NEWGENE stimulation/NN induces/VBZ CREMalpha/NEWGENE to/IN activate/VB the/DT complex/JJ native/JJ promoter/NN in/IN the/DT phosphoenolpyruvate/NEWGENE carboxykinase/NEWGENE (/( PEPCK/NEWGENE )/SYM gene/NN ./.
@@104551895473 The/DT calcitonin-induced/JJ tyrosine/NN phosphorylation/NN of/IN HEF1/NEWGENE increased/VBN in/IN a/DT time-/NN and/CC dose-dependent/NN manner/NN ./.
@@25954516105 These/DT data/NN locate/VB the/DT aniridia/NEWGENE gene/NEWGENE (/( AN2/NEWGENE )/SYM and/CC a/DT recurrent/JJ T-cell/NEWGENE leukemia/NEWGENE breakpoint/NEWGENE (/( TCL2/NEWGENE )/SYM in/IN the/DT marker/NN sequence/NN ,/, on/IN opposite/NN sides/NNS of/IN MIC1/NEWGENE ./.
@@15458181811 The/DT p130/NEWGENE and/CC p62/NEWGENE tyrosine-phosphorylated/JJ proteins/NNS that/WDT complexed/VBN v-Src/NEWGENE SH2/NEWGENE1 in/IN vitro/FW also/RB associated/VBN with/IN v-Src/NEWGENE in/IN v-src-transformed/JJ Rat-2/NNP cells/NNS ;/: this/DT in/NN vivo/NN binding/NN was/VBD dependent/JJ on/IN the/DT v-Src/NEWGENE SH2/NEWGENE1 domain/NN ./.
@@33354444015 A/DT study/NN was/VBD conducted/VBN of/IN a/DT human/JJ male/JJ who/WP had/VBP inhaled/JJ a/DT mixture/NN of/IN 241Am/CD and/CC Pu/NNP ./NNP
@@110846493331 In/NN slightly/RB older/JJR embryos/NNS ,/, the/DT expression/NN was/VBD skewed/VBN to/IN one/PRP side/NN of/IN the/DT embryo/NN and/CC by/IN E6/CD ./CD 5/CD ,/, at/IN the/DT onset/NN of/IN gastrulation/NN ,/, expression/NN was/VBD seen/VBP in/IN the/DT epiblast/NN ,/, visceral/JJ endoderm/NN ,/, nascent/JJ mesoderm/NN ,/, and/CC the/DT primitive/JJ streak/NN ./.
@@75690757467 As/IN for/IN 31/CD stage/NN I-II/NNS lung/NN cancer/NN patients/NNS ,/, CR/NN has/VBZ been/VBN observed/VBN in/IN 82/CD ./CD 8%/CD of/IN them/PRP and/CC PR/NNP in/IN 13/CD ./CD 8%/CD ;/: the/DT response/NN was/VBD always/RB assessed/VBN with/IN chest/NN radiography/NN ,/, CT/NN ,/, FBS/NN ,/, cytology/NN and/DT //DT or/DT histology/NN ./.
@@14080903169 The/DT technique/NN of/IN the/DT TEE/NN visualization/NN of/IN the/DT proximal/JJ coronary/JJ arteries/NNS is/VBZ described/VBN ./.
@@13585927360 This/DT negative/JJ regulatory/JJ pathway/NN may/MD be/VB important/JJ for/IN determining/VBG cell/NN fate/NN or/CC maintaining/VBG an/DT inducible/JJ state/NN in/IN the/DT ventroposterior/NN region/NN of/IN the/DT embryo/NN ./.
@@13157062234 Myogenic/NN differentiation/NN can/MD be/VB inhibited/VBN by/IN the/DT adenovirus/NN E1a/NEWGENE protein/NEWGENE in/IN the/DT rat/NN L6/NN muscle/NN cell/NN line/NN ./.
@@13161251949 Two/CD points/NNS are/VBP indicated/VBN :/: first/JJ ,/, the/DT photosensitized/JJ damage/NN of/IN YHPD/NN is/VBZ interrelated/VBN to/IN not/RB only/RB 1O2/CD ,/, but/CC also/RB free/JJ radicals/NNS (/( O2-/NN ./. ./CD OH/CD and/CC YHPD-/NNP ./NNP )/SYM ;/: second/JJ ,/, although/IN the/DT photosensitized/JJ damage/NN of/IN YHPD/NN is/VBZ stronger/JJR than/IN that/DT of/IN BHPD/NNP ,/, yet/RB the/DT photosensitized/JJ damage/NN is/VBZ negatively/RB correlated/VBN to/IN the/DT yield/NN of/IN 1O2/CD but/CC positively/RB correlated/VBN to/IN those/DT of/IN O2-/NN ./. and/CC OH/NN ./NN
@@88804058837 Selection/NN using/VBG SC/NN EPD/NNS was/VBD more/RB effective/JJ than/IN phenotypic/JJ selection/NN in/IN reducing/JJ age/NN at/IN puberty/NN in/IN daughters/NNS ./.
@@12442361882 The/DT results/NNS indicate/VBP that/WDT increased/VBD pulmonary/JJ blood/NN flow/NN and/CC decreased/VBN pulmonary/JJ vascular/JJ resistance/NN with/IN advancing/JJ gestation/NN are/VBP due/NN to/IN an/DT increase/NN in/IN the/DT total/JJ number/NN of/IN vessels/NNS and/CC increased/VBN vasomotor/JJ reactivity/NN is/VBZ related/VBN to/IN an/DT increase/NN in/IN the/DT total/JJ amount/NN of/IN smooth/JJ muscle/NN while/CC the/DT thickness/NN of/IN muscle/NN in/IN individual/JJ vessels/NNS remains/VBP constant/JJ ./.
@@113675232456 Immunofixation/NNS experiments/NNS of/IN C4A/NEWGENE and/CC C4B/NEWGENE demonstrate/VB >/SYM 41/CD allotypes/NNS in/IN the/DT two/JJ classes/NNS of/IN proteins/NNS ./.
@@30098262685 Thirty/CD of/IN the/DT clones/NNS contained/VBD a/DT complete/JJ 340/CD base-pair/NN dimer/NN unit/NN of/IN the/DT repeat/NN ./.
@@76651876264 Primer/NNS extension/NN and/CC cDNA/NN cloning/NN were/VBD used/VBN to/IN isolate/NN the/DT complete/JJ 5'/CD end/NN of/IN the/DT Nramp1/NEWGENE mRNA/NEWGENE ./.
@@25808308367 A/DT 736-bp/JJ sequence/NN of/IN the/DT 5'/CD flanking/JJ region/NN adjacent/JJ to/IN the/DT cap/NN site/NN of/IN the/DT human/NEWGENE AFP/NEWGENE gene/NEWGENE shows/VBZ a/DT 61%/JJ similarity/NN with/IN the/DT corresponding/JJ region/NN of/IN the/DT mouse/NEWGENE AFP/NEWGENE gene/NEWGENE ./.
@@11354975812 A/DT new/JJ species/NN of/IN Euspondylus/NN is/VBZ described/VBN based/VBN on/IN a/DT female/JJ (/( taken/VBP within/IN a/DT bromeliad/NN )/SYM from/IN Cerro/NNP El/NNP Humo/NNP ,/, Sucre/NNP ,/, northeastern/JJ Venezuela/NN ./.
@@79829952803 The/DT effect/NN of/IN site-specific/NN mutations/NN in/IN the/DT mouse/NEWGENE platelet-derived/NEWGENE growth/NEWGENE factor/NEWGENE (/NEWGENE PDGF/NEWGENE )/NEWGENE beta-receptor/NEWGENE on/IN activation/NN of/IN the/DT Na+/NEWGENE //NEWGENE H+/NEWGENE exchanger/NEWGENE was/VBD examined/VBN in/IN normal/JJ murine/JJ mammary/JJ gland/NN epithelial/JJ (/( NMuMG/NNP )/SYM and/CC Chinese/JJ hamster/NN ovary/NN (/( CHO/NN )/SYM cells/NNS ./.
@@9861365115 The/DT Og4C3/NEWGENE enzyme-linked/JJ immunosorbent/JJ assay/NN (/( ELISA/NN )/SYM to/IN detect/VB circulating/JJ Wuchereria/NEWGENE bancrofti/NEWGENE antigen/NEWGENE uses/VBZ 50/CD microL/NN of/IN serum/NN ./.
@@40213059940 Pharmacological/JJ desympathization/NN leads/VBP to/IN the/DT development/NN of/IN hyper-reactivity/NN of/IN the/DT true/JJ pacemakers/NNS to/IN noradrenaline/NN and/CC dopamine/NN and/CC triggers/VBP off/RB changes/VBZ in/IN the/DT regulation/NN of/IN the/DT electric/JJ activity/NN of/IN these/DT cells/NNS by/IN catecholamines/NNS ./.
@@94821078551 The/DT inhibition/NN of/IN focus/NN formation/NN observed/VBN in/IN the/DT presence/NN of/IN C3G/NEWGENE was/VBD not/RB due/NN to/IN toxic/JJ effects/NNS on/IN cell/NN viability/NN ,/, since/IN transfected/VBN C3G/NEWGENE cells/NNS exhibited/VBD the/DT same/JJ survival/NN and/CC growth/NN rates/NNS as/IN untransfected/JJ NIH3T3/NNP cells/NNS or/CC cells/NNS transfected/VBN with/IN plasmid/NN vector/NN alone/RB ./.
@@69972036785 In/NN rubella/NN patients/NNS with/IN serologic/JJ confirmation/NN by/IN HI/NN ,/, the/DT IF/IN test/NN detected/VBD significant/JJ rises/NNS in/IN 219/CD (/( 99/CD ./CD 1%/CD )/SYM of/IN 221/CD patients/NNS and/CC the/DT PHA/NEWGENE test/NN detected/VBD antibody/NN conversion/NN in/IN 68/CD (/( 93%/CD )/SYM of/IN 73/CD patients/NNS ./.
@@86408667210 Exposure/NN of/IN peripheral/JJ blood/NN T/NN cells/NNS from/IN young/JJ subjects/NNS to/IN PHA/NN or/CC cross-linked/VBN anti-CD3/NEWGENE monoclonal/NEWGENE antibodies/NEWGENE stimulated/VBD rapid/JJ increases/NNS in/IN MAPK/NEWGENE and/CC MEK/NEWGENE enzymatic/JJ activity/NN ./.
@@82068678485 Southern/NNP blotting/NN analysis/NN implied/VBD the/DT occurrence/NN of/IN multiple/JJ COXVb/NEWGENE genes/NEWGENE in/IN the/DT rat/NN genome/NN ./.
@@84957868460 Cryopreservation/NNS straws/NNS filled/VBN with/IN media/NN plus/IN additive/JJ are/VBP emersed/VBN below/RB the/DT surface/NN of/IN an/DT unprocessed/JJ donor/NN ejaculate/VB ./.
@@44826614980 Clinical/NNP course/NN and/CC nursing/JJ care/NN of/IN patients/NNS with/IN decubitus/NN ulcer--use/NN of/IN pillows/NNS stuffed/JJ with/IN buckwheat/NN chaff/NN ./.
@@80469238037 An/DT examination/NN was/VBD performed/VBN in/IN 15/CD patients/NNS who/WP had/VBP developed/VBN pronounced/VBN osteomalacia/NN following/IN gastric/JJ resection/NN ./.
@@118820541773 Adjacent/JJ to/IN those/DT lesions/NNS ,/, and/CC in/IN homologous/JJ contralateral/JJ structures/NNS ,/, FMZ/NN binding/NN was/VBD analysed/VBN in/IN four/CD pairs/NNS of/IN cortical/JJ 9/CD x/NN 9-mm/CD regions/NNS of/IN interest/NN (/( ROIs/NNS )/SYM placed/VBN on/IN transaxial/JJ and/CC coronal/JJ slices/NNS ,/, respectively/RB ,/, as/RB well/VB as/IN in/IN the/DT lesion/NN volume/NN and/CC its/PRP mirror/NN region/NN ./.
@@76676217596 Doppler/NN ultrasound/JJ studies/NNS of/IN long-term/JJ follow-up/NN of/IN children/NNS with/IN hemolytic-uremic/JJ syndrome/NN ./.
@@112201663233 The/DT contrasting/JJ effects/NNS of/IN dopaminergic/JJ stimulation/NN on/IN the/DT motor/JJ performance/NN and/CC on/IN some/DT aspects/NNS of/IN cognitive/JJ processing/NN suggest/VB the/DT existence/NN of/IN complex/NN interactions/NNS within/IN pre-/JJ and/CC postsynaptic/JJ brain/NEWGENE dopamine/NEWGENE receptors/NEWGENE ,/, and/CC an/DT intervention/NN of/IN segregated/VBN basal/JJ ganglia-prefrontal/JJ cortex/NN loops/NNS in/IN motor/JJ and/CC cognitive/JJ behaviour/NN ./.
@@77375085328 As/IN in/IN Tb/NN ,/, U6/NEWGENE is/VBZ a/DT single-copy/JJ gene/NN and/CC two/JJ tRNA/NEWGENE genes/NEWGENE ,/, tRNAGln/NEWGENE and/CC tRNAIle/NEWGENE ,/, are/VBP found/VB upstream/RB to/IN the/DT gene/NN ./.
@@77023279129 Experimental/JJ adhesion/NN prophylaxis/NN with/IN recombinant/NEWGENE tissue/NEWGENE plasminogen/NEWGENE activator/NEWGENE ./.
@@18704282473 Thigh/NNP girth/NN correlated/VBN positively/RB with/IN HDL/NEWGENE and/CC HDL2-C/NEWGENE and/CC mass/JJ ,/, and/CC with/IN LDL/NEWGENE particle/NN size/NN among/IN women/NNS ./.
@@95289875785 Cotransfection/NNS analyses/NNS of/IN the/DT T/NEWGENE //NEWGENE EBP/NEWGENE promoter-reporter/NEWGENE constructs/NEWGENE with/IN a/DT T/NEWGENE //NEWGENE EBP/NEWGENE expression/NN vector/NN into/IN human/JJ HepG2/NNP cells/NNS ,/, which/WDT do/VBP not/RB express/VB T/NEWGENE //NEWGENE EBP/NEWGENE ,/, suggested/VBD that/DT autoregulation/NN may/MD be/VB involved/VBN in/IN controlling/VBG both/DT rat/NN and/CC human/NEWGENE T/NEWGENE //NEWGENE EBP/NEWGENE gene/NEWGENE expression/NN ./.
@@1512941549 A/DT newly/RB developed/VBN broad-spectrum/JJ fluoroquinolone/NN ,/, levofloxacin/NN (/( LVFX/NN ,/, DR-3355/NN )/SYM ,/, was/VBD evaluated/VBN in/IN vitro/FW and/CC in/IN vivo/NN in/IN comparison/NN with/IN ciprofloxacin/NN (/( CPFX/NNP )/SYM ,/, ofloxacin/NN (/( OFLX/NNP )/SYM and/CC norfloxacin/NN (/( NFLX/NN )/SYM ./.
@@83256397237 Previous/JJ studies/NNS indicated/VBN that/IN the/DT 20S/NEWGENE proteasome/NEWGENE is/VBZ a/DT catalytic/JJ core/NN of/IN the/DT 26S/NEWGENE proteolytic/NEWGENE complex/NEWGENE that/WDT possesses/VBZ a/DT latent/JJ multicatalytic/JJ proteinase/NEWGENE activity/NN and/CC catalyzes/VBZ an/DT ATP-dependent/NN ,/, selective/JJ breakdown/NN of/IN proteins/NNS ligated/VBN to/IN ubiquitin/NEWGENE ./.
@@84853174136 The/DT fission/NEWGENE yeast/NEWGENE dsk1+/NEWGENE gene/NEWGENE ,/, a/DT multicopy/JJ suppressor/NN for/IN cold-sensitive/JJ dis1/NEWGENE mutants/NEWGENE ,/, encodes/VBZ a/DT novel/JJ 61-kd/NEWGENE protein/NEWGENE kinase/NEWGENE ./.
@@24897537763 The/DT results/NNS were/VBD as/IN follows/VBZ :/: 1/NN )/NN Total/JJ integrated/JJ EMG/JJ activity/NN of/IN FB/NN group/NN was/VBD approximately/RB equal/VB in/IN any/DT occluded/VBN position/NN ,/, whereas/IN that/DT of/IN CG/NN and/CC GF/JJ group/NN varied/VBN from/IN position/NN to/IN position/NN ./.
@@31194853840 The/DT requirement/NN of/IN different/JJ essential/JJ fatty/JJ acids/NNS in/IN patients/NNS with/IN total/JJ parenteral/JJ nutrition/NN after/IN heavy/JJ injury/NN is/NNS of/IN special/JJ interest/NN with/IN respect/NN to/IN the/DT development/NN and/CC prognosis/NN of/IN shock/NN ,/, sepsis/NN or/CC adult/JJ respiratory/JJ distress/NN syndrome/NN ./.
@@6859226315 These/DT consisted/VB of/IN beading/NN and/CC strictures/NNS mainly/RB of/IN the/DT intrahepatic/JJ biliary/JJ tree/NN (/( IHB/NN )/SYM ./.
@@78318292434 Comparison/NNS of/IN the/DT genomes/NNS of/IN PMTV/NNP ,/, BNYVV/NNP ,/, and/CC SBWMV/NN shows/VBZ that/IN furoviruses/NNS exhibit/VBP considerable/JJ heterogeneity/NN in/IN genome/NN organization/NN ./.
@@61417646824 Hybrid-selection/NNP experiments/NNS against/IN total/JJ PB-inducible/NNP RNA/NN were/VBD performed/VBN with/IN plasmid/NN DNA/NN derived/VBN from/IN clones/NNS enriched/VBN in/IN PB-inducible/NNP information/NN ./.
@@81253371530 Sterol/NN analysis/NN of/IN the/DT disrupted/VBN mutant/RB demonstrated/VBN the/DT accumulation/NN of/IN ignosterol/NN ,/, indicating/VBG a/DT loss/NN of/IN Erg24p/NEWGENE activity/NN ./.
@@80944646856 However/RB ,/, tyrA/NEWGENE can/MD be/VB expressed/VBN efficiently/RB from/IN an/DT internal/JJ promoter/NN which/WDT appears/VBZ to/IN lie/NN within/IN the/DT 3'/CD portion/NN of/IN aroF/NEWGENE ./.
@@106843048951 The/DT interaction/NN between/IN U/NN (/NN L/NN )/NN 3/NN ./.
@@98723379774 The/DT percutaneous/JJ absorption/NN of/IN clindamycin/NN was/VBD studied/VBN in/IN healthy/JJ male/JJ volunteers/NNS ,/, comparing/VBG two/JJ investigative/JJ clindamycin/NN (/( %/NN w/NN //NN v/NN )/NN //NN tretinoin/NN (/( 0/CD ./CD 025%/CD w/NN //NN v/NN )/SYM gels/NNS ,/, containing/JJ clindamycin/NN phosphate/NN ester/NN and/CC clindamycin/NN HCl/NN ,/, respectively/RB ,/, relative/JJ to/IN a/DT clindamycin/NN phosphate/NN lotion/NN (/( 1%/JJ clindamycin/NN ;/: Dalacin/NN T/NN )/SYM ./SYM
@@66846247645 Urinary/NEWGENE N-acetylglucosaminidase/NEWGENE activity/NN per/IN mg/NN creatinine/NN did/VBD not/RB differ/VB significantly/RB between/IN groups/NNS ./.
@@22995432953 To/TO those/DT of/IN us/PRP who/WP are/VBP not/RB satisfied/VBN with/IN the/DT present/NN outlook/NN there/RB is/VBZ much/JJ to/IN be/VB investigated/VBN and/CC much/JJ to/IN be/VB contributed/VBN ./.
@@3108171854 Ritanserin/NN is/VBZ a/DT new/JJ substance/NN with/IN highly/RB selective/JJ blocking/JJ activity/NN on/IN S2/NEWGENE receptors/NEWGENE for/IN 5-HT/JJ in/IN the/DT central/JJ nervous/JJ system/NN ./.
@@89808198926 Mortality/NN on/IN the/DT last/NN ranch/NN was/VBD particularly/RB severe/JJ among/IN certain/RB segregated/VBN groups/NNS of/IN turkeys/NNS that/WDT included/VBD toms/NNS ,/, heavier/JJR birds/NNS ,/, and/CC birds/NNS undergoing/VBG a/DT stressful/JJ event/NN such/JJ as/IN artificial/JJ insemination/NN ./.
@@27211691049 NERVTRACK/NN contains/VBZ 4000/CD anatomical/JJ data/NN items/NNS arranged/VBN in/IN a/DT tree-like/JJ manner/NN reflecting/JJ structural/JJ and/CC functional/JJ relationships/NNS ./.
@@16751542265 Myocardial/JJ infarction/NN in/IN patients/NNS with/IN previous/JJ bypass/NN surgery/NN ./.
@@63070996084 Lung/NNP density/NN increased/VBN in/IN quartz-exposed/JJ ,/, but/CC not/RB in/IN volcanic-ash-exposed/JJ animals/NNS ./.
@@63849836181 Management/NNP of/IN hypertension/NN in/IN the/DT elderly/NN ./.
@@82645826648 By/IN using/VBG the/DT full-length/JJ cytoplasmic/JJ domain/NN and/CC mutants/NNS with/IN progressive/JJ carboxy-terminal/JJ deletions/NNS ,/, internal/JJ deletions/NNS ,/, or/CC point/NN mutations/NNS ,/, we/PRP identified/VBD the/DT first/JJ 150/CD amino/JJ acid/NN residues/NNS of/RB LIFR/NEWGENE as/IN the/DT minimal/JJ region/NN necessary/JJ for/IN signaling/NN ./.
@@93446504051 In/NN the/DT predicted/VBN transmembrane/JJ domain/NN ,/, Casr-rs2/NEWGENE and/CC Casr-rs3/NEWGENE are/VBP 95%/NN identical/JJ to/IN Casr-rs1/NEWGENE ./.
@@75553737441 Serum/NN magnesium/NN in/IN 79/CD patients/NNS of/IN gynecologic/JJ neoplasms/NNS treated/VBN with/IN cisplatin/NN and/CC their/PRP controls/NNS was/VBD measured/VBN ./.
@@113332637810 A/DT new/JJ intron/NN of/IN 476/CD base/NN pairs/NNS was/VBD found/VBN in/IN the/DT middle/NN of/IN the/DT 5'-untranslated/JJ leader/NN sequence/NN and/CC was/VBD shown/VBP to/IN robustly/RB enhance/VB the/DT promoter/NN activity/NN ./.
@@117320884250 In/NN order/NN to/IN overcome/VB the/DT false/JJ positive/JJ readings/NNS that/WDT are/VBP possible/JJ in/IN sphincter/NN manometry/NN ,/, we/PRP proposed/VBD to/IN use/NN secretin/NEWGENE stimulated/VBD endoscopic/JJ ultrasound/JJ (/( SSEUS/NNP )/SYM to/IN measure/NN pancreatic/JJ ductal/JJ response/NN as/IN an/DT adjunctive/JJ method/NN to/IN aid/NN and/CC supplement/VB the/DT diagnosis/NN ./.
@@94439733133 CES4/NEWGENE on/IN a/DT multicopy/JJ plasmid/NN was/VBD unable/JJ to/IN suppress/VB tif1-A79V/NEWGENE ./.
@@114864763604 A/DT prospective/JJ trial/NN was/VBD undertaken/VBP to/IN determine/VB (/( 1/CD )/SYM clinical/JJ characteristics/NNS of/IN patients/NNS with/IN chest/NN pain/NN ;/: (/( 2/CD )/SYM value/NN of/IN cardiac/NN markers/NN troponin/NEWGENE T/NEWGENE ,/, myoglobin/NEWGENE and/CC CK-MB/NEWGENE mass/JJ in/IN differentiating/JJ cardiac/JJ and/CC noncardiac/JJ chest/NN pain/NN ;/: (/( 3/CD )/SYM the/DT proportion/NN of/IN patients/NNS with/IN ACS/NN in/IN whom/WP these/DT markers/NNS provided/VBD helpful/JJ additional/JJ information/NN on/IN admission/NN and/CC afterwards/RB ./.
@@12791976861 Mutational/JJ analysis/NN of/IN the/DT major/JJ homology/NN region/NN of/IN Mason-Pfizer/NN monkey/NN virus/NN by/IN use/NN of/IN saturation/NN mutagenesis/NN ./.
@@20020516620 We/PRP report/VBP here/RB the/DT isolation/NN of/IN a/DT full-length/JJ cDNA/NN clone/NN coding/JJ for/IN a/DT hitherto/RB undiscovered/JJ isoform/NN of/IN the/DT bovine/NEWGENE C-subunit/NEWGENE ./.
@@114490147798 STUDY/NN OBJECTIVE/IN :/: This/DT study/NN assessed/VBD several/DT methodological/JJ aspects/NNS related/VBN to/IN the/DT quality/NN of/IN published/VBN controlled/VBN clinical/JJ trials/NNS (/( CCTs/NNS )/SYM in/IN relation/NN to/IN the/DT participation/NN of/IN an/DT epidemiologist/JJ //JJ biostatistician/JJ (/( E/NN //NN B/NN )/SYM ./.
@@106482116028 Neuronal/JJ signaling/JJ properties/NNS are/VBP largely/RB determined/VBN by/IN the/DT quantity/NN and/CC combination/NN of/IN ion/NN channels/NNS expressed/VBN ./.
@@71587266975 Triumph/NNS of/IN Leninist/JJ national/JJ policy/NN ./.
@@13923582192 If/IN no/DT reply/NN was/VBD received/VBN ,/, telephone/NN contact/NN or/CC home/NN visits/NN were/VBD made/VBP ./.
@@70071816513 The/DT effect/NN of/IN sodium/NN saccharin/NN in/IN the/DT diet/NN on/IN caecal/JJ microflora/NN ./.
@@87026448940 A/DT cDNA/NN encoding/VBG the/DT amino-terminal/JJ 17%/NN of/IN apoB/NEWGENE (/( apoB17/NEWGENE )/SYM was/VBD fused/VBN to/IN a/DT cDNA/NN coding/JJ for/IN the/DT last/NN 37/CD amino/JJ acids/NNS of/IN decay-accelerating/NEWGENE factor/NEWGENE (/( DAF/NEWGENE )/SYM ,/, which/WDT contains/VBZ the/DT signal/NN for/IN glycosylphosphatidylinositol/NN anchor/NN attachment/NN ./.
@@68238376608 It/PRP then/RB merged/VBD with/IN right/JJ ventricular/JJ wavefronts/NNS ending/NN along/IN the/DT right/JJ ventricular/JJ anterior/JJ atrioventricular/JJ groove/NN and/CC outflow/NN tract/NN ./.
@@1070026256 Selective/JJ visual/JJ attention/NN involves/VBZ dynamic/JJ interplay/NN between/IN attentional/JJ control/NN systems/NNS and/CC sensory/JJ brain/NN structures/NNS ./.
@@113890773187 A/DT variety/NN of/IN receptor-mediated/JJ signaling/JJ pathways/NNS are/VBP controlled/VBN by/IN both/DT positive/JJ and/CC negative/JJ extracellular/JJ regulators/NNS ./.
@@13138463490 Comparison/NNS with/IN the/DT sequence/NN databanks/NNS show/VBP that/IN Tactile/NEWGENE is/VBZ a/DT member/NN of/IN the/DT immunoglobulin/NEWGENE gene/NEWGENE superfamily/NEWGENE ,/, with/IN similarity/NN to/IN Drosophila/NEWGENE amalgam/NEWGENE ,/, the/DT melanoma/NEWGENE Ag/NEWGENE MUC-18/NEWGENE ,/, members/NNS of/IN the/DT carcinoembryonic/NEWGENE Ag/NEWGENE family/NEWGENE ,/, the/DT poliovirus/NEWGENE receptor/NEWGENE ,/, and/CC the/DT neural/NEWGENE cell/NEWGENE adhesion/NEWGENE molecule/NEWGENE ./.
@@11454239317 Statistical/NNP Analysis/NNP included/VBD ANOVA/NN ,/, the/DT Pearson/NNP Product/NNP Moment/NNS Correlation/NNS Coefficient/NNS ,/, Principal/NNP Components/NNP Analysis/NNP and/CC Discriminant/NNP Function/NNP Analysis/NNP and/CC the/DT calculation/NN of/IN Cronbach's/NNP alpha/NN (/( alpha/NN )/SYM RESULTS/NNS :/: Both/DT Sensitivity/NNS and/CC specificity/NN exceed/VB 90/CD ./CD 00/CD at/IN 23/CD //CD 24/CD ,/, Chronbach's/NN alpha/NN for/IN the/DT total/JJ scale/NN was/VBD equal/VB to/IN 0/CD ./CD 95/CD ./.
@@93082348883 Mnt/NEWGENE :/NEWGENE Max/NEWGENE complexes/NEWGENE also/RB efficiently/RB suppress/VB Myc-dependent/NNP activation/NN from/IN the/DT same/JJ promoter/NN ./.
@@35821494243 An/DT epidemiological/JJ survey/NN of/IN rheumatic/JJ valve/NN disease/NN and/CC rheumatic/JJ fever/NN in/IN primary/JJ and/CC secondary/JJ school/NN students/NNS in/IN Jiangxi/NNP Province/NNP ./.
@@7829102395 Haplotype/NN mapping/NN and/CC sequence/NN analysis/NN of/IN the/DT mouse/NN Nramp/NEWGENE gene/NEWGENE predict/VB susceptibility/NN to/IN infection/NN with/IN intracellular/JJ parasites/NNS ./.
@@62817594759 Because/IN RNase/NEWGENE III/NEWGENE host/NEWGENE mutants/NEWGENE are/VBP defective/JJ in/IN sib/NEWGENE regulation/NN ,/, processing/NN of/IN the/DT PL/NEWGENE mRNA/NEWGENE at/IN sib/NEWGENE by/IN this/DT endoribonuclease/NEWGENE may/MD cause/NN int/NEWGENE mRNA/NEWGENE decay/NN and/CC decrease/NN int/NEWGENE synthesis/NN ./.
@@90576488609 Transient/JJ cotransfection/NN of/IN tat/NEWGENE cDNA/NEWGENE in/IN sense/NN orientation/NN (/( tat/NEWGENE //NEWGENE S/NEWGENE )/SYM ,/, together/RB with/IN a/DT plasmid/NN containing/JJ the/DT c-fos/NEWGENE promoter/NEWGENE (/( FC3/NEWGENE ,/, from/IN -711/CD to/IN +42/NN )/SYM in/IN front/NN of/IN the/DT bacterial/NEWGENE chloramphenicol/NEWGENE acetyltransferase/NEWGENE (/( CAT/NEWGENE )/SYM gene/NN significantly/RB enhanced/VBD CAT/NEWGENE activity/NN in/IN Jurkat/NN cells/NNS activated/VBN by/IN the/DT addition/NN of/IN 15%/JJ fetal/JJ calf/NN serum/JJ (/( FCS/NN )/SYM or/CC 5/CD micrograms/NN //NN mL/NN phytohemagglutinin/NEWGENE plus/IN 10/NN (/NN -7/NN )/NN mol/NN //NN L/NN phorbol/NN myristate/NN acetate/NN (/( PMA/NN )/SYM and/CC U937/CD cells/NNS activated/VBN by/IN 15%/JJ FCS/NN or/CC 10/NN (/NN -7/NN )/NN mol/NN //NN L/NN PMA/NN ./.
@@91822819175 The/DT most/RB important/JJ one/PRP among/IN them/PRP is/VBZ Cyclosporin/NN A/NN ,/, which/WDT is/VBZ a/DT selective/JJ immunosuppressive/JJ drug/NN ./.
@@78313107963 A/DT genetic/JJ complementation/NN system/NN was/VBD developed/VBN in/IN which/WDT tobacco/NEWGENE etch/NEWGENE virus/NEWGENE (/NEWGENE TEV/NEWGENE )/NEWGENE polymerase/NEWGENE (/( NIb/NEWGENE )/NN -expressing/NN transgenic/JJ plants/NNS or/CC protoplasts/NNS were/VBD inoculated/VBN with/IN NIb-defective/NNP TEV/NEWGENE mutants/NEWGENE ./.
@@108733874712 Furthermore/RB ,/, as/IN in/IN the/DT human/JJ gene/NN ,/, the/DT 3'/CD end/NN of/IN the/DT Cacna1f/NEWGENE gene/NEWGENE maps/NNS within/IN 5/CD kb/NN of/IN the/DT 5'/CD end/NN of/IN the/DT mouse/NEWGENE synaptophysin/NEWGENE gene/NEWGENE in/IN a/DT region/NN orthologous/JJ to/IN Xp11/NNP ./NNP 23/NNP ./.
@@82945115263 The/DT following/JJ evidence/NN indicates/VBZ that/IN the/DT 69-kD/NN protein/NN is/VBZ a/DT common/NN ,/, rather/RB than/IN a/DT U1-specific/NN ,/, protein/NN ,/, possibly/RB associating/JJ with/IN the/DT snRNP/NEWGENE core/NEWGENE particles/NEWGENE by/IN protein-protein/JJ interaction/NN ./.
@@86901185866 The/DT logistic/JJ regression/NN analysis/NN of/IN the/DT manual/JJ method/NN (/( percentage/NN normal/JJ morphology/NN )/SYM and/CC IVOS/NN indicated/VBD that/IN both/DT were/VBD predictors/NNS of/IN fertilization/NN ./.
@@79025321913 In/NN this/DT study/NN ,/, we/PRP demonstrate/VBP that/IN BOX/NEWGENE DNA/NEWGENE enhances/VBZ transcription/NN from/IN the/DT thymidine/NEWGENE kinase/NEWGENE (/( TK/NEWGENE )/SYM promoter/NN in/IN various/JJ EC/NN cells/NNS ./.
@@63613181971 The/DT clinical/JJ efficacy/NN rates/NNS evaluated/VBN in/IN 151/CD cases/NNS (/( KS-R1/NN group/NN in/IN 77/CD cases/NNS ,/, oral/JJ group/NN in/IN 74/CD cases/NNS )/SYM on/IN standard/JJ criteria/NNS of/IN committee/NN members/NNS were/VBD 88/CD ./CD 3%/CD for/IN the/DT KS-R1/NN group/NN and/CC 86/CD ./CD 5%/CD for/IN the/DT oral/JJ group/NN ,/, respectively/RB ./.
@@105854805270 We/PRP show/VBP here/RB that/IN the/DT third/RB SH3/NEWGENE domain/NEWGENE binds/VBZ to/IN Sos/NEWGENE ,/, a/DT guanine/NEWGENE nucleotide/NEWGENE exchange/NEWGENE factor/NEWGENE for/IN Ras/NEWGENE and/CC Rac/NEWGENE ,/, both/DT in/NN vitro/FW and/CC in/IN vivo/NN ./.
@@30010862228 Its/PRP predicted/VBN amino/JJ acid/NN sequence/NN shows/VBZ extensive/JJ homology/NN to/IN those/DT of/IN Drosophila/NEWGENE hsp70/NEWGENE ,/, trout/NEWGENE hsp70/NEWGENE ,/, Xenopus/NEWGENE hsp70/NEWGENE ,/, yeast/NEWGENE hsp70/NEWGENE ,/, and/CC some/DT homology/NN to/IN the/DT heat-inducible/NEWGENE dnaK/NEWGENE gene/NEWGENE product/NEWGENE of/IN Escherichia/NN coli/JJ ./.
@@20203149619 A/DT dose/NN of/IN 3/CD and/CC 6/CD micrograms/NN //NN kg/NN //NN day/NN GM-CSF/NNP reduces/VBZ the/DT severity/NN of/IN neutropenia/NN and/CC thrombocytopenia/NN after/IN carboplatin-cyclophosphamide/JJ chemotherapy/NN ,/, which/WDT may/MD lead/VB to/IN more/RB effective/JJ chemotherapy/NN for/IN ovarian/JJ cancer/NN in/IN the/DT future/JJ ./.
@@113133866760 SH2D1A/NEWGENE protein/NEWGENE levels/NNS are/VBP up-regulated/IN by/IN CD40/NEWGENE cross-linking/VBG and/CC down-regulated/IN by/IN B/NEWGENE cell/NEWGENE receptor/NEWGENE ligation/NN ./.
@@66626233356 [/NN 82Br/NN ]/NN MISO/NN was/VBD prepared/VBN by/IN irradiating/VBG samples/NNS of/IN Br-MISO/NNP in/IN a/DT SLOWPOKE/NNP reactor/NN for/IN 2/CD h/NN at/IN a/DT thermal/JJ neutron/NN flux/NN of/IN 10/NN (/NN 12/NN )/NN n/NN cm-2/NN s-1/NN ./.
@@8195186679 A/DT partial/JJ cDNA/NN sequence/NN indicated/VBN that/IN the/DT T/NEWGENE lymphocyte/NEWGENE early-activation/NEWGENE gene/NEWGENE (/( Tea/NEWGENE )/SYM encodes/VBZ a/DT protein/NN related/VBN to/IN the/DT dual-function/JJ ecotropic/NEWGENE retrovirus/NEWGENE receptor/NEWGENE //NEWGENE cationic/NEWGENE amino/NEWGENE acid/NEWGENE transporter/NEWGENE (/( ecoR/NEWGENE //NEWGENE CAT1/NEWGENE )/SYM ,/, and/CC RNA/NN blots/NNS suggested/VBN highest/JJS Tea/NEWGENE expression/NN in/IN T/NN lymphocytes/NNS and/CC liver/NN (/( MacLeod/NNP ,/, C/NNS ./NNS L/NNS ./NNS ,/, Finley/NNP ,/, K/NNP ./NNP ,/, Kakuda/NNP ,/, D/NN ./NN
@@7683546372 Vitrectomy/NN with/IN an/DT alternative/JJ instrument/NN system/NN ./. pp/NNS ./NNS
@@26150783290 Precipitating/VBG antibodies/NNS for/IN Thermophilic/NNP actinomycetes/NNS and/CC M/NNP ./NNP f/NNP ./. were/VBD negative/JJ ./.
@@25387206199 UbiA/NEWGENE is/VBZ also/RB unique/JJ among/IN known/VBP polyubiquitin/NEWGENE genes/NEWGENE in/IN containing/JJ four/CD cis-spliced/JJ introns/NNS within/IN its/PRP coding/JJ sequence/NN ./.
@@102122786141 Stress-inducible/NEWGENE protein/NEWGENE kinases/NEWGENE capable/JJ of/IN activating/NN c-jun/NEWGENE expression/NN include/VB stress-activated/NEWGENE protein/NEWGENE kinase/NEWGENE //NEWGENE c-Jun/NEWGENE N-terminal/NEWGENE protein/NEWGENE kinase/NEWGENE (/( SAPK/NEWGENE //NEWGENE JNK/NEWGENE )/SYM and/CC p38/NEWGENE members/NN of/IN the/DT mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE (/( MAPK/NEWGENE )/SYM superfamily/NN of/IN signaling/NN molecules/NN ./.
@@81726535325 The/DT variable/JJ regions/NNS of/IN vertebrate/JJ striated/JJ TnT/NEWGENE isoforms/NEWGENE reflect/VBP the/DT subsequent/JJ addition/NN and/CC modification/NN of/IN genomic/JJ sequences/NNS to/IN give/NN rise/NN to/IN members/NNS of/IN the/DT TnT/NEWGENE multigene/NEWGENE family/NEWGENE ./.
@@105271802535 RESULTS/NNS :/: Factors/NNS associated/VBN with/IN significantly/RB (/( P/CD </CD ./CD 05/CD )/SYM increased/VBN risk/NN of/IN treatment/NN failure/NN in/IN a/DT Cox/NN multivariate/JJ analysis/NN included/VBD age/NN older/JJR than/IN 45/CD years/NNS (/( relative/JJ hazard/NN ,/, 1/CD ./CD 17/CD ;/: 95%/CD confidence/NN interval/NN [/NN CI/NN ]/NN ,/, 1/CD ./CD 02-1/CD ./CD 33/CD )/SYM ,/, Karnofsky/NN performance/NN score/NN less/PRP than/IN 90%/CD (/( 1/CD ./CD 27/CD ;/: 95%/CD CI/NN ,/, 1/CD ./CD 07-1/CD ./CD 51/CD )/SYM ,/, absence/NN of/IN hormone/NN receptors/NN (/( 1/CD ./CD 31/CD ;/: 95%/CD CI/NN ,/, 1/CD ./CD 15-1/CD ./CD 51/CD )/SYM ,/, prior/NN use/NN of/IN adjuvant/JJ chemotherapy/NN (/( 1/CD ./CD 31/CD ;/: 95%/CD CI/NN ,/, 1/CD ./CD 10-1/CD ./CD 56/CD )/SYM ,/, initial/JJ disease-free/NN survival/NN interval/NN after/IN adjuvant/JJ treatment/NN of/IN no/DT more/RB than/IN 18/CD months/NNS (/( 1/CD ./CD 99/CD ;/: 95%/CD CI/NN ,/, 1/CD ./CD 62-2/CD ./CD 43/CD )/SYM ,/, metastases/NNS in/IN the/DT liver/NN (/( 1/CD ./CD 47/CD ;/: 95%/CD CI/NN ,/, 1/CD ./CD 20-1/CD ./CD 80/CD )/SYM or/CC central/JJ nervous/JJ system/NN (/( 1/CD ./CD 56/CD ;/: 95%/CD CI/NN ,/, 0/CD ./CD 99-2/CD ./CD 46/CD [/NN approaches/NN significance/NN ]/NN )/SYM vs/NNP soft/JJ tissue/NN ,/, bone/NN ,/, or/CC lung/NN ,/, 3/CD or/CC more/JJ sites/NNS of/IN metastatic/JJ disease/NN (/( 1/CD ./CD 32/CD ;/: 95%/CD CI/NN ,/, 1/CD ./CD 13-1/CD ./CD 54/CD )/SYM ,/, and/CC incomplete/JJ response/NN vs/NNP complete/JJ response/NN to/IN standard-dose/NN chemotherapy/NN (/( 1/CD ./CD 65/CD ;/: 95%/CD CI/NN ,/, 1/CD ./CD 36-1/CD ./CD 99/CD )/SYM ./.
@@79940217897 Alternative/JJ splicing/JJ of/IN the/DT cytoplasmic/JJ tail/NN appears/VBZ to/IN generate/VB multiple/JJ PECAM-1/NEWGENE isoforms/NEWGENE that/WDT may/MD regulate/VB phosphorylation/NN ,/, cytoskeletal/JJ association/NN ,/, and/CC affinity/NN modulation/NN of/IN the/DT mature/JJ protein/NN ./.
@@22774526529 In/NN 26/CD patients/NNS with/IN angina/NN pectoris/JJ ,/, the/DT changes/NNS of/IN LVEF/NN ,/, LVESV/NN and/CC PSP/NN //NN LVESV/NN were/VBD more/RB sensitive/JJ for/IN the/DT detection/NN of/IN exercise-induced/JJ ischemia/NN than/IN the/DT appearance/NN of/IN chest/NN pain/NN and/CC the/DT changes/NNS of/IN ECG/NN ./.
@@22019017553 Here/RB ,/, we/PRP have/VBP used/VBN specific/JJ antibody/NN to/IN identify/VB and/CC characterize/VB the/DT SSN6/NEWGENE protein/NEWGENE ./.
@@60919147007 Many/JJ mammary/JJ tumors/NNS induced/VBN by/IN mouse/NN mammary/JJ tumor/NN virus/NN (/( MMTV/NN )/SYM contain/VB a/DT provirus/NN in/IN the/DT same/JJ region/NN of/IN the/DT host-cell/NN genome/NN ,/, leading/JJ to/IN expression/NN of/IN a/DT putative/JJ cellular/JJ oncogene/NN called/VBN int-1/NEWGENE ./.
@@88360327658 Bifunctionality/NNS of/IN the/DT AcMNPV/NEWGENE homologous/NEWGENE region/NEWGENE sequence/NEWGENE (/( hr1/NEWGENE )/SYM :/: enhancer/NN and/CC ori/NN functions/NNS have/VBP different/JJ sequence/NN requirements/NNS ./.
@@25506821326 Grossly/RB ,/, the/DT incidence/NN of/IN a/DT type/NN IIc/NN carcinoma/NN was/VBD 46/CD ./CD 5%/CD and/CC that/IN of/IN a/DT IIc/NN +/SYM III/NNP type/NN was/VBD 20/CD ./CD 5%/CD ,/, respectively/RB ./.
@@102242571433 In/NN XO/NN males/NNS ,/, two/JJ her-1/NEWGENE mRNAs/NEWGENE ,/, her-1a/NEWGENE and/CC her-1b/NEWGENE ,/, are/VBP transcribed/VBN from/IN two/JJ separate/JJ promoters/NNS :/: P1/NN ,/, located/VBN in/IN the/DT 5'-flanking/JJ region/NN ,/, and/CC P2/NN ,/, located/VBN in/IN the/DT large/JJ second/JJ intron/NN ./.
@@79647707953 One/CD hundred/JJ fifty/CD patients/NNS were/VBD reviewed/VBN at/IN 1/CD year/NN after/IN arthroplasty/NN ./.
@@90745087982 The/DT human/NEWGENE CD38/NEWGENE gene/NEWGENE consists/VBZ of/IN 8/CD exons/NNS that/WDT extend/VBP more/RB than/IN 77/CD kb/NN on/IN the/DT human/JJ genome/NN ./.
@@110560193471 MED1/NEWGENE has/VBZ a/DT weak/JJ glycosylase/NEWGENE activity/NN on/IN the/DT mutagenic/NN adduct/NN 3/NN ,/NN N/NN (/NN 4/NN )/NN -ethenocytosine/NN ,/, a/DT metabolite/NN of/IN vinyl/NN chloride/NN and/CC ethyl/NN carbamate/NN ./.
@@5931197377 Screening/NN of/IN asthma/NN patients/NNS by/IN determination/NN of/IN IgE/NEWGENE and/CC by/IN comprehension/NN of/IN spectrum/NN of/IN allergospecific/NEWGENE IgE/NEWGENE antibodies/NEWGENE ./.
@@36738816452 To/TO evaluate/VB the/DT relative/JJ accuracy/NN of/IN continuous/JJ wave/NN (/( CW/JJ )/SYM and/CC high/JJ pulse/NN repetition/NN frequency/NN (/( HPRF/NN )/SYM Doppler/NN for/IN estimating/VBG aortic/JJ transvalvular/JJ pressure/NN gradients/NNS ,/, Doppler/NN examinations/NNS with/IN both/DT devices/NNS were/VBD obtained/VBN in/IN 87/CD consecutive/JJ patients/NNS with/IN aortic/JJ valve/NN disease/NN ./.
@@112876544804 PABP/NEWGENE is/VBZ a/DT modular/JJ protein/NN ,/, with/IN four/CD N-terminal/NN RNA-binding/NN domains/NN and/CC an/DT extensive/JJ C/NN terminus/NN ./.
@@85049339975 Pit-1/NEWGENE is/VBZ a/DT tissue-specific/JJ POU/NEWGENE domain/NEWGENE factor/NEWGENE obligatory/JJ for/IN the/DT appearance/NN of/IN three/CD cell/NN phenotypes/NNS in/IN the/DT anterior/JJ pituitary/JJ gland/NN ./.
@@110036537040 Deletion/NNS of/IN an/DT intergenic/JJ DNA-binding/NN site/NN for/IN this/DT complex/NN from/IN a/DT human/NEWGENE beta-globin/NEWGENE locus/NEWGENE construct/NEWGENE results/NNS in/IN delayed/NN human/NEWGENE gamma-/NEWGENE to/IN beta-globin/NEWGENE switching/NN in/IN transgenic/JJ mice/NNS ,/, suggesting/VBG that/IN the/PDT PYR/NEWGENE complex/NEWGENE acts/NNS to/IN facilitate/VB the/DT switch/NN ./.
@@78968177273 Proteins/NNPS immunoprecipitated/VBN from/IN lysates/NNS of/IN control-/JJ and/CC VEGF-stimulated/JJ BAEC/NN with/IN antisera/NNS to/IN phospholipase/NEWGENE C-gamma/NEWGENE (/( PLC-gamma/NEWGENE )/SYM were/VBD fractionated/VBN by/IN SDS-polyacrylamide/NNP gel/NN electrophoresis/NN and/CC transferred/VBN to/IN Immobilon-P/NNP ./.
@@78412307814 Dissociation/NN and/CC complexation/NN of/IN the/DT fluoroquinolone/NN antimicrobials--an/JJ update/NN ./.
@@100228757810 These/DT data/NN suggest/VB that/IN other/DT Ras/NEWGENE effectors/NEWGENE can/MD collaborate/VB with/IN PI/NEWGENE 3-kinase/NEWGENE and/CC with/IN each/DT other/DT to/IN activate/VB Pak/NEWGENE ./.
@@21817602792 Blood/NNP flow/NN and/CC velocity/NN (/( measured/VBN using/VBG Doppler/NN ultrasound/JJ )/SYM gradually/RB decreased/VBN during/IN diastole/NN and/CC ultimately/RB reversed/VBN in/RB direction/NN as/IN cotyledon/NN resistance/NN was/VBD increased/VBN up/JJ to/IN 14/CD fold/NN ./.
@@25075234918 The/DT ORF1/NN product/NN was/VBD required/VBN for/IN competence/NN ,/, while/CC ORF2/NN ,/, which/WDT was/VBD cotranscribed/VBN with/IN ORF1/NN and/CC encoded/VBN a/DT predicted/VBN protein/NN of/IN 126/CD amino/JJ acids/NNS ,/, was/VBD not/RB ./.
@@76309349331 Harel/NNP ,/, E/NNP ./NNP M/NNP ./.
@@40869934778 Daily/NNP and/CC seasonal/JJ rhythmicity/NN in/IN the/DT methylation/NN of/IN pineal/JJ indolic/JJ compounds/NNS in/IN adult/JJ male/JJ golden/JJ hamsters/NNS ,/, kept/VBP under/IN natural/JJ conditions/NNS ./.
@@4015214677 Seventy-one/NNS percent/NN of/IN patients/NNS treated/VBN with/IN ticarcillin/NN alone/RB responded/VBD favorably/RB ./.
@@82981294141 Isolation/NNS and/CC characterization/NN of/IN a/DT TATA-less/NNP promoter/NN for/IN the/DT human/NEWGENE beta/NEWGENE 3/NEWGENE integrin/NEWGENE gene/NEWGENE ./.
@@117936146564 OBJECTIVE/IN :/: To/TO demonstrate/VB a/DT lack/NN of/IN effect/NN of/IN steady-state/JJ concentrations/NNS of/IN cilomilast/NN ,/, a/DT new/JJ oral/JJ phosphodiesterase/NEWGENE 4/NEWGENE inhibitor/NN for/IN the/DT treatment/NN of/IN chronic/JJ obstructive/JJ pulmonary/JJ disease/NN ,/, on/IN warfarin-induced/JJ anticoagulation/NN ./.
@@45240815011 Histopathologic/NNP response/NN of/IN gingival/JJ tissues/NNS to/IN hemodent/NN and/CC aluminum/NN chloride/NN solutions/NNS as/IN tissue/NN displacement/NN materials/NNS ./.
@@106879454959 Deglutition/NN is/VBZ considered/VBN to/IN be/VB immature/JJ in/IN infants/NNS and/CC to/IN mature/JJ postnatally/RB ./.
@@97982639163 Antidepressant-like/NNP properties/NNS of/IN some/DT serotonin/NEWGENE receptor/NEWGENE ligands/NN and/CC calcium/NN channel/NN antagonists/NNS measured/VBN with/IN the/DT forced/JJ swimming/JJ test/NN in/IN mice/NNS ./.
@@105242587002 Regulation/NN of/IN avian/NEWGENE fibroblast/NEWGENE growth/NEWGENE factor/NEWGENE receptor/NEWGENE 1/NEWGENE (/( FGFR-1/NEWGENE )/SYM gene/NN expression/NN during/IN skeletal/JJ muscle/NN differentiation/NN ./.
@@34060546310 Data/NNP on/IN the/DT line/NN spread/NN function/NN (/( LSF/NN )/SYM were/VBD obtained/VBN from/IN the/DT image/NN of/IN a/DT 0/CD ./CD 2/CD mm/NN wide/JJ slit/NN between/IN tungsten/NN blocks/NNS that/WDT were/VBD positioned/VBN at/IN the/DT isocentre/NN in/IN front/NN of/IN a/DT polystyrene/NN phantom/NN ./.
@@79366404627 To/TO confirm/VB the/DT binding/NN of/IN protein/NN to/IN these/DT sites/NNS in/IN cells/NNS ,/, we/PRP carried/VBD out/RB an/DT in/NN vivo/NN genomic/JJ footprinting/VBG analysis/NN of/IN this/DT portion/NN of/IN the/DT TGF/NEWGENE alpha/NEWGENE promoter/NEWGENE in/IN normal/JJ and/CC transformed/VBN rat/NN liver/NN epithelial/JJ cell/NN lines/NNS that/WDT express/VBP the/DT endogenous/JJ gene/NN at/IN varying/JJ levels/NNS ./.
@@90813899032 Grade/NNP 3-4/CD mucositis/NN was/VBD present/VB in/IN 13%/NN of/IN the/DT cycles/NNS ./.
@@62003006020 Subdural/JJ electrodes/NNS may/MD yield/VB larger/JJR VEP/NN amplitudes/NNS than/IN skull/NN or/CC scalp/NN electrodes/NNS ./.
@@114786272842 The/DT desirability/NN function/NN is/VBZ based/VBN on/IN the/DT search/NN for/IN a/DT global/JJ optimum/JJ [/NN D/NN =/SYM f/NN (/( Y1/NN ,/, Y2/NN ,/, ./: ./: ./: ,/, Yn/VB )/VBG ]/VBG by/IN the/DT transformation/NN of/IN the/DT measured/VBN property/NN to/IN a/DT dimensionless/JJ scale/NN for/IN each/DT criterion/NN ./.
@@11919649325 Three/CD groups/NNS of/IN patients/NNS who/WP had/VBP undergone/VBP subtotal/JJ thyroidectomy/NN for/IN Graves's/NNPS disease/NN ,/, toxic/JJ multinodular/JJ goitre/NN ,/, or/CC euthyroid/JJ multinodular/JJ goitre/NN 12/CD to/IN 15/CD years/NNS before/IN and/CC in/IN whom/WP a/DT normal/JJ serum/JJ thyroxine/NN (/( T-4/NN )/SYM level/NN was/VBD found/VBN were/VBD each/DT divided/VBN into/IN two/JJ subgroups/NNS on/IN the/DT basis/NN of/IN a/DT normal/JJ or/CC a/DT raised/VBN serum/JJ thyrotrophin/NN concentration/NN ./.
@@85956271609 (/( ii/NN )/SYM opening/NN of/IN KATP/NN attenuates/VBZ ,/, inhibition/NN of/IN the/DT channel/NN exacerbates/VBZ functional/JJ consequences/NNS of/IN coronary/JJ occlusion/NN ,/, and/CC (/( iii/NN )/SYM KATP/NN opening/NN attenuates/VBZ reperfusion-induced/NN VF/NN ,/, but/CC it/PRP triggers/VBP ischemia-induced/NNP VF/NNP ./NNP
@@113414058261 CONCLUSIONS/IN AND/CC CLINICAL/NNP RELEVANCE/NNP :/: Increased/VBN cortical/JJ thickness/NN and/CC geometric/JJ properties/NNS of/IN left/NN MCB-IV/NNP and/CC -V/CD of/IN Greyhounds/NNS ,/, together/RB with/IN altered/VBN turnover/NN and/CC orientation/NN of/IN osteons/NNS in/IN the/DT dorsal/JJ quadrants/NNS of/IN left/NN MCB/NN ,/, are/VBP site-specific/JJ adaptive/JJ responses/NNS associated/VBN with/IN asymmetric/JJ cyclic/JJ loading/NN as/IN a/DT result/NN of/IN racing/JJ on/IN circular/JJ tracks/NNS ./.
@@103395529680 In/NN the/DT present/NN study/NN ,/, we/PRP show/VBP that/IN SRm160/NEWGENE //NEWGENE 300/NEWGENE is/VBZ required/VBN for/IN a/DT purine-rich/JJ ESE/NEWGENE to/IN promote/VB the/DT splicing/JJ of/IN a/DT pre-mRNA/NN derived/VBN from/IN the/DT Drosophila/NEWGENE doublesex/NEWGENE gene/NEWGENE ./.
@@111683669290 In/NN addition/NN ,/, we/PRP have/VBP isolated/VBN a/DT genomic/JJ fragment/NN containing/JJ the/DT most/RB distal/JJ 5'/CD sequences/NNS of/IN the/DT major/JJ GGT/NEWGENE mRNA/NEWGENE in/IN HepG2/NNP cells/NNS ./.
@@26741414887 The/DT seventh/JJ cysteine/NN residue/NN of/IN CTSE/NEWGENE is/VBZ located/VBN within/IN the/DT activation/NN peptide/NN region/NN of/IN the/DT proenzyme/NN ./.
@@5554925592 (/( 5/CD )/SYM No/DT changes/NNS were/VBD observed/VBN in/IN the/DT gastric/JJ venous/JJ blood/NN flow/NN by/IN continuous/JJ intravenous/JJ injection/NN of/IN cimetidine/NN ,/, but/CC by/IN rapid/JJ injection/NN both/PDT the/DT flow/NN was/VBD augmented/VBN and/CC the/DT systemic/JJ blood/NN pressure/NN decreased/VBN transiently/RB ./.
@@86549834902 To/TO determine/VB the/DT signal/NEWGENE recognition/NEWGENE particle/NEWGENE (/NEWGENE SRP/NEWGENE )/NEWGENE -SRP/NEWGENE receptor/NEWGENE (/NEWGENE Srb/NEWGENE )/NEWGENE system/NEWGENE in/NEWGENE Bacillus/NEWGENE subtilis/NEWGENE (/NEWGENE Bs/NEWGENE )/NEWGENE ,/, we/PRP cloned/VBN the/PDT Bs/NEWGENE srb/NEWGENE gene/NEWGENE ,/, which/WDT encodes/VBZ a/DT homologue/NN of/IN the/DT mammalian/NEWGENE SRP/NEWGENE receptor/NEWGENE alpha-subunit/NEWGENE [/NN Oguro/NN et/FW al/NNS ./NNS ,/, DNA/NN Res/NNS ./.
@@21961765365 TREB7/NEWGENE and/CC TREB36/NEWGENE protected/VBN all/DT three/CD repeats/NNS of/IN the/DT 21/CD bp/NN ,/, but/CC TREB5/NEWGENE protected/VBN only/RB the/DT second/JJ repeat/NN ./.
@@107579759966 Biol/NNP ./.
@@104282943392 Preheparin/NN LPL/NN mass/JJ level/NN did/VBD not/RB significantly/RB differ/VB in/IN individuals/NNS from/IN 19/CD to/IN 70/CD years/NNS old/JJ ,/, for/IN both/DT men/NNS and/CC women/NNS ./.
@@40214311675 OODG/NN is/VBZ a/DT diagnostic/JJ method/NN permitting/VBG assessment/NN of/IN ocular/JJ pulse/NN curves/NNS and/CC objective/JJ determination/NN of/IN blood/NN pressures/NNS in/IN the/DT ophthalmic/JJ circulatory/JJ system/NN (/( retinal/JJ and/CC ciliary/JJ arterial/JJ blood/NN pressures/NNS )/SYM simultaneously/RB for/IN both/DT eyes/NNS ,/, without/IN dilatation/NN of/IN the/DT pupils/NNS ./.
@@91152659645 The/DT carboxyl-terminal/NEWGENE CCCC/NEWGENE module/NEWGENE is/VBZ structurally/RB related/VBN to/IN the/DT DNA-binding/NN domain/NN of/IN the/DT erythroid/NEWGENE transcription/NEWGENE factor/NEWGENE GATA-1/NEWGENE ./.
@@10780764739 The/DT median/JJ levels/NNS of/IN particles/NNS with/IN 50%/CD cut-off/JJ aerodynamic/JJ diameters/NNS of/IN 10/CD (/( PM10/IN )/SYM and/CC 2/CD ./CD 5/CD microm/NN (/( PM2/CD ./CD 5/CD )/SYM were/VBD 170/CD (/( range/NN 103-613/JJ )/SYM and/CC 95/CD (/( range/NN 61-218/JJ )/SYM micro/NN x/NN m-3/NN ,/, respectively/RB ./.
@@114697015640 The/DT novel/JJ approach/NN to/IN insulin/NEWGENE administration/NN known/VBP as/IN chronic/JJ intermittent/JJ intravenous/JJ insulin/NEWGENE therapy/NN (/( CIIIT/NN )/SYM delivers/VBZ insulin/NEWGENE in/IN a/DT pulsatile/JJ fashion/NN and/CC achieves/VBZ physiological/JJ insulin/NEWGENE concentration/NN in/IN the/DT portal/JJ vein/NN ./.
@@78358867920 The/DT kallistatin/NEWGENE gene/NEWGENE was/VBD localized/VBN by/IN in/IN situ/NN hybridization/NN to/IN human/JJ chromosome/NN 14q31-q32/CD ./CD 1/CD ,/, close/JJ to/IN the/DT serpin/NEWGENE genes/NEWGENE encoding/VBG alpha/NEWGENE 1-antichymotrypsin/NEWGENE ,/, protein/NEWGENE C/NEWGENE inhibitor/NEWGENE ,/, alpha/NEWGENE 1-antitrypsin/NEWGENE ,/, and/CC corticosteroid-binding/NEWGENE globulin/NEWGENE ./.
@@14296241373 The/DT shift/NN to/IN the/DT nonpermissive/JJ temperature/NN is/VBZ accompanied/VBN by/IN the/DT loss/NN of/IN guanyl/NN nucleotide-dependent/NN activity/NN of/IN adenylylcyclase/NEWGENE in/IN vitro/FW ./.
@@90026727473 In/NN vitro/FW translation/NN of/IN the/DT mTRF1/NEWGENE cDNA/NEWGENE resulted/VBN in/IN a/DT 56/NN kDa/NN protein/NN that/WDT binds/VBZ to/IN TTAGGG/NEWGENE repeat/NEWGENE arrays/NNS ./. mTRF1/NEWGENE displayed/VBN the/DT same/JJ sequence/NN specificity/NN as/IN hTRF1/NEWGENE ,/, preferring/JJ arrays/NNS of/IN TTAGGG/NEWGENE repeats/NEWGENE as/IN a/DT binding/JJ substrate/NN over/RB TTAGGC/NEWGENE and/CC TTGGGG/NEWGENE repeats/NEWGENE ./.
@@10670681487 4/CD ./CD
@@74361879782 Our/PRP study/NN differs/VBZ from/IN previous/JJ studies/NNS in/IN that/DT it/PRP is/VBZ limited/VBN to/IN one/PRP diagnostic/JJ entity/NN ,/, yet/RB at/IN the/DT same/JJ time/NN evaluates/VBZ a/DT broad/JJ range/NN of/IN social/JJ and/CC work-related/NN factors/NN in/IN disability/NN ./.
@@89461667320 From/IN these/DT results/NNS ,/, we/PRP concluded/VBD that/IN this/DT ORF/NN is/VBZ the/DT FRDS/NEWGENE gene/NEWGENE ./.
@@39148754569 Oral/NNP candidiasis/NN ./.
@@7835710618 Intron-exon/NNP structure/NN of/IN the/DT porcine/NEWGENE I/NEWGENE kappa/NEWGENE B/NEWGENE alpha-encoding/NEWGENE gene/NEWGENE ./.
@@94524443222 Interleukin-6/NEWGENE (/( IL-6/NEWGENE )/SYM is/VBZ a/DT pleiotropic/JJ cytokine/NN ,/, which/WDT is/VBZ involved/VBN in/IN inflammatory/JJ and/CC immune/JJ responses/NNS ,/, acute/JJ phase/NN reactions/NNS ,/, and/CC hematopoiesis/NN ./.
@@51238845378 Bacterial/JJ metabolism/NN of/IN 4-chlorophenoxyacetate/NN ./.
@@41944664857 Serotonin/NNS levels/NNS in/IN infant/NN hypothyroidism/NN ./.
@@76607125956 The/DT character/NN of/IN specific/JJ immune/JJ response/NN in/IN 101/CD immunized/VBN children/NNS and/CC in/IN 12/CD adults/NNS belonging/NN to/IN a/DT high/JJ risk/NN group/NN with/IN respect/NN to/IN VHB/NN ./.
@@45837915046 A/DT short/JJ history/NN of/IN dermatology/NN in/IN Lagos/NN ,/, Nigeria/NN ./.
@@80347417932 We/PRP report/VBP the/DT identification/NN and/CC characterization/NN of/IN myr/NEWGENE 4/NEWGENE (/( myosin/NEWGENE from/NEWGENE rat/NEWGENE )/SYM ,/, the/DT first/JJ mammalian/NEWGENE myosin/NEWGENE I/NEWGENE that/WDT is/VBZ not/RB closely/RB related/VBN to/IN brush/NN border/NN myosin/NEWGENE I/NEWGENE ./.
@@112512761088 Only/RB nine/JJ patients/NNS were/VBD offered/VBN surgery/NN (/( six/CD were/VBD resected/VBN and/CC three/CD were/VBD found/VBN inoperable/JJ )/SYM ./.
@@110901728378 The/DT time/NN course/NN of/IN RNA1/NEWGENE replication/NN and/CC RNA3/NEWGENE synthesis/NN in/IN induced/VBN yeast/NN paralleled/VBN that/IN in/IN yeast/NN transfected/VBN with/IN natural/NN FHV/NN virion/NN RNA/NN ./.
@@90371635022 The/DT relevance/NN of/IN these/DT elements/NNS in/IN conferring/JJ anaerobic/JJ induction/NN of/IN gpc4/NEWGENE gene/NEWGENE expression/NN is/VBZ discussed/VBN ./.
@@97045692340 The/DT genomic/JJ structure/NN and/CC chromosomal/JJ location/NN of/IN the/DT human/NEWGENE TR2/NEWGENE orphan/NEWGENE receptor/NEWGENE ,/, a/DT member/NN of/IN the/DT steroid/NEWGENE receptor/NEWGENE superfamily/NEWGENE ./.
@@87067319239 We/PRP identify/VBP considerable/JJ spatio-temporal/JJ similarities/NNS between/IN reported/VBN expression/NN patterns/NNS of/IN Ypr10/NEWGENE genes/NEWGENE and/CC ribonuclease/NEWGENE genes/NEWGENE ,/, which/WDT ,/, together/RB with/IN the/DT significant/JJ sequence/NN similarity/NN to/IN the/DT ginseng/NEWGENE ribonuclease/NEWGENE ,/, support/NN the/DT hypothesis/NN of/IN a/DT ribonuclease/NEWGENE function/NN for/IN PR-10/NEWGENE proteins/NEWGENE and/CC allow/VB the/DT prediction/NN of/IN possible/JJ biological/JJ roles/NNS ./.
@@92019806166 The/DT p20-CGGBP/NEWGENE gene/NEWGENE is/VBZ conserved/VBN among/IN mammals/NNS but/CC shows/VBZ no/DT homology/NN to/IN non-vertebrate/NN species/NN ./.
@@37209669373 Estimated/VBN nucleic/JJ acid/NN N/NN absorption/NN is/VBZ 7-8%/JJ of/IN N/JJ intake/NN ./.
@@8067013198 The/DT diagnostic/JJ significance/NN of/IN creatine/NEWGENE phosphokinase/NEWGENE antibodies/NNS in/IN the/DT cardiac/JJ muscle/NN in/IN non-coronarogenic/JJ myocardial/JJ diseases/NNS ./.
@@60516445881 Note/VB on/IN Slot's/NNP method/NN for/IN the/DT specific/JJ determination/NN of/IN creatinine/NN ./.
@@115724671452 When/WRB the/DT blood/NN clot/NN is/VBZ formed/VBN in/IN the/DT vitreous/JJ cavity/NN ,/, intravitreal/JJ injection/NN of/IN t-PA/NEWGENE can/MD convert/VB plasminogen/NEWGENE to/IN plasmin/NN and/CC remove/VB the/DT clot/NN ./.
@@90353075308 We/PRP report/VBP herein/RB the/DT case/NN of/IN a/DT 30-year-old/CD man/NN in/IN whom/WP ectopic/JJ mediastinal/JJ parathyroid/JJ adenoma/NN was/VBD detected/VBN by/IN 99mTc-methoxyisobutylisonitrile/NNP scintigraphy/NN (/( 99mTc-MIBI/NN )/SYM ./.
@@22708342917 1/CD (/( "long/NN method"/NN )/SYM and/CC the/DT HML/NNS method/NN ./.
@@1425921445 The/DT distinguishing/JJ features/NNS involved/VBN eight/CD amino/JJ acid/JJ changes/NNS ,/, including/JJ a/DT single/JJ lysine/NN deletion/NN relative/JJ to/IN a/DT primate/NN consensus/NN sequence/NN in/IN the/DT first/JJ complementary-determing/JJ region/NN of/IN V1J1/NEWGENE ./.
@@93288331718 We/PRP cloned/VBN a/DT complete/JJ cDNA/NN (/( 2/CD ./CD 9/CD kb/NN )/SYM for/IN HET/NEWGENE from/IN an/DT MCF-7/NN cDNA/NN library/NN ./.
@@110637429789 NF-kappaB/NEWGENE is/VBZ a/DT redox-sensitive/JJ transcription/NN factor/NN known/VBP to/IN be/VB activated/VBN by/IN oxidative/JJ stress/NN as/RB well/VB as/IN chemical/JJ and/CC biological/JJ reductants/NNS ./.
@@115622783237 Many/JJ of/IN the/DT important/JJ genes/NNS associated/VBN with/IN G1/NN regulation/NN have/NN been/VBN shown/VBP to/IN play/NN a/DT key/NN role/NN in/IN proliferation/NN ,/, differentiation/NN and/CC oncogenic/JJ transformation/NN and/CC programmed/JJ cell/NN death/NN (/( apoptosis/NN )/SYM ./.
@@95369017508 On/IN a/DT separate/JJ occasion/NN the/DT T1/NN weighted/JJ and/CC T2/NN weighted/JJ sagittal/JJ and/CC T2/NN weighted/JJ axial/JJ sequences/NNS were/VBD reported/VBN blind/JJ in/IN relation/NN to/IN the/DT initial/JJ assessment/NN ./.
@@34635437260 Enoxacin/NN appears/VBZ to/IN be/VB well/NN suited/VBN for/IN the/DT treatment/NN of/IN complicated/VBN UTI/NN ./.
@@17353475208 The/DT primary/JJ pancreatic/JJ insult/NN seemed/VBN to/IN be/VB unaffected/JJ by/IN the/DT treatment/NN ,/, because/IN neither/DT the/DT rise/NN in/IN plasma/NEWGENE lipase/NEWGENE nor/CC the/DT development/NN of/IN ascites/NN or/CC the/DT extension/NN of/IN the/DT pancreatic/JJ necrosis/NN were/VBD diminished/VBN ./.
@@11087141140 Detailed/VBN analysis/NN of/IN alpha1/NEWGENE ,/NEWGENE 3GT/NEWGENE transcripts/NEWGENE revealed/VBD two/JJ major/JJ alternative/JJ splicing/JJ patterns/NNS in/IN the/DT 5'-untranslated/JJ region/NN (/( 5'-UTR/CD )/SYM and/CC evidence/NN for/IN minor/JJ splicing/JJ activity/NN that/WDT occurs/VBZ in/IN a/DT tissue-specific/JJ manner/NN ./.
@@65278729194 The/DT segmental/JJ and/CC regional/JJ projections/NNS of/IN the/DT sciatic/JJ ,/, tibial/JJ and/CC common/JJ peroneal/JJ nerves/NNS to/IN the/DT substantia/NN gelatinosa/NN of/IN the/DT spinal/JJ cord/NN in/IN rats--an/VB experimental/JJ study/NN by/IN means/NN of/IN an/DT acid/NEWGENE phosphatase/NEWGENE (/( ACP/NEWGENE )/SYM method/NN ./.
@@24740939979 Angiotensin/NEWGENE converting/NEWGENE enzyme/NEWGENE inhibitors/NN enhance/VBP the/DT antihypertensive/JJ efficacy/NN of/IN diuretics/NNS and/CC blunt/JJ or/CC prevent/VB adverse/JJ metabolic/JJ effects/NNS ./.
@@88164825493 Two/CD closely/RB related/VBN variants/NNS of/IN Stat5/NEWGENE ,/, Stat5a/NEWGENE and/CC Stat5b/NEWGENE ,/, are/VBP encoded/VBN by/IN distinct/JJ genes/NNS ./.
@@112141777487 Also/RB ,/, small/JJ ,/, sense/NN and/CC antisense/NN approximately/RB 22/CD nt/JJ RNAs/NNS ,/, derived/VBN from/IN the/DT satRNA/NEWGENE ,/, were/VBD associated/VBN with/IN the/DT replicating/JJ satellite/JJ ./.
@@37144733386 Induction/NNS of/IN both/DT potential/JJ transcripts/NNS follows/VBZ heat/NN shock/NN in/IN vivo/NN ./.
@@66077146362 Limb/NN allografts/NNS in/IN rats/NNS immunosuppressed/JJ with/IN cyclosporin/NN A/NNP ./NNP
@@86000488580 Pseudomembranous/JJ conjunctivitis/NN following/IN bone/NN marrow/NN transplantation/NN :/: immunopathological/JJ and/CC ultrastructural/JJ study/NN of/IN one/PRP case/NN ./.
@@96352768386 Regulation/NN of/IN myosin/NEWGENE phosphatase/NEWGENE activity/NN involves/VBZ changes/NNS in/IN subunit/NN interactions/NNS ,/, although/IN molecular/JJ mechanisms/NNS are/VBP not/RB defined/VBN ./.
@@66025803988 However/RB ,/, the/DT history/NN of/IN acute/JJ severe/JJ complications/NNS from/IN otitis/NN media/NN revealed/VBD a/DT higher/JJ frequency/NN in/IN those/DT individuals/NNS with/IN alpha/NEWGENE 1-antitrypsin/NEWGENE deficiency/NN as/IN compared/VBN to/IN normals/NNS ./.
@@30060663657 Unlike/IN P135gag-myb-ets/NEWGENE and/CC the/DT Mr/NNP 75/NN ,/NN 000/NN translation/NN product/NN of/IN c-myb/NEWGENE (/( P75c-myb/NEWGENE )/SYM ,/, which/WDT are/VBP nuclear/JJ proteins/NNS ,/, P54c-ets/NEWGENE was/VBD found/VBN to/IN be/VB predominantly/RB cytoplasmic/JJ ./.
@@37802481392 Although/IN differences/NNS were/VBD not/RB significant/JJ ,/, infants/NNS in/IN the/DT experimental/JJ group/NN had/VBP more/RB changes/VBZ in/IN the/DT intermittent/JJ mandatory/JJ ventilation/NN (/( IMV/NN )/SYM settings/NNS during/IN transport/NN ,/, and/CC more/RB such/JJ infants/NNS arrived/VBN at/IN the/DT receiving/JJ hospital/NN with/IN acceptable/JJ pH/NN and/CC PCO2/NN values/NNS ./.
@@107481136062 We/PRP now/RB describe/VBP a/DT second/JJ RIM/NEWGENE protein/NEWGENE ,/, called/VBN RIM2/NEWGENE ,/, that/WDT is/VBZ highly/RB homologous/JJ to/IN RIM1/NEWGENE and/CC also/RB expressed/VBN primarily/RB in/IN brain/NN ./.
@@24193279281 The/DT priming/JJ activity/NN of/IN DNA/NN incised/VBN by/IN either/DT of/IN the/DT Drosophila/NN enzymes/NN can/MD be/VB enhanced/VBN ,/, however/RB ,/, by/IN an/DT additional/JJ incubation/NN with/IN E/NEWGENE ./NEWGENE coli/NEWGENE endonuclease/NEWGENE IV/NEWGENE ,/, which/WDT is/NNS known/VBP to/IN cleave/VB depurinated/VBN DNA/NN on/IN the/DT 5'-side/NN of/IN an/DT apurinic/JJ site/NN ./.
@@115185055214 Subsequently/RB ,/, these/DT coordinates/NNS must/MD be/VB interpreted/VBN to/IN define/VB particular/JJ tissues/NNS and/CC organs/NNS ./.
@@25738368195 To/TO assess/VB the/DT functional/JJ importance/NN of/IN these/DT NBS/NNP in/IN the/DT overall/JJ drug/NN resistance/NN phenotype/NN conferred/VBN by/IN mdr1/NEWGENE ,/, we/PRP introduced/VBD amino/JJ acid/NN substitutions/NNS in/IN the/DT core/NN consensus/NN sequence/NN for/IN nucleotide/NN binding/JJ ,/, GXGKST/NEWGENE ./.
@@90962292463 Excision/NN repair/NN at/IN the/DT level/NN of/IN the/DT nucleotide/NN in/IN the/DT Saccharomyces/NEWGENE cerevisiae/NEWGENE MFA2/NEWGENE gene/NEWGENE :/: mapping/NN of/IN where/CC enhanced/VBN repair/NN in/IN the/DT transcribed/VBN strand/NN begins/VBZ or/CC ends/NNS and/CC identification/NN of/IN only/RB a/DT partial/JJ rad16/NEWGENE requisite/NN for/IN repairing/JJ upstream/JJ control/NN sequences/NNS ./.
@@23235178601 After/IN 4/CD h/NN ,/, lesions/NNS in/IN the/DT secretory/JJ part/NN of/IN the/DT stomach/NN were/VBD scored/VBN and/CC mucosal/JJ prostaglandin/NN E2/NN synthesis/NN was/VBD determined/VBN by/IN the/DT ex/NN vivo/NN prostaglandin/NN generation/NN technique/NN ./.
@@54251952392 Behavior/NN of/IN aspartate/NEWGENE aminotransferase/NEWGENE (/( EC/NEWGENE 2/NEWGENE ./NEWGENE 6/NEWGENE ./NEWGENE 1/NEWGENE ./NEWGENE 1/NEWGENE )/SYM and/CC alanine/NEWGENE aminotransferase/NEWGENE (/( EC/NEWGENE 2/NEWGENE ./NEWGENE 6/NEWGENE ./NEWGENE 1/NEWGENE ./NEWGENE 2/NEWGENE )/SYM in/IN rat/NN serum/JJ during/IN the/DT course/NN of/IN acute/JJ radiation/NN syndrome/NN following/IN whole/JJ body/NN X-irradiation/NNS ./.
@@90012452750 NUP145/NEWGENE was/VBD previously/RB identified/VBN by/IN using/VBG a/DT genetic/JJ synthetic/JJ lethal/JJ screen/NN (/( E/NNP ./NNP
@@108948867246 However/RB ,/, there/RB is/VBZ still/RB a/DT subset/NN of/IN tumors/NNS that/WDT displayed/VBD no/DT changes/NNS in/IN these/DT genes/NNS ./.
@@105714741693 Results/NNS confirmed/VBD that/DT stress/NN produced/VBN CA3/NN dendritic/JJ atrophy/NN and/CC tianeptine/NN prevented/VBN it/CD ./CD
@@7499409981 TPBF/NEWGENE has/VBZ two/JJ potential/JJ coiled-coil/NN regions/NN ,/, a/DT basic/JJ region/NN ,/, a/DT proline-rich/JJ region/NN ,/, a/DT histidine-rich/JJ N/JJ terminus/NN ,/, and/CC a/DT nuclear/NN targeting/NN sequence/NN ./.
@@317127951 This/DT led/VBN to/IN the/DT conclusion/NN that/IN the/DT metatarsal/JJ artery/NN should/MD be/VB used/VBN for/IN toe/NN MP/NN joint/JJ grafts/NNS ,/, while/CC the/DT unilateral/JJ proper/JJ digital/JJ artery/NN is/VBZ suitable/JJ for/IN toe/NN PIP/JJ joint/JJ grafts/NNS ,/, together/RB with/IN concomitant/JJ or/CC dorsal/JJ cutaneous/JJ vein/NN ./.
@@58585714617 Clinical/NNP trials/NNS with/IN 1/NN ,/NN 3-bis/NN (/NN 2-chloroethyl/NN )/NN -1-nitrosourea/NN ,/, NSC-409962/NN ./.
@@104386277160 Identity/NNS elements/NNS in/IN tRNA/NEWGENE for/IN mono-/NN and/CC dimethylation/NN reactions/NNS by/IN the/DT recombinant/NEWGENE pfTrm1p/NEWGENE were/VBD identified/VBN using/VBG in/IN vitro/NN T7/NN transcripts/NN of/IN 33/CD variants/NNS of/IN tRNA/NEWGENE (/NEWGENE Asp/NEWGENE )/NEWGENE and/NEWGENE tRNA/NEWGENE (/NEWGENE Phe/NEWGENE )/NEWGENE from/NEWGENE yeast/NEWGENE ./.
@@80856092659 Results/NNS indicate/VBP that/IN KNM-LU/NN 335/CD differs/VBZ from/IN both/DT human/NN and/CC chimpanzee/NN M1s/NNP in/IN relative/JJ distances/NNS (/( measured/VBN in/IN three/CD dimensions/NNS )/SYM between/IN crown/NN fissure/NN termini/NNS ./.
@@96059348440 This/DT E/NEWGENE box/NEWGENE sequence/NEWGENE (/NEWGENE CACGTG/NEWGENE )/NEWGENE is/VBZ identical/JJ to/IN the/DT binding/JJ element/NN for/IN USF/NEWGENE (/( upstream/NEWGENE stimulatory/NEWGENE factor/NEWGENE )/SYM ,/, a/DT member/NN of/IN the/DT helix-loop-helix/NEWGENE family/NEWGENE of/NEWGENE transcription/NEWGENE factors/NEWGENE ./.
@@75475108928 We/PRP have/VBP demonstrated/VBN previously/RB that/IN two/JJ binding/JJ sites/NNS in/IN the/DT -184/NEWGENE HNF-3/NEWGENE beta/NEWGENE promoter/NEWGENE are/VBP recognized/VBN by/IN widely/RB distributed/JJ factors/NNS and/CC that/WDT there/RB is/VBZ also/RB a/DT critical/JJ autoregulatory/NN site/NN ,/, we/PRP identified/VBD a/DT binding/JJ site/NN for/IN a/DT cell-specific/NN factor/NN ,/, LF-H3/NEWGENE beta/NEWGENE ,/, that/WDT may/MD function/VB in/IN restricting/JJ HNF-3/NEWGENE beta/NEWGENE gene/NEWGENE expression/NN to/IN hepatocytes/NNS ./.
@@84499861907 Overlapping/NN clones/NNS representing/VBG full-length/JJ cDNAs/NNS for/IN MMI/NEWGENE alpha/NEWGENE were/VBD obtained/VBN from/IN mouse/NN brain/NN ./.
@@8855625624 Since/IN GAGs/NNS are/VBP the/DT components/NNS of/IN cartilage/NN matrix/NN ,/, the/DT depletion/NN of/IN which/WDT is/VBZ associated/VBN with/IN osteoarthrosis/NN ,/, a/DT method/NN for/IN measuring/JJ sulphated/JJ GAG/NN synthesis/NN in/IN culture/NN has/VBZ been/VBN investigated/VBN ./.
@@18449824739 Chagas'/NNPS disease/NN ,/, visceral/JJ leishmaniasis/NN ,/, anti-nuclear/NEWGENE factor/NEWGENE ,/, schistosomiasis/NN ,/, rheumatoid/NEWGENE factor/NEWGENE and/CC normal/JJ controls/NNS ./.
@@75793288749 MZF-1/NEWGENE represses/VBZ CAT/NEWGENE reporter/NEWGENE gene/NEWGENE expression/NN via/NN GAL4/NEWGENE binding/NEWGENE sites/NEWGENE in/IN the/DT nonhematopoietic/JJ cell/NN lines/NNS NIH/NN 3T3/CD and/CC 293/CD ./.
@@84961575399 The/DT bcl-2/NEWGENE gene/NEWGENE can/MD potentially/RB encode/VB 26-/DT and/CC 22-kDa/NN proteins/NN that/WDT differ/VBP only/RB in/IN their/PRP carboxyl/NN tails/NNS because/IN of/IN an/DT alternative/JJ splicing/JJ mechanism/NN ./.
@@87943266340 We/PRP have/VBP identified/VBN a/DT strong/JJ Tas-responsive/NEWGENE element/NEWGENE ,/, designated/VBN TRE/NEWGENE (/( GP/NEWGENE )/SYM ,/, near/IN the/DT 3'/CD end/NN of/IN the/DT gag/NEWGENE gene/NEWGENE and/CC preceding/JJ the/DT pol/NEWGENE gene/NEWGENE of/IN SFV-1/NN ./.
@@91380767088 In/NN gel/NN mobility/NN shift/NN assays/NNS ,/, factors/NNS present/VBP in/IN nuclear/JJ extracts/NNS derived/VBN from/IN differentiated/VBN osteoblast/NN bound/JJ to/IN oligonucleotide/NN probes/NNS containing/JJ the/DT E-box/NEWGENE 1/NEWGENE and/CC E-box/NEWGENE 2/NEWGENE elements/NEWGENE ./.
@@28509678489 Induction/NNS of/IN proto-oncogene/NEWGENE fos/NEWGENE transcription/NN through/RB the/DT adenylate/NEWGENE cyclase/NEWGENE pathway/NEWGENE :/: characterization/NN of/IN a/DT cAMP-responsive/NEWGENE element/NEWGENE ./.
@@100538521191 Role/NN of/IN g2/NN in/IN relating/VBG the/DT Schwinger/NNP and/CC Gerasimov-Drell-Hearn/NNP sum/NN rules/NNS ./.
@@88876431187 We/PRP conclude/VBP that/IN common/JJ upstream/RB signals/VBZ cause/NN activation/NN of/IN Ras/NEWGENE and/CC TC21/NEWGENE ,/, but/CC activated/VBN TC21/NEWGENE controls/NNS cell/NN growth/NN via/NN distinct/JJ Raf-independent/NNP downstream/RB signaling/JJ pathways/NNS ./.
@@13965921856 Our/PRP experiments/NNS suggest/VBP that/IN the/DT SCL/NEWGENE gene/NEWGENE can/MD be/VB a/DT target/NN for/IN the/DT erythroid/NEWGENE transcription/NEWGENE factor/NEWGENE GATA-1/NEWGENE and/CC that/IN the/DT SCL/NEWGENE gene/NEWGENE product/NEWGENE serves/VBP as/IN a/DT positive/JJ regulator/NN of/IN erythroid/JJ differentiation/NN ./.
@@109659052395 Because/IN GH-induced/NN Akt/NEWGENE activation/NN was/VBD completely/RB inhibited/VBN in/IN both/DT cells/NNS by/IN the/DT same/JJ concentration/NN of/IN LY294002/NN ,/, these/DT findings/NNS indicate/VBP that/IN the/DT wortmannin/NN sensitivity/NN of/IN both/PDT the/DT IRS-1-independent/NNP and/CC -dependent/NN GH-induced/NN MAP/NEWGENE kinase/NEWGENE activation/NN may/MD reflect/VB the/DT activity/NN of/IN another/DT wortmannin-sensitive/JJ target/NN (/NN s/NN )/NN in/IN addition/NN to/IN PI3K/NEWGENE in/IN mediation/NN of/IN GH-induced/NN MAP/NEWGENE kinase/NEWGENE activation/NN in/IN these/DT cells/NNS ./.
@@84132607541 These/DT results/NNS indicate/VBP that/DT Rb/NEWGENE protein/NEWGENE is/VBZ interacting/VBG with/IN some/DT component/NN (/NN s/NN )/NN of/IN the/DT cell/NN cycle-regulatory/JJ machinery/NN during/IN G2/NN phase/NN ./.
@@7697294980 A/DT small/JJ amount/NN of/IN HSP81-1/NEWGENE mRNA/NEWGENE was/VBD detected/VBN only/RB in/IN roots/NNS ./.
@@10936051261 The/DT RS447/NEWGENE human/NEWGENE1 megasatellite/NEWGENE1 tandem/NEWGENE1 repetitive/NEWGENE1 sequence/NEWGENE1 encodes/VBZ a/DT novel/JJ deubiquitinating/JJ enzyme/NN with/IN a/DT functional/JJ promoter/NN ./.
@@40855897004 There/EX was/VBD no/DT correlation/NN between/IN secretor/NN status/NN and/CC clinical/JJ status/NN ,/, spirometry/NN measurements/NNS ,/, salivary/JJ and/CC serum/NEWGENE lysozyme/NEWGENE levels/NNS or/CC rates/NNS of/IN respiratory/JJ tract/NN colonization/NN with/IN P/NNP ./NNP aeruginosa/NN and/CC S/NNP ./NNP aureus/NN ./.
@@19649893015 Urine/NNS specimens/NNS containing/JJ either/DT phencyclidine/NN (/( PCP/NN )/SYM or/CC 11-nor-delta/JJ 9-tetrahydrocannabinol-9-carboxylic/NN acid/NN (/( 9-THC-COOH/CD )/SYM were/VBD adulterated/JJ with/IN sodium/NN chloride/NN ,/, bleach/NN ,/, vinegar/NN ,/, potassium/NN hydroxide/NN ,/, liquid/JJ soap/NN ,/, 2-propanol/JJ ,/, and/CC ammonia/NN ./.
@@75902647371 We/PRP sought/VBP to/IN determine/VB whether/IN such/JJ differences/NNS in/IN polyadenylation/NN affect/NN the/DT steady-state/JJ levels/NNS of/IN DHFR/NEWGENE and/CC mRNAs/NNS expressed/VBN from/IN either/DT allele/NN and/CC ,/, in/IN a/DT more/RB general/JJ sense/NN ,/, to/IN ask/VB whether/IN differences/NNS in/IN 3'/CD end/NN RNA/NN processing/VBG in/IN a/DT gene/NN containing/JJ multiple/JJ poly/NN (/NN A/NN )/NN sites/NNS affects/VBP the/DT final/JJ level/NN of/IN gene/NN expression/NN ./.
@@98435777241 Schizosaccharomyces/NN pombe/NN cells/NNS respond/VBP to/IN nutrient/JJ deprivation/NN by/IN altering/VBG G2/NN //NN M/NN cell/NN size/NN control/NN ./.
@@3036933553 ACTH/NEWGENE release/NN is/VBZ transiently/RB suppressed/VBN in/IN some/DT children/NNS after/IN exogenous/JJ ACTH/NEWGENE treatment/NN ./.
@@101980617026 In/NN the/DT cell-free/JJ import/NN assay/NN ,/, beta-catenin/NEWGENE rapidly/RB migrates/VBZ into/IN the/DT nucleus/NN without/IN the/DT exogenous/JJ addition/NN of/IN cytosol/NN ,/, Ran/NEWGENE ,/, or/CC ATP/NNP //NNP GTP/NNP ./.
@@23786155733 The/DT protein/NN sequence/NN contains/VBZ seven/JJ potential/JJ N-linked/NN glycosylation/NN sites/NN and/CC a/DT threonine/NN //NN serine-rich/NN region/NN which/WDT is/VBZ a/DT potential/JJ site/NN for/IN attachment/NN of/IN O-linked/JJ carbohydrate/NN ./.
@@42143452146 Inverse/JJ relation/NN between/IN serum/JJ IgG/NEWGENE concentration/NN and/CC glucose/NN and/CC xylose/NN absorption/NN in/IN Zambian/JJ African/JJ adults/NNS ./.
@@87548403103 Moreover/RB ,/, glucan/NEWGENE synthase/NEWGENE activity/NN ,/, which/WDT is/VBZ activated/VBN by/IN Rho1p/NEWGENE ,/, was/VBD significantly/RB reduced/VBN in/IN the/DT deltabem4/NEWGENE mutant/NEWGENE ./.
@@1278251780 The/DT authors/NNS report/NN the/DT results/NNS of/IN a/DT series/NN of/IN toxicological/JJ tests/NNS conducted/VBN on/IN plastic/JJ materials/NNS (/( polyethylene/NN )/SYM activated/VBN with/IN tetraphenylbutadiene/NN (/( TPB/NN )/SYM an/DT additive/JJ recently/RB proposed/VBN as/IN a/DT sensitizer/NN capable/JJ of/IN photodegrading/JJ plastic/JJ materials/NNS ./.
@@97652618337 The/DT human/NEWGENE T/NEWGENE cell/NEWGENE lymphotropic/NEWGENE retrovirus/NEWGENE type/NEWGENE I/NEWGENE (/NEWGENE HTLV-I/NEWGENE )/NEWGENE trans-activator/NEWGENE ,/, Tax/NEWGENE ,/, interacts/VBZ specifically/RB with/IN the/DT basic-domain/NEWGENE //NEWGENE leucine-zipper/NEWGENE (/NEWGENE bZip/NEWGENE )/NEWGENE protein/NEWGENE ,/, cAMP/NEWGENE response/NEWGENE element/NEWGENE binding/NEWGENE protein/NEWGENE (/( CREB/NEWGENE )/SYM ,/, bound/JJ to/IN the/DT viral/NEWGENE Tax-responsive/NEWGENE element/NEWGENE consisting/VBG of/IN three/CD imperfect/JJ 21-base/JJ pair/NN repeats/NNS ,/, each/DT with/IN a/DT cAMP/NEWGENE response/NEWGENE element/NEWGENE core/NEWGENE flanked/VBN by/IN G/NN //NN C-rich/NN sequences/NN ./.
@@106480205683 METHODS/IN :/: Von/NEWGENE Willebrand/NEWGENE factor/NEWGENE (/( vWF/NEWGENE )/SYM and/CC the/DT fibrinolytic/JJ factors/NNS tissue/NEWGENE plasminogen/NEWGENE activator/NEWGENE (/( tPA/NEWGENE )/SYM ,/, measured/VBN as/IN tPA/NEWGENE capacity/NN ,/, and/CC plasminogen/NEWGENE activator/NEWGENE inhibitor/NEWGENE 1/NEWGENE (/( PAI-1/NEWGENE )/SYM ,/, platelets/NNS ,/, fibrinogen/NEWGENE ,/, and/CC inflammatory/JJ markers/NNS were/VBD measured/VBN in/IN 74/CD patients/NNS with/IN active/JJ seropositive/JJ RA/NN ./NN
@@85870753810 Regressing/VBG microaneurysms/NNS in/IN 5/CD cases/NNS of/IN hepatitis/NN B/NN virus/NN related/VBD polyarteritis/NN nodosa/NN ./.
@@37716703506 Prevention/NNP by/IN a/DT heparin-antithrombin/NEWGENE III/NEWGENE combination/NN ./.
@@93278812289 Positron/NN emission/NN tomography/NN radioligands/NNS for/IN dopamine/NEWGENE transporters/NEWGENE and/CC studies/NNS in/IN human/JJ and/CC nonhuman/JJ primates/NNS ./.
@@8973917103 Several/JJ cDNAs/NNS corresponding/JJ to/IN the/DT human/NEWGENE PWP2/NEWGENE gene/NEWGENE were/VBD identified/VBN and/CC partially/RB sequenced/VBN ./.
@@28447677535 The/DT primary/JJ structure/NN and/CC cotranscription/NN of/IN the/DT petCA/NEWGENE genes/NEWGENE encoding/VBG the/DT Rieske-FeS/NEWGENE (/( nuclear/NEWGENE encoded/NEWGENE in/NEWGENE plants/NEWGENE )/SYM and/CC apocytochrome/NEWGENE f/NEWGENE proteins/NEWGENE has/VBZ been/VBN described/VBN previously/RB (/( Kallas/NNP ,/, T/NNP ./NNP ,/, Spiller/NNP ,/, S/NNP ./NNP ,/, and/CC Malkin/NNP ,/, R/NNP ./NNP
@@48247475192 Nonteratogenicity/NNS in/IN rats/NNS of/IN blighted/JJ potatoes/NNS and/CC compounds/NNS contained/VBN in/IN them/PRP ./.
@@9596564500 Pregnant/NNP women/NNS at/IN term/NN had/VBP the/DT lowest/JJS levels/NNS of/IN antithrombin/NEWGENE III/NEWGENE ./.
@@2838246208 Herpes/NN virus/NN infection/NN was/VBD characterized/VBN by/IN inversion/NN of/IN the/DT T4/NN //NN T8/NN ratio/NN below/RB 1/CD ./CD 0/CD (/( sensitivity/NN 90%/CD ,/, specificity/NN 88%/JJ )/SYM ,/, caused/VBN by/IN proliferation/NN of/IN the/DT T8/NNP subpopulation/NN ,/, which--compared/JJ with/IN the/DT findings/NNS in/IN patients/NNS with/IN rejection/NN crises--was/NNS significantly/RB raised/VBN (/( P/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ./.
@@112569623293 Sequence/NN analysis/NN revealed/VBD significant/JJ differences/NNS between/IN the/DT 5'/CD region/NN of/IN the/DT beta/NEWGENE subunit/NEWGENE gene/NEWGENE and/CC the/DT corresponding/JJ regions/NNS of/IN the/DT homologous/NEWGENE GlyR/NEWGENE alpha/NEWGENE subunit/NEWGENE genes/NEWGENE ;/: it/PRP also/RB identified/VBD a/DT novel/JJ exon/NN (/( exon/NN 0/CD )/SYM that/IN encodes/VBZ most/RB of/IN the/DT 5'-untranslated/JJ portion/NN of/IN the/DT GlyR/NEWGENE beta/NEWGENE mRNA/NEWGENE ./.
@@43942904957 A/DT study/NN in/IN vivo/NN of/IN adrenergic/NEWGENE receptors/NEWGENE in/IN the/DT rectum/NN and/CC in/IN the/DT internal/NN and/CC sphincter/NN of/IN the/DT cat/NN ./.
@@108932586290 The/DT unfolded/JJ protein/NN response/NN regulates/VBZ multiple/JJ aspects/NNS of/IN secretory/JJ and/CC membrane/NN protein/NN biogenesis/NN and/CC endoplasmic/JJ reticulum/NN quality/NN control/NN ./.
@@96968197622 The/DT resulting/VBG mutants/NNS were/VBD coexpressed/VBN with/IN gE/NEWGENE in/IN the/DT vaccinia/NN virus-based/JJ vTF7-3/NN system/NN ,/, and/CC the/DT formation/NN and/CC endoplasmic/JJ reticulum/NN (/( ER/NN )/NN -to-Golgi/NN transport/NN of/IN the/DT hetero-oligomeric/JJ complex/NN were/VBD monitored/VBN ./.
@@78065075267 Molecular/NNP dissection/NN of/IN the/DT multimeric/NEWGENE CD3-TCR/NEWGENE complex/NEWGENE revealed/VBN that/IN at/IN least/RB two/RB associated/VBN polypeptides/NNS ,/, CD3/NEWGENE zeta/NEWGENE and/CC CD3/NEWGENE epsilon/NEWGENE ,/, autonomously/RB couple/VBP antigenic/JJ recognition/NN event/NN to/IN early/JJ and/CC late/JJ events/NNS of/IN the/DT intracytoplasmic/JJ activation/NN cascade/NN ./.
@@16068736 Comparison/NNS with/IN alkaline/NEWGENE phosphatases/NEWGENE and/CC 5-nucleotidase/NEWGENE ./.
@@10207049666 The/DT GAC1/NEWGENE gene/NEWGENE encodes/VBZ the/DT regulatory/JJ subunit/NN for/IN a/DT type/NEWGENE 1/NEWGENE serine/NEWGENE //NEWGENE threonine/NEWGENE phosphoprotein/NEWGENE phosphatase/NEWGENE ,/, Glc7/NEWGENE ./.
@@15945542218 These/DT results/NNS are/VBP consistent/JJ with/IN the/DT roles/NNS that/WDT CCK/NEWGENE and/CC trypsin/NEWGENE inhibitors/NN are/VBP believed/VBN to/IN play/NN in/IN the/DT negative/JJ feedback/NN control/NN of/IN pancreatic/JJ exocrine/JJ function/NN ./.
@@72781049705 Leukocyte/NN enzyme/NN activity/NN and/CC blood/NN lymphocyte/NN blast/NN transformation/NN in/IN chronic/JJ bronchitis/NN ./.
@@63793636179 The/DT numerous/JJ tests/NNS demonstrate/VBP that/IN the/DT HDL-2M/NN can/MD be/VB extensively/RB and/CC successfully/RB used/VBN for/IN therapy/NN of/IN insulin-dependent/JJ diabetes/NN mellitus/MD in/IN clinical/JJ practice/NN ./.
@@93546762725 These/DT findings/NNS indicate/VBP that/IN the/DT t/NN (/NN 4/NN ;/: 14/NN )/NN (/NN p16/NN ./NN 3/NN ;/: q32/NN )/NN represents/VBZ a/DT novel/NN ,/, recurrent/JJ chromosomal/JJ translocation/NN in/IN MM/NN ,/, and/CC suggest/VB that/IN the/DT FGFR3/NEWGENE gene/NEWGENE may/MD be/VB the/DT target/NN of/IN this/DT abnormality/NN and/CC thus/RB contribute/VB to/IN tumorigenesis/NN in/IN MM/NNP ./NNP
@@98298438147 All/DT injections/NNS of/IN CSF/NEWGENE were/VBD given/VBP after/IN the/DT initiation/NN of/IN neutropenia/NN and/CC continued/VBN until/IN the/DT occurrence/NN of/IN an/DT absolute/JJ neutrophil/JJ recovery/NN ./. rHu/NEWGENE GM-CSF/NEWGENE and/CC rHu/NEWGENE G-CSF/NEWGENE ,/, administered/VBN once/CC daily/JJ at/IN the/DT 250/CD microg/NN m/NN (/NN -2/NN )/NN day/NN (/NN -1/NN )/NN and/CC 5/CD microg/NN kg/NN (/NN -1/NN )/NN day/NN (/NN -1/NN )/NN level/NN ,/, were/VBD effective/JJ in/IN increasing/JJ the/DT absolute/JJ neutrophil/JJ count/NN and/CC neutrophil/JJ function/NN ,/, as/IN measured/VBN by/IN an/DT automated/JJ chemiluminescence/NN system/NN ./.
@@15487562005 Stringent/JJ hybridization/NN of/IN EHS-1/NEWGENE back/NN to/IN primate/NN genomic/JJ DNA/NN indicates/VBZ two/JJ distinct/JJ EHS-1/NEWGENE loci/NEWGENE in/IN normal/JJ human/JJ DNA/NN ,/, an/DT identical/JJ band/NN pattern/NN in/IN chimpanzee/NN DNA/NN ,/, and/CC a/DT single/JJ locus/NN in/IN rhesus/NN monkey/NN DNA/NN ./.
@@75295161927 All/DT subsequent/JJ patients/NNS were/VBD treated/VBN at/IN the/DT maximal/RB tolerated/VBN dose/NN of/IN EDXR/NN (/( 35/CD mg/CD //CD m2/CD //CD day/CD )/SYM ./.
@@40413071925 The/DT results/NNS suggest/VBP that/IN the/DT calcium/NN antagonist/NN ,/, diltiazem/NN ,/, may/MD modify/VB the/DT effects/NNS of/IN isoflurane/NN on/IN myocardial/JJ function/NN ./.
@@109157284140 Twenty/CD eligible/JJ patients/NNS with/IN cirrhosis/NN were/VBD randomized/JJ into/IN two/JJ groups/NNS :/: 10/CD patients/NNS treated/VBN with/IN 6/CD million/NN units/NNS of/IN natural/NN IFN-beta/NEWGENE twice/RB a/DT week/NN for/IN 36/CD months/NNS and/CC 10/CD patients/NNS without/IN IFN/NEWGENE therapy/NN ./.
@@94188617147 The/DT multidomain/JJ structure/NN includes/VBZ a/DT cysteine-rich/JJ motif/NN resembling/VBG those/DT of/IN protein/NEWGENE kinase/NEWGENE C/NEWGENE and/CC n-chimaerin/NEWGENE and/CC a/DT putative/JJ pleckstrin/NEWGENE homology/NEWGENE domain/NEWGENE ./.
@@115251021402 For/IN the/DT sample/NN of/IN systematic/JJ reviews/VBP drawn/VBP from/IN ACP/NNP Journal/NNP Club/NNP (/( n/NN =/SYM 103/CD )/SYM ,/, the/DT PubMed/JJ strategy/NN achieved/VBD a/DT sensitivity/NN of/IN 97%/CD (/( CI/NN ,/, 91%/NN to/IN 99%/CD )/SYM ./.
@@45447049410 Method/NN of/IN synthesis/NN of/IN the/DT rheumatoid/NEWGENE factor/NEWGENE in/IN clinico-immunological/JJ studies/NNS ./.
@@67769186542 Trypanosoma/JJ cruzi/NN ./.
@@8637738601 Dangers/NNS in/IN use/NN of/IN live-virus/NN vaccines/NNS [/NN letter/NN ]/NN ./.
@@81494841117 Expression/NNS plasmids/NNS harboring/VBG full-length/NN or/CC kinase/NN domain/NN of/IN PKC/NEWGENE alpha/NEWGENE and/CC PKC/NEWGENE delta/NEWGENE (/( PKC/NEWGENE alpha/NEWGENE K/NEWGENE and/CC PKC/NEWGENE delta/NEWGENE K/NEWGENE )/SYM were/VBD constructed/VBN ./.
@@103697576666 The/DT major/JJ transcription/NN factors/NNS controlling/JJ arginine/NN metabolism/NN in/IN Escherichia/NN coli/NN and/CC Bacillus/NN subtilis/JJ ,/, ArgR/NEWGENE and/CC AhrC/NEWGENE ,/, respectively/RB ,/, are/VBP homologous/JJ multimeric/JJ proteins/NNS that/WDT form/VBP l/NN -arginine-dependent/NN DNA-binding/NN complexes/NNS capable/JJ of/IN repressing/JJ transcription/NN of/IN the/DT biosynthetic/JJ genes/NNS (/( both/DT )/SYM ,/, activating/JJ transcription/NN of/IN catabolic/JJ genes/NNS (/( AhrC/NEWGENE only/RB )/SYM or/CC facilitating/JJ plasmid/NN dimer/NN resolution/NN (/( both/DT )/SYM ./.
@@107292208842 The/DT asymmetric/JJ methylation/NN was/VBD associated/VBN with/IN tissue-specific/JJ disruption/NN of/IN H19/NEWGENE genomic/JJ imprinting/NN in/IN fetal/JJ brain/NN ./.
@@115092663950 On/IN Cox/NN proportional/JJ hazards/NNS regression/NN adenocarcinoma/NN (/( P/NNP =/NNP 0/NNP ./NNP 006/NNP )/SYM ,/, the/DT development/NN of/IN BPF/NN (/( P/NN =/NN 0/NN ./NN 003/NN )/SYM ,/, older/JJR age/NN (/( P/CD =/CD 0/CD ./CD 03/CD )/SYM and/CC higher/JJ pathological/JJ stage/NN (/( P/CD =/CD 0/CD ./CD 02/CD )/SYM were/VBD independent/JJ adverse/JJ predictors/NNS of/IN survival/NN ./.
@@86750265731 Interestingly/RB ,/, however/RB ,/, it/PRP is/VBZ homologous/JJ to/IN several/DT expressed/VBN sequence/NN tags/NNS (/( EST/NN )/SYM of/IN unknown/JJ function/NN from/IN Caenorhabditis/NNP elegans/NNS ,/, Oryza/NNP sativa/NN and/CC Homo/NN sapiens/JJ ./.
@@23357131677 A/DT poor/JJ correlation/NN was/VBD also/RB observed/VBN between/IN PbB/NN and/CC ALAD/NEWGENE activity/NN of/IN the/DT stearate/NN workers/NNS ./.
@@76089682069 Analysis/NNP of/IN several/DT Tat/NEWGENE mutants/NEWGENE indicated/VBN that/IN both/PDT the/DT cysteine-rich/JJ and/CC the/DT core/NN domains/NNS of/IN this/DT transactivator/NN are/VBP necessary/JJ and/CC sufficient/JJ to/IN activate/VB transcription/NN when/CC TBP/NEWGENE is/VBZ overexpressed/VBN ./.
@@14489323572 Rice/NEWGENE dwarf/NEWGENE phytoreovirus/NEWGENE segment/NEWGENE S12/NEWGENE transcript/NEWGENE is/VBZ tricistronic/JJ in/IN vitro/FW ./.
@@13101549902 These/DT results/NNS indicate/VBP that/IN both/PDT N-/DT and/CC C-terminal/NN mutations/NN are/VBP required/VBN to/IN inhibit/VB transrepression/NN by/IN FBR/NEWGENE protein/NEWGENE and/CC that/IN multiple/JJ structural/JJ mutations/NNS accompanied/VBN by/IN posttranslational/JJ protein/NN modification/NN alter/VB gene/NN regulation/NN by/IN FBR/NEWGENE protein/NEWGENE ./.
@@69624926728 Alveolar/JJ growth/NN ,/, contemporary/JJ with/IN dental/JJ eruption/NN ,/, is/VBZ sufficient/JJ to/IN compensate/VB possible/JJ hypotrophy/NN of/IN maxillary/JJ bone/NN bases/NNS ./.
@@93680064561 The/DT results/NNS of/IN this/DT study/NN suggest/VB that/IN NF-kappaB/NEWGENE activity/NN may/MD be/VB regulated/VBN by/IN its/PRP interaction/NN with/IN the/DT cell/NN cycle/NN regulatory/JJ protein/NN ,/, E2F-1/NEWGENE ./.
@@94174939372 In/NN accordance/NN with/IN clinical/JJ improvement/NN we/PRP found/VBP a/DT decrease/NN of/IN laboratory/NN indicators/NNS of/IN inflammation/NN (/( C-reactive/NEWGENE protein/NEWGENE ,/, alpha/NEWGENE 2-globuline/NEWGENE ,/, prostaglandin/NN E2/NN )/SYM ./.
@@10362652199 Dominant/JJ negative/JJ Sos/NEWGENE did/VBD not/RB affect/VB carbachol/NN stimulation/NN of/IN HA-ERK2/NEWGENE but/CC inhibited/VBD the/DT stimulatory/JJ effect/NN of/IN EGF/NEWGENE by/IN 60%/CD ./.
@@82190811478 The/DT PRB-1b/NEWGENE gene/NEWGENE encodes/VBZ for/IN a/DT basic-type/NN component/NN of/IN the/DT pathogenesis-related/NN PR-1/NEWGENE protein/NEWGENE family/NEWGENE ./.
@@76811479959 Two-dimensional/JJ phosphotryptic/JJ analyses/NNS indicate/VBP that/DT phosphorylation/NN on/IN Ser-12/NN and/CC Ser-48/NN in/IN unstimulated/JJ cells/NNS is/VBZ associated/VBN with/IN the/DT ability/NN of/IN overexpressed/VBN pp60c-src/NEWGENE to/IN potentiate/VB beta-adrenergic/JJ signalling/JJ ./.
@@15226992144 Methods/NNS included/VBD 24-hour/JJ dietary/JJ recall/NN ,/, menu/NN weights/NNS ,/, and/CC recipe/NN analysis/NN ./.
@@109549135520 A/DT 2/CD ./CD 3-kb/CD full-length/JJ cDNA/NN clone/NN of/IN an/DT Atlantic/NEWGENE halibut/NEWGENE Mx/NEWGENE gene/NEWGENE was/VBD isolated/VBN from/IN a/DT liver/NN cDNA/NN library/NN ./.
@@112785214578 A/DT 20-base/JJ pair/NN oligonucleotide/NN containing/JJ this/DT nonamer/NN confers/VBZ up-regulation/NN by/IN hypoxia/NN and/CC inhibition/NN by/IN unsaturated/JJ fatty/JJ acids/NNS when/CC placed/VBN upstream/RB of/IN a/DT heterologous/JJ promoter/NN in/IN a/DT lacZ/NEWGENE reporter/NEWGENE construct/NEWGENE ./.
@@13330354281 Mapping/VBG the/DT cAMP/NEWGENE receptor/NEWGENE protein/NEWGENE contact/NEWGENE site/NEWGENE on/IN the/DT alpha/NN subunit/NN of/IN Escherichia/NEWGENE coli/NEWGENE RNA/NEWGENE polymerase/NEWGENE ./.
@@102122841772 Transforming/NEWGENE growth/NEWGENE factor/NEWGENE (/NEWGENE TGF/NEWGENE )/NEWGENE -beta1/NEWGENE induces/VBZ extracellular/JJ matrix/NN deposition/NN and/CC proliferation/NN of/IN mesenchymal/JJ cells/NNS ./.
@@86384358603 Results/NNS were/VBD supported/VBN by/IN the/DT agar/NN diffusion/NN method/NN for/IN Y/NNP ./NNP enterocolitica/NN ,/, whereas/IN inhibition/NN activity/NN was/VBD not/RB found/VB for/IN A/NNP ./NNP hydrophila/NN ./.
@@97262019710 JCAHO/NN revised/VBN interpretation/NN ./.
@@30138418232 Cattaneo/NNP ,/, and/CC J/NNP ./NNP
@@303864370 These/DT data/NN suggest/VB that/IN mammalian/JJ erythroid/NN alpha-spectrin/NEWGENE evolved/VBN by/IN duplication/NN and/CC rapid/JJ divergence/NN from/IN an/DT ancestral/JJ alpha-fodrin-like/NEWGENE gene/NEWGENE ./.
@@63464277031 Immunologically/JJ reactive/NN insulin/NEWGENE levels/NNS were/VBD determined/VBN in/IN freely-moving/JJ normal/JJ rats/NNS offered/VBN three/CD different/JJ test-meals/NNS ./.
@@86608926292 Transcriptional/JJ blockade/NN was/VBD reversed/VBN by/IN co-transfections/NNS of/IN a/DT wild-type/NEWGENE SRF/NEWGENE expression/NN vector/NN ,/, but/CC was/VBD not/RB rescued/VBN by/IN the/DT expression/NN of/IN other/DT myogenic/JJ factors/NNS ,/, such/JJ as/IN MyoD/NEWGENE and/CC Mef-2C/NEWGENE ./.
@@57339525683 The/DT significance/NN of/IN structural/JJ integrity/NN of/IN lymphoid/JJ tissue/NN for/IN antibody/NN production/NN in/IN culture/NN in/IN vivo/NN ./.
@@20065586239 Displacement/NN thresholds/NNS of/IN peripheral/JJ sites/NNS in/IN monocular/JJ human/NN vision/NN were/VBD obtained/VBN ./.
@@10950398770 Losartan/DT Intervention/NN For/IN Endpoint/NNS ./.
@@36596032987 In/NN the/DT evening/NN ,/, the/DT amplitude/NN of/IN the/DT responses/NNS to/IN both/DT O2/NN and/CC CO2/NN increased/VBN but/CC the/DT increase/NN in/IN CO2/NNP sensitivity/NN was/VBD proportionally/RB more/RB important/JJ ./.
@@38066966344 The/DT lethal/JJ toxicity/NN of/IN inorganic/JJ (/( HgCl2/NN )/SYM and/CC organic/JJ (/( CH3HgCl/NN )/SYM mercury/NN chloride/NN was/VBD compared/VBN for/IN Coturnix/NNP (/( Japanese/JJ quail/NN ,/, Coturnix/NNP japonica/NN )/SYM of/IN different/JJ ages/NNS from/IN hatch/NN through/JJ adulthood/NN by/IN single-dose/JJ acute/JJ oral/JJ and/CC intramuscular/JJ injections/NNS and/CC by/IN a/DT 5-d/JJ dietary/JJ trial/NN ./.
@@68530426646 Distal/JJ tubular/JJ acidification/NN and/CC the/DT threshold/NN for/IN proximal/JJ tubular/JJ bicarbonate/NN reabsorption/NN were/VBD normal/JJ ,/, as/IN was/VBD urine/NN concentrating/JJ capacity/NN ./.
@@105749136340 By/IN negatively/RB regulating/JJ GRK-mediated/JJ receptor/NN phosphorylation/NN ,/, beta-arrestin-mediated/JJ processes/NNS such/JJ as/IN Src/NEWGENE recruitment/NN and/CC clathrin-mediated/JJ internalization/NN ,/, which/WDT are/VBP required/VBN for/IN GPCR-mediated/JJ ERK/NEWGENE activation/NN ,/, are/VBP inhibited/VBN ,/, thus/RB dampening/JJ further/JJ ERK/NEWGENE activation/NN ./.
@@113405251752 Of/IN the/DT patients/NNS in/IN each/DT regimen/NN who/WP reached/VBD study/NN end/JJ points/NNS ,/, 17/CD of/IN 29/CD (/( 59%/CD )/SYM were/VBD in/IN regimen/NN A/DT ,/, 11/CD of/IN 20/CD (/( 55%/JJ )/SYM were/VBD in/IN regimen/NN B/NNP ,/, and/CC 28/CD of/IN 43/CD (/( 65%/JJ )/SYM were/VBD in/IN regimen/NN C/NN met/NN the/DT treatment/NN success/NN criterion/NN ./.
@@108244858653 The/DT patients/NNS who/WP presented/VBD with/IN mucocutaneous/JJ disease/NN also/RB had/VBP low/VB CD4+/NEWGENE T/NN lymphocyte/NN counts/NNS ,/, and/CC most/RB of/IN them/PRP had/VBP AIDS/NN defining/VBG illnesses/NNS ./.
@@10967890802 The/DT results/NNS indicate/VBP that/IN the/DT relationship/NN between/IN comprehension/NN and/CC production/NN is/VBZ different/JJ at/IN different/JJ stages/NNS in/IN development/NN ./.
@@94829023893 C/NNP ./NNP D2-Chr/NNP 4/CD congenic/JJ strains/NNS harboring/VBG DBA/NEWGENE //NEWGENE 2/NEWGENE alleles/NEWGENE associated/VBN with/IN the/DT Pctr1/NEWGENE locus/NEWGENE contained/VBN DBA/NEWGENE //NEWGENE 2/NEWGENE "resistant"/NEWGENE alleles/NEWGENE of/IN the/DT CDK4/NEWGENE //NEWGENE CDK6/NEWGENE inhibitors/NN p16/NEWGENE and/CC p15/NEWGENE ./.
@@113093894028 We/PRP previously/RB showed/VBD that/IN this/DT proteolysis/NN 1/NN )/NN can/MD be/VB acutely/RB promoted/VBN by/IN the/DT phorbol/NN ester/NN phorbol/NN 12-myristate/JJ 13-acetate/JJ (/( PMA/NN )/SYM ,/, 2/NN )/NN requires/VBZ a/DT metalloprotease/NEWGENE activity/NN ,/, 3/NN )/NN generates/VBZ both/DT shed/NN GHBP/NEWGENE and/CC a/DT membrane-associated/NEWGENE GHR/NEWGENE transmembrane/NEWGENE //NEWGENE cytoplasmic/NEWGENE domain/NEWGENE remnant/NN ,/, and/CC 4/NN )/NN results/NNS in/IN down-regulation/NN of/IN GHR/NEWGENE abundance/NN and/CC GH/NEWGENE signaling/JJ ./.
@@108013307458 Finally/RB ,/, Cas/NEWGENE existed/VBN mainly/RB in/IN cytosol/NN and/CC membrane/NN cytoskeleton/NN fractions/NNS in/IN the/DT resting/JJ state/NN ,/, and/CC remained/VBD unchanged/JJ during/IN platelet/NN aggregation/NN ,/, when/CC FAK/NEWGENE translocated/VBN to/IN the/DT cytoskeletal/JJ fraction/NN ./.
@@3048064972 On/IN the/DT basis/NN of/IN serum/NEWGENE alpha1AT/NEWGENE quantitation/NN ,/, newborn/JJ infants/NNS may/MD be/VB separated/VBN into/IN two/JJ groups/NNS ,/, characterized/VBD respectively/RB by/IN concentrations/NNS above/RB or/CC below/RB 150/CD mg%/NN ./.
@@6270396066 Elimination/NN of/IN bagassosis/NN in/IN Louisiana/NN paper/NN manufacturing/JJ plant/NN workers/NNS ./.
@@26919982054 The/DT present/NN data/NN also/RB suggest/VB that/IN when/CC compared/VBN to/IN the/DT systemic/JJ vascular/JJ bed/NN ,/, the/DT pulmonary/JJ vascular/JJ bed/NN is/VBZ less/PRP responsive/JJ to/IN bolus/NN administration/NN of/IN ET-1/NEWGENE ./.
@@91674217838 Intracavitary/NNP irradiation/NN was/VBD carried/VBN out/RB with/IN a/DT microSelectron/NN HDR/NN afterloading/JJ device/NN and/CC usually/RB 22/CD ./CD 5/CD Gy/NN was/VBD given/VBP in/IN three/CD fractions/NNS repeated/JJ weekly/NN ./.
@@40014901562 The/DT POEMS/NN syndrome/NN (/( Polyneuropathy/NN ,/, Organomegaly/RB ,/, Endocrinopathy/NNP ,/, Monoclonal/JJ component/NN ,/, Skin/VB )/SYM ./.
@@94256768069 Neuronal/JJ mechanisms/NNS underlying/JJ stimulus-response/JJ (/( S-R/NN )/SYM associations/NNS in/IN S-R/NNP compatibility/NN tasks/NNS were/VBD identified/VBN in/IN 2/CD experiments/NNS with/IN monkeys/NNS ./.
@@88164722091 Identification/NNP of/RB Ste4/NEWGENE as/IN a/DT potential/JJ regulator/NN of/IN Byr2/NEWGENE in/IN the/DT sexual/JJ response/NN pathway/NN of/IN Schizosaccharomyces/NN pombe/NN ./.
@@108714121459 After/IN two/JJ successive/JJ rounds/NNS of/IN selection/NN by/IN focus/NN formation/NN assay/NN ,/, a/DT transforming/NEWGENE ribozyme/NEWGENE (/( Rz007/NEWGENE )/SYM was/VBD identified/VBN ./.
@@74131447253 Analysis/NNP of/IN an/DT autopsy/NN population/NN ./.
@@79366503729 This/DT work/NN unravels/VBZ a/DT new/JJ model/NN for/IN the/DT ets-1/NEWGENE //NEWGENE ets-2/NEWGENE gene's/NNS evolution/NN ,/, based/VBN for/IN the/DT first/JJ time/NN on/IN both/DT structural/JJ and/CC functional/JJ evidences/NNS ./.
@@7844142507 Molecular/NNP cloning/NN and/CC sequencing/VBG of/IN a/DT cDNA/NN encoding/VBG SR/NEWGENE beta/NEWGENE revealed/VBD that/DT SR/NEWGENE beta/NEWGENE is/VBZ a/DT transmembrane/JJ protein/NN and/CC ,/, like/JJ SR/NEWGENE alpha/NEWGENE and/CC SRP54/NEWGENE ,/, is/VBZ a/DT member/NN of/IN the/DT GTPase/NEWGENE superfamily/NEWGENE ./.
@@103798999072 The/DT major/JJ findings/NNS of/IN our/PRP studies/NNS are/VBP as/IN follows/VBZ :/: 1/NN )/NN There/EX are/VBP no/DT detectable/JJ signals/NNS around/IN GDF-9-deficient/NN follicles/NNS for/IN several/DT theca/NN cell/NN layer/NN markers/NNS [/NN i/NN ./NN e/NN ./.
@@17412491129 W/NN ./NN G/NN ./.
@@95841655581 RACK1/NEWGENE ,/, a/DT receptor/NN for/IN activated/NEWGENE C/NEWGENE kinase/NEWGENE and/CC a/DT homolog/NN of/IN the/DT beta/NN subunit/NN of/IN G/NEWGENE proteins/NEWGENE ,/, inhibits/VBZ activity/NN of/IN src/NEWGENE tyrosine/NEWGENE kinases/NEWGENE and/CC growth/NN of/IN NIH/NN 3T3/CD cells/NNS ./.
@@80878878958 The/DT polyubiquitin/NEWGENE gene/NEWGENE was/VBD transcribed/VBN throughout/IN the/PDT Volvox/DT life/NN cycle/NN with/IN peaks/NNS in/IN the/DT 1/CD ./CD 6-kb/CD mRNA/NN levels/NNS during/IN pre-cleavage/NN ,/, cleavage/NN ,/, and/CC post-inversion/JJ ./.
@@92713943595 DNase/NEWGENE I/NEWGENE and/CC 1/JJ ,/JJ 10-phenanthroline-copper/JJ footprinting/VBG of/IN MURA-Mu1/NEWGENE TIR/NEWGENE complexes/NEWGENE indicate/VBP that/IN MURA/NEWGENE binds/VBZ to/IN a/DT conserved/VBN approximately/RB 32-bp/JJ region/NN in/IN the/DT TIR/NEWGENE of/IN Mu1/NEWGENE ./.
@@8621719764 We/PRP and/CC others/NNS have/VB demonstrated/VBN that/IN the/DT c-cbl/NEWGENE proto-oncogene/NEWGENE product/NEWGENE is/VBZ one/PRP of/IN the/DT earliest/JJS targets/NNS of/IN tyrosine/NN phosphorylation/NN upon/IN T/NEWGENE cell/NEWGENE receptor/NEWGENE stimulation/NN ./.
@@25436216828 Analysis/NNP of/IN the/DT DNA/NN from/IN 15/CD cases/NNS of/IN sporadic/JJ and/CC familial/JJ Wilms'/NN tumor/NN did/VBD not/RB reveal/VB any/DT changes/NNS ,/, indicating/VBG that/IN the/DT translocation/NN breakpoint/NN does/VBP not/RB reside/VB in/IN this/DT gene/NN ./.
@@2686980601 In/NN order/NN to/IN study/NN the/DT structural/JJ and/CC functional/JJ organization/NN of/IN the/DT eukaryotic/JJ nucleolus/NN ,/, we/PRP have/VBP started/VBN to/IN isolate/NN and/CC characterize/VB nucleolar/JJ components/NNS of/IN the/DT yeast/NN Saccharomyces/NN cerevisiae/NN ./.
@@7908827819 The/DT use/NN of/IN specific/JJ antibodies/NNS allowed/VBD the/DT identification/NN of/IN at/IN least/JJ RAR/NEWGENE beta/NEWGENE in/IN some/DT of/IN the/DT DNA-protein/JJ complexes/NNS ,/, although/IN the/DT four/CD sequences/NNS bind/VBP single/JJ RARs/NEWGENE transfected/VBN in/IN COS/NN cells/NNS much/JJ less/PRP efficiently/RB ,/, or/CC not/RB at/IN all/DT ,/, when/CC compared/VBD to/IN a/DT canonical/JJ RAR/NEWGENE responsive/NEWGENE element/NEWGENE ./.
@@108914892801 Although/IN increased/VBN expression/NN of/IN the/DT HMG-I/NEWGENE //NEWGENE Y/NEWGENE proteins/NEWGENE is/VBZ associated/VBN with/IN cellular/JJ proliferation/NN ,/, neoplastic/JJ transformation/NN ,/, and/CC several/DT human/JJ cancers/NNS ,/, the/DT role/NN of/IN these/DT proteins/NNS in/IN the/DT pathogenesis/NN of/IN malignancy/NN remains/VBP unclear/JJ ./.
@@75681161602 The/DT hydropathy/NN plot/NN revealed/VBD a/DT rather/RB hydrophilic/NN N-terminal/NN region/NN and/CC the/DT absence/NN of/IN a/DT hydrophobic/JJ signal/JJ peptide/NN ./.
@@86178024732 These/DT results/NNS demonstrate/VBP that/IN sequences/NNS in/IN the/DT SH2/NEWGENE //NEWGENE SH3/NEWGENE //NEWGENE SH2/NEWGENE region/NEWGENE of/IN p120/NEWGENE GAP/NEWGENE are/VBP required/VBN for/IN full/JJ catalytic/JJ activity/NN toward/IN Ras/NEWGENE ./.
@@105720873872 We/PRP have/VBP isolated/VBN a/DT binding/JJ partner/NN for/IN the/DT Fanconi/NEWGENE anemia/NEWGENE group/NEWGENE C/NEWGENE protein/NEWGENE (/( FANCC/NEWGENE )/SYM by/IN yeast/NN two-hybrid/JJ screening/NN ./.
@@22135668665 The/DT effects/NNS of/IN coenzyme/NEWGENE Q10/NEWGENE (/( CoQ/NEWGENE )/SYM and/CC captopril/NN on/IN functional/JJ capacity/NN ,/, hemodynamics/NN and/CC survival/NN were/VBD studied/VBN in/IN 154/CD rats/NNS that/WDT recovered/VBD after/IN experimental/JJ myocardial/JJ infarction/NN ./.
@@115171907794 Novel/NN intronic/JJ promoter/NN in/IN the/DT rat/NEWGENE ER/NEWGENE alpha/NEWGENE gene/NEWGENE responsible/JJ for/IN the/DT transient/JJ transcription/NN of/IN a/DT variant/NN receptor/NN ./.
@@105313343522 In/NN assays/NNS with/IN purified/VBN enzymes/NNS ,/, wild-type/NN but/CC not/RB PTPS-S19A/NEWGENE was/VBD a/DT specific/JJ substrate/NN for/IN the/DT cGMP-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE (/NEWGENE cGK/NEWGENE )/NEWGENE type/NEWGENE I/NEWGENE and/NEWGENE II/NNS ./NNS
@@79130803718 A/DT decanucleotide/NN promoter/NN sequence/NN homologous/JJ to/IN those/DT found/VB in/IN humans/NNS and/CC mice/NNS was/VBD located/VBN in/IN the/DT 5'/CD untranslated/JJ region/NN of/IN one/PRP horse/NN gene/NN ./.
@@97386938345 Effects/NNPS of/IN rhG-CSF/NEWGENE on/IN neutrophil/JJ functions/NNS and/CC survival/NN in/IN sepsis/NN induced/VBD diabetic/JJ rats/NNS ./.
@@100712054924 Each/DT of/IN these/DT genes/NNS contains/VBZ a/DT putative/JJ upstream/JJ ORF/NN ,/, while/CC STA2/NEWGENE has/VBZ two/JJ additional/JJ in-frame/NN AUG/NNS codons/NNS 5'/CD to/IN the/DT major/JJ cistron/NN ./.
@@95381561524 BRCA1/NEWGENE protein/NEWGENE contains/VBZ an/DT amino-terminal/NN zinc/NN finger/NN motif/NN and/CC a/DT carboxy-terminal/JJ acidic/NN region/NN ./.
@@81609053077 Eleven/CD patients/NNS tested/VBD positive/JJ for/IN the/DT hepatitis/NEWGENE B/NEWGENE surface/NEWGENE antigen/NEWGENE (/( HBsAg/NEWGENE )/SYM ./.
@@97971891978 Gel-mobility/NNP shift/NN analysis/NN was/VBD also/RB performed/VBN for/IN the/DT CCAAT/NN motif/NN at/IN -67/CD ./.
@@68268136611 Vesicles/NNS could/MD be/VB induced/VBN only/RB with/IN multiple/JJ exposures/NNS to/IN UVA/NN ./.
@@103641634718 Hrs/NEWGENE has/VBZ a/DT FYVE/NEWGENE double/NEWGENE zinc/NEWGENE finger/NEWGENE domain/NEWGENE ,/, which/WDT specifically/RB binds/VBZ phosphatidylinositol/NN (/NN 3/NN )/NN -phosphate/NN and/CC is/VBZ conserved/VBN in/IN several/DT proteins/NNS involved/VBN in/IN vesicular/JJ traffic/NN ./.
@@9334475671 PATIENTS/IN AND/CC METHODS/IN :/: In/NN 807/CD consecutive/JJ patients/NNS from/IN the/DT Chilean/JJ National/NNP Registry/NNP of/IN Acute/JJ Myocardial/JJ Infarction/NNS we/PRP analyzed/VBD the/DT resolution/NN of/IN chest/NN pain/NN and/CC ST/NN segment/NN elevation/NN over/RB 50%/CD within/IN the/DT first/JJ 90/CD min/NN ,/, abrupt/JJ CK/NN rise/NN within/IN 8/CD h/NN and/CC T/NN wave/NN inversion/NN in/IN infarct/NN related/VBD EKG/NN leads/VBP within/IN the/DT first/JJ 24/CD h/NN after/IN thrombolysis/NN ./.
@@106724339208 For/IN each/DT night/NN ,/, the/DT diary/NN allowed/VBD the/DT subjective/JJ measurement/NN of/IN bedtime/NN ,/, wake/NN time/NN ,/, time/NN in/IN bed/NN (/( TIB/NN )/SYM ,/, sleep/NN efficiency/NN ,/, number/NN of/IN minutes/NNS of/IN wake/NN after/IN sleep/NN onset/NN (/( WASO/NNP )/SYM ,/, alertness/NN on/IN awakening/NN ,/, and/CC percentage/NN of/IN morning/NN needing/VBG an/DT alarm/NN (/( or/CC a/DT person/NN functioning/NN as/IN one/PRP )/SYM ./.
@@30608466968 Mutational/JJ analysis/NN of/IN the/DT L1/NEWGENE binding/NEWGENE site/NEWGENE of/IN 23S/NEWGENE rRNA/NEWGENE in/NEWGENE Escherichia/NEWGENE coli/NEWGENE ./.
@@10600171808 We/PRP propose/VBP that/IN the/DT reduced/VBN responsiveness/NN of/IN CYP3A2/NEWGENE is/VBZ the/DT result/NN of/IN preferential/JJ binding/NN of/IN COUP-TF/NEWGENE at/IN the/DT CYP3A2/NEWGENE DexRE-1/NEWGENE site/NEWGENE ./.
@@81704007977 Location/NNP and/CC orientation/NN of/IN an/DT activating/NN region/NN in/IN the/DT Escherichia/NN coli/JJ transcription/NN factor/NN ,/, FNR/NEWGENE ./.
@@61313786491 (/( iii/NN )/SYM The/DT mRNA/NN is/VBZ not/RB efficiently/RB polyadenylated/JJ at/IN sequences/NNS in/IN the/DT 3'/CD end/NN of/IN the/DT DHFR/NEWGENE cDNA/NEWGENE but/CC rather/RB uses/VBZ polyadenylation/NN signals/NNS downstream/RB from/IN the/DT DHFR/NEWGENE cDNA/NEWGENE ./.
@@115961042095 Northern/NNP blot/NN analysis/NN with/IN one/PRP of/IN the/DT PARNAs/NEWGENE revealed/VBD a/DT highly/RB abundant/JJ signal/NN of/IN approximately/RB 2/CD ./CD 0/CD kilobases/NNS (/( kb/NN )/SYM present/VB in/IN all/DT cell/NN lines/NNS tested/VBN ./.
@@90533095256 Therefore/RB ,/, the/DT impaired/VBN floor/NN plate/NN development/NN in/IN oep/NEWGENE mutants/NEWGENE is/VBZ not/RB caused/VBN by/IN the/DT absence/NN of/IN the/DT floor/NEWGENE plate/NEWGENE inducer/NEWGENE shh/NEWGENE ./.
@@13098602846 The/DT cellular/JJ sequences/NNS 5'/CD to/IN the/DT viral/NN integration/NN site/NN exhibited/VBN 85/CD to/IN 97%/NN identity/NN to/IN several/DT sequences/NNS belonging/NN to/IN the/DT mouse/NEWGENE L1/NEWGENE family/NEWGENE of/IN long/JJ interspersed/JJ repetitive/JJ sequences/NNS ./.
@@11054539920 The/DT gene/NN is/VBZ separated/VBN into/IN four/CD exons/NNS by/IN three/CD short/JJ introns/NNS ,/, and/CC the/DT open/JJ reading/JJ frame/NN consists/VBZ of/IN 6660/CD base/NN pairs/NNS (/( bp/NN )/SYM capable/JJ of/IN encoding/VBG a/DT polypeptide/NN of/IN 2220/CD amino/JJ acid/NN residues/NNS ./.
@@13243857379 METHODS/IN :/: IgG/NEWGENE antibodies/NEWGENE vs/NNP HHV-6/IN (/( anti-HHV-6-IgG/NEWGENE )/SYM were/VBD determined/VBN by/IN indirect/JJ immunofluorescence/NN in/IN 100/CD IVDA/NN (/( 29/CD seronegative/JJ and/CC 71/CD seropositive/JJ for/IN HIV-1/NNP of/IN which/WDT 45/CD were/VBD in/IN stage/NN II/NNP and/CC 26/CD in/IN IV-C1/NNP of/IN CDC/NN )/SYM as/RB well/VB as/IN in/IN 100/CD healthy/JJ subjects/NNS of/IN a/DT similar/JJ age/NN (/( control/NN group/NN )/SYM ./.
@@105565957768 An/DT analysis/NN of/IN sequence/NN of/IN the/DT mutant/NEWGENE recN/NEWGENE gene/NEWGENE revealed/VBD a/DT G/NN :/: C/NN to/IN T/NN :/: A/DT transversion/NN near/IN the/DT 3'/CD end/NN of/IN the/DT coding/JJ region/NN ./.
@@91991676895 Overexpression/NNS of/IN Sed5p/NEWGENE allowed/VBN growth/NN in/IN the/DT absence/NN of/IN Vti1p/NEWGENE ./.
@@17368442315 Testosterone/IN ,/, free/JJ testosterone/NN ,/, non-sex/NN hormone-binding/JJ globulin-bound/JJ testosterone/NN ,/, and/CC free/JJ androgen/NN index/NN :/: which/WDT testosterone/NN measurement/NN is/VBZ most/RB relevant/JJ to/IN reproductive/JJ and/CC sexual/JJ function/NN in/IN men/NNS with/IN epilepsy/NN ?/.
@@6351942682 Kodak/NN XV-2/NN film/NN is/VBZ wrapped/VBN around/IN a/DT cylindrical/JJ water-filled/JJ phantom/NN and/CC the/DT dose/NN distribution/NN is/VBZ recorded/VBN ./.
@@2763467950 When/WRB two-dimensional/JJ polyacrylamide/NN gel/NN electrophoretic/JJ patterns/NNS of/IN [/NN 35S/NN ]/NN methionine-labeled/NN proteins/NNS secreted/VBN from/IN cells/NNS infected/VBN with/IN parental/JJ and/CC recombinant/JJ viruses/NNS were/VBD compared/VBN ,/, a/DT spot/JJ missing/JJ from/IN the/DT latter/RB corresponded/VBN in/IN molecular/JJ weigh/VB and/CC isoelectric/JJ point/NN with/IN that/DT predicted/VBD from/IN the/DT N1L/NEWGENE ORF/NEWGENE ./.
@@111088395423 T/NN cells/NNS express/VBP two/JJ isoforms/NNS of/IN S6k1/NEWGENE :/: a/DT 70/NEWGENE kDa/NEWGENE cytoplasmic/NEWGENE kinase/NEWGENE and/CC an/DT 85/NN kDa/NN isoform/NN that/WDT has/VBZ a/DT classic/JJ nuclear/JJ localisation/NN ./.
@@105176755941 Western/JJ blot/NN analysis/NN showed/VBD a/DT rapid/JJ corresponding/JJ increase/NN in/IN p21WAF1/NEWGENE //NEWGENE CIP1/NEWGENE protein/NEWGENE ,/, whereas/IN protein/NN levels/NNS of/IN another/DT member/NN of/IN the/DT cyclin-dependent/NEWGENE kinase/NEWGENE inhibitor/NEWGENE family/NEWGENE ,/, p27kip1/NEWGENE ,/, were/VBD unchanged/JJ ./.
@@1150091349 C/NEWGENE //NEWGENE EBPbeta/NEWGENE LIP/NEWGENE overexpressing/JJ HC11/NNP cells/NNS did/VBD not/RB express/VB beta-casein/NEWGENE mRNA/NEWGENE (/( mammary/JJ epithelial/JJ cell/NN differentiation/NN marker/NN )/SYM in/IN response/NN to/IN lactogenic/JJ hormones/NNS ./.
@@57929119603 Effects/NNPS of/IN beta-adrenergic/NEWGENE receptor/NEWGENE blockade/NN on/IN airway/NN conductance/NN and/CC lung/NN volume/NN in/IN normal/JJ and/CC asthmatic/JJ subjects/NNS ./.
@@97294814744 Co-transfection/NNS of/IN the/DT Sp1/NEWGENE expression/NN plasmid/NN and/CC the/DT -58/NN promoter/NN construct/NN into/IN Drosophila/NN Schneider/NN cells/NNS revealed/VBN that/IN Sp1/NEWGENE contributed/VBN to/IN the/DT kinase/NEWGENE basal/NEWGENE promoter/NEWGENE activity/NN by/IN binding/JJ to/IN the/DT non-consensus/NN site/NN in/IN the/DT -58/CD region/NN ./.
@@6815716593 Incidental/JJ findings/NNS in/IN the/DT epidermis/NN and/CC in/IN the/DT intraepidermal/JJ eccrine/JJ sweat/NN duct/NN units/NNS ./.
@@106715196547 Protein/NN sequence/NN analysis/NN reveals/VBZ that/IN MAN1/NEWGENE shares/VBP a/DT conserved/VBN globular/JJ domain/NN of/IN approximately/RB 40/CD amino/JJ acids/NNS ,/, which/WDT we/PRP term/VBP the/DT LEM/NEWGENE module/NEWGENE ,/, with/IN inner/JJ nuclear/JJ membrane/NN proteins/NNS lamina-associated/NEWGENE polypeptide/NEWGENE 2/NEWGENE and/CC emerin/NEWGENE ./.
@@76705046912 This/DT shows/VBZ that/IN the/DT characteristically/RB diffuse/JJ banding/JJ pattern/NN of/IN plant/NN nuclear/JJ proteins/NNS interacting/VBG with/IN the/DT G-box/NN is/VBZ also/RB observed/VBN in/IN a/DT binding/JJ assay/NN using/VBG only/RB one/PRP recombinant/NEWGENE GBF/NEWGENE ./.
@@91993537928 Based/VBN on/IN these/DT results/NNS and/CC because/IN Cdc68/NEWGENE has/VBZ been/VBN implicated/VBN as/IN a/DT regulator/NN of/IN chromatin/NN structure/NN ,/, we/PRP postulate/VBP that/DT polymerase/NEWGENE alpha/NEWGENE may/MD interact/VB with/IN these/DT proteins/NNS to/IN gain/NN access/NN to/IN its/PRP template/NN or/CC to/IN origins/NNS of/IN replication/NN in/IN vivo/NN ./.
@@89772357287 Mutants/NNS lacking/VBG any/DT tyrosine/NN residues/NNS in/IN the/DT cytoplasmic/JJ domain/NN maintain/VB their/PRP ability/NN to/IN activate/VB STAT5/NEWGENE and/CC STAT1/NEWGENE but/CC cannot/MD activate/VB STAT3/NEWGENE ,/, implying/VBG that/IN STAT5/NEWGENE and/CC STAT1/NEWGENE activation/NN does/VBP not/RB require/VB receptor/NN tyrosine/NN phosphorylation/NN ./.
@@97338151311 Tyrosine/NN 112/CD of/IN latent/NEWGENE membrane/NEWGENE protein/NEWGENE 2A/NEWGENE is/VBZ essential/JJ for/IN protein/NEWGENE tyrosine/NEWGENE kinase/NEWGENE loading/NN and/CC regulation/NN of/IN Epstein-Barr/NNP virus/NN latency/NN ./.
@@50838723692 The/DT status/NN of/IN education/NN and/CC training/NN programs/NNS in/IN speech/NN pathology/NN and/CC audiology--1971-72/NN ./.
@@108690761981 These/DT results/NNS support/NN the/DT hypothesis/NN that/IN in/IN the/DT presence/NN of/IN tryptophan/NN the/DT ribosome/NN translating/JJ tnaC/NEWGENE blocks/NNS Rho's/NNP access/NN to/IN the/DT boxA/NEWGENE and/CC rut/NEWGENE sites/NEWGENE ,/, thereby/RB preventing/JJ transcription/NN termination/NN ./.
@@26855652737 Recently/RB ,/, an/DT alternatively/RB spliced/VBN form/NN of/IN c-myb-encoded/NEWGENE mRNA/NEWGENE has/VBZ been/VBN identified/VBN in/IN murine/JJ cells/NNS containing/JJ either/DT normal/JJ or/CC rearranged/JJ c-myb/NEWGENE genes/NEWGENE ./.
@@94439485592 A/DT comparative/JJ study/NN was/VBD undertaken/VBP between/IN an/DT enzymatic/JJ immunohistochemical/JJ technique/NN (/( EIT/IN )/SYM developed/VBN for/IN the/DT diagnosis/NN of/IN human/JJ trichinellosis/NN and/CC the/DT indirect/JJ immunofluorescence/NN test/NN (/( IIF/NN )/SYM ,/, analysing/VBG sera/NNS from/IN outbreaks/NNS of/IN human/JJ trichinellosis/NN in/IN Argentina/NN ./.
@@98194403669 Endogenous/JJ RMP/NEWGENE was/VBD immunologically/RB detected/VBN interacting/VBG with/IN assembled/VBN RPB5/NEWGENE in/IN RNA/NEWGENE polymerase/NEWGENE in/IN mammalian/JJ cells/NNS ./.
@@77084979022 Transcriptional/JJ activation/NN by/IN thyroid/JJ hormone/NN (/( T3/NN )/SYM requires/VBZ interactions/NNS between/IN the/DT T3/NEWGENE receptor/NEWGENE (/( TR/NEWGENE )/SYM and/CC T3/NEWGENE response/NEWGENE elements/NEWGENE (/( TREs/NEWGENE )/SYM composed/VBN of/IN two/JJ copies/NNS of/IN sequences/NNS related/VBN to/IN AGGTCA/NEWGENE ./.
@@19105052537 Fufang/NNP wuzi/NN yanzong/NN pills/NNS have/VBP strong/JJ leukogenic/JJ effect/NN on/IN cyclophosphamide/NN induced/VBD leukopenia/NN in/IN mice/NNS ./.
@@84295685397 Rhizobium/NN meliloti/NN large/JJ plasmid/NN pRmeGR4b/NN carries/VBZ the/DT nodulation/NN competitiveness/NN locus/NN nfe/NEWGENE responsible/JJ for/IN the/DT nodulation/NN efficiency/NN and/CC competitive/JJ ability/NN of/IN strain/NN GR4/CELL on/IN alfalfa/NN roots/NNS ./.
@@90069359981 Sp1/NEWGENE binds/VBZ the/DT CTC/NN repeat/NN with/IN an/DT affinity/NN ,/, KD/NN =/SYM 0/CD ./CD 37/CD nM/NN ,/, at/RB least/RB as/RB high/JJ as/IN the/DT consensus/NN GC/NN box/NN ./.
@@8105994219 Clinical/NNP aspects/NNS of/IN early/JJ increase/NN in/IN serum/JJ gamma-glutamyl/NEWGENE transferase/NEWGENE in/IN cerebral/JJ infarction/NN ./.
@@25501183204 However/RB ,/, bilateral/JJ diffuse/JJ pulmonary/JJ infiltrations/NNS developed/VBN 21/CD days/NNS later/JJR ./.
@@107715287759 A/DT cause/NN of/IN increase/NN of/IN alkaline/NEWGENE phosphatase/NEWGENE in/IN children/NNS ./.
@@76728213795 The/DT physical/JJ linkage/NN of/IN the/DT FHR2/NEWGENE and/CC the/DT factor/NEWGENE H/NEWGENE genes/NEWGENE provides/VBZ additional/JJ evidence/NN for/IN a/DT close/JJ relatedness/NN of/IN complement/NEWGENE factor/NEWGENE H/NEWGENE and/CC the/DT factor/NEWGENE H-related/NEWGENE proteins/NEWGENE ./.
@@104908351954 Protein/NEWGENE kinase/NEWGENE A-Ialpha/NEWGENE subunit-directed/JJ antisense/NN inhibition/NN of/IN ovarian/JJ cancer/NN cell/NN growth/NN :/: crosstalk/NN with/IN tyrosine/NEWGENE kinase/NEWGENE signaling/JJ pathway/NN ./.
@@14804705525 BiP670/NEWGENE retains/VBZ basal/JJ and/CC Ca2+/NN ionophore/NN A23187-inducible/NNP activities/NNS ./.
@@101878422032 This/DT is/VBZ in/IN contrast/NN to/IN PPARgamma2/NEWGENE ,/, which/WDT was/VBD previously/RB shown/VBP to/IN be/VB phosphorylated/VBN at/IN a/DT single/JJ site/NN in/IN a/DT motif/NN that/WDT is/VBZ not/RB homologous/JJ to/IN the/DT sites/NNS now/RB described/VBN in/IN PPARalpha/NEWGENE ./.
@@25755673228 Materials/NNPS science/NN studies/NNS on/IN the/DT soldering/JJ of/IN different/JJ orthodontic/JJ wires/NNS ./.
@@112891493733 Also/RB ,/, the/DT EWS/NEWGENE protein/NEWGENE stimulates/VBZ transcription/NN mediated/JJ by/IN the/DT COOH-terminal/NN transactivation/NN domain/NN of/IN the/DT cofactor/NN CREB-binding/NEWGENE protein/NEWGENE (/( CBP/NEWGENE )/SYM ./.
@@93263179677 This/DT is/VBZ the/DT first/JJ study/NN in/IN which/WDT mutation/NN screening/NN has/VBZ been/VBN performed/VBN for/IN both/PDT the/DT EXT1/NEWGENE and/CC EXT2/NEWGENE genes/NEWGENE prior/NN to/IN any/DT linkage/NN analysis/NN ./.
@@23337498473 In/NN a/DT stepwise/JJ logistic/JJ regression/NN analysis/NN of/IN SPT/NN and/CC RAST/NN data/NN ,/, the/DT occurrence/NN of/IN serum/NEWGENE IgE/NEWGENE antibodies/NEWGENE to/NEWGENE P/NEWGENE ./NEWGENE orbiculare/NEWGENE had/VBP the/DT highest/JJS explanatory/JJ value/NN for/IN current/JJ eczema/NN ./.
@@84609185126 Group/NNP I/PRP consisted/VBP of/IN six/CD noncholestatic/JJ patients/NNS ;/: group/NN II/NNP consisted/VB of/IN nine/JJ mildly/RB cholestatic/JJ patients/NNS with/IN mild/JJ hepatic/JJ impairment/NN (/( conjugated/NN bilirubin/NN ,/, 47/CD mumol/NN liter-1/NN ;/: alkaline/NEWGENE phosphatase/NEWGENE ,/, 280/CD IU/NN liter-1/NN ;/: gamma-glutamyltranspeptidase/NEWGENE ,/, 190/CD IU/NN liter-1/NN )/SYM ;/: group/NN III/NNP consisted/VB of/IN six/CD benign/JJ intrahepatic/JJ cholestatic/JJ patients/NNS with/IN high/RB isolated/VBN conjugated/JJ hyperbilirubinemia/NN (/( 98/CD ./CD 1/CD mumol/NN liter-1/NN )/SYM ./.
@@53943525523 Genitography/NNP in/IN intersexual/JJ states/NNS ./.
@@78441553315 To/TO understand/VB the/DT function/NN of/IN receptor-linked/NEWGENE tyrosine/NEWGENE phosphatases/NEWGENE in/IN neural/JJ development/NN ,/, we/PRP sought/VBP to/IN identify/VB LAR/NEWGENE isoforms/NEWGENE preferentially/RB expressed/VBN in/IN the/DT nervous/JJ system/NN and/CC cellular/JJ processes/NNS regulating/JJ LAR/NEWGENE alternative/JJ splicing/JJ ./.
@@84358858397 There/EX was/VBD a/DT positive/JJ correlation/NN between/IN pyridinium/NN cross-link/NN excretion/NN and/CC thyroid/JJ hormone/NN concentrations/NNS ./.
@@28330497349 An/DT analysis/NN of/IN the/DT steady/JJ state/NN RNA/NN levels/NNS in/IN T-lymphoid/JJ cell/NN lines/NNS showed/VBN that/IN at/IN least/RB three/CD different/JJ incomplete/JJ proviral/JJ transcripts/NNS and/CC their/PRP spliced/VBN products/NNS made/VBP up/VB the/DT majority/NN of/IN expressed/VBN RD-114/NEWGENE mRNA/NEWGENE ,/, and/CC further/RB demonstrated/VBN that/IN partially/RB deleted/VBN proviral/JJ loci/NNS have/VBP the/DT potential/NN to/IN be/VB transcriptionally/NN vigorous/NN in/IN certain/JJ feline/JJ cell/NN types/NNS ./.
@@108724732840 The/DT ATR-X/NNP syndrome/NN results/NNS from/IN mutations/NNS of/IN the/DT XH2/NEWGENE gene/NEWGENE ,/, located/VBN on/IN the/DT X/NN chromosome/NN (/( Xq13/NNP ./NNP 3/NNP )/SYM and/CC coding/JJ for/IN a/DT transacting/JJ factor/NN which/WDT regulates/VBZ gene/NN expression/NN ./.
@@98801039140 MPO/NN was/VBD labeled/JJ with/IN 1/NN mCi/NN 125I/NN by/IN a/DT technique/NN of/IN self-labeling/JJ in/IN the/DT presence/NN of/IN 10/NN (/NN -4/NN )/NN M/NN hydrogen/NN peroxide/NN ./.
@@84300956197 These/DT data/NN establish/VB Smd1p/NEWGENE as/IN a/DT required/VBN component/NN of/IN the/DT cellular/JJ splicing/JJ apparatus/NN and/CC a/DT factor/NN in/IN snRNA/NN maturation/NN and/CC stability/NN ./.
@@10751583570 Erratum/NNP to/IN :/: corticostriatal/JJ and/CC corticosubthalamic/JJ input/NN zones/NNS from/IN the/DT presupplementary/JJ motor/JJ area/NN in/IN the/DT macaque/NN monkey/NN :/: comparison/NN with/IN the/DT input/NN zones/NNS from/IN the/DT supplementary/JJ motor/JJ area/NN ./.
@@95496329184 Their/PRP use/NN resulted/VBN in/IN a/DT sensitivity/NN of/IN 73%/JJ and/CC a/DT specificity/NN of/IN 74%/JJ with/IN regard/NN to/IN predictability/NN of/IN ALT/NEWGENE levels/NNS increasing/JJ during/IN the/DT trial/NN ./.
@@109252072741 It/PRP contains/VBZ 25/CD exons/NNS coding/JJ for/IN a/DT 4/NN ./NN 7kb/NN transcript/NN including/JJ large/JJ 5'-/JJ and/CC 3'-/JJ (/( 1218bp/NN and/CC 701bp/NN ,/, respectively/RB )/SYM untranslated/JJ regions/NNS (/( UTRs/NNS )/SYM ./.
@@16531731783 This/DT repression/NN was/VBD mediated/JJ through/RB binding/JJ to/IN the/DT E2/NEWGENE DNA-binding/NEWGENE site/NEWGENE immediately/RB upstream/RB of/IN the/DT P105/NEWGENE promoter/NN TATA/NN box/NN and/CC could/MD be/VB abrogated/VBN by/IN preincubation/NN of/IN the/DT HPV-18/NEWGENE P105/NEWGENE promoter/NEWGENE template/NN with/IN the/DT nuclear/JJ extract/NN allowing/VBG the/DT formation/NN of/IN the/DT preinitiation/JJ complex/NN ./.
@@88558043484 These/DT results/NNS were/VBD corroborated/VBN in/IN a/DT subsequent/JJ study/NN in/IN which/WDT 30/CD hypogonadal/JJ men/NNS were/VBD supplemented/VBN with/IN SLT/NN 5/NN mg/NN three/CD times/NNS daily/JJ for/IN 6/CD months/NNS ./.
@@77823025330 We/PRP demonstrate/VBP here/RB that/IN the/DT -DEDDDL/NEWGENE sequence/NEWGENE stabilizes/VBZ GDP/NN binding/JJ to/IN Ran/NEWGENE ,/, and/CC that/IN the/DT domain/NN is/VBZ required/VBN for/IN high/JJ affinity/NN interaction/NN with/IN a/DT Ran-binding/NEWGENE protein/NEWGENE ,/, HTF9A/NEWGENE //NEWGENE RanBP1/NEWGENE ./.
@@80638361183 We/PRP conclude/VBP that/IN c-Abl/NEWGENE activates/VBZ c-myc/NEWGENE transcription/NN indirectly/RB with/IN no/DT requirement/NN for/IN DNA/NN binding/JJ by/IN c-Abl/NEWGENE ./.
@@93715962494 Differential/JJ regulation/NN of/IN the/DT pre-C/JJ and/CC pregenomic/JJ promoters/NNS of/IN human/NN hepatitis/NN B/NN virus/NN by/IN members/NNS of/IN the/DT nuclear/NEWGENE receptor/NEWGENE superfamily/NEWGENE ./.
@@101026275009 Despite/IN this/DT DNA/NN binding/JJ activity/NN ,/, AP-1/NEWGENE reporter/NEWGENE activity/NN was/VBD suppressed/VBN in/IN these/DT cells/NNS ./.
@@106697516770 Multiple/NNP mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE signaling/JJ pathways/NNS connect/VBP the/DT cot/NEWGENE oncoprotein/NEWGENE to/IN the/DT c-jun/NEWGENE promoter/NEWGENE and/CC to/IN cellular/JJ transformation/NN ./.
@@8253387769 Inspection/NNP of/IN enhancer/NN mutants/NNS suggests/VBZ that/DT trans-activation/NN by/IN hLEF/NEWGENE //NEWGENE GAL4/NEWGENE is/VBZ especially/RB dependent/JJ on/IN TCF-2/NEWGENE ,/, a/DT distinct/JJ T-cell-enriched/JJ protein/NN that/WDT binds/VBZ to/IN sequences/NNS flanking/JJ the/DT hLEF-binding/NEWGENE site/NEWGENE in/IN the/DT enhancer/NN ./.
@@92714967907 Mapping/NN features/NNS of/IN HIV-1/NEWGENE integrase/NEWGENE near/IN selected/VBN sites/NNS on/IN viral/JJ and/CC target/NN DNA/NN molecules/NNS in/IN an/DT active/JJ enzyme-DNA/NN complex/NN by/IN photo-cross-linking/NN ./.
@@93342647427 Surprisingly/RB ,/, calf/NEWGENE thymus/NEWGENE CstF/NEWGENE contained/VBN an/DT additional/JJ ,/, novel/JJ form/NN of/IN the/DT 64-kDa/NN subunit/NN with/IN a/DT molecular/JJ mass/NN of/IN 70/CD kDa/NN ./.
@@22536632886 The/DT circadian/JJ rhythm/NN ,/, however/RB ,/, was/VBD not/RB affected/VBN and/CC the/DT difference/NN between/IN minimum/JJ (/( 12/CD ./CD 00/CD h/NN )/SYM and/CC maximum/JJ (/( 18/CD ./CD 50/CD h/NN )/SYM serum/JJ concentrations/NNS was/VBD 31/CD ./CD 3%/CD ./.
@@89188108219 In/NN vitro/NN DNase/NEWGENE I/NEWGENE footprinting/VBG showed/VBN that/IN OxyR-C199S/NEWGENE protected/VBN Pmom/NEWGENE from/IN -104/CD to/IN -46/CD on/IN the/DT top/JJ strand/NN and/CC produced/VBD a/DT protection/NN pattern/NN characteristic/NN of/IN reduced/NEWGENE wild-type/NEWGENE OxyR/NEWGENE ./.
@@89001904119 Growth/NEWGENE factors/NEWGENE induce/VBP the/DT expression/NN of/IN the/DT immediate/NEWGENE early/NEWGENE gene/NEWGENE products/NEWGENE MAP/NEWGENE1 kinase/NEWGENE1 phosphatase-1/NEWGENE1 (/( MKP-1/NEWGENE )/SYM ,/, c-Fos/NEWGENE and/CC c-Jun/NEWGENE ./.
@@33514788482 There/EX are/VBP regions/NNS with/IN long/JJ runs/VBP of/IN up/JJ to/IN 45%/JJ C/NN or/CC 35%/JJ G/NN residues/NNS ./.
@@28220813520 7/CD ./CD
@@93722873155 Three/CD monopolar/JJ electrodes/NNS were/VBD inserted/VBN into/IN the/DT left/JJ and/CC right/JJ lateral/JJ vestibulospinal/JJ tract/NN (/( LVST/NNP )/SYM and/CC medial/JJ vestibulospinal/JJ tract/NN (/( MVST/NNP )/SYM of/IN the/DT C1/NN segment/NN ,/, to/IN determine/VB the/DT pathway/NN of/IN axons/NNS ./.
@@27116011742 The/DT corresponding/JJ inhibition/NN of/IN acid/NEWGENE phosphatase/NEWGENE activity/NN in/IN control/NN male/JJ and/CC female/JJ guinea/NN pigs/NNS was/VBD 15/CD ./CD 91%/CD and/CC 20/CD ./CD 33%/CD respectively/RB ./.
@@18464894743 It/PRP also/RB contains/VBZ a/DT picornaviral/NEWGENE 3C-like/NEWGENE protease/NEWGENE domain/NEWGENE and/CC two/JJ papain-like/NEWGENE protease/NEWGENE domains/NEWGENE ./.
@@5749565692 It/PRP is/VBZ concluded/VBN that/DT stereotypy/NN can/MD be/VB evoked/VBN also/RB in/IN the/DT case/NN when/CC the/DT striatal/JJ dopaminergic/JJ tone/NN is/VBZ normal/JJ or/CC even/VB below/RB normal/JJ :/: it/PRP is/VBZ the/DT equilibrium/NN of/IN the/DT striatal/JJ cholinergic-dopaminergic/JJ systems/NNS which/WDT must/MD be/VB shifted/VBN towards/IN dopamine/NN ,/, which/WDT is/VBZ necessary/JJ for/IN the/DT development/NN of/IN this/DT behavioral/JJ manifestation/NN ./.
@@81084132136 All/PDT other/DT normal/JJ and/CC transformed/VBN lymphoid/JJ and/CC nonlymphoid/JJ cell/NN lines/NNS and/CC normal/JJ tissues/NNS were/VBD negative/JJ for/IN PANG/NEWGENE expression/NN except/VB for/IN the/DT brain/NN ,/, wherein/CC unique/JJ 4/CD ./CD 0-/CD and/CC 6/CD ./CD 1-kb/CD transcripts/NNS were/VBD detected/VBN ./.
@@95602212791 A/DT cDNA/NN ,/, cak1At/NEWGENE ,/, was/VBD isolated/VBN that/WDT suppressed/VBD the/DT CAK/NEWGENE mutation/NEWGENE in/IN budding/JJ yeast/NN ,/, and/CC it/PRP also/RB complemented/VBD a/DT fission/NEWGENE yeast/NEWGENE CAK/NEWGENE mutant/NEWGENE ./. cak1At/NEWGENE encodes/VBZ a/DT protein/NN related/VBN to/IN animal/NEWGENE CAKs/NEWGENE ./.
@@88686606311 The/DT main/JJ aim/NN of/IN the/DT contribution/NN ,/, which/WDT opens/VBZ an/DT arena/NN for/IN discussion/NN on/IN the/DT Rivista/NN dell'Infermiere/NN is/VBZ to/IN critically/RB appraise/VB published/VBN research/NN works/NNS focusing/VBG both/DT on/IN strengths/NNS and/CC novelty/NN and/CC weaknesses/NNS in/IN the/DT hypothesis/NN formulation/NN ,/, methods/NNS and/CC instruments/NNS used/VBN ,/, discussion/NN of/IN results/NNS ./.
@@22468038116 The/DT result/NN suggests/VBZ that/IN this/DT non-invasive/JJ TTD/NN method/NN is/VBZ easily/RB available/JJ and/CC useful/JJ in/IN monitoring/VBG the/DT intraoperative/JJ cardiac/JJ output/NN ./.
@@83025895571 The/DT HGF-induced/JJ cell/NN motility/NN was/VBD mimicked/VBN by/IN 12-0-tetradecanoyl-phorbol-13-acetate/JJ ,/, a/DT protein/NEWGENE kinase/NEWGENE C-activating/JJ phorbol/NN ester/NN ,/, but/CC not/RB by/IN Ca2+/NN ionophore/NN ./.
@@80290012437 These/DT results/NNS demonstrate/VBP that/IN a/DT class/NN of/IN proline-rich/JJ activator/NN proteins/NNS and/CC RNA/NEWGENE polymerase/NEWGENE II/NEWGENE possess/VB a/DT common/JJ structural/JJ and/CC functional/JJ component/NN which/WDT can/MD interact/VB with/IN the/DT same/JJ target/NN in/IN the/DT general/JJ transcription/NN machinery/NN ./.
@@10363517227 In/NN this/DT paper/NN ,/, such/JJ lesions/NNS in/IN two/JJ cases/NNS were/VBD evaluated/VBN by/IN ultrasonography/NN ./.
@@112875792113 Another/DT mutant/NN ,/, T255A/NNP ,/, lost/VBP the/DT ability/NN to/IN bind/NN E4orf6/NEWGENE ,/, but/CC unexpectedly/RB ,/, viral/JJ late-gene/JJ expression/NN was/VBD not/RB affected/VBN ./.
@@87219996187 In/NN addition/NN ,/, they/PRP display/NN common/JJ features/NNS that/WDT make/VBP them/PRP strikingly/RB related/VBD to/IN snoRNA/NEWGENE U14/NEWGENE ./.
@@90657686056 The/DT second/JJ class/NN of/IN cDNA/NN hybridized/VBN to/IN a/DT 13/CD kb/NN transcript/NN ,/, which/WDT was/VBD approximately/RB twice/RB as/RB large/JJ as/IN the/DT mammalian/NEWGENE lactase/NEWGENE mRNA/NEWGENE ./.
@@114163931287 Five/CD modalities/NNS of/IN nonpharmacologic/JJ approaches/NNS are/VBP recommended/VBN at/IN present/NN for/IN lifestyle/NN modification/NN and/CC control/NN of/IN arterial/JJ blood/NN pressure/NN elevation/NN :/: 1/NN )/NN weight/NN reduction/NN to/IN ideal/JJ body/NN weight/NN ,/, since/IN it/PRP reduces/VBZ risk/NN of/RB hypertension/NN as/RB well/VB as/IN overall/JJ cardiovascular/JJ morbidity/NN and/CC mortality/NN ;/: 2/NN )/NN dietary/JJ sodium/NN restriction/NN to/IN less/PRP than/IN 2/CD g/NN a/DT day/NN ,/, without/IN assurance/NN that/IN it/PRP will/MD normalize/VB arterial/JJ pressure/NN although/IN it/PRP may/MD help/VB reduce/VB dosage/NN and/CC numbers/NNS of/IN prescribed/VBN antihypertensive/JJ drugs/NNS ;/: 3/NN )/NN moderation/NN of/IN alcohol/NN consumption/NN to/IN less/PRP than/IN 1/CD ounce/NN a/DT day/NN ;/: 4/NN )/NN a/DT regular/JJ isotonic/JJ exercise/NN program/NN ;/: and/CC 5/NN )/NN cessation/NN of/IN tobacco/NN consumption/NN ./.
@@100739474524 The/DT corresponding/JJ differences/NNS in/IN FVIIa/NEWGENE and/CC PAI-1/NEWGENE were/VBD not/RB statistically/RB significant/JJ ./.
@@104462064577 Deletion/NNS mapping/NN of/IN the/DT human/NEWGENE presenilin-1/NEWGENE (/( PS1/NEWGENE )/SYM promoter/NN delineated/VBN the/DT most/RB active/JJ fragment/NN from/IN -118/CD to/IN +178/CD in/IN relation/NN to/IN the/DT transcription/NN start/NN site/NN mapped/VBN in/IN this/DT study/NN ,/, in/IN both/DT human/NN neuroblastoma/NN SK-N-SH/NN and/CC hepatoma/NN HepG2/NNP cells/NNS ./.
@@8065368644 Ariga/NNP ,/, Biochem/NNP ./.
@@31842673876 The/DT feed/JJ given/NN to/IN young/JJ broiler/NN chickens/NNS was/VBD contaminated/VBN artificially/RB with/IN Salmonella/NN kedougou/NN ,/, a/DT serotype/NN associated/VBN with/IN both/DT subclinical/JJ infections/NNS in/IN commercially/RB reared/VBN chickens/NNS and/CC food/NN poisoning/VBG in/IN humans/NNS ./.
@@80134574322 Src/NEWGENE homology/NEWGENE (/( SH/NEWGENE )/SYM domain/NN dependent/NN protein-protein/NN interactions/NNS are/VBP important/JJ to/IN tyrosine/NEWGENE kinase/NEWGENE receptor/NEWGENE signal/JJ transduction/NN ./.
@@74993946782 J/NNP ./NNP
@@26479373320 It/PRP suggests/VBZ a/DT sequence/NN of/IN surgical/JJ planning/NN that/WDT can/MD prevent/VB them/PRP and/CC also/RB offers/VBP ways/NNS of/IN dealing/VBG with/IN the/DT problems/NNS should/MD they/PRP occur/VBP ./.
@@90491986330 To/TO gain/VB insight/NN into/IN the/DT possible/JJ involvement/NN of/IN p21/NEWGENE in/IN liver/NN cell/NN growth/NN ,/, the/DT expression/NN and/CC regulation/NN of/IN the/DT p21/NEWGENE gene/NEWGENE was/VBD evaluated/VBN in/IN rodent/NN models/NNS of/IN liver/NN regeneration/NN and/CC specimens/NNS of/IN human/JJ liver/NN diseases/NNS ./.
@@28894953592 In/NN a/DT randomised/JJ double-blind/JJ study/NN ,/, 46/CD first/JJ episode/NN schizophrenics/NNS were/VBD given/VBP pimozide/NN or/CC flupenthixol/NN for/IN up/JJ to/IN 5/CD weeks/NNS ;/: the/DT mean/JJ daily/JJ dose/NN at/IN the/DT end/NN was/VBD 18/CD ./CD 8/CD mg/NN pimozide/NN and/CC 20/CD mg/NN flupenthixol/NN ./.
@@71247435116 A/DT limited/VBN study/NN in/IN a/DT glassware/NN factory/NN (/( As2O3/NN exposure/NN )/SYM involving/VBG the/DT measurement/NN of/IN total/JJ airborne/JJ arsenic/NN ,/, the/DT determination/NN of/IN urinary/JJ arsenic/NN ,/, and/CC the/DT evaluation/NN of/IN hand/NN and/CC mouth/NN contamination/NN by/IN arsenic/NN before/IN and/CC after/IN the/DT workshift/NN suggests/VBZ that/IN the/DT high/JJ urinary/JJ arsenic/NN levels/NNS (/( 300/CD microgram/NN //NN g/NN creatinine/NN )/SYM are/VBP likely/RB to/IN be/VB more/RB related/VBN to/IN an/DT increased/VBN oral/JJ intake/NN from/IN contaminated/VBN hands/NNS than/IN to/IN an/DT increased/VBN absorption/NN from/IN the/DT lungs/NNS ./.
@@88505858824 The/DT enzyme/NN activities/NNS studied/VBN are/VBP important/JJ elements/NNS in/IN the/DT pathophysiology/NN of/IN dental/JJ caries/NN and/CC may/MD even/VB be/VB addressed/VBN as/IN virulence/NN factors/NNS ./.
@@113905811469 A/DT central/JJ finding/NN is/VBZ the/DT identification/NN of/IN a/DT GC-rich/NNP sequence/NN in/IN the/DT -99/NN //NN -91/NN Cp/NN region/NN that/WDT is/VBZ essential/JJ for/RB oriPI-EBNA1-independent/JJ as/RB well/VB as/IN oriPI-EBNA1-dependent/JJ activity/NN of/IN the/DT promoter/NN ./.
@@77395426836 Moreover/RB ,/, we/PRP found/VBP that/DT cyclin/NEWGENE E/NEWGENE ,/, in/IN contrast/NN to/IN cyclin/NEWGENE D1/NEWGENE ,/, was/VBD required/VBN for/IN the/DT G1/NN //NN S/NN transition/NN even/VB in/IN cells/NNS lacking/VBG retinoblastoma/NEWGENE protein/NEWGENE function/NN ./.
@@25764053175 In/NN patients/NNS resistant/JJ to/IN VAD/DT ,/, high-dose/JJ therapies/NNS with/IN intravenous/JJ melphalan/NN ,/, a/DT CBV/NN combination/NN (/( cyclophosphamide-BCNU-VP-16/NN )/SYM or/CC an/DT EDAP/NN regimen/NN (/( VP-16/NN -platinum/CD )/SYM produced/VBN responses/NNS in/IN about/RB 40%/CD of/IN patients/NNS ./.
@@96327349210 Whereas/IN p82/NEWGENE expression/NN had/VBP no/DT effect/NN on/IN ERK2/NEWGENE activation/NN by/IN p126/NEWGENE ,/, p70/NEWGENE completely/RB abrogated/VBN this/DT activity/NN ./.
@@8554723368 We/PRP tested/VBD 10/CD rats/NNS with/IN electrophysiologically/RB guided/VBN ,/, ibotenic/JJ acid/NN lesions/NNS of/IN the/DT PBN/NN (/( PBNx/NNP )/SYM to/IN determine/VB whether/IN they/PRP could/MD acquire/VB a/DT LiCl-induced/NN CTA/NN to/IN l-alanine/NN (/( 0/CD ./CD 3/CD M/NN )/SYM or/CC demonstrate/VB a/DT sodium/NN appetite/NN following/IN furosemide/NN treatment/NN and/CC overnight/JJ access/NN to/IN sodium/NN deficient/JJ chow/NN ./.
@@92784503933 Electrophoretic/JJ mobility/NN shift/NN assays/NNS and/CC competition/NN experiments/NNS showed/VBD that/DT site/NN A/NN is/VBZ recognized/VBN by/IN an/DT NF1/NEWGENE protein/NEWGENE ./.
@@95219073360 Drosophila/NEWGENE orthodenticle/NEWGENE (/( otd/NEWGENE )/SYM and/CC murine/NEWGENE Otx/NEWGENE genes/NEWGENE exemplify/VBP this/DT ,/, both/DT in/NN terms/NNS of/IN expression/NN patterns/NNS and/CC mutant/JJ phenotypes/NNS ./.
@@13836906778 The/DT ARG/NEWGENE SH2/NEWGENE1 domain/NEWGENE1 exhibited/VBD relatively/JJ weak/JJ affinity/NN for/IN BCR/NEWGENE and/CC was/VBD determined/VBN to/IN bind/NN about/RB 10-fold/JJ less/PRP strongly/RB than/IN the/DT ABL/NEWGENE SH2/NEWGENE1 domain/NEWGENE1 ./.
@@71919727016 At/NN an/DT ambient/JJ temperature/NN of/IN 25/CD degrees/NNS C/NN ,/, the/DT responses/NNS to/IN spinal/JJ cooling/NN are/VBP reduced/VBN during/IN the/DT dark/JJ phase/NN ./.
@@32960193981 Time/NNP delay/NN effects/NNS on/IN the/DT tensile/JJ bond/NN strength/NN developed/VBN by/IN the/DT Silicoater/NNP ./.
@@37335632360 Liver/NN TG/NN and/CC serum/JJ NEFA/NN concentrations/NNS were/VBD positively/RB correlated/VBN ./.
@@80994439278 We/PRP show/VBP that/IN HRI/NEWGENE and/CC dsRNA-PK/NEWGENE phosphorylate/NN yeast/NEWGENE eIF-2/NEWGENE alpha/NEWGENE in/IN vitro/FW and/CC in/IN vivo/NN and/CC functionally/RB substitute/VB for/IN GCN2/NEWGENE protein/NEWGENE to/IN stimulate/VB GCN4/NEWGENE translation/NN in/IN yeast/NN ./.
@@92674316731 Two/CD soybean/NN cDNA/NN clones/NNS ,/, SPK-3/NEWGENE and/CC SPK-4/NEWGENE ,/, encoding/VBG putative/JJ protein/NEWGENE kinases/NEWGENE were/VBD isolated/VBN and/CC characterized/VBN ./.
@@94047259360 At/NN 60/CD days/NNS the/DT amount/NN of/IN gangliosides/NNS was/VBD on/IN average/RB lower/JJR in/IN females/NNS than/IN in/IN males/NNS ,/, even/VB if/IN with/IN some/DT exception/NN ./.
@@112510836720 Mechanism/NNS in/IN the/DT sequential/JJ control/NN of/IN cell/NN morphology/NN and/CC S/NNP phase/NN entry/NN by/IN epidermal/NEWGENE growth/NEWGENE factor/NEWGENE involves/VBZ distinct/JJ MEK/NEWGENE //NEWGENE ERK/NEWGENE activations/NNS ./.
@@8465596678 Eleven/CD strains/NNS of/IN Fusarium/NN poae/NNS and/CC F/NN ./NN sporotrichioides/NNS from/IN the/DT U/NNP ./NNP S/NNP ./NNP S/NNP ./NNP R/NNP ./. and/CC 7/CD strains/NNS of/IN these/DT species/NN and/CC one/PRP of/IN F/NN ./NN sporotrichioides/NNS var/NN ./. tricinctum/NN from/IN U/NNP ./NNP S/NNP ./NNP A/NNP ./. and/CC France/NN have/NN been/VBN compared/VBN as/IN to/IN their/PRP capacity/NN to/IN yield/NN T-2/NEWGENE toxin/NEWGENE ./.
@@15770561096 In/NN a/DT randomized/JJ double-blind/JJ cross-over/JJ study/NN ,/, the/DT subjects/NNS received/VBD theophylline/NN 5/NN mg/NN ./NN kg-1/NN per/IN day/NN with/IN omeprazole/NN 20/CD mg/NN per/IN day/NN or/CC identical/JJ placebo/NN during/IN two/JJ periods/NNS ,/, each/DT of/IN 7/CD days/NNS ,/, separated/VBN by/IN a/DT washout/NN period/NN of/IN 7/CD days/NNS ./.
@@16716759060 This/DT conclusion/NN was/VBD confirmed/VBN by/IN Northern/NNP blotting/NN analysis/NN of/IN the/DT 5'-flanking/JJ region/NN of/IN CAD/NEWGENE gene/NEWGENE ./.
@@97746625497 The/DT ARF/NEWGENE promoter/NEWGENE was/VBD also/RB found/VB to/IN be/VB highly/RB responsive/JJ to/IN E2F1/NEWGENE expression/NN ,/, in/IN keeping/VBG with/IN previous/JJ results/NNS at/IN the/DT RNA/NN level/NN ./.
@@14188348796 Thus/RB ,/, chronic/JJ hematocrit/NN decrease/NN induced/VBN by/IN H/NN or/CC P/NN resulted/VBN in/IN a/DT significant/JJ fall/NN in/IN blood/NN pressure/NN compared/VBN to/IN control/NN (/( 201/CD +/NN //NN -/NN 3/NN v/NN 175/NN +/NN //NN -/NN 4/CD ,/, 167/CD +/NN //NN -/NN 4/CD mm/NN Hg/NN ,/, respectively/RB ;/: P/NN </SYM ./CD 05/CD )/SYM ./.
@@25418823182 Radiation/NN therapy/NN was/VBD effective/JJ in/IN controlling/JJ symptomatic/JJ metastasis/NN in/IN all/DT three/CD patients/NNS ./.
@@28611446846 Further/JJ analysis/NN of/IN this/DT DNA/NN fragment/NN showed/VBN that/IN four/CD genes/NNS are/VBP present/VB encoding/VBG proteins/NNS of/IN 16/CD ,/, 18/CD ./CD 5/CD ,/, 21/CD and/CC 89/CD kDal/JJ ./.
@@38103614491 Since/IN the/DT integrated/JJ 13h00-16h00/JJ plasma/NN cortisol/NN estimation/NN is/VBZ cheaper/JJR and/CC simpler/JJR than/IN the/DT mean/JJ 13h00-16h00/JJ plasma/NN cortisol/NN estimation/NN ,/, we/PRP recommend/VBP it/PRP as/IN an/DT adjunct/NN in/IN the/DT diagnosis/NN of/IN Cushing's/NNP syndrome/NN ./.
@@97907717773 Using/VBG an/DT interspecific/JJ backcross/NN panel/NN ,/, we/PRP localized/VBN both/DT Gng3/NEWGENE and/CC Gng3lg/NEWGENE to/IN the/DT same/JJ locus/NN on/IN chromosome/NN 19/CD ./CD
@@14753818396 Brucellosis--1990/NN ./.
@@32129291107 An/DT ELISA/NN procedure/NN was/VBD developed/VBN for/IN monitoring/VBG the/DT specific/NN IgE/NEWGENE response/NN in/IN dogs/NNS to/IN Dirofilaria/NN immitis/JJ infection/NN ./.
@@6260146064 The/DT malignity/NN of/IN nevoid/JJ lentigo/NN ./.
@@9197241869 In/NN adherent/JJ macrophages/NNS ,/, absence/NN of/IN CD45/NEWGENE led/VBN to/IN the/DT hyperphosphorylation/NN and/CC hyperactivation/NN of/IN p56/NEWGENE //NEWGENE 59/NEWGENE (/NEWGENE hck/NEWGENE )/NEWGENE and/CC p53/NEWGENE //NEWGENE 56/NEWGENE (/NEWGENE lyn/NEWGENE )/NEWGENE ,/, but/CC not/RB of/IN p58/NEWGENE (/NEWGENE c-fgr/NEWGENE )/NEWGENE ./.
@@19079412242 Additionally/RB ,/, I/NEWGENE kappa/NEWGENE B/NEWGENE beta/NEWGENE ,/, but/CC not/RB I/NEWGENE kappa/NEWGENE B/NEWGENE alpha/NEWGENE ,/, also/RB prevented/VBN the/DT binding/NN of/IN Rel/NEWGENE to/IN the/DT kappa/NEWGENE B/NEWGENE site/NEWGENE ./.
@@90322488465 Although/IN Pho85/NEWGENE is/VBZ not/RB essential/JJ for/IN viability/NN ,/, Pcl1/NEWGENE ,/NEWGENE 2-Pho85/NEWGENE kinase/NEWGENE complexes/NEWGENE become/VBP essential/JJ for/IN Start/NN in/IN the/DT absence/NN of/IN Cln1/NEWGENE ,/NEWGENE 2-Cdc28/NEWGENE kinases/NEWGENE ./.
@@90580025446 Exploratory-motor/NN task/NN to/IN evaluate/VB right/JJ frontal/JJ lobe/NN damage/NN ./.
@@58506526227 Study/NNP of/IN the/DT alterations/NNS of/IN intestinal/JJ absorption/NN ,/, by/IN means/NN of/IN I-131-triolein/NN ,/, in/IN the/DT whole/JJ body/NN irradiated/JJ rat/NN ./.
@@6394106194 Cortisone/NNP induced/VBD bone/NN changes/NNS and/CC its/PRP response/NN to/IN lipid/NN clearing/NN agents/NNS ./.
@@118812681771 The/DT purpose/NN of/IN this/DT study/NN was/VBD to/IN develop/VB a/DT reliable/JJ and/CC culturally/RB meaningful/JJ exercise/NN self-efficacy/NN questionnaire/NN for/IN older/RBR Mexican/JJ American/JJ women/NNS ./.
@@84539508410 Following/VBG seizure/NN induction/NN ,/, MABP/NN increased/VBD to/IN 105/CD mm/NN Hg/NN and/CC brain/NN pHi/NN fell/NN to/IN 6/CD ./CD 79/CD +/NN //NN -/NN 0/CD ./CD 03/CD within/IN 15/CD min/NN and/CC remained/VBN at/IN this/DT level/NN for/IN 1/CD h/NN (/( P/NN </SYM 0/CD ./CD 001/CD )/SYM ./.
@@147024334 However/RB ,/, in/IN the/DT subgroup/NN with/IN normal/JJ Ht/NN (/( </SYM 0/CD ./CD 45/CD l/NN //NN l/NN ;/: n/NN =/SYM 201/CD )/SYM there/RB was/VBD a/DT significant/JJ reduction/NN (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM of/IN the/DT mortality/NN after/IN 3/CD months/NNS (/( 27%/JJ and/CC 16%/JJ ,/, respectively/RB )/SYM and/CC an/DT increase/NN of/IN independence/NN at/IN home/JJ (/( 35%/JJ and/CC 48%/JJ ,/, respectively/RB )/SYM due/NN to/IN a/DT reduction/NN of/IN the/DT viscosity/NN by/IN means/NN of/IN haemodilution/NN with/IN albumin/NEWGENE (/( a/DT specific/NN viscosity/NN effect/NN in/IN the/DT normovolaemic/JJ group/NN )/SYM ./.
@@88381487916 A/DT stable/JJ heterologous/JJ cell/NN line/NN containing/JJ the/DT mouse/NEWGENE TRH/NEWGENE receptor/NEWGENE was/VBD constructed/VBN by/IN transfection/NN of/IN nonexcitable/JJ 293/CD cells/NNS ,/, which/WDT lack/VBP L/JJ channel/NN activity/NN ./.
@@78940214271 These/DT data/NN suggest/VB that/IN the/DT function/NN of/IN the/DT DS2/NEWGENE may/MD be/VB the/DT protection/NN of/IN the/DT nuclear/JJ DNA/NN from/IN desiccation/NN ./.
@@103812573300 A/DT recently/RB described/VBN protein/NN ,/, metaxin/NEWGENE 1/NEWGENE ,/, serves/VBP as/IN a/DT component/NN of/IN a/DT preprotein/NN import/NN complex/NN in/IN the/DT outer/JJ membrane/NN of/IN the/DT mammalian/JJ mitochondrion/NN ./.
@@111005154205 Thyrotoxicosis/NN due/NN to/IN amiodarone/NN is/VBZ difficult/JJ to/IN treat/NN and/CC is/VBZ further/RB complicated/VBN by/IN the/DT pro-arrhythmic/JJ potential/NN of/IN thyrotoxicosis/NN and/CC the/DT fading/JJ antiarrhythmic/JJ effect/NN after/IN amiodarone/NN withdrawal/NN ./.
@@89371128894 RESULTS/NNS :/: The/DT age/NN distribution/NN was/VBD 28/CD to/IN 83/CD years/NNS old/JJ (/( mean/NN was/VBD 54/CD ./CD 1/CD years/NNS )/SYM ./.
@@7937656883 Univariate/JJ statistical/JJ analysis/NN based/VBN on/IN Kaplan-Meier-estimates/VBZ and/CC Log-Rank-Test/NN showed/VBD the/DT following/NN prognostically/RB beneficial/JJ factors/NNS :/: Limited/NNP disease/NN stage/NN (/( p/NN =/SYM 0/CD ./CD 009/CD )/SYM ,/, NSE/NN serum/JJ level/NN less/PRP than/IN 25/CD micrograms/NN //NN l/NN (/( p/NN =/SYM 0/CD ./CD 016/CD )/SYM ,/, serum/JJ alkaline/NEWGENE phosphatase/NEWGENE less/PRP than/IN 200/CD U/NNS //NNS l/NNS (/( p/NN =/SYM 0/CD ./CD 035/CD )/SYM ,/, normal/JJ serum/JJ albumin/NEWGENE (/( p/NN =/SYM 0/CD ./CD 003/CD )/SYM and/CC activity/NN index/NN of/IN minimum/NN of/IN 70/CD (/( p/NN </SYM 0/CD ./CD 001/CD )/SYM ./.
@@108732863035 GAP/NN JUNCTIONS/NN IN/IN THE/DT BRAIN/NNP :/: PREFACE/NNP ./.
@@72676754066 The/DT new/JJ semi-synthetic/JJ oral/JJ cephalosporin/NN ,/, CGP/NN 9/NN ,/NN 000/NN ,/, has/VBZ been/VBN evaluated/VBN in/IN a/DT large/JJ number/NN of/IN hospitalized/VBN patients/NNS with/IN urinary/JJ infections/NNS ./.
@@39776035828 Piroxicam/NN produced/VBN a/DT lower/JJR incidence/NN of/IN gastric/JJ ulcers/NNS than/IN equivalent/JJ doses/NNS of/IN indomethacin/NN ./.
@@79691369342 Electrophoretic/JJ mobility/NN shift/NN assays/NNS with/IN each/DT of/IN these/DT sequences/NNS demonstrated/VBD complexes/NNS with/IN mobilities/NNS identical/JJ to/IN those/DT of/IN the/DT NF-kappa/NEWGENE B/NEWGENE site/NEWGENE from/IN the/DT kappa/NEWGENE light-chain/NEWGENE gene/NEWGENE ./.
@@103193207830 Taken/VBN together/RB ,/, these/DT findings/NNS show/NN that/IN 16K/NEWGENE hPRL/NEWGENE inhibits/VBZ the/DT VEGF-induced/NN Ras/NEWGENE activation/NN ;/: this/DT antagonism/NN represents/VBZ a/DT novel/JJ and/CC potentially/RB important/JJ mechanism/NN for/IN the/DT control/NN of/IN angiogenesis/NN ./.
@@107274339624 Transfection/NNS with/IN a/DT CSF-1R/NEWGENE expression/NN plasmid/NN permitted/VBN CSF-1-dependent/NNP activation/NN of/IN the/DT signalling/JJ pathway/NN targeting/JJ an/DT Ets/NEWGENE //NEWGENE AP1/NEWGENE (/( activator/NEWGENE protein/NEWGENE 1/NEWGENE )/SYM element/NN in/IN the/DT uPA/NEWGENE promoter/NEWGENE that/WDT has/VBZ been/VBN shown/VBP previously/RB to/IN be/VB a/DT target/NN of/IN oncogenic/NEWGENE ras/NEWGENE and/CC protein/NEWGENE kinase/NEWGENE C/NEWGENE pathways/NEWGENE ./.
@@15455231887 During/IN the/DT 1980's/CD ,/, quantifications/NNS of/IN immunoserological/JJ testings/NNS ,/, especially/RB C/NEWGENE reactive/NEWGENE protein/NEWGENE ,/, rheumatoid/NEWGENE factor/NEWGENE and/CC antistreptolysin/NEWGENE O/NEWGENE ,/, progressed/VBD rapidly/RB ./.
@@113088771141 It/PRP is/NNS shown/VBP that/IN ,/, for/IN any/DT periodic/JJ input/NN ,/, the/DT map/NN representing/VBG the/DT relation/NN between/IN input/NN phases/NNS at/IN consecutive/JJ discharge/NN times/NNS can/MD be/VB restricted/VBN to/IN a/DT piecewise/JJ continuous/JJ ,/, orientation/NN preserving/JJ circle/NN map/NN ./.
@@22173072851 Evidence/NN that/IN therapeutic/JJ alterations/NNS of/IN a/DT circadian/JJ rhythm/NN for/IN gastric/JJ emptying/NN response/NN may/MD be/VB possible/JJ ./.
@@21546025809 It/PRP is/VBZ the/DT human/JJ homolog/NN of/IN the/DT mouse/NEWGENE Mx/NEWGENE protein/NEWGENE involved/VBN in/IN resistance/NN to/IN influenza/NN virus/NN ./.
@@23303333159 Accumulations/NNS of/IN Tl+1/NN (/( 202Tl/NN label/NN )/SYM were/VBD 6/CD times/VBZ those/DT for/JJ Ga/NN or/CC In/NN in/IN the/DT brain/NN and/CC muscles/NNS ,/, and/CC ./CD 1/CD times/NNS in/IN plasma/NN ./.
@@37682084437 These/DT results/NNS indicate/VBP that/IN during/IN pregnancy/NN there/RB are/VBP increases/NNS in/IN bone/NN formation/NN rates/NNS contributing/JJ to/IN the/DT increases/NNS in/IN skeletal/JJ mass/NN ./.
@@85557534608 CBT/NN is/VBZ discussed/VBN in/IN comparison/NN with/IN the/DT Wisconsin/NNP Card/NNP Sorting/VBG Test/NNP as/IN a/DT potential/JJ cognitive/JJ activation/NN task/NN for/IN functional/JJ neuroimaging/NN of/IN the/DT frontal/JJ lobes/NNS ./.
@@67285802427 In/NN a/DT recent/JJ measles/NN epidemic/JJ in/IN El/NNP Paso/NNP ,/, TX/NN ,/, 120/NN ,/NN 000/NN records/NNS were/VBD screened/VBN using/VBG these/DT criteria/NNS ,/, and/CC as/IN a/DT result/NN 13/CD ,/CD 000/CD students/NNS were/VBD vaccinated/VBN ./.
@@90997024085 Recently/RB ,/, we/PRP have/VBP reported/VBN the/DT cloning/NN of/IN the/DT germ/NN cell-specific/JJ ,/, nuclear/NEWGENE orphan/NEWGENE receptor/NEWGENE germ/NEWGENE cell/NEWGENE nuclear/NEWGENE factor/NEWGENE (/NEWGENE GCNF/NEWGENE )/NEWGENE //NEWGENE RTR/NEWGENE ./.
@@76680438208 (/( 1991/CD )/SYM ./.
@@75438681837 Appropriate/JJ restriction/NN sites/NNS allow/VBP one/PRP to/IN insert/NN virtually/RB any/DT desired/JJ cDNA/NN fragment/NN directly/RB behind/RB the/DT epitope-specific/NN sequence/NN and/CC before/IN a/DT long/JJ poly/NN (/NN A/NN )/NN tail/NN ./.
@@115595471474 Transcriptional/JJ regulation/NN of/IN the/DT estrogen-inducible/JJ pS2/NEWGENE breast/NEWGENE1 cancer/NEWGENE1 marker/NEWGENE1 gene/NEWGENE1 by/IN the/DT ERR/NEWGENE family/NEWGENE of/IN orphan/NEWGENE nuclear/NEWGENE receptors/NEWGENE ./.
@@114374393921 The/DT promoter/NN activity/NN of/IN the/DT proximal/JJ region/NN was/VBD found/VBN to/IN be/VB restricted/VBN to/IN a/DT subset/NN of/IN prestalk/JJ cells/NNS ./.
@@87922178469 Such/JJ an/DT increase/NN in/IN the/DT steady-state/JJ testicular/NEWGENE TIMP-2/NEWGENE mRNA/NEWGENE level/NN apparently/RB is/VBZ not/RB the/DT result/NN of/IN an/DT up-regulation/NN by/IN germ/NN cells/NNS because/IN germ/NN cells/NNS cocultured/VBN with/IN Sertoli/NN cells/NNS failed/VBN to/IN elicit/VB an/DT increase/NN in/IN the/DT Sertoli/NN cell/NN steady-state/JJ TIMP-2/NEWGENE mRNA/NEWGENE level/NN ./.
@@84132916992 Transgenic/NNP mice/NNS harboring/VBG the/DT rat/NEWGENE TnI-CAT/NEWGENE fusion/NEWGENE gene/NEWGENE expressed/VBD the/DT reporter/NN specifically/RB in/IN the/DT skeletal/JJ muscle/NN ./.
@@88702662807 Taken/VBN together/RB ,/, these/DT observations/NNS indicate/VBP that/IN the/DT C-terminal/NN 24/NN amino/JJ acids/NNS are/VBP sufficient/JJ for/IN NodO/NEWGENE secretion/NN although/IN the/DT region/NN adjacent/JJ to/IN this/DT domain/NN appears/VBZ to/IN affect/NN secretion/NN efficiency/NN ./.
@@21577645045 A/DT rabbit/NN antiserum/NN was/VBD raised/VBN against/IN a/DT synthetic/JJ peptide/NN corresponding/JJ to/IN a/DT hydrophilic/JJ portion/NN of/IN the/DT translated/VBN murine/NN cDNA/NN sequence/NN ./.
@@86682108897 Substantial/JJ evidence/NN supports/VBP a/DT critical/JJ role/NN for/IN the/DT activation/NN of/IN the/DT Raf-1/NEWGENE //NEWGENE MEK/NEWGENE //NEWGENE mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE pathway/NEWGENE in/IN oncogenic/JJ Ras-mediated/JJ transformation/NN ./.
@@94884662445 The/DT 3'/CD fragment/NN was/VBD shown/VBP to/RB accumulate/VB as/IN full-length/JJ mRNA/NN disappeared/VBN in/IN actinomycin/NN D-treated/JJ cells/NNS ,/, indicating/VBG a/DT precursor-product/JJ relationship/NN ./.
@@50663165348 Relation/NN between/IN mixing/NN ratio/NN of/IN raw/JJ materials/NNS and/CC composition/NN of/IN products/NNS in/IN the/DT synthesis/NN of/IN aluminosilicates/NNS ./.
@@1030985184 I/NNP ./NNP
@@85866431817 The/DT purified/VBN recombinant/JJ enzyme/NN catalyzed/VBN specific/JJ phosphoryl/NN transfer/NN from/IN ATP/NN to/IN UMP/NN and/CC CMP/NN ./.
@@3935984594 The/DT course/NN of/IN endotoxin/NEWGENE fever/NN remained/VBD uninfluenced/JJ by/IN ALS/NN ./.
@@96331717051 The/DT brackets/NNS were/VBD bonded/VBN to/IN 100/CD freshly/RB extracted/VBN bovine/NN incisors/NN ,/, and/CC ,/, after/IN storage/NN in/IN tap/NN water/NN at/IN room/NN temperature/NN for/IN 24/CD hours/NNS ,/, they/PRP were/VBD subsequently/RB tested/VBN in/IN a/DT shear/NN mode/NN using/VBG a/DT universal/JJ testing/NN machine/NN ./.
@@26429763790 Potential/JJ consensus/NN sequences/NNS for/IN early/JJ and/CC late/JJ regulatory/JJ elements/NNS were/VBD identified/VBN ./.
@@84545915628 Sequencing/NN of/IN a/DT 1/NN ./NN 3-kilobase/NN fragment/NN of/IN the/DT 5'-flanking/JJ region/NN of/IN the/DT TSG6/NEWGENE gene/NEWGENE identified/VBN TATA-like/NN and/CC CAAT/NN sequences/NN near/IN the/DT transcription/NN start/NN site/NN ./.
@@10022032201 In/NN support/NN of/IN clinical/JJ antianginal/JJ studies/NNS ,/, the/DT vasodilator/JJ nicorandil/NN (/( NIC/IN )/SYM was/VBD combined/JJ with/IN the/DT beta-adrenergic/NEWGENE receptor/NEWGENE antagonists/NNS propranolol/NN (/( PRO/FW )/SYM and/CC atenolol/NN (/( ATN/NN )/SYM and/CC with/IN the/DT calcium/NN channel/NN blocker/NN diltiazem/NN (/( DTZ/NNP )/SYM to/IN determine/VB their/PRP cardiovascular/JJ and/CC pharmacokinetic/JJ interactions/NNS ./.
@@92944522814 When/WRB the/DT downstream/JJ operator/NN was/VBD altered/VBN ,/, there/RB was/VBD a/DT fourfold/JJ reduction/NN in/IN reporter/NN enzyme/NN levels/NNS ./.
@@97247542268 Tyrosine/NN phosphorylated/VBN STATs/NEWGENE dimerize/VB and/CC translocate/VB into/IN the/DT nucleus/NN to/IN activate/VB specific/JJ genes/NNS ./.
@@80211779683 The/DT fepA-entD/NEWGENE and/CC fes-entF/NEWGENE operons/NEWGENE in/IN the/DT enterobactin/NN synthesis/NN and/CC transport/NN system/NN are/VBP divergently/RB transcribed/VBN from/IN overlapping/JJ promoters/NNS ,/, and/CC both/DT are/VBP inhibited/VBN by/IN the/DT Fur/NEWGENE repressor/NEWGENE protein/NEWGENE under/IN iron-replete/JJ conditions/NNS ./.
@@107774996487 Results/NNS from/IN transient/JJ assays/NNS using/VBG these/DT mutants/NNS showed/VBN that/IN the/DT DE1/NEWGENE received/VBN signals/NNS from/IN phytochromes/NNS A/DT and/CC B/NNP ,/, demonstrating/VBG that/IN this/DT element/NN is/VBZ indeed/RB a/DT light-responsive/JJ element/NN ./.
@@27924307322 Experiments/NNS on/IN 23/CD white/JJ rats/NNS and/CC 10/CD guinea/NN pigs/NNS have/VBP shown/VBP that/IN preliminarily/RB indomethacin-induced/JJ inhibition/NN of/IN prostaglandins/NNS synthesis/NN prevented/VBD development/NN of/IN pulmonary/JJ oedema/NN ,/, evoked/VBN by/IN heterologous/JJ serum/NN in/IN rats/NNS and/CC by/IN vagotomy/NN in/IN guinea/NN pigs/NNS ./.
@@66855366443 After/IN 1/CD ./CD 5/CD years/NNS of/IN such/JJ photoperiodic/JJ control/NN ,/, all/DT ewes/NNS were/VBD blinded/JJ by/IN bilateral/JJ orbital/JJ enucleation/NN ./.
@@92944719256 Refined/NNP Cox/NN models/NNS using/VBG a/DT CD4/NEWGENE count/NN of/IN 150/CHEM //CHEM microL/CHEM rather/RB than/IN 200/CHEM //CHEM microL/CHEM to/IN distinguish/VB I0/IN and/CC I1/NN yielded/VBN a/DT simplified/JJ model/NN with/IN better/JJR fit/NN to/IN the/DT observed/VBN data/NN ./.
@@88281524995 The/DT RPO1/NEWGENE of/IN LCDV/ORG shows/VBZ the/DT highest/JJS similarity/NN to/IN the/DT RPO1/NEWGENE of/IN IIV6/NN and/CC significant/JJ lower/JJR similarity/NN to/IN the/DT eukaryotic/NEWGENE polymerases/NEWGENE II/NEWGENE and/NEWGENE III/NEWGENE as/NNP well/VB as/IN to/IN the/DT archaebacteral/JJ subunit/NN ./.
@@77994378241 Other/JJ assays/NNS also/RB distinguished/VBN the/DT processive/JJ replication/NN of/IN pNeo/CD ./CD Myc-2/NEWGENE ./CD 4/CD from/IN the/DT dispersive/JJ labeling/NN of/IN control/NN plasmids/NNS ./.
@@99141563376 Next/JJ ,/, to/IN identify/VB regions/NNS of/IN the/DT promoter/NN involved/VBN ,/, we/PRP examined/VBD a/DT series/NN of/IN tenascin-C/NEWGENE promoter/NEWGENE constructs/NEWGENE with/IN 5'/CD deletions/NNS and/CC showed/VBD that/IN denatured/JJ collagen-dependent/NEWGENE promoter/NEWGENE activity/NN was/VBD retained/VBN by/IN a/DT 122-base/JJ pair/NN element/NN ,/, located/VBN -43/CD to/IN -165/CD bp/NN upstream/RB of/IN the/DT RNA/NN start/NN site/NN ./.
@@23789453031 Thus/RB adaptation/NN to/IN continuous/JJ mild/JJ stress/NN has/VBZ a/DT potent/JJ antiarrhythmic/JJ effect/NN which/WDT occurs/VBZ due/NN to/IN the/DT increased/VBN vagal/JJ tone/NN ./.
@@98001872895 Because/IN Trp53/NEWGENE (/( the/DT mouse/NEWGENE homolog/NEWGENE of/NEWGENE human/NEWGENE TP53/NEWGENE )/SYM is/VBZ located/VBN with/IN Tk1/NEWGENE on/IN chromosome/NN 11/CD and/CC is/VBZ critical/JJ in/IN regulating/JJ cellular/JJ responses/NNS following/IN exposure/NN to/IN DNA/NN damaging/JJ agents/NNS ,/, we/PRP wanted/VBD to/IN determine/VB if/IN these/DT mouse/NN lymphoma/NN cells/NNS harbor/VBP mutations/NNS in/IN Trp53/NEWGENE ./.
@@108913991710 We/PRP concluded/VBD that/DT activation/NN of/IN c-fosER/NEWGENE mediated/JJ transcriptional/JJ inhibition/NN of/IN p21/NEWGENE (/NEWGENE Cip1/NEWGENE //NEWGENE WAF1/NEWGENE )/NEWGENE through/RB a/DT previously/RB uncharacterized/JJ AP-1/NEWGENE site/NEWGENE ,/, revealing/JJ an/DT important/JJ role/NN for/IN c-fos/NEWGENE in/IN negative/JJ control/NN of/IN cell/NN cycle/NN regulatory/JJ genes/NNS ./.
@@104978746010 On/IN the/PDT other/DT hand/NN ,/, phosphatidyl/JJ inositol/NN 4/CD ,/CD 5/CD bisphosphate/NN (/( PIP2/NN )/SYM hydrolysis/NN requires/VBZ direct/JJ phosphorylation/NN at/IN tyrosine/NN residue/NN of/IN the/DT PLC-gamma1/NEWGENE isozyme/NEWGENE ./.
@@31497741076 In/NN the/DT IA/NN task/NN ,/, post-training/JJ intraperitoneal/JJ injections/NNS of/IN picrotoxin/NN and/CC bicuculline/NN induced/VBD a/DT dose-dependent/NN enhancement/NN of/IN retention/NN measured/VBN 24/CD h/NN after/IN the/DT training/NN ,/, while/CC retention/NN was/VBD not/RB affected/VBN by/IN bicuculline/NN methiodide/NN (/( a/DT GABA/NEWGENE receptor/NEWGENE antagonist/NN that/WDT does/VBP not/RB readily/RB cross/VB the/DT blood-brain/JJ barrier/NN )/SYM ./.
@@111520708040 The/DT actA/NEWGENE gene/NEWGENE is/VBZ present/VB as/IN a/DT single/JJ copy/NN in/IN the/DT genome/NN of/IN A/NNP ./NNP chrysogenum/NN ;/: and/CC its/PRP expression/NN level/NN ,/, opposite/NN to/IN pcbC/NEWGENE and/CC cefEF/NEWGENE cephalosporin/NEWGENE biosynthetic/NEWGENE genes/NEWGENE ,/, was/VBD steady/JJ during/IN cephalosporin/NEWGENE fermentation/NN ,/, showing/VBG a/DT single/JJ 1/CD ./CD 4-kb/CD transcript/NN ./.
@@6254403615 The/DT antibody/NN titer/NN of/IN 202/CD chickens/NNS to/IN SA-11/NN rotavirus/NN was/VBD determined/VBN by/IN enzyme-linked/JJ immunosorbent/JJ blocking/JJ assay/NN ./.
@@14046123266 Therefore/RB ,/, recombinant/JJ human/JJ Ads/NNS that/WDT express/VBP noninfectious/JJ HIV/NN or/CC other/DT microbial/JJ proteins/NNS are/VBP attractive/JJ vaccine/NN candidates/NNS ./.
@@119178829722 Based/VBN on/IN a/DT morphological/JJ study/NN of/IN the/DT resin-dentine/JJ interface/NN ,/, a/DT broad/JJ selection/NN of/IN dentine/NN adhesive/JJ systems/NNS was/VBD classified/VBN following/IN their/PRP adhesion-strategy/JJ ./.
@@117816151633 Chronic/NN graft-versus-host/JJ disease/NN (/( cGVHD/NN )/SYM is/VBZ a/DT major/JJ complication/NN of/IN allogeneic/JJ hematopoietic/JJ cell/NN transplantation/NN ./.
@@72494977078 These/DT women/NNS should/MD not/RB be/VB given/VBP the/DT current/JJ estrogen/NN PPI/NN ,/, which/WDT was/VBD designed/VBN to/IN warn/VB women/NNS of/IN the/DT risks/NNS of/IN long-term/JJ estrogen/NN use/NN ;/: a/DT PPI/NN should/MD be/VB written/VBP specifically/RB for/IN patients/NNS receiving/JJ short/JJ courses/NNS ./.
@@18860432504 For/IN SMX/NN at/IN pH/NN 7/CD ./CD 0/CD ,/, a/DT 1/CD :/: 1/CD complex/NN is/VBZ formed/VBN ,/, but/CC at/IN pH/NN 7/CD ./CD 5/CD HPCD/WDT has/VBZ little/JJ effect/NN on/IN the/DT solubility/NN of/IN the/DT highly/RB ionized/JJ SMX/NN ,/, presumably/RB since/IN only/RB un-ionized/JJ molecules/NNS can/MD form/VB inclusion/NN complexes/NNS with/IN the/DT HPCD/NN ./.
@@119126771827 With/IN such/JJ analysis/NN ,/, one/PRP can/MD test/VB hypotheses/NNS about/RB the/DT structure/NN of/IN latent/JJ variability/NN within/IN a/DT given/NN data/NN set/NN ./.
@@105560468713 Here/RB ,/, we/PRP propose/VBP that/IN an/DT antagonistic/JJ ,/, BMP/JJ //JJ ALK2/JJ //JJ Smad-mediated/JJ signaling/JJ pathway/NN is/VBZ active/JJ on/IN the/DT right/JJ side/NN of/IN the/DT Xenopus/NN embryo/NN ./.
@@77981342424 The/DT hsp70/NEWGENE gene/NEWGENE family/NEWGENE of/IN Neurospora/NN crassa/NN :/: cloning/NN ,/, sequence/NN analysis/NN ,/, expression/NN ,/, and/CC genetic/JJ mapping/NN of/IN the/DT major/JJ stress-inducible/JJ member/NN ./.
@@117239281563 The/DT process/NN has/VBZ been/VBN applied/VBN to/IN the/DT river/NN reclamation/NN in/IN Yangpu/NNP District/NNP of/IN Shanghai/NNP City/NNP ,/, China/NN ./.
@@2994336794 FK/NN 33-824/JJ ,/, a/DT methionine-enkephalin/NN analogue/NN ,/, suppressed/VBN plasma/NN ACTH/NEWGENE to/IN 85%/NN of/IN basal/JJ level/NN ,/, while/CC bromocriptine/NN (/( CB-154/IN )/SYM caused/VBN no/DT significant/JJ change/NN ./.
@@38108674495 Most/JJS of/IN the/DT patients/NNS had/VBP locally/RB advanced/JJ lesions/NNS (/( 63/CD T3-4/NN :/: 91/CD ./CD 5%/CD )/SYM according/VBG to/IN the/DT adopted/VBN TNM/NN system/NN (/( Lederman-Gadeberg/NNP ,/, Sisson-Jesse/NNP )/SYM ./.
@@1516829103 Previously/RB ,/, we/PRP showed/VBD that/IN SNF2/NEWGENE ,/, SNF5/NEWGENE ,/, and/CC SNF6/NEWGENE function/NN interdependently/RB in/IN transcriptional/JJ activation/NN ,/, possibly/RB forming/JJ a/DT heteromeric/JJ complex/NN ./.
@@23543813012 There/EX were/VBD 5/CD treatments/NNS :/: control/NN (/( C/NN )/SYM ;/: a/DT wooden/JJ surround/VB in/IN one/PRP rear/NN corner/NN of/IN the/DT cage/NN (/( S/NNP )/SYM ;/: a/DT fiberglass/NN rollaway/NN hollow/JJ in/IN one/PRP rear/NN corner/NN of/IN the/DT cage/NN (/( H/NN )/SYM ;/: a/DT hollow/JJ and/CC a/DT surround/VB (/( H/NNP //NNP S/NNP )/SYM ;/: a/DT nest/NN box/NN attached/VBN to/IN the/DT back/NN of/IN the/DT cage/NN ,/, containing/JJ a/DT hollow/JJ (/( N/JJ )/SYM ./.
@@51523145402 Sinusoidal/JJ oscillations/NNS of/IN a/DT gas/NN dilution/NN indicator/NN ./.
@@39775774632 Shoulder/NN forearm/NN support/NN for/IN the/DT subluxed/VBN shoulder/NN ./.
@@30918493814 The/DT effects/NNS of/IN glutaraldehyde/NN on/IN dimensions/NNS and/CC ultrastructure/NN of/IN microvascular/JJ beds/NNS in/IN rat/NN mesentery/NN were/VBD studied/VBN in/IN two/JJ kinds/NNS of/IN experiment/NN ,/, administering/JJ the/DT fixative/NN by/IN intra-arterial/JJ perfusion/NN at/IN a/DT pressure/NN of/IN 80/CD mm/NN Hg/NN and/CC by/IN superfusion/NN of/IN the/DT exteriorized/VBN mesenteric/JJ membrane/NN ./.
@@869019818 METHODS/IN :/: Rats/NNP received/VBD continuous/JJ intragastric/JJ infusion/NN of/IN elemental/JJ diet/NN or/CC with/IN supplementation/NN of/IN oatbase/NN ,/, Lactobacillus/NN reuteri/JJ R2LC/NN ,/, and/CC Lactobacillus/NN plantarum/NN DSM/NN 9843/CD ,/, with/IN and/CC without/IN fermentation/NN ,/, from/IN the/DT beginning/NN of/IN the/DT study/NN ./.
@@19363486201 The/DT examinations/NNS were/VBD performed/VBN on/IN two/JJ groups/NNS of/IN 20/CD (/( using/VBG AmF/NN //NN SnF2/NN )/JJ -/JJ ,/, resp/NN ./.
@@84131861355 The/DT Ntl1/NEWGENE gene/NEWGENE is/VBZ present/VB as/IN a/DT unique/JJ copy/NN in/IN the/DT diploid/JJ N/NNP ./NNP plumbaginifolia/NN species/NN ./.
@@9892021637 Overexpression/NNS of/IN PTTG/NEWGENE in/IN transfected/VBN NIH/NN 3T3/CD cells/NNS also/RB stimulated/VBN expression/NN and/CC secretion/NN of/IN basic/NEWGENE fibroblast/NEWGENE growth/NEWGENE factor/NEWGENE ,/, a/DT human/JJ pituitary/JJ tumor/NN growth-regulating/JJ factor/NN ./.
@@31348723848 Apropos/RB of/IN a/DT case/NN ./.
@@3104982422 After/IN age/NN 30/CD ,/, mean/JJ hemoglobin/NEWGENE levels/NNS for/IN men/NNS gradually/RB declined/VBN ,/, while/CC those/DT in/NN women/NNS rose/VBD ,/, so/RB that/IN the/DT sex/NN difference/NN diminished/VBN after/IN 60/CD years/NNS of/IN age/NN ./.
@@98274467178 Familial/JJ autoimmune/JJ hepatitis/NN and/CC C4/NEWGENE deficiency/NN ./.
@@8756617354 Biol/NNP ./.
@@29060271872 Among/IN unusual/JJ features/NNS ,/, we/PRP report/VBP numerous/JJ large/NN G/NN +/SYM C-rich/NN conserved/VBN sequences/NNS located/VBN in/IN the/DT first/JJ intron/NN ./.
@@79691167200 The/DT Nur77/NEWGENE protein/NEWGENE can/MD act/VB as/IN a/DT potent/JJ transcription/NN activator/NN and/CC may/MD function/VB to/IN regulate/VB the/DT expression/NN of/IN downstream/JJ genes/NNS in/IN response/NN to/IN extracellular/JJ stimuli/NNS ./.
@@84768542764 DNase/NEWGENE I/NEWGENE footprinting/VBG with/IN rat/NN liver/NN nuclear/JJ extracts/NNS identified/VBN 7/CD major/JJ protein-binding/NN domains/NN termed/JJ P1/NEWGENE through/RB P7/NEWGENE in/IN a/DT 796/CD base/NN pair/NN DNA/NN fragment/NN (/( base/NN pairs/NNS -763/JJ to/IN +33/CD )/SYM ./.
@@1140401069 The/DT observed/VBN triplexes/NNS depend/VBP on/IN the/DT length/NN of/IN the/DT repeat/NN ./.
@@88255564967 This/DT element/NN ,/, termed/JJ CREsp-a/NEWGENE (/( TGACCTCA/NEWGENE )/SYM ,/, differs/VBZ by/IN one/PRP nucleotide/NN from/IN a/DT palindromic/JJ CRE/NEWGENE (/( CREpal/NEWGENE ,/, TGACGTCA/NEWGENE )/SYM ,/, which/WDT is/NNS known/VBP to/IN bind/NN CREB/NEWGENE as/IN a/DT homodimer/NN ./.
@@68906226687 Its/PRP vasodilatory/JJ ,/, anti-vasopressor/JJ ,/, and/CC platelet/NN stabilizing/JJ effects/NNS could/MD be/VB expected/VBN to/IN counteract/VB the/DT placental/JJ ischemia/NN ,/, hypertension/NN and/CC excessive/JJ coagulation/NN that/WDT are/VBP seen/VBP in/IN pre-eclampsia/NN ./.
@@106406835273 Transient/JJ transfection/NN assays/NNS using/VBG P19/CD cells/NNS revealed/VBD that/DT expression/NN of/IN NDRF/NEWGENE //NEWGENE NeuroD2/NEWGENE increased/VBN the/DT transactivation/NN of/IN the/DT rat/NEWGENE insulin/NEWGENE promoter/NEWGENE element/NEWGENE 3/NEWGENE (/( RIPE3/NEWGENE )/SYM enhancer/NN up/JJ to/IN approximately/RB 12-fold/JJ and/CC that/DT co-expression/NN of/IN catalytically/RB active/JJ form/NN of/IN PKN/NEWGENE ,/, but/CC not/RB kinase-deficient/JJ derivative/NN ,/, resulted/VBN in/IN a/DT further/RB threefold/JJ increase/NN of/IN NDRF/JJ //JJ NeuroD2-mediated/JJ transcription/NN ./.
@@94657839425 Platelet/NN aggregation/NN in/IN response/NN to/IN 10/CD micrograms/NNS collagen/NN //NN ml/NN was/VBD decreased/VBN in/IN parallel/JJ after/IN treatment/NN with/IN ASA/NN ./.
@@87470788734 Low-dose/NNP aspirin/NN and/CC recurrent/JJ miscarriage/NN ./.
@@1063349952 Arhythmacanthus/NNP Yamaguti/NN ,/, 1935/CD is/VBZ maintained/VBN as/IN a/DT synonym/NN of/IN Heterosentis/NNP because/IN the/DT distinction/NN between/IN two/JJ and/CC three/CD hook/NN types/NNS is/NNS made/VBP equivocal/JJ when/CC the/DT transition/NN between/IN the/DT apical/JJ and/CC subapical/JJ hooks/NNS is/VBZ gradual/JJ ./.
@@90911255959 Autorosette-forming/VBG cells/NNS are/VBP characterized/VBN by/IN a/DT high/JJ activity/NN of/IN alkaline/NEWGENE and/NEWGENE acid/NEWGENE phosphatases/NEWGENE and/CC low/JJ NBT-test/NNP values/NNS ./.
@@18394142436 The/DT spectrum/NN of/IN histologically/RB diagnosed/VBN malignant/JJ neoplasms/NNS in/IN Sabah/NNP ,/, 1983-1988/CD ./.
@@6093354773 Eight/CD recombinant/JJ DNA/NN clones/NNS of/IN endogenous/JJ murine/JJ leukemia/NN virus/NN (/( MuLV/NN )/NN -related/NN DNA/NN sequences/NNS have/VBP been/VBN isolated/VBN from/IN a/DT lambdaphage/JJ genomic/JJ library/NN of/IN Balb/NN //NN c/NN mouse/NN DNA/NN ./.
@@63006627599 A/DT cDNA/NN cloning/NN vector/NN that/WDT permits/VBP expression/NN of/IN cDNA/NN inserts/NNS in/IN mammalian/JJ cells/NNS ./.
@@15439095224 When/WRB transiently/RB transfected/VBN into/IN K562/NNP cells/NNS ,/, this/DT Lg/NEWGENE genomic/JJ clone/NN is/VBZ actively/RB transcribed/VBN ,/, suggesting/VBG that/IN ,/, although/IN it/PRP possesses/VBZ the/DT characteristics/NNS of/IN a/DT processed/VBN pseudogene/NN ,/, it/PRP is/VBZ likely/RB to/IN correspond/VB to/IN the/DT gene/NN encoding/VBG this/DT new/JJ ferritin/NEWGENE subunit/NEWGENE ./.
@@94171086853 The/DT murine/NEWGENE Htf9-a/NEWGENE //NEWGENE RanBP1/NEWGENE and/CC Htf9-c/NEWGENE genes/NEWGENE are/VBP divergently/RB transcribed/VBN from/IN a/DT shared/VBN TATA-less/NNP promoter/NN ./.
@@30902373811 Under/IN these/DT schedules/NNS ,/, a/DT reinforced/VBN response/NN run/NN consisted/VB of/IN responding/VBG between/IN eight/CD and/CC 12/CD times/NNS on/IN one/PRP response/NN key/NN (/( work/NN key/NN )/SYM and/CC then/RB responding/VBG once/CC on/IN a/DT second/JJ response/NN key/NN (/( reinforced/VBN key/NN )/SYM ./.
@@108725355039 AIMS/IN :/: To/TO evaluate/VB the/DT role/NN of/IN environmental/JJ intra-uterine/NN factors/NN in/IN determining/VBG the/DT birthweights/NNS of/IN twins/NNS with/IN increased/VBN susceptibility/NN to/IN diabetes/NN and/CC discordant/JJ for/IN abnormal/JJ responses/NNS to/IN the/DT oral/JJ glucose/NN tolerance/NN test/NN (/( OGTT/NN )/SYM and/CC verify/VB the/DT possible/JJ association/NN of/IN within-pair/JJ birthweight/NN differences/NNS and/CC metabolic/JJ abnormalities/NNS in/IN adult/JJ life/NN ./.
@@30666253778 Although/IN large/JJ epidemiologic/JJ studies/NNS are/VBP best/JJS able/JJ to/IN identify/VB the/DT relative/JJ contributions/NNS of/IN specific/JJ risk/NN factors/NNS while/CC controlling/VBG for/IN other/DT risk/NN factors/NNS ,/, new/JJ studies/NNS need/NN to/IN focus/NN on/IN important/JJ unresolved/JJ questions/NNS ./.
@@13507806148 Amino/NN acid/NN sequence/NN comparison/NN revealed/VBD significant/JJ homology/NN between/IN the/DT yeast/NEWGENE and/NEWGENE Escherichia/NEWGENE coli/NEWGENE gamma-glutamyl/NEWGENE kinases/NEWGENE throughout/IN their/PRP lengths/NNS ./.
@@82825765460 Tumours/NNS of/IN the/DT cavum/NN oris/NN and/CC oropharynx/NN of/IN T1-stage/NN are/VBP possible/JJ only/RB in/IN 1/CD of/IN 3/CD cases/NNS ./.
@@75656889352 Expression/NNS and/CC regulation/NN by/IN interferon/NN of/IN a/DT double-stranded-RNA-specific/NEWGENE adenosine/NEWGENE deaminase/NEWGENE from/IN human/JJ cells/NNS :/: evidence/NN for/IN two/JJ forms/NNS of/IN the/DT deaminase/NEWGENE ./.
@@107776694547 The/DT ZNF274/NEWGENE gene/NEWGENE is/VBZ mapped/VBN distal/JJ to/IN marker/NN RP/NN S28/NN 1/CD in/IN the/DT human/JJ chromosome/NN 19qter/NN region/NN ,/, by/IN RH/NN mapping/NN ./.
@@94133755433 In/NN ICU/NN patients/NNS ,/, the/DT LIS/NN related/VBN to/IN the/DT postoperative/JJ rise/NN in/IN IL-6/NEWGENE level/NN only/RB ,/, even/VB though/CC the/DT rise/NN in/IN plasma/NN concentrations/NNS of/IN cytokines/NNS interrelated/VBN ./.
@@22290687840 Gene/NNP constructs/NNS possessing/VBG the/DT complete/NEWGENE tat/NEWGENE ,/, rev/NEWGENE (/( tat+/NEWGENE rev+/NEWGENE1 )/SYM and/CC env/NEWGENE genes/NEWGENE were/VBD transiently/RB expressed/VBN in/IN COS-1/NNP cells/NNS as/IN precursor/NEWGENE SU-TM/NEWGENE (/( gp160/NEWGENE )/SYM ,/, SU/NEWGENE ./NEWGENE TM/NEWGENE (/( gp120/NEWGENE x/NEWGENE 41/NEWGENE )/SYM ,/, and/CC nucleolar/NEWGENE rev/NEWGENE protein/NEWGENE ./.
@@118281868196 The/DT population/NN studied/VBN comprised/VBN 4472/CD men/NNS and/CC 5212/CD women/NNS aged/VBD 30-74/JJ years/NNS ,/, without/IN coronary/JJ heart/NN disease/NN ,/, who/WP had/VBP CRP/NN measurements/NNS in/IN the/DT Third/NNP National/NNP Health/NNP and/CC Nutrition/NNP Examination/NNP Survey/NNP (/( NHANES/NN III/NN )/SYM ./.
@@14471399229 V/NNP ./NNP
@@21232955488 Disruption/NNS of/IN ARF2/NEWGENE causes/VBZ no/DT detectable/JJ phenotype/NN ./.
@@104545703147 The/DT analysis/NN of/IN two/JJ distinct/JJ mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE pathways/NNS shows/VBZ that/IN stress-activated/NEWGENE protein/NEWGENE kinase-Jun/NEWGENE N-terminal/NEWGENE kinase/NEWGENE activation/NN ,/, resulting/JJ in/IN the/DT phosphorylation/NN of/IN ATF-2/NEWGENE ,/, c-Jun/NEWGENE ,/, and/CC JunD/NEWGENE ,/, is/VBZ required/VBN not/RB only/RB for/IN the/DT IL-1-/NNP but/CC also/RB for/IN the/DT TPA-dependent/NNP induction/NN ,/, while/CC the/DT extracellular/NEWGENE signal-related/NEWGENE kinase/NEWGENE 1/NEWGENE (/( ERK-1/NEWGENE )/SYM and/CC ERK-2/NEWGENE activation/NN is/VBZ involved/VBN in/IN the/DT TPA-/NNP but/CC not/RB in/IN the/DT IL-1-dependent/NNP stimulation/NN of/IN the/DT uPA/NEWGENE enhancer/NEWGENE ./.
@@12150671860 The/DT specific/JJ electrical/JJ resistance/NN of/IN the/DT cerebrospinal/JJ fluid/NN was/VBD measured/VBN by/IN means/NN of/IN conductometry/NN in/IN 14/CD cases/NNS of/IN meningitis/NN purulenta/NN ,/, 17/CD cases/NNS of/IN meningitis/NN serosa/NN ,/, 10/CD cases/NNS of/IN encephalitis/NN and/CC in/IN 32/CD control/NN subjects/NNS ./.
@@76597578527 Incubation/NNS of/IN the/DT purified/VBN fusion/NN proteins/NNS with/IN [/NN gamma-32P/NN ]/NN ATP/NN in/IN an/DT in/NN vitro/FW assay/NN showed/VBN that/IN both/DT proteins/NNS were/VBD capable/JJ of/IN autophosphorylation/NN ./.
@@10208893142 Overall/RB ,/, our/PRP results/NNS suggest/VBP that/IN resistant/JJ genotypes/NNS exist/VBP among/IN the/DT WAD/NNP goat/NN population/NN ./.
@@83310673002 Complete/JJ nucleotide/NN sequence/NN of/IN the/DT bacteriophage/NEWGENE K1F/NEWGENE tail/NEWGENE gene/NEWGENE encoding/VBG endo-N-acylneuraminidase/NEWGENE (/( endo-N/NEWGENE )/SYM and/CC comparison/NN to/IN an/DT endo-N/NEWGENE homolog/NEWGENE in/IN bacteriophage/NN PK1E/NNP ./.
@@79597342874 In/NN human/JJ brain/NN ,/, contactin/NEWGENE was/VBD first/RB identified/VBN by/IN amino/JJ terminal/NN and/CC peptide/NN sequencing/VBG of/IN the/DT lentil-lectin-binding/NEWGENE glycoprotein/NEWGENE Gp135/NEWGENE ./.
@@73806157219 It/PRP was/VBD argued/VBN that/IN this/DT arose/VBD from/IN the/DT possibility/NN that/IN the/DT nature/NN of/IN blue/JJ collar/NN jobs/NNS was/VBD physical/JJ ,/, and/CC that/DT loss/NN of/IN myocardial/JJ tissue/NN might/MD be/VB expected/VBN to/IN more/RB markedly/RB interfere/VB with/IN their/PRP work/NN efficiency/NN (/( on/IN returning/VBG to/IN work/NN )/SYM than/IN it/PRP would/MD the/DT efficiency/NN of/IN the/DT more/RB sedentary/JJ jobs/NNS of/IN white/JJ collar/NN workers/NNS ./.
@@91713897958 Based/VBN on/IN the/DT occurrence/NN of/IN several/DT transcription/NN signals/NNS in/IN the/DT Thermus/NEWGENE pyr/NEWGENE promoter/NEWGENE region/NEWGENE and/CC strong/JJ amino/JJ acid/NN sequence/NN identities/NNS (/( about/RB 60%/CD )/SYM between/IN Thermus/NEWGENE PyrR/NEWGENE and/CC the/DT PyrR/NEWGENE attenuation/NEWGENE proteins/NEWGENE of/IN two/JJ Bacillus/NN sp/NN ./NN ,/, we/PRP propose/VBP a/DT regulatory/JJ mechanism/NN involving/VBG transcriptional/JJ attenuation/NN to/IN control/NN pyr/NEWGENE gene/NEWGENE expression/NN in/IN Thermus/NNP ./.
@@11231287128 The/DT sensitivity/NN of/IN human/JJ neuroblastoma/NN cells/NNS SK-N-SH/WDT to/IN undergo/VB apoptosis/NN induced/VBN by/IN thapsigargin/NN was/VBD examined/VBN ./.
@@93144879282 Detection/NNS of/IN airborne/JJ Mycobacterium/NN tuberculosis/NN by/IN air/NN filtration/NN and/CC polymerase/NEWGENE chain/NN reaction/NN ./.
@@29502165816 Functional/JJ flow/NN was/VBD evaluated/VBN using/VBG laser/NN Doppler/NN flowmetry/NN (/( LDF/NN )/SYM ,/, for/IN which/WDT the/DT output/NN signal/JJ ,/, blood/NN cell/NN flux/NN (/( BCF/NN )/SYM ,/, is/VBZ expressed/VBN in/IN terms/NNS of/IN volts/NNS ./.
@@77748074656 The/DT bHLH/NEWGENE proteins/NEWGENE function/NN as/IN potent/JJ transcriptional/JJ activators/NNS of/IN tissue-specific/NN genes/NN by/IN forming/NN heterodimers/NN between/IN ubiquitous/JJ and/CC cell-restricted/NN family/NN members/NN ./.
@@72371239092 Evoked/JJ potential/JJ and/CC single/JJ unit/NN responses/NNS to/IN olfactory/JJ nerve/NN volleys/NNS in/IN the/DT isolated/VBN turtle/NN olfactory/NN bulb/NN ./.
@@88876527824 Selection/NN was/VBD based/VBN on/IN expression/NN of/IN an/DT integrated/JJ DNA/NN fragment/NN containing/JJ the/DT con-10/NEWGENE promoter-regulatory/NEWGENE region/NEWGENE followed/VBN by/IN the/DT initial/JJ segment/NN of/IN the/DT con-10/NEWGENE open/NEWGENE reading/NEWGENE frame/NEWGENE fused/VBN in/IN frame/NN with/IN the/DT bacterial/NEWGENE hygromycin/NEWGENE B/NEWGENE phosphotransferase/NEWGENE structural/NEWGENE gene/NEWGENE (/( con10'-'hph/NEWGENE )/SYM ./.
@@61215775946 3/CD Significant/JJ reductions/NNS in/IN lying/NN mean/JJ arterial/JJ blood/NN pressure/NN were/VBD observed/VBN with/IN daily/JJ doses/NNS of/IN 200/CD mg/NN (/( -/: 9%/CD )/SYM ,/, 400/CD mg/NN (/( -/: 10%/CD )/SYM and/CC 800/CD mg/NN (/( -/: 14%/JJ )/SYM ,/, and/CC were/VBD associated/VBN with/IN significant/JJ decreases/NNS in/IN heart/NN rate/NN and/CC plasma/NEWGENE renin/NEWGENE activity/NN ./.
@@19751572592 The/DT antilog/NN transformation/NN of/IN pH/NN did/VBD not/RB improve/VB the/DT results/NNS ./.
@@37040874569 All/DT 33/CD subjects/NNS were/VBD given/VBP psychometric/JJ instruments/NNS for/IN measuring/JJ various/JJ components/NNS of/IN anger/NN and/CC anxiety/NN :/: Spielberger's/NNP State-Trait/NN Personality/NNP Inventory/NN ,/, the/DT Anger/NN Expression/NNP Scale/NNP ,/, and/CC the/DT State/NNP Anger/NN Reaction/NN Scale/NNP ./.
@@92021475161 The/DT data/NN suggest/VB that/IN like/JJ in/IN yeast/NN ,/, in/IN plants/VBZ a/DT certain/JJ subfamily/NN of/IN UBC/NEWGENE is/VBZ specifically/RB involved/VBN in/IN the/DT proteolytic/JJ degradation/NN of/IN abnormal/JJ proteins/NNS as/IN result/NN of/IN stress/NN ./.
@@84095932873 1/NN )/NN CFDN/NNP ,/, AMPC/NNS and/CC MNZ/NN showed/VBD a/DT potent/JJ antimicrobial/JJ activity/NN against/IN H/NNP ./NNP pylori/NNS ,/, and/CC especially/RB ,/, AMPC/NNS showed/VBD a/DT marked/JJ bactericidal/JJ activity/NN in/IN a/DT short/JJ time/NN ./.
@@96019219568 Tributyltin/NNP and/CC its/PRP breakdown/NN products/NNS ,/, mono-/JJ and/CC di-butyltin/JJ ,/, were/VBD determined/VBN in/IN water/NN birds/NNS collected/VBN from/IN Lake/NNP Huron/NN (/( the/DT Great/NNP Lakes/NNPS )/SYM ,/, marine/JJ coastal/JJ United/NNP States/NNPS ,/, and/CC the/DT west/NN coast/NN of/IN British/JJ Columbia/NN ,/, Canada/NN ./.
@@75184261289 Interleukin-8/NEWGENE (/( IL-8/NEWGENE )/SYM is/VBZ a/DT potent/JJ inflammatory/JJ mediator/NN that/WDT belongs/VBZ to/IN the/DT family/NN of/IN C-X-C/NEWGENE chemokines/NEWGENE ./.
@@105236637678 This/DT motif/NN ,/, first/RB described/VBN for/IN the/DT Drosophila/NEWGENE homeobox/NEWGENE activator/NEWGENE DEAF-1/NEWGENE ,/, identifies/VBZ an/DT emerging/JJ group/NN of/IN metazoan/JJ transcriptional/JJ modulators/NNS ./.
@@84413943701 Therefore/RB ,/, PC-PLC/NEWGENE is/VBZ a/DT component/NN of/IN a/DT signal/JJ transduction/NN pathway/NN leading/JJ to/IN transcription/NN of/IN c-fos/NEWGENE and/CC junB/NEWGENE that/WDT collaborates/VBZ with/IN c-myc/NEWGENE and/CC is/VBZ independent/NN of/IN PKC-delta/NEWGENE and/CC Ras/NEWGENE activation/NN ./.
@@111664788743 Peripheral/JJ and/CC preemptive/JJ opioid/JJ antinociception/NN in/IN a/DT mouse/NN visceral/NN pain/NN model/NN ./.
@@109083649582 G-DNA/NEWGENE is/VBZ a/DT four-stranded/JJ DNA/NN structure/NN with/IN diverse/JJ putative/JJ biological/JJ roles/NNS ./.
@@10902104571 Mean/VB total/JJ lung/NN capacity/NN ,/, functional/JJ residual/JJ capacity/NN ,/, and/CC residual/JJ volume/NN increased/VBN significantly/RB ,/, and/CC the/DT mean/JJ closing/JJ volume/NN ,/, the/DT lung/NN volume/NN above/RB residual/JJ volume/NN at/IN which/WDT phase/VBP IV/NN begins/VBZ ,/, decreased/VBN significantly/RB with/IN 11/CD cm/NN H20/NN continuous/JJ positive/JJ airway/NN pressure/NN ;/: differences/NNS at/IN 5/CD cm/NN H20/NN were/VBD not/RB significant/JJ ./.
@@13965729924 Negatively/RB supercoiled/VBN plasmid/NN pUC19/NN did/VBD not/RB compete/VB ,/, whereas/IN an/DT otherwise/RB identical/JJ plasmid/NN pUC19/NN (/NN CG/NN )/NN ,/, which/WDT contained/VBD a/DT (/( dG-dC/JJ )/NN 7/NN segment/NN in/IN the/DT Z-form/NN was/VBD an/DT excellent/JJ competitor/NN ./.
@@1918010565 Deletion/NNS of/IN the/DT proximal/JJ octanucleotide/NN motif/NN from/IN the/DT plasmid/NN containing/JJ the/DT -461/CD fragment/NN of/IN the/DT LPL/NEWGENE promoter/NEWGENE ,/, resulted/VBN in/IN a/DT 79/CD and/CC 76%/CD decrease/NN in/IN the/DT level/NN of/IN expression/NN in/IN transfected/VBN 3T3-L1/CD adipocytes/NNS and/CC HepG2/NN hepatocytes/NNS ,/, respectively/RB ./.
@@109251596241 Whereas/IN MARTA1/NEWGENE is/VBZ clearly/RB detectable/JJ in/IN crude/JJ lysates/NNS ,/, cytosolic/JJ and/CC ribosomal/JJ salt-wash/JJ fractions/NNS ,/, and/CC in/IN nuclear/JJ extracts/NNS ,/, MARTA2/NEWGENE is/VBZ preferentially/RB found/VB in/IN the/DT ribosomal/JJ salt-wash/NN preparation/NN ./.
@@36968994644 Blood/NEWGENE serum/NEWGENE erythropoietin/NEWGENE level/NN and/CC basic/JJ hematological/JJ indices/NNS during/IN the/DT adaptation/NN of/IN healthy/JJ newborn/JJ infants/NNS ./.
@@106287506015 Angiotensin/NEWGENE II/NEWGENE induces/VBZ nuclear/NEWGENE factor/NEWGENE (/NEWGENE NF/NEWGENE )/NEWGENE -kappaB1/NEWGENE isoforms/NEWGENE to/IN bind/NN the/DT angiotensinogen/NEWGENE gene/NEWGENE acute-phase/NN response/NN element/NN :/: a/DT stimulus-specific/JJ pathway/NN for/IN NF-kappaB/NEWGENE activation/NN ./.
@@17366514079 SETTING--Women/NN ,/, Infants/NNS ,/, and/CC Children/NNS clinics/NNS in/IN Minneapolis/NN ,/, Minn/NNP ./.
@@40882334780 The/DT transit/NN time/NN was/VBD significantly/RB shortened/VBN ./.
@@9596738121 Roles/NNS of/IN the/DT Candida/NEWGENE albicans/NEWGENE mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE homolog/NEWGENE ,/, Cek1p/NEWGENE ,/, in/IN hyphal/JJ development/NN and/CC systemic/JJ candidiasis/NN ./.
@@86722422197 By/IN using/VBG reporter/NN gene/NN constructs/NNS ,/, it/PRP is/NNS shown/VBP that/IN upstream/JJ sequences/NNS of/IN the/DT P1/NEWGENE promoter/NEWGENE contain/VB several/DT regions/NNS that/WDT modulate/VBP the/DT expression/NN either/DT positively/RB or/CC negatively/RB ./.
@@95124169261 RESULTS/NNS :/: Using/VBG information/NN in/IN the/DT dbEST/NN database/NN of/IN expressed/VBN sequence/NN tags/NNS ,/, we/PRP isolated/VBD an/DT Arabidopsis/NN thaliana/NN gene/NN (/( GCR1/NEWGENE )/SYM that/IN encodes/VBZ a/DT protein/NN with/IN seven/RB predicted/VBN membrane-spanning/NN domains/NN and/CC other/DT features/NNS characteristic/NN of/IN 7TM/NEWGENE receptors/NEWGENE ./.
@@10556145376 Gentamicin/WDT given/VBP by/IN DPI/NN and/CC SVN/NN significantly/RB decreased/VBD the/DT sputum/NN Psa/NN density/NN (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM ,/, by/IN almost/RB one/PRP order/NN of/IN magnitude/NN ./.
@@30004572795 The/DT 210/CD kDa/NN precursor/NN is/VBZ converted/VBN slowly/RB (/( t/NN 1/CD //CD 2/CD =/SYM 2/CD h/NN )/SYM by/IN proteolytic/JJ processing/NN into/IN a/DT 125/CD kDa/NN (/( alpha'/NN )/SYM and/CC 83/CD kDa/NN (/( beta'/NN )/SYM species/NN ./.
@@82235927425 TATA/NN and/CC CCAAT/NNP boxes/NNS are/VBP located/VBN 34-bp/JJ and/CC 68-bp/JJ ,/, respectively/RB ,/, upstream/RB of/IN the/DT transcription/NN start/NN site/NN ,/, the/DT 5'-untranslated/JJ leader/NN is/VBZ 78/CD nucleotides/NNS long/JJ ,/, and/CC the/DT intronless/JJ gene/NN has/VBZ at/IN least/RB two/JJ different/JJ polyadenylation/NN sites/NN ./.
@@93938755658 We/PRP speculate/VBP that/IN the/DT human/JJ papillomavirus/NN late/JJ mRNAs/NNS ,/, produced/VBN from/IN several/DT hundred/JJ copies/NNS of/IN the/DT virus/NN genome/NN present/NN in/IN infected/VBN cells/NNS ,/, compete/VB with/IN the/DT c-fos/NEWGENE mRNAs/NEWGENE for/IN destabilizing/JJ cellular/JJ factors/NNS and/CC that/IN this/DT may/MD lead/NN to/IN elevated/VBN Fos/NEWGENE protein/NEWGENE levels/NNS in/IN human/JJ papillomavirus/NN infected/VBD cells/NNS ./.
@@93156338199 The/DT deduced/VBN amino/JJ acid/NN sequence/NN of/IN the/DT gene/NN has/VBZ significant/JJ homology/NN to/IN the/DT interferon/NEWGENE regulatory/NEWGENE factors/NEWGENE (/( IRFs/NEWGENE )/SYM ./.
@@93454955001 PET/NN activation/NN studies/NNS are/VBP performed/VBN widely/RB to/IN study/NN human/JJ brain/NN function/NN ./.
@@112812011114 Deterministic/JJ effects/NNS ./.
@@107884802985 Regulation/NN of/IN mitochondrial/NEWGENE single-stranded/NEWGENE DNA-binding/NEWGENE protein/NEWGENE gene/NEWGENE expression/NN links/NNS nuclear/JJ and/CC mitochondrial/JJ DNA/NN replication/NN in/IN drosophila/NN ./.
@@84414118377 In/NN mitogen-stimulated/JJ splenocytes/NNS ,/, Gfi-1/NEWGENE expression/NN begins/VBZ to/IN rise/NN at/IN 12/CD h/NN after/IN stimulation/NN and/CC reaches/VBP very/RB high/JJ levels/NNS after/IN 50/CD h/NN ,/, suggesting/VBG that/IN it/PRP may/MD be/VB functionally/RB involved/VBN in/IN events/NNS occurring/VBG after/IN the/DT interaction/NN of/IN IL-2/NEWGENE with/IN its/PRP receptor/NN ,/, perhaps/RB during/IN the/DT transition/NN from/IN the/DT G1/NN to/IN the/DT S/NNP phase/NN of/IN the/DT cell/NN cycle/NN ./.
@@110148212096 The/DT LAMMER/NEWGENE protein/NEWGENE1 kinase/NEWGENE1 encoded/VBN by/IN the/DT Doa/NEWGENE locus/NEWGENE of/IN Drosophila/NN is/VBZ required/VBN in/IN both/DT somatic/JJ and/CC germline/NN cells/NNS and/CC is/VBZ expressed/VBN as/IN both/DT nuclear/JJ and/CC cytoplasmic/JJ isoforms/NNS throughout/IN development/NN ./.
@@72289557059 Several/JJ authors/NNS have/VBP recently/RB reported/VBN interference/NN in/IN theophylline/NN analysis/NN by/IN paraxanthine/NN (/( 1/JJ ,/JJ 7-dimethylxanthine/JJ )/SYM ,/, an/DT important/JJ metabolite/NN of/IN caffeine/NN ./.
@@85217175326 An/DT immunoperoxidase/NEWGENE reaction/NN ,/, PAP/NEWGENE method/NN ,/, with/IN the/DT antiserum/NN of/IN Factor/NEWGENE VIII/NEWGENE as/IN the/DT primary/JJ antibody/NN ,/, was/VBD carried/VBN out/RB in/IN the/DT endometrial/JJ biopsies/NNS to/IN detect/VB the/DT Factor/NEWGENE VIII/NEWGENE activity/NN in/IN the/DT endometrial/JJ endothelium/NN before/IN and/CC after/IN insertion/NN of/IN LNG-IUD-20/NNP ./.
@@118494171737 Age/NNP was/VBD categorized/VBN into/IN four/CD groups/NNS :/: 20-44/JJ ,/, 45-64/JJ ,/, 65-74/JJ ,/, and/CC 75+/CD ./CD RESULTS/CD :/: At/NN the/DT initiation/NN of/IN dialysis/NN PD/NN patients/NNS were/VBD approximately/RB 6/CD years/NNS younger/JJR (/( P/NN </SYM 0/CD ./CD 0001/CD )/SYM than/IN HD/NN patients/NNS ./.
@@101537598185 UPMC/NN is/VBZ not/RB the/DT only/JJ organization/NN pursuing/VBG controlled/VBN NHBC/NN organ/NN procurement/NN ,/, however/RB ./.
@@97780681909 Multivariate/JJ Cox/NN survival/NN analysis/NN identified/VBD baseline/NN EF/NN </SYM or/CC =/SYM 30%/CD ,/, presence/NN of/IN significant/JJ mitral/JJ regurgitation/NN (/( >/SYM 2+/CD )/SYM before/IN ablation/NN ,/, and/CC failure/NN to/IN exhibit/NN improved/VBD cardiac/JJ performance/NN by/IN 1/CD month/NN after/JJ ablation/NN as/IN the/DT only/RB independent/NN predictors/NN of/IN death/NN ./.
@@76155416277 Functional/JJ analysis/NN of/IN DNase-I/NEWGENE hypersensitive/JJ sites/NNS at/IN the/DT mouse/NEWGENE porphobilinogen/NEWGENE deaminase/NEWGENE gene/NEWGENE locus/NEWGENE ./.
@@76631609434 The/DT synthetic/JJ DNA/NN sequence/NN was/VBD constructed/VBN to/IN achieve/VB efficient/JJ base/NN pairing/NN with/IN Escherichia/NEWGENE coli/NEWGENE 16S/NEWGENE ribosomal/NEWGENE RNA/NEWGENE ,/, avoidance/NN of/IN internal/JJ secondary/JJ structure/NN ,/, and/CC optimal/JJ codon/NN usage/NN for/IN high-level/JJ protein/NN expression/NN in/IN accord/NN with/IN the/DT known/VBP preferences/NNS in/IN E/NNP ./NNP coli/JJ ./.
@@27254954246 Similarly/RB ,/, the/DT sequence/NN of/IN the/DT U2/NEWGENE RNA/NEWGENE region/NEWGENE shown/VBP to/IN be/VB involved/VBN in/IN pre-mRNA/NN branchpoint/NN recognition/NN in/IN yeast/NN ,/, and/CC exactly/RB conserved/VBN in/IN metazoan/NEWGENE U2/NEWGENE RNAs/NEWGENE ,/, was/VBD totally/RB divergent/JJ in/IN trypanosomes/NNS ./.
@@98194306798 The/DT Ras-related/NEWGENE GTPases/NEWGENE are/VBP small/JJ ,/, 20-/CD to/IN 25-kDa/NN proteins/NN which/WDT cycle/VBP between/IN an/DT inactive/JJ GDP-bound/NNP form/NN and/CC an/DT active/JJ GTP-bound/NNP state/NN ./.
@@87611698743 Cognitive/JJ visual/JJ dysfunction/NN in/IN a/DT child/NN with/IN cerebral/JJ damage/NN ./.
@@10365883228 The/DT most/RB common/JJ characteristics/NNS of/IN VRE/NN patients/NNS were/VBD recent/JJ prior/NN vancomycin/NN use/NN ,/, recent/JJ prior/NN susceptible/JJ enterococcal/JJ infection/NN ,/, coinfection/NN with/IN other/DT microbial/JJ pathogens/NNS ,/, and/CC concurrent/JJ fungal/JJ infection/NN ./.
@@114327768521 Northern/NNP and/CC Western/JJ blot/NN analyses/NNS demonstrated/VBN that/IN Graf/NEWGENE 2/NEWGENE is/VBZ expressed/VBN in/IN several/DT tissues/NNS ,/, with/IN the/DT highest/JJS expression/NN in/IN skeletal/JJ muscle/NN ./.
@@112512522929 3D/JJ image-processing/NN permits/VBP to/IN analyse/VB ultrasound/JJ data/NN interactively/RB in/IN three/CD orthogonal/JJ planes/NNS (/( section/NN mode/NN )/SYM or/CC in/IN realistic/JJ 3D/NN views/NN (/( rendering/VBG mode/NN )/SYM ./.
@@15633435444 Lac/NNP operators/NNS were/VBD introduced/VBN into/IN several/DT positions/NNS within/IN the/DT CAB/NEWGENE promoter/NEWGENE and/CC operator-free/JJ plasmid/NN was/VBD used/VBN as/IN control/NN ./.
@@80725471047 c-Fos/NEWGENE transcriptional/JJ activity/NN stimulated/VBN by/IN H-Ras-activated/NEWGENE protein/NEWGENE kinase/NEWGENE distinct/JJ from/IN JNK/NEWGENE and/CC ERK/NEWGENE ./.
@@8675821728 However/RB ,/, if/IN EMPD/NN involves/VBZ the/DT glans/NN penis/NN or/CC perianal/JJ area/NN ,/, a/DT search/NN for/IN internal/JJ malignancy/NN is/VBZ still/RB warranted/VBN ./.
@@118403658564 There/EX was/VBD a/DT significant/JJ effect/NN of/IN hematocrit/NN on/IN the/DT General/NNP Health/NNP scale/NN on/IN the/DT SF-36/NN (/( P/NN =/SYM 0/CD ./CD 03/CD )/SYM ./.
@@78960882897 The/DT function/NN of/IN the/DT C-terminal/NN tail/NN in/IN telomere/NN maintenance/NN is/VBZ not/RB mediated/JJ through/RB the/DT RAP1/NEWGENE interacting/NEWGENE factor/NEWGENE RIF1/NEWGENE1 :/: rap1/NEWGENE alleles/NEWGENE defective/JJ in/IN both/PDT the/DT C-terminal/NN tail/NN and/CC RIF1/NEWGENE interaction/NEWGENE domains/NEWGENE have/VBP additive/JJ effects/NNS on/IN telomere/NN length/NN ./.
@@78621541765 Cloning/VBG by/IN complementation/NN and/CC subsequent/JJ physical/JJ and/CC genetic/JJ analysis/NN revealed/VBN that/IN it/PRP maps/NNS to/IN RAF1/NEWGENE ./.
@@13404703068 An/DT RNA-binding/NEWGENE protein/NEWGENE gene/NEWGENE (/( rbp1/NEWGENE )/SYM from/IN Drosophila/NN melanogaster/NN ,/, encoding/VBG an/DT RNA/NN recognition/NN motif/NN and/CC an/DT Arg-Ser/NNP rich/JJ (/( RS/NN )/SYM domain/NN ,/, has/VBZ been/VBN characterized/VBN ./.
@@103768741231 These/DT single/JJ mutational/JJ defects/NNS in/IN the/DT eRF1-eRF3/NEWGENE interaction/NN became/VBD evident/JJ when/CC either/DT truncated/JJ protein/NN eRF3C/NEWGENE or/CC C-terminally/RB altered/VBN eRF1/NEWGENE proteins/NN were/VBD used/VBN for/IN the/DT authentic/JJ protein/NN ,/, providing/CC further/JJ support/NN for/IN the/DT presence/NN of/IN a/DT C-terminal/NN interaction/NN ./.
@@88790809014 Eight-four/CD ACOAs/NNS were/VBD tested/VBN in/IN order/NN to/IN examine/VB the/DT fit/NN of/IN the/DT model/NN to/IN the/DT data/NN by/IN path/NN analysis/NN with/IN LISREL/NN VII/NN ./.
@@91650399455 In/NN conclusion/NN ,/, marmoset/NEWGENE monkey/NEWGENE LHR/NEWGENE seems/VBZ to/IN lack/NN the/DT sequence/NN corresponding/JJ to/IN exon/NN 10/CD of/IN the/DT LHR/NEWGENE gene/NEWGENE in/IN other/DT mammalian/JJ species/NN ./.
@@9323366392 By/IN deletion/NN analysis/NN of/IN the/DT MLS1/NEWGENE control/NN region/NN ,/, we/PRP identified/VBD two/JJ sites/NNS ,/, UAS1/NEWGENE and/CC UAS2/NEWGENE ,/, as/IN important/JJ for/IN efficient/JJ derepression/NN of/IN the/DT gene/NN ./.
@@10714985598 3'/CD RNA/NN boundary/NN experiments/NNS indicate/VBP that/IN the/DT 5'/NN structure/NN reduces/VBZ the/DT number/NN of/IN (/( G/NNP //NNP U/NNP )/NN AG/NN repeats/NNS required/VBN for/IN stable/JJ TRAP-trp/NEWGENE leader/NEWGENE RNA/NEWGENE association/NN ./.
@@14297681900 Human/NNP neutrophil/JJ response/NN to/IN short-term/JJ exposure/NN to/IN F-75/NN cobalt-based/JJ alloy/NN ./.
@@107795085534 Overexpressing/VBG the/DT coactivator/NN ,/, SRC1a/NEWGENE or/CC GRIP1/NEWGENE ,/, further/RB enhances/VBZ ERRalpha1-induced/JJ transcriptional/JJ activity/NN ./.
@@88948268849 Individuals/NNS attending/VBG the/DT GUM/NNP Department/NNP in/IN the/DT Royal/NNP Infirmary/NNP of/IN Edinburgh/NN between/IN 1990/CD and/CC 1994/CD with/IN the/DT diagnosis/NN of/IN HIV/NN infection/NN ,/, genital/JJ warts/NNS ,/, genital/JJ herpes/NN ,/, non-specific/JJ genital/JJ infection/NN (/( NSGI/NNP )/SYM ,/, gonorrhoea/NN and/CC syphilis/NN were/VBD included/VBN in/IN the/DT study/NN ./.
@@72740427124 DMI/NN and/CC 2-OH-DMI/JJ concentrations/NNS were/VBD determined/VBN in/IN a/DT similar/JJ group/NN of/IN 61/CD DMI-treated/JJ patients/NNS ./.
@@96181506465 In/NN addition/NN ,/, insulin/NEWGENE induced/NN AP-1/NEWGENE DNA/NN binding/JJ activity/NN ,/, this/DT effect/NN being/NN totally/RB prevented/VBD in/IN the/DT presence/NN of/IN MEK-1/NEWGENE inhibitor/NN ./.
@@36850734350 A/DT rate-decreasing/JJ dose/NN of/IN physostigmine/NN ,/, an/DT acetylcholinesterase/NEWGENE inhibitor/NN ,/, was/VBD studied/VBN in/IN combination/NN with/IN the/DT range/NN of/IN atropine/NN doses/NNS ./.
@@12418661641 (/( 5/CD )/SYM An/DT increase/NN in/IN leukocyte-counts/NNS occurred/VBN on/IN the/DT administration/NN of/IN serum/RB obtained/VBN from/IN rabbit/NN during/IN phase-2/NN ./.
@@110821855737 In/NN addition/NN ,/, we/PRP identified/VBD a/DT novel/JJ type/NN of/IN inhibitory/JJ domain/NN in/IN the/DT N-terminal/NN 60/NN amino/JJ acids/NNS of/IN IRF-1/NEWGENE which/WDT strongly/RB inhibits/VBZ its/PRP transcriptional/JJ activity/NN ./.
@@85242675502 Similarly/RB ,/, expression/NN of/IN a/DT transiently/RB transfected/VBN wild-type/NEWGENE prothymosin/NEWGENE alpha/NEWGENE gene/NEWGENE as/IN the/DT reporter/NN was/VBD not/RB affected/VBN by/IN a/DT repertoire/NN of/IN myc-derived/NEWGENE genes/NEWGENE ,/, including/JJ myc/NEWGENE itself/PRP and/CC dominant/JJ or/CC recessive/JJ negative/JJ myc/NEWGENE mutants/NEWGENE ./.
@@107793525286 Identification/NNP of/IN a/DT novel/JJ E2F3/NEWGENE product/NEWGENE suggests/VBZ a/DT mechanism/NN for/IN determining/JJ specificity/NN of/IN repression/NN by/IN Rb/NEWGENE proteins/NEWGENE ./.
@@77159221809 In/NN this/DT paper/NN ,/, a/DT comparison/NN between/IN the/DT number/NN and/CC shape/NN of/IN corneal/JJ endothelial/JJ cells/NNS has/VBZ been/VBN performed/VBN in/IN 25/CD patients/NNS before/IN and/CC 6/CD months/NNS after/IN PRK/NN ./.
@@113879502530 Experimental/JJ study/NN of/IN ta/NN chengchi/NN tang/NN decoction/NN for/IN relieving/JJ lung/NN injury/NN during/IN acute/JJ necrotizing/JJ pancreatitis/NN The/DT objectives/NNS of/IN the/DT study/NN were/VBD to/IN investigate/VB the/DT changes/NNS of/IN leukocyte/NN adhesiveness/NN and/CC tumor/NEWGENE necrosis/NEWGENE factor/NEWGENE (/( TNF/NEWGENE )/SYM in/IN the/DT early/JJ stage/NN of/IN acute/JJ necrotizing/JJ pancreatitis/NN (/( ANP/NNP )/SYM ,/, to/IN go/NN further/RB into/IN the/DT relation/NN of/IN those/DT changes/NNS to/IN lung/NN injury/NN of/IN ANP/NNP ,/, and/CC to/IN evaluate/VB the/DT prohibitive/JJ effect/NN of/IN ta/NN chengchi/NN tang/NN Decoction/NNS on/IN leukocyte/NN adhesion/NN and/CC TNF/NEWGENE secretion/NN ./.
@@80355056470 Processing/NNP of/IN the/DT NS3'-5B/NEWGENE polyprotein/NEWGENE was/VBD complex/NN and/CC occurred/VBN rapidly/RB ./.
@@10799863389 Sequential/JJ cleavage/NN by/IN metallopeptidases/NEWGENE and/CC proteasomes/NNS is/VBZ involved/VBN in/IN processing/VBG HIV-1/NEWGENE ENV/NEWGENE epitope/NEWGENE for/IN endogenous/JJ MHC/NEWGENE class/NEWGENE I/NEWGENE antigen/NEWGENE presentation/NN ./.
@@107479879746 The/DT recombinant/JJ enzymes/NNS exist/VBP as/IN monomers/NNS ./.
@@98068584565 Identification/NNP of/IN a/DT new/JJ gene/NN in/IN the/DT streptococcal/JJ plasmid/NN pLS1/NN :/: the/DT rnaI/NEWGENE gene/NEWGENE ./.
@@80969448076 We/PRP recommend/VBP that/IN ovarian/JJ stimulation/NN is/NNS done/VBP only/RB if/IN there/RB is/VBZ a/DT valid/JJ indication/NN after/IN proper/JJ assessment/NN of/IN the/DT ovaries/NNS ,/, and/CC that/IN women/NNS who/WP have/VBP had/VBP ovarian/JJ stimulation/NN are/VBP followed/VBN for/IN longer/JJR than/IN at/IN present/NN ./.
@@90134998978 In/NN Experiment/NN 1/CD ,/, pups/NNS that/WDT had/VBP received/VBN an/DT injection/NN of/IN the/DT noncompetitive/JJ N-methyl-D-aspartate/NEWGENE receptor/NEWGENE antagonist/NN MK-801/NN (/( 0/CD ./CD 1/CD mg/CD //CD kg/CD ,/, i/CD ./CD p/CD ./CD )/SYM either/DT 30/CD min/NN before/IN or/CC immediately/RB after/IN conditioning/JJ spent/VBP less/PRP time/NN over/RB the/DT conditioned/JJ odor/NN than/IN saline-treated/JJ controls/NNS ./.
@@29403342527 Group/NNP A/DT was/VBD treated/VBN with/IN three/CD or/CC four/CD doses/NNS of/IN hepatitis/NEWGENE B/NEWGENE immune/NEWGENE globulin/NEWGENE (/( HBIG/NEWGENE )/SYM in/IN one/PRP of/IN three/CD different/JJ schedules/NNS ./.
@@75488587421 The/DT flow/NN rate/NN of/IN phosphate/NN buffered/JJ saline/JJ through/JJ dermis/NN was/VBD measured/VBN as/IN a/DT function/NN of/IN applied/VBN pressure/NN ./.
@@76037267501 Vestibular/JJ adaptation/NN exercises/NNS and/CC recovery/NN :/: acute/JJ stage/NN after/IN acoustic/JJ neuroma/NN resection/NN ./.
@@15838199622 SEA/NN was/VBD recorded/VBN with/IN bidirectional/JJ filters/NNS at/IN 25-250/JJ HZ/NNS and/CC 40-250/JJ Hz/NN using/VBG Simson/NNP method/NN ./.
@@117442901589 (/( Cactaceae/NNP )/SYM waste/JJ matter/NN ./.
@@7905413668 During/IN chronic/JJ treatment/NN ,/, when/CC plasma/NN concentrations/NNS fluctuated/VBN between/IN 23/CD ./CD 5/CD ng/CD ./CD ml-1/CD at/IN 8/CD h/NN and/CC 14/CD ng/CD ./CD ml-1/CD at/IN 24/CD h/NN post-dosing/NN ,/, ST/NN segment/NN depression/NN at/IN an/DT individually/RB comparable/JJ workload/NN was/VBD significantly/RB decreased/VBN by/IN 28%/RB compared/VBN with/IN placebo/NN (/( P/NN </SYM 0/CD ./CD 005/CD )/SYM at/IN both/DT points/NNS in/IN time/NN ./.
@@84845146659 Both/DT inhaled/JJ and/CC superfused/VBN isoflurane/NN dilated/JJ the/DT baseline/NN vein/NN diameter/NN before/IN stimulation/NN ./.
@@89223845861 Immunoblotting/NN of/IN expressed/VBN recombinant/JJ proteins/NNS with/IN the/DT monoclonal/NEWGENE 08L/NEWGENE antibody/NEWGENE localized/VBN the/DT 08L/NEWGENE epitope/NN to/IN the/DT carboxyl/NN end/NN of/IN the/DT protein/NN ./.
@@106522285712 Consistently/RB ,/, activation/NN of/IN c-Jun/NEWGENE N-terminal/NEWGENE kinase/NEWGENE downstream/RB of/IN Rho/NEWGENE family/NEWGENE GTP-binding/NEWGENE proteins/NEWGENE was/VBD also/RB enhanced/VBN when/CC Dbl/NEWGENE was/VBD tyrosine-phosphorylated/JJ ./.
@@97220438634 However/RB ,/, both/DT TPN/NN groups/NNS showed/VBD a/DT marked/JJ increase/NN in/IN activities/NNS of/IN liver/NEWGENE lysosomal/NEWGENE enzymes/NEWGENE ./.
@@82768716016 267/CD ,/, 4870-4877/NN )/NN )/NN indicates/VBZ an/DT overall/JJ identity/NN of/IN 58/CD and/CC 56%/CD ,/, respectively/RB ,/, with/IN a/DT 91/CD and/CC 92%/NN identity/NN in/IN the/DT highly/RB conserved/VBN transmembrane/JJ and/CC cytoplasmic/JJ domains/NNS ./.
@@78116393641 Endo16/NEWGENE transcripts/NEWGENE are/VBP confined/VBN to/IN the/DT definitive/JJ vegetal/JJ plate/NN in/IN blastula/NN stage/NN embryos/NNS ;/: at/IN gastrula/NN stage/NN this/DT gene/NN is/VBZ expressed/VBN throughout/IN the/DT archenteron/NN ,/, but/CC later/RBR only/RB in/IN the/DT midgut/NN ./.
@@84632845121 Nuclear/NEWGENE beta/NEWGENE II/NEWGENE PKC/NEWGENE ,/, like/JJ p34cdc2/NEWGENE kinase/NEWGENE ,/, may/MD function/VB to/IN regulate/VB nuclear/JJ lamina/NN structural/JJ stability/NN during/IN cell/NN cycle/NN ./.
@@82789298026 When/WRB Hy-Vac/NNP SPF/NN type/NN V/NN embryos/NNS were/VBD exposed/VBN to/IN either/DT 0/CD ./CD 20/CD ml/NN 50%/CD ethanol/NN in/IN CRS/NN or/CC to/IN 0/CD ./CD 20/CD ml/NN CRS/NN (/( controls/NNS )/SYM ,/, ethanol-treated/JJ embryos/NNS showed/VBD a/DT VSD/NN incidence/NN of/IN 34/CD ./CD 1%/CD compared/VBN with/IN a/DT 3/CD ./CD 6%/CD incidence/NN in/IN the/DT controls/NNS (/( P/NN =/SYM 0/CD ./CD 0017/CD )/SYM ./.
@@40864034773 Gains/NNS increased/VBN 3/CD ./CD 5%/CD (/( P/NN less/PRP than/IN ./CD 10/CD )/SYM and/CC feed/JJ conversion/NN improved/VBN 5/CD ./CD 9%/CD (/( P/NN less/PRP than/IN ./CD 07/CD )/SYM in/IN steers/VBZ fed/VBN ./CD 28%/CD AS-VFA/NNP compared/VBD with/IN gain/NN and/CC feed/JJ conversion/NN of/IN the/DT control/NN steers/NNS ./.
@@24742045240 Endocrine/NN cells/NNS were/VBD studied/VBN by/IN means/NN of/IN Grimelius'/NN silver/JJ staining/NN and/CC immunostaining/VBG for/IN chromogranin/NEWGENE ,/, a/DT general/NN marker/NN of/IN endocrine/JJ cells/NNS ./.
@@15373348507 The/DT gene/NN encoding/VBG TRP-2/NEWGENE maps/NNS to/IN mouse/NN chromosome/NN 14/CD ,/, in/IN the/DT region/NN of/IN the/DT coat/NEWGENE colour/NEWGENE mutation/NEWGENE slaty/NEWGENE ./.
@@98587134202 Genetic/NNP and/CC molecular/JJ data/NN indicate/VB that/DT wild-type/NEWGENE Pan/NEWGENE and/CC CiD/NEWGENE compete/VB for/IN binding/JJ to/IN Arm/NEWGENE ,/, leading/JJ to/IN a/DT compromised/VBN transduction/NN of/IN the/DT Wg/NEWGENE signal/JJ in/IN heterozygous/JJ ciD/NEWGENE //NEWGENE +/NEWGENE animals/NNS and/CC to/IN a/DT dramatic/JJ enhancement/NN of/IN the/DT gain-of-function/NN activity/NN of/IN CiD/NEWGENE in/IN homozygous/JJ mutants/NNS ./.
@@103953787972 Our/PRP data/NN therefore/RB indicate/VB that/IN it/PRP is/VBZ possible/JJ to/IN engineer/NN the/DT HA/NEWGENE envelope/NEWGENE glycoprotein/NEWGENE by/IN fusing/JJ ligands/NNS to/IN its/PRP amino-terminal/JJ end/NN without/IN affecting/VBG its/PRP fusion/NN activity/NN ./.
@@39461254607 Drug/NNP and/CC nutrient/JJ interactions/NNS ./.
@@107134534671 The/DT protein/NN first/RB identified/VBD by/IN the/DT monoclonal/NEWGENE antibody/NEWGENE Q18/NEWGENE is/VBZ encoded/VBN by/IN a/DT gene/NN located/VBN in/IN 57A/CD on/IN polytene/JJ chromosomes/NNS and/CC has/VBZ been/VBN consequently/RB named/VBN Hrb57A/NEWGENE ./.
@@115968388193 This/DT analysis/NN supports/VBP the/DT use/NN of/IN fluticasone/NN propionate/NN 88/NN microg/NN twice/RB daily/JJ as/IN first-line/NN treatment/NN in/IN patients/NNS with/IN persistent/JJ asthma/NN previously/RB treated/VBD with/IN short-acting/JJ beta2-agonist/CD alone/RB ./.
@@27526519492 On/IN admission/NN to/IN our/PRP department/NN in/IN September/NN ,/, 1987/CD ,/, the/DT patient/NN was/VBD alert/NN and/CC had/VBP spastic/JJ paraparesis/NN ,/, the/DT impairment/NN of/IN all/DT sensory/JJ modalities/NNS below/RB the/DT level/NN of/IN Th/NN 10/NN and/CC urinary/JJ disturbance/NN ./.
@@84985701569 In/NN conclusion/NN ,/, changes/VBZ in/IN carotid/JJ sinus/NN stimulation/NN alters/VBZ blood/NN flow/NN to/IN the/DT hindlimb/NN through/RB changes/VBZ in/IN both/DT Pcrit/NN and/CC Ra/NN ./NN
@@90102237272 This/DT R-domain/NNS may/MD modulate/VB the/DT interaction/NN with/IN SRF/NEWGENE ,/, providing/CC a/DT mechanism/NN that/WDT would/MD be/VB unique/JJ to/IN FLI1/NEWGENE and/CC EWS-FLI1/NEWGENE ,/, thus/RB implicating/VBG a/DT novel/JJ function/NN for/IN these/DT ETS/NEWGENE transcription/NEWGENE factors/NEWGENE in/IN the/DT regulation/NN of/IN the/DT Egr1/NEWGENE gene/NEWGENE ./.
@@8073505870 A/DT new/JJ generation/NN of/IN information/NN retrieval/NN tools/NNS for/IN biologists/NNS :/: the/DT example/NN of/IN the/DT ExPASy/NN WWW/NN server/NN ./.
@@1674177443 Histamine-2/NN blockade/NN in/IN psoriasis/NN ./.
@@77040408329 We/PRP have/VBP cloned/VBN and/CC sequenced/VBN the/DT mouse/NEWGENE NMO1/NEWGENE cDNA/NEWGENE ,/, which/WDT encodes/VBZ the/DT NAD/NEWGENE (/NEWGENE P/NEWGENE )/NEWGENE H/NEWGENE :/NEWGENE menadione/NEWGENE oxidoreductase/NEWGENE [/NN also/NN called/VBN NAD/NEWGENE (/NEWGENE P/NEWGENE )/NEWGENE H/NEWGENE :/NEWGENE (/NEWGENE quinone/NEWGENE acceptor/NEWGENE )/NEWGENE oxidoreductase/NEWGENE ;/NEWGENE quinone/NEWGENE reductase/NEWGENE ;/: azo/NEWGENE dye/NEWGENE reductase/NEWGENE ;/: DT/NEWGENE diaphorase/NEWGENE ;/: EC/NEWGENE 1/NEWGENE ./NEWGENE 6/NEWGENE ./NEWGENE 99/NEWGENE ./NEWGENE 2/NEWGENE ]/NEWGENE ./.
@@10102136133 Type/NN I/NN cysts/NNS (/( with/IN a/DT high/JJ K+/NNP //NNP Na+/NN ratio/NN )/SYM tend/VB to/IN have/NN higher/JJ total/JJ PSA/NEWGENE than/IN Type/NN II/NN cysts/NNS ./.
@@17984077501 The/DT presence/NN of/IN local/JJ abnormalities/NNS in/IN both/DT patients/NNS can/MD support/NN the/DT hypothesis/NN that/IN the/DT cortex/NN ,/, especially/RB of/IN the/DT temporal/NN anterior/NN lobe/NN ,/, is/VBZ involved/VBN in/IN the/DT origin/NN of/IN the/DT laughing/NN seizures/NNS ./.
@@105939508005 In/NN summary/NN ,/, WT1/NEWGENE is/VBZ enriched/VBN by/IN oligo/NN (/NN dT/NN )/NN chromatography/NN ,/, as/IN are/VBP U2AF65/NEWGENE ,/, the/DT U5/NEWGENE small/NEWGENE nuclear/NEWGENE RNP-associated/NEWGENE protein/NEWGENE p116/NEWGENE and/CC hnRNP/NEWGENE A1/NNP ./NNP
@@102366517027 Predictors/NNS of/IN success/NN in/IN pharmacy/NN school/NN :/: PCAT/NN vs/IN ./IN other/DT admission/NN criteria/NNS ./.
@@116915857653 Electrophoretic/JJ mobility/NN shift/NN assays/NNS and/CC coimmunoprecipitation/NN studies/NNS suggest/VBP that/DT homo-/NN and/CC heterodimerization/NN occurs/VBZ between/IN cKrox/NEWGENE family/NEWGENE members/NEWGENE ./.
@@83999708361 A/DT new/JJ bioencapsulation/NN technology/NN for/IN microbial/JJ inoculants/NNS ./.
@@9203586581 This/DT indicates/VBZ that/DT recruitment/NN of/IN large/NEWGENE T/NEWGENE antigen/NEWGENE to/IN the/DT rRNA/NN promoter/NN by/IN SL1/NEWGENE constitutes/VBZ a/DT crucial/JJ step/NN in/IN the/DT activation/NN process/NN ./.
@@2324564227 Anatomy/NNS of/IN the/DT RNA/NN and/CC gene/NN products/NNS of/IN MC29/NN and/CC MH2/NN ,/, two/JJ defective/JJ avian/JJ tumor/NN viruses/NNS causing/JJ acute/JJ leukemia/NN and/CC carcinoma/NN :/: evidence/NN for/IN a/DT new/JJ class/NN of/IN transforming/NN genes/NN ./.
@@26460079476 Concomitant/JJ chronic/JJ lymphocytic/JJ leukemia/NN ,/, acute/JJ myeloid/JJ leukemia/NN ,/, and/CC thrombosis/NN with/IN protein/NEWGENE C/NEWGENE deficiency/NN ./.
@@11679441907 NO/DT metabolites/NNS were/VBD determined/VBN by/IN the/DT measurement/NN of/IN nitrate/NN //NN nitrite/NN (/( NOx/NN ,/, micromol/NN //NN mmol/NN creatinine/NN )/SYM and/CC cyclic/JJ guanosine/NN monophosphate/NN (/( cGMP/NN ,/, nmol/NN //NN mmol/NN creatinine/NN )/SYM in/IN plasma/NN and/CC urine/NN ./.
@@23007598788 The/DT therapeutic/JJ protocole/NN used/VBN at/IN the/DT Gustave/NNP Roussy/NNP Institute/NNP for/IN invasive/JJ epithelioma/NN of/IN the/DT uterine/JJ cervix/NN rests/NNS ,/, for/IN limited/VBN forms/NNS (/( T1B-T2/NN proximal/JJ )/SYM ,/, on/IN combined/JJ radiology/NN and/CC surgery/NN ./.
@@104846955754 Thus/RB ,/, NART-R/NN performance/NN may/MD not/RB be/VB a/DT valid/JJ estimate/NN of/IN baseline/NN IQ/NN for/IN patients/NNS with/IN neurologic/JJ disorders/NNS with/IN suspected/VBN language/NN impairment/NN ./.
@@75673009381 Staphylococcal/NEWGENE enterotoxin/NEWGENE A/NEWGENE involvement/NN in/IN the/DT illness/NN of/IN a/DT 20-month-old/NN burn/NN patient/NN ./.
@@100063194 Surface/NN spin/NN waves/NNS in/IN a/DT Heisenberg/NNP ferrimagnet/NN with/IN a/DT single-ion/JJ anisotropy/NN (/( uniaxial/JJ and/CC nonuniaxial/JJ )/SYM ./.
@@107335815209 Importantly/RB ,/, concomitant/JJ expression/NN of/IN constitutive/RB activated/VBN Raf/NEWGENE and/CC V12N38/NEWGENE Ras/NEWGENE results/NNS in/IN almost/RB complete/JJ loss/NN of/IN TTF-1/NEWGENE activity/NN ./.
@@22891022946 Using/VBG an/DT audiotape/NN cassette/NN and/CC headphones/NNS the/DT duration/NN of/IN the/DT hallucinations/NNS decreased/VBN significantly/RB ./.
@@85821436045 These/DT studies/NNS indicate/VBP that/IN the/DT acidimetric/JJ test/NN was/VBD less/PRP sensitive/JJ than/IN the/DT chromogenic/JJ cephalosporin/NN substrates/NN and/CC that/DT nitrocefin/NN and/CC S1/NN could/MD be/VB used/VBN to/IN screen/NN for/IN beta-lactamase/NEWGENE production/NN in/IN these/DT tested/VBN species/NN ./.
@@112684596910 We/PRP performed/VBD the/DT present/NN study/NN to/IN clarify/VB the/DT relationship/NN between/IN the/DT DOX/NN binding/JJ ability/NN (/( %DB/NN )/SYM and/CC the/DT histologic/JJ response/NN ,/, rate/NN of/IN decrease/NN in/IN tumor/NN volume/NN of/IN malignant/JJ soft/JJ tissue/NN tumors/NNS after/IN preoperative/JJ chemotherapy/NN and/CC prognosis/NN ./.
@@94142873310 Gel-shift/NNP assays/NNS identified/VBD two/JJ Sp1/NEWGENE binding/NEWGENE sites/NEWGENE within/IN this/DT element/NN ./.
@@110325998410 2000/CD update/VB of/IN recommendations/NNS for/IN the/DT use/NN of/IN hematopoietic/NEWGENE colony-stimulating/NEWGENE factors/NEWGENE :/: evidence-based/JJ ,/, clinical/JJ practice/NN guidelines/NNS ./.
@@23005771996 The/DT beta/NN chain/NN contains/VBZ five/CD potential/JJ N-linked/NN glycosylation/NN sites/NN ,/, and/CC endoglycosidase/NEWGENE digestion/NN suggested/VBN that/IN the/DT beta/NN chain/NN contained/VBD multiple/JJ complex/NN carbohydrate/NN side/JJ chains/NNS ./.
@@80769371544 Rapid/NNP detection/NN of/IN this/DT mutation/NN is/VBZ achieved/VBN by/IN restriction/NN digestion/NN of/IN PCR-amplified/JJ genomic/JJ DNA/NN ;/: a/DT mismatch/NN primer/NN combined/JJ with/IN the/DT point/NN mutation/NN creates/VBZ a/DT Tru9I/NEWGENE restriction/NEWGENE site/NEWGENE ./.
@@81646792215 Transactivation/NNS domain/NN is/VBZ located/VBN downstream/RB of/IN the/DT 128-amino-acid/NEWGENE runt/NEWGENE homology/NEWGENE region/NEWGENE ,/, referred/VBN to/RB as/IN the/DT Runt/NEWGENE domain/NEWGENE ./.
@@64116596211 This/DT generally/RB means/NN an/DT energy/NN intake/NN of/IN 1/CD ./CD 4/CD to/IN 1/CD ./CD 6/CD times/VBZ the/DT energy/NN expenditure/NN ,/, with/IN a/DT N/JJ intake/NN of/IN 250/CD to/IN 400/CD mg/NN //NN kg/NN //NN day/NN ./.
@@112741498366 Mutational/JJ analysis/NN showed/VBN that/IN the/DT U-box/NNP ,/, like/NN the/DT RING/NN finger/NN in/IN other/DT proteins/NNS ,/, forms/VBZ the/DT physical/JJ basis/NN for/IN the/DT interaction/NN with/IN E2/NEWGENE enzymes/NEWGENE ./.
@@1136577755 Pb/NN foil/NN (/( 0/CD ./CD 55/CD gcm-2/NN )/SYM provided/VBN the/DT best/JJS overall/JJ improvement/NN ./.
@@11123089961 This/DT article/NN reviews/VBP recent/JJ information/NN on/IN the/DT frequency/NN ,/, characteristics/NNS ,/, and/CC possible/JJ pathogenic/JJ mechanisms/NNS of/IN the/DT vasculitides/NNS occurring/VBG in/IN patients/NNS with/IN the/DT main/JJ connective/JJ tissue/NN diseases/NNS ./.
@@8712379658 During/IN activity/NN III/NN ,/, one/PRP patient/NN developed/VBD angina/NN ./.
@@21462666274 A/DT 4/NEWGENE ./NEWGENE 8-kilobase/NEWGENE BamHI-HindIII/NEWGENE fragment/NEWGENE encoding/VBG the/DT entire/NEWGENE Neurospora/NEWGENE crassa/NEWGENE CuZn/NEWGENE superoxide/NEWGENE dismutase/NEWGENE gene/NEWGENE (/( herein/RB designated/VBN sod-1/NEWGENE )/SYM was/VBD isolated/VBN from/IN a/DT genomic/JJ library/NN using/VBG two/JJ 60-base/JJ deoxyoligonucleotide/NN probes/NNS corresponding/JJ to/IN the/DT published/VBN N/NNP ./NNP crassa/NN amino/JJ acid/NN sequence/NN ./.
@@72433809198 Eight/CD hr/NN of/IN acidosis/NN caused/VBD a/DT significant/JJ (/( P/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM decrease/NN in/IN P50/NN in/IN vitro/FW which/WDT fell/VBP from/IN 29/CD ./CD 0/CD to/IN 24/CD ./CD 4/CD torr/NN ./.
@@99471913876 Neutron/JJ scattering/JJ measurements/NNS of/IN critical/JJ exponents/NNS in/IN CsMnBr3/NNP :/: A/DT Z2/NN >/SYM =/SYM 1/CD antiferromagnet/NN ./.
@@91758583449 Thus/RB ,/, the/DT B-S/NNP mutant/JJ does/VBP not/RB mimic/VB efficiently/RB the/DT chloroplastic/NEWGENE GAPDHs/NEWGENE ,/, and/CC long-range/JJ and/IN //IN or/IN second-layer/JJ effects/NNS ,/, not/RB easily/RB predictable/JJ from/IN visual/JJ inspection/NN of/IN three-dimensional/JJ structures/NNS ,/, need/NN to/IN be/VB taken/VBP into/IN account/NN for/IN designing/JJ a/DT true/JJ "chloroplastic-like"/JJ mutant/NN of/IN cytosolic/NEWGENE GAPDH/NEWGENE ./.
@@93352988029 It/PRP has/VBZ been/VBN proposed/VBN that/IN the/DT parCBA/NEWGENE operon/NEWGENE encodes/VBZ a/DT plasmid/NN partitioning/NN system/NN (/( M/NNP ./NNP
@@72495444527 The/DT oral/JJ temperature/NN rose/VBD and/CC the/DT serum/NEWGENE creatine/NEWGENE kinase/NEWGENE levels/NNS fell/NN only/RB in/IN those/DT patients/NNS who/WP were/VBD actively/RB warmed/VBN ./.
@@97379211472 Genome/NNP plasticity/NN in/IN the/DT distal/NEWGENE tail/NEWGENE fiber/NEWGENE locus/NEWGENE of/IN the/DT T-even/NNP bacteriophage/NN :/: recombination/NN between/IN conserved/VBN motifs/NNS swaps/NNS adhesin/NEWGENE specificity/NN ./.
@@33687014054 Because/IN of/IN its/PRP great/JJ reliability/NN ,/, conventional/JJ arteriography/NN occupies/VBZ a/DT place/NN of/IN choice/JJ among/IN the/DT medical/JJ imaging/NN techniques/NNS ./.
@@17249827306 They/PRP were/VBD checked/VBN for/IN anti-HCV/NEWGENE (/( anti-C100-3/NEWGENE )/SYM with/IN HCV/NN EIA/NN kit/NN (/( Abbott/NN Lab/NNS ./NNS ,/, North/JJ Chicago/NN ,/, IL/NN )/SYM ./.
@@90813929033 Therefore/RB more/RB active/JJ and/CC tolerable/JJ salvage/NN regimens/NNS are/VBP needed/VBN ./.
@@87028269448 Furthermore/RB ,/, upstream/JJ insertion/NN of/IN the/DT GSTP1/NEWGENE silencer/NEWGENE element/NEWGENE failed/VBN to/IN inhibit/VB activity/NN of/IN a/DT heterologous/JJ promoter/NN in/IN MCF7/NNP cells/NNS ./.
@@107524506957 A/DT variety/NN of/IN professional/JJ and/CC self-applied/JJ fluoride/NN products/NN are/VBP available/JJ and/CC new/JJ fluoride/NN delivery/NN systems/NNS have/VBP recently/RB entered/VBN the/DT market/NN ./.
@@76577053065 These/DT results/NNS indicate/VBP that/IN K-glypican/NEWGENE is/VBZ a/DT novel/JJ GPI-anchored/NEWGENE HSPG/NEWGENE involved/VBN in/IN embryonic/JJ development/NN ./.
@@984209472 Serum/NN gastrin/NEWGENE levels/NNS did/VBD not/RB change/VB in/IN either/DT group/NN ;/: however/RB ,/, background/NN serum/JJ gastrin/NEWGENE concentrations/NNS were/VBD significantly/RB greater/JJR for/IN V&P/NNP patients/NNS than/IN V&A/NNP patients/NNS throughout/IN the/DT study/NN ./.
@@93609533518 These/DT residues/NNS ,/, Ile244/NN at/IN the/DT extracellular/JJ end/NN of/IN transmembrane/JJ helix/NN 3/CD ,/, and/CC Tyr318/NN at/IN the/DT COOH-terminal/NN portion/NN of/IN extracellular/JJ loop/NN 2/CD ,/, are/VBP replaced/VBN by/IN Leu/NN and/CC Ile/NN in/IN the/DT PTH-1/NEWGENE receptor/NEWGENE ,/, respectively/RB ./.
@@103927103445 Lung/NNP mesenchyme/NN serves/VBP as/IN a/DT 'compleat'/NN inducer/NN of/IN lung/NN morphogenesis/NN by/IN secreting/JJ soluble/NN peptide/NN growth/NN factors/NN ./.
@@2462047333 Viable/NN flap/NN areas/NNS were/VBD established/VBN following/IN vascular/JJ pedicle/NN ligation/NN (/( both/DT vessels/NNS or/CC only/JJ artery/NN or/CC vein/NN )/SYM ,/, on/IN the/DT third/JJ day/NN after/IN flap/NN replantation/NN in/IN both/DT island/NN and/CC free/JJ flaps/NN ./.
@@97212079002 Using/VBG backcross/NN analysis/NN ,/, both/DT exons/NNS 1/CD and/CC 4/CD mapped/VBN to/IN a/DT proximal/JJ region/NN of/IN murine/NN Chromosome/NN 4/NN indistinguishable/JJ from/IN the/DT vacillans/NEWGENE gene/NEWGENE ./.
@@1019207129 It/PRP was/VBD found/VBN that/IN under/IN the/DT selected/VBN conditions/NNS a/DT linear/JJ dependence/NN exists/VBZ between/IN the/DT betaI%/NN value/NN and/CC lgC/NN within/IN the/DT range/NN of/IN 0/NN ./NN 5--10/NN mug/NN ruscogenin/NN ./.
@@101954259578 Characterization/NNS of/IN the/DT transcription/NEWGENE factor/NEWGENE MTF-1/NEWGENE from/IN the/DT Japanese/JJ pufferfish/NN (/( Fugu/NN rubripes/NNS )/SYM reveals/VBZ evolutionary/JJ conservation/NN of/IN heavy/JJ metal/NN stress/NN response/NN ./.
@@171662949 We/PRP characterized/VBD cDNA/NN clones/NNS specific/JJ for/IN the/DT extracellular/JJ matrix/NN glycoprotein/NN undulin/NEWGENE ./.
@@63272924531 Furthermore/RB ,/, no/DT Shine-Dalgarno/NNP sequences/NNS are/VBP present/VB upstream/RB of/IN the/DT presumed/VBN translational/JJ start/NN codons/NNS ./.
@@10184191123 Holger/NNP v/NN ./NN
@@113405165859 Tolerance/NN to/IN ADAL-2/NN was/VBD similar/JJ to/IN that/DT of/IN Vicryl/NN suture/NN and/CC tolerance/NN to/IN ADAL-2/NN was/VBD superior/JJ to/IN that/DT to/IN Tisuacryl/NNP ./.
@@104415064297 PKNbeta/NEWGENE had/VBP high/JJ sequence/NN homology/NN with/IN PKNalpha/NEWGENE ,/, originally/RB isolated/VBN PKN/NEWGENE ,/, especially/RB in/IN the/DT repeats/NNS of/IN charged/VBN amino/JJ acid-rich/JJ region/NN with/IN leucine-zipper/JJ like/JJ sequences/NNS (/( CZ/NEWGENE region/NEWGENE //NEWGENE HR1/NEWGENE )/SYM ,/, in/IN the/DT carboxyl-terminal/JJ catalytic/JJ domain/NN ,/, and/CC in/IN approximately/RB 130/CD amino/JJ acid/NN stretch/NN (/( D/NEWGENE region/NEWGENE //NEWGENE HR2/NEWGENE )/SYM ,/, located/VBN between/NN CZ/NEWGENE region/NEWGENE //NEWGENE HR1/NEWGENE and/CC the/DT catalytic/JJ domain/NN ./.
@@22511191655 Results/NNS have/VBP surprisingly/RB revealed/VBN the/DT presence/NN of/IN three/CD U14/NEWGENE snRNA-homologous/NEWGENE regions/NEWGENE positioned/VBN within/IN introns/NNS 5/CD ,/, 6/CD ,/, and/CC 8/CD of/IN the/DT mouse/NN cognate/NN hsc70/NEWGENE heat/NN shock/NN gene/NN ./.
@@114300426501 [/NN figure/NN :/: see/VB text/NN ]/NN The/DT Stille/NNP coupling/NN reaction/NN has/VBZ been/VBN performed/VBN in/IN 1-butyl-3-methylimidazolium/JJ tetrafluoroborate/NN (/( BMIM/NN BF4/NN )/SYM ,/, a/DT room-temperature/JJ ionic/JJ liquid/JJ (/( RTIL/NN )/SYM ./.
@@30451173675 In/NN general/JJ ,/, the/DT values/NNS obtained/VBN by/IN the/DT two/JJ methods/NNS were/VBD in/IN agreement/NN for/IN each/DT species/NN of/IN epidermal/NEWGENE growth/NEWGENE factor/NEWGENE and/CC followed/VBD the/DT order/NN :/: wild/JJ type/NN greater/JJR than/IN Glu24----Gly/RB greater/JJR than/IN Asp27----Gly/JJ much/RB greater/JJR than/IN Pro7----Thr/NNP greater/JJR than/IN Tyr29----Gly/CD greater/JJR than/IN Leu47----His/NNP ./.
@@62980141148 The/DT ensembles/NNS are/VBP considered/VBN to/IN be/VB one/PRP of/IN the/DT forms/NNS of/IN activity/NN of/IN the/DT structured/JJ morphofunctional/JJ cortical/JJ units/NNS ,/, i/CD ./CD e/CD ./. the/DT columns/NNS ./.
@@112820295941 The/DT mouse/NEWGENE platelet-derived/NEWGENE growth/NEWGENE factor/NEWGENE (/NEWGENE PDGF/NEWGENE )/NEWGENE beta-receptor/NEWGENE promoter/NEWGENE contains/VBZ a/DT CCAAT/NN motif/NN ,/, and/CC NF-Y/NEWGENE plays/VBP an/DT essential/JJ role/NN in/IN its/PRP transcription/NN ./.
@@2254282322 Sequence/NN and/CC genetic/JJ organization/NN of/IN a/DT Zymomonas/NN mobilis/NN gene/NN cluster/NN that/IN encodes/VBZ several/DT enzymes/NNS of/IN glucose/NN metabolism/NN ./.
@@93288249755 The/DT growth-promoting/JJ properties/NNS of/IN the/DT retroviral/NEWGENE v-erbA/NEWGENE oncogene/NEWGENE ,/, a/DT highly/RB mutated/JJ version/NN of/IN the/DT chicken/NEWGENE thyroid/NEWGENE hormone/NEWGENE receptor/NEWGENE (/NEWGENE TR/NEWGENE )/NEWGENE alpha/NEWGENE ,/, have/VB so/RB far/RB exclusively/RB been/VBN linked/JJ to/IN dominant/JJ repression/NN of/IN the/DT antimitogenic/JJ roles/NNS of/IN TR/NEWGENE and/CC retinoic/NEWGENE acid/NEWGENE receptors/NEWGENE ./.
@@78866108968 With/IN a/DT population/NN of/IN 853/CD million/NN there/RB should/MD be/VB 51/CD ,/CD 204/CD patients/NNS with/IN hemophilia/NN A/NN in/NNP India/NNP assuming/VBG a/DT prevalence/NN of/IN 6/CD //CD 100/CD ,/CD 000/CD population/NN ./.
@@88453782939 Restriction/NNS enzyme/NN mapping/NN and/CC Southern/NNP analysis/NN indicated/VBN further/RB that/IN the/DT human/NEWGENE MZF-1/NEWGENE gene/NEWGENE is/VBZ a/DT single-copy/JJ gene/NN ./.
@@14375629861 Anti-CRK/NEWGENE antibodies/NEWGENE detect/VBP a/DT 53kDa/NN protein/NN in/IN extracts/NNS of/IN C/NNP ./NNP fasciculata/NNP in/IN agreement/NN with/IN the/DT size/NN predicted/VBN from/IN the/DT nucleotide/NN sequence/NN of/IN the/DT cloned/VBN gene/NN ./.
@@75388185009 To/TO identify/VB critical/JJ regions/NNS mediating/JJ growth/NN signal/NN transduction/NN by/IN hG-CSFR/NEWGENE ,/, deletions/NNS or/CC site-directed/JJ amino/JJ acid/NN substitutions/NNS were/VBD introduced/VBN into/IN the/DT cytoplasmic/JJ domain/NN of/IN hG-CSFR/NEWGENE ,/, and/CC the/DT mutant/JJ cDNAs/NNS were/VBD transfected/VBN into/IN the/DT murine/NEWGENE interleukin-3/NEWGENE (/( IL-3/NEWGENE )/NN -dependent/NN Ba/CELL //CELL F3/CELL and/CC FDCP/NN cell/NN lines/NNS ./.
@@114698532525 We/PRP developed/VBD a/DT system/NN for/IN domain/NN shuffling/NN to/IN establish/VB the/DT function/NN of/IN C1/NEWGENE domains/NEWGENE from/IN human/NEWGENE Raf/NEWGENE kinase/NEWGENE and/CC rat/NEWGENE PKC/NEWGENE eta/NEWGENE in/IN yeast/NN ./.
@@98494212522 This/DT survey/NN included/VBN 3000/CD randomly/RB selected/VBN Norwegians/NNS above/RB 18/CD years/NNS of/IN age/NN who/WP received/VBD the/DT European/NNP Organization/NNP for/IN Research/NNP and/CC Treatment/NNP of/IN Cancer/NNP Core/NNP Quality/NN of/IN Life/NNP Questionnaire/NN (/( EORTC/NN QLQ-C30/NN (/( +3/CD )/SYM by/IN mail/NN ./.
@@108334616849 To/TO isolate/VB this/DT gene/NN ,/, a/DT P-1/NN artificial/JJ chromosome/NN (/( PAC/NN )/SYM library/NN was/VBD screened/VBN with/IN a/DT full/NEWGENE length/NEWGENE UGT2B7/NEWGENE probe/NN and/CC a/DT clone/NN of/IN approximately/RB 100/CD kb/NN in/IN length/NN was/VBD isolated/VBN ./.
@@22833788313 Simple/JJ method/NN for/IN determination/NN of/IN the/DT cephalosporin/NN DQ-2556/NN in/IN biological/JJ fluids/NNS by/IN high-performance/JJ liquid/JJ chromatography/NN ./.
@@104305805300 Repair/NNS of/IN double-strand/NN breaks/NNS (/( DSBs/NNS )/SYM in/IN chromosomal/JJ DNA/NN by/IN nonhomologous/JJ end-joining/NN (/( NHEJ/NN )/SYM is/VBZ not/RB well/VB characterized/VBN in/IN the/DT yeast/NN Saccharomyces/NN cerevisiae/NN ./.
@@86881908671 Two/CD new/JJ flavone/NN glucosides/NNS ,/, nevadensin/NN 5-O-beta-D-glucoside/NN and/CC nevadensin/NN 5-O-beta-D-glucosyl/NN (/NN 1--/NN >/NN 6/NN )/NN beta-D-glucoside/NN ,/, have/VB been/VBN isolated/VBN from/IN the/DT aerial/JJ parts/NNS of/IN Lysionotus/NNP pauciflorus/NN ./.
@@107275115634 Molecule/NN (/NN s/NN )/NN secreted/VBN by/IN neuronal/JJ cultures/NNS contribute/VBP to/IN this/DT induction/NN of/IN GLT-1/NEWGENE ,/, but/CC little/NN is/NNS known/VBP about/RB the/DT signaling/JJ pathways/NNS mediating/JJ this/DT regulation/NN ./.
@@5503995577 The/DT six/CD commonest/JJS causes/NNS of/IN death/NN varied/VBN in/IN the/DT three/CD ethnic/JJ groups/NNS ./.
@@76182801045 These/DT "nucleocapsid-like"/JJ structures/NNS were/VBD readily/RB purified/VBN by/IN density/NN gradient/NN centrifugation/NN ./.
@@10608893520 Similar/JJ to/IN Hp140/NEWGENE ,/, isolated/VBN Hp55/NEWGENE binds/VBZ DNA/NN with/IN moderate/JJ strength/NN and/CC was/VBD a/DT specificity/NN for/IN double-stranded/JJ primer-template/NN DNA/NN ./.
@@104898223892 Montelukast/NN reduces/VBZ airway/NN eosinophilic/JJ inflammation/NN in/IN asthma/NN :/: a/DT randomized/JJ ,/, controlled/VBN trial/NN ./.
@@74769711502 This/DT is/VBZ particularly/RB intriguing/JJ because/IN SKUT-1B-20/NNP cells/NNS lack/NN the/DT transcription/NN factor/NN Pit-1/NEWGENE ./.
@@30047398481 Surprisingly/RB ,/, a/DT C/NN to/IN G/NN transversion/NN at/IN the/DT first/JJ residue/NN of/IN the/DT CAT/NEWGENE pentanucleotide/NEWGENE ,/, which/WDT severely/RB impairs/VBZ the/DT activity/NN of/IN both/DT promoters/NNS ,/, appears/VBZ to/IN increase/NN affinity/NN of/IN the/DT CAT/NEWGENE binding/NEWGENE protein/NEWGENE ./.
@@82886064694 Using/VBG a/DT polymerase/NEWGENE chain/NN reaction-based/JJ approach/NN ,/, we/PRP cloned/VBN a/DT 150-base/JJ pair/NN fragment/NN of/IN a/DT new/JJ sialymotif/NN from/IN human/JJ placenta/NN mRNA/NN ,/, which/WDT was/VBD then/RB used/VBN as/IN a/DT probe/NN to/IN clone/NN the/DT complete/JJ coding/JJ sequence/NN of/IN the/DT corresponding/JJ gene/NN from/IN a/DT cDNA/NN library/NN ./.
@@27647973464 PULSE/NN is/VBZ used/VBN to/IN set/NN such/JJ NMR/NN spectroscopic/JJ parameters/NNS as/IN the/DT delay/NN and/CC duration/NN of/IN rf/NN transmit/VB and/CC receive/VB gates/NNS ,/, rf/NN phase/NN ,/, sampling/JJ times/NNS ,/, and/CC such/JJ imaging/NN parameters/NNS as/IN rf/NN pulse/NN shape/NN and/CC gradient/NN waveforms/NNS ./.
@@29014982466 The/DT biosynthesis/NN and/CC stability/NN of/IN the/DT three/CD mutant/JJ proteins/NNS were/VBD similar/JJ to/IN those/DT of/IN the/DT wild-type/NEWGENE erbB/NEWGENE protein/NEWGENE ,/, and/CC all/DT three/CD retained/VBN the/DT ability/NN to/IN transform/VB chicken/NN embryo/NN fibroblasts/NNS ./.
@@82893577789 The/DT results/NNS indicate/VBP that/DT rep/NEWGENE strongly/RB enhances/VBZ the/DT function/NN of/IN negative/JJ regulatory/JJ elements/NNS of/IN the/DT LTR/NN ./.
@@79371479144 A/DT genetic/JJ system/NN was/VBD devised/VBN to/IN select/VB for/IN pi/NEWGENE protein/NEWGENE mutants/NEWGENE which/WDT discriminate/VBP between/IN IR/NN and/CC DR/NN (/( York/NN et/FW al/NNS ./NNS ,/, Gene/NNP (/( Amst/NNP ./NNP )/SYM 116/CD ,/, 7-12/CD ,/, 1992/CD ;/: York/NN and/CC Filutowicz/NNP ,/, J/NNP ./NNP
@@15266902152 Mitochondria-lytic/JJ action/NN of/IN warfarin/NN in/IN lymphocytes/NNS ./.
@@113890859404 TT/JJ cells/NNS ,/, a/DT human/JJ MTC/NN cell/NN line/NN expressing/NN MEN/NEWGENE 2A/NEWGENE type/NEWGENE RET/NEWGENE ,/, display/NN transcriptionally/NEWGENE active/NEWGENE RelA/NEWGENE (/NEWGENE p65/NEWGENE )/NEWGENE in/IN the/DT nucleus/NN ./.
@@115699491447 Zarix/NNP expected/VBD patient/NN enrollment/NN in/IN Canadian/JJ clinical/JJ sites/NNS to/IN begin/VB in/IN Spring/NNP 2001/CD [/NN 397955/NN ]/NN ,/, [/NN 405928/NN ]/NN ./.
@@8132574942 Members/NNS of/IN SVA/NEWGENE are/VBP also/RB present/VB in/IN the/DT complement/NEWGENE C2/NEWGENE gene/NEWGENE located/VBN about/RB 20/CD kilobases/NNS upstream/RB of/IN RP1/NEWGENE in/IN the/DT HLA/NEWGENE and/CC in/IN the/DT cytochrome/NEWGENE CYP1A1/NEWGENE gene/NEWGENE ./.
@@109559986833 The/DT reduced/VBN efficiency/NN in/IN the/DT glycosylase/NEWGENE activity/NN is/VBZ also/RB reflected/VBN in/IN a/DT reduced/VBN ability/NN of/IN S120K/NEWGENE MutY/NEWGENE to/IN prevent/VB DNA/NN mutations/NNS in/IN vivo/NN ./.
@@72609873606 The/DT plasma/NN half-life/NN of/IN slow/JJ disposition/NN phase/NN t1/NN //NN 2/NN beta/NN ,/, increases/VBZ from/IN 0/CD ./CD 26/CD hour/NN in/IN rabbits/NNS with/IN normal/JJ renal/JJ function/NN to/IN 5/CD ./CD 41/CD hours/NNS in/IN rabbits/NNS with/IN severe/JJ renal/JJ impairment/NN ./.
@@93249229289 Fermentation/NNS process/NN after/IN supplementation/NN of/IN nitrate/NN ,/, nitrite/NN ,/, lactic/JJ acid/NN bacteria/NNS and/CC formic/JJ acid/NN ./.
@@94757248602 TOR2/NEWGENE is/VBZ part/NN of/IN two/RB related/VBN signaling/JJ pathways/NNS coordinating/JJ cell/NN growth/NN in/IN Saccharomyces/NN cerevisiae/NN ./.
@@82204948176 The/DT T-cyt/NEWGENE promoter/NEWGENE ,/, although/IN of/IN bacterial/JJ origin/NN is/VBZ active/JJ in/IN planta/NN and/CC the/DT 30/NEWGENE bp/NEWGENE cyt-1/NEWGENE element/NEWGENE is/VBZ located/VBN within/IN a/DT region/NN that/WDT is/VBZ essential/JJ for/IN T-cyt/NEWGENE promotor/NEWGENE activity/NN in/IN leaf/NN ,/, stem/NN and/CC root/JJ cells/NNS of/IN tobacco/NN plants/NNS ./.
@@96197771644 The/DT weak/JJ base/NN ketoconazole/NN showed/VBD complete/JJ dissolution/NN from/IN a/DT tablet/NN formulation/NN in/IN Simulated/JJ Gastric/NNP Fluid/NNS without/IN pepsin/NEWGENE (/( SGFsp/NN )/SYM within/IN 30/CD minutes/NNS ,/, 70%/CD dissolution/NN in/IN 2/CD hours/NNS under/IN fed/VBN state/NN simulated/JJ upper/JJ jejunal/JJ conditions/NNS but/CC only/RB 6%/JJ dissolution/NN in/IN 2/CD hours/NNS under/IN fasted/VBN state/NN conditions/NNS ./.
@@98730603615 Phosphorylation/NNS analyses/NNS indicated/VBD that/DT inhibition/NN of/IN ERK-1/NEWGENE //NEWGENE 2/NEWGENE decreased/VBN okadaic/JJ acid-elevated/JJ phosphorylation/NN of/IN JunD/NEWGENE and/CC FosB/NEWGENE ./.
@@80209621659 This/DT sequenced/VBN region/NN of/IN the/DT V/NEWGENE beta/NEWGENE locus/NEWGENE contains/VBZ an/DT average/JJ number/NN of/IN repetitive/JJ DNA/NN elements/NNS (/( 21/CD Alu/NN ,/, three/CD L1/NN ,/, three/CD MER/NN ,/, and/CC three/CD retrovirus-related/NN elements/NN ./.
@@10503540630 A/DT total/NN of/IN 174/CD primer/NN pairs/NNS gave/VBD interpretable/JJ banding/JJ patterns/NNS ,/, 137/CD (/( 79%/CD )/SYM of/IN which/WDT revealed/VBD at/IN least/RB two/JJ alleles/NNS on/IN native/JJ polyacrylamide/NN gels/NNS ./.
@@10612918433 All/DT problems/NNS were/VBD associated/VBN with/IN fractured/JJ or/CC lost/VBP screws/NNS ./.
@@115751091456 Following/VBG baseline/NN clinical/JJ examination/NN and/CC initial/JJ periodontal/JJ therapy/NN ,/, 32/CD patients/NNS received/VBD mucogingival/JJ surgery/NN with/IN free/JJ gingival/JJ grafts/NNS for/IN treatment/NN of/IN insufficient/JJ attached/VBN gingiva/NN ./.
@@108668863053 This/DT effect/NN was/VBD not/RB seen/VBP in/IN conjunction/NN with/IN oxycodone/NN ,/, a/DT morphine-like/NEWGENE mu-receptor/NEWGENE agonist/NN ./.
@@98460339833 RESULTS/NNS :/: Significant/JJ changes/NNS from/IN pretreatment/JJ to/IN posttreatment/JJ were/VBD observed/VBN (/( p/NN </SYM 0/CD ./CD 001/CD )/SYM ./.
@@98226025648 Here/RB we/PRP demonstrate/VBP that/IN the/DT mechanism/NN of/IN activation/NN of/IN HIF-1alpha/NEWGENE is/VBZ a/DT multi-step/NN process/NN which/WDT includes/VBZ hypoxia-dependent/JJ nuclear/JJ import/NN and/CC activation/NN (/( derepression/NN )/SYM of/IN the/DT transactivation/NN domain/NN ,/, resulting/JJ in/IN recruitment/NN of/IN the/DT CREB-binding/NEWGENE protein/NEWGENE (/( CBP/NEWGENE )/NN //NEWGENE p300/NEWGENE coactivator/NEWGENE ./.
@@10599013424 There/EX were/VBD 15/CD deaths/NNS ,/, seven/NN of/IN which/WDT were/VBD felt/VBP to/IN be/VB avoidable/JJ ./.
@@102161614836 Sequence/NN comparison/NN of/IN cytochromes/NEWGENE bd/NEWGENE and/CC their/PRP homologs/NNS from/IN various/JJ organisms/NNS demonstrates/VBZ that/IN the/DT proteins/NNS can/MD be/VB classified/VBN into/IN two/JJ subfamilies/NNS ,/, a/DT proteobacterial/JJ type/NN including/JJ E/NEWGENE ./NEWGENE coli/NEWGENE bd/NEWGENE and/CC a/DT more/RB widely/RB distributed/VBN type/NN including/JJ the/DT B/NNP ./NNP stearothermophilus/NN enzyme/NN ,/, suggesting/VBG that/IN the/DT latter/JJ type/NN is/VBZ evolutionarily/RB older/JJR ./.
@@95358922713 The/DT beta/NN subunit/NN of/IN the/DT heterotrimeric/NEWGENE G/NEWGENE proteins/NEWGENE that/WDT transduce/VBP signals/NNS across/IN the/DT plasma/NN membrane/NN is/NNS made/VBP up/NN of/IN an/DT amino-terminal/NN alpha-helical/NN segment/NN followed/VBN by/IN seven/JJ repeating/JJ units/NNS called/VBN WD/IN (/( Trp-Asp/NN )/SYM repeats/NNS that/WDT occur/VBP in/IN about/RB 140/CD different/JJ proteins/NNS ./.
@@114863998821 The/DT combination/NN of/IN ifosfamide/NN ,/, epirubicin/NN and/CC etoposide/NN (/( IEV/NN )/SYM is/VBZ an/DT effective/JJ salvage/NN regimen/NN for/IN lymphoproliferative/JJ disease/NN ./.
@@88785731342 Administration/NNP of/IN RIFA/NN at/IN 200/CD mg/NN //NN kg/NN //NN day/NN in/IN combination/NN with/IN ATO/NN at/IN 100/CD mg/NN //NN kg/NN //NN day/NN resulted/VBN in/IN a/DT marked/JJ prolongation/NN of/IN survival/NN compared/VBN with/IN that/IN for/IN mice/NNS that/WDT received/VBD ATO/NN or/CC RIFA/NN alone/RB ./.
@@117272091573 The/DT patients/NNS and/CC their/PRP families/NNS were/VBD closely/RB questioned/VBN ,/, and/CC full/JJ clinical/JJ examination/NN included/VBD a/DT test/NN for/IN orthostasia/NN ./.
@@18624552459 Thyroid/NN lymphoma/NN and/CC its/PRP management/NN ./.
@@90567615874 In/NN eukaryotic/JJ cells/NNS ,/, premature/JJ termination/NN of/IN translation/NN at/IN nonsense/NN codons/NNS has/VBZ been/VBN implicated/VBN as/IN the/DT cause/NN of/IN a/DT variety/NN of/IN posttranscriptional/JJ events/NNS ,/, including/JJ rapid/JJ mRNA/NN decay/NN in/IN the/DT cytoplasm/NN or/CC the/DT nucleus/NN ,/, altered/VBN splice/NN site/NN selection/NN ,/, and/CC exon/NN skipping/NN ./.
@@83221173687 The/DT two/JJ methods/NNS identify/VBP the/DT same/JJ patients/NNS only/RB if/IN micturitional/JJ pressures/NNS are/VBP normal/JJ (/( 40/CD to/IN 60/CD cmH2O/NN )/SYM to/IN high/JJ (/( over/RB 60/CD cmH2O/NN )/SYM and/CC the/DT Sussett/NN formula/NN is/VBZ used/VBN with/IN a/DT higher/JJ (/( 95th/CD centile/NN )/SYM cutoff/NN ./.
@@88780459212 Thus/RB ,/, the/DT N-Nus/NEWGENE complex/NEWGENE may/MD be/VB affected/VBN through/RB contacts/VBZ with/IN the/DT CTD/NN of/IN the/DT alpha/NN subunit/NN of/IN RNA/NEWGENE polymerase/NEWGENE ,/, as/IN is/VBZ a/DT group/NN of/IN regulatory/JJ proteins/NNS that/WDT influences/NNS initiation/NN of/IN transcription/NN ./.
@@98434123244 The/DT highly/RB amyloidogenic/JJ 42-residue/JJ form/NN of/IN Abeta/NEWGENE (/( Abeta42/NEWGENE )/SYM is/VBZ the/DT first/JJ species/NN to/IN be/VB deposited/VBN in/IN both/DT sporadic/JJ and/CC familial/JJ AD/NNP ./NNP
@@107808831388 Kaposi's/NNP sarcoma-associated/JJ herpesvirus/NN viral/NEWGENE interferon/NEWGENE regulatory/NEWGENE factor/NEWGENE confers/VBZ resistance/NN to/IN the/DT antiproliferative/JJ effect/NN of/IN interferon-alpha/NEWGENE ./.
@@102296826415 Regulatory/NNP motifs/NNS for/IN gene/NN expression/NN such/JJ as/IN nuclear-factor-kappaB-binding-site-like/NEWGENE sequence/NEWGENE (/( kappaB/NEWGENE site/NEWGENE )/SYM and/CC nuclear-factor-interleukin-6-binding-site-like/NEWGENE sequence/NEWGENE (/( NF-IL-6/NEWGENE site/NEWGENE )/SYM were/VBD found/VBN in/IN the/DT 5'-upstream/JJ regulatory/JJ region/NN ./.
@@94420722605 In/NN vitro/NN DNase/NEWGENE I/NEWGENE footprinting/VBG of/IN the/DT 200-bp/JJ proximal/JJ region/NN of/IN the/DT promoter/NN with/IN a/DT murine/JJ Hepa/NNP 1-6/JJ cell/NN nuclear/JJ extract/NN revealed/VBD a/DT clear/JJ footprint/NN of/IN a/DT region/NN corresponding/JJ to/IN -80/CD to/IN -28/CD bp/NN of/IN the/DT murine/NEWGENE fVII/NEWGENE gene/NEWGENE ,/, suggesting/VBG that/IN liver/NN factors/NNS interact/VBP with/IN this/DT region/NN of/IN the/DT DNA/NN ./.
@@3428274352 Nuclear/NEWGENE factor/NEWGENE III/NEWGENE (/( NFIII/NEWGENE )/SYM is/VBZ a/DT protein/NN from/IN HeLa/DT cells/NNS that/WDT stimulates/VBZ the/DT initiation/NN of/IN adenovirus/NN type/NN 2/CD (/( Ad2/NN )/SYM DNA/NN replication/NN by/IN binding/JJ to/IN a/DT specific/JJ nucleotide/NN sequence/NN in/IN the/DT origin/NN ,/, adjacent/JJ to/IN the/DT nuclear/NEWGENE factor/NEWGENE I/NEWGENE recognition/NEWGENE site/NEWGENE ./.
@@93364552731 We/PRP have/VBP measured/VBN the/DT kinetics/NN of/IN the/DT recovery/NN of/IN mRNA/NN synthesis/NN in/IN the/DT inducible/NN GAL10/NEWGENE and/CC RNR3/NEWGENE genes/NEWGENE after/IN exposure/NN of/IN yeast/NN cells/NNS to/IN ultraviolet/JJ (/( UV/NN )/SYM radiation/NN ./.
@@112833546674 These/DT data/NN define/VB a/DT conserved/VBN pathway/NN wherein/CC sequential/JJ histone/NEWGENE modifications/NNS establish/VBP a/DT "histone/NN code"/NN essential/JJ for/IN the/DT epigenetic/JJ inheritance/NN of/IN heterochromatin/NN assembly/NN ./.
@@97744847263 UGA/DT codon/NN position/NN affects/VBP the/DT efficiency/NN of/IN selenocysteine/NN incorporation/NN into/IN glutathione/NEWGENE peroxidase-1/NEWGENE ./.
@@89398918822 Using/VBG the/DT yeast/NN one-hybrid/JJ screen/NN with/IN integrated/JJ NRE/NNS and/CC flanking/JJ DNA/NN as/IN bait/NN ,/, the/DT predominant/JJ clone/NN obtained/VBN was/VBD bovine/NEWGENE Nrl/NEWGENE ./.
@@78736317854 The/DT regions/NNS of/IN the/DT tooth/NN fracture/NN are/VBP determined/VBN ./.
@@105518675740 It/PRP consists/VBZ of/IN 2185/CD amino/JJ acid/NN residues/NNS encoded/VBN by/IN a/DT 9-kilobase/CD pair/NN mRNA/NN ;/: several/DT splice/NN variants/NNS have/VBP been/VBN detected/VBN in/IN human/NN and/CC rat/NN cDNA/NN libraries/NNS ./.
@@27665083098 A/DT correlation/NN coefficient/NN was/VBD used/VBN for/IN assessing/JJ the/DT similarity/NN of/IN each/DT map/NN pattern/NN with/IN the/DT normal/JJ mean/JJ IQRST/NN map/NN ./.
@@765138661 Furthermore/RB ,/, this/DT element/NN confers/VBZ p53/NEWGENE induction/NN to/IN the/DT otherwise/RB nonresponsive/JJ adenovirus/NN major/JJ late/JJ promoter/NN ./.
@@79350947194 RESULTS/NNS :/: The/DT diagnostic/JJ quality/NN of/IN FDG/NN images/NNS was/VBD at/RB least/RB as/RB good/JJ as/IN that/DT of/IN their/PRP Tl-201/NN counterparts/NNS ,/, with/IN less/PRP liver/NN background/NN in/IN all/DT but/CC one/PRP FDG/NN study/NN ./.
@@10758726573 Systemic/JJ impact/NN of/IN risk-sharing/JJ arrangements/NNS ./.
@@89757135100 By/IN screening/JJ a/DT cDNA/NN library/NN with/IN a/DT probe/NN derived/VBN from/IN sequences/NNS downstream/RB of/IN the/DT p53p2/NEWGENE start/NN site/NN ,/, we/PRP have/VBP cloned/VBN and/CC characterized/VBD a/DT cDNA/NN that/WDT represents/VBZ a/DT mRNA/NN that/WDT appears/VBZ to/IN have/NN been/VBN initiated/VBN from/IN the/DT p53p2/NEWGENE promoter/NEWGENE ./.
@@9668108126 Manipulation/NNS of/IN the/DT checkpoint/NN regulators/NNS involved/VBN in/IN cell/NN cycle/NN arrest/NN and/CC apoptosis/NN may/MD thus/RB provide/VB a/DT novel/JJ strategy/NN to/IN cancer/NN therapy/NN ./.
@@106509394774 Induction/NNS was/VBD reversed/VBN by/IN coexpression/NN of/IN A-Fos/NEWGENE ,/, a/DT dominant/JJ negative/NN to/IN AP-1/NEWGENE ./.
@@92870369246 Plasma/NEWGENE leptin/NEWGENE concentrations/NNS were/VBD higher/JJ in/IN women/NNS than/IN men/NNS ,/, even/VB after/IN the/DT adjustment/NN for/IN differences/NNS in/IN fat/JJ mass/JJ (/( 28/CD +/NN //NN -/NN 3/CD ng/NN //NN ml/NN for/IN women/NNS vs/IN ./IN
@@21578828709 Conservation/NNP of/IN function/NN of/IN Drosophila/NEWGENE melanogaster/NEWGENE abl/NEWGENE and/CC murine/NEWGENE v-abl/NEWGENE proteins/NEWGENE in/IN transformation/NN of/IN mammalian/JJ cells/NNS ./.
@@84511879099 There/EX are/VBP ,/, however/RB ,/, several/DT differences/NNS between/IN the/DT two/JJ new/JJ ars/NEWGENE sequences/NEWGENE ./.
@@98194146044 These/DT sorting/NEWGENE nexins/NEWGENE also/RB associated/VBN with/IN the/DT long/JJ isoform/NN of/IN the/DT leptin/NEWGENE receptor/NEWGENE but/CC not/RB with/IN the/DT short/NN and/CC medium/NN isoforms/NNS ./.
@@15426869924 Molecular/NNP cloning/NN of/IN the/DT polypeptide/NN component/NN of/IN the/DT Rel-related/NEWGENE human/NEWGENE p75/NEWGENE nucleoprotein/NEWGENE complex/NEWGENE has/VBZ revealed/VBN its/PRP identity/NN with/IN the/DT 65-kDa/NN (/( p65/NEWGENE )/SYM subunit/NN of/IN NF-kappa/NEWGENE B/NEWGENE ./.
@@110367866020 Following/VBG the/DT results/NNS of/IN toxicological/JJ experiments/NNS in/IN the/DT target/NN animals/NNS "Toxicological/JJ Drinking/VBG Water/NNP Standards/NNPS for/IN Animals"/NN can/MD be/VB established/VBN ./.
@@110192573527 We/PRP find/VBP that/IN 3T1-3T2/NN mixing/NN has/VBZ a/DT pronounced/VBN effect/NN on/IN the/DT line/NN shape/NN and/CC radiative/JJ decay/NN rate/NN of/IN emission/NN from/IN the/DT 3T2/CD state/NN and/CC that/IN the/DT extent/NN of/IN mixing/NN depends/VBZ critically/RB on/IN the/DT magnitude/NN of/IN nontetrahedral/JJ distortions/NNS ./.
@@21651812772 This/DT cohort/NN of/IN patients/NNS was/VBD selected/VBN on/IN the/DT basis/NN of/IN clinical/JJ stage/NN ./.
@@36588664327 Systemic/JJ lupus/NN erythematosus/NN was/VBD diagnosed/VBN ./.
@@111024589974 We/PRP describe/VBP the/DT identification/NN and/CC initial/JJ characterization/NN of/IN neurobeachin/NEWGENE ,/, a/DT neuron-specific/NN multidomain/NN protein/NN of/IN 327/CD kDa/NN with/IN a/DT high-affinity/JJ binding/JJ site/NN (/( K/NN (/NN d/NN )/SYM ,/, 10/CD nm/NN )/NN for/IN the/DT type/NEWGENE II/NEWGENE regulatory/NEWGENE subunit/NEWGENE of/NEWGENE protein/NEWGENE kinase/NEWGENE A/NEWGENE (/( PKA/NEWGENE RII/NEWGENE )/SYM ./.
@@23151519205 Senior/JJ systems--45/JJ ;/: Mental/NNP health/NN and/CC illness/NN in/IN old/JJ age--3/NN ./.
@@23225355853 Intron/NN 1/CD is/VBZ 6/CD ./CD 5/CD kb/NN long/JJ ,/, and/CC the/DT minimal/JJ sizes/NNS of/IN introns/NNS 2/CD and/CC 3/CD are/VBP estimated/VBN to/IN be/VB 32/CD kb/NN each/DT ./.
@@89401348684 In/NN 3Y1/CD and/CC 3Y1/CD v-crk-transformed/JJ fibroblasts/NNS ,/, almost/RB all/DT of/IN the/DT total/JJ PTP1B/NEWGENE and/CC about/RB 40%/CD of/IN total/JJ p130/NEWGENE (/NEWGENE Cas/NEWGENE )/NEWGENE co-sediment/NN with/IN membranes/NNS composed/VBN primarily/RB of/IN endoplasmic/JJ reticulum/NN ./.
@@89224888880 Several/JJ agents/NNS have/VBP been/VBN tried/VBN for/IN treatment/NN ,/, often/RB limited/VBN by/IN toxic/JJ side/JJ effects/NNS ./.
@@10489688454 These/DT studies/NNS have/NN shown/VBP that/IN the/DT majority/NN of/IN tested/VBN staphylococci/NNS were/VBD resistant/JJ to/IN penicillin/NN G/NN ,/, erythromycin/NN ,/, and/CC produced/VBD beta-lactamase/NEWGENE ./.
@@37597314098 Renal/JJ clearance/NN fell/NN from/IN 19/CD ./CD 0/CD +/NN //NN -/NN 4/CD ./CD 9/CD ml/CD //CD min/CD //CD 1/CD ./CD 73/CD m2/NN (/( group/NN I/PRP )/SYM to/IN 1/CD ./CD 0/CD +/NN //NN -/NN 0/CD ./CD 4/CD ml/CD //CD min/CD //CD 1/CD ./CD 73/CD m2/NN (/( group/NN IV/NN )/SYM ./.
@@8153698129 19-32/CD ./.
@@79355777997 Treatment/NNP with/IN amphotericin/NN B/NN and/CC flucytosine/NN led/VBN to/IN improvement/NN of/IN the/DT symptoms/NNS but/CC did/VBD not/RB eradicate/VB the/DT micro-organisms/NNS from/IN the/DT cerebrospinal/JJ fluid/NN (/( CSF/NN )/SYM ./.
@@937293774 The/DT yeast/NN silent/NEWGENE information/NEWGENE regulator/NEWGENE Sir4p/NEWGENE anchors/NN and/CC partitions/NNS plasmids/NNS ./.
@@32809123966 Antituberculosis/NNP agents/NNS ./.
@@31853225480 A/DT poor/JJ correlation/NN was/VBD found/VBN between/IN a/DT mildly-atypical/JJ (/( inflammatory/JJ )/SYM cytological/JJ result/NN (/( class/NN 2/CD )/SYM and/CC a/DT benign/JJ histological/JJ diagnosis/NN :/: 48%/NN of/IN class-2/NN smears/NNS were/VBD diagnosed/VBN histologically/RB as/IN dysplasia/NN or/CC worse/JJ ./.
@@77917834618 SRY-related/NEWGENE cDNA/NEWGENE encoding/VBG a/DT protein/NN with/IN a/DT high-mobility-group/NEWGENE (/( HMG/NEWGENE )/SYM box/NN and/CC a/DT leucine/NN zipper/NN motif/NN ,/, which/WDT was/VBD designated/VBN SOX-LZ/NEWGENE ,/, was/VBD isolated/VBN from/IN a/DT rainbow/NN trout/NN testis/NN cDNA/NN library/NN ./.
@@14678282085 These/DT results/NNS indicate/VBP a/DT possible/JJ involvement/NN of/IN endogenous/NEWGENE opioid/NEWGENE peptides/NEWGENE in/IN the/DT cardiac/JJ effects/NNS due/NN to/IN myocardial/JJ ischaemia/NN and/CC reperfusion/NN ,/, mediated/JJ by/IN opiate/NEWGENE receptors/NEWGENE through/RB opiate/JJ antagonism/NN ./.
@@31124126097 In/NN addition/NN ,/, a/DT wild-type/NN strain/NN containing/JJ a/DT temperature-sensitive/NEWGENE threonyl-tRNA/NEWGENE synthetase/NEWGENE mutation/NEWGENE showed/VBD increased/VBN thr/NEWGENE operon/NEWGENE expression/NN at/IN the/DT non-permissive/JJ temperature/NN ,/, whereas/IN none/NN of/IN the/DT mutants/NNS showed/VBD any/DT change/NN ./.
@@63888181020 Ten/CD patients/NNS with/IN advanced/JJ ,/, diffuse/JJ Hodgkin's/NNP and/CC non-Hodgkin's/JJ lymphomas/NNS responding/VBG poorly/RB to/IN the/DT most/RB widely/RB employed/VBN primary/JJ chemotherapy/NN regimens/NNS were/VBD treated/VBN with/IN a/DT high-dose/JJ chemotherapy/NN (/( HDC/NN )/SYM followed/VBN by/IN rescue/NN with/IN non-frozen/JJ autologous/JJ bone/NN marrow/NN infusion/NN (/( ABMT/NN )/SYM ./.
@@21130152712 Maternal/JJ seizures/NNS had/VBP occurred/VBN during/IN pregnancy/NN in/IN 52/NNP per/IN cent/NN ./.
@@75287726423 All/DT four/CD doubly/RB tyrosine/NN phosphorylated/VBN TAM/NEWGENE peptides/NEWGENE cross-compete/JJ with/IN each/DT other/DT for/IN binding/JJ to/IN the/DT tandem/NN SH2/NEWGENE domains/NEWGENE of/IN ZAP-70/NEWGENE ./.
@@23283285220 Axillary/NNP nodal/JJ status/NN ,/, tumour/NN progesterone/NEWGENE receptor/NEWGENE status/NN ,/, and/CC season/NN of/IN tumour/NN detection/NN significantly/RB influenced/VBD survival/NN in/IN both/DT older/JJR (/( greater/JJR than/IN 50/CD yrs/NNS )/SYM and/CC younger/JJR (/( less/PRP than/IN 50/CD yrs/NNS )/SYM patients/NNS ./.
@@90126368977 Adjustment/NNP for/IN age/NN ,/, total/JJ cholesterol/NN ,/, HDL/NN cholesterol/NN ,/, triglycerides/NNS ,/, current/JJ smoking/NN ,/, and/CC systolic/JJ pressure/NN slightly/RB reduced/VBD the/DT association/NN between/IN fibrinogen/NEWGENE and/CC atherosclerosis/NN ./.
@@14066565598 However/RB ,/, a/DT cosmid/NN clone/NN containing/JJ the/DT entire/JJ mouse/NEWGENE alpha/NEWGENE 1/NEWGENE (/NEWGENE I/NEWGENE )/NEWGENE gene/NEWGENE ,/, including/JJ 3/CD ./CD 7/CD kb/NN of/IN 5'-/JJ and/CC 4/CD kb/NN of/IN 3'-flanking/JJ DNA/NN ,/, was/VBD expressed/VBN at/IN reduced/VBN levels/NNS in/IN fibroblasts/NNS overexpressing/JJ oncogenic/NEWGENE ras/NEWGENE ./.
@@27255135098 It/PRP is/VBZ striking/JJ that/IN the/DT active/JJ CHO/NEWGENE spacer/NEWGENE promoter/NEWGENE violated/VBD the/DT otherwise/RB universal/JJ rule/NN that/IN metazoan/NEWGENE RNA/NEWGENE polymerase/NEWGENE I/NEWGENE promoters/NEWGENE all/DT have/NN a/DT G/NN residue/NN at/IN position/NN -16/CD ./.
@@94910741968 To/TO understand/VB the/DT regulatory/JJ mechanism/NN controlling/JJ its/PRP expression/NN at/IN low/JJ temperature/NN ,/, the/DT promoter/NN region/NN has/VBZ been/VBN characterized/VBN ./.
@@1332141961 2/NNS ./NNS --concepts/NNS of/IN higher/JJ nervous/JJ function/NN in/IN the/DT USSR/NN ./.
@@81906331092 The/DT mature/JJ AP-2/NEWGENE mRNA/NEWGENE is/VBZ spliced/VBN from/IN 7/CD exons/NNS distributed/VBN over/RB a/DT region/NN of/IN 18/CD kb/NN genomic/JJ DNA/NN ./.
@@97247637366 Nonsynonymous/JJ substitution/NN in/IN abalone/NN sperm/NN fertilization/NN genes/NNS exceeds/VBZ substitution/NN in/IN introns/NNS and/CC mitochondrial/JJ DNA/NN ./.
@@111393363803 The/DT molecular/JJ associations/NNS dictating/VBG INCENP/NEWGENE behavior/NN during/IN mitosis/NN are/VBP currently/RB unknown/JJ ./.
@@3815054494 202-8/JJ ./.
@@92829859238 There/EX were/VBD differences/NNS between/IN males/NNS (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM for/IN most/RB of/IN the/DT characteristics/NNS studied/VBN ./.
@@14967842109 The/DT results/NNS of/IN this/DT study/NN demonstrate/VB that/DT strongyloidiasis/NN was/VBD the/DT cause/NN of/IN sudden/JJ death/NN ./.
@@13164764867 Many/JJ canonical/JJ TATA/NN sequences/NN are/VBP present/VB upstream/RB from/IN these/DT VZV/NN transcriptional/JJ start/NN sites/NNS but/CC ,/, apparently/RB ,/, are/VBP not/RB used/VBN ./.
@@30725802011 Van/NNP der/NNP Ende/NNP ,/, R/NNP ./NNP
@@49990865301 A/DT comparative/JJ study/NN of/IN the/DT cortical/JJ end/NN of/IN the/DT auditory/JJ analyzer/NN during/IN postnatal/JJ ontogenesis/NN in/IN lower/JJR monkeys/NNS and/CC man/NN ./.
@@30329648699 Constitutive/JJ function/NN of/IN a/DT positively/RB regulated/VBN promoter/NN reveals/VBZ new/JJ sequences/NNS essential/JJ for/IN activity/NN ./.
@@30792763802 Analysis/NNP in/IN 3/CD groups/NNS of/IN patients/NNS suffering/VBG from/IN simple/JJ acute/JJ and/CC pernicious/JJ malarial/JJ flare-ups/NNS ./.
@@89313886396 The/DT mobility/NN shift/NN assay/NN of/IN the/DT 65/CD bp/NN (/( -318/JJ //JJ -254/CD )/SYM fragment/NN with/IN nuclear/JJ extract/NN from/IN the/DT dark-adapted/JJ sample/NN showed/VBD an/DT additional/JJ band/NN ,/, not/RB seen/VBP with/IN the/DT light-grown/JJ sample/NN ./.
@@20171599127 Grasso/NNP ,/, and/CC A/NNP ./NNP
@@16543497716 Feed/VB intake/NN was/VBD not/RB affected/VBN by/IN dietary/JJ KCl/NN or/CC NaHCO3/NN supplementation/NN ,/, but/CC average/JJ daily/JJ gain/NN increased/VBN with/IN increased/VBN K/NN and/CC tended/VBN to/IN be/VB reduced/VBN by/IN dietary/JJ NaHCO3/NN ./.
@@78727886939 The/DT high/JJ degree/NN of/IN sequence/NN identity/NN (/( 96%/CD )/SYM between/IN hydrolase/NEWGENE B/NEWGENE and/NEWGENE C/NEWGENE ,/, particularly/RB in/IN the/DT 3'/CD untranslated/JJ region/NN ,/, suggests/VBZ that/IN the/DT genes/NNS encoding/VBG these/DT two/JJ carboxylesterases/NEWGENE evolved/VBN by/IN duplication/NN and/CC divergence/NN of/IN a/DT common/JJ ancestral/JJ gene/NN ./.
@@73543677201 Hypotension/NNS was/VBD produced/VBN by/IN head/JJ up/RP tilt/NN ./.
@@80494018039 Immunodepression/NNS was/VBD combined/JJ with/IN the/DT increase/NN of/IN glucocorticoid/NN activity/NN of/IN adrenal/JJ cortex/NN ,/, while/CC no/DT significant/JJ changes/NNS in/IN thyroid/JJ hormones/NNS were/VBD registered/VBN ./.
@@79733977964 Determination/NNS of/IN potassium/NN iodide/NN in/IN Polish/JJ edible/JJ salt/NN ./.
@@90397441297 Enhanced/NNP period-peak/JJ analysis/NN of/IN electro-encephalograms/NNS using/VBG a/DT fast/JJ sinc/NN function/NN ./.
@@97178355073 These/DT sequence/NN analyses/NNS suggest/VBP that/DT xIRS-u/NEWGENE is/VBZ a/DT novel/JJ member/NN of/IN the/DT IRS/NEWGENE family/NEWGENE rather/RB than/IN a/DT Xenopus/NN homolog/NN of/IN an/DT existing/JJ member/NN ./.
@@22987415468 Analysis/NNP with/IN additional/JJ anti-peptide/NN antibodies/NNS specific/JJ for/IN alpha/NEWGENE ,/NEWGENE beta/NEWGENE ,/NEWGENE or/NEWGENE gamma/NEWGENE PKC/NEWGENE indicated/VBN that/IN all/DT three/CD types/NNS of/IN PKC/NEWGENE are/VBP expressed/VBN in/IN JK/NNP cells/NNS ;/: however/RB ,/, JKPE/NNP cells/NNS lost/VBP a/DT major/JJ approximately/RB 82/CD kDa/NN immunoreactive/JJ cytosolic/JJ protein/NN detectable/JJ with/IN anti-PKC/NEWGENE alpha/NEWGENE antibody/NEWGENE ./.
@@105675338619 Reverse/VB transcription/NN (/( RT/JJ )/NN -PCR/NN products/NNS were/VBD synthesized/VBN with/IN two/JJ degenerate/JJ primers/NNS derived/VBN from/IN the/DT conserved/VBN motifs/NNS of/IN various/JJ tyrosine/NEWGENE kinases/NEWGENE ./.
@@81852888158 The/DT experiment/NN included/VBN 6/CD male/JJ and/CC 4/CD female/JJ healthy/JJ subjects/NNS who/WP ,/, during/IN a/DT 24-hour/JJ stay/NN in/IN the/DT respiration/NN chambers/NNS ,/, performed/VBN ,/, in/IN the/DT morning/NN and/CC afternoon/JJ ,/, 15/CD min/NN cycling/JJ with/IN the/DT total/JJ work/NN of/IN 6/CD ,/CD 750/CD kg/NN m/CD ./CD
@@80988424284 Mutations/NNS in/IN a/DT region/NN located/VBN 15/CD to/IN 30/CD bp/NN downstream/RB from/IN the/DT major/JJ transcription/NN start/NN site/NN that/WDT shows/VBZ good/JJ homology/NN to/IN a/DT sequence/NN in/IN the/DT first/JJ exon/NN of/IN c-fos/NEWGENE implicated/VBN as/IN a/DT negative/JJ regulatory/JJ element/NN resulted/VBN in/IN a/DT significant/JJ increase/NN in/IN basal/JJ gene/NN expression/NN but/CC did/VBD not/RB affect/VB regulation/NN ./.
@@113253911173 After/IN all/DT doses/NNS of/IN d-amphetamine/NN ,/, responding/VBG occurred/VBN largely/RB on/IN the/DT saline/JJ key/NN under/IN both/DT schedules/NNS ./.
@@89640675596 Thrombosis/NNS of/IN the/DT renal/NN vein/NN may/MD be/VB dramatic/JJ and/CC include/VB renal/JJ failure/NN ./.
@@2131666842 The/DT experimental/JJ group/NN consisted/VB of/IN 61/CD examinees/NNS class/NN II/NN //NN 2/NN orthodontic/JJ anomalies/NNS ./.
@@101980565500 Many/JJ eukaryotic/JJ cell/NN surface/NN proteins/NNS are/VBP anchored/VBN in/IN the/DT lipid/NN bilayer/JJ through/JJ glycosylphosphatidylinositol/NN (/( GPI/NN )/SYM ./.
@@85240369109 Contrary/JJ to/IN expectations/NNS ,/, we/PRP find/VBP a/DT relatively/JJ high/JJ level/NN of/IN variation/NN in/IN the/DT stripe/NEWGENE 2/NEWGENE enhancer/NEWGENE region/NEWGENE ,/, including/JJ point/NN substitutions/NNS and/CC insertion/NNS //NNS deletions/NNS in/IN binding/JJ sites/NNS ,/, and/CC a/DT comparable/JJ level/NN of/IN variation/NN in/IN the/PDT other/DT noncoding/JJ regions/NNS ./.
@@68025005759 Thyreoliberin/NN VUFB/NN in/IN thyroid/JJ gammagraphy/NN ./.
@@92201581356 A/DT soluble/NN 62-kDa/NN protein/NN was/VBD produced/VBN without/IN the/DT proteolytic/JJ processing/NN by/IN inserting/VBG the/DT coding/JJ sequence/NN of/IN amino/JJ acids/NNS 112/CD to/IN 660/CD of/IN ORF-2/NNP in/IN a/DT baculovirus/NN expression/NN vector/NN and/CC using/VBG the/DT corresponding/JJ virus/NN to/IN infect/VB Sf9/CD cells/NNS ./.
@@66670158308 While/IN these/DT findings/NNS may/MD reflect/VB the/DT sensitivity/NN of/IN a/DT thick/JJ myocardial/JJ wall/NN to/IN ischaemia/NN during/IN surgery/NN ,/, the/DT postoperative/JJ recovery/NN was/VBD not/RB related/VBN to/IN the/DT serum/NEWGENE CK-MB/NEWGENE level/NN ./.
@@89255458885 Recombinant/NEWGENE erythropoietin/NEWGENE (/( r-HuEPO/NEWGENE )/SYM in/IN the/DT treatment/NN of/IN anemia/NN in/IN multiple/JJ myeloma/NN ./.
@@15132132133 Model/NN predictions/NNS were/VBD in/IN accord/NN with/IN the/DT nine-year/JJ survival/NN experience/NN of/IN women/NNS in/IN the/DT HIP/NN trial/NN ,/, and/CC ,/, with/IN the/DT exception/NN of/IN women/NNS 40-44/JJ years/NNS old/JJ ,/, with/IN HIP/NN data/NN on/IN 18-year/JJ survival/NN ./.
@@63738556171 Eleven/CD biopsy/NN specimens/NNS (/( five/CD papules/NNS and/CC six/CD dusky/JJ or/CC crusted/VBN lesions/NNS )/SYM from/IN four/CD patients/NNS with/IN pityriasis/NN lichenoides/NNS et/FW varioliformis/NN acuta/NN (/( PLEVA/NNP )/SYM were/VBD studied/VBN by/IN direct/JJ immunofluorescence/NN and/CC immunoperoxidase/NN technics/NNS ./.
@@10557008377 Detection/NNS of/IN poisoning/VBG by/IN Impila/NNP (/( Callilepis/NNP laureola/NN )/SYM in/IN a/DT mother/NN and/CC child/NN ./.
@@10892823719 Screening/NN ,/, counseling/NN ,/, and/CC treatment/NN for/IN alcohol/NN and/CC illicit/JJ drug/NN use/NN should/MD be/VB essential/JJ components/NNS in/IN comprehensive/JJ HBP/NN care/NN ./.
@@10318806168 Analyses/NNS of/IN tyrosine/NN residue-mutated/NN PDGF/NEWGENE receptors/NEWGENE show/VBP that/IN Src/NEWGENE homology/NEWGENE 2/NEWGENE domain-containing/NEWGENE proteins/NEWGENE including/JJ Src/NEWGENE family/NEWGENE kinases/NEWGENE ,/, phosphatidylinositol/NEWGENE 3-kinase/NEWGENE ,/, the/DT GTPase-activating/NEWGENE protein/NEWGENE of/IN Ras/NEWGENE ,/, the/PDT Src/NEWGENE homology/NEWGENE 2/NEWGENE domain-containing/NEWGENE phosphatase/NEWGENE SHP-2/NEWGENE1 ,/, phospholipase/NEWGENE C-gamma/NEWGENE ,/, and/CC Crk/NEWGENE do/NN not/RB play/VB a/DT major/JJ role/NN in/IN mediating/JJ the/DT PDGF-induced/JJ activation/NN of/IN p38/NEWGENE ./.
@@74873632415 The/DT serum/JJ levels/NNS of/IN IgE/NEWGENE ,/, and/CC asIgE/NEWGENE and/CC IgG-4/NEWGENE against/IN 14/CD common/JJ food/NN allergens/NNS were/VBD determined/VBN ./.
@@9858094830 Also/RB ,/, the/DT amplitude/NN of/IN the/DT oscillatory/JJ potentials/NNS (/( O1+O2+O3+O4/NN )/SYM was/VBD significantly/RB reduced/VBN in/IN the/DT early/JJ postoperative/JJ period/NN ./.
@@13712757231 Differential/JJ expression/NN of/IN the/DT "B"/NN subunit/NN of/IN the/DT vacuolar/NEWGENE H/NEWGENE (/NEWGENE +/NEWGENE )/NEWGENE -ATPase/NEWGENE in/IN bovine/JJ tissues/NNS ./.
@@75695327468 Pediatric/NNP medical/JJ emergencies/NNS in/IN a/DT regional/JJ hospital/NN :/: appropriate/JJ locale/NN ?/.
@@88582689491 CONCLUSION/IN :/: During/IN chronic/JJ treatment/NN ,/, the/DT haemodynamic/JJ response/NN to/IN oral/JJ cilazapril/NN was/VBD attenuated/VBN ,/, indicating/VBG that/WDT continued/VBD clinical/JJ improvement/NN in/IN patients/NNS with/IN CHF/NN on/IN CLZ/NN is/VBZ independent/NN of/IN to/IN its/PRP acute/JJ haemodynamic/JJ effects/NNS ./.
@@95623984513 Trichloroethylene/NNP ,/, in/IN turn/NN ,/, increased/VBD the/DT AUC/NN 5/NN ./NN 0/NN (/( 1/CD ./CD 9-13/CD ./CD 4/CD )/SYM ,/, 25/CD ./CD 8/CD (/( 8/CD ./CD 2-80/CD ./CD 8/CD )/SYM and/CC 2/CD ./CD 9/CD (/( 1/CD ./CD 6-5/CD ./CD 4/CD )/SYM ,/, respectively/RB ,/, whereas/IN the/DT corresponding/JJ values/NNS for/IN n-hexane/NN were/VBD 1/CD ./CD 9/CD (/( 0/CD ./CD 7-5/CD ./CD 1/CD )/SYM ,/, 1/CD ./CD 5/CD (/( 0/CD ./CD 5-4/CD ./CD 6/CD )/SYM ,/, and/CC 3/CD ./CD 2/CD (/( 1/CD ./CD 8-5/CD ./CD 9/CD )/SYM ./.
@@97617911458 The/DT interaction/NN of/IN U1-70K/NEWGENE with/IN the/DT SRZ/NEWGENE proteins/NEWGENE is/VBZ confirmed/VBN further/RB in/IN vitro/FW using/VBG a/DT blot/NN overlay/NN assay/NN ./.
@@21964505114 Analysis/NNP of/IN various/JJ deletion/NN mutants/NNS indicates/VBZ that/IN the/DT sequence/NN requirements/NNS for/IN binding/JJ by/IN QBP/NEWGENE in/IN vitro/FW are/VBP indistinguishable/JJ from/IN those/DT necessary/JJ for/IN Q/NEWGENE activity/NN in/IN vivo/NN ,/, strongly/RB suggesting/VBG that/DT QBP/NEWGENE is/VBZ required/VBN for/IN the/DT function/NN of/IN this/DT TATA-independent/NN promoter/NN ./.
@@74961847386 Common/NNP history/NN and/CC prospects/NNS in/IN surgical/JJ gynecology/NN of/IN the/DT Charite/NNS and/CC the/DT Vienna/NNP University/NNP Clinic/NNP ./.
@@18409025172 Therefore/RB ,/, we/PRP have/VBP developed/VBN a/DT system/NN to/IN study/NN nuclear/JJ targeting/NN in/IN plants/NNS and/CC have/VB established/VBN that/IN the/DT nuclear/JJ transport/NN machinery/NN is/VBZ similar/JJ in/IN monocots/NNS and/CC dicots/NNS ./.
@@11148589462 CONCLUSIONS/IN :/: Under/IN current/JJ immunization/NN practices/NNS ,/, the/DT authors/NNS estimate/NN that/IN nearly/RB 13/NN ,/NN 000/NN Asian/JJ and/CC Pacific/NNP Islander/NNP children/NNS living/VBG in/IN the/DT United/NNP States/NNPS today/NN will/MD become/VB infected/VBN with/IN HBV/NN in/IN the/DT future/JJ ,/, resulting/JJ in/IN more/RB than/IN 600/CD liver/NN carcinoma/NN deaths/NNS ./.
@@57255095670 Steroids/NNS in/IN germfree/NN and/CC conventional/JJ rats/NNS ./.
@@115555163154 Cardiac/NNP output/NN at/IN anaerobic/JJ threshold/NN (/( COAT/NN )/SYM </SYM or/CC =/SYM 7/CD ./CD 3/CD L/NNS //NNS min/NNS was/VBD the/DT best/JJS cutoff/NN value/NN for/IN identifying/JJ multivessel/JJ coronary/JJ artery/NN disease/NN (/( relative/JJ risk/NN ,/, 3/CD ./CD 1/CD )/SYM ./.
@@21624672215 We/PRP show/VBP that/DT cytR/NEWGENE expression/NN is/VBZ negatively/RB controlled/VBN by/IN the/DT CytR/NEWGENE protein/NEWGENE and/CC positively/RB affected/VBN by/IN the/DT cAMP/NEWGENE //NEWGENE CAP/NEWGENE complex/NEWGENE ./.
@@39720387964 The/DT topography/NN and/CC trajectories/NNS of/IN the/DT commissural/JJ fibers/NNS of/IN the/DT superior/JJ temporal/NN region/NN (/( STR/NN )/SYM are/VBP studied/VBN using/VBG the/DT autoradiographic/JJ technique/NN ./.
@@85093357222 SSG1/NEWGENE ,/, a/DT gene/NN encoding/VBG a/DT sporulation-specific/NEWGENE 1/NEWGENE ,/NEWGENE 3-beta-glucanase/NEWGENE in/IN Saccharomyces/NN cerevisiae/NN ./.
@@96241129 T4/NN and/CC FT4I/NN followed/VBD parallel/JJ courses/NNS in/IN both/DT groups/NNS ;/: during/IN the/DT first/JJ 45/CD days/NNS ,/, however/RB ,/, the/DT values/NNS were/VBD significantly/RB lower/JJR in/IN premature/JJ infants/NNS under/IN 34/CD weeks'/NNP EGA/NNP than/IN in/IN term/NN infants/NNS (/( P/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ./.
@@113729592944 Multiple/NNP regression/NN analysis/NN performed/VBN between/IN these/DT long-term/JJ abiotic/JJ factors/NNS and/CC nymphal/JJ abundance/NN in/IN positive/JJ sites/NNS showed/VBD high/JJ relationship/NN (/( R2/NN coefficients/NNS )/SYM for/IN every/DT habitat/NN category/NN and/CC explained/VBN >/SYM 50%/CD of/IN the/DT variation/NN in/IN tick/NN abundance/NN ./.
@@112072165281 The/DT regulation/NN of/IN PGHS-2/NEWGENE mRNA/NEWGENE and/CC protein/NN was/VBD studied/VBN in/IN primary/JJ cultures/NNS of/IN bovine/JJ uterine/JJ stromal/JJ cells/NNS stimulated/VBN with/IN phorbol/NN 12-myristate/JJ 13-acetate/JJ (/( PMA/NN ;/: 100/CD nM/NN )/SYM ./.
@@109002691901 When/WRB cells/NNS were/VBD microinjected/VBN with/IN TFOs/NN designed/VBN to/IN bind/NN to/IN a/DT 30-bp/JJ polypurine/NN site/NN situated/VBN between/IN the/DT two/JJ TK/NEWGENE genes/NEWGENE ,/, recombination/NN was/VBD observed/VBN at/IN frequencies/NNS in/IN the/DT range/NN of/IN 1%/JJ ,/, 2/JJ ,/JJ 500-fold/JJ above/RB the/DT background/NN ./.
@@79901364013 Moreover/RB ,/, the/DT ability/NN to/IN selectivity/NN arrest/NN elongation/NN by/IN polIII/NEWGENE at/IN defined/VBN positions/NNS within/IN the/DT tRNA/NEWGENE gene/NEWGENE transcription/NEWGENE unit/NEWGENE has/VBZ permitted/VBN the/DT identification/NN of/IN discrete/JJ functional/JJ properties/NNS of/IN paused/VBN mammalian/NEWGENE polIII/NEWGENE ternary/NEWGENE complexes/NEWGENE ./.
@@9410509365 The/DT effect/NN of/IN food/NN on/IN procainamide/NN absorption/NN ./.
@@16908124750 Approximately/RB 50%/CD of/IN the/DT ribosomal/JJ DNA/NN (/( rDNA/NN )/SYM units/NNS of/IN Drosophila/NN melanogaster/NN are/VBP inactivated/VBN by/IN two/JJ different/JJ 28/NEWGENE S/NEWGENE RNA/NEWGENE ribosomal/NEWGENE gene/NEWGENE insertions/NNS (/( type/NN I/NN and/CC type/NN II/NN )/SYM ./.
@@95117607495 Based/VBN on/IN restriction/NN enzyme/NN analysis/NN ,/, Southern/NNP blots/NNS ,/, polymerase/NN chain/NN reaction/NN analysis/NN and/CC DNA/NN sequencing/VBG ,/, it/PRP was/VBD confirmed/VBN that/IN the/DT three/CD overlapping/JJ clones/NNS isolated/VBD cover/NN the/DT entire/JJ cHO-1/NEWGENE gene/NEWGENE ,/, as/RB well/VB as/IN approximately/RB 10/CD kb/NN of/IN the/DT flanking/JJ regions/NNS on/IN both/DT ends/NNS ./.
@@112433365056 GafChromic/NN (/( MD-55-2/NN )/SYM radiochromic/JJ film/NN has/VBZ become/VBN increasingly/RB popular/JJ for/IN medical/JJ applications/NNS and/CC has/VBZ proven/VBP to/IN be/VB useful/JJ for/IN brachytherapy/NN dosimetry/NN ./.
@@40288714697 The/DT pharmacokinetics/NN of/IN each/DT tetracycline/NN in/IN serum/JJ and/CC dermal/JJ ,/, suction/NN blister/NN fluid/NN were/VBD determined/VBN after/IN oral/JJ doses/NNS of/IN 300/CD mg/NN lymecycline/NN or/CC 100/CD mg/NN doxycycline/NN on/IN the/DT 3rd/CD day/NN ./.
@@86549726630 Defects/NNPS in/IN the/DT Schizosaccharomyces/NN pombe/NN (/( Sp/NNP )/SYM cell/NN cycle-controlling/JJ genes/NNS prevent/VBP the/DT cell/NN cycle/NN progression/NN ./.
@@15534072161 Problems/NNS remain/VBP to/IN be/VB resolved/VBN in/IN the/DT area/NN of/IN quantitative/JJ risk/NN assessment/NN ./.
@@80766316060 The/DT binding/NN of/IN transcription/NN factor/NN AP-1/NEWGENE and/CC vitamin/NEWGENE D/NEWGENE receptor/NEWGENE (/( VDR/NEWGENE )/SYM to/IN the/DT composite/JJ AP-1/NEWGENE plus/IN vitamin-D-responsive/NEWGENE promoter/NEWGENE region/NEWGENE (/( AP-1/NEWGENE +/NEWGENE VDRE/NEWGENE )/SYM of/IN the/DT human/NEWGENE osteocalcin/NEWGENE gene/NEWGENE was/VBD characterized/VBN in/IN osteocalcin-producing/JJ (/( MG-63/CELL )/SYM and/CC non-producing/JJ (/( U2-Os/NN ,/, SaOs-2/CELL )/SYM human/JJ osteosarcoma/NN cell/NN lines/NNS ./.
@@4328746719 Ultrasound/NNS effect/NN on/IN the/DT cytochrome/NEWGENE oxidase/NEWGENE activity/NN ./.
@@94384271621 To/TO examine/VB the/DT role/NN of/IN this/DT CE2/NEWGENE element/NEWGENE in/IN regulating/JJ Hoxa1/NEWGENE expression/NN in/IN vivo/NN ,/, transgenic/JJ mice/NNS were/VBD generated/VBN which/WDT express/VBP a/DT Hoxa1/NEWGENE beta-galactosidase/NEWGENE1 reporter/NN gene/NN that/WDT contains/VBZ a/DT mutation/NN in/IN the/DT CE2/NEWGENE element/NEWGENE ./.
@@111345086530 We/PRP produced/VBD transgenic/JJ plants/NNS expressing/JJ the/DT antisense/NEWGENE Arabidopsis/NEWGENE HD/NEWGENE (/( AtHD1/NEWGENE )/SYM gene/NN ./.
@@18496751368 To/TO determine/VB the/DT relationship/NN of/IN these/DT viruses/NNS ,/, the/DT complete/JJ DNA/NN sequence/NN of/IN KV/NNP consisting/VBG of/IN 4754/CD bp/NN was/VBD determined/VBN ./.
@@8119907982 We/PRP have/VBP investigated/VBN the/DT role/NN of/IN cellular/NEWGENE p21ras/NEWGENE protein/NEWGENE in/IN insulin/NEWGENE and/CC insulin-like/NEWGENE growth/NEWGENE factor-I/NEWGENE (/( IGF-I/NEWGENE )/SYM signaling/JJ pathways/NNS ./.
@@91993273655 This/DT effect/NN was/VBD abolished/VBN once/CC the/DT EM/NEWGENE motif/NEWGENE in/IN the/DT promoter-reporter/NN construct/NN was/VBD mutated/JJ ,/, thus/RB suggesting/VBG that/IN the/DT synergistic/JJ transactivation/NN function/NN of/IN the/DT TEF-1-Max/NEWGENE heterotypic/NEWGENE complex/NEWGENE is/VBZ mediated/JJ through/JJ binding/NN of/IN the/DT complex/NN to/IN the/DT EM/NEWGENE motif/NEWGENE ./.
@@66926316453 A/DT stable/JJ interface/NN depends/VBZ on/IN overall/JJ stress/NN and/CC microstress/NN distribution/NN on/IN the/DT bone/NN ,/, particularly/RB trabecular/JJ bone/NN ./.
@@58056444677 Variation/NNS in/IN the/DT temporal-spatial/JJ distribution/NN of/IN 228Ra/CD and/CC 224Ra/CD in/IN the/DT RES/NN and/CC marrow-free/JJ skeleton/NN after/IN incorporation/NN of/IN colloidal/JJ ThO2/NN ./.
@@48016635177 Hypoglycemic/NNP and/CC antidiabetic/JJ properties/NNS ./.
@@10782640595 The/DT method/NN is/VBZ applied/VBN to/IN determine/VB aberration/NN constants/NNS of/IN a/DT CM300/NN FEG/NNP //NNP UT/NNP microscope/NN with/IN correction/NN of/IN the/DT three-fold/JJ astigmatism/NN ./.
@@88716358148 B/NEWGENE cell/NEWGENE antigen/NEWGENE receptor/NEWGENE (/( BCR/NEWGENE )/NN -induced/NN apoptosis/NN in/IN the/DT WEHI-231/NN B/NNP lymphoma/NN cell/NN line/NN can/MD be/VB prevented/VBN by/IN engaging/VBG CD40/NEWGENE ./.
@@97247724529 Gel/NNP retardation/NN assays/NNS detected/VBD ZiaR-dependent/NNP complexes/NNS forming/JJ with/IN the/DT zia/NEWGENE operator-promoter/NEWGENE and/CC ZiaR-DNA/NNP binding/NN was/VBD enhanced/VBN by/IN treatment/NN with/IN a/DT metal-chelator/NN in/IN vitro/FW ./.
@@108740449665 Similarly/RB ,/, co-expression/NN of/IN a/DT dominant-negative/JJ mutant/NN of/IN p38alpha/NEWGENE ,/, but/CC not/RB of/IN ERK1/NEWGENE ,/, ERK2/NEWGENE ,/, JNK1/NEWGENE ,/, or/CC JNK2/NEWGENE ,/, reduces/VBZ basal/JJ and/CC cadmium-induced/JJ pE1-luc/NEWGENE activity/NN ./.
@@21394739807 A/DT contiguous/JJ and/CC sequentially/RB occupied/VBN secondary/JJ Fur-binding/NEWGENE site/NEWGENE in/IN entC/NEWGENE was/VBD protected/VBN at/IN higher/JJ Fur/NEWGENE concentrations/NNS ,/, extending/VBG the/DT protected/VBN region/NN to/IN +49/CD ,/, and/CC sequestering/JJ the/DT putative/JJ Shine-Dalgarno/NNP sequence/NN ./.
@@4760205135 The/DT biochemistry/NN of/IN amniotic/JJ fluid/NN with/IN poor/JJ fetal/JJ growth/NN ./.
@@88938225155 Northern/NNP analysis/NN of/IN the/DT 3/NEWGENE ./NEWGENE 1-kb/NEWGENE PWP2H/NEWGENE cDNA/NEWGENE revealed/VBN that/IN a/DT 3/NN ./NN 3-kb/NN major/JJ transcript/NN is/VBZ ubiquitously/RB expressed/VBN in/IN human/JJ adult/JJ tissues/NNS ./.
@@9802559770 Application/NNP of/IN the/DT 2-deoxy-D-glucose/JJ method/NN to/IN the/DT coupling/NN of/IN cerebral/JJ metabolism/NN and/CC blood/NN flow/NN ./.
@@94509324562 Genetic/NNP analysis/NN has/VBZ subsequently/RB identified/VBN subpathways/NNS of/IN the/DT DNA/NN structure/NN checkpoints/NNS ,/, including/JJ the/DT reversible/JJ arrest/NN of/IN DNA/NN synthesis/NN ./.
@@90060105748 One/CD linker-peptide/JJ insertion/NN in/IN the/DT RsaA/NEWGENE C/NEWGENE terminus/NEWGENE (/NEWGENE amino/NEWGENE acid/NEWGENE 784/NEWGENE )/NEWGENE had/VBP no/DT effect/NN on/IN S-layer/NNS biogenesis/NN ,/, while/CC another/DT (/( amino/JJ acid/NN 907/CD )/SYM disrupted/VBN secretion/NN of/IN the/DT protein/NN ,/, suggesting/VBG that/DT RsaA/NEWGENE possesses/VBZ a/DT secretion/NN signal/JJ lying/NN C/NN terminal/JJ to/IN amino/JJ acid/NN 784/CD ,/, near/IN or/CC including/JJ amino/JJ acid/NN 907/CD ./.
@@66851776441 Dipetalonema/NNP (/( Alafilaria/NNP )/SYM hydrochoerus/NN subgen/NN ./. et/FW sp/NN ./NN n/CD ./CD
@@74747728163 The/DT Laser/NNP Scanning/NN Ophthalmoscope/NN enables/VBZ a/DT fundus-based/JJ examination/NN and/CC therefore/RB allows/VBZ exact/JJ comparison/NN between/IN morphologic/JJ appearance/NN and/CC corresponding/JJ function/NN ./.
@@105292464580 356/CD ,/, 93-98/NN ]/NN ./.
@@95835929535 DESIGN/IN AND/CC METHODS/IN :/: Case/NNP study/NN ./.
@@11769051607 Like/IN pineal/JJ melatonin/NN ,/, serum/JJ melatonin/NN was/VBD high/JJ at/IN mid-dark/NN and/CC low/JJ at/IN mid-light/NN ./.
@@23038743732 After/IN an/DT initial/JJ titration/NN period/NN and/CC adjustment/NN of/IN the/DT therapeutic/JJ dose/NN ,/, the/DT individual/JJ doses/NNS were/VBD from/IN 21/CD to/IN 500/CD micrograms/NN //NN 24/NN hrs/NN (/( mean/JJ 160/CD micrograms/NN //NN 24/NN hrs/NN )/SYM ./.
@@108601964274 For/IN an/DT unsupervised/JJ program/NN ,/, the/DT costs/NNS were/VBD estimated/VBN at/IN $311/NN for/IN the/DT first/JJ year/NN and/CC $73/CD for/IN all/DT additional/JJ years/NNS ./.
@@10841593647 The/DT model/NN indicates/VBZ that/IN a/DT 0/NN ./NN 076%/NN reduction/NN in/IN cigarette/NN consumption/NN is/VBZ associated/VBN with/IN the/DT availability/NN of/IN nicotine/NN patches/NNS after/IN 1992/CD ./.
@@98926422077 E1/NEWGENE ,/, a/DT DNA/NEWGENE helicase/NEWGENE ,/, collaborates/VBZ with/IN the/DT HPV/NEWGENE E2/NEWGENE protein/NEWGENE in/IN ori-dependent/JJ replication/NN ./.
@@111233167616 Tec/NEWGENE kinase/NEWGENE signaling/JJ in/IN T/NN cells/NNS is/VBZ regulated/VBN by/IN phosphatidylinositol/NEWGENE 3-kinase/NEWGENE and/CC the/DT Tec/NEWGENE pleckstrin/NEWGENE1 homology/NEWGENE1 domain/NEWGENE1 ./.
@@93624737712 Together/RB ,/, our/PRP results/NNS show/VBP that/DT tinman/NEWGENE is/VBZ controlled/VBN by/IN an/DT array/NN of/IN discrete/JJ enhancer/NN elements/NNS that/WDT are/VBP activated/VBN successively/RB by/IN differential/JJ genetic/JJ inputs/NNS ,/, as/RB well/VB as/IN by/IN closely/RB linked/NN activator/NN and/CC repressor/NN binding/JJ sites/NNS within/IN an/DT early-acting/JJ enhancer/NN ,/, which/WDT restrict/VBP twist/NEWGENE activity/NN to/IN specific/JJ areas/NNS within/IN the/DT twist/NEWGENE expression/NEWGENE domain/NEWGENE ./.
@@75219162720 Effects/NNPS of/IN alterations/NNS of/IN primer-binding/NN site/NN sequences/NN on/IN human/JJ immunodeficiency/NN virus/NN type/NN 1/CD replication/NN ./.
@@75779047481 Infant/JJ aged/VBN 3/CD ./CD 5/CD years/NNS presents/VBP persistence/NN of/IN primordial/JJ vitreous/JJ body/NN with/IN crystalline/JJ dislocation/NN in/IN the/DT camera/NN aquosa/NN and/CC secondary/JJ buphthalmos/NN of/IN the/DT left/NN eye/NN and/CC microphthalmos/NN with/IN dislocation/NN of/IN the/DT crystalline/JJ in/IN the/DT vitreous/JJ body/NN of/IN the/DT right/JJ eye/NN ./.
@@84126653460 The/DT scr/NEWGENE regulon/NEWGENE of/IN pUR400/NN and/CC the/DT chromosomally/NEWGENE encoded/NEWGENE scr/NEWGENE regulon/NEWGENE of/NEWGENE Klebsiella/NEWGENE pneumoniae/NEWGENE KAY2026/NEWGENE are/VBP both/DT negatively/RB controlled/VBN by/IN a/DT specific/JJ repressor/NN (/( ScrR/NEWGENE )/SYM ./.
@@25114307686 A/DT 215-base-pair/JJ (/( bp/NN )/SYM region/NN of/IN the/DT mouse/NEWGENE MOPC/NEWGENE 41/NEWGENE kappa/NEWGENE light-chain/NEWGENE immunoglobulin/NEWGENE gene/NEWGENE enhancer/NEWGENE has/VBZ been/VBN analyzed/VBN for/IN specific/JJ binding/NN of/IN lymphoid/JJ and/CC nonlymphoid/NN nuclear/NN factors/NN ./.
@@80898341673 These/DT mutants/NNS had/VBP deletions/NNS of/IN the/DT extreme/JJ amino-terminal/JJ residues/NNS as/RB far/RB as/IN amino/JJ acid/NN residue/NN 30/CD ./CD
@@87233527918 This/DT transition/NN is/VBZ regulated/VBN positively/RB by/IN G1-specific/NEWGENE cyclin-dependent/NEWGENE kinases/NEWGENE (/( cdks/NEWGENE )/SYM and/CC negatively/RB by/IN the/DT product/NN of/IN the/DT retinoblastoma/NEWGENE tumour/NEWGENE suppressor/NEWGENE gene/NEWGENE ,/, pRb/NEWGENE ./.
@@91851839129 She/PRP was/VBD able/JJ to/IN stand/NN unaided/JJ by/IN 3/CD years/NNS of/IN age/NN with/IN then/RB progressive/JJ worsening/NN of/IN motor/JJ abilities/NNS ./.
@@79354915717 These/DT RZR/NEWGENE subtypes/NNS represent/VBP members/NNS of/IN a/DT new/JJ family/NN of/IN orphan/NEWGENE nuclear/NEWGENE receptors/NEWGENE that/WDT most/RB likely/RB regulate/VB specific/JJ gene/NN expression/NN ./.
@@111691134295 To/TO study/VB the/DT in/NN vivo/NN role/NN of/IN p16/NEWGENE ./NEWGENE 7/NEWGENE ,/, a/DT phi29/NN mutant/NN containing/JJ a/DT suppressible/JJ mutation/NN in/IN gene/NEWGENE 16/NEWGENE ./NEWGENE 7/NEWGENE was/VBD constructed/VBN ./.
@@8025074248 In/NN an/DT in/NN vitro/FW study/NN ,/, 10/CD //CD 0/CD nylon/NN was/VBD found/VBN to/IN require/VB a/DT significantly/RB lower/JJR laser/NN energy/NN density/NN to/IN produce/NN suture/NN lysis/NN following/IN a/DT single/NN shot/NN than/IN either/DT 10/CD //CD 0/CD Dacron/NN or/CC 10/CD //CD 0/CD prolene/NN ./.
@@104877605088 In/NN order/NN to/IN screen/NN for/IN such/JJ cofactors/NNS ,/, we/PRP have/VBP used/VBN a/DT transcriptionally/RB inactive/JJ mutant/NN of/IN Xenopus/NEWGENE MEF2D/NEWGENE in/IN a/DT yeast/NN two-hybrid/JJ screen/NN ./.
@@2910496711 A/DT decamer/NN sequence/NN ,/, 5'-CGA-CCCCUCC-3'/NEWGENE ,/, complementary/JJ to/IN a/DT conserved/VBN sequence/NN adjacent/JJ to/IN the/DT enzymatic/JJ cleavage/NN site/NN on/IN the/DT mitochondrial/JJ RNA/NN substrate/NN ,/, is/VBZ present/VB in/IN the/DT RNAase/NEWGENE MRP/NEWGENE RNA/NEWGENE ./.
@@35405916093 In/NN vitro/FW translation/NN of/IN RNA/NN synthesized/VBN from/IN the/DT cloned/VBN cDNAs/NNS predicts/VBZ that/IN P0/NEWGENE transcripts/NEWGENE are/VBP translated/VBN into/IN a/DT novel/JJ 12/CD ./CD 5-kilodalton/CD protein/NN corresponding/JJ to/IN the/DT first/JJ open/JJ reading/JJ frame/NN ./.
@@113119092666 In/NN the/DT remaining/JJ case/NN ,/, the/DT aneurysm/NN originated/VBN from/IN the/DT proximal/JJ end/NN of/IN the/DT associated/VBN A1/NN fenestration/NN ./.
@@34733794173 The/DT diagnosis/NN of/IN amyloidosis/NN was/VBD determined/VBN from/IN a/DT labial/JJ salivary/JJ gland/NN biopsy/NN ./.
@@87660494133 CASE/NNP REPORT/NNP :/: Referred/JJ because/IN of/IN a/DT right/JJ corneal/JJ perforation/NN with/IN cellular/JJ reaction/NN in/IN anterior/JJ chamber/NN ,/, a/DT patient/NN was/VBD sutured/VBN and/CC treated/VBN with/IN a/DT single/JJ intravitreal/JJ injection/NN of/IN 0/CD ./CD 2/CD ml/NN (/( 1/CD mg/NN )/SYM Amikacin/NN and/CC 0/CD ./CD 2/CD ml/NN (/( 1/CD mg/NN )/SYM Vancomycin/NN ./.
@@92308941227 We/PRP further/RB found/VBP that/IN KmMig1p/NEWGENE is/VBZ fully/RB functional/JJ when/CC expressed/VBN in/IN S/NNP ./NNP cerevisiae/NN ./.
@@91474205775 It/PRP has/VBZ repeatedly/RB been/VBN shown/VBP that/DT HCMV/NEWGENE IE1/NEWGENE //NEWGENE IE2/NEWGENE can/MD independently/NN transactivate/NN HIV-1/NEWGENE LTR/NEWGENE ./.
@@68955596691 Terbutaline/NNS ;/: a/DT beta2-adrenergic/NN agonist/NN ,/, and/CC aminophyllin/NN ,/, a/DT phosphodiesterase/NEWGENE inhibitor/NN ,/, were/VBD given/VBP separately/RB ,/, or/CC in/IN combination/NN ,/, to/IN rabbit/NN fetuses/NNS on/IN the/DT 28th/CD day/NN of/IN gestation/NN ./.
@@74907705302 Comparison/NNS to/IN other/DT coxI/NEWGENE genes/NEWGENE revealed/VBD a/DT 966-bp/NEWGENE group/NEWGENE I/NEWGENE intron/NEWGENE ,/, which/WDT ,/, based/VBN on/IN homology/NN with/IN the/DT related/VBN yeast/NEWGENE coxI/NEWGENE intron/NEWGENE aI4/NEWGENE ,/, potentially/RB encodes/VBZ a/DT 279-amino-acid/NEWGENE site-specific/NEWGENE DNA/NEWGENE endonuclease/NEWGENE ./.
@@11296442197 In/NN conclusion/NN ,/, tube/NN size/NN estimated/VBN by/IN Cole's/NN formula/NN tends/VBZ to/IN be/VB smaller/JJR than/IN practically/RB appropriate/JJ tube/NN size/NN for/IN pediatric/JJ cardiac/JJ anesthesia/NN ,/, and/CC therefore/RB we/PRP suggest/VBP new/JJ formula/NN to/IN estimate/NN the/DT tube/NN size/NN ./.
@@10695685509 Antipyretic/JJ therapy/NN :/: physiologic/JJ rationale/NN ,/, diagnostic/JJ implications/NNS ,/, and/CC clinical/JJ consequences/NNS ./.
@@77435153982 Upon/IN analysis/NN of/IN the/DT tissue/NN distribution/NN of/IN AAMP/NEWGENE ,/, it/PRP was/VBD found/VBN to/IN be/VB expressed/VBN strongly/RB in/IN endothelial/JJ cells/NNS ,/, cytotrophoblasts/NNS ,/, and/CC poorly/RB differentiated/VBN colon/NN adenocarcinoma/NN cells/NNS found/VBP in/IN lymphatics/NNS ./.
@@96715795255 We/PRP propose/VBP that/IN noi/NEWGENE //NEWGENE pax2/NEWGENE ./NEWGENE 1/NEWGENE participates/VBZ in/IN sequential/JJ signaling/JJ processes/NNS as/IN a/DT key/NN integrator/NN of/IN midbrain-hindbrain/JJ boundary/NN development/NN ./.
@@32828138065 Finally/RB ,/, over/RB a/DT similar/JJ range/NN of/IN QO2/NN ,/, oxygen/NN extraction/NN was/VBD greater/JJR in/IN patients/NNS with/IN ARDS/NNS compared/VBN to/IN patients/NNS with/IN non-ARDS/JJ respiratory/JJ failure/NN (/( r/JJ =/SYM -0/CD ./CD 67/CD and/CC slope/NN =/SYM -0/CD ./CD 62/CD vs/NNP r/JJ =/SYM -0/CD ./CD 45/CD and/CC slope/NN =/SYM -0/CD ./CD 35/CD ;/: p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@77467947701 In/NN the/DT commercially/RB available/JJ intravenous/JJ formulation/NN of/IN Cyclosporin/NN A/NN (/( Sandimmun/NN )/SYM ,/, polyoxyethylated/JJ castor/NN oil/NN (/( Cremophor/NN EL/NN )/SYM is/VBZ used/VBN as/IN a/DT solubilizing/JJ agent/NN ./.
@@38368542189 Inhibition/NNS of/IN histalog-stimulated/JJ gastric/JJ secretion/NN by/IN 40/NN 749/NN RP/NN ,/, a/DT new/JJ long-acting/JJ gastric/JJ antisecretory/JJ agent/NN ./.
@@85033489535 The/DT HMG/NEWGENE CoA/NEWGENE reductase/NEWGENE inhibitors/NN are/VBP the/DT most/RB effective/JJ cholesterol-lowering/JJ agents/NNS currently/RB available/JJ ./.
@@33297167502 The/DT activity/NN of/IN the/DT EGF/NEWGENE receptor/NEWGENE promoter/NEWGENE can/MD be/VB modulated/VBN by/IN E1A/NEWGENE protein/NEWGENE and/CC receptor/NN RNA/NN levels/NNS increased/VBN by/IN stimulation/NN with/IN phorbol/NN ester/NN or/CC fetal/JJ calf/NN serum/JJ ./.
@@96208735511 Moreover/RB ,/, the/DT observation/NN of/IN enhanced/VBN luteal/NEWGENE HSP-27/NEWGENE phosphorylation/NN in/IN vivo/NN ,/, in/IN late/JJ pregnancy/NN ,/, when/CC PKC-delta/NEWGENE is/VBZ abundant/JJ and/CC active/JJ ,/, suggests/VBZ that/WDT select/VBP PKC/NEWGENE family/NEWGENE members/NEWGENE contribute/VBP to/IN sHSP/NEWGENE phosphorylation/NN events/NNS in/IN vivo/NN ./.
@@92721087034 Analysis/NNP of/IN the/DT 5'/CD flanking/JJ region/NN of/IN the/DT gene/NN also/RB revealed/VBD the/DT presence/NN of/IN multiple/JJ TATA/NN and/CC CAAT/NN sequences/NN ./.
@@113114801153 Sural/JJ nerve/NN biopsy/NN showed/VBD mild/JJ thickening/NN of/IN the/DT perineurium/NN ,/, vascular/JJ alterations/NNS with/IN inflammatory/JJ cell/NN infiltration/NN in/IN the/DT perineurium/NN ,/, and/CC remarkable/JJ loss/NN of/IN large/JJ and/CC small/JJ myelinated/JJ fibers/NNS ./.
@@10739408552 Family/NNP environment/NN was/VBD an/DT important/JJ influence/NN on/IN interpersonal/JJ relationships/NNS ,/, substance/NN use/NN ,/, and/CC social/JJ support/NN ./.
@@111782487981 Finally/RB ,/, we/PRP compared/VBD the/DT differential/JJ screening/JJ techniques/NNS in/IN terms/NNS of/IN sensitivity/NN ,/, efficiency/NN and/CC occurrence/NN of/IN false/JJ positives/NNS ./.
@@25566033210 There/EX has/VBZ been/VBN similar/JJ improvement/NN in/IN treating/JJ ampullary/JJ and/CC periampullary/JJ cancer/NN ,/, gallbladder/NN cancer/NN ,/, or/CC extrahepatic/JJ bile/NN duct/NN cancer/NN ./.
@@52999935461 Modification/NNS of/IN the/DT growth/NN of/IN Tetrahymena/NN by/IN compounds/NNS which/WDT affect/VBP the/DT adrenergic/JJ mechanism/NN ./.
@@11568141444 Editorial/JJ :/: Low-dose/NNP heparin/NN and/CC the/DT prevention/NN of/IN venous/JJ thromboembolic/JJ disease/NN ./.
@@98824515371 These/DT genes/NNS were/VBD expressed/VBN in/IN a/DT Saccharomyces/NN cerevisiae/NN mutant/JJ in/IN which/WDT the/DT endogenous/NEWGENE ferrochelatase/NEWGENE gene/NEWGENE (/( HEM15/NEWGENE )/SYM had/VBP been/VBN deleted/VBN ,/, and/CC the/DT phenotypes/NNS of/IN the/DT transformants/NNS were/VBD characterized/VBN ./.
@@8626437945 Lyn/NEWGENE kinase/NEWGENE immunoprecipitated/VBN from/IN lysates/NNS of/IN irradiated/JJ BCP/NN as/RB well/VB as/IN a/DT full-length/NEWGENE glutathione/NEWGENE S-transferase/NEWGENE (/( GST/NEWGENE )/NN -Lyn/NN fusion/NN protein-phosphorylated/JJ recombinant/NEWGENE human/NEWGENE p34cdc2/NEWGENE on/IN tyrosine/NN 15/CD ./CD
@@15690159967 Computer-aided/JJ "FRAME"/NN analysis/NN revealed/VBN four/CD possible/JJ open/JJ reading/JJ frames/NNS (/( ORFs/NNS )/SYM ,/, three/CD in/IN one/PRP direction/NN and/CC one/PRP in/IN the/DT opposite/NN direction/NN ./.
@@95453124107 Our/PRP observations/NNS suggest/VBP that/IN members/NNS of/IN the/DT HMG-I/NEWGENE family/NEWGENE play/NN an/DT important/JJ role/NN in/IN SRF-dependent/NNP transcription/NN and/CC that/IN their/PRP effect/NN is/VBZ mediated/JJ primarily/RB by/IN a/DT protein-protein/JJ interaction/NN ./.
@@51249725384 I/NNP ./NNP
@@115990795814 The/DT corresponding/JJ orifice/NN voltages/NNS for/IN the/DT three/CD instruments/NNS were/VBD 20/CD //CD 50/CD //CD 80/CD V/NN (/( API/NN 365/NN )/SYM ,/, 30/CD //CD 90/CD //CD 130/CD V/NN (/( API/NNP 2000/CD )/SYM and/CC 40/CD //CD 80/CD //CD 120/CD V/NN (/( API/NNP 3000/CD )/SYM ./.
@@78534768931 Schnell/NNP ,/, J/NNP ./NNP
@@82178628183 Continued/VBN development/NN of/IN the/DT rat/NN conditioning/JJ paradigm/NN is/VBZ especially/RB warranted/VBN because/IN of/IN the/DT ability/NN to/IN record/NN sympathetic/JJ nerve/NN activity/NN in/IN intact/JJ ,/, awake/JJ subjects/NNS and/CC the/DT large/JJ number/NN of/IN readily/RB available/JJ genetic/JJ strains/NNS ,/, which/WDT model/VBP human/JJ pathological/JJ states/NNS ./.
@@96940349668 These/DT results/NNS with/IN clozapine/NN illustrate/VB that/DT LI/NN is/VBZ sensitive/JJ to/IN antipsychotics/NNS which/WDT differ/VBP in/IN their/PRP mode/NN of/IN action/NN and/CC furthermore/RB emphasize/VB the/DT value/NN of/RB LI/NN as/IN a/DT test/NN model/NN for/IN detecting/JJ the/DT antipsychotic/JJ potential/NN of/IN novel/JJ drugs/NNS ./.
@@87338748719 Patients/NNS who/WP have/VBP undergone/VBP thyroidectomy/NN for/IN thyroid/JJ carcinoma/NN are/VBP frequently/RB subjected/VBN to/IN periods/NNS of/IN induced/VBN severe/JJ hypothyroidism/NN in/IN preparation/NN for/IN 131I/CD whole/JJ body/NN scanning/NN and/CC measurement/NN of/IN serum/JJ TG/NNP ./NNP
@@28768203580 In/NN metabolic/JJ acidosis/NN there/RB was/VBD a/DT marked/JJ stimulation/NN when/CC clamped/VBN at/IN -10/CD to/IN -100/CD mV/CD ./CD
@@13095873271 Synergistic/JJ transactivation/NN of/IN the/DT BMRF1/NEWGENE promoter/NEWGENE by/IN the/DT Z/NEWGENE //NEWGENE c-myb/NEWGENE combination/NN appears/VBZ to/IN involve/VB direct/JJ binding/NN by/IN the/DT Z/NEWGENE protein/NEWGENE but/CC not/RB the/DT c-myb/NEWGENE protein/NEWGENE ./.
@@10488088336 Insulin-like/NEWGENE growth/NEWGENE factor-I/NEWGENE induces/VBZ bcl-2/NEWGENE promoter/NEWGENE through/RB the/DT transcription/NN factor/NN cAMP-response/NEWGENE element-binding/NEWGENE protein/NEWGENE ./.
@@107596935679 METHODS/IN :/: We/PRP determined/VBD an/DT odds/NNS ratio/NN (/( OR/NN )/SYM ,/, as/IN a/DT measure/NN of/IN the/DT relative/JJ risk/NN of/IN being/VBP exposed/VBN to/IN a/DT potential/JJ interaction/NN ,/, comparing/VBG the/DT use/NN of/IN the/DT H2-receptor/NEWGENE antagonist/NEWGENE ,/, cimetidine/NN ,/, with/IN that/DT of/IN the/DT noninteracting/JJ agents/NNS ranitidine/NN ,/, famotidine/NN and/CC nizatidine/NN in/IN users/NNS and/CC nonusers/NNS of/IN warfarin/NN ,/, phenytoin/NN and/CC theophylline/NN ./.
@@111566184915 Long-range/JJ comparison/NN of/IN human/NEWGENE and/NEWGENE mouse/NEWGENE SCL/NEWGENE loci/NEWGENE :/: localized/VBN regions/NNS of/IN sensitivity/NN to/IN restriction/NEWGENE endonucleases/NEWGENE correspond/VBP precisely/RB with/IN peaks/NNS of/IN conserved/VBN noncoding/JJ sequences/NNS ./.
@@24822934222 In/NNP TNF-resistant/NNP T24/DT bladder/NN carcinoma/NN cells/NNS ,/, TNF/NEWGENE failed/VBD to/IN alter/VB EGF-R/NEWGENE tyrosine/NEWGENE1 protein/NEWGENE1 kinase/NEWGENE1 activity/NN although/IN both/DT EGF/NEWGENE and/CC phorbol/NN ester/NN were/VBD shown/VBP to/IN modulate/VB the/DT enzymatic/JJ activity/NN of/IN the/DT receptor/NN in/IN these/DT cells/NNS ./.
@@98910469333 We/PRP isolated/VBD a/DT ribosomal/NEWGENE protein/NEWGENE L18/NEWGENE by/IN interaction/NN with/IN PKR/NEWGENE ./.
@@17087711942 Sequence/NN determination/NN of/IN isolated/VBN peptides/NNS suggested/VBN that/IN Asn120/NN is/VBZ glycosylated/JJ ,/, Asn65/NN and/CC Asn109/NN glycosylated/JJ in/IN some/DT molecules/NNS but/CC not/RB in/IN others/NNS ,/, and/CC Asn72/NN not/RB glycosylated/JJ ./.
@@27441233435 Qualitatively/RB ,/, the/DT results/NNS are/VBP similar/JJ for/IN the/DT two/JJ species/NN :/: Both/DT rhesus/NN monkey/NN and/CC man/NN have/NN photopic/JJ and/CC scotopic/JJ branches/NNS ,/, which/WDT cross/VBP at/IN approximately/RB the/DT same/JJ time/NN in/IN the/DT dark/JJ and/CC at/IN approximately/RB the/DT same/JJ background/NN luminance/NN ./.
@@13279673346 Insertional/JJ inactivation/NN of/IN sms/NEWGENE led/VBN to/IN increased/VBN sensitivity/NN to/IN the/DT alkylating/JJ agent/NN methylmethane/NN sulfonate/NN ,/, but/CC not/RB to/IN a/DT requirement/NN for/IN serine/NN or/CC other/DT metabolites/NNS ./.
@@17024262018 Since/IN the/DT 5'-flanking/JJ region/NN of/IN this/DT gene/NN is/VBZ likely/RB involved/VBN in/IN hormonal/JJ regulation/NN of/IN its/PRP expression/NN ,/, we/PRP have/VBP isolated/VBN and/CC partially/RB characterized/VBN an/DT avian/JJ fatty/NEWGENE acid/NEWGENE synthase/NEWGENE gene/NN ./.
@@26642291252 Improved/VBN cosmesis/NN ,/, extension/NN of/IN the/DT scope/NN of/IN the/DT problems/NNS that/WDT can/MD be/VB addressed/VBN with/IN this/DT repair/NN (/( including/JJ treatment/NN of/IN a/DT distal/JJ urethrocutaneous/JJ fistula/NN )/SYM and/CC the/DT ease/NN with/IN which/WDT the/DT Arap/NN procedure/NN can/MD be/VB performed/VBN are/VBP the/DT advantages/NNS that/WDT this/DT operation/NN has/VBZ over/RB other/DT 1-stage/JJ distal/JJ hypospadias/NN repairs/NNS ./.
@@13790321994 Thirty/CD percent/NN of/IN patients/NNS were/VBD tapered/JJ off/RB all/DT steroids/NNS ,/, and/CC the/DT average/JJ steroid/JJ dose/NN in/IN the/DT group/NN who/WP received/VBD steroids/NNS was/VBD 8/CD ./CD 6/CD mg/NN of/IN prednisone/NN per/IN day/NN ./.
@@74740781981 However/RB ,/, in/IN contrast/NN with/IN previous/JJ in/IN vitro/FW cell-free/JJ integration/NN studies/NNS ,/, alteration/NN of/IN the/DT highly/RB conserved/VBN CA/NN dinucleotide/NN resulted/VBN in/IN a/DT mutant/JJ which/WDT still/RB retained/VBN 40%/CD of/IN wild-type/NN integration/NN activity/NN ./.
@@85417938514 Spontaneous/JJ recovery/NN occurs/VBZ within/IN 30/CD min/NN to/IN 2/CD hrs/NN ./.
@@86377178706 A/DT p21/NEWGENE peptide/NEWGENE spanning/VBG amino/JJ acids/NNS 139-164/CD was/VBD found/VBN to/IN bind/NN PCNA/NEWGENE in/IN a/DT filter/NN binding/JJ assay/NN and/CC this/DT peptide/NN suppressed/VBD recombinant/NEWGENE p21-PCNA/NEWGENE interaction/NN ./.
@@85523877806 Molecular/NNP characterization/NN of/IN malignant/JJ melanoma/NN of/IN soft/JJ parts/NNS or/CC soft/JJ tissue/NN clear/JJ cell/NN sarcoma/NN which/WDT shares/VBP t/NN (/NN 12/NN ;/: 22/NN )/NN chromosome/NN translocation/NN revealed/VBD fusion/NN of/IN EWS/NEWGENE with/IN a/DT transcriptional/NN factor/NN gene/NEWGENE ATF-1/NEWGENE ./.
@@97053248721 Thus/RB ,/, these/DT studies/NNS on/IN rat/NEWGENE Std/NEWGENE promoter/NEWGENE function/NN indicate/VB that/IN (/( i/NN )/SYM HNF1/NEWGENE and/CC C/NEWGENE //NEWGENE EBP/NEWGENE are/VBP responsible/JJ for/IN liver/NN specificity/NN of/IN the/DT rat/NEWGENE Std/NEWGENE gene/NEWGENE ;/: (/( ii/NN )/SYM androgenic/JJ repression/NN of/IN the/DT gene/NN requires/VBZ the/DT presence/NN of/IN all/DT of/IN the/DT OCT-1/NEWGENE and/CC C/NEWGENE //NEWGENE EBP/NEWGENE elements/NEWGENE between/IN positions/NNS -231/CD and/CC -292/CD ;/: and/CC (/( iii/NN )/SYM AR/NEWGENE may/MD exert/VB its/PRP negative/JJ regulatory/JJ effect/NN indirectly/RB through/RB transcriptional/JJ interference/NN of/IN OCT-1/NEWGENE and/CC C/NEWGENE //NEWGENE EBP/NEWGENE rather/RB than/IN through/RB a/DT direct/JJ DNA-AR/NEWGENE interaction/NN ./.
@@26853313109 The/DT R/NEWGENE ./NEWGENE meliloti/NEWGENE nifH/NEWGENE promoter/NEWGENE but/CC not/RB the/DT K/NEWGENE ./NEWGENE pneumoniae/NEWGENE nifH/NEWGENE promoter/NEWGENE showed/VBD sigma/NN 54-dependent/JJ methylation/NN protection/NN of/IN guanine/NN residues/NNS at/IN -14/CD ,/, -25/CD and/CC -26/CD ,/, the/DT most/RB conserved/VBN nucleotides/NNS characteristic/NN of/IN sigma/NEWGENE 54-dependent/NEWGENE promoters/NEWGENE ./.
@@98117306885 Competition/NN EMSA/NN established/VBN that/IN constitutively/RB expressed/VBN nuclear/JJ proteins/NNS bound/VBD the/DT KCS/NEWGENE element/NEWGENE selectively/RB ;/: KCS/NEWGENE protein/NEWGENE binding/JJ activity/NN correlated/VBN with/IN promoter/NN activity/NN in/IN the/DT transient/JJ transfection/NN reporter/NN assay/NN ./.
@@106200108569 CONCLUSION/IN :/: In/NN Cdks/NEWGENE functioning/NN throughout/IN the/DT cell/NN cycle/NN ,/, tyrosine/NN phosphorylation/NN is/VBZ inhibitory/JJ to/IN the/DT activation/NN of/IN kinase/NN ,/, whereas/IN the/DT phosphorylation/NN of/IN threonine/NN in/IN the/DT T-loop/NNS is/VBZ essential/JJ for/IN activation/NN ./.
@@78144052072 For/IN the/DT first/JJ time/NN we/PRP describe/VBP deletion/NN and/CC point/NN mutations/NNS within/IN the/DT plasma/NEWGENE membrane/NEWGENE family/NEWGENE of/NEWGENE guanylyl/NEWGENE cyclase/NEWGENE receptors/NEWGENE that/WDT result/VBP in/IN the/DT formation/NN of/IN effective/JJ dominant/JJ negative/JJ proteins/NNS ./.
@@1057137391 No/DT difference/NN in/IN the/DT clinical/JJ acceptability/NN could/MD be/VB ascertained/VBN between/IN the/DT two/JJ groups/NNS ./.
@@106756101877 MSSPs/NEWGENE are/VBP believed/VBN to/IN regulate/VB DNA/NN replication/NN ,/, transcription/NN ,/, apopotosis/NN and/CC cell/NN cycle/NN progression/NN by/IN interacting/VBG with/IN the/DT C-MYC/NEWGENE protein/NEWGENE ./.
@@21429932747 The/DT clinical/JJ picture/NN of/IN the/DT disease/NN was/VBD significantly/RB different/JJ from/IN anthropogenic/JJ cutaneous/JJ leishmaniasis/NN caused/VBN by/IN L/NNP ./NNP tropica/NN but/CC similar/JJ to/IN cutaneous/JJ patterns/NNS caused/VBN by/IN L/NNP ./NNP infantum/NN which/WDT was/VBD a/DT prevalent/JJ pattern/NN in/IN the/DT southern/JJ France/NN ./.
@@98132548508 The/DT human/NEWGENE 2'/NEWGENE ,/NEWGENE 5'-oligoadenylate/NEWGENE (/NEWGENE 2-5A/NEWGENE )/NEWGENE synthetases/NEWGENE are/VBP members/NNS of/IN a/DT family/NN interferon/NEWGENE (/( IFN/NEWGENE )/NN -inducible/NN anti-viral/NEWGENE proteins/NEWGENE ./.
@@90459196137 Taken/VBN together/RB ,/, we/PRP provide/VBP evidence/VBP for/IN the/DT existence/NN of/IN an/DT activator/NN ,/, NFE/NEWGENE ,/, which/WDT in/IN combination/NN with/IN the/DT p50/NEWGENE and/CC c-Rel/NEWGENE proteins/NEWGENE ,/, are/VBP part/NN of/IN the/DT transcription/NN factor/NN machinery/NN that/WDT regulates/VBZ 3'/NN enhancer/NN activity/NN ,/, and/CC thus/RB the/DT control/NN of/IN the/DT IgH/NEWGENE locus/NEWGENE in/IN late/JJ B/NNP lymphocyte/NN development/NN ./.
@@100680408291 We/PRP show/VBP that/IN the/DT mouse/NN genome/NN contains/VBZ four/CD copies/NNS of/IN the/DT ubc-9/NEWGENE gene/NEWGENE ./.
@@107153257637 The/DT AtERF/NEWGENE genes/NEWGENE were/VBD differentially/RB regulated/VBN by/IN ethylene/NN and/CC by/IN abiotic/JJ stress/NN conditions/NNS ,/, such/JJ as/IN wounding/VBG ,/, cold/JJ ,/, high/JJ salinity/NN ,/, or/CC drought/NN ,/, via/NN ETHYLENE-INSENSITIVE2/NEWGENE (/( EIN2/NEWGENE )/NN -dependent/NN or/CC -independent/CD pathways/NNS ./.
@@24936444080 In/NN resting/JJ 3T3/CD cells/NNS ,/, jun-D/NEWGENE is/VBZ expressed/VBN at/IN a/DT higher/JJ level/NN compared/VBN to/IN c-jun/NEWGENE and/CC jun-B/NEWGENE ,/, and/CC its/PRP transcription/NN is/VBZ stimulated/VBN only/RB slightly/RB by/IN serum/JJ growth/NEWGENE factors/NEWGENE ./.
@@72173297035 A/DT method/NN is/VBZ described/VBN for/IN the/DT simultaneous/JJ determination/NN of/IN 1/CD ,/, alpha-acetylmethadol/NN (/( LAAM/NN )/SYM and/CC five/CD active/JJ metabolites--noracetylmethadol/NN ,/, dinoracetylmethadol/NN ,/, methadol/NN ,/, normethadol/NN ,/, and/CC dinormethadol--in/JJ biofluids/NNS by/IN high-performance/JJ liquid/JJ chromatography/NN using/VBG a/DT normal-phase/JJ column/NN and/CC a/DT UV/NN detector/NN at/IN 218/CD nm/NN ./NN
@@92829113257 The/DT goal/NN of/IN this/DT study/NN was/VBD to/IN identify/VB neuronal/JJ cell/NN cultures/NNS that/WDT express/VBP RC3/NEWGENE //NEWGENE neurogranin/NEWGENE ,/, to/IN check/NN whether/IN they/PRP are/VBP sensitive/JJ to/IN T3/NN ,/, and/CC to/IN examine/VB the/DT mechanism/NN of/IN regulation/NN ./.
@@9160993030 Self-emasculation/NN is/VBZ the/DT end/NN result/NN of/IN an/DT unusual/JJ psychiatric/JJ disorder/NN ,/, which/WDT initially/RB requires/VBZ surgical/JJ treatment/NN ./.
@@108279528576 Here/RB ,/, it/PRP is/NNS shown/VBP that/IN TAFII250/NEWGENE ,/, the/DT largest/JJS subunit/NN of/IN TFIID/NEWGENE ,/, contains/VBZ two/JJ tandem/NN bromodomain/NN modules/NNS that/WDT bind/VBP selectively/RB to/IN multiply/RB acetylated/JJ histone/NEWGENE H4/NEWGENE peptides/NEWGENE ./.
@@114133199028 Reovirus/NNP mRNAs/NNS are/VBP efficiently/RB translated/VBN within/IN host/NN cells/NNS despite/IN the/DT absence/NN of/IN 3'/CD polyadenylated/JJ tails/NNS ./.
@@20200828322 The/DT disturbance/NN of/IN pulmonary/JJ gas/NN exchange/NN ,/, as/IN revealed/VBN by/IN the/DT high/JJ value/NN of/IN AaDO2/NN ,/, existed/VBN without/IN left/NN ventricular/JJ dysfunction/NN ,/, and/CC AaDO2/NN had/VBP no/DT significant/JJ relationship/NN with/IN any/DT of/IN the/DT hemodynamic/JJ parameters/NNS including/JJ the/DT difference/NN between/IN plasma/NN colloid/NN osmotic/JJ pressure/NN and/CC PCW/NN ./.
@@108562989529 Transfection/NNS of/IN cDNAs/NNS for/IN three/CD mutant/JJ enzymes/NNS into/IN FPGS-null/NNP Chinese/JJ hamster/NN ovary/NN cells/NNS restored/VBD a/DT reduced/VBN level/NN of/IN clonal/JJ growth/NN ,/, whereas/IN a/DT T339I/NN mutant/NN supported/VBN growth/NN at/IN a/DT level/JJ comparable/JJ to/IN that/DT of/IN the/DT wild-type/NN enzyme/NN ./.
@@18448785676 A/DT vector/NN containing/JJ a/DT transcriptionally/RB inactive/JJ neomycin/NEWGENE phosphotransferase/NEWGENE II/NEWGENE gene/NEWGENE was/VBD used/VBN to/IN select/VB promoter/NN sequences/NNS from/IN a/DT pool/NN of/IN random/JJ genomic/JJ DNA/NN fragments/NNS ./.
@@25903913465 None/NN of/IN the/DT measured/VBN parameters/NNS (/( heart/NN contents/NNS of/IN neutral/JJ lipids/NNS ,/, total/JJ phospholipids/NNS ,/, phosphatidylcholine/NN ,/, phosphatidylethanolamine/NN ,/, diphosphatidylglycerol/NN ,/, sphingomyelin/NN and/CC fatty/JJ acid/NN composition/NN of/IN each/DT phospholipid/NN class/NN )/SYM appeared/VBN to/IN be/VB related/VBN with/IN the/DT grading/NN of/IN the/DT lesions/NNS ./.
@@103596631649 In/NN co-transfection/JJ studies/NNS ,/, the/DT expression/NN of/IN c-Jun/NEWGENE plus/IN c-Fos/NEWGENE enhanced/VBN the/DT transactivation/NN of/IN oIFNtau-CAT/NEWGENE but/CC the/DT expression/NN of/IN GATA-1/NEWGENE ,/, GATA-2/NEWGENE or/CC GATA-3/NEWGENE did/VBD not/RB ./.
@@30238595453 In/NN the/DT DNAs/NNS of/IN all/DT Ph1-positive/NNP chronic/JJ myelocytic/JJ leukemia/NN patients/NNS studied/VBN to/IN date/NN ,/, a/DT breakpoint/NN on/IN chromosome/NN 22/CD (/( the/DT Ph1/NN chromosome/NN )/SYM can/MD be/VB demonstrated/VBN with/IN a/DT probe/NN from/IN the/DT bcr/NN (/( breakpoint/NN cluster/NN region/NN )/SYM ./.
@@80784168058 The/DT bactericidal/JJ effect/NN of/IN disinfectants/NNS against/IN biofilm/NN cells/NNS was/VBD found/VBN to/IN be/VB considerably/RB enhanced/VBN by/IN increasing/JJ the/DT concentrations/NNS of/IN the/DT disinfectants/NNS ./.
@@15691028496 Domain/NN II/NNP is/VBZ highly/RB homologous/JJ to/IN the/DT LDL/NEWGENE receptor/NEWGENE and/CC contains/VBZ four/CD repeats/NNS with/IN perfect/JJ conservation/NN of/IN all/DT 6/CD consecutive/JJ cysteines/NNS ./.
@@103428298875 In/NN light/NN of/IN the/DT importance/NN of/IN GnRHR/NEWGENE ,/, the/DT molecular/JJ mechanisms/NNS underlying/JJ the/DT transcriptional/JJ regulation/NN of/IN the/DT human/NEWGENE GnRHR/NEWGENE (/( hGnRHR/NEWGENE )/SYM gene/NN become/VB a/DT key/NN issue/NN in/IN understanding/NN human/JJ reproduction/NN ./.
@@97802283695 Sequencing/NN of/IN a/DT 40-kb/JJ DNA/NN segment/NN of/IN the/DT FK506/NEWGENE gene/NEWGENE cluster/NN from/IN Streptomyces/NN sp/NN ./NN
@@114386513009 Thus/RB ,/, replication/NN fork/JJ movement/NN near/IN HML/NEWGENE pauses/NNS at/IN a/DT silent/JJ origin/NN which/WDT is/VBZ competent/JJ for/IN replication/NN initiation/NN but/CC kept/VBP silent/JJ through/RB Orc2p/NEWGENE ,/, a/DT component/NN of/IN the/DT replication/NN initiator/NN ./.
@@41762494838 Assessment/NNP of/IN nutrient/JJ media/NN in/IN the/DT diagnosis/NN of/IN diptheria/NNS ./.
@@89376318895 Histological/JJ changes/NNS ,/, including/JJ cortical/JJ cell/NN involution/NN and/CC hemorrhage/NN occurring/VBG during/IN the/DT neonatal/JJ period/NN ,/, would/MD seem/VB to/IN have/NN crucial/JJ relevance/NN to/IN the/DT remodeling/NN of/IN the/DT adrenal/JJ vasculature/NN ./.
@@94262397095 The/DT cglIM/NEWGENE gene/NEWGENE is/VBZ organized/VBN in/IN an/DT unusual/JJ operon/NN which/WDT contains/VBZ ,/, in/IN addition/NN ,/, two/JJ genes/NNS encoding/VBG stress-sensitive/JJ restriction/NEWGENE enzymes/NEWGENE ./.
@@112445683286 The/DT Gap69C/NEWGENE is/VBZ a/DT single-copy/JJ gene/NN producing/JJ a/DT major/JJ 2/CD ./CD 1-kb/CD mRNA/NN throughout/IN development/NN ,/, but/CC its/PRP amount/NN is/VBZ decreased/VBN in/IN larvae/NNS ./.
@@113111539483 The/DT relationship/NN of/IN the/DT factor/NEWGENE V/NEWGENE Leiden/NEWGENE mutation/NEWGENE or/CC the/DT deletion-deletion/JJ polymorphism/NN of/IN the/DT angiotensin/NEWGENE converting/NEWGENE enzyme/NEWGENE to/IN postoperative/JJ thromboembolic/JJ events/NNS following/IN total/JJ joint/JJ arthroplasty/NN ./.
@@75922202375 End-tidal/JJ PO2/NN and/CC the/DT ratio/NN of/IN minute/JJ ventilation/NN to/IN oxygen/NN consumption/NN (/( VE/NN //NN VO2/NN )/SYM were/VBD lower/JJR while/CC PETCO2/NN was/VBD higher/JJ for/IN Hyp/NN (/( P/NN </SYM or/CC =/SYM 0/CD ./CD 01/CD )/SYM ./.
@@9962729956 Considering/VBG these/DT sources/NNS of/IN error/NN some/DT of/IN the/DT variability/NN in/IN the/DT present/NN investigation/NN might/MD be/VB avoided/VBN by/IN systematic/JJ instructions/NNS ./.
@@10981794 Results/NNS obtained/VBN for/IN chloramphenicol-containing/JJ preparations/NNS are/VBP presented/VBN ,/, and/CC both/DT dissolution/NN curves/NNS and/CC cup-plate/JJ assays/NNS demonstrate/VBP that/DT chloramphenicol/NN has/VBZ far/RB superior/JJ release/NN (/( and/CC hence/RB activity/NN )/SYM from/IN creams/NNS than/IN from/IN ophthalmic/JJ ointments/NNS ./.
@@75237107402 Diagnosis/NNP of/IN prostatic/JJ carcinoma/NN :/: the/DT yield/NN of/IN serum/NEWGENE prostate/NEWGENE specific/NEWGENE antigen/NEWGENE ,/, digital/JJ rectal/JJ examination/NN and/CC transrectal/JJ ultrasonography/NN ./.
@@88730634185 The/DT deduced/VBN amino/JJ acid/NN sequence/NN of/IN LvUSF2/NEWGENE is/VBZ nearly/RB identical/JJ to/IN LvUSF1/NEWGENE except/VB at/IN the/DT amino/JJ end/NN ,/, where/CC they/PRP are/VBP sharply/RB divergent/JJ ./.
@@10210952145 In/NN retrospect/NN ,/, the/DT diagnoses/NNS were/VBD reconsidered/VBN applying/VBG strict/JJ criteria/NNS ./.
@@92412321243 A/DT consensus/NN sequence/NN indicates/VBZ a/DT highly/RB conserved/VBN lysine/NN residue/NN ,/, K120/NNP of/IN endonuclease/NEWGENE III/NEWGENE or/CC K241/NN of/IN Ogg1/NEWGENE ,/, respectively/RB ./.
@@113288539646 Examination/NN of/IN various/JJ promoter/NN deletion/NN mutants/NNS indicated/VBN that/IN SF-1/NEWGENE acts/NNS through/RB the/DT proximal/JJ promoter/NN region/NN and/CC upstream/JJ promoter/NN sequences/NNS ./.
@@79971742219 The/DT data/NN show/NN conclusively/RB that/DT phosphorylation/NN of/IN His-304/NN is/VBZ not/RB essential/JJ for/IN any/DT of/IN the/DT known/VBP functions/NNS of/IN A/NEWGENE ./NEWGENE vinelandii/NEWGENE NifL/NEWGENE ./.
@@80703936361 The/DT maximal/JJ effect/NN was/VBD seen/VBP at/IN 100/CD ng/NN //NN ml/NN EGF/NEWGENE ,/, with/IN a/DT time/NN lag/NN of/IN about/RB 5/CD h/CD ./CD
@@114804973316 Effects/NNPS of/IN aerosol-vapor/NN JP-8/NN jet/NN fuel/NN on/IN the/DT functional/JJ observational/JJ battery/NN ,/, and/CC learning/NN and/CC memory/NN in/IN the/DT rat/NN ./.
@@83491045237 The/DT Saccharomyces/NEWGENE cerevisiae/NEWGENE GAL1/NEWGENE and/CC GAL10/NEWGENE genes/NEWGENE are/VBP controlled/VBN in/IN response/NN to/IN the/DT availability/NN of/IN galactose/NN and/CC glucose/NN by/IN multiple/JJ activating/JJ and/CC repressing/JJ proteins/NNS bound/JJ at/IN adjacent/JJ or/CC overlapping/JJ sites/NNS in/IN UASG/NEWGENE ./.
@@91217744924 These/DT activities/NNS are/VBP all/DT required/VBN for/IN stimulation/NN of/IN cell/NN growth/NN by/IN middle-T/NEWGENE and/CC activate/VB members/NNS of/IN the/DT MAP/NEWGENE kinase/NEWGENE family/NEWGENE ./.
@@85351387183 When/WRB differentiated/VBN G0-arrested/JJ leaf/NN cells/NNS were/VBD induced/VBN to/IN resume/NN cell/NN division/NN by/IN treatment/NN with/IN plant/NN hormones/NNS ,/, cycMs4/NEWGENE transcription/NN was/VBD induced/VBN before/IN the/DT onset/NN of/IN DNA/NN synthesis/NN ./.
@@35448584773 Also/RB ,/, component/NN I/NN significantly/RB correlated/VBD with/IN fasting/JJ insulin/NEWGENE and/CC VO2/NN max/JJ for/IN both/DT sexes/NNS and/CC with/IN basal/JJ metabolism/NN and/CC HDL-cholesterol/NEWGENE for/IN females/NNS and/CC males/NNS ,/, respectively/RB ./.
@@97514589740 Desmethyltrimebutine/NNP was/VBD inactive/JJ ./.
@@86320151226 The/DT antibodies/NNS inhibited/VBN specifically/RB the/DT transcription/NN of/IN DNA/NEWGENE polymerase/NEWGENE alpha/NEWGENE promoter/NN in/IN vitro/FW ./.
@@111796643418 Architecture/NNP and/CC anatomy/NN of/IN the/DT genomic/JJ locus/NN encoding/VBG the/DT human/NEWGENE leukemia-associated/NEWGENE transcription/NEWGENE factor/NEWGENE RUNX1/NEWGENE //NEWGENE AML1/NEWGENE ./.
@@90583731149 RNase/NEWGENE protection/NN experiments/NNS confirmed/VBD the/DT presence/NN of/IN the/DT GHR1-279/NEWGENE variant/NEWGENE in/IN IM-9/CD cells/NNS and/CC human/JJ liver/NN ./.
@@30117939662 The/DT open/JJ reading/JJ frames/NNS of/IN rbsD/NEWGENE ,/, rbsA/NEWGENE ,/, and/CC rbsC/NEWGENE encode/VB proteins/NNS of/IN 139/CD ,/, 501/CD ,/, and/CC 321/CD amino/JJ acid/JJ residues/NNS ,/, respectively/RB ./.
@@85504674984 Sucrose-specific/NNP regulation/NN of/IN scrB/NEWGENE was/VBD also/RB lost/VBP upon/IN deletion/NN of/IN 4/CD bp/NN of/IN a/DT palindromic/JJ sequence/NN (/( OB/JJ )/SYM covering/VBG positions/NNS +6/CD to/IN +21/NN downstream/RB of/IN the/DT scrB/NEWGENE transcriptional/JJ start/NN site/NN ./.
@@3338154119 High/NNP concentrations/NNS of/IN tumor-associated/NN trypsin/NEWGENE inhibitor/NN in/IN hemodialyzed/JJ patients/NNS ./.
@@107254331803 A/DT mutation/NN which/WDT abrogates/VBZ the/DT binding/NN of/IN these/DT factors/NNS reduces/VBZ Wp/NEWGENE reporter/NEWGENE activity/NN specifically/RB in/IN B/NNP cell/NN lines/NNS ,/, whereas/IN a/DT mutation/NN which/WDT converts/VBP the/DT site/NN to/IN a/DT consensus/NN CREB-binding/NEWGENE sequence/NEWGENE maintains/VBZ wild-type/NN promoter/NN function/NN ./.
@@23313612982 There/EX was/VBD a/DT gradual/JJ increase/NN in/IN the/DT myocyte/NN diameter/NN according/VBG to/IN age/NN in/IN the/DT biopsy/NN and/CC autopsy/NN specimens/NNS ./.
@@77798117429 Mutation/NN of/IN the/DT Sp1/NEWGENE element/NEWGENE ,/, which/WDT abolishes/VBZ Sp1/NEWGENE binding/JJ ,/, results/VBZ in/IN a/DT 6-10-fold/CD reduction/NN in/IN reporter/NN activity/NN ./.
@@109658305602 INTERVENTIONS/NNP :/: Subcutaneous/JJ tissue/NN PO2/NN and/CC PCO2/NN tensions/NNS were/VBD measured/VBN directly/RB in/IN patients/NNS with/IN necrotising/JJ fasciitis/NN and/CC in/IN healthy/JJ volunteers/NNS during/IN normobaric/JJ and/CC hyperbaric/JJ conditions/NNS ./.
@@89933935790 Because/IN of/IN the/DT potential/JJ implications/NNS of/IN these/DT findings/NNS in/IN human/JJ physiology/NN ,/, we/PRP cloned/VBN the/DT hPACAP-R/NEWGENE gene/NEWGENE ./.
@@110807965585 The/DT Tax/NEWGENE //NEWGENE IKKgamma/NEWGENE interaction/NN serves/VBP to/IN recruit/NN Tax/NEWGENE to/IN the/DT IKK/NEWGENE catalytic/NEWGENE subunits/NEWGENE ,/, IKKalpha/NEWGENE and/CC IKKbeta/NEWGENE ,/, and/CC this/DT recruitment/NN appears/VBZ to/IN be/VB an/DT essential/JJ mechanism/NN by/IN which/WDT Tax/NEWGENE stimulates/VBZ the/DT activity/NN of/IN IKK/NEWGENE ./.
@@30834413808 Modifications/NNS of/IN the/DT involuntary/JJ postcontraction/NN in/IN diseased/JJ people/NN ./.
@@70813276864 Although/IN noninhibitory/CD fluid/NN had/VBP higher/JJ mean/JJ concentrations/NNS of/IN phosphorus/NN and/CC zinc/NN ,/, these/DT differences/NNS did/VBD not/RB hold/VB after/IN meconium-stained/JJ samples/NNS were/VBD excluded/VBN ./.
@@94381653793 Normal/JJ baseline/NN (/( day-8/JJ )/SYM PC/NN levels/NNS (/( 86/CD and/CC 89%/CD )/SYM were/VBD markedly/RB reduced/VBN in/IN both/DT patients/NNS at/IN the/DT time/NN of/IN VOD/NN manifestation/NN on/IN day/NN 20/CD and/CC 40/CD ,/, respectively/RB (/( 26/CD and/CC 31%/CD )/SYM ./.
@@80510598305 The/DT sequence/NN upstream/RB of/IN the/DT rhlA/NEWGENE promoter/NEWGENE contains/VBZ two/JJ inverted/JJ repeats/NNS which/WDT define/VBP putative/JJ binding/JJ sites/NNS for/IN the/DT RhlR/NEWGENE regulator/NEWGENE ./.
@@20918902691 In/NN this/DT model/NN ,/, eltoprazine/NN has/VBZ a/DT very/RB specific/JJ anti-aggressive/JJ (/( serenic/JJ )/SYM profile/NN ,/, inhibiting/JJ aggression/NN while/CC social/JJ interaction/NN and/CC exploration/NN are/VBP not/RB decreased/VBN but/CC even/VB enhanced/VBN ;/: inactivity/NN ,/, a/DT measure/NN for/IN sedation/NN ,/, is/VBZ not/RB affected/VBN ./.
@@93672885471 A/DT second/JJ aim/NN was/VBD to/IN determine/VB whether/IN the/DT decrease/NN in/IN muscle-tendon/JJ unit/NN rest/NN length/NN produced/VBN by/IN prolonged/JJ immobilisation/NN in/IN a/DT shortened/VBN position/NN is/VBZ mediated/JJ primarily/RB by/IN adaptations/NNS of/IN the/DT muscle/NN or/CC tendon/NN ./.
@@47899161760 Analysis/NNP of/IN clearance/NN curve/NN of/IN rose/VBD bengal-I-131/NN ./.
@@157314640 Intravenous/JJ administration/NN (/( 25/CD mg/CD //CD kg/CD )/SYM of/IN carbonic/NEWGENE anhydrase/NEWGENE inhibitors/NN (/( acetazolamide/NN ,/, methazolamide/NN ,/, dichlorphenamide/NN ,/, sulthiame/NN )/SYM induced/VBN an/DT early/JJ important/JJ rise/NN of/IN cortical/JJ p/NN O2/NN ,/, which/WDT is/VBZ not/RB dependent/JJ on/IN increase/NN of/IN p/NN O2/NN and/CC p/NN CO2/NN and/CC decrease/NN of/IN pH/NN in/IN arterial/JJ blood/NN ./.
@@50272955316 Cholinesterase/NEWGENE ./.
@@91421466418 RESULTS/NNS :/: Surprisingly/RB ,/, PAF/NEWGENE blockade/NN increased/VBD mortality/NN after/IN trauma/NN (/( 5/CD of/IN 11/CD WEB-2086/NNP animals/NNS versus/IN 1/CD of/IN 9/CD vehicle/NN animals/NNS ;/: p/NN =/SYM 0/CD ./CD 15/CD )/SYM and/CC depressed/VBN cardiac/JJ index/NN and/CC O2/NN delivery/NN at/IN 72/CD hours/NNS (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@97431281543 Moritta/NN )/NN and/CC contains/VBZ Bis-GMA/NN ./.
@@112024341143 Single/NNP amino/JJ acid/NN substitutions/NNS at/IN the/DT acyl-CoA-binding/JJ domain/NN interrupt/VB 14/NN [/NN C/NN ]/NN palmitoyl-CoA/NN binding/NN of/IN ACBP2/NEWGENE ,/, an/DT Arabidopsis/NN acyl-CoA-binding/NEWGENE protein/NEWGENE with/IN ankyrin/NEWGENE repeats/NNS ./.
@@104068438878 Expression/NNS of/IN GlcNAc-TI/NEWGENE mRNA/NEWGENE in/IN tobacco/NN leaves/NNS was/VBD detected/VBN using/VBG RT-PCR/NN ./.
@@9327387256 At/NN a/DT systolic/JJ blood/NN pressure/NN (/( BP/NN )/SYM of/IN 60/CD mmHg/NN ,/, C02/NN responsiveness/NN was/VBD abolished/VBN ,/, but/CC was/VBD maintained/VBN at/IN higher/JJ levels/NNS of/IN BP/NNP ./NNP
@@97101319694 Both/DT methods/NNS were/VBD employed/VBN for/IN various/JJ focal-film/JJ distances/NNS ,/, image/NN intensifier/NN tube/NN modes/NNS and/CC laser/NN printer/NN formats/NNS ./.
@@114111981274 Colorectal/JJ cancer/NN was/VBD shown/VBP to/IN disproportionately/RB overburden/VB Ashkenazi/NN Jews/NN ,/, who/WP may/MD also/RB be/VB at/IN increased/VBN risk/NN for/IN ovarian/JJ ,/, pancreatic/JJ and/CC stomach/NN cancer/NN ,/, and/CC non-Hodgkin's/JJ lymphoma/NN ./.
@@113614939298 HIV-1/NNP and/CC hepatitis/NN B/NN virus/NN infections/NNS in/IN adolescents/NNS lodged/VBN in/IN security/NN institutes/NNS of/IN Buenos/NNP Aires/NNP ./.
@@106842655445 Covalent/JJ modification/NN of/IN the/DT transactivator/NEWGENE protein/NEWGENE IE2-p86/NEWGENE of/IN human/JJ cytomegalovirus/NN by/IN conjugation/NN to/IN the/DT ubiquitin-homologous/NEWGENE proteins/NEWGENE SUMO-1/NEWGENE1 and/CC hSMT3b/NEWGENE ./.
@@78773087858 The/DT full/JJ protocol/NN was/VBD completed/VBN by/IN 33/CD patients/NNS (/( 45%/NN of/IN original/JJ cohort/NN )/SYM ./.
@@97746415565 Forskolin/IN significantly/RB enhanced/VBN heregulin-stimulated/JJ expression/NN of/IN cyclin/NEWGENE D/NEWGENE and/CC phosphorylation/NN of/IN the/DT retinoblastoma/NEWGENE gene/NEWGENE product/NEWGENE ./.
@@112411666666 TaqMan/NN analysis/NN of/IN gene/NN expression/NN following/IN chronic/JJ FA/NN treatment/NN showed/VBD neither/DT a/DT decrease/NN in/IN the/DT amount/NN of/IN leptin/NEWGENE receptor/NEWGENE (/( Ob-R/NEWGENE )/SYM mRNA/NN ,/, nor/CC an/DT increase/NN in/IN the/DT negative/JJ regulators/NNS of/IN STAT/NEWGENE signalling/JJ ,/, SOCS3/NEWGENE (/( suppressors/NEWGENE of/NEWGENE cytokine/NEWGENE signalling/NEWGENE )/SYM or/CC cytokine/NEWGENE inducible/NEWGENE sequence/NEWGENE (/( CIS/NEWGENE )/SYM ./.
@@84556114280 It/PRP was/VBD shown/VBP by/IN transient/JJ expression/NN assay/NN that/IN HS-40/NEWGENE behaved/VBD as/IN an/DT authentic/JJ enhancer/NN for/IN high-level/JJ zeta/NEWGENE 2/NEWGENE globin/NEWGENE promoter/NEWGENE activity/NN in/IN K562/NNP cells/NNS ,/, an/DT erythroid/JJ cell/NN line/NN of/IN embryonic/JJ and/IN //IN or/IN fetal/JJ origin/NN ./.
@@88206487898 Despite/IN the/DT presence/NN of/IN one/PRP additional/JJ ribonucleotide/NEWGENE reductase/NEWGENE ,/, the/DT nrdAB-encoded/NEWGENE enzyme/NEWGENE is/VBZ essential/JJ to/IN the/DT aerobic/JJ growth/NN of/IN the/DT cell/NN because/IN nrdAB-defective/NEWGENE mutants/NEWGENE of/IN both/DT species/NN are/VBP not/RB viable/JJ in/IN the/DT presence/NN of/IN oxygen/NN ./.
@@95773953596 We/PRP studied/VBD the/DT human/JJ vestibulo-ocular/JJ reflex/NN (/( VOR/NN )/SYM in/IN response/NN to/IN head/JJ 'impulses'/NN :/: brief/JJ ,/, unpredictable/JJ ,/, passive/JJ ,/, high-acceleration/JJ (/( up/JJ to/IN 4000/CD degrees/NN //NN s2/NN )/SYM ,/, low-amplitude/JJ (/( 20-30/CD degrees/NNS )/SYM head/JJ rotations/NNS ./.
@@710372629 A/DT suspected/VBN hypothalamic/JJ dysfunction/NN and/CC a/DT slightly/RB impaired/VBN pituitary/JJ function/NN manifested/VBN as/IN GH/NEWGENE deficiency/NN were/VBD their/PRP common/JJ endocrinological/JJ features/NNS ./.
@@104007575366 CXCR4/NEWGENE is/VBZ a/DT chemokine/NEWGENE receptor/NEWGENE and/CC a/DT coreceptor/NN for/IN T-cell-line-tropic/NN (/( X4/NN )/SYM and/CC dual-tropic/JJ (/( R5X4/NN )/SYM human/JJ immunodeficiency/NN virus/NN type/NN 1/CD (/( HIV-1/NNP )/SYM isolates/NNS ./.
@@9131139710 Implication/NNS of/IN PAF/NEWGENE and/CC acetylhydrolase/NEWGENE (/( PAF-AH/NEWGENE )/SYM activity/NN in/IN periodontal/JJ disease/NN ./.
@@107275152771 Coactivation/NNS of/IN endogenous/JJ or/CC exogenous/JJ G/NEWGENE (/NEWGENE q/NEWGENE )/NEWGENE -coupled/NEWGENE receptors/NEWGENE with/IN the/DT delta-opioid/NEWGENE receptor/NEWGENE produced/VBD strong/JJ stimulations/NNS of/IN PLCbeta/NEWGENE and/CC such/JJ responses/NNS could/MD be/VB partially/RB blocked/VBN by/IN pertussis/NEWGENE toxin/NEWGENE ./.
@@87204079973 CONCLUSION/IN :/: The/DT results/NNS demonstrate/VBP that/IN at/IN the/DT site/NN of/IN lumbar/JJ disc/NN herniation/NN ,/, inflammatory/JJ cytokines/NNS such/JJ as/IN interleukin-1/NEWGENE alpha/NEWGENE are/VBP produced/VBN ,/, which/WDT increases/VBZ prostaglandin/NN E2/NN production/NN ./.
@@13631662550 Currents/NNS aspects/NNS of/IN H2/NEWGENE receptor/NEWGENE antagonists/NNS in/IN the/DT treatment/NN of/IN ulcers/NNS ./.
@@10095062904 Here/RB ,/, we/PRP report/VBP the/DT complete/JJ structure/NN of/IN the/DT human/NEWGENE topoisomerase/NEWGENE IIalpha/NEWGENE gene/NEWGENE ,/, which/WDT consists/VBZ of/IN 35/CD exons/NNS spanning/VBG 27/CD ./CD 5/CD kb/CD ./CD
@@23715173029 100/CD of/IN the/DT patients/NNS who/WP would/MD have/VB died/VBN survive/VB ./.
@@100243836639 Calcitonin/NEWGENE simultaneously/RB regulates/VBZ both/DT periosteal/JJ hyperostosis/NN and/CC trabecular/JJ osteopenia/NN in/IN the/DT spinal/JJ hyperostotic/JJ mouse/NN (/( twy/NEWGENE //NEWGENE twy/NEWGENE )/SYM in/IN vivo/NN ./.
@@76291131920 SCA/NEWGENE was/VBD resistant/JJ to/IN inhibitors/NNS of/IN serine/NN ,/, aspartyl/NN ,/, and/CC metalloproteases/NEWGENE ,/, but/CC it/PRP was/VBD sensitive/JJ to/IN N-ethylmaleimide/NN ./.
@@75855593414 A/DT pyrazolo-quinoline/JJ compound/NN ,/, 6-methoxy-4-/NN [/NN 2-/NN [/NN (/NN 2-hydroxyethoxyl/NN )/NN -ethyl/NN ]/NN amino/NN ]/NN -3-methyl-1M-pyrazo/NN lo/JJ [/NN 3/NN ,/NN 4-b/NN ]/NN quinoline/NN (/( SCH/IN 51344/CD )/SYM ,/, was/VBD identified/VBN based/VBN on/IN its/PRP ability/NN to/IN derepress/VB human/NN smooth/NN muscle/NN alpha-actin/NEWGENE promoter/NEWGENE activity/NN in/IN ras-transformed/JJ cells/NNS ./.
@@4938185248 The/DT failures/NNS frequently/RB were/VBD related/VBN to/IN patient/NN intolerance/NN or/CC poor/JJ mechanical/JJ fit/NN and/CC occurred/VBN in/IN the/DT first/JJ few/JJ days/NNS or/CC first/JJ few/JJ months/NNS after/IN insertion/NN ./.
@@18728562480 Recovery/NNP of/IN radiolabelled/JJ BA/NN through/JJ urine/NN (/( 28%/JJ )/SYM and/CC faeces/NNS (/( 22%/JJ )/SYM up/JJ to/IN 96/CD hrs/NN averaged/VBN 50%/CD ,/, whereas/IN residual/JJ radioactivity/NN in/IN liver/NN and/CC testis/NN experienced/VBD a/DT recovery/NN of/IN 29%/CD in/IN scorbutic/JJ animals/NNS ./.
@@87092242221 Epstein-Barr/NEWGENE virus/NEWGENE nuclear/NEWGENE protein/NEWGENE 2/NEWGENE (/NEWGENE EBNA2/NEWGENE )/NEWGENE binds/VBZ to/IN a/DT component/NN of/IN the/DT human/NEWGENE SNF-SWI/NEWGENE complex/NEWGENE ,/, hSNF5/NEWGENE1 //NEWGENE1 Ini1/NEWGENE1 ./.
@@118608764310 HIV-1/NN C/NN subtype/NN in/IN IDUs/NNS accounted/VBN for/IN 61/CD ./CD 3%/CD ./.
@@86611047156 The/DT gene/NN was/VBD expressed/VBN as/IN an/DT approximately/RB 1/CD ./CD 5-kb/CD mRNA/NN in/IN most/RB nonlymphoid/JJ human/JJ cells/NNS //NNS tissues/NNS including/JJ prostate/NN ,/, lung/NN ,/, liver/NN ,/, and/CC colon/NN ./.
@@75570912808 METHODS/IN :/: rHb1/NEWGENE ./NEWGENE 1/NEWGENE or/CC human/NEWGENE serum/NEWGENE albumin/NEWGENE was/VBD administered/VBN intravenously/RB to/IN fasting/JJ male/JJ volunteers/NNS ./.
@@76654775143 EsaR/NEWGENE can/MD repress/VB its/PRP own/VB expression/NN but/CC seems/VBZ not/RB to/IN regulate/VB the/DT expression/NN of/IN esaI/NEWGENE ./.
@@25340672114 Administration/NNP of/IN dexamethasone/NN was/VBD associated/VBN with/IN progressive/JJ rises/NNS in/IN plasma/NN 17/NN alpha/NN OH/NN progesterone/NN ,/, 11/CD beta-desoxycortisol/JJ ,/, DHEA/NN sulphate/NN ,/, androstenedione/NN and/CC testosterone/NN ,/, together/RB with/IN increased/VBN urinary/JJ excretion/NN of/IN androsterone/NN ,/, 11/NN beta/NN OH/NN androsterone/NN ,/, etiocholanolone/NN ,/, DHEA/NN ,/, and/CC 16/NN alpha/NN OH/NN DHEA/NN ./.
@@104469129212 In/NN the/DT course/NN of/IN investigating/VBG the/DT mechanisms/NNS by/IN which/WDT OF5/NEWGENE and/CC OF3/NEWGENE regulated/VBN CYP11A1/NEWGENE transcription/NN ,/, we/PRP found/VBP that/IN OF5/NEWGENE and/CC OF3/NEWGENE bound/JJ Sp1/NEWGENE and/CC Sp3/NEWGENE in/IN JEG-3/NNP cells/NNS ./.
@@8524314532 The/DT TEA1/NEWGENE (/( Ty/NEWGENE enhancer/NEWGENE activator/NEWGENE )/SYM gene/NN sequence/NN predicts/VBZ a/DT protein/NN of/IN 86/CD ./CD 9/CD kDa/NN whose/WP N/JJ terminus/NN contains/VBZ a/DT zinc/NN cluster/NN and/CC dimerization/NN motif/NN typical/JJ of/IN the/DT Gal4-type/NEWGENE family/NEWGENE of/IN DNA-binding/NN proteins/NN ./.
@@100262755557 Several/JJ secondary/JJ structure/NN elements/NNS were/VBD identified/VBN ./.
@@12282581717 Streptococcal/JJ preparation/NN (/( OK-432/NN )/SYM ,/, a/DT new/JJ type/NN of/IN anti-cancer/JJ agent/NN ,/, was/VBD given/VBP to/IN the/DT patients/NNS with/IN advanced/JJ cancer/NN in/IN combination/NN with/IN Mitomycin-C/NNP ,/, 5-FU/NN and/CC Cytosine/NN arabinoside/NN ./.
@@95289508963 The/DT genomic/JJ fragments/NNS were/VBD fused/VBN upstream/RB of/IN the/DT luciferase/NEWGENE reporter/NEWGENE gene/NEWGENE ./.
@@16584682257 At/NN 1/CD ,/, 5/CD ,/, and/CC 9/CD months/NNS after/IN initial/JJ isolation/NN of/IN C/NNP ./NNP kutscheri/NN from/IN the/DT oral/JJ cavity/NN ,/, hamsters/NNS were/VBD euthanatized/VBN ,/, and/CC attempts/NNS were/VBD made/VBP to/IN culture/NN C/NNP ./NNP kutscheri/NN from/IN 13/CD additional/JJ sites/NNS ./.
@@112239388654 Copyright/NNP 2000/CD John/NNP Wiley/NNP &/CC Sons/NNP ,/, Ltd/NNP ./.
@@16282012222 Incidence/NNS rate/NN ranging/VBG between/IN 122/NN //NN 100/NN ,/NN 000/NN //NN year/NN and/CC 190/NN //NN 100/NN ,/NN 000/NN //NN year/NN were/VBD found/VBN (/( minimum/JJ ,/, estimated/VBN and/CC raw/JJ datasets/NNS )/SYM ./.
@@43770034948 An/DT automated/JJ method/NN for/IN the/DT quantitative/JJ analysis/NN of/IN the/DT polyamines/NNS putrescine/NN ,/, spermidine/NN and/CC spermine/NN in/IN cerebrospinal/JJ fluid/NN (/( CSF/NN )/SYM was/VBD used/VBN to/IN analyze/VB CSF/NN samples/NNS from/IN 37/CD patients/NNS with/IN central/JJ nervous/JJ system/NN (/( CNS/NN )/SYM tumors/NNS and/CC from/IN 13/CD patients/NNS without/IN tumors/NNS ./.
@@78038098467 Further/RB studies/VBZ established/VBN that/IN the/DT Ep-induced/JJ increase/NN in/IN beta-globin/NEWGENE mRNA/NEWGENE could/MD be/VB inhibited/VBN by/IN the/DT tyrosine/NEWGENE kinase/NEWGENE inhibitor/NN genistein/NN and/CC the/DT protein/NEWGENE kinase/NEWGENE C/NEWGENE inhibitor/NN Compound/JJ 3/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@72669697113 The/DT relationship/NN between/IN estrogenic/JJ properties/NNS of/IN Tamoxifen/DT and/CC breast/NN cancer/NN management/NN is/VBZ discussed/VBN ./.
@@116534913357 Disciplinary/NNP action/NN for/IN DNA/NN violation/NN ./.
@@105274758876 In/NN PC/NN ,/, rare/JJ MNGCs/NN had/VBP intranuclear/JJ inclusions/NNS and/CC grooves/NNS ./.
@@100688346023 The/DT costs/NNS were/VBD DM/NN 11/CD ,/CD 562/CD for/IN a/DT PE/NN ,/, DM/NN 12/CD ,/CD 477/CD for/IN a/DT VR/NN and/CC DM/NN 7/NN ,/NN 532/NN for/IN a/DT MR/NNP ./NNP
@@77848707758 The/DT provisional/JJ reports/NNS are/VBP based/VBN mainly/RB upon/IN macroscopic/JJ findings/NNS ,/, whereas/IN the/DT final/JJ reports/NNS include/VBP the/DT information/NN provided/VBN by/IN supplementary/JJ investigations/NNS such/JJ as/IN microscopy/NN ,/, histochemistry/NN ,/, more/RB rarely/RB electron/NN microscopy/NN ,/, immunohistochemistry/NN and/DT //DT or/DT microbiology/NN ./.
@@112381053300 Cells/NNS containing/NN alpha/NN subunits/NN that/WDT lacked/VBD a/DT distal/NEWGENE domain/NN (/( term-3/NEWGENE )/SYM or/CC had/VBP the/DT alternatively/RB spliced/VBN alpha-2/NEWGENE distal/NEWGENE domain/NEWGENE showed/VBD markedly/RB decreased/VBN ability/NN to/IN support/NN tyrosine/NN phosphorylation/NN of/IN Jak-2/NEWGENE and/CC its/PRP substrates/NNS or/CC to/IN up-regulate/DT CD86/NEWGENE ./.
@@103808782664 Consistent/JJ with/IN this/DT possibility/NN ,/, a/DT non-MBD/JJ region/NN of/IN Bin1/NEWGENE was/VBD sufficient/JJ to/IN recruit/NN a/DT repression/NN function/NN to/IN DNA/NN that/WDT was/VBD unrelated/JJ to/IN histone/NEWGENE deacetylase/NEWGENE ./.
@@25083063155 Abundant/NNP infiltration/NN of/IN lymphocytes/NNS and/CC plasma/NN cells/NNS was/VBD also/RB wide-spread/JJ beneath/IN the/DT carcinoma/NN in/IN situ/NN ,/, together/RB with/IN the/DT lymphoid/JJ follicles/NNS ./.
@@96584033797 Addition/NN of/IN Rap/NN or/CC KN62/NN after/IN exposure/NN of/IN cells/NNS to/IN progesterone/NN agonist/NN Org/NN 2058/CD had/VBP no/DT effect/NN on/IN induction/NN of/IN CAT/NEWGENE activity/NN ./.
@@21424869643 Teicoplanin/NN was/VBD given/VBP most/RB often/RB because/IN of/IN persistent/JJ fever/NN or/CC initial/JJ Gram-positive/NN bacteraemia/NN and/CC only/JJ one-third/NN of/IN these/DT cases/NNS responded/VBN ./.
@@116143981500 A/DT peculiar/JJ people/NN :/: "the/JJ physiological/JJ aspects/NNS of/IN Mormonism/NNP 1850-1975/CD ./CD "/CD
@@117117019216 Two/CD nuclear/JJ medicine/NN physicians/NNS blinded/JJ to/IN the/DT surgical/JJ findings/NNS interpreted/VBD all/DT available/JJ images/NNS and/CC various/JJ Tc-99m/NN MIBI/DT image/NN combinations/NNS at/IN 15/CD minutes/NNS alone/RB ;/: 15/CD minutes/NNS and/CC 2/CD hours/NNS ,/, 15/CD minutes/NNS and/CC 4/CD hours/NNS ;/: and/CC 15/CD minutes/NNS and/CC 2/CD and/CC 4/CD hours/VBZ each/DT with/IN and/CC without/IN correlative/JJ pertechnetate/NN thyroid/JJ imaging/NN ./.
@@15665768864 Keck/NNP ,/, C/NNP ./NNP J/NNP ./.
@@108512678973 E2F/NEWGENE -1/NEWGENE is/VBZ a/DT transcription/NN factor/NN that/WDT regulates/VBZ cell/NN cycle/NN progression/NN into/IN S-phase/JJ ./.
@@40689698221 L3-L4/NN compressive/JJ load/NN was/VBD calculated/VBN using/VBG a/DT model/NN of/IN the/DT anatomy/NN of/IN the/DT trunk/NN musculoskeletal/JJ system/NN ./.
@@11223186321 Transactivation/NNS of/IN oIFNtau/NEWGENE enhancer-reporter/NN constructs/NN was/VBD primarily/RB regulated/VBN by/IN three/CD regions/NN containing/NN AP-1/NEWGENE site/NEWGENE ,/, GATA/NEWGENE like/JJ sequence/NN and/CC site/NN (/NN s/NN )/NN unidentified/JJ ./.
@@118248011693 Interestingly/RB ,/, continuation/NN of/IN the/DT interferon/NEWGENE therapy/NN in/IN the/DT presence/NN of/IN a/DT mild-to-moderate/JJ exacerbation/NN of/IN sarcoidosis/NN may/MD be/VB safe/JJ in/IN a/DT minority/NN of/IN patients/NNS with/IN noncritical/JJ organ/NN involvement/NN ./.
@@82235542797 The/DT lengths/NNS of/IN the/DT complete/JJ polypeptide/NN chain/NN of/IN the/DT recombinant/JJ enzyme/NN and/CC its/PRP transit/NN peptide/NN are/VBP 388/CD and/CC 53/CD residues/NNS ,/, respectively/RB ./.
@@85303459214 Transfection/NNS analyses/NNS indicate/VBP that/DT mutation/NN of/IN any/DT one/PRP of/IN these/DT TGACCT/NEWGENE motifs/NEWGENE or/CC truncation/NN of/IN the/DT entire/JJ HD/NEWGENE PPRE/NEWGENE1 into/IN a/DT separate/JJ DR1/NEWGENE and/CC DR2/NEWGENE element/NEWGENE significantly/RB reduced/VBD the/DT transcriptional/JJ response/NN of/IN HD/NEWGENE PPRE/NEWGENE1 to/IN peroxisome/NN proliferators/NNS ./.
@@104545404024 The/DT amino/JJ acid/NN changes/NNS D206A/NNP and/CC D208A/NNP abolish/VB singly/RB or/CC in/IN combination/NN the/DT exonuclease/NEWGENE activity/NN in/IN vivo/NN ./.
@@78144034272 Chem/NNP ./.
@@3406924971 (/( Emeritus/NNP )/SYM John/NNP Henri/NNP Roosegaarde/NNP Bisschop/NN ./.
@@33529478009 A/DT case/NN of/IN AIDS-related/NN complex/NN (/( ARC/NN //NN LAS/NN )/SYM in/IN a/DT health/NN worker/NN ./.
@@18440172440 There/EX occurred/VBN a/DT linear/JJ relationship/NN between/IN the/DT drop/NN in/IN glucose-6-phosphatase/NEWGENE dehydrogenase/NEWGENE activity/NN and/CC in/IN vitamin/NN E/NN level/NN ,/, on/IN one/PRP hand/NN ,/, and/CC the/DT duration/NN of/IN poisoning/VBG with/IN sodium/NN nitrite/NN ./.
@@8663141397 A/DT cis-acting/JJ DNA/NN element/NN located/VBN between/IN TATA/NN box/NN and/CC transcription/NN initiation/NN site/NN is/VBZ critical/JJ in/IN response/NN to/IN regulatory/JJ sequences/NNS in/IN human/NN angiotensinogen/NEWGENE gene/NEWGENE ./.
@@3525694198 Hepatic/JJ oxygen/NN supply/NN and/CC selected/VBN blood/NN parameters/NNS were/VBD recorded/VBN in/IN fasted/VBN male/JJ rates/NNS given/VBP 20--30/JJ mg/CD //CD kg/CD Escherichia/NEWGENE coli/NEWGENE endotoxin/NEWGENE intraperitoneally/RB ./.
@@92768826275 The/DT addition/NN of/IN culture/NN to/IN the/DT CC/NN and/CC CC/NN :/: SW/NN by-products/NN resulted/VBN in/IN pH/NN values/NNS lower/JJR (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM than/IN those/DT without/IN culture/NN on/IN Day/NN 21/CD ,/, and/CC the/DT 15%/JJ carbohydrate/NN treatment/NN significantly/RB reduced/VBD pH/NN beyond/RB the/DT 5%/JJ carbohydrate/NN ./.
@@24058183072 Branch/NNP occlusion/NN of/IN Heubner's/NNP artery/NN ,/, or/CC perforators/NNS from/IN the/DT proximal/JJ anterior/JJ or/CC middle/JJ cerebral/JJ arteries/NNS were/VBD the/DT posited/VBN mechanism/NN of/IN infarction/NN ./.
@@104935807464 We/PRP propose/VBP that/IN Gly84/NN is/VBZ part/NN of/IN a/DT putative/JJ "oxyanion/NN hole"/NN involved/VBN in/IN the/DT stabilization/NN of/IN the/DT transition/NN state/NN similar/JJ to/IN the/DT C/NEWGENE group/NEWGENE of/IN the/DT esterase/NEWGENE //NEWGENE lipase/NEWGENE family/NEWGENE ./.
@@92347252306 While/IN important/JJ for/IN ligand-dependent/JJ transactivation/NN ,/, this/DT interaction/NN surface/NN is/VBZ not/RB directly/RB involved/VBN in/IN transrepression/NN of/IN AP-1/NEWGENE activity/NN ./.
@@89591178387 To/TO elucidate/VB whether/IN potential/JJ endocrine/JJ changes/NNS resulted/VBN from/IN acute/JJ hypoxaemia/NN alone/RB ,/, the/DT underlying/JJ disease/NN ,/, or/CC unspecific/JJ influences/NNS connected/VBN with/IN the/DT ICU/NN setting/NN ,/, all/DT measurements/NNS were/VBD compared/VBN to/IN those/DT of/IN a/DT completely/RB healthy/JJ reference/NN group/NN (/( REF/NN )/SYM with/IN comparable/JJ acute/JJ experimental/JJ hypoxaemia/NN ./.
@@113858401237 An/DT integrated/JJ RTC/NNP algorithm/NN for/IN the/DT urban/JJ wastewater/NN system/NN is/VBZ formulated/VBN ,/, the/DT parameters/NNS of/IN which/WDT are/VBP optimized/VBN using/VBG various/JJ global/JJ optimization/NN routines/NNS ./.
@@95668821483 Their/PRP function/NN is/VBZ not/RB only/RB to/IN recruit/NN Pho2/NEWGENE to/IN the/DT promoter/NN but/CC to/IN allow/VB cooperative/JJ binding/NN of/IN Pho4/NEWGENE together/RB with/IN Pho2/NEWGENE ./.
@@74731693424 EUK-8/NN is/VBZ a/DT novel/NN ,/, synthetic/JJ ,/, low-molecular-weight/JJ salen-manganese/JJ complex/NN that/WDT exhibits/VBP both/DT superoxide/NEWGENE dismutase/NEWGENE and/CC catalase/NEWGENE activities/NNS in/IN vitro/FW ./.
@@75656698863 Ras/NEWGENE p21Val/NEWGENE inhibits/VBZ myogenesis/NN without/IN altering/VBG the/DT DNA/NN binding/JJ or/CC transcriptional/JJ activities/NNS of/IN the/DT myogenic/NEWGENE basic/NEWGENE helix-loop-helix/NEWGENE factors/NEWGENE ./.
@@94367066650 The/DT patient/NN underwent/VBD two/JJ intracytoplasmic/JJ sperm/NN injection/NN cycles/NNS with/IN thawed/JJ epididymal/JJ spermatozoa/NNS ,/, in/IN which/WDT ,/, due/NN to/IN a/DT pharmacist's/NN mistake/NN ,/, ovarian/JJ stimulation/NN was/VBD carried/VBN out/RB by/IN a/DT combination/NN of/IN long-acting/JJ gonadotrophin-releasing/NEWGENE hormone/NEWGENE agonist/NN (/( leuprolide/NN depot/NN )/SYM and/CC gonadotrophins/NEWGENE ./.
@@8468475687 In/NN F42A-stimulated/JJ internalization/NN assays/NNS on/IN forskolin-induced/JJ YT-1/NNP cells/NNS ,/, the/DT IL-2R/NEWGENE alpha/NEWGENE chain/NEWGENE is/VBZ consistently/RB endocytosed/VBN together/RB with/IN the/DT IL-2R/NEWGENE beta/NEWGENE subunit/NEWGENE indicating/VBG that/IN IL-2R/NEWGENE alpha/NEWGENE is/VBZ stably/RB associated/VBN with/IN the/DT F42A-IL-2R/NEWGENE beta/NEWGENE complex/NEWGENE even/VB though/CC the/DT alpha-subunit/NN contributes/VBZ little/JJ if/IN any/DT affinity/NN to/IN the/DT F42A/NEWGENE binding/JJ reaction/NN ./.
@@115770943263 These/DT findings/NNS suggest/VBP that/IN an/DT intracellular/NEWGENE WT1/NEWGENE //NEWGENE Hsal/NEWGENE 2/NEWGENE pathway/NN may/MD play/VB a/DT role/NN in/IN development/NN and/CC hematopoiesis/NN ./.
@@112548641090 Adjuvant/NN and/CC neoadjuvant/JJ treatment/NN of/IN breast/NN cancer/NN ./.
@@80183617393 This/DT was/VBD obtained/VBN with/IN the/DT thermal/JJ neutron/NN fluency/NN 2/CD ./CD 0/CD x/NN 10/NN (/NN 10/NN )/NN n/NN //NN cm2/NN ./.
@@84431228952 In/NN contrast/NN to/IN T/NN cells/NNS ,/, in/IN fibroblasts/NN PILOT/NEWGENE gene/NEWGENE expression/NN requires/VBZ only/RB one/PRP signal/JJ (/( PMA/NN )/SYM and/CC is/VBZ not/RB affected/VBN by/IN CyA/NN ./.
@@96266629905 Similar/JJ experiments/NNS with/IN TR/NEWGENE support/NN the/DT high/JJ affinity/NN of/IN RIP140/NEWGENE to/IN the/PDT RXR/NEWGENE subunit/NEWGENE and/CC also/RB suggest/VB that/IN either/DT partner/NN in/IN the/DT TR/NEWGENE //NEWGENE RXR/NEWGENE heterodimer/NEWGENE can/MD independently/RB respond/VB to/IN ligand/NN ./.
@@18476655068 The/DT findings/NNS are/VBP compatible/JJ with/IN the/DT idea/NN that/IN the/DT genes/NNS encoding/VBG PDGF/NEWGENE receptors/NEWGENE in/IN glioma/NN cells/NNS are/VBP regulated/VBN in/IN concert/NN with/IN other/DT genes/NNS ,/, the/DT expression/NN of/IN which/WDT may/MD reflect/VB the/DT developmental/JJ program/NN of/IN normal/JJ glia/NN cell/NN lineages/NNS ./.
@@83901208352 Current/JJ clinical/JJ trials/NNS should/MD answer/VB the/DT question/NN of/IN which/WDT of/IN the/DT therapeutic/JJ options/NNS impairs/VBZ quality/NN of/IN life/NN less/PRP ./.
@@105019657207 Several/JJ genes/NNS or/CC transcriptional/JJ units/NNS were/VBD identified/VBN ,/, including/JJ the/DT 3'/CD end/NN of/IN ribosomal/NEWGENE s6/NEWGENE kinase/NEWGENE (/( Rsk3/NEWGENE )/SYM ;/: two/JJ apparently/RB intronless/JJ and/CC ORF-less/NN genes/NNS ;/: and/CC Gpr31/NEWGENE ,/, an/DT intronless/NN ,/, putative/JJ G-protein/NEWGENE coupled/NEWGENE receptor/NEWGENE ./.
@@78837542072 Using/VBG gel/NN retardation/NN assays/NNS with/IN HepG2/NN nuclear/JJ extract/NN ,/, we/PRP demonstrated/VBD the/DT presence/NN of/IN a/DT specific/JJ protein/NN which/WDT bound/JJ to/IN the/DT NRE/NEWGENE fragment/NN ./.
@@25273654955 Xenopus/NEWGENE homolog/NEWGENE of/NEWGENE the/NEWGENE mos/NEWGENE protooncogene/NEWGENE transforms/VBZ mammalian/JJ fibroblasts/NNS and/CC induces/VBZ maturation/NN of/IN Xenopus/NN oocytes/NNS ./.
@@25543103034 In/NN contrast/NN ,/, a/DT similar/JJ fragment/NN lacking/JJ the/DT 38-base-pair/JJ region/NN had/VBP no/DT such/JJ stabilizing/JJ effect/NN ./.
@@105642806366 Here/RB ,/, we/PRP describe/VBP a/DT tyrosine-phosphorylated/JJ nuclear/JJ protein/NN ,/, YT521-B/NEWGENE ,/, and/CC show/VB that/IN it/PRP interacts/VBZ with/IN the/DT nuclear/NEWGENE transcriptosomal/NEWGENE component/NEWGENE scaffold/NEWGENE attachment/NEWGENE factor/NEWGENE B/NEWGENE ,/, and/CC the/DT 68-kDa/NEWGENE Src/NEWGENE substrate/NN associated/VBN during/IN mitosis/NN ,/, Sam68/NEWGENE ./.
@@103699267176 The/DT exon/NN :/: intron/NN structure/NN of/IN chicken/NEWGENE IL8/NEWGENE corresponds/VBZ almost/RB exactly/RB to/IN that/DT of/IN human/NEWGENE IL8/NEWGENE and/CC differs/VBZ from/IN those/DT of/IN other/DT known/VBP mammalian/NEWGENE CXC/NEWGENE chemokine/NEWGENE genes/NEWGENE ./.
@@72089841578 Brain/NN scan/NN with/IN 99mTc-labelled/NN macroaggregated/NN albumin/NEWGENE (/( MAA/NN brain/NN scan/NN )/SYM and/CC computed/JJ tomography/NN studies/NNS (/( CT/NN )/SYM were/VBD performed/VBN on/IN 78/CD patients/NNS with/IN intracranial/JJ diseases/NNS ./.
@@6815506591 Procion/NNP yellow/JJ dye/NN was/VBD injected/VBN intracellularly/RB into/IN large/JJ auditory/JJ fibers/NNS of/IN goldfish/NN to/IN investigate/VB the/DT relationship/NN between/IN the/DT response/NN type/NN of/IN these/DT fibers/NNS and/CC their/PRP site/NN of/IN termination/NN in/IN the/DT saccular/JJ macula/NN ./.
@@22589187310 First/RB ,/, each/DT lung/NN was/VBD cut/JJ into/IN slices/NNS ,/, from/IN which/WDT primary/NN disectors/NN were/VBD sampled/VBN systematically/RB with/IN a/DT known/VBP sampling/JJ fraction/NN ./.
@@13206406133 Tumor/NNP cells/NNS were/VBD focally/RB immunoreactive/JJ for/IN neuron-specific/NEWGENE enolase/NEWGENE ,/, insulin/NEWGENE ,/, glucagon/NEWGENE and/CC VIP/NEWGENE ./.
@@18719714263 Analysis/NNP of/IN viral/JJ mutants/NNS in/IN vivo/NN demonstrated/VBN that/IN the/DT NFIII/NEWGENE //NEWGENE OCT-1/NEWGENE binding/NEWGENE site/NEWGENE and/CC a/DT conserved/VBN ATF/NEWGENE motif/NEWGENE were/VBD important/JJ for/IN efficient/JJ viral/JJ growth/NN ./.
@@79514105498 E1A/NEWGENE autoactivation/NN mediated/JJ by/IN these/DT sites/NNS was/VBD about/RB twofold/RB compared/VBN with/IN a/DT ninefold/JJ activation/NN described/VBN for/IN the/DT complete/JJ E1A/NEWGENE promoter/NEWGENE ./.
@@87191558633 We/PRP report/VBP here/RB the/DT molecular/JJ cloning/NN of/IN a/DT putative/JJ adhesive/JJ molecule/NN from/IN P/NNP ./NNP falciparum/NN that/WDT shares/VBP both/DT sequence/NN and/CC structural/JJ similarities/NNS with/IN a/DT sporozoite/NN surface/NN molecule/NN from/IN Plasmodium/NN termed/VBD the/DT thrombospondin-related/NEWGENE anonymous/NEWGENE protein/NEWGENE (/( TRAP/NEWGENE )/SYM and/CC ,/, to/IN a/DT lesser/JJ extent/NN ,/, with/IN the/DT circumsporozoite/JJ (/( CS/NN )/SYM protein/NN ./.
@@17763062381 In/NN a/DT second/JJ patient/NN the/DT VT/NN became/VBD nonsustained/JJ ./.
@@8981371607 Further/RB ,/, the/DT PIP2/NN content/NN of/IN the/DT 85-90/NN kDa/NN protein/NN appeared/VBN to/IN decrease/NN with/IN CSF-1/NEWGENE treatment/NN ./.
@@111457172636 The/DT epitope-protected/JJ lysine/NN (/( K/NN )/SYM was/VBD present/VB in/IN a/DT 30-aa/NEWGENE TPO/NEWGENE fragment/NEWGENE that/IN ,/, by/IN N-terminal/NN sequencing/VBG ,/, was/VBD found/VBN to/IN be/VB K713/NNP ./.
@@86542008617 Therefore/RB ,/, magnetic/JJ resonance/NN imaging/JJ was/VBD used/VBN to/IN determine/VB liver/NN volume/NN in/IN pediatric/JJ and/CC adolescent/JJ patients/NNS ,/, in/IN whom/WP systemic/JJ clearance/NN of/IN three/CD model/NN substrates/NNS [/NN lorazepam/NN (/( 0/CD ./CD 03/CD mg/CD //CD kg/CD )/SYM ,/, antipyrine/NN (/( 10/CD mg/CD //CD kg/CD )/SYM ,/, and/CC indocyanine/NN green/JJ (/( ICG/NN ;/: 0/CD ./CD 5/CD mg/CD //CD kg/CD )/NN ]/NN was/VBD also/RB determined/VBN ./.
@@17024327304 Northern/NNP blotting/NN analysis/NN indicates/VBZ that/DT expression/NN of/IN the/DT genes/NNS corresponding/JJ to/IN these/DT clones/NNS is/VBZ confined/VBN to/IN pollen/NN tissue/NN ./.
@@29026566404 Like/IN scrotal/JJ testes/NNS ,/, undescended/JJ testes/NNS were/VBD hypointense/JJ to/IN fat/JJ on/IN sequences/NNS with/IN a/DT short/JJ repetition/NN time/NN (/( TR/NN )/SYM and/CC echo/NN time/NN (/( TE/NN )/SYM in/IN all/DT cases/NNS ,/, and/CC hyperintense/JJ or/CC isointense/JJ to/IN fat/JJ on/IN long/NN TR/NN //NN TE/NN sequences/NN in/IN all/DT but/CC two/JJ cases/NNS ./.
@@36285966662 Samples/NNS from/IN 1415/CD neurological/JJ patients/NNS were/VBD used/VBN to/IN study/NN the/DT diagnostic/JJ value/NN of/IN acid/NEWGENE alpha/NEWGENE 1-glycoprotein/NEWGENE in/IN the/DT lumbar/JJ cerebrospinal/JJ fluid/NN ./.
@@88331535678 In/NN addition/NN ,/, a/DT comparison/NN of/IN the/DT hCHLR/NEWGENE gene/NEWGENE sequences/NEWGENE with/IN available/JJ databases/NNS indicates/VBZ that/IN a/DT large/JJ portion/NN of/IN these/DT genes/NNS ,/, including/JJ exons/NNS encoding/VBG two/JJ functional/JJ domains/NNS of/IN the/DT carboxyl-terminal/NN region/NN of/IN these/DT proteins/NNS ,/, has/VBZ been/VBN duplicated/VBN as/IN part/NN of/IN a/DT larger/RBR human/NN telomeric/NN repeat/NN sequence/NN found/VB on/IN many/JJ human/JJ chromosomes/NNS ./.
@@13521134946 The/DT pulmonary/JJ effects/NNS observed/VBN ,/, became/VBD more/RB pronounced/VBN with/IN increasing/JJ NO2/NN concentrations/NNS (/( 0/CD ,/, 25/CD ,/, 75/CD ,/, 125/CD ,/, 175/CD or/CC 200/CD ppm/NN ,/, 1/CD ppm/NN NO2/NN =/SYM 1/CD ./CD 88/CD mg/NN m-3/NN NO2/NN )/SYM and/CC exposure/NN times/NNS (/( 5/CD ,/, 10/CD ,/, 20/CD or/CC 30/CD min/NN )/SYM ./.
@@10652102722 Moreover/RB ,/, increasing/JJ the/DT dosage/NN of/IN wild-type/NEWGENE Fus3/NEWGENE intensifies/VBZ the/DT inhibition/NN of/IN both/DT Ty1/NEWGENE transposition/NN and/CC invasive/JJ growth/NN ./.
@@983791325 Type/NEWGENE 2/NEWGENE deiodinase/NEWGENE (/( D2/NEWGENE )/SYM catalyzes/VBZ the/DT 5'-deiodination/CD of/IN thyroxine/NN to/IN form/NN 3/NN ,/NN 5/NN ,/NN 3'-triiodothyronine/NN ./.
@@93763256407 Comparison/NNS of/IN genomic/JJ sequence/NN shows/VBZ that/IN the/DT ph/NEWGENE locus/NEWGENE has/VBZ been/VBN duplicated/VBN ,/, and/CC that/IN it/PRP contains/VBZ proximal/JJ and/CC distal/JJ transcription/NN units/NNS ./.
@@94592417015 Pao2/NN increased/VBN from/IN 15/CD ./CD 5/CD +/NN //NN -/NN 5/CD ./CD 6/CD kPa/NN (/( 116/NN +/NN //NN -/NN 42/CD mm/NN Hg/NN )/SYM to/IN 17/CD ./CD 3/CD +/NN //NN -/NN 6/CD ./CD 3/CD kPa/NN (/( 130/CD +/NN //NN -/NN 47/CD mm/NN Hg/NN )/SYM (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@22067892827 The/DT efficacy/NN and/CC safety/NN of/IN a/DT novel/JJ percutaneous/JJ anaesthetic/JJ preparation/NN based/VBN on/IN amethocaine/NN has/VBZ been/VBN investigated/VBN in/IN the/DT paediatric/JJ clinical/JJ environment/NN ./.
@@20831995141 Phosphopeptide/NN mapping/NN revealed/VBD the/DT same/JJ autophosphorylation/NN sites/NN utilized/VBN by/RB EGFR-IC/NEWGENE as/IN those/DT identified/VBN in/IN wild-type/NEWGENE EGFR/NEWGENE ./.
@@113697597960 Cell/NNP ./.
@@78320867406 The/DT drug/NN sensitivity/NN was/VBD 100%/CD for/IN vancomycin/NN (/( VCM/IN )/SYM ,/, 30%/CD for/IN imipenam/NN (/( IMP/NN )/SYM ,/, 31%/JJ for/IN minomycin/NN (/( MINO/NN )/SYM ,/, 31%/JJ for/IN amikacin/NN (/( AMK/NN )/SYM ,/, and/CC 7%/JJ for/IN fosfomycin/NN (/( FOM/NN )/SYM ./.
@@10773351679 Induction/NNS of/IN CD86/NEWGENE expression/NN by/IN stimulation/NN of/IN U937/CD cells/NNS with/IN IFN-gamma/NEWGENE revealed/VBD the/DT presence/NN of/IN two/JJ functional/JJ GAS/NEWGENE (/( gamma-interferon/NEWGENE activation/NEWGENE site/NEWGENE )/SYM elements/NNS ./.
@@67676486533 Measurements/NNS of/IN perfusion/NN also/RB showed/VBD significantly/RB higher/JJ values/NNS under/IN active/JJ therapy/NN ./.
@@97141096842 BACKGROUND/IN :/: It/PRP is/VBZ generally/RB accepted/VBN that/IN smoking/NN increases/NNS blood/NN pressure/NN and/CC inhibits/VBZ muscle/NN sympathetic/JJ nerve/NN activity/NN (/( SNA/NN )/SYM ./.
@@92220573865 Serum/NN and/CC peritoneal/JJ dialysis/NN fluid/NN (/( PDF/NN )/SYM were/VBD collected/VBN for/IN assay/NN throughout/IN the/DT course/NN of/IN the/DT study/NN and/CC for/IN 5/CD days/NNS thereafter/RB ./.
@@100493576186 These/DT results/NNS show/NN that/IN Ski/NEWGENE is/VBZ a/DT component/NN of/IN the/DT HDAC/NEWGENE complex/NEWGENE and/CC that/IN Ski/NEWGENE is/VBZ required/VBN for/IN the/DT transcriptional/JJ repression/NN mediated/JJ by/IN this/DT complex/NN ./.
@@72213547045 Theory/NNP and/CC applications/NNS of/IN pulse/NN dosing/VBG :/: a/DT summary/NN of/IN the/DT symposium/NN ./.
@@14520371459 The/DT structural/JJ genes/NNS encoding/VBG glyceraldehyde-3-phosphate/NEWGENE dehydrogenase/NEWGENE (/( GAPDH/NEWGENE )/SYM ,/, 3-phosphoglycerate/NEWGENE kinase/NEWGENE (/( PGK/NEWGENE )/SYM and/CC the/DT N-terminal/NN part/NN of/IN triosephosphate/NEWGENE isomerase/NEWGENE (/( TIM/NEWGENE )/SYM from/IN mesophilic/JJ Bacillus/NN megaterium/NN DSM319/NN have/VB been/VBN cloned/VBN as/IN a/DT gene/NN cluster/NN (/( gap/NEWGENE operon/NEWGENE )/SYM by/IN complementation/NN of/IN an/DT Escherichia/NN coli/JJ gap/NEWGENE amber/NEWGENE mutant/NEWGENE ./.
@@77062916981 An/DT E/NN box/NN element/NN is/VBZ required/VBN for/IN the/DT expression/NN of/IN the/DT ad4bp/NEWGENE gene/NEWGENE ,/, a/DT mammalian/NEWGENE homologue/NEWGENE of/NEWGENE ftz-f1/NEWGENE gene/NEWGENE ,/, which/WDT is/VBZ essential/JJ for/IN adrenal/JJ and/CC gonadal/JJ development/NN ./.
@@27797528927 1-/NN (/NN m-Chlorophenyl/NN )/NN piperazine/NN (/( mCPP/NN ,/, 0/CD ./CD 1-3/CD ./CD 0/CD mg/CD //CD kg/CD )/SYM and/CC 1-/NN (/NN m-trifluoromethylphenyl/NN )/NN piperazine/NN (/( TFMPP/NN ,/, 0/CD ./CD 1-3/CD ./CD 0/CD mg/CD //CD kg/CD )/SYM ,/, both/DT thought/NN to/IN act/NN primarily/RB at/IN 5-HT1/NEWGENE sites/NEWGENE ,/, also/RB decreased/VBN responding/VBG and/CC this/DT effect/NN was/VBD blocked/VBN by/IN methysergide/NN and/CC by/IN 1-NP/JJ ,/, but/CC not/RB by/IN ketanserin/NN ./.
@@10784367602 METHOD/IN :/: The/DT sample/NN of/IN subjects/NNS was/VBD drawn/VBP from/IN the/DT Suffolk/NNP County/NNP Mental/NNP Health/NNP Project/NNP ,/, a/DT longitudinal/JJ epidemiologic/JJ study/NN of/IN first-hospitalized/JJ subjects/NNS with/IN psychotic/JJ disorders/NNS ;/: the/DT present/NN study/NN focused/VBN on/IN patients/NNS with/IN schizophrenic/JJ disorders/NNS ./.
@@74727366593 The/DT temporal/NN component/NN lacked/VBD a/DT mandibular/JJ fossa/NN as/RB well/VB as/IN articular/JJ eminence/NN ./.
@@111081519461 Ang/NEWGENE II-induced/NEWGENE fibronectin/NEWGENE mRNA/NEWGENE was/VBD not/RB affected/VBN by/IN PKC/NEWGENE inhibitors/NN or/CC PKC/NEWGENE depletion/NN ,/, whereas/IN specific/JJ inhibition/NN of/IN EGF-R/NEWGENE function/NN by/IN a/DT dominant/NEWGENE negative/NEWGENE EGF-R/NEWGENE mutant/NEWGENE and/CC tyrphostin/NN AG1478/NN abolished/VBD induction/NN of/IN fibronectin/NEWGENE mRNA/NEWGENE ./.
@@61982416999 These/DT fusions/NNS are/VBP contained/VBN on/IN plasmids/NNS which/WDT have/VBP both/DT yeast/NN and/CC E/NNP ./NNP coli/JJ replication/NN origins/NNS and/CC selectable/JJ markers/NNS and/CC ,/, therefore/RB ,/, can/MD be/VB used/VBN to/IN transform/VB either/DT yeast/NN or/CC E/NNP ./NNP coli/JJ cells/NNS ./.
@@88394988816 Furthermore/RB ,/, although/IN the/DT regional/JJ distribution/NN of/IN lean/JJ tissue/NN mass/JJ in/IN the/DT trunk/NN and/CC legs/NNS remained/VBN fairly/RB constant/JJ at/IN different/JJ pubertal/JJ stages/NNS ,/, the/DT regional/JJ distribution/NN of/IN fat/NN was/VBD altered/VBN significantly/RB ,/, becoming/VBG more/RB central/JJ and/CC less/PRP peripheral/JJ ./.
@@90988991151 Coliphage/NEWGENE 186/NEWGENE B/NEWGENE is/VBZ a/DT 72-amino/JJ acid/NN protein/NN belonging/NN to/IN the/DT Ogr/NEWGENE family/NN of/IN analogous/JJ transcription/NN factors/NNS present/VBP in/IN P2-like/NNP phage/NN ,/, which/WDT contain/VBP a/DT Cys-X2-Cys-X22-Cys-X4-Cys/NNP presumptive/JJ zinc-finger/NN motif/NN ./.
@@35287487021 In/NN a/DT maxicell/JJ system/NN a/DT protein/NN with/IN an/DT approximate/JJ molecular/JJ weight/NN of/IN 36/CD ,/CD 000/CD was/VBD synthesized/VBN ./.
@@103596039463 Vac1p/NEWGENE was/VBD found/VBN to/IN bind/NN the/DT Sec1p/NEWGENE homologue/NEWGENE Vps45p/NEWGENE1 ./.
@@25854921146 Interspecific/NNP complementation/NN tests/NNS showed/VBN that/IN the/DT P7/NEWGENE proteins/NEWGENE are/VBP unable/JJ to/IN complement/NN P1/NEWGENE parA/NEWGENE or/CC parB/NEWGENE mutants/NEWGENE ,/, and/CC the/DT P1/NEWGENE proteins/NEWGENE fail/NN to/IN complement/NN the/DT P7/NEWGENE mutations/NEWGENE ./.
@@110982173877 The/DT Aie1/NEWGENE locus/NEWGENE was/VBD mapped/VBN to/IN mouse/NN chromosome/NN 7A2-A3/JJ by/IN fluorescent/JJ in/IN situ/NN hybridization/NN ./.
@@99845269983 Effects/NNPS of/IN point/NN defects/NNS on/IN lattice/NN parameters/NNS of/IN semiconductors/NNS ./.
@@118338631700 There/EX was/VBD no/DT difference/NN in/IN apnea/NN duration/NN between/IN the/DT supine/JJ and/CC prone/RB positions/VBZ ./.
@@92490703130 Cell/NNP 49/CD ,/, 753-761/NN ]/NN ./.
@@118496771413 Erratum/NNP to/IN "Cholesteryl/NEWGENE ester/NEWGENE transfer/NEWGENE protein/NEWGENE and/CC atherosclerosis/NN in/IN Japanese/JJ subjects/NNS :/: a/DT study/NN based/VBN on/IN coronary/JJ angiography"/NN ./.
@@17719592374 After/IN PTCA/NN ,/, ejection/NN fraction/NN increased/VBN from/IN 54/CD +/NN //NN -/NN 8%/JJ to/IN 59/CD +/NN //NN -/NN 8%/JJ (/( p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM and/CC regional/JJ function/NN improved/VBN significantly/RB (/( maximal/JJ standard/JJ deviation/NN before/IN PTCA/NN :/: 2/CD ./CD 8/CD +/NN //NN -/NN 0/CD ./CD 8/CD ;/: after/IN PTCA/NN :/: 1/CD ./CD 9/CD +/NN //NN -/NN 0/CD ./CD 9-/CD segments/NNS below/RB the/DT first/JJ standard/JJ deviation/NN before/IN PTCA/NN :/: 31/CD +/NN //NN -/NN 16/CD ;/: after/IN PTCA/NN :/: 19/CD +/NN //NN -/NN 17/CD )/SYM ./.
@@8101134302 The/DT concentrations/NNS of/IN plasma/NN ACTH/NEWGENE and/CC cortisol/NN increased/VBN by/IN 40%/CD and/CC 60%/CD after/IN MPTP/NN treatment/NN ,/, respectively/RB ./.
@@82949068188 This/DT distribution/NN parallels/VBP that/IN of/IN the/DT neurotransmitters/NNS glutamate/NN and/CC aspartate/NN ;/: however/RB ,/, neither/DT of/IN these/DT excitatory/JJ amino/JJ acids/NNS is/VBZ a/DT substrate/NN for/IN transport/NN ./.
@@79354267144 Only/JJ two/NN of/IN the/DT isoforms/NNS possess/VBP the/DT N-terminal/NN zinc/NN finger/NN domain/NN that/WDT is/VBZ necessary/JJ and/CC sufficient/JJ for/IN TdT/NEWGENE promoter/NEWGENE binding/JJ ./.
@@95150323309 RT-PCR/NN indicated/VBN that/IN p21/NEWGENE mRNA/NEWGENE was/VBD induced/VBN 1/CD ./CD 4-/CD ,/, 2/CD ./CD 0-/CD ,/, and/CC 3/CD ./CD 1-fold/CD in/IN the/DT 2-day/JJ neonatal/JJ ,/, 7-day/CD neonatal/JJ ,/, and/CC adult/JJ stages/NNS ,/, respectively/RB ,/, compared/VBN to/IN the/DT 17-day/CD fetal/JJ stage/NN ./.
@@10852221659 This/DT demonstrates/VBZ that/DT treatment/NN of/IN the/DT graft/NN recipient/NN for/IN a/DT relatively/JJ short/JJ period/NN during/IN and/CC after/IN surgery/NN has/VBZ a/DT favorable/JJ effect/NN on/IN the/DT survival/NN of/IN grafted/VBN dopaminergic/JJ neurons/NNS ./.
@@103189006524 Three-dimensional/JJ structural/JJ studies/NNS using/VBG electron/NN cryomicroscopy/NN showed/VBN that/IN the/DT binding/NN of/IN one/PRP Fab/NEWGENE (/( 8H2/CD //CD G5/CD )/SYM does/VBP not/RB affect/VB the/DT conformation/NN of/IN the/DT capsid/NN ,/, and/CC the/DT efficiency/NN of/IN mRNA/NN production/NN is/VBZ similar/JJ to/IN that/DT of/IN the/DT native/JJ subviral/JJ particle/NN ./.
@@20951502698 Femoral/JJ strain/NN adaptation/NN after/IN total/JJ hip/NN replacement/NN :/: a/DT comparison/NN of/IN cemented/VBN and/CC porous/JJ ingrowth/NN components/NNS in/IN canines/NNS ./.
@@61678062245 The/DT ability/NN of/IN chronic/JJ UM-272/NN (/( dimethylpropranolol/NN )/SYM treatment/NN to/IN prevent/VB the/DT induction/NN of/IN reentrant/JJ ventricular/JJ tachyarrhythmias/NNS was/VBD assessed/VBN in/IN the/DT conscious/JJ dog/NN subjected/VBN to/IN serial/JJ programmed/JJ electrical/JJ stimulation/NN on/IN days/NNS 3--5/JJ after/IN myocardial/JJ infarction/NN ./.
@@34911905261 The/DT detectability/NN of/IN the/DT defects/NNS in/IN RCA/NN or/CC LAD/NN region/NN was/VBD 80%/CD in/IN single-position/CD scans/NNS in/IN stress/NN studies/NNS ./.
@@92612006520 MR/NN imaging/JJ of/IN traumatic/JJ head/JJ injuries/NNS using/VBG FLAIR/NN technique/NN ./.
@@11220151571 With/IN 0/CD ./CD 5/CD vol/CD ./CD -%/CD ,/, the/DT corresponding/JJ values/NNS were/VBD 345/CD mumol/NN //NN 1/NN (/( 5/CD ./CD 72/CD mg/CD //CD 100/CD ml/NN )/SYM and/CC 137/CD mumol/NN //NN 1/NN (/( 2/CD ./CD 25/CD mg/CD //CD 100/CD ml/NN )/SYM respectively/RB ./.
@@107939916131 Given/VBN its/PRP relative/JJ longevity/NN on/IN the/DT Web/NN ,/, TIE/NN researchers/NNS have/VBP been/VBN in/IN a/DT unique/JJ position/NN to/IN observe/VB trends/NNS in/IN telemedicine/NN ./.
@@93654317673 She/PRP improved/VBD with/IN a/DT combination/NN of/IN benzodiazepines/NNS and/CC the/DT acetylcholinesterase/NEWGENE inhibitor/NN physostigmine/NN ./.
@@26486464209 Platelet/NEWGENE activating/NEWGENE factor/NEWGENE was/VBD given/VBP in/IN six/CD doses/NNS at/IN 15/CD minute/JJ intervals/NNS and/CC airway/NN response/NN measured/VBN as/IN change/NN in/IN partial/JJ expiratory/JJ flow/NN at/IN 30%/CD of/IN vital/JJ capacity/NN (/( Vp30/NN )/SYM ./.
@@100298604333 Those/DT radiological/JJ aspects/NNS were/VBD distributed/VBN in/IN two/JJ categories/NNS :/: 1/NN )/NN type/NN I-presenting/NN variable/JJ sinusoidal/JJ filling/NN ./.
@@7683375306 Since/IN we/PRP have/VBP observed/VBN effects/NNS of/IN growth/NEWGENE factors/NEWGENE and/CC cAMP/NN as/RB well/VB as/IN estradiol/NN (/( E2/NN )/SYM on/IN regulation/NN of/IN expression/NN of/IN some/DT genes/NNS stimulated/VBN by/IN the/DT estrogen/NEWGENE receptor/NEWGENE (/( ER/NEWGENE )/SYM ,/, we/PRP have/VBP undertaken/VBP studies/NNS to/IN examine/VB directly/RB whether/IN activators/NNS of/IN protein/NEWGENE kinases/NEWGENE can/MD modulate/VB transcriptional/JJ activity/NN of/IN the/DT ER/NEWGENE ./,
@@90026487281 BCL-2/NEWGENE ,/, an/DT inhibitor/NN of/IN apoptosis/NN in/IN a/DT wide/JJ variety/NN of/IN cell/NN types/NNS ,/, has/VBZ been/VBN reported/VBN to/IN prevent/VB oxidative/JJ stress-induced/JJ cell/NN death/NN ./.
@@2659643337 This/DT mechanism/NN is/VBZ not/RB due/NN to/IN the/DT observed/VBN grain/NN boundary/NN precipitates/NNS ./.
@@15425652852 Mature/NEWGENE tobacco/NEWGENE L12/NEWGENE protein/NEWGENE has/VBZ 44%/JJ amino/JJ acid/NN identity/NN with/IN ribosomal/NEWGENE protein/NEWGENE L7/NEWGENE //NEWGENE L12/NEWGENE of/NEWGENE Escherichia/NEWGENE coli/NEWGENE ./.
@@22646012902 Taste/NN reactivity/NN tests/NNS were/VBD used/VBN to/IN examine/VB the/DT orofacial/JJ responses/NNS of/IN alcohol/NN preferring/JJ (/( P/NN )/SYM rats/NNS and/CC alcohol/NN nonpreferring/JJ (/( NP/NN )/SYM rats/NNS to/IN the/DT taste/NN of/IN alcohol/NN ./.
@@10074282266 On/IN the/PDT other/DT side/NN ,/, when/CC the/DT aortic/JJ ring/NN was/VBD perfused/VBN with/IN L-NNA/NN (/( NO-synthesis/NNP inhibitor/NN )/SYM or/CC methylene/NN blue/JJ (/( soluble/NN cGMPase/NEWGENE inhibitor/NN )/SYM ,/, the/DT changes/NNS could/MD be/VB attenuated/VBN ./.
@@75940473981 Effects/NNPS of/IN verapamil/NN and/CC propranolol/NN on/IN early/JJ afterdepolarizations/NNS and/CC ventricular/JJ arrhythmias/NNS induced/VBN by/IN epinephrine/NN in/IN congenital/JJ long/NN QT/NN syndrome/NN ./.
@@6193056013 This/DT implies/VBZ that/IN the/DT groups/NNS do/NN not/RB just/RB differ/VB along/IN one/PRP dimension/NN ,/, but/CC along/IN three/CD dimensions/NNS ./.
@@76363377556 These/DT results/NNS are/VBP very/RB useful/JJ for/IN deciding/VBG on/IN the/DT doses/NNS of/IN hormones/NNS and/CC the/DT expected/VBN serum/JJ estradiol/NN level/NN in/IN HRT/NN for/IN Japanese/JJ women/NNS ./.
@@28594343547 Poor/NNP response/NN when/CC laboratory/NN recommended/VBD range/NN for/IN serum/JJ lithium/NN is/VBZ changed/VBN ./.
@@117066686843 Hydrocoele/NN is/VBZ common/JJ in/IN men/NNS in/IN Wuchereria/VBZ bancrofti-endemic/JJ areas/NNS ,/, the/DT treatment/NN for/IN which/WDT is/VBZ currently/RB surgical/JJ intervention/NN ./.
@@13277587579 Replication/NNS of/IN bovine/NN papillomavirus-1/NN (/( BPV-1/NN )/SYM DNA/NN requires/VBZ two/JJ viral/JJ gene/NN products/NNS ,/, the/DT E1/NEWGENE protein/NEWGENE and/CC the/DT full-length/NEWGENE E2/NEWGENE protein/NEWGENE ./.
@@28946899343 We/PRP have/VBP been/VBN able/JJ to/IN map/NN specific/JJ DNA/NN fragments/NNS at/IN the/DT bases/NNS of/IN chromatin/NN loops/NNS with/IN the/DT help/NN of/IN a/DT novel/JJ extraction/NN procedure/NN by/IN using/VBG lithium-3'/JJ ,/JJ 5'-diiodosalicylate/JJ ./.
@@98517009823 The/DT gene/NEWGENE encoding/NEWGENE human/NEWGENE tissue-type/NEWGENE plasminogen/NEWGENE activator/NEWGENE (/( t-PA/NEWGENE )/SYM is/VBZ regulated/VBN in/IN a/DT cell-type-specific/JJ manner/NN ./.
@@76366487562 One/CD month/NN after/IN the/DT DTaP/NNP booster/NN vaccination/NN ,/, both/DT groups/NNS had/VBP 6-/CD to/IN 40-fold/CD increases/NNS in/IN serum/JJ antibody/NN concentrations/NNS to/IN all/DT antigens/NNS tested/VBN ;/: the/DT concentrations/NNS against/IN the/DT three/CD pertussis/NEWGENE antigens/NEWGENE were/VBD higher/JJ in/IN the/DT DTaP-primed/JJ children/NNS (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@9537361569 The/DT iron/NN dependence/NN of/IN transcription/NN and/CC expression/NN of/IN cvaA/NEWGENE ,/, which/WDT encodes/VBZ a/DT transporter/NN accessory/JJ protein/NN ,/, and/CC cvi/NEWGENE ,/, encoding/VBG the/DT colicin/NEWGENE V/NEWGENE immunity/NEWGENE protein/NEWGENE ,/, was/VBD assessed/VBN under/IN conditions/NNS of/IN iron/NN excess/NN or/CC depletion/NN ./.
@@106287556242 Synthetic/JJ ligands/NNS have/VBP been/VBN identified/VBN that/WDT reset/VBP and/CC amplify/VB the/DT cycle/NN of/IN pulsatile/JJ GH/NEWGENE secretion/NN by/IN interacting/VBG with/IN the/DT orphan/NEWGENE GH-secretagogue/NEWGENE receptor/NEWGENE (/( GHS-R/NEWGENE )/SYM ./.
@@6829082721 Self-heating/VBG after/IN deep/JJ hypothermia/NN (/( 20/CD degrees/NNS C/NN )/SYM causes/VBZ a/DT considerable/JJ increase/NN in/IN the/DT brain/NN tissues/NNS glutaminase/NEWGENE activity/NN at/IN all/DT studied/VBN incubation/NN temperatures/NNS (/( 37/CD ,/, 30/CD ,/, 20/CD and/CC 10/CD degrees/NNS C/NN )/SYM as/IN compared/VBN to/IN control/NN rats/NNS and/CC rats/NNS under/IN hypothermia/NN ./.
@@112434941073 RESULTS/NNS :/: Within/IN 7/CD days/NNS ,/, all/DT groups/NNS re-acquired/JJ responding/VBG for/IN heroin/NN under/IN CRF/NN at/IN rates/NNS similar/JJ to/IN their/PRP pre-lesion/JJ performance/NN ./.
@@108107453915 HFA/NN 134a/NN had/VBP a/DT greater/JJR tendency/NN to/IN take/NN up/RP moisture/NN from/IN the/DT environment/NN than/IN did/VBD HFA/NN 227/NN ./.
@@76369624708 We/PRP also/RB show/VBP that/IN in/IN fusions/NNS with/IN the/DT DNA/NN binding/JJ domain/NN of/IN GAL4/NEWGENE ,/, full/JJ activity/NN requires/VBZ the/DT entire/JJ BHV-alpha/NEWGENE TIF/NEWGENE ,/, although/IN both/DT amino/JJ and/CC carboxyl/NN termini/NNS display/NN some/DT activity/NN on/IN their/PRP own/VB ./.
@@113051293964 Effects/NNPS of/IN a/DT booster/NN dose/NN of/IN tetanus/NN toxoid/NN after/IN different/JJ primary/JJ courses/NNS of/IN vaccination/NN :/: implications/NNS on/IN the/DT use/NN of/IN immune/NEWGENE globulin/NEWGENE ./.
@@111210436605 In/NN Xenopus/NN ,/, BMPs/NEWGENE act/VB as/IN epidermal/JJ inducers/NNS and/CC also/RB as/IN negative/JJ regulators/NNS of/IN neurogenesis/NN ./.
@@75831907949 These/DT early/JJ structural/JJ processes/NNS are/VBP assumed/VBN to/IN be/VB subserved/VBN by/IN the/DT anterior/JJ parts/NNS of/IN the/DT left/NN hemisphere/NN ,/, as/IN event-related/JJ brain/NN potentials/NNS show/VBP this/DT area/NN to/IN be/VB maximally/RB activated/VBN when/CC phrase/NN structure/NN violations/NN are/VBP processed/VBN and/CC as/IN circumscribed/JJ lesions/NNS in/IN this/DT area/NN lead/NN to/IN an/DT impairment/NN of/IN the/DT on-line/JJ structural/JJ assignment/NN ./.
@@77917762914 Characterization/NNS of/IN fus1/NEWGENE of/IN Schizosaccharomyces/NN pombe/NN :/: a/DT developmentally/RB controlled/VBN function/NN needed/VBN for/IN conjugation/NN ./.
@@81008438729 Southern/NNP analysis/NN on/IN genomic/JJ DNA/NN isolated/VBN from/IN tissues/NNS and/CC cell/NN lines/NNS from/IN several/DT mouse/NN strains/NNS using/VBG mCD22/NEWGENE cDNA/NEWGENE demonstrated/VBN that/IN the/DT Cd22/NEWGENE locus/NEWGENE encoding/VBG mCD22/NEWGENE is/VBZ a/DT single/JJ copy/NN gene/NN of/IN </SYM or/CC =/SYM 30/CD kb/CD ./CD
@@73855437220 Importance/NN of/IN determining/JJ the/DT blood/NN sulfhydryl/NN groups/NNS in/IN fractures/NNS of/IN the/DT long/JJ tubular/JJ bones/NNS complicated/VBN by/IN infection/NN ./.
@@15589421077 Similar/JJ observations/NNS have/VBP been/VBN made/VBP previously/RB for/IN other/DT genes/NNS ./.
@@75657318996 A/DT general/JJ model/NN for/IN ARE-mediated/JJ mRNA/NN degradation/NN involving/VBG a/DT potential/JJ role/NN for/IN certain/JJ heterogeneous/JJ nuclear/JJ ribonucleoproteins/NNS and/CC ARE-binding/VBG proteins/NNS is/VBZ proposed/VBN ./.
@@95397216457 Therefore/RB ,/, we/PRP conclude/VBP that/DT DnaA/NEWGENE may/MD contact/NN the/DT beta/NN subunit/NN of/IN RNA/NEWGENE polymerase/NEWGENE during/IN activation/NN of/IN the/DT pR/NEWGENE promoter/NEWGENE ./.
@@46006035049 Letter/NNP :/: Salmonella/NN detection/NN ./.
@@8995659729 Fourth/NNP ,/, the/DT 3'-region/CD splice/NN junctions/NNS of/IN the/DT MSRs/NEWGENE during/IN latent/JJ and/CC productive/JJ infection/NN were/VBD determined/VBN by/IN sequencing/VBG RNA-PCR/NN products/NN generated/VBN with/IN primers/NNS that/WDT flank/VBP the/DT 3'/CD splice/NN region/NN ./.
@@87782652063 A/DT neuropsychological/JJ test/NN battery/NN was/VBD used/VBN that/WDT contained/VBD the/DT Wisconsin/NN card/NN sorting/JJ test/NN ,/, Street/NNP completion/NN test/NN ,/, Stroop/NN test/NN ,/, a/DT dichotic/JJ memory/NN listening/JJ test/NN ,/, and/CC a/DT facial/JJ recognition/NN test/NN ./.
@@26176234345 LON-72/NN (/( 34/CD isolates/NNS )/SYM ,/, LON-73/NN (/( 1/CD )/SYM ,/, LON-71/NN (/( 2/CD )/SYM and/CC LON-10/NN (/( 2/CD )/SYM were/VBD found/VBN at/IN altitudes/NNS around/IN 2000/CD m/NN ,/, 3/CD of/IN them/PRP in/IN a/DT single/NN village/NN ./.
@@7257522867 Treatment/NNP of/IN hypertension/NN with/IN a/DT combination/NN of/IN the/DT adrenergic/NEWGENE beta/NEWGENE receptor/NEWGENE blockader/NN ,/, obsidan/NN ,/, and/CC the/DT vasodilator/NN ,/, apressin/NN ./.
@@105793319056 The/DT results/NNS of/IN these/DT studies/NNS demonstrate/VBP that/IN the/DT rat/NEWGENE HDL/NEWGENE receptor/NEWGENE SR-BI/NEWGENE promoter/NEWGENE contains/VBZ two/JJ sterol/NEWGENE response/NEWGENE elements/NEWGENE (/( pSRE/NEWGENE and/CC dSRE/NEWGENE )/SYM through/RB which/WDT SREBP-1a/NEWGENE can/MD bind/VB and/CC activate/VB transcription/NN of/IN this/DT gene/NN ./.
@@1597462544 Disruption/NNS demonstrates/VBZ that/IN CDC14/NEWGENE is/VBZ an/DT essential/JJ gene/NN ./.
@@21548854317 The/DT sites/NNS targeted/VBN for/IN mutagenesis/NN ,/, residues/NNS 60/CD ,/, 61/CD ,/, and/CC 66/CD ,/, are/VBP located/VBN within/IN a/DT putative/JJ helical/JJ loop/NN structure/NN which/WDT may/MD be/VB involved/VBN in/IN substrate/NN recognition/NN by/IN the/DT enzyme/NN ./.
@@913070076 Further/JJ support/NN for/IN a/DT direct/JJ interaction/NN of/IN Tub4p/NEWGENE ,/, Spc98p/NEWGENE and/CC Spc97p/NEWGENE comes/NN from/IN the/DT toxicity/NN of/IN strong/JJ SPC97/NEWGENE overexpression/NN which/WDT is/VBZ suppressed/VBN by/IN co-overexpression/NN of/IN TUB4/NEWGENE or/CC SPC98/NEWGENE ./.
@@30720219793 The/DT amino/JJ acid/NN sequences/NNS of/IN the/DT yeast/NN and/CC mammalian/JJ mitochondrial/NN targeting/NN sequences/NN are/VBP similar/JJ but/CC less/PRP related/VBN than/IN the/DT mature/JJ polypeptides/NNS ./.
@@113769467574 Our/PRP previous/JJ studies/NNS have/VBP shown/VBP that/IN SHP-1/NEWGENE ,/, a/DT SH2/NEWGENE domain-containing/NEWGENE protein-tyrosine/NEWGENE phosphatase/NEWGENE ,/, is/VBZ expressed/VBN not/RB only/RB in/IN cells/NNS of/IN hematopoietic/JJ lineages/NNS ,/, but/CC also/RB in/IN many/JJ non-hematopoietic/JJ cells/NNS under/IN the/DT control/NN of/IN an/DT alternative/JJ tissue-specific/NN promoter/NN ,/, P1/NEWGENE ./.
@@11249441087 Owing/RB to/IN parental/JJ attitude/NN ,/, a/DT low/JJ protein/NN diet/NN (/( 1-5/CD g/NN //NN kg/NN )/SYM was/VBD introduced/VBN only/RB late/JJ ./.
@@78881567867 Current/JJ status/NN of/IN telepathology/NN ./.
@@90165669862 The/DT Y-type/NEWGENE structural/NEWGENE motif/NEWGENE is/VBZ also/RB conserved/VBN among/IN a/DT number/NN of/IN divergent/JJ BiP/NEWGENE mRNAs/NEWGENE ./.
@@13497051976 Effects/NNPS of/IN dioxins/NNS on/IN thyroid/JJ function/NN in/IN newborn/JJ babies/NNS ./.
@@31461502251 Potentiation/NNS of/IN the/DT thrombolytic/JJ efficacy/NN of/IN single-chain/NEWGENE urokinase/NEWGENE (/( Pro-urokinase/NEWGENE )/SYM by/IN heparin/NN ./.
@@22902168152 Effect/NN of/IN biliary/JJ obstruction/NN and/CC cholangitis/NN on/IN serum/NEWGENE SPan-1/NEWGENE level/NN ./.
@@75343062638 The/DT overexpressed/VBN His6-tagged/NEWGENE GrsA/NEWGENE derivatives/NEWGENE were/VBD affinity-purified/JJ ,/, and/CC the/DT catalytic/JJ properties/NNS of/IN the/DT deletion/NN mutants/NNS were/VBD examined/VBN by/IN biochemical/JJ studies/NNS including/JJ ATP-dependent/JJ amino/JJ acid/NN activation/NN ,/, carboxyl/NN thioester/NN formation/NN ,/, and/CC the/DT ability/NN to/IN racemize/VB the/DT covalently/RB bound/JJ phenylalanine/NN from/IN L-/DT to/IN the/DT D-isomer/NNS ./.
@@19862411277 Induction/NNS requires/VBZ the/DT ACE1/NEWGENE gene/NEWGENE product/NEWGENE ,/, which/WDT binds/VBZ to/IN specific/JJ sites/NNS in/IN the/DT promoter/NN region/NN of/IN the/DT CUP1/NEWGENE gene/NEWGENE ./.
@@23906333047 Fatal/NNP encephalitis/NN in/IN a/DT patient/NN with/IN chronic/JJ graft-versus-host/JJ disease/NN ./.
@@58236245759 The/DT need/NN in/IN the/DT small/JJ hospital/NN ./.
@@113714175568 Mechanical/JJ ventilation/NN in/IN control/NN lungs/NNS produced/VBD a/DT 47%/JJ decrease/NN in/IN chord/NN compliance/NN ,/, an/DT increase/NN in/IN lung/NN lavage/NN levels/NNS of/IN tumor/NEWGENE necrosis/NEWGENE factor/NEWGENE (/NEWGENE TNF/NEWGENE )/NEWGENE -alpha/NEWGENE (/( 722/NN +/NN //NN -/NN 306/CD pg/NN //NN ml/NN )/SYM ,/, interleukin/NEWGENE (/NEWGENE IL/NEWGENE )/NEWGENE -1beta/NEWGENE (/( 902/NN +/NN //NN -/NN 322/CD pg/NN //NN ml/NN )/SYM ,/, and/CC macrophage/NEWGENE inflammatory/NEWGENE protein-2/NEWGENE (/( MIP-2/NEWGENE )/SYM (/( 363/CD +/NN //NN -/NN 104/CD pg/NN //NN ml/NN )/SYM as/IN compared/VBN with/IN low/JJ levels/NNS of/IN cytokines/NNS detected/VBN in/IN preventilation/NN data/NN ,/, and/CC no/DT change/NN in/IN percentage/NN of/IN surfactant/JJ large/JJ aggregates/NNS (/( LA/NN )/SYM ./.
@@5575595607 Of/IN the/DT compounds/NNS tested/VBN ,/, alpha-/NN (/NN 3-methyl-2-quinoxalinyl/NN )/NN -N-methylnitrone/NN 1/NN ,/NN 4-dioxide/NN (/( 2/CD )/SYM was/VBD the/DT most/RB active/JJ agent/NN in/IN vivo/NN against/IN the/DT gram-negative/JJ and/CC the/DT gram-positive/JJ organisms/NNS ./.
@@86493937062 A/DT chromosome/NN transmission/NN fidelity/NN (/( ctf/NN )/SYM mutant/JJ ,/, s138/NN ,/, of/IN Saccharomyces/NN cerevisiae/NN was/VBD identified/VBN by/IN its/PRP centromere/NN (/( CEN/NN )/SYM transcriptional/JJ readthrough/NN phenotype/NN ,/, suggesting/VBG perturbed/VBN kinetochore/NN integrity/NN in/IN vivo/NN ./.
@@28113784072 Immunohistochemical/JJ studies/NNS revealed/VBD positive/JJ staining/NN for/IN S100/NEWGENE protein/NEWGENE in/IN all/PDT the/DT granular/JJ cell/NN tumors/NNS of/IN the/DT adult/JJ but/CC in/IN none/NN of/IN the/DT congenital/JJ granular/JJ cell/NN epulides/NNS ./.
@@14274574457 In/NN a/DT prospective/NN ,/, randomized/JJ clinical/JJ trial/NN we/PRP compared/VBD the/DT efficacy/NN of/IN subcutaneously/RB (/( SC/NN )/SYM administered/VBN (/( every/DT 8/CD h/NN )/SYM calcium/NN heparin/NN to/IN intravenous/JJ (/( IV/NN )/SYM sodium/NN heparin/NN in/IN the/DT treatment/NN of/IN proximal/JJ deep-vein/JJ thrombosis/NN (/( DVT/NN )/SYM ./.
@@86757638307 Mean/VB increase/NN of/IN milk/NN protein/NN yield/NN was/VBD 46/CD g/NN //NN d/NN with/IN Met/NNP plus/IN Lys/NN ,/, and/CC mean/JJ increase/NN of/IN true/JJ protein/NN content/NN was/VBD 1/CD ./CD 1/CD g/NN //NN kg/NN of/IN milk/NN ./.
@@55442915589 V/NNP ./NNP
@@16562218104 Alignment/NNS of/IN the/DT amino/JJ acid/NN sequences/NNS surrounding/JJ Tyr-766/NNP with/IN corresponding/JJ regions/NNS of/IN other/DT FGFRs/NEWGENE revealed/VBN conserved/VBN tyrosine/NN residues/NNS in/IN all/DT known/VBP members/NNS of/IN the/DT FGFR/NEWGENE family/NEWGENE ./.
@@114732613844 Mss4/NEWGENE also/RB acts/VBZ as/IN a/DT relatively/JJ inefficient/JJ guanine/NEWGENE nucleotide/NEWGENE exchange/NEWGENE factor/NEWGENE (/( GEF/NEWGENE )/SYM ./.
@@5801065738 Treatment/NNP of/IN Graves'/NNPS disease/NN ./.
@@106049451169 Some/DT artificial/JJ promoter/NN constructs/NNS containing/JJ multiple/JJ Sp1/NEWGENE sites/NEWGENE were/VBD highly/RB responsive/JJ to/IN ethanol/NN ,/, but/CC others/NNS were/VBD not/RB ,/, suggesting/VBG that/IN the/DT organization/NN of/IN the/DT proximal/JJ promoter/NN region/NN was/VBD an/DT additional/JJ factor/NN that/WDT affected/VBD the/DT ethanol/NN response/NN ./.
@@110272677110 Polysome/NEWGENE and/CC 40S/NEWGENE ribosome/NEWGENE fractions/NNS were/VBD severely/RB decreased/VBN in/IN the/DT krr1/NEWGENE mutant/NEWGENE and/CC Kri1p-depleted/JJ cells/NNS ./.
@@20346551259 The/DT alpha/NEWGENE 4/NEWGENE gene/NEWGENE 5'/CD flanking/JJ region/NN acted/VBN as/IN a/DT promoter/NN in/IN transfection/NN assays/NNS ./.
@@86791318661 Atopic/NN allergy/NN and/CC other/DT hypersensitivities/NNS ./.
@@10699354738 Reaction/NN time/NN (/( RT/JJ )/SYM and/CC P300/NN were/VBD collected/VBN simultaneously/RB ./.
@@9612351704 There/EX was/VBD no/DT evidence/NN of/IN any/DT persistent/JJ oscillation/NN within/IN the/DT ULF/NN band/NN ./.
@@15650934058 From/IN March/NN 5/CD through/JJ October/NN 26/CD ,/, 1991/CD ,/, eight/CD persons/NNS were/VBD diagnosed/VBN with/IN elevated/VBN blood/NN lead/NN levels/NNS (/( BLLs/NNS )/SYM at/IN a/DT local/JJ hospital/NN and/CC were/VBD reported/VBN to/IN the/DT notifiable/JJ disease/NN surveillance/NN system/NN maintained/VBN by/IN the/DT Alabama/NNP Department/NNP of/IN Public/NNP Health/NNP (/( ADPH/NN )/SYM ./.
@@82450132474 Delineating/VBG the/DT molecular/JJ basis/NN for/IN agonist-induced/JJ destabilization/NN of/IN mRNA/NN of/IN G-protein-linked/NEWGENE receptors/NEWGENE that/WDT contributes/VBZ to/IN receptor/NN down-regulation/NN is/VBZ fundamental/JJ to/IN our/PRP understanding/NN of/IN long-term/JJ regulation/NN of/IN receptors/NNS by/IN agonist/NN ./.
@@94730408858 The/DT cloned/VBN alcR/NEWGENE gene/NEWGENE provided/VBN in/IN trans/RB restored/VBN these/DT siderophore/NN system/NN activities/NNS to/IN the/DT mutants/NNS ./.
@@66719256699 Amikacin/NN concentrations/NNS in/IN serum/NN and/CC blister/NN fluid/NN in/IN healthy/JJ volunteers/NNS and/CC in/IN patients/NNS with/IN renal/JJ impairment/NN ./.
@@63197403185 We/PRP conclude/VBP that/IN the/DT gp54/NEWGENE structural/NEWGENE gene/NEWGENE is/VBZ required/VBN for/IN initiation/NN or/CC amplification/NN of/IN the/DT splenic/JJ erythroblast/NN hyperplasia/NN which/WDT characterizes/VBZ the/DT preleukemic/JJ phase/NN of/IN Rauscher/NNP disease/NN ./.
@@72634211648 With/IN Sair/NN and/CC So2/NN ,/, mean/JJ vital/JJ capacity/NN was/VBD reduced/VBN by/IN 44%/JJ from/IN control/NN ./.
@@11598221489 The/DT bronchial/JJ epithelia/NNS of/IN all/DT smoke-exposed/JJ animals/NNS were/VBD hyperplastic/JJ ,/, and/CC their/PRP ultrastructure/NN showed/VBD invaginations/NNS ,/, tilt/NN of/IN nuclear/JJ axes/NNS ,/, an/DT increase/NN in/IN the/DT number/NN and/CC size/NN of/IN lysosomes/NNS and/CC multivesiculated/VBN bodies/NNS ,/, and/CC increased/VBD numbers/NNS of/IN enlarged/JJ intramitochondrial/JJ granules/NNS ./.
@@21749742211 Transcription/NNS of/IN the/DT first/JJ operon/NN coding/JJ for/IN m-xylene-degrading/JJ enzymes/NNS on/IN the/PDT TOL/DT plasmid/NN of/IN Pseudomonas/NNS putida/NN is/VBZ activated/VBN by/IN the/DT xylR/NEWGENE gene/NEWGENE product/NEWGENE in/IN the/DT presence/NN of/IN m-xylene/NN ./.
@@112868331428 Three/CD patients/NNS received/VBD additional/JJ cycles/NNS of/IN 5-fluorouracil/NN +/NN //NN -/NN leucovorin/NN as/IN maintenance/NN chemotherapy/CD ./CD RESULTS/CD :/: Thirty/CD males/NNS and/CC 21/CD females/NNS with/IN a/DT median/JJ age/NN of/IN 55/CD years/NNS (/( range/NN 31--73/JJ years/NNS )/SYM were/VBD treated/VBN ./.
@@10967413798 Epididymal/JJ growth/NN was/VBD retarded/VBN in/IN animals/NNS maintained/VBN solely/RB on/IN chickpea/NN haulm/NN and/CC improved/VBN with/IN supplementation/NN ./.
@@71835761998 The/DT mean/RB extracted/VBN concentration/NN of/IN flucloxacillin/NN obtained/VBN at/IN operation/NN was/VBD 12/CD ./CD 9/CD micrograms/NN //NN ml/NN (/( SD/NN 5/NN ./NN 25/NN )/SYM in/IN synovial/JJ fluid/NN ;/: 2/CD ./CD 9/CD micrograms/NN //NN g/NN (/( SD/NN 3/NN ./NN 59/NN )/SYM in/IN synovium/NN ;/: 2/CD ./CD 0/CD micrograms/NN //NN g/NN (/( SD/NN 1/NN ./NN 48/NN )/SYM in/IN cancellous/JJ bone/NN and/CC 1/CD ./CD 3/CD micrograms/NN //NN g/NN (/( SD/NN 1/NN ./NN 25/NN )/SYM in/IN cortical/JJ bone/NN ./.
@@84132743160 MDBP/NEWGENE from/IN HeLa/DT and/CC Raji/IN cells/NNS formed/VBD DNA-protein/NN complexes/NNS with/IN X-box/NN oligonucleotides/NN that/WDT coelectrophoresed/VBD with/IN those/DT containing/JJ standard/JJ MDBP/NEWGENE sites/NEWGENE ./.
@@93432085662 Interestingly/RB ,/, segment/NN nesting/JJ differentially/RB increases/VBZ the/DT copy/NN number/NN of/IN genes/NNS encoded/VBN by/IN segment/NN W/NN ,/, suggesting/VBG that/IN the/DT unusual/JJ genomic/JJ organization/NN of/IN PDVs/NNP may/MD be/VB directly/RB linked/JJ to/IN the/DT unique/JJ functions/NNS of/IN this/DT virus/NN in/IN its/PRP obligate/JJ mutualistic/JJ association/NN with/IN parasitic/JJ wasps/NNS ./.
@@107381393792 Molecular/NNP mimicry/NN of/IN human/JJ cytokine/NN and/CC cytokine/NN response/NN pathway/NN genes/NN by/IN KSHV/NN ./.
@@10652800468 The/DT insulin/NEWGENE therapy/NN regimen/NN did/VBD not/RB affect/VB the/DT evolution/NN of/IN the/DT patients/NNS and/CC no/DT significant/JJ relationship/NN existed/VBN between/IN the/DT age/NN at/IN diagnosis/NN ,/, duration/NN of/IN diabetes/NN ,/, daily/JJ insulin/NEWGENE dosage/NN or/CC metabolic/JJ control/NN and/CC height/NN or/CC BMI/NN ./.
@@16312292226 Cutis/NNP aplasia/NN ./.
@@22360027819 As/IN in/IN mammals/NNS ,/, considerable/JJ nucleotide/NN diversity/NN was/VBD observed/VBN at/IN the/DT junctions/NNS of/IN the/DT variable/NN ,/, diversity/NN ,/, and/CC joining/VBG elements/NNS in/IN chicken/NEWGENE TCR/NEWGENE beta/NEWGENE cDNAs/NEWGENE ./.
@@18406072907 Two/CD alternatively/RB spliced/VBN 5'/CD UTRs/NNS ,/, designated/VBN type/NN I/NN and/CC type/NN II/NN ,/, of/IN 222/CD and/CC 115/CD bp/NN ,/, respectively/RB ,/, were/VBD found/VBN associated/VBN with/IN PFP/NEWGENE ./.
@@89954106982 Our/PRP data/NN ,/, combined/JJ with/IN those/DT of/IN Hershey/NNP and/CC co-workers/NNS ,/, suggest/VB that/IN mammalian/NEWGENE eIF3/NEWGENE is/VBZ composed/VBN of/IN at/IN least/RB 10/CD subunits/NNS :/: p170/NEWGENE ,/, p116/NEWGENE (/( hPrt1/NEWGENE )/SYM ,/, p110/NEWGENE ,/, p66/NEWGENE ,/, p48/NEWGENE ,/, p47/NEWGENE ,/, p44/NEWGENE ,/, p40/NEWGENE ,/, p36/NEWGENE ,/, and/CC p35/NEWGENE ./.
@@14213902042 A/DT controlled/VBN trial/NN of/IN recombinant/NEWGENE human/NEWGENE granulocyte-macrophage/NEWGENE colony-stimulating/NEWGENE factor/NEWGENE after/IN total/JJ body/NN irradiation/NN ,/, high-dose/JJ chemotherapy/NN ,/, and/CC autologous/JJ bone/NN marrow/NN transplantation/NN for/IN acute/JJ lymphoblastic/JJ leukemia/NN or/CC malignant/JJ lymphoma/NN ./.
@@36941024358 The/DT development/NN of/IN a/DT data/NN base/NN is/VBZ described/VBN which/WDT can/MD be/VB used/VBN as/IN common/JJ reference/NN for/IN ECG/NN computer/NN programs/NNS analyzing/VBG 12/CD or/CC 15/CD simultaneously/RB recorded/VBN leads/VBP ./.
@@12610051896 However/RB ,/, we/PRP did/VBD detect/VB lot-to-lot/JJ variation/NN and/CC differences/NNS in/IN performance/NN between/IN narrow/JJ bandpass/NN and/CC wide/JJ bandpass/NN spectrophotometers/NNS ./.
@@73939768376 The/DT ability/NN of/IN sodium/NN phenobarbital/NN (/( 60/CD mg/CD //CD kg/CD )/SYM and/CC sodium/NN barbital/NN (/( 80/CD mg/NN //NN kg/NN )/SYM to/IN produce/NN a/DT taste/NN aversion/NN in/IN 23/CD hr/NN fluid/NN deprived/VBD rats/NNS was/VBD examined/VBN using/VBG a/DT discrimination/NN or/CC two/JJ bottle/NN taste/NN aversion/NN task/NN (/( 0/CD ./CD 125%/CD sodium/NN saccharin/NN solution/NN or/CC water/NN )/SYM ./.
@@59827005854 Study/NNP on/IN the/DT evagination/NN of/IN Cysticercus/NN pisiformis/NN ./.
@@93036353630 Gaucher's/NN disease/NN is/VBZ a/DT rare/JJ metabolic/JJ disorder/NN characterized/VBN by/IN the/DT lack/NN of/IN beta-glucocerebrosidase/NEWGENE enzyme/NEWGENE ./.
@@78636191899 In/NN order/NN to/IN infer/VB shape/NN from/IN contour/NN ,/, the/DT human/NN visual/NN system/NN must/MD selectively/RB integrate/VB fragments/NNS projecting/VBG from/IN a/DT common/JJ object/NN while/CC keeping/VBG fragments/NNS from/IN different/JJ objects/NNS separate/JJ ./.
@@74384827318 Simultaneous/JJ right/NN and/CC left/NN adrenal/JJ and/CC peripheral/JJ blood/NN samples/NNS were/VBD collected/VBN for/IN determination/NN of/IN oestrone/NN (/( E1/NN )/SYM and/CC oestradiol/NN (/( E2/NN )/SYM ./.
@@89011357723 The/DT NIT2/NEWGENE protein/NEWGENE is/VBZ localised/VBN in/IN nuclei/NNS and/CC could/MD not/RB be/VB detected/VBN in/IN the/DT cytoplasmic/JJ fraction/NN of/IN cells/NNS subjected/VBN to/IN nitrogen/NN derepression/NN or/CC nitrogen/NN repression/NN ,/, indicating/VBG that/IN the/DT nuclear/JJ import/NN of/IN NIT2/NEWGENE is/VBZ not/RB regulated/VBN ./.
@@11689087890 Prostaglandins/NNS F/NN (/( PGF/NN )/SYM were/VBD measured/VBN in/IN uterine/NN vein/NN ,/, ovarian/JJ artery/NN ,/, and/CC jugular/JJ vein/NN plasma/NN and/CC in/IN the/DT endometrial/JJ tissues/NNS at/IN various/JJ times/NNS during/IN the/DT bovine/JJ estrous/JJ cycle/NN ,/, and/CC were/VBD compared/VBN to/IN peripheral/JJ plasma/NN progesterone/NN levels/NNS ./.
@@107964868172 SELECTION/NN CRITERIA/NNP :/: Randomised/JJ trials/NNS comparing/VBG children/NNS undergoing/VBG systematic/JJ therapy/NN focusing/NN on/IN the/DT family/NN in/IN conjunction/NN with/IN asthma/NN medication/NN ,/, with/IN children/NNS taking/VBG asthma/NN medication/NN only/RB ./.
@@100950599558 All/DT numbers/NNS refer/VBP to/IN nucleotide/NN positions/NNS on/IN the/DT wild-type/NN HIV-1/NN transcript/NN ./.
@@111394732940 Promoter/NNS analysis/NN demonstrated/VBN that/IN the/DT sequence/NN identical/JJ to/IN consensus/NEWGENE cAMP-responsive/NEWGENE element/NEWGENE (/( CRE/NEWGENE )/SYM located/VBN at/IN -481/CD of/IN the/DT SMemb/NEWGENE promoter/NEWGENE was/VBD critical/JJ for/IN Hex/NEWGENE responsiveness/NN ./.
@@109553139921 PLUS-3/NN is/VBZ a/DT new/JJ Swedish/JJ protocol/NN of/IN natural/JJ speech/NN in/IN 3-year-old/CD children/NNS ./.
@@97317049489 Transfection/NNS of/IN increasing/JJ amounts/NNS of/IN delta5ERalpha/NEWGENE expression/NN vector/NN into/IN [/NN ERalpha+/NN ]/NN OS/NN cells/NNS resulted/VBN in/IN potentiation/NN of/IN E2-stimulated/NNP ERELuc/NEWGENE activity/NN in/IN a/DT synergistic/JJ ,/, dose-dependent/NN manner/NN ./.
@@57980636112 Specialist/NNP in/IN family/NN practice--prototype/NN of/IN a/DT doctor/NN ./.
@@55013475575 The/DT effect/NN of/IN low/JJ dosage/NN radiation/NN on/IN metabolism/NN and/CC function/NN of/IN the/DT rat/NN kidney/NN damaged/VBN by/IN ischemia/NN ./.
@@2293664100 By/IN introducing/JJ a/DT series/NN of/IN deletions/NNS in/IN the/DT vimentin/NEWGENE promoter/NN ,/, we/PRP further/RB restrict/VBP these/DT sequences/NNS to/IN 30/CD base/JJ pairs/NNS ,/, located/VBN between/IN 241/CD and/CC 210/CD base/NN pairs/NNS upstream/RB of/IN the/DT mRNA/NN cap/NN site/NN ./.
@@110852673264 Transformation/NNS of/IN the/DT sconC3/NEWGENE mutant/NEWGENE with/IN sconB+/NEWGENE restores/VBZ the/DT wild-type/NN phenotype/NN ./.
@@7862092222 We/PRP have/VBP attempted/VBN to/IN clone/NN two/JJ recessive/JJ extragenic/JJ suppressors/NNS of/IN such/JJ ts/NN mutants/NN (/( sdp1/NN for/IN mutation/NEWGENE pol3-14/NEWGENE and/CC sdp5-1/NN for/IN mutation/NEWGENE pol3-11/NEWGENE )/SYM by/IN transforming/JJ thermoresistant/JJ haploid/JJ strains/NNS pol3-14/NEWGENE sdp1/NEWGENE and/CC pol3-11/NEWGENE sdp5-1/NEWGENE with/IN wild-type/JJ genomic/JJ libraries/NNS in/IN singlecopy/NN or/CC multicopy/JJ vectors/NNS ./.
@@91888636119 Alternative/JJ splicing/JJ of/IN CDC25B/NEWGENE may/MD therefore/RB contribute/VB to/IN the/DT control/NN of/IN cell/NN proliferation/NN ./.
@@106433132131 After/IN i/CD ./CD v/CD ./. administration/NN of/IN 500/CD mg/NN acetazolamide/NN and/CC disinfection/NN of/IN the/DT conjunctiva/NN ,/, 50/CD micrograms/NNS rt-PA/NN in/IN 0/CD ./CD 1/CD ml/NN (/( BSS/IN )/SYM and/CC 0/CD ./CD 5/CD ml/NN SF6/WDT were/VBD injected/VBN intravitreally/RB ./.
@@25523163208 Of/IN 202/CD initially/RB seronegative/JJ caretakers/NNS (/( observed/VBN for/IN an/DT average/NN of/IN 305/CD days/NNS per/IN woman/NN )/SYM ,/, 19/CD seroconverted/VBN ,/, for/IN an/DT annual/JJ seroconversion/NN rate/NN of/IN 11/CD percent/NN ./.
@@24543903434 Enhancer/NNS and/CC promoter/NN elements/NNS directing/VBG activation/NN and/CC glucocorticoid/NN repression/NN of/IN the/DT alpha/NEWGENE 1-fetoprotein/NEWGENE gene/NEWGENE in/IN hepatocytes/NNS ./.
@@26573883168 The/DT terminator/NN region/NN supported/VBD termination/NN of/IN transcripts/NNS initiated/VBN by/IN RNA/NEWGENE polymerase/NEWGENE I/NEWGENE in/IN vivo/NN ./.
@@84972592793 The/DT level/NN of/IN the/DT SUP4A53T61/NEWGENE transcript/NEWGENE was/VBD threefold/RB higher/JJ in/IN the/DT tap1-1/NEWGENE mutant/NEWGENE than/IN in/IN the/DT wild/JJ type/NN ./.
@@86026086333 However/RB ,/, for/IN the/DT evaluable/JJ cases/NNS ,/, the/DT performances/NNS of/IN the/DT CD3500/NN and/CC the/DT STKS/NN were/VBD broadly/RB similar/JJ and/CC generally/RB correlated/VBN well/VB with/IN the/DT manual/JJ reference/NN procedure/NN ./.
@@71621466980 The/DT application/NN of/IN ultrafiltration/NN to/IN sample/NN preparation/NN in/IN the/DT detection/NN and/CC quantification/NN of/IN ethylene/NN glycol/NN in/IN plasma/NN by/IN gas/NN chromatography/NN is/VBZ described/VBN ./.
@@47640495145 Familial/JJ juvenile/JJ nephronophthisis/NN ./.
@@70881951009 A/DT note/NN on/IN some/DT consequences/NNS of/IN UV/NN vision/NN in/IN birds/NNS ./.
@@112792176256 Biol/NNP ./.
@@29347783642 The/DT data/NN indicates/VBZ the/DT presence/NN of/IN 5-HT2/NEWGENE serotonergic/NEWGENE receptors/NEWGENE in/IN the/DT bronchial/JJ artery/NN of/IN these/DT species/NN ./.
@@8719156438 There/EX are/VBP no/DT introns/NNS within/IN the/DT gene/NN ,/, which/WDT contains/VBZ a/DT 9360-bp/CD open/JJ reading/JJ frame/NN and/CC encodes/VBZ a/DT 377-kDa/NN protein/NN ./.
@@74632943314 At/NN 4/CD wk/NN however/RB ,/, tumor/NN relapse/NN was/VBD noted/VBN in/IN 6/CD of/IN 7/NN group/NN 4/NN responders/NNS ,/, 10/CD of/IN 12/CD in/IN group/NN 5/CD ,/, 13/CD of/IN 16/CD in/IN group/NN 7/CD ,/, but/CC only/RB 4/CD of/IN 19/NN group/NN 8/NN responders/NNS (/( p/NN less/PRP than/IN ./NN 001/NN group/NN 8/NN versus/IN 4/CD ,/, 5/CD ,/, 7/CD )/SYM ./SYM
@@108710454831 This/DT study/NN shows/VBZ that/IN C/NEWGENE //NEWGENE EBPbeta/NEWGENE is/VBZ the/DT predominant/JJ C/NEWGENE //NEWGENE EBP/NEWGENE isoform/NEWGENE found/VB in/IN activated/VBN stellate/JJ cells/NNS and/CC that/DT increased/VBD C/NEWGENE //NEWGENE EBPbeta/NEWGENE protein/NEWGENE and/CC C/NEWGENE //NEWGENE EBPbeta/NEWGENE binding/JJ to/IN a/DT proximal/JJ C/NEWGENE //NEWGENE EBP/NEWGENE binding/NEWGENE site/NEWGENE in/IN the/DT promoter/NN mediates/VBZ the/DT activating/JJ effect/NN of/IN acetaldehyde/NN ./.
@@118878036066 The/DT mean/JJ thickness/NN of/IN the/DT visceral/JJ peritoneum/NN was/VBD comparable/JJ in/IN both/DT groups/NNS of/IN animals/NNS ,/, but/CC ,/, macroscopically/RB ,/, more/RB severe/JJ fibrosis/NN was/VBD found/VBN in/IN the/DT peritoneum/NN of/IN rats/NNS exposed/VBN to/IN CAPD/NN 3/NN as/IN compared/VBN with/IN animals/NNS treated/VBN with/IN CAPD/NN 3/NN Balance/NNP (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@15528537129 Hence/RB temperature/NN and/CC virF/NEWGENE are/VBP both/DT required/VBN for/IN the/DT induction/NN of/IN the/DT yop/NEWGENE regulon/NEWGENE ./.
@@109381139127 However/RB ,/, it/PRP is/VBZ not/RB known/VBP whether/IN the/DT recently/RB identified/VBN isoforms/NN Vav2/NEWGENE and/CC Vav3/NEWGENE ,/, which/WDT are/VBP broadly/RB expressed/VBN ,/, can/MD couple/VB with/IN similar/JJ classes/NNS of/IN receptors/NNS ,/, nor/CC is/VBZ it/PRP known/VBP whether/IN all/DT Vav/NEWGENE isoforms/NEWGENE possess/VBP identical/JJ functional/JJ activities/NNS ./.
@@35610364228 Lymphatics/NNS in/IN the/DT aorta/NN of/IN rats/NNS treated/VBN with/IN a/DT soy-bean/JJ oil/NN extract/NN (/( lipofundin/NN )/SYM ./.
@@10940892742 Two/CD distinct/JJ recessive/JJ susceptibility/NN loci/NNS for/IN vasculitis/NN were/VBD mapped/VBN on/IN chromosome/NN (/( Chr/NN )/SYM 4/CD at/IN D4Mit89/NEWGENE and/CC D4Mit147/NEWGENE in/IN both/DT progenies/NNS ./.
@@8382300529 These/DT cell/NN lines/NNS ,/, selected/VBN for/IN the/DT ability/NN to/IN support/NN the/DT replication/NN of/IN a/DT temperature-sensitive/JJ VP5/NEWGENE mutant/NEWGENE ,/, were/VBD used/VBN to/IN isolate/NN VP5/NEWGENE and/CC VP23/NEWGENE null/JJ mutants/NNS ./.
@@65397389086 The/DT toxicological/JJ evaluation/NN of/IN chlorofluorocarbon/NN 22/CD (/( CFC/NN 22/NN )/SYM ./.
@@18174972425 Resolution/NNP of/IN thermographic/JJ asymmetry/NN and/DT //DT or/DT decrease/NN in/IN Delta/NN T/NN was/VBD demonstrated/VBN in/IN approximately/JJ 81%/NN of/IN the/DT post-treatment/JJ population/NN ./.
@@12625961898 The/DT cochlear/JJ compromise/NN ./.
@@92644662739 The/DT Cut9/NEWGENE subunit/NEWGENE is/VBZ likely/RB to/IN be/VB a/DT target/NN for/IN regulating/JJ APC/NEWGENE //NEWGENE cyclosome/NEWGENE function/NN through/RB protein-protein/JJ interactions/NNS and/CC phosphorylation/NN ./.
@@10205933141 Bacteria/NNS can/MD also/RB cause/VB a/DT labyrinthitis/NN acting/JJ directly/RB on/IN the/DT inner/JJ ear/NN :/: among/IN these/DT ,/, Treponemas/NNP Pallidum/NNP ,/, a/DT spirochaete/NN which/WDT causes/NNS syphilis/NN and/CC Borrelia/NNP Burgdorferi/NNP ,/, a/DT spirochaete/NN that/IN causes/NNS Lyme/NNP Disease/NNP ,/, must/MD be/VB mentioned/VBN ./.
@@26932084141 We/PRP have/VBP examined/VBN the/DT role/NN of/IN two/JJ recombination-/JJ and/CC repair-defective/JJ mutations/NNS ,/, rad1/NEWGENE and/CC rad52/NEWGENE ,/, on/IN direct/JJ repeat/NN recombination/NN in/IN transcriptionally/RB active/JJ and/CC inactive/JJ sequences/NNS ./.
@@36192492394 The/DT following/NN markers/NNS were/VBD looked/VBN for/IN in/IN the/DT serum/NN ,/, skin/NN and/CC liver/NN of/IN all/DT patients/NNS with/IN chronic/JJ hepatitis/NN :/: HBV/NN (/( HBs/NN Ag/NN and/CC HBe/NN Ag/NN ,/, anti-HBs/NEWGENE ,/, anti-HBe/NEWGENE and/CC anti-HBc/NEWGENE in/IN the/DT serum/NN ,/, HBs/NNS and/CC HBc/NN Ag/NN in/IN the/DT liver/NN )/SYM ;/: non-A/JJ non-B/NN (/( non-A/NN ,/, non-B/NN Ag/NN and/CC antibody/NN ,/, anti/NEWGENE non-A/NEWGENE non-Bc/NEWGENE in/IN the/DT serum/NN ,/, non-A/JJ ,/, non-Bc/JJ Ag/NN in/IN the/DT liver/NN )/SYM ./.
@@88206427954 The/DT harpin-encoding/JJ hrpZ/NEWGENE gene/NEWGENE is/VBZ located/VBN in/IN an/DT operon/NN that/WDT also/RB encodes/VBZ Hrp/NEWGENE secretion/NEWGENE pathway/NEWGENE components/NEWGENE and/CC is/VBZ part/NN of/IN the/DT functional/JJ cluster/NN of/IN hrp/NEWGENE genes/NEWGENE carried/VBN on/IN cosmid/NN pHIR11/NN that/WDT enables/VBZ saprophytic/JJ bacteria/NNS like/JJ Escherichia/NN coli/JJ and/CC Pseudomonas/NNS fluorescens/NNS to/IN elicit/VB the/DT HR/NN in/IN tobacco/NN leaves/NNS ./.
@@42479661847 Lactation/NN of/IN baboons/NNS fed/VBD a/DT low/JJ protein/NN maintenance/NN diet/NN ./.
@@86244458332 We/PRP present/VBP here/RB a/DT detailed/JJ genomic/JJ sequencing/VBG analysis/NN of/IN the/DT cytosine/NN methylation/NN patterns/NNS of/IN the/DT transposase/NN binding/NN sites/NN within/IN both/DT Ac/NEWGENE ends/NNS in/IN the/DT wx-m9/NEWGENE :/: :/: Ac/NEWGENE allele/NEWGENE ,/, where/CC Ac/NEWGENE is/VBZ inserted/VBN into/IN the/DT tenth/JJ exon/NN of/IN the/DT Waxy/NEWGENE gene/NEWGENE ./.
@@70846176867 During/IN an/DT 8-wk/JJ follow-up/NN ,/, parasites/NNS reappeared/VBN in/IN 10/CD patients/NNS ,/, 5/CD after/IN each/DT drug/NN ,/, between/IN 1/CD and/CC 7/CD wk/NN after/IN treatment/NN ./.
@@111685887391 Expression/NNS of/IN herpes/NEWGENE simplex/NEWGENE virus/NEWGENE type/NEWGENE 2/NEWGENE US3/NEWGENE affects/VBP the/DT Cdc42/NEWGENE //NEWGENE Rac/NEWGENE pathway/NN and/CC attenuates/VBZ c-Jun/NEWGENE N-terminal/NEWGENE kinase/NEWGENE activation/NN ./.
@@91434659385 Pure/NNP T1/NN and/CC dual-T1/NN images/NNS were/VBD visually/RB evaluated/VBN for/IN image/NN quality/NN (/( IQ/NN )/SYM on/IN a/DT five-point/JJ scale/NN (/( 0/CD =/SYM unacceptable/JJ to/IN 4/CD =/SYM excellent/JJ )/SYM ./.
@@56213391657 Changing/VBG and/CC predicting/JJ doses/NNS of/IN Cs137/NN irradiation/NN ./.
@@183011499 Thus/RB ,/, the/DT positive/JJ effect/NN of/IN NS1/NEWGENE on/IN the/DT steady-state/JJ levels/NNS of/IN P4/NEWGENE transcripts/NEWGENE depends/VBZ on/IN the/DT amplification/NN of/IN gene/NN copy/NN number/NN and/CC the/DT integrity/NN of/IN the/DT terminal/JJ repeats/NNS ./.
@@74987276675 However/RB ,/, the/DT requirement/NN of/IN rev3/NEWGENE for/IN the/DT production/NN of/IN G/NNP ./NNP C--/NNP >/NNP T/NNP ./NNP A/NNP transversions/NNS by/IN the/DT rad18/NEWGENE mutator/NEWGENE ,/, which/WDT induces/VBZ only/RB these/DT substitutions/NNS ,/, was/VBD similar/JJ to/IN that/DT for/IN rad6-mediated/NNP G/NNP ./NNP C--/NNP >/NNP T/NNP ./NNP A/NNP transversion/NN ./.
@@106494561140 All/DT clones/NNS and/CC strains/NNS produced/VBN have/VB been/VBN deposited/VBN in/IN the/DT EUROFAN/NNP genetic/JJ stock/NN centre/NN (/( EUROSCARF/NN ,/, Frankfurt/NN )/SYM ./.
@@111578792047 METHODS/IN :/: The/DT passive/JJ and/CC active/JJ transport/NN of/IN fluorescein/NN through/RB the/DT BRB/NN was/VBD quantitated/VBN by/IN vitreous/JJ fluorometry/NN ./.
@@93003239776 As/IN a/DT result/NN ,/, the/DT subendocardial/JJ //JJ subepicardial/JJ blood/NN flow/NN ratio/NN (/( ENDO/NNP //NNP EPI/NNP )/SYM increased/VBN from/IN 0/CD ./CD 44/CD +/NN //NN -/NN 0/CD ./CD 09/CD during/IN control/NN stenosis/NN to/IN 0/CD ./CD 85/CD +/NN //NN -/NN 0/CD ./CD 13/CD after/IN ITF/NN 1129/CD (/( 10/CD micrograms/NN //NN kg/NN //NN min/NN i/CD ./CD v/CD ./CD )/SYM and/CC to/IN 0/CD ./CD 81/CD +/NN //NN -/NN 0/CD ./CD 12/CD after/IN NTG/NNP ./.
@@95103989474 The/DT risk/NN factors/NNS for/IN hematuria/NN in/IN patients/NNS with/IN renal/JJ hypouricemia/NN are/VBP the/DT elevation/NN of/IN urinary/JJ urate/NN concentration/NN and/CC the/DT subtypes/NNS of/IN Post/NNP and/CC Secretion/NN ./.
@@1002991720 Results/NNS demonstrated/VBN that/IN the/DT presence/NN of/IN myofibroblasts/NNS varied/VBN considerably/RB from/IN case/NN to/IN case/NN and/CC was/VBD always/RB related/VBN to/IN smooth/JJ muscle/NN cell/NN dispersion/NN ,/, which/WDT occurred/VBD around/IN medium-sized/JJ damaged/VBN portal/JJ vein/NN branches/NNS ./.
@@105666303771 Serum/NEWGENE insulin-like/NEWGENE growth/NEWGENE factor/NEWGENE I/NEWGENE (/( IGF-I/NEWGENE )/SYM SD/NN score/NN increased/VBN from/IN -2/CD ./CD 2/CD and/CC -4/CD ./CD 2/CD in/IN men/NNS and/CC women/NNS ,/, respectively/RB ,/, to/IN 1/CD ./CD 8/CD and/CC -0/CD ./CD 9/CD at/IN 6/CD months/NNS and/CC 0/CD ./CD 8/CD and/CC -0/CD ./CD 7/CD at/IN 12/CD months/NNS ./.
@@24247435182 The/DT N1/NN and/CC P2/NN were/VBD comparable/JJ in/IN amplitude/NN and/CC both/DT had/VBP prolonged/JJ refractory/JJ periods/NNS ./.
@@75118183398 These/DT human/JJ IFN-beta-transformed/JJ cell/NN populations/NNS have/VBP acquired/VBN a/DT low/NN ,/, constitutive/JJ production/NN of/IN human/NEWGENE IFN/NEWGENE ,/, while/CC replicating/JJ at/IN a/DT rate/NN similar/JJ to/IN that/DT of/IN untransformed/JJ cells/NNS and/CC of/IN cells/NNS transformed/VBN with/IN the/DT control/NN vector/NN carrying/JJ a/DT human/NEWGENE IFN-beta/NEWGENE sequence/NEWGENE encoding/VBG an/DT inactive/JJ ,/, mutated/NN protein/NN ./.
@@863138597 Thirty-five/CD strains/NNS of/IN Legionnaires'/NNP disease/NN bacteria/NNS were/VBD shown/VBP to/IN belong/VB in/IN four/CD distinct/JJ serologic/JJ groups/NNS on/IN the/DT basis/NN of/IN findings/NNS obtained/VBN with/IN direct/JJ fluorescent/JJ antibody/NN testing/NN ./.
@@39084934559 An/DT additional/JJ advantage/NN is/VBZ that/IN the/DT resin/NN can/MD be/VB removed/VBN and/CC the/DT immunoperoxidase/NN technique/NN carried/VBN out/RB on/IN thin/JJ sections/NNS ./.
@@94283892042 CONCLUSIONS/IN :/: A/DT 50-mg/JJ daily/JJ dose/NN of/IN bicalutamide/NN is/VBZ sufficient/JJ when/CC given/VBP in/IN combination/NN with/IN an/DT agent/NN ,/, such/JJ as/IN a/DT LHRH-A/NN ,/, that/WDT lowers/VBP serum/JJ testosterone/NN ,/, but/CC higher/JJ doses/NNS of/IN bicalutamide/NN may/MD be/VB needed/VBN when/CC the/DT drug/NN is/NNS given/VBP as/IN monotherapy/NN ./.
@@23241041185 The/DT alternative/JJ exon/NN introduces/VBZ the/DT novel/JJ carboxyl/NN terminus/NN and/CC a/DT new/JJ translation/NN stop/NN signal/JJ ,/, while/CC simultaneously/RB converting/JJ the/DT coding/JJ sequence/NN for/IN 40/CD carboxyl-terminal/NN residues/NNS in/IN CeCAT/NEWGENE alpha/NEWGENE into/IN 3'-untranslated/JJ nucleotides/NNS ./.
@@41527254822 Studies/NNS on/IN alcoholic/JJ liver/NN injury/NN ./.
@@10360454221 However/RB ,/, the/DT serum/NEWGENE TNF-a/NEWGENE concentration/NN decreased/VBN significantly/RB in/IN patients/NNS receiving/JJ pentoxifylline/NN (/( basal/JJ 623+/JJ //JJ -366/JJ pg/NN //NN ml/NN ;/: 6th/CD month/NN 562+/JJ //JJ -358/JJ pg/NN //NN ml/NN ,/, p/NN </SYM 0/CD ./CD 01/CD )/SYM ,/, but/CC not/RB in/IN the/DT control/NN group/NN ./.
@@23552933013 While/IN no/DT significant/JJ differences/NNS in/IN the/DT tensile/JJ responses/NNS or/CC failure/NN characteristics/NNS were/VBD noted/VBN for/IN irradiated/JJ and/CC nonirradiated/JJ grafts/NNS in/IN the/DT drip/NN ,/, in/IN the/DT bath/NN environment/NN the/DT nonirradiated/JJ tissues/NNS had/VBP greater/JJR strength/NN and/CC modulus/NN ./.
@@49483251821 Isolation/NNS of/IN Proteus/NN vulgaris/NN MC-63/NN from/IN carcinoma/NN 63/NN and/CC its/PRP antitumor/JJ effect/NN on/IN Crocker/NN sarcoma/NN 180/NN and/CC Ehrlich/NN carcinoma/NN ./.
@@111087205153 Pretreatment/NNS of/IN cells/NNS with/IN the/DT mitogen-activated/NEWGENE protein-extracellular/NEWGENE signal-regulated/NEWGENE kinase/NEWGENE kinase/NEWGENE (/( MEK/NEWGENE )/SYM inhibitor/NN U0126/NN inhibited/VBD S6K2/NEWGENE activation/NN to/IN a/DT greater/JJR extent/NN than/IN S6K1/NEWGENE ./.
@@21734052783 No/DT symptomatic/JJ abnormality/NN has/VBZ been/VBN noted/VBN in/IN the/DT neonatal/JJ period/NN except/VB periventricular/JJ calcifications/NNS ./.
@@10939030760 The/DT differences/NNS were/VBD as/IN follows/VBZ :/: for/IN overall/JJ response/NN rate/NN p/NN =/SYM 0/CD ./CD 004/CD ;/: power/NN (/( for/IN p/NN =/SYM 0/CD ./CD 05/CD )/SYM 85%/JJ ;/: for/IN survival/NN p/NN =/SYM 0/CD ./CD 09/CD ;/: for/IN grade/NN IV/NN granulocytopenia/NN p/NN =/SYM 0/CD ./CD 3/CD ;/: and/CC for/IN febrile/JJ neutropenia/NN p/NN =/SYM 0/CD ./CD 61/CD ./.
@@35408534618 The/DT N-terminal/NN amino/JJ acid/NN sequence/NN of/IN Mop/NEWGENE has/VBZ sequence/NN homology/NN with/IN DNA/NN binding/JJ proteins/NNS ./.
@@95655767102 A/DT catalytic/JJ domain/NN of/IN eukaryotic/NEWGENE DNA/NEWGENE topoisomerase/NEWGENE I/NNP ./NNP
@@113472011195 Nutritional/NNP status/NN in/IN adults/NNS on/IN an/DT alternative/JJ or/CC traditional/JJ diet/NN BACKGROUND/IN :/: Plant/NNP food/NN lacks/VBZ vitamin/NN B12/NN ,/, vitamin/NN D/NN and/CC higher/JJ n-3/CD polyunsaturated/JJ fatty/JJ acids/NNS ./.
@@29255687776 Thus/RB ,/, the/DT effects/NNS of/IN father/NN absence/NN under/IN routine/JJ conditions/NNS in/IN relatively/JJ healthy/JJ samples/NNS may/MD exert/VB no/DT significant/JJ effects/NNS independent/NN of/IN intervening/JJ family/NN stressors/NN or/CC maternal/JJ psychopathology/NN ./.
@@22743432923 Common/NNP foot/JJ pathologies/NNS are/VBP heel/NN pain/NN ,/, metatarsalgia/NN ,/, hammertoes/NNS and/CC clawtoes/NNS ,/, bunions/NNS ,/, hallux/NN rigidus/NN ,/, corns/NNS and/CC calluses/NNS ,/, nail/NN pathologies/NNS ,/, arthritis/NN ,/, and/CC neuropathies/NNS ./.
@@109319278704 Using/VBG an/DT oligomer/NN duplex/JJ 5'-A/NEWGENE (/NEWGENE GGGTTA/NEWGENE )/NEWGENE (/NEWGENE 5/NEWGENE )/NEWGENE -3'/NEWGENE //NEWGENE 5'-/NEWGENE (/NEWGENE TAACCC/NEWGENE )/NEWGENE (/NEWGENE 5/NEWGENE )/NEWGENE T-3'/NEWGENE as/IN a/DT template-primer/NN ,/, we/PRP show/VBP that/IN both/PDT the/DT Klenow/NEWGENE fragment/NEWGENE of/NEWGENE Escherichia/NEWGENE coli/NEWGENE DNA/NEWGENE polymerase/NEWGENE I/NEWGENE and/CC HIV/NEWGENE reverse/NEWGENE transcriptase/NEWGENE could/MD expand/VB telomere/NN DNA/NN sequences/NNS as/IN well/NN ,/, giving/JJ products/NNS greater/JJR than/IN the/DT size/NN of/IN the/DT template/NN DNA/NN ./.
@@78470367823 VIII/NNP in/IN doses/NNS 2-3/CD times/NNS higher/JJ than/IN usually/RB used/VBN in/IN haemophiliacs/NNS without/IN inhibitor/NN were/VBD successful/JJ ./.
@@80207028016 Endotoxemia/NN induced/VBN by/IN gram-negative/JJ bacteria/NNS leads/VBP to/IN endotoxic/JJ shock/NN pathogenetically/RB stemming/VBG from/IN the/DT integral/JJ component/NN of/IN the/DT bacterial/JJ wall--lipid/NNP A/NNP ./NNP
@@88398328031 Constitutive/JJ phosphorylation/NN of/IN the/DT CD30v/NEWGENE protein/NEWGENE was/VBD demonstrated/VBN by/IN in/IN vitro/FW labeling/VBG with/IN [/NN 32P/NN ]/NN ./.
@@111941017048 Baseline/NN BMD/NN values/NNS were/VBD significantly/RB lower/JJR in/IN the/DT oligo-amenorrheic/JJ group/NN than/IN in/IN the/DT two/JJ others/NNS at/IN the/DT level/NN of/IN lumbar/JJ spine/NN (/( anteroposterior/NN view/NN :/: 0/CD ./CD 941+/CD //CD -0/CD ./CD 039/CD in/IN oligo-amenorrheic/NNP vs/NNP 1/CD ./CD 077+/CD //CD -0/CD ./CD 029/CD or/CC 1/CD ./CD 051/CD +/CD //CD -0/CD ./CD 017/CD g/NN x/NN cm/NN (/NN -2/NN )/SYM ,/, P/NN </SYM 0/CD ./CD 005/CD ,/, in/IN the/DT eumenorrheic/JJ and/CC contraceptive/JJ user/NN groups/NNS ,/, respectively/NN )/NN but/CC not/RB in/IN weight-bearing/NN bone/NN such/JJ as/IN proximal/JJ and/CC midshaft/NN femur/NN ./.
@@64028591650 Antithrombin/NEWGENE III/NEWGENE (/( AT/NEWGENE III/NEWGENE )/SYM is/VBZ a/DT plasma/NN protein/NN which/WDT acts/NNS as/IN the/DT principal/JJ inhibitor/NN of/IN thrombin/NEWGENE and/CC is/VBZ a/DT major/JJ modulator/NN of/IN intravascular/JJ coagulation/NN ./.
@@61090171305 The/DT effects/NNS of/IN cardioselective/JJ beta-1/NN adrenergic/JJ agonist/NN ,/, 1-/NN (/NN 4-hydroxyphenoxy/NN )/NN -isopropylamino-2-propanol/NN )/NN ,/, i/FW ./FW e/FW ./FW ,/, prenalterol/NN ,/, were/VBD examined/VBN on/IN direct/JJ and/CC continuous/JJ measurements/NNS of/IN left/NN ventricular/JJ (/( LV/JJ )/SYM pressure/NN ,/, diameter/NN ,/, dP/NN //NN dt/NN ,/, velocity/NN of/IN shortening/NN ,/, arterial/JJ pressure/NN ,/, iliac/JJ blood/NN flow/NN and/CC heart/NN rate/NN in/IN 10/CD conscious/JJ dogs/NNS ./.
@@94020885688 These/DT defects/NNS no/DT doubt/NN impair/NN the/DT folding/NN and/CC configuration/NN necessary/JJ for/IN normal/JJ processing/NN of/IN the/DT AVP/NEWGENE gene/NEWGENE precursor/NEWGENE ./.
@@112604687792 The/DT results/NNS presented/VBN here/RB show/VB that/IN AR1/NEWGENE of/IN the/DT promoter-proximal/NN CAP/NEWGENE subunit/NEWGENE was/VBD required/VBN for/IN papBA/NEWGENE transcription/NN even/VB in/IN the/DT absence/NN of/IN the/DT histone-like/NEWGENE protein/NEWGENE H-NS/NEWGENE1 ./.
@@113568535524 In/NNP Ka13/NNP cells/NNS ,/, CoCl/NN (/NN 2/NN )/NN stimulated/VBD expression/NN of/IN a/DT luciferase/NEWGENE reporter/NEWGENE gene/NEWGENE under/IN the/DT control/NN of/IN a/DT 15-kilobase/NEWGENE pair/NEWGENE mouse/NEWGENE ho-1/NEWGENE promoter/NEWGENE (/( pHO15luc/NEWGENE )/SYM ./.
@@15695842121 Hybridization/NNS data/NN indicate/VB that/IN 6F6/NEWGENE ./NEWGENE 2/NEWGENE corresponds/VBZ to/IN the/DT previously/RB characterized/VBN m6F6/NEWGENE cDNA/NEWGENE clone/NEWGENE and/CC that/IN 6F6/NEWGENE ./NEWGENE 1/NEWGENE and/CC 6F6/NEWGENE ./NEWGENE 3/NEWGENE ,/, but/CC not/RB 6F6/NEWGENE ./NEWGENE 2/NEWGENE ,/, are/VBP adjacent/JJ to/IN alpha-type/NEWGENE genes/NEWGENE ./.
@@3513989153 Neither/CC ethanol/NN nor/CC estrogen/NN has/VBZ been/VBN shown/VBP to/IN cause/NN UROD-deficiency/NNP in/IN animals/NNS ./.
@@76587777583 The/DT test/NN was/VBD not/RB performed/VBN in/IN 3923/CD patients/NNS because/IN of/IN contraindications/NNS ./.
@@96257623773 The/DT viral/NEWGENE oncoprotein/NEWGENE E1A/NEWGENE inhibits/VBZ NFAT-dependent/NN transactivation/NN in/IN a/DT p300-dependent/JJ manner/NN ./.
@@1935872140 EEG/NN theta/NN waves/NNS and/CC psychological/JJ phenomena/NNS :/: a/DT review/NN and/CC analysis/NN ./.
@@69725016758 Correlation/NNS between/IN intraocular/JJ involvement/NN and/CC systemic/JJ outcome/NN was/VBD poor/JJ ./.
@@55532615591 Health/NNP :/: an/DT integrative/JJ reticulum/NN ./.
@@8132541394 Genomic/NN DNA/NN clones/NNS containing/JJ the/DT T-cell-specific/NEWGENE human/NEWGENE MAL/NEWGENE gene/NEWGENE were/VBD isolated/VBN ./.
@@77379442133 Hematopoietic/NEWGENE growth/NEWGENE factors/NEWGENE have/VBP already/RB had/VBP an/DT enormous/JJ impact/NN on/IN transfusion/NN practice/NN by/IN eliminating/JJ or/CC reducing/JJ the/DT need/NN for/IN red/JJ blood/NN cell/NN transfusions/NNS in/IN a/DT variety/NN of/IN anemic/JJ states/NNS characterized/VBN by/IN an/DT absolute/JJ or/CC relative/JJ decrease/NN in/IN erythropoietin/NEWGENE ./.
@@76086492191 Increased/VBN blood/NN pressure/NN during/IN CyA/NN treatment/NN was/VBD independent/NN of/IN circulating/JJ ET-1/NEWGENE levels/NNS ./.
@@23355217801 An/DT NF1-related/NEWGENE vitellogenin/NEWGENE activator/NEWGENE element/NEWGENE mediates/VBZ transcription/NN from/IN the/DT estrogen-regulated/JJ Xenopus/NEWGENE laevis/NEWGENE vitellogenin/NEWGENE promoter/NEWGENE ./.
@@111338303745 Engagement/NNS of/IN human/NEWGENE CD2/NEWGENE by/IN mitogenic/JJ pairs/NNS of/IN anti-CD2/NEWGENE mAb/NEWGENE induces/VBZ tyrosine/NN phosphorylation/NN of/IN a/DT number/NN of/IN intracellular/JJ proteins/NNS including/JJ a/DT 120/NN kDa/NN phosphoprotein/NN that/IN we/PRP identify/VBP as/IN the/DT proto-oncogene/NEWGENE c-Cbl/NEWGENE ./.
@@107675602559 As/IN an/DT extension/NN of/IN our/PRP structural/JJ characterization/NN of/IN the/DT exon-intron/JJ organization/NN of/IN the/DT mouse/NEWGENE Pkr/NEWGENE gene/NEWGENE ,/, we/PRP now/RB have/VBP isolated/VBN and/CC characterized/VBD the/DT mouse/NEWGENE Pkr/NEWGENE promoter/NEWGENE region/NEWGENE required/VBN for/IN IFN-inducible/NNP transcription/NN ./.
@@107274136055 Therefore/RB the/DT binding/JJ sites/NNS for/IN liver-enriched/JJ factors/NNS ,/, present/VB in/IN the/DT hamster/NEWGENE CYP7A1/NEWGENE proximal/NEWGENE promoter/NEWGENE in/IN close/JJ vicinity/NN and/CC conserved/VBN between/IN species/NN ,/, constitute/VB a/DT regulatory/JJ unit/NN important/JJ for/IN basal/JJ hepatic/JJ expression/NN and/CC tissue/NN restriction/NN of/IN the/DT action/NN of/IN hormones/NNS such/JJ as/IN insulin/NEWGENE ./.
@@9672239639 I/NNP ./NNP
@@83430418316 Although/IN antisperm/NEWGENE antibodies/NEWGENE are/VBP associated/VBN with/IN infertility/NN ,/, many/JJ hospital/NN laboratories/NNS do/VBP not/RB test/VB for/IN these/DT antibodies/NNS ./.
@@114297024654 We/PRP demonstrated/VBD that/IN ,/, under/IN serum-starved/JJ conditions/NNS ,/, KMS-11/NN and/CC OPM-2/CELL cells/NNS express/VBP appreciable/JJ levels/NNS of/IN phosphorylated/VBN FGFR3/NEWGENE mutants/NEWGENE indicating/VBG a/DT constitutive/JJ activation/NN of/IN the/DT Y373C/NEWGENE and/CC K650E/NEWGENE receptors/NEWGENE ;/: the/DT addition/NN of/IN the/DT aFGF/NEWGENE ligand/NEWGENE further/RB increased/VBD the/DT level/NN of/IN receptor/NN phosphorylation/NN ./.
@@41130114799 Is/VBZ desensitization'/NN for/IN ragweed/NN hay/NN fever/NN immunologically/RB specific/JJ ?/.
@@103188593334 Here/RB we/PRP show/VBP that/DT calpeptin/NEWGENE inhibits/VBZ tyrosine/NEWGENE phosphatases/NEWGENE ,/, enhancing/JJ tyrosine/NN phosphorylation/NN particularly/RB of/IN paxillin/NEWGENE ./.
@@88336539743 We/PRP show/VBP here/RB that/IN the/DT LIM/NEWGENE domain/NEWGENE homeobox/NEWGENE1 protein/NEWGENE1 isl-1/NEWGENE activates/VBZ the/DT rat/NEWGENE amylin/NEWGENE promoter/NEWGENE in/IN both/DT fibroblast/NN and/CC islet/NN cell/NN lines/NNS ./.
@@83950049318 The/DT ability/NN of/IN spt2/NEWGENE mutations/NEWGENE to/IN suppress/VB the/DT transcriptional/JJ interference/NN caused/VBN by/IN the/DT delta/NEWGENE promoter/NEWGENE insertion/NEWGENE his-4-912/NEWGENE delta/NEWGENE correlates/VBP with/IN an/DT increase/NN in/IN wild-type/NEWGENE HIS4/NEWGENE mRNA/NEWGENE levels/NNS ./.
@@86928928520 The/DT Pro-258--/NN >/NN Leu/NN (/( P258L/NN )/SYM mutation/NN caused/VBD constitutive/JJ receptor/NN signaling/JJ that/WDT was/VBD equivalent/JJ to/IN about/JJ 45%/NN of/IN the/DT maximum/JJ level/NN observed/VBN in/IN wild-type/NN cells/NNS stimulated/VBN with/IN alpha-factor/NEWGENE ./.
@@113711156057 The/DT proportion/NN of/IN the/DT biopsies/NNS found/VBP to/IN be/VB seropositive/JJ for/IN HBs/NN antigen/NN was/VBD 27/CD ./CD 9%/CD ,/, and/CC these/DT showed/VBD either/DT MGN/NN or/CC MPGN/NN pattern/NN ./.
@@91397376177 A/DT sterol-regulated/NEWGENE protease/NEWGENE initiates/VBP release/NN of/IN the/DT NH2-terminal/NN segments/NN of/IN sterol/NEWGENE regulatory/NEWGENE element-binding/NEWGENE proteins/NEWGENE (/( SREBPs/NEWGENE )/SYM from/IN cell/NN membranes/NNS ,/, thereby/RB allowing/VBG them/PRP to/IN enter/VB the/DT nucleus/NN and/CC to/IN stimulate/VB transcription/NN of/IN genes/NNS involved/VBN in/IN the/DT uptake/NN and/CC synthesis/NN of/IN cholesterol/NN and/CC fatty/JJ acids/NNS ./.
@@27578623456 Initial/JJ experience/NN with/IN a/DT microprocessor/NN controlled/VBN current/RB based/VBN defibrillator/NN ./.
@@92270999181 The/DT following/JJ technique/NN describes/VBZ a/DT modification/NN to/IN a/DT bar/NN superstructure/NN that/WDT provided/VBD the/DT advantages/NNS of/IN convenience/NN ,/, security/NN ,/, and/CC consistent/JJ positioning/NN even/VB though/CC one/PRP implant/NN was/VBD lost/VBP and/CC the/DT angulation/NN of/IN implants/NNS limited/VBD accuracy/NN ./.
@@95530407573 Cell/NNP survival/NN by/IN Epo/NEWGENE did/VBD not/RB require/VB activation/NN of/IN other/DT known/VBP signaling/JJ pathways/NNS including/JJ PI-3/NEWGENE kinase/NEWGENE ,/, PLC-gamma/NEWGENE ,/, Ras/NEWGENE or/CC Stats/NEWGENE ./.
@@112824331118 Phase/NNP II/NNP study/NN of/IN paclitaxel/NN and/CC oral/JJ etoposide/NN in/IN patients/NNS with/IN locally/RB advanced/JJ or/CC metastatic/JJ non-small/JJ cell/NN lung/NN cancer/NN ./.
@@25694113224 After/IN termination/NN of/IN medication/NN the/DT animals/NNS were/VBD kindled/JJ electrically/RB in/IN the/DT nucleus/NN amygdala/NN ./.
@@16363392238 Account/NNP was/VBD taken/VBP of/IN noncellular/JJ and/CC nonhuman/JJ elements/NNS in/IN the/DT smears/NNS ;/: they/PRP included/VBD mucus/NN ,/, Charcot-Layden/NNP crystals/NNS ,/, pollen/NN grains/NNS ,/, vegetal/JJ fragments/NNS and/CC fungi/NNS ./.
@@22433866857 We/PRP have/VBP now/RB identified/VBN ,/, after/IN 21/CD serial/JJ undiluted/JJ passages/NNS of/IN MHV/NN ,/, a/DT small/NEWGENE DI/NEWGENE RNA/NEWGENE ,/, DIssF/NEWGENE ,/, which/WDT is/VBZ efficiently/RB packaged/VBN into/IN virions/NNS ./.
@@16748177336 No/DT homology/NN was/VBD found/VBN between/IN RNA14/NEWGENE and/CC RNA15/NEWGENE or/CC between/IN RNA14/NEWGENE and/CC other/DT proteins/NNS contained/VBN in/IN data/NN banks/NNS ./.
@@117245101565 Physical/NNP principles/NNS in/IN therapeutic/JJ apheresis/NN ./.
@@92425065473 E2F/NEWGENE is/VBZ a/DT heterodimeric/NN complex/NN consisting/VBG of/IN E2F/NEWGENE family/NEWGENE members/NEWGENE (/NEWGENE 1-5/NEWGENE )/NEWGENE and/CC DP/NEWGENE proteins/NEWGENE (/NEWGENE 1-3/NEWGENE )/NEWGENE ./.
@@109745417474 We/PRP screened/VBD a/DT K562/NN cDNA/NN library/NN and/CC identified/VBN novel/JJ transcripts/NNS ,/, MZF1B/NEWGENE and/CC MZF1C/NEWGENE ./.
@@21957159174 Ischemic/NNP stroke/NN due/NN to/IN protein/NEWGENE C/NEWGENE deficiency/NN ./.
@@86987563720 CONCLUSIONS/IN :/: Our/PRP findings/NNS suggest/VBP that/DT pre-treatment/NN with/IN coenzyme/NN Q10/NN may/MD play/VB a/DT protective/JJ role/NN during/IN routine/JJ vascular/JJ procedures/NNS requiring/JJ abdominal/JJ aortic/JJ cross/NN clamping/NN by/IN attenuating/JJ the/DT degree/NN of/IN peroxidative/JJ damage/NN ./.
@@75657233118 The/DT kinase/NEWGENE is/VBZ essential/JJ in/IN vivo/NN for/IN normal/JJ phosphorylation/NN of/IN the/DT CTD/NN and/CC for/IN normal/JJ growth/NN and/CC differentiation/NN ./.
@@13253865109 The/DT hit1-1/NEWGENE mutation/NN caused/VBD a/DT defect/NN in/IN synthesis/NN of/IN a/DT 74-kD/NEWGENE heat/NEWGENE shock/NEWGENE protein/NEWGENE ./.
@@104305838084 A/DT new/JJ DNA/NEWGENE repair/NEWGENE gene/NEWGENE from/NEWGENE Schizosaccharomyces/NEWGENE pombe/NEWGENE with/IN homology/NN to/IN RecA/NEWGENE was/VBD identified/VBN and/CC characterized/VBN ./.
@@89551362288 Recombinant/JJ ,/, bacterially/RB expressed/VBN PIP5KIalpha/NEWGENE possessed/VBD PIP5K/NEWGENE activity/NN and/CC was/VBD immunoreactive/JJ with/IN erythroid/NEWGENE PIP5KI/NEWGENE antibodies/NEWGENE ./.
@@24986522241 After/IN transfection/NN ,/, specific/NN TSH/NEWGENE beta/NEWGENE promoter/NEWGENE activity/NN was/VBD evident/JJ in/IN both/DT TRH-responsive/NNP pituitary-derived/NN GH3/NN and/CC primary/JJ pituitary/JJ cell/NN cultures/NNS ./.
@@96294498426 The/DT results/NNS show/NN that/DT ROS/NN production/NN by/IN viable/JJ spermatozoa/NNS is/VBZ highly/RB correlated/VBN with/IN the/DT concentration/NN of/IN PMN/NEWGENE elastase/NEWGENE and/CC the/DT number/NN of/IN both/DT peroxidase-positive/JJ and/CC round/JJ cells/NNS ./.
@@100493591308 Recombinant/JJ unr/NEWGENE acts/NNS synergistically/RB with/IN recombinant/JJ PTB/NEWGENE to/IN stimulate/VB translation/NN dependent/JJ on/IN the/DT rhinovirus/NN IRES/NNS ./.
@@81180443164 GATA-1/NEWGENE mRNA/NEWGENE was/VBD present/VB in/IN equivalent/JJ levels/NNS in/IN both/DT erythroid/JJ cell/NN lines/NNS ,/, but/CC at/IN a/DT low/JJ level/NN in/IN FDC-P1/NNP cells/NNS ./.
@@19723795441 DNA/NN sequence/NN and/CC evolution/NN of/IN the/DT CPS/NEWGENE domain/NEWGENE of/IN the/DT Syrian/NEWGENE hamster/NEWGENE multifunctional/NEWGENE protein/NEWGENE CAD/NEWGENE ./.
@@84712418441 The/DT short-term/JJ synthesis/NN and/CC infant-regulated/JJ removal/NN of/IN milk/NN in/IN lactating/JJ women/NNS ./.
@@92713936736 Together/RB ,/, these/DT data/NN support/NN a/DT model/NN in/IN which/WDT Tax/NEWGENE anchors/NN CBP/NEWGENE to/IN the/DT HTLV-1/NEWGENE promoter/NEWGENE ,/, with/IN strong/JJ transcriptional/JJ activation/NN resulting/JJ from/IN the/DT CBP-associated/JJ activities/NNS of/IN nucleosome/NN remodeling/NN and/CC recruitment/NN of/IN the/DT general/JJ transcription/NN machinery/NN ./.
@@86486658181 ORF/NEWGENE E8/NEWGENE colinear/JJ with/IN ORF/NEWGENE E6/NEWGENE ,/, which/WDT could/MD generate/VB a/DT 50-amino-acid/JJ protein/NN with/IN a/DT hydrophobic/JJ segment/NN ,/, did/VBD not/RB transform/VB cells/NNS when/CC cloned/VBN into/IN the/DT pZipNeo/JJ vector/NN ./.
@@91518373566 Rep-Rep/NEWGENE protein/NEWGENE interaction/NN was/VBD confirmed/VBN in/IN vitro/FW through/JJ coimmunoprecipitation/NN experiments/NNS with/IN a/DT bacterially/RB expressed/VBN maltose-binding/NEWGENE protein-Rep78/NEWGENE fusion/NEWGENE protein/NEWGENE in/IN combination/NN with/IN [/NN 35S/NN ]/NN methionine-labeled/NN Rep78/NEWGENE synthesized/VBN in/IN a/DT coupled/VBN in/IN vitro/FW transcription-translation/NN system/NN ./.
@@98325183106 The/DT repression/NN domain/NN ,/, and/CC indeed/RB the/DT entire/JJ Cdc68/NEWGENE protein/NEWGENE ,/, is/VBZ highly/RB conserved/VBN ,/, as/IN shown/VBP by/IN the/DT sequence/NN of/IN the/DT Cdc68/NEWGENE functional/NEWGENE homolog/NEWGENE from/IN the/DT yeast/NN Kluyveromyces/NN lactis/NN and/CC by/IN database/NN searches/NNS ./.
@@114386548939 These/DT findings/NNS suggest/VBP that/IN the/DT adapter/NN Gab1/NEWGENE may/MD redirect/VB c-Met/NEWGENE signaling/JJ through/RB PI3K/NEWGENE away/RB from/IN a/DT c-Akt/NEWGENE //NEWGENE Pak1/NEWGENE cell/NN survival/NN pathway/NN ./.
@@99491607618 (/( 2/CD )/SYM Erythroid/JJ 32D/CD Epo1/NEWGENE cells/NNS showed/VBD a/DT lower/JJR level/NN of/IN bulk/NN PKC/NEWGENE catalytic/JJ activity/NN ,/, lacked/VBD the/DT expression/NN of/IN epsilon/NEWGENE and/CC eta/NEWGENE PKC/NEWGENE isoforms/NEWGENE ,/, and/CC showed/VBD a/DT weak/JJ or/CC absent/VB upregulation/NN of/IN the/DT remaining/JJ isoforms/NNS ,/, except/VB betaI/NEWGENE ,/, upon/IN readdition/NN of/IN Epo/NEWGENE to/IN growth/NN factor-starved/NN cells/NNS ./.
@@106371496864 Downstream/NNS of/IN the/DT G-A/NN anastomosis/NN ,/, the/DT RD/NN ,/, CC/NN ,/, E/NN (/NN p/NN )/NN and/NN loop/NN areas/NNS were/VBD significantly/RB different/JJ from/IN REF/NN ,/, but/CC significantly/RB different/JJ from/IN A-A/NN ./.
@@91973429150 Secretion/NN in/IN milk/NN and/CC transplacental/JJ transfer/NN of/IN two/JJ iodized/JJ oils/NNS ,/, Lipiodol/NN UF/NN and/CC Oriodol/NNP ,/, in/IN rabbits/NNS ./.
@@62525206049 Catecholamines/NNS and/CC aversive/JJ learning/JJ :/: a/DT review/NN ./.
@@111087208773 S6K2/NEWGENE is/VBZ highly/RB homologous/JJ to/IN S6K1/NEWGENE in/IN the/DT core/NEWGENE kinase/NEWGENE and/CC linker/NN regulatory/JJ domains/NNS but/CC differs/VBZ from/IN S6K1/NEWGENE in/IN the/PDT N-/DT and/CC C-terminal/NN regions/NN and/CC is/VBZ differently/RB localized/VBN primarily/RB to/IN the/DT nucleus/NN because/IN of/IN a/DT C-terminal/NN nuclear/JJ localization/NN signal/JJ unique/NN to/IN S6K2/NEWGENE ./.
@@110461481714 LMP2A/NEWGENE enhances/VBZ Lyn/NEWGENE and/CC Syk/NEWGENE ubiquitination/NN in/IN vivo/NN in/IN a/DT fashion/NN that/WDT depends/VBZ on/IN the/DT activity/NN of/IN Nedd4/NEWGENE family/NN members/NN and/CC correlates/VBP with/IN destabilization/NN of/IN the/DT Lyn/NEWGENE tyrosine/NEWGENE kinase/NEWGENE ./.
@@105422699241 Amyloid/NEWGENE beta-protein/NEWGENE (/( Abeta/NEWGENE )/SYM is/VBZ the/DT main/JJ constituent/NN of/IN amyloid/JJ fibrils/NNS found/VBP in/IN senile/JJ plaques/NNS and/CC cerebral/JJ vessels/NNS in/IN Alzheimer's/NN disease/NN (/( AD/NN )/SYM and/CC is/VBZ derived/VBN by/IN proteolysis/NN from/IN the/DT beta-amyloid/NEWGENE precursor/NEWGENE protein/NEWGENE (/( APP/NEWGENE )/SYM ./.
@@115843283814 Drug/NNP interactions/NNS have/VBP been/VBN found/VB with/IN drugs/NNS that/WDT compete/VBP for/IN the/DT same/JJ CYP450/NEWGENE isoenzymes/NEWGENE as/IN statins/NEWGENE ./.
@@85745834346 The/DT Clb5/NEWGENE kinase/NEWGENE ,/, which/WDT promotes/VBZ S/NNP phase/NN ,/, remains/VBP active/JJ during/IN the/DT G2-phase/NN arrest/NN of/IN cells/NNS of/IN the/DT parental/JJ strain/NN ,/, but/CC its/PRP activity/NN declines/NNS rapidly/RB in/IN sim/NEWGENE mutants/NEWGENE ./.
@@77484517705 The/DT mean/JJ marginal/JJ discrepancy/NN of/IN provisional/JJ restorations/NNS was/VBD compared/VBN for/IN restorations/NNS fabricated/VBN from/IN stone/NN ,/, low-viscosity/JJ poly/NN (/NN vinyl/NN siloxane/NN )/NN ,/, and/CC medium-viscosity/JJ poly/NN (/NN vinyl/NN siloxane/NN )/NN ./.
@@95752179070 A/DT site-directed/NN R618K/NEWGENE mutation/NEWGENE in/IN the/DT Stat5/NEWGENE SH2/NEWGENE1 domain/NEWGENE1 abolished/VBD the/DT phosphorylation/NN by/IN Jak2/NEWGENE ,/, while/CC deletion/NN of/IN the/DT C/NN terminus/NN led/VBN to/IN Stat5/NEWGENE hyperphosphorylation/NN ./.
@@11093745162 Another/DT putative/JJ HNF3/NEWGENE site/NEWGENE in/IN close/JJ apposition/NN to/IN a/DT NF1/NEWGENE //NEWGENE CTF/NEWGENE site/NEWGENE was/VBD localized/VBN upstream/RB of/IN the/DT silencer-like/NEWGENE element/NEWGENE ./.
@@68833856683 In/NN patients/NNS with/IN complete/JJ or/CC partial/JJ remission/NN of/IN the/DT tumor/NN ,/, the/DT neopterine/NN excretion/NN dropped/VBN to/IN normal/JJ values/NNS ./.
@@112162471052 The/DT child/NN left/NN behind/RB ./.
@@100928473504 With/IN respect/NN to/IN the/DT distribution/NN of/IN active/JJ MREs/NEWGENE over/RB the/DT promoter/NN region/NN ,/, the/DT hMT-IIA/NEWGENE gene/NEWGENE is/VBZ largely/RB different/JJ from/IN the/DT mouse/NN metallothionein-I/NEWGENE gene/NEWGENE ,/, suggesting/VBG that/DT MRE/NEWGENE arrangement/NN is/VBZ not/RB an/DT important/JJ factor/NN for/IN metal/NN regulation/NN ./.
@@45101025003 Electrocardiograms/NNS of/IN the/DT month/NN ./.
@@60746405894 Symposium/NNP on/IN presenile/JJ spongy/JJ encephalopathies/NNS ./.
@@85840266752 The/DT hIGF-I/NEWGENE gene/NEWGENE has/VBZ two/JJ promoters/NNS ,/, P1/NN and/CC P2/NNP ./NNP
@@1193391842 In/NN this/DT animal/NN ,/, infected/VBN with/IN what/WP was/VBD judged/VBN previously/RB to/IN be/VB the/DT less/PRP virulent/JJ of/IN the/DT two/JJ T/NNP ./NNP cruzi/NN stocks/NNS used/VBN (/( 'strain/NN 7'/CD )/SYM ,/, there/RB was/VBD severe/JJ myocarditis/NN ,/, with/IN myofibre/NN degeneration/NN ,/, and/CC lesions/NNS of/IN the/DT oesophagus/NN ./.
@@8533757165 Five/CD families/NNS of/IN Ashkenazi/NN Jewish/JJ descent/NN carried/VBD the/DT 185delAG/NN mutation/NN and/CC shared/VBD the/DT same/JJ haplotype/NN at/IN eight/CD polymorphic/JJ markers/NNS spanning/VBG approximately/RB 850/CD kb/NN at/IN BRCA1/NEWGENE ./.
@@9639565331 3/NN )/NN and/CC one/PRP distal/JJ (/( -11/CD ./CD 8/CD //CD -10/CD ./CD 9/CD )/SYM ,/, presented/VBD an/DT enhancer/NN activity/NN in/IN pituitary/JJ cells/NNS when/CC placed/VBN upstream/RB of/IN the/DT SV40/NN promoter/NN ./.
@@114710774690 RESULTS/NNS :/: There/EX is/VBZ a/DT considerable/JJ amount/NN of/IN variation/NN between/IN the/DT results/NNS of/IN TRA1/NN and/CC TRA2/NN and/CC between/IN the/DT results/NNS of/IN both/DT TRA's/NNP and/CC the/DT door-to-door/JJ survey/NN ./.
@@63416616134 Clinical/NNP use/NN of/IN absorbable/JJ polyglycolic/JJ acid/NN suture/NN in/IN Blalock-Taussig's/NNP operation/NN ./.
@@87175598698 The/DT standard/JJ dosage/NN of/IN anti-D/NEWGENE currently/RB given/VBP at/IN all/DT gestational/JJ ages/NNS is/VBZ 1/CD ampoule/NN containing/JJ 125/CD micrograms/NNS of/IN anti-D/NEWGENE ./.
@@54121223819 3'-Methyl/JJ ,/, 8-methyl/JJ ,/, and/CC 8-phenyl/JJ derivatives/NNS of/IN 5/NN ,/NN 9-dimethyl-6/NN ,/NN 7-benzomorphans/NN ./.
@@21512297758 Mean/VB ROI-A/NN //NN B/NN ratio/NN was/VBD 49/CD ./CD 6/CD +/NN //NN -/NN 1/CD ./CD 7%/CD in/IN the/DT diabetic/JJ group/NN ,/, significantly/RB lower/JJR than/IN the/DT 57/CD ./CD 9/CD +/NN //NN -/NN 1/CD ./CD 6%/CD at/IN the/DT nondiabetic/JJ group/NN (/( p/NN less/PRP than/IN 0/CD ./CD 005/CD )/SYM ./.
@@83141633488 Recovery/NNP of/IN carbimazole-induced/JJ agranulocytosis/NN following/IN recombinant/NEWGENE granulocyte-macrophage/NEWGENE colony/NEWGENE stimulating/NEWGENE factor/NEWGENE (/( rhGM-CSF/NEWGENE )/SYM administration/NN ./.
@@90980667910 This/DT locus/NN maps/NNS approximately/RB 160/CD kbp/NN from/IN the/DT genes/NNS encoding/VBG cytadherence-associated/NN proteins/NN HMW1/NEWGENE and/CC HMW3/NEWGENE ,/, and/CC yet/RB insertions/NNS therein/RB result/VBP in/IN loss/NN of/IN these/DT proteins/NNS and/CC a/DT hemadsorption-negative/JJ (/( HA-/NNP )/SYM phenotype/NN ,/, prompting/VBG the/DT designation/NN cytadherence-regulatory/NEWGENE locus/NEWGENE (/( crl/NEWGENE )/SYM ./.
@@19474499043 The/DT effect/NN of/IN diffusion/NN limitation/NN was/VBD quantified/VBN in/IN terms/NNS of/IN the/DT ratio/NN O2/NN uptake/NN //NN O2/NN requirement/NN (/( =/SYM fraction/NN of/IN cross-sectional/JJ area/NN supplied/VBN with/IN O2/NN )/SYM ,/, assuming/VBG local/JJ O2/NN requirement/NN per/IN unit/NN volume/NN to/IN be/VB constant/NN and/CC independent/NN of/IN PO2/NN at/IN PO2/NN greater/JJR than/IN 0/CD ./CD
@@95049066595 Analysis/NNP of/IN intragenic/JJ revertants/NNS shows/VBZ that/IN this/DT function/NN depends/VBZ on/IN the/DT amino/JJ acid/NN preceding/JJ the/DT first/JJ cysteine/NN residue/NN of/IN the/DT DNA-binding/NN domain/NN of/IN Hap1p/NEWGENE ./.
@@96714966299 Here/RB we/PRP investigate/VBP the/DT role/NN of/IN c-Cbl/NEWGENE in/IN development/NN and/CC homeostasis/NN in/IN mice/NNS by/IN targeted/JJ disruption/NN of/IN the/DT c-Cbl/NEWGENE locus/NEWGENE ./. c-Cbl-deficient/NN mice/NNS were/VBD viable/JJ ,/, fertile/JJ ,/, and/CC outwardly/RB normal/JJ in/IN appearance/NN ./.
@@11108374941 Acoust/NNP ./.
@@55942777251 The/DT modification/NN of/IN P32/NN uptake/NN into/IN the/DT Jensen/NNP sarcoma/NN in/IN vitro/FW by/IN adding/NN of/IN peroxide/NN to/IN the/DT nutritive/JJ medium/NN ./.
@@79163267166 Detailed/VBN molecular/JJ organization/NN of/IN the/DT coding/JJ and/CC upstream/RB regulatory/JJ regions/NNS of/IN the/DT murine/NN homeodomain-containing/NN gene/NN ,/, Msx-1/NEWGENE ,/, is/VBZ reported/VBN ./.
@@86265965278 There/EX is/VBZ growing/JJ evidence/NN that/IN mammalian/NEWGENE AMP-activated/NEWGENE protein/NEWGENE kinase/NEWGENE (/( AMPK/NEWGENE )/SYM plays/VBP a/DT role/NN in/IN protecting/JJ cells/NNS from/IN stresses/VBZ that/DT cause/NN ATP/NN depletion/NN by/IN switching/NN off/RB ATP-consuming/JJ biosynthetic/JJ pathways/NNS ./.
@@11129724971 Studies/NNS are/VBP necessary/JJ to/IN assess/VB the/DT source/NN of/IN contamination/NN and/CC potential/JJ role/NN of/IN MRSA-contaminated/JJ milk/NN in/IN the/DT transmission/NN of/IN MRSA/NN to/IN neonates/NNS ./.
@@71476226957 A/DT suspected/VBN new/JJ storage/NN disease/NN in/IN cattle/NNS ./.
@@80822928061 Reduced/NNP NK/NN activity/NN correlates/VBP with/IN active/JJ disease/NN in/IN HIV-/NNP patients/NNS with/IN multidrug-resistant/JJ pulmonary/JJ tuberculosis/NN ./.
@@112231991706 These/DT results/NNS indicate/VBP that/DT evaluation/NN of/IN exposure/NN to/IN S/NNP ./NNP neurona/NN by/IN WB/NN analysis/NN of/IN serum/NN may/MD be/VB misleading/JJ in/IN young/JJ horses/NNS ./.
@@101944515753 Because/IN of/IN the/DT probable/JJ causal/JJ relationship/NN between/IN constitutive/JJ p210/NEWGENE (/NEWGENE bcr/NEWGENE //NEWGENE abl/NEWGENE )/NEWGENE protein/NEWGENE1 tyrosine/NEWGENE1 kinase/NEWGENE1 activity/NN and/CC manifestations/NNS of/IN chronic-phase/NN chronic/JJ myelogenous/JJ leukemia/NN (/( CML/NN ;/: myeloid/JJ expansion/NN )/SYM ,/, a/DT key/NN goal/NN is/VBZ to/IN identify/VB relevant/JJ p210/NEWGENE substrates/NN in/IN primary/JJ chronic-phase/NN CML/NN hematopoietic/JJ progenitor/NN cells/NNS ./.
@@21544676430 The/DT PC2/NEWGENE protein/NEWGENE also/RB shows/VBZ great/JJ similarity/NN to/IN the/DT incomplete/JJ NH2-terminal/NN sequence/NN of/IN the/DT human/NEWGENE furin/NEWGENE gene/NEWGENE product/NEWGENE ,/, a/DT putative/JJ membrane-inserted/NN receptor-like/NN molecule/NN ./.
@@54215373904 Difficulties/NNS bound/JJ to/IN measuring/NN of/IN sputum/NN viscosity/NN ./.
@@21544742301 Whether/IN or/CC not/RB there/RB are/VBP sequences/NNS conferring/JJ cAMP/NN responsiveness/NN which/WDT are/VBP common/JJ both/DT to/IN P-450scc/NEWGENE and/CC the/PDT other/DT steroidogenic/JJ P-450/NEWGENE genes/NEWGENE remains/VBP to/IN be/VB established/VBN ./.
@@75041715264 We/PRP have/VBP also/RB tested/VBN Src/NEWGENE SH2/NEWGENE mutants/NEWGENE for/IN their/PRP binding/JJ properties/NNS and/CC have/VB interpreted/VBN our/PRP results/NNS in/IN light/NN of/IN the/DT recent/JJ crystal/NN structure/NN solution/NN for/IN the/DT Src/NEWGENE SH2/NEWGENE domain/NEWGENE ./.
@@86361246161 This/DT protein/NN encoded/VBN by/IN this/DT cDNA/NN ,/, which/WDT we/PRP have/VBP termed/JJ p150TSP/NEWGENE (/( for/IN TPR-containing/NEWGENE ,/NEWGENE SH2-binding/NEWGENE phosphoprotein/NEWGENE )/SYM ,/, is/VBZ located/VBN predominantly/RB in/IN the/DT nucleus/NN and/CC is/VBZ highly/RB conserved/VBN in/IN evolution/NN ./.
@@84002401642 We/PRP linked/JJ hypersensitivity/NEWGENE site/NEWGENE 2/NEWGENE (/( HS2/NEWGENE )/SYM from/IN the/DT locus/NN control/NN region/NN (/( LCR/NN )/SYM to/IN a/DT A/NEWGENE gamma-globin/NEWGENE gene/NN (/( A/NEWGENE gamma*/NEWGENE )/SYM mutationally/RB marked/JJ to/IN allow/VB its/PRP transcript/NN to/IN be/VB distinguished/VBN from/IN endogenous/JJ gamma-globin/NEWGENE mRNA/NN ./.
@@72745057127 In/JJ controls/NNS ,/, only/RB modest/JJ differences/NNS were/VBD observed/VBN ./.
@@21151165395 Our/PRP results/NNS suggest/VBP that/IN a/DT sequence/NN match/NN between/IN enhancers/NNS and/CC certain/JJ promoter/NN elements/NNS is/VBZ critical/JJ ./.
@@96383427336 A/DT conserved/VBN role/NN for/JJ L1/NEWGENE as/IN a/DT transmembrane/JJ link/NN between/IN neuronal/JJ adhesion/NN and/CC membrane/NN cytoskeleton/NN assembly/NN ./.
@@87423858731 The/DT most/RB frequent/VB causes/NNS of/IN the/DT meningitis/NN was/VBD the/DT external/JJ ventricular/JJ drainage/NN (/( 14/CD ./CD 8%/CD )/SYM ,/, post-neurosurgical/JJ (/( 0/CD ./CD 8%/CD )/SYM and/CC head/JJ injury/NN (/( 0/CD ./CD 0007%/CD )/SYM ./.
@@14246742045 Cicatricial/JJ pemphigoid/NN is/VBZ an/DT autoimmune/JJ systemic/JJ disease/NN characterized/VBN by/IN chronic/JJ conjunctival/JJ cicatrization/NN ./.
@@25919933241 1/CD ./CD
@@8491383846 We/PRP conclude/VBP that/IN the/DT alpha-subunit/NN of/IN the/DT telomere-binding/NEWGENE protein/NEWGENE ,/, like/JJ many/JJ transcription/NN factors/NNS ,/, has/VBZ separable/JJ DNA-binding/NN and/CC protein-protein/JJ interaction/NN domains/NNS ./.
@@90247934518 In/NN the/DT electrophoresis/NN mobility/NN shift/NN assay/NN using/VBG nuclear/JJ extracts/NNS of/IN the/DT myogenic/JJ cells/NNS ,/, MyoD/NEWGENE and/CC myogenin/NEWGENE bound/JJ to/IN the/DT right/JJ E-box/NNS in/IN the/DT enhancer/NN region/NN of/IN the/DT MCK/NEWGENE gene/NEWGENE even/VB in/IN the/DT presence/NN of/IN BMP-2/NEWGENE ./.
@@17236192302 The/DT reduced/VBN rate/NN of/IN F/NN absorption/NN and/CC slower/JJR rise/NN in/IN plasma/NN F/NN concentration/NN accompanying/JJ delayed/JJ gastric/JJ emptying/NN indicate/VB that/DT passage/NN of/IN F/NN into/IN the/DT small/JJ intestine/NN is/VBZ the/DT major/JJ factor/NN in/IN rapid/JJ F/NN absorption/NN ./.
@@45630455032 1/NN ,/NN 3-bis/NN (/NN 2-chloroethyl/NN )/NN -1-nitrosourea/NN (/( bcnu/NN )/SYM and/CC other/DT nitrosoureas/NNS in/IN cancer/NN treatment/NN :/: a/DT review/NN ./.
@@21374583203 9/CD ,/, 1498-1506/NN )/NN ./.
@@115226586129 Therefore/RB ,/, to/IN understand/VB how/RB ErbB1/NEWGENE //NEWGENE ErbB2/NEWGENE signaling/NN contributes/VBZ to/IN this/DT process/NN ,/, we/PRP used/VBD the/DT ErbB/NEWGENE kinase/NEWGENE inhibitor/NN AG1478in/NN ErbB2-dependent/NN BT-474/NN and/CC SKBR-3/CELL human/JJ breast/NN cancer/NN cells/NNS ./.
@@8798298900 Infants/NNS who/WP died/VBD in/IN the/DT first/JJ 12/CD hours/NNS from/IN 'IVH/NN only'/NN had/VBP suffered/VBN severe/JJ birth/NN asphyxia/NN but/CC in/IN those/DT who/WP died/VBD later/JJR the/DT main/JJ symptom/NN was/VBD recurrent/JJ apnoea/NN ./.
@@4377494950 Various/JJ treatment/NN modalities/NNS are/VBP reviewed/VBN in/IN the/DT context/NN of/IN the/DT psychology/NN as/RB well/NN as/IN the/DT physiology/NN of/IN severe/JJ intractable/JJ pain/NN ./.
@@70612635177 When/WRB vascular/JJ pressure/NN (/( Pvas/NNP )/SYM was/VBD raised/VBN abruptly/RB from/IN -5/CD to/IN +25/CD cmH2O/NN by/IN air/NN inflation/NN for/IN 60/CD min/NN ,/, Px/NN (/( f/NN )/SYM became/VBD abruptly/RB less/PRP negative/JJ ,/, then/RB remained/VBN stable/JJ ./.
@@106075668746 Consistent/JJ with/IN this/DT finding/NN ,/, beta-catenin/NEWGENE interacted/VBN directly/RB with/IN the/DT RA/NEWGENE receptor/NEWGENE (/( RAR/NEWGENE )/SYM in/IN a/DT retinoid-dependent/JJ manner/NN ,/, but/CC not/RB with/IN the/DT retinoid/NEWGENE X/NEWGENE receptor/NEWGENE (/( RXR/NEWGENE )/SYM ,/, and/CC RAR/NEWGENE competed/VBN with/IN TCF/NEWGENE for/IN beta-catenin/NEWGENE binding/JJ ./.
@@85198627045 Measurement/NNP of/IN anti-HCV/NEWGENE IgM/NEWGENE antibodies/NEWGENE with/IN an/DT experimental/JJ kit/NN ./.
@@111590811002 In/NN three/CD cases/NNS (/( 21/CD ./CD 4%/CD )/SYM ,/, the/DT MR/NN imaging/JJ was/VBD interpreted/VBN as/IN negative/JJ ,/, but/CC microscopic/JJ tumor/NN was/VBD shown/VBP around/IN seroma/NN on/IN reexcision/NN ./.
@@88876745762 In/NN both/DT settings/NNS ,/, it/PRP can/MD be/VB phosphorylated/VBN by/IN cyclin/NEWGENE D-dependent/NEWGENE kinases/NEWGENE ,/, suggesting/VBG that/IN its/PRP transcriptional/JJ activity/NN may/MD normally/RB be/VB regulated/VBN through/RB such/JJ mechanisms/NNS ./.
@@93120256102 Protein/NEWGENE phosphatase/NEWGENE 2A/NEWGENE is/VBZ a/DT critical/JJ regulator/NN of/IN protein/NEWGENE kinase/NEWGENE C/NEWGENE zeta/NEWGENE signaling/NN targeted/VBN by/IN SV40/NEWGENE small/NEWGENE t/NEWGENE to/IN promote/VB cell/NN growth/NN and/CC NF-kappaB/NEWGENE activation/NN ./.
@@29980162049 The/DT homology/NN to/IN v-mil/NEWGENE starts/VBP within/IN the/DT coding/JJ sequence/NN of/IN exon/NN 1/CD and/CC ends/NNS within/IN the/DT 3'/CD untranslated/JJ region/NN of/IN exon/NN 11/CD ,/, 12/CD nucleotides/NNS downstream/RB from/IN the/DT nonsense/NN codon/NN terminating/JJ the/DT large/JJ open/JJ reading/JJ frame/NN shared/VBN between/IN c-mil/NEWGENE and/CC v-mil/NEWGENE ./.
@@113183631165 DESIGN/IN :/: Retrospective/JJ study/NN ./.
@@113251957770 The/DT R2/NN between/IN MFI/NNS of/IN fresh/JJ and/CC frozen/JJ muscle/NN was/VBD 0/CD ./CD 94/CD and/CC 0/CD ./CD 92/CD for/IN lamb/NN and/CC pork/NN longissimus/JJ ,/, respectively/RB ./.
@@173860647 Riboflavin/NN did/VBD not/RB affect/VB the/DT percentage/NN of/IN aflatoxin-treated/JJ animals/NNS with/IN abnormal/JJ urinary/JJ excretion/NN patterns/NNS ,/, but/CC did/VBD increase/NN the/DT magnitude/NN of/IN the/DT disturbances/NNS in/IN elimination/NN of/IN kynurenic/JJ and/CC xanthurenic/JJ acids/NNS ./.
@@97006449687 The/DT spectrum/NN of/IN age-associated/JJ brain/NN abnormalities/NNS :/: their/PRP measurement/NN and/CC histopathological/JJ correlates/VBP ./.
@@37655526548 The/DT mechanism/NN of/IN action/NN is/VBZ explored/VBN in/IN some/DT detail/NN ,/, specifically/RB as/IN it/PRP relates/VBZ to/IN reticuloendothelial/JJ system/NN (/( RES/NN )/SYM Fc/NEWGENE receptor/NEWGENE blockade/NN and/CC suppression/NN of/IN antiplatelet/JJ antibody/NN synthesis/NN ./.
@@89022144546 During/IN this/DT period/NN ,/, administration/NN of/IN additional/JJ exogenous/NEWGENE PRL/NEWGENE did/VBD not/RB stimulate/VB further/JJ activation/NN (/( binding/JJ )/SYM of/IN the/DT Stat/NEWGENE factors/NEWGENE ./.
@@80037003487 Differential/JJ screening/NN of/IN mitochondrial/JJ cDNA/NN libraries/NNS from/IN male-fertile/JJ and/CC cytoplasmic/JJ male-sterile/JJ sugar-beet/NN reveals/VBZ genome/NN rearrangements/NNS at/IN atp6/NEWGENE and/CC atpA/NEWGENE loci/NEWGENE ./.
@@94556959410 ALT/NEWGENE levels/NNS in/IN responders/NNS were/VBD lowered/VBN by/IN 46%/NN and/CC AST/NEWGENE levels/NNS were/VBD lowered/VBN by/IN 35%/JJ after/IN 12/CD weeks/NNS of/IN vitamin/NN E/NN treatment/NN ./.
@@21034032706 No/DT patient/NN had/VBP a/DT history/NN of/IN excess/NN alcohol/NN intake/NN ,/, or/CC prolonged/JJ intake/NN of/IN hepatotoxic/JJ drugs/NNS and/CC steroids/NNS ,/, and/CC were/VBD not/RB obese/JJ or/CC malnourished/JJ ./.
@@111010084289 Chaperones/NEWGENE //NEWGENE HSPs/NEWGENE thus/RB play/VB important/JJ roles/NNS within/IN cell/NN cycle/NN processes/NNS ./.
@@4115870896 Experiences/NNS with/IN the/DT clinical/JJ and/CC experimental/JJ use/NN of/IN Urat-I/NN lithotriptor/NN ./.
@@80143778009 Under/IN resting/JJ conditions/NNS ,/, activity/NN levels/NNS of/IN cardiac/JJ vagal/JJ and/CC sympathetic/JJ outflows/NNS are/VBP not/RB related/VBN across/IN young/JJ ,/, healthy/JJ human/JJ subjects/NNS and/CC peripheral/JJ interaction/NN is/VBZ not/RB manifest/VB between/IN the/DT autonomic/JJ divisions/NNS ./.
@@13587582679 The/DT distal/JJ portion/NN of/IN the/DT rat/NEWGENE insulin/NEWGENE I/NEWGENE gene/NEWGENE 5'-flanking/NEWGENE DNA/NEWGENE contains/VBZ two/JJ sequence/NN elements/NNS ,/, the/DT Far/NEWGENE and/CC FLAT/NEWGENE elements/NEWGENE ,/, that/WDT can/MD function/VB in/IN combination/NN ,/, but/CC not/RB separately/RB ,/, as/IN a/DT beta-cell-specific/NN transcriptional/NN enhancer/NN ./.
@@92045701632 This/DT study/NN describes/VBZ a/DT new/JJ MADS/NEWGENE box/NEWGENE gene/NEWGENE ,/, nmhC5/NEWGENE ,/, which/WDT along/IN with/IN nmh7/NEWGENE (/( J/NNP ./NNP
@@88381446435 To/TO explore/VB the/DT functional/JJ significance/NN of/IN these/DT subdomains/NNS in/IN PRL/NEWGENE binding/JJ and/CC signal/JJ transduction/NN ,/, deletion/NN mutants/NNS of/IN S1/NEWGENE or/NN //NN and/NN S2/NEWGENE subdomains/NEWGENE were/VBD constructed/VBN ./.
@@14975822110 A/DT second/JJ large/JJ group/NN of/IN disorders/NNS in/IN pregnancy/NN is/VBZ caused/VBN by/IN effects/NNS of/IN infections/NNS of/IN the/DT mother/NN without/IN pathogens/NNS being/VBP transmitted/VBN to/IN the/DT embryo/NN or/CC the/DT placenta/NN ./.
@@88096808789 Melatonin/IN and/CC seasonality/NN :/: filling/JJ the/DT gap/NN ./.
@@28612383548 Hantaan/NNP virus/NN ./.
@@9701609950 Our/PRP laboratory/NN has/VBZ recently/RB identified/VBN two/JJ phosducin-like/NEWGENE orphan/NEWGENE proteins/NEWGENE (/( PhLOP1/NEWGENE and/CC PhLOP2/NEWGENE )/SYM that/DT lack/NN the/DT ability/NN to/IN interact/VB with/IN Gbetagamma/NEWGENE ./.
@@23103001940 In/NN 18%/JJ lymphography/NN was/VBD clearly/RB positive/NN and/CC CT/NN negative/JJ ./.
@@97440957117 Surprisingly/RB ,/, double/JJ mutants/NNS of/IN the/DT shy2-1D/NEWGENE mutant/NEWGENE with/IN the/DT phytochrome-deficient/JJ mutants/NN hy2/NEWGENE ,/, hy3/NEWGENE (/NEWGENE phyB-1/NEWGENE )/NEWGENE and/CC fre1-1/NEWGENE (/NEWGENE phyA-201/NEWGENE )/NEWGENE showed/VBD reduced/VBN photomorphogenic/JJ response/NN in/IN darkness/NN with/IN a/DT longer/JJR hypocotyl/NN ,/, a/DT longer/JJR inflorescence/NN stem/NN ,/, and/CC a/DT lower/JJR level/NN expression/NN of/IN the/DT CAB/NEWGENE gene/NEWGENE than/IN the/DT shy2-1D/NEWGENE single/NEWGENE mutant/NEWGENE ./.
@@13486841974 1/CD ./CD
@@27090812640 Validation/NNS of/IN the/DT survey/NN of/IN work/NN styles/NNS :/: a/DT profile/NN measure/NN of/IN the/DT type/NN A/NN behaviour/NN pattern/NN ./.
@@97164356190 During/IN the/DT CR/NN //NN PP/NN diet/NN only/RB the/DT HS/JJ subjects/NNS did/VBD not/RB show/VB the/DT stress-induced/JJ rise/NN in/IN depression/NN ,/, decline/NN in/IN vigour/NN and/CC cortisol/NN elevation/NN that/IN they/PRP showed/VBD after/IN the/DT PR/NNP //NNP CP/NNP diet/NN ./.
@@115507957058 Overexpression/NNS of/IN RORgamma/NEWGENE has/VBZ been/VBN shown/VBP to/IN inhibit/VB T/NN cell/NN receptor-mediated/NN apoptosis/NN in/IN T/NN cell/NN hybridomas/NNS and/CC to/IN repress/VB the/DT induction/NN of/IN Fas-ligand/NEWGENE and/CC interleukin/NEWGENE 2/NEWGENE ./.
@@90938679094 Circularized/NEWGENE Ac/NEWGENE //NEWGENE Ds/NEWGENE transposons/NEWGENE :/: formation/NN ,/, structure/NN and/CC fate/NN ./.
@@114250761300 Since/IN the/DT latter/NN is/VBZ very/RB small/JJ for/IN physiological/JJ flows/NNS ,/, the/DT result/NN is/VBZ that/DT alpha/NN </SYM 1/CD even/VB at/IN relatively/JJ high/JJ values/NNS of/IN the/DT Reynolds/NN number/NN (/( i/FW ./FW e/FW ./FW ,/, for/IN non-negligible/JJ inertia/NN )/SYM and/CC we/PRP validate/VBP our/PRP perturbation/NN theory/NN results/NNS by/IN comparison/NN with/IN a/DT numerical/JJ integration/NN of/IN the/DT full/JJ model/NN ./.
@@36089164275 In/NN cases/NNS of/IN 1/CD degrees/NNS HPT/NN ,/, the/DT plasma/NN 1/NN ,/NN 25-/NN (/NN OH/NN )/NN 2D/NN level/NN rose/VBD significantly/RB in/IN all/DT cases/NNS (/( P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ,/, although/IN the/DT pattern/NN of/IN the/DT increase/NN was/VBD not/RB uniform/JJ ./.
@@95179892416 The/DT study/NN enrolled/VBN 994/CD people/NN co-infected/JJ with/IN CMV/NN and/CC HIV/NN ,/, with/IN at/IN least/RB one/PRP CD4/NEWGENE count/NN recorded/VBN </SYM 100/CD x/NN 10/NN (/NN 6/NN )/NN cells/NN //NN l/NN ./.
@@33527274042 UK's/NNP biotechnology/NN lacking/JJ specialists/NNS ./.
@@79353751246 Expression/NNS of/IN a/DT dominant-negative/NEWGENE ras/NEWGENE gene/NEWGENE also/RB blocks/NNS TIS10/NEWGENE //NEWGENE PGS2/NEWGENE induction/NN by/IN v-src/NEWGENE ./.
@@105176664998 High-affinity/NNP binding/JJ sites/NNS for/IN both/DT GR/NEWGENE and/CC AP-1/NEWGENE nucleoproteins/NEWGENE were/VBD identified/VBN at/IN adjacent/JJ elements/NNS within/IN the/DT nGRE/NEWGENE ./.
@@37335634399 A/DT significant/JJ herd/NN X/NN period/NN interaction/NN existed/VBN for/IN liver/NN TG/NN and/CC serum/JJ dextran/NN precipitable/JJ cholesterol/NN concentrations/NNS ./.
@@30049824158 The/DT nucleotide/NN sequence/NN of/IN 3874/CD bp/NN of/IN cloned/VBN R/NNP ./NNP sphaeroides/VBZ chromosomal/JJ DNA/NN ,/, including/JJ the/DT three/CD structural/NN genes/NN fbcF/NEWGENE ,/, fbcB/NEWGENE and/CC fbcC/NEWGENE has/VBZ been/VBN determined/VBN ./.
@@17527922343 We/PRP obtained/VBD quantitative/JJ evidence/NN on/IN the/DT coding/NN of/IN interaural/JJ time/NN differences/NNS (/( ITDs/NNS )/SYM of/IN click/NN stimuli/NNS by/IN 40/CD single/JJ neurons/NNS in/IN the/DT auditory/JJ cortex/NN of/IN anesthetized/JJ albino/NN rats/NNS ./.
@@81771438153 Renal/JJ cell/NN carcinoma/NN in/IN children/NNS :/: a/DT single/JJ institution's/NNS experience/NN ./.
@@110662456284 What/WP to/IN look/NN for/IN during/IN a/DT compliance/NN review/NN :/: 10/CD common/JJ mistakes/NNS made/VBP by/IN SNFs/NN ./.
@@76291632026 NH2-/NNP and/CC COOH-terminal/NN deletion/NN analysis/NN revealed/VBN that/IN both/PDT the/DT PH/NEWGENE and/CC putative/JJ guanine/NEWGENE nucleotide/NEWGENE exchange/NEWGENE factor/NEWGENE domains/NEWGENE are/VBP required/VBN ,/, but/CC the/DT zinc/NN butterfly/NN is/VBZ dispensable/JJ ,/, for/IN transformation/NN ./.
@@24851883621 Following/VBG chondroitinase/NEWGENE AC/NEWGENE and/CC ABC/NEWGENE digestion/NN ,/, staining/NN reactions/NNS suggested/VBN that/IN the/DT highest/JJS levels/NNS of/IN dermatan/NN sulfate/NN were/VBD in/IN the/DT diabetes/NN resistant/JJ group/NN (/( p/NN less/PRP than/IN 0/CD ./CD 001/CD compared/VBN to/IN diabetic/JJ ,/, p/NN less/PRP than/IN 0/CD ./CD 001/CD compared/VBN to/IN diabetes/NN prone/RB )/SYM and/CC the/DT highest/JJS levels/NNS of/IN chondroitin/NN sulfates/NNS were/VBD in/IN the/DT diabetes/NN prone/JJ group/NN (/( p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ./.
@@75342858683 In/NN this/DT paper/NN we/PRP report/VBP that/DT ligand/NN binding/JJ induced/VBN tyrosine/NN phosphorylation/NN in/IN BaF3/NNP cells/NNS engineered/VBN to/IN express/NN the/DT murine/NEWGENE Mpl/NEWGENE receptor/NEWGENE (/( BaF3/NEWGENE //NEWGENE mMpl/NEWGENE )/SYM ./.
@@37174754393 New/NNP and/CC successful/JJ steps/NNS have/VBP been/VBN made/VBP in/IN immunodiagnostics/NN ,/, immunotherapy/NN ,/, and/CC immunoprophylaxis/NN of/IN immunologically/RB conditioned/JJ infertility/NN ./.
@@84287501629 Localization/NNS of/IN the/DT intronless/JJ gene/NN coding/JJ for/IN calmodulin-like/NEWGENE protein/NEWGENE CLP/NEWGENE1 to/IN human/JJ chromosome/NN 10p13-ter/JJ ./.
@@84862764692 Sequence/NN comparison/NN between/IN the/DT translated/VBN ORF/NN and/CC a/DT protein/NN database/NN reveal/VB between/IN 26/CD ./CD 5/CD and/CC 23/CD ./CD 4%/CD aa/NNS sequence/NN homology/NN to/IN bacterial/NEWGENE transmembrane/NEWGENE (/NEWGENE TM/NEWGENE )/NEWGENE proteins/NEWGENE including/JJ those/DT mediating/JJ chloramphenicol/NN (/( Cm/NN )/SYM and/CC tetracycline/NN (/( Tc/NN )/SYM resistance/NN and/CC an/DT arabinose-proton/JJ symport/NN protein/NN ./.
@@102129694485 Uroflowmetry/NN can/MD detect/VB dysuria/NN ,/, which/WDT may/MD be/VB poorly/RB perceived/JJ or/CC even/VB unknown/JJ to/IN the/DT subjects/NNS themselves/PRP ./.
@@65312866315 Removal/NNP of/IN lipid/NN fractions/NNS of/IN plant/NN extractions/NNS with/IN hexane/NN is/VBZ recommended/VBN to/IN avoid/VB damage/NN to/IN the/DT HPLC/NN column/NN ./.
@@94170825897 However/RB ,/, the/DT signaling/JJ cascade/NN utilized/VBN by/IN the/DT urokinase/NEWGENE receptor/NEWGENE is/VBZ only/RB incompletely/RB understood/VBP ./.
@@92784454322 Substrate/NNS specificity/NN of/IN the/DT RNase/NEWGENE activity/NN of/IN yeast/NEWGENE RNA/NEWGENE polymerase/NEWGENE III/NEWGENE ./.
@@95315382386 Despite/IN its/PRP requirement/NN for/IN enhancer-dependent/JJ splicing/JJ activity/NN in/IN vitro/FW ,/, the/DT dU2AF38/NEWGENE RS/NEWGENE domain/NEWGENE was/VBD also/RB inessential/JJ in/IN vivo/NN ./.
@@1963419150 The/DT rear/JJ silver/JJ liquid/JJ chamber/NN was/VBD threefold/RB thick/JJ to/IN 17/CD MeV/NN protons/NNS in/IN water/NN and/CC it/PRP efficiently/RB produced/VBD either/DT 13N/CD by/IN the/DT 16O/NN (/NN p/NN ,/, alpha/NN )/NN 13N/NN reaction/NN or/CC [/NN 18F/NN ]/NN fluoride/NN ion/NN by/IN the/DT 18O/NN (/NN p/NN ,/, n/NN )/NN 18F/NN reaction/NN ./.
@@107500216192 Furthermore/RB ,/, analysis/NN of/IN deletion/NN promoter-reporter/NN constructs/NN found/VBP that/IN the/DT basal/JJ activity/NN of/IN P2/NN resided/VBN in/IN the/DT proximal/JJ region/NN of/IN P2/NN ./NN
@@94076429362 We/PRP introduced/VBD the/DT gel/NN technique/NN as/IN a/DT routine/JJ assay/NN for/IN antibody/NN detection/NN and/CC identification/NN in/IN 1993/CD ./.
@@4903365232 Their/PRP conduction/NN velocity/NN ranged/VBN from/IN 0/CD ./CD 23/CD to/IN 0/CD ./CD 98/CD m/NN //NN sec/NN (/( group/NN C/NN )/SYM ./SYM
@@83378285928 Similar/JJ results/NNS were/VBD seen/VBP on/IN Western/JJ blots/NNS of/IN Autographa/NNP californica/NN MNPV/NNS (/( AcMNPV/NN )/NN -infected/NN Spodoptera/NN frugiperda/NN cells/NNS ./.
@@114629524236 Fasting/NN gastrin/NEWGENE levels/NNS (/( normal/JJ range/NN :/: 25-110/JJ mU/NN //NN L/NN )/SYM varied/VBN from/IN 48/CD ./CD 78/CD mU/CD //CD L-168/CD ./CD 20/CD (/( mean/JJ :/: 85/CD ./CD 23/CD mU/NN //NN L/NN )/SYM ./.
@@80589484273 CONCLUSION/IN :/: Sonographic/NN angiography/NN has/VBZ a/DT possible/JJ role/NN in/IN the/DT detection/NN of/IN small/JJ nodules/NNS in/IN patients/NNS with/IN CRF/NN ./.
@@113115507560 To/TO examine/VB transcriptional/JJ regulation/NN of/IN the/DT rat/NEWGENE eIF4E/NEWGENE gene/NEWGENE ,/, 2/CD ./CD 1/CD kB/CELL of/IN the/DT rat/NEWGENE eIF4E/NEWGENE promoter/NEWGENE region/NEWGENE was/VBD cloned/VBN and/CC the/DT contribution/NN of/IN specific/JJ elements/NNS in/IN regulating/JJ transcription/NN was/VBD determined/VBN in/IN primary/JJ cultures/NNS of/IN rat/NN cardiocytes/NNS and/CC in/IN a/DT murine/JJ C/NN (/NN 2/NN )/NN C/NN (/NN 12/NN )/NN myoblast/NN cell/NN line/NN ./.
@@95330304035 Cytochrome/NEWGENE b/NEWGENE in/IN human/NEWGENE complex/NEWGENE II/NEWGENE (/( succinate-ubiquinone/NEWGENE oxidoreductase/NEWGENE )/SYM :/: cDNA/NN cloning/NN of/IN the/DT components/NNS in/IN liver/NN mitochondria/NNS and/CC chromosome/NN assignment/NN of/IN the/DT genes/NNS for/IN the/DT large/JJ (/( SDHC/NEWGENE )/SYM and/CC small/JJ (/( SDHD/NEWGENE )/SYM subunits/NNS to/IN 1q21/CD and/CC 11q23/CD ./.
@@98324363597 Molecular/NNP cloning/NN and/CC characterization/NN of/IN a/DT new/JJ member/NN of/IN the/DT rat/NEWGENE placental/NEWGENE prolactin/NEWGENE (/( PRL/NEWGENE )/SYM family/NN ,/, PRL-like/NEWGENE protein/NEWGENE H/NNP ./NNP
@@106237588415 During/IN latency/NN ,/, more/RB than/IN 1%/NN of/IN neurons/NNS in/IN ganglia/NNS that/WDT innervate/VBP the/DT footpad/NN expressed/VBD beta-galactosidase/NEWGENE ,/, with/IN the/DT number/NN of/IN positive/JJ cells/NNS remaining/JJ constant/NN for/IN at/IN least/RB 5/CD months/NNS ./.
@@112301697706 Using/VBG a/DT novel/JJ method/NN combining/JJ chromatin/NN immunoprecipitation/NN and/CC genomic/JJ array/NN hybridization/NN ,/, we/PRP have/VBP identified/VBN a/DT 460-kb/NEWGENE CENP-A-binding/NEWGENE DNA/NEWGENE domain/NEWGENE of/IN a/DT neocentromere/NN derived/VBN from/IN the/DT 20p12/NN region/NN of/IN an/DT invdup/NN (/( 20p/CD )/SYM human/JJ marker/NN chromosome/NN ./.
@@89533401595 The/DT effects/NNS of/IN oral/JJ vanadyl/NN sulfate/NN (/( VOSO4/NN )/SYM (/( 0/CD ./CD 5/CD mg/NN //NN kg/NN //NN day/NN )/SYM on/IN anthropometry/NN ,/, body/NN composition/NN ,/, and/CC performance/NN were/VBD investigated/VBN in/IN a/DT 12-week/NN ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN involving/VBG weight-training/NN volunteers/NNS ./.
@@8273648249 A/DT new/JJ instrument/NN has/VBZ been/VBN designed/VBN for/IN freeze-fracturing/NN of/IN biological/JJ material/NN in/IN ultra/JJ high/JJ vacuum/NN ./.
@@1113946931 Ang/NEWGENE II/NEWGENE significantly/RB induced/VBD Ang2/NEWGENE mRNA/NEWGENE accumulations/NNS without/IN affecting/VBG Ang1/NEWGENE or/CC Tie2/NEWGENE expression/NN ,/, which/WDT was/VBD inhibited/VBN by/IN protein/NEWGENE kinase/NEWGENE C/NEWGENE inhibitors/NN and/CC by/IN intracellular/JJ Ca/NN (/NN 2+/NN )/NN chelating/JJ agents/NNS ./.
@@13241722589 Antibodies/NNS against/IN this/DT purified/VBN protein/NN localize/VB RIM1/NEWGENE to/IN mitochondria/NNS ./.
@@91187043547 RESULTS/NNS :/: Of/IN the/DT 29/CD patients/NNS who/WP received/VBD concurrent/JJ chemotherapy/NN and/CC G-CSF/NEWGENE ,/, ten/CD (/( 34%/JJ ;/: 95%/CD confidence/NN interval/NN [/NN CI/NN ]/NN ,/, 17/CD ./CD 9/CD to/IN 54/CD ./CD 3%/CD )/SYM were/VBD believed/VBN to/IN have/NN clinically/RB significant/JJ bleomycin/NN toxicity/NN ./.
@@96336309610 The/DT growth/NN of/IN Aer/NNP ./. hydrophila/NN in/IN filter-sterilized/JJ lettuce/NN extract/NN was/VBD completely/RB inhibited/VBN by/IN 0/CD ./CD 1%/CD (/( v/NN //NN v/NN )/SYM BMC/NN whereas/IN that/DT of/IN Ps/NN ./NN fluorescens/NNS was/VBD not/RB significantly/RB affected/VBN by/IN 1%/JJ (/( v/NN //NN v/NN )/SYM BMC/NN ./.
@@92236471919 Crystal/NNP structure/NN of/IN an/DT oligomer/NN of/IN proteolytic/NEWGENE zymogens/NEWGENE :/: detailed/JJ conformational/JJ analysis/NN of/IN the/DT bovine/JJ ternary/JJ complex/NN and/CC implications/NNS for/IN their/PRP activation/NN ./.
@@73118818889 MSMS/NN Council/NNP hears/VBZ new/JJ public/JJ health/NN director/NN ./.
@@18229957920 Maize/NEWGENE rbcS/NEWGENE promoter/NEWGENE activity/NN depends/VBZ on/IN sequence/NN elements/NNS not/RB found/VBP in/IN dicot/NEWGENE rbcS/NEWGENE promoters/NEWGENE ./.
@@27397399374 COUP/NEWGENE transcription/NEWGENE factor/NEWGENE is/VBZ a/DT member/NN of/IN the/DT steroid/NEWGENE receptor/NEWGENE superfamily/NEWGENE ./.
@@118610925081 When/WRB a/DT plateau/NN of/IN enhancement/NN was/VBD reached/VBN ,/, a/DT single/JJ lesion/NN in/IN each/DT patient/NN was/VBD imaged/VBN using/VBG five/CD different/JJ continuous/JJ scanning/JJ modes/NNS ,/, fundamental/JJ grey/JJ scale/NN (/( FGS/IN )/SYM ;/: fundamental/JJ colour/NN Doppler/NN (/( FCD/NNS )/SYM ;/: fundamental/JJ power/NN Doppler/NN (/( FPD/NNS )/SYM ;/: second/JJ harmonic/NN grey/JJ scale/NN (/( HGS/NN )/SYM ;/: and/CC pulse/NN inversion/NN mode/NN (/( Pim/NNP )/SYM using/VBG an/DT HDI5000/NNP scanner/NN and/CC C5-2/NN probe/NN (/( ATL/NN ,/, Bothell/NNP ,/, WA/NN )/SYM ./.
@@104288114148 Cat/NEWGENE proteins/NEWGENE are/VBP tyrosine-phosphorylated/JJ when/CC co-expressed/JJ in/IN cells/NNS with/IN the/DT focal/NEWGENE adhesion/NEWGENE kinase/NEWGENE Fak/NEWGENE1 and/CC Src/NEWGENE ./.
@@66864546444 Less/RBR antibacterial/JJ activity/NN was/VBD shown/VBP toward/IN the/DT Gram-negative/JJ bacilli/NNS ,/, i/FW ./FW e/FW ./FW ,/, Pseudomonas/NNS ,/, Klebsiella-Enterobacter/NNP ,/, Shigella/NN ,/, Escherichia/NN coli/JJ ,/, Serratia/NN marcescens/NNS and/CC Proteus/NN ./.
@@70445626819 From/IN Pap/NN to/IN ApUp/NN ./.
@@110940664200 This/DT transcriptional/JJ regulation/NN occurs/VBZ through/JJ modulation/NN of/IN the/DT forkhead/NEWGENE transcription/NEWGENE factor/NEWGENE FKHR-L1/NEWGENE1 ,/, and/CC IL-3/NEWGENE inhibited/VBN FKHR-L1/NEWGENE activity/NN in/IN a/DT PI3K-dependent/NN manner/NN ./.
@@6957125660 Utero-placental/JJ blood/NN flow/NN and/CC the/DT effect/NN of/IN beta/NEWGENE 2-adrenoceptor/NEWGENE stimulating/JJ drugs/NNS ./.
@@9642238774 Intron/NN 8/CD harbored/VBN a/DT strong/JJ erythroid-specific/NN enhancer/NN activity/NN which/WDT was/VBD orientation-dependent/JJ ./.
@@57183863308 Dermoid/NN cyst/NN in/IN a/DT free/JJ skin/NN flap/NN as/IN the/DT complication/NN after/IN treatment/NN of/IN recurring/JJ hernia/NN ./.
@@45124965007 Hodgkin's/NNP disease/NN ./.
@@70448423901 The/DT relationship/NN between/IN the/DT rare/JJ complications/NNS mentioned/VBN above/RB and/CC the/DT pathophysiology/NN of/IN Bartter's/NN syndrome/NN is/VBZ still/RB obscure/VB ./.
@@96097056267 Examination/NN of/IN the/DT mitochondrial/NEWGENE bc1/NEWGENE complex/NEWGENE crystal/NEWGENE structure/NEWGENE [/NN Zhang/NN ,/, Z/NNP ./NNP ,/, Huang/NNP ,/, L/NNP ./NNP ,/, Shulmeister/NNP ,/, V/NNP ./NNP
@@19179437771 Sequence/NN analysis/NN of/IN the/DT sMtCK/NEWGENE genomic/NEWGENE upstream/NEWGENE sequences/NEWGENE reveals/VBZ a/DT typical/JJ TATAA/NN box/NN within/IN the/DT 80/CD base/NN pairs/NNS (/( bp/NN )/SYM that/IN ,/, by/IN transfection/NN experiments/NNS ,/, are/VBP sufficient/JJ to/IN promote/VB expression/NN of/IN chimeric/JJ plasmids/NNS with/IN the/DT chloramphenicol/NEWGENE acetyltransferase/NEWGENE reporter/NEWGENE ./.
@@3543154210 Gonadal/JJ dysfunction/NN in/IN patients/NNS with/IN ataxia/NN telangiectasia/NN ./.
@@78577629367 The/DT MAP/NEWGENE kinase/NEWGENE cascade/NEWGENE is/VBZ highly/RB conserved/VBN in/IN all/DT eukaryotes/NNS and/CC involved/VBN in/IN numerous/JJ cellular/JJ responses/NNS ./.
@@11094066211 Taken/VBN together/RB ,/, these/DT observations/NNS indicate/VBP that/DT inhibition/NN of/IN p27/NEWGENE (/NEWGENE KIP1/NEWGENE )/NEWGENE transcription/NN through/RB PI3K-induced/NEWGENE FKHR-L1/NEWGENE phosphorylation/NN provides/VBZ a/DT novel/JJ mechanism/NN of/IN regulating/JJ cytokine-mediated/JJ survival/NN and/CC proliferation/NN ./.
@@1850105858 The/DT effects/NNS of/IN c-myc/NEWGENE were/VBD further/RB dissected/VBN by/IN showing/VBG that/DT c-myc/NEWGENE can/MD inhibit/VB differentiation/NN independently/RB of/IN Id/NEWGENE ,/, a/DT negative/JJ regulator/NN of/IN muscle/NN differentiation/NN ./.
@@31927997556 Statement/NN of/IN the/DT American/NNP Academy/NNP of/IN Implant/NNP Dentistry/NNP ./.
@@11539522747 The/DT NAUSICAA/NN system/NN gives/VBZ a/DT good/JJ knowledge/NN of/IN LET/NN spectra/NNS for/IN the/DT first/JJ time/NN in/IN space/NN dosimetry/NN ./.
@@79615457950 Other/JJ adverse/JJ events/NNS with/IN incidences/NNS significantly/RB higher/JJ than/IN with/IN placebo/NN were/VBD dizziness/NN ,/, constipation/NN ,/, sweating/NN ,/, nervousness/NN ,/, and/CC abnormal/JJ ejaculation/NN ./.
@@61756915998 Bacillus/NN cereus/NN cross-infection/NN in/IN a/DT maternity-unit/NN ./.
@@10564939388 The/DT effect/NN of/IN smoking/NN was/VBD not/RB examined/VBN in/IN this/DT study/NN ,/, as/IN such/JJ data/NN were/VBD not/RB available/JJ ./.
@@99187203681 The/DT S229A/NN variant/NN can/MD better/RBR flip/JJ modified/JJ bases/NNS but/CC does/VBP not/RB tightly/RB lock/VB the/DT flipped/VBN base/NN into/IN the/DT adenine-binding/JJ pocket/NN ,/, suggesting/VBG that/IN Ser229/NN could/MD form/VB a/DT contact/NN to/IN the/DT flipped/VBN adenine/NN ./.
@@51247075380 Dynamics/NNP of/IN hospital/NN stay/NN in/IN peptic/JJ ulcer/NN patients/NNS ./.
@@85053406207 Characterization/NNS and/CC hormonal/JJ regulation/NN of/IN the/DT promoter/NN of/IN the/DT rat/NEWGENE prostaglandin/NEWGENE endoperoxide/NEWGENE synthase/NEWGENE 2/NEWGENE gene/NEWGENE in/IN granulosa/NN cells/NNS ./.
@@22417422882 Cerebral/NNP flow/NN and/CC resistance/NN showed/VBD minor/JJ reductions/NNS with/IN HD/NNP ./NNP
@@118045101674 Losses/NNS of/IN dichlofluanid/NN (/( 54%/JJ )/SYM ,/, chlozolinate/NN (/( 22%/JJ )/SYM ,/, and/CC etridiazole/NN (/( 40%/CD )/SYM ,/, previously/RB reported/VBN to/IN occur/VB during/IN ambient/JJ processing/NN of/IN apples/NNS ,/, were/VBD reduced/VBN to/IN barely/RB significant/JJ levels/NNS (/( 10/CD ,/, 17/CD ,/, and/CC 14%/JJ ,/, respectively/RB )/SYM by/IN cryogenic/JJ processing/NN ./.
@@22311622873 Further/JJ studies/NNS of/IN mandibular/JJ movement/NN at/IN initial/JJ tooth/NN contact/NN ./.
@@93318641071 Serum/NN concentrations/NNS of/IN E2/NN and/CC TBOH/NN were/VBD measured/VBN on/IN d/NN 0/NN ,/, 1/CD ,/, 3/CD ,/, 5/CD ,/, 7/CD ,/, 13/CD ,/, 21/CD ,/, 28/CD ,/, 42/CD ,/, 56/CD ,/, 84/CD ,/, 112/CD ,/, and/CC 140/CD in/IN finishing/JJ heifers/NNS administered/VBD the/DT following/NN treatments/NNS :/: 1/NN )/NN control/NN ;/: 2/NN )/NN MGA/IN ,/, ./CD 5/CD mg/NN per/IN heifer/NN daily/JJ ;/: 3/NN )/NN Revalor-H/NNP (/( 140/CD mg/NN TBA/NN +/SYM 14/CD mg/NN E2/NN )/SYM ;/: 4/NN )/NN Revalor-H/NNP +/SYM MGA/IN ;/: 5/NN )/NN Finaplix-H/NNP (/( 200/CD mg/NN TBA/NN )/SYM ;/: and/CC 6/NN )/NN Finaplix-H/NNP +/SYM MGA/DT ./.
@@74907421601 This/DT finding/NN is/VBZ consistent/JJ with/IN the/DT notion/NN that/IN the/DT dsRNA/NN binding/NN domains/NN may/MD be/VB composed/VBN of/IN two/JJ separate/JJ functional/JJ subdomains/NNS ./.
@@80347082463 The/DT molecular/JJ basis/NN for/IN commitment/NN of/IN progenitors/NNS to/IN the/DT eosinophil/JJ lineage/NN and/CC mechanisms/NNS by/IN which/WDT eosinophil-specific/NN genes/NN are/VBP expressed/VBN and/CC regulated/VBN during/IN differentiation/NN is/VBZ unknown/JJ ./.
@@114062779824 To/TO test/VB the/DT hypothesis/NN that/IN these/DT elements/NNS are/VBP required/VBN for/IN promoter/NN activity/NN ,/, we/PRP compared/VBD the/DT reporter/NN expression/NN activity/NN of/IN segments/NN containing/NN mutations/NN of/IN these/DT elements/NNS with/IN activity/NN of/IN the/DT parent/NEWGENE Hlx/NEWGENE promoter/NEWGENE sequence/NEWGENE ./.
@@115767761462 2/CD :/: The/DT dynamic/JJ moduli/NNS of/IN microcrystalline/NEWGENE cellulose/NEWGENE ./.
@@37717034443 N-Substituted/JJ trimethylsilylcarbamates/NNS were/VBD tested/VBN as/IN derivatizing/JJ reagents/NNS for/IN gas/NN chromatographic/JJ analysis/NN ./.
@@70496906820 Glomerular/JJ lesions/NNS in/IN renal/JJ allografts/NNS ./.
@@94097743565 At/NN the/DT genomic/JJ level/NN ,/, the/DT sequences/NNS of/IN two/JJ members/NNS of/IN this/DT family/NN are/VBP known/VBP in/IN the/DT rat/NN Rattus/NNP norvegicus/NN :/: the/DT VCSA1/NEWGENE gene/NEWGENE ,/, encoding/VBG the/DT prohormone-like/NEWGENE polypeptide/NEWGENE SMR1/NEWGENE ,/, and/CC the/DT VCSB1/NEWGENE gene/NEWGENE ,/, encoding/VBG a/DT salivary/JJ Pro-rich/NNP polypeptide/NN ./.
@@6767907151 Angiotensin/NEWGENE effect/NN in/IN the/DT human/JJ kidney/NN ./.
@@18407116739 The/DT RNA/NN genome/NN of/IN rabbit/NN hemorrhagic/JJ disease/NN virus/NN (/( RHDV/ORG )/SYM was/VBD molecularly/RB cloned/VBN ./.
@@98521367063 We/PRP have/VBP introduced/VBN a/DT mutation/NN (/( Ser36/NN --/JJ >/JJ Asn/NN )/SYM into/IN this/DT domain/NN of/IN p190/NEWGENE that/WDT decreased/VBD its/PRP ability/NN to/IN bind/NN guanine/NN nucleotide/NN when/CC expressed/VBN as/IN a/DT hemagglutinin/NEWGENE (/( HA/NEWGENE )/NN -tagged/NN protein/NN in/IN COS/NN cells/NNS ./.
@@90538351123 Increased/VBN p53/NEWGENE activity/NN induced/VBN by/IN OP/NN is/VBZ not/RB due/NN to/IN elevated/VBN p53/NEWGENE mRNA/NEWGENE nor/CC to/IN protein/NN levels/NNS ./.
@@16191142203 In/NN an/DT ongoing/JJ study/NN the/DT performance/NN of/IN the/DT SMSP/NNP is/NNS being/VBP compared/VBN with/IN that/DT of/IN the/PDT Mini/DT Speech/NN Processor/NN (/( MSP/NN )/SYM ./.
@@2669199829 Tumor/NEWGENE necrosis/NEWGENE factor/NEWGENE (/( TNF/NEWGENE )/SYM is/VBZ reported/VBN to/IN cause/VBG a/DT shock/NN syndrome/NN similar/JJ to/IN that/DT produced/VBD by/IN endotoxin/NEWGENE (/( LPS/NEWGENE )/SYM ./.
@@77393822125 Phylogenetic/JJ analyses/NNS of/IN 19/CD amino/JJ acid/NN sequences/NNS of/IN 6/NN related/NN protein/NN types/NNS indicate/VBP that/IN actin-associated/NN proteins/NN related/VBN to/IN gelsolin/NEWGENE are/VBP monophyletic/JJ to/IN a/DT common/JJ ancestor/NN and/CC include/VB flightless/NEWGENE proteins/NEWGENE ./.
@@91929981294 Whereas/IN the/DT mutant/JJ enzymes/NNS terminate/VBP normally/RB at/IN the/DT late/JJ terminator/NN in/IN T7/NN DNA/NN (/( T/NN (/NN phi/NN )/NN )/NN and/CC rrnB/NN T2/NN ,/, they/PRP fail/NN to/IN terminate/VB at/IN one/PRP of/IN the/DT termination/NN sites/NNS of/IN rrnB/NN T1/NN ,/, and/CC also/RB fail/VB to/IN recognize/VB the/DT PTH/NEWGENE and/CC CJ/NN signals/NNS ./.
@@28267173526 Anoxia/NNS was/VBD introduced/VBN by/IN perfusing/JJ the/DT gill/NN with/IN water/NN deprived/VBN of/IN oxygen/NN or/CC by/IN halting/JJ the/DT water/NN flow/NN to/IN the/DT gill/NN ./.
@@92246557460 Alternative/JJ splicing/JJ of/IN ClC-6/NEWGENE (/( a/DT member/NN of/IN the/DT CIC/NEWGENE chloride-channel/NEWGENE family/NEWGENE )/SYM transcripts/NNS generates/VBZ three/CD truncated/JJ isoforms/NNS one/PRP of/IN which/WDT ,/, ClC-6c/NEWGENE ,/, is/VBZ kidney-specific/JJ ./.
@@13345181658 Strategies/NNS for/IN blood/NN screening/JJ for/IN the/DT hepatitis/NN C/NN virus/NN and/CC for/IN the/DT human/JJ immunodeficiency/NN virus/NN in/IN high/JJ risk/NN groups/NNS ./.
@@76464393650 We/PRP purified/VBN both/DT proteins/NNS from/IN human/JJ platelet/NN membranes/NNS using/VBG DEAE-Sepharose/DT chromatography/NN followed/VBN by/IN mAb/NEWGENE F11/NEWGENE affinity/NN chromatography/NN ./.
@@67915003500 The/DT evaluation/NN of/IN amniotic/JJ fluid/NN delta/NN OD450/NN is/VBZ considered/VBN to/IN be/VB the/DT cornerstone/NN of/IN clinical/JJ management/NN ./.
@@5132848191 5/NN )/NN Before/IN and/CC ten/CD days/NNS after/IN DOTC/NN infusion/NN ,/, laboratory/NN tests/NNS for/IN liver/NN and/CC renal/JJ functions/NNS and/CC blood/NN were/VBD performed/VBN ./.
@@13212774454 A/DT recombinant/NN with/IN a/DT 5'/CD end/NN from/IN src/NEWGENE and/CC a/DT 3'/CD end/NN from/IN ros/NEWGENE ,/, called/VBN SRC/NEWGENE x/NN ROS/NEWGENE ,/, transformed/VBN chicken/NN embryo/NN fibroblasts/NNS (/( CEF/NNP )/SYM to/IN a/DT spindle/NN shape/NN morphology/NN ,/, mimicking/VBG that/IN of/IN UR2/NEWGENE ./.
@@29756803692 After/IN one/PRP accommodation/NN night/NN ,/, sleep/NN EEG/NN recordings/NNS were/VBD performed/VBN during/IN three/CD consecutive/JJ nights/NNS in/IN ten/CD drug-free/JJ inpatients/NNS presenting/VBG generalized/JJ anxiety/NN disorder/NN (/( GAD/NN )/SYM with/IN significant/JJ depression/NN ,/, compared/VBN with/IN a/DT age-/JJ and/CC sex-matched/JJ group/NN of/IN patients/NNS with/IN GAD/NN and/CC a/DT group/NN of/IN primary/JJ major/JJ depressive/JJ disorder/NN (/( MDD/NNS )/SYM patients/NNS ./.
@@22360645131 S6/NEWGENE kinase/NEWGENE activation/NN requires/VBZ displacement/NN of/IN this/DT inhibitory/JJ segment/NN ,/, which/WDT is/VBZ proposed/VBN to/IN occur/VB consequent/JJ to/IN its/PRP multiple/JJ phosphorylation/NN ./.
@@91910528468 Thus/RB ,/, the/DT PCE/NEWGENE binds/VBZ a/DT Pbx/NEWGENE dimer/NEWGENE partner/NEWGENE that/WDT behaves/VBZ unlike/IN Class/NEWGENE I/NEWGENE Hox/NEWGENE proteins/NEWGENE ./.
@@99893399990 Most/JJS recently/RB ,/, the/DT use/NN of/IN the/DT product/NN of/IN brain/NN weight/NN and/CC clearance/NN has/VBZ been/VBN proposed/VBN ./.
@@90862687388 Purified/NEWGENE P7/NEWGENE could/MD be/VB assembled/VBN onto/IN particles/NNS lacking/VBG P7/NEWGENE and/CC particles/NNS lacking/VBG both/DT P2/NEWGENE (/( RNA/NEWGENE polymerase/NEWGENE )/SYM and/CC P7/NNP ./NNP
@@81223643538 Deletion/NNS analyses/NNS of/IN the/DT pCD41/NEWGENE ORF-A/NEWGENE and/CC the/DT use/NN of/IN promoter/NN constructs/NNS further/RB mapped/VBN an/DT internal/JJ functional/JJ promoter/NN within/IN the/DT pCD41/NEWGENE sequence/NEWGENE that/WDT can/MD direct/VB the/DT synthesis/NN of/IN the/DT trans-activating/JJ protein/NN ./.
@@86895208672 Reproductive/NNP period/NN affects/VBP water/NN intake/NN in/IN heat-stressed/RB dehydrated/VBN goats/NNS ./.
@@86000289311 Our/PRP data/NN suggest/VB that/DT trans-activation/NN from/IN the/DT prothymosin/NEWGENE intron/NEWGENE enhancer/NEWGENE is/VBZ a/DT faithful/JJ reflection/NN of/IN the/DT transforming/JJ properties/NNS of/IN the/DT Myc/NEWGENE protein/NEWGENE ./.
@@103301349094 The/DT mRNA/NN expression/NN of/IN RFX1/NEWGENE ,/, RFX2/NEWGENE ,/, and/CC RFX3/NEWGENE was/VBD detected/VBN ubiquitously/RB ,/, but/CC in/IN transient-transfection/JJ assays/NNS ,/, multimerized/NEWGENE RFX/NEWGENE binding/NEWGENE sites/NEWGENE in/IN front/NN of/IN a/DT basal/JJ promoter/NN efficiently/RB functioned/VBD in/IN a/DT tissue-/JJ and/CC lineage-specific/JJ manner/NN ./.
@@93954564043 To/TO study/VB the/DT role/NN of/IN heavy/NEWGENE chain/NEWGENE motifs/NEWGENE in/IN substrate/NN recognition/NN ,/, secreted/VBN variants/NNS of/IN recombinant/NEWGENE bovine/NEWGENE proenteropeptidase/NEWGENE were/VBD constructed/VBN by/IN replacing/VBG the/DT transmembrane/JJ domain/NN with/IN a/DT signal/JJ peptide/NN ./.
@@74138067260 The/DT centromedial/JJ amygdala/NN and/CC gastric/JJ pathology/NN in/IN rats/NNS ./.
@@107772173307 The/DT p53-homolog/NEWGENE p73beta/NEWGENE1 also/RB activated/VBN the/DT PIG3/NEWGENE promoter/NEWGENE ,/, but/CC in/IN contrast/NN to/IN p53/NEWGENE ,/, the/DT proline-rich/JJ domain/NN of/IN p73beta/NEWGENE (/NEWGENE residues/NEWGENE 81-113/NEWGENE )/NEWGENE was/VBD dispensable/JJ to/IN induce/VB the/DT PIG3/NEWGENE promoter/NEWGENE ./.
@@95358335647 The/DT predicted/VBN amino/JJ acid/NN sequence/NN of/IN m-Staf/NEWGENE is/VBZ highly/RB homologous/JJ to/IN that/DT of/IN Staf/NEWGENE ,/, another/DT selenocysteine/NEWGENE tRNA/NEWGENE gene/NEWGENE transcription/NEWGENE activating/NEWGENE factor/NEWGENE of/IN Xenopus/NN laevis/NNS ./.
@@16334351615 The/DT DRF-2/NEWGENE nuclear/NEWGENE protein/NEWGENE has/VBZ characteristics/NNS similar/JJ to/IN those/DT of/IN the/DT muscle-specific/NN regulatory/NN factor/NN ,/, MEF-2/NEWGENE (/( Buskin/VBP and/CC Hauschka/NNP 1989/CD ;/: Gossett/NNP et/FW al/NNS ./NNS ,/, 1989/CD )/SYM ./.
@@114284871305 Pulmonary/NNP vein/NN varix/NN in/IN association/NN with/IN bilateral/JJ pulmonary/JJ vein/NN stenosis/NN ./.
@@82731228247 RESULTS/NNS :/: At/NN the/DT beginning/NN of/IN the/DT QA/NNP //NNP QI/NNP process/NN ,/, monitoring/NN of/IN blood/NN administration/NN practices/NNS revealed/VBN that/IN a/DT variance/NN from/IN institutional/JJ blood/NN administration/NN policy/NN occurred/VBN during/IN 50/CD percent/NN of/IN blood/NN and/CC component/NN transfusions/NNS ./.
@@118363033036 TNFalpha/NEWGENE and/CC IL-6/NEWGENE levels/NNS were/VBD determined/VBN in/IN the/DT culture/NN supernatants/NNS ./.
@@85235454189 The/DT human/NEWGENE papillomavirus/NEWGENE type/NEWGENE 16/NEWGENE E7/NEWGENE protein/NEWGENE complements/NNS adenovirus/NEWGENE type/NEWGENE 5/NEWGENE E1A/NEWGENE amino-terminus-dependent/JJ transactivation/NN of/IN adenovirus/NN type/NN 5/NN early/NN genes/NN and/CC increases/NNS ATF/NEWGENE and/CC Oct-1/NEWGENE DNA/NN binding/JJ activity/NN ./.
@@75813646627 In/NN two/JJ further/RB cases/VBZ (/( one/PRP type/NN I/NN and/CC one/PRP type/NN III/NN SMA/NN )/SYM ,/, de/FW novo/FW deletions/NNS of/IN only/RB one/PRP copy/NN of/IN Ag1-CA/NEWGENE and/CC C212/NEWGENE were/VBD found/VBN ./.
@@25304131232 In/NN supine/JJ position/NN ,/, plasma/NN ANP/NEWGENE levels/NNS ranged/VBN from/IN 12/CD pg/NN //NN ml/NN to/IN 51/CD ./CD 5/CD pg/NN //NN ml/NN ,/, with/IN an/DT average/JJ level/NN of/IN 35/CD ./CD 3/CD +/NN //NN -/NN 11/CD ./CD 5/CD pg/NN //NN ml/NN ./.
@@24817797318 NIK-244/NN suppressed/VBN coronary/JJ ligation-/JJ and/CC digitalis-induced/JJ arrhythmias/NNS ,/, and/CC the/DT minimum/JJ effective/JJ plasma/NN concentrations/NNS for/IN arrhythmias/NNS induced/VBN by/IN 24-h/JJ and/CC 48-h/JJ coronary/JJ ligation/NN and/CC digitalis/NN were/VBD 0/CD ./CD 41/CD +/NN //NN -/NN 0/CD ./CD 10/CD (/( by/IN 1/CD mg/CD //CD kg/CD i/CD ./CD v/CD ./CD )/SYM ,/, 0/CD ./CD 70/CD +/NN //NN -/NN 0/CD ./CD 13/CD (/( by/IN 1/CD mg/CD //CD kg/CD i/CD ./CD v/CD ./CD )/SYM ,/, and/CC 0/CD ./CD 21/CD +/NN //NN -/NN 0/CD ./CD 08/CD (/( by/IN 0/CD ./CD 5/CD mg/CD //CD kg/CD i/CD ./CD v/CD ./CD )/SYM microgram/NN //NN ml/NN ,/, respectively/RB (/( mean/JJ +/NN //NN -/NN SD/NN of/IN the/DT mean/NN ,/, n/NN =/SYM 6/CD )/SYM ./SYM
@@86012849350 The/DT 5'/CD external/NN transcribed/VBN spacer/NN (/( ETS/NN )/SYM region/NN of/IN the/DT pre-rRNA/NN in/IN Saccharomyces/NN cerevisiae/NN contains/VBZ a/DT sequence/NN with/IN 10/CD bp/NN of/IN perfect/JJ complementarity/NN to/IN the/DT U3/NEWGENE snoRNA/NEWGENE ./.
@@104064627084 This/DT constitutes/VBZ evidence/NN for/IN an/DT in/NN vivo/NN role/NN of/IN SRC-1/NEWGENE in/IN dimerization-induced/JJ activation/NN by/IN OR1/NEWGENE //NEWGENE RXRalpha/NEWGENE ./.
@@75287724968 To/TO further/RB define/VB the/DT structural/JJ requirements/NNS for/IN ZAP-70/NEWGENE interaction/NN with/IN the/DT TCR/NEWGENE ,/, we/PRP developed/VBD a/DT binding/JJ assay/NN using/VBG immobilized/JJ glutathione/NEWGENE S-transferase/NEWGENE fusion/NEWGENE proteins/NEWGENE containing/JJ the/DT NH2-/NNP and/DT //DT or/DT COOH-terminal/NEWGENE SH2/NEWGENE domains/NEWGENE of/IN ZAP-70/NEWGENE ,/, and/CC soluble/JJ synthetic/JJ peptides/NNS with/IN the/DT sequence/NN of/IN the/DT cytoplasmic/JJ region/NN of/IN the/DT TCR/NEWGENE zeta/NEWGENE chain/NEWGENE (/( TCR/NEWGENE zeta/NEWGENE cyt/NEWGENE )/SYM or/CC individual/JJ TCR/NEWGENE zeta/NEWGENE and/CC CD3/NEWGENE epsilon/NEWGENE TAM/NEWGENE motifs/NEWGENE ./.
@@22813302554 The/DT inspiratory/JJ oxygen/NN concentration/NN needed/VBN (/( FiO2/NN )/SYM and/CC the/DT Horowitz/NNP quotient/NN differed/VBN in/IN a/DT highly/RB significant/JJ manner/NN beginning/NN on/IN the/DT 1st/CD day/NN after/IN trauma/NN ./.
@@8985004716 The/DT sera/NNS and/CC nasal/JJ secretions/NNS of/IN 142/CD patients/NNS ,/, who/WP were/VBD positive/JJ in/IN HD/NN or/CC mites/NNS skin/NN test/NN ,/, were/VBD subjected/VBN to/IN a/DT radioallergosorbent/JJ test/NN (/( RAST/NN )/SYM for/IN estimating/VBG the/DT specific/NN IgE/NEWGENE antibody/NEWGENE activity/NN to/IN mites/NNS ./.
@@105552855362 This/DT organization/NN suggests/VBZ that/IN duplication/NN events/NNS that/WDT have/VBP generated/VBN the/DT primate/NEWGENE FUT3-FUT5-FUT6/NEWGENE cluster/NEWGENE might/MD have/VB occurred/VBN through/RB a/DT long-interspersed-nuclear-element-based/JJ mechanism/NN of/IN unequal/JJ crossing/NN over/RB ,/, as/IN described/VBN for/IN the/DT globin/NEWGENE cluster/NEWGENE ./.
@@1003461530 Structure/NNS determination/NN of/IN an/DT adsorbate-induced/JJ multilayer/JJ reconstruction/NN :/: (/( 1/CD x/NN 2/CD )/NN -H/NN //NN Ni/NN (/NN 110/NN )/NN ./.
@@99905075310 BACKGROUND/IN :/: In/NN the/DT ubiquitin-dependent/JJ proteolysis/NN pathway/NN ,/, a/DT ubiquitin/NEWGENE ligase/NEWGENE (/( E3/NEWGENE )/SYM is/VBZ responsible/JJ for/IN substrate/NN selectivity/NN and/CC timing/NN of/IN degradation/NN ./.
@@16505242876 The/DT initial/JJ phase/NN of/IN increased/VBN vascular/JJ permeability/NN in/IN the/DT peritoneal/JJ cavity/NN and/CC LTB4/NN production/NN was/VBD dose/NN dependently/RB inhibited/VBD by/IN the/DT 5-LO/NN inhibitors/NN phenidone/NN ,/, BW/NN A4C/NN ,/, A63162/NN ,/, and/CC ICI/NN 207/NN 968/NN but/CC not/RB by/IN dexamethasone/NN or/CC colchicine/NN ./.
@@9310899270 Circulatory/JJ arrest/NN in/IN the/DT operating/JJ room/NN ./.
@@110970795284 This/DT study/NN is/VBZ a/DT further/RB and/CC more/RB extensive/JJ validation/NN of/IN the/DT clinician/NN rated/JJ NIMH-LCM-p/NN ./.
@@38877696294 The/DT Mean/VB was/VBD 74/CD ,/CD 3/CD +/NN //NN -/NN 53/CD ,/CD 6/CD micrograms/NNS J/NNS //NNS g/NNS Cr/NN ,/, the/DT Median/JJ 61/CD micrograms/NNS J/NN //NN g/NN Cr/NNP ./NNP
@@86112808915 Left/NNP atrial/JJ volumes/NNS were/VBD greater/JJR in/IN old/RB compared/VBN with/IN young/JJ subjects/NNS (/( maximal/JJ :/: 31/CD +/NN //NN -/NN 10/CD cm3/NN //NN m2/NN vs/NNP 24/CD +/NN //NN -/NN 8/CD cm3/NN //NN m2/NN ,/, p/NN =/SYM 0/CD ./CD 02/CD ;/: at/IN onset/NN of/IN atrial/JJ systole/NN :/: 23/CD +/NN //NN -/NN 8/CD cm3/NN //NN m2/NN vs/NNP 15/CD +/NN //NN -/NN 5/CD cm3/NN //NN m2/NN ,/, p/NN =/SYM 0/CD ./CD 0002/CD ;/: minimal/JJ :/: 13/CD +/NN //NN -/NN 5/CD cm3/NN //NN m2/NN vs/NNP 9/CD +/NN //NN -/NN 4/CD cm3/NN //NN m2/NN ,/, p/NN =/SYM 0/CD ./CD 001/CD )/SYM ./.
@@14032222022 This/DT article/NN describes/VBZ the/DT collaborative/JJ care/NN of/IN the/DT woman/NN participating/JJ in/IN maternal/JJ blood/NN donation/NN for/IN intrauterine/JJ transfusion/NN ./.
@@13545061979 Gestational/JJ trophoblastic/JJ diseases/NNS :/: recent/JJ advances/NNS in/IN the/DT understanding/NN of/IN cytogenetics/NN ,/, histopathology/NN ,/, and/CC natural/JJ history/NN ./.
@@91307202966 A/DT genetic/JJ screen/NN applied/VBN to/IN mutants/NNS in/IN the/DT branch/NN site/NN region/NN shows/VBZ that/IN all/DT positions/NNS in/IN the/DT conserved/VBN TACTAAC/NN sequence/NN are/VBP important/JJ for/IN intron/NN recognition/NN ./.
@@118432521722 A/DT global/JJ response/NN rate/NN was/VBD 17%/JJ (/( 95%/CD confidence/NN interval/NN (/( 95%/CD CI/NN )/SYM :/: 2%-32%/NN )/NN and/CC the/DT median/JJ overall/JJ survival/NN was/VBD 12/CD months/NNS ./.
@@27948283483 The/DT system/NN consisted/VB of/IN the/DT intact/JJ canine/JJ heart/NN connected/VBN to/IN a/DT microcomputer/NN that/WDT operated/VBD as/IN the/DT modulated/VBN parasystolic/JJ pacemaker/NN ./.
@@113598272558 Immunological/JJ and/CC biochemical/JJ characterization/NN of/IN streptococcal/NEWGENE pyrogenic/NEWGENE exotoxins/NEWGENE I/NEWGENE and/NEWGENE J/NEWGENE (/( SPE-I/NEWGENE and/CC SPE-J/NEWGENE )/SYM from/IN Streptococcus/NN pyogenes/NNS ./.
@@16464872250 Patients/NNS with/IN an/DT enzymatic/JJ activity/NN below/RB X--1/NN manifested/VBN a/DT decrease/NN of/IN the/DT content/NN of/IN IgA/NEWGENE ,/, IgG/NEWGENE ,/, IgM/NEWGENE ,/, T/NN and/CC B/NNP lymphocytes/NNS ,/, and/CC of/IN phagocytic/JJ activity/NN of/RB neutrophils/NNS as/IN compared/VBN to/IN patients/NNS exhibiting/VBG a/DT high/JJ enzymatic/JJ activity/NN ./.
@@1772341313 These/DT data/NN suggest/VB that/IN the/DT combined/JJ treatment/NN with/IN a/DT thromboxane/NEWGENE synthetase/NEWGENE inhibitor/NN and/CC a/DT thromboxane/NEWGENE receptor/NEWGENE antagonist/NN provides/VBZ a/DT better/JJR protection/NN against/IN digoxin/NN intoxication/NN than/IN with/IN either/DT agent/NN alone/RB ./.
@@10228795171 RESULTS/NNS :/: Cholinergic/NN nerves/NNS are/VBP mainly/RB involved/VBN in/IN the/DT regulation/NN of/IN enteric/JJ nerve/NN responses/NNS to/IN EFS/NNS in/IN the/DT normal/JJ IAS/NNS ./.
@@94202525558 These/DT are/VBP the/DT long/NEWGENE terminal/NEWGENE repeat/NEWGENE (/NEWGENE LTR/NEWGENE )/NEWGENE promoter/NEWGENE ,/, which/WDT regulates/VBZ expression/NN of/IN the/DT viral/JJ structural/JJ proteins/NNS ,/, and/CC a/DT second/JJ internal/JJ promoter/NN ,/, located/VBN towards/IN the/DT 3'/CD end/NN of/IN the/DT env/NEWGENE gene/NEWGENE ,/, that/WDT directs/VBZ expression/NN of/IN the/DT viral/NN auxiliary/NN proteins/NN ./.
@@91873716296 The/DT 1/CD ./CD 1-/CD and/CC 1/CD ./CD 3-kb/CD mRNA/NN species/NN were/VBD found/VBN only/RB in/IN the/DT heart/NN ,/, and/CC the/DT 2/CD ./CD 6-kb/CD species/NN was/VBD found/VBN in/IN the/DT heart/NN ,/, kidney/NN and/CC brain/NN ,/, but/CC not/RB in/IN skeletal/JJ muscle/NN or/CC liver/NN ./.
@@39880014645 It/PRP has/VBZ been/VBN reported/VBN that/DT rat/NN blood/NN chloroform/NN levels/NNS were/VBD significantly/RB decreased/VBN after/IN treatment/NN with/IN ClO2/NN ./.
@@21673212823 A/DT DNA/NN motif/NN related/VBN to/IN the/DT cAMP-responsive/NEWGENE element/NEWGENE and/CC an/DT exon-located/NEWGENE activator/NEWGENE protein-2/NEWGENE binding/NEWGENE site/NEWGENE in/IN the/DT human/NEWGENE tissue-type/NEWGENE plasminogen/NEWGENE activator/NEWGENE gene/NEWGENE promoter/NEWGENE cooperate/VB in/IN basal/JJ expression/NN and/CC convey/VB activation/NN by/IN phorbol/NN ester/NN and/CC cAMP/NN ./.
@@20455243292 To/TO facilitate/VB the/DT availability/NN of/IN important/JJ new/JJ therapeutic/JJ agents/NNS ,/, the/DT Food/NNP and/CC Drug/NNP Administration/NNP (/( FDA/NN )/SYM in/IN the/DT mid-1970s/NNS began/VBD assigning/JJ therapeutic/JJ ratings/NNS to/IN investigational/JJ new/JJ drugs/NNS and/CC holding/JJ end-of-phase/NN II/NN conferences/NNS with/IN drug/NN sponsors/NNS ./.
@@1005517356 Band/NNP structure/NN effects/NNS of/IN transport/NN properties/NNS in/IN icosahedral/JJ quasicrystals/NNS ./.
@@77244527680 Each/DT dietary/JJ treatment/NN was/VBD fed/VBN to/IN six/CD pen/NN replicates/NNS of/IN five/CD chicks/NNS per/IN pen/NN for/IN 21/CD d/CD ./CD
@@75882455696 Repression/NN of/IN glucocorticoid/NN receptor-mediated/NN transcriptional/JJ activation/NN by/IN unliganded/NN thyroid/NEWGENE hormone/NEWGENE receptor/NEWGENE (/( TR/NEWGENE )/SYM is/VBZ TR/NEWGENE isoform-specific/NN ./.
@@75746826681 cDNA/NN encoding/VBG a/DT functional/JJ feline/NEWGENE liver/NEWGENE //NEWGENE bone/NEWGENE //NEWGENE kidney-type/NEWGENE alkaline/NEWGENE phosphatase/NEWGENE ./.
@@80001122715 Goodpasture's-like/NNP syndrome/NN and/CC effect/NN of/IN extracorporeal/JJ membrane/NN oxygenator/NN support/NN ./.
@@85756189156 RNase/NEWGENE protection/NN assays/NNS revealed/VBD a/DT correlation/NN between/IN the/DT levels/NNS of/IN dorsal/JJ and/CC ventral/JJ skin/NN expression/NN with/IN pigmentation/NN //NN phaeomelanin/NN phenotypes/NNS ./.
@@87005319911 Because/IN chromosome/NN X/NN is/VBZ frequently/RB involved/VBN in/IN structural/JJ alterations/NNS in/IN neoplastic/JJ Syrian/JJ hamster/NN cells/NNS transformed/VBN by/IN chemical/JJ carcinogens/NNS and/CC oncogenic/JJ viruses/NNS ,/, the/DT localization/NN of/IN the/DT cph/NEWGENE locus/NEWGENE on/IN this/DT chromosome/NN supports/VBP the/DT notion/NN that/IN the/DT cph/NEWGENE oncogene/NEWGENE plays/VBP a/DT role/NN in/IN the/DT malignant/JJ conversion/NN of/IN chemically/RB transformed/VBN hamster/NN fibroblasts/NNS ./.
@@10308312183 In/NN this/DT paper/NN ,/, the/DT current/JJ status/NN of/IN the/DT understanding/NN of/IN the/DT interaction/NN mechanisms/NNS of/IN ultrasound/JJ with/IN biological/JJ media/NN and/CC the/DT factors/NNS that/WDT govern/VBP different/JJ biological/JJ effects/NNS are/VBP surveyed/VBN ./.
@@3613404283 Most/JJS of/IN the/DT phenomena/NNS of/IN azotaemic/JJ osteodystrophy/NN are/VBP encountered/VBN in/IN simple/JJ vitamin/NN D/NN deficiency/NN ;/: as/IN in/IN that/DT condition/NN ,/, deficiency/NN of/IN 1/NN ,/NN 25-dihydroxycholecalciferol/NN may/MD be/VB of/IN primary/JJ significance/NN in/IN causing/JJ secondary/JJ hyperparathyroidism/NN in/IN renal/JJ failure/NN ./.
@@10498616916 A/DT G22V/NEWGENE mutant/NEWGENE of/IN M-Ras/NEWGENE was/VBD constitutively/RB active/JJ and/CC its/PRP expression/NN in/IN an/DT interleukin-3/NEWGENE (/( IL-3/NEWGENE )/NN -dependent/NN mast/NN cell/NN //NN megakaryocyte/NN cell/NN line/NN resulted/VBN in/IN increased/VBN survival/NN in/IN the/DT absence/NN of/IN IL-3/NEWGENE ,/, increased/VBN growth/NN in/IN IL-4/NEWGENE ,/, and/CC ,/, at/IN high/JJ expression/NN levels/NNS ,/, in/IN factor-independent/JJ growth/NN ./.
@@85427468524 Diabetes/NNP care/NN :/: a/DT guideline/NN to/IN the/DT facilities/NNS needed/VBN to/IN support/NN internationally/RB endorsed/VBD standards/NNS ./.
@@113842297254 However/RB ,/, the/DT N63S/NN mutation/NN in/IN the/DT wild-type/NEWGENE VP5/NEWGENE background/NN increased/VBD the/DT interaction/NN ,/, as/IN judged/VBN by/IN the/DT beta-galactosidase/NEWGENE activity/NN ,/, by/IN a/DT factor/NN of/IN 9/CD relative/JJ to/IN when/CC the/DT PR7/NN mutation/NN was/VBD present/VB ./.
@@37701434441 The/DT possibility/NN of/IN a/DT hereditary/JJ disorder/NN leading/JJ to/IN a/DT minor/JJ defect/NN in/IN elastic/JJ fibre/NN structure/NN which/WDT could/MD be/VB responsible/JJ for/IN the/DT spontaneous/JJ lesions/NNS is/VBZ discussed/VBN ./.
@@102202759470 The/DT binding/NN of/IN PH/NEWGENE domains/NEWGENE to/IN Gbetagamma/NEWGENE was/VBD inhibited/VBN by/IN preincubation/NN of/IN Gbetagamma/NEWGENE with/IN the/DT GDP-bound/NNP but/CC not/RB the/DT GTP-bound/NNP form/NN of/IN Gialpha/NEWGENE ./.
@@79420767913 It/PRP was/VBD shown/VBP that/IN estradiol/NN concentrations/NNS obtained/VBN after/IN estradiol/NN valerate/NN and/CC micronized/JJ estradiol/NN ingestion/NN were/VBD dependent/JJ on/IN the/DT patient's/NNS age/NN as/RB well/VB as/IN on/IN the/DT constitutional/JJ type/NN ./.
@@668744181 False/NNP positive/JJ amniotic/NEWGENE fluid/NEWGENE alpha/NEWGENE fetoprotein/NEWGENE levels/NNS resulting/JJ from/IN contamination/NN with/IN fetal/JJ blood/NN :/: results/NNS of/IN an/DT experiment/NN ./.
@@76065874666 Piperacillin-tazobactam/NN can/MD be/VB used/VBN for/IN the/DT treatment/NN of/IN infections/NNS caused/VBN by/IN gram-negative/JJ ,/, gram-positive/JJ ,/, aerobic/JJ ,/, and/CC anaerobic/JJ bacteria/NNS ./.
@@100499128511 Identification/NNP of/IN RNase/NEWGENE T/NEWGENE as/IN a/DT high-copy/JJ suppressor/NN of/IN the/DT UV/NN sensitivity/NN associated/VBN with/IN single-strand/NEWGENE DNA/NEWGENE exonuclease/NEWGENE deficiency/NN in/IN Escherichia/NN coli/JJ ./.
@@38944825350 All/DT patients/NNS had/VBP elevated/VBN levels/NNS of/IN serum/NEWGENE IgE/NEWGENE antibodies/NEWGENE to/IN the/DT crude/JJ soybean/NN extract/NN ;/: binding/JJ values/NNS ranged/VBN from/IN 2/CD ./CD 3/CD to/IN 28/CD ./CD 1/CD times/NNS that/WDT of/IN a/DT negative/JJ control/NN serum/JJ ./.
@@84290208194 The/DT gene/NN includes/VBZ three/CD exons/NNS and/CC two/JJ introns/NNS within/IN 1/CD ./CD 6/CD kilobases/NNS of/IN DNA/NN ,/, and/CC the/DT entire/JJ open/JJ reading/JJ frame/NN for/IN glycoprotein/NEWGENE IX/NEWGENE is/VBZ included/VBN within/IN the/DT third/JJ exon/NN ./.
@@86709108053 DNA/NEWGENE polymerase/NEWGENE E/NEWGENE ,/, DNA/NEWGENE ligase/NEWGENE III/NEWGENE and/CC a/DT DNA/NEWGENE structure-specific/NEWGENE endonuclease/NEWGENE co-purify/NN with/IN the/DT five/CD polypeptide/NN complex/NN ./.
@@96302456206 Yeast/NEWGENE U1/NEWGENE snRNP/NEWGENE therefore/RB contains/VBZ 16/CD different/JJ proteins/NNS ,/, including/JJ seven/JJ snRNP/NEWGENE core/NEWGENE proteins/NEWGENE ,/, three/CD homologues/NNS of/IN the/DT metazoan/NEWGENE U1/NEWGENE snRNP-specific/NEWGENE proteins/NEWGENE ,/, and/CC six/CD yeast-specific/NEWGENE U1/NEWGENE snRNP/NEWGENE proteins/NEWGENE ./.
@@85645883071 Strontium/NNP chloride/NN Sr/NN 89/NN is/VBZ costly/JJ ,/, but/CC preliminary/JJ analysis/NN indicates/VBZ that/IN it/PRP may/MD reduce/VB management/NN expenditures/NNS overall/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@6575516339 Measurement/NNP of/IN magnesium/NN absorption/NN in/IN man/NN using/VBG stable/JJ 26Mg/CD as/IN a/DT tracer/NN ./.
@@76520668271 On/IN the/DT basis/NN of/IN this/DT anatomic/JJ concept/NN ,/, the/DT brachioplasty/NN procedure/NN was/VBD modified/JJ to/IN provide/VB secure/VB anchoring/JJ of/IN the/DT arm/NN flap/NN to/IN the/DT axillary/JJ fascia/NN along/IN with/IN strong/JJ superficial/JJ fascial/JJ system/NN repair/NN of/IN incisions/NNS ,/, reducing/JJ the/DT risk/NN of/IN widening/VBG or/CC migration/NN of/IN scars/NNS and/CC unnatural/JJ contours/NNS ./.
@@113533921721 The/DT frameshift/RB initiated/VBN by/IN ADEx2/NN is/VBZ believed/VBN to/IN alter/VB the/DT regular/JJ coding/JJ sequence/NN ,/, acting/JJ as/IN a/DT loss-of-function/NN ASIP/NEWGENE mutation/NEWGENE ./.
@@33542954436 Distant/JJ spread/NN was/VBD found/VBN in/IN 46/CD patients/NNS (/( 34%/JJ )/SYM ,/, 42/CD of/IN whom/WP had/VBP serum/JJ Tg/NN greater/JJR than/IN 10/CD micrograms/NN //NN l/NN ./.
@@77463976958 METHODS/IN :/: Out/IN of/IN 171/CD patients/NNS receiving/JJ anticoagulation/NN between/IN July/NN 1992/CD and/CC December/NN 1993/CD ,/, 83/CD patients/NNS with/IN hemispheric/JJ embolisms/NNS received/VBD heparin/NN within/IN 72/CD hours/NNS from/IN onset/NN (/( activated/VBN partial/JJ thromboplastin/NEWGENE time/NN [/NN aPTT/NN ]/NN 1/CD ./CD 5/CD times/NNS control/NN value/NN )/SYM ./.
@@110434697877 These/DT probable/JJ border/NN sequences/NNS are/VBP closely/RB related/VBN to/IN those/DT of/IN other/DT known/VBP T-regions/NNS and/CC define/VB a/DT second/JJ T-region/NNS of/IN pTiChry5/NN ,/, called/VBN T-right/NNP (/( TR/NN )/SYM ,/, that/WDT confers/VBZ production/NN of/IN the/DT Amadoriopines/NN ./.
@@82094234165 Open/NNP reading/JJ frames/NNS in/IN a/DT 4556/CD nucleotide/NN sequence/NN within/IN MDV-1/NEWGENE BamHI-D/NEWGENE DNA/NEWGENE fragment/NEWGENE :/: evidence/NN for/IN splicing/JJ of/IN mRNA/NN from/IN a/DT new/JJ viral/JJ glycoprotein/NN gene/NN ./.
@@19139554679 The/DT structural/JJ changes/NNS in/IN intra-acinar/JJ artery/NN manifested/VBN mainly/RB by/IN an/DT increase/NN in/IN number/NN of/IN muscular/JJ artery/NN resulting/JJ from/IN muscularization/NN of/IN precursor/NN cells/NNS (/( pericytes/NNS and/CC intermediate/JJ cells/NNS )/SYM located/VBN within/IN partially/RB muscular/JJ and/CC nonmuscular/JJ arterial/JJ wall/NN to/IN smooth/JJ muscle/NN cell/NN ,/, and/CC by/IN the/DT medial/JJ wall/NN thickened/JJ due/NN to/IN hypertrophy/NN and/CC hyperplasia/NN of/IN smooth/JJ muscle/NN cells/NNS as/RB well/VBP as/IN accumulation/NN of/IN a/DT large/JJ amount/NN of/IN collagen/NEWGENE ,/, especially/RB the/DT type/NEWGENE 1/NEWGENE collagen/NEWGENE ./.
@@35922972604 In/NN subjects/NNS (/( n/NN =/SYM 5/CD )/SYM with/IN quadriplegia/NN and/CC reduced/VBN sympathetic/JJ tone/NN secondary/JJ to/IN cervical/JJ cord/NN trauma/NN ,/, TcpO2/NN at/IN 42/CD degrees/NNS C/NN and/CC vasodilation/NN index/NN were/VBD increased/VBN (/( 45/CD ./CD 0/CD mmHg/NN and/CC 0/CD ./CD 61/CD )/SYM ;/: TcpO2/NN at/IN 45/CD degrees/NNS C/NN did/VBD not/RB change/VB ./.
@@9527349483 Letter/NNP :/: Is/VBZ actinic/JJ (/( solar/JJ )/SYM damage/NN the/DT provoking/JJ cause/NN of/IN 'post-inflammatory/JJ elastolysis/NN and/CC cutis/NN laxa/NN (/( PECL/NNP )/NN '/NN ?/.
@@24623051064 The/DT size/NN discrepancy/NN is/VBZ not/RB due/NN to/IN glycosylation/NN or/CC phosphorylation/NN of/IN Ag35/NEWGENE but/CC may/MD result/VB from/IN a/DT proline-rich/JJ sequence/NN which/WDT occurs/VBZ in/IN this/DT polypeptide/NN ./.
@@34597364162 The/DT criterion/NN was/VBD reached/VBN after/IN two/JJ sessions/NNS and/CC generalization/NN to/IN a/DT variety/NN of/IN pills/NNS and/CC capsules/NNS occurred/VBN ./.
@@15312143586 Moreover/RB ,/, LD50/NN in/IN mice/NNS of/IN RP-170/NN (/( 4/CD ./CD 3/CD g/NN //NN kg/NN on/IN i/CD ./CD v/CD ./CD )/SYM was/VBD increased/VBN to/IN 5/CD ./CD 2/CD g/NN //NN kg/NN by/IN oral/JJ administration/NN ./.
@@114040161249 The/DT co-existence/NN of/IN TE/NEWGENE domains/NEWGENE within/IN modular/JJ PKSs/NEWGENE along/IN with/IN physically/RB separated/VBN ,/, monofunctional/JJ TEs/NEWGENE (/( TE/NEWGENE IIs/NEWGENE )/SYM has/VBZ been/VBN reported/VBN for/IN a/DT number/NN of/IN modular/JJ polyketide/JJ and/CC non-ribosomal/NEWGENE peptide/NEWGENE synthases/NEWGENE (/( NRPS/NEWGENE )/SYM ./.
@@101962484767 The/DT complete/JJ circular/JJ TTV/NN genome/NN contained/VBD a/DT novel/JJ sequence/NN of/IN 113/CD nt/NN (/( nt/NN 3740/CD to/IN 3852/CD [/NN =/NN 0/NN ]/NN )/SYM in/IN between/IN the/DT known/VBP 3'-/JJ and/CC 5'-end/CD arms/NNS ,/, forming/JJ a/DT 117-nt/NNP GC-rich/NNP stretch/NN (/( GC/NN content/NN ,/, 90/NN ./NN 6%/NN at/IN nt/NN 3736/CD to/IN 3852/CD )/SYM ./.
@@107734581521 SNAP-23/NEWGENE plays/VBP an/DT important/JJ role/NN in/IN the/DT regulation/NN of/IN vesicle/NN trafficking/NN in/IN mammalian/JJ cells/NNS ./.
@@76873207317 Recombinant/JJ plasmid/NN pFV100/NN was/VBD subsequently/RB isolated/VBN by/IN its/PRP ability/NN to/IN complement/NN B-band/NN expression/NN in/IN ge6/NEWGENE ./.
@@1697928878 Surprisingly/RB ,/, there/RB is/VBZ no/DT sequence/NN homology/NN between/IN this/DT region/NN of/IN Ly-6E/NEWGENE and/CC the/DT established/VBN consensus/NN for/IN the/DT interferon-stimulated/NEWGENE response/NEWGENE element/NEWGENE ,/, which/WDT has/VBZ been/VBN shown/VBP functionally/RB important/JJ to/IN all/DT previously/RB characterized/VBN alpha/NEWGENE //NEWGENE beta/NEWGENE interferon-inducible/NEWGENE promoters/NEWGENE ./.
@@111953382806 Ectopic/NN expression/NN of/IN the/DT dominant/NEWGENE mutant/NEWGENE Lg3/NEWGENE allele/NEWGENE is/VBZ believed/VBN to/IN cause/VBG the/DT phenotype/NN ./.
@@81326671276 Expression/NNS of/IN the/DT dibasic/JJ proprotein/NN processing/VBG enzyme/NN furin/NEWGENE is/VBZ directed/VBN by/IN multiple/JJ promoters/NNS ./.
@@106772148704 Structural/NNP changes/NNS in/IN the/DT kinetically/RB more/RB damaged/VBN E44D/NN mutant/NN detected/VBD in/IN (/( 1/CD )/NN H-/NN (/NN 15/NN )/NN N/NN HSQC/NNP spectra/NNS were/VBD largely/RB limited/VBN to/IN the/DT loop/NN I-helix/NN I/NN motif/NN ,/, suggesting/VBG that/IN Glu-44/NN stabilizes/VBZ the/DT active/JJ site/NN region/NN ./.
@@98816666466 A/DT motif/NN (/( TGATGTCA/NEWGENE )/SYM which/WDT matches/VBZ a/DT CREB/NEWGENE site/NEWGENE and/CC is/VBZ similar/JJ to/IN an/DT AP-1/NEWGENE site/NEWGENE is/VBZ embedded/VBN within/IN ER2/NEWGENE ./.
@@117160437688 Between/IN 1967/CD and/CC 1994/CD ,/, 495/CD patients/NNS underwent/VBD surgery/NN for/IN primary/NN PTC/NN at/IN the/DT Department/NNP of/IN Surgery/NNP ,/, Helsinki/NNP University/NNP Central/NNP Hospital/NNP ./.
@@7136524888 According/VBG to/IN the/DT literature/NN ,/, second/JJ malignant/JJ epithelial/JJ tumours/NNS are/VBP ,/, in/IN contrast/NN to/IN mesenchymal/JJ tumours/NNS such/JJ as/IN osteosarcoma/NN ,/, very/RB rare/JJ in/IN retinoblastoma/NN survivors/NNS ./.
@@74503887337 In/JJ patients/NNS ,/, the/DT effect/NN of/IN CCK-PZ/DT on/IN the/DT movement/NN of/IN the/DT terminal/JJ part/NN of/IN the/DT bile/NN duct/NN was/VBD measured/VBN with/IN a/DT pressure/NN sensor/NN using/VBG a/DT duodenofiberscope/NN ./.
@@4183414851 Intestinal/JJ adaptation/NN (/( first/NN of/IN two/JJ parts/NNS )/SYM ./.
@@117384042602 Their/PRP chemical/JJ structures/NNS were/VBD elucidated/VBN as/IN 1/CD alpha/NN ,/NN 2/NN alpha-diacetoxy-8/JJ beta-isobutanoyloxy-/JJ 9/CD alpha-benzoyloxy-13-/NN (/NN alpha-methyl/NN )/NN butanoyloxy-4/NN beta/NN ,/, 6/CD beta-dihydroxy-beta-dihydroagarofuran/JJ (/( 1/CD )/SYM ,/, 1/CD alpha/NN ,/NN 2/NN alpha-diacetoxy-8/JJ beta-/NN (/NN beta-/NN furancarbonyloxy/NN )/NN -9/NN alpha-benzoyloxy-13-isobutanoyloxy-4/JJ beta/NN ,/, 6/CD beta-dihydroxy-beta-dihydroagarofuran/JJ (/( 2/CD )/SYM and/CC 1/CD alpha/NN ,/, 6/CD beta/NN ,/, 8/NN alpha/NN ,/NN 13-tetraacetoxy-9/NN alpha-benzoyloxy-2/NN alpha-hydroxy-beta-dihydroagarofuran/NN (/( 3/CD )/SYM mainly/RB by/IN analyses/NNS NMR/NN and/CC MS/NN spectral/JJ data/NN ./.
@@90516569007 Tissue/NN samples/NNS were/VBD obtained/VBN either/DT from/IN rats/NNS that/WDT had/VBP been/VBN exposed/VBN to/IN opiate/JJ withdrawal/NN following/IN a/DT seven/JJ day/NN morphine/NN infusion/NN or/CC sham/NN treated/VBD control/NN subjects/NNS ./.
@@89184566429 The/DT optimal/JJ sequence/NN for/IN interaction/NN with/IN mu/NEWGENE 2/NEWGENE and/CC with/IN AP-2/NEWGENE has/VBZ tyrosine/NN as/IN an/DT anchor/NN and/CC prefers/VBZ arginine/NN at/IN position/NN Y/NN +/SYM 2/CD and/CC leucine/NN at/IN position/NN Y/NN +/SYM 3/CD ./CD
@@77840619960 Unlike/IN most/RB other/DT small/NEWGENE G/NEWGENE proteins/NEWGENE which/WDT are/VBP expressed/VBN ubiquitously/RB ,/, TTF/NEWGENE was/VBD transcribed/VBN only/RB in/IN hemopoietic/JJ cells/NNS as/IN a/DT 2/CD ./CD 2/CD kb/NN transcript/NN ./.
@@40003473435 The/DT generally/RB adopted/VBN criteria/NNS enabling/VBG to/IN classify/VB the/DT examined/VBN persons/NNS into/IN the/DT following/JJ 3/CD groups/NNS have/VBP been/VBN used/VBN :/: (/( a/DT )/SYM diseased/JJ of/IN BEN/NN ;/: (/( b/NN )/SYM suspect/VB to/IN be/VB diseased/JJ of/IN BEN/NN ,/, and/CC (/( c/NN )/SYM individuals/NNS without/IN signs/NNS of/IN a/DT renal/JJ disease/NN ./.
@@98486531377 Nhp2p/NEWGENE is/VBZ a/DT highly/RB basic/JJ protein/NN that/WDT belongs/VBZ to/IN a/DT family/NN of/IN putative/JJ RNA-binding/NEWGENE proteins/NEWGENE ./.
@@26230383299 No/DT changes/NNS were/VBD evident/JJ in/IN the/DT FR-task/NNP performance/NN of/IN controls/NNS that/WDT received/VBD daily/JJ saline/JJ injections/NNS ./.
@@25905403235 Of/IN 165/CD women/NNS with/IN non-malignant/JJ diagnoses/NNS 26/CD (/( 16%/JJ )/SYM had/VBP CA/NEWGENE 125/NEWGENE levels/NNS in/IN excess/NN of/IN 35/CD U/NNS //NNS ml/NNS and/CC 8/CD (/( 5%/JJ )/SYM greater/JJR than/IN 65/CD U/NNS //NNS ml/NNS ./.
@@98379334891 P-CIP1/NEWGENE ,/, a/DT novel/JJ protein/NN that/WDT interacts/VBZ with/IN the/DT cytosolic/JJ domain/NN of/IN peptidylglycine/NEWGENE alpha-amidating/NEWGENE monooxygenase/NEWGENE ,/, is/VBZ associated/VBN with/IN endosomes/NNS ./.
@@111937041032 Contagious/JJ bovine/JJ pleuropneumonia/NN is/VBZ a/DT major/JJ threat/NN for/IN cattle/NNS in/IN Africa/NN ./.
@@11901204991 However/RB ,/, a/DT 10--15%/JJ lengthening/NN of/IN the/DT partial/JJ thromboplastin/NEWGENE time/NN is/VBZ evident/JJ after/IN 24/CD hours/NNS of/IN storage/NN ./.
@@106712249157 In/NN the/DT present/NN study/NN we/PRP have/VBP investigated/VBN the/DT regulatory/JJ mechanism/NN for/IN CD95L/NEWGENE expression/NN ./.
@@114060074799 SELECTION/NN CRITERIA/NNP :/: All/DT randomised/JJ controlled/VBN trials/NNS comparing/VBG IUSs/NNP with/IN other/DT forms/NNS of/IN reversible/JJ contraceptives/NNS and/CC reporting/JJ on/IN pre-determined/JJ outcomes/NNS in/IN women/NNS of/IN reproductive/JJ years/NNS ./.
@@25849693231 The/DT experimental/JJ design/NN incorporated/VBD a/DT multiple/JJ regression/NN model/NN ,/, sequential/JJ treatments/NNS and/CC a/DT proportional/JJ end/NN point/NN (/( 95%/CD )/SYM for/IN protection/NN time/NN ./.
@@18428672438 In/NN conclusion/NN ,/, we/PRP observed/VBD a/DT great/JJ regeneration/NN ability/NN following/IN mechanical/JJ injury/NN in/IN the/DT nasal/JJ mucosa/NN ./.
@@79665805475 Infect/NNP ./.
@@95258888515 Full-length/NEWGENE FLAP/NEWGENE clones/NNS were/VBD isolated/VBN from/IN a/DT mouse/NN skeletal/JJ muscle/NN cDNA/NN library/NN ./.
@@2274509987 Liver/NN dysfunction/NN in/IN the/DT presence/NN of/IN different/JJ adverse/JJ reactions/NNS presented/VBN with/IN a/DT higher/JJ activity/NN in/IN the/DT blood/NN serum/NN of/IN indicator/NN liver/NN enzymes/NN and/CC its/PRP impaired/VBN protein-forming/JJ function/NN ./.
@@95255984176 Regulation/NN of/IN the/PDT Raf/NEWGENE kinase/NEWGENE in/IN T/NN cells/NNS differs/VBZ from/IN findings/NNS with/IN a/DT variety/NN of/IN cell/NN lines/NNS that/IN the/DT catalytic/NEWGENE domain/NEWGENE of/NEWGENE Raf/NEWGENE (/( Raf/NEWGENE (/NEWGENE delta26-303/NEWGENE )/NN )/NN shows/VBZ no/DT activity/NN ./.
@@87198328700 The/DT experience/NN of/IN the/DT lateral/JJ rhinotomy/NN approach/NN in/IN transsphenoidal/JJ surgery/NN of/IN acromegaly/NN has/VBZ been/VBN favourable/NN ./.
@@11008139840 Perceptual/JJ learning/NN for/IN a/DT pattern/NN discrimination/NN task/NN ./.
@@10566862390 BACKGROUND/IN :/: Measurement/NNP of/IN stereoacuity/NN at/IN varying/JJ distances/NNS ,/, by/IN real/JJ or/CC simulated/JJ depth/NN stereoacuity/NN tests/NNS ,/, is/VBZ helpful/JJ in/IN the/DT evaluation/NN of/IN patients/NNS with/IN binocular/JJ imbalance/NN or/CC strabismus/NN ./.
@@15399963883 A/DT comparison/NN of/IN the/DT amino/JJ acid/NN sequence/NN of/IN the/DT T/NNP ./NNP thermophilus/JJ enzyme/NN with/IN that/DT of/IN the/DT Escherichia/NN coli/JJ enzyme/NN showed/VBD (/( i/NN )/SYM a/DT 37%/JJ overall/JJ similarity/NN ;/: (/( ii/NN )/SYM the/DT conservation/NN of/IN the/DT Ser/NN residue/NN ,/, which/WDT is/NNS known/VBP to/IN be/VB phosphorylated/VBN in/IN the/DT E/NNP ./NNP coli/JJ enzyme/NN ,/, and/CC of/IN the/DT surrounding/JJ sequence/NN ;/: and/CC (/( iii/NN )/SYM the/DT presence/NN of/IN 141/CD extra/JJ residues/NNS at/IN the/DT C/NN terminus/NN of/IN the/DT T/NNP ./NNP thermophilus/JJ enzyme/NN ./.
@@66913046451 The/DT range/NN of/IN serum/JJ concentrations/NNS ,/, mean/JJ values/NNS ,/, median/JJ values/NNS ,/, and/CC standard/JJ deviations/NNS for/IN each/DT analyte/NN are/VBP reported/VBN for/IN males/NNS and/CC females/NNS and/CC for/IN three/CD age/NN groups/NNS (/( 25-44/JJ ,/, 45-59/CD ,/, 60-70/JJ )/SYM ./.
@@21949723843 Therapeutic/JJ effects/NNS of/IN cefpirome/NN (/( HR/NN 810/NN )/SYM on/IN experimental/JJ mixed/JJ infections/NNS with/IN Enterococcus/DT faecalis/NN and/CC Escherichia/NN coli/JJ in/IN mice/NNS ./.
@@82885544823 The/DT deduced/VBN amino/JJ acid/NN sequence/NN of/IN the/DT mouse/NEWGENE HO-1/NEWGENE gene/NEWGENE is/VBZ identical/JJ to/IN that/DT of/IN p32/NEWGENE ,/, initially/RB identified/VBN as/IN a/DT stress-induced/NN protein/NN in/IN mouse/NN BALBc/NNP //NNP 3T3/NNP cells/NNS ./.
@@114673491342 This/DT is/VBZ a/DT challenging/JJ task/NN insofar/NN as/IN direct/JJ measures/NNS of/IN ISF/NN glucose/NN are/VBP not/RB readily/RB available/JJ ./.
@@105721301915 These/DT results/NNS suggest/VBP that/IN both/DT transcription/NN activators/NNS depend/VBP on/IN or/CC interact/VB with/IN different/JJ subunits/NNS of/IN RNA/NEWGENE polymerase/NEWGENE ,/, although/IN their/PRP role/NN in/IN formation/NN of/IN proper/JJ DNA/NN geometry/NN may/MD also/RB be/VB crucial/JJ ./.
@@77062996658 Inhibition/NNS assays/NNS performed/VBN with/IN over/RB 30/CD different/JJ natural/JJ and/CC synthetic/JJ sialylated/JJ and/IN //IN or/IN sulfated/JJ compounds/NNS are/VBP utilized/VBN to/IN define/VB in/IN greater/JJR detail/NN specific/JJ structural/JJ features/NNS involved/VBN in/IN oligosaccharide-protein/JJ binding/NN ./.
@@23913447575 Molecular/NNP cloning/NN of/IN a/DT cDNA/NN encoding/VBG rat/NEWGENE NADH-cytochrome/NEWGENE b5/NEWGENE reductase/NEWGENE and/CC the/DT corresponding/JJ gene/NN ./.
@@117684671606 Pyrethroid/JJ insecticides/NNS are/VBP widely/RB used/VBN in/IN agriculture/NN and/CC private/JJ households/NNS ./.
@@103590149678 We/PRP also/RB localized/VBN the/DT Fra-2/NEWGENE phosphorylation/NEWGENE sites/NEWGENE by/IN MAPK/NEWGENE to/IN three/CD threonine/NN and/CC three/CD serine/NN residues/NNS in/IN the/DT COOH-terminal/NN region/NN by/IN means/NN of/IN site-directed/JJ mutagenesis/NN and/CC showed/VBD that/IN the/DT threonine/NN residues/NNS were/VBD more/RB susceptible/JJ to/IN MAPK/NEWGENE ./.
@@38575771837 Deletion/NNS mapping/NN studies/NNS revealed/VBN that/IN the/DT upstream/JJ DNA/NN sequences/NNS up/JJ to/IN -86/CD were/VBD sufficient/JJ for/IN the/DT optimal/JJ basal/JJ level/NN transcription/NN in/IN HeLa/DT cells/NNS and/CC also/RB for/IN the/DT EIA-induced/JJ transcription/NN ./.
@@110742105046 The/DT QT/NN interval/NN was/VBD related/VBN to/IN various/JJ components/NNS of/IN the/DT insulin/NEWGENE resistance/NN syndrome/NN ,/, including/JJ BP/NN and/CC insulin/NEWGENE sensitivity/NN ./.
@@28610672758 The/DT aim/NN of/IN this/DT study/NN was/VBD to/IN investigate/VB the/DT effects/NNS of/IN nebulized/JJ ipratropium/NN in/IN patients/NNS with/IN acute/JJ asthma/NN in/IN order/NN to/IN determine/VB whether/IN it/PRP augments/VBZ the/DT bronchodilator/JJ effect/NN of/IN a/DT beta/NN agonist/NN drug/NN ./.
@@64608891864 Intravenous/JJ injections/NNS of/IN SG-75/NN (/( 0/CD ./CD 03-1/CD mg/CD //CD kg/CD )/SYM decreased/VBN systemic/JJ blood/NN pressure/NN (/( SBP/NN )/SYM and/CC increased/VBN peripheral/JJ (/( coronary/JJ ,/, renal/JJ ,/, mesenteric/JJ and/CC femoral/JJ )/SYM blood/NN flow/NN (/( PBF/NN )/SYM dose-dependently/JJ ./.
@@86102726365 Ongoing/JJ and/CC future/JJ investigations/NNS may/MD better/JJR define/VB the/DT optimal/JJ approach/NN for/IN local/JJ control/NN ,/, the/DT optimal/JJ duration/NN of/IN maintenance/NN chemotherapy/NN ,/, and/CC the/DT possible/JJ role/NN of/IN biologic/JJ response/NN modifiers/NNS and/CC growth/NEWGENE factors/NEWGENE in/IN further/RB improving/JJ the/DT outcome/NN for/IN patients/NNS with/IN this/DT disease/NN ./.
@@31149953835 Effects/NNPS of/IN long-term/JJ parenteral/JJ nutrition/NN on/IN gastrin/NEWGENE release/NN in/IN dogs/NNS ./.
@@77395445455 The/DT predicted/VBN amino/JJ acid/NN sequence/NN of/IN the/DT SGC1/NEWGENE gene/NEWGENE product/NEWGENE includes/VBZ a/DT region/NN with/IN substantial/JJ similarity/NN to/IN the/DT basic-helix-loop-helix/JJ domain/NN of/IN the/DT Myc/NEWGENE family/NEWGENE of/IN DNA-binding/NN proteins/NN ./.
@@117607961596 Evidence/NN suggests/VBZ that/IN PHACES/NNS syndrome/NN is/VBZ not/RB a/DT random/JJ association/NN but/CC a/DT true/JJ phakomatosis/NN ;/: further/JJ studies/NNS are/VBP awaited/VBN to/IN shed/NN light/NN on/IN a/DT possible/JJ genetic/JJ background/NN ./.
@@760826859 To/TO discern/VB whether/IN these/DT disorders/NNS of/IN GnRH/NEWGENE deficiency/NN are/VBP associated/VBN with/IN altered/VBN melatonin/NN secretion/NN profiles/NNS ,/, we/PRP compared/VBD untreated/JJ young/JJ males/NNS IGD/NNP (/( n/NN =/SYM 7/CD )/SYM and/CC DP/NN (/( n/NN =/SYM 7/CD )/SYM to/IN normal/JJ pubertal/JJ male/JJ controls/NNS (/( n/NN =/SYM 6/CD )/SYM ./SYM
@@19543552222 Monitoring/NN patients/NNS with/IN acute/JJ leukemia/NN for/IN IL-1/NEWGENE and/CC TNF/NEWGENE levels/NNS throughout/IN the/DT clinical/JJ course/NN of/IN disease/NN may/MD help/VB clarify/VB the/DT causes/NNS of/IN febrile/JJ episodes/NNS ./.
@@78155462060 Virol/NNP ./.
@@79646249548 The/DT P131/NEWGENE ORF/NEWGENE is/VBZ followed/VBN in-frame/NN by/IN a/DT second/JJ ORF/NN which/WDT is/VBZ probably/RB expressed/VBN by/IN partial/JJ readthrough/NN of/IN the/PDT UGA/DT termination/NN codon/NN of/IN the/DT P131/NEWGENE ORF/NEWGENE to/IN produce/NN a/DT polypeptide/NN of/IN M/NN (/NN r/NN )/NN 191044/CD (/( P191/NEWGENE )/SYM ./.
@@13303093568 The/DT CANNTG/NEWGENE motifs/NEWGENE were/VBD found/VBN to/IN bind/NN MyoD/NEWGENE and/CC myogenin/NEWGENE fusion/NEWGENE proteins/NEWGENE and/CC to/IN interact/VB with/IN proteins/NNS in/IN nuclear/JJ extracts/NNS from/IN cultured/JJ myotubes/NNS ./.
@@10380659254 Baseline/NN data/NN were/VBD obtained/VBN from/IN 10/CD adults/NNS ./.
@@103859158024 D3S1261/NEWGENE is/VBZ physically/RB located/VBN at/IN or/CC near/IN the/DT MITF/NEWGENE locus/NEWGENE ,/, while/CC D3S2465/NEWGENE and/CC D3S1766/NEWGENE are/VBP flanking/JJ the/DT locus/NN at/IN about/RB 17/CD ./CD 5/CD cM/NN genetic/JJ distance/NN each/DT side/NN ./.
@@95027208418 CyIIa/NEWGENE transcription/NN follows/VBZ ,/, and/CC is/VBZ therefore/RB downstream/RB of/IN ,/, the/DT initial/JJ specification/NN of/IN these/DT embryonic/NN domains/NN ./.
@@21760212785 Determination/NNS of/IN diquat/NN in/IN biological/JJ materials/NNS by/IN electron/NN spin/NN resonance/NN spectroscopy/NN ./.
@@106815621884 As/IN no/DT complete/JJ PPARgamma/NEWGENE antagonists/NNS have/VBP been/VBN described/VBN hitherto/RB ,/, we/PRP have/VBP constructed/VBN a/DT dominant-negative/JJ mutant/JJ receptor/NN to/IN inhibit/VB wild-type/NN PPARgamma/NEWGENE action/NN ./.
@@10450815300 The/DT present/NN investigation/NN conducted/VBN in/IN a/DT population/NN of/IN 258/CD dentally/RB aware/JJ individuals/NNS in/IN the/DT age/NN range/NN 20-69/CD years/NNS ,/, was/VBD initiated/VBN to/IN elucidate/VB the/DT relationship/NN between/IN tobacco/NN smoking/NN and/CC supragingival/JJ calculus/NN ,/, taking/VBG into/IN account/NN possible/JJ confounding/JJ factors/NNS such/JJ as/IN age/NN ,/, gender/NN ,/, oral/JJ hygiene/NN and/CC gingival/JJ inflammation/NN ./.
@@88121062859 PCNA/NEWGENE mRNA/NEWGENE has/VBZ a/DT 3'UTR/NN antisense/NN to/IN yellow/JJ crescent/JJ RNA/NN and/CC is/VBZ localized/VBN in/IN ascidian/NN eggs/NNS and/CC embryos/NNS ./.
@@9622121906 Anti-PTB/NEWGENE antibodies/NEWGENE did/VBD not/RB inhibit/VB the/DT binding/NN of/IN PTB/NEWGENE to/IN RNA/NN because/IN they/PRP were/VBD able/JJ to/IN supershift/NN RNA-PTB/NEWGENE complexes/NEWGENE ./.
@@117873228225 Influence/NNS of/IN different/JJ methods/NNS of/IN chemical/JJ disinfection/NN on/IN the/DT physical/JJ properties/NNS of/IN type/NN IV/NN and/CC V/NN gypsum/NN dies/VBZ Several/JJ instruments/NNS and/CC materials/NNS frequently/RB used/VBN in/RB prosthodontics--such/JJ as/IN stone/NN casts/NNS ,/, dental/JJ impressions/NNS ,/, interocclusal/JJ records--are/RB classified/VBN ,/, by/IN the/DT dental/JJ literature/NN ,/, as/IN vehicles/NNS of/IN transmission/NN of/IN infectious/JJ diseases/NNS to/IN those/DT who/WP handle/VBP them/PRP ./.
@@39374814598 Spectrophotometric/NNP microanalysis/NN of/IN ethylenediaminotetracetic/JJ acid/NN in/IN pharmaceutical/JJ preparations/NNS ./.
@@67329466497 The/DT measurement/NN of/IN the/DT areas/NNS of/IN fibrin/NEWGENE ,/, of/IN tissue/NN and/CC fibrinolysis/NN ,/, at/IN the/DT above/RB mentioned/VBN times/NNS ,/, has/VBZ been/VBN effected/VBN at/IN standard/JJ magnification/NN (/( 15/CD X/NN )/SYM by/IN an/DT image/NN analyser/NN (/( Videoplan/NNP )/SYM scale/NN 1/CD :/: 8/CD ./.
@@28148207124 Pacing/VBG the/DT Roux/NNP limb/NN abolished/VBD the/DT ectopic/JJ pacemakers/NNS ,/, restored/VBD the/DT slow/JJ emptying/NN of/IN liquids/NNS to/IN the/DT more/RB rapid/JJ rate/NN found/VB in/IN the/DT Billroth/NN dogs/NNS (/( t1/NN //NN 2/NN :/: paced/VBN Roux/NN ,/, 72/NN +/NN //NN -/NN 15/CD minutes/NNS ;/: Billroth/IN ,/, 43/CD +/NN //NN -/NN 9/CD minutes/NNS ;/: p/NN greater/JJR than/IN 0/CD ./CD 05/CD )/SYM and/CC did/VBD not/RB change/VB emptying/NN of/IN solids/NNS ./.
@@22845731447 Staining/VBG with/IN IF/NEWGENE MoAB/NN alone/RB of/IN BAL/NN fluid/NN only/RB seemed/VBD to/IN be/VB even/VB more/RB sensitive/JJ than/IN silver/JJ methenamine/NN staining/NN of/IN BAL/NN ,/, TBB/NN and/CC brushing/NN material/NN ./.
@@102242441725 Evidence/NN for/IN the/DT involvement/NN of/IN the/DT Glc7-Reg1/NEWGENE phosphatase/NEWGENE and/CC the/DT Snf1-Snf4/NEWGENE kinase/NEWGENE in/IN the/DT regulation/NN of/IN INO1/NEWGENE transcription/NN in/IN Saccharomyces/NN cerevisiae/NN ./.
@@80044422007 The/DT effects/NNS of/IN social/JJ isolation/NN on/IN morphine-induced/NN locomotor/NN activity/NN were/VBD compared/VBN in/IN :/: (/( i/NN )/SYM animals/NNS with/IN an/DT intact/JJ hypothalamo-pituitary-adrenal/JJ (/( HPA/JJ )/SYM axis/NN ;/: (/( ii/NN )/SYM animals/NNS in/IN which/WDT stress-induced/JJ corticosterone/NN secretion/NN was/VBD blocked/VBN by/IN adrenalectomy/NN ./.
@@84634853173 Effects/NNPS of/IN intramammary/JJ endotoxin/NN infusion/NN on/IN milking-induced/NN oxytocin/NEWGENE release/NN ./.
@@3468294171 255-61/CD ./.
@@2360336223 Drug/NNP and/CC personnel/NN costs/NNS were/VBD reduced/VBN when/CC batch/NN manufacturing/JJ with/IN 40-mL/NN multidose/NN vials/NN was/VBD compared/VBN with/IN extemporaneous/JJ compounding/NN with/IN unit-dose/NN vials/NNS ./.
@@11331589527 The/DT MSL/NEWGENE complex/NEWGENE is/VBZ specifically/RB localized/VBN on/IN the/DT male/JJ X/NN chromosome/NN to/IN increase/NN its/PRP expression/NN approximately/RB 2-fold/JJ ./.
@@79951737980 Transfer/NN also/RB correlated/VBD inversely/RB with/IN gastric/JJ juice/NN pH/NN (/( r/JJ =/SYM -0/CD ./CD 619/CD ,/, P/NN </SYM 0/CD ./CD 02/CD )/SYM ./.
@@61539365977 In/NN several/DT cases/NNS of/IN definite/JJ SjS/NN ,/, labial/JJ salivary/JJ gland/NN examinations/NNS after/IN more/RB than/IN a/DT one/PRP year/NN interval/NN were/VBD performed/VBN on/IN two/JJ occasions/NNS ,/, and/CC the/DT clinical/JJ and/CC histopathological/JJ changes/NNS were/VBD investigated/VBN ./.
@@99222305317 Taken/VBN together/RB ,/, our/PRP results/NNS demonstrate/VBP that/IN CAP1/NEWGENE is/VBZ involved/VBN in/IN multidrug/JJ resistance/NN and/CC oxidative/JJ stress/NN response/NN in/IN C/NNP ./NNP albicans/JJ ./.
@@84971906619 Sequence/NN analysis/NN and/CC identification/NN of/IN two/JJ hyp/NEWGENE regulatory/NEWGENE mutants/NEWGENE ./.
@@96677959636 Acute/JJ pancreatitis/NN is/VBZ a/DT rather/RB common/JJ abdominal/JJ disorder/NN ./.
@@103982866983 Using/VBG Scheffe's/NNP procedure/NN as/IN an/DT illustration/NN ,/, comparisons/NNS are/VBP made/VBP to/IN usual/JJ sample/NN size/NN methods/NNS that/WDT incorrectly/RB ignore/VB the/DT stochastic/JJ nature/NN of/IN S2p/NN ./.
@@85251868497 Refugees/NNS living/VBG in/IN Lund/NN and/CC repatriated/VBN to/IN Chile/NN considered/VBD their/PRP health/NN as/IN bad/JJ in/IN a/DT higher/JJ proportion/NN than/IN their/PRP Swedish/JJ counterparts/NNS ,/, with/IN an/DT odds/NNS ratio/NN of/IN 3/CD ./CD 48/CD (/( 2/CD ./CD 03-5/CD ./CD 66/CD )/SYM and/CC 4/CD ./CD 78/CD (/( 2/CD ./CD 1-10/CD ./CD 25/CD )/SYM respectively/RB ./.
@@105024027246 Recently/RB ,/, cell-surface/NN TRAIL/NEWGENE has/VBZ been/VBN shown/VBP to/IN be/VB expressed/VBN by/IN activated/JJ human/NN and/CC mouse/NN T/NN lymphocytes/NNS ,/, raising/VBG the/DT possibility/NN that/IN TRAIL/NEWGENE might/MD be/VB involved/VBN in/IN T/NN cell-mediated/JJ cytotoxicity/NN and/IN //IN or/IN immune/JJ regulation/NN ./.
@@10406466911 Classical/NNP ligand-activated/NEWGENE nuclear/NEWGENE receptors/NEWGENE (/( e/NN ./NN g/NN ./. thyroid/NEWGENE hormone/NEWGENE receptor/NEWGENE ,/, retinoic/NEWGENE acid/NEWGENE receptor/NEWGENE )/SYM ,/, orphan/NEWGENE nuclear/NEWGENE receptors/NEWGENE (/( e/NN ./NN g/NN ./.
@@73555274963 Therefore/RB the/DT procedure/NN of/IN Lich-Gregoir/NN is/VBZ not/RB to/IN be/VB recommended/VBN in/IN adults/NNS ./.
@@63500926155 In/NN the/DT posthospital/JJ phase/NN of/IN AMI/NN ,/, as/RB well/VB as/IN in/IN CCHD/NNP ,/, the/DT occurrence/NN of/IN high-grade/JJ VPBs/NN usually/RB indicates/VBZ more/RB advanced/JJ degrees/NNS of/IN both/DT coronary/NN and/CC left/NN ventricular/JJ disease/NN as/RB well/VB as/IN the/DT possibility/NN of/IN cardiac/JJ and/IN //IN or/IN sudden/JJ death/NN ./.
@@39920225812 Activities/NNP of/IN hepatic/JJ cytochrome/NN P-450-dependent/NNP metabolizing/JJ enzymes/NNS such/JJ as/IN aminopyrine-/NEWGENE and/NEWGENE TMO/NEWGENE N-demethylase/NEWGENE and/CC aniline/NEWGENE hydroxylase/NEWGENE activity/NN were/VBD decreased/VBN by/IN pretreatment/NN of/IN rats/NNS with/IN cimetidine/NN ,/, whereas/IN in/IN the/DT rats/NNS pretreated/VBN with/IN ranitidine/NN ,/, these/DT enzyme/NN activities/NNS were/VBD not/RB changed/VBN ./.
@@44289814966 Kinetics/NNS of/IN calcium/NN metabolism/NN ./.
@@84968489834 However/RB ,/, essential/JJ contrast/NN differences/NNS existing/JJ between/IN the/DT FSE/NN sequences/NN and/CC their/PRP routine/JJ asymmetric/JJ dual/JJ SE/NN counterpart/NN can/MD be/VB identified/VBN ./.
@@115724676511 Management/NNP of/IN postvitrectomy/NN diabetic/JJ vitreous/JJ hemorrhage/NN with/IN tissue/NEWGENE plasminogen/NEWGENE activator/NEWGENE (/( t-PA/NEWGENE )/SYM and/CC volume/NN homeostatic/JJ fluid-fluid/JJ exchanger/NN ./.
@@82694242584 After/IN peripheral/JJ administration/NN of/IN both/DT CRF/NEWGENE and/CC TRH/NEWGENE ,/, ACTH/NEWGENE levels/NNS were/VBD significantly/RB higher/JJ on/IN the/DT tumor/NN side/JJ in/IN all/DT patients/NNS ./.
@@119027387098 PATIENTS/IN AND/CC METHODS/IN :/: This/DT study/NN is/VBZ a/DT retrospective/JJ cohort/NN study/NN of/IN all/DT children/NNS with/IN cancer/NN admitted/VBN to/IN a/DT single/JJ institution/NN with/IN fever/NN and/CC neutropenia/NN (/( defined/VBN as/IN an/DT absolute/JJ neutrophil/JJ count/NN </SYM 500/CD cells/NN //NN mm3/NN )/SYM in/IN a/DT 1-year/JJ period/NN ./.
@@7696878678 The/DT leader/NN sequence/NN of/IN the/DT isolated/VBN cDNA/NN clone/NN contains/VBZ several/DT small/JJ open/JJ reading/JJ frames/NNS upstream/RB of/IN the/DT initiation/NN codon/NN of/IN the/DT largest/JJS open/JJ reading/JJ frame/NN coding/JJ for/IN the/DT homeodomain/NN protein/NN ./.
@@70381896811 The/DT foregoing/JJ results/NNS show/VBP that/IN CXD/NN has/VBZ high/JJ efficacy/NN and/CC safety/NN and/CC it/PRP can/MD be/VB said/VB that/IN it/PRP is/VBZ a/DT drug/NN required/VBN in/IN the/DT pediatric/JJ field/NN ./.
@@88852706651 Three/CD mutants/NNS were/VBD isolated/VBN from/IN the/DT widely/RB used/VBN strain/NN ,/, PAO1/NN ./.
@@65919926351 No/DT anisotropism/NN was/VBD recorded/VBN in/IN a/DT tetrahydrofuran/NN solution/NN ./.
@@98672533546 This/DT c-Jun/NEWGENE activity/NN is/VBZ inhibited/VBN by/IN c-Fos/NEWGENE ,/, another/DT protooncoprotein/NN that/WDT can/MD dimerize/VB with/IN c-Jun/NEWGENE to/IN form/NN the/DT transcription/NN factor/NN AP-1/NEWGENE ./.
@@115998401491 The/DT moduli/NNS of/IN elasticity/NN of/IN the/DT gray/JJ and/CC white/JJ matter/NN were/VBD 3/CD ./CD 4+/CD //CD -1/CD ./CD 4/CD kPa/NN (/( mean/JJ +/NN //NN -/NN standard/JJ deviation/NN )/SYM and/CC 3/CD ./CD 4+/CD //CD -0/CD ./CD 9/CD kPa/NN in/IN the/DT axial/JJ section/NN ,/, 3+/NN //NN -0/NN ./NN 3/NN kPa/NN and/CC 3/CD ./CD 5+/CD //CD -0/CD ./CD 5/CD kPa/NN in/IN the/DT frontal/JJ section/NN ,/, and/CC 3/CD ./CD 5+/CD //CD -0/CD ./CD 9/CD kPa/NN and/CC 2/CD ./CD 8+/CD //CD -0/CD ./CD 4/CD kPa/NN in/IN the/DT sagittal/JJ section/NN ,/, respectively/RB ./.
@@21213718868 The/DT NF1/NEWGENE locus/NEWGENE encodes/VBZ a/DT protein/NN functionally/RB related/VBD to/IN mammalian/NEWGENE GAP/NEWGENE and/CC yeast/NEWGENE IRA/NEWGENE proteins/NEWGENE ./.
@@98825933859 In/NN the/DT second/JJ experiment/NN ,/, a/DT stable/JJ nickel/NN isotope/NN ,/, 61Ni/NN ,/, was/VBD given/VBP in/IN drinking/JJ water/NN to/IN 20/CD nickel-sensitized/JJ women/NNS and/CC 20/CD age-matched/JJ controls/NNS ,/, both/DT groups/NNS having/VBG vesicular/JJ hand/NN eczema/NN of/IN the/DT pompholyx/NN type/NN ./.
@@87708969203 Subsequent/JJ to/IN their/PRP secretion/NN ,/, the/DT IGF-II/NEWGENE in/IN xz97/NN and/CC G11/NN cells/NNS accumulated/VBN in/IN the/DT conditioned/JJ medium/NN mostly/RB as/IN two/JJ partially/RB processed/VBN species/NN with/IN appMr/NN ,/, of/IN 17K/NN and/CC 14K/NN ,/, respectively/RB ./.
@@38376097125 Five-year/JJ prospective/JJ study/NN of/IN peripheral/NN white/NN blood/NN cells/NNS in/IN infectious/JJ mononucleosis/NN ./.
@@14493012064 Cold/NNP cardioplegia/NN was/VBD administered/VBN at/IN 45/CD mm/NN Hg/JJ every/DT 20/CD minutes/NNS for/IN 2/CD hours/NNS ./.
@@90216848937 Experimental/JJ data/NN showed/VBN that/IN these/DT abnormal/JJ proteins/NNS are/VBP constitutively/RB localized/VBN in/IN the/DT nucleus/NN ,/, have/NN lost/VBP the/DT transcriptional/JJ repressor/NN functions/NNS typical/JJ of/IN normal/JJ NF-kappa/NEWGENE B2p52/NEWGENE and/CC may/MD be/VB capable/JJ of/IN transactivation/NN activity/NN ./.
@@40212814688 Ultrastructure/NNS of/IN the/DT heart/NN muscle/NN in/IN experimental/JJ myocardial/JJ infarct/NN following/IN physical/JJ training/NN ./.
@@76018276599 By/IN using/VBG lacZ/NEWGENE fusions/NEWGENE ,/, it/PRP was/VBD possible/JJ to/IN localize/VB the/DT DNA/NN sequences/NNS required/VBN to/IN mediate/VB nitrate/NN repression/NN to/IN the/DT pfl/NEWGENE promoter-regulatory/NEWGENE region/NEWGENE ./.
@@88409977299 MVR/NN typing/NN of/IN rare-length/JJ alleles/NNS indicates/VBZ that/IN they/PRP are/VBP comprised/VBN of/IN disorganized/VBN sequences/NNS ,/, although/IN they/PRP usually/RB bear/VBP a/DT resemblance/NN to/IN one/PRP of/IN the/DT common/JJ alleles/NNS at/IN the/DT 5'-most/JJ end/NN ./.
@@109381057974 Splicing/NN of/IN the/DT K-SAM/NEWGENE alternative/JJ exon/NN of/IN the/DT fibroblast/NEWGENE growth/NEWGENE factor/NEWGENE receptor/NEWGENE 2/NEWGENE gene/NEWGENE is/VBZ heavily/RB dependent/JJ on/IN the/DT U-rich/NNP sequence/NN IAS1/NEWGENE lying/NN immediately/RB downstream/RB from/IN its/PRP 5'/CD splice/NN site/NN ./.
@@109073488361 Biochemical/NNP examinations/NNS of/IN calcium-phosphorus/NN metabolism/NN included/VBD ions/NNS and/CC PTH/NEWGENE concentrations/NNS in/IN blood/NN serum/JJ ,/, and/CC the/DT activity/NN of/IN bone/NN isoenzyme/NN of/IN AP/NEWGENE ./.
@@23610083015 Changes/NNS in/IN prognosis/NN of/IN twin/NN births/NNS over/RB 20/CD years/NNS ./.
@@83922218357 Losses/NNS during/IN the/DT complete/JJ procedure/NN are/VBP corrected/VBN for/IN using/VBG radioactive/JJ estrogen/NN conjugates/NNS during/IN the/DT first/JJ steps/NNS and/CC later/JJR by/IN adding/JJ deuterated/JJ internal/JJ standards/NNS of/IN all/DT compounds/NNS measured/VBN (/( matairesinol/NN ,/, enterodiol/NN ,/, enterolactone/NN ,/, daidzein/NN ,/, O-desmethylangolensin/NNP ,/, equol/NN ,/, and/CC genistein/NN )/SYM ./.
@@8163546423 Altogether/RB ,/, these/DT data/NN suggest/VB that/IN Ypt51p/NEWGENE ,/, Ypt52p/NEWGENE ,/, and/CC Ypt53p/NEWGENE are/VBP required/VBN for/IN transport/NN in/IN the/DT endocytic/JJ pathway/NN and/CC for/IN correct/JJ sorting/NN of/IN vacuolar/NEWGENE hydrolases/NEWGENE suggesting/VBG a/DT possible/JJ intersection/NN of/IN the/DT endocytic/JJ with/IN the/DT vacuolar/JJ sorting/JJ pathway/NN ./.
@@81309428096 Regionalization/NNS of/IN drug/NN delivery/NN is/VBZ a/DT potential/JJ method/NN to/IN avoid/VB this/DT problem/NN ./.
@@77456962732 Restriction/NNS mapping/NN analysis/NN localized/VBN this/DT cDNA/NN to/IN the/DT HHV-6A/NEWGENE (/NEWGENE U1102/NEWGENE )/NEWGENE genomic/NEWGENE BamHI/NEWGENE G/NEWGENE fragment/NEWGENE ,/, at/IN the/DT right/JJ end/NN of/IN the/DT unique/JJ long/JJ segment/NN of/IN the/DT genome/NN and/CC to/IN the/DT SalI/NEWGENE L/NEWGENE and/CC SalI/NEWGENE O/NEWGENE fragments/NEWGENE within/IN the/DT left/NN and/CC right/JJ terminal/JJ direct/JJ repeat/JJ regions/NNS ,/, respectively/RB ./.
@@96581224286 Fowlpox/ORG virus/NN encodes/VBZ nonessential/JJ homologs/NNS of/IN cellular/NEWGENE alpha-SNAP/NEWGENE ,/, PC-1/NEWGENE ,/, and/CC an/DT orphan/NN human/NN homolog/NN of/IN a/DT secreted/VBN nematode/JJ protein/NN ./.
@@110393411331 The/DT purpose/NN of/IN this/DT study/NN was/VBD to/IN analyze/VB the/DT temporal/JJ characteristics/NNS and/CC the/DT spatial/JJ mapping/NN of/IN the/DT independent/JJ components/NNS identified/VBN by/IN ICA/NN when/CC the/DT subject/NN performs/VBZ a/DT finger-tapping/NN task/NN ./.
@@108058234975 CONCLUSIONS/IN :/: Physiologic/NN pacing/NN provides/VBZ little/JJ benefit/NN over/RB ventricular/JJ pacing/NN for/IN the/DT prevention/NN of/IN stroke/NN or/CC death/NN due/NN to/IN cardiovascular/JJ causes/NNS ./.
@@50919705364 Antiviral/JJ agents/NNS ./.
@@1361751980 The/DT maintenance/NN of/IN increased/VBN myocardial/JJ capillary/JJ density/NN required/VBD a/DT similar/JJ amount/NN of/IN exercise/NN ,/, and/CC at/IN least/RB 1/CD h/NN of/IN exercise/NN once/CC a/DT week/NN was/VBD necessary/JJ to/IN maintain/VB the/DT enlargement/NN of/IN ECA/NNP ./NNP 20/NNP
@@102183574477 RESULTS/NNS AND/CC CONCLUSIONS/IN :/: Brandt's/NNP double/JJ cuff-tubes/NNS (/( G2/NN )/SYM succeed/VB in/IN avoiding/JJ uncontrolled/JJ increase/NN of/IN cuff-pressure/NN during/IN anaesthesia/NN with/IN N2O/NN ./.
@@33988234095 The/DT effects/NNS produced/VBN by/IN oral/JJ administration/NN of/IN 500/CD mg/CD //CD kg/CD p-xylene/NN or/CC toluene/NN lasted/VBN at/IN least/RB 8/CD hr/NN ,/, while/CC the/DT effect/NN of/IN inhaled/JJ p-xylene/NN dissipated/VBN within/IN 75/CD min/NN of/IN removal/NN from/IN the/DT exposure/NN ./.
@@110581207229 One/CD of/IN these/DT factors/NNS ,/, IRF-2/NEWGENE ,/, was/VBD initially/RB cloned/VBN as/IN an/DT antagonistic/JJ counterpart/NN to/IN IRF-1/NEWGENE with/IN oncogenic/JJ potential/NN ./.
@@75642107454 This/DT combined/JJ intravenous/JJ anaesthetic/JJ regimen/NN gave/VBD good/JJ anaesthesia/NN and/CC analgesia/NN to/IN pigs/NNS for/IN up/JJ to/IN 2/CD h/NN as/IN monitored/VBN by/IN clinical/JJ signs/NNS ./.
@@93318647542 Serum/NN E2/NN concentrations/NNS increased/VBN numerically/RB two-/DT to/IN threefold/RB from/IN d/NN 56/NN to/IN 140/CD in/IN controls/NNS fed/VBN MGA/IN ,/, compared/VBN with/IN controls/NNS not/RB fed/VBN MGA/DT ./.
@@23078485540 The/DT coding/JJ sequences/NNS of/IN the/DT Crry/NEWGENE gene/NEWGENE encompass/VB over/RB 25/CD kb/NN of/IN DNA/NN ,/, whereas/IN the/DT Crry-ps/NEWGENE sequences/NEWGENE are/VBP included/VBN within/IN a/DT single/JJ 5/NEWGENE ./NEWGENE 6-kb/NEWGENE Eco-R1/NEWGENE fragment/NEWGENE ./.
@@12531911891 A/DT note/NN on/IN the/DT phase-plane/JJ technique/NN representation/NN of/IN cardiac/JJ action/NN potentials/NNS ./.
@@6560084014 Prevention/NNP of/IN acute/JJ paraquat/NN toxicity/NN in/IN rats/NNS by/IN superoxide/NEWGENE dismutase/NEWGENE ./.
@@30156113370 The/DT amino/JJ acid/NN sequence/NN was/VBD determined/VBN to/IN be/VB residues/NNS 716-724/JJ and/CC hence/RB lysine/NN residue/NN 721/CD is/VBZ located/VBN within/IN the/DT ATP-binding/NN site/NN ./.
@@86216286184 Thus/RB ,/, hGRbeta/NEWGENE potentially/RB functions/VBZ as/IN a/DT dominant/JJ negative/JJ inhibitor/NN of/IN hGRalpha/NEWGENE activity/NN ./.
@@112645617662 OBJECTIVE/IN :/: To/TO determine/VB whether/IN RSTD/NN predicts/VBZ coronary/JJ anatomy/NN during/IN acute/JJ coronary/JJ occlusion/NN ./.
@@10641688457 Alignment/NNS of/IN the/DT cervical/JJ spine/NN ,/, vertebral/JJ abnormalities/NNS ,/, and/CC disc/NN changes/NNS also/RB were/VBD evaluated/VBN ./.
@@8935931145 CONCLUSION/IN :/: Intravenous/JJ diazepam/NN administration/NN before/IN EGD/NN produces/VBZ a/DT significant/JJ fall/NN in/IN SpO2/NNP during/IN the/DT procedure/NN ,/, and/CC so/RB should/MD be/VB avoided/VBN ;/: continuous/JJ monitoring/NN of/IN SpO2/NN should/MD be/VB done/VBP during/IN EGD/NN ./.
@@75057985223 There/EX are/VBP two/JJ immunogenic/JJ sites/NNS on/IN the/DT type/NEWGENE A/NEWGENE influenza/NEWGENE A/NEWGENE //NEWGENE Japan/NEWGENE //NEWGENE 57/NEWGENE (/NEWGENE H2N2/NEWGENE )/NEWGENE hemagglutinin/NEWGENE (/( HA/NEWGENE )/SYM that/WDT can/MD be/VB recognized/VBN by/IN class/NEWGENE I/NEWGENE major/NEWGENE histocompatibility/NEWGENE complex/NEWGENE (/( MHC/NEWGENE )/SYM ,/, H-2Kd-restricted/JJ cytolytic/JJ T/NN lymphocytes/NNS (/( CTLs/NNS )/SYM ./.
@@99876345914 However/RB ,/, after/IN PRK/NN at/IN 5/CD weeks/NNS of/IN age/NN ,/, partial/JJ retreatment/NN may/MD be/VB necessary/JJ due/NN to/IN regression/NN of/IN the/DT PRK/NN effect/NN ./.
@@114895971374 One/CD maternal/JJ death/NN ,/, reduced/VBN body/NN weight/NN ,/, and/CC reduced/VBD weight/NN gain/NN were/VBD noted/VBN at/IN the/DT high/JJ dose/NN ;/: confirmed/VBN pregnancy/NN rates/NNS were/VBD 84/CD to/IN 100%/CD for/IN each/DT group/NN ./.
@@13868976405 Entry/NN of/IN yeast/NN cells/NNS into/IN the/DT mitotic/JJ cell/NN cycle/NN (/( Start/VB )/SYM involves/VBZ a/DT form/NN of/IN the/DT CDC28/NEWGENE kinase/NEWGENE that/WDT associates/VBP with/IN G1-specific/NNP cyclins/NEWGENE encoded/VBN by/IN CLN1/NEWGENE and/CC CLN2/NEWGENE (/( ref/NN ./.
@@98469279836 The/DT tip/NN of/IN the/DT button/NN caused/VBD a/DT perforation/NN of/IN the/DT posterior/JJ stomach/NN wall/NN ,/, leading/JJ to/IN death/NN ./.
@@94194157970 In/NN this/DT study/NN ,/, we/PRP investigated/VBD STAT/NEWGENE activation/NN in/IN a/DT panel/NN of/IN rodent/NN fibroblast/NN cell/NN lines/NNS stably/RB transformed/VBN by/IN diverse/JJ viral/NN oncoproteins/NN ./.
@@81931479095 Comparison/NNS with/IN the/DT crystal/NN structure/NN of/IN Desulfovibrio/ORG gigas/VBZ ,/, Dg/NNS ,/, Fd/NN (/( Kissinger/NNP et/FW al/NNS ./NNS ,/, 1991/CD )/SYM reveals/VBZ a/DT very/RB similar/JJ folding/NN topology/NN ,/, although/IN several/DT secondary/JJ structural/JJ elements/NNS are/VBP extended/VBN in/IN Pf/NN relative/JJ to/IN Dg/NNP Fd/NNP ./NNP
@@104308905611 Thus/RB ,/, elongin/NEWGENE C/NEWGENE is/VBZ found/VBN to/IN oligomerize/VB in/IN solution/NN and/CC to/IN undergo/VB significant/JJ structural/JJ rearrangements/NNS upon/IN binding/NN of/IN two/JJ different/JJ partner/NN proteins/NNS ./.
@@95242296324 The/DT gene/NEWGENE lac-1/NEWGENE ,/, encoding/VBG the/DT enzyme/NN laccase/NEWGENE ,/, is/VBZ the/DT best/RBS characterized/VBN of/IN a/DT number/NN of/IN genes/NNS in/IN the/DT chestnut/NN blight/NN fungus/NN ,/, Cryphonectria/NNP parasitica/NN ,/, that/WDT are/VBP repressed/VBN by/IN hypoviruses/NNS ,/, a/DT group/NN of/IN virulence-attenuating/JJ mycoviruses/NNS ./. lac-1/NEWGENE has/VBZ also/RB been/VBN shown/VBP to/IN be/VB transcriptionally/RB activated/VBN by/IN low/JJ concentrations/NNS of/IN the/DT translational/JJ inhibitor/NN cycloheximide/NN (/( CHX/IN )/SYM and/CC by/IN the/DT immunosuppressant/NN cyclosporin/NN A/NNP ./NNP
@@92798139237 4/CD ./CD
@@104038394090 Using/VBG sequence/NN information/NN from/IN human/NEWGENE BMAL1/NEWGENE (/( hBMAL1/NEWGENE )/SYM cDNAs/NNS previously/RB reported/VBN by/IN our/PRP laboratory/NN ,/, we/PRP have/VBP isolated/VBN and/CC characterized/VBN cDNAs/NNS encoding/VBG three/CD splice/NN variants/NNS of/IN the/DT mouse/NEWGENE BMAL1/NEWGENE (/( mBMAL1/NEWGENE )/SYM gene/NN ./.
@@95841941497 In/NN support/NN of/IN a/DT role/NN at/IN the/DT spindle/NN ,/, two-hybrid/JJ library/NN screening/JJ with/IN HEF1/NEWGENE identifies/VBZ the/DT human/JJ homolog/NN of/IN the/DT G2/NEWGENE //NEWGENE M/NEWGENE spindle-regulatory/NEWGENE protein/NEWGENE Dim1p/NEWGENE as/IN a/DT specific/NN interactor/NN with/IN a/DT region/NN of/IN HEF1/NEWGENE encompassed/VBN in/IN p55/NEWGENE (/NEWGENE HEF1/NEWGENE )/NEWGENE ./.
@@102004733252 An/DT endogenous/JJ mammalian/JJ regulator/NN of/IN this/DT process/NN ,/, named/VBN Usurpin/NEWGENE ,/, has/VBZ been/VBN identified/VBN (/( aliases/NNS for/IN Usurpin/NEWGENE include/VB CASH/NEWGENE ,/, Casper/NEWGENE ,/, CLARP/NEWGENE ,/, FLAME-1/NEWGENE ,/, FLIP/NEWGENE ,/, I-FLICE/NEWGENE and/CC MRIT/NEWGENE )/SYM ./.
@@93894928769 In/NN a/DT similar/JJ fashion/NN to/IN adipose/JJ stromal/JJ cells/NNS ,/, serum/RB potentiated/VBN the/DT response/NN to/IN dexamethasone/NN but/CC had/VBP no/DT effect/NN on/IN phorbol/NN ester-stimulated/JJ activity/NN ./.
@@107274289499 Although/IN MAP/NEWGENE (/NEWGENE mitogen-activated/NEWGENE protein/NEWGENE )/NEWGENE kinases/NEWGENE are/VBP implicated/VBN in/IN cell/NN proliferation/NN and/CC differentiation/NN in/IN many/JJ cell/NN types/NNS ,/, the/DT role/NN of/IN MAP/NEWGENE kinases/NEWGENE in/IN cardiac/JJ hypertrophy/NN remains/VBP unclear/JJ ./.
@@110169545586 AGO1/NEWGENE is/VBZ similar/JJ to/IN QDE-2/NEWGENE required/VBN for/IN quelling/VBG and/CC RDE-1/NEWGENE required/VBN for/IN RNAi/NN ./.
@@90472525340 METHODS/IN :/: Fifty-eight/NNS patients/NNS who/WP underwent/VBD a/DT curative/JJ hepatic/JJ resection/NN for/IN HCC/NN and/CC whose/WP preoperative/JJ AFP/NEWGENE levels/NNS were/VBD >/SYM 100/CD ng/NN //NN ml/NN ,/, were/VBD selected/VBN for/IN this/DT study/NN ./.
@@65010864763 Significant/JJ alterations/NNS in/IN the/DT vasectomized/JJ rats/NNS from/IN sham/NN rats/NNS included/VBN :/: testicular/JJ and/CC epididymal/JJ hypertrophy/NN ,/, formation/NN of/IN pathologic/JJ vas/NN deferens/NN granulomas/NNS ,/, decreased/VBN total/JJ serum/JJ protein/NN ,/, lowered/VBN alpha-globulin/NEWGENE levels/NNS as/IN shown/VBP by/IN serum/JJ electrophoresis/NN ,/, and/CC increased/VBD sperm/NN agglutinin/NN antibody/NN titers/NNS ./.
@@100651761491 There/EX was/VBD no/DT difference/NN in/IN the/DT hormone/NN receptor/NN status/NN between/IN the/DT cases/NNS without/IN lymph/NN node/NN metastases/NNS and/CC with/IN lymph/NN node/NN metastases/NNS ,/, 'clandestine'/NN or/CC macrometastases/NNS ./.
@@97486699731 It/PRP may/MD be/VB time/VB to/IN reevaluate/VB the/DT dichotomy/NN between/IN AD/NN and/CC VaD/DT ./.
@@95966384150 Comparative/JJ mapping/NN of/IN the/DT Brassica/NEWGENE S/NEWGENE locus/NEWGENE region/NEWGENE and/CC its/PRP homeolog/NN in/IN Arabidopsis/NN ./.
@@103608396903 In/NN addition/NN ,/, we/PRP show/VBP that/IN the/DT expression/NN of/IN individual/JJ members/NNS of/IN one/PRP subfamily/NN of/IN KRAB/NEWGENE zinc/NEWGENE finger/NEWGENE genes/NEWGENE is/VBZ restricted/VBN to/IN specific/JJ hematopoietic/JJ cell/NN lineages/NNS ./.
@@88405064077 Two/CD of/IN the/DT ORFs/NNS are/VBP completely/RB internal/JJ to/IN longer/JJR ones/NNS and/CC a/DT third/RB is/VBZ partially/RB embedded/VBN in/IN G2850/NEWGENE ./.
@@37582504426 Fast/NNP goal-directed/JJ voluntary/JJ movements/NNS of/IN the/DT human/JJ upper/JJ extremity/NN are/VBP known/VBP to/IN be/VB associated/VBN with/IN three/CD distinct/JJ bursts/NNS of/IN EMG/JJ activity/NN in/IN antagonistic/JJ muscles/NNS ./.
@@114282831304 A/DT 5-month-old/CD infant/NN with/IN persistent/JJ congenital/JJ stridor/NN and/CC acute/JJ respiratory/JJ distress/NN is/VBZ presented/VBN ./.
@@9418882796 Nevertheless/RB ,/, antibodies/NNS directed/VBN against/IN an/DT epitope-tagged/JJ version/NN of/IN Prp42p/NEWGENE specifically/RB precipitate/VB U1/NEWGENE snRNA/NEWGENE from/IN yeast/NN extracts/NNS ./.
@@89218656778 They/PRP lack/NN a/DT predicted/VBN single/JJ stranded/JJ (/( ss/NNS )/SYM DNA/NN binding/JJ motif/NN that/WDT is/VBZ unique/JJ the/DT large/NN terminase/NEWGENE proteins/NEWGENE in/IN T4/NEWGENE gp17/NEWGENE ,/, and/CC that/DT has/VBZ been/VBN implicated/VBN in/IN recognizing/VBG ssDNA/NN regions/NN in/IN replicating/JJ and/CC recombining/JJ T4DNA/NNP destined/VBN to/IN be/VB packaged/VBN ./.
@@68563066650 The/DT Tullio/NNP phenomenon/NN ,/, fistula/NN test/NN ,/, and/CC Hennebert's/NNP sign/NN :/: clinical/JJ significance/NN ./.
@@92944536624 The/DT ORF3/NN mutant/NN produced/VBN reduced/VBN levels/NNS of/IN tabtoxin/NEWGENE ,/, indicating/VBG that/IN ORF3/NN may/MD have/VB a/DT role/NN in/IN T/NEWGENE beta/NEWGENE L/NEWGENE biosynthesis/NN ./.
@@86220304095 No/DT significant/JJ differences/NNS existed/VBN between/IN the/DT two/JJ age/NN groups/NNS in/IN baseline/JJ characteristics/NNS ,/, including/JJ treatment/NN protocol/NN ,/, performance/NN status/NN ,/, and/CC serum/NEWGENE lactate/NEWGENE dehydrogenase/NEWGENE (/( LDH/NEWGENE )/SYM level/NN ./.
@@88827107195 Interferon/NEWGENE stimulated/NEWGENE gene/NEWGENE factor/NEWGENE 3/NEWGENE (/( ISGF3/NEWGENE )/SYM is/VBZ a/DT trimeric/JJ transcription/NN factor/NN activated/VBN on/IN treatment/NN of/IN cells/NNS with/IN interferon-alpha/NEWGENE and/NEWGENE beta/NEWGENE (/( type/NEWGENE I/NEWGENE IFNs/NEWGENE )/SYM ./.
@@19830262594 Although/IN heart/NN rate/NN and/CC diastolic/JJ pressure/NN rose/VBD in/IN some/DT degree/NN 1/CD min/NN after/IN intubation/NN ,/, free/JJ and/CC total/JJ CA/NN concentrations/NNS did/VBD not/RB increase/VB during/IN study/NN period/NN ./.
@@9837914708 Biol/NNP ./.
@@79354683695 Activation/NNS of/IN c-fos/NEWGENE gene/NEWGENE expression/NN by/IN a/DT kinase-deficient/JJ epidermal/NEWGENE growth/NEWGENE factor/NEWGENE receptor/NEWGENE ./.
@@10414451831 Fifty/CD six/CD young/JJ patients/NNS (/( age/NN </SYM 45/CD yr/NN )/SYM with/IN doppler-proven/JJ DVT/NN were/VBD investigated/VBN for/IN the/DT presence/NN of/IN resistance/NN to/IN activated/NEWGENE protein/NEWGENE C/NEWGENE (/( APC-R/NEWGENE )/SYM ,/, lupus/NN anticoagulant/JJ (/( LA/NN )/SYM ,/, anticardiolipin/NEWGENE antibodies/NEWGENE and/CC deficiencies/NNS of/IN protein/NEWGENE C/NEWGENE ,/, protein/NEWGENE S/NEWGENE ,/, ATIII/NEWGENE activities/NNS ./.
@@88120129993 The/DT effects/NNS of/IN procedural/JJ variations/NNS on/IN lateralized/JJ Stroop/NN effects/NNS ./.
@@67937646561 Host/NNP lipids/NNS in/IN tuberculous/JJ infection/NN ./.
@@100684462678 However/RB ,/, in/IN those/DT studies/NNS due/NN to/IN the/DT presence/NN of/IN thiol/NN agents/NNS in/IN the/DT PKC/NEWGENE preparations/NNS ,/, the/DT sensitive/JJ reaction/NN of/IN BPO/DT with/IN redox-active/JJ cysteine/NN residues/NNS in/IN PKC/NEWGENE was/VBD not/RB observed/VBN ./.
@@66522936384 Increasing/VBG the/DT cut-off/JJ point/NN to/IN 3/CD positive/JJ responses/NNS decreased/VBD the/DT sensitivity/NN to/IN 81%/JJ and/CC increased/VBD the/DT specificity/NN to/IN 94%/CD ./.
@@95954965977 Recently/RB ,/, extremely/RB high/JJ levels/NNS of/IN endothelin-1/NEWGENE (/( ET-1/NEWGENE )/SYM were/VBD detected/VBN in/IN the/DT pericardial/JJ fluid/NN of/IN patients/NNS undergoing/VBG cardiac/JJ surgery/NN ./.
@@21451952323 The/DT 3'/NN stem-loop/NN is/VBZ highly/RB divergent/JJ in/IN structure/NN among/IN species/NN and/CC lies/NNS immediately/RB upstream/RB of/IN the/DT binding/JJ site/NN for/IN Sm/NEWGENE proteins/NEWGENE ./.
@@28684463325 The/DT C-terminal/NN domains/NN (/( CTDs/NN )/SYM of/IN the/DT RPase/NEWGENE beta/NEWGENE subunit/NEWGENE and/CC DNA/NEWGENE primase/NEWGENE (/( dnaG/NEWGENE protein/NEWGENE )/SYM were/VBD not/RB only/RB strongly/RB homologous/JJ to/IN each/DT other/DT but/CC also/RB considerably/RB homologous/JJ to/IN the/DT RPase/NEWGENE alpha/NEWGENE ,/, suggesting/VBG that/IN an/DT alpha/NN subunit-like/NN enzyme/NN must/MD have/VB been/VBN commonly/RB ancestral/JJ to/IN core/NEWGENE enzyme/NEWGENE subunits/NEWGENE and/CC primase/NEWGENE ./.
@@60920485919 In/NN these/DT cases/NNS ,/, asbestos/NN or/CC erionite-tissue/JJ burden/NN followed/VBN by/IN fibrosis/NN was/VBD frequently/RB observed/VBN ./.
@@10839593646 OBJECTIVE/IN :/: To/TO determine/VB the/DT efficacy/NN and/CC safety/NN of/IN amphotericin/NN B/NN oral/JJ suspension/NN (/( ABOS/NNP )/SYM for/IN the/DT treatment/NN of/IN fluconazole/NN refractory/JJ oral/JJ candidiasis/NN in/IN persons/NNS with/IN HIV/NN infection/NN ./.
@@12753351912 Chlamydial/JJ agents/NNS were/VBD isolated/VBN from/IN the/DT semen/NN near/IN the/DT end/NN of/IN the/DT chlamydemic/JJ phase/NN ./.
@@98657754276 This/DT study/NN was/VBD undertaken/VBP to/IN evaluate/VB how/RB couplers/NNS and/CC their/PRP placement/NN affect/NN the/DT ALGO2/NN click/NN spectral/JJ properties/NNS ./.
@@8255718239 III/NNP ./.
@@104702207991 The/DT arrangement/NN of/IN these/DT cutoff-levels/NNS leads/VBP to/IN a/DT sensitivity/NN of/IN 85%/JJ at/IN a/DT specificity/NN of/IN 55%/JJ for/IN Protein/NEWGENE S100/NEWGENE when/CC measured/VBN by/IN RIA/NN ,/, and/CC to/IN a/DT sensitivity/NN of/IN 77%/JJ at/IN a/DT specificity/NN of/IN 61%/JJ when/CC measured/VBN by/IN LIA/NN ./.
@@38830524537 In/NN memory/NN of/IN Magdelaine/NNP Comtesse/NNP ./.
@@88467759171 In/NN the/DT absence/NN of/IN Swi4/NEWGENE and/CC Swi6/NEWGENE cell/NN viability/NN is/NNS lost/VBP ,/, but/CC can/MD be/VB regained/VBN by/IN ectopic/JJ expression/NN of/IN the/DT G1/NEWGENE cyclin/NEWGENE encoding/NEWGENE genes/NEWGENE ,/, CLN1/NEWGENE or/CC CLN2/NEWGENE ./.
@@80207022855 The/DT study/NN made/VBP to/IN define/VB the/DT ability/NN of/IN lipid/NEWGENE A/NEWGENE monoclonal/NEWGENE antibodies/NEWGENE to/IN correct/JJ hemodynamic/JJ disturbances/NNS due/NN to/IN endotoxemia/NN in/IN dog/NN experiments/NNS showed/VBD the/DT efficacy/NN of/IN the/DT antibodies/NNS administration/NN ./.
@@118600971749 Data/NNP on/IN prosthesis/NN use/NN are/VBP encouraging/JJ ,/, although/IN a/DT follow-up/JJ study/NN is/VBZ required/VBN to/IN determine/VB the/DT functional/JJ outcome/NN for/IN prosthesis/NN users/NNS and/CC non-users/NNS ./.
@@7937954478 HBx/NEWGENE strongly/RB elevates/VBZ levels/NNS of/IN GTP-bound/NNP Ras/NEWGENE ,/, activated/VBN and/CC phosphorylated/VBN Raf/NEWGENE ,/, and/CC tyrosine-phosphorylated/JJ and/CC activated/VBN MAP/NEWGENE kinase/NEWGENE ./.
@@78416631371 These/DT studies/NNS indicate/VBP that/IN in/IN vitro/FW and/CC in/IN vivo/NN electrical/JJ stimulation/NN generate/VB reactive/NN oxygen/NN species/NN and/CC affect/VB SOD/NEWGENE activity/NN ,/, which/WDT in/IN part/NN are/VBP responsible/JJ for/IN decreased/VBN sperm/NN motion/NN and/CC viability/NN ./.
@@92435051519 In/NN addition/NN ,/, the/DT DNA-binding/NN experiments/NNS show/VBP that/IN either/DT one/PRP of/IN the/DT two/JJ MADS/NEWGENE domains/NEWGENE of/IN a/DT dimer/NN can/MD be/VB sufficient/JJ to/IN confer/VB a/DT particular/JJ DNA-binding/NN specificity/NN to/IN the/DT complex/NN and/CC that/IN sequences/NNS outside/RB the/DT amino-terminal/NN basic/NN region/NN of/IN the/DT MADS/NEWGENE domain/NN can/MD ,/, in/IN some/DT cases/NNS ,/, contribute/VB to/IN the/DT DNA-binding/NN specificity/NN of/IN the/DT proteins/NNS ./.
@@106886662274 Finally/RB ,/, the/DT mechanism/NN of/IN ASK1/NEWGENE activation/NN involves/VBZ ,/, in/IN part/NN ,/, homo-oligomerization/NN ./.
@@79417502386 A/DT third/RB one/PRP is/VBZ homologous/JJ in/IN half/NN of/IN its/PRP length/NN to/IN the/DT prokaryotic/NEWGENE hydantoinase/NEWGENE HyuA/NEWGENE1 and/CC in/IN the/PDT other/DT half/NN to/IN hydatoinase/NEWGENE HyuB/NEWGENE1 ./.
@@37882314473 One/CD of/IN the/DT most/RB relevant/JJ aspects/NNS in/IN achieving/JJ the/DT consistent/JJ survival/NN of/IN an/DT animal/NN undergoing/VBG the/DT experimental/JJ implantation/NN of/IN a/DT total/JJ artificial/JJ heart/NN is/VBZ obviously/RB related/VBN to/IN the/DT correct/JJ anatomic/JJ placement/NN of/IN prosthetic/JJ ventricles/NNS inside/IN the/DT chest/NN ./.
@@23689313977 In/NN addition/NN serum/NEWGENE IgE/NEWGENE concentrations/NNS were/VBD not/RB statistically/RB different/JJ ./.
@@8721989754 Our/PRP results/NNS demonstrate/VBP that/IN distinct/JJ cytoplasmic/JJ domains/NNS of/IN these/DT cytokine/NEWGENE receptors/NEWGENE elicit/VBP convergent/JJ signaling/JJ pathways/NNS and/CC provide/VB evidence/NN that/DT beta/NEWGENE c/NEWGENE and/CC IL-2R/NEWGENE beta/NEWGENE function/NN as/IN a/DT complete/JJ signal/NN transducer/NN ./.
@@81992043005 H-7/NNS ,/, which/WDT specifically/RB ,/, although/IN weakly/RB ,/, inhibited/VBN PKC/NEWGENE activation/NN ,/, had/VBP no/DT effect/NN on/IN tyrosine/NN phosphorylation/NN and/CC PtdIns/NN (/NN 3/NN ,/NN 4/NN )/NN P2/NN production/NN ./.
@@114725231352 CONCLUSION/IN :/: Extrusion/NNS cooking/NN is/VBZ effective/JJ for/IN the/DT inactivation/NN of/IN DON/NN but/CC is/NNS of/IN limited/VBN value/NN for/IN AFB1/NN ,/, even/VB if/IN metabisulphite/NN is/VBZ added/VBN ./.
@@2118819003 Efforts/NNS were/VBD made/VBP to/IN determine/VB the/DT amount/NN of/IN time/NN required/VBN for/IN kidney/NN lesions/NNS to/IN develop/VB and/CC ,/, if/IN possible/JJ ,/, to/IN delineate/VB the/DT potential/JJ site/NN of/IN action/NN of/IN PBB/NN ./.
@@104097552112 In/NN summary/NN ,/, Ca/NN (/NN 2+/NN )/NN -dependent/NN activation/NN of/IN NO/DT production/NN mediates/VBZ apoptosis/NN after/IN TG/NN exposure/NN in/IN JT/NNP //NNP Neo/NNP cells/NNS ./.
@@75688657465 All/DT carcasses/NNS resulted/VBN in/IN contamination/NN with/IN aerobic/JJ mesophilic/JJ bacteria/NNS in/IN the/DT range/NN from/IN 6/CD x/NN 10/NN (/NN 3/NN )/NN to/IN 1/CD ./CD 2/CD x/NN 10/NN (/NN 6/NN )/NN CFU/NNS //NNS ml/NNS liquid/RB washed/VBN ,/, and/CC 94%/NN them/PRP with/IN sporulate/VB bacteria/NNS ,/, the/DT threshold/NN being/NN under/IN 100/CD CFU/NNS //NNS ml/NNS (/( Figure/NN 1/CD )/SYM ./SYM
@@9748261820 Saccharomyces/NN cerevisiae/NN contains/VBZ four/CD known/VBP acyl-CoA/NEWGENE synthetases/NEWGENE (/( fatty/NEWGENE acid/NEWGENE activation/NEWGENE proteins/NEWGENE ,/, Faaps/NEWGENE )/SYM ./.
@@75529747433 Specific/JJ requirements/NNS for/IN branched-chain/JJ amino/JJ acids/NNS ,/, glutamine/NN ,/, and/CC arginine/NN are/VBP evaluated/VBN ./.
@@22819482929 The/DT corn/NN and/CC mineral/JJ oil/NN emulsions/NNS were/VBD almost/RB as/RB effective/JJ as/IN milk/NN but/CC less/PRP effective/JJ than/IN sucrose/NN (/( 0/CD ./CD 3M/CD )/SYM in/IN stimulating/JJ ingestion/NN ./.
@@76555053585 In/NN both/DT shoots/NNS and/CC roots/NNS ,/, GT-2/NEWGENE protein/NEWGENE is/VBZ undetectable/JJ in/IN meristematic/JJ tissue/NN but/CC becomes/VBZ expressed/VBN at/IN later/JJR stages/NNS of/IN cellular/JJ development/NN ,/, consistent/JJ with/IN a/DT role/NN in/IN contributing/JJ to/IN the/DT pattern/NN of/IN phytochrome/NEWGENE A/NEWGENE gene/NEWGENE expression/NN ./.
@@26704573342 The/DT calcium/NN requirement/NN for/IN hypothermic/JJ storage/NN of/IN the/DT cardiac/JJ explant/NN ./.
@@13965834359 A/DT cDNA/NN library/NN of/IN tumour/NN cells/NNS was/VBD screened/VBN with/IN an/DT interleukin/NEWGENE 2/NEWGENE gene-specific/JJ probe/NN ./.
@@112779137944 An/DT element/NN within/IN the/DT 5'/CD untranslated/JJ region/NN of/IN human/NEWGENE Hsp70/NEWGENE mRNA/NEWGENE which/WDT acts/NNS as/IN a/DT general/NN enhancer/NN of/IN mRNA/NN translation/NN ./.
@@76337565739 The/DT ARX2/NN procedure/NN models/NNS the/DT recorded/VBN signal/JJ as/IN the/DT sum/NN of/IN three/CD signals/NNS :/: (/( a/DT )/SYM the/DT background/NN EEG/NN activity/NN ,/, modelled/VBN as/IN an/DT autoregressive/JJ process/NN driven/VBP by/IN a/DT white/JJ noise/NN ;/: (/( b/NN )/SYM a/DT filtered/JJ version/NN of/IN a/DT reference/NN signal/JJ carrying/NN the/DT average/JJ information/NN contained/VBN in/IN each/DT sweep/NN ;/: (/( c/NN )/SYM a/DT signal/JJ due/NN to/IN the/DT ocular/JJ artefact/NN propagation/NN ./.
@@61013595926 Diagnosis/NNP and/CC treatment/NN of/IN insulin-secreting/JJ tumours/NNS ./.
@@79353708591 The/DT coordinated/JJ expression/NN of/IN CD4/NEWGENE and/CC CD8/NEWGENE during/IN T-cell/NN development/NN is/VBZ tightly/RB coupled/VBN with/IN the/DT maturation/NN state/NN of/IN the/DT T/NN cell/NN ./.
@@77282017394 In/NN contrast/NN ,/, recent/JJ evidence/NN suggests/VBZ that/IN children/NNS with/IN sickle-hemoglobin/NEWGENE C/NEWGENE disease/NN do/NN not/RB develop/VB functional/JJ asplenia/NN before/IN 3/CD to/IN 4/CD years/NNS of/IN age/NN and/CC thus/RB may/MD not/RB benefit/VB from/IN penicillin/NN prophylaxis/NN ./.
@@36977984365 Contraction/NN of/IN the/DT tracheal/JJ muscle/NN and/CC the/DT activity/NN of/IN stretch/NN receptors/NNS in/IN the/DT trachea/NN ./.
@@18321975810 Imaging/NNP of/IN D2/NEWGENE dopamine/NEWGENE receptor/NEWGENE ./.
@@71549286972 Modification/NNS of/IN enteral/JJ resorption/NN by/IN cytostatic/JJ therapy/NN ./.
@@107291513799 This/DT mutation/NN no/RB longer/RB repressed/VBN the/DT HPV-11/NN upstream/RB regulatory/JJ region-controlled/JJ reporter/NN expression/NN ./.
@@114805554909 The/DT production/NN of/IN ceramide/NN is/VBZ emerging/JJ as/IN a/DT fixture/NN of/IN programmed/JJ cell/NN death/NN ./.
@@22197512856 Foveating/VBG saccades/NNS ,/, therefore/RB ,/, can/MD be/VB distinguished/VBN from/IN other/DT FEMs/NNP on/IN the/DT basis/NN of/IN speed/NN ./.
@@1477021925 RESULTS/NNS :/: In/NN the/DT AGA/NN group/NN ,/, both/DT fetal/JJ and/CC maternal/JJ serum/JJ prolactin/NEWGENE concentration/NN increased/VBN significantly/RB with/IN gestation/NN (/( P/NN </SYM 0/CD ./CD 001/CD and/CC P/NN </SYM 0/CD ./CD 01/CD ,/, respectively/RB )/SYM ./.
@@67646693874 Colorimetric/NNP determination/NN of/IN urinary/JJ iron/NN ,/, chelated/VBN with/IN deferoxamine/NN B/NN ,/, using/VBG a/DT single/JJ reagent/NN ./.
@@117150791558 We/PRP hypothesize/VBP that/DT proprioception/NN may/MD be/VB used/VBN to/IN calibrate/VB the/DT efference/NN copy/NN during/IN development/NN and/CC in/IN response/NN to/IN perturbations/NNS by/IN signaling/JJ potential/JJ mismatches/NNS between/IN eye/NN movement/NN information/NN derived/VBN from/IN the/DT efferent/JJ command/NN and/CC the/DT actual/JJ motion/NN of/IN the/DT eye/NN transduced/VBN by/IN the/DT proprioceptive/JJ organs/NNS ./.
@@67482276513 The/DT maps/NNS of/IN Case/NNP 2/CD showed/VBD that/IN a/DT maximum/JJ first/RB appeared/VBN on/IN the/DT upper/JJ right/JJ back/NN and/CC then/RB moved/VBN down/NN the/DT right/JJ side/NN of/IN the/DT posterior/JJ thorax/NN ./.
@@105128823181 Assembly/NNP of/IN a/DT complex/NN between/IN FAK/NEWGENE and/CC Src/NEWGENE kinases/NEWGENE may/MD serve/VB to/IN regulate/VB the/DT subcellular/JJ localization/NN and/CC the/DT enzymatic/JJ activity/NN of/IN members/NNS of/IN the/PDT Src/NEWGENE family/NEWGENE of/IN kinases/NEWGENE ./.
@@59024585813 Naphthalene/NN and/CC paradichlorobenzene/NN in/IN clinical/JJ toxicology/NN ./.
@@96581047283 Role/NN of/IN the/DT transcription/NN start/NN site/NN core/NN region/NN and/CC transcription/NEWGENE factor/NEWGENE YY1/NEWGENE in/IN Rous/NEWGENE sarcoma/NEWGENE virus/NEWGENE long/NEWGENE terminal/NEWGENE repeat/NEWGENE promoter/NEWGENE activity/NN ./.
@@90798787813 Some/DT 8/CD ./CD 8/CD kb/NN of/IN the/DT Lactobacillus/NN sake/NN plasmid/NN pCIM1/NN was/VBD sequenced/VBN ,/, revealing/VBG eight/CD tightly/RB clustered/VBN open/JJ reading/JJ frames/NNS (/( ORFs/NNS )/SYM downstream/RB from/IN lasA/NEWGENE ,/, which/WDT encodes/VBZ pre-lactocin/NEWGENE S/NNP ./NNP
@@104498995495 These/DT overall/JJ results/NNS indicate/VBP that/WDT there/RB is/VBZ generally/RB one/PRP PERV/NNP copy/NN per/IN integration/NN site/NN ./.
@@90900541068 Until/IN now/RB ,/, each/DT of/IN these/DT loci/NNS was/VBD considered/VBN to/IN contain/VB three/CD genes/NNS (/( for/IN regulator/NEWGENE ,/, permease/NEWGENE and/CC alpha-glucosidase/NEWGENE )/SYM ,/, but/CC a/DT fourth/NN gene/NN ,/, presumably/RB an/DT extra/JJ alpha-glucosidase/NEWGENE gene/NEWGENE ,/, was/VBD found/VBN at/IN MAL1/NEWGENE adjacent/JJ to/IN the/DT usual/JJ cluster/NN of/IN three/CD genes/NNS ./.
@@109733857870 In/NN patients/NNS with/IN type/NN II/NN tumors/NNS ,/, the/DT pattern/NN of/IN lymphatic/JJ spread/NN was/VBD primarily/RB directed/VBN toward/IN the/DT paracardial/NN ,/, lesser/JJ curvature/NN ,/, and/CC left/NN gastric/JJ artery/NN nodes/NNS ;/: esophagectomy/NN offered/VBD no/DT survival/NN benefit/NN over/RB extended/VBD gastrectomy/NN in/IN these/DT patients/NNS ./.
@@76525827576 INF-alpha/NEWGENE therapy/NN has/VBZ been/VBN a/DT major/JJ development/NN in/IN the/DT treatment/NN of/IN CML/NN ./.
@@44292694969 On/IN the/DT transport/NN of/IN mucus/NN and/CC its/PRP rheologic/JJ simulants/NNS in/IN ciliated/JJ systems/NNS ./.
@@95087753625 The/DT cAMP-dependent/JJ mitogenic/JJ pathway/NN is/VBZ unique/JJ as/IN it/PRP is/VBZ independent/NN of/IN mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE activation/NN and/CC differs/VBZ from/IN growth/NN factor-dependent/NN pathways/NNS at/IN the/DT level/NN of/IN the/DT expression/NN of/IN several/DT protooncogenes/NN //NN transcription/NN factors/NN ./.
@@75924855084 If/IN NCR-sensitive/NN gene/NN expression/NN occurs/VBZ exclusively/RB by/IN this/DT pathway/NN ,/, as/IN has/VBZ been/VBN thought/VBP to/IN be/VB the/DT case/NN ,/, then/RB the/DT NCR/NNP sensitivity/NN of/IN a/DT gene's/NNS expression/NN should/MD be/VB abolished/VBN by/IN a/DT ure2/NEWGENE delta/NEWGENE mutation/NEWGENE ./.
@@96531824404 These/DT data/NN show/NN that/IN heterologous/JJ virus/NN RNAs/NNS (/( BSMV/ORG )/SYM can/MD serve/VB as/IN primer/NN donors/NNS for/IN MStV/NN mRNA/NN capped/VBD RNA-primed/JJ transcription/NN in/IN doubly/RB infected/VBN plants/NNS ./.
@@5355205485 With/IN certain/JJ exceptions/NNS the/DT method/NN was/VBD considered/VBN suitable/JJ in/IN the/DT routine/JJ intravenous/JJ cholangiography/NN ./.
@@71908697012 CDDP/NN is/VBZ active/JJ as/IN a/DT single/JJ agent/NN in/IN non-Hodgkin's/JJ lymphoma/NN ./.
@@95576828553 Four/CD possible/JJ isoforms/NNS (/( hGli2/NEWGENE alpha/NEWGENE ,/NEWGENE beta/NEWGENE ,/NEWGENE gamma/NEWGENE ,/NEWGENE and/NEWGENE delta/NEWGENE )/SYM are/VBP formed/VBN by/IN combinations/NNS of/IN two/JJ independent/JJ alternative/JJ splicings/NNS ,/, and/CC all/PDT the/DT isoforms/NNS could/MD bind/NN to/IN a/DT DNA/NN motif/NN ,/, TRE2S/NEWGENE ,/, in/IN the/DT LTR/NN ./.
@@89323636385 When/WRB the/DT E1A/NEWGENE N-terminus/NEWGENE is/VBZ used/VBN as/IN a/DT competitor/NN in/IN squelshing/JJ experiments/NNS it/PRP abolishes/VBZ CBP-induced/JJ activation/NN of/IN E2F1/NEWGENE //NEWGENE DP1/NEWGENE ,/, whereas/IN an/DT E1A/NEWGENE mutant/NEWGENE lacking/JJ CBP/NEWGENE binding/JJ ability/NN fails/VBZ to/IN do/NN so/CD ./CD
@@9557708274 Specialized/NNP actin/NEWGENE tails/NNS that/WDT propel/VBP IEV/NNP particles/NNS to/IN the/DT periphery/NN and/CC virus-tipped/JJ microvilli/NNS (/( both/DT common/NN in/IN wild-type-infected/JJ cells/NNS )/SYM were/VBD absent/VB in/IN cells/NNS infected/VBN with/IN vA33delta/CD ./.
@@92359956008 (/( 1996a/CD )/SYM Biochemistry/NNP 35/CD ,/, 1589-1598/NN ]/NN ./.
@@1009161989 Schwab/NNP and/CC England/NN ADL/NN scores/NNS in/IN the/DT "off"/NN state/NN were/VBD improved/VBN by/IN 18%/JJ and/CC in/IN the/DT "on"/NN state/NN the/DT scores/NNS declined/VBN by/IN 2%/CD ./CD
@@82646646968 TGF/NEWGENE beta/NEWGENE 1/NEWGENE expression/NN is/VBZ largely/RB governed/VBN by/IN three/CD AP-1/NEWGENE binding/NEWGENE sites/NEWGENE located/VBN in/IN two/JJ different/JJ promoters/NNS of/IN this/DT gene/NN ./.
@@67238496871 The/DT pyramidal/JJ tract/NN and/CC Mesencephalic/NNP Reticular/NNP Formation/NNP (/( MRF/NN )/SYM were/VBD stimulated/VBN before/IN and/CC after/IN the/DT transection/NN ./.
@@71138971194 There/EX were/VBD no/DT significant/JJ differences/NNS in/IN EF/NN between/IN the/DT two/JJ studies/NNS ,/, both/DT at/IN rest/NN (/( 56/CD ./CD 0/CD +/NN //NN -/NN 13/CD ./CD 8%/CD vs/NNP 58/CD ./CD 2/CD +/NN //NN -/NN 11/CD ./CD 7%/CD ,/, p/NN =/SYM NS/NNP )/SYM and/CC with/IN exercise/NN (/( 51/CD ./CD 1/CD +/NN //NN -/NN 17/CD ./CD 6%/CD vs/NNP 54/CD ./CD 3/CD +/NN //NN -/NN 17/CD ./CD 6%/CD ,/, p/NN =/SYM NS/NNP )/SYM and/CC a/DT highly/RB significant/JJ correlation/NN was/VBD shown/VBP between/IN the/DT two/JJ groups/NNS of/IN values/NNS (/( rest/NN r/NN =/SYM 0/CD ./CD 90/CD ,/, exercise/NN r/JJ =/SYM 0/CD ./CD 93/CD ,/, p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ./.
@@95491799496 Serum/NN levels/NNS of/IN testosterone/NN also/RB showed/VBD no/DT significant/JJ changes/NNS by/IN exposure/NN to/IN p/NN ,/NN p'-DDE/NN under/IN the/DT conditions/NNS of/IN this/DT study/NN ./.
@@85971778575 Effects/NNPS of/IN repeated/JJ exposures/NNS of/IN hydrogen/NN sulphide/NN on/IN rat/NN hippocampal/JJ EEG/NN ./.
@@115527244326 CONCLUSIONS/IN :/: ChromaFlo-enhanced/NN IVUS/NN demonstrates/VBZ colorized/VBN blood/NN flow/NN inside/IN the/DT vessel/NN lumen/NN ,/, which/WDT is/VBZ helpful/JJ in/IN distinguishing/JJ echolucent/JJ disease/NN from/IN luminal/JJ blood/NN flow/NN and/CC can/MD also/RB be/VB used/VBN to/IN perform/VB peripheral/JJ interventions/NNS in/IN patients/NNS with/IN renal/JJ failure/NN or/CC allergy/NN ,/, avoiding/JJ the/DT use/NN of/IN contrast/NN media/NN ./.
@@14298363881 Disruption/NNS of/IN microtubules/NNS did/VBD not/RB affect/VB the/DT fidelity/NN or/CC kinetics/NN of/IN vacuolar/JJ protein/NN sorting/JJ ,/, indicating/VBG that/IN Vps1p/NEWGENE function/NN is/VBZ not/RB dependent/JJ on/IN microtubules/NNS ./.
@@93911735416 Transcription/NNS start/NN sites/NNS of/IN the/DT plastid/NN ACCase/NEWGENE genes/NEWGENE were/VBD estimated/VBN from/IN the/DT longest/JJS cDNA/NN clones/NNS obtained/VBN by/IN 5'-RACE/JJ (/( rapid/JJ amplification/NN of/IN cDNA/NN ends/NNS )/SYM ./.
@@91620922644 MKK3/NEWGENE autophosphorylation/NN and/CC activation/NN of/IN p38/NEWGENE was/VBD also/RB observed/VBN following/IN coexpression/NN of/IN MKK3/NEWGENE with/IN MEKK3/NEWGENE ,/, but/CC not/RB with/IN MEKK2/NEWGENE ./.
@@62419806041 Oxygen/NN profiles/NNS calculated/VBN for/IN the/DT Krogh/NNP model/NN with/IN excentric/JJ diffusion/NN were/VBD similar/JJ to/IN those/DT derived/VBN for/IN the/DT two/JJ models/NNS of/IN concentric/JJ diffusion/NN ./.
@@114615958158 We/PRP investigate/VBP the/DT reaction/NN kinetics/NN of/IN small/JJ spherical/JJ particles/NNS with/IN inertia/NN ,/, obeying/VBG coalescence/NN type/NN of/IN reaction/NN ,/, B+B--/NN >/NN B/NN ,/, and/CC being/VBP advected/VBN by/IN hydrodynamical/JJ flows/NNS with/IN time-periodic/JJ forcing/VBG ./.
@@98136351988 These/DT striations/NNS were/VBD caused/VBN by/IN contact/NN between/IN the/DT sharp/JJ edge/NN of/IN the/DT upper/JJ canine/JJ and/CC the/DT P3/NN during/IN honing/JJ (/( canine/NN //NN premolar/NN complex/NN )/SYM ./.
@@11571916077 At/NN the/DT very/RB high/JJ dose/NN levels/NNS used/VBN ,/, sodium/NN saccharin/NN and/CC sodium/NN cyclamate/NN were/VBD weak/JJ solitary/JJ carcinogens/NNS producing/JJ 4/CD //CD 253/CD and/CC 3/CD //CD 228/CD bladder/NN tumours/NNS respectively/RB ,/, and/CC the/DT first/NN of/IN these/DT tumours/NNS did/VBD not/RB appear/VB for/IN more/RB than/IN 80/CD weeks/NNS ./.
@@108057394241 Our/PRP analysis/NN of/IN nonsense/NN mutations/NNS indicates/VBZ that/IN the/DT C/NN terminus/NN of/IN eIF2Bepsilon/NEWGENE (/NEWGENE residues/NEWGENE 518/NEWGENE to/NEWGENE 712/NEWGENE )/NEWGENE is/VBZ required/VBN for/IN both/DT catalytic/JJ activity/NN and/CC interaction/NN with/IN eIF2/NEWGENE ./.
@@115047099355 This/DT study/NN demonstrates/VBZ that/IN inducible/JJ expression/NN in/IN response/NN to/IN either/DT PMA/NN or/CC TPO/NEWGENE is/VBZ mediated/JJ through/RB the/DT Ets/NEWGENE site/NEWGENE in/IN the/DT proximal/JJ promoter/NN of/IN GPIX/NEWGENE and/CC is/VBZ dependent/JJ upon/IN the/DT upstream/JJ activation/NN of/IN MAPK/NEWGENE //NEWGENE extracellular/NEWGENE signal-regulated/NEWGENE kinase/NEWGENE ./.
@@111799563885 While/IN these/DT results/NNS are/VBP consistent/JJ with/IN previously/RB reported/VBN effects/NNS of/IN the/DT C-terminal/NN domain/NN on/IN nucleotide/NN binding/JJ ,/, they/PRP also/RB demonstrate/VBP that/IN interactions/NNS with/IN the/DT N-terminal/NN domains/NN are/VBP necessary/JJ to/IN inhibit/VB proton/NN transport/NN ./.
@@102259458472 In/NN contrast/NN ,/, the/DT loss/NN of/IN MAD2/NEWGENE staining/NN in/IN meiosis/NN was/VBD not/RB correlated/VBN with/IN initial/JJ microtubule/NN attachment/NN but/CC was/VBD correlated/VBN with/IN a/DT measure/NN of/IN tension/NN :/: the/DT distance/NN between/IN homologous/JJ or/CC sister/NN kinetochores/NNS (/( in/IN meiosis/NN I/PRP and/CC II/NNP ,/, respectively/RB )/SYM ./.
@@90322598527 Furthermore/RB ,/, Rac1/NEWGENE activation/NN of/IN JNK/NEWGENE or/CC SRF/NEWGENE ,/, or/CC induction/NN of/IN lamellipodia/NNS ,/, was/VBD neither/DT necessary/JJ nor/CC sufficient/JJ for/IN Rac1/NEWGENE transforming/JJ activity/NN ./.
@@88697631551 It/PRP is/VBZ suggested/VBN that/IN the/DT observed/VBN clinical/JJ phenomena/NNS in/IN response/NN to/IN morphine/NN can/MD be/VB explained/VBN by/IN differences/NNS in/IN expression/NN and/CC sensitivity/NN of/IN some/DT opioid/NEWGENE receptor/NEWGENE subtypes/NNS in/IN migraine/NN ./.
@@87089848686 Aggravating/VBG process/NN induced/VBN by/IN indomethacin/NN on/IN chronic/JJ gastric/JJ lesion/NN in/IN rat/NN ./.
@@84760878443 These/DT protective/JJ influences/NNS were/VBD observed/VBN throughout/IN the/DT range/NN of/IN filling/JJ pressures/NNS measured/VBN ,/, from/IN 0/CD to/IN 30/CD mmHg/NN ./.
@@48430315091 The/DT levels/NNS of/IN galactosyltransferase/NEWGENE activity/NN in/IN sera/NNS from/IN normal/JJ children/NNS and/CC patients/NNS with/IN cystic/JJ fibrosis/NN ./.
@@110690114938 SSF/NN experiments/NNS were/VBD carried/VBN out/RB in/IN bench-scale/JJ bioreactors/NNS (/( equipped/VBN with/IN CO2/NN and/CC volatile/JJ organic/JJ traps/NNS )/SYM containing/JJ a/DT mixture/NN of/IN lignocellulosic/JJ materials/NNS and/CC a/DT radiolabeled/JJ pesticide/NN ./.
@@14690427391 Since/IN CENP-B/NEWGENE gene/NEWGENE is/VBZ conserved/VBN in/IN mammalian/JJ species/NN and/CC CENP-B/NEWGENE boxes/NEWGENE are/VBP found/VB also/RB in/IN mouse/NN centromere/NN satellite/JJ DNA/NN (/( minor/JJ satellite/JJ )/SYM ,/, this/DT sequence-specific/NN DNA-protein/NN interaction/NN may/MD be/VB important/JJ for/IN some/DT kind/NN of/IN common/JJ centromere/NN function/NN ./.
@@85853247614 (/( 1989/CD )/SYM ,/, which/WDT is/VBZ identical/JJ to/IN the/DT SSC1/NEWGENE gene/NEWGENE (/( Smith/NN et/FW al/NNS ./NNS ,/, 1988/CD )/SYM ./.
@@23084963520 The/DT paper/NN is/VBZ concerned/VBN with/IN the/DT data/NN on/IN change/NN in/IN the/DT blood/NN level/NN of/IN ACTH/NEWGENE ,/, STH/NEWGENE ,/NEWGENE TSH/NEWGENE ,/, cortisol/NN ,/, T3/NN ,/, insulin/NEWGENE ,/, C-peptide/NEWGENE during/IN a/DT 25-minute/JJ session/NN of/IN respiration/NN using/VBG a/DT gaseous/JJ hypoxic/JJ mixture/NN with/IN 10%/CD oxygen/NN (/( GHM-10/NN )/SYM ./.
@@28855172023 Testing/NN blood/NN donors/NNS for/IN non-A/NN ,/, non-B/NN hepatitis/NN :/: irrational/JJ ,/, perhaps/RB ,/, but/CC inescapable/JJ ./.
@@113121082487 Raes/NN ,/, P/NNP ./NNP
@@9652737693 Blocked/VBN shift/NN //NN supershift/NN analysis/NN indicates/VBZ that/IN Fos/NEWGENE family/NEWGENE member/NN proteins/NN especially/RB Fra-1/NEWGENE and/CC Fra-2/NEWGENE are/VBP related/VBN to/IN progression/NN and/CC no/DT changes/NNS found/VBP in/IN the/DT Jun/NEWGENE family/NEWGENE member/NN proteins/NN although/IN they/PRP are/VBP present/VB in/IN the/DT AP-1/NEWGENE //NEWGENE DNA/NEWGENE binding/NEWGENE complex/NEWGENE ./.
@@79589116341 A/DT strong/JJ trithorax/NEWGENE binding/NEWGENE site/NEWGENE was/VBD found/VBN at/IN the/DT cytological/JJ location/NN of/IN the/DT fork/NEWGENE head/NEWGENE gene/NEWGENE ,/, a/DT region-specific/NN homeotic/NEWGENE gene/NEWGENE not/RB located/VBD within/IN a/DT homeotic/NEWGENE complex/NEWGENE ./.
@@20814635227 To/TO investigate/VB the/DT regulation/NN of/IN Spec/NEWGENE gene/NEWGENE activity/NN ,/, the/DT region/NN around/IN the/DT Spec1/NEWGENE transcriptional/NEWGENE initiation/NEWGENE site/NEWGENE was/VBD analyzed/VBN for/IN sites/NNS of/IN protein-DNA/JJ interaction/NN ./.
@@104854701915 In/NN this/DT study/NN ,/, we/PRP identified/VBD Sp1/NEWGENE and/CC Sp3/NEWGENE as/IN major/JJ factors/NNS binding/JJ to/IN the/DT Sp1/NEWGENE sites/NEWGENE of/IN the/DT p21/NEWGENE //NEWGENE WAF1/NEWGENE //NEWGENE Cip1/NEWGENE promoter/NEWGENE in/IN MG63/NNP cells/NNS through/RB electrophoretic/JJ mobility/NN shift/NN assays/NNS and/CC showed/VBD that/DT TSA/NN treatment/NN did/VBD not/RB change/VB their/PRP binding/JJ activities/NNS ./.
@@58841835791 Experience/NN with/IN the/DT restoration/NN of/IN agglutination/NN properties/NNS of/IN non-agglutinating/JJ dysenterial/JJ cultures/NNS with/IN the/DT use/NN of/IN Rzhaninov's/NNP method/NN ./.
@@40271822988 Vitiligo/NN in/IN diabetes/NN mellitus/MD ./.
@@78288526865 It/PRP is/VBZ possible/JJ that/IN the/DT telomeres/NNS of/IN the/DT two/JJ nuclei/NNS have/VBP different/JJ functions/NNS ./.
@@75074587216 Therefore/RB ,/, we/PRP studied/VBD ninety/CD coagulopathic/JJ patients/NNS with/IN the/DT aim/NN of/IN determining/JJ the/DT prevalence/NN of/IN hepatitis/NN C/NN virus/NN (/( HCV/NN )/SYM antibodies/NNS using/VBG the/DT ELISA/NN and/CC RIBA/NN methods/NNS ./.
@@112516971089 Direct/JJ superoxide/NN scavenging/JJ activity/NN of/IN nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS :/: determination/NN by/IN electron/NN spin/NN resonance/NN using/VBG the/DT spin/NN trap/NN method/NN ./.
@@114314725338 Low/NNP affinity/NN binding/NN of/IN Rab6A-GTP/NEWGENE was/VBD also/RB observed/VBN (/( K/NN (/NN d/NN )/SYM =/SYM 16/CD &mgr/NN ;/: m/NN )/NN ,/, whereas/IN Rab1B/NEWGENE ,/NEWGENE -5/NEWGENE ,/NEWGENE -7/NEWGENE ,/NEWGENE -8/NEWGENE ,/NEWGENE or/NEWGENE -11A/NEWGENE did/VBD not/RB bind/VB ./.
@@86282517609 CM-ACO3/NEWGENE is/VBZ expressed/VBN in/IN flowers/NNS and/CC is/VBZ not/RB induced/VBN by/IN any/DT of/IN the/DT stimuli/NNS tested/VBN ./.
@@78966154366 The/DT contribution/NN of/IN skin/NN flow/NN to/IN the/DT changes/NNS in/IN 760-800/JJ nm/NN absorption/NN was/VBD investigated/VBN by/IN simultaneous/JJ measurement/NN of/IN skin/NN flow/NN by/IN laser/NN flow/NN Doppler/NN and/CC NIR/NN recordings/NNS during/IN hot/JJ water/NN immersion/NN ./.
@@95242224852 PCR/NN analysis/NN indicates/VBZ that/IN this/DT new/JJ beta-adducin/NEWGENE isoform/NEWGENE is/VBZ expressed/VBN in/IN fetal/JJ brain/NN and/CC liver/NN ,/, bone/NN marrow/NN ,/, and/CC NT-2/NN (/( neuroepithelial/JJ )/SYM cells/NNS ,/, but/CC is/VBZ not/RB detected/VBN in/IN several/DT other/DT tissues/NNS ./.
@@75443571175 Both/DT PPC-1/NN and/CC ALVA-31/NN cells/NNS display/NN tumorigenesis/NN and/CC invasiveness/NN in/IN nude/JJ mice/NNS ,/, whereas/IN LNCap/NNP cells/NNS exhibit/VBP a/DT less/PRP malignant/JJ phenotype/NN ,/, suggesting/VBG a/DT correlation/NN between/IN CD44/NEWGENE variant/NEWGENE (/( CD44v/NEWGENE )/SYM expression/NN and/CC aggressive/JJ prostate/NN tumor/NN behavior/NN ./.
@@86609983963 The/DT mMIWC1/NEWGENE promoter/NEWGENE was/VBD identified/VBN and/CC contained/VBN TATA/NN ,/, CAAT/NN ,/, GATA/NEWGENE ,/, and/CC AP-2/NEWGENE elements/NEWGENE ;/: primer/NN extension/NN revealed/VBD mMIWC/NEWGENE transcription/NN initiation/NN at/IN 621/CD bp/NN upstream/RB from/IN the/DT mMIWC1/NEWGENE translational/JJ initiation/NN site/NN ./.
@@10483945662 RESULTS/NNS :/: CK-MB/NEWGENE elevation/NN was/VBD detected/VBN in/IN 313/CD patients/NNS (/( 18/CD ./CD 7%/CD )/SYM ,/, with/IN 1-3x/JJ in/IN 12/CD ./CD 8%/CD ,/, 3-5x/JJ in/IN 3/CD ./CD 5%/CD and/CC >/SYM 5x/CD normal/JJ in/IN 2/CD ./CD 4%/CD of/IN patients/NNS ./.
@@16527553368 In/NN similar/JJ transient/JJ transfection/NN experiments/NNS in/IN HeLa/DT cells/NNS ,/, overexpression/NN of/IN the/DT wt/NEWGENE human/NEWGENE retinoblastoma/NEWGENE susceptibility/NEWGENE gene/NEWGENE product/NEWGENE ,/, RB/NEWGENE ,/, was/VBD found/VBN to/IN repress/VB the/DT serum-induced/NN IL-6/NEWGENE (/( -225/CD to/IN +13/CD )/SYM ,/, c-fos/NEWGENE (/( -711/CD to/IN +42/NN )/SYM ,/, and/CC beta-actin/NEWGENE (/( -3400/JJ to/IN +912/NN )/SYM promoters/NNS but/CC not/RB the/DT PRV-induced/NN IL-6/NEWGENE (/( -110/NN to/IN +13/CD )/SYM or/CC the/DT serum-induced/NN MHC/NEWGENE (/( -528/CD to/IN -38/CD )/SYM promoters/NNS ./.
@@22046253347 This/DT gene/NN joins/VBP the/DT group/NN of/IN genes/NNS whose/WP members/NNS are/VBP rapidly/RB transcribed/VBN in/IN response/NN to/IN insulin/NEWGENE and/CC other/DT mitogens/NNS ./.
@@21452682266 The/DT deleted/VBN nucleotide/NN sequence/NN corresponded/VBN to/IN sequences/NNS that/WDT ,/, by/IN analogy/NN to/IN the/DT organization/NN of/IN the/DT type/NEWGENE I/NEWGENE collagen/NEWGENE genes/NEWGENE ,/, should/MD be/VB precisely/RB encoded/VBN by/IN exon/NN 41/CD of/IN the/DT COL3A1/NEWGENE gene/NEWGENE ./.
@@5946175060 A/DT highly/RB significant/JJ correlation/NN was/VBD found/VBN between/IN the/DT presence/NN of/IN fibrinolytic/JJ degradation/NN products/NNS (/( FDP/NN )/SYM and/CC the/DT incidence/NN of/IN nephropathy/NN and/CC renal/JJ insufficiency/NN ,/, as/RB well/VB as/IN between/IN the/DT presence/NN of/IN fibrin/NEWGENE monomers/NEWGENE (/( Godal's/NNP ethanol-gelification/JJ test/NN )/SYM and/CC the/DT evolutive/JJ signs/NNS of/IN the/DT primary/JJ disease/NN (/( fever/NN ,/, accelerated/JJ ESR/NN )/SYM ./.
@@98924228816 The/DT perifascicular/JJ connective/JJ tissue/NN sheath/NN is/VBZ important/JJ in/IN organising/JJ the/DT contraction/NN of/IN the/DT myocardium/NN by/IN preventing/JJ lateral/JJ spread/NN of/IN conduction/NN and/CC by/IN permitting/VBG transmission/NN of/IN the/DT impulse/NN only/RB at/IN the/DT termination/NN of/IN the/DT purkinje/NN fibre/NN ./.
@@103931921218 Neurospora/NN crassa/ORG CYT-18/NEWGENE ,/, can/MD rescue/VB the/DT exonic/JJ trap/NN and/CC intron/NN mutants/NNS which/WDT cause/VBG a/DT structural/JJ defect/NN ./.
@@84218977371 During/IN the/DT past/JJ decade/NN ,/, different/JJ types/NNS of/IN endogenous/JJ retroviral/NN sequences/NN have/VBP been/VBN defined/VBN in/IN the/DT human/JJ genome/NN usually/RB by/IN low/JJ stringency/NN hybridization/NN employing/VBG DNA/NN probes/NNS of/IN evolutionary/RB conserved/VBN animal/NN retrovirus/NN genes/NNS ./.
@@88497782959 Previous/JJ work/NN showed/VBN that/IN repA/NEWGENE (/( initiator/NEWGENE protein/NEWGENE )/SYM expression/NN requires/VBZ tap/NEWGENE (/( leader/NEWGENE peptide/NEWGENE )/SYM translation/NN ./.
@@95234787363 In/NN addition/NN ,/, IgM/NEWGENE can/MD be/VB absent/VB in/IN children/NNS with/IN congenital/JJ toxoplasmosis/NN or/CC subjects/NNS with/IN secondary/JJ reactivation/NN ./.
@@80888183317 The/DT high/JJ level/NN of/IN transformation-associated/JJ deletions/NNS in/IN the/DT human/JJ YACs/NNS was/VBD reduced/VBN over/RB 10-fold/JJ when/CC the/DT host/NN was/VBD a/DT recombination-deficient/JJ strain/NN deleted/VBN for/IN the/DT RAD52/NEWGENE gene/NEWGENE ./.
@@86633105253 Notably/RB ,/, SRF/NEWGENE has/VBZ been/VBN found/VB to/IN be/VB a/DT key/NN regulator/NN of/IN members/NNS of/IN a/DT class/NN of/IN cellular/JJ response/NN genes/NN termed/JJ immediate-early/NEWGENE genes/NEWGENE (/( IEGs/NEWGENE )/SYM ,/, many/NN of/IN which/WDT are/VBP believed/VBN to/IN be/VB involved/VBN in/IN regulating/JJ cell/NN growth/NN and/CC differentiation/NN ./.
@@55368034693 Total/JJ body/NN water/NN ,/, rhodanide/NN space/NN and/CC I-131-albumin/NEWGENE space/NN under/IN the/DT acute/JJ effect/NN of/IN furosemide/NN ./.
@@80403366719 Furthermore/RB ,/, an/DT upstream/JJ element/NN ,/, collagen/NEWGENE element/NEWGENE I/NEWGENE (/NEWGENE -370/NEWGENE //NEWGENE -344/NEWGENE )/NEWGENE ,/, which/WDT shares/VBP homology/NN with/IN the/DT LAP/NEWGENE binding/NN cis-element/NN of/IN the/DT albumin/NEWGENE promoter/NEWGENE (/( 9/CD of/IN 13/CD bp/NN )/SYM is/VBZ described/VBN ./.
@@19929532610 Cut-off/NNP levels/NNS that/WDT define/VBP abnormality/NN are/VBP rather/RB arbitrary/JJ and/CC this/DT decreases/VBZ the/DT specificity/NN of/IN the/DT test/NN in/IN apparently/RB healthy/JJ patients/NNS ./.
@@82897836854 The/DT Oct-3/NEWGENE //NEWGENE 4/NEWGENE gene/NEWGENE product/NEWGENE ,/, which/WDT belongs/VBZ to/IN the/DT POU/NEWGENE family/NEWGENE of/NEWGENE transcription/NEWGENE factors/NEWGENE ,/, is/VBZ a/DT good/JJ candidate/NN for/IN regulating/JJ initial/JJ differentiation/NN decisions/NNS ./.
@@98083668905 Fatal/NNP apneusis/NN was/VBD observed/VBN under/IN following/IN conditions/NNS :/: (/( 1/CD )/SYM Persistent/JJ apnea/NN was/VBD produced/VBN after/IN a/DT single/NN KA/NN microinjection/NN in/IN one/PRP side/NN of/IN the/DT VRG-Apa/NNP (/( 5/CD animals/NNS )/SYM ./.
@@45156313791 Value/NNP of/IN Normotest/NNP and/CC antithrombin/NEWGENE 3/NEWGENE in/IN the/DT assessment/NN of/IN liver/NN function/NN ./.
@@7265815760 Orthop/NN ./.
@@99145259723 Recombinant/NEWGENE Ffh/NEWGENE has/VBZ a/DT melting/JJ point/NN of/IN tm/NN =/SYM 89/CD degreesC/NN ./.
@@16271062220 In/NN a/DT similar/JJ experiment/NN ,/, simultaneous/JJ nitrofurazone/NN administration/NN and/CC S/NNP ./NNP enteritidis/NN challenge/NN resulted/VBN in/IN no/DT significant/JJ differences/NNS in/IN S/NNP ./NNP enteritidis/NN isolation/NN frequency/NN ./.
@@86624991643 The/DT front/NN (/( F/NN )/SYM interaction/NN occurs/VBZ ahead/RB of/IN the/DT growing/JJ end/NN of/IN RNA/NN ./.
@@27124503392 Normocapnic/NN (/( PACO2/NN =/SYM 40/CD mm/NN Hg/NN )/SYM ventilatory/JJ drive/NN increased/VBN significantly/RB (/( p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM in/IN six/CD subjects/NNS (/( Type/NN 1/NN response/NN )/SYM and/CC decreased/VBN substantially/RB in/IN the/DT others/NNS (/( Type/NN 2/NN response/NN )/SYM ;/: with/IN hypercapnia/NN ,/, the/DT changes/NNS in/IN drive/NN were/VBD attenuated/VBN in/IN both/DT groups/NNS ./.
@@9079689881 MOP5/NEWGENE contained/VBN the/DT characteristic/JJ PAS/NEWGENE domain/NEWGENE and/CC a/DT variable/NN C/NN terminus/NN ;/: it/PRP is/VBZ possible/JJ that/IN the/DT cDNA/NN contains/VBZ a/DT bHLH/NEWGENE domain/NN ,/, but/CC the/DT entire/JJ open/JJ reading/JJ frame/NN has/VBZ yet/RB to/IN be/VB completed/VBN ./.
@@2479823735 Sequence/NN analysis/NN of/IN the/DT 5'/CD flanking/JJ region/NN revealed/VBD several/DT GC/NN boxes/NNS but/CC no/DT identifiable/JJ TATA/NN box/NN ./.
@@25654053213 Drug/NNP use/NN in/IN trauma/NN victims/NNS ./.
@@10619062441 Haycocknema/NNP perplexum/NN n/CD ./CD g/CD ./CD ,/, n/CD ./CD sp/NN ./NN
@@104532488880 It/PRP applies/VBZ Udry's/NN biosocial/JJ perspective/NN ,/, which/WDT attempts/VBZ to/IN reconcile/VB the/DT biological/JJ and/CC sociological/JJ models/NNS of/IN premarital/JJ sexual/JJ and/CC reproductive/JJ behaviour/NN ./.
@@99718153142 We/PRP conclude/VBP that/IN (/( i/NN )/SYM we/PRP have/VBP identified/VBN several/DT candidate/NN latency/NN genes/NNS of/IN murine/NN gammaHV68/NN ,/, (/( ii/NN )/SYM expression/NN of/IN genes/NNS during/IN latency/NN may/MD be/VB different/JJ in/IN different/JJ organs/NNS ,/, consistent/JJ with/IN multiple/JJ latency/NN programs/NNS and/WDT //WDT or/WDT multiple/JJ cellular/JJ sites/NNS of/IN latency/NN ,/, and/CC (/( iii/NN )/SYM regions/NNS of/IN the/DT viral/JJ genome/NN (/( v-bcl-2/NEWGENE gene/NEWGENE ,/, v-GCR/NEWGENE gene/NEWGENE ,/, and/CC gene/NEWGENE 73/NEWGENE )/SYM are/VBP transcribed/VBN during/IN latency/NN with/IN both/DT gammaHV68/CD and/CC primate/NN gammaherpesviruses/NNS ./.
@@107775866900 Co-immunoprecipitation/NNS and/CC DNA/NN affinity/NN chromatography/NN prove/VB that/IN Sp1/NEWGENE heterodimerizes/VBZ with/IN ZBP-89/NEWGENE when/CC bound/JJ to/IN the/DT silencer/NN element/NN to/IN yield/NN a/DT DNA-protein/NN complex/NN whose/WP mobility/NN is/VBZ indistinguishable/JJ from/IN that/DT displayed/VBD by/IN HeLa/DT nuclear/JJ extract/NN in/IN band/NN shift/NN assays/NNS ./.
@@86628522397 The/DT location/NN of/IN multiple/JJ GRK2/NEWGENE and/CC GRK5/NEWGENE phosphoacceptor/NEWGENE sites/NEWGENE at/IN the/DT extreme/JJ carboxyl/NN terminus/NN of/IN the/DT beta2AR/NEWGENE is/VBZ highly/RB reminiscent/NN of/IN GRK1-mediated/JJ phosphorylation/NN of/IN rhodopsin/NEWGENE ./.
@@36256884302 Immobilization/NNS of/IN the/DT fracture/NN in/IN a/DT collar/NN and/CC cuff/NN sling/NN was/VBD as/RB effective/JJ as/IN more/RB elaborate/JJ methods/NNS ./.
@@9764741511 Focused/JJ beams/NNS of/IN classical/JJ light/NN ablate/NN elements/NN of/IN the/DT cell/NN division/NN machinery/NN and/CC switch/VB the/DT beating/NN of/IN hearts/NNS on/IN a/DT cellular/JJ basis/NN ./.
@@115834288852 In/NN Exp/NN ./.
@@77982719072 This/DT last/NN region/NN contains/VBZ two/JJ sites/NNS that/WDT bind/VBP Ets-related/NEWGENE proteins/NEWGENE present/VBP in/IN liver/NN nuclear/JJ extracts/NNS as/RB well/VBP as/IN recombinant/NEWGENE purified/NEWGENE Ets-1/NEWGENE protein/NEWGENE ./.
@@10607899959 Sequence/NN analysis/NN of/IN the/DT promoter/NN region/NN showed/VBD no/DT TATA/NN box/NN but/CC identified/VBN consensus/NN binding/JJ motifs/NNS for/IN Sp1/NEWGENE ,/, CREB/NEWGENE ,/, and/CC half/NN sites/NNS of/IN the/DT estrogen/NEWGENE receptor/NEWGENE binding/NEWGENE site/NEWGENE ./.
@@51729705418 The/DT problem/NN of/IN disablement/NN due/NN to/IN pulmonary/JJ tuberculosis/NN ,/, on/IN the/DT basis/NN of/IN an/DT analysis/NN of/IN the/DT history/NN of/IN 395/CD cases/NNS as/IN observed/VBN in/IN Gdansk/NNP in/IN the/DT years/NNS 1946-1965/CD ./.
@@90508494493 Cytohesin-1/NEWGENE ,/, a/DT protein/NN abundant/JJ in/IN cells/NNS of/IN the/DT immune/JJ system/NN ,/, has/VBZ been/VBN proposed/VBN to/IN be/VB a/DT human/JJ homolog/NN of/IN the/DT Saccharomyces/NEWGENE cerevisiae/NEWGENE Sec7/NEWGENE gene/NEWGENE product/NEWGENE ,/, which/WDT is/VBZ crucial/JJ in/IN protein/NN transport/NN ./.
@@106289713002 Also/RB in/IN the/DT spectrum/NN of/IN mutants/NNS with/IN TGN/JJ sorting/JJ defects/NNS are/VBP isolates/NNS with/IN mutations/NNS in/IN the/DT following/NN :/: RIC1/NEWGENE ,/, encoding/VBG a/DT product/NN originally/RB proposed/VBD to/IN participate/VB in/IN ribosome/NN biogenesis/NN ;/: LUV1/NEWGENE ,/, encoding/VBG a/DT product/NN potentially/RB involved/VBD in/IN vacuole/NN and/CC microtubule/NN organization/NN ;/: and/CC INP53/NEWGENE ,/, encoding/VBG a/DT synaptojanin-like/NEWGENE inositol/NEWGENE polyphosphate/NEWGENE 5-phosphatase/NEWGENE ./.
@@17524415203 Transcriptional/JJ activation/NN by/IN the/DT HIV-1/NEWGENE Tat/NEWGENE protein/NEWGENE requires/VBZ specific/JJ residues/NNS in/IN the/DT hexanucleotide/NN loop/NN and/CC trinucleotide/NN bulge/NN of/IN the/DT TAR/NEWGENE RNA/NEWGENE stem-loop/NN structure/NN found/VB in/IN the/DT 5'-untranslated/JJ leader/NN of/IN all/DT viral/JJ transcripts/NNS ./.
@@9671791656 Ligand-independent/NNP activation/NN of/IN platelet-derived/NEWGENE growth/NEWGENE factor/NEWGENE receptor/NEWGENE is/VBZ a/DT necessary/JJ intermediate/NN in/IN lysophosphatidic/JJ ,/, acid-stimulated/JJ mitogenic/JJ activity/NN in/IN L/JJ cells/NNS ./.
@@95668767273 The/DT general/NN transcription/NEWGENE factor/NEWGENE IIA/NEWGENE (/( TFIIA/NEWGENE )/SYM interacts/VBZ with/IN the/DT TATA/NEWGENE binding/NEWGENE protein/NEWGENE (/( TBP/NEWGENE )/SYM and/CC promoter/NN DNA/NN to/IN mediate/VB transcription/NN activation/NN in/IN vitro/FW ./.
@@118040816406 Since/IN August/NN 1994/CD ,/, the/DT ENRP/NN has/VBZ retained/VBN 70/CD ./CD 3/CD metric/JJ tons/NNS of/IN TP/NN that/IN otherwise/RB would/MD have/VB entered/VBN the/DT Everglades/NNP ./.
@@83780821281 These/DT findings/NNS suggest/VBP a/DT functional/JJ cross-talk/NN between/IN RB/NEWGENE protein/NEWGENE and/CC p21ras/NEWGENE ,/, which/WDT balances/VBZ the/DT cell/NN phenotype/NN between/IN normal/JJ and/CC transformed/VBN states/NNS ./.
@@111339863567 Previous/JJ studies/NNS have/VBP demonstrated/VBN that/IN tissue-restricted/NN transcription/NN factors/NN including/JJ PU/NEWGENE ./NEWGENE 1/NEWGENE and/CC PU/NEWGENE ./NEWGENE 1/NEWGENE interaction/NEWGENE partner/NEWGENE (/( PIP/NEWGENE )/SYM function/NN synergistically/RB with/IN c-Fos/NEWGENE plus/IN c-Jun/NEWGENE to/IN stimulate/VB the/DT kappaE3'-enhancer/NEWGENE in/IN 3T3/CD cells/NNS ./.
@@10078876761 The/DT origins/NNS of/IN reflected/VBN light/NN changes/NNS associated/VBN with/IN neuronal/JJ activity/NN (/( optical/JJ signals/NNS )/SYM were/VBD investigated/VBN in/IN rat/NN somatosensory/JJ cortex/NN with/IN optical/JJ imaging/NN ,/, microspectrophotometry/NN ,/, and/CC laser-Doppler/JJ flowmetry/NN ,/, and/CC dynamic/JJ changes/NNS in/IN local/JJ hemoglobin/NEWGENE concentration/NN and/CC oxygenation/NN were/VBD focused/VBN on/CD ./CD
@@97016167248 Reverse/VB transcriptase-polymerase/JJ chain/NN reaction/NN (/( RT-PCR/NN )/SYM was/VBD performed/VBN using/VBG eyestalk/NN complementary/JJ DNA/NN of/IN the/DT sand/NN shrimp/NN Metapenaeus/NNP ensis/NN ./.
@@11919551832 This/DT reveals/VBZ a/DT new/JJ test/NN for/IN short/JJ saphenous/JJ incompetence/NN and/CC shows/VBZ that/IN 14/CD per/IN cent/NN of/IN varices/NNS stem/NN from/IN a/DT saphenopopliteal/JJ reflux/NN ./.
@@20613335965 These/DT observations/NNS ,/, together/RB with/IN the/DT occurrence/NN of/IN putative/JJ 4'-phosphopantetheine-attachment/JJ sites/NNS and/CC a/DT putative/JJ thioesterase/NEWGENE site/NEWGENE ,/, are/VBP discussed/VBN with/IN reference/NN to/IN the/DT reaction/NN sequence/NN leading/JJ to/IN production/NN of/IN the/DT ACV/NEWGENE tripeptide/NEWGENE ./.
@@98081556319 Examination/NN of/IN DNA/NN :/: protein/NN binding/JJ complexes/NNS by/IN gel-shift/JJ analysis/NN indicated/VBN that/IN nuclear/JJ factors/NNS from/IN both/DT proliferative/JJ and/CC growth-arrested/JJ cells/NNS bound/JJ to/IN the/DT DNA/NN fragment/NN spanning/VBG -949-/CD -722/CD bp/CD ./CD
@@95536864480 The/DT pharmacokinetic/JJ patterns/NNS of/IN estradiol/NN (/( CAS/NN 50-28-2/NN )/SYM and/CC of/IN estrone/NN (/( CAS/IN 53-16-7/JJ )/SYM were/VBD investigated/VBN in/IN 18/CD women/NNS in/IN natural/JJ or/CC surgical/JJ menopause/NN during/IN the/DT application/NN of/IN a/DT new/JJ estradiol/NN transdermal/JJ patch/NN with/IN active/JJ matrix/NN and/CC without/IN absorption/NN enhancers/NNS designed/VBN for/IN epicutaneous/JJ applications/NNS of/IN 7/CD days/NNS (/( hereinafter/NN called/VBN "patch/NN 7D"/CD )/SYM ./.
@@2018812629 A/DT striking/JJ finding/NN in/IN all/DT of/IN the/DT studies/NNS was/VBD a/DT positive/JJ correlation/NN between/IN PI/NN ACTH/NEWGENE and/CC MSH/NEWGENE contents/NNS ./.
@@91082797067 The/DT capacity/NN to/IN repair/NN 8-OxoG/NN has/VBZ been/VBN measured/VBN in/IN cell-free/JJ extracts/NNS of/IN wild-type/NN and/CC ogg1/NEWGENE strains/NNS using/VBG a/DT 34mer/NN DNA/NN fragment/NN containing/NN a/NN single/NN 8-OxoG/NN residue/NN paired/JJ with/IN a/DT cytosine/NN (/( 8-OxoG/JJ //JJ C/JJ )/SYM as/IN a/DT substrate/NN ./.
@@26389649388 The/DT maximum/JJ stress/NN due/NN to/IN the/DT hygroscopic/JJ examination/NN of/IN the/DT composite/NN was/VBD 0/CD ./CD 74/CD kg/NN //NN mm2/NN at/IN equilibrium/NN of/IN the/DT water/NN absorbed/VBN of/IN the/DT composite/NN ./.
@@9650299343 VirD2/NEWGENE is/VBZ one/PRP of/IN the/DT key/NN Agrobacterium/NN tumefaciens/NN proteins/NNS involved/VBN in/IN T-DNA/NN processing/VBG and/CC transfer/NN ./.
@@90231973968 The/DT dnaK/NEWGENE operon/NEWGENE of/NEWGENE Bacillus/NEWGENE subtilis/NEWGENE is/VBZ heptacistronic/JJ ./.
@@11410110643 NIRS/NN was/VBD used/VBN for/IN the/DT quantitative/JJ measurement/NN of/IN muscle/NN O/NN (/NN 2/NN )/NN consumption/NN (/( mV/NN ./NN O/NN (/NN 2/NN )/NN )/NN and/CC forearm/NN blood/NN flow/NN (/( FBF/NN )/SYM in/IN 78/CD healthy/JJ subjects/NNS ./.
@@95141569038 Alterations/NNS in/IN DNase/NEWGENE I/NEWGENE reactivity/NN of/IN the/DT GC-response/NNP element/NN region/NN suggest/VB that/DT GC/NEWGENE receptor-GC/NEWGENE complexes/NEWGENE may/MD associate/VB ,/, in/IN a/DT transient/JJ manner/NN ,/, with/IN the/DT promoter/NN in/IN the/DT actively/RB transcribing/JJ control/NN state/NN ./.
@@77999257388 Reconstitution/NNS of/IN complexes/NN containing/NN p62/NEWGENE and/CC the/DT src/NEWGENE family/NEWGENE kinase/NEWGENE p59fyn/NEWGENE1 in/IN HeLa/DT cells/NNS demonstrated/VBD that/DT complex/NN formation/NN resulted/VBN in/IN tyrosine/NN phosphorylation/NN of/IN p62/NEWGENE and/CC was/VBD mediated/JJ by/IN both/PDT the/DT SH3/NEWGENE and/CC SH2/NEWGENE domains/NEWGENE of/IN p59fyn/NEWGENE ./.
@@113211875882 Sixteen/CD out/RB of/IN 52/CD seropositive/JJ MS/NN patients/NNS (/( 30/CD ./CD 8%/CD )/SYM showed/VBD intrathecal/JJ synthesis/NN of/IN C/NEWGENE ./NEWGENE pneumoniae-specific/NEWGENE IgG/NEWGENE but/CC only/RB one/PRP of/IN 43/CD seropositive/JJ controls/NNS (/( 2/CD ./CD 3%/CD )/SYM ./.
@@18406086909 The/DT N-terminus/NN of/IN another/DT open/JJ reading/JJ frame/NN was/VBD found/VBN 3'/CD from/IN nifA/NEWGENE and/CC tentatively/RB identified/VBN as/IN nifB/NEWGENE by/IN amino/JJ acid/NN sequence/NN comparison/NN ./.
@@105451922770 Phosphatidylinositol/NEWGENE 3-kinase/NEWGENE requirement/NN in/IN activation/NN of/IN the/DT ras/NEWGENE //NEWGENE C-raf-1/NEWGENE //NEWGENE MEK/NEWGENE //NEWGENE ERK/NEWGENE and/CC p70/NEWGENE (/NEWGENE s6k/NEWGENE )/NEWGENE signaling/JJ cascade/NN by/IN the/DT insulinomimetic/JJ agent/NN vanadyl/NN sulfate/NN ./.
@@10514808342 Cortical/JJ dysplasias/NNS ,/, genetics/NN ,/, and/CC epileptogenesis/NN ./.
@@104530063107 In/NN addition/NN to/IN homologues/NNS of/IN the/DT human/NEWGENE genes/NEWGENE PSMB5/NEWGENE through/RB PSMB9/NEWGENE ,/, two/JJ new/JJ genes/NNS ,/, PSMB11/NEWGENE and/CC PSMB12/NEWGENE ,/, have/VB been/VBN found/VB for/IN which/WDT there/RB are/VBP no/DT known/VBP corresponding/JJ genes/NNS in/IN humans/NNS ./.
@@83827698119 We/PRP conclude/VBP that/IN the/DT conservation/NN of/IN nucleotides/NNS 154/CD to/IN 156/CD is/VBZ likely/RB to/IN be/VB a/DT consequence/NN of/IN their/PRP role/NN as/IN a/DT sequence-specific/NN recognition/NN element/NN for/IN the/DT SRP54/NEWGENE protein/NEWGENE ./.
@@31397504299 The/DT genetic/JJ basis/NN for/IN the/DT expression/NN of/IN a/DT latent/JJ VH/NEWGENE allotype/NEWGENE in/IN the/DT rabbit/NN was/VBD investigated/VBN ./.
@@55934695608 Open/NNP head-brain/JJ injuries/NNS ./.
@@89439288896 Administration/NNP of/IN a/DT second/JJ dose/NN of/IN vaccine/NN during/IN the/DT outbreak/NN was/VBD not/RB protective/JJ ./.
@@82493198235 Clipping/NN resulted/VBN in/IN a/DT serious/JJ mislocalization/NN of/IN the/DT position/NN of/IN the/DT peak/NN of/IN the/DT epicortical/JJ potential/JJ field/NN ./.
@@113779758440 Unexpectedly/RB ,/, Arg1-expressing/JJ COS1/NNP cells/NNS showed/VBD no/DT significant/JJ proteinase/NEWGENE activity/NN to/IN various/RB synthesized/VBN substrates/NNS under/IN neutral/NN or/CC acidic/NN conditions/NNS in/IN this/DT study/NN ./.
@@5774405716 In/NN the/DT duodenum/NN a/DT small/JJ part/NN of/IN the/DT administered/VBN dose/NN was/VBD transformed/VBN to/IN 3H-alpha-acetyldigoxin/NN ./.
@@29075338830 Effects/NNPS of/IN a/DT perfluorochemical/JJ blood/NN substitute/NN on/IN diazepam/NN binding/JJ by/IN human/NEWGENE albumin/NEWGENE ./.
@@92941616192 These/DT findings/NNS suggest/VBP one/PRP potential/JJ mechanism/NN for/IN direct/JJ recruitment/NN of/IN distal/JJ regulatory/JJ regions/NNS of/IN the/DT globin/NEWGENE loci/NEWGENE to/IN the/DT individual/JJ promoters/NNS ./.
@@97617238358 GETS-1/NEWGENE is/VBZ expressed/VBN in/IN many/JJ tissues/NNS ,/, but/CC is/VBZ enriched/VBN in/IN retina/NN and/CC brain/NN ./.
@@21230294981 A/DT second/JJ isotype/NN of/IN Raja/NEWGENE immunoglobulin/NEWGENE heavy/NEWGENE chain/NEWGENE genes/NEWGENE has/VBZ been/VBN detected/VBN by/IN screening/JJ a/DT spleen/NN cDNA/NN library/NN with/IN homologous/JJ Raja/NN VH-/NNP and/CC CH1-specific/NNP probes/NNS complementing/JJ the/DT respective/JJ regions/NNS of/IN the/DT mu-like/NEWGENE isotype/NEWGENE ./.
@@77573157728 Thereafter/RB ,/, the/DT aggregation/NN rose/VBD to/IN the/DT initial/JJ 100%/CD value/NN 4/CD h/NN after/IN drug/NN application/NN and/CC remained/VBN at/IN this/DT level/NN during/IN the/DT observation/NN period/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@78597395940 Lack/NN of/IN cyclin/NEWGENE D-Cdk/NEWGENE complexes/NEWGENE in/IN Rb-negative/NNP cells/NNS correlates/VBP with/IN high/JJ levels/NNS of/IN p16INK4/NEWGENE //NEWGENE MTS1/NEWGENE tumour/NEWGENE suppressor/NEWGENE gene/NEWGENE product/NEWGENE ./.
@@19528272574 At/NN the/DT time/NN of/IN the/DT seizure/NN ,/, the/DT patient/NN was/VBD asked/VBN to/IN read/NN a/DT test/NN phrase/NN aloud/RB until/IN it/PRP was/VBD read/VBN correctly/RB and/CC clearly/RB ./.
@@73691837208 Two/CD new/JJ artifacts/NNS in/IN automated/JJ coagulation/NN testing/NN ./.
@@97317041544 This/DT study/NN examines/VBZ the/DT cooperative/JJ effects/NNS of/IN a/DT human/NN estrogen/NEWGENE receptor-alpha/NEWGENE (/( ERalpha/NEWGENE )/SYM isoform/NN on/IN estrogen/NEWGENE (/( E2/NEWGENE )/NN -mediated/NN gene/NN activation/NN in/IN U2-OS/NNP osteosarcoma/NN cells/NNS ./.
@@100229051336 Three/CD mog-1/NEWGENE alleles/NEWGENE possess/VBP premature/JJ stop/NN codons/NNS and/CC are/VBP likely/RB to/IN be/VB null/JJ alleles/NNS ,/, and/CC one/PRP is/VBZ a/DT missense/JJ mutation/NN and/CC is/VBZ likely/RB to/IN retain/VB residual/JJ activity/NN ./. mog-1/NEWGENE mRNA/NEWGENE is/VBZ expressed/VBN in/IN both/DT germ/NN line/NN and/CC somatic/JJ tissues/NNS and/CC appears/VBZ to/IN be/VB ubiquitous/JJ ./.
@@92996969258 The/DT distribution/NN of/IN cryptosporidia/NNS in/IN the/DT intestine/NN and/CC number/NN of/IN cryptosporidia/NNS per/IN ileal/JJ villus/NN on/IN different/JJ DPI/NN were/VBD also/RB estimated/VBN for/IN detailed/JJ characterization/NN of/IN the/DT infection/NN in/RB kids/VBZ as/IN a/DT model/NN for/IN experimental/JJ cryptosporidiosis/NN ./.
@@105728669521 Marked/JJ hemolysis/NN significantly/RB increased/VBD plasma/NN values/NNS of/IN potassium/NN ,/, phosphorus/NN ,/, total/JJ protein/NN ,/, and/CC aspartate/NEWGENE aminotransferase/NEWGENE ./.
@@93267274243 The/DT regurgitation/NN of/IN large/NN vitreous/NN injections/NNS ./.
@@1101272843 Assessment/NNP of/IN the/DT carcinogenicity/NN of/IN non-nutritive/NNP sweetners/NNP II/NNP :/: Cyclamates/NNS and/CC cyclohexylamine/NN ./.
@@112005684754 Blood/NNP from/IN dams/NNS was/VBD collected/VBN prior/NN to/IN inoculation/NN and/CC at/IN time/NN of/IN necropsy/NN for/IN measurement/NN of/IN IgM/NEWGENE and/CC IgG/NEWGENE antibodies/NEWGENE to/IN M/NNP ./NNP pulmonis/NNS ./.
@@87871102376 We/PRP conclude/VBP that/IN CPET/NN is/VBZ a/DT useful/JJ investigation/NN in/IN the/DT management/NN of/IN patients/NNS with/IN cardiopulmonary/JJ disease/NN and/CC complements/VBZ the/DT various/JJ other/DT investigations/NNS offered/VBN by/IN a/DT pulmonary/JJ function/NN laboratory/NN ./.
@@22736902921 Effects/NNPS of/IN cisapride/NN on/IN upper-gastrointestinal/JJ motility/NN and/CC digestive/JJ hormones/NNS ./.
@@24235336259 The/DT cDNAs/NNS cross-hybridize/NN with/IN genomic/JJ sequences/NNS in/IN rat/NN ,/, human/JJ ,/, and/CC chicken/NN DNA/NN ,/, but/CC not/RB with/IN DNA/NN from/IN frog/NN ,/, Drosophila/NN ,/, or/CC sea/NN urchin/NN ./.
@@57326415679 Trials/NNS of/IN sevine/NN activity/NN against/IN mosquito/NN larvae/NNS ./.
@@104873079285 Immediately/RB before/IN surgery/NN patients/NNS received/VBD either/DT intravenous/JJ hydrocortisone/NN 100/NN mg/NN or/CC placebo/NN in/IN random/JJ ,/, double-blind/JJ order/NN ./.
@@105061439955 In/NN HeLa/IN cells/NNS ,/, the/DT JNKK2-JNK1/NEWGENE fusion/NEWGENE protein/NEWGENE showed/VBD significant/JJ JNK/NEWGENE activity/NN ,/, which/WDT was/VBD comparable/JJ with/IN that/DT of/IN JNK1/NEWGENE activated/VBN by/IN many/JJ stimuli/NNS and/CC activators/NNS ,/, including/JJ EGF/NEWGENE ,/, TNF-alpha/NEWGENE ,/, anisomycin/NN ,/, UV/NN irradiation/NN ,/, MEKK1/NEWGENE ,/, and/CC small/NEWGENE GTP/NEWGENE binding/NEWGENE proteins/NEWGENE Rac1/NEWGENE and/CC Cdc42Hs/NEWGENE ./.
@@1732752685 In/NN some/DT early/JJ B/NNP cells/NNS and/CC Abelson/NN murine/JJ leukemia/NN virus-transformed/JJ pre-B-cell/JJ lines/NNS ,/, LT/NEWGENE mRNA/NEWGENE is/VBZ constitutively/RB expressed/VBN ./.
@@96015169888 Substitution/NNS of/IN bulky/JJ hydrophobic/JJ residues/NNS with/IN charged/VBN residues/NNS within/IN PEP1/NEWGENE affects/VBP the/DT fusion/NN activity/NN of/IN the/DT S/NEWGENE protein/NEWGENE without/IN affecting/VBG processing/VBG and/CC surface/NN expression/NN ./.
@@79353797380 The/DT dying/JJ tTG-transfected/JJ cells/NNS exhibit/VBP both/DT cytoplasmic/JJ and/CC nuclear/JJ changes/NNS characteristic/NN of/IN cells/NNS undergoing/VBG apoptosis/NN ./.
@@79666028959 Roizman/NNP ,/, J/NNP ./NNP
@@10684646195 In/NN this/DT study/NN ,/, a/DT common/JJ mechanism/NN has/VBZ been/VBN identified/VBN to/IN coordinate/NN the/DT growth-/JJ and/CC FC-dependent/NN expression/NN of/IN caveolin/NEWGENE ./.
@@88103236894 There/EX are/VBP four/CD polyglutamine/NN motifs/NN interspersed/JJ with/IN histidine-rich/JJ regions/NNS ./.
@@75852464490 SL1/NEWGENE trans-splicing/NN specified/VBN by/IN AU-rich/NNP synthetic/JJ RNA/NN inserted/VBN at/IN the/DT 5'/CD end/NN of/IN Caenorhabditis/NNP elegans/NNS pre-mRNA/NN ./.
@@89971215 When/WRB CSF/NN [/NN HCO3-/NN ]/NN is/NNS shown/VBP as/IN a/DT function/NN of/IN CSF/NN PCO2/NN the/DT data/NN of/IN K-depleted/JJ rats/NNS are/VBP no/RB longer/RB displaced/VBN when/CC compared/VBN to/IN controls/NNS but/CC still/RB have/VB a/DT significantly/RB greater/JJR slope/NN (/( 1/CD ./CD 21/CD +/NN //NN -/NN 0/CD ./CD 23/CD vs/IN ./IN
@@16696112263 The/DT patient/NN with/IN a/DT prolonged/JJ fever/NN caused/VBN by/IN dissecting/JJ aneurysm/NN of/IN the/DT aorta/NN in/IN whom/WP pleuropneumonia/NN masked/VBD the/DT real/JJ diseases/NNS has/VBZ been/VBN presented/VBN ./.
@@96501869621 The/DT low/JJ number/NN of/IN false/JJ positives/NNS indicates/VBZ that/IN our/PRP scheme/NN would/MD not/RB confuse/VB the/DT radiologist/NN by/IN suggesting/VBG normal/JJ regions/NNS as/IN suspicious/JJ ./.
@@82939933870 ENV/NEWGENE also/RB was/VBD secreted/VBN from/IN P/NNP ./NNP pastoris/NN using/VBG the/DT S/NEWGENE ./NEWGENE cerevisiae/NEWGENE alpha-factor/NEWGENE prepro/NEWGENE secretion/NEWGENE leader/NEWGENE and/CC the/DT S/NEWGENE ./NEWGENE cerevisiae/NEWGENE invertase/NEWGENE signal/NEWGENE sequence/NEWGENE ./.
@@43058506629 Androgens/NN and/CC growth/NN ./.
@@114168791293 Arterial/JJ blood/NN gas/NN tensions/NNS were/VBD similar/JJ across/IN all/DT ventilation/NN modes/NNS ./.
@@108381393792 Accordingly/RB ,/, no/DT Ha-ras/NEWGENE codon/NEWGENE 12/NEWGENE mutations/NNS are/VBP found/VB in/IN the/DT EtNU-induced/JJ mammary/JJ tumors/NNS ./.
@@86346976794 The/DT sequence/NN and/CC isolated/VBN cDNAs/NNS will/MD provide/VB useful/JJ reagents/NNS for/IN studying/VBG the/DT expression/NN of/IN Brca1/NEWGENE in/IN the/DT mouse/NN ,/, and/CC for/IN testing/VBG the/DT importance/NN of/IN the/DT evolutionarily/RB conserved/VBN domains/NNS ./.
@@81603877121 Functional/JJ postnatal/JJ development/NN of/IN the/DT rat/NN primary/NN visual/NN cortex/NN and/CC the/DT role/NN of/IN visual/JJ experience/NN :/: dark/JJ rearing/JJ and/CC monocular/JJ deprivation/NN ./.
@@82161155405 The/DT patients/NNS in/IN one/PRP group/NN had/VBP intrauterine/JJ catheters/NNS inserted/VBN and/CC oxytocin/NN was/VBD titrated/VBN to/IN achieve/VB the/DT 75th/CD percentile/NN of/IN uterine/NN activity/NN observed/VBN in/IN spontaneous/JJ normal/JJ labour/NN according/VBG to/IN parity/NN ./.
@@17426064868 A/DT mouse/NEWGENE brain/NEWGENE beta-spectrin/NEWGENE of/IN cDNA/NN was/VBD identified/VBN within/IN a/DT lambda/NN Gt11/NN expression/NN library/NN using/VBG an/DT antibody/NN which/WDT specifically/RB binds/VBZ with/IN the/DT 235/NEWGENE kDa/NEWGENE spectrin/NEWGENE beta-subunit/NEWGENE ./.
@@69633376741 Renal/JJ and/CC extrarenal/JJ arterial/JJ fibromuscular/JJ hyperplasia/NN with/IN hypertension/NN ./.
@@17666663648 Antibodies/NNS specific/JJ to/IN rE12/NEWGENE and/CC rNFIL-6/NEWGENE disrupt/VB nucleoprotein/NN complexes/NNS with/IN these/DT DNA-binding/NN sites/NN ,/, confirming/VBG the/DT interaction/NN of/IN native/JJ in/IN vivo/NN factors/NN ./.
@@83811217308 The/DT other/DT transmembrane/JJ regions/NNS as/RB well/VBP as/IN the/DT nucleoplasmic/JJ domain/NN are/VBP not/RB required/VBN for/IN sorting/NN ./.
@@14732072090 The/DT major/JJ pathological/JJ findings/NNS of/IN the/DT placenta/NN were/VBD prematuration/NN and/CC hypoplasia/NN ./.
@@81162454438 Viral/JJ genomic/JJ RNA/NN for/IN these/DT reactions/NNS was/VBD obtained/VBN directly/RB from/IN fecal/JJ specimens/NNS of/IN infected/VBN infant/NN rats/NNS ./.
@@64838631777 In/NN two/JJ experiments/NNS ,/, neonatal/JJ female/JJ BALB/NN //NN cCrgl/NN or/CC BALB/NN //NN cfC3HCrgl/NN mice/NNS were/VBD given/VBP subcutaneous/JJ injections/NNS of/IN 5/CD micrograms/NNS 17/CD beta-estradiol/NN or/CC sesame/NN oil/NN for/IN the/DT first/JJ 3/CD days/NNS of/IN life/NN and/CC were/VBD ovariectomized/JJ at/IN 60/CD days/NNS of/IN age/NN ,/, at/IN which/WDT time/VBP vaginal/JJ concretions/NNS (/( Experiments/NNS I/PRP and/CC II/NNP )/SYM or/CC silica/NN (/( Experiment/NN II/NNP )/SYM were/VBD implanted/VBN intravaginally/RB ./.
@@31794968561 Evaluation/NN of/IN human/JJ and/CC bovine/NN modified-hemoglobin/NN solution/NN as/IN oxygen-carrying/JJ fluid/NN for/IN blood/NN volume/NN replacement/NN ./.
@@65489533517 Human/NEWGENE thyroid/NEWGENE stimulator/NEWGENE (/( HTS/NEWGENE )/SYM in/IN thyroid/JJ diseases/NNS ./.
@@17629174738 Substituting/VBG a/DT Ser/NN for/IN Gly69/CD or/CC a/DT Glu/NN for/IN Lys/NN 71/CD in/IN the/DT conserved/VBN TGEK/NEWGENE tetrapeptide/NEWGENE in/IN finger/NN II/NN of/IN TFIIIA/NEWGENE resulted/VBN in/IN the/DT loss/NN of/IN DNA/NN binding/JJ ./.
@@87953041121 Plasma/NN thrombomodulin/NEWGENE :/: a/DT marker/NN for/IN microvascular/JJ complications/NNS in/IN diabetes/NN mellitus/MD ./.
@@92338013090 Thus/RB ,/, the/DT L45/NEWGENE sequence/NEWGENE between/IN kinase/NEWGENE subdomains/NEWGENE IV/NEWGENE and/NEWGENE V/NEWGENE specifies/VBZ TGF-beta/NEWGENE responsiveness/NN of/IN the/DT type/NEWGENE I/NEWGENE receptor/NEWGENE ./.
@@93714558280 We/PRP have/VBP cloned/VBN and/CC sequenced/VBN a/DT region/NN encoding/VBG a/DT lipase/NEWGENE operon/NEWGENE and/CC a/DT putative/JJ ,/, previously/RB uncharacterized/JJ metalloprotease/NEWGENE of/NEWGENE Vibrio/NEWGENE cholerae/NEWGENE O1/NEWGENE ./.
@@93724519788 Epitopes/NNS of/IN adhesion-perturbing/JJ monoclonal/JJ antibodies/NNS map/NN within/IN a/DT predicted/VBN alpha-helical/JJ domain/NN of/IN the/DT integrin/NEWGENE beta/NEWGENE 1/NEWGENE subunit/NEWGENE ./.
@@107513984220 In/NN addition/NN ,/, the/DT transcription/NN of/IN c-IAP2/NEWGENE promoter/NEWGENE was/VBD strongly/RB up-regulated/IN when/CC CD40/NEWGENE or/CC Epstein-Barr/NEWGENE virus/NEWGENE latent/NEWGENE membrane/NEWGENE protein/NEWGENE 1/NEWGENE was/VBD overexpressed/VBN ./.
@@105115544270 A/DT local/NN ,/, high-density/JJ ,/, single-nucleotide/JJ polymorphism/NN map/NN used/VBN to/IN clone/NN Caenorhabditis/NEWGENE elegans/NEWGENE cdf-1/NEWGENE ./.
@@63338786124 Tiaprofenic/NNP acid/NN overdose/NN ./.
@@105505713186 PURPOSE/NNS :/: Previous/JJ WR-2721/NN human/JJ pharmacokinetic/JJ studies/NNS were/VBD limited/VBN to/IN plasma/NN levels/NNS in/IN patients/NNS receiving/JJ platinum-based/JJ compounds/NNS ,/, and/CC none/NN includes/VBZ the/DT effects/NNS of/IN WR-2721/NN on/IN endogenous/JJ thiols/NNS ./.
@@28691253551 Fentanyl/IN ,/, a/DT prototypic/JJ mu-opiate/NEWGENE receptor/NEWGENE agonist/NN ,/, has/VBZ been/VBN previously/RB shown/VBP to/IN produce/NN a/DT syndrome/NN characterized/VBN by/IN marked/JJ analgesia/NN and/CC locomotor/JJ stimulation/NN as/RB well/VB as/IN tachycardia/NN ,/, tachypnoea/NN and/CC behavioural/JJ arousal/NN ./.
@@82580258240 CONCLUSIONS/IN :/: In/NN our/PRP patients/NNS and/CC within/IN the/DT range/NN of/IN treatment/NN variables/NNS studied/VBN ,/, age/NN ,/, Karnofsky/NN index/NN ,/, and/CC graft-versus-host/JJ disease/NN are/VBP the/DT most/RB important/JJ factors/NNS related/VBN with/IN early/JJ mortality/NN ./.
@@24809591545 Once/RB P-450scc/NEWGENE mRNA/NEWGENE is/VBZ induced/VBN as/IN a/DT consequence/NN of/IN the/DT LH/NEWGENE //NEWGENE hCG/NEWGENE surge/NN it/PRP is/VBZ constitutively/RB maintained/VBN by/IN luteinized/JJ cells/NNS in/IN vivo/NN (/( 0-4/JJ days/NNS )/SYM and/CC in/IN vitro/FW (/( 0-9/CD days/NNS )/SYM in/IN the/DT absence/NN of/IN gonadotropins/NEWGENE ,/, is/VBZ susceptible/JJ to/IN modulation/NN by/IN prolactin/NEWGENE and/CC is/VBZ no/RB longer/RB regulated/VBN by/IN cAMP/NN ./.
@@113094006661 Effects/NNPS of/IN 3'/CD terminus/NN modifications/NNS on/IN mRNA/NN functional/JJ decay/NN during/IN in/IN vitro/NN protein/NN synthesis/NN ./.
@@93521276868 A/DT positive/JJ correlation/NN between/IN serum/NEWGENE myoglobin/NEWGENE and/CC CA/NEWGENE III/NEWGENE concentrations/NNS (/( rs/NNS =/SYM 0/CD ./CD 933/CD ,/, P/NN </SYM 0/CD ./CD 001/CD )/SYM was/VBD observed/VBN in/IN hemodialyzed/JJ patients/NNS with/IN chronic/JJ renal/JJ failure/NN ./.
@@3589454251 The/DT maximum/JJ period/NN of/IN treatment/NN was/VBD 73/CD (/( oral/JJ )/SYM ,/, 73/CD (/( intraperitoneal/JJ )/SYM or/CC 75/CD (/( dermal/JJ )/SYM weeks/NNS ./.
@@26424665636 Sequence/NN analysis/NN of/IN the/DT 47-kilodalton/NEWGENE major/NEWGENE integral/NEWGENE membrane/NEWGENE immunogen/NEWGENE of/NEWGENE Treponema/NEWGENE pallidum/NEWGENE ./.
@@82318168965 By/IN using/VBG total-protein/JJ extracts/NNS from/IN mycelia/NNS grown/VBP under/IN penicillin/NN producing/JJ conditions/NNS we/PRP have/VBP detected/VBN a/DT DNA-binding/NN activity/NN that/WDT specifically/RB shifts/VBZ a/DT promoter/NN fragment/NN located/VBN between/IN -654/JJ and/CC -455/CD (/( relative/JJ to/IN IPNS/NEWGENE tsp/NEWGENE )/SYM ./.
@@23938953056 The/DT RF/NN values/NNS correlated/VBN well/VB with/IN the/DT angiographic/JJ semiquantitative/JJ scale/NN of/IN severity/NN of/IN aortal/JJ insufficiency/NN (/( r/JJ =/SYM 0/CD ./CD 805/CD ;/: p/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ,/, although/IN they/PRP enabled/VBD the/DT authors/NNS only/RB to/IN make/NN a/DT partial/JJ differentiation/NN of/IN haemodynamically/RB severe/JJ regurgitations/NNS and/CC mild/JJ or/CC insignificant/JJ ones/NNS ./.
@@93406414616 Effect/NN of/IN alcohol/NN on/IN minimal/JJ effective/JJ nCPAP/NN pressure/NN ./.
@@85555972213 Hb/NEWGENE levels/NNS remained/VBD adequate/JJ (/( Hb/NEWGENE =/SYM 10/CD ./CD 68/CD +/NN //NN -/NN 0/CD ./CD 77/CD g/NN //NN dl/NN )/SYM after/IN 14/CD ./CD 6/CD +/NN //NN -/NN 7/CD ./CD 64/CD months/NNS ./.
@@112955231131 Their/PRP numbers/NNS have/VBP regularly/RB increased/VBN since/IN the/DT mid-1970s/NNS ./.
@@93624803785 An/DT unusual/JJ cysteine/NN triplet/NN conserved/VBN in/IN the/DT sequences/NNS of/IN TB/NEWGENE domains/NEWGENE is/VBZ localized/VBN to/IN the/DT hydrophobic/JJ core/NN ,/, at/IN the/DT C-terminus/NN of/IN an/DT alpha-helix/NN ./.
@@53082717142 BIM/NN 130/NN ./.
@@23920323048 The/DT results/NNS corroborate/VBP the/DT idea/NN that/IN the/DT structure/NN of/IN relaxation/NN curves/NNS contains/VBZ information/NN on/IN the/DT distance/NN scale/NN and/CC on/IN the/DT architecture/NN of/IN the/DT pore/NN space/NN ,/, even/VB if/IN it/PRP is/VBZ difficult/JJ to/IN extract/NN it/PRP without/IN ambiguities/NNS ./.
@@76881127623 Prostate/NEWGENE specific/NEWGENE antigen/NEWGENE shows/VBZ the/DT metastatic/JJ cases/NNS better/JJR [/NN correction/NN of/IN worse/NN ]/NN than/IN prostatic/NEWGENE acid/NEWGENE phosphatase/NEWGENE ./.
@@3473253588 An/DT industry-wide/JJ retrospective/JJ cohort/NN mortality/NN study/NN was/VBD conducted/VBN on/IN 6/NN ,/NN 152/NN chemical/JJ workers/NNS (/( 2/CD ,/CD 460/CD exposed/VBN and/CC 3/CD ,/CD 692/CD nonexposed/JJ )/SYM engaged/VBN in/IN chloromethyl/JJ ether/NN manufacture/NN at/IN 7/CD major/JJ U/NNP ./NNP S/NNP ./. companies/NNS between/IN 1948/CD and/CC 1980/CD ./.
@@97818749099 The/DT cwg2-1/NEWGENE mutation/NEWGENE was/VBD identified/VBN as/IN a/DT guanine/NN to/IN adenine/NN substitution/NN at/IN nucleotide/NN 604/CD of/IN the/DT coding/JJ region/NN ,/, originating/VBG the/DT change/NN A202T/NNP in/IN the/DT cwg2p/NEWGENE ./.
@@75582637447 Closure/NNS of/IN an/DT open/JJ high/JJ below-knee/JJ guillotine/NN amputation/NN wound/JJ using/VBG a/DT skin-stretching/JJ device/NN ./.
